PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Futai, E; Yagishita, S; Ishiura, S				Futai, Eugene; Yagishita, Sosuke; Ishiura, Shoichi			Nicastrin Is Dispensable for gamma-Secretase Protease Activity in the Presence of Specific Presenilin Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; AMYLOID PRECURSOR PROTEIN; TERMINAL PAL MOTIF; TRANSMEMBRANE DOMAIN-4; ALZHEIMERS-DISEASE; ASPARTIC PROTEASE; CATALYTIC PORE; C-TERMINUS; COMPLEX; BINDING	gamma-Secretase is a multisubunit membrane protein complex consisting of presenilin (PS1), nicastrin (NCT), anterior pharynx-1, and presenilin enhancer 2. To analyze the activity of familial Alzheimer disease mutants and to understand the roles of the subunits, we established a yeast transcriptional activator Gal4p system with artificial gamma-secretase substrates containing amyloid precursor protein or Notch fragments. The gamma-secretase activities were evaluated by transcriptional activation of reporter genes upon Gal4p release from the membrane-bound substrates, i.e. growth of yeast on histidine and adenine, or beta-galactosidase assay. We screened and evaluated gamma-secretase mutants using this reconstitution system in yeast, which does not possess endogenous gamma-secretase activity. When we introduced familial Alzheimer mutants of PS1 in this system, their activities were shown to be loss of function. Although the protease activity of wild type PS1 depends on the other three subunits introduced, we obtained 15 new PS1 mutants, which are active in the absence of NCT. They possessed a S438P mutation at the ninth transmembrane domain (TM9) together with one missense mutation distributed through transmembrane and loop regions. These mutations were not related to familial Alzheimer mutations of PS1 as identified so far. The S438P mutant was partially active but required other mutations for full activation. Results of the beta-galactosidase assay suggested that they have wild type protease activities, which were further confirmed by the endoproteolysis of PS1, amyloid beta peptides, and Notch intracellular domain production in mammalian cells. These results suggest that NCT is dispensable for the protease activity of gamma-secretase.	[Futai, Eugene; Yagishita, Sosuke; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Futai, E (corresponding author), 3-8-1 Komaba,Meguro Ku, Tokyo 1538902, Japan.	futai@bio.c.u-tokyo.ac.jp		Futai, Eugene/0000-0002-0879-6117	Human Frontier Science Program and the Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology; The Uehara Memorial Foundation; Takeda Chemical Science Foundation	Human Frontier Science Program and the Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Chemical Science Foundation	This work was supported by research grants from Human Frontier Science Program and the Ministry of Health, Labor, and Welfare, Japan (to S.I.), the Ministry of Education, Culture, Sports, Science, and Technology (to E. F. and S.Y.), The Uehara Memorial Foundation, and Takeda Chemical Science Foundation (to E. F.).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; *CLONT, 2001, YEAST PROT HDB; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; James P, 1996, GENETICS, V144, P1425; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Li T, 2003, J NEUROSCI, V23, P3272; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	45	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13013	13022		10.1074/jbc.M807653200	http://dx.doi.org/10.1074/jbc.M807653200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19254953	hybrid, Green Published			2022-12-25	WOS:000265688300049
J	Liu, Z; Wang, HR; Huang, CL				Liu, Zhen; Wang, Hao-Ran; Huang, Chou-Long			Regulation of ROMK Channel and K+ Homeostasis by Kidney-specific WNK1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; POTASSIUM CHANNEL; DEFECTIVE ISOFORM; MUTANT WNK4; ENDOCYTOSIS; GENE; HYPERKALEMIA; HYPERTENSION; EXPRESSION; PATHWAY	WNK kinases are serine-threonine kinases with an atypical placement of the catalytic lysine. WNK1, the first member discovered, has multiple alternatively spliced isoforms, including a ubiquitously expressed full-length long form (L-WNK1) and a kidney-specific form (KS-WNK1) predominantly expressed in the kidney. Intronic deletions of WNK1 that increase WNK1 transcript cause pseudohypoaldosteronism type 2, an autosomal-dominant disease characterized by hypertension and hyperkalemia. L-WNK1 inhibits renal K+ channel ROMK, likely contributing to hyperkalemia in PHAII. Previously, we reported that KS-WNK1 by itself has no effect on ROMK1 but antagonizes L-WNK1-mediated inhibition of ROMK1. Amino acids 1-253 of KS-WNK1 (KS-WNK1(1-253)) are sufficient for reversing the inhibition of ROMK1 caused by L-WNK1(1 491). Here, we further investigated the mechanisms by which KS-WNK1 counteracts L-WNK1 regulation of ROMK1. We reported that two regions of KS-WNK1(1-253) are involved in the antagonism of L-WNK1; one includes the first 30 amino acids unique for KS-WNK1 encoded by the alternatively spliced initiating exon 4A, and the other is equivalent to the autoinhibitory domain (AID) of L-WNK1. Mutations of two phenylalanine residues known to be critical for autoinhibitory function of AID abolish the ability of the AID region of KS-WNK1 to antagonize L-WNK1. To examine the physiological role of KS-WNK1 in the regulation of renal K+ secretion, we generated transgenic mice that overexpress amino acids 1-253 of KS-WNK1 under the control of a kidney-specific promoter. Transgenic mice have lower serum K+ levels and higher urinary fractional excretion of K+ compared with wild type littermates despite the same amount of daily urinary K+ excretion. Moreover, transgenic mice (compared with wild type littermates) displayed a higher abundance of ROMK on the apical membrane of distal nephron. Thus, KS-WNK1 is an important physiological regulator of renal K+ excretion, likely through its effects on the ROMK1 channel.	[Liu, Zhen; Wang, Hao-Ran; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chou-long.huang@utsouthwestern.edu	liu, zhen/B-3815-2011		National Institutes of Health [DK-59530, DK-079328]; American Heart Association Established Investigator award [0440019N]; National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059530, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator award(American Heart Association); National Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59530 and DK-079328. This work was also supported by American Heart Association Established Investigator award 0440019N and a research fellowship award from the National Kidney Foundation (to Z. L.).	Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kohda Y, 1998, KIDNEY INT, V54, P1214, DOI 10.1046/j.1523-1755.1998.00120.x; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Naray-Fejes-Toth A, 2004, P NATL ACAD SCI USA, V101, P17434, DOI 10.1073/pnas.0408146101; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Palmer LG, 1999, AM J PHYSIOL-RENAL, V277, pF805, DOI 10.1152/ajprenal.1999.277.5.F805; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang HR, 2008, AM J PHYSIOL-RENAL, V295, pF438, DOI 10.1152/ajprenal.90287.2008; Wang WH, 2000, AM J PHYSIOL-RENAL, V278, pF165, DOI 10.1152/ajprenal.2000.278.1.F165; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	28	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12198	12206		10.1074/jbc.M806551200	http://dx.doi.org/10.1074/jbc.M806551200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244242	hybrid, Green Published			2022-12-25	WOS:000265494600051
J	Tran, QK; Leonard, J; Black, DJ; Nadeau, OW; Boulatnikov, IG; Persechini, A				Tran, Quang-Kim; Leonard, Jared; Black, D. J.; Nadeau, Owen W.; Boulatnikov, Igor G.; Persechini, Anthony			Effects of Combined Phosphorylation at Ser-617 and Ser-1179 in Endothelial Nitric-oxide Synthase on EC50(Ca2+) Values for Calmodulin Binding and Enzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; ELECTRON-TRANSFER; DEPENDENT REGULATION; CONTROL ELEMENT; NO SYNTHESIS; IDENTIFICATION; PROTEIN; CA2+; ENOS; AKT	We have investigated the possible biochemical basis for enhancements in NO production in endothelial cells that have been correlated with agonist- or shear stress-evoked phosphorylation at Ser-1179. We have found that a phosphomimetic substitution at Ser-1179 doubles maximal synthase activity, partially disinhibits cytochrome c reductase activity, and lowers the EC50(Ca2+) values for calmodulin binding and enzyme activation from the control values of 182 +/- 2 and 422 +/- 22 nMto 116 +/- 2 and 300 +/- 10 nM. These are similar to the effects of a phosphomimetic substitution at Ser-617 (Tran, Q. K., Leonard, J., Black, D. J., and Persechini, A. (2008) Biochemistry 47, 7557-7566). Although combining substitutions at Ser-617 and Ser-1179 has no additional effect on maximal synthase activity, cooperativity between the two substitutions completely disinhibits reductase activity and further reduces the EC50(Ca2+) values for calmodulin binding and enzyme activation to 77 +/- 2 and 130 +/- 5 nM. We have confirmed that specific Akt-catalyzed phosphorylation of Ser-617 and Ser- 1179 and phosphomimetic substitutions at these positions have similar functional effects. Changes in the biochemical properties of eNOS produced by combined phosphorylation at Ser- 617 and Ser- 1179 are predicted to substantially increase synthase activity in cells at a typical basal free Ca2+ concentration of 50-100 nM.	[Tran, Quang-Kim; Leonard, Jared; Black, D. J.; Persechini, Anthony] Univ Missouri Kansas City, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; [Nadeau, Owen W.; Boulatnikov, Igor G.] Univ Kansas, Med Ctr, Dept Mol Biol & Biochem, Kansas City, KS 66160 USA	University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center	Persechini, A (corresponding author), Univ Missouri Kansas City, Div Mol Biol & Biochem, 5007 Rockhill Rd, Kansas City, MO 64110 USA.	Persechinia@umkc.edu		Tran, Kim/0000-0003-1881-1357	National Institutes of Health [GM074887]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074887 (to A.P.).	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gao YT, 2007, J BIOL CHEM, V282, P7921, DOI 10.1074/jbc.M609814200; GEIGER RV, 1992, AM J PHYSIOL, V262, pC1411, DOI 10.1152/ajpcell.1992.262.6.C1411; KING MM, 1983, J BIOL CHEM, V258, P9925; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Matsubara M, 2003, J BIOCHEM, V133, P773, DOI 10.1093/jb/mvg099; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Nadeau OW, 2007, J MOL BIOL, V365, P1429, DOI 10.1016/j.jmb.2006.10.061; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Persechini A, 1997, CELL CALCIUM, V22, P209, DOI 10.1016/S0143-4160(97)90014-2; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; Persechini A, 1996, BIOCHEMISTRY-US, V35, P224, DOI 10.1021/bi952383x; Persechini A, 1996, J BIOL CHEM, V271, P32217, DOI 10.1074/jbc.271.50.32217; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2008, BIOCHEMISTRY-US, V47, P7557, DOI 10.1021/bi8003186; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; ZHANG MJ, 1994, J BIOL CHEM, V269, P981	35	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11892	11899		10.1074/jbc.M806205200	http://dx.doi.org/10.1074/jbc.M806205200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251696	hybrid, Green Published			2022-12-25	WOS:000265494600021
J	Newell, JL; Fay, PJ				Newell, Jennifer L.; Fay, Philip J.			Cleavage at Arg-1689 Influences Heavy Chain Cleavages during Thrombin-catalyzed Activation of Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN; FACTOR XA; A2 SUBUNIT; FACTOR-IXA; FACTOR-V; SITE; COFACTOR; A1; INACTIVATION; COAGULATION	The procofactor, factor VIII, is activated by thrombin or factor Xa-catalyzed cleavage at three P1 residues: Arg-372, Arg-740, and Arg-1689. The catalytic efficiency for thrombin cleavage at Arg-740 is greater than at either Arg-1689 or Arg-372 and influences reaction rates at these sites. Because cleavage at Arg-372 appears rate-limiting and dependent upon initial cleavage at Arg-740, we investigated whether cleavage at Arg-1689 influences catalysis at this step. Recombinant B-domainless factor VIII mutants, R1689H and R1689Q were prepared and stably expressed to slow and eliminate cleavage, respectively. Specific activity values for the His and Gln mutations were similar to 50 and similar to 10%, respectively, that of wild type. Thrombin activation of the R1689H variant showed an similar to 340-fold reduction in the rate of Arg-1689 cleavage, whereas the R1689Q variant was resistant to thrombin cleavage at this site. Examination of heavy chain cleavages showed similar to 4- and 11-fold reductions in A2 subunit generation and similar to 3- and 7-fold reductions in A1 subunit generation for the R1689H and R1689Q mutants, respectively. These results suggest a linkage between light chain cleavage and cleavages in heavy chain. Results obtained evaluating proteolysis of the factor VIII mutants by factor Xa revealed modest rate reductions (<5-fold) in generating A2 and A1 subunits and in cleaving light chain at Arg-1721 from either variant, suggesting little dependence upon prior cleavage at residue 1689 as compared with thrombin. Overall, these results are consistent with a competition between heavy and light chains for thrombin exosite binding and subsequent proteolysis with binding of the former chain preferred.	[Fay, Philip J.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Sch Med, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199, HL76213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38199 and HL76213. An account of this work was presented at the 50th Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6, 2008.	Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; CASILLAS G, 1971, COAGULATION, V4, P107; Donath MJSH, 1996, EUR J BIOCHEM, V240, P365, DOI 10.1111/j.1432-1033.1996.0365h.x; DONATH MJSH, 1995, J BIOL CHEM, V270, P3648, DOI 10.1074/jbc.270.8.3648; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; HILLEUBANKS DC, 1990, J BIOL CHEM, V265, P17854; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MANN KG, 1990, BLOOD, V76, P1; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Newell JL, 2007, J BIOL CHEM, V282, P25367, DOI 10.1074/jbc.M703433200; Nogami K, 2005, BLOOD, V105, P4362, DOI 10.1182/blood-2004-10-3939; Nogami K, 2005, J BIOL CHEM, V280, P18476, DOI 10.1074/jbc.M412778200; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Parker ET, 1997, BIOCHEMISTRY-US, V36, P9365, DOI 10.1021/bi970599o; PIETERS J, 1989, BLOOD, V74, P1021; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	29	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11080	11089		10.1074/jbc.M900234200	http://dx.doi.org/10.1074/jbc.M900234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240027	hybrid, Green Published			2022-12-25	WOS:000265494500012
J	Li, WZ; Brudecki, LE; Senior, AE; Ahmad, Z				Li, Wenzong; Brudecki, Laura E.; Senior, Alan E.; Ahmad, Zulfiqar			Role of alpha-Subunit VISIT-DG Sequence Residues Ser-347 and Gly-351 in the Catalytic Sites of Escherichia coli ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-BINDING SUBDOMAIN; F1F0-ATP SYNTHASE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL ATPASE; HEART-MITOCHONDRIA; NUCLEOTIDE-BINDING; MUTANT STRAINS; PI BINDING; F-1-ATPASE; MECHANISM	This paper describes the role of alpha-subunit VISIT-DG sequence residues alpha Ser-347 and alpha Gly-351 in catalytic sites of Escherichia coli F1F0 ATP synthase. X-ray structures show the very highly conserved alpha-subunit VISIT-DG sequence in close proximity to the conserved phosphate-binding residues alpha Arg-376, beta Arg-182, beta Lys-155, and beta Arg-246 in the phosphate-binding subdomain. Mutations alpha S347Q and alpha G351Q caused loss of oxidative phosphorylation and reduced ATPase activity of F1F0 in membranes by 100- and 150-fold, respectively, whereas alpha S347A mutation showed only a 13-fold loss of activity and also retained some oxidative phosphorylation activity. The ATPase of alpha S347Q mutant was not inhibited, and the alpha S347A mutant was slightly inhibited by MgADP-azide, MgADP-fluoroaluminate, or MgADP-fluoroscandium, in contrast to wild type and alpha G351Q mutant. Whereas 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) inhibited wild type and alpha G351Q mutant ATPase essentially completely, ATPase in alpha S347A or alpha S347Q mutant was inhibited maximally by similar to 80-90%, although reaction still occurred at residue beta Tyr-297, proximal to the alpha-subunit VISIT-DG sequence, near the phosphate-binding pocket. Inhibition characteristics supported the conclusion that NBD-Cl reacts in beta E(empty) catalytic sites, as shown previously by x-ray structure analysis. Phosphate protected against NBD-Cl inhibition in wild type and alpha G351Q mutant but not in alpha S347Q or alpha S347A mutant. The results demonstrate that alpha Ser-347 is an additional residue involved in phosphate-binding and transition state stabilization in ATP synthase catalytic sites. In contrast, alpha Gly-351, although strongly conserved and clearly important for function, appears not to play a direct role.	[Li, Wenzong; Brudecki, Laura E.; Ahmad, Zulfiqar] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA; [Senior, Alan E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	East Tennessee State University; University of Rochester	Ahmad, Z (corresponding author), E Tennessee State Univ, Dept Biol Sci, Box 70703, Johnson City, TN 37614 USA.	ahmadz@etsu.edu		Ahmad, Zulfiqar/0000-0001-7306-8151	East Tennessee State University Major Research Development Committee [0061]; Honors College, East Tennessee State University	East Tennessee State University Major Research Development Committee; Honors College, East Tennessee State University	This work was partly supported by East Tennessee State University Major Research Development Committee Grant 0061 (to Z.A.) and Student-Faculty Collaborative Research Grants through Honors College, East Tennessee State University.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ahmad Z, 2005, J BIOENERG BIOMEMBR, V37, P437, DOI 10.1007/s10863-005-9486-8; Ahmad Z, 2006, FEBS LETT, V580, P517, DOI 10.1016/j.febslet.2005.12.057; Ahmad Z, 2005, J BIOL CHEM, V280, P27981, DOI 10.1074/jbc.M503955200; Ahmad Z, 2005, FEBS LETT, V579, P523, DOI 10.1016/j.febslet.2004.12.022; Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P886, DOI 10.1021/bi00118a034; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Brudecki LE, 2008, ARCH BIOCHEM BIOPHYS, V471, P168, DOI 10.1016/j.abb.2008.01.013; Chen C, 2006, J BIOL CHEM, V281, P13777, DOI 10.1074/jbc.M513369200; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; FERGUSON SJ, 1975, EUR J BIOCHEM, V54, P127, DOI 10.1111/j.1432-1033.1975.tb04121.x; FERGUSON SJ, 1975, EUR J BIOCHEM, V54, P117, DOI 10.1111/j.1432-1033.1975.tb04120.x; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; Frasch WD, 2000, BBA-BIOENERGETICS, V1458, P310, DOI 10.1016/S0005-2728(00)00083-9; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Karrasch S, 1999, J MOL BIOL, V290, P379, DOI 10.1006/jmbi.1999.2897; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, J BIOL CHEM, V274, P7052, DOI 10.1074/jbc.274.11.7052; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9; Pedersen PL, 2005, J BIOENERG BIOMEMBR, V37, P349, DOI 10.1007/s10863-005-9470-3; Penefsky HS, 2005, FEBS LETT, V579, P2250, DOI 10.1016/j.febslet.2005.02.072; PEREZ JA, 1986, FEBS LETT, V198, P113, DOI 10.1016/0014-5793(86)81195-4; RAO R, 1987, ARCH BIOCHEM BIOPHYS, V255, P309, DOI 10.1016/0003-9861(87)90398-5; Ren HM, 2000, BBA-BIOENERGETICS, V1458, P221, DOI 10.1016/S0005-2728(00)00075-X; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tombline G, 2004, J BIOL CHEM, V279, P5363, DOI 10.1074/jbc.M311964200; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; WEBER J, 1994, J BIOL CHEM, V269, P20462; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1995, J BIOL CHEM, V270, P12653, DOI 10.1074/jbc.270.21.12653; Weber J, 1998, BIOCHEMISTRY-US, V37, P608, DOI 10.1021/bi972370e; Weber J, 2007, TRENDS BIOCHEM SCI, V32, P53, DOI 10.1016/j.tibs.2006.12.006; YOSHIDA M, 1982, J BIOL CHEM, V257, P33	52	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10747	10754		10.1074/jbc.M809209200	http://dx.doi.org/10.1074/jbc.M809209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240022	Green Published, hybrid			2022-12-25	WOS:000265104600049
J	Yamazaki, D; Kurisu, S; Takenawa, T				Yamazaki, D.; Kurisu, S.; Takenawa, T.			Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates	ONCOGENE			English	Article						cancer; invasion; migration; mesenchymal; amoeboid; Rac	ACTIN-RELATED PROTEIN-2; PERICELLULAR PROTEOLYSIS; INVASION; MIGRATION; GTPASES; WAVE2; MODES; MECHANISMS; PLASTICITY; MEMBRANE	The motility of cancer cells in 3D matrices is of two types: mesenchymal motility, in which the cells are elongated and amoeboid motility, in which the cells are round. Amoeboid motility is driven by an actomyosin-based contractile force, which is regulated by the Rho/ROCK pathway. However, the molecular mechanisms underlying the motility of elongated cells remain unknown. Here, we show that the motility of elongated cells is regulated by Rac signaling through the WAVE2/Arp2/3-dependent formation of elongated pseudopodia and cell-substrate adhesion in 3D substrates. The involvement of Rac signaling in cell motility was different in cell lines that displayed an elongated morphology in 3D substrates. In U87MG glioblastoma cells, most of which exhibit mesenchymal motility, inhibition of Rac signaling blocked the invasion of these cells in 3D substrates. In HT1080 fibrosarcoma cells, which display mixed cell motility involving both elongated and rounded cells, inhibition of Rac1 signaling not only blocked mesenchymal motility but also caused a mesenchymal-amoeboid transition. Additionally, Rac1 and RhoA signaling regulated the mesenchymal and amoeboid motility in these cells, respectively, and the inhibition of both pathways dramatically decreased cell invasion. Hence, we could conclude that Rac1 and RhoA signaling simultaneously regulate cell invasion in 3D matrices.	[Takenawa, T.] Kobe Univ, Grad Sch Med, Lab Lipid Biochem, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Yamazaki, D.] Kobe Univ, Grad Sch Med, Div Membrane Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kurisu, S.] RIKEN, Brain Sci Inst, Lab Dev Gene Regulat, Brain Sci Inst,Inst Phys Chem Res, Saitama, Japan	Kobe University; Kobe University; RIKEN	Takenawa, T (corresponding author), Kobe Univ, Grad Sch Med, Lab Lipid Biochem, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Kurisu, Shusaku/AAB-1799-2022	Kurisu, Shusaku/0000-0002-4876-4419				Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Furutani M, 2006, J BIOCHEM, V139, P663, DOI 10.1093/jb/mvj076; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Iwaya K, 2007, CANCER SCI, V98, P992, DOI 10.1111/j.1349-7006.2007.00488.x; Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Semba S, 2006, CLIN CANCER RES, V12, P2449, DOI 10.1158/1078-0432.CCR-05-2566; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Torka R, 2006, EXP CELL RES, V312, P3857, DOI 10.1016/j.yexcr.2006.08.025; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298	41	146	151	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1570	1583		10.1038/onc.2009.2	http://dx.doi.org/10.1038/onc.2009.2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19234490				2022-12-25	WOS:000264780500002
J	Carpentier, B; Pierobon, P; Hivroz, C; Henry, N				Carpentier, Benoit; Pierobon, Paolo; Hivroz, Claire; Henry, Nelly			T-Cell Artificial Focal Triggering Tools: Linking Surface Interactions with Cell Response	PLOS ONE			English	Article								T-cell activation is a key event in the immune system, involving the interaction of several receptor ligand pairs in a complex intercellular contact that forms between T-cell and antigen-presenting cells. Molecular components implicated in contact formation have been identified, but the mechanism of activation and the link between molecular interactions and cell response remain poorly understood due to the complexity and dynamics exhibited by whole cell-cell conjugates. Here we demonstrate that simplified model colloids grafted so as to target appropriate cell receptors can be efficiently used to explore the relationship of receptor engagement to the T-cell response. Using immortalized Jurkat T cells, we monitored both binding and activation events, as seen by changes in the intracellular calcium concentration. Our experimental strategy used flow cytometry analysis to follow the short time scale cell response in populations of thousands of cells. We targeted both T-cell receptor CD3 (TCR/CD3) and leukocyte-function-associated antigen (LFA-1) alone or in combination. We showed that specific engagement of TCR/CD3 with a single particle induced a transient calcium signal, confirming previous results and validating our approach. By decreasing anti-CD3 particle density, we showed that contact nucleation was the most crucial and determining step in the cell-particle interaction under dynamic conditions, due to shear stress produced by hydrodynamic flow. Introduction of LFA-1 adhesion molecule ligands at the surface of the particle overcame this limitation and elucidated the low TCR/CD3 ligand density regime. Despite their simplicity, model colloids induced relevant biological responses which consistently echoed whole cell behavior. We thus concluded that this biophysical approach provides useful tools for investigating initial events in T-cell activation, and should enable the design of intelligent artificial systems for adoptive immunotherapy.	[Carpentier, Benoit; Pierobon, Paolo; Henry, Nelly] Univ Paris 06, CNRS, UMR 168, Inst Curie,Lab Phys Chim Curie, Paris, France; [Hivroz, Claire] INSERM, Inst Curie, Lab Immun Canc, U 653, Pavillon Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Carpentier, B (corresponding author), Univ Paris 06, CNRS, UMR 168, Inst Curie,Lab Phys Chim Curie, Paris, France.	nelly.henry@curie.fr	Pierobon, Paolo/G-7395-2014; Hivroz, Claire/H-2711-2014	Hivroz, Claire/0000-0002-6794-2890	Agence Nationale de la Recherche (ANR); 'Association de Recherche contre le Cancer (ARC)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); 'Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work has been supported by the 'Agence Nationale de la Recherche (ANR)' and by the 'Association de Recherche contre le Cancer (ARC)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Blanchard N, 2002, BIOL CELL, V94, P345, DOI 10.1016/S0248-4900(02)00007-2; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; GOLDSMITH HL, 1967, RHEOLOGY THEORY APPL, V4, P87; Groves JT, 2003, J IMMUNOL METHODS, V278, P19, DOI 10.1016/S0022-1759(03)00193-5; Guelly C, 2002, EUR J IMMUNOL, V32, P182, DOI 10.1002/1521-4141(200201)32:1<182::AID-IMMU182>3.0.CO;2-P; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hashemi BB, 1996, J IMMUNOL, V156, P3660; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.smim.2007.02.011; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JEDDITEHRANI M, 1992, CELL IMMUNOL, V141, P1, DOI 10.1016/0008-8749(92)90122-6; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kim JV, 2004, NAT BIOTECHNOL, V22, P403, DOI 10.1038/nbt955; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Leboeuf D, 2006, LANGMUIR, V22, P127, DOI 10.1021/la0518501; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lu XL, 2008, CANCER LETT, V271, P129, DOI 10.1016/j.canlet.2008.05.049; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Randriamampita C, 2004, BIOL CELL, V96, P69, DOI 10.1016/j.biolcel.2003.10.008; RICH RR, 1973, J EXP MED, V137, P649, DOI 10.1084/jem.137.3.649; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sarda S, 2004, BIOPHYS J, V86, P3291, DOI 10.1016/S0006-3495(04)74377-5; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; [No title captured]	48	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4784	10.1371/journal.pone.0004784	http://dx.doi.org/10.1371/journal.pone.0004784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274104	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496000021
J	Ingold, B; Schraml, P; Heppner, FL; Moch, H				Ingold, Barbara; Schraml, Peter; Heppner, Frank L.; Moch, Holger			Homogeneous MGMT Immunoreactivity Correlates with an Unmethylated MGMT Promoter Status in Brain Metastases of Various Solid Tumors	PLOS ONE			English	Article								The O-6-methylguanine-methyltransferase (MGMT) promoter methylation status is a predictive parameter for the response of malignant gliomas to alkylating agents such as temozolomide. First clinical reports on treating brain metastases with temozolomide describe varying effects. This may be due to the fact that MGMT promoter methylation of brain metastases has not yet been explored in depth. Therefore, we assessed MGMT promoter methylation of various brain metastases including those derived from lung (n = 91), breast (n = 72) kidney (n = 49) and from malignant melanomas (n = 113) by methylation-specific polymerase chain reaction (MS-PCR) and MGMT immunoreactivity. Fifty-nine of 199 brain metastases (29.6%) revealed a methylated MGMT promoter. The methylation rate was the highest in brain metastases derived from lung carcinomas (46.5%) followed by those from breast carcinoma (28.8%), malignant melanoma (24.7%) and from renal carcinoma (20%). A significant correlation of homogeneous MGMT-immunoreactivity (>95% MGMT positive tumor cells) and an unmethylated MGMT promoter was found. Promoter methylation was detected in 26 of 61 (43%) tumors lacking MGMT immunoreactivity, in 17 of 63 (27%) metastases with heterogeneous MGMT expression, but only in 5 of 54 brain metastases (9%) showing a homogeneous MGMT immunoreactivity. Our results demonstrate that a significant number of brain metastases reveal a methylated MGMT-promoter. Based on an obvious correlation between homogeneous MGMT immunoreactivity and unmethylated MGMT promoter, we hypothesize that immunohistochemistry for MGMT may be a helpful diagnostic tool to identify those tumors that probably will not benefit from the use of alkylating agents. The discrepancy between promoter methylation and a lack of MGMT immunoreactivity argues for assessing MGMT promoter methylation both by immunohistochemical as well as by molecular approaches for diagnostic purposes.	[Ingold, Barbara; Schraml, Peter; Moch, Holger] Univ Hosp Zurich, Inst Surg Pathol, Dept Pathol, Zurich, Switzerland; [Heppner, Frank L.] Unive Hosp Zurich, Inst Neuropathol, Dept Pathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Ingold, B (corresponding author), Charite, Inst Pathol, Campus Mitte, D-13353 Berlin, Germany.	barbara.ingold-heppner@charite.de	Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917	Essex Oncology, Lucerne, Switzerland	Essex Oncology, Lucerne, Switzerland	The study was funded by Essex Oncology, Lucerne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda T, 2003, NEUROL RES, V25, P241, DOI 10.1179/016164103101201445; Antonadou D, 2002, J CLIN ONCOL, V20, P3644, DOI 10.1200/JCO.2002.04.140; Bearzatto A, 2000, CANCER RES, V60, P3262; Bello MJ, 2004, MUTAT RES-FUND MOL M, V554, P23, DOI 10.1016/j.mrfmmm.2004.02.011; Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; CAPPER D, 2007, ACTA NEUROPATHOL BER; Chinot OL, 2007, J CLIN ONCOL, V25, P1470, DOI 10.1200/JCO.2006.07.4807; Crone TM, 1996, MUTAT RES-DNA REPAIR, V363, P15, DOI 10.1016/0921-8777(95)00058-5; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; *G S, 2006, LEITLINIENPAPIER DIA; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gonzalez-Gomez P, 2004, INT J MOL MED, V13, P93; Grasbon-Frodl EM, 2007, INT J CANCER, V121, P2458, DOI 10.1002/ijc.23020; Grombacher T, 1996, CARCINOGENESIS, V17, P2329, DOI 10.1093/carcin/17.11.2329; Harbeck N, 2008, J CLIN ONCOL, V26, P5036, DOI 10.1200/JCO.2007.14.1697; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LIU LL, 1994, CANCER RES, V54, P4648; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Nakasu S, 2004, J NEURO-ONCOL, V70, P333, DOI 10.1007/s11060-004-9170-6; NELSON JS, 1997, PATHOLOGY GENETICS T, P200; OLSSON M, 1980, J BIOL CHEM, V255, P569; Palmisano WA, 2000, CANCER RES, V60, P5954; Park DK, 2002, CANCER CHEMOTH PHARM, V50, P160, DOI 10.1002/s00280-002-0473-z; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Peereboom DM, 2005, NEUROSURGERY, V57, P54, DOI 10.1227/01.NEU.0000182740.39014.9A; Pollack IF, 2006, J CLIN ONCOL, V24, P3431, DOI 10.1200/JCO.2006.05.7265; PREUSSER M, 2008, BRAIN PATHOL; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Rastetter M, 2007, HISTOL HISTOPATHOL, V22, P1005, DOI 10.14670/HH-22.1005; Richards GM, 2007, CRIT REV ONCOL HEMAT, V61, P70, DOI 10.1016/j.critrevonc.2006.06.012; Rolhion C, 1999, INT J CANCER, V84, P416, DOI 10.1002/(SICI)1097-0215(19990820)84:4<416::AID-IJC15>3.0.CO;2-A; Srivenugopal KS, 2001, CLIN CANCER RES, V7, P1398; Srivenugopal KS, 1996, BIOCHEMISTRY-US, V35, P1328, DOI 10.1021/bi9518205; Stupp R, 2007, J CLIN ONCOL, V25, P1459, DOI 10.1200/JCO.2006.09.7139; Theurillat JP, 2007, CANCER IMMUNOL IMMUN, V56, P1723, DOI 10.1007/s00262-007-0316-1; Verger E, 2005, INT J RADIAT ONCOL, V61, P185, DOI 10.1016/j.ijrobp.2004.04.061; Weller Michael, 2005, Future Oncol, V1, P747, DOI 10.2217/14796694.1.6.747	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4775	10.1371/journal.pone.0004775	http://dx.doi.org/10.1371/journal.pone.0004775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274096	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496000014
J	Michelsen, KS; Thomas, LS; Taylor, KD; Yu, QT; Mei, L; Landers, CJ; Derkowski, C; McGovern, DPB; Rotter, JI; Targan, SR				Michelsen, Kathrin S.; Thomas, Lisa S.; Taylor, Kent D.; Yu, Qi T.; Mei, Ling; Landers, Carol J.; Derkowski, Carrie; McGovern, Dermot P. B.; Rotter, Jerome I.; Targan, Stephan R.			IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein	PLOS ONE			English	Article								Background: The recently identified member of the TNF superfamily TL1A (TNFSF15) increases IFN-gamma production by T cells in peripheral and mucosal CCR9+ T cells. TL1A and its receptor DR3 are up-regulated during chronic intestinal inflammation in ulcerative colitis and Crohn's disease (CD). TL1A gene haplotypes increase CD susceptibility in Japanese, European, and US cohorts. Methodology and Principal Findings: Here we report that the presence of TL1A gene haplotype B increases risk in Jewish CD patients with antibody titers for the E. coli outer membrane porin C (OmpC+) (Haplotype B frequency in Jewish CD patients: 24.9% for OmpC negative and 41.9% for OmpC positive patients, respectively, P <= 0.001). CD14+ monocytes isolated from Jewish OmpC+ patients homozygous for TL1A gene haplotype B express higher levels of TL1A in response to Fc gamma R stimulation, a known inducing pathway of TL1A, as measured by ELISA. Furthermore, the membrane expression of TL1A is increased on peripheral monocytes from Jewish but not non-Jewish CD patients with the risk haplotype. Conclusions and Significance: These findings suggest that TL1A gene variation exacerbates induction of TL1A in response to Fc gamma R stimulation in Jewish CD patients and this may lead to chronic intestinal inflammation via overwhelming T cell responses. Thus, TL1A may provide an important target for therapeutic intervention in this subgroup of IBD patients.	[Michelsen, Kathrin S.; Thomas, Lisa S.; Yu, Qi T.; Landers, Carol J.; Derkowski, Carrie; McGovern, Dermot P. B.; Targan, Stephan R.] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Michelsen, Kathrin S.; Thomas, Lisa S.; Yu, Qi T.; Landers, Carol J.; Derkowski, Carrie; McGovern, Dermot P. B.; Targan, Stephan R.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Taylor, Kent D.; Mei, Ling; Rotter, Jerome I.] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Michelsen, KS (corresponding author), Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA.	targans@cshs.org	Rotter, Jerome/AAY-6598-2021		NIH [DK056328, DK046763]; Cedars-Sinai Board of Governor's Chair in Medical Genetics; General Clinical Research Center [RR000425]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK056328, P01DK046763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Board of Governor's Chair in Medical Genetics; General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK056328 (S.R.T.) and DK046763 (S.R.T., J.I.R.) and in part by the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). Genotyping was supported in part by the General Clinical Research Center Genotyping Core (RR000425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; BARRETT JC, 2008, NAT GENET; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Dubinsky MC, 2007, INFLAMM BOWEL DIS, V13, P511, DOI 10.1002/ibd.20126; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; MEYLAN F, 2008, IMMUNITY; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Shih DQ, 2008, GASTROENTEROLOGY, V134, pA23; Silverberg MS, 2007, EUR J HUM GENET, V15, P328, DOI 10.1038/sj.ejhg.5201756; Sugimura K, 2003, AM J HUM GENET, V72, P509, DOI 10.1086/367848; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; TAYLOR KD, 2008, INFLAMM BOWEL DIS; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517	41	69	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4719	10.1371/journal.pone.0004719	http://dx.doi.org/10.1371/journal.pone.0004719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262684	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600029
J	Chaurasia, P; Mezei, M; Zhou, MM; Ossowski, L				Chaurasia, Pratima; Mezei, Mihaly; Zhou, Ming-Ming; Ossowski, Liliana			Computer Aided Identification of Small Molecules Disrupting uPAR/alpha 5 beta 1-Integrin Interaction: A New Paradigm for Metastasis Prevention	PLOS ONE			English	Article								Background: Disseminated dormant cancer cells can resume growth and eventually form overt metastases, but the underlying molecular mechanism responsible for this change remains obscure. We previously established that cell surface interaction between urokinase receptor (uPAR) and alpha 5 beta 1-integrin initiates a sequel of events, involving MAPK-ERK activation that culminates in progressive cancer growth. We also identified the site on uPAR that binds alpha 5 beta 1-integrin. Disruption of uPAR/integrin interaction blocks ERK activation and forces cancer cells into dormancy. Methods and Principle Findings: Using a target structure guided computation docking we identified 68 compounds from a diversity library of 13,000 small molecules that were predicted to interact with a previously identified integrin-binding site on uPAR. Of these 68 chemical hits, ten inhibited ERK activation in a cellular assay and of those, 2 compounds, 2-(Pyridin-2-ylamino)-quinolin-8-ol and, 2,2'-(methylimino)di (8-quinolinol) inhibited ERK activation by disrupting the uPAR/integrins interaction. These two compounds, when applied in vivo, inhibited ERK activity and tumor growth and blocked metastases of a model head and neck carcinoma. Conclusions/Significance: We showed that interaction between two large proteins (uPAR and alpha 5 beta 1-integrin) can be disrupted by a small molecule leading to profound downstream effects. Because this interaction occurs in cells with high uPAR expression, a property almost exclusive to cancer cells, we expect a new therapy based on these lead compounds to be cancer cell specific and minimally toxic. This treatment, rather than killing disseminated metastatic cells, should induce a protracted state of dormancy and prevent overt metastases.	[Chaurasia, Pratima; Ossowski, Liliana] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA; [Mezei, Mihaly; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chaurasia, P (corresponding author), Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA.	Liliana.Ossowski@mssm.edu			USPHS [CA87658, CA80058, CA-40578]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work was supported by funds from the Dr. Golden and Harold Lamport Chair and USPHS Research Grants CA87658 and CA80058 (to M-M.Z), and USPHS Research Grant CA-40578 and the Samuel Waxman Cancer Research Foundation (to LO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Allgayer H, 2008, APMIS, V116, P602, DOI 10.1111/j.1600-0463.2008.00997.x; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; de Bock CE, 2004, MED RES REV, V24, P13, DOI 10.1002/med.10054; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Heiss MM, 2002, J CLIN ONCOL, V20, P2005, DOI 10.1200/jco.2002.08.003; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Laufs S, 2006, CELL CYCLE, V5, P1760; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; OSSOWSKI L, 1980, CANCER RES, V40, P2300; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; Petty HR, 2002, IMMUNOL RES, V25, P75, DOI 10.1385/IR:25:1:75; Pierga JY, 2005, INT J CANCER, V114, P291, DOI 10.1002/ijc.20698; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Romer J, 2004, CURR PHARM DESIGN, V10, P2359, DOI 10.2174/1381612043383962; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x	33	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4617	10.1371/journal.pone.0004617	http://dx.doi.org/10.1371/journal.pone.0004617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242538	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487500018
J	Guedj, F; Sebrie, C; Rivals, I; Ledru, A; Paly, E; Bizot, JC; Smith, D; Rubin, E; Gillet, B; Arbones, M; Delabar, JM				Guedj, Faycal; Sebrie, Catherine; Rivals, Isabelle; Ledru, Aurelie; Paly, Evelyne; Bizot, Jean C.; Smith, Desmond; Rubin, Edward; Gillet, Brigitte; Arbones, Mariona; Delabar, Jean M.			Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A	PLOS ONE			English	Article								Individuals with partial HSA21 trisomies and mice with partial MMU16 trisomies containing an extra copy of the DYRK1A gene present various alterations in brain morphogenesis. They present also learning impairments modeling those encountered in Down syndrome. Previous MRI and histological analyses of a transgenic mice generated using a human YAC construct that contains five genes including DYRK1A reveal that DYRK1A is involved, during development, in the control of brain volume and cell density of specific brain regions. Gene dosage correction induces a rescue of the brain volume alterations. DYRK1A is also involved in the control of synaptic plasticity and memory consolidation. Increased gene dosage results in brain morphogenesis defects, low BDNF levels and mnemonic deficits in these mice. Epigallocatechin gallate ( EGCG) - a member of a natural polyphenols family, found in great amount in green tea leaves - is a specific and safe DYRK1A inhibitor. We maintained control and transgenic mice overexpressing DYRK1A on two different polyphenol-based diets, from gestation to adulthood. The major features of the transgenic phenotype were rescued in these mice.	[Guedj, Faycal; Ledru, Aurelie; Paly, Evelyne; Delabar, Jean M.] Univ Paris 07, Paris, France; [Guedj, Faycal; Ledru, Aurelie; Paly, Evelyne; Delabar, Jean M.] CNRS, Paris, France; [Sebrie, Catherine; Gillet, Brigitte] ICSN, CNRS, Lab RMN Biol, Gif Sur Yvette, France; [Rivals, Isabelle] ESPCI, Equipe Stat Appliquee, Paris, France; [Bizot, Jean C.] Parc Technol Source, Key Obs SA, Orleans, France; [Smith, Desmond; Rubin, Edward] Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; LBNL, Dept Genome Sci, Berkeley, CA USA; [Arbones, Mariona] UPF, Ctr Genom Regulat, Barcelona, Spain	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Guedj, F (corresponding author), Univ Paris 07, Paris, France.	delabar@univ-paris-diderot.fr	Arbones, Maria/D-4668-2016; Rivals, Isabelle/AAE-7971-2022	Arbones, Maria/0000-0002-6035-0235; Rivals, Isabelle/0000-0002-8736-7010	EU [FP5, FP6]	EU(European Commission)	This work was supported by EU grants: T21 targets(FP5) and AnEUploidy (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2006, BIOCHEMISTRY-US, V45, P12011, DOI 10.1021/bi060632j; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Aldridge K, 2007, AM J MED GENET A, V143A, P1060, DOI 10.1002/ajmg.a.31721; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Chabert C, 2004, BEHAV GENET, V34, P559, DOI 10.1007/s10519-004-5584-3; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353; Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2; Dahmane N, 1998, GENOMICS, V48, P12, DOI 10.1006/geno.1997.5146; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hattori M, 2000, NATURE, V407, P110; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Korenberg JR, 1997, CYTOGENET CELL GENET, V79, P22; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olofsdotter K, 2000, NEUROSCIENCE, V101, P531, DOI 10.1016/S0306-4522(00)00428-0; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Ronan A, 2007, J MED GENET, V44, P448, DOI 10.1136/jmg.2006.047373; Sebrie C, 2008, ANAT REC, V291, P254, DOI 10.1002/ar.20640; Siarey RJ, 1999, NEUROPHARMACOLOGY, V38, P1917, DOI 10.1016/S0028-3908(99)00083-0; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Tanaka T, 1997, J NEUROSCI, V17, P2959; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; VANPRAAG H, 2007, J NEUROSCI, V27, pR2; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; XIE W, 2007, NEUROCHEM RES; Yang DJ, 2007, J CHROMATOGR A, V1156, P312, DOI 10.1016/j.chroma.2006.11.088	47	146	150	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4606	10.1371/journal.pone.0004606	http://dx.doi.org/10.1371/journal.pone.0004606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242551	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487500011
J	Karpinets, TV; Pelletier, DA; Pan, CL; Uberbacher, EC; Melnichenko, GV; Hettich, RL; Samatova, NF				Karpinets, Tatiana V.; Pelletier, Dale A.; Pan, Chongle; Uberbacher, Edward C.; Melnichenko, Galina V.; Hettich, Robert L.; Samatova, Nagiza F.			Phenotype Fingerprinting Suggests the Involvement of Single-Genotype Consortia in Degradation of Aromatic Compounds by Rhodopseudomonas palustris	PLOS ONE			English	Article							NITROGEN-FIXATION; MOLECULAR CHARACTERIZATION; ANAEROBIC DEGRADATION; MARINE ECOSYSTEMS; CARBON SOURCE; FRESH-WATER; EXPRESSION; METABOLISM; SPHAEROIDES; ESTUARINE	Anaerobic degradation of complex organic compounds by microorganisms is crucial for development of innovative biotechnologies for bioethanol production and for efficient degradation of environmental pollutants. In natural environments, the degradation is usually accomplished by syntrophic consortia comprised of different bacterial species. This strategy allows consortium organisms to reduce efforts required for maintenance of the redox homeostasis at each syntrophic level. Cellular mechanisms that maintain the redox homeostasis during the degradation of aromatic compounds by one organism are not fully understood. Here we present a hypothesis that the metabolically versatile phototrophic bacterium Rhodopseudomonas palustris forms its own syntrophic consortia, when it grows anaerobically on p-coumarate or benzoate as a sole carbon source. We have revealed the consortia from large-scale measurements of mRNA and protein expressions under p-coumarate, benzoate and succinate degrading conditions using a novel computational approach referred as phenotype fingerprinting. In this approach, marker genes for known R. palustris phenotypes are employed to determine the relative expression levels of genes and proteins in aromatics versus non-aromatics degrading condition. Subpopulations of the consortia are inferred from the expression of phenotypes and known metabolic modes of the R. palustris growth. We find that p-coumarate degrading conditions may lead to at least three R. palustris subpopulations utilizing p-coumarate, benzoate, and CO2 and H-2. Benzoate degrading conditions may also produce at least three subpopulations utilizing benzoate, CO2 and H-2, and N-2 and formate. Communication among syntrophs and inter-syntrophic dynamics in each consortium are indicated by up-regulation of transporters and genes involved in the curli formation and chemotaxis. The N-2-fixing subpopulation in the benzoate degrading consortium has preferential activation of the vanadium nitrogenase over the molybdenum nitrogenase. This subpopulation in the consortium was confirmed in an independent experiment by consumption of dissolved nitrogen gas under the benzoate degrading conditions.	[Karpinets, Tatiana V.] Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA; [Karpinets, Tatiana V.; Pan, Chongle; Samatova, Nagiza F.] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN USA; [Pelletier, Dale A.; Uberbacher, Edward C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Pan, Chongle; Hettich, Robert L.] Oak Ridge Natl Lab, Chem Sci Div, Oak Ridge, TN USA; [Karpinets, Tatiana V.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Melnichenko, Galina V.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA; [Samatova, Nagiza F.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of North Carolina; North Carolina State University	Karpinets, TV (corresponding author), Oak Ridge Natl Lab, Computat Biol Inst, Oak Ridge, TN 37831 USA.	karpinetstv@ornl.gov	Pelletier, Dale/F-4154-2011; Hettich, Robert L/N-1458-2016; Pan, Chongle/C-6960-2008	Hettich, Robert L/0000-0001-7708-786X; Pan, Chongle/0000-0003-2860-0334; Pelletier, Dale/0000-0002-4321-7918	U.S. Department of Energy (Office of Advanced Scientific Computing Research, Office of Science); Office of Biological and Environmental Research, U.S. Department of Energy; BioEnergy Science Center (BESC); UT-Battelle, LLC [DE-AC05-00OR22725]	U.S. Department of Energy (Office of Advanced Scientific Computing Research, Office of Science)(United States Department of Energy (DOE)); Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE)); BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); UT-Battelle, LLC	This research has been supported by the "Exploratory Data Intensive Computing for Complex Biological Systems" project from U.S. Department of Energy (Office of Advanced Scientific Computing Research, Office of Science). Research also sponsored by the Office of Biological and Environmental Research, U.S. Department of Energy, through the ORNL Genomics:GTL Center for Molecular and Cellular Systems (CMCS). This research was sponsored in part by the BioEnergy Science Center (BESC). The BioEnergy Science Center is a U.S. Department of Energy Bioenergy. Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. Oak Ridge National Laboratory (ORNL) is managed and operated under contract No. DE-AC05-00OR22725 by UT-Battelle, LLC. The work of Nagiza Samatova was partially supported by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory.	BARASSI CA, 1985, J BACTERIOL, V163, P778, DOI 10.1128/JB.163.2.778-782.1985; Barbosa MJ, 2001, J BIOTECHNOL, V85, P25, DOI 10.1016/S0168-1656(00)00368-0; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Becker JG, 2005, ENVIRON HEALTH PERSP, V113, P310, DOI 10.1289/ehp.6933; Boll M, 2005, J MOL MICROB BIOTECH, V10, P132, DOI 10.1159/000091560; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Castonguay MH, 2006, RES MICROBIOL, V157, P471, DOI 10.1016/j.resmic.2005.10.003; Chen LL, 2007, BIOSENS BIOELECTRON, V22, P1487, DOI 10.1016/j.bios.2006.06.038; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; ELDER DJE, 1992, ARCH MICROBIOL, V157, P148, DOI 10.1007/BF00245283; FALCONE DL, 1991, J BACTERIOL, V173, P2099, DOI 10.1128/jb.173.6.2099-2108.1991; Ficker M, 1999, APPL ENVIRON MICROB, V65, P5576; FISHER SH, 1991, ANNU REV MICROBIOL, V45, P107, DOI 10.1146/annurev.mi.45.100191.000543; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; HALLENBECK PL, 1990, J BACTERIOL, V172, P1736, DOI 10.1128/jb.172.4.1736-1748.1990; Harrison FH, 2005, MICROBIOL-SGM, V151, P727, DOI 10.1099/mic.0.27731-0; HARRISON FH, 2005, THESIS U IOWA IOWA C; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Heider J, 1997, EUR J BIOCHEM, V243, P577, DOI 10.1111/j.1432-1033.1997.00577.x; HELRICK K, 1990, OFFICIAL METHODS ANA, V1422, P2; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; KARL D, 2004, DINITROGEN FIXATION, P47; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kasai Y, 2005, ENVIRON MICROBIOL, V7, P806, DOI 10.1111/j.1462-2920.2005.00754.x; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; MCEWAN AG, 1994, ANTON LEEUW INT J G, V66, P151, DOI 10.1007/BF00871637; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oda Y, 2005, J BACTERIOL, V187, P7784, DOI 10.1128/JB.187.22.7784-7794.2005; OREMLAND RS, 1978, GEOCHIM COSMOCHIM AC, V42, P209, DOI 10.1016/0016-7037(78)90133-3; Pan C, 2008, MOL CELL PROTEOMICS, V7, P938, DOI 10.1074/mcp.M700147-MCP200; QADRI SM, 1968, J BACTERIOL, V95, P2344, DOI 10.1128/JB.95.6.2344-2357.1968; Qian YL, 1998, J BACTERIOL, V180, P4644, DOI 10.1128/JB.180.17.4644-4649.1998; Rey FE, 2007, APPL ENVIRON MICROB, V73, P1665, DOI 10.1128/AEM.02565-06; Rey FE, 2006, J BACTERIOL, V188, P6143, DOI 10.1128/JB.00381-06; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Sawayama S, 2001, J BIOSCI BIOENG, V91, P195, DOI 10.1263/jbb.91.195; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; Thompson MR, 2008, ANAL CHEM, V80, P9517, DOI 10.1021/ac801707s; VARGA AR, 1983, J BACTERIOL, V154, P1414, DOI 10.1128/JB.154.3.1414-1430.1983; VerBerkmoes NC, 2006, J PROTEOME RES, V5, P287, DOI 10.1021/pr0503230; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; WANG X, 1993, J BACTERIOL, V175, P3372, DOI 10.1128/jb.175.11.3372-3379.1993; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WEBER A, 1986, PLANT SOIL, V90, P419, DOI 10.1007/BF02277413; Wolin M.J., 1982, ASM NEWS, V48, P561; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zwolinski MD, 2000, BIODEGRADATION, V11, P141, DOI 10.1023/A:1011190316012	50	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4615	10.1371/journal.pone.0004615	http://dx.doi.org/10.1371/journal.pone.0004615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242537	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500017
J	Carrara, VI; Zwang, J; Ashley, EA; Price, RN; Stepniewska, K; Barends, M; Brockman, A; Anderson, T; McGready, R; Phaiphun, L; Proux, S; van Vugt, M; Hutagalung, R; Lwin, KM; Phyo, AP; Preechapornkul, P; Imwong, M; Pukrittayakamee, S; Singhasivanon, P; White, NJ; Nosten, F				Carrara, Verena Ilona; Zwang, Julien; Ashley, Elizabeth A.; Price, Ric N.; Stepniewska, Kasia; Barends, Marion; Brockman, Alan; Anderson, Tim; McGready, Rose; Phaiphun, Lucy; Proux, Stephane; van Vugt, Michele; Hutagalung, Robert; Lwin, Khin Maung; Phyo, Aung Pyae; Preechapornkul, Piyanuch; Imwong, Mallika; Pukrittayakamee, Sasithon; Singhasivanon, Pratap; White, Nicholas J.; Nosten, Francois			Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment	PLOS ONE			English	Article								Background: Artemisinin combination treatments (ACT) are recommended as first line treatment for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of a 3-day regimen of mefloquine and artesunate regimen (MAS(3)), over a 13 year period of continuous deployment as first-line treatment in camps for displaced persons and in clinics for migrant population along the Thai-Myanmar border. Methods and Findings: 3,264 patients were enrolled in prospective treatment trials between 1995 and 2007 and treated with MAS(3). The proportion of patients with parasitaemia persisting on day-2 increased significantly from 4.5% before 2001 to 21.9% since 2002 (p<0.001). Delayed parasite clearance was associated with increased risk of developing gametocytaemia (AOR = 2.29; 95% CI, 2.00-2.69, p = 0.002). Gametocytaemia on admission and carriage also increased over the years (p = 0.001, test for trend, for both). MAS(3) efficacy has declined slightly but significantly (Hazards ratio 1.13; 95% CI, 1.07-1.19, p<0.001), although efficacy in 2007 remained well within acceptable limits: 96.5% (95% CI, 91.0-98.7). The in vitro susceptibility of P. falciparum to artesunate increased significantly until 2002, but thereafter declined to levels close to those of 13 years ago (geometric mean in 2007: 4.2 nM/l; 95% CI, 3.2-5.5). The proportion of infections caused by parasites with increased pfmdr1 copy number rose from 30% (12/40) in 1996 to 53% (24/45) in 2006 (p = 0.012, test for trend). Conclusion: Artesunate-mefloquine remains a highly efficacious antimalarial treatment in this area despite 13 years of widespread intense deployment, but there is evidence of a modest increase in resistance. Of particular concern is the slowing of parasitological response to artesunate and the associated increase in gametocyte carriage.	[Carrara, Verena Ilona; Zwang, Julien; Ashley, Elizabeth A.; Barends, Marion; McGready, Rose; Phaiphun, Lucy; Proux, Stephane; van Vugt, Michele; Hutagalung, Robert; Lwin, Khin Maung; Phyo, Aung Pyae; Nosten, Francois] Shoklo Malaria Res Unit, Tak, Thailand; [Ashley, Elizabeth A.; Stepniewska, Kasia; McGready, Rose; Preechapornkul, Piyanuch; Imwong, Mallika; Pukrittayakamee, Sasithon; Singhasivanon, Pratap; White, Nicholas J.; Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Ashley, Elizabeth A.; Price, Ric N.; Stepniewska, Kasia; McGready, Rose; White, Nicholas J.; Nosten, Francois] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Price, Ric N.; Brockman, Alan] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Anderson, Tim] Southwest Fdn Biomed Res, San Antonio, TX USA	Mahidol University; Mahidol University; University of Oxford; Charles Darwin University; Menzies School of Health Research; Texas Biomedical Research Institute	Carrara, VI (corresponding author), Shoklo Malaria Res Unit, Tak, Thailand.	smru@tropmedres.ac	Carrara, Verena/R-6492-2019; Phyo, Aung Pyae/K-2413-2019; Phyo, Aung Pyae/GYU-6181-2022; Imwong, Mallika/ABE-6493-2020; Nosten, Francois/AAC-5509-2019; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019; McGready, Rose/A-3290-2014	Carrara, Verena/0000-0002-2758-0872; Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; McGready, Rose/0000-0003-1621-3257; Stepniewska, Kasia/0000-0002-1713-6209; Singhasivanon, Pratap/0000-0002-9759-1702; Price, Richard/0000-0003-2000-2874	Wellcome Trust of Great Britain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048071] Funding Source: NIH RePORTER	Wellcome Trust of Great Britain(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from the Wellcome Trust of Great Britain. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Ashley EA, 2006, TROP MED INT HEALTH, V11, P1653, DOI 10.1111/j.1365-3156.2006.01724.x; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Chareonviriyaphap Theeraphap, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P225; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P213, DOI 10.1016/0035-9203(94)90303-4; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Nosten F, 2005, LANCET, V365, P653; PREECHAPORNKUL P, ANTIMICROB IN PRESS; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Rojanawatsirivej C., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P536; Rojanawatsirivet Chaiporn, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P560; Rooney W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P131; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Thimasarn Krongthong, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P465; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; van Vugt M, 2002, CLIN INFECT DIS, V35, P1498, DOI 10.1086/344901; van Vugt M, 1998, ANTIMICROB AGENTS CH, V42, P135, DOI 10.1128/AAC.42.1.135; Vijaykadga S, 2006, TROP MED INT HEALTH, V11, P211, DOI 10.1111/j.1365-3156.2005.01557.x; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; Wongsrichanalai Chansuda, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P300	33	187	190	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4551	10.1371/journal.pone.0004551	http://dx.doi.org/10.1371/journal.pone.0004551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234601	Green Submitted, gold, Green Published			2022-12-25	WOS:000265487200007
J	Ghafoori, P; Yoshimura, T; Turpie, B; Masli, S				Ghafoori, Paiman; Yoshimura, Takeru; Turpie, Bruce; Masli, Sharmila			Increased I kappa B alpha expression is essential for the tolerogenic property of TGF-beta-exposed APCs	FASEB JOURNAL			English	Article						monocytes; macrophages; antigen presentation; antigen processing; tolerance	ANTIGEN-PRESENTING CELLS; SITE-SPECIFIC PHOSPHORYLATION; CLONED MACROPHAGE HYBRIDOMAS; GROWTH-FACTOR-BETA; DENDRITIC CELLS; IMMUNE DEVIATION; FUNCTIONAL-ANALYSIS; NUCLEAR-LOCALIZATION; PROMOTING PROPERTIES; ENDOTHELIAL-CELLS	I kappa B alpha is an inhibitor of the transcriptional factor NF-kappa B, and it is an essential component of the signaling pathways that lead to expression of inflammatory molecules. These include cytokines and costimulatory molecules associated with antigen presentation in an inflammatory immune response. In this study, we report that antigen-presenting cells exposed to TGF-beta induce peripheral tolerance by increasing I kappa B alpha expression. Exposure of antigen presenting cells (APCs) to TGF-beta is known to impair their ability to secrete IL-12, and such impairment correlated with reduced NF-kappa B activity as indicated by significantly reduced nuclear levels of p50, an essential subunit of NF-kappa B for IL-12 transcription. Blockade of increased nuclear I kappa B alpha in APCs by expression of small interfering RNA molecules (siRNAs) targeting I kappa B alpha transcripts prevented IL-12 impairment and the decline in nuclear p50 levels. Furthermore, such I kappa B alpha blockade also interfered with the tolerogenic property of TGF-beta-exposed APCs. However, increased expression of I kappa B alpha in APCs, independent of TGF-beta exposure, reduced nuclear p50 levels and permitted tolerance induction by APCs. Thus, our findings attribute a direct and significant role to I kappa B alpha in the tolerogenic potential of APCs. Increased I kappa B alpha expression in APCs may therefore offer a therapeutic approach to achieve antigen-specific immuno-modulation.-Ghafoori, P., Yoshimura, T., Turpie, B., Masli, S. Increased I kappa B alpha expression is essential for the tolerogenic property of TGF-beta-exposed APCs. FASEB J. 23, 2226-2234 (2009)	[Ghafoori, Paiman; Yoshimura, Takeru; Turpie, Bruce; Masli, Sharmila] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute	Masli, S (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	sharmila.masli@schepens.harvard.edu			U.S. National Institutes of Health [EY015472]; NATIONAL EYE INSTITUTE [R01EY015472] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by U.S. National Institutes of Health grant EY015472.	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chakrabarti S, 2007, J BIOL CHEM, V282, P18307, DOI 10.1074/jbc.M700211200; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dabir P, 2008, CIRC RES, V102, P1558, DOI 10.1161/CIRCRESAHA.108.176990; Gao JX, 1999, IMMUNOLOGY, V98, P159; HARA Y, 1992, J IMMUNOL, V149, P1531; HARA Y, 1993, J IMMUNOL, V151, P5162; Hecker KH, 1999, IMMUNOLOGY, V96, P372; Hill JA, 2003, J IMMUNOL, V171, P691, DOI 10.4049/jimmunol.171.2.691; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; ISHIKURA H, 1989, J IMMUNOL, V143, P414; Jobin C, 1998, J IMMUNOL, V160, P410; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1410; KUCHROO VK, 1988, J IMMUNOL, V141, P10; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Li GL, 2005, J IMMUNOL, V174, P4706, DOI 10.4049/jimmunol.174.8.4706; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Masli S, 2006, INT IMMUNOL, V18, P689, DOI 10.1093/intimm/dxl006; Masli S, 2002, J IMMUNOL, V168, P2264, DOI 10.4049/jimmunol.168.5.2264; MASLI S, 2008, IMMUNOLOGY, DOI DOI 10.1111/J.1365-2567.2008.2933.X; McLaughlin JN, 2005, J BIOL CHEM, V280, P22172, DOI 10.1074/jbc.M500721200; Na SY, 1999, J BIOL CHEM, V274, P7674, DOI 10.1074/jbc.274.12.7674; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; SCHMITT DA, 1995, J IMMUNOL, V154, P5114; Streilein JW, 2002, HUM IMMUNOL, V63, P435, DOI 10.1016/S0198-8859(02)00393-2; Takeuchi M, 1997, EUR J IMMUNOL, V27, P1648, DOI 10.1002/eji.1830270709; Takeuchi M, 1998, J IMMUNOL, V160, P1589; Taoufik Y, 2001, EUR J IMMUNOL, V31, P3228, DOI 10.1002/1521-4141(200111)31:11<3228::AID-IMMU3228>3.0.CO;2-7; Thommesen L, 2005, J BIOCHEM MOL BIOL, V38, P281; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; UCHIDA T, 1985, J IMMUNOL, V134, P772; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P1031, DOI 10.1002/eji.1830220423; Xu H, 2007, BIOCHEM BIOPH RES CO, V353, P812, DOI 10.1016/j.bbrc.2006.12.108; Yoshimura S, 2003, SCAND J IMMUNOL, V58, P165, DOI 10.1046/j.1365-3083.2003.01246.x; Yoshimura S, 2001, EUR J IMMUNOL, V31, P1883, DOI 10.1002/1521-4141(200106)31:6<1883::AID-IMMU1883>3.0.CO;2-V; Yoshimura S, 2001, INT IMMUNOL, V13, P675, DOI 10.1093/intimm/13.5.675; Zhang-Hoover J, 2004, J IMMUNOL, V172, P178, DOI 10.4049/jimmunol.172.1.178; Zhou LF, 2006, ACTA PHARMACOL SIN, V27, P609, DOI 10.1111/j.1745-7254.2006.00310.x	47	14	14	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2226	2234		10.1096/fj.08-124545	http://dx.doi.org/10.1096/fj.08-124545			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19237504	Green Published			2022-12-25	WOS:000268836500022
J	Babich, V; Knipe, L; Hewlett, L; Meli, A; Dempster, J; Hannah, MJ; Carter, T				Babich, Victor; Knipe, Laura; Hewlett, Lindsay; Meli, Athinoula; Dempster, John; Hannah, Matthew J.; Carter, Tom			Differential Effect of Extracellular Acidosis on the Release and Dispersal of Soluble and Membrane Proteins Secreted from the Weibel-Palade Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; PLATELET VONWILLEBRAND-FACTOR; HUMAN ENDOTHELIAL-CELLS; INTRACELLULAR PH; TISSUE PH; BODIES; ISCHEMIA; PROPOLYPEPTIDE; MICRODOMAINS; INFLAMMATION	Proteins secreted from Weibel-Palade bodies (WPBs) play important roles in regulating inflammatory and hemostatic responses. Inflammation is associated with the extracellular acidification of tissues and blood, conditions that can alter the behavior of secreted proteins. The effect of extracellular pH (pH(o)) on the release of von Willebrand factor (VWF), the VWF-propolypeptide (Proregion), interleukin-8, eotaxin-3, P-selectin, and CD63 from WPBs was investigated using biochemical approaches and by direct optical analysis of individual WPB fusion events in human endothelial cells expressing green or red fluorescent fusions of these different cargo proteins. Between pH(o) 7.4 and 7.0, ionomycin-evoked WPB exocytosis was characterized by the adhesion of VWF to the cell surface and the formation of long filamentous strands. The rapid dispersal of Proregion, interleukin-8, and eotaxin-3 into solution, and of P-selectin and CD63 into the plasma membrane, was unaltered over this pH(o) range. At pHo 6.8 or lower, Proregion remained associated with VWF, in many cases WPB failed to collapse fully and VWF failed to form filamentous strands. At pH(o) 6.5 dispersal of interleukin-8, eotaxin-3, and the membrane protein CD63 remained unaltered compared with that at pH(o) 7.4; however, P-selectin dispersal into the plasma membrane was significantly slowed. Thus, extracellular acidification to levels of pH(o) 6.8 or lower significantly alters the behavior of secreted VWF, Proregion, and P-selectin while rapid release of the small pro-inflammatory mediators IL-8 and eotaxin-3 is essentially unaltered. Together, these data suggest that WPB exocytosis during extracellular acidosis may favor the control of inflammatory processes.	[Babich, Victor; Knipe, Laura; Hewlett, Lindsay; Meli, Athinoula; Hannah, Matthew J.; Carter, Tom] Natl Inst Med Res, MRC, London NW7 1AA, England; [Dempster, John] Univ Strathclyde, Glasgow G40 NR, Lanark, Scotland	MRC National Institute for Medical Research; University of Strathclyde	Carter, T (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	tcarter@nimr.mrc.ac.uk	Carter, Tom/E-5035-2016	Carter, Tom/0000-0002-6248-7278; Dempster, John/0000-0003-2199-2945	MRC [MC_U117570589, MC_U117573808] Funding Source: UKRI; Medical Research Council [MC_U117570589, MC_U117573808] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andersson SE, 1999, J RHEUMATOL, V26, P2018; Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Bierings R, 2007, J THROMB HAEMOST, V5, P2512, DOI 10.1111/j.1538-7836.2007.02768.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Christou H, 2005, AM J PHYSIOL-HEART C, V288, pH2647, DOI 10.1152/ajpheart.00937.2004; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; FOLEY ME, 1977, LANCET, V1, P1230; FRESSINAUD E, 1987, BLOOD, V70, P1214; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Goodis HE, 2006, J DENT RES, V85, P1046, DOI 10.1177/154405910608501114; GRALNICK HR, 1991, MAYO CLIN PROC, V66, P634, DOI 10.1016/S0025-6196(12)60524-2; HAGBERG H, 1985, PFLUG ARCH EUR J PHY, V404, P342, DOI 10.1007/BF00585346; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Huck V, 2007, J CELL PHYSIOL, V211, P399, DOI 10.1002/jcp.20947; Ihrcke NS, 1998, J CELL PHYSIOL, V175, P255, DOI 10.1002/(SICI)1097-4652(199806)175:3<255::AID-JCP3>3.0.CO;2-N; Isobe T, 1997, J BIOL CHEM, V272, P8447, DOI 10.1074/jbc.272.13.8447; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kiskin NI, 2005, BIOPHYS J, V88, p264A; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Marumo M, 2001, THROMB RES, V104, P353, DOI 10.1016/S0049-3848(01)00374-7; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Michaux G, 2006, BLOOD, V107, P3922, DOI 10.1182/blood-2005-09-3635; NEMOTO EM, 1981, STROKE, V12, P77, DOI 10.1161/01.STR.12.1.77; Radhakrishnan R, 2005, J PHARMACOL EXP THER, V313, P921, DOI 10.1124/jpet.104.082776; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; VISCHER UM, 1994, BLOOD, V83, P3536; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WATSON RM, 1984, AM J PHYSIOL, V246, pH232, DOI 10.1152/ajpheart.1984.246.2.H232; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZUCKER MB, 1979, J LAB CLIN MED, V94, P675	39	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12459	12468		10.1074/jbc.M809235200	http://dx.doi.org/10.1074/jbc.M809235200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258324	hybrid, Green Published			2022-12-25	WOS:000265494600075
J	Watanabe, H; Matsumaru, H; Ooishi, A; Feng, YW; Odahara, T; Suto, K; Honda, S				Watanabe, Hideki; Matsumaru, Hiroyuki; Ooishi, Ayako; Feng, YanWen; Odahara, Takayuki; Suto, Kyoko; Honda, Shinya			Optimizing pH Response of Affinity between Protein G and IgG Fc HOW ELECTROSTATIC MODULATIONS AFFECT PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE-BINDING; DOMAIN; MECHANISM; SWITCH; THERMODYNAMICS; CONFORMATION; DEPENDENCE; PROGRAM; DESIGN; B1	Protein-protein interaction in response to environmental conditions enables sophisticated biological and biotechnological processes. Aiming toward the rational design of a pH-sensitive protein-protein interaction, we engineered pH-sensitive mutants of streptococcal protein G B1, a binder to the IgG constant region. We systematically introduced histidine residues into the binding interface to cause electrostatic repulsion on the basis of a rigid body model. Exquisite pH sensitivity of this interaction was confirmed by surface plasmon resonance and affinity chromatography employing a clinically used human IgG. The pH-sensitive mechanism of the interaction was analyzed and evaluated from kinetic, thermodynamic, and structural viewpoints. Histidine-mediated electrostatic repulsion resulted in significant loss of exothermic heat of the binding that decreased the affinity only at acidic conditions, thereby improving the pH sensitivity. The reduced binding energy was partly recovered by "enthalpy-entropy compensation." Crystal structures of the designed mutants confirmed the validity of the rigid body model on which the effective electrostatic repulsion was based. Moreover, our data suggested that the entropy gain involved exclusion of water molecules solvated in a space formed by the introduced histidine and adjacent tryptophan residue. Our findings concerning the mechanism of histidine-introduced interactions will provide a guideline for the rational design of pH-sensitive protein-protein recognition.	[Watanabe, Hideki; Matsumaru, Hiroyuki; Ooishi, Ayako; Feng, YanWen; Odahara, Takayuki; Suto, Kyoko; Honda, Shinya] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Honda, S (corresponding author), Cent 6, Tsukuba, Ibaraki 3058566, Japan.	s.honda@aist.go.jp	Odahara, Takayuki/L-6943-2018; Watanabe, Hideki/M-2711-2018; Honda, Shinya/K-6894-2016; Ooishi, Ayako/L-8654-2018	Watanabe, Hideki/0000-0002-9561-4077; Honda, Shinya/0000-0002-7878-3944; Ooishi, Ayako/0000-0003-4062-868X	NEDO (New Energy and Industrial Technology Development Organization of Japan)	NEDO (New Energy and Industrial Technology Development Organization of Japan)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the grant program "Development of New Functional Antibody Technologies" from NEDO (New Energy and Industrial Technology Development Organization of Japan).	Asayama S, 2008, MOL PHARM, V5, P162, DOI 10.1021/mp7001076; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Broz P, 2006, NANO LETT, V6, P2349, DOI 10.1021/nl0619305; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dincbas-Renqvist V, 2004, J AM CHEM SOC, V126, P11220, DOI 10.1021/ja047727y; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHNESTOCK SR, 1986, J BACTERIOL, V167, P870, DOI 10.1128/jb.167.3.870-880.1986; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Gulich S, 2000, J BIOTECHNOL, V76, P233, DOI 10.1016/S0168-1656(99)00197-2; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; Honda S, 1999, BIOCHEMISTRY-US, V38, P1203, DOI 10.1021/bi982271g; Honda S, 2000, J MOL BIOL, V295, P269, DOI 10.1006/jmbi.1999.3346; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Leach JL, 1996, J IMMUNOL, V157, P3317; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Linder M, 1999, FEBS LETT, V447, P13, DOI 10.1016/S0014-5793(99)00253-7; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Olson LJ, 2008, J BIOL CHEM, V283, P10124, DOI 10.1074/jbc.M708994200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sloan DJ, 1999, PROTEIN SCI, V8, P1643, DOI 10.1110/ps.8.8.1643; Sprague ER, 2006, PLOS BIOL, V4, P975, DOI 10.1371/journal.pbio.0040148; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Stevens MM, 2004, LANGMUIR, V20, P7747, DOI 10.1021/la030440e; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Welfle K, 1999, BBA-PROTEIN STRUCT M, V1431, P120, DOI 10.1016/S0167-4838(99)00046-1; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	38	40	66	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12373	12383		10.1074/jbc.M809236200	http://dx.doi.org/10.1074/jbc.M809236200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269963	hybrid, Green Published			2022-12-25	WOS:000265494600068
J	Meng, Y; Katsuma, S; Daimon, T; Banno, Y; Uchino, K; Sezutsu, H; Tamura, T; Mita, K; Shimada, T				Meng, Yan; Katsuma, Susumu; Daimon, Takaaki; Banno, Yutaka; Uchino, Keiro; Sezutsu, Hideki; Tamura, Toshiki; Mita, Kazuei; Shimada, Toru			The Silkworm Mutant lemon (lemon lethal) Is a Potential Insect Model for Human Sepiapterin Reductase Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPA-RESPONSIVE DYSTONIA; BOMBYX-MORI; TETRAHYDROBIOPTERIN DEFICIENCIES; PARKINSONS-DISEASE; DROSOPHILA MODEL; PURIFICATION; ENZYME; HYPERPHENYLALANINEMIA; BIOSYNTHESIS; CARBONYL	Tetrahydrobiopterin (BH4) is an essential cofactor for aromatic acid hydroxylases, which control the levels of monoamine neurotransmitters. BH4 deficiency has been associated with many neuropsychological disorders. An inherited defect in BH4 biosynthesis is caused by the deficiency of sepiapterin reductase (SPR), which catalyzes the biosynthesis of BH4 from guanosine triphosphate at the terminal step. The human SPR gene has been mapped at the PARK3 locus, which is related to the onset of Parkinson disease. In this study, we report that mutant strains, lemon (lem) and its lethal allele lemon lethal (lem(1)) with yellow body coloration, of the silkworm Bombyx mori could be used as the first insect model for human SPR deficiency diseases. We demonstrated that mutations in the SPR gene (BmSpr) were responsible for the irregular body coloration of lem and lem(l). Moreover, biochemical analysis revealed that SPR activity in lem(l) larvae was almost completely diminished, resulting in a lethal phenotype that the larvae cannot feed and that die immediately after the first ecdysis. Oral administration of BH4 and dopamine to lem(l) larvae effectively increased their survival rates and feeding abilities. Our data demonstrate that BmSPR plays a crucial role in the generation of BH4, and monoamine neurotransmitters in silkworms and the lem (lem(l)) mutant strains will be an invaluable resource to address many questions regarding SPR and BH4 deficiencies.	[Meng, Yan; Katsuma, Susumu; Daimon, Takaaki; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Banno, Yutaka] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Inst Genet Resources, Higashi Ku, Fukuoka 8128581, Japan; [Uchino, Keiro; Sezutsu, Hideki; Tamura, Toshiki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Ctr, Tsukuba, Ibaraki 3058634, Japan; [Mita, Kazuei] Natl Inst Agrobiol Sci, Insect Sci Dept, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; Kyushu University; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Shimada, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp	meng, yan/GSE-2653-2022; Meng, Yan/HGC-0394-2022; Shimada, Toru/A-2033-2011; Shimada, Toru/AAZ-2703-2021	Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000; Daimon, Takaaki/0000-0002-8382-1132; Sezutsu, Hideki/0000-0001-8886-1611; Uchino, Keiro/0000-0003-3650-7359	Ministry of Education, Culture, Sports, Science, and Technology [17018007]; Japan Science and Technology Agency; Japan Society for the Promotion of Science [P07427]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-aid for Scientific Research 17018007 (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, the Professional Program for Agricultural Bioinformatics from Japan Science and Technology Agency, and Japan Society for the Promotion of Science Postdoctoral Fellowship for Foreign Researchers Grant P07427 (to Y.M.).	Abeling NG, 2006, MOL GENET METAB, V89, P116, DOI 10.1016/j.ymgme.2006.03.010; Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Banno YF., 2005, GUIDE SILKWORM MUTAN; Blau N, 1996, J INHERIT METAB DIS, V19, P8, DOI 10.1007/BF01799342; Blau N, 2001, MOL GENET METAB, V74, P172, DOI 10.1006/mgme.2001.3213; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Daimon T, 2008, J BIOL CHEM, V283, P15271, DOI 10.1074/jbc.M709350200; Friedman J, 2006, NEUROLOGY, V67, P2032, DOI 10.1212/01.wnl.0000247274.21261.b4; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; GOTO M, 1966, B CHEM SOC JPN, V39, P929, DOI 10.1246/bcsj.39.929; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Iino T, 1996, BBA-PROTEIN STRUCT M, V1297, P191, DOI 10.1016/S0167-4838(96)00087-8; Iino T, 2000, ARCH BIOCHEM BIOPHYS, V373, P442, DOI 10.1006/abbi.1999.1561; IINO T, 1992, ZOOL SCI, V9, P119; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; KATOH S, 1971, ARCH BIOCHEM BIOPHYS, V146, P202, DOI 10.1016/S0003-9861(71)80057-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MATSUBARA M, 1963, NATURE, V199, P908, DOI 10.1038/199908a0; MAZDA T, 1980, INSECT BIOCHEM, V10, P357, DOI 10.1016/0020-1790(80)90003-7; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Ohashi M, 1983, J SERICULT SCI JPN, V52, P498; Orihara Y, 2008, J GEN VIROL, V89, P188, DOI 10.1099/vir.0.83208-0; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; RuizVazquez P, 1996, COMP BIOCHEM PHYS B, V113, P131, DOI 10.1016/0305-0491(96)02005-6; SUEOKA T, 1982, BIOCHIM BIOPHYS ACTA, V717, P265, DOI 10.1016/0304-4165(82)90178-7; Takazawa C, 2008, BIOCHEM BIOPH RES CO, V367, P787, DOI 10.1016/j.bbrc.2008.01.028; TSUJITA MITSUO, 1955, JAPANESE JOUR GENETICS, V30, P107, DOI 10.1266/jjg.30.107; TSUSUE M, 1965, ZOOL MAG TOKYO, V74, P91; WSZOLEK ZK, 1993, NERVENARZT, V64, P331; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372	38	42	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11698	11705		10.1074/jbc.M900485200	http://dx.doi.org/10.1074/jbc.M900485200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19246455	hybrid, Green Published			2022-12-25	WOS:000265494500072
J	Yamaguchi, H; Woods, NT; Piluso, LG; Lee, HH; Chen, JD; Bhalla, KN; Monteiro, A; Liu, X; Hung, MC; Wang, HG				Yamaguchi, Hirohito; Woods, Nicholas T.; Piluso, Landon G.; Lee, Heng-Huan; Chen, Jiandong; Bhalla, Kapil N.; Monteiro, Alvaro; Liu, Xuan; Hung, Mien-Chie; Wang, Hong-Gang			p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; CELL-DEATH; APOPTOTIC RESPONSE; KU70 ACETYLATION; DNA-BINDING; IN-VIVO; BCL-2 FAMILY; ACTIVATION; BAX	Acetylation of p53 at carboxyl-terminal lysine residues enhances its transcriptional activity associated with cell cycle arrest and apoptosis. Here we demonstrate that p53 acetylation at Lys-320/Lys-373/Lys-382 is also required for its transcription-independent functions in BAX activation, reactive oxygen species production, and apoptosis in response to the histone deacetylase inhibitors (HDACi) suberoylanilide hydroxamic acid and LAQ824. Knock-out of p53 markedly reduced HDACi-induced apoptosis. Unexpectedly, expression of transactivation-deficient p53 variants sensitized p53-null cells to HDACi-mediated BAX-dependent apoptosis, whereas knockdown of endogenous mutant p53 in cancer cells reduced HDACi-mediated cytotoxicity. Evaluation of the mechanisms controlling this response led to the discovery of a novel interaction between p53 and Ku70. The association between these two proteins was acetylation-independent, but acetylation of p53 could prevent and disrupt the Ku70-BAX complex and enhance apoptosis. These results suggest a new mechanism of acetylated p53 transcription-independent regulation of apoptosis.	[Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Woods, Nicholas T.; Chen, Jiandong; Monteiro, Alvaro] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Yamaguchi, Hirohito; Lee, Heng-Huan; Hung, Mien-Chie] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Piluso, Landon G.; Liu, Xuan] Univ Calif Riverside, Riverside, CA 92521 USA; [Bhalla, Kapil N.] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of California System; University of California Riverside; University System of Georgia; Augusta University	Wang, HG (corresponding author), 500 Univ Dr,POB 850, Hershey, PA 17033 USA.	hwang3@hmc.psu.edu	Hung, Mien-Chie/ABD-5911-2021; Bhalla, Amar S/E-2203-2011; Wang, Hong-Gang/A-3018-2015; Monteiro, Alvaro N. A./A-7566-2009	Hung, Mien-Chie/0000-0003-4317-4740; Wang, Hong-Gang/0000-0003-0551-0571; Monteiro, Alvaro N. A./0000-0002-8448-4801; Woods, Nicholas/0000-0002-4962-9083; Bhalla, Kapil/0000-0001-5209-5126	National Institutes of Health; American Cancer Society and Flight Attendant Medical Research Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society and Flight Attendant Medical Research Institute(American Cancer Society)	This work was supported, in whole or in part, by National Institutes of Health grants. This work was also supported by grants from American Cancer Society and Flight Attendant Medical Research Institute.	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bissonnette N, 1997, BIOCHEM CELL BIOL, V75, P351, DOI 10.1139/bcb-75-4-351; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mahyar-Roemer M, 2004, ONCOGENE, V23, P6226, DOI 10.1038/sj.onc.1207637; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; MIYASHITA T, 1994, CANCER RES, V54, P3131; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nishita M, 1998, EXP CELL RES, V244, P357, DOI 10.1006/excr.1998.4203; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pietrzak M, 2008, BIOL CHEM, V389, P383, DOI 10.1515/BC.2008.039; Piluso LG, 2005, PROTEIN EXPRES PURIF, V40, P370, DOI 10.1016/j.pep.2004.12.015; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Raffo AJ, 2000, ONCOGENE, V19, P6216, DOI 10.1038/sj.onc.1203995; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Terui T, 2003, CANCER RES, V63, P8948; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	57	96	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11171	11183		10.1074/jbc.M809268200	http://dx.doi.org/10.1074/jbc.M809268200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19265193	hybrid, Green Published			2022-12-25	WOS:000265494500021
J	Collins, R; Karlberg, T; Lehtio, L; Schutz, P; van den Berg, S; Dahlgren, LG; Hammarstrom, M; Weigelt, J; Schuler, H				Collins, Ruairi; Karlberg, Tobias; Lehtio, Lari; Schutz, Patrick; van den Berg, Susanne; Dahlgren, Lars-Goran; Hammarstrom, Martin; Weigelt, Johan; Schuler, Herwig			The DEXD/H-box RNA Helicase DDX19 Is Regulated by an alpha-Helical Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA; CRYSTAL-STRUCTURE; PROTEIN DBP5; EXPORT; SOFTWARE	DEXD/H-box RNA helicases couple ATP hydrolysis to RNA remodeling by an unknown mechanism. We used x-ray crystallography and biochemical analysis of the human DEXD/H-box protein DDX19 to investigate its regulatory mechanism. The crystal structures of DDX19, in its RNA-bound prehydrolysis and free posthydrolysis state, reveal an alpha-helix that inserts between the conserved domains of the free protein to negatively regulate ATPase activity. This finding was corroborated by biochemical data that confirm an autoregulatory function of the N-terminal region of the protein. This is the first study describing crystal structures of a DEXD/H-box protein in its open and closed cleft conformations.	[Collins, Ruairi; Karlberg, Tobias; Lehtio, Lari; Schutz, Patrick; van den Berg, Susanne; Dahlgren, Lars-Goran; Hammarstrom, Martin; Weigelt, Johan; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Schuler, H (corresponding author), Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, Scheeles Vag 2, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501; Lehtio, Lari/0000-0001-7250-832X				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424	29	106	108	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10296	10300		10.1074/jbc.C900018200	http://dx.doi.org/10.1074/jbc.C900018200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244245	Green Published, hybrid			2022-12-25	WOS:000265104600003
J	Noonan, EJ; Place, RF; Pookot, D; Basak, S; Whitson, JM; Hirata, H; Giardina, C; Dahiya, R				Noonan, E. J.; Place, R. F.; Pookot, D.; Basak, S.; Whitson, J. M.; Hirata, H.; Giardina, C.; Dahiya, R.			miR-449a targets HDAC-1 and induces growth arrest in prostate cancer	ONCOGENE			English	Article						miRNA; miR-449a; miR-34; HDAC-1; HDAC inhibitors; prostate cancer; senescence	HISTONE DEACETYLASE INHIBITORS; MICRORNA EXPRESSION; CLASS-I; VALPROIC ACID; SOLID TUMORS; CELLS; APOPTOSIS; SENESCENCE; MIR-34A; GENE	Histone deacetylases (HDACs) are frequently over-expressed in broad range of cancer types, where they alter cellular epigenetic programming to promote cell proliferation and survival. However, the mechanism by which HDACs become overexpressed in human cancers remains somewhat of a mystery. In this study, we investigated the expression and functional significance of miR-449a in prostate cancer cells. Using real-time PCR, we found that miR-449a is downregulated in prostate cancer tissues relative to patient-matched control tissue. Introduction of miR-449a into PC-3 prostate cancer cells resulted in cell-cycle arrest, apoptosis and a senescent-like phenotype. In silico analysis of 3'-UTR regions identified a number of genes involved in cell-cycle regulation as putative targets of miR-449a. Using a luciferase 3'-UTR reporter system, we established that HDAC-1 (histone deacetylase 1), a gene that is frequently overexpressed in many types of cancer, is a direct target of miR-449a. Further, our data indicate that miR-449a regulates cell growth and viability in part by repressing the expression of HDAC-1 in prostate cancer cells. Our findings provide new insight into the function of miRNA in regulating HDAC expression in normal versus cancerous tissue.	[Noonan, E. J.; Place, R. F.; Pookot, D.; Basak, S.; Hirata, H.; Dahiya, R.] Vet Affairs Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Place, R. F.; Whitson, J. M.; Dahiya, R.] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA; [Giardina, C.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Connecticut	Noonan, EJ (corresponding author), Vet Affairs Med Ctr, Dept Urol, 4150 Clement St, San Francisco, CA 94121 USA.	emily.noonan@gmail.com; Rdahiya@urology.ucsf.edu			Veterans Affairs Research Enhancement Award Program (REAP); National Institutes of Health [RO1CA101844, RO1CA111470s, T32DK007790]; NATIONAL CANCER INSTITUTE [R01CA101844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	Veterans Affairs Research Enhancement Award Program (REAP)(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R Erickson for his critical reading and discussion of the paper. This work was supported by the Veterans Affairs Research Enhancement Award Program (REAP), VA Merit Review grant and the National Institutes of Health grants RO1CA101844, RO1CA111470s and T32DK007790 (PI: Rajvir Dahiya).	Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen JS, 2005, J CELL PHYSIOL, V202, P87, DOI 10.1002/jcp.20094; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hitomi T, 2003, FEBS LETT, V554, P347, DOI 10.1016/S0014-5793(03)01186-4; Iacomino G, 2008, ANTICANCER RES, V28, P855; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HR, 2006, EXP MOL MED, V38, P616, DOI 10.1038/emm.2006.73; Kim JH, 2004, J GASTROEN HEPATOL, V19, P218, DOI 10.1111/j.1440-1746.2004.03336.x; Kim JH, 2001, COMPOS INTERFACE, V7, P443, DOI 10.1163/156855400750262932; Kummar S, 2007, CLIN CANCER RES, V13, P5411, DOI 10.1158/1078-0432.CCR-07-0791; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pan Y, 2001, GENE CHROMOSOME CANC, V30, P187, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1075>3.3.CO;2-8; Patra SK, 2001, BIOCHEM BIOPH RES CO, V287, P705, DOI 10.1006/bbrc.2001.5639; Place RF, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-37; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Pressman S, 2007, CELL, V130, DOI 10.1016/j.cell.2007.07.042; Qian DZ, 2007, PROSTATE, V67, P1182, DOI 10.1002/pros.20611; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Shabbeer S, 2007, PROSTATE, V67, P1099, DOI 10.1002/pros.20587; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wagner M, 2001, FEBS LETT, V499, P101, DOI 10.1016/S0014-5793(01)02524-8; Wedel SA, 2008, J CELL MOL MED, V12, P2457, DOI 10.1111/j.1582-4934.2008.00271.x; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Wiklund F, 2003, PROSTATE, V57, P290, DOI 10.1002/pros.10303; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1	57	306	326	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2009	28	14					1714	1724		10.1038/onc.2009.19	http://dx.doi.org/10.1038/onc.2009.19			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	430WQ	19252524				2022-12-25	WOS:000265022000006
J	Longo, C; Patanarut, A; George, T; Bishop, B; Zhou, WD; Fredolini, C; Ross, MM; Espina, V; Pellacani, G; Petricoin, EF; Liotta, LA; Luchini, A				Longo, Caterina; Patanarut, Alexis; George, Tony; Bishop, Barney; Zhou, Weidong; Fredolini, Claudia; Ross, Mark M.; Espina, Virginia; Pellacani, Giovanni; Petricoin, Emanuel F., III; Liotta, Lance A.; Luchini, Alessandra			Core-Shell Hydrogel Particles Harvest, Concentrate and Preserve Labile Low Abundance Biomarkers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IMATINIB MESYLATE; SERUM; TEMPERATURE; TARGET; MARKER; LIGAND; FUTURE; URINE; TRIAL	Background: The blood proteome is thought to represent a rich source of biomarkers for early stage disease detection. Nevertheless, three major challenges have hindered biomarker discovery: a) candidate biomarkers exist at extremely low concentrations in blood; b) high abundance resident proteins such as albumin mask the rare biomarkers; c) biomarkers are rapidly degraded by endogenous and exogenous proteinases. Methodology and Principal Findings: Hydrogel nanoparticles created with a N-isopropylacrylamide based core (365 nm)-shell (167 nm) and functionalized with a charged based bait (acrylic acid) were studied as a technology for addressing all these biomarker discovery problems, in one step, in solution. These harvesting core-shell nanoparticles are designed to simultaneously conduct size exclusion and affinity chromatography in solution. Platelet derived growth factor (PDGF), a clinically relevant, highly labile, and very low abundance biomarker, was chosen as a model. PDGF, spiked in human serum, was completely sequestered from its carrier protein albumin, concentrated, and fully preserved, within minutes by the particles. Particle sequestered PDGF was fully protected from exogenously added tryptic degradation. When the nanoparticles were added to a 1 mL dilute solution of PDGF at non detectable levels (less than 20 picograms per mL) the concentration of the PDGF released from the polymeric matrix of the particles increased within the detection range of ELISA and mass spectrometry. Beyond PDGF, the sequestration and protection from degradation for a series of additional very low abundance and very labile cytokines were verified. Conclusions and Significance: We envision the application of harvesting core-shell nanoparticles to whole blood for concentration and immediate preservation of low abundance and labile analytes at the time of venipuncture.	[Longo, Caterina; Pellacani, Giovanni] Univ Modena, Dept Dermatol, I-41100 Modena, Italy; [Longo, Caterina; George, Tony; Zhou, Weidong; Fredolini, Claudia; Ross, Mark M.; Espina, Virginia; Petricoin, Emanuel F., III; Liotta, Lance A.; Luchini, Alessandra] George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA USA; [Patanarut, Alexis; Bishop, Barney] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA	Universita di Modena e Reggio Emilia; George Mason University; George Mason University	Longo, C (corresponding author), Univ Modena, Dept Dermatol, I-41100 Modena, Italy.	aluchini@gmu.edu	pellacani, giovanni/E-8573-2011; Luchini, Alessandra/M-5340-2014; Longo, Caterina/A-8046-2012	pellacani, giovanni/0000-0002-7222-2951; Luchini, Alessandra/0000-0003-1599-0214; Longo, Caterina/0000-0002-8218-3896; Fredolini, Claudia/0000-0002-7674-2014; Espina, Virginia/0000-0001-5080-5972	George Mason University; Italian Istituto Superiore di Sanita; U.S. Department of Energy [DE-FC52-04NA25455]; NIH [1R21CA137706-01]; NATIONAL CANCER INSTITUTE [R21CA137706] Funding Source: NIH RePORTER	George Mason University; Italian Istituto Superiore di Sanita; U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by 1) George Mason University, 2) the Italian Istituto Superiore di Sanita' in the framework of the Italy/USA cooperation agreement between the U.S. Department of Health and Human Services, George Mason University, and the Italian Ministry of Public Health, and 3) the U.S. Department of Energy (grant number DE-FC52-04NA25455). The data herein was incorporated in the NIH grant submission number 1R21CA137706-01. The funding organizations did not have any role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ayache S, 2006, AM J CLIN PATHOL, V126, P174, DOI 10.1309/3WM7XJ7RD8BCLNKX; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Borst C, 2008, J CHROMATOGR A, V1204, P191, DOI 10.1016/j.chroma.2008.05.052; BOWENPOPE DF, 1984, BLOOD, V64, P458; Braude E. A., 1955, DETERMINATION ORGANI; Cai WS, 2005, J INCL PHENOM MACRO, V51, P41, DOI 10.1007/s10847-004-5238-3; Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e; Couvreur P, 2008, SMALL, V4, P247, DOI 10.1002/smll.200700731; Denizli A, 2001, J BIOCHEM BIOPH METH, V49, P391, DOI 10.1016/S0165-022X(01)00209-3; Dodziuk H., 2006, CYCLODEXTRINS THEIR; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Elmas B, 2002, COLLOID POLYM SCI, V280, P1137, DOI 10.1007/s00396-002-0740-x; Fortina P, 2005, TRENDS BIOTECHNOL, V23, P168, DOI 10.1016/j.tibtech.2005.02.007; Frederick M J, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003301; Fredolini C, 2008, NANO RES, V1, P502, DOI 10.1007/s12274-008-8054-z; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/j.addr.2012.09.009; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Jahnz-Rozyk K, 2003, ALLERGY, V58, P595, DOI 10.1034/j.1398-9995.2003.00083.x; JIN S, ARCH DERMATOL RES, V8, P451; Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kagami S, 2005, J INVEST DERMATOL, V124, P1088, DOI 10.1111/j.0022-202X.2005.23700.x; KATAOKA K, 1994, MACROMOLECULES, V27, P1061, DOI 10.1021/ma00082a028; Kubo T, 2008, CANCER-AM CANCER SOC, V112, P2119, DOI 10.1002/cncr.23437; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Lopez MF, 2005, CLIN CHEM, V51, P1946, DOI 10.1373/clinchem.2005.053090; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Mader HS, 2008, MICROCHIM ACTA, V162, P1, DOI 10.1007/s00604-008-0947-8; Mathew P, 2004, J CLIN ONCOL, V22, P3323, DOI 10.1200/JCO.2004.10.116; McArthur GA, 2005, J CLIN ONCOL, V23, P866, DOI 10.1200/JCO.2005.07.088; Merrell Karen, 2004, J Biomol Tech, V15, P238; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Nayak S, 2005, SMALL, V1, P416, DOI 10.1002/smll.200400089; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Robak E, 2007, EUR CYTOKINE NETW, V18, P181, DOI 10.1684/ecn.2007.0103; Sakamoto JH, 2005, TECHNOL CANCER RES T, V4, P627, DOI 10.1177/153303460500400606; Sereikaite J, 2006, BIOMED CHROMATOGR, V20, P195, DOI 10.1002/bmc.552; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Uekama K, 2006, J INCL PHENOM MACRO, V56, P3, DOI 10.1007/s10847-006-9052-y; Yamauchi A., 2006, GLUCOSE SENSING TOPI, P237; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zhang YL, 2006, CHEM-EUR J, V12, P1377, DOI 10.1002/chem.200500982; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	54	77	79	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4763	10.1371/journal.pone.0004763	http://dx.doi.org/10.1371/journal.pone.0004763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274087	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000004
J	Matamales, M; Bertran-Gonzalez, J; Salomon, L; Degos, B; Deniau, JM; Valjent, E; Herve, D; Girault, JA				Matamales, Miriam; Bertran-Gonzalez, Jesus; Salomon, Lucas; Degos, Bertrand; Deniau, Jean-Michel; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine			Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; BASAL GANGLIA; SUBSTANCE-P; DOPAMINE-RECEPTORS; ENKEPHALIN NEURONS; RAT STRIATUM; NEOSTRIATUM; ACTIVATION; DARPP-32; CELLS	Precise identification of neuronal populations is a major challenge in neuroscience. In the striatum, more than 95% of neurons are GABAergic medium-sized spiny neurons (MSNs), which form two intermingled populations distinguished by their projections and protein content. Those expressing dopamine D-1-receptors (D1Rs) project preferentially to the substantia nigra pars reticulata (SNr), whereas those expressing dopamine D-2-receptors (D2Rs) project preferentially to the lateral part of the globus pallidus (LGP). The degree of segregation of these populations has been a continuous subject of debate, and the recent introduction of bacterial artificial chromosome (BAC) transgenic mice expressing fluorescent proteins driven by specific promoters was a major progress to facilitate striatal neuron identification. However, the fraction of MSNs labeled in these mice has been recently called into question, casting doubt on the generality of results obtained with such approaches. Here, we performed an in-depth quantitative analysis of striatal neurons in drd1a-EGFP and drd2-EGFP mice. We first quantified neuronal and non-neuronal populations in the striatum, based on nuclear staining with TO-PRO-3, and immunolabeling for NeuN, DARPP-32 (dopamine- and cAMP-regulated phosphoprotein Mr similar to 32,000), and various markers for interneurons. TO-PRO-3 staining was sufficient to identify MSNs by their typical nuclear morphology and, with a good probability, interneuron populations. In drd1a-EGFP/drd2-EGFP double transgenic mice all MSNs expressed EGFP, which was driven in about half of them by drd1a promoter. Retrograde labeling showed that all MSNs projecting to the SNr expressed D1R and very few D2R (<1%). In contrast, our results were compatible with the existence of some D1R-EGFP-expressing fibers giving off terminals in the LGP. Thus, our study shows that nuclear staining is a simple method for identifying MSNs and other striatal neurons. It also unambiguously confirms the degree of segregation of MSNs in the mouse striatum and allows the full exploitation of results obtained with BAC-transgenic mice.	[Matamales, Miriam; Bertran-Gonzalez, Jesus; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine] INSERM, UMR S 839, Paris, France; [Matamales, Miriam; Bertran-Gonzalez, Jesus; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine] Univ Paris 06, F-75252 Paris, France; [Matamales, Miriam; Bertran-Gonzalez, Jesus; Valjent, Emmanuel; Herve, Denis; Girault, Jean-Antoine] Inst Fer Moulin, Paris, France; [Salomon, Lucas; Degos, Bertrand; Deniau, Jean-Michel] Inserm, Coll France, U667, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Matamales, M (corresponding author), INSERM, UMR S 839, Paris, France.	jean-antoine.girault@inserm.fr	Girault, Jean-Antoine/F-7518-2013; Longo, Kenneth A/A-5631-2010; HERVE, Denis/E-2929-2017; Matamales, Miriam/J-5189-2014; Bertran-Gonzalez, J/L-1410-2017	Girault, Jean-Antoine/0000-0002-7900-1705; HERVE, Denis/0000-0003-1376-1522; Matamales, Miriam/0000-0001-9978-0091; Bertran-Gonzalez, J/0000-0002-3794-1782; Valjent, Emmanuel/0000-0002-1034-606X	Inserm; Agence Nationale de la Recherche [ANR-05-NEUR-020]; Fondation pour la Recherche Medicale; Neuropole de Recherche Francilien (NeRF); Region Ile de France	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Neuropole de Recherche Francilien (NeRF); Region Ile de France(Region Ile-de-France)	This work was supported by Inserm, Agence Nationale de la Recherche (ANR-05-NEUR-020), Fondation pour la Recherche Medicale, and Neuropole de Recherche Francilien (NeRF), Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AUGOOD SJ, 1994, MOL BRAIN RES, V22, P204, DOI 10.1016/0169-328X(94)90048-5; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; BECKSTEAD RM, 1988, NEUROSCIENCE, V27, P851, DOI 10.1016/0306-4522(88)90188-1; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bink K, 2001, HISTOCHEM CELL BIOL, V115, P293; BISHOP GA, 1982, NEUROSCIENCE, V7, P179, DOI 10.1016/0306-4522(82)90159-2; Borgkvist A, 2008, NEUROPHARMACOLOGY, V55, P230, DOI 10.1016/j.neuropharm.2008.05.028; BROWNSTEIN MJ, 1977, BRAIN RES, V135, P315, DOI 10.1016/0006-8993(77)91034-4; DIFIGLIA M, 1986, J COMP NEUROL, V244, P36, DOI 10.1002/cne.902440104; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Gurney K, 2004, TRENDS NEUROSCI, V27, P453, DOI 10.1016/j.tins.2004.06.003; HERRERAMARSCHITZ M, 1984, BRAIN RES, V323, P269, DOI 10.1016/0006-8993(84)90297-X; HONG JS, 1977, NEUROPHARMACOLOGY, V16, P451, DOI 10.1016/0028-3908(77)90089-2; HONG JS, 1977, BRAIN RES, V122, P541, DOI 10.1016/0006-8993(77)90464-4; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; LEMOINE C, 1990, NEUROSCI LETT, V117, P248, DOI 10.1016/0304-3940(90)90671-U; LEMOINE C, 1990, P NATL ACAD SCI USA, V87, P230, DOI 10.1073/pnas.87.1.230; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; MROZ EA, 1977, BRAIN RES, V125, P305, DOI 10.1016/0006-8993(77)90623-0; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; OUIMET CC, 1984, J NEUROSCI, V4, P111; OUIMET CC, 1990, J NEUROCYTOL, V19, P39, DOI 10.1007/BF01188438; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107; TAKAGI H, 1983, J COMP NEUROL, V214, P1, DOI 10.1002/cne.902140102; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	49	174	175	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4770	10.1371/journal.pone.0004770	http://dx.doi.org/10.1371/journal.pone.0004770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274089	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000010
J	Xu, XJ; Kasembeli, MM; Jiang, XQ; Tweardy, BJ; Tweardy, DJ				Xu, Xuejun; Kasembeli, Moses M.; Jiang, Xueqing; Tweardy, Benjamin J.; Tweardy, David J.			Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation	PLOS ONE			English	Article								Signal transducer and activator of transcription (Stat) 3 is an oncogene constitutively activated in many cancer systems where it contributes to carcinogenesis. To develop chemical probes that selectively target Stat3, we virtually screened 920,000 small drug-like compounds by docking each into the peptide-binding pocket of the Stat3 SH2 domain, which consists of three sites-the pY-residue binding site, the +3 residue-binding site and a hydrophobic binding site, which served as a selectivity filter. Three compounds satisfied criteria of interaction analysis, competitively inhibited recombinant Stat3 binding to its immobilized pY-peptide ligand and inhibited IL-6-mediated tyrosine phosphorylation of Stat3. These compounds were used in a similarity screen of 2.47 million compounds, which identified 3 more compounds with similar activities. Examination of the 6 active compounds for the ability to inhibit IFN-gamma-mediated Stat1 phosphorylation revealed that 5 of 6 were selective for Stat3. Molecular modeling of the SH2 domains of Stat3 and Stat1 bound to compound revealed that compound interaction with the hydrophobic binding site was the basis for selectivity. All 5 selective compounds inhibited nuclear-to-cytoplasmic translocation of Stat3, while 3 of 5 compounds induced apoptosis preferentially of breast cancer cell lines with constitutive Stat3 activation. Thus, virtual ligand screening of compound libraries that targeted the Stat3 pY-peptide binding pocket identified for the first time 3 lead compounds that competitively inhibited Stat3 binding to its pY-peptide ligand; these compounds were selective for Stat3 vs. Stat1 and induced apoptosis preferentially of breast cancer cells lines with constitutively activated Stat3.	[Xu, Xuejun; Kasembeli, Moses M.; Jiang, Xueqing; Tweardy, Benjamin J.; Tweardy, David J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Xu, XJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.	dtweardy@bcm.edu	Tweardy, David/L-3929-2019		National Cancer Institute of the NIH [CA072261]; NATIONAL CANCER INSTITUTE [R01CA072261] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by grant CA072261 (DJT) from the National Cancer Institute of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chen JY, 2007, BIOORG MED CHEM LETT, V17, P3939, DOI 10.1016/j.bmcl.2007.04.096; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Costantino L, 2008, CURR MED CHEM, V15, P834, DOI 10.2174/092986708783955464; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Dong S, 2003, LEUKEMIA LYMPHOMA, V44, P2023, DOI 10.1080/1042819031000116670; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jing N, 2003, DNA CELL BIOL, V22, P685, DOI 10.1089/104454903770946665; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Jing NJ, 2006, MOL CANCER THER, V5, P279, DOI 10.1158/1535-7163.MCT-05-0302; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kato T, 2004, J BIOL CHEM, V279, P31076, DOI 10.1074/jbc.M400637200; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Maloney KN, 2006, ORG LETT, V8, P4067, DOI 10.1021/ol061556f; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Redell Michele S, 2006, Drug Discov Today Technol, V3, P261, DOI 10.1016/j.ddtec.2006.09.010; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; SATYAPRAKASH KL, 1981, CANCER GENET CYTOGEN, V3, P61, DOI 10.1016/0165-4608(81)90057-1; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Shao H, 2006, J IMMUNOL, V176, P2933, DOI 10.4049/jimmunol.176.5.2933; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Totrov M, 1997, PROTEINS, P215; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; TWEARDY DJ, 1995, BLOOD, V86, P4409, DOI 10.1182/blood.V86.12.4409.bloodjournal86124409; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; ZHANG RD, 1991, INVAS METAST, V11, P204; Zhu QQ, 2007, J COMPUT AID MOL DES, V21, P641, DOI 10.1007/s10822-007-9147-6	49	95	103	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4783	10.1371/journal.pone.0004783	http://dx.doi.org/10.1371/journal.pone.0004783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274102	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000020
J	Baskind, HA; Na, L; Ma, QH; Patel, MP; Geenen, DL; Wang, QT				Baskind, Heather A.; Na, Lucy; Ma, Quanhong; Patel, Mayur P.; Geenen, David L.; Wang, Q. Tian			Functional Conservation of Asxl2, a Murine Homolog for the Drosophila Enhancer of Trithorax and Polycomb Group Gene Asx	PLOS ONE			English	Article							ADDITIONAL-SEX-COMBS; HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEINS; HOX GENE; RESPONSE ELEMENTS; BINDING-PROTEIN; DNA-BINDING; COMPLEX; IDENTIFICATION; METHYLATION	Background: Polycomb-group (PcG) and trithorax-group (trxG) proteins regulate histone methylation to establish repressive and active chromatin configurations at target loci, respectively. These chromatin configurations are passed on from mother to daughter cells, thereby causing heritable changes in gene expression. The activities of PcG and trxG proteins are regulated by a special class of proteins known as Enhancers of trithorax and Polycomb (ETP). The Drosophila gene Additional sex combs (Asx) encodes an ETP protein and mutations in Asx enhance both PcG and trxG mutant phenotypes. The mouse and human genomes each contain three Asx homologues, Asx-like 1, 2, and 3. In order to understand the functions of mammalian Asx-like (Asxl) proteins, we generated an Asxl2 mutant mouse from a gene-trap ES cell line. Methodology/Principal Findings: We show that the Asxl2 gene trap is expressed at high levels in specific tissues including the heart, the axial skeleton, the neocortex, the retina, spermatogonia and developing oocytes. The gene trap mutation is partially embryonic lethal and approximately half of homozygous animals die before birth. Homozygotes that survive embryogenesis are significantly smaller than controls and have a shortened life span. Asxl2(-/-) mice display both posterior transformations and anterior transformation in the axial skeleton, suggesting that the loss of Asxl2 disrupts the activities of both PcG and trxG proteins. The PcG-associated histone modification, trimethylation of histone H3 lysine 27, is reduced in Asxl2(-/-) heart. Necropsy and histological analysis show that mutant mice have enlarged hearts and may have impaired heart function. Conclusions/Significance: Our results suggest that murine Asxl2 has conserved ETP function and plays dual roles in the promotion of PcG and trxG activity. We have also revealed an unexpected role for Asxl2 in the heart, suggesting that the PcG/trxG system may be involved in the regulation of cardiac function.	[Baskind, Heather A.; Na, Lucy; Ma, Quanhong; Patel, Mayur P.; Wang, Q. Tian] Univ Chicago, Dept Biol Sci, Chicago, IL 60637 USA; [Geenen, David L.] Univ Illinois, Dept Med, Sect Cardiol, Chicago, IL 60680 USA; [Geenen, David L.] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL 60680 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Baskind, HA (corresponding author), Univ Chicago, Dept Biol Sci, Chicago, IL 60637 USA.	qtwang@uic.edu			WISER Fund Award; Leukemia Research Foundation [2007-04173]	WISER Fund Award; Leukemia Research Foundation	This work was partially supported by a WISER Fund Award (www.uicwise.org/) to QTW and a Leukemia Research Foundation (www.leukemia-research.org) grant (#2007-04173) to QTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bel S, 1998, DEVELOPMENT, V125, P3543; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; BROWN KL, 1998, RRD INORG CHEM, V1, P1; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Core N, 1997, DEVELOPMENT, V124, P721; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Decoville M, 2001, GENETICS, V157, P237; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Duncan I, 1996, BIOESSAYS, V18, P91, DOI 10.1002/bies.950180203; Durand JB, 1999, CURR OPIN CARDIOL, V14, P225, DOI 10.1097/00001573-199905000-00006; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Gildea JJ, 2000, GENETICS, V156, P645; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Katoh M, 2004, INT J ONCOL, V24, P1617; Katoh M, 2003, INT J ONCOL, V23, P845; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Lorente M, 2006, MECH DEVELOP, V123, P312, DOI 10.1016/j.mod.2006.02.003; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Ramocki MB, 2003, EUR J HUM GENET, V11, P527, DOI 10.1038/sj.ejhg.5200995; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shirai M, 2002, J CLIN INVEST, V110, P177, DOI 10.1172/JCI200214839; SINCLAIR DAR, 1992, GENETICS, V130, P817; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4750	10.1371/journal.pone.0004750	http://dx.doi.org/10.1371/journal.pone.0004750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270745	Green Published, gold, Green Submitted			2022-12-25	WOS:000265495900017
J	Meli, ML; Cattori, V; Martinez, F; Lopez, G; Vargas, A; Simon, MA; Zorrilla, I; Munoz, A; Palomares, F; Lopez-Bao, JV; Pastor, J; Tandon, R; Willi, B; Hofmann-Lehmann, R; Lutz, H				Meli, Marina L.; Cattori, Valentino; Martinez, Fernando; Lopez, Guillermo; Vargas, Astrid; Simon, Miguel A.; Zorrilla, Irene; Munoz, Alvaro; Palomares, Francisco; Lopez-Bao, Jose V.; Pastor, Josep; Tandon, Ravi; Willi, Barbara; Hofmann-Lehmann, Regina; Lutz, Hans			Feline Leukemia Virus and Other Pathogens as Important Threats to the Survival of the Critically Endangered Iberian Lynx (Lynx pardinus)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DONANA-NATIONAL-PARK; IMMUNODEFICIENCY VIRUS; BOVINE TUBERCULOSIS; MOLECULAR CHARACTERIZATION; EXPERIMENTAL TRANSMISSION; MYCOBACTERIUM-BOVIS; WILD CARNIVORES; GENE-SEQUENCES; DISEASE AGENTS	Background: The Iberian lynx (Lynx pardinus) is considered the most endangered felid species in the world. In order to save this species, the Spanish authorities implemented a captive breeding program recruiting lynxes from the wild. In this context, a retrospective survey on prevalence of selected feline pathogens in free-ranging lynxes was initiated. Methodology/Principal Findings: We systematically analyzed the prevalence and importance of seven viral, one protozoan (Cytauxzoon felis), and several bacterial (e.g., hemotropic mycoplasma) infections in 77 of approximately 200 remaining free-ranging Iberian lynxes of the Donana and Sierra Morena areas, in Southern Spain, between 2003 and 2007. With the exception of feline immunodeficiency virus (FIV), evidence of infection by all tested feline pathogens was found in Iberian lynxes. Fourteen lynxes were feline leukemia virus (FeLV) provirus-positive; eleven of these were antigenemic (FeLV p27 positive). All 14 animals tested negative for other viral infections. During a six-month period in 2007, six of the provirus-positive antigenemic lynxes died. Infection with FeLV but not with other infectious agents was associated with mortality (p < 0.001). Sequencing of the FeLV surface glycoprotein gene revealed a common origin for ten of the eleven samples. The ten sequences were closely related to FeLV-A/61E, originally isolated from cats in the USA. Endogenous FeLV sequences were not detected. Conclusions/Significance: It was concluded that the FeLV infection most likely originated from domestic cats invading the lynx's habitats. Data available regarding the time frame, co-infections, and outcome of FeLV-infections suggest that, in contrast to the domestic cat, the FeLV strain affecting the lynxes in 2007 is highly virulent to this species. Our data argue strongly for vaccination of lynxes and domestic cats in and around lynx's habitats in order to prevent further spread of the virus as well as reduction the domestic cat population if the lynx population is to be maintained.	[Meli, Marina L.; Cattori, Valentino; Tandon, Ravi; Willi, Barbara; Hofmann-Lehmann, Regina; Lutz, Hans] Univ Zurich, Clin Lab, Vetsuisse Fac, Zurich, Switzerland; [Martinez, Fernando; Vargas, Astrid] Espac Nat Donana, Programa Conservac Ex Situ Lince Iberico, Matalascanas, Spain; [Lopez, Guillermo; Simon, Miguel A.] Egmasa Consejeria Medio Ambiente, Cordoba, Spain; [Zorrilla, Irene; Munoz, Alvaro] Ctr Anal Diagnost, Malaga, Spain; [Palomares, Francisco; Lopez-Bao, Jose V.] CSIC, Dept Biol Conservac, Estn Biol Donana, Seville, Spain; [Pastor, Josep] Univ Autonoma Barcelona, Fac Vet, Dept Med Cirurg Anim, Barcelona, Spain	University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Autonomous University of Barcelona	Meli, ML (corresponding author), Univ Zurich, Clin Lab, Vetsuisse Fac, Zurich, Switzerland.	mmeli@vetclinics.uzh.ch	Zorrilla, Irene/G-2885-2014; Pastor, Josep/J-9990-2015; Palomares, Francisco/F-5327-2016; Hofmann-Lehmann, Regina/C-6528-2009; Willi, Barbara/B-7636-2018; Willi, Barbara/AAZ-8136-2021	Pastor, Josep/0000-0003-1702-9531; Palomares, Francisco/0000-0002-4655-7205; Hofmann-Lehmann, Regina/0000-0001-9750-4296; Willi, Barbara/0000-0002-8010-1180; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Cattori, Valentino/0000-0001-6856-1347	Spanish Ministry of Education and Science [CGL2004-00346/BOS]; Spanish Ministry of the Environment [17/2005]; FPU [fellow]; Swiss National Science Foundation [PP00B 102866, PP00P3-119136]; University of Zurich, Switzerland	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of the Environment(Spanish Government); FPU(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich, Switzerland	The authors are indebted to the Environmental Council of the government of Andalusia, southern Spain, for providing the Iberian lynx samples. Some of the lynxes used in the present study were trapped and radio-tracked under research projects CGL2004-00346/BOS of the Spanish Ministry of Education and Science, and 17/2005 of the Spanish Ministry of the Environment under the National Parks research program, with the collaboration of Land Rover Espana S.A. JVLB is an FPU fellow (Ministry of Education). Laboratory work was performed using the logistics of the Center for Clinical Studies at the Vetsuisse Faculty of the University of Zurich. RHL is the recipient of a professorship by the Swiss National Science Foundation (PP00B 102866 and PP00P3-119136). The project was supported by the University of Zurich, Switzerland, by financing the operational activities of the Clinical laboratory of the Vetsuisse Faculty, Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Arjona A, 2000, J CLIN MICROBIOL, V38, P3448, DOI 10.1128/JCM.38.9.3448-3449.2000; Briones V, 2000, EMERG INFECT DIS, V6, P189, DOI 10.3201/eid0602.000214; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; Brown MA, 2008, EMERG INFECT DIS, V14, P252, DOI 10.3201/eid1402.070981; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Cattori V, 2006, MOL CELL PROBE, V20, P172, DOI 10.1016/j.mcp.2005.11.007; Chandhasin C, 2005, J VIROL, V79, P5278, DOI 10.1128/JVI.79.9.5278-5287.2005; Chandhasin C, 2005, J VIROL, V79, P1351, DOI 10.1128/JVI.79.3.1351-1360.2005; Chandhasin C, 2004, J GEN VIROL, V85, P2937, DOI 10.1099/vir.0.80149-0; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coelho FM, 2008, J GEN VIROL, V89, P2799, DOI 10.1099/vir.0.2008/003855-0; Delibes M., 2000, ACTION PLAN CONSERVA; EVERMANN JF, 1988, ARCH VIROL, V102, P155, DOI 10.1007/BF01310822; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; GAONA P, 1998, ECOL MONOGR, P349; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gut M, 1999, J VIROL METHODS, V77, P37, DOI 10.1016/S0166-0934(98)00129-3; GUZMAN JN, 2002, IBERIAN LYNX LYNX PA; HEENEY JL, 1990, J VIROL, V64, P1964, DOI 10.1128/JVI.64.5.1964-1972.1990; Helps C, 2002, J VIROL METHODS, V106, P241, DOI 10.1016/S0166-0934(02)00167-2; Helps C, 2001, J CLIN MICROBIOL, V39, P2675, DOI 10.1128/JCM.39.7.2675-2676.2001; Hofmann-Lehmann R, 2007, VACCINE, V25, P5531, DOI 10.1016/j.vaccine.2006.12.022; HofmannLehmann R, 1997, CLIN DIAGN LAB IMMUN, V4, P33, DOI 10.1128/CDLI.4.1.33-42.1997; HofmannLehmann R, 1996, CLIN DIAGN LAB IMMUN, V3, P554, DOI 10.1128/CDLI.3.5.554-562.1996; HOOVER EA, 1991, J AM VET MED ASSOC, V199, P1287; HOOVER EA, 1987, BLOOD, V70, P1880; IUCN, 2007, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; Jimenez MA, 2008, VET IMMUNOL IMMUNOP, V121, P34, DOI 10.1016/j.vetimm.2007.07.018; Johnson WE, 2004, J HERED, V95, P19, DOI 10.1093/jhered/esh006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leutenegger CM, 1999, J VIROL METHODS, V78, P105, DOI 10.1016/S0166-0934(98)00166-9; LOPEZ G, ANIMAL CONSERV UNPUB; Lopez-Bao JV, 2008, MAMM BIOL, V73, P404, DOI 10.1016/j.mambio.2007.10.012; Luaces I, 2005, J WILDLIFE DIS, V41, P810, DOI 10.7589/0090-3558-41.4.810; Luaces I, 2008, J VET DIAGN INVEST, V20, P381, DOI 10.1177/104063870802000325; LUTZ H, 1983, AM J VET RES, V44, P2054; Martin-Atance P, 2006, J WILDLIFE DIS, V42, P704, DOI 10.7589/0090-3558-42.3.704; MATSUMOTO Y, 1992, VIROLOGY, V189, P745, DOI 10.1016/0042-6822(92)90598-J; Meli M, 2004, J FELINE MED SURG, V6, P69, DOI 10.1016/j.jfms.2003.08.007; Millan J, 2007, PARASITOLOGY, V134, P995, DOI 10.1017/S003118200700248X; Molia S, 2004, VET MICROBIOL, V100, P31, DOI 10.1016/j.vetmic.2004.01.007; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nei M., 2000, MOL EVOLUTION PHYLOG; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NOWELL K, 2002, IUCN SSC CAT SPECIAL; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Palomares F, 2002, MOL ECOL, V11, P2171, DOI 10.1046/j.1365-294X.2002.01608.x; PALOMARES F, 2001, WILDLIFE MONOGRAPHS; Palomares F, 2003, MEMORIAM PROF ISIDOR, P505; Parra A, 2005, VET MICROBIOL, V110, P293, DOI 10.1016/j.vetmic.2005.07.013; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; Pena L, 2006, COMP IMMUNOL MICROB, V29, P114, DOI 10.1016/j.cimid.2006.01.003; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Pusterla N, 1999, J CLIN MICROBIOL, V37, P1329, DOI 10.1128/JCM.37.5.1329-1331.1999; Ramsauer S, 2007, CLIN VACCINE IMMUNOL, V14, P808, DOI 10.1128/CVI.00307-06; Rodriguez A, 2002, ECOGRAPHY, V25, P314, DOI 10.1034/j.1600-0587.2002.250308.x; Roelke ME, 2008, EUR J WILDLIFE RES, V54, P171, DOI 10.1007/s10344-007-0122-2; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; RoyBurman P, 1995, VIRUS GENES, V11, P147, DOI 10.1007/BF01728655; Ryser-Degiorgis MP, 2005, J WILDLIFE DIS, V41, P58, DOI 10.7589/0090-3558-41.1.58; Sobrino R, 2007, VET PARASITOL, V148, P187, DOI 10.1016/j.vetpar.2007.06.038; Tandon R, 2005, J VIROL METHODS, V130, P124, DOI 10.1016/j.jviromet.2005.06.017; TANDON R, 2008, VIRUS RES; Tandon R, 2007, MOL CELL PROBE, V21, P257, DOI 10.1016/j.mcp.2007.01.003; TARTAGLIA J, 1993, J VIROL, V67, P2370, DOI 10.1128/JVI.67.4.2370-2375.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres J, 1998, J HELMINTHOL, V72, P221, DOI 10.1017/S0022149X00016473; Vicente J, 2004, J HELMINTHOL, V78, P179, DOI 10.1079/JOH2003216; Vogtlin A, 2002, J CLIN MICROBIOL, V40, P519, DOI 10.1128/JCM.40.2.519-523.2002; Willi B, 2006, J CLIN MICROBIOL, V44, P961, DOI 10.1128/JCM.44.3.961-969.2006; Willi B, 2005, J CLIN MICROBIOL, V43, P2581, DOI 10.1128/JCM.43.6.2581-2585.2005; Willi B, 2007, J CLIN MICROBIOL, V45, P1159, DOI 10.1128/JCM.02005-06	79	103	103	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4744	10.1371/journal.pone.0004744	http://dx.doi.org/10.1371/journal.pone.0004744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270739	Green Published, gold			2022-12-25	WOS:000265495900012
J	Wiedemann, T; Loell, E; Mueller, S; Stoeckelhuber, M; Stolte, M; Haas, R; Rieder, G				Wiedemann, Tobias; Loell, Eva; Mueller, Susanna; Stoeckelhuber, Mechthild; Stolte, Manfred; Haas, Rainer; Rieder, Gabriele			Helicobacter pylori cag-Pathogenicity Island-Dependent Early Immunological Response Triggers Later Precancerous Gastric Changes in Mongolian Gerbils	PLOS ONE			English	Article								Infection with Helicobacter pylori, carrying a functional cag type IV secretion system (cag-T4SS) to inject the Cytotoxin associated antigen (CagA) into gastric cells, is associated with an increased risk for severe gastric diseases in humans. Here we studied the pathomechanism of H. pylori and the role of the cag-pathogenicity island (cag-PAI) for the induction of gastric ulcer and precancerous conditions over time (2-64 weeks) using the Mongolian gerbil model. Animals were challenged with H. pylori B128 (WT), or an isogenic B128 Delta cagY mutant-strain that produces CagA, but is unable to translocate it into gastric cells. H. pylori colonization density was quantified in antrum and corpus mucosa separately. Paraffin sections were graded for inflammation and histological changes verified by immunohistochemistry. Physiological and inflammatory markers were quantitated by RIA and RT-PCR, respectively. An early cag-T4SS-dependent inflammation of the corpus mucosa (4-8 weeks) occurred only in WT-infected animals, resulting in a severe active and chronic gastritis with a significant increase of proinflammatory cytokines, mucous gland metaplasia, and atrophy of the parietal cells. At late time points only WT-infected animals developed hypochlorhydria and hypergastrinemia in parallel to gastric ulcers, gastritis cystica profunda, and focal dysplasia. The early cag-PAI-dependent immunological response triggers later physiological and histopathological alterations towards gastric malignancies.	[Wiedemann, Tobias; Loell, Eva; Haas, Rainer; Rieder, Gabriele] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Mueller, Susanna] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Stoeckelhuber, Mechthild] Univ Munich, Inst Anat, D-80539 Munich, Germany; [Stolte, Manfred] Klin Bayreuth GmbH, Inst Pathol, Bayreuth, Germany	University of Munich; University of Munich; University of Munich; Klinikum Bayreuth	Wiedemann, T (corresponding author), Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany.	rieder@mvp.uni-muenchen.de			Deutsche Forschungsgemeinschaft [RI 972/3-1, SFB576]; ERA-NET PathoGenoMics [0313930D]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERA-NET PathoGenoMics	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RI 972/3-1) to GR and (SFB576) to RH and ERA-NET PathoGenoMics (0313930D) to RH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bach S, 1999, EUR J CLIN MICROBIOL, V18, P807, DOI 10.1007/s100960050405; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Beales ILP, 1998, GUT, V43, P176, DOI 10.1136/gut.43.2.176; CORREA P, 1988, CANCER RES, V48, P3554; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Zimaity HMT, 2002, CANCER-AM CANCER SOC, V94, P1428, DOI 10.1002/cncr.10375; Elfvin A, 2005, SCAND J GASTROENTERO, V40, P1313, DOI 10.1080/00365520510023611; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Fox JG, 2003, CANCER RES, V63, P942; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Honda S, 1998, CANCER RES, V58, P4255; International Agency for Research on Cancer, 1994, IARC MONOGR EVAL CAR, V61, P1; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Meining A, 1998, VIRCHOWS ARCH, V432, P311, DOI 10.1007/s004280050171; Miehlke S, 2001, AM J GASTROENTEROL, V96, P1008, DOI 10.1111/j.1572-0241.2001.03685.x; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Neu B, 2003, BIOCHEM PHARMACOL, V65, P1755, DOI 10.1016/S0006-2952(03)00124-2; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Prinz C, 1997, GASTROENTEROLOGY, V112, P364, DOI 10.1053/gast.1997.v112.pm9024290; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schmidt PH, 1999, LAB INVEST, V79, P639; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Sozzi M, 2001, FEMS MICROBIOL LETT, V203, P109, DOI 10.1016/S0378-1097(01)00338-X; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100; Zavros Y, 2005, BIOCHEM PHARMACOL, V69, P365, DOI 10.1016/j.bcp.2004.07.043	48	50	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4754	10.1371/journal.pone.0004754	http://dx.doi.org/10.1371/journal.pone.0004754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270747	Green Published, Green Submitted, gold			2022-12-25	WOS:000265495900021
J	Ke, XS; Qu, Y; Rostad, K; Li, WC; Lin, BY; Halvorsen, OJ; Haukaas, SA; Jonassen, I; Petersen, K; Goldfinger, N; Rotter, V; Akslen, LA; Oyan, AM; Kalland, KH				Ke, Xi-Song; Qu, Yi; Rostad, Kari; Li, Wen-Cheng; Lin, Biaoyang; Halvorsen, Ole Johan; Haukaas, Svein A.; Jonassen, Inge; Petersen, Kjell; Goldfinger, Naomi; Rotter, Varda; Akslen, Lars A.; Oyan, Anne M.; Kalland, Karl-Henning			Genome-Wide Profiling of Histone H3 Lysine 4 and Lysine 27 Trimethylation Reveals an Epigenetic Signature in Prostate Carcinogenesis	PLOS ONE			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; MIR-200 FAMILY; CANCER; METHYLATION; PROLIFERATION; SUBGROUPS; PHENOTYPE; CELLS; MARKS	Background: Increasing evidence implicates the critical roles of epigenetic regulation in cancer. Very recent reports indicate that global gene silencing in cancer is associated with specific epigenetic modifications. However, the relationship between epigenetic switches and more dynamic patterns of gene activation and repression has remained largely unknown. Methodology/Principal Findings: Genome-wide profiling of the trimethylation of histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3) was performed using chromatin immunoprecipitation coupled with whole genome promoter microarray (ChIP-chip) techniques. Comparison of the ChIP-chip data and microarray gene expression data revealed that loss and/or gain of H3K4me3 and/or H3K27me3 were strongly associated with differential gene expression, including microRNA expression, between prostate cancer and primary cells. The most common switches were gain or loss of H3K27me3 coupled with low effect on gene expression. The least prevalent switches were between H3K4me3 and H3K27me3 coupled with much higher fractions of activated and silenced genes. Promoter patterns of H3K4me3 and H3K27me3 corresponded strongly with coordinated expression changes of regulatory gene modules, such as HOX and microRNA genes, and structural gene modules, such as desmosome and gap junction genes. A number of epigenetically switched oncogenes and tumor suppressor genes were found overexpressed and underexpressed accordingly in prostate cancer cells. Conclusions/Significance: This work offers a dynamic picture of epigenetic switches in carcinogenesis and contributes to an overall understanding of coordinated regulation of gene expression in cancer. Our data indicate an H3K4me3/H3K27me3 epigenetic signature of prostate carcinogenesis.	[Ke, Xi-Song; Qu, Yi; Rostad, Kari; Li, Wen-Cheng; Akslen, Lars A.; Oyan, Anne M.; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Li, Wen-Cheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan, Peoples R China; [Lin, Biaoyang] Swedish Med Ctr, Seattle, WA USA; [Lin, Biaoyang] Zhejiang Univ, Zhejiang Calif Int Nanosyst Inst ZCNI, Hangzhou, Peoples R China; [Halvorsen, Ole Johan; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Haukaas, Svein A.] Univ Bergen, Dept Surgical Sci, N-5020 Bergen, Norway; [Haukaas, Svein A.] Haukeland Hosp, Dept Surg, Bergen, Norway; [Jonassen, Inge; Petersen, Kjell] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, N-5020 Bergen, Norway; [Jonassen, Inge; Petersen, Kjell] Univ Bergen, Dept Informat, N-5020 Bergen, Norway; [Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Oyan, Anne M.; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway	University of Bergen; Huazhong University of Science & Technology; Swedish Medical Center; Zhejiang University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Weizmann Institute of Science; University of Bergen; Haukeland University Hospital	Ke, XS (corresponding author), Univ Bergen, Gade Inst, Bergen, Norway.	Xisong.Ke@gades.uib.no; Kalland@gades.uib.no	Lin, Biaoyang/AAA-1258-2020; Akslen, Lars A./AAG-6097-2021; Jonassen, Inge/AAC-7035-2020	Lin, Biaoyang/0000-0002-2189-0407; Akslen, Lars A./0000-0003-2710-9543; Jonassen, Inge/0000-0003-4110-0748	Helse Vest [911005, 911227, 911401]; Research Council of Norway [154942/310, 163920/V50, 185676/V40]; The Norwegian Cancer Society [HS01-2006-0446, HS01-2006-0468, HS02-2008-0188]; European Commission 6th Framework Program [504743]; UroBergen Research Fund	Helse Vest; Research Council of Norway(Research Council of Norway); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); European Commission 6th Framework Program(European CommissionEuropean Commission Joint Research Centre); UroBergen Research Fund	This work was supported by Helse Vest (grants no. 911005, 911227 and 911401), the Research Council of Norway (grants. no. 154942/310, 163920/V50 and 185676/V40) and The Norwegian Cancer Society (grants no. HS01-2006-0446, HS01-2006-0468, HS02-2008-0188), the European Commission 6th Framework Program Contract 504743 and the UroBergen Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Halvorsen OJ, 2005, INT J ONCOL, V26, P329; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller GJ, 2003, CANCER RES, V63, P5879; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Petersen K, 2007, ANAL BIOCHEM, V366, P46, DOI 10.1016/j.ab.2007.03.013; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rostad K, 2007, INT J ONCOL, V30, P19; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Shioji G, 2005, J HUM GENET, V50, P507, DOI 10.1007/s10038-005-0285-1; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	43	110	115	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4687	10.1371/journal.pone.0004687	http://dx.doi.org/10.1371/journal.pone.0004687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262738	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600015
J	Govern, CC; Chakraborty, AK				Govern, Christopher C.; Chakraborty, Arup K.			Signaling Cascades Modulate the Speed of Signal Propagation through Space	PLOS ONE			English	Article							KINASE CASCADE	Background: Cells are not mixed bags of signaling molecules. As a consequence, signals must travel from their origin to distal locations. Much is understood about the purely diffusive propagation of signals through space. Many signals, however, propagate via signaling cascades. Here, we show that, depending on their kinetics, cascades speed up or slow down the propagation of signals through space, relative to pure diffusion. Methodology/Principal Findings: We modeled simple cascades operating under different limits of Michaelis-Menten kinetics using deterministic reaction-diffusion equations. Cascades operating far from enzyme saturation speed up signal propagation; the second mobile species moves more quickly than the first through space, on average. The enhanced speed is due to more efficient serial activation of a downstream signaling module (by the signaling molecule immediately upstream in the cascade) at points distal from the signaling origin, compared to locations closer to the source. Conversely, cascades operating under saturated kinetics, which exhibit zero-order ultrasensitivity, can slow down signals, ultimately localizing them to regions around the origin. Conclusions/Significance: Signal speed modulation may be a fundamental function of cascades, affecting the ability of signals to penetrate within a cell, to cross-react with other signals, and to activate distant targets. In particular, enhanced speeds provide a way to increase signal penetration into a cell without needing to flood the cell with large numbers of active signaling molecules; conversely, diminished speeds in zero-order ultrasensitive cascades facilitate strong, but localized, signaling.	[Govern, Christopher C.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Govern, CC (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu			NIH Director's Pioneer Award; NIH [2 T32 GM008334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH Director's Pioneer Award; NIH Grant 2 T32 GM008334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, TRENDS CELL BIOL, V12, P173, DOI 10.1016/S0962-8924(02)02251-1; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; Naka T, 2006, BIOSYSTEMS, V83, P167, DOI 10.1016/j.biosystems.2005.06.015; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Slepchenko BM, 2003, MOL BIOL CELL, V14, P4695, DOI 10.1091/mbc.E03-04-0248; Stelling J, 2009, J MATH BIOL, V58, P35, DOI 10.1007/s00285-008-0162-6; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4639	10.1371/journal.pone.0004639	http://dx.doi.org/10.1371/journal.pone.0004639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247484	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487800020
J	Hans, S; Kaslin, J; Freudenreich, D; Brand, M				Hans, Stefan; Kaslin, Jan; Freudenreich, Dorian; Brand, Michael			Temporally-Controlled Site-Specific Recombination in Zebrafish	PLOS ONE			English	Article								Conventional use of the site-specific recombinase Cre is a powerful technology in mouse, but almost absent in other vertebrate model organisms. In zebrafish, Cre-mediated recombination efficiency was previously very low. Here we show that using transposon-mediated transgenesis, Cre is in fact highly efficient in this organism. Furthermore, temporal control of recombination can be achieved by using the ligand-inducible CreER(T2). Site-specific recombination only occurs upon administration of the drug tamoxifen (TAM) or its active metabolite, 4-hydroxy-tamoxifen (4-OHT). Cre-mediated recombination is detectable already 4 or 2 hours after administration of TAM or 4-OHT, demonstrating fast recombination kinetics. In addition, low doses of TAM allow mosaic labeling of single cells. Combined, our results show that conditional Cre/lox will be a valuable tool for both, embryonic and adult zebrafish studies. Furthermore, single copy insertion transgenesis of Cre/lox constructs suggest a strategy suitable also for other organisms.	[Hans, Stefan; Kaslin, Jan; Freudenreich, Dorian; Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Hans, Stefan; Kaslin, Jan; Freudenreich, Dorian; Brand, Michael] Tech Univ Dresden, Ctr Regenerative Therapies Dresden, D-8027 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hans, S (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Kaslin, Jan/E-7780-2010; Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Kaslin, Jan/0000-0002-6207-1889	EU; ZF-MODELS; Endotrack;  [SFB 655]	EU(European Commission); ZF-MODELS; Endotrack; 	This work was supported by grants from the EU, ZF-MODELS, Endotrack and SFB 655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Driever W, 1996, DEVELOPMENT, V123, P37; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Feil R, 2007, Handb Exp Pharmacol, P3; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feng H, 2007, BRIT J HAEMATOL, V138, P169, DOI 10.1111/j.1365-2141.2007.06625.x; Haffter P, 1996, DEVELOPMENT, V123, P1; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Iyengar A, 1996, TRANSGENIC RES, V5, P147, DOI 10.1007/BF01969704; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Picker A, 2002, DEVELOPMENT, V129, P3227; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STUART GW, 1988, DEVELOPMENT, V103, P403; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	30	144	146	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4640	10.1371/journal.pone.0004640	http://dx.doi.org/10.1371/journal.pone.0004640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247481	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800021
J	Papeo, L; Vallesi, A; Isaja, A; Rumiati, RI				Papeo, Liuba; Vallesi, Antonino; Isaja, Alessio; Rumiati, Raffaella Ida			Effects of TMS on Different Stages of Motor and Non-Motor Verb Processing in the Primary Motor Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; WORD RECOGNITION; MENTAL ROTATION; LANGUAGE; BRAIN; ACTIVATION; MECHANISMS; SYSTEM; REPRESENTATION; COMPATIBILITY	The embodied cognition hypothesis suggests that motor and premotor areas are automatically and necessarily involved in understanding action language, as word conceptual representations are embodied. This transcranial magnetic stimulation (TMS) study explores the role of the left primary motor cortex in action-verb processing. TMS-induced motor-evoked potentials from right-hand muscles were recorded as a measure of M1 activity, while participants were asked either to judge explicitly whether a verb was action-related (semantic task) or to decide on the number of syllables in a verb (syllabic task). TMS was applied in three different experiments at 170, 350 and 500 ms post-stimulus during both tasks to identify when the enhancement of M1 activity occurred during word processing. The delays between stimulus onset and magnetic stimulation were consistent with electrophysiological studies, suggesting that word recognition can be differentiated into early (within 200 ms) and late (within 400 ms) lexical-semantic stages, and post-conceptual stages. Reaction times and accuracy were recorded to measure the extent to which the participants' linguistic performance was affected by the interference of TMS with M1 activity. No enhancement of M1 activity specific for action verbs was found at 170 and 350 ms post-stimulus, when lexical-semantic processes are presumed to occur (Experiments 1-2). When TMS was applied at 500 ms post-stimulus (Experiment 3), processing action verbs, compared with non-action verbs, increased the M1-activity in the semantic task and decreased it in the syllabic task. This effect was specific for hand-action verbs and was not observed for action-verbs related to other body parts. Neither accuracy nor RTs were affected by TMS. These findings suggest that the lexical-semantic processing of action verbs does not automatically activate the M1. This area seems to be rather involved in post-conceptual processing that follows the retrieval of motor representations, its activity being modulated (facilitated or inhibited), in a top-down manner, by the specific demand of the task.	[Papeo, Liuba; Isaja, Alessio; Rumiati, Raffaella Ida] Scuola Int Super Studi Avanzati, Sector Cognit Neurosci, Trieste, Italy; [Vallesi, Antonino] Rotman Res Inst Baycrest, Toronto, ON, Canada	International School for Advanced Studies (SISSA); University of Toronto; University Toronto Affiliates; Baycrest	Papeo, L (corresponding author), Scuola Int Super Studi Avanzati, Sector Cognit Neurosci, Trieste, Italy.	rumiati@sissa.it	Vallesi, Antonino/E-8987-2011; Papeo, Liuba/O-4336-2017	Vallesi, Antonino/0000-0002-4087-2845; 	PRIN	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by a PRIN to RIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Ben Shalom D, 2008, NEUROSCIENTIST, V14, P119, DOI 10.1177/1073858407305726; Berndt RS, 2002, J NEUROLINGUIST, V15, P353, DOI 10.1016/S0911-6044(01)00030-6; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Carreiras M, 2005, J COGNITIVE NEUROSCI, V17, P1803, DOI 10.1162/089892905774589217; DeRenzi E, 1995, CORTEX, V31, P619, DOI 10.1016/S0010-9452(13)80016-0; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; EIMER M, 1995, ACTA PSYCHOL, V90, P301, DOI 10.1016/0001-6918(95)00022-M; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Floel A, 2003, EUR J NEUROSCI, V18, P704, DOI 10.1046/j.1460-9568.2003.02774.x; Fodor J. A, 2001, MIND DOESNT WORK WAY; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Iwaki S, 1999, NEUROREPORT, V10, P1793, DOI 10.1097/00001756-199906030-00031; Jeannerod M, 1999, Q J EXP PSYCHOL-A, V52, P1, DOI 10.1080/027249899391205; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Kellenbach ML, 2002, J COGNITIVE NEUROSCI, V14, P561, DOI 10.1162/08989290260045819; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; KORNBLUM S, 1992, TUTORIALS MOTOR BEHA, P713; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; LAWS KR, 1995, MEMORY, V3, P397, DOI 10.1080/09658219508253158; LU C, 2005, PSYCHON B RES, V2, P174; Luzzatti C, 2002, BRAIN LANG, V81, P432, DOI 10.1006/brln.2001.2536; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Paivio A, 1971, IMAGERY VERBAL PROCE; PAPAGNO C, 1993, J NEUROL NEUROSUR PS, V56, P286, DOI 10.1136/jnnp.56.3.286; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2002, PROG NEUROBIOL, V67, P85, DOI 10.1016/S0301-0082(02)00014-X; PULVERMULLER F, 2004, BRAIN LANG, V78, P113; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; ROBERTSON EM, 2008, J COGNITIVE NEUROSCI, V15, P948; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Southgate V, 2008, COGNITION, V107, P1059, DOI 10.1016/j.cognition.2007.10.002; TALMY L, 1985, WEAVING LEXICON, P57; TAYLOR B., 1977, LINGUIST PHILOS, V1, P199, DOI DOI 10.1007/BF00351103; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tomasino B, 2005, COGN NEUROPSYCHOL, V22, P348, DOI 10.1080/02643290442000185; Tomasino B, 2007, NEUROIMAGE, V36, pT128, DOI 10.1016/j.neuroimage.2007.03.035; Tomasino B, 2008, NEUROPSYCHOLOGIA, V46, P1915, DOI 10.1016/j.neuropsychologia.2008.01.015; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; YENDLER Z, 1957, PHYLOSOPHICAL REV, V66, P143	66	137	138	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4508	10.1371/journal.pone.0004508	http://dx.doi.org/10.1371/journal.pone.0004508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240793	Green Published, Green Submitted, gold			2022-12-25	WOS:000278086700001
J	Roy, SW				Roy, Scott William			Phylogenomics: Gene Duplication, Unrecognized Paralogy and Outgroup Choice	PLOS ONE			English	Article								Comparative genomics has revealed the ubiquity of gene and genome duplication and subsequent gene loss. In the case of gene duplication and subsequent loss, gene trees can differ from species trees, thus frequent gene duplication poses a challenge for reconstruction of species relationships. Here I address the case of multi-gene sets of putative orthologs that include some unrecognized paralogs due to ancestral gene duplication, and ask how outgroups should best be chosen to reduce the degree of non-species tree (NST) signal. Consideration of expected internal branch lengths supports several conclusions: (i) when a single outgroup is used, the degree of NST signal arising from gene duplication is either independent of outgroup choice, or is minimized by use of a maximally closely related post-duplication (MCRPD) outgroup; (ii) when two outgroups are used, NST signal is minimized by using one MCRPD outgroup, while the position of the second outgroup is of lesser importance; and (iii) when two outgroups are used, the ability to detect gene trees that are inconsistent with known aspects of the species tree is maximized by use of one MCRPD, and is either independent of the position of the second outgroup, or is maximized for a more distantly related second outgroup. Overall, these results generalize the utility of closely-related outgroups for phylogenetic analysis.	[Roy, Scott William] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Roy, SW (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	royscott@ncbi.nlm.nih.gov			National Library of Medicine Internal Research Training Award	National Library of Medicine Internal Research Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Library of Medicine Internal Research Training Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYANT D, 2002, LCNS, V242, P375; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Huelsenbeck JP, 1996, SYST BIOL, V45, P92, DOI 10.2307/2413514; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Penny D, 2008, MOL BIOL EVOL, V25, P239, DOI 10.1093/molbev/msm263; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zheng CF, 2008, J COMPUT BIOL, V15, P947, DOI 10.1089/cmb.2008.0118; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	23	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4568	10.1371/journal.pone.0004568	http://dx.doi.org/10.1371/journal.pone.0004568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234600	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487200019
J	Strom, K; Gundersen, TE; Hansson, O; Lucas, S; Fernandez, C; Blomhoff, R; Holm, C				Strom, Kristoffer; Gundersen, Thomas E.; Hansson, Ola; Lucas, Stephanie; Fernandez, Celine; Blomhoff, Rune; Holm, Cecilia			Hormone-sensitive lipase (HSL) is also a retinyl ester hydrolase: evidence from mice lacking HSL	FASEB JOURNAL			English	Article						adipocyte differentiation; brown adipocyte; cAMP; retinoic acid	RECEPTOR COREPRESSOR RIP140; ADIPOSE-TISSUE; PPAR-GAMMA; ACID; EXPRESSION; DIFFERENTIATION; ADIPOCYTES; CELLS; WHITE; RETINOIDS	Here, we investigated the importance of hormone-sensitive lipase (HSL) as a retinyl ester hydrolase (REH). REH activity was measured in vitro using recombinant HSL and retinyl palmitate. The expression of retinoic acid (RA)-regulated genes and retinoid metabolites were measured in high-fat diet fed HSL-null mice using real-time quantitative PCR and triplestage liquid chromatography/tandem mass spectrometry, respectively. Age- and gender-matched wild-type littermates were used as controls. The REH activity of rat HSL was found to be higher than that against the hitherto best known HSL substrate, i.e., diacylglycerols. REH activity in white adipose tissue (WAT) of HSL-null mice was completely blunted and accompanied by increased levels of retinyl esters and decreased levels of retinol, retinaldehyde and all-trans RA. Accordingly, genes known to be positively regulated by RA were down-regulated in HSL-null mice, including pRb and RIP140, key factors promoting differentiation into the white over the brown adipocyte lineage. Dietary RA supplementation partly restored WAT mass and the expression of RA-regulated genes in WAT of HSL-null mice. These findings demonstrate the importance of HSL as an REH of adipose tissue and suggest that HSL via this action provides RA and other retinoids for signaling events that are crucial for adipocyte differentiation and lineage commitment.-Strom, K., Gundersen, T. E., Hansson, O., Lucas, S., Fernandez, C., Blomhoff, R., Holm, C. Hormone-sensitive lipase (HSL) is also a retinyl ester hydrolase: evidence from mice lacking HSL. FASEB J. 23, 2307-2316 (2009)	[Strom, Kristoffer] Lund Univ, Div Diabet Metab & Endocrinol, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Gundersen, Thomas E.; Blomhoff, Rune] Univ Oslo, Dept Nutr, Fac Med, Oslo, Norway	Lund University; University of Oslo	Strom, K (corresponding author), Lund Univ, Div Diabet Metab & Endocrinol, Dept Expt Med Sci, BMC C11, SE-22184 Lund, Sweden.	kristoffer.strom@med.lu.se	Fernandez, Celine/ABH-9332-2020; Hansson, Ola/F-1793-2011	Fernandez, Celine/0000-0003-1290-4982; Hansson, Ola/0000-0002-7394-7639; LUCAS, Stephanie/0000-0001-7530-7486	Swedish Research Council [11284]; Juvenile Diabetes Foundation, USA; Knut and Alice Wallenberg Foundation, Sweden; Swedish Diabetes Association; Novo Nordisk; A. Pahlsson, Salubrin/Druvan; Torsten and Ragnar Soderberg; Cell Factory for Functional Genomics; Swedish Foundation for Strategic Research; Foundation of Tage Blucher for Medical Research; Swedish Research School of Genomics and Bioinformatics	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Foundation, USA; Knut and Alice Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Novo Nordisk(Novo Nordisk); A. Pahlsson, Salubrin/Druvan; Torsten and Ragnar Soderberg; Cell Factory for Functional Genomics; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Tage Blucher for Medical Research; Swedish Research School of Genomics and Bioinformatics	We thank Birgitta Danielsson and Ann-Helen Thoren-Fischer for excellent technical assistance. Financial support was provided by the Swedish Research Council (project no. 11284 to C. H); a Center of Excellence grant from the Juvenile Diabetes Foundation, USA; the Knut and Alice Wallenberg Foundation, Sweden; and the Swedish Diabetes Association; as well as the following foundations: Novo Nordisk, A. Pahlsson, Salubrin/Druvan, and Torsten and Ragnar Soderberg. O.H. was supported by the Cell Factory for Functional Genomics, a program funded by the Swedish Foundation for Strategic Research, S. L was supported by the Foundation of Tage Blucher for Medical Research, and C. F. was supported by the Swedish Research School of Genomics and Bioinformatics.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; BLANER WS, 1994, J BIOL CHEM, V269, P16559; BLOMHOFF R, 1992, ANNU REV NUTR, V12, P37, DOI 10.1146/annurev.nu.12.070192.000345; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Chen QY, 2004, EXP CELL RES, V297, P68, DOI 10.1016/j.yexcr.2004.02.017; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Dani C, 1997, J CELL SCI, V110, P1279; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE820, DOI 10.1152/ajpendo.90206.2008; Gagnon I, 2002, BBA-PROTEIN STRUCT M, V1596, P156, DOI 10.1016/S0167-4838(02)00213-3; Gundersen TE, 2007, RAPID COMMUN MASS SP, V21, P1176, DOI 10.1002/rcm.2946; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hansson O, 2006, J PROTEOME RES, V5, P1701, DOI 10.1021/pr060101h; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Holm C, 1999, METH MOL B, V109, P109; Holm C, 1999, METH MOL B, V109, P165; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Mic FA, 2002, DEVELOPMENT, V129, P2271; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; MURRAY T, 1980, J SUPRAMOL STR CELL, V14, P255, DOI 10.1002/jss.400140214; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Park EY, 2005, CANCER RES, V65, P9923, DOI 10.1158/0008-5472.CAN-05-1604; RIAZULHAQ, 1991, P NATL ACAD SCI USA, V88, P8272, DOI 10.1073/pnas.88.18.8272; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	44	65	67	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2307	2316		10.1096/fj.08-120923	http://dx.doi.org/10.1096/fj.08-120923			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246492				2022-12-25	WOS:000268836500030
J	Okamura, T; Singh, S; Buolamwini, J; Haystead, T; Friedman, H; Bigner, D; Ali-Osman, F				Okamura, Tatsunori; Singh, Simendra; Buolamwini, John; Haystead, Timothy; Friedman, Henry; Bigner, Darell; Ali-Osman, Francis			Tyrosine Phosphorylation of the Human Glutathione S-Transferase P1 by Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC-ACTIVITY; GLIOBLASTOMA; KINASE; CELLS; EXPRESSION; PROTEIN; OVEREXPRESSION; METABOLISM; ACTIVATION; PREDICTION	Epidermal growth factor receptor (EGFR) gene amplification, mutations, and/or aberrant activation are frequent abnormalities in malignant gliomas and other human cancers and have been associated with an aggressive clinical course and a poor therapeutic outcome. Elevated glutathione S-transferase P1 (GSTP1), a major drug-metabolizing and stress response signaling protein, is also associated with drug resistance and poor clinical outcome in gliomas and other cancers. Here, we provide evidence that GSTP1 is a downstream EGFR target and that EGFR binds to and phosphorylates tyrosine residues in the GSTP1 protein in vitro and in vivo. Mass spectrometry and mutagenesis analyses in a cell-free system and in gliomas cells identified Tyr-7 and Tyr-198 as major EGFR-specific phospho-acceptor residues in the GSTP1 protein. The phosphorylation increased GSTP1 enzymatic activity significantly, and computer-based modeling showed a corresponding increase in electronegativity of the GSTP1 active site. In human glioma and breast cancer cells, epidermal growth factor stimulation rapidly increased GSTP1 tyrosine phosphorylation and decreased cisplatin sensitivity. Lapatinib, a clinically active EGFR inhibitor, significantly reversed the epidermal growth factor-induced cisplatin resistance. These data define phosphorylation and activation of GSTP1 by EGFR as a novel, heretofore unrecognized component of the EGFR signaling network and a novel mechanism of tumor drug resistance, particularly in tumors with elevated GSTP1 and/or activated EGFR.	[Ali-Osman, Francis] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Haystead, Timothy] Duke Univ, Dept Pharmacol, Durham, NC 27710 USA; [Bigner, Darell] Duke Univ, Dept Pathol, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Bigner, Darell] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Buolamwini, John] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA	Duke University; Duke University; Duke University; Duke University; University of Tennessee System; University of Tennessee Health Science Center	Ali-Osman, F (corresponding author), Duke Univ, Med Ctr, Dept Surg, 421 Med Sci Res Bldg 1, Durham, NC 27710 USA.	francis.aliosman@duke.edu			National Institutes of Health [RO1 CA127872, RO1 CA 112519, P50CA108786, P30-CA14236]; NATIONAL CANCER INSTITUTE [R01CA112519, R01CA127872, P30CA014236, P50CA108786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA127872, RO1 CA 112519, P50CA108786, and P30-CA14236.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; Ali-Osman F, 2004, CONT CANC RES, P359; Ali-Osman F, 1997, CLIN CANCER RES, V3, P2253; AliOsman F, 1997, J BIOL CHEM, V272, P10004; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Barker FG, 2001, INT J RADIAT ONCOL, V51, P410, DOI 10.1016/S0360-3016(01)01609-1; BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Chakravarti A, 2002, CANCER RES, V62, P4307; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Gurney JG, 2001, CURR OPIN ONCOL, V13, P160, DOI 10.1097/00001622-200105000-00005; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Halatsch ME, 2003, ANTICANCER RES, V23, P2315; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Kamata H, 2000, EUR J BIOCHEM, V267, P1933, DOI 10.1046/j.1432-1327.2000.01194.x; Kleihues P, 2000, PATHOLOGY GENETICS T; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; Lo Bello M, 1998, J MOL BIOL, V284, P1717; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lo HW, 2004, CANCER RES, V64, P9131, DOI 10.1158/0008-5472.CAN-04-0283; Narita Y, 2002, CANCER RES, V62, P6764; Nishiyama M, 1997, INT J CANCER, V72, P649; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Okamura T, 2000, INT J ONCOL, V16, P295; Orozco M, 1997, PROTEINS, V28, P530, DOI 10.1002/(SICI)1097-0134(199708)28:4<530::AID-PROT7>3.3.CO;2-U; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Raizer RJ, 2005, J NEURO-ONCOL, V74, P77, DOI 10.1007/s11060-005-0603-7; Ranganathan PN, 2005, BIOCHEM J, V386, P525, DOI 10.1042/BJ20041419; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Segel IH, 1976, BIOCH CALCULATIONS, P208; Shinojima N, 2003, CANCER RES, V63, P6962; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03	40	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16979	16989		10.1074/jbc.M808153200	http://dx.doi.org/10.1074/jbc.M808153200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19254954	Green Published, hybrid			2022-12-25	WOS:000266962400035
J	Salgado, MT; Nagababu, E; Rifkind, JM				Salgado, Maria T.; Nagababu, Enika; Rifkind, Joseph M.			Quantification of Intermediates Formed during the Reduction of Nitrite by Deoxyhemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSOHEMOGLOBIN; HUMAN CIRCULATION; VASCULAR CONTROL; RED-CELL; OXIDE; HEMOGLOBIN; MECHANISM; BLOOD; NO; NITROSYLATION	Nitric oxide (NO) plays a crucial role in human physiology by regulating vascular tone and blood flow. The short life-span of NO in blood requires a mechanism to retain NO bioactivity in the circulation. Recent studies have suggested a mechanism involving the reduction of nitrite back to NO by deoxyhemoglobin in RBCs. A role for RBCs in transporting NO must, however, bypass the scavenging of NO in RBCs by hemoglobin. To understand how the nitrite reaction can deliver bioactive NO to the vasculature, we have studied the intermediates formed during the reaction. A reliable measure of the total concentration of heme-associated nitrite/NO intermediates formed was provided by combining filtration to measure free nitrite by chemiluminescence and electron paramagnetic resonance to measure the final product Hb(II)NO. By modifying the chemiluminescence method used to detect NO, we have been able to identify two intermediates: 1) a heme-associated nitrite complex that is released as NO in acid solution in the presence of ascorbate and 2) an intermediate that releases NO at neutral pH in the presence of ferricyanide when reacted with an Fe(III) ligand like azide. This species designated as "Hb(II)NO+reversible arrow Hb(III)NO" has properties of both isomeric forms resulting in a slower NO dissociation rate and much higher stability than Hb(III)NO, but provides a potential source for bioactive NO, which can be released from the RBC. This detailed analysis of the nitrite reaction with deoxyHb provides important insights into the mechanism for nitrite induced vasodilation by RBCs.	[Salgado, Maria T.; Nagababu, Enika; Rifkind, Joseph M.] NIA, Mol Dynam Sect, Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Rifkind, JM (corresponding author), 251 Bayview Blvd,Rm 05B129, Baltimore, MD 21224 USA.	rifkindj@mail.nih.gov			National Institutes of Health NIA Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000433, Z01AG000433] Funding Source: NIH RePORTER	National Institutes of Health NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health NIA Intramural Research Program.	ADDISON AW, 1986, BIOCHEMISTRY-US, V25, P4104, DOI 10.1021/bi00362a018; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Brittain T, 2000, J INORG BIOCHEM, V81, P99, DOI 10.1016/S0162-0134(00)00116-1; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kehmeier ES, 2008, FREE RADICAL BIO MED, V44, P1945, DOI 10.1016/j.freeradbiomed.2008.02.014; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Lissi E, 1998, FREE RADICAL BIO MED, V24, P1535, DOI 10.1016/S0891-5849(98)00004-5; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Lundberg JO, 2005, ARTERIOSCL THROM VAS, V25, P915, DOI 10.1161/01.ATV.0000161048.72004.c2; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; NAGABABU E, 2008, 15 INT C OX BIND SEN, pP27; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Nagababu E, 2007, FREE RADICAL BIO MED, V42, P1146, DOI 10.1016/j.freeradbiomed.2006.12.029; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rifkind JM, 2007, BIOPHYS J, p383A; Rifkind JM, 2006, ANTIOXID REDOX SIGN, V8, P1193, DOI 10.1089/ars.2006.8.1193; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; WANG Y, 1960, J AM CHEM SOC, V118, P3972	31	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12710	12718		10.1074/jbc.M808647200	http://dx.doi.org/10.1074/jbc.M808647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19270306	hybrid, Green Published			2022-12-25	WOS:000265688300015
J	Liu, JZ; Wang, SQ; Zhang, P; Said-Al-Naief, N; Michalek, SM; Feng, X				Liu, Jianzhong; Wang, Shunqing; Zhang, Ping; Said-Al-Naief, Nasser; Michalek, Suzanne M.; Feng, Xu			Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ALVEOLAR BONE DESTRUCTION; RANK CYTOPLASMIC MOTIF; RECEPTOR ACTIVATOR; TNF-ALPHA; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; FAMILY-MEMBER	Lipopolysaccharide (LPS), a common bacteria-derived product, has long been recognized as a key factor implicated in periodontal bone loss. However, the precise cellular and molecular mechanisms by which LPS induces bone loss still remains controversial. Here, we show that LPS inhibited osteoclastogenesis from freshly isolated osteoclast precursors but stimulated osteoclast formation from those pretreated with RANKL in vitro in tissue culture dishes, bone slices, and a co-culture system containing osteoblasts, indicating that RANKL-mediated lineage commitment is a prerequisite for LPS-induced osteoclastogenesis. Moreover, the RANKL-mediated lineage commitment is long term, irreversible, and TLR4-dependent. LPS exerts the dual function primarily by modulating the expression of NFATc1, a master regulator of osteoclastogenesis, in that it abolished RANKL-induced NFATc1 expression in freshly isolated osteoclast precursors but stimulated its expression in RANKL-pretreated cells. In addition, LPS prolonged osteoclast survival by activating the Akt, NF-kappa B, and ERK pathways. Our current work has not only unambiguously defined the role of LPS in osteoclastogenesis but also has elucidated the molecular mechanism underlying its complex functions in osteoclast formation and survival, thus laying a foundation for future delineation of the precise mechanism of periodontal bone loss.	[Liu, Jianzhong; Wang, Shunqing; Said-Al-Naief, Nasser; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhang, Ping] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Michalek, Suzanne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Wang, Shunqing] First Municipal Peoples Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; South China University of Technology	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, Volker Hall G046B,1670 Univ Blvd, Birmingham, AL 35294 USA.	xufeng@uab.edu		Zhang, Ping/0000-0002-4585-9893	NIAMS [AR47830]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR47830 from NIAMS.	AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chung JY, 2002, J CELL SCI, V115, P679; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ebersole JL, 2003, PERIODONTOL 2000, V31, P135, DOI 10.1034/j.1600-0757.2003.03109.x; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Hayashi S, 2004, ENDOCRINOLOGY, V145, P2721, DOI 10.1210/en.2004-0172; Henderson B, 2003, TRENDS MICROBIOL, V11, P570, DOI 10.1016/j.tim.2003.10.005; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; Jiang YL, 2002, INFECT IMMUN, V70, P3143, DOI 10.1128/IAI.70.6.3143-3148.2002; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Jimi E, 1999, J IMMUNOL, V163, P434; JONES BW, 2001, ANN RHEUM DIS     S3, V60, P6; Kaneko H, 2007, PROSTAG LEUKOTR ESS, V77, P181, DOI 10.1016/j.plefa.2007.09.002; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawata T, 1999, J CRAN GENET DEV BIO, V19, P221; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kirkwood KL, 2007, PERIODONTOL 2000, V43, P294, DOI 10.1111/j.1600-0757.2006.00166.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nagasawa T, 2007, PERIODONTOL 2000, V43, P65, DOI 10.1111/j.1600-0757.2006.00185.x; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; ORCEL P, 1993, AM J PHYSIOL, V264, pE391, DOI 10.1152/ajpendo.1993.264.3.E391; ROSS FP, 2001, OSTEOPOROSIS, P73; ROWE DJ, 1977, CALC TISS RES, V23, P283, DOI 10.1007/BF02012798; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; SHIINA Y, 1986, CALCIFIED TISSUE INT, V39, P28, DOI 10.1007/BF02555737; SISMEYDURRANT HJ, 1987, ARCH ORAL BIOL, V32, P911, DOI 10.1016/0003-9969(87)90106-3; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Suda K, 2002, J CELL PHYSIOL, V190, P101, DOI 10.1002/jcp.10041; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; SVEEN K, 1980, SCAND J DENT RES, V88, P535; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381, DOI 10.1002/jlb.61.4.381; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; UMEZU A, 1989, J PERIODONTAL RES, V24, P378, DOI 10.1111/j.1600-0765.1989.tb00886.x; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zambon J J, 1996, Ann Periodontol, V1, P879, DOI 10.1902/annals.1996.1.1.879; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	70	80	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12512	12523		10.1074/jbc.M809789200	http://dx.doi.org/10.1074/jbc.M809789200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258321	hybrid, Green Published			2022-12-25	WOS:000265494600080
J	Gu, ZL; Liu, WH; Yan, Z				Gu, Zhenglin; Liu, Wenhua; Yan, Zhen			beta-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; DENDRITIC SPINE LOSS; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY-95; NATURAL OLIGOMERS; CORTICAL-NEURONS	A fundamental feature of Alzheimer disease (AD) is the accumulation of beta-amyloid (A beta), a peptide generated from the amyloid precursor protein (APP). Emerging evidence suggests that soluble A beta oligomers adversely affect synaptic function, which leads to cognitive failure associated with AD. The A beta-induced synaptic dysfunction has been attributed to the synaptic removal of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (AMPARs); however, it is unclear how A beta induces the loss of AMPARs at the synapses. In this study we have examined the potential involvement of Ca2+/calmodulin-dependent protein kinase II (CaMKII), a signaling molecule critical for AMPAR trafficking and function. We found that the synaptic pool of CaMKII was significantly decreased in cortical neurons from APP transgenic mice, and the density of CaMKII clusters at synapses was significantly reduced by A beta oligomer treatment. In parallel, the surface expression of GluR1 subunit as well as AMPAR-mediated synaptic response and ionic current was selectively decreased in APP transgenic mice and A beta-treated cultures. Moreover, the reducing effect of A beta on AMPAR current density was mimicked and occluded by knockdown of CaMKII and blocked by overexpression of CaMKII. These results suggest that the A beta-induced change in CaMKII subcellular distribution may underlie the removal of AMPARs from synaptic membrane by A beta.	[Gu, Zhenglin; Liu, Wenhua; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Liu, Wenhua/0000-0003-0903-8497	National Institutes of Health [AG21923, MH84233]; National Science Foundation of China [NSFC 30528009]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG21923 and MH84233. This work was also supported by National Science Foundation of China Grant NSFC 30528009 (to Z.Y.).	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Gu ZL, 2006, MOL PHARMACOL, V69, P813, DOI 10.1124/mol.105.018853; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shemer I, 2006, EUR J NEUROSCI, V23, P2035, DOI 10.1111/j.1460-9568.2006.04733.x; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tang KX, 2004, J NEUROCHEM, V91, P429, DOI 10.1111/j.1471-4159.2004.02733.x; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813	56	147	154	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10639	10649		10.1074/jbc.M806508200	http://dx.doi.org/10.1074/jbc.M806508200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240035	hybrid, Green Published			2022-12-25	WOS:000265104600038
J	Worobey, CC; Fisher, NDL; Cox, D; Forman, JP; Curhan, GC				Worobey, Cynthia Cooper; Fisher, Naomi D. L.; Cox, David; Forman, John P.; Curhan, Gary C.			Genetic Polymorphisms and the Risk of Accelerated Renal Function Decline in Women	PLOS ONE			English	Article							CONVERTING-ENZYME GENE; ALDOSTERONE SYNTHASE GENE; CHRONIC KIDNEY-DISEASE; ANGIOTENSINOGEN GENE; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; PROGRESSION; ADDUCIN; ASSOCIATION; IMPACT	Background: Reduced glomerular filtration rate is an important predictor of cardiovascular disease and death. Genetic polymorphisms, particularly in genes involved in the renin-angiotensin system (RAS), may influence the rate of renal function decline. Methodology/Principal Findings: We examined the relation between specific single nucleotide polymorphisms (SNPs), including those in the RAS, apolipoprotein E and alpha-adducin, and renal function decline assessed by estimated glomerular filtration rate (eGFR) over an 11-year period in 2578 Caucasian participants of the Nurses' Health Study. Logistic regression was used to examine the associations between genotype and risk of eGFR decline of >= 25%. Results: After 11 years between creatinine measurements, the eGFR declined by >= 25% in 423 of 2578 (16%) women. The angiotensinogen (AGT) A-20C polymorphism was associated with a higher risk of renal function decline when two risk alleles were present than if one or no alleles were present (CC vs AA and AC) OR 1.83 (95% CI 1.02-3.26; p = 0.04). The angiotensin II type 1 receptor (AT(1)R) A1166C polymorphism was marginally associated with a higher risk of renal function decline when two risk alleles were present (CC vs AA, OR = 1.41; 95% CI 0.98-2.01; p = 0.06). The alpha-adducin G460W polymorphism was associated with a lower risk of renal function decline when any number of risk alleles were present (WG vs GG, OR = 0.78, 95% CI 0.61-0.99, p = 0.04; WW vs GG, OR = 0.46; 95% CI 0.20-1.07, p = 0.07). Linear regression analysis with change in eGFR as the outcome showed a larger decline of 3.5 (95% CI 0.5 to 6.4, p = 0.02) ml/min/1.73 m(2) in AGT A-20C CC homozygotes. No other polymorphisms were significantly associated with renal function decline or absolute change in eGFR over the study period. Conclusions: Genetic variants in the angiotensinogen, angiotensin II type 1 receptor and alpha-adducin genes may contribute to loss of renal function in the general female Caucasian population.	[Worobey, Cynthia Cooper] Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA; [Fisher, Naomi D. L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Div Endocrine Hypertens, Boston, MA USA; [Cox, David; Forman, John P.; Curhan, Gary C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Forman, John P.; Curhan, Gary C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Worobey, CC (corresponding author), Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02114 USA.	gcurhan@partners.org	Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009	Cox, David G/0000-0002-2152-9259	National Institutes of Health [DK66574, CA87969, DK07791]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066574, T32DK007791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by Grants DK66574, CA87969 and DK07791 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; Amoroso A, 1998, NEPHROL DIAL TRANSPL, V13, P3184, DOI 10.1093/ndt/13.12.3184; Beeks E, 2004, HYPERTENSION, V44, P419, DOI 10.1161/01.HYP.0000141410.72537.fd; Bianchi G, 2004, HYPERTENSION, V44, P394, DOI 10.1161/01.HYP.0000141413.91223.2c; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Brand E, 1998, HYPERTENSION, V32, P198, DOI 10.1161/01.HYP.32.2.198; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Buraczynska M, 2002, NEPHRON, V92, P51, DOI 10.1159/000064455; Butkus Donald E, 2002, J Miss State Med Assoc, V43, P71; Casiglia E, 2005, J HYPERTENS, V23, P1991, DOI 10.1097/01.hjh.0000183119.92455.a7; Castellano M, 1997, J HYPERTENS, V15, P1707, DOI 10.1097/00004872-199715120-00076; Coll E, 2003, J NEPHROL, V16, P357; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; Doria A, 1998, HORM RES, V50, P6, DOI 10.1159/000053095; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Fisher NDL, 2002, HYPERTENSION, V39, P914, DOI 10.1161/01.HYP.0000013784.18175.51; Freedman BI, 1997, J AM SOC NEPHROL, V8, P1942; Goto S, 2002, KIDNEY INT, V62, P980, DOI 10.1046/j.1523-1755.2002.00517.x; HANKINSON SE, 1989, CLIN CHEM, V35, P2313; Hopkins PN, 1996, J HYPERTENS, V14, P199, DOI 10.1097/00004872-199602000-00008; Hsu CC, 2005, JAMA-J AM MED ASSOC, V293, P2892, DOI 10.1001/jama.293.23.2892; Hunley TE, 1996, KIDNEY INT, V49, P571, DOI 10.1038/ki.1996.81; Jeunemaitre X, 1997, AM J HUM GENET, V60, P1448, DOI 10.1086/515452; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kimura H, 1998, AM J KIDNEY DIS, V31, P666, DOI 10.1053/ajkd.1998.v31.pm9531184; Knight EL, 2003, ANN INTERN MED, V138, P460, DOI 10.7326/0003-4819-138-6-200303180-00009; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lovati E, 2001, KIDNEY INT, V60, P46, DOI 10.1046/j.1523-1755.2001.00769.x; MARRE M, 1994, DIABETES, V43, P384, DOI 10.2337/diabetes.43.3.384; Mayeux R, 2005, J CLIN INVEST, V115, P1404, DOI 10.1172/JCI25421; Miller JA, 1999, KIDNEY INT, V56, P2173, DOI 10.1046/j.1523-1755.1999.00770.x; Miller JA, 2004, CURR OPIN NEPHROL HY, V13, P101, DOI 10.1097/00041552-200401000-00014; Nakanishi K, 2004, PEDIATR NEPHROL, V19, P144, DOI 10.1007/s00467-003-1350-7; Nicod J, 2002, KIDNEY INT, V61, P1270, DOI 10.1046/j.1523-1755.2002.00275.x; Parving HH, 1996, J AM SOC NEPHROL, V7, P2509; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Quinn M, 1996, DIABETOLOGIA, V39, P940; Ribstein J, 2005, J AM SOC NEPHROL, V16, P1320, DOI 10.1681/ASN.2004100878; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rogus JJ, 1998, HYPERTENSION, V31, P627, DOI 10.1161/01.HYP.31.2.627; Schmidt S, 1996, NEPHROL DIAL TRANSPL, V11, P1755; SCHMIDT S, 1995, KIDNEY INT, V47, P1176, DOI 10.1038/ki.1995.167; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Solini A, 1999, AM J KIDNEY DIS, V34, P1002, DOI 10.1016/S0272-6386(99)70004-1; SPRAY BJ, 1995, J AM SOC NEPHROL, V5, P1806; Tonelli M, 2003, ANN INTERN MED, V138, P98, DOI 10.7326/0003-4819-138-2-200301210-00010; Tsujita Y, 2001, HYPERTENS RES, V24, P105, DOI 10.1291/hypres.24.105; Tsukada K, 2002, J HUM HYPERTENS, V16, P789, DOI 10.1038/sj.jhh.1001484; van Dijk MA, 2000, NEPHROL DIAL TRANSPL, V15, P836, DOI 10.1093/ndt/15.6.836; Wattanakit K, 2006, J AM COLL CARDIOL, V48, P1183, DOI 10.1016/j.jacc.2006.05.047; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4787	10.1371/journal.pone.0004787	http://dx.doi.org/10.1371/journal.pone.0004787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274077	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496000023
J	Latzin, P; Roth, S; Thamrin, C; Hutten, GJ; Pramana, I; Kuehni, CE; Casaulta, C; Nelle, M; Riedel, T; Frey, U				Latzin, Philipp; Roth, Stefan; Thamrin, Cindy; Hutten, Gerard J.; Pramana, Isabelle; Kuehni, Claudia E.; Casaulta, Carmen; Nelle, Matthias; Riedel, Thomas; Frey, Urs			Lung Volume, Breathing Pattern and Ventilation Inhomogeneity in Preterm and Term Infants	PLOS ONE			English	Article								Background: Morphological changes in preterm infants with bronchopulmonary dysplasia (BPD) have functional consequences on lung volume, ventilation inhomogeneity and respiratory mechanics. Although some studies have shown lower lung volumes and increased ventilation inhomogeneity in BPD infants, conflicting results exist possibly due to differences in sedation and measurement techniques. Methodology/Principal Findings: We studied 127 infants with BPD, 58 preterm infants without BPD and 239 healthy term-born infants, at a matched post-conceptional age of 44 weeks during quiet natural sleep according to ATS/ERS standards. Lung function parameters measured were functional residual capacity (FRC) and ventilation inhomogeneity by multiple breath washout as well as tidal breathing parameters. Preterm infants with BPD had only marginally lower FRC (21.4 mL/kg) than preterm infants without BPD (23.4 mL/kg) and term-born infants (22.6 mL/kg), though there was no trend with disease severity. They also showed higher respiratory rates and lower ratios of time to peak expiratory flow and expiratory time (t(PTEF)/t(E)) than healthy preterm and term controls. These changes were related to disease severity. No differences were found for ventilation inhomogeneity. Conclusions: Our results suggest that preterm infants with BPD have a high capacity to maintain functional lung volume during natural sleep. The alterations in breathing pattern with disease severity may reflect presence of adaptive mechanisms to cope with the disease process.	[Latzin, Philipp; Roth, Stefan; Thamrin, Cindy; Hutten, Gerard J.; Pramana, Isabelle; Casaulta, Carmen; Frey, Urs] Univ Bern, Inselspital, Dept Paediat, Div Resp Med, CH-3010 Bern, Switzerland; [Latzin, Philipp; Kuehni, Claudia E.] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Nelle, Matthias; Riedel, Thomas] Univ Bern, Inselspital, Dept Paediat, Div Paediat & Neonatal Intensive Care, CH-3012 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Latzin, P (corresponding author), Univ Bern, Inselspital, Dept Paediat, Div Resp Med, CH-3010 Bern, Switzerland.	philipp.latzin@insel.ch	; Latzin, Philipp/F-2206-2017	Thamrin, Cindy/0000-0003-3284-3558; Latzin, Philipp/0000-0002-5239-1571; Riedel, Thomas/0000-0002-7153-5251; Kuehni, Claudia E./0000-0001-8957-2002; Hutten, Jeroen/0000-0003-4368-6519	Swiss National Foundation [3200-B0-112099, 3200-069349]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Swiss National Foundation grant 3200-B0-112099 to U.F. and P.L. and Swiss National Foundation PROSPER grnt 3200-069349 to C.K. The funding sources had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Baldwin DN, 2006, PEDIATR PULM, V41, P391, DOI 10.1002/ppul.20400; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; BURGER EJ, 1968, J APPL PHYSIOL, V25, P139, DOI 10.1152/jappl.1968.25.2.139; Bush A, 2008, COPD, V5, P53, DOI 10.1080/15412550701815965; CLARKE JR, 1994, PEDIATR PULM, V17, P285, DOI 10.1002/ppul.1950170504; de Winter JP, 2000, AM J PERINAT, V17, P377, DOI 10.1055/s-2000-13446; DEZATEUX CA, 1994, PEDIATR PULM, V18, P299, DOI 10.1002/ppul.1950180507; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Friedrich L, 2006, AM J RESP CRIT CARE, V173, P442, DOI 10.1164/rccm.200503-444OC; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Gappa M, 2006, PEDIATR PULM, V41, P291, DOI 10.1002/ppul.20380; Gappa M, 2003, AM J RESP CRIT CARE, V168, P399, DOI 10.1164/ajrccm.168.3.955; Gustafsson PM, 2003, EUR RESPIR J, V21, P1033, DOI 10.1183/09031936.03.00049302; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hjalmarson O, 2005, J PEDIATR-US, V146, P86, DOI 10.1016/j.jpeds.2004.08.044; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; Hofhuis W, 2002, AM J RESP CRIT CARE, V166, P1539, DOI 10.1164/rccm.2202046; Hulskamp G, 2006, PEDIATR PULM, V41, P1, DOI 10.1002/ppul.20318; Hulskamp G, 2003, AM J RESP CRIT CARE, V168, P1003, DOI 10.1164/rccm.200303-460OC; HULSKAMP G, 2003, EUR RESP J S45, V22, pS382; Hutten GJ, 2008, PEDIATR PULM, V43, P882, DOI 10.1002/ppul.20874; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; KATZSALAMON M, 1995, PEDIATR PULM, V20, P101, DOI 10.1002/ppul.1950200209; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; KOSCH PC, 1984, J APPL PHYSIOL, V57, P1126, DOI 10.1152/jappl.1984.57.4.1126; Kumar R, 2008, J ALLERGY CLIN IMMUN, V121, P878, DOI 10.1016/j.jaci.2008.01.030; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Latzin P, 2006, AM J RESP CRIT CARE, V174, P1292, DOI 10.1164/rccm.200606-782OC; MORTOLA JP, 1982, J APPL PHYSIOL, V52, P1209, DOI 10.1152/jappl.1982.52.5.1209; Narang I, 2008, AM J RESP CRIT CARE, V178, P74, DOI 10.1164/rccm.200705-701OC; Pillow JJ, 2006, PEDIATR PULM, V41, P105, DOI 10.1002/ppul.20319; Poets CF, 1997, AM J RESP CRIT CARE, V155, P649, DOI 10.1164/ajrccm.155.2.9032208; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; Prisk GK, 1996, J APPL PHYSIOL, V80, P1126, DOI 10.1152/jappl.1996.80.4.1126; RIEDEL T, 2008, INTENSIVE CARE MED; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Schmalisch G, 2005, BMC Pediatr, V5, P36, DOI 10.1186/1471-2431-5-36; Stocks J, 2007, PEDIATR PULM, V42, P3, DOI 10.1002/ppul.20520; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Totapally BR, 2002, CRIT CARE, V6, P160, DOI 10.1186/cc1476; van der Walt J, 2006, PEDIATR ANESTH, V16, P1205, DOI 10.1111/j.1460-9592.2006.02073.x; Vrijlandt EJLE, 2007, J PEDIATR-US, V150, P256, DOI 10.1016/j.jpeds.2006.12.007; Vrijlandt EJLE, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-117; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC; WILLIAMS BA, 1991, J PHYSIOL-LONDON, V442, P81, DOI 10.1113/jphysiol.1991.sp018783; 1993, LANCET, V342, P193	49	78	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4635	10.1371/journal.pone.0004635	http://dx.doi.org/10.1371/journal.pone.0004635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247491	gold, Green Submitted, Green Published			2022-12-25	WOS:000265487800017
J	Wang, CM; Wu, YY; Qin, JH; Sun, HX; He, HX				Wang, Chengmin; Wu, Yanyun; Qin, Jianhua; Sun, Haoxue; He, Hongxuan			Induced Susceptibility of Host Is Associated with an Impaired Antioxidant System Following Infection with Cryptosporidium parvum in Se-Deficient Mice	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; GAMMA-INTERFERON; SELENIUM SUPPLEMENTATION; IMMUNE-RESPONSE; T-LYMPHOCYTES; C57BL/6 MICE; MOUSE MODEL; 2 STRAINS; RESISTANCE; EXPRESSION	Background: Susceptibility or resistance to infection with Cryptosporidium parvum (C. parvum) correlates with Selenium (Se) deficiency in response to infection. Both adult Se-adequate and Se-deficient mouse models of cryptosporidiosis were used to study the cell-mediated immune response during the course of C. parvum infection. Methodology/Principal Findings: Blood samples from mouse models were used for Se status. The concentration of MDA, SOD, GPx and CAT in blood has revealed that lower Se level exist in Se-deficient mice. Mesenteric lymph node (MLN) lymphocytes from both mouse models were proliferated after ex vivo re-stimulation with C. parvum sporozoite antigen. The study of the cytokine profiles from the supernatant of proliferated MLN cells revealed that Se-adequate mice produced higher levels of Th1 (IFN-gamma and IL-2) and moderate amounts of Th2 (IL-4) cytokines throughout the course of infection. Whereas, MLN cells from Se-deficient mice produced lower levels of IFN-gamma, IL-2 and IL-4 cytokines. The counts of total white cell and CD3, CD4, CD8 cell in Se-adequate were higher than that in Se-deficient mice. Significance: These results suggest that Cell immunity is affected by Se status after infection with C. parvum from kinetic changes of different white cells and cytokine. In conclusion, induced susceptibility of host is associated with an impaired antioxidant system following infection with C. parvum in C57BL/6 Selenium deficient mice.	[Wang, Chengmin; Wu, Yanyun; Sun, Haoxue; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Qin, Jianhua] Hebei Agr Univ, Dept Animal Sci & Technol, Baoding, Hebei, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Hebei Agricultural University	Wang, CM (corresponding author), Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	hehx@ioz.ac.cn			The National Key Basic Research and Development Program of China [9732007BC109103]; The National Natural Sciences Foundation of China [30671576]; World Conservation Association [ECBP/06/085]	The National Key Basic Research and Development Program of China(National Basic Research Program of China); The National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); World Conservation Association	The study was supported by grants from The National Key Basic Research and Development Program of China (9732007BC109103), The National Natural Sciences Foundation of China (30671576) and World Conservation Association (ECBP/06/085). The sponsor had no role in any aspects of this study.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguirre SA, 1998, J IMMUNOL, V161, P1891; AGUIRRE SA, 1994, INFECT IMMUN, V62, P697, DOI 10.1128/IAI.62.2.697-699.1994; ANDREA P, 2002, EXP PARASITOL, V101, P193; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Arthur JR, 1999, P NUTR SOC, V58, P507; BECK MA, 1994, J INFECT DIS, V170, P351, DOI 10.1093/infdis/170.2.351; Beck MA, 2000, AM J CLIN NUTR, V71, p1676S, DOI 10.1093/ajcn/71.6.1676S; BEDWAL RS, 1994, EXPERIENTIA, V50, P626, DOI 10.1007/BF01952862; BOYNE R, 1986, J NUTR, V116, P816, DOI 10.1093/jn/116.5.816; Briviba K, 1998, CHEM RES TOXICOL, V11, P1398, DOI 10.1021/tx980086y; Chan S, 1998, CLIN LAB MED, V18, P673; CHANDRA S, 1986, PROG FOOD NUTR SCI, V10, P1; CHEN WX, 1993, INFECT IMMUN, V61, P3548, DOI 10.1128/IAI.61.8.3548-3551.1993; CHEN WX, 1993, INFECT IMMUN, V61, P3928, DOI 10.1128/IAI.61.9.3928-3932.1993; CURRENT WL, 1983, NEW ENGL J MED, V309, P1326; Davis CD, 1998, J PARASITOL, V84, P1274, DOI 10.2307/3284689; DHUR A, 1990, COMP BIOCHEM PHYS C, V96, P271, DOI 10.1016/0742-8413(90)90007-V; DIPLOCK AT, 1987, FREE RADICAL BIO MED, V3, P199, DOI 10.1016/0891-5849(87)90006-2; ENRIQUEZ FJ, 1993, FOLIA PARASIT, V40, P307; FAYER R, 1986, MICROBIOL REV, V50, P458, DOI 10.1128/MMBR.50.4.458-483.1986; Harbige Laurence S., 1996, Nutrition and Health (Bicester), V10, P285; Hayward AR, 2000, J INFECT DIS, V182, P1001, DOI 10.1086/315802; HOLLY JR, 2005, BIOL CONTROL, V32, P419; Jensen P, 2003, REC RES DEV ENTOMOL, V4, P1; Kaushal N, 2007, J NUTR BIOCHEM, V18, P553, DOI 10.1016/j.jnutbio.2006.11.003; Kautiainen A, 2000, J NUTR BIOCHEM, V11, P425, DOI 10.1016/S0955-2863(00)00099-1; KEVIN B, 2001, J NUTR BIOCH, V12, P693; KOSSAKOWSKI S, 1980, MEDWET, V35, P108; KUHLS TL, 1994, J PARASITOL, V80, P480, DOI 10.2307/3283423; Lacroix S, 2001, INFECT IMMUN, V69, P1635, DOI 10.1128/IAI.69.3.1635-1642.2001; Lean IS, 2003, INFECT IMMUN, V71, P4580, DOI 10.1128/IAI.71.8.4580-4585.2003; LIU DY, 2006, SCI AGR SINICA, V22, P32; MCDONALD V, 1994, PARASITE IMMUNOL, V16, P315, DOI 10.1111/j.1365-3024.1994.tb00354.x; Mead JR, 1998, J PARASITOL, V84, P1045, DOI 10.2307/3284643; MELINDA BA, 2005, FREE RADICAL BIOMED, V38, P112; MILLER RA, 1990, LAB ANIM SCI, V40, P42; Miller TA, 2006, VET PARASITOL, V141, P66, DOI 10.1016/j.vetpar.2006.04.016; Moreno-Reyes R, 2001, J BONE MINER RES, V16, P1556, DOI 10.1359/jbmr.2001.16.8.1556; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ribeiro F, 1998, PARASITOLOGY, V116, P229, DOI 10.1017/S0031182097002291; ROY M, 1993, P SOC EXP BIOL MED, V202, P295, DOI 10.3181/00379727-202-43538; SEGAL R, 1987, DERMATOLOGICA, V175, P205, DOI 10.1159/000248827; SMITH AM, 1982, AM J CLIN NUTR, V35, P521, DOI 10.1093/ajcn/35.3.521; Smith LM, 2000, J PARASITOL, V86, P300, DOI 10.2307/3284773; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; SUTTLE NF, 1989, J NUTR, V119, P1055, DOI 10.1093/jn/119.7.1055; Theodos CM, 1997, INFECT IMMUN, V65, P4761, DOI 10.1128/IAI.65.11.4761-4769.1997; TZIPORI S, 1988, ADV PARASIT, V27, P63, DOI 10.1016/S0065-308X(08)60353-X; TZIPORI S, 1995, J INFECT DIS, V172, P1160, DOI 10.1093/infdis/172.4.1160; UNGAR BLP, 1991, J IMMUNOL, V147, P1014; UNGAR BLP, 1990, INFECT IMMUN, V58, P961, DOI 10.1128/IAI.58.4.961-969.1990; Urban JF, 1996, J IMMUNOL, V156, P263; VERMA S, 2008, VIROL J, V66, P1; Waters WR, 1996, INFECT IMMUN, V64, P1854, DOI 10.1128/IAI.64.5.1854-1857.1996; WHITMIRE WM, 1990, J PARASITOL, V76, P450, DOI 10.2307/3282689; WINNEFELD K, 1997, MED KLIN S3, V15, P8; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005	59	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4628	10.1371/journal.pone.0004628	http://dx.doi.org/10.1371/journal.pone.0004628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247447	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487800010
J	Colombatti, M; Grasso, S; Porzia, A; Fracasso, G; Scupoli, MT; Cingarlini, S; Poffe, O; Naim, HY; Heine, M; Tridente, G; Mainiero, F; Ramarli, D				Colombatti, Marco; Grasso, Silvia; Porzia, Alessandra; Fracasso, Giulio; Scupoli, Maria Teresa; Cingarlini, Sara; Poffe, Ornella; Naim, Hassan Y.; Heine, Martin; Tridente, Giuseppe; Mainiero, Fabrizio; Ramarli, Dunia			The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways	PLOS ONE			English	Article								The interleukin-6 (IL-6) and the chemokine CCL5 are implicated in the development and progression of several forms of tumours including that of the prostate. The expression of the prostate specific membrane antigen (PSMA) is augmented in high-grade and metastatic tumors. Observations of the clinical behaviour of prostate tumors suggest that the increased secretion of IL-6 and CCL5 and the higher expression of PSMA may be correlated. We hypothesized that PSMA could be endowed with signalling properties and that its stimulation might impact on the regulation of the gene expression of IL-6 and CCL5. We herein demonstrate that the cross-linking of cell surface PSMA with specific antibodies activates the small GTPases RAS and RAC1 and the MAPKs p38 and ERK1/2 in prostate carcinoma LNCaP cells. As downstream effects of the PSMA-fostered RAS-RAC1-MAPK pathway activation we observed a strong induction of NF-kappa B activation associated with an increased expression of IL-6 and CCL5 genes. Pharmacological blockade with specific inhibitors revealed that both p38 and ERK1/2 participate in the phenomenon, although a major role exerted by p38 was evident. Finally we demonstrate that IL-6 and CCL5 enhanced the proliferative potential of LNCaP cells synergistically and in a dose-dependent manner and that CCL5 functioned by receptor-mediated activation of the STAT5-Cyclin D1 pro-proliferative pathway. The novel functions attributable to PSMA which are described in the present report may have profound influence on the survival and proliferation of prostate tumor cells, accounting for the observation that PSMA overexpression in prostate cancer patients is related to a worse prognosis.	[Colombatti, Marco; Grasso, Silvia; Fracasso, Giulio; Cingarlini, Sara; Poffe, Ornella; Tridente, Giuseppe] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Tridente, Giuseppe; Ramarli, Dunia] Giovanni Battista Rossi Hosp, Verona, Italy; [Porzia, Alessandra; Mainiero, Fabrizio] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dept Expt Med, Rome, Italy; [Scupoli, Maria Teresa] Univ Verona, LURM, I-37100 Verona, Italy; [Naim, Hassan Y.; Heine, Martin] Sch Vet Med, Dept Physiol Chem, Hannover, Germany	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Verona; University of Veterinary Medicine Hannover, Foundation	Colombatti, M (corresponding author), Univ Verona, Dept Pathol, I-37100 Verona, Italy.	dunia.ramarli@univr.it	Fracasso, Giulio/O-3955-2019; SCUPOLI, Maria/AAX-9712-2021; Cingarlini, Sara/AAJ-5263-2021; Heine, Martin/C-6285-2011; cingarlini, sara/ABB-5280-2020; porzia, alessandra/AAA-7753-2020; Fracasso, Giulio/E-1271-2013	Fracasso, Giulio/0000-0003-3024-0307; SCUPOLI, Maria/0000-0002-3352-7859; Cingarlini, Sara/0000-0003-4786-4781; Fracasso, Giulio/0000-0003-3024-0307; porzia, alessandra/0000-0002-7545-3018; Mainiero, Fabrizio/0000-0002-7136-9839	Fondazione Cariverona; MIUR; ABO-Project	Fondazione Cariverona(Fondazione Cariverona); MIUR(Ministry of Education, Universities and Research (MIUR)); ABO-Project	This work was partially supported by grants from Fondazione Cariverona (Progetti Bando 2004, Progetti Bando 2007), by MIUR (PRIN 2005), and by ABO-Project (to MC).	Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Bander NH, 2005, J CLIN ONCOL, V23, P4591, DOI 10.1200/JCO.2005.05.160; Barwe SP, 2007, INT J ONCOL, V30, P899; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Carey AM, 2007, INT J CANCER, V121, P520, DOI 10.1002/ijc.22715; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chen TS, 2000, CANCER RES, V60, P2132; Colombara M, 2005, J IMMUNOL, V175, P7021, DOI 10.4049/jimmunol.175.10.7021; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Dagvadorj A, 2008, CLIN CANCER RES, V14, P1317, DOI 10.1158/1078-0432.CCR-07-2024; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Ghosh A, 2005, CANCER RES, V65, P727; Hobisch A, 2000, J PATHOL, V191, P239, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee SO, 2003, CLIN CANCER RES, V9, P370; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liu H, 1997, CANCER RES, V57, P3629; Mainiero F, 2003, EUR J IMMUNOL, V33, P3038, DOI 10.1002/eji.200323931; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Rajasekaran AK, 2005, AM J PHYSIOL-CELL PH, V288, pC975, DOI 10.1152/ajpcell.00506.2004; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; SIEGALL CB, 1990, CANCER RES, V50, P7786; Silver DA, 1997, CLIN CANCER RES, V3, P81; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wong M, 1998, J BIOL CHEM, V273, P309, DOI 10.1074/jbc.273.1.309; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Zerbini LF, 2003, CANCER RES, V63, P2206	34	59	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4608	10.1371/journal.pone.0004608	http://dx.doi.org/10.1371/journal.pone.0004608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242540	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487500012
J	Lee, G; Santat, LA; Chang, MS; Choi, S				Lee, Gwang; Santat, Leah A.; Chang, Mi Sook; Choi, Sangdun			RNAi Methodologies for the Functional Study of Signaling Molecules	PLOS ONE			English	Article							SMALL INTERFERING RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; CPG DNA; G-ALPHA-I2-DEFICIENT MICE; STRANDED-RNA; CYCLOOXYGENASE-2 EXPRESSION; RIG-I; ACTIVATION; KINASE	RNA interference (RNAi) was investigated with the aim of achieving gene silencing with diverse RNAi platforms that include small interfering RNA (siRNA), short hairpin RNA (shRNA) and antisense oligonucleotides (ASO). Different versions of each system were used to silence the expression of specific subunits of the heterotrimeric signal transducing G-proteins, G alpha i2 and G beta 2, in the RAW 264.7 murine macrophage cell line. The specificity of the different RNA interference (RNAi) platforms was assessed by DNA microarray analysis. Reliable RNAi methodologies against the genes of interest were then developed and applied to functional studies of signaling networks. This study demonstrates a successful knockdown of target genes and shows the potential of RNAi for use in functional studies of signaling molecules.	[Lee, Gwang; Choi, Sangdun] Ajou Univ, Coll Nat Sci, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Gwang] Ajou Univ, Coll Nat Sci, Inst Med Sci, Suwon 441749, South Korea; [Santat, Leah A.; Chang, Mi Sook] CALTECH, Mol Biol Lab, Div Biol, Alliance Cellular Signaling, Pasadena, CA 91125 USA; [Choi, Sangdun] Ajou Univ, Coll Nat Sci, Dept Biol Sci, Suwon 441749, South Korea	Ajou University; Ajou University; California Institute of Technology; Ajou University	Lee, G (corresponding author), Ajou Univ, Coll Nat Sci, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr			Korea Science and Engineering Foundation (KOSEF); Korean Government (MOST) [R01-2007-000-20533-0]; Korea Research Foundation; MOEHRD [KRF-2006-311-C00482]; Ajou University Research Fellowship	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korean Government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Korea Research Foundation(National Research Foundation of Korea); MOEHRD(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ajou University Research Fellowship	This work was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean Government (MOST) (R01-2007-000-20533-0). This work was also partly supported by a Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2006-311-C00482) and by the Ajou University Research Fellowship of 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baritono E, 2004, J HYPERTENS, V22, P783, DOI 10.1097/00004872-200404000-00022; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjursten M, 2005, SCAND J IMMUNOL, V61, P29, DOI 10.1111/j.0300-9475.2005.01535.x; Bjursten M, 2004, CELL IMMUNOL, V228, P77, DOI 10.1016/j.cellimm.2004.05.001; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Endesfelder S, 2005, J MOL MED, V83, P64, DOI 10.1007/s00109-004-0607-3; FAN H, 2005, AM J PHYSL CELL PHYS; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hwang JI, 2004, P NATL ACAD SCI USA, V101, P488, DOI 10.1073/pnas.0307549100; HWANG JI, 2005, P NATL ACAD SCI US; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koller E, 2006, NUCLEIC ACIDS RES, V34, P4467, DOI 10.1093/nar/gkl589; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Overhoff M, 2005, J MOL BIOL, V348, P871, DOI 10.1016/j.jmb.2005.03.012; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RUDOLPH U, 1995, J CLIN IMMUNOL, V15, P101; Salmon P, 2000, BLOOD, V96, P3392; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stovall SH, 2004, J BIOL CHEM, V279, P13809, DOI 10.1074/jbc.M311434200; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang Q, 1999, J BIOL CHEM, V274, P17365, DOI 10.1074/jbc.274.24.17365; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yeo SJ, 2003, J BIOL CHEM, V278, P40590, DOI 10.1074/jbc.M306280200; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711; YIN C, 2005, J MOL CELL CARDIOL; Zhang YJ, 2005, INT IMMUNOL, V17, P233, DOI 10.1093/intimm/dxh204	55	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4559	10.1371/journal.pone.0004559	http://dx.doi.org/10.1371/journal.pone.0004559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238203	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000265487400001
J	Almeida, T; Alonso, I; Martins, S; Ramos, EM; Azevedo, L; Ohno, K; Amorim, A; Saraiva-Pereira, ML; Jardim, LB; Matsuura, T; Sequeiros, J; Silveira, I				Almeida, Teresa; Alonso, Isabel; Martins, Sandra; Ramos, Eliana Marisa; Azevedo, Luisa; Ohno, Kinji; Amorim, Antonio; Saraiva-Pereira, Maria Luiza; Jardim, Laura Bannach; Matsuura, Tohru; Sequeiros, Jorge; Silveira, Isabel			Ancestral Origin of the ATTCT Repeat Expansion in Spinocerebellar Ataxia Type 10 (SCA10)	PLOS ONE			English	Article								Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disease characterized by cerebellar ataxia and seizures. The disease is caused by a large ATTCT repeat expansion in the ATXN10 gene. The first families reported with SCA10 were of Mexican origin, but the disease was soon after described in Brazilian families of mixed Portuguese and Amerindian ancestry. The origin of the SCA10 expansion and a possible founder effect that would account for its geographical distribution have been the source of speculation over the last years. To unravel the mutational origin and spread of the SCA10 expansion, we performed an extensive haplotype study, using closely linked STR markers and intragenic SNPs, in families from Brazil and Mexico. Our results showed (1) a shared disease haplotype for all Brazilian and one of the Mexican families, and (2) closely-related haplotypes for the additional SCA10 Mexican families; (3) little or null genetic distance in small normal alleles of different repeat sizes, from the same SNP lineage, indicating that they are being originated by a single step mechanism; and (4) a shared haplotype for pure and interrupted expanded alleles, pointing to a gene conversion model for its generation. In conclusion, we show evidence for an ancestral common origin for SCA10 in Latin America, which might have arisen in an ancestral Amerindian population and later have been spread into the mixed populations of Mexico and Brazil.	[Almeida, Teresa; Alonso, Isabel; Ramos, Eliana Marisa; Sequeiros, Jorge; Silveira, Isabel] Univ Porto, UnIGENe, IBMC, P-4100 Oporto, Portugal; [Martins, Sandra; Azevedo, Luisa; Amorim, Antonio] IPATIMUP, Oporto, Portugal; [Ohno, Kinji; Matsuura, Tohru] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet & Bioinformat, Nagoya, Aichi, Japan; [Amorim, Antonio] Univ Porto, Fac Ciencias, Oporto, Portugal; [Saraiva-Pereira, Maria Luiza; Jardim, Laura Bannach] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Sequeiros, Jorge] Univ Porto, ICBAS, Oporto, Portugal	Universidade do Porto; Nagoya University; Universidade do Porto; Universidade do Porto	Almeida, T (corresponding author), Univ Porto, UnIGENe, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	isilveir@ibmc.up.pt	Inagemp, Inct/J-9451-2013; Jardim, Laura B/B-6149-2013; Alonso, Isabel/I-4307-2013; Ohno, Kinji/H-4020-2012; Amorim, Antonio/A-7938-2008; Martins, Sandra/I-5159-2013; Ohno, Kinji/ABD-5787-2020; Saraiva-Pereira, Maria Luiza/H-6302-2013; Azevedo, Luisa/J-4051-2013; Silveira, Isabel/D-6881-2012; Martins, Sandra/AAG-2601-2020; Pereira, Maria/GZA-9681-2022	Alonso, Isabel/0000-0001-8549-6903; Ohno, Kinji/0000-0002-1529-2750; Amorim, Antonio/0000-0002-7518-6247; Martins, Sandra/0000-0002-3720-2920; Ohno, Kinji/0000-0002-1529-2750; Saraiva-Pereira, Maria Luiza/0000-0003-3905-9563; Azevedo, Luisa/0000-0002-3157-7342; Silveira, Isabel/0000-0002-2610-5260; Martins, Sandra/0000-0002-3720-2920; Sequeiros, Jorge/0000-0002-9846-1037	FCT, Portugal [POCI/SAU-MMO/56387/2004, scholarships]; FEDER [POCI/SAU-MMO/56387/2004]; CNPq (Brazilian Funding Agency); POCI 2010, VI Programa Quadro	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); CNPq (Brazilian Funding Agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); POCI 2010, VI Programa Quadro	This work was supported by a research grant POCI/SAU-MMO/56387/2004, FCT, and co-funded by FEDER. T.A., I.A. and S.M. are recipients of scholarships from FCT, Portugal. MLSP and LBJ are supported by CNPq (Brazilian Funding Agency). IPATIMUP is partially supported by POCI 2010, VI Programa Quadro (2002 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2006, NEUROLOGY, V66, P1602, DOI 10.1212/01.wnl.0000216266.30177.bb; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gatto EM, 2007, NEUROLOGY, V69, P216, DOI 10.1212/01.wnl.0000265596.72492.89; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; Matsuura T, 2002, NEUROLOGY, V58, P983, DOI 10.1212/WNL.58.6.983; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Raskin S, 2007, ARCH NEUROL-CHICAGO, V64, P591, DOI 10.1001/archneur.64.4.591; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Sambrook J., 2002, MOL CLONING LAB MANU; Seixas AI, 2005, AM J MED GENET A, V136A, P87, DOI 10.1002/ajmg.a.30761; Smith AFA, REPEATMASKER OPEN 3; Teive HAG, 2004, NEUROLOGY, V63, P1509; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	20	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4553	10.1371/journal.pone.0004553	http://dx.doi.org/10.1371/journal.pone.0004553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234597	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487200009
J	Zhai, XH; Malakhova, ML; Pike, HM; Benson, LM; Bergen, HR; Sugar, IP; Malinina, L; Patel, DJ; Brown, RE				Zhai, Xiuhong; Malakhova, Margarita L.; Pike, Helen M.; Benson, Linda M.; Bergen, H. Robert, III; Sugar, Istvan P.; Malinina, Lucy; Patel, Dinshaw J.; Brown, Rhoderick E.			Glycolipid Acquisition by Human Glycolipid Transfer Protein Dramatically Alters Intrinsic Tryptophan Fluorescence INSIGHTS INTO GLYCOLIPID BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSBILAYER DISTRIBUTION; STRUCTURAL BASIS; SITES; GLYCOSPHINGOLIPIDS; MODEL; SUGAR; GALACTOSYLCERAMIDE; GLUCOSYLCERAMIDE; IDENTIFICATION; SPHINGOMYELIN	Glycolipid transfer proteins (GLTPs) are small, soluble proteins that selectively accelerate the intermembrane transfer of glycolipids. The GLTP fold is conformationally unique among lipid binding/transfer proteins and serves as the prototype and founding member of the new GLTP superfamily. In the present study, changes in human GLTP tryptophan fluorescence, induced by membrane vesicles containing glycolipid, are shown to reflect glycolipid binding when vesicle concentrations are low. Characterization of the glycolipid-induced "signature response," i.e. similar to 40% decrease in Trp intensity and similar to 12-nm blue shift in emission wavelength maximum, involved various modes of glycolipid presentation, i.e. microinjection/dilution of lipid-ethanol solutions or phosphatidylcholine vesicles, prepared by sonication or extrusion and containing embedded glycolipids. High resolution x-ray structures of apo- and holo-GLTP indicate that major conformational alterations are not responsible for the glycolipid-induced GLTP signature response. Instead, glycolipid binding alters the local environment of Trp-96, which accounts for similar to 70% of total emission intensity of three Trp residues in GLTP and provides a stacking platform that aids formation of a hydrogen bond network with the ceramide-linked sugar of the glycolipid head group. The changes in Trp signal were used to quantitatively assess human GLTP binding affinity for various lipids including glycolipids containing different sugar headgroups and homogenous acyl chains. The presence of the glycolipid acyl chain and at least one sugar were essential for achieving a low-to-submicromolar dissociation constant that was only slightly altered by increased sugar headgroup complexity.	[Malinina, Lucy] CICbioGUNE, Struct Biol, Derio 48160, Spain; [Zhai, Xiuhong; Malakhova, Margarita L.; Pike, Helen M.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Benson, Linda M.; Bergen, H. Robert, III] Mayo Clin, Coll Med, Mayo Prote Res Ctr, Rochester, MN 55905 USA; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Sugar, Istvan P.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	University of Minnesota System; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai	Malinina, L (corresponding author), CICbioGUNE, Struct Biol, Parque Tecnol Vizcaya Ed 800, Derio 48160, Spain.	lucy@cicbiogune.es; pateld@mskcc.org; reb@umn.edu	Malinina, Lucy/B-8161-2013; Sugar, Istvan/AAU-4351-2020	Brown, Rhoderick/0000-0002-7337-3604; Malinina, Lucy/0000-0001-7973-1831	National Institutes of Health [CA121493, GM45928]; United States Public Health Service and NCI; Abby Rockefeller Mauze Trust; Dewitt Wallace Fund; Maloris Foundation; Mayo Foundation; Medical Educationand Research; The Hormel Foundation.; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service and NCI; Abby Rockefeller Mauze Trust; Dewitt Wallace Fund; Maloris Foundation; Mayo Foundation; Medical Educationand Research; The Hormel Foundation.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121493 and GM45928 from the United States Public Health Service and NCI. This work was also supported by grants from the Abby Rockefeller Mauze Trust and the Dewitt Wallace Fund, the Maloris Foundation, the Mayo Foundation for Medical Educationand Research, and The Hormel Foundation.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bektas M, 2003, GLYCOCONJUGATE J, V20, P39, DOI 10.1023/B:GLYC.0000016741.88476.8b; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P803, DOI 10.1016/j.bbalip.2006.08.012; Chowdary TK, 2007, BIOCHEM J, V401, P437, DOI 10.1042/BJ20061046; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Corti M, 2007, CURR OPIN COLLOID IN, V12, P148, DOI 10.1016/j.cocis.2007.05.002; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; JOSEPH M, 1995, J BIOL CHEM, V270, P16749, DOI 10.1074/jbc.270.28.16749; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Mattjus P, 2002, J BIOL CHEM, V277, P19476, DOI 10.1074/jbc.M201305200; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nylund M, 2007, LANGMUIR, V23, P11726, DOI 10.1021/la701927u; Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d; PRINETTI A, 2009, BIOCHIM BIOPHYS ACTA, V1778, P184; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Sabourdy F, 2008, BBA-MOL CELL BIOL L, V1781, P145, DOI 10.1016/j.bbalip.2008.01.004; Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019; Sillence DJ, 2000, J LIPID RES, V41, P1252; SIXMA TK, 1992, NATURE, V355, P561, DOI 10.1038/355561a0; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; Soisson SM, 1997, J MOL BIOL, V273, P226, DOI 10.1006/jmbi.1997.1314; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Sykora J, 2005, CHEM PHYS LIPIDS, V135, P213, DOI 10.1016/j.chemphyslip.2005.03.003; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Viard M, 2003, GLYCOCONJUGATE J, V20, P213, DOI 10.1023/B:GLYC.0000024253.48791.d9; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; West G, 2008, FEBS J, V275, P3421, DOI 10.1111/j.1742-4658.2008.06498.x; West G, 2006, BBA-BIOMEMBRANES, V1758, P1732, DOI 10.1016/j.bbamem.2006.06.020; Yu ZW, 1998, BIOCHEMISTRY-US, V37, P1540, DOI 10.1021/bi971010o; Zhai XH, 2006, BIOPHYS J, V91, P2490, DOI 10.1529/biophysj.106.084921; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	53	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13620	13628		10.1074/jbc.M809089200	http://dx.doi.org/10.1074/jbc.M809089200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19270338	Green Published, hybrid			2022-12-25	WOS:000265877300039
J	Tamura, T; Smith, M; Kanno, T; Dasenbrock, H; Nishiyama, A; Ozato, K				Tamura, Tomohiko; Smith, Matthew; Kanno, Tomohiko; Dasenbrock, Hormuzdiyer; Nishiyama, Akira; Ozato, Keiko			Inducible Deposition of the Histone Variant H3.3 in Interferon-stimulated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE GENES; EPIGENETIC INHERITANCE; GENOME-WIDE; CHROMATIN; TRANSCRIPTION; METHYLATION; PROMOTERS; CELLS; MARKS; RNA	The H3.3 histone variant is synthesized throughout cell cycle and deposited onto chromatin in a replication-independent manner. It is enriched in transcriptionally active regions of chromatin and is implicated in epigenetic memory. The dynamics of H3.3 deposition during transcriptional activation, however, have not been fully studied so far. Here we examined H3.3 incorporation into interferon (IFN)-stimulated genes in confluent mouse NIH3T3 cells expressing H3.3 fused to the yellow fluorescent protein (YFP). Following IFN stimulation, H3.3-YFP was rapidly incorporated into all four IFN-activated genes tested, with the highest enrichment seen in the distal end of the coding region. Surprisingly, H3.3 enrichment in the coding region continued for an extended period of time, long after transcription ceased. The promoter region, although constitutively enriched with H3.3-YFP, did not show an increase in its deposition in response to IFN stimulation. Further, although H3.3-YFP deposition stably remained in non-dividing cells for days after IFN stimulation, it was rapidly diminished in dividing cells. Lastly, we examined the role of H3.3 in IFN-stimulated transcription by a short hairpin RNA approach and found that IFN-stimulated transcription was significantly impaired in H3.3 knockdown cells. Results indicate that H3.3 plays a role in IFN-mediated transcription, and its deposition leaves a prolonged post-transcriptional mark in these genes.	[Tamura, Tomohiko; Smith, Matthew; Kanno, Tomohiko; Dasenbrock, Hormuzdiyer; Nishiyama, Akira; Ozato, Keiko] Eunice Kennedy Shriver NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ozato, K (corresponding author), NICHD, Lab Mol Growth Regulat, NIH, Bldg 6,Rm 2A01,6 Ctr Dr,MSC 2753, Bethesda, MD 20892 USA.	ozatok@mail.nih.gov		Smith, Matthew/0000-0001-6614-569X	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant through the Intramural Research Program of Eunice Kennedy Shriver NICHD.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Lacoste N, 2008, NAT CELL BIOL, V10, P7, DOI 10.1038/ncb0108-7; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Placek BJ, 2009, J VIROL, V83, P1416, DOI 10.1128/JVI.01276-08; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Sen GC, 2007, CURR TOP MICROBIOL, V316, P233; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011	42	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12217	12225		10.1074/jbc.M805651200	http://dx.doi.org/10.1074/jbc.M805651200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244243	hybrid, Green Published			2022-12-25	WOS:000265494600053
J	Thomas, S; Ritter, B; Verbich, D; Sanson, C; Bourbonniere, L; McKinney, RA; McPherson, PS				Thomas, Sebastien; Ritter, Brigitte; Verbich, David; Sanson, Claire; Bourbonniere, Lyne; McKinney, R. Anne; McPherson, Peter S.			Intersectin Regulates Dendritic Spine Development and Somatodendritic Endocytosis but Not Synaptic Vesicle Recycling in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PROTEIN INTERSECTIN; DOWN-SYNDROME; DROSOPHILA AMPHIPHYSIN; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; NERVE-TERMINALS; ADAPTER PROTEIN; EH DOMAIN; N-WASP	Intersectin-short (intersectin-s) is a multimodule scaffolding protein functioning in constitutive and regulated forms of endocytosis in non-neuronal cells and in synaptic vesicle (SV) recycling at the neuromuscular junction of Drosophila and Caenorhabditis elegans. In vertebrates, alternative splicing generates a second isoform, intersectin-long (intersectin-1), that contains additional modular domains providing a guanine nucleotide exchange factor activity for Cdc42. In mammals, intersectin-s is expressed in multiple tissues and cells, including glia, but excluded from neurons, whereas intersectin-1 is a neuron-specific isoform. Thus, intersectin-1 may regulate multiple forms of endocytosis in mammalian neurons, including SV endocytosis. We now report, however, that intersectin-1 is localized to somatodendritic regions of cultured hippocampal neurons, with some juxtanuclear accumulation, but is excluded from synaptophysin-labeled axon terminals. Consistently, intersectin-1 knockdown (KD) does not affect SV recycling. Instead intersectin-1 co-localizes with clathrin heavy chain and adaptor protein 2 in the somatodendritic region of neurons, and its KD reduces the rate of transferrin endocytosis. The protein also co-localizes with F-actin at dendritic spines, and intersectin-1 KD disrupts spine maturation during development. Our data indicate that intersectin-1 is indeed an important regulator of constitutive endocytosis and neuronal development but that it is not a prominent player in the regulated endocytosis of SVs.	[Thomas, Sebastien; Ritter, Brigitte; Sanson, Claire; Bourbonniere, Lyne; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Verbich, David; McKinney, R. Anne] McGill Univ, Dept Pharmacol & Therapeut, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Ritter, Brigitte/0000-0002-0094-0460; Thomas, Sebastien/0000-0002-9263-2296	Canadian Institutes of Health Research [MOP-15396, MOP-86724]; Canadian Institutes of Health Research; Natural Sciences and Engineering Rgpin [341942-07]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Rgpin	This work was supported by Grants MOP-15396 and MOP-86724 from the Canadian Institutes of Health Research (to P. S. M. and R. A. M.), respectively, and from Natural Sciences and Engineering Rgpin 341942-07 (to R. A. M.).	Adams A, 2000, J BIOL CHEM, V275, P27414; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Burman JL, 2005, FEBS LETT, V579, P2177, DOI 10.1016/j.febslet.2005.03.008; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Evergren E, 2006, NEUROSCIENCE, V141, P123, DOI 10.1016/j.neuroscience.2006.03.038; Evergren E, 2007, J NEUROSCI, V27, P379, DOI 10.1523/JNEUROSCI.4683-06.2007; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 1998, J NEUROSCI, V18, P8900; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Kobayashi T, 1998, SEMIN CELL DEV BIOL, V9, P517, DOI 10.1006/scdb.1998.0257; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Leventis PA, 2001, TRAFFIC, V2, P839; Ma YJ, 2003, J NEUROSCI RES, V71, P468, DOI 10.1002/jnr.10500; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martin NP, 2006, MOL PHARMACOL, V70, P1643, DOI 10.1124/mol.106.028274; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; McPherson PS, 1999, CELL SIGNAL, V11, P229, DOI 10.1016/S0898-6568(98)00059-X; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869, DOI 10.1093/oxfordjournals.jbchem.a022200; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; O'Bryan JP, 2001, ONCOGENE, V20, P6300, DOI 10.1038/sj.onc.1204773; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Pucharcos C, 1999, EUR J HUM GENET, V7, P704, DOI 10.1038/sj.ejhg.5200356; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tsyba L, 2004, GENOMICS, V84, P106, DOI 10.1016/j.ygeno.2004.02.005; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zelhof AC, 2001, DEVELOPMENT, V128, P5005	58	67	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12410	12419		10.1074/jbc.M809746200	http://dx.doi.org/10.1074/jbc.M809746200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258322	Green Published, hybrid			2022-12-25	WOS:000265494600071
J	Yau, MH; Wang, Y; Lam, KSL; Zhang, JL; Wu, DH; Xu, AM				Yau, Ming-hon; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Wu, Donghai; Xu, Aimin			A Highly Conserved Motif within the NH2-terminal Coiled-coil Domain of Angiopoietin-like Protein 4 Confers Its Inhibitory Effects on Lipoprotein Lipase by Disrupting the Enzyme Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-METABOLISM; ADIPOSE-TISSUE; TARGET GENE; ANGPTL4; MICE; PLASMA; OLIGOMERIZATION; TRIGLYCERIDE; HEART; OVEREXPRESSION	Lipoprotein lipase (LPL) is a principal enzyme responsible for the clearance of chylomicrons and very low density lipoproteins from the bloodstream. Two members of the Angptl (angiopoietin-like protein) family, namely Angptl3 and Angptl4, have been shown to inhibit LPL activity in vitro and in vivo. Here, we further investigated the structural basis underlying the LPL inhibition by Angptl3 and Angptl4. By multiple sequence alignment analysis, we have identified a highly conserved 12-amino acid consensus motif that is present within the coiled-coil domain (CCD) of both Angptl3 and Angptl4, but not other members of the Angptl family. Substitution of the three polar amino acid residues (His46, Gln50, and Gln53) within this motif with alanine abolishes the inhibitory effect of Angptl4 on LPL in vitro and also abrogates the ability of Angptl4 to elevate plasma triglyceride levels in mice. The CCD of Angptl4 interacts with LPL and converts the catalytically active dimers of LPL to its inactive monomers, whereas the mutant protein with the three polar amino acids being replaced by alanine loses such a property. Furthermore, a synthetic peptide consisting of the 12-amino acid consensus motif is sufficient to inhibit LPL activity, although the potency is much lower than the recombinant CCD of Angptl4. In summary, our data suggest that the 12-amino acid consensus motif within the CCD of Angptl4, especially the three polar residues within this motif, is responsible for its interaction with and inhibition of LPL by blocking the enzyme dimerization.	[Yau, Ming-hon; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Ming-hon; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 10663, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Xu, AM (corresponding author), Univ Hong Kong, Dept Med, L8-40,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940	General Research Fund of Hong Kong Research Council [HKU 7609/05M]; Outstanding Young Researcher award; University of Hong Kong; National 973 Program of China [2006CB910202]	General Research Fund of Hong Kong Research Council; Outstanding Young Researcher award; University of Hong Kong(University of Hong Kong); National 973 Program of China(National Basic Research Program of China)	This work was supported by the General Research Fund of Hong Kong Research Council Grant HKU 7609/05M, Outstanding Young Researcher award (to A. X.), a small project grant (to M. H. Y.) from the University of Hong Kong, and National 973 Program of China Grant 2006CB910202.	Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004; CHENG Q, 1990, BIOCHEM J, V269, P403, DOI 10.1042/bj2690403; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P4570; ENERBACK S, 1988, GENE, V64, P97, DOI 10.1016/0378-1119(88)90484-2; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Fujimoto K, 2006, EXP ANIM TOKYO, V55, P27, DOI 10.1538/expanim.55.27; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Katoh Y, 2006, INT J MOL MED, V17, P1145; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; RIMMER ANNE DAVENPORT, 1962, CLIN CHIM ACTA, V7, P877, DOI 10.1016/0009-8981(62)90075-X; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; VAINIO P, 1983, BIOCHEMISTRY-US, V22, P2270, DOI 10.1021/bi00278a033; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102; Zhang LY, 2005, J BIOL CHEM, V280, P42580, DOI 10.1074/jbc.M507252200	43	90	98	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11942	11952		10.1074/jbc.M809802200	http://dx.doi.org/10.1074/jbc.M809802200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246456	Green Published, hybrid			2022-12-25	WOS:000265494600026
J	Kong, YW; Jing, G; Yan, ZG; Li, CZ; Gong, NP; Zhu, FJ; Li, DX; Zhang, YR; Zheng, GL; Wang, HZ; Xie, LP; Zhang, RQ				Kong, Yawei; Jing, Gu; Yan, Zhenguang; Li, Changzhong; Gong, Ningping; Zhu, Fangjie; Li, Dongxian; Zhang, Yaorun; Zheng, Guilan; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			Cloning and Characterization of Prisilkin-39, a Novel Matrix Protein Serving a Dual Role in the Prismatic Layer Formation from the Oyster Pinctada fucata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLLUSK SHELL FORMATION; JAPANESE PEARL OYSTER; ORGANIC MATRIX; PINNA-NOBILIS; FRAMEWORK FORMATION; NACREOUS LAYER; EXPRESSION; ARAGONITE; CALCIUM; MACROMOLECULES	Molluscs form their shells out of CaCO3 and a matrix of biomacromolecules. Understanding the role of matrices may shed some light on the mechanism of biomineralization. Here, a 1401-bp full-length cDNA sequence encoding a novel matrix protein was cloned from the mantle of the bivalve oyster, Pinctada fucata. The deduced protein (Prisilkin-39), which has a molecular mass of 39.3 kDa and an isoelectric point of 8.83, was fully characterized, and its role in biomineralization was demonstrated using both in vivo and in vitro crystal growth assays. Prisilkin-39 is a highly repetitive protein with an unusual composition of Gly, Tyr, and Ser residues. Expression of Prisilkin-39 was localized to columnar epithelial cells of the mantle edge, corresponding to the calcitic prismatic layer formation. Immunostaining in situ and immunodetection in vitro revealed the presence of a characteristic pattern of Prisilkin-39 in the organic sheet and in sheaths around the prisms. Prisilkin-39 binds tightly with chitin, an insoluble polysaccharide that forms the highly structured framework of the shell. Antibody injection in vivo resulted in dramatic morphological deformities in the inner shell surface structure, where large amounts of CaCO3 were deposited in an uncontrolled manner. Moreover, Prisilkin-39 strictly prohibited the precipitation of aragonite in vitro. Taken together, Prisilkin-39 is the first protein shown to have dual function, involved both in the chitinous framework building and in crystal growth regulation during the prismatic layer mineralization. These observations may extend our view on the rare group of basic matrices and their functions during elaboration of the molluscan shell.	[Kong, Yawei; Jing, Gu; Yan, Zhenguang; Li, Changzhong; Gong, Ningping; Zhu, Fangjie; Li, Dongxian; Zhang, Yaorun; Zheng, Guilan; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Dept Biol Sci & Biotechnol, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn	Jing, Gu/B-7678-2011		National High Technology Research and Development Program of China [2006AA09Z441, 2006AA09Z413]; National Natural Science Foundation of China [30530600, 30221003, U0831001]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China Grants 2006AA09Z441 and 2006AA09Z413 and the National Natural Science Foundation of China Grants 30530600, 30221003 and U0831001 (Joint Fund with Guandong).	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; Andersen SO, 1998, COMP BIOCHEM PHYS A, V121, P375, DOI 10.1016/S1095-6433(98)10146-0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowen CE, 1996, COMP BIOCHEM PHYS A, V115, P269, DOI 10.1016/S0300-9629(96)00059-X; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Dauphin Y, 2003, J BIOL CHEM, V278, P15168, DOI 10.1074/jbc.M204375200; Faircloth LM, 2007, COMP BIOCHEM PHYS B, V146, P370, DOI 10.1016/j.cbpb.2006.11.008; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Feng QL, 2000, J CRYST GROWTH, V216, P459, DOI 10.1016/S0022-0248(00)00396-1; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hasegawa Y, 2005, FISHERIES SCI, V71, P1174, DOI 10.1111/j.1444-2906.2005.01078.x; Huang WQ, 2001, LIFE SCI, V68, P1727; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lakshminarayanan R, 2003, J BIOL CHEM, V278, P2928, DOI 10.1074/jbc.M201518200; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; Lowenstam HA, 1989, BIOMINERALIZATION; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; MANN S, 2001, BIOMINERALIZATION PR, P89; Marin F, 2005, MAT SCI ENG C-BIO S, V25, P105, DOI 10.1016/j.msec.2005.01.003; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matsushiro A, 2004, J BONE MINER METAB, V22, P163, DOI 10.1007/s00774-003-0484-9; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2007, FEBS J, V274, P5158, DOI 10.1111/j.1742-4658.2007.06036.x; Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140; Suzuki N, 2000, ENDOCRINOLOGY, V141, P4247, DOI 10.1210/en.141.11.4247; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wada K., 1976, MECH MINERALIZATION, P175; WADA K, 1966, B NATL PEARL RES, V20, P2209; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	62	80	86	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10841	10854		10.1074/jbc.M808357200	http://dx.doi.org/10.1074/jbc.M808357200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233851	Green Published, hybrid			2022-12-25	WOS:000265104600058
J	Shapira, Y; Katz, M; Ali, M; Kaplan, M; Brazowski, E; Halpern, Z; Elinav, E				Shapira, Yami; Katz, Meirav; Ali, Muhammad; Kaplan, Michael; Brazowski, Eli; Halpern, Zamir; Elinav, Eran			Utilization of Murine Laparoscopy for Continuous In-Vivo Assessment of the Liver in Multiple Disease Models	PLOS ONE			English	Article								Background: Current strategies for follow up of murine models of liver disease are flawed by inability to continuously monitor disease progression in the tissue level, and necessitate sacrifice of animals for tissue sampling. Aims: In this study we aimed at developing a safe repetitive tool for sampling livers in vivo, by utilization of a miniaturized endoscopy system for laparoscopic liver biopsies and for injection of tumor cells into livers. Results: We report the development of a protocol for murine laparoscopy that allows repeated visualization of murine intra-abdominal organs. The system enables safe and repeated liver biopsies in mice and rats, yielding adequate tissue for histological staining and RNA extraction. In addition, injection of tumor cells into livers facilitates under-vision implantation of hepatic tumors in liver, followed by visualization of tumor growth. Conclusions: Murine laparoscopy may be employed as a novel imaging modality for continuous assessment and manipulation of chronic liver disease models.	[Shapira, Yami; Katz, Meirav; Ali, Muhammad; Kaplan, Michael; Brazowski, Eli; Halpern, Zamir; Elinav, Eran] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Shapira, Y (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel.	erane@tasmc.health.gov.il	Elinav, Eran/C-8077-2011; Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Denzer U, 2007, J CLIN GASTROENTEROL, V41, P103, DOI 10.1097/01.mcg.0000225612.86846.82; FIDLER IJ, 1994, CANCER METAST REV, V13, P209, DOI 10.1007/BF00689637; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Goetz M, 2007, ENDOSCOPY, V39, P350, DOI 10.1055/s-2007-966262; Goetz M, 2008, J HEPATOL, V48, P91, DOI 10.1016/j.jhep.2007.07.029; Helmreich-Becker I, 2003, ENDOSCOPY, V35, P55, DOI 10.1055/s-2003-36419; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; MORIKAWA K, 1988, CANCER RES, V48, P6863; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Oren R, 1996, HEPATOLOGY, V24, P419; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; RUSCIANO D, 1994, INVAS METAST, V14, P349; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Weltman MD, 1996, GASTROENTEROLOGY, V111, P1645, DOI 10.1016/S0016-5085(96)70028-8	16	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4776	10.1371/journal.pone.0004776	http://dx.doi.org/10.1371/journal.pone.0004776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274092	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000015
J	Couture, JP; Daviau, A; Fradette, J; Blouin, R				Couture, Jean-Philippe; Daviau, Alex; Fradette, Julie; Blouin, Richard			The Mixed-Lineage Kinase DLK Is a Key Regulator of 3T3-L1 Adipocyte Differentiation	PLOS ONE			English	Article								Background: The mixed-lineage kinase (MLK) family member DLK has been proposed to serve as a regulator of differentiation in various cell types; however, its role in adipogenesis has not been investigated. In this study, we used the 3T3-L1 preadipocyte cell line as a model to examine the function of DLK in adipocyte differentiation. Methods and Findings: Immunoblot analyses and kinase assays performed on 3T3-L1 cells showed that the expression and activity of DLK substantially increase as differentiation occurs. Interestingly, DLK appears crucial for differentiation since its depletion by RNA interference impairs lipid accumulation as well as expression of the master regulators of adipogenesis C/EBP alpha and PPAR gamma 2 at both the mRNA and protein levels. In contrast, neither the expression nor the DNA binding activity of C/EBP beta, an activator for C/EBP alpha and PPAR gamma, is affected by DLK loss. Conclusions: Taken together, these results suggest that DLK is important for expression of mature adipocyte markers and that its action most likely takes place via regulation of C/EBP beta transcriptional activity and/or initiation of C/EBP alpha and PPAR gamma 2 gene transcription.	[Couture, Jean-Philippe; Daviau, Alex; Blouin, Richard] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Fradette, Julie] Univ Quebec, Hop St Sacrement, Ctr Hosp Affilie, Lab Organogenese Expt, Quebec City, PQ, Canada	University of Sherbrooke; Laval University; University of Quebec	Couture, JP (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	Richard.Blouin@USherbrooke.ca		Fradette, Julie/0000-0002-1851-5112	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR). CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, GASTROENTEROLOGY, V132, P2103, DOI 10.1053/j.gastro.2007.03.058; Blouin R, 1996, DNA CELL BIOL, V15, P631, DOI 10.1089/dna.1996.15.631; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Daviau A, 2009, CELL SIGNAL, V21, P577, DOI 10.1016/j.cellsig.2008.12.009; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fan G, 1996, J BIOL CHEM, V271, P24788, DOI 10.1074/jbc.271.40.24788; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Feve B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hirai S, 1996, ONCOGENE, V12, P641; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Nadeau A, 1997, J HISTOCHEM CYTOCHEM, V45, P107, DOI 10.1177/002215549704500114; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Robitaille H, 2005, J BIOL CHEM, V280, P12732, DOI 10.1074/jbc.M411619200; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	45	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4743	10.1371/journal.pone.0004743	http://dx.doi.org/10.1371/journal.pone.0004743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270737	Green Published, Green Submitted, gold			2022-12-25	WOS:000265495900011
J	Gegg, ME; Cooper, JM; Schapira, AHV; Taanman, JW				Gegg, Matthew E.; Cooper, J. Mark; Schapira, Anthony H. V.; Taanman, Jan-Willem			Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells	PLOS ONE			English	Article							LOSS-OF-FUNCTION; PARKINSONS-DISEASE; COMPLEX-I; RESPIRATORY-CHAIN; COPY NUMBER; MUTATIONS; DEPLETION; DYSFUNCTION; MUTANTS; RELEASE	Background: Mitochondrial dysfunction has been implicated in the pathogenesis of Parkinson's disease (PD). Impairment of the mitochondrial electron transport chain (ETC) and an increased frequency in deletions of mitochondrial DNA (mtDNA), which encodes some of the subunits of the ETC, have been reported in the substantia nigra of PD brains. The identification of mutations in the PINK1 gene, which cause an autosomal recessive form of PD, has supported mitochondrial involvement in PD. The PINK1 protein is a serine/threonine kinase localized in mitochondria and the cytosol. Its precise function is unknown, but it is involved in neuroprotection against a variety of stress signalling pathways. Methodology/Principal Findings: In this report we have investigated the effect of silencing PINK1 expression in human dopaminergic SH-SY5Y cells by siRNA on mtDNA synthesis and ETC function. Loss of PINK1 expression resulted in a decrease in mtDNA levels and mtDNA synthesis. We also report a concomitant loss of mitochondrial membrane potential and decreased mitochondrial ATP synthesis, with the activity of complex IV of the ETC most affected. This mitochondrial dysfunction resulted in increased markers of oxidative stress under basal conditions and increased cell death following treatment with the free radical generator paraquat. Conclusions: This report highlights a novel function of PINK1 in mitochondrial biogenesis and a role in maintaining mitochondrial ETC activity. Dysfunction of both has been implicated in sporadic forms of PD suggesting that these may be key pathways in the development of the disease.	[Gegg, Matthew E.; Cooper, J. Mark; Schapira, Anthony H. V.; Taanman, Jan-Willem] UCL, Dept Clin Neurosci, Inst Neurol, London, England	University of London; University College London	Gegg, ME (corresponding author), UCL, Dept Clin Neurosci, Inst Neurol, London, England.	j.taanman@medsch.ucl.ac.uk	Gegg, Matthew E/B-4826-2011; Schapira, Anthony H V/A-1245-2010; Taanman, Jan W/A-5379-2011; Cooper, Jonathan/GLS-9195-2022; Cooper, J Mark/D-5826-2013	Gegg, Matthew E/0000-0001-8093-0723; Schapira, Anthony H V/0000-0002-3018-3966; Taanman, Jan W/0000-0002-5476-9785; Cooper, Jonathan/0000-0002-2358-1050; Cooper, J Mark/0000-0002-3007-3054	Parkinson's Disease Society of the United Kingdom [4071]; Bachmann-Strauss Dystonia and Parkinson Foundation, Inc; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0601943] Funding Source: UKRI	Parkinson's Disease Society of the United Kingdom; Bachmann-Strauss Dystonia and Parkinson Foundation, Inc; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Parkinson's Disease Society of the United Kingdom (4071) and the Bachmann-Strauss Dystonia and Parkinson Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bohm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2002, ANAL BIOCHEM, V304, P26, DOI 10.1006/abio.2001.5607; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; MOISOI N, 2009, CELL DEATH IN PRESS; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Seidel-Rogol BL, 2002, NUCLEIC ACIDS RES, V30, P1929, DOI 10.1093/nar/30.9.1929; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xu N, 2005, GENE, V354, P37, DOI 10.1016/j.gene.2005.03.018; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008	51	154	158	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4756	10.1371/journal.pone.0004756	http://dx.doi.org/10.1371/journal.pone.0004756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270741	Green Published, gold, Green Submitted			2022-12-25	WOS:000265495900023
J	Kobayashi, T; Kim, TS; Jacob, A; Walsh, MC; Kadono, Y; Fuentes-Panana, E; Yoshioka, T; Yoshimura, A; Yamamoto, M; Kaisho, T; Akira, S; Monroe, JG; Choi, Y				Kobayashi, Takashi; Kim, Tae Soo; Jacob, Anand; Walsh, Matthew C.; Kadono, Yuho; Fuentes-Panana, Ezequiel; Yoshioka, Tomoko; Yoshimura, Akihiko; Yamamoto, Masahiro; Kaisho, Tsuneyasu; Akira, Shizuo; Monroe, John G.; Choi, Yongwon			TRAF6 Is Required for Generation of the B-1a B Cell Compartment as well as T Cell-Dependent and -Independent Humoral Immune Responses	PLOS ONE			English	Article							CD40-DEFICIENT MICE; ACTIVATION; BAFF; MATURATION; SUBSETS; REVEALS; ANTIGEN	TNF receptor superfamily members, such as CD40 and the Toll-like receptors (TLRs), regulate many aspects of B cell differentiation and activation. TRAF6 is an intracellular signaling adaptor molecule for these receptors, but its role in B cells has not been clarified by previous genetic approaches, as the systemic deletion of the TRAF6 gene results in perinatal lethality. Here we show that B cell-specific TRAF6 deficiency results in a reduced number of mature B cells in the bone marrow and spleen. Optimal T cell-dependent (TD) antigen responses, as characterized by isotype switching and long-lived plasma cell generation, are also impaired in B cell-specific TRAF6-deficient mice. B cell-specific TRAF6-deficient mice also exhibit lower levels of serum IgM and IgG2b and defective antigen-specific IgM production in response to T cell-independent (TI) antigens. Unexpectedly, TRAF6-deficient B cell progenitors are unable to generate CD5(+) B-1 cells. These results reveal critical roles for TRAF6 in TD and TI humoral immune responses and in inductive fate decisions necessary to generate the B-1 B cell compartment.	[Kobayashi, Takashi; Yoshioka, Tomoko] Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan; [Kim, Tae Soo; Jacob, Anand; Walsh, Matthew C.; Kadono, Yuho; Fuentes-Panana, Ezequiel; Monroe, John G.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Kim, Tae Soo; Jacob, Anand; Walsh, Matthew C.; Kadono, Yuho; Fuentes-Panana, Ezequiel; Monroe, John G.; Choi, Yongwon] Univ Penn, Sch Med, Lab Med, Philadelphia, PA 19104 USA; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 108, Japan; [Yamamoto, Masahiro; Kaisho, Tsuneyasu; Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Host Defense, Suita, Osaka 565, Japan; [Yamamoto, Masahiro; Kaisho, Tsuneyasu; Akira, Shizuo] Osaka Univ, Res Inst Microb Dis, Dept Host Defense, Suita, Osaka 565, Japan	Kyushu University; University of Pennsylvania; University of Pennsylvania; Keio University; Osaka University; Osaka University	Kobayashi, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan.	takashik@bioreg.kyushu-u.ac.jp; ychoi3@mail.med.upenn.edu	Fuentes-Pananá, Ezequiel/AAI-2856-2020; Kaisho, Tsuneyasu/B-4130-2012; Kadono, Yuho/AAO-2405-2020; Yoshimura, Akihiko/K-5515-2013; Akira, Shizuo/C-3134-2009	Fuentes-Panana, Ezequiel M./0000-0003-2872-0459	National Institutes of Health [RO1-AI32592, P01-AI43260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants RO1-AI32592, P01-AI43260 (to J.G.M and Y.C.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Cervenak L, 2001, IMMUNOL LETT, V78, P89, DOI 10.1016/S0165-2478(01)00239-5; Chung JY, 2002, J CELL SCI, V115, P679; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DEFRANCO AL, 1982, IMMUNOL REV, V64, P161, DOI 10.1111/j.1600-065X.1982.tb00423.x; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; MCKEARN JP, 1984, J IMMUNOL, V132, P332; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Schneider P, 2003, IMMUNOL LETT, V88, P57, DOI 10.1016/S0165-2478(03)00050-6; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	35	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4736	10.1371/journal.pone.0004736	http://dx.doi.org/10.1371/journal.pone.0004736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270748	Green Published, Green Submitted, gold			2022-12-25	WOS:000265495900005
J	Cate, AD; Herron, TJ; Yund, EW; Stecker, GC; Rinne, T; Kang, XJ; Petkov, CI; Disbrow, EA; Woods, DL				Cate, Anthony D.; Herron, Timothy J.; Yund, E. William; Stecker, G. Christopher; Rinne, Teemu; Kang, Xiaojian; Petkov, Christopher I.; Disbrow, Elizabeth A.; Woods, David L.			Auditory Attention Activates Peripheral Visual Cortex	PLOS ONE			English	Article							CONGENITALLY BLIND HUMANS; EVENT-RELATED POTENTIALS; PRIMATE STRIATE CORTEX; CROSS-MODAL PLASTICITY; LATE-ONSET BLINDNESS; HUMAN BRAIN; SPATIAL ATTENTION; OCCIPITAL CORTEX; FUNCTIONAL MRI; CEREBRAL-CORTEX	Background: Recent neuroimaging studies have revealed that putatively unimodal regions of visual cortex can be activated during auditory tasks in sighted as well as in blind subjects. However, the task determinants and functional significance of auditory occipital activations (AOAs) remains unclear. Methodology/Principal Findings: We examined AOAs in an intermodal selective attention task to distinguish whether they were stimulus-bound or recruited by higher-level cognitive operations associated with auditory attention. Cortical surface mapping showed that auditory occipital activations were localized to retinotopic visual cortex subserving the far peripheral visual field. AOAs depended strictly on the sustained engagement of auditory attention and were enhanced in more difficult listening conditions. In contrast, unattended sounds produced no AOAs regardless of their intensity, spatial location, or frequency. Conclusions/Significance: Auditory attention, but not passive exposure to sounds, routinely activated peripheral regions of visual cortex when subjects attended to sound sources outside the visual field. Functional connections between auditory cortex and visual cortex subserving the peripheral visual field appear to underlie the generation of AOAs, which may reflect the priming of visual regions to process soon-to-appear objects associated with unseen sound sources.	[Cate, Anthony D.; Herron, Timothy J.; Yund, E. William; Kang, Xiaojian; Woods, David L.] Vet Adm No Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA USA; [Kang, Xiaojian; Disbrow, Elizabeth A.; Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA USA; [Disbrow, Elizabeth A.; Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA USA; [Stecker, G. Christopher] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Rinne, Teemu] Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland; [Petkov, Christopher I.] Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Disbrow, Elizabeth A.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of Helsinki; Newcastle University - UK; University of California System; University of California San Francisco	Cate, AD (corresponding author), Vet Adm No Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA USA.	acate@ebire.org	Rinne, Teemu/A-6090-2009; Cate, Anthony/R-5104-2019; Petkov, Christopher/O-5318-2015	Rinne, Teemu/0000-0002-3142-9438; Cate, Anthony/0000-0003-0135-1622; Petkov, Christopher/0000-0002-4932-7907; Herron, Timothy/0000-0002-4297-014X	DLW [DCD5814]; VA Research Service	DLW; VA Research Service(US Department of Veterans Affairs)	Supported by grant DCD5814 to DLW and the VA Research Service.	Alain C, 2005, NEUROIMAGE, V26, P592, DOI 10.1016/j.neuroimage.2005.02.006; ALHO K, 1993, ELECTROEN CLIN NEURO, V86, P418, DOI 10.1016/0013-4694(93)90137-K; Amunts K, 2007, NEUROIMAGE, V37, P1061, DOI 10.1016/j.neuroimage.2007.02.037; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2006, NEUROSCI LETT, V392, P38, DOI 10.1016/j.neulet.2005.09.015; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Carmody DP, 2006, BRAIN RES, V1116, P153, DOI 10.1016/j.brainres.2006.07.121; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Degerman A, 2007, NEUROIMAGE, V34, P1683, DOI 10.1016/j.neuroimage.2006.11.019; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eckert MA, 2008, HUM BRAIN MAPP, V29, P848, DOI 10.1002/hbm.20560; Eisenberg DF, 2005, NEUROREPORT, V16, P1473; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Falchier A, 2002, J NEUROSCI, V22, P5749; Fieger A, 2006, J COGNITIVE NEUROSCI, V18, P149, DOI 10.1162/089892906775783697; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Garg A, 2007, NEUROPSYCHOLOGIA, V45, P2307, DOI 10.1016/j.neuropsychologia.2007.02.015; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Just MA, 2004, NEUROIMAGE, V21, P112, DOI 10.1016/j.neuroimage.2003.08.042; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; KANG XJ, 2007, MAGN RESON IN PRESS; Kansaku K, 2006, NEUROIMAGE, V31, P649, DOI 10.1016/j.neuroimage.2005.12.023; Kawashima R, 1999, NEUROIMAGE, V10, P209, DOI 10.1006/nimg.1999.0452; Kerkhoff G, 1999, NEUROREPORT, V10, P3555, DOI 10.1097/00001756-199911260-00017; KUJALA T, 1992, ELECTROEN CLIN NEURO, V84, P469, DOI 10.1016/0168-5597(92)90034-9; Kujala T, 2005, NEUROSCI LETT, V379, P127, DOI 10.1016/j.neulet.2004.12.070; Kujala T, 1997, PSYCHOPHYSIOLOGY, V34, P213, DOI 10.1111/j.1469-8986.1997.tb02134.x; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Langers DRM, 2007, NEUROIMAGE, V35, P709, DOI 10.1016/j.neuroimage.2006.12.013; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lewald J, 2004, J COGNITIVE NEUROSCI, V16, P828, DOI 10.1162/089892904970834; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Liotti M, 1998, NEUROREPORT, V9, P1007, DOI 10.1097/00001756-199804200-00010; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Mayer AR, 2006, NEUROIMAGE, V30, P938, DOI 10.1016/j.neuroimage.2005.10.050; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; MUCHNIK C, 1991, SCAND AUDIOL, V20, P19, DOI 10.3109/01050399109070785; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Neville H, 2002, PROG BRAIN RES, V138, P177, DOI 10.1016/S0079-6123(02)38078-6; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Ross DA, 2003, MAGN RESON IMAGING, V21, P821, DOI 10.1016/S0730-725X(03)00103-6; Sabri M, 2008, NEUROIMAGE, V39, P1444, DOI 10.1016/j.neuroimage.2007.09.052; Saito DN, 2005, CEREB CORTEX, V15, P1750, DOI 10.1093/cercor/bhi052; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; SMITH RB, 1981, QUAL QUANT, V15, P279; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Stenbacka L, 2007, CLIN NEUROPHYSIOL, V118, P1303, DOI 10.1016/j.clinph.2007.01.023; Stevens AA, 2007, J NEUROSCI, V27, P10734, DOI 10.1523/JNEUROSCI.1669-07.2007; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Voss P, 2006, NEUROREPORT, V17, P383, DOI 10.1097/01.wnr.0000204983.21748.2d; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Weaver KE, 2007, J COGNITIVE NEUROSCI, V19, P315, DOI 10.1162/jocn.2007.19.2.315; Weeks R, 2000, J NEUROSCI, V20, P2664; WOODS DL, 2009, FUNCTIONAL MAP UNPUB; WOODS DL, 2008, FUNCTIONAL MAP UNPUB; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Zhang NY, 2006, EXP BRAIN RES, V172, P57, DOI 10.1007/s00221-005-0304-7; Zimmer U, 2005, NEURON, V47, P893, DOI 10.1016/j.neuron.2005.07.019; Zimmer U, 2004, EUR J NEUROSCI, V20, P3148, DOI 10.1111/j.1460-9568.2004.03766.x	102	75	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4645	10.1371/journal.pone.0004645	http://dx.doi.org/10.1371/journal.pone.0004645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247451	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800025
J	Lohmus, M; Bjorklund, M				Lohmus, Mare; Bjorklund, Mats			Leptin Affects Life History Decisions in a Passerine Bird: A Field Experiment	PLOS ONE			English	Article								Background: Organisms face trade-offs regarding their life-history strategies, such as decisions of single or multiple broods within a year. In passerines displaying facultative multiple breeding, the probability of laying a second clutch is influenced by several life-history factors. However, information about the mechanistic background of these trade-offs is largely lacking. Leptin is a protein hormone produced by white fat cells, and acts as a signal between peripheral energy depots and the central nervous system. In addition, leptin affects cells at all levels of the reproductive axis and plays a critical role in regulating the allocation of metabolic energy to reproduction. As such, it is possible that leptin levels influence the decision of whether or not to invest time and energy into a second clutch. Accordingly, we expect a treatment with exogenous leptin to result in an increased number of second broods. Methodology/Principal Findings: At a later stage during the first brood, female great tits were treated either with long-term leptin-filled cholesterol pellets (the experimental birds) or with pellets containing only cholesterol (the control birds). We found that leptin-treated females were significantly more likely to have a second brood and that the earlier females were more likely to lay a second clutch than the late females. Conclusions/Significance: As both timing of first brood and treatment with leptin were important in the decision of having multiple broods, the trade-offs involved in the breeding strategy most likely depend on multiple factors. Presumably leptin has evolved as a signal of energy supply status to regulate the release of reproductive hormones so that reproduction is coordinated with periods of sufficient nutrients. This study investigated the role of leptin as a mediator between energy resources and reproductive output, providing a fundamentally new insight into how trade-offs work on a functional basis.	[Lohmus, Mare; Bjorklund, Mats] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Lohmus, M (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	mare.lohmus@ebc.uu.se	Lõhmus, Mare/E-2442-2012	Lohmus, Mare/0000-0002-6619-9679	Swedish Research Council [Post-doc in Sweden]; Stiftelsen for Zoologisk Forskning, Uppsala	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stiftelsen for Zoologisk Forskning, Uppsala	This study was funded by a Post-doc in Sweden grant from the Swedish Research Council (VR) to ML, by research grants from VR to MB, and by Stiftelsen for Zoologisk Forskning, Uppsala to ML and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb CR, 2004, DOMEST ANIM ENDOCRIN, V26, P201, DOI 10.1016/j.domaniend.2003.10.004; Both C, 1998, J ANIM ECOL, V67, P667, DOI 10.1046/j.1365-2656.1998.00228.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brinkhof MWG, 2002, EVOLUTION, V56, P400; Budak E, 2006, FERTIL STERIL, V85, P1563, DOI 10.1016/j.fertnstert.2005.09.065; DELAET JF, 1989, IBIS, V131, P281; DRENT RH, 1980, ARDEA, V68, P225; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Hansson B, 2000, OIKOS, V90, P575, DOI 10.1034/j.1600-0706.2000.900315.x; Henson M. C., 2003, LEPTIN REPROD; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; La Cava A, 2004, J MOL MED, V82, P4, DOI 10.1007/s00109-003-0492-1; LINDEN M, 1988, OIKOS, V51, P285, DOI 10.2307/3565309; Magi M, 2004, ECOSCIENCE, V11, P361; Perrins C.M., 1979, BRIT TITS; Roff Derek, 2002, pi; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; SMITH HG, 1987, AUK, V104, P700, DOI 10.1093/auk/104.4.700; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; SVENSSON E, 1995, ANIM BEHAV, V49, P1569, DOI 10.1016/0003-3472(95)90078-0; TINBERGEN JM, 1987, ARDEA, V75, P111; Tremblay I, 2003, ECOLOGY, V84, P3033, DOI 10.1890/02-0663; Verboven N, 2001, ARDEA, V89, P387; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wiktander U, 2001, IBIS, V143, P72, DOI 10.1111/j.1474-919X.2001.tb04171.x; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2	28	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4602	10.1371/journal.pone.0004602	http://dx.doi.org/10.1371/journal.pone.0004602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242553	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487500008
J	van Leeuwen, WMA; Lehto, M; Karisola, P; Lindholm, H; Luukkonen, R; Sallinen, M; Harma, M; Porkka-Heiskanen, T; Alenius, H				van Leeuwen, Wessel M. A.; Lehto, Maili; Karisola, Piia; Lindholm, Harri; Luukkonen, Ritva; Sallinen, Mikael; Harma, Mikko; Porkka-Heiskanen, Tarja; Alenius, Harri			Sleep Restriction Increases the Risk of Developing Cardiovascular Diseases by Augmenting Proinflammatory Responses through IL-17 and CRP	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NATURAL-KILLER; INTERLEUKIN-6; DURATION; HEPATOCYTES; DEPRIVATION; CYTOKINES; MARKERS; CELLS; BETA	Background:Sleep restriction, leading to deprivation of sleep, is common in modern 24-h societies and is associated with the development of health problems including cardiovascular diseases. Our objective was to investigate the immunological effects of prolonged sleep restriction and subsequent recovery sleep, by simulating a working week and following recovery weekend in a laboratory environment. Methods and Findings:After 2 baseline nights of 8 hours time in bed (TIB), 13 healthy young men had only 4 hours TIB per night for 5 nights, followed by 2 recovery nights with 8 hours TIB. 6 control subjects had 8 hours TIB per night throughout the experiment. Heart rate, blood pressure, salivary cortisol and serum C-reactive protein (CRP) were measured after the baseline (BL), sleep restriction (SR) and recovery (REC) period. Peripheral blood mononuclear cells (PBMC) were collected at these time points, counted and stimulated with PHA. Cell proliferation was analyzed by thymidine incorporation and cytokine production by ELISA and RT-PCR. CRP was increased after SR (145% of BL; p<0.05), and continued to increase after REC (231% of BL; p<0.05). Heart rate was increased after REC (108% of BL; p<0.05). The amount of circulating NK-cells decreased (65% of BL; p<0.005) and the amount of B-cells increased (121% of BL; p<0.005) after SR, but these cell numbers recovered almost completely during REC. Proliferation of stimulated PBMC increased after SR (233% of BL; p<0.05), accompanied by increased production of IL-1 beta (137% of BL; p<0.05), IL-6 (163% of BL; p<0.05) and IL-17 (138% of BL; p<0.05) at mRNA level. After REC, IL-17 was still increased at the protein level (119% of BL; p<0.05). Conclusions:5 nights of sleep restriction increased lymphocyte activation and the production of proinflammatory cytokines including IL-1 beta IL-6 and IL-17; they remained elevated after 2 nights of recovery sleep, accompanied by increased heart rate and serum CRP, 2 important risk factors for cardiovascular diseases. Therefore, long-term sleep restriction may lead to persistent changes in the immune system and the increased production of IL-17 together with CRP may increase the risk of developing cardiovascular diseases.	[van Leeuwen, Wessel M. A.; Sallinen, Mikael; Harma, Mikko] Finnish Inst Occupat Hlth, Brain & Work Res Ctr, Helsinki, Finland; [Lehto, Maili; Karisola, Piia; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Excellence Immunotoxicol, Helsinki, Finland; [van Leeuwen, Wessel M. A.; Porkka-Heiskanen, Tarja] Univ Helsinki, Inst Biomed, Dept Physiol, Helsinki, Finland; [Lindholm, Harri] Finnish Inst Occupat Hlth, Ctr Excellence Hlth & Work Abil, Helsinki, Finland; [Luukkonen, Ritva] Finnish Inst Occupat Hlth, Stat Serv Team, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Helsinki; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health	van Leeuwen, WMA (corresponding author), Finnish Inst Occupat Hlth, Brain & Work Res Ctr, Helsinki, Finland.	Harri.Alenius@ttl.fi	van Leeuwen, Wessel M.A./A-5812-2019	van Leeuwen, Wessel M.A./0000-0003-0834-0811; Stenberg, Tarja/0000-0003-1843-7625; Alenius, Harri/0000-0003-0106-8923; Sallinen, Mikael/0000-0001-6507-3807; Karisola, Piia/0000-0003-0635-2704	European Union [MCRTN-CT-2004-512362]; Finnish Work Environment Fund [104073, 108203]	European Union(European Commission); Finnish Work Environment Fund	This work was supported by the European Union Framework 6 (MCRTN-CT-2004-512362) and the Finnish Work Environment Fund (104073 and 108203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; ERRIE JE, 2007, SLEEP, V30, P1659; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Foglar C, 1998, ORTHOPEDICS, V21, P687; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Gonzales XF, 2008, BRAIN BEHAV IMMUN, V22, P552, DOI 10.1016/j.bbi.2007.11.005; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Jean-Louis G, 2000, BIOL PSYCHIAT, V47, P921, DOI 10.1016/S0006-3223(99)00169-9; Kohatsu ND, 2006, ARCH INTERN MED, V166, P1701, DOI 10.1001/archinte.166.16.1701; Kronholm E, 2008, J SLEEP RES, V17, P54, DOI 10.1111/j.1365-2869.2008.00627.x; Lehto M, 2007, CLIN EXP ALLERGY, V37, P133, DOI 10.1111/j.1365-2222.2006.02622.x; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; UAACK M, 2007, SLEEP, V30, P1145; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002	31	284	287	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4589	10.1371/journal.pone.0004589	http://dx.doi.org/10.1371/journal.pone.0004589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240794	Green Submitted, Green Published, gold			2022-12-25	WOS:000278086700007
J	Liu, T; Dartevelle, L; Yuan, CY; Wei, HP; Wang, Y; Ferveur, JF; Guo, A				Liu, Tong; Dartevelle, Laurence; Yuan, Chunyan; Wei, Hongping; Wang, Ying; Ferveur, Jean-Francois; Guo, Aike			Reduction of Dopamine Level Enhances the Attractiveness of Male Drosophila to Other Males	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; GENETIC-CONTROL; COURTSHIP; SEROTONIN; EVOLUTION; MUTANTS	Dopamine is an important neuromodulator in animals and its roles in mammalian sexual behavior are extensively studied. Drosophila as a useful model system is widely used in many fields of biological studies. It has been reported that dopamine reduction can affect female receptivity in Drosophila and leave male-female courtship behavior unaffected. Here, we used genetic and pharmacological approaches to decrease the dopamine level in dopaminergic cells in Drosophila, and investigated the consequence of this manipulation on male homosexual courtship behavior. We find that reduction of dopamine level can induce Drosophila male-male courtship behavior, and that this behavior is mainly due to the increased male attractiveness or decreased aversiveness towards other males, but not to their enhanced propensity to court other males. Chemical signal input probably plays a crucial role in the male-male courtship induced by the courtees with reduction of dopamine. Our finding provides insight into the relationship between the dopamine reduction and male-male courtship behavior, and hints dopamine level is important for controlling Drosophila courtship behavior.	[Liu, Tong; Yuan, Chunyan; Wei, Hongping; Wang, Ying; Guo, Aike] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Liu, Tong; Wei, Hongping] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Guo, Aike] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognitive Sci, Beijing 100864, Peoples R China; [Dartevelle, Laurence; Ferveur, Jean-Francois] Univ Bourgogne, CNRS, UMRS 5548, F-21004 Dijon, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Liu, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	jean-francois.ferveur@u-bourgogne.fr; akguo@ion.ac.cn			National Science Foundation of China [30270341, 30630028, 30621004]; Multidisciplinary Research Program (Brain and Mind) of the Chinese Academy of Sciences; Major State Basic Research Program [G20000 77800, 2006CB806600, 2006CB911003]; Precedent Project of Important Intersectional Disciplines in the Knowledge Innovation Engineering Department of the Chinese Academy of Sciences [KJCX1-09-03, KSCX2-YW-R-28]; CNRS; Burgundy Regional Council	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Multidisciplinary Research Program (Brain and Mind) of the Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Program(National Basic Research Program of China); Precedent Project of Important Intersectional Disciplines in the Knowledge Innovation Engineering Department of the Chinese Academy of Sciences; CNRS(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte)	This research was supported by the National Science Foundation of China (Grant 30270341, 30630028, and 30621004) (A.G), the Multidisciplinary Research Program (Brain and Mind) of the Chinese Academy of Sciences, and the Major State Basic Research Program (G20000 77800, 2006CB806600, and 2006CB911003) (A.G), and the Precedent Project of Important Intersectional Disciplines in the Knowledge Innovation Engineering Department of the Chinese Academy of Sciences (Grant No. KJCX1-09-03, KSCX2-YW-R-28) (A.G), and by the CNRS and the Burgundy Regional Council (L.D. and JF.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Bradbury Jack W., 1998, pi; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Llopart A, 2002, NATURE, V419, P360, DOI 10.1038/419360a; Marican C, 2004, INSECT BIOCHEM MOLEC, V34, P823, DOI 10.1016/j.ibmb.2004.05.002; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; ROBERTSON HM, 1983, EVOLUTION, V37, P1283, DOI 10.1111/j.1558-5646.1983.tb00244.x; Savarit F, 2002, J EXP BIOL, V205, P3241; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Villella A, 1997, GENETICS, V147, P1107; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; Yamamoto D, 1999, CELL MOL LIFE SCI, V56, P634, DOI 10.1007/s000180050458	26	28	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4574	10.1371/journal.pone.0004574	http://dx.doi.org/10.1371/journal.pone.0004574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238209	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487400007
J	Akan, P; Sahlen, M; Deloukas, P				Akan, Pelin; Sahlen, Martin; Deloukas, Panagiotis			A Histone Map of Human Chromosome 20q13.12	PLOS ONE			English	Article								Background: We present a systematic search for regulatory elements in a 3.5 Mb region on human chromosome 20q13.12, a region associated with a number of medical conditions such as type II diabetes and obesity. Methodology/Principal Findings: We profiled six histone modifications alongside RNA polymerase II (PolII) and CTCF in two cell lines, HeLa S3 and NTERA-2 clone D1 (NT2/D1), by chromatin immunoprecipitation using an in-house spotted DNA array, constructed with 1.8 kb overlapping plasmid clones. In both cells, more than 90% of transcription start sites (TSSs) of expressed genes showed enrichments with PolII, di-methylated lysine 4 of histone H3 (H3K4me2), tri-methylated lysine 4 of histone H3 (H3K4me3) or acetylated H3 (H3Ac), whereas mono-methylated lysine 4 of histone H3 (H3K4me1) signals did not correlate with expression. No TSSs were enriched with tri-methylated lysine 27 of histone H3 (H3K27me3) in HeLa S3, while eight TSSs (4 expressed) showed enrichments in NT2/D1. We have also located several CTCF binding sites that are potential insulator elements. Conclusions/Significance: In summary, we annotated a number of putative regulatory elements in 20q13.12 and went on to verify experimentally a subset of them using dual luciferase reporter assays. Correlating this data to sequence variation can aid identification of disease causing variants.	[Akan, Pelin; Deloukas, Panagiotis] Wellcome Trust Sanger Inst, Cambridge, England; [Sahlen, Martin] Univ Sussex, Astron Ctr, Brighton BN1 9RH, E Sussex, England	Wellcome Trust Sanger Institute; University of Sussex	Akan, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	pa2@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Sahlén, Martin/N-7951-2019; Sahlen, Pelin/AAJ-1824-2021	Deloukas, Panos/0000-0001-9251-070X; Sahlén, Martin/0000-0003-0973-4804; 	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dimova I, 2005, EUR J OBSTET GYN R B, V118, P81, DOI 10.1016/j.ejogrb.2004.06.007; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; Hani E, 1998, J CLIN INVEST, V101, P521, DOI 10.1172/JCI1403; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hunt SC, 2001, HUM GENET, V109, P279, DOI 10.1007/s004390100581; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klochkov D, 2006, MOL CELL BIOL, V26, P1589, DOI 10.1128/MCB.26.5.1589-1597.2006; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kumar S, 1999, J BIOL CHEM, V274, P17123, DOI 10.1074/jbc.274.24.17123; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Mahajan MA, 2002, MOL CELL BIOL, V22, P6883, DOI 10.1128/MCB.22.19.6883-6894.2002; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; SPENCER CCA, 2006, PLOS GENETICS PREPRI; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033	54	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4479	10.1371/journal.pone.0004479	http://dx.doi.org/10.1371/journal.pone.0004479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229332	Green Submitted, Green Published, gold			2022-12-25	WOS:000265486200001
J	Jansson, L; Tobias, J; Jarefjall, C; Lebens, M; Svennerholm, AM; Teneberg, S				Jansson, Lena; Tobias, Joshua; Jarefjall, Catharina; Lebens, Michael; Svennerholm, Ann-Mari; Teneberg, Susann			Sulfatide Recognition by Colonization Factor Antigen CS6 from Enterotoxigenic Escherichia coli	PLOS ONE			English	Article								The first step in the pathogenesis of enterotoxigenic Escherichia coli (ETEC) infections is adhesion of the bacterium to the small intestinal epithelium. Adhesion of ETEC is mediated by a number of antigenically distinct colonization factors, and among these, one of the most commonly detected is the non-fimbrial adhesin coli surface antigen 6 (CS6). The potential carbohydrate recognition by CS6 was investigated by binding of recombinant CS6-expressing E. coli and purified CS6 protein to a large number of variant glycosphingolipids separated on thin-layer chromatograms. Thereby, a highly specific binding of the CS6-expressing E. coli, and the purified CS6 protein, to sulfatide (SO3-3Gal beta 1Cer) was obtained. The binding of the CS6 protein and CS6-expressing bacteria to sulfatide was inhibited by dextran sulfate, but not by dextran, heparin, galactose 4-sulfate or galactose 6-sulfate. When using recombinantly expressed and purified CssA and CssB subunits of the CS6 complex, sulfatide binding was obtained with the CssB subunit, demonstrating that the glycosphingolipid binding capacity of CS6 resides within this subunit. CS6-binding sulfatide was present in the small intestine of species susceptible to CS6-mediated infection, e. g. humans and rabbits, but lacking in species not affected by CS6 ETEC, e. g. mice. The ability of CS6-expressing ETEC to adhere to sulfatide in target small intestinal epithelium may thus contribute to virulence.	[Jansson, Lena; Jarefjall, Catharina; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Tobias, Joshua; Lebens, Michael; Svennerholm, Ann-Mari] Univ Gothenburg, Inst Biomed, Dept Med Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Jansson, L (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Medical Research Council [12628, 16X-09084]; Swedish Cancer Foundation; Magnus Bergvalls Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Foundation; Magnus Bergvalls Foundation	This study was supported by the Swedish Medical Research Council (Grant nos. 12628 (ST), and 16X-09084 (AMS)), the Swedish Cancer Foundation, and Magnus Bergvalls Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gallas N, 2007, AM J TROP MED HYG, V77, P571, DOI 10.4269/ajtmh.2007.77.571; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; BREIMER ME, 1983, J BIOCHEM, V93, P1473, DOI 10.1093/oxfordjournals.jbchem.a134285; BRENNAN MJ, 1991, J BIOL CHEM, V266, P18827; ESKO JD, 1999, ESSENTIALS GLYCOBIOL, P429; FALK KE, 1979, FEBS LETT, V101, P273, DOI 10.1016/0014-5793(79)81024-8; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Helander A, 1997, MICROB PATHOGENESIS, V23, P335, DOI 10.1006/mpat.1997.0163; Huesca M, 1998, INFECT IMMUN, V66, P4061; Huesca M, 1996, INFECT IMMUN, V64, P2643, DOI 10.1128/IAI.64.7.2643-2648.1996; Jansson L, 2006, INFECT IMMUN, V74, P3488, DOI 10.1128/IAI.02006-05; Kamisago S, 1996, INFECT IMMUN, V64, P624, DOI 10.1128/IAI.64.2.624-628.1996; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Khan AS, 1996, INFECT IMMUN, V64, P3688, DOI 10.1128/IAI.64.9.3688-3693.1996; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; KRIVAN HC, 1989, J BIOL CHEM, V264, P9283; LEFFLER H, 1985, J BIOL CHEM, V261, P1440; NILSSON O, 1981, FEBS LETT, V133, P197, DOI 10.1016/0014-5793(81)80504-2; OFEK I, 1994, BACTERIAL ADHESION C, P94; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P2269, DOI 10.1128/IAI.01856-06; Rousset E, 1998, INFECT IMMUN, V66, P5650, DOI 10.1128/IAI.66.12.5650-5658.1998; Sack DA, 2007, VACCINE, V25, P4392, DOI 10.1016/j.vaccine.2007.03.034; SAITOH T, 1991, FEBS LETT, V282, P385, DOI 10.1016/0014-5793(91)80519-9; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; SVENNERHOLM AM, 1988, INFECT IMMUN, V56, P523, DOI 10.1128/IAI.56.2.523-528.1988; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; TENEBERG S, 1990, FEBS LETT, V263, P10, DOI 10.1016/0014-5793(90)80693-D; TENEBERG S, 1994, J BIOCHEM, V116, P560, DOI 10.1093/oxfordjournals.jbchem.a124562; Tobias J, 2008, VACCINE, V26, P5373, DOI 10.1016/j.vaccine.2008.07.091; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569	36	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4487	10.1371/journal.pone.0004487	http://dx.doi.org/10.1371/journal.pone.0004487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19242561	Green Published, Green Submitted, gold			2022-12-25	WOS:000265485700012
J	Heeb, MJ; Prashun, D; Griffin, JH; Bouma, BN				Heeb, Mary J.; Prashun, Duane; Griffin, John H.; Bouma, Bonno N.			Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor	FASEB JOURNAL			English	Article; Proceedings Paper	21st Congress of the International-Society-on-Thrombosis-and-Haemostasis	JUL 06-12, 2007	Geneva, SWITZERLAND	Int Soc Thrombosis & Haemostasis		blood coagulation regulation; zinc metalloprotein; vitamin K-dependent protein	K-DEPENDENT PROTEIN; CRYSTAL-STRUCTURE; FACTOR-IX; FACTOR VA; DEFICIENCY; AFFINITY; GLOBULIN; COMPLEX; DOMAIN; CARBOXYPEPTIDASE	Protein S ( PS) is a cofactor for activated protein C (APC), which inactivates coagulation factors (F) Va and VIIIa. Deficiency of protein C or PS is associated with risk of thrombosis. We found that PS also has APC-independent anticoagulant activity (PS-direct) and directly inhibits thrombin generated by FXa/FVa (prothrombinase complex). Here we report that PS contains Zn(2+) that is required for PS-direct and that is lost during certain purification procedures. Immunoaffinity-purified PS contained 1.4 +/- 0.6 Zn(2+)/mol, whereas MonoQ-purified and commercial PS contained 0.15 +/- 0.15 Zn(2+)/mol. This may explain the controversy regarding the validity of PS-direct. Zn(2+) content correlated positively with PS-direct in prothrombinase assays and clotting assays, but APC-cofactor activity of PS was independent of Zn(2+) content. PS-direct and Zn(2+) were restored to inactive PS under mildly denaturing conditions. Conversely, o-phenanthroline reversibly impaired the PS-direct of active PS. Zn(2+)-containing PS bound FXa more efficiently (K(dapp) = 9.3 nM) than Zn(2+)-deficient PS (K(dapp) = 110 nM). PS bound TFPI efficiently, independently of Zn(2+) content (K(dapp) = 21 nM). Antibodies that block PS-direct preferentially recognized Zn(2+)-containing PS, suggesting conformation differences at or near the interface of 2 laminin G-like domains near the PS C terminus. Thus, Zn(2+) is required for PS-direct and efficient FXa binding and may play a role in stabilizing PS conformation.-Heeb, M. J., Prashun, D., Griffin, J. H., Bouma, B. N. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor. FASEB J. 23, 2244-2253 (2009)	[Heeb, Mary J.; Griffin, John H.; Bouma, Bonno N.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Prashun, Duane] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Prashun, Duane] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Heeb, MJ (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM276,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	heeb@scripps.edu		Griffin, John/0000-0002-4302-2547	NHLBI NIH HHS [R01 HL021544, R01 HL070002, R01 HL088375, HL 0888375, HL70002, HL21544] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088375, R01HL021544, R01HL070002] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avvakumov GV, 2002, J BIOL CHEM, V277, P45219, DOI 10.1074/jbc.M207762200; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; BAJAJ SP, 1983, PREP BIOCHEM, V13, P191, DOI 10.1080/00327488308064248; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; GRINNELL BW, 1990, BLOOD, V76, P2546; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Heeb MJ, 2006, J THROMB HAEMOST, V4, P2215, DOI 10.1111/j.1538-7836.2006.02117.x; Heeb MJ, 2006, J THROMB HAEMOST, V4, P385, DOI 10.1111/j.1538-7836.2006.01743.x; Heeb MJ, 1999, J BIOL CHEM, V274, P36187, DOI 10.1074/jbc.274.51.36187; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; Heeb MJ, 2004, J THROMB HAEMOST, V2, P1766, DOI 10.1111/j.1538-7836.2004.00901.x; Heeb MJ, 2002, BLOOD CELL MOL DIS, V29, P190, DOI 10.1006/bcmd.2002.0558; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; HEEB MJ, 2007, J THROMB HAEMOST S2, V5, pE0; Jensen AF, 2002, J BIOL INORG CHEM, V7, P490, DOI 10.1007/s00775-001-0324-0; Koenen RR, 2003, BLOOD, V102, P1686, DOI 10.1182/blood-2003-02-0620; MAHASANDANA C, 1990, LANCET, V335, P61, DOI 10.1016/0140-6736(90)90201-F; Mahmoodi BK, 2008, CIRCULATION, V118, P1659, DOI 10.1161/CIRCULATIONAHA.108.780759; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Marx PF, 2002, BIOCHEMISTRY-US, V41, P1211, DOI 10.1021/bi0115683; Passerini A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-39; Petersen LC, 2000, PROTEIN SCI, V9, P859, DOI 10.1110/ps.9.5.859; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; SCHWARZ HP, 1984, BLOOD, V64, P1297; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; Sere KM, 2001, BIOCHEMISTRY-US, V40, P8852; Shikamoto Y, 2003, J BIOL CHEM, V278, P24090, DOI 10.1074/jbc.M300650200; Stenberg Y, 1998, EUR J BIOCHEM, V251, P558, DOI 10.1046/j.1432-1327.1998.2510558.x; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; STENFLO J, 1976, J BIOL CHEM, V251, P355; VALLEE BL, 1960, J BIOL CHEM, V235, P64; van Wijnen M, 1998, THROMB HAEMOSTASIS, V80, P930; van Wijnen M, 1998, BIOCHEM J, V330, P389; Villoutreix BO, 2001, PROTEINS, V43, P203, DOI 10.1002/1097-0134(20010501)43:2<203::AID-PROT1031>3.0.CO;2-W; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; Yegneswaran S, 2008, J BIOL CHEM, V283, P33046, DOI 10.1074/jbc.M806527200	38	27	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2009	23	7					2244	2253		10.1096/fj.08-123174	http://dx.doi.org/10.1096/fj.08-123174			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19244162	Green Published			2022-12-25	WOS:000268836500024
J	Jindal, R; Nahmias, Y; Tilles, AW; Berthiaume, F; Yarmush, ML				Jindal, Rohit; Nahmias, Yaakov; Tilles, Arno W.; Berthiaume, Francois; Yarmush, Martin L.			Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model	FASEB JOURNAL			English	Article						acute phase proteins; coculture; extracellular matrix; liver	EXTRACELLULAR-MATRIX; HEPATOCYTE FUNCTION; ENDOTHELIAL-CELLS; LIVER; RAT; CULTURE; COCULTURE; GEL; TRANSCRIPTION; METABOLISM	Tissue-engineered models that mimic in vivo tissue organization offer the potential of capturing complex signaling pathways in vitro. In the liver, hepatocytes and endothelial cells are closely associated but separated by the extracellular matrix of the space of Disse. This unique configuration was mimicked by embedding primary hepatocytes in collagen gel and overlaying the matrix with endothelial cells. We demonstrate that during the first few days of culture, the secretion of albumin and fibrinogen was 2-fold higher in cocultures compared to hepatocytes alone. Hepatocyte function in both cultures stabilized to a similar level during the second week, suggesting that endothelial cells can induce the early recovery of hepatocytes after isolation and seeding. Endothelial cell-conditioned medium reproduced the effect of coculture in a dose-dependent fashion, suggesting a role for endothelial cell-derived soluble factors. Endothelial cell-conditioned medium increased mRNA levels of various acute-phase proteins such as albumin, fibrinogen, transferrin, and alpha-macroglobulin in hepatocytes. Surprisingly, the effect of endothelial cell-conditioned medium was not mediated by growth factors or cytokines, or by secreted extracellular matrix, but by the release of the amino acid proline, which mediates endogenous collagen synthesis by hepatocytes. These findings suggest an important role for proline secretion by endothelial cells as a paracrine factor regulating hepatocyte function.-Jindal, R., Nahmias, Y., Tilles, A. W., Berthiaume, F., Yarmush, M. L. Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J. 23, 2288-2298 (2009)	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA USA; Shriners Hosp Children, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Yarmush, ML (corresponding author), 51 Blossom St, Boston, MA 02114 USA.	ireis@sbi.org	Nahmias, Yaakov/H-4725-2013; Berthiaume, Francois/ABD-2139-2020; Nahmias, Yaakov/AAM-3872-2020	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	NIH BioMEMS Resource Center [P41 EB-002503, RO1AI063795]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K01DK080241] Funding Source: NIH RePORTER	NIH BioMEMS Resource Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Chris Pohun Chen, Avrum Leeder, Luke Selby, and Carley Shulman for the isolation of cells from rat livers. We appreciate the help of Dr. David Yarmush in conducting collagen measurement studies. This work was supported by NIH BioMEMS Resource Center grant P41 EB-002503 and NIH grant RO1AI063795. Microscopic imaging studies were made possible by a core morphology facility, and gene expression measurements were carried out at the Genomic and Proteomic Facility at Boston's Shriners Burns Hospital.	Arai K, 2001, HEPATOLOGY, V34, P360, DOI 10.1053/jhep.2001.26515; Behnia K, 2000, TISSUE ENG, V6, P467, DOI 10.1089/107632700750022125; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; CARON JM, 1990, MOL CELL BIOL, V10, P1239, DOI 10.1128/MCB.10.3.1239; Davidson AJ, 2003, SCIENCE, V299, P835, DOI 10.1126/science.1082006; Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; GOULET F, 1988, HEPATOLOGY, V8, P1010, DOI 10.1002/hep.1840080506; Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228; HONDA H, 1995, BIOTECHNOL LETT, V17, P365, DOI 10.1007/BF00130791; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Ito A, 2004, TISSUE ENG, V10, P833, DOI 10.1089/1076327041348301; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LEE J, 1993, FASEB J, V7, P586, DOI 10.1096/fasebj.7.6.8472895; LEE JW, 1992, BIOTECHNOL BIOENG, V40, P298, DOI 10.1002/bit.260400214; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; MORIN O, 1986, J CELL PHYSIOL, V129, P103, DOI 10.1002/jcp.1041290115; Nahmias Y, 2006, HEPATOLOGY, V43, P257, DOI 10.1002/hep.21016; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Peters K, 2002, MICROVASC RES, V64, P334, DOI 10.1006/mvre.2002.2438; Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553; ROJKIND M, 1995, AM J PATHOL, V146, P1508; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; UITTO J, 1975, SCIENCE, V190, P1202, DOI 10.1126/science.1198105; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	32	36	37	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2288	2298		10.1096/fj.08-114934	http://dx.doi.org/10.1096/fj.08-114934			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246486	Green Published			2022-12-25	WOS:000268836500028
J	Ben Mkaddem, S; Werts, C; Goujon, JM; Bens, M; Pedruzzi, E; Ogier-Denis, E; Vandewalle, A				Ben Mkaddem, Sanae; Werts, Catherine; Goujon, Jean-Michel; Bens, Marcelle; Pedruzzi, Eric; Ogier-Denis, Eric; Vandewalle, Alain			Heat Shock Protein gp96 Interacts with Protein Phosphatase 5 and Controls Toll-like Receptor 2 (TLR2)-mediated Activation of Extracellular Signal-regulated Kinase (ERK) 1/2 in Post-hypoxic Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 CHAPERONE COMPLEX; EPITHELIAL-CELLS; ISCHEMIA/REPERFUSION INJURY; PHOSPHOINOSITIDE 3-KINASE; RAF-1 ACTIVATION; IN-VIVO; APOPTOSIS; PROTEIN-PHOSPHATASE-5; PATHWAY; INHIBITION	Ischemia/reperfusion injury (IRI) induces an innate immune response, leading to an inflammatory reaction and tissue damage that have been attributed to engagement of the Toll-like receptor (TLR) 2 and 4. However, the respective roles of TLR2 and/or TLR4 in mediating downstream activation of mitogen-activated protein kinase (MAPK) pathways during IRI have not been fully elucidated. Here we show that extracellular signal-regulated kinase (ERK) 1/2 is activated in both intact kidneys and cultured renal tubule epithelial cells (RTECs) from wildtype and Tlr4 knockout mice, but not those from Tlr2 knockout mice subjected to transient ischemia. Geldanamycin (GA), an inhibitor of heat shock protein 90 and reticulum endoplasmic-resident gp96, and gp96mRNAsilencing (siRNA), did not affect ERK1/2 activation in either post-hypoxic wild-type or Tlr4-deficient RTECs, but did restore its activation in post-hypoxic Tlr2-deficient RTECs. Immunoprecipitation studies revealed that gp96 co-immunoprecipitates with the serine-threonine protein phosphatase 5 (PP5), identified as a negative modulator of the mitogen extracellular kinase (MEK)-ERK pathway, in unstressed wild-type and post-hypoxic Tlr2-deficient RTECs. In contrast, PP5 co-immunoprecipitation with gp96 was strikingly reduced in post-hypoxic wild-type RTECs, suggesting that the inactivation of PP5 resulting from the dissociation of PP5 from gp96 allows the activation of ERK1/2 to occur. Inhibition of PP5 by okadaic acid, and Pp5 siRNA also restored TLR2-mediated phosphorylation of ERK1/2, and apoptosis signal-regulating kinase 1 (ASK1)/c-Jun N-terminal kinase (JNK)-mediated apoptosis in post-hypoxic Tlr2-deficient RTECs. These findings indicate that gp96 interacts with PP5 and controls TLR2-mediated induction of ERK1/2 in post-hypoxic renal tubule cells.	[Ben Mkaddem, Sanae; Bens, Marcelle; Pedruzzi, Eric; Ogier-Denis, Eric; Vandewalle, Alain] Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, U773,UFR Med Xavier Bichat, F-75870 Paris 18, France; [Werts, Catherine] INSERM, Inst Pasteur, Grp Biol & Genet Parois Bacteriennes, Grp Avenir, F-75724 Paris 15, France; [Goujon, Jean-Michel] Ctr Hosp Univ Poitiers, Serv Anat & Cytol Pathol, F-86021 Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Poitiers; Universite de Poitiers	Vandewalle, A (corresponding author), Univ Paris 07, INSERM, Ctr Rech Biomed Bichat Beaujon CRB3, U773,UFR Med Xavier Bichat, Site Bichat,BP 416,16 Rue Henri Huchard, F-75870 Paris 18, France.	alain.vandewalle@inserm.fr	WERTS, Catherine/AAD-5447-2020; pedruzzi, eric/B-6050-2017; Ogier-Denis, Eric/E-5030-2016	WERTS, Catherine/0000-0003-3079-5476; Ben Mkaddem, Sanae/0000-0001-7919-2233; Ogier-Denis, Eric/0000-0002-0057-7593	INSERM; Agence Nationale de la Recherche [ANR-08-MIE-030]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM and in part by an Agence Nationale de la Recherche grant (ANR-08-MIE-030, to A. V.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hindley A, 2002, J CELL SCI, V115, P1575; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; LACAVE R, 1993, J CELL SCI, V104, P705; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Stefanelli C, 2002, FEBS LETT, V527, P223, DOI 10.1016/S0014-5793(02)03242-8; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; VANDEWALLE A, 1989, J CELL PHYSIOL, V141, P203, DOI 10.1002/jcp.1041410128; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang C, 2007, ARTERIOSCL THROM VAS, V27, P1760, DOI 10.1161/ATVBAHA.107.144881; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao SY, 1997, PHOTOCHEM PHOTOBIOL, V66, P727, DOI 10.1111/j.1751-1097.1997.tb03214.x; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	57	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12541	12549		10.1074/jbc.M808376200	http://dx.doi.org/10.1074/jbc.M808376200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265198	hybrid, Green Published			2022-12-25	WOS:000265494600083
J	Domenzain-Reyna, C; Hernandez, D; Miquel-Serra, L; Docampo, MJ; Badenas, C; Fabra, A; Bassols, A				Domenzain-Reyna, Clelia; Hernandez, Daniel; Miquel-Serra, Laia; Jose Docampo, Maria; Badenas, Celia; Fabra, Angels; Bassols, Anna			Structure and Regulation of the Versican Promoter THE VERSICAN PROMOTER IS REGULATED BY AP-1 AND TCF TRANSCRIPTION FACTORS IN INVASIVE HUMAN MELANOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA; BREAST-CANCER; UP-REGULATION; G3 DOMAIN; DIFFERENTIAL EXPRESSION; CHONDROITIN SULFATE; ISOFORM EXPRESSION; BRAF MUTATIONS; CELL-ADHESION; GROWTH-FACTOR	Versican is a large chondroitin sulfate proteoglycan of the extracellular matrix that is involved in a variety of cellular processes. We showed previously that versican, which is overexpressed in cutaneous melanomas as well as in premalignant lesions, contributes to melanoma progression, favoring the detachment of cells and the metastatic dissemination. Here, we investigated the transcriptional regulation of the versican promoter in melanoma cell lines with different levels of biological aggressiveness and stages of differentiation. We show that versican promoter up-regulation accounts for the differential expression levels of mRNA and protein detected in the invasive SK-mel-131 human melanoma cells. The activity of the versican promoter increased 5-fold in these cells in comparison with that measured in non-invasive MeWo melanoma cells. Several transcriptional regulatory elements were identified in the proximal promoter, including AP-1, Sp1, AP-2, and two TCF-4 sites. We show that promoter activation is mediated by the ERK/MAPK and JNK signaling pathways acting on the AP-1 site, suggesting that BRAF mutation present in SK-mel-131 cells impinge upon the up-regulation of the versican gene through signaling elicited by the ERK/MAPK pathway. This is the first time the AP-1 transcription factor family has been shown to be related to the regulation of versican expression. Furthermore, deletion of the TCF-4 binding sites caused a 60% decrease in the promoter activity in SK-mel-131 cells. These results showing that AP-1 and TCF-4 binding sites are the main regulatory regions directing versican production provide new insights into versican promoter regulation during melanoma progression.	[Domenzain-Reyna, Clelia; Hernandez, Daniel; Miquel-Serra, Laia; Jose Docampo, Maria; Bassols, Anna] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Vet, Cerdanyola Del Valles 08193, Spain; [Badenas, Celia] Hosp Barcelona, Unitat Genet, Barcelona 08036, Spain; [Fabra, Angels] Inst Invest Biomed Bellvitge IDIBEL, Lhospitalet De Llobregat 08907, Spain	Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Bassols, A (corresponding author), Edifici 5, Cerdanyola Del Valles 08193, Spain.	anna.bassols@uab.cat	Bassols, Anna/K-7961-2014; Badenas, Celia/ABH-5480-2020; Docampo, María José/A-4957-2009	Bassols, Anna/0000-0003-4213-2274; Badenas, Celia/0000-0002-0621-0477; Miquel Serra, Laia/0000-0001-8382-3341; Docampo, Maria Jose/0000-0003-1242-222X; Domenzain, Clelia/0000-0002-3080-6799	Ministerio de Educacion y Ciencia [SAF2003-08750]; Ministerio de Sanidad y Consumo [FIS-PI-06194]; Generalitat de Catalunya [2005SGR00542]; FEDER program of the European Union	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); FEDER program of the European Union(European Commission)	This work was supported by Grants SAF2003-08750 from the Ministerio de Educacion y Ciencia (to A. B.), FIS-PI-06194 from the Ministerio de Sanidad y Consumo (to A.F.), and 2005SGR00542 from the Generalitat de Catalunya (to A. B.). This work was also supported in part by the FEDER program of the European Union.	Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Chen DH, 2003, CANCER RES, V63, P6626; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Docampo MJ, 2007, AM J VET RES, V68, P1376, DOI 10.2460/ajvr.68.12.1376; Domenzain C, 2003, BBA-MOL CELL RES, V1642, P107, DOI 10.1016/S0167-4889(03)00104-6; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Gorden A, 2003, CANCER RES, V63, P3955; Govindarajan B, 2003, J BIOL CHEM, V278, P9790, DOI 10.1074/jbc.M212929200; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Hsu MY, 2002, DIFFERENTIATION, V70, P522, DOI 10.1046/j.1432-0436.2002.700906.x; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kodama J, 2007, ANN ONCOL, V18, P269, DOI 10.1093/annonc/mdl370; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; NASO MF, 1994, J BIOL CHEM, V269, P32999; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Sakko AJ, 2003, CANCER RES, V63, P4786; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Touab M, 2003, AM J CLIN PATHOL, V119, P587, DOI 10.1309/ME25J1G5E57LM3; Touab M, 2002, AM J PATHOL, V160, P549, DOI 10.1016/S0002-9440(10)64874-2; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zizola CF, 2007, MATRIX BIOL, V26, P419, DOI 10.1016/j.matbio.2007.04.002	62	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12306	12317		10.1074/jbc.M807108200	http://dx.doi.org/10.1074/jbc.M807108200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269971	Green Published, hybrid			2022-12-25	WOS:000265494600062
J	Lam, BYH; Zhang, WT; Enticknap, N; Haggis, E; Cader, MZ; Chawla, S				Lam, Brian Yee Hong; Zhang, Wenting; Enticknap, Nicola; Haggis, Eleanor; Cader, M. Zaeem; Chawla, Sangeeta			Inverse Regulation of Plasticity-related Immediate Early Genes by Calcineurin in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SENSITIVE COINCIDENCE DETECTOR; SERUM RESPONSE ELEMENT; C-FOS; SYNAPTIC PLASTICITY; TRANSCRIPTION FACTORS; CALCIUM-CHANNELS; CORTICAL-NEURONS; RAT HIPPOCAMPUS; TERNARY COMPLEX	In the mammalian hippocampus, changes in the expression of immediate early genes (IEGs) is thought to contribute to long term plastic changes in neurons brought about by learning tasks and high frequency stimulation of synapses. The phosphatase calcineurin has emerged as an important negative regulator of hippocampus-dependent learning and long term potentiation. Here we investigated the possibility that the constraining action of calcineurin on hippocampal plasticity is mediated in part by regulation of gene expression through negative control of transcription factors, such as cAMP-response element (CRE)-binding protein (CREB). We assessed the effect of calcineurin inhibitors on CREB activation by neuronal activity and show that calcineurin activity is in fact required for CREB-mediated gene expression. However, inhibition of calcineurin had disparate effects on the transcriptional induction of CREB-dependent IEGs. We find that the IEG c-fos is unaffected by suppression of calcineurin activity, the plasticity-related genes Egr1/Zif268 and Egr2/Krox-20 are up-regulated, and genes encoding the orphan nuclear hormone receptors Nor1 and Nur77 are down-regulated. We further show that the up-regulation of particular IEGs is probably due to the presence of serum response elements (SREs) in their promoters, because SRE-mediated gene expression is enhanced by calcineurin blockers. Moreover, expression of the c-fos gene, which is unaffected by calcineurin inhibitors, could be down-regulated by mutating the SRE. Conversely, SRE-mediated c-fos induction in the absence of a functional CRE was enhanced by calcineurin inhibitors. Our experiments thus implicate calcineurin as a negative regulator of SRE-dependent neuronal genes.	[Lam, Brian Yee Hong; Zhang, Wenting; Enticknap, Nicola; Haggis, Eleanor; Cader, M. Zaeem; Chawla, Sangeeta] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Chawla, S (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	sc10008@cam.ac.uk	Lam, Brian YH/AAH-5749-2021	Lam, Brian YH/0000-0002-3638-9025; Cader, Mohammed Zaeem/0000-0002-4121-748X	Biotechnology and Biological Sciences Research Council; Royal Society; Biotechnology and Biological Sciences Research Council [JF20603] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and the Royal Society.	ALEXANDRE C, 1991, ONCOGENE, V6, P1851; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Calella AM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-4; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; Garcia-Rodriguez C, 2000, EUR J IMMUNOL, V30, P2432, DOI 10.1002/1521-4141(2000)30:8<2432::AID-IMMU2432>3.0.CO;2-F; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guerini D, 2000, J BIOL CHEM, V275, P3706, DOI 10.1074/jbc.275.5.3706; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Kramer D, 2003, MOL CELL NEUROSCI, V23, P325, DOI 10.1016/S1044-7431(03)00057-5; Lam BYH, 2007, NEUROSCI LETT, V427, P153, DOI 10.1016/j.neulet.2007.09.030; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Sun W, 2007, J NEUROCHEM, V100, P269, DOI 10.1111/j.1471-4159.2006.04214.x; Tian JM, 1999, J BIOL CHEM, V274, P15173, DOI 10.1074/jbc.274.21.15173; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; WILLIAMS J, 1995, MOL BRAIN RES, V28, P87, DOI 10.1016/0169-328X(94)00187-J; Wilson HL, 2001, MOL CELL ENDOCRINOL, V181, P27, DOI 10.1016/S0303-7207(01)00540-8; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	49	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12562	12571		10.1074/jbc.M901121200	http://dx.doi.org/10.1074/jbc.M901121200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270309	hybrid, Green Published			2022-12-25	WOS:000265494600085
J	Damek-Poprawa, M; Diemer, T; Lopes, VS; Lillo, C; Harper, DC; Marks, MS; Wu, Y; Sparrow, JR; Rachel, RA; Williams, DS; Boesze-Battaglia, K				Damek-Poprawa, Monika; Diemer, Tanja; Lopes, Vanda S.; Lillo, Concepcion; Harper, Dawn C.; Marks, Michael S.; Wu, Yalin; Sparrow, Janet R.; Rachel, Rivka A.; Williams, David S.; Boesze-Battaglia, Kathleen			Melanoregulin (MREG) Modulates Lysosome Function in Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE DILUTE SUPPRESSOR; AGE-RELATED-CHANGES; COAT-COLOR PHENOTYPE; CATHEPSIN-D; OUTER SEGMENTS; DEGRADATIVE FUNCTIONS; RETINOID COMPONENT; RPE LIPOFUSCIN; GENE DSU; A2E	Melanoregulin (MREG), the product of the Mreg(dsu) gene, is a small highly charged protein, hypothesized to play a role in organelle biogenesis due to its effect on pigmentation in dilute, ashen, and leaden mutant mice. Here we provide evidence that MREG is required in lysosome-dependent phagosome degradation. In the Mreg(-/-) mouse, we show that loss of MREG function results in phagosome accumulation due to delayed degradation of engulfed material. Over time, the Mreg(-/-) mouse retinal pigment epithelial cells accumulate the lipofuscin component, A2E. MREG-deficient human and mouse retinal pigment epithelial cells exhibit diminished activity of the lysosomal hydrolase, cathepsin D, due to defective processing. Moreover, MREG localizes to small intracellular vesicles and associates with the endosomal phosphoinositide, phosphatidylinositol 3,5-biphosphate. Collectively, these studies suggest that MREG is required for lysosome maturation and support a role for MREG in intracellular trafficking.	[Damek-Poprawa, Monika; Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Sch Dent Med, Philadelphia, PA 19104 USA; [Diemer, Tanja; Lopes, Vanda S.; Williams, David S.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Diemer, Tanja; Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Diemer, Tanja; Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Wu, Yalin; Sparrow, Janet R.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Sparrow, Janet R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Rachel, Rivka A.] NEI, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania; Columbia University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Boesze-Battaglia, K (corresponding author), Univ Penn, Dept Biochem, Sch Dent Med, 240 S 40th St, Philadelphia, PA 19104 USA.	battagli@biochem.dental.upenn.edu	Marks, Michael S/Q-7223-2019; Lillo, Concepcion/A-6321-2009; 2009, Secribsal/A-1266-2012	Marks, Michael S/0000-0001-7435-7262; Lillo, Concepcion/0000-0001-5814-9826; 	National Institutes of Health [EY-10420]; NEI [P30 EY001583, EY07042, EY-12951]; NEI, National Institutes of Health Core [P30 EY12598, EY00331]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012598, R01EY015625, P30EY000331, P30EY001583, R01EY012951, R21EY018705, R01EY010420, R01EY007042, R29EY010420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI, National Institutes of Health Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Public Health Service Grant EY-10420 from the National Institutes of Health, NEI and services were available through a Vision Core Grant (P30 EY001583) (to K. B.-B. and M. D.- P.), Public Health Service grant EY07042 from the NEI and services available through NEI, National Institutes of Health Core Grants (P30 EY12598 and EY00331) (to D. S. W.), Public Health Service Grant EY-12951 from the NEI (to J. R. S. and Y. W.), and Public Health Service Grant EY-15625 from the NEI (to M. S. M.). This work was also supported by an E. Matilda Ziegler Vision Award and University of Pennsylvania Research Foundation Award (KB- B). (to J. R. S. and Y. W.).	Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bermann M, 2001, EXP EYE RES, V72, P191; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; BESHARSE JC, 1998, RETINAL PIGMENT EPIT, P152; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cingle KA, 1996, CURR EYE RES, V15, P433, DOI 10.3109/02713689608995834; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; Damek-Poprawa M, 2006, BIOCHEMISTRY-US, V45, P3325, DOI 10.1021/bi0515927; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; DEDUVE C, 1964, FED PROC, V23, P1045; DELAEY JJ, 1995, RETINA-J RET VIT DIS, V15, P399, DOI 10.1097/00006982-199515050-00005; DELBRUCK R, 1994, EUR J CELL BIOL, V64, P7; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; FEENEYBURNS L, 1983, T OPHTHAL SOC UK, V103, P416; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1115; Gibbs D, 2003, ADV EXP MED BIOL, V533, P347; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; HASILIK A, 1980, J BIOL CHEM, V255, P4946; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HAYASAKA S, 1975, J BIOCHEM-TOKYO, V78, P1365, DOI 10.1093/oxfordjournals.jbchem.a131034; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Hoppe G, 2004, CELL MOL LIFE SCI, V61, P1664, DOI 10.1007/s00018-004-4080-5; Hoppe G, 2004, BBA-MOL BASIS DIS, V1689, P33, DOI 10.1016/j.bbadis.2004.01.004; Hoppe G, 2001, INVEST OPHTH VIS SCI, V42, P2714; Jacobson SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/hmg/ddn140; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LEMANSKY P, 1984, J BIOL CHEM, V259, P129; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Marks MS, 2008, PIGM CELL MELANOMA R, V21, P11, DOI 10.1111/j.1755-148X.2007.00421.x; Massey AC, 2006, CELL CYCLE, V5, P1292, DOI 10.4161/cc.5.12.2865; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; MOORE KJ, 1994, GENETICS, V138, P491; MOORE KJ, 1988, GENETICS, V119, P933; MOORE KJ, 1990, GENETICS, V125, P421; NABI IR, 1993, J CELL SCI, V104, P37; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; NOVAK EK, 1979, GENETICS, V92, P189; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; PLANTNER JJ, 1991, EXP EYE RES, V53, P269, DOI 10.1016/0014-4835(91)90083-Q; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; RAKOCZY PE, 1994, INVEST OPHTH VIS SCI, V35, P4100; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; REGAN CM, 1980, EXP EYE RES, V30, P183, DOI 10.1016/0014-4835(80)90112-8; RICHO GR, 1994, J BIOL CHEM, V269, P14806; SIAKOTOS AN, 1978, INVEST OPHTH VIS SCI, V17, P618; Sparrow JR, 2008, ADV EXP MED BIOL, V613, P393, DOI 10.1007/978-0-387-74904-4_46; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; SWEET HO, 1983, J HERED, V74, P305, DOI 10.1093/oxfordjournals.jhered.a109794; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Verdugo ME, 1997, EXP EYE RES, V65, P231, DOI 10.1006/exer.1997.0325; Volpicelli-Daley L, 2007, NAT MED, V13, P784, DOI 10.1038/nm0707-784; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X; WILCOX DK, 1988, INVEST OPHTH VIS SCI, V29, P1205; Yasuda Y, 1999, J BIOCHEM-TOKYO, V125, P1137, DOI 10.1093/oxfordjournals.jbchem.a022396; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	88	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10877	10889		10.1074/jbc.M808857200	http://dx.doi.org/10.1074/jbc.M808857200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240024	Green Published, hybrid			2022-12-25	WOS:000265104600061
J	Capyk, JK; D'Angelo, I; Strynadka, NC; Eltis, LD				Capyk, Jenna K.; D'Angelo, Igor; Strynadka, Natalie C.; Eltis, Lindsay D.			Characterization of 3-Ketosteroid 9 alpha-Hydroxylase, a Rieske Oxygenase in the Cholesterol Degradation Pathway of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-ERYTHROPOLIS SQ1; TERMINAL OXYGENASE; NAPHTHALENE DIOXYGENASE; PHTHALATE DIOXYGENASE; CRYSTAL-STRUCTURE; DELTA(1)-DEHYDROGENASE ISOENZYME; FUNCTIONAL-CHARACTERIZATION; BRIDGING ASPARTATE-178; BIPHENYL DIOXYGENASE; STRAIN SQ1	KshAB (3-Ketosteroid 9 alpha-hydroxylase) is a two-component Rieske oxygenase (RO) in the cholesterol catabolic pathway of Mycobacterium tuberculosis. Although the enzyme has been implicated in pathogenesis, it has largely been characterized by bioinformatics and molecular genetics. Purified KshB, the reductase component, was a monomeric protein containing a plant-type [2Fe-2S] cluster and FAD. KshA, the oxygenase, was a homotrimer containing a Rieske [2Fe-2S] cluster and mononuclear ferrous iron. Of two potential substrates, reconstituted KshAB had twice the specificity for 1,4-androstadiene-3,17-dione as for 4-androstene-3,17-dione. The transformation of both substrates was well coupled to the consumption of O-2. Nevertheless, the reactivity of KshAB with O-2 was low in the presence of 1,4- androstadiene-3,17-dione, with a k(cat)/K-mO2 of 2450 +/- 80 M-1 s(-1). The crystallographic structure of KshA, determined to 2.3 angstrom, revealed an overall fold and a head-to-tail subunit arrangement typical of ROs. The central fold of the catalytic domain lacks all insertions found in characterized ROs, consistent with a minimal and perhaps archetypical RO catalytic domain. The structure of KshA is further distinguished by a C-terminal helix, which stabilizes subunit interactions in the functional trimer. Finally, the substrate-binding pocket extends farther into KshA than in other ROs, consistent with the large steroid substrate, and the funnel accessing the active site is differently orientated. This study provides a solid basis for further studies of a key steroid transforming enzyme of biotechnological and medical importance.	[Capyk, Jenna K.; D'Angelo, Igor; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6 1Z3, Canada; [Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Canadian Institute for Health Research; British Columbia Lung Association; Michael Smith Foundation for Health Research; Emerging Team programs.	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Emerging Team programs.	This work was supported by grants from the Canadian Institute for Health Research ( to L. D. E. and N. S.), the British Columbia Lung Association (to L. D. E.), and the Michael Smith Foundation for Health Research (MSFHR) Infrastructure ( to N. S.) and Emerging Team programs.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andor A, 2006, APPL ENVIRON MICROB, V72, P6554, DOI 10.1128/AEM.00941-06; BERNHARDT FH, 1981, EUR J BIOCHEM, V120, P547, DOI 10.1111/j.1432-1033.1981.tb05735.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cornish-Bowden A., 1994, ANAL ENZYME KINETIC; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong XS, 2005, J BACTERIOL, V187, P2483, DOI 10.1128/JB.187.7.2483-2490.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferraro DJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-10; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Furukawa K, 2003, TRENDS BIOTECHNOL, V21, P187, DOI 10.1016/S0167-7799(03)00054-4; Furusawa Y, 2004, J MOL BIOL, V342, P1041, DOI 10.1016/j.jmb.2004.07.062; Ge Y, 2002, J BACTERIOL, V184, P4096, DOI 10.1128/JB.184.15.4096-4103.2002; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee K, 1999, J BACTERIOL, V181, P2719, DOI 10.1128/JB.181.9.2719-2725.1999; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nojiri H, 2005, J MOL BIOL, V351, P355, DOI 10.1016/j.jmb.2005.05.059; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Pinto A, 2006, BIOCHEMISTRY-US, V45, P9032, DOI 10.1021/bi060216z; PULLEYBLANK D, 1983, MOL BIOL REP, V9, P191, DOI 10.1007/BF00775367; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; STRIJEWSKI A, 1982, EUR J BIOCHEM, V128, P125; Tarasev M, 2005, BIOCHEMISTRY-US, V44, P6197, DOI 10.1021/bi047724y; Tarasev M, 2006, BIOCHEMISTRY-US, V45, P10208, DOI 10.1021/bi060219b; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; van der Geize R, 2008, APPL ENVIRON MICROB, V74, P7197, DOI 10.1128/AEM.00888-08; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2000, APPL ENVIRON MICROB, V66, P2029, DOI 10.1128/AEM.66.5.2029-2036.2000; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; *WHO, 2008, 4 WHO, P14; YAM K, 2009, PLOS PATHOG IN PRESS; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012	62	109	115	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9937	9946		10.1074/jbc.M900719200	http://dx.doi.org/10.1074/jbc.M900719200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19234303	hybrid, Green Published			2022-12-25	WOS:000264892900036
J	Agrillo, C; Dadda, M; Serena, G; Bisazza, A				Agrillo, Christian; Dadda, Marco; Serena, Giovanna; Bisazza, Angelo			Use of Number by Fish	PLOS ONE			English	Article							NUMERICAL COMPETENCE; MACACA-MULATTA; NUMEROSITY DISCRIMINATION; QUANTITY DISCRIMINATION; INFANTS DISCRIMINATION; FEMALE MOSQUITOFISH; CONTINUOUS EXTENT; PAN-TROGLODYTES; CONTOUR LENGTH; CEBUS-APELLA	Background: Research on human infants, mammals, birds and fish has demonstrated that rudimentary numerical abilities pre-date the evolution of human language. Yet there is controversy as to whether animals represent numbers mentally or rather base their judgments on non-numerical perceptual variables that co-vary with numerosity. To date, mental representation of number has been convincingly documented only for a few mammals. Methodology/Principal Findings: Here we used a training procedure to investigate whether mosquitofish could learn to discriminate between two and three objects even when denied access to non-numerical information. In the first experiment, fish were trained to discriminate between two sets of geometric figures. These varied in shape, size, brightness and distance, but no control for non-numerical variables was made. Subjects were then re-tested while controlling for one non-numerical variable at a time. Total luminance of the stimuli and the sum of perimeter of figures appeared irrelevant, but performance dropped to chance level when stimuli were matched for the cumulative surface area or for the overall space occupied by the arrays, indicating that these latter cues had been spontaneously used by the fish during the learning process. In a second experiment, where the task consisted of discriminating 2 vs 3 elements with all non-numerical variables simultaneously controlled for, all subjects proved able to learn the discrimination, and interestingly they did not make more errors than the fish in Experiment 1 that could access non-numerical information in order to accomplish the task. Conclusions/Significance: Mosquitofish can learn to discriminate small quantities, even when non-numerical indicators of quantity are unavailable, hence providing the first evidence that fish, like primates, can use numbers. As in humans and non-human primates, genuine counting appears to be a 'last resort' strategy in fish, when no other perceptual mechanism may suggest the quantity of the elements. However, our data suggest that, at least in fish, the priority of perceptual over numerical information is not related to a greater cognitive load imposed by direct numerical computation.	[Agrillo, Christian; Dadda, Marco; Serena, Giovanna; Bisazza, Angelo] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Agrillo, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it	Dadda, Marco/D-2417-2014; DADDA, Marco/ABI-7266-2020	DADDA, Marco/0000-0001-7944-4058; Bisazza, Angelo/0000-0003-0209-7638; Agrillo, Christian/0000-0002-7391-8934	Progetti di Ricerca di Ateneo [CPDA087853/08]	Progetti di Ricerca di Ateneo	This study was funded by "Progetti di Ricerca di Ateneo", No. CPDA087853/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2007, ETHOL ECOL EVOL, V19, P145, DOI 10.1080/08927014.2007.9522574; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2008, ETHOLOGY, V114, P479, DOI 10.1111/j.1439-0310.2008.01493.x; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2008, J EXP PSYCHOL ANIM B, V34, P63, DOI 10.1037/0097-7403.34.1.63; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Binoy VV, 2004, CURR SCI INDIA, V86, P207; Brannon E. M., 2005, HDB MATH COGNITION; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Breukelaar JWC, 1998, J EXP PSYCHOL ANIM B, V24, P84, DOI 10.1037/0097-7403.24.1.84; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2008, CHILD DEV, V79, P476, DOI 10.1111/j.1467-8624.2007.01137.x; DAVIS H, 1982, PSYCHOL BULL, V92, P547, DOI 10.1037/0033-2909.92.3.547; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P149, DOI 10.1037/0096-1523.21.1.149; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; IRIESUGIMOTO N, 2009, ANIMAL COGNITION, V21, P193; Jordan KE, 2006, ANIM COGN, V9, P159, DOI 10.1007/s10071-006-0017-8; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; Kamil A. C., 1987, FORAGING BEHAV; Kilian A, 2003, LEARN BEHAV, V31, P133; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; MCARTHUR RH, 1966, AM NAT, V100, P603; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Roberts WA, 2000, PSYCHOL SCI, V11, P218, DOI 10.1111/1467-9280.00244; Rugani R, 2007, J EXP PSYCHOL ANIM B, V33, P21, DOI 10.1037/0097-7403.33.1.21; RUMBAUGH DM, 1987, J EXP PSYCHOL ANIM B, V13, P107, DOI 10.1037/0097-7403.13.2.107; Seron X, 2001, MIND LANG, V16, P76, DOI 10.1111/1468-0017.00158; Sovrano VA, 2002, COGNITION, V85, pB51, DOI 10.1016/S0010-0277(02)00110-5; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Tomonaga M, 2008, ANIM COGN, V11, P43, DOI 10.1007/s10071-007-0089-0; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; VOS PG, 1988, PSYCHOL RES-PSYCH FO, V50, P148, DOI 10.1007/BF00310175; West RE, 2002, ANIM COGN, V5, P183, DOI 10.1007/s10071-002-0140-0; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	48	107	108	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4786	10.1371/journal.pone.0004786	http://dx.doi.org/10.1371/journal.pone.0004786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OE	19274079	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496000022
J	Aivaliotis, M; Macek, B; Gnad, F; Reichelt, P; Mann, M; Oesterhelt, D				Aivaliotis, Michalis; Macek, Boris; Gnad, Florian; Reichelt, Peter; Mann, Matthias; Oesterhelt, Dieter			Ser/Thr/Tyr Protein Phosphorylation in the Archaeon Halobacterium salinarum-A Representative of the Third Domain of Life	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; PHOSPHOPROTEOME ANALYSIS; SULFOLOBUS-SOLFATARICUS; SIGNAL-TRANSDUCTION; SITE DATABASE; IN-VIVO; KINASE; IDENTIFICATION; PHOSPHATASES; EVOLUTION	In the quest for the origin and evolution of protein phosphorylation, the major regulatory post-translational modification in eukaryotes, the members of archaea, the "third domain of life", play a protagonistic role. A plethora of studies have demonstrated that archaeal proteins are subject to post-translational modification by covalent phosphorylation, but little is known concerning the identities of the proteins affected, the impact on their functionality, the physiological roles of archaeal protein phosphorylation/dephosphorylation, and the protein kinases/phosphatases involved. These limited studies led to the initial hypothesis that archaea, similarly to other prokaryotes, use mainly histidine/aspartate phosphorylation, in their two-component systems representing a paradigm of prokaryotic signal transduction, while eukaryotes mostly use Ser/Thr/Tyr phosphorylation for creating highly sophisticated regulatory networks. In antithesis to the above hypothesis, several studies showed that Ser/Thr/Tyr phosphorylation is also common in the bacterial cell, and here we present the first genome-wide phosphoproteomic analysis of the model organism of archaea, Halobacterium salinarum, proving the existence/conservation of Ser/Thr/Tyr phosphorylation in the "third domain" of life, allowing a better understanding of the origin and evolution of the so-called "Nature's premier" mechanism for regulating the functional properties of proteins.	[Aivaliotis, Michalis; Reichelt, Peter; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, Martinsried, Germany; [Macek, Boris; Gnad, Florian; Mann, Matthias] Max Planck Inst Biochem, Dept Proteom & Sign Transduct, Martinsried, Germany	Max Planck Society; Max Planck Society	Aivaliotis, M (corresponding author), Acad Athens, Biomed Res Ctr, Ctr Basic Res 2, Athens, Greece.	michalis@biochem.mpg.de	Macek, Boris/N-1442-2015; Aivaliotis, Michalis/D-4841-2011; Mann, Matthias/A-3454-2013	Macek, Boris/0000-0002-1206-2458; Aivaliotis, Michalis/0000-0003-1173-7705; Mann, Matthias/0000-0003-1292-4799	German Federal Ministry for Education and Research BMBF [0316865B]; European Union Interaction Proteome; Alexander von Humboldt Foundation; Max Planck Society	German Federal Ministry for Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); European Union Interaction Proteome(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the German Federal Ministry for Education and Research BMBF (grant 0316865B) (QuantPro) and the European Union Interaction Proteome (6th Framework Program). M.A. thanks Alexander von Humboldt Foundation and Max Planck Society for the financial support.	Aivaliotis M, 2007, J PROTEOME RES, V6, P2195, DOI 10.1021/pr0700347; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BONET ML, 1992, INT J BIOCHEM, V24, P839; CHANG CL, 1994, NATURE, V370, P335, DOI 10.1038/370335a0; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Daas PJH, 1996, J BIOL CHEM, V271, P22339, DOI 10.1074/jbc.271.37.22339; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Grabowski B, 2001, J BACTERIOL, V183, P5459, DOI 10.1128/JB.183.18.5459-5464.2001; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Jedrzejas MJ, 2000, EMBO J, V19, P1419, DOI 10.1093/emboj/19.7.1419; Jeon SJ, 2002, BIOCHEM BIOPH RES CO, V295, P508, DOI 10.1016/S0006-291X(02)00705-2; Johnston M, 1996, CURR BIOL, V6, P500, DOI 10.1016/S0960-9822(02)00526-2; Kennelly PJ, 2003, BIOCHEM J, V370, P373, DOI 10.1042/BJ20021547; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Koch MK, 2005, MOL MICROBIOL, V55, P1681, DOI 10.1111/j.1365-2958.2005.04516.x; Koonin EV, 2000, J MOL MICROB BIOTECH, V2, P509; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; LEFFERS H, 1989, J MOL BIOL, V206, P1, DOI 10.1016/0022-2836(89)90519-6; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; Lower BH, 2003, J BACTERIOL, V185, P3436, DOI 10.1128/JB.185.11.3436-3445.2003; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; OESTERHELT D, 1983, ANN INST PASTEUR MIC, VB134, P137, DOI 10.1016/S0769-2609(83)80101-X; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Osorio G, 1996, MICROBIOL-SGM, V142, P1531, DOI 10.1099/13500872-142-6-1531; OXENRIDER KA, 1993, BIOCHEM BIOPH RES CO, V194, P1330, DOI 10.1006/bbrc.1993.1970; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ray WK, 2005, J BACTERIOL, V187, P4270, DOI 10.1128/JB.187.12.4270-4275.2005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; RUDOLPH J, 1995, EMBO J, V14, P4249, DOI 10.1002/j.1460-2075.1995.tb00099.x; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Serganov A, 2002, J MOL BIOL, V320, P963, DOI 10.1016/S0022-2836(02)00553-3; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SKORKO R, 1989, J BACTERIOL, V171, P5162, DOI 10.1128/jb.171.9.5162-5164.1989; SKORKO R, 1984, EUR J BIOCHEM, V145, P617, DOI 10.1111/j.1432-1033.1984.tb08601.x; Smith SC, 1997, J BACTERIOL, V179, P2418, DOI 10.1128/jb.179.7.2418-2420.1997; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Solow B, 1998, PROTEIN SCI, V7, P105, DOI 10.1002/pro.5560070111; SOUFI B, 2008, PROTEOMICS IN PRESS; SPUDICH JL, 1980, J BIOL CHEM, V255, P5501; STREIF S, 2009, REV SCI INS IN PRESS; Tahara M, 2004, J BIOCHEM, V135, P479, DOI 10.1093/jb/mvh055; Tebbe A, 2005, PROTEOMICS, V5, P168, DOI 10.1002/pmic.200400910; Wurgler-Murphy SM, 2004, PROTEOMICS, V4, P1562, DOI 10.1002/pmic.200300711; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248	69	67	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4777	10.1371/journal.pone.0004777	http://dx.doi.org/10.1371/journal.pone.0004777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274099	Green Published, gold			2022-12-25	WOS:000265496000016
J	Thines, M				Thines, Marco			Bridging the Gulf: Phytophthora and Downy Mildews Are Connected by Rare Grass Parasites	PLOS ONE			English	Article								Downy mildews and root and foliar rots caused by Phytophthora are among the most destructive plant pathogens and therefore have attracted considerable attention during the past two decades. Although it has been realized that a close phylogenetic relationship exists, so far sharp distinction has been made between the obligate biotrophic downy mildews and the hemibiotrophic Phytophthora. In the study presented here, it is shown that a continuum of character states from hemibiotrophic Phytophthora species to obligate biotrophic downy mildews is present. Intermediate character states between downy mildews and Phytophthora species exist in several rare parasites of grasses, which are not embedded within the major clades of the downy mildews but are placed sister to these, with unresolved affinities to both these clades and to Phytophthora. They still have retained traits hitherto thought to be exclusive for Phytophthora. A careful review of previous research is presented and it is highlighted that uniquely for downy mildews, Poakatesthia may form an intracellular mycelium, growing through several host cells. In addition, scanning electron microscopy reveals that sporangiophore growth is not determinate in Viennotia and that outgrowth from sporangiophores is very similar to Phytophthora infestans. It is concluded that the sharp morphological distinction between downy mildews and Phytophthora species (that are often placed in separate families and even different orders), is rather artificial, since all features thought to be exclusive to Phytophthora or the downy mildews are united in the rare grass-parasitizing down mildew genera Viennotia and Poakatesthia and the enigmatic genus Sclerophthora. Therefore, several paradigms regarding the distinction between Phytophthora and the downy mildews need to be reconsidered.	[Thines, Marco] Univ Hohenheim, Inst Bot, D-7000 Stuttgart, Germany	University Hohenheim	Thines, M (corresponding author), Univ Hohenheim, Inst Bot, D-7000 Stuttgart, Germany.	thines@uni-hohenheim.de	Thines, Marco/H-1685-2011		German Science Foundation; Elite Program for Post-Docs of the Landesstiftung Baden-Wurttemberg	German Science Foundation(German Research Foundation (DFG)); Elite Program for Post-Docs of the Landesstiftung Baden-Wurttemberg	This study has been funded by grants from the German Science Foundation and the Elite Program for Post-Docs of the Landesstiftung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bary De, 1863, ANN SCI NAT BOT BIOL, V20, P5; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; DICK MW, 1984, BOT J LINN SOC, V89, P171, DOI 10.1111/j.1095-8339.1984.tb01008.x; Dick MW, 2001, STRAMINIPILOUS FUNGI; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FRAYMOUTH JOAN, 1956, TRANS BRIT MYCOL SOC, V39, P79; FRY WE, 1992, ANNU REV PHYTOPATHOL, V30, P107, DOI 10.1146/annurev.py.30.090192.000543; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2003, CAN J BOT, V81, P672, DOI [10.1139/b03-066, 10.1139/B03-066]; GOKER M, 2006, GERM C BIOINF 2006 T; Greenshields DL, 2008, CURR BIOL, V18, pR128, DOI 10.1016/j.cub.2007.11.064; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kenneth RG., 1981, DOWNY MILDEWS, P367; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; NOVOTELNOVA, 1966, MUCHNISTAYA ROSA POS; Parniske M, 2000, CURR OPIN PLANT BIOL, V3, P320, DOI 10.1016/S1369-5266(00)00088-1; PAYAK MM, 1967, PHYTOPATHOLOGY, V57, P394; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Ristaino JB, 2002, MICROBES INFECT, V4, P1369, DOI 10.1016/S1286-4579(02)00010-2; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Ryley MJ, 2001, AUST J BOT, V49, P487, DOI 10.1071/BT00088; Saccardo PA, 1890, HEDWIGIA, V29, P154; Sasabe M, 2000, EUR J BIOCHEM, V267, P5005, DOI 10.1046/j.1432-1327.2000.01553.x; SHAW CG, 1978, MYCOLOGIA, V70, P594, DOI 10.2307/3759397; Shaw CG, 1981, DOWNY MILDEWS, P17; TANAKA I., 1940, Annals of the Phytopathological Society of Japan, V10, P127; TAVEL F, 1892, VERGLEICHENDE MORPHO; Thines M, 2008, MYCOL RES, V112, P345, DOI 10.1016/j.mycres.2007.10.010; Thines M, 2007, MYCOL RES, V111, P1377, DOI 10.1016/j.mycres.2007.09.006; Thines M, 2006, MYCOTAXON, V97, P195; Thines M, 2006, MYCOL RES, V110, P646, DOI 10.1016/j.mycres.2006.04.001; THIRUMALACHAR M. J., 1953, Bulletin of the Torrey Botanical Club, V80, P299, DOI 10.2307/2481765; TIPPETT JT, 1976, ARCH MICROBIOL, V108, P231, DOI 10.1007/BF00454847; TIWARI MM, 1969, SCIENCE, V163, P291, DOI 10.1126/science.163.3864.291; Tokura R, 1975, TROP AGRIC RES SER, V8, P57; Waterhouse GM, 1963, 92 CMI; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	41	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4790	10.1371/journal.pone.0004790	http://dx.doi.org/10.1371/journal.pone.0004790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274081	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496000026
J	Shajahan, TK; Nayak, AR; Pandit, R				Shajahan, T. K.; Nayak, Alok Ranjan; Pandit, Rahul			Spiral-Wave Turbulence and Its Control in the Presence of Inhomogeneities in Four Mathematical Models of Cardiac Tissue	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; IONIC CURRENTS; BREAKUP; OBSTACLE; CHAOS; HETEROGENEITY; ELIMINATION; TACHYCARDIA; ATTACHMENT; MOVEMENT	Regular electrical activation waves in cardiac tissue lead to the rhythmic contraction and expansion of the heart that ensures blood supply to the whole body. Irregularities in the propagation of these activation waves can result in cardiac arrhythmias, like ventricular tachycardia (VT) and ventricular fibrillation (VF), which are major causes of death in the industrialised world. Indeed there is growing consensus that spiral or scroll waves of electrical activation in cardiac tissue are associated with VT, whereas, when these waves break to yield spiral- or scroll-wave turbulence, VT develops into life-threatening VF: in the absence of medical intervention, this makes the heart incapable of pumping blood and a patient dies in roughly two-and-a-half minutes after the initiation of VF. Thus studies of spiral- and scroll-wave dynamics in cardiac tissue pose important challenges for in vivo and in vitro experimental studies and for in silico numerical studies of mathematical models for cardiac tissue. A major goal here is to develop low-amplitude defibrillation schemes for the elimination of VT and VF, especially in the presence of inhomogeneities that occur commonly in cardiac tissue. We present a detailed and systematic study of spiral- and scroll-wave turbulence and spatiotemporal chaos in four mathematical models for cardiac tissue, namely, the Panfilov, Luo-Rudy phase 1 (LRI), reduced Priebe-Beuckelmann (RPB) models, and the model of ten Tusscher, Noble, Noble, and Panfilov (TNNP). In particular, we use extensive numerical simulations to elucidate the interaction of spiral and scroll waves in these models with conduction and ionic inhomogeneities; we also examine the suppression of spiral- and scroll-wave turbulence by low-amplitude control pulses. Our central qualitative result is that, in all these models, the dynamics of such spiral waves depends very sensitively on such inhomogeneities. We also study two types of control schemes that have been suggested for the control of spiral turbulence, via low amplitude current pulses, in such mathematical models for cardiac tissue; our investigations here are designed to examine the efficacy of such control schemes in the presence of inhomogeneities. We find that a local pulsing scheme does not suppress spiral turbulence in the presence of inhomogeneities; but a scheme that uses control pulses on a spatially extended mesh is more successful in the elimination of spiral turbulence. We discuss the theoretical and experimental implications of our study that have a direct bearing on defibrillation, the control of life-threatening cardiac arrhythmias such as ventricular fibrillation.	[Shajahan, T. K.; Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Shajahan, T. K.] IISER, CET Campus, Thiruvananthapuram, Kerala, India; [Pandit, Rahul] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Shajahan, TK (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rahul@physics.iisc.ernet.in	Nayak, Alok Ranjan/AAF-1119-2020; Nayak, Alok/E-2979-2016; Shajahan, T K/AAG-4094-2019	Nayak, Alok/0000-0003-0102-0778; Shajahan, TK/0000-0001-5551-1324	Department of Science and Technology, India; University Grants Commission, India; Council for Scientific and Industrial Research (CSIR), India [fellowship]; Jawaharlal Nehru Centre for Advanced Scientific Research, India [fellowship]	Department of Science and Technology, India(Department of Science & Technology (India)); University Grants Commission, India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Jawaharlal Nehru Centre for Advanced Scientific Research, India(Department of Science & Technology (India))	This study was supported by research grants from Department of Science and Technology, India and University Grants Commission, India. While this study was being conducted TKS was supported by research fellowships from the Council for Scientific and Industrial Research (CSIR), India and the Jawaharlal Nehru Centre for Advanced Scientific Research, India; ARN was also supported by a CSIR fellowship. Computational resources were also provided by SERC (IISc).	AGLADZE K, 1994, SCIENCE, V264, P1746, DOI 10.1126/science.264.5166.1746; ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; Antzelevitch C, 2001, BASIC RES CARDIOL, V96, P517, DOI 10.1007/s003950170002; BECK CS, 1947, JAMA-J AM MED ASSOC, V135, P985, DOI 10.1001/jama.1947.62890150005007a; Bernus O, 2002, AM J PHYSIOL-HEART C, V282, pH2296, DOI 10.1152/ajpheart.00731.2001; Biktashev VN, 1998, CHAOS, V8, P48, DOI 10.1063/1.166307; Biktashev VN, 1999, J ELECTROCARDIOL, V32, P76; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Christini DJ, 2002, CHAOS, V12, P732, DOI 10.1063/1.1504061; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; DAVIDENKO JM, 1990, P NATL ACAD SCI USA, V87, P8785, DOI 10.1073/pnas.87.22.8785; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Garfinkel A, 1997, J CLIN INVEST, V99, P305, DOI 10.1172/JCI119159; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Gray RA, 1996, INT J BIFURCAT CHAOS, V6, P415, DOI 10.1142/S0218127496000163; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hwang SM, 2005, P NATL ACAD SCI USA, V102, P10363, DOI 10.1073/pnas.0501539102; Ikeda T, 1997, CIRC RES, V81, P753; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; JALIFE J, 1998, CHAOS, V8, P5764; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Kim YH, 1997, J CLIN INVEST, V100, P2486, DOI 10.1172/JCI119791; KRISNSKY VI, 1966, BIOFIZIKA, V11, P676; Lim ZY, 2006, CIRCULATION, V114, P2113, DOI 10.1161/CIRCULATIONAHA.105.598631; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nash MP, 2006, CIRCULATION, V114, P536, DOI 10.1161/CIRCULATIONAHA.105.602870; Osipov GV, 1998, PHYS REV E, V58, P6955, DOI 10.1103/PhysRevE.58.6955; Osipov GV, 1999, PHYS REV E, V60, P54, DOI 10.1103/PhysRevE.60.54; Pandit R, 2002, PHYSICA A, V306, P211, DOI 10.1016/S0378-4371(02)00499-5; PANFILOV A, 1993, PHYS LETT A, V176, P295, DOI 10.1016/0375-9601(93)90921-L; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; POOL R, 1990, SCIENCE, V247, P1294, DOI 10.1126/science.2315697; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Pumir A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208101; Qu ZL, 2000, ANN BIOMED ENG, V28, P755, DOI 10.1114/1.1289474; Rappel WJ, 1999, PHYS REV LETT, V83, P456, DOI 10.1103/PhysRevLett.83.456; SEPULVEDA NG, 1989, BIOPHYS J, V55, P987, DOI 10.1016/S0006-3495(89)82897-8; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Shajahan TK, 2003, INT J MOD PHYS B, V17, P5645, DOI 10.1142/S0217979203023318; SHAJAHAN TK, 2007, LIFE SCI SE IN PRESS; Shajahan TK, 2008, THESIS INDIAN I SCI; SHAJAHAN TK, 2005, P INDIAN NATL SCI A, V71, P4757; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; SRIDHAR S, 2008, EUROPHYSICS IN PRESS; Starobin JM, 1996, PHYS REV E, V54, P430, DOI 10.1103/PhysRevE.54.430; TACKER WA, 1968, ELECT DEFIBRILLATION; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; Ten Tusscher KHWJ, 2006, PROG BIOPHYS MOL BIO, V90, P326, DOI 10.1016/j.pbiomolbio.2005.05.015; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Valderrabano M, 2000, J AM COLL CARDIOL, V36, P2000, DOI 10.1016/S0735-1097(00)00941-4; Winfree AT, 2002, J BIOSCIENCES, V27, P465, DOI 10.1007/BF02705042; Winfree AT, 1998, CHAOS, V8, P1, DOI 10.1063/1.166306; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Xie FG, 2001, AM J PHYSIOL-HEART C, V280, pH535, DOI 10.1152/ajpheart.2001.280.2.H535; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; ZYKOVE VS, 1980, BIOPHYSICS-USSR, V25, P940	64	61	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4738	10.1371/journal.pone.0004738	http://dx.doi.org/10.1371/journal.pone.0004738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270753	gold, Green Published, Green Submitted			2022-12-25	WOS:000265495900007
J	Delfosse, V; Girard, E; Birck, C; Delmarcelle, M; Delarue, M; Poch, O; Schultz, P; Mayer, C				Delfosse, Vanessa; Girard, Eric; Birck, Catherine; Delmarcelle, Michael; Delarue, Marc; Poch, Olivier; Schultz, Patrick; Mayer, Claudine			Structure of the Archaeal Pab87 Peptidase Reveals a Novel Self-Compartmentalizing Protease Family	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINOPEPTIDASE; PYROCOCCUS; PATHWAYS; SOFTWARE; SYSTEM	Self-compartmentalizing proteases orchestrate protein turnover through an original architecture characterized by a central catalytic chamber. Here we report the first structure of an archaeal member of a new self-compartmentalizing protease family forming a cubic-shaped octamer with D4 symmetry and referred to as CubicO. We solved the structure of the Pyrococcus abyssi Pab87 protein at 2.2 angstrom resolution using the anomalous signal of the high-phasing-power lanthanide derivative Lu-HPDO3A. A 20 angstrom wide channel runs through this supramolecular assembly of 0.4 MDa, giving access to a 60 angstrom wide central chamber holding the eight active sites. Surprisingly, activity assays revealed that Pab87 degrades specifically D-amino acid containing peptides, which have never been observed in archaea. Genomic context of the Pab87 gene showed that it is surrounded by genes involved in the amino acid/peptide transport or metabolism. We propose that CubicO proteases are involved in the processing of D-peptides from environmental origins.	[Delfosse, Vanessa; Mayer, Claudine] Univ Paris 06, INSERM, LRMA, Ctr Rech Cordeliers,UMR S 872, Paris, France; [Girard, Eric] UJF, CNRS, CEA, Inst Biol Structurale, UMR5075, Grenoble, France; [Birck, Catherine; Poch, Olivier; Schultz, Patrick] IGBMC, Dept Biol Genom Structurales, Illkirch Graffenstaden, France; [Delmarcelle, Michael] Univ Liege, Inst Chim B6, Ctr Ingenier Proteines, B-4000 Liege, Belgium; [Delarue, Marc; Mayer, Claudine] Inst Pasteur, CNRS, URA 2185, Dept Biol Structurale Chim, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Delfosse, V (corresponding author), Univ Paris 06, INSERM, LRMA, Ctr Rech Cordeliers,UMR S 872, Paris, France.	mayer@pasteur.fr		Girard, Eric/0000-0002-5758-6095; schultz, patrick/0000-0002-7310-6186; Delfosse, Vanessa/0000-0002-7436-7935	French Ministry of Research and higher education	French Ministry of Research and higher education	Vanessa Delfosse was supported by a scholarship from the French Ministry of Research and higher education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett AJ, 2007, BIOL CHEM, V388, P1151, DOI 10.1515/BC.2007.151; Bishop RE, 2000, BBA-PROTEIN STRUCT M, V1482, P73, DOI 10.1016/S0167-4838(00)00138-2; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Delfosse V, 2005, ACTA CRYSTALLOGR F, V61, P1006, DOI 10.1107/S1744309105033464; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1877, DOI 10.1107/S0907444903016871; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GRACY J, 1993, PROTEIN ENG, V6, P821, DOI 10.1093/protein/6.8.821; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; Jawhari A, 2006, EMBO REP, V7, P500, DOI 10.1038/sj.embor.7400663; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kecha M, 2007, EXTREMOPHILES, V11, P65, DOI 10.1007/s00792-006-0010-9; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Rasulova FS, 1998, FEBS LETT, V432, P179, DOI 10.1016/S0014-5793(98)00859-X; Remaut H, 2001, NAT STRUCT BIOL, V8, P674, DOI 10.1038/90380; Rockel B, 2005, P NATL ACAD SCI USA, V102, P10135, DOI 10.1073/pnas.0504569102; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Schoehn G, 2006, J BIOL CHEM, V281, P36327, DOI 10.1074/jbc.M604417200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Vandeputte-Rutten L, 2002, CURR OPIN STRUC BIOL, V12, P704, DOI 10.1016/S0959-440X(02)00393-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walz J, 1999, J STRUCT BIOL, V128, P65, DOI 10.1006/jsbi.1999.4169; Yao TT, 1999, CURR BIOL, V9, pR551, DOI 10.1016/S0960-9822(99)80352-2	46	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4712	10.1371/journal.pone.0004712	http://dx.doi.org/10.1371/journal.pone.0004712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19266066	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490600022
J	Pages, F; Peyrefitte, CN; Mve, MT; Jarjaval, F; Brisse, S; Iteman, I; Gravier, P; Nkoghe, D; Grandadam, M				Pages, Frederic; Peyrefitte, Christophe N.; Mve, Medard Toung; Jarjaval, Fanny; Brisse, Sylvain; Iteman, Isabelle; Gravier, Patrick; Nkoghe, Dieudonne; Grandadam, Marc			Aedes albopictus Mosquito: The Main Vector of the 2007 Chikungunya Outbreak in Gabon	PLOS ONE			English	Article								The primary vector at the origin of the 2007 outbreak in Libreville, Gabon is identified as Aedes albopictus, trapped around the nearby French military camp. The Chikungunya virus was isolated from mosquitoes and found to be identical to the A226V circulating human strain. This is the first field study showing the role of the recently arrived species Aedes albopictus in Chikungunya virus transmission in Central Africa, and it demonstrates this species' role in modifying the epidemiological presentation of Chikungunya in Gabon.	[Pages, Frederic; Jarjaval, Fanny] Inst Trop Med, Serv Sante Armees, Unite Entomol Med, URMITE UMR 6236, Marseille, France; [Peyrefitte, Christophe N.; Gravier, Patrick; Grandadam, Marc] Inst Med Trop Serv Sante Armees, Unite Virol Trop, Marseille, France; [Mve, Medard Toung; Nkoghe, Dieudonne] Minist Sante Publ, Libreville, Gabon; [Brisse, Sylvain; Iteman, Isabelle] Inst Pasteur, Paris, France; [Gravier, Patrick] Serv Med du 6e BIMA, Libreville, Gabon	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pages, F (corresponding author), Inst Trop Med, Serv Sante Armees, Unite Entomol Med, URMITE UMR 6236, Marseille, France.	frederic_pages@yahoo.com	Brisse, Sylvain/M-8723-2013; GRANDADAM, Marc/GNP-7470-2022	Brisse, Sylvain/0000-0002-2516-2108; 	french surgeon general	french surgeon general	This work is supported by the french surgeon general. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, S AFR I MED RES; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; EDWARDS FW, 1941, MOSQUITOES ETHIOPIAN; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415; Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078; MATHIOT CC, 1990, AM J TROP MED HYG, V42, P386, DOI 10.4269/ajtmh.1990.42.386; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Peyrefitte CN, 2008, J MED VIROL, V80, P430, DOI 10.1002/jmv.21090; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSS R. W., 1956, JOUR HYG, V54, P177; SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262; Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Vazeille M, 2008, TROP MED INT HEALTH, V13, P1176, DOI 10.1111/j.1365-3156.2008.02123.x; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; YIAUMINHUANG, 2004, ZOOTAXA, V700, P1	27	90	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4691	10.1371/journal.pone.0004691	http://dx.doi.org/10.1371/journal.pone.0004691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259263	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490500010
J	Kijas, JW; Townley, D; Dalrymple, BP; Heaton, MP; Maddox, JF; McGrath, A; Wilson, P; Ingersoll, RG; McCulloch, R; McWilliam, S; Tang, D; McEwan, J; Cockett, N; Oddy, VH; Nicholas, FW; Raadsma, H				Kijas, James W.; Townley, David; Dalrymple, Brian P.; Heaton, Michael P.; Maddox, Jillian F.; McGrath, Annette; Wilson, Peter; Ingersoll, Roxann G.; McCulloch, Russell; McWilliam, Sean; Tang, Dave; McEwan, John; Cockett, Noelle; Oddy, V. Hutton; Nicholas, Frank W.; Raadsma, Herman		International Sheep Genomics Conso	A Genome Wide Survey of SNP Variation Reveals the Genetic Structure of Sheep Breeds	PLOS ONE			English	Article							POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; DOMESTIC SHEEP; DIVERSITY; SEQUENCE; SELECTION; ASSOCIATION; HAPLOTYPES; DISCOVERY; LINEAGES	The genetic structure of sheep reflects their domestication and subsequent formation into discrete breeds. Understanding genetic structure is essential for achieving genetic improvement through genome-wide association studies, genomic selection and the dissection of quantitative traits. After identifying the first genome-wide set of SNP for sheep, we report on levels of genetic variability both within and between a diverse sample of ovine populations. Then, using cluster analysis and the partitioning of genetic variation, we demonstrate sheep are characterised by weak phylogeographic structure, overlapping genetic similarity and generally low differentiation which is consistent with their short evolutionary history. The degree of population substructure was, however, sufficient to cluster individuals based on geographic origin and known breed history. Specifically, African and Asian populations clustered separately from breeds of European origin sampled from Australia, New Zealand, Europe and North America. Furthermore, we demonstrate the presence of stratification within some, but not all, ovine breeds. The results emphasize that careful documentation of genetic structure will be an essential prerequisite when mapping the genetic basis of complex traits. Furthermore, the identification of a subset of SNP able to assign individuals into broad groupings demonstrates even a small panel of markers may be suitable for applications such as traceability.	[Kijas, James W.; Townley, David; Dalrymple, Brian P.; McCulloch, Russell; McWilliam, Sean; Tang, Dave] CSIRO Livestock Ind, Brisbane, Qld, Australia; [Heaton, Michael P.] USDA, ARS, Meat Anim Res Ctr, Clay Ctr, NE USA; [Maddox, Jillian F.] Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia; [McGrath, Annette; Wilson, Peter] Australian Genome Res Ctr, Brisbane, Qld, Australia; [Ingersoll, Roxann G.] Johns Hopkins Univ, Inst Genet Med, Baltimore, MD 21218 USA; [McEwan, John] Invermay Agr Ctr, AgResearch, Mosgie, New Zealand; [Cockett, Noelle] Utah State Univ, Coll Agr, ADVS Dept, Logan, UT 84322 USA; [Oddy, V. Hutton] Univ New England, Sch Meat Sci, Armidale, NSW, Australia; [Nicholas, Frank W.; Raadsma, Herman] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Agriculture (USDA); University of Melbourne; Johns Hopkins University; Utah System of Higher Education; Utah State University; University of New England; University of Sydney	Kijas, JW (corresponding author), CSIRO Livestock Ind, Brisbane, Qld, Australia.	James.Kijas@csiro.au	Tang, Dave/G-9670-2014; Nicholas, Frank William/AAE-5566-2022; Kijas, James W/A-4656-2011; McGrath, Annette/T-7991-2018; Simianer, Henner/A-6574-2015; Dalrymple, Brian P/F-8721-2010; Nicholas, Frank/AGY-8318-2022; McWilliam, Sean M/H-8978-2013; McEwan, John/A-1143-2008; AJMONE MARSAN, Paolo/M-2466-2018; Coltman, David/A-4453-2012; Hunt, Peter/H-3545-2013	Tang, Dave/0000-0002-4790-9014; Nicholas, Frank William/0000-0002-9178-3965; Kijas, James W/0000-0002-1417-8278; McGrath, Annette/0000-0002-1765-7039; Simianer, Henner/0000-0002-7551-3797; Dalrymple, Brian P/0000-0003-3891-5233; Nicholas, Frank/0000-0002-9178-3965; McWilliam, Sean M/0000-0002-3148-0428; McEwan, John/0000-0003-4801-6207; , Roxann/0000-0002-4266-613X; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Coltman, David/0000-0002-1268-2307; Hunt, Peter/0000-0001-5679-2404; Hanotte, Olivier/0000-0002-2877-4767; Heaton, Michael/0000-0003-1386-1208	Australian Government [International Science Linkage grant]; sheepGENOMICS; Meat and Livestock Australia; Australian Wool Innovation; National Key Technology R&D Program [2007BAD52B05]; USDA Agricultural Research Service; Alliance for Animal Genome Research; USDA/CSREES	Australian Government(Australian GovernmentCGIAR); sheepGENOMICS; Meat and Livestock Australia(Meat and Livestock Australia); Australian Wool Innovation(Australian Wool Innovation); National Key Technology R&D Program(National Key Technology R&D Program); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Alliance for Animal Genome Research; USDA/CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	The work was supported by an Australian Government International Science Linkage grant, sheepGENOMICS, a joint initiative of Meat and Livestock Australia and Australian Wool Innovation, the National Key Technology R&D Program during the 11th "Five-Year" Plan in China (2007BAD52B05), the USDA Agricultural Research Service and the Alliance for Animal Genome Research. Funding for the BAC end sequencing was provided by USDA/CSREES. The funders had no role in study design, data collection or analysis. sheepGENOMICS approved the contents of the manuscript prior to publication.	Alvarez I, 2004, J ANIM SCI, V82, P2246; [Anonymous], AUSTR MERINO; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gizaw S, 2007, ANIM GENET, V38, P621, DOI 10.1111/j.1365-2052.2007.01659.x; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; Hayes BJ, 2008, ANIM GENET, V39, P105, DOI 10.1111/j.1365-2052.2007.01683.x; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Khatkar MS, 2006, GENETICS, V174, P79, DOI 10.1534/genetics.106.060418; Legge T., 1996, ORIGINS SPREAD AGR P, P238; Lewis PO, 2001, GENETIC DATA ANAL GD; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; McRae AF, 2005, GENETICS, V171, P251, DOI 10.1534/genetics.105.040972; Meadows JRS, 2006, ANIM GENET, V37, P444, DOI 10.1111/j.1365-2052.2006.01496.x; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Meadows JRS, 2004, ANIM GENET, V35, P379, DOI 10.1111/j.1365-2052.2004.01180.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Mukesh M, 2006, J ANIM BREED GENET, V123, P258, DOI 10.1111/j.1439-0388.2006.00599.x; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Panitz F, 2007, BIOINFORMATICS, V23, pI387, DOI 10.1093/bioinformatics/btm192; Parsonson Ian M, 1998, AUSTR ARK HIST DOMES; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Piper L, 1997, GENETICS SHEEP; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quignon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001324; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Scherf D.B., 2000, WORLD WATCH LIST DOM; Tapio I, 2005, HEREDITY, V94, P448, DOI 10.1038/sj.hdy.6800640; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	59	225	239	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2009	4	3							e4668	10.1371/journal.pone.0004668	http://dx.doi.org/10.1371/journal.pone.0004668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LX	19270757	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490100001
J	Basso, A; Martinez, L; Manso, F				Basso, Alicia; Martinez, Laura; Manso, Fanny			The Significance of Genetic Polymorphisms within and between Founder Populations of Ceratitis capitata (Wied.) from Argentina	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; FRUIT-FLY DIPTERA; TRANSPOSABLE ELEMENTS; AUTOCIDAL CONTROL; TEPHRITIDAE; EVOLUTION; BEHAVIOR; FLOW	Background: The Mediterranean fruit fly Ceratitis Capitata (DIPTERA: Tephritidae) is a major agricultural pest in Argentina. One main cause for the success of non-contaminant control programs based on genetic strategies is compatibility between natural and laboratory germplasms. A comprehensive characterization of the fruit fly based on genetic studies and compatibility analysis was undertaken on two founder populations from the provinces of Buenos Aires and Mendoza, used in pioneering sterile male technique control programmes in our country. The locations are 1,000 km apart from each other. Methodology/Principal Findings: We compared the genetic composition of both populations based on cytological, physiological and morphological characterization. Compatibility studies were performed in order to determine the presence of isolation barriers. Results indicate that the Buenos Aires germplasm described previously is partially different from that of the Mendoza population. Both laboratory colonies are a reservoir of mutational and cytological polymorphisms. Some sexual chromosome variants such as the XL and the YL resulting from attachment of a B-chromosome to the X-chromosome or Y-chromosome behave as a lethal sex-linked factor. Our results also show incompatibility between both germplasms and pre-zygotic isolation barriers between them. Our evidence is consistent with the fact that polymorphisms are responsible for the lack of compatibility. Conclusions: The genetic control mechanism should be directly produced in the germplasm of the target population in order to favour mating conditions. This is an additional requirement for the biological as well as economic success of control programs based on genetic strategies such as the sterile insect technique. The analysis of representative samples also revealed natural auto-control mechanisms which could be used in modifying pest population dynamics.	[Basso, Alicia] Univ Buenos Aires, Fac Agron, Catedra Genet, Buenos Aires, DF, Argentina; [Basso, Alicia; Martinez, Laura; Manso, Fanny] CNIA Inst Nacl Tecnol Agropecuar, Inst Genet Ewald A Favret, Lab Insectos, Castelar, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Basso, A (corresponding author), Univ Buenos Aires, Fac Agron, Catedra Genet, Buenos Aires, DF, Argentina.	abasso@agro.uba.ar			Instituto Nacional de Tecnologia Agropecuaria [320101, 81048]	Instituto Nacional de Tecnologia Agropecuaria	This work was supported by the Instituto Nacional de Tecnologia Agropecuaria (INTA- 320101, and INTA-81048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60; BASSO A, 1995, REV BRAS GENET, V18, P165; Basso A., 1995, Cytobios, V83, P237; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Brookfield JFY, 2004, CURR BIOL, V14, pR344, DOI 10.1016/j.cub.2004.04.021; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Cayol JP, 1999, J ECON ENTOMOL, V92, P140, DOI 10.1093/jee/92.1.140; Cayol JP, 2002, FLA ENTOMOL, V85, P51, DOI 10.1653/0015-4040(2002)085[0051:SCIMDT]2.0.CO;2; CLADERA JL, 1981, EXPERIENTIA, V37, P342, DOI 10.1007/BF01959852; CLADERA JL, 1981, MENDELIANA, V5, P33; Crow James F., 1992, P132; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; DELPRAT A, 1999, THESIS U BUENOS AIRE; Dyer KA, 2007, P NATL ACAD SCI USA, V104, P1587, DOI 10.1073/pnas.0605578104; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Ford EB, 1971, ECOLOGICAL GENETICS; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gasparich GE, 1997, ANN ENTOMOL SOC AM, V90, P790, DOI 10.1093/aesa/90.6.790; Gasperi G, 2002, GENETICA, V116, P125, DOI 10.1023/A:1020971911612; Gomulski LM, 2004, INSECT BIOCHEM MOLEC, V34, P139, DOI 10.1016/j.ibmb.2003.06.015; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Hall DW, 2004, EVOLUTION, V58, P925; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Kourti A, 2004, J ECON ENTOMOL, V97, P1186, DOI 10.1603/0022-0493(2004)097[1186:POVWAB]2.0.CO;2; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Lerner I. M., 1958, GENETIC BASIS SELECT; Lewontin RC, 1974, GENETIC BASIS EVOLUT; LIFSCHITZ E, 1989, FRUIT FLIES THEIR B, V3, P3; LIFSCHITZ E, 1980, CONS M GEN SEX MECH, P2; LIFSCHITZ E, 1983, REP RES COORD M DEV; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; MANSO F, 1979, B GENETICO I FITOTEC, V10, P31; Manso F. C, 1992, CIENC INVEST, V44, P225; MANSO FC, 1986, 2 P INT S FRUIT FLIE, P159; MARSHALL E, 1981, SCIENCE, V213, P417, DOI 10.1126/science.213.4506.417; MARTINEZ L, 1988, P 19 ARG GEN M SOC A; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Pizarro JM, 1997, ANN ENTOMOL SOC AM, V90, P220, DOI 10.1093/aesa/90.2.220; Reyes A, 2004, J APPL ENTOMOL, V128, P358, DOI 10.1111/j.1439-0418.2004.00858; RICHARDSON RH, 1982, SCIENCE, V215, P361, DOI 10.1126/science.7199204; Robinson AS, 2002, GENETICA, V116, P5, DOI 10.1023/A:1020951407069; Robinson AS, 2002, FLA ENTOMOL, V85, P171, DOI 10.1653/0015-4040(2002)085[0171:RFOMSB]2.0.CO;2; Sokal R. R., 2012, BIOMETRY; Strickberger M. W., 2000, EVOLUTION; Swanson C.P., 1957, CYTOLOGY CYTOGENETIC; TERAN H R, 1977, Revista Agronomica del Noroeste Argentino, V14, P17; Torti C, 2005, GENETICA, V123, P313, DOI 10.1007/s10038-004-7126-5; Torti C, 2000, CHROMOSOMA, V108, P523, DOI 10.1007/s004120050404; WEDEKIND L, 2007, SCI SEX SUPERFLIES F, P1; Zar JH, 1999, BIOSTATISTICAL ANAL	52	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4665	10.1371/journal.pone.0004665	http://dx.doi.org/10.1371/journal.pone.0004665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252742	Green Published, gold, Green Submitted			2022-12-25	WOS:000265489900007
J	Dinkla, K; Talay, SR; Morgelin, M; Graham, RMA; Rohde, M; Nitsche-Schmitz, DP; Chhatwal, GS				Dinkla, Katrin; Talay, Susanne R.; Moergelin, Matthias; Graham, Rikki M. A.; Rohde, Manfred; Nitsche-Schmitz, D. Patric; Chhatwal, Gursharan S.			Crucial Role of the CB3-Region of Collagen IV in PARF-Induced Acute Rheumatic Fever	PLOS ONE			English	Article								Acute rheumatic fever (ARF) and rheumatic heart disease are serious autoimmune sequelae to infections with Streptococcus pyogenes. Streptococcal M-proteins have been implicated in ARF pathogenesis. Their interaction with collagen type IV (CIV) is a triggering step that induces generation of collagen-specific auto-antibodies. Electron microscopy of the protein complex between M-protein type 3 (M3-protein) and CIV identified two prominent binding sites of which one is situated in the CB3-region of CIV. In a radioactive binding assay, M3-protein expressing S. pyogenes and S. gordonii bound the CB3-fragment. Detailed analysis of the interactions by surface plasmon resonance measurements and site directed mutagenesis revealed high affinity interactions with dissociation constants in the nanomolar range that depend on the recently described collagen binding motif of streptococcal M-proteins. Because of its role in the induction of disease-related collagen autoimmunity the motif is referred to as "peptide associated with rheumatic fever'' (PARF). Both, sera of mice immunized with M3-protein as well as sera from patients with ARF contained anti-CB3 auto-antibodies, indicating their contribution to ARF pathogenesis. The identification of the CB3-region as a binding partner for PARF directs the further approaches to understand the unusual autoimmune pathogenesis of PARF-dependent ARF and forms a molecular basis for a diagnostic test that detects rheumatogenic streptococci.	[Dinkla, Katrin; Talay, Susanne R.; Graham, Rikki M. A.; Rohde, Manfred; Nitsche-Schmitz, D. Patric; Chhatwal, Gursharan S.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany; [Moergelin, Matthias] Lund Univ, BMC B14, Dept Clin Sci, Lund, Sweden	Helmholtz Association; Helmholtz-Center for Infection Research; Lund University	Dinkla, K (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Braunschweig, Germany.	gsc@helmholtz-hzi.de			European Community's Sixth Framework Program [FP6-2004-INCO-DEV-3-032390]	European Community's Sixth Framework Program	This work was supported by a grant of the European Community's Sixth Framework Program under Contract No. FP6-2004-INCO-DEV-3-032390. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Dinkla K, 2007, J BIOL CHEM, V282, P18686, DOI 10.1074/jbc.M701047200; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; Oggioni MR, 1996, GENE, V169, P85, DOI 10.1016/0378-1119(95)00775-X; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; *WHO, 2004, 923923 WHO	15	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4666	10.1371/journal.pone.0004666	http://dx.doi.org/10.1371/journal.pone.0004666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252743	Green Published, gold, Green Submitted			2022-12-25	WOS:000265489900008
J	Al-Ejeh, F; Darby, JM; Tsopelas, C; Smyth, D; Manavis, J; Brown, MP				Al-Ejeh, Fares; Darby, Jocelyn M.; Tsopelas, Chris; Smyth, Douglas; Manavis, Jim; Brown, Michael P.			APOMAB (R), a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy	PLOS ONE			English	Article								Background: Antineoplastic therapy may impair the survival of malignant cells to produce cell death. Consequently, direct measurement of tumor cell death in vivo is a highly desirable component of therapy response monitoring. We have previously shown that APOMAB (R) representing the DAB4 clone of a La/SSB-specific murine monoclonal autoantibody is a malignant cell-death ligand, which accumulates preferentially in tumors in an antigen-specific and dose-dependent manner after DNA-damaging chemotherapy. Here, we aim to image tumor uptake of APOMAB (R) (DAB4) and to define its biological correlates. Methodology/Principal Findings: Brisk tumor cell apoptosis is induced in the syngeneic EL4 lymphoma model after treatment of tumor-bearing mice with DNA-damaging cyclophosphamide/etoposide chemotherapy. Tumor and normal organ accumulation of Indium 111 (In-111)-labeled La-specific DAB4 mAb as whole IgG or IgG fragments was quantified by whole-body static imaging and organ assay in tumor-bearing mice. Immunohistochemical measurements of tumor caspase-3 activation and PARP-1 cleavage, which are indicators of early and late apoptosis, respectively, were correlated with tumor accumulation of DAB4. Increased tumor accumulation of DAB4 was associated directly with both the extent of chemotherapy-induced tumor cell death and DAB4 binding per dead tumor cell. Tumor DAB4 accumulation correlated with cumulative caspase-3 activation and PARP-1 cleavage as tumor biomarkers of apoptosis and was directly related to the extended median survival time of tumor-bearing mice. Conclusions/Significance: Radiolabeled La-specific monoclonal antibody, DAB4, detected dead tumor cells after chemotherapy, rather than chemosensitive normal tissues of gut and bone marrow. DAB4 identified late apoptotic tumor cells in vivo. Hence, radiolabeled DAB4 may usefully image responses to human carcinoma therapy because DAB4 would capture the protracted cell death of carcinoma. We believe that the ability of radiolabeled DAB4 to rapidly assess the apoptotic tumor response and, consequently, to potentially predict extended survival justifies its future clinical development as a radioimmunoscintigraphic agent. This article is part I of a two-part series providing proof-of-concept for the the diagnostic and therapeutic use of a La-specific monoclonal antibody, the DAB4 clone of which is represented by the registered trademark, APOMAB (R).	[Al-Ejeh, Fares; Darby, Jocelyn M.; Brown, Michael P.] Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia; [Tsopelas, Chris; Smyth, Douglas] Royal Adelaide Hosp, Dept Nuclear Med, Adelaide, SA, Australia; [Manavis, Jim] Hanson Inst, Ctr Neurol Dis, Adelaide, SA, Australia; [Brown, Michael P.] Univ Adelaide, Royal Adelaide Hosp Canc Ctr, Dept Med Oncol, Adelaide, SA 5005, Australia; [Brown, Michael P.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	Hanson Institute; Royal Adelaide Hospital; Hanson Institute; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	Al-Ejeh, F (corresponding author), Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia.	michael.brown@health.sa.gov.au	Al-Ejeh, Fares/M-7032-2016; Brown, Michael/C-2081-2014	Al-Ejeh, Fares/0000-0002-1553-0077; Darby, Jocelyn/0000-0002-1819-6000; Brown, Michael/0000-0002-5796-1932	Oncaidia Ltd; National Health and Medical Research Council Research [ID511303]	Oncaidia Ltd; National Health and Medical Research Council Research	Oncaidia Ltd funded the salary of FA for 2007, the salary of JMD as well as equipment and research. National Health and Medical Research Council Research also supplied funding through Project Grant ID511303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5519S, DOI 10.1158/1078-0432.CCR-07-0964; Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; ALEJEH F, NUCL MED BI IN PRESS; Ayukawa K, 2000, J BIOL CHEM, V275, P34465, DOI 10.1074/jbc.M003673200; BEHR TM, 1995, CANCER RES, V55, P3825; Belhocine T, 2004, TECHNOL CANCER RES T, V3, P23, DOI 10.1177/153303460400300103; Biggiogera M, 2004, BIOL CELL, V96, P603, DOI 10.1016/j.biolcel.2004.04.013; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; CARMOFONSECA M, 1989, EXP CELL RES, V185, P73, DOI 10.1016/0014-4827(89)90038-4; Chang J, 2000, CANCER-AM CANCER SOC, V89, P2145, DOI 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO;2-S; Corsten MF, 2006, CANCER RES, V66, P1255, DOI 10.1158/0008-5472.CAN-05-3000; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Davis DW, 2003, CLIN CANCER RES, V9, P955; El-Deiry WS, 2006, J CLIN ONCOL, V24, P3261, DOI 10.1200/JCO.2006.06.5623; Green AM, 2002, CANCER J, V8, P82, DOI 10.1097/00130404-200203000-00002; Gwyther SJ, 2006, EUR J NUCL MED MOL I, V33, pS11, DOI 10.1007/s00259-006-0130-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Kartachova M, 2007, J CLIN ONCOL, V25, P2534, DOI 10.1200/JCO.2006.10.1337; Kelloff GJ, 2005, CLIN CANCER RES, V11, P7967, DOI 10.1158/1078-0432.CCR-05-1302; Kenan DJ, 2004, NAT STRUCT MOL BIOL, V11, P303, DOI 10.1038/nsmb0404-303; Larson SM, 2006, J NUCL MED, V47, P901; Leers MPG, 2002, CELL MOL LIFE SCI, V59, P1358, DOI 10.1007/s00018-002-8513-8; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mason KA, 1999, INT J RADIAT ONCOL, V44, P1125, DOI 10.1016/S0360-3016(99)00134-0; Neufing PJ, 2005, ARTHRITIS RHEUM-US, V52, P3934, DOI 10.1002/art.21486; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Shankar LK, 2006, J NUCL MED, V47, P1059; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Thiede B, 2004, MASS SPECTROM REV, V23, P333, DOI 10.1002/mas.10079; Tran HB, 2002, ARTHRITIS RHEUM, V46, P202, DOI 10.1002/1529-0131(200201)46:1<202::AID-ART10062>3.0.CO;2-Y; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; Vand de Wiele C, 2003, J CLIN ONCOL, V21, P3483, DOI 10.1200/JCO.2003.12.096; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weber WA, 2008, NAT CLIN PRACT ONCOL, V5, P44, DOI 10.1038/ncponc0982; Weber WA, 2006, J CLIN ONCOL, V24, P3282, DOI 10.1200/JCO.2006.06.6068; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; White RJ, 2004, EUR J CANCER, V40, P21, DOI 10.1016/j.ejca.2003.09.027; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wood W, 2000, DEVELOPMENT, V127, P5245; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241	48	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4558	10.1371/journal.pone.0004558	http://dx.doi.org/10.1371/journal.pone.0004558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247492	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487800001
J	Iida, S; Miyagi, A; Aoki, S; Ito, M; Kadono, Y; Kosuge, K				Iida, Satoko; Miyagi, Atsuko; Aoki, Seishiro; Ito, Motomi; Kadono, Yasuro; Kosuge, Keiko			Molecular Adaptation of rbcL in the Heterophyllous Aquatic Plant Potamogeton	PLOS ONE			English	Article								Background: Heterophyllous aquatic plants show marked phenotypic plasticity. They adapt to environmental changes by producing different leaf types: submerged, floating and terrestrial leaves. By contrast, homophyllous plants produce only submerged leaves and grow entirely underwater. Heterophylly and submerged homophylly evolved under selective pressure modifying the species-specific optima for photosynthesis, but little is known about the evolutionary outcome of habit. Recent evolutionary analyses suggested that rbcL, a chloroplast gene that encodes a catalytic subunit of RuBisCO, evolves under positive selection in most land plant lineages. To examine the adaptive evolutionary process linked to heterophylly or homophylly, we analyzed positive selection in the rbcL sequences of ecologically diverse aquatic plants, Japanese Potamogeton. Principal Findings: Phylogenetic and maximum likelihood analyses of codon substitution models indicated that Potamogeton rbcL has evolved under positive Darwinian selection. The positive selection has operated specifically in heterophyllous lineages but not in homophyllous ones in the branch-site models. This suggests that the selective pressure on this chloroplast gene was higher for heterophyllous lineages than for homophyllous lineages. The replacement of 12 amino acids occurred at structurally important sites in the quaternary structure of RbcL, two of which (residue 225 and 281) were identified as potentially under positive selection. Conclusions/Significance: Our analysis did not show an exact relationship between the amino acid replacements and heterophylly or homophylly but revealed that lineage-specific positive selection acted on the Potamogeton rbcL. The contrasting ecological conditions between heterophyllous and homophyllous plants have imposed different selective pressures on the photosynthetic system. The increased amino acid replacement in RbcL may reflect the continuous fine-tuning of RuBisCO under varying ecological conditions.	[Iida, Satoko; Kosuge, Keiko] Kobe Univ, Res Ctr Environm Genom, Kobe, Hyogo, Japan; [Miyagi, Atsuko; Kadono, Yasuro] Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo, Japan; [Aoki, Seishiro; Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan	Kobe University; Kobe University; University of Tokyo	Iida, S (corresponding author), Kobe Univ, Res Ctr Inland Seas, Awaji, Hyogo, Japan.	iida@kobe-u.ac.jp	Miyagi, Atsuko/N-8621-2015	Miyagi, Atsuko/0000-0003-4314-6555; Iida, Satoko/0000-0002-2693-6996				ALBERT VA, 1994, ANN MO BOT GARD, V81, P534, DOI 10.2307/2399902; Amano M, 2008, BUNRUI, V8, P129; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arber A., 1920, WATER PLANTS STUDY A; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; Cook C.D.K., 1990, AQUATIC PLANT BOOK; COOK SA, 1968, EVOLUTION, V22, P496, DOI 10.1111/j.1558-5646.1968.tb03988.x; FROSTCHRISTENSEN H, 1995, AQUAT BOT, V51, P121, DOI 10.1016/0304-3770(95)00455-9; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOLADAY AS, 1980, PLANT PHYSIOL, V65, P331, DOI 10.1104/pp.65.2.331; Hutchinson G.E., 1975, TREATISE LIMNOLOGY, VIII; Iida S, 2004, AQUAT BOT, V80, P115, DOI 10.1016/j.aquabot.2004.08.005; Iida S, 2007, J PLANT RES, V120, P473, DOI 10.1007/s10265-007-0087-y; IKUSIMA I, 1972, SEITAIGAKUKOUZA 7 SU, V1; KADONO Y, 1982, BOT MAG TOKYO, V95, P63, DOI 10.1007/BF02493411; KADONO Y, 1984, Japanese Journal of Ecology, V34, P161; Kaplan Z, 2003, PLANT SYST EVOL, V239, P95, DOI 10.1007/s00606-002-0252-7; Kaplan Z, 2002, FOLIA GEOBOT, V37, P141, DOI 10.1007/BF02804229; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kellogg EA, 1997, AM J BOT, V84, P413, DOI 10.2307/2446015; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Larcher W., 1994, OKOPHYSIOLOGIE PFLAN; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; LES DH, 1983, RHODORA, V85, P301; Li GF, 2002, BIOCHEM BIOPH RES CO, V290, P1128, DOI 10.1006/bbrc.2001.6322; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Maberly SC, 2002, FUNCT PLANT BIOL, V29, P393, DOI 10.1071/PP01187; Magnin NC, 1997, PLANT PHYSIOL, V115, P1681, DOI 10.1104/pp.115.4.1681; Miller SR, 2003, MOL ECOL, V12, P1237, DOI 10.1046/j.1365-294X.2003.01831.x; Moreno J, 1999, J BIOL CHEM, V274, P26789, DOI 10.1074/jbc.274.38.26789; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; Parry MAJ, 2002, ANN BOT-LONDON, V89, P833, DOI 10.1093/aob/mcf103; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P169, DOI 10.1016/S0022-0981(00)00196-9; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; WIEGLEB G, 1988, Feddes Repertorium, V99, P249; WIEGLEB G, 1989, NORD J BOT, V9, P167, DOI 10.1111/j.1756-1051.1989.tb02112.x; Wolfe AD, 1997, PLANT MOL BIOL, V33, P965, DOI 10.1023/A:1005739223993; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; WOOTEN JW, 1970, J ECOL, V58, P233, DOI 10.2307/2258178; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	52	44	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4633	10.1371/journal.pone.0004633	http://dx.doi.org/10.1371/journal.pone.0004633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247501	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487800015
J	Bibby, TS; Zhang, YA; Chen, M				Bibby, Thomas S.; Zhang, Yinan; Chen, Min			Biogeography of Photosynthetic Light-Harvesting Genes in Marine Phytoplankton	PLOS ONE			English	Article							CHLOROPHYLL-PROTEIN COMPLEX; PROCHLOROCOCCUS ECOTYPES; ANTENNA RING; IRON LIMITATION; PHOTOSYSTEM-I; PACIFIC-OCEAN; EVOLUTION; GENOME; SYNECHOCOCCUS; DIVERSITY	Background: Photosynthetic light-harvesting proteins are the mechanism by which energy enters the marine ecosystem. The dominant prokaryotic photoautotrophs are the cyanobacterial genera Prochlorococcus and Synechococcus that are defined by two distinct light-harvesting systems, chlorophyll-bound protein complexes or phycobilin-bound protein complexes, respectively. Here, we use the Global Ocean Sampling (GOS) Project as a unique and powerful tool to analyze the environmental diversity of photosynthetic light-harvesting genes in relation to available metadata including geographical location and physical and chemical environmental parameters. Methods: All light-harvesting gene fragments and their metadata were obtained from the GOS database, aligned using ClustaIX and classified phylogenetically. Each sequence has a name indicative of its geographic location; subsequent biogeographical analysis was performed by correlating light-harvesting gene budgets for each GOS station with surface chlorophyll concentration. Conclusion/Significance: Using the GOS data, we have mapped the biogeography of light-harvesting genes in marine cyanobacteria on ocean-basin scales and show that an environmental gradient exists in which chlorophyll concentration is correlated to diversity of light-harvesting systems. Three functionally distinct types of light-harvesting genes are defined: (1) the phycobilisome (PBS) genes of Synechococcus; (2) the pcb genes of Prochlorococcus; and (3) the iron-stress-induced (isiA) genes present in some marine Synechococcus. At low chlorophyll concentrations, where nutrients are limited, the Pcb-type light-harvesting system shows greater genetic diversity; whereas at high chlorophyll concentrations, where nutrients are abundant, the PBS-type light-harvesting system shows higher genetic diversity. We interpret this as an environmental selection of specific photosynthetic strategy. Importantly, the unique light-harvesting system isiA is found in the iron-limited, high-nutrient low-chlorophyll region of the equatorial Pacific. This observation demonstrates the ecological importance of isiA genes in enabling marine Synechococcus to acclimate to iron limitation and suggests that the presence of this gene can be a natural biomarker for iron limitation in oceanic environments.	[Bibby, Thomas S.] Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton, Hants, England; [Bibby, Thomas S.; Zhang, Yinan; Chen, Min] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	NERC National Oceanography Centre; University of Sydney	Bibby, TS (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton, Hants, England.	minchen@bio.usyd.edu.au	Bibby, Thomas/C-9159-2014	Bibby, Thomas/0000-0003-1743-473X; Chen, Min/0000-0001-8070-3248	Australian Research Council (ARC) [DP0878174, DP0665169]; University of Sydney, Australia; Natural Environment Research Council [NE/E009670/1] Funding Source: researchfish; NERC [NE/E009670/1] Funding Source: UKRI	Australian Research Council (ARC)(Australian Research Council); University of Sydney, Australia(University of Sydney); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Australian Research Council (ARC)(DP0878174) and (DP0665169) to Dr Chen. University of Sydney, Australia for providing an International Visiting Research Fellowship to Dr Bibby. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bibby TS, 2001, NATURE, V413, P590, DOI 10.1038/35098153; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; CAMPBELL L, 1993, DEEP-SEA RES PT I, V40, P2043, DOI 10.1016/0967-0637(93)90044-4; Chen M, 2005, PHOTOSYNTH RES, V86, P165, DOI 10.1007/s11120-005-1330-9; Chen M, 2008, PHOTOSYNTH RES, V95, P147, DOI 10.1007/s11120-007-9255-0; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Everroad RC, 2006, J PHYCOL, V42, P1300, DOI 10.1111/j.1529-8817.2006.00282.x; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; GEIDER RJ, 1996, LIMNOLOGY OCEANOGRAP, V43, P679; Geiss U, 2001, APPL ENVIRON MICROB, V67, P5247; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hess WR, 2001, PHOTOSYNTH RES, V70, P53, DOI 10.1023/A:1013835924610; HESSWR, 1996, P NATL ACAD SCI USA, V93, P11126; Heywood JL, 2006, DEEP-SEA RES PT II, V53, P1530, DOI 10.1016/j.dsr2.2006.05.005; Hopkinson BM, 2008, LIMNOL OCEANOGR, V53, P1303, DOI 10.4319/lo.2008.53.4.1303; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutchins DA, 1998, LIMNOL OCEANOGR, V43, P1037, DOI 10.4319/lo.1998.43.6.1037; Jensen PR, 2008, ANTON LEEUW INT J G, V94, P51, DOI 10.1007/s10482-008-9239-x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Partensky F, 2003, ADV PHOTO RESPIRAT, V14, P29; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Ting CS, 2001, MICROBIOL-SGM, V147, P3171, DOI 10.1099/00221287-147-11-3171; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang RR, 2008, SMART STRUCT SYST, V4, P1; Zhang YN, 2007, J MOL EVOL, V64, P321, DOI 10.1007/s00239-006-0058-2; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	53	37	37	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4601	10.1371/journal.pone.0004601	http://dx.doi.org/10.1371/journal.pone.0004601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240807	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000278086700016
J	Kovas, Y; Giampietro, V; Viding, E; Ng, V; Brammer, M; Barker, GJ; Happe, FGE; Plomin, R				Kovas, Yulia; Giampietro, Vincent; Viding, Essi; Ng, Virginia; Brammer, Michael; Barker, Gareth J.; Happe, Francesca G. E.; Plomin, Robert			Brain Correlates of Non-Symbolic Numerosity Estimation in Low and High Mathematical Ability Children	PLOS ONE			English	Article							INTRAPARIETAL SULCUS; NUMBER; MAGNITUDE; REPRESENTATIONS; DYSCALCULIA; ACTIVATION; ORIGINS; CORTEX; ADULTS; SIZE	Previous studies have implicated several brain areas as subserving numerical approximation. Most studies have examined brain correlates of adult numerical approximation and have not considered individual differences in mathematical ability. The present study examined non-symbolic numerical approximation in two groups of 10-year-olds: Children with low and high mathematical ability. The aims of this study were to investigate the brain mechanisms associated with approximate numerosity in children and to assess whether individual differences in mathematical ability are associated with differential brain correlates during the approximation task. The results suggest that, similarly to adults, multiple and distributed brain areas are involved in approximation in children. Despite equal behavioral performance, there were differences in the brain activation patterns between low and high mathematical ability groups during the approximation task. This suggests that individual differences in mathematical ability are reflected in differential brain response during approximation.	Kings Coll London, Inst Psychiat, London WC2R 2LS, England; UCL, Div Psychol & Language Sci, London WC1E 6BT, England; Univ London, Dept Psychol, London WC1E 7HU, England	University of London; King's College London; University of London; University College London; University of London	Kovas, Y (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	y.kovas@iop.kcl.ac.uk	Barker, Gareth J/C-9616-2009; Kovas, Yulia/L-7116-2019; Plomin, Robert/B-8911-2008; Brammer, Michael J/B-7128-2012; Giampietro, Vincent P/D-1279-2011	Barker, Gareth J/0000-0002-5214-7421; Kovas, Yulia/0000-0001-9633-6374; Brammer, Michael J/0000-0001-9800-2052; Giampietro, Vincent P/0000-0002-9381-8201; Viding, Essi/0000-0001-8468-8874; Plomin, Robert/0000-0002-0756-3629; Happe, Francesca/0000-0001-9226-4000	U.K. Medical Research Council [G9424799, G050079]; US National Institute of Child Health and Human Development; Office of Special Education and Rehabilitative Services [HD 46167]; Medical Research Council [G9817803B, G0500079, G19/2] Funding Source: researchfish; MRC [G19/2, G0500079] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046167] Funding Source: NIH RePORTER	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Special Education and Rehabilitative Services; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	TEDS has been funded since 1995 by a programme grant from the U.K. Medical Research Council (G9424799, now G050079). Our work on mathematics is supported in part by the US National Institute of Child Health and Human Development and the Office of Special Education and Rehabilitative Services (HD 46167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; BRAMMER M, 2007, XBAM V3 4 METHOD; BRAMMER M, 2005, XBAM V3 4 MANUAL; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kovas Y, 2007, J LEARN DISABIL-US, V40, P554, DOI 10.1177/00222194070400060601; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Kucian K, 2005, PSYCHOL SCI, V47, P112; Kucian Karin, 2006, Behav Brain Funct, V2, P31; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Price GR, 2007, CURR BIOL, V17, pR1042, DOI 10.1016/j.cub.2007.10.013; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005	22	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4587	10.1371/journal.pone.0004587	http://dx.doi.org/10.1371/journal.pone.0004587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KW	19238205	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000265487400016
J	Ruas, LP; Bernardes, ES; Fermino, ML; de Oliveira, LL; Hsu, DK; Liu, FT; Chammas, R; Roque-Barreira, MC				Ruas, Luciana Pereira; Bernardes, Emerson Soares; Fermino, Marise Lopes; de Oliveira, Leandro Licursi; Hsu, Daniel K.; Liu, Fu-Tong; Chammas, Roger; Roque-Barreira, Maria-Cristina			Lack of Galectin-3 Drives Response to Paracoccidioides brasiliensis toward a Th2-Biased Immunity	PLOS ONE			English	Article								There is recent evidence that galectin-3 participates in immunity to infections, mostly by tuning cytokine production. We studied the balance of Th1/Th2 responses to P. brasiliensis experimental infection in the absence of galectin-3. The intermediate resistance to the fungal infection presented by C57BL/6 mice, associated with the development of a mixed type of immunity, was replaced with susceptibility to infection and a Th2-polarized immune response, in galectin-3-deficient (gal3(-/-)) mice. Such a response was associated with defective inflammatory and delayed type hypersensitivity (DTH) reactions, high IL-4 and GATA-3 expression and low nitric oxide production in the organs of infected animals. Gal3(-/-) macrophages exhibited higher TLR2 transcript levels and IL-10 production compared to wild-type macrophages after stimulation with P. brasiliensis antigens. We hypothesize that, during an in vivo P. brasiliensis infection, galectin-3 exerts its tuning role on immunity by interfering with the generation of regulatory macrophages, thus hindering the consequent Th2-polarized type of response.	[Ruas, Luciana Pereira; Bernardes, Emerson Soares; Fermino, Marise Lopes; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA USA; [Chammas, Roger] Univ Sao Paulo, Fac Med, Lab Oncol Expt, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Vicosa; University of California System; University of California Davis; Universidade de Sao Paulo	Ruas, LP (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, Brazil.	mcrbarre@fmrp.usp.br	Roque-Barreira, Maria-Cristina/A-4552-2008; Ruas, Luciana/A-4259-2013; Chammas, Roger/A-8004-2011; Bernardes, Emerson Soares/D-3711-2017; de Oliveira, Leandro Licursi/D-3616-2009; Liu, FU-TONG/A-5749-2019	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Ruas, Luciana/0000-0002-1028-7872; Chammas, Roger/0000-0003-0342-8726; Bernardes, Emerson Soares/0000-0002-0029-7313; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Liu, FU-TONG/0000-0002-3354-1001	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [scholarship]; Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq). L.P.R. is a PhD student with a scholarship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda C, 2004, INFECT IMMUN, V72, P3932, DOI 10.1128/IAI.72.7.3932-3940.2004; Bernardes ES, 2006, AM J PATHOL, V168, P1910, DOI 10.2353/ajpath.2006.050636; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Burger E, 1996, AM J TROP MED HYG, V55, P235, DOI 10.4269/ajtmh.1996.55.235; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; de Brito T, 1994, Rev Inst Med Trop Sao Paulo, V36, P185, DOI 10.1590/S0036-46651994000200016; Fava Netto C, 1969, REV INST MED TROP SP, V11, P177; FAZIOLI RD, 1994, MYCOPATHOLOGIA, V126, P137, DOI 10.1007/BF01103767; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; HO MK, 1982, J IMMUNOL, V128, P1221; HOSTETLER JS, 1993, CLIN EXP IMMUNOL, V94, P11, DOI 10.1111/j.1365-2249.1993.tb05969.x; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; KASHINO SS, 1995, MYCOPATHOLOGIA, V130, P131, DOI 10.1007/BF01103095; Kashino SS, 2000, J INTERF CYTOK RES, V20, P89, DOI 10.1089/107999000312766; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; MAGEE DM, 1995, INFECT IMMUN, V63, P3514, DOI 10.1128/IAI.63.9.3514-3519.1995; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; MIYAJI M, 1983, MYCOPATHOLOGIA, V82, P129, DOI 10.1007/BF00439218; MOSCARDIBACCHI M, 1994, J MED MICROBIOL, V40, P159, DOI 10.1099/00222615-40-3-159; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Pina A, 2004, INFECT IMMUN, V72, P2369, DOI 10.1128/IAI.72.4.2369-2378.2004; ROMANI L, 1992, J EXP MED, V176, P19, DOI 10.1084/jem.176.1.19; San-Blas G, 2005, J CLIN MICROBIOL, V43, P4255, DOI 10.1128/JCM.43.8.4255-4257.2005; SINGERVERMES LM, 1993, CLIN EXP IMMUNOL, V94, P75, DOI 10.1111/j.1365-2249.1993.tb05980.x; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	39	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4519	10.1371/journal.pone.0004519	http://dx.doi.org/10.1371/journal.pone.0004519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229338	gold, Green Published, Green Submitted			2022-12-25	WOS:000265486200006
J	Kienhofer, J; Haussler, DJF; Ruckelshausen, F; Muessig, E; Weber, K; Pimentel, D; Ullrich, V; Burkle, A; Bachschmid, MM				Kienhoefer, Joachim; Haeussler, Dagmar Johanna Franziska; Ruckelshausen, Florian; Muessig, Elisabeth; Weber, Klaus; Pimentel, David; Ullrich, Volker; Buerkle, Alexander; Bachschmid, Markus Michael			Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents	FASEB JOURNAL			English	Article						SOD2; nucleoid complex; aging; smooth muscle cell; TFAM; Pol gamma	TRANSCRIPTION-FACTOR-A; MANGANESE SUPEROXIDE-DISMUTASE; NITROCELLULOSE-FILTER BINDING; RAT-LIVER MITOCHONDRIA; ESCHERICHIA-COLI K-12; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; PROSTANOID SYNTHESIS; REDOX REGULATION	Mitochondrial DNA ( mtDNA) is organized in protein-DNA macrocomplexes called nucleoids. Average nucleoids contain 2-8 mtDNA molecules, which are organized by the histone-like mitochondrial transcription factor A. Besides well-characterized constituents, such as single-stranded binding protein or polymerase gamma (Pol gamma), various other proteins with ill-defined functions have been identified. We report for the first time that mammalian nucleoids contain essential enzymes of an integral antioxidant system. Intact nucleoids were isolated with sucrose density gradients from rat and bovine heart as well as human Jurkat cells. Manganese superoxide dismutase (SOD2) was detected by Western blot in the nucleoid fractions. DNA, mitochondrial glutathione peroxidase (GPx1), and Pol gamma were coimmunoprecipitated with SOD2 from nucleoid fractions, which suggests that an antioxidant system composed of SOD2 and GPx1 are integral constituents of nucleoids. Interestingly, in cultured bovine endothelial cells the association of SOD2 with mtDNA was absent. Using a sandwich filter-binding assay, direct association of SOD2 by salt-sensitive ionic forces with a chemically synthesized mtDNA fragment was demonstrated. Increasing salt concentrations during nucleoid isolation on sucrose density gradients disrupted the association of SOD2 with mitochondrial nucleoids. Our biochemical data reveal that nucleoids contain an integral antioxidant system that may protect mtDNA from superoxide-induced oxidative damage.-Kienhofer, J., Haussler, D. J. F., Ruckelshausen, F., Muessig, E., Weber, K., Pimentel, D., Ullrich, V., Burkle, A., Bachschmid, M. M. Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J. 23, 2034-2044 (2009)	[Haeussler, Dagmar Johanna Franziska; Bachschmid, Markus Michael] Boston Univ, Med Ctr, Vasc Biol Unit, Boston, MA 02118 USA; [Kienhoefer, Joachim; Ruckelshausen, Florian; Muessig, Elisabeth; Ullrich, Volker; Buerkle, Alexander] Univ Konstanz, Dept Biol, Constance, Germany; [Pimentel, David] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Unit, Boston, MA 02118 USA; [Weber, Klaus] Herz Zentrum Bodensee, Kreuzlingen, Switzerland	Boston University; University of Konstanz; Boston University	Bachschmid, MM (corresponding author), Boston Univ, Med Ctr, Vasc Biol Unit, X726,650 Albany St, Boston, MA 02118 USA.	bach@bu.edu	Ruckelshausen, Florian/E-8194-2014; Weber, Klaus/P-8241-2019	Ruckelshausen, Florian/0000-0002-2942-606X; Weber, Klaus/0000-0002-2421-6178; Pimentel, David/0000-0002-0537-7195; Bachschmid, Markus Michael/0000-0002-0748-5528	Deutsche Forschungsgemeinschaft [BU 698/6-1]; Whitaker Cardiovascular Institute; NIH [R01 AG027080-04, P01 HL081738-03, K08HL071563]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587, K08HL071563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027080] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Whitaker Cardiovascular Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Elisa Ferrando-May for assistance with the confocal microscope, Dr. Rudolf J. Wiesner (University of Heidelberg, Heidelberg, Germany) for supplying the anti-TFAM antibody, Dr. W. Hofer for assisting with the MDH activity assays, Rebecca Zee and Alicia Evangelista for preparing the manuscript, and Dr. Richard A. Cohen for his support. This work was supported by grant BU 698/6-1 of the Deutsche Forschungsgemeinschaft (DFG). D. J. F. H. and M. M. B. were supported by the Whitaker Cardiovascular Institute and NIH grants R01 AG027080-04 and P01 HL081738-03. D. P. was supported by NIH grant K08HL071563.	Aime S, 2003, BIOCHEM BIOPH RES CO, V307, P962, DOI 10.1016/S0006-291X(03)01307-X; ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955; ANNEX BH, 1990, MOL CELL BIOL, V10, P5671, DOI 10.1128/MCB.10.11.5671; Bachschmid M, 2005, BIOCHEM BIOPH RES CO, V338, P536, DOI 10.1016/j.bbrc.2005.08.157; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7; Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Czerwinski JD, 2005, ANAL BIOCHEM, V336, P300, DOI 10.1016/j.ab.2004.10.029; Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Finsterer J, 2006, NETH J MED, V64, P61; FISHER RP, 1992, J BIOL CHEM, V267, P3358; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717; GARSTKA HL, 1994, BIOCHEM BIOPH RES CO, V200, P619, DOI 10.1006/bbrc.1994.1493; Gensler S, 2001, NUCLEIC ACIDS RES, V29, P3657, DOI 10.1093/nar/29.17.3657; Gouliaeva NA, 2006, BIOFIZIKA+, V51, P692; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; HOKE GD, 1990, ARCH BIOCHEM BIOPHYS, V282, P116, DOI 10.1016/0003-9861(90)90094-F; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625; Kang D, 2005, ANN NY ACAD SCI, V1042, P101, DOI 10.1196/annals.1338.010; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee HC, 1997, J BIOMED SCI, V4, P319, DOI 10.1007/BF02258357; Lee HC, 2007, EXP BIOL MED, V232, P592; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; MIYAKAWA I, 1984, J CELL SCI, V66, P21; MIYAKAWA I, 1987, J CELL SCI, V88, P431; MIYAKAWA I, 1995, PLANT CELL PHYSIOL, V36, P1179; Miyakawa I, 1996, PLANT CELL PHYSIOL, V37, P816, DOI 10.1093/oxfordjournals.pcp.a029017; NASS MMK, 1969, SCIENCE, V165, P25, DOI 10.1126/science.165.3888.25; NASS MMK, 1965, EXP CELL RES, V37, P516, DOI 10.1016/0014-4827(65)90204-1; NEMETH PM, 1981, J PHYSIOL-LONDON, V311, P489, DOI 10.1113/jphysiol.1981.sp013600; OBERLEY LW, 1979, CANCER RES, V39, P1141; Osiewacz HD, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1275; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; PAVCO PA, 1985, J CELL BIOL, V100, P258, DOI 10.1083/jcb.100.1.258; RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K; Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7; Schildknecht S, 2005, BIOCHEM BIOPH RES CO, V327, P43, DOI 10.1016/j.bbrc.2004.11.132; Schildknecht S, 2008, FASEB J, V22, P215, DOI 10.1096/fj.06-8015com; Shadel GS, 2005, TRENDS BIOCHEM SCI, V30, P294, DOI 10.1016/j.tibs.2005.04.007; Shen EL, 2001, NUCLEIC ACIDS RES, V29, P2822, DOI 10.1093/nar/29.13.2822; Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3; SPAMER C, 1979, HISTOCHEMISTRY, V60, P9, DOI 10.1007/BF00495725; STEINMAN HM, 1994, J BIOL CHEM, V269, P28629; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; van der Loo B, 2006, BIOCHEM BIOPH RES CO, V344, P972, DOI 10.1016/j.bbrc.2006.03.224; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251; VANTUYLE GC, 1979, J BIOL CHEM, V254, P6044; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wei YH, 2001, CHINESE J PHYSIOL, V44, P1; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	82	60	64	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2034	2044		10.1096/fj.08-113571	http://dx.doi.org/10.1096/fj.08-113571			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19228881	Green Submitted, Green Published			2022-12-25	WOS:000268836500004
J	Liu, YL; Ren, WY; Warburton, R; Toksoz, D; Fanburg, BL				Liu, Yinglin; Ren, Wenying; Warburton, Rod; Toksoz, Deniz; Fanburg, Barry L.			Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells	FASEB JOURNAL			English	Article						5-HT; BMP receptor; pulmonary hypertension; RhoA; 5-HT1B receptor	BONE MORPHOGENETIC PROTEINS; II RECEPTOR; BETA RECEPTOR; HYPERTENSION; GROWTH; KINASE; TRANSACTIVATION; MITOGENESIS; EXPRESSION; MUTATIONS	Serotonin (5-HT) stimulates pulmonary artery smooth muscle cell proliferation and has been associated with pulmonary arterial hypertension (PAH). Bone morphogenetic protein receptor 2 (BMPR2) mutations similarly have been linked to PAH. However, possible crosstalk between 5-HT and BMPR signaling remains poorly characterized. We report here that 5-HT activates Smads 1/5/8 in bovine and human pulmonary artery smooth muscle cells (SMCs) and causes translocation of these Smads from cytoplasm to the nucleus. DN BMPR1A blocked 5-HT activation of Smads 1/5/8 by 5-HT and BMPR1A overexpression enhanced it. Activation of Smads by 5-HT occurred through the 5-HT 1B/1D receptor as it was blocked with the inhibitor GR 55562 but unaffected by inhibitors of the 5-HT transporter and a variety of 5-HT receptors. Activation of the Smads by 5-HT depended on Rho/Rho kinase signaling as it was blocked by Y27632, but unaffected by inhibitors of PI3K or MAPK. Transfection of cells with BMPR1A and ligation of the BMP receptor with BMP-2 also activated GTP-Rho A of these SMCs, while DN BMPR1A blocked the activation. 5-HT stimulated an increase in serine/threonine phosphorylation of BMPR1A, supporting the activation of BMPR1A by 5-HT in SMCs. Infusion of 5-HT into mice with miniosmotic infusion pumps caused activation of Smads 1/5/8 in lung tissue, demonstrating the effect in vivo. The studies support a unique concept that 5-HT trans-activates the serine kinase receptor, BMPR 1A, to activate Smads 1/5/8 via Rho and Rho kinase in pulmonary artery SMCs. Rho and Rho kinase also participate in the activation of Smads by BMP.-Liu, Y., Ren, W., Warburton, R., Toksoz, D., Fanburg, B. L. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells. FASEB J. 23, 2299-2306 (2009)	[Liu, Yinglin; Ren, Wenying; Warburton, Rod; Toksoz, Deniz; Fanburg, Barry L.] Tufts Med Ctr, Pulm Crit Care & Sleep Div, Tupper Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Fanburg, BL (corresponding author), Tufts Med Ctr, Pulm Crit Care & Sleep Div, Tupper Res Inst, 750 Washington St,257, Boston, MA 02111 USA.	bfanburg@tuftsmedicalcenter.org						Adnot S, 2003, B ACAD NAT MED PARIS, V187, P1529, DOI 10.1016/S0001-4079(19)33889-0; ADNOT S, 2003, B ACAD NATL MED, V187, P1543; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Day RM, 2006, BIOCHEM PHARMACOL, V71, P386, DOI 10.1016/j.bcp.2005.10.035; De Caestecker M, 2001, RESPIR RES, V2, P193; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Eguchi S, 2000, REGUL PEPTIDES, V91, P13, DOI 10.1016/S0167-0115(00)00126-9; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Grewal JS, 1999, AM J PHYSIOL-RENAL, V276, pF922, DOI 10.1152/ajprenal.1999.276.6.F922; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; HERVE P, 1990, AM J MED, V89, P117, DOI 10.1016/0002-9343(90)90111-P; Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kintscher U, 2002, CIRC RES, V91, pE35, DOI 10.1161/01.RES.0000046017.96083.34; LEE SL, 1991, CIRC RES, V68, P1362, DOI 10.1161/01.RES.68.5.1362; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Liu Y, 2008, AM J PHYSIOL-LUNG C, V295, pL471, DOI 10.1152/ajplung.00071.2008; Liu YL, 2007, FASEB J, V21, P2725, DOI 10.1096/fj.06-8058com; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Morse JH, 2001, ANN MED, V33, P596, DOI 10.3109/07853890109002105; Nichol SM, 2005, J VASC SURG, V41, P672, DOI 10.1016/j.jvs.2005.01.007; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; SZTRYMF B, 2005, DIFFUSE LUNG DIS S1, V22, pS91; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thomasson AL, 2001, TOPOI-INT REV PHILOS, V20, P149, DOI 10.1023/A:1017900607919; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Voisin L, 2002, AM J PHYSIOL-CELL PH, V283, pC446, DOI 10.1152/ajpcell.00261.2001; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yang CM, 2005, J CELL PHYSIOL, V203, P538, DOI 10.1002/jcp.20250; Yu PB, 2008, J BIOL CHEM, V283, P3877, DOI 10.1074/jbc.M706797200; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	35	33	35	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2299	2306		10.1096/fj.08-127910	http://dx.doi.org/10.1096/fj.08-127910			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19244313				2022-12-25	WOS:000268836500029
J	Sztainberg, Y; Kuperman, Y; Issler, O; Gil, S; Vaughan, J; Rivier, J; Vale, W; Chen, A				Sztainberg, Yehezkel; Kuperman, Yael; Issler, Orna; Gil, Shosh; Vaughan, Joan; Rivier, Jean; Vale, Wylie; Chen, Alon			A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease	FASEB JOURNAL			English	Article						cardiovascular disease; urocortins; isoform; alternative splicing; ER retention	MESSENGER-RNA EXPRESSION; RAT CARDIOVASCULAR-SYSTEM; HORMONE-RECEPTOR; ENDOPLASMIC-RETICULUM; REPERFUSION INJURY; HIV-1 INFECTION; TYPE-2 RECEPTOR; SKELETAL-MUSCLE; CRF RECEPTORS; UROCORTIN-III	A growing body of experimental and clinical studies supports a strong association between psychological stress and cardiovascular disease. An important endogenous cardioprotective role in heart physiology has been attributed to corticotropin-releasing factor receptor type 2 beta(CRFR2 beta). Here, we report the isolation of cDNA from mouse (m) heart encoding a novel CRFR2 beta splice variant. Translation of this insertion variant (iv)-mCRFR2 beta isoform produces a 421-aa protein that includes a unique C-terminal cytoplasmic tail. Our functional analysis and cellular localization studies demonstrated that when coexpressed with wild-type mCRFR2 beta, iv-mCRFR2 beta significantly inhibited the wild-type mCRFR2 beta membrane expression and its functional signaling by ER-Golgi complex retention, suggesting a dose-dependent dominant negative effect. Interestingly, mice exposed to a 4-wk paradigm of chronic variable stress, a model of chronic psychological stress in humans, presented significantly lower levels of mCRFR2 beta and higher levels of iv-mCRFR2 beta mRNA expression in their hearts, compared to nonstressed control mice. The dominant-negative effect of iv-mCRFR2 beta and its up-regulation by psychological stress suggest a new form of regulation of the mCRFR2 beta cardioprotective effect and a potential role for this novel isoform in stress-induced heart disease.-Sztainberg, Y., Kuperman, Y., Issler, O., Gil, S., Vaughan, J., Rivier, J., Vale, W., Chen, A. A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J. 23, 2186-2196 (2009)	[Sztainberg, Yehezkel; Kuperman, Yael; Issler, Orna; Gil, Shosh; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sztainberg, Yehezkel] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Vaughan, Joan; Rivier, Jean; Vale, Wylie] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Weizmann Institute of Science; Bar Ilan University; Salk Institute	Chen, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	alon.chen@weizmann.ac.il		Chen, Alon/0000-0003-3625-8233; Issler, Orna/0000-0003-1473-8295	NIDDK NIH HHS [5P01DK026741-29, P01 DK026741] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boonprasert P, 2008, INT J CARDIOL, V127, P307, DOI 10.1016/j.ijcard.2007.11.026; Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Brar BK, 2000, J BIOL CHEM, V275, P8508, DOI 10.1074/jbc.275.12.8508; Brar BK, 2004, ENDOCRINOLOGY, V145, P24, DOI 10.1210/en.2003-0689; BRAR BK, 2002, ENCY HORMONES RELATE, P313; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; Charles Christopher J., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P43, DOI 10.2174/1568016043477341; Chen A, 2005, MOL ENDOCRINOL, V19, P441, DOI 10.1210/me.2004-0300; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Coste SC, 2001, ENDOCRINOLOGY, V142, P3537, DOI 10.1210/en.142.8.3537; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Hashimoto K, 2004, PEPTIDES, V25, P1711, DOI 10.1016/j.peptides.2004.05.024; Heldwein KA, 1996, ENDOCRINOLOGY, V137, P3631, DOI 10.1210/en.137.9.3631; Heldwein KA, 1997, MOL CELL ENDOCRINOL, V131, P167, DOI 10.1016/S0303-7207(97)00103-2; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Jasper JR, 1997, BRIT J PHARMACOL, V122, P126, DOI 10.1038/sj.bjp.0701336; Jiang Wei, 2008, Cleve Clin J Med, V75 Suppl 2, pS20; Kageyama K, 2000, ENDOCRINOLOGY, V141, P2285, DOI 10.1210/en.141.7.2285; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Kostich WA, 1998, MOL ENDOCRINOL, V12, P1077, DOI 10.1210/me.12.8.1077; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; MINAKAMI R, 1993, BIOCHEM BIOPH RES CO, V194, P622, DOI 10.1006/bbrc.1993.1866; Minneman K P, 2001, Mol Interv, V1, P108; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Nazarloo HP, 2002, REGUL PEPTIDES, V105, P121, DOI 10.1016/S0167-0115(02)00006-X; Parkes DG, 1997, AM J PHYSIOL-HEART C, V272, pH2115, DOI 10.1152/ajpheart.1997.272.5.H2115; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pisarchik A, 2004, EUR J BIOCHEM, V271, P2821, DOI 10.1111/j.1432-1033.2004.04216.x; Pournajafi-Nazarloo H, 2007, NEUROENDOCRINOLOGY, V86, P17, DOI 10.1159/000103587; Rademaker MT, 2006, EUR HEART J, V27, P2088, DOI 10.1093/eurheartj/ehl138; Rademaker MT, 2005, CIRCULATION, V112, P3624, DOI 10.1161/CIRCULATIONAHA.105.561308; Rademaker MT, 2005, EUR HEART J, V26, P2055, DOI 10.1093/eurheartj/ehi351; Rademaker MT, 2002, J AM COLL CARDIOL, V40, P1495, DOI 10.1016/S0735-1097(02)02170-8; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shang LJL, 2007, CIRC RES, V101, P1146, DOI 10.1161/CIRCRESAHA.107.152918; Shioda T, 2001, J VIROL, V75, P3462, DOI 10.1128/JVI.75.7.3462-3468.2001; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Terui K, 2001, J ENDOCRINOL, V169, P177, DOI 10.1677/joe.0.1690177; Vale S, 2005, POSTGRAD MED J, V81, P429, DOI 10.1136/pgmj.2004.028977; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; VAUGHAN JM, 1989, METHODS ENZYMOL, V168, P588; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Zmijewski MA, 2009, J CELL PHYSIOL, V218, P593, DOI 10.1002/jcp.21632	66	20	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2186	2196		10.1096/fj.08-128066	http://dx.doi.org/10.1096/fj.08-128066			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246489	Green Published			2022-12-25	WOS:000268836500018
J	Hang, JQ; Yang, YL; Harris, SF; Leveque, V; Whittington, HJ; Rajyaguru, S; Ao-Ieong, G; McCown, MF; Wong, A; Giannetti, AM; Le Pogam, S; Talamas, F; Cammack, N; Najera, I; Klumpp, K				Hang, Julie Qi; Yang, Yanli; Harris, Seth F.; Leveque, Vincent; Whittington, Hannah J.; Rajyaguru, Sonal; Ao-Ieong, Gloria; McCown, Matthew F.; Wong, April; Giannetti, Anthony M.; Le Pogam, Sophie; Talamas, Francisco; Cammack, Nick; Najera, Isabel; Klumpp, Klaus			Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; HCVNS5B POLYMERASE; MOLECULAR-MECHANISM; ANTIVIRAL ACTIVITY; REPLICON VARIANTS; CRYSTAL-STRUCTURE; SERINE-PROTEASE; REPLICATION; DISCOVERY; IDENTIFICATION	The binding affinity of four palm and thumb site representative non-nucleoside inhibitors (NNIs) of HCV polymerase NS5B to wild-type and resistant NS5B polymerase proteins was determined, and the influence of RNA binding on NNI binding affinity was investigated. NNIs with high binding affinity potently inhibited HCV RNA polymerase activity and replicon replication. Among the compounds tested, HCV-796 showed slow binding kinetics to NS5B. The binding affinity of HCV-796 to NS5B increased 27-fold over a 3-h incubation period with an equilibrium K-d of 71 +/- 2 nM. Slow binding kinetics of HCV-796 was driven by slow dissociation from NS5B with a k(off) of 4.9 +/- 0.5 x 10(-4) s(-1). NS5B bound a long, 378-nucleotide HCV RNA oligonucleotide with high affinity (K-d = 6.9 +/- 0.3 nM), whereas the binding affinity was significantly lower for a short, 21-nucleotide RNA (K-d = 155.1 +/- 16.2 nM). The formation of the NS5B-HCV RNA complex did not affect the slow binding kinetics profile and only slightly reduced NS5B binding affinity of HCV-796. The magnitude of reduction of NNI binding affinity for the NS5B proteins with various resistance mutations in the palm and thumb binding sites correlated well with resistance-fold shifts in NS5B polymerase activity and replicon assays. Co-crystal structures of NS5B-Con1 and NS5B-BK with HCV-796 revealed a deep hydrophobic binding pocket at the palm region of NS5B. HCV-796 interaction with the induced binding pocket on NS5B is consistent with slow binding kinetics and loss of binding affinity with mutations at amino acid position 316.	[Hang, Julie Qi; Yang, Yanli; Harris, Seth F.; Leveque, Vincent; Whittington, Hannah J.; Rajyaguru, Sonal; Ao-Ieong, Gloria; McCown, Matthew F.; Wong, April; Giannetti, Anthony M.; Le Pogam, Sophie; Talamas, Francisco; Cammack, Nick; Najera, Isabel; Klumpp, Klaus] Roche Palo Alto LLC, Palo Alto, CA 94304 USA	Roche Holding	Hang, JQ (corresponding author), Roche Palo Alto LLC, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	julie.hang@roche.com; klaus.klumpp@roche.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; yang, yang/HGT-7999-2022					BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Beaulieu PL, 2006, CURR OPIN DRUG DISC, V9, P618; Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chan L, 2004, BIOORG MED CHEM LETT, V14, P797, DOI 10.1016/j.bmcl.2003.10.068; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Dhanak D, 2002, J BIOL CHEM, V277, P38322, DOI 10.1074/jbc.M205566200; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Howe AYM, 2008, ANTIMICROB AGENTS CH, V52, P3327, DOI 10.1128/AAC.00238-08; Howe AYM, 2006, ANTIMICROB AGENTS CH, V50, P4103, DOI 10.1128/AAC.00365-06; Howe AYM, 2004, ANTIMICROB AGENTS CH, V48, P4813, DOI 10.1128/AAC.48.12.4813-4821.2004; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kukolj G, 2005, J BIOL CHEM, V280, P39260, DOI 10.1074/jbc.M506407200; LACKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P446; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Liu YY, 2003, BIOCHEMISTRY-US, V42, P8862, DOI 10.1021/bi034661v; Ma H, 2005, VIROLOGY, V332, P8, DOI 10.1016/j.virol.2004.11.024; Malcolm BA, 2006, ANTIMICROB AGENTS CH, V50, P1013, DOI 10.1128/AAC.50.3.1013-1020.2006; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Mo HM, 2005, ANTIMICROB AGENTS CH, V49, P4305, DOI 10.1128/AAC.49.10.4305-4314.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TT, 2003, ANTIMICROB AGENTS CH, V47, P3525, DOI 10.1128/AAC.47.11.3525-3530.2003; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauwels F, 2007, J VIROL, V81, P6909, DOI 10.1128/JVI.01543-06; RAJAGOPALAN PTR, 2007, 58 ANN M AM ASS STUD; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tomei L, 2004, J VIROL, V78, P938, DOI 10.1128/JVI.78.2.938-946.2004; Tomei L, 2003, J VIROL, V77, P13225, DOI 10.1128/JVI.77.24.13225-13231.2003; Tomei Licia, 2005, Antiviral Chemistry & Chemotherapy, V16, P225; Villano S, 2007, HEPATOLOGY, V46, p815A; Villano S, 2006, HEPATOLOGY, V44, p607A	45	70	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15517	15529		10.1074/jbc.M808889200	http://dx.doi.org/10.1074/jbc.M808889200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19246450	hybrid, Green Published			2022-12-25	WOS:000266501000020
J	Chigaev, A; Waller, A; Amit, O; Halip, L; Bologa, CG; Sklar, LA				Chigaev, Alexandre; Waller, Anna; Amit, Or; Halip, Liliana; Bologa, Cristian G.; Sklar, Larry A.			Real-time Analysis of Conformation-sensitive Antibody Binding Provides New Insights into Integrin Conformational Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; SWISS-MODEL; ALPHA(4)BETA(1)-INTEGRIN AFFINITY; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; RECEPTOR; ACTIVATION; ALPHA-V-BETA-3; ENVIRONMENT; CHEMOKINES	Integrins are heterodimeric adhesion receptors that regulate immune cell adhesion. Integrin-dependent adhesion is controlled by multiple conformational states that include states with different affinity to the ligand, states with various degrees of molecule unbending, and others. Affinity change and molecule unbending play major roles in the regulation of cell adhesion. The relationship between different conformational states of the integrin is unclear. Here we have used conformationally sensitive antibodies and a small LDV-containing ligand to study the role of the inside-out signaling through formyl peptide receptor and CXCR4 in the regulation of alpha(4)beta(1) integrin conformation. We found that in the absence of ligand, activation by formyl peptide or SDF-1 did not result in a significant exposure of HUTS-21 epitope. Occupancy of the ligand binding pocket without cell activation was sufficient to induce epitope exposure. EC50 for HUTS-21 binding in the presence of LDV was identical to a previously reported ligand equilibrium dissociation constant at rest and after activation. Furthermore, the rate of HUTS-21 binding was also related to the VLA-4 activation state even at saturating ligand concentration. We propose that the unbending of the integrin molecule after guanine nucleotide-binding protein-coupled receptor-induced signaling accounts for the enhanced rate of HUTS-21 binding. Taken together, current results support the existence of multiple conformational states independently regulated by both inside-out signaling and ligand binding. Our data suggest that VLA-4 integrin hybrid domain movement does not depend on the affinity state of the ligand binding pocket.	[Chigaev, Alexandre; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Chigaev, Alexandre; Waller, Anna; Amit, Or; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Halip, Liliana; Bologa, Cristian G.] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Halip, Liliana] Acad Romana, Inst Chem, Timisoara 300223, Romania	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Romanian Academy of Sciences; Institute of Chemistry, Timisoara	Sklar, LA (corresponding author), MSC08 4630,915 Camino de Salud, Albuquerque, NM 87131 USA.	lsklar@salud.unm.edu	Bologa, Cristian G/A-7952-2010; BOLOGA, CRISTINA/T-8927-2017; Chigaev, Alexandre/A-3103-2010	Bologa, Cristian G/0000-0003-2232-4244; Chigaev, Alexandre/0000-0002-7726-638X; Halip, Liliana/0000-0002-2600-0186; Waller, Anna/0000-0003-3676-2501	National Institutes of Health [HL56384, HL081062]; Leukemia and Lymphoma Society [7388-06]; University of New Mexico School of Medicine [C-2297-RAC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062, P50HL056384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of New Mexico School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56384 and HL081062 (to L. A. S.). This work was also supported by Leukemia and Lymphoma Society Grant 7388-06 (to L. A. S.) and by Dedicated Health Research Funds of the University of New Mexico School of Medicine Grant C-2297-RAC (to A. C.).	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Barthel SR, 2006, J BIOL CHEM, V281, P32175, DOI 10.1074/jbc.M600943200; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2004, J BIOL CHEM, V279, P32435, DOI 10.1074/jbc.M404387200; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Escudero E, 2000, J AM SOC NEPHROL, V11, P1075, DOI 10.1681/ASN.V1161075; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutierrez-Lopez MD, 2003, J BIOL CHEM, V278, P208, DOI 10.1074/jbc.M207805200; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Lorentz A, 2002, BLOOD, V99, P966, DOI 10.1182/blood.V99.3.966; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Luque R, 2002, BRIT J HAEMATOL, V119, P70, DOI 10.1046/j.1365-2141.2002.03792.x; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sklar LA, 2002, ANNU REV BIOPH BIOM, V31, P97, DOI 10.1146/annurev.biophys.31.082901.134406; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	36	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14337	14346		10.1074/jbc.M901178200	http://dx.doi.org/10.1074/jbc.M901178200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19251697	Green Published, hybrid			2022-12-25	WOS:000266286100040
J	Brautigam, CA; Wynn, RM; Chuang, JL; Chuang, DT				Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Chuang, David T.			Subunit and Catalytic Component Stoichiometries of an in Vitro Reconstituted Human Pyruvate Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; SIZE-DISTRIBUTION ANALYSIS; MULTIENZYME COMPLEX; DIHYDROLIPOAMIDE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING-PROTEIN; ANALYTICAL ULTRACENTRIFUGATION; MAMMALIAN PYRUVATE; ESCHERICHIA-COLI	The human pyruvate dehydrogenase complex (PDC) is a 9.5-megadalton catalytic machine that employs three catalytic components, i.e. pyruvate dehydrogenase (E1p), dihydrolipoyl transacetylase (E2p), and dihydrolipoamide dehydrogenase (E3), to carry out the oxidative decarboxylation of pyruvate. The human PDC is organized around a 60-meric dodecahedral core comprising the C-terminal domains of E2p and a noncatalytic component, E3-binding protein (E3BP), which specifically tethers E3 dimers to the PDC. A central issue concerning the PDC structure is the subunit stoichiometry of the E2p/E3BP core; recent studies have suggested that the core is composed of 48 copies of E2p and 12 copies of E3BP. Here, using an in vitro reconstituted PDC, we provide densitometry, isothermal titration calorimetry, and analytical ultracentrifugation evidence that there are 40 copies of E2p and 20 copies of E3BP in the E2p/E3BP core. Reconstitution with saturating concentrations of E1p and E3 demonstrated 40 copies of E1p heterotetramers and 20 copies of E3 dimers associated with the E2p/E3BP core. To corroborate the 40/20 model of this core, the stoichiometries of E3 and E1p binding to their respective binding domains were reexamined. In these binding studies, the stoichiometries were found to be 1:1, supporting the 40/20 model of the core. The overall maximal stoichiometry of this in vitro assembled PDC for E2p:E3BP:E1p:E3 is 40:20:40:20. These findings contrast a previous report that implicated that two E3-binding domains of E3BP bind simultaneously to a single E3 dimer (Smolle, M., Prior, A. E., Brown, A. E., Cooper, A., Byron, O.,and Lindsay, J.G. (2006) J. Biol. Chem. 281, 19772-19780).	[Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brautigam, CA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chad.brautigam@utsouthwestern.edu; david.chuang@utsouthwestern.edu		Wynn, Richard/0000-0002-1879-2136; Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [DK26758, DK62306]; Welch Foundation [I-1286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062306, R01DK062306, R01DK026758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26758 and DK62306. This work was also supported by Grant I-1286 from the Welch Foundation.	Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; BARRERA CR, 1972, ARCH BIOCHEM BIOPHYS, V148, P343, DOI 10.1016/0003-9861(72)90152-X; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; DANSON MJ, 1978, P NATL ACAD SCI USA, V75, P5386, DOI 10.1073/pnas.75.11.5386; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Fries M, 2007, J MOL BIOL, V366, P132, DOI 10.1016/j.jmb.2006.11.018; GILBERT GA, 1959, PROC R SOC LON SER-A, V253, P420, DOI 10.1098/rspa.1959.0204; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; HACKERT ML, 1983, P NATL ACAD SCI-BIOL, V80, P2226, DOI 10.1073/pnas.80.8.2226; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Howard MJ, 1998, GASTROENTEROLOGY, V115, P139, DOI 10.1016/S0016-5085(98)70375-0; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; JILKA JM, 1986, J BIOL CHEM, V261, P1858; Jung HI, 2003, EUR J BIOCHEM, V270, P4488, DOI 10.1046/j.1432-1033.2003.03842.x; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MANDE SS, 1995, STRUCTURE LOND, V4, P277; MOMEN AZM, 2006, PROTEIN DATA BANK, DOI DOI 10.2210/PDB2DNE/PDB; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Sanderson SJ, 1996, EUR J BIOCHEM, V236, P68, DOI 10.1111/j.1432-1033.1996.00068.x; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Smolle M, 2006, BIOCHEM SOC T, V34, P815, DOI 10.1042/BST0340815; Smolle M, 2006, J BIOL CHEM, V281, P19772, DOI 10.1074/jbc.M601140200; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024	45	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13086	13098		10.1074/jbc.M806563200	http://dx.doi.org/10.1074/jbc.M806563200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240034	hybrid, Green Published			2022-12-25	WOS:000265688300056
J	Uchiki, T; Kim, HT; Zhai, B; Gygi, SP; Johnston, JA; O'Bryan, JP; Goldberg, AL				Uchiki, Tomoaki; Kim, Hyoung Tae; Zhai, Bo; Gygi, Steven P.; Johnston, Jennifer A.; O'Bryan, John P.; Goldberg, Alfred L.			The Ubiquitin-interacting Motif Protein, S5a, Is Ubiquitinated by All Types of Ubiquitin Ligases by a Mechanism Different from Typical Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; END RULE PATHWAY; COUPLED MONOUBIQUITINATION; CONJUGATING ENZYMES; PROTEASOME; DEGRADATION; IDENTIFICATION; SUBUNIT; COMPLEX; DOMAIN	S5a/Rpn10 is a ubiquitin (Ub)-binding protein that is a subunit of the 26S proteasome but also exists free in the cytosol. It binds poly-Ub chains through its two Ub-interacting motifs (UIMs). We discovered that, unlike typical substrates of Ub ligases (E3s), S5a can be ubiquitinated by all E3s tested including multimeric and monomeric Ring finger E3s (MuRF1, Siah2, Parkin, APC, and SCF beta TRCP1), the U-box E3, CHIP, and HECT domain E3s (E6AP and Nedd4) when assayed with UbcH5 or related Ub-conjugating enzymes. However, the E2s, UbcH1 and UbcH13/Uev1a, which function by distinct mechanisms, do not support S5a ubiquitination. Thus, S5a can be used for assay of probably all E3s with UbcH5. Ubiquitination of S5a results from its binding to Ub chains on the E3 (after self-ubiquitination) or on the substrate, as a mutant lacking the UIM domain was not ubiquitinated. Furthermore, if the S5a UIM domains were fused to GST, the protein was rapidly ubiquitinated by MuRF1 and CHIP. In addition, polyubiquitination (but not monoubiquitination) of MuRF1 allowed S5a to bind to MuRF1 and accelerated S5a ubiquitination. This tendency of S5a to associate with the growing Ub chain can explain how S5a, unlike typical substrates, which are recognized by certain E3s through specific motifs, is ubiquitinated by all E3s tested and is rapidly degraded in vivo.	[Uchiki, Tomoaki; Kim, Hyoung Tae; Zhai, Bo; Gygi, Steven P.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; [Johnston, Jennifer A.] Elan Pharmaceut Inc, San Francisco, CA 94080 USA; [O'Bryan, John P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu		Kim, Hyoung Tae/0000-0002-0270-2749; HyoungTae, Kim/0000-0002-2482-6064; Johnston, Jennifer/0000-0002-4867-9230; O'Bryan, John/0000-0001-5386-1080	National Institutes of Health [GM51923, AR055255, GM67945]; Fund for Innovation from Elan Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Innovation from Elan Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51923 and AR055255 (to A. L. G.) and Grant GM67945(to S. P. G.). This work was also supported by the Fund for Innovation from Elan Pharmaceuticals (to A. L. G.).	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Haglund K, 2006, NAT CELL BIOL, V8, P1218, DOI 10.1038/ncb1106-1218; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rubin DM, 1997, MOL BIOL REP, V24, P17; Sasiela CA, 2008, J BIOMOL SCREEN, V13, P229, DOI 10.1177/1087057108315038; Sato S, 2008, BIOORG MED CHEM LETT, V18, P3354, DOI 10.1016/j.bmcl.2008.04.031; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Timsit YE, 2005, BIOCHEM BIOPH RES CO, V328, P550, DOI 10.1016/j.bbrc.2005.01.022; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	54	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12622	12632		10.1074/jbc.M900556200	http://dx.doi.org/10.1074/jbc.M900556200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240029	Green Published, hybrid			2022-12-25	WOS:000265688300006
J	Ganley, IG; Lam, DH; Wang, JR; Ding, XJ; Chen, S; Jiang, XJ				Ganley, Ian G.; Lam, Du H.; Wang, Junru; Ding, Xiaojun; Chen, She; Jiang, Xuejun			ULK1 center dot ATG13 center dot FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR MACHINERY; YEAST AUTOPHAGY; MUTANTS; ULK1; MECHANISM; PATHWAY; FIP200; GENES	Autophagy is a degradative process that recycles long-lived and faulty cellular components. It is linked to many diseases and is required for normal development. ULK1, a mammalian serine/threonine protein kinase, plays a key role in the initial stages of autophagy, though the exact molecular mechanism is unknown. Here we report identification of a novel protein complex containing ULK1 and two additional protein factors, FIP200 and ATG13, all of which are essential for starvation-induced autophagy. Both FIP200 and ATG13 are critical for correct localization of ULK1 to the pre-autophagosome and stability of ULK1 protein. Additionally, we demonstrate by using both cellular experiments and a de novo in vitro reconstituted reaction that FIP200 and ATG13 can enhance ULK1 kinase activity individually but both are required for maximal stimulation. Further, we show that ATG13 and ULK1 are phosphorylated by the mTOR pathway in a nutrient starvation-regulated manner, indicating that the ULK1 center dot ATG13 center dot FIP200 complex acts as a node for integrating incoming autophagy signals into autophagosome biogenesis.	[Ganley, Ian G.; Wang, Junru; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Lam, Du H.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Ding, Xiaojun; Chen, She] Natl Inst Biol Sci, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institute of Biological Sciences, Beijing	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 522, New York, NY 10065 USA.	jiangx@mskcc.org		Ganley, Ian/0000-0003-1481-9407	National Institutes of Health [R01 CA113890]; NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA113890 (to X.J.).	Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Carrera AC, 2004, J CELL SCI, V117, P4615, DOI 10.1242/jcs.01311; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	33	983	1025	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12297	12305		10.1074/jbc.M900573200	http://dx.doi.org/10.1074/jbc.M900573200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258318	Green Published, hybrid			2022-12-25	WOS:000265494600061
J	Paul, AS; Pollard, TD				Paul, Aditya S.; Pollard, Thomas D.			Energetic Requirements for Processive Elongation of Actin Filaments by FH1FH2-formins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMIN HOMOLOGY-2 DOMAIN; CAPPING PROTEIN; ATP HYDROLYSIS; FISSION YEAST; MOUSE FORMIN; FH2 DOMAIN; ADP-ACTIN; PROFILIN; NUCLEATION; POLYMERIZATION	Formin-homology (FH) 2 domains from formin proteins associate processively with the barbed ends of actin filaments through many rounds of actin subunit addition before dissociating completely. Interaction of the actin monomer-binding protein profilin with the FH1 domain speeds processive barbed end elongation by FH2 domains. In this study, we examined the energetic requirements for fast processive elongation. In contrast to previous proposals, direct microscopic observations of single molecules of the formin Bni1p from Saccharomyces cerevisiae labeled with quantum dots showed that profilin is not required for formin-mediated processive elongation of growing barbed ends. ATP-actin subunits polymerized by Bni1p and profilin release the gamma-phosphate of ATP on average > 2.5 min after becoming incorporated into filaments. Therefore, the release of gamma-phosphate from actin does not drive processive elongation. We compared experimentally observed rates of processive elongation by a number of different FH2 domains to kinetic computer simulations and found that actin subunit addition alone likely provides the energy for fast processive elongation of filaments mediated by FH1FH2-formin and profilin. We also studied the role of FH2 structure in processive elongation. We found that the flexible linker joining the two halves of the FH2 dimer has a strong influence on dissociation of formins from barbed ends but only a weak effect on elongation rates. Because formins are most vulnerable to dissociation during translocation along the growing barbed end, we propose that the flexible linker influences the lifetime of this translocative state.	[Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Paul, Aditya S.; Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, KBT 548,POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			National Institutes of Health [GM026338]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026132, R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM026338 ( to T. D. P.). This work was also supported by a National Science Foundation predoctoral fellowship ( to A. S. P.).	Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Shemesh T, 2007, BIOPHYS J, V92, P1512, DOI 10.1529/biophysj.106.098459; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; VALENTINRANC C, 1989, J BIOL CHEM, V264, P20871; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	34	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12533	12540		10.1074/jbc.M808587200	http://dx.doi.org/10.1074/jbc.M808587200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251693	hybrid, Green Published			2022-12-25	WOS:000265494600082
J	Belmiro, CLR; Castelo-Branco, MTL; Melim, LMC; Schanaider, A; Elia, C; Madi, K; Pavao, MSG; de Souza, HSP				Belmiro, Celso L. R.; Castelo-Branco, Morgana T. L.; Melim, Leandra M. C.; Schanaider, Alberto; Elia, Celeste; Madi, Kalil; Pavao, Mauro S. G.; de Souza, Heitor S. P.			Unfractionated Heparin and New Heparin Analogues from Ascidians (Chordate-Tunicate) Ameliorate Colitis in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; CROHNS-DISEASE; FACTOR-ALPHA; ULCERATIVE-COLITIS; MOLECULAR-WEIGHT; ANTICOAGULANT ACTIVITY; INCREASED EXPRESSION; MAINTENANCE THERAPY	The anti-inflammatory effect of mammalian heparin analogues, named dermatan sulfate and heparin, isolated from the ascidian Styela plicata was accessed in a TNBS-induced colitis model in rats. Subcutaneous administration of the invertebrate compounds during a 7-day period drastically reduced inflammation as observed by the normalization of the macroscopic and histological characteristics of the colon. At the molecular level, a decrease in the production of TNF-alpha, TGF-beta, and VEGF was observed, as well as a reduction of NF-kappa B and MAPK kinase activation. At the cellular level, the heparin analogues attenuated lymphocyte and macrophage recruitment and epithelial cell apoptosis. Adrastic reduction in collagen-mediated fibrosis was also observed. No hemorrhagic events were observed after glycan treatment. These results strongly indicate the potential therapeutic use of these compounds for the treatment of colonic inflammation with a lower risk of hemorrhage when compared with mammalian heparin.	[Belmiro, Celso L. R.; Melim, Leandra M. C.; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Tecido Conjunt, BR-21941913 Rio De Janeiro, Brazil; [Belmiro, Celso L. R.; Melim, Leandra M. C.; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941913 Rio De Janeiro, Brazil; [Castelo-Branco, Morgana T. L.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embryol, BR-21941590 Rio de Janeiro, Brazil; [Schanaider, Alberto] Univ Fed Rio de Janeiro, HUCFF, Dept Cirurgia Expt, BR-21941590 Rio de Janeiro, Brazil; [Elia, Celeste; Madi, Kalil; de Souza, Heitor S. P.] Univ Fed Rio de Janeiro, HUCFF, Dept Clin Med, BR-21941913 Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Souza, HSP (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Multidisciplinar Pesquisa Sub Solo, Ilha Fundao, Rua Prof Rodolpho Paulo Rocco 255, BR-21941913 Rio de Janeiro, Brazil.	hsouza@hucff.ufrj.br	de Souza, Heitor Siffert Pereira/G-3297-2012; Pavao, Mauro Sergio Goncalves/B-1979-2010	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324; Pavao, Mauro Sergio Goncalves/0000-0002-1336-4271	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao JoseBonifacio (FUJB); Mizutani Foundation for Glycoscience	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao JoseBonifacio (FUJB); Mizutani Foundation for Glycoscience	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo 'a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao JoseBonifacio (FUJB), Mizutani Foundation for Glycoscience (to M.S.G.P.).	Andoh A, 2005, AM J GASTROENTEROL, V100, P2042, DOI 10.1111/j.1572-0241.2005.50381.x; Ang YS, 2000, ALIMENT PHARM THERAP, V14, P1015, DOI 10.1046/j.1365-2036.2000.00802.x; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P975, DOI 10.1053/gast.1996.v110.pm8613031; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beddy DJ, 2004, J AM COLL SURGEONS, V199, P234, DOI 10.1016/j.jamcollsurg.2004.02.028; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Belmiro CLR, 2005, INT J COLORECTAL DIS, V20, P295, DOI 10.1007/s00384-004-0677-2; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Brass DM, 2007, AM J PHYSIOL-LUNG C, V293, pL77, DOI 10.1152/ajplung.00282.2006; Cardilo-Reis L, 2006, BRAZ J MED BIOL RES, V39, P1409, DOI 10.1590/S0100-879X2006001100004; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P137, DOI 10.1053/j.gastro.2007.04.069; Dignass AU, 1996, EXP CELL RES, V225, P422, DOI 10.1006/excr.1996.0193; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; DOLBER PC, 1987, STAIN TECHNOL, V62, P23, DOI 10.3109/10520298709107961; DZIARSKI R, 1994, J BIOL CHEM, V269, P2100; Elsayed E, 2003, J THROMB THROMBOLYS, V15, P11, DOI 10.1023/A:1026184100030; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Firestein GS, 1999, J CLIN INVEST, V103, P3, DOI 10.1172/JCI5929; Folwaczny C, 1999, AM J GASTROENTEROL, V94, P1551; GAFFNEY PR, 1995, AM J GASTROENTEROL, V90, P220; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Khorana AA, 2003, ARTERIOSCL THROM VAS, V23, P2110, DOI 10.1161/01.ATV.0000090671.56682.D7; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P16, DOI 10.1097/00054725-200102000-00003; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P226, DOI 10.1097/00054725-200108000-00008; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Marchetti M, 2008, THROMB RES, V121, P637, DOI 10.1016/j.thromres.2007.06.015; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; Papa A, 2000, ALIMENT PHARM THER, V14, P1403, DOI 10.1046/j.1365-2036.2000.00860.x; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Pavao MSG, 1995, J BIOL CHEM, V270, P31027, DOI 10.1074/jbc.270.52.31027; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; Pavao MSG, 2002, AN ACAD BRAS CIENC, V74, P105, DOI 10.1590/S0001-37652002000100007; Perera PY, 1997, J IMMUNOL, V158, P4422; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; RODEN L, 1992, ADV EXP MED BIOL, V313, P1; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Santos JC, 2007, THROMB RES, V121, P213, DOI 10.1016/j.thromres.2007.03.025; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; SCHURMANN GM, 1995, GUT, V36, P411, DOI 10.1136/gut.36.3.411; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; VANDULLEMEN HM, 1995, J GASTROENTEROL, V109, P129; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Vicente CP, 2001, THROMB HAEMOSTASIS, V86, P1215, DOI 10.1055/s-0037-1616054; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	62	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11267	11278		10.1074/jbc.M807211200	http://dx.doi.org/10.1074/jbc.M807211200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258310	Green Published, hybrid			2022-12-25	WOS:000265494500030
J	Fisk, JC; Sayegh, J; Zurita-Lopez, C; Menon, S; Presnyak, V; Clarke, SG; Read, LK				Fisk, John C.; Sayegh, Joyce; Zurita-Lopez, Cecilia; Menon, Sarita; Presnyak, Vladimir; Clarke, Steven G.; Read, Laurie K.			A Type III Protein Arginine Methyltransferase from the Protozoan Parasite Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION EXCHANGE CHROMATOGRAPHY; INDUCIBLE EXPRESSION SYSTEM; RNA-BINDING PROTEIN; MESSENGER-RNA; SUBSTRATE-SPECIFICITY; GUIDE RNA; IN-VITRO; SUBCELLULAR-LOCALIZATION; N-METHYLTRANSFERASE; GENE-EXPRESSION	Arginine methylation is a widespread post-translational modification of proteins catalyzed by a family of protein arginine methyltransferases (PRMTs). The ancient protozoan parasite, Trypanosoma brucei, possesses five putative PRMTs, a relatively large number for a single-celled eukaryote. Trypanosomatids lack gene regulation at the level of transcription, instead relying on post-transcriptional control mechanisms that act at the levels of RNA turnover, translation, and editing, all processes that likely involve multiple RNA-binding proteins, which are common targets of arginine methylation. Here, we report the characterization of a trypanosome PRMT, TbPRMT7, which is homologous to human PRMT7. Interestingly, trypanosomatids are the only single-celled eukaryotes known to harbor a PRMT7 homologue. TbPRMT7 differs dramatically from all known metazoan PRMT7 homologues in lacking the second AdoMet binding-like domain that is required for activity of the human enzyme. Nevertheless, bacterially expressed TbPRMT7 exhibits robust methyltransferase activity toward multiple targets in vitro. High resolution ion exchange chromatography analysis of methylated substrates reveals that TbPRMT7 is a type III PRMT, catalyzing the formation of only monomethylarginine, thereby representing the only exclusively type III PRMT identified to date. TbPRMT7 is expressed in both mammalian and insect stage T. brucei and is apparently dispensable for growth in both life cycle stages. The enzyme is cytoplasmically localized and is a component of several higher order complexes in vivo. Together, our studies indicate that TbPRMT7 is a Type III PRMT, and its robust activity and presence in numerous complexes suggest it plays multiple roles during the complex T. brucei life cycle.	[Fisk, John C.; Menon, Sarita; Presnyak, Vladimir; Read, Laurie K.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14124 USA; [Sayegh, Joyce; Zurita-Lopez, Cecilia; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sayegh, Joyce; Zurita-Lopez, Cecilia; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Read, LK (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14124 USA.	lread@buffalo.edu	Menon, Sarita/B-5609-2012; Zurita-Lopez, Cecilia I./AAC-6509-2020	Menon, Sarita/0000-0001-9548-149X; Presnyak, Vladimir/0000-0001-6695-7102	National Institutes of Health [R01AI060260, R37GM026020]; American Heart Association [0725984T]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI060260 (to L.K.R.) and Grant R37GM026020 (to S.G.C.). This work was also supported by American Heart Association Postdoctoral Fellowship 0725984T (to S.M.).	Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; BOISVERT FM, 2005, SCI STKE, pRE2, DOI DOI 10.1126/STKE.2712005RE2; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Goulah CC, 2007, J BIOL CHEM, V282, P7181, DOI 10.1074/jbc.M609485200; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; KLEIN PD, 1967, ANAL CHEM, V39, P1276, DOI 10.1021/ac60255a005; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lake AN, 2007, MUTAT RES-FUND MOL M, V618, P91, DOI 10.1016/j.mrfmmm.2006.09.010; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Miranda TB, 2006, BIOCHEM J, V395, P563, DOI 10.1042/BJ20051771; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pasternack DA, 2007, EUKARYOT CELL, V6, P1665, DOI 10.1128/EC.00133-07; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; XIE HY, 1993, J BIOL CHEM, V268, P13364; Zeiner GM, 2003, EUKARYOT CELL, V2, P222, DOI 10.1128/EC.2.2.222-230.2003	57	46	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11590	11600		10.1074/jbc.M807279200	http://dx.doi.org/10.1074/jbc.M807279200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19254949	Green Published, hybrid			2022-12-25	WOS:000265494500063
J	Jana, SS; Kim, KY; Mao, J; Kawamoto, S; Sellers, JR; Adelstein, RS				Jana, Siddhartha S.; Kim, Kye-Young; Mao, Jian; Kawamoto, Sachiyo; Sellers, James R.; Adelstein, Robert S.			An Alternatively Spliced Isoform of Non-muscle Myosin II-C Is Not Regulated by Myosin Light Chain Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-BINDING LOOP; HEAVY-CHAIN; RHO; EXPRESSION; MEROMYOSIN; LOCALIZATION; CYTOKINESIS; MECHANISM; KINASES	We report a novel isoform of non-muscle myosin II-C (NM II-C), NM II-C2, that is generated by alternative splicing of an exon, C2, encoding 41 amino acids in mice (33 in humans). The 41 amino acids are inserted into loop 2 of the NM II-C heavy chain within the actin binding region. Unlike most vertebrate non-muscle and smooth muscle myosin IIs, baculovirus-expressed mouse heavy meromyosin (HMM) II-C2 demonstrates no requirement for regulatory myosin light chain(MLC20) phosphorylation for maximum actin-activated MgATPase activity or maximum in vitro motility as measured by the sliding actin filament assay. In contrast, noninserted HMM II-C0 and another alternatively spliced isoform HMM II-C1, which contains 8 amino acids inserted into loop 1, are dependent on MLC20 phosphorylation for both actin-activated MgATPase activity and in vitro motility (Kim, K. Y., Kovacs, M., Kawamoto, S., Sellers, J. R., and Adelstein, R. S. (2005) J. Biol. Chem. 280, 22769-22775). HMM II-C1C2, which contains both the C1 and C2 inserts, does not require MLC20 phosphorylation for full activity similar to HMM II-C2. These constitutively active C2-inserted isoforms of NM II-C are expressed only in neuronal tissue. This is in contrast to NM II-C1 and NM II-C0, both of which are ubiquitously expressed. Full-lengthNMII-C2-GFP expressed in COS-7 cells localizes to filaments in interphase cells and to the cytokinetic ring in dividing cells.	[Jana, Siddhartha S.; Kim, Kye-Young; Mao, Jian; Kawamoto, Sachiyo; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; [Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Jana, Siddhartha S.] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata 700032, India	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Jana, SS (corresponding author), NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA.	bcssj@iacs.res.in		Adelstein, Robert/0000-0002-8683-2144	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004235, ZIAHL004235, ZIAHL001786, ZICHL006019] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alhopuro P, 2008, P NATL ACAD SCI USA, V105, P5513, DOI 10.1073/pnas.0801213105; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Conti M, 2008, MYOS SUP MOL MOT, V7, P223; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Jana SS, 2006, J BIOL CHEM, V281, P24662, DOI 10.1074/jbc.M604606200; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Rovner AS, 1998, J BIOL CHEM, V273, P27939, DOI 10.1074/jbc.273.43.27939; Rovner AS, 1995, J BIOL CHEM, V270, P30260, DOI 10.1074/jbc.270.51.30260; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Takahashi M, 1999, BIOCHEM BIOPH RES CO, V259, P29, DOI 10.1006/bbrc.1999.0717; Takahashi M, 2001, J BIOL CHEM, V276, P1034, DOI 10.1074/jbc.M005370200; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Tullio AN, 2001, J COMP NEUROL, V433, P62, DOI 10.1002/cne.1125; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098	38	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11563	11571		10.1074/jbc.M806574200	http://dx.doi.org/10.1074/jbc.M806574200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240025	Green Published, hybrid			2022-12-25	WOS:000265494500060
J	Mares, J; Kumaran, S; Gobbo, M; Zerbe, O				Mares, Jiri; Kumaran, Sowmini; Gobbo, Marina; Zerbe, Oliver			Interactions of Lipopolysaccharide and Polymyxin Studied by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP ROUGH MUTANT; DODECYL-SULFATE MICELLES; GRAM-NEGATIVE BACTERIA; ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; ORBITAL ELECTRONEGATIVITY; PARTIAL EQUALIZATION; HIGH-SENSITIVITY; ATOMIC CHARGES; FORCE-FIELD	In the light of occurrence of bacterial strains with multiple resistances against most antibiotics, antimicrobial peptides that interact with the outer layer of Gram-negative bacteria, such as polymyxin (PMX), have recently received increased attention. Here we present a study of the interactions of PMX-B, -E, and -M with lipopolysaccharide (LPS) from a deep rough mutant strain of Escherichia coli. A method for efficient purification of biosynthetically produced LPS using reversed-phase high-performance liquid chromatography in combination with ternary solvent mixtures was developed. LPS was incorporated into a membrane model, dodecylphosphocholine micelles, and its interaction with polymyxins was studied by heteronuclear NMR spectroscopy. Data from chemical shift mapping using isotope-labeled LPS or labeled polymyxin, as well as from isotope-filtered nuclear Overhauser effect spectroscopy experiments, reveal the mode of interaction of LPS with polymyxins. Using molecular dynamics calculations the complex of LPS with PMX-B in the presence of dodecylphosphocholine micelles was modeled using restraints derived from chemical shift mapping data and intermolecular nuclear Overhauser effects. In the modeled complex the macrocycle of PMX is centered around the phosphate group at GlcN-B, and additional contacts from polar side chains are formed to GlcN-A and Kdo-C, whereas hydrophobic side chains penetrate the acyl-chain region.	[Mares, Jiri; Kumaran, Sowmini; Zerbe, Oliver] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; [Gobbo, Marina] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy	University of Zurich; University of Padua	Zerbe, O (corresponding author), Univ Zurich, Inst Organ Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	oliver.zerbe@oci.uzh.ch	Mares, Jiri/ABA-4314-2020		Swiss National Science Foundation [3100A0-11173]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Grant 3100A0-11173).	Agrawal PK, 1998, MAGN RESON CHEM, V36, P1, DOI 10.1002/(SICI)1097-458X(199801)36:1<1::AID-OMR164>3.0.CO;2-J; Andra J, 2005, BIOCHEM J, V385, P135, DOI 10.1042/BJ20041270; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; Bhattacharjya S, 2007, BIOCHEMISTRY-US, V46, P5864, DOI 10.1021/bi6025159; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; BLOMMERS MJJ, 2003, BIONMR DRUG RES, P355; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; David SA, 2001, J MOL RECOGNIT, V14, P370, DOI 10.1002/jmr.549; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; GEMMECKER G, 2003, BIONMR DRUG RES, P373; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gobbo M, 2006, J PEPT SCI, V12, P132, DOI 10.1002/psc.695; Goddard TD, 2006, SPARKY 3 VERSION 3 1; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jarvet J, 1997, BIOCHEMISTRY-US, V36, P8153, DOI 10.1021/bi970193b; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEELER J, 1994, METHOD ENZYMOL, V239, P145; Keller R., 2004, COMPUTER AIDED RESON, V1; Koch PJ, 1999, J COLLOID INTERF SCI, V213, P557, DOI 10.1006/jcis.1999.6137; LIVE DH, 1984, J AM CHEM SOC, V106, P6104, DOI 10.1021/ja00332a071; MARCHIORO C, 2003, BIONMR DRUG RES, P321; Martin NI, 2003, J BIOL CHEM, V278, P13124, DOI 10.1074/jbc.M212364200; NO KT, 1990, J PHYS CHEM-US, V94, P4732, DOI 10.1021/j100374a066; OLEJNICZAK ET, 1992, J BIOMOL NMR, V2, P655, DOI 10.1007/BF02192854; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PAPAVOINE CHM, 1994, BIOCHEMISTRY-US, V33, P12990, DOI 10.1021/bi00248a007; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Pristovsek P, 2005, J MED CHEM, V48, P1666, DOI 10.1021/jm049217k; QURESHI N, 1988, J BIOL CHEM, V263, P11971; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; RANA FR, 1991, FEBS LETT, V293, P11, DOI 10.1016/0014-5793(91)81141-T; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yeagle P.L, 2016, MEMBRANES CELLS	52	76	82	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11498	11506		10.1074/jbc.M806587200	http://dx.doi.org/10.1074/jbc.M806587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244241	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000265494500054
J	Zakariassen, H; Aam, BB; Horn, SJ; Varum, KM; Sorlie, M; Eijsink, VGH				Zakariassen, Henrik; Aam, Berit Bjugan; Horn, Svein J.; Varum, Kjell M.; Sorlie, Morten; Eijsink, Vincent G. H.			Aromatic Residues in the Catalytic Center of Chitinase A from Serratia marcescens Affect Processivity, Enzyme Activity, and Biomass Converting Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLINE CELLULOSE DEGRADATION; CARBOHYDRATE-BINDING MODULES; VIBRIO-CARCHARIAE CHITINASE; TRICHODERMA-REESEI; SUBSTRATE-BINDING; FAMILY-18 CHITINASE; CELLOBIOHYDROLASE CEL6A; THERMOMONOSPORA-FUSCA; GLYCOSYL HYDROLASES; STRUCTURAL BASIS	The processive Serratia marcescens chitinases A(ChiA) and B (ChiB) are thought to degrade chitin in the opposite directions. A recent study of ChiB suggested that processivity is governed by aromatic residues in the +1 and +2 (aglycon) subsites close to the catalytic center. To further investigate the roles of aromatic residues in processivity and to gain insight into the structural basis of directionality, we have mutated Trp(167), Trp(275), and Phe(396) in the -3, +1, and +2 subsites of ChiA, respectively, and characterized the hydrolytic activities of the mutants toward beta-chitin and the soluble chitin-derivative chitosan. Although the W275A and F396A mutants showed only modest reductions in processivity, it was almost abolished by the W167A mutation. Thus, although aglycon subsites seem to steer processivity in ChiB, a glycon (-3) subsite seems to be adapted to do so in ChiA, in line with the notion that the two enzymes have different directionalities. Remarkably, whereas all three single mutants and the W167A/W275A double mutant showed reduced efficiency toward chitin, they showed up to 20-fold higher activities toward chitosan. These results show that the processive mechanism is essential for an efficient conversion of crystalline substrates but comes at a large cost in terms of intrinsic enzyme speed. This needs to be taken into account when devising enzymatic strategies for biomass turnover.	[Zakariassen, Henrik; Aam, Berit Bjugan; Horn, Svein J.; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Varum, Kjell M.] Norwegian Univ Sci & Technol, Norwegian Biopolymer Lab NOBIPOL, Dept Biotechnol, N-7491 Trondheim, Norway	Norwegian University of Life Sciences; Norwegian University of Science & Technology (NTNU)	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	vincent.eijsink@umb.no	Horn, Svein Jarle/C-6258-2008; Horn, Svein/F-9723-2010	Horn, Svein Jarle/0000-0002-1590-9001; 	Norwegian Research Council [164653, 174972]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Grants 164653 and 174972 from the Norwegian Research Council.	Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DRAGET KI, 1992, BIOMATERIALS, V13, P635, DOI 10.1016/0142-9612(92)90032-J; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; EPHRAIM C, 1993, ARCH INSECT BIOCH PH, V22, P245; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kim J, 2006, MACROMOLECULES, V39, P4202, DOI 10.1021/ma060261e; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Oliveira EN, 2008, MYCOPATHOLOGIA, V166, P163, DOI 10.1007/s11046-008-9125-0; Pantoom Supansa, 2008, BMC Biochemistry, V9, P2, DOI 10.1186/1471-2091-9-2; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; SANNAN T, 1978, POLYMER, V19, P458, DOI 10.1016/0032-3861(78)90256-2; SCHINDLER M, 1977, BIOCHIM BIOPHYS ACTA, V482, P386, DOI 10.1016/0005-2744(77)90252-2; Sikorski P, 2005, BIOPOLYMERS, V77, P273, DOI 10.1002/bip.20224; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Sorbotten A, 2005, FEBS J, V272, P538, DOI 10.1111/j.1742-4658.2004.04495.x; Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2; Vinetz JM, 2000, J BIOL CHEM, V275, P10331, DOI 10.1074/jbc.275.14.10331; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Zhang S, 1997, J BIOTECHNOL, V57, P101, DOI 10.1016/S0168-1656(97)00093-X; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	62	129	130	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10610	10617		10.1074/jbc.M900092200	http://dx.doi.org/10.1074/jbc.M900092200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244232	Green Published, hybrid			2022-12-25	WOS:000265104600035
J	Bhatnagar, S; Damron, HA; Hillgartner, FB				Bhatnagar, Sushant; Damron, Holly A.; Hillgartner, F. Bradley			Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; ELEMENT-BINDING PROTEIN-1C; LIPOGENIC GENE-EXPRESSION; IMPROVES INSULIN SENSITIVITY; ORPHAN NUCLEAR RECEPTOR; TRANSCRIPTION FACTORS; LIPID-METABOLISM; NUTRITIONAL REGULATION; RAT HEPATOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE	Previous studies have shown that administration of fibroblast growth factor-19 (FGF-19) reverses diabetes, hepatic steatosis, hyperlipidemia, and adipose accretion in animal models of obesity. To investigate the mechanism for this effect, we determined whether FGF-19 modulated hepatic fatty acid synthesis, a key process controlling glucose tolerance and triacylglycerol accumulation in liver, blood, and adipose tissue. Incubating primary hepatocyte cultures with recombinant FGF-19 suppressed the ability of insulin to stimulate fatty acid synthesis. This effect was associated with a reduction in the expression of lipogenic enzymes. FGF-19 also suppressed the insulin-induced expression of sterol regulatory element-binding protein-1c (SREBP-1c), a key transcriptional activator of lipogenic genes. FGF-19 inhibition of lipogenic enzyme expression was not mediated by alterations in the activity of the insulin signal transduction pathway or changes in the activity of ERK, p38 MAPK, and AMP-activated protein kinase (AMPK). In contrast, FGF-19 increased the activity of STAT3, an inhibitor of SREBP-1c expression and decreased the expression of peroxisome proliferator-activated receptor-gamma coactivator-1 beta (PGC-1 beta), an activator of SREBP-1c activity. FGF-19 also increased the expression of small heterodimer partner (SHP), a transcriptional repressor that inhibits lipogenic enzyme expression via a SREBP-1c-independent mechanism. Inhibition of SREBP-1c activity by changes in STAT3 and PGC-1 beta activity and inhibition of gene transcription by an elevation in SHP expression can explain the inhibition of lipogenesis caused by FGF-19. In summary, the inhibitory effect of FGF-19 on insulin activation of hepatic fatty acid synthesis constitutes a mechanism that would explain the beneficial effect of FGF-19 on metabolic syndrome.	[Bhatnagar, Sushant; Damron, Holly A.; Hillgartner, F. Bradley] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA	West Virginia University	Hillgartner, FB (corresponding author), W Virginia Univ, Dept Biochem, POB 9142, Morgantown, WV 26506 USA.	fbhillgartner@hsc.wvu.edu			National Research Initiative Competitive [2007-35206-17845]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service	National Research Initiative Competitive(United States Department of Agriculture (USDA)); United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by National Research Initiative Competitive Grant 2007-35206-17845 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service.	Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gregori C, 2006, FEBS LETT, V580, P410, DOI 10.1016/j.febslet.2005.12.032; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Koo SH, 2001, J BIOL CHEM, V276, P9437, DOI 10.1074/jbc.M010029200; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lowenstein J M, 1975, Methods Enzymol, V35, P279, DOI 10.1016/0076-6879(75)35165-3; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NARKEWICZ MR, 1990, BIOCHEM J, V271, P585, DOI 10.1042/bj2710585; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; PETTY KJ, 1989, J BIOL CHEM, V264, P11483; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Salati LM, 2004, J NUTR, V134, p2437S, DOI 10.1093/jn/134.9.2437S; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Stabile LP, 1998, J LIPID RES, V39, P1951; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Streeper RS, 1998, MOL ENDOCRINOL, V12, P1778, DOI 10.1210/me.12.11.1778; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	66	143	148	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10023	10033		10.1074/jbc.M808818200	http://dx.doi.org/10.1074/jbc.M808818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233843	hybrid, Green Published			2022-12-25	WOS:000264892900045
J	Vongsa, RA; Zimmerman, NP; Dwinell, MB				Vongsa, Rebecca A.; Zimmerman, Noah P.; Dwinell, Michael B.			CCR6 Regulation of the Actin Cytoskeleton Orchestrates Human Beta Defensin-2-and CCL20-mediated Restitution of Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; LIGHT-CHAIN KINASE; GROWTH-FACTOR-BETA; CROHNS-DISEASE; IN-VITRO; INTESTINAL PERMEABILITY; CHEMOKINE RECEPTORS; DENDRITIC CELLS; ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2	Intestinal inflammation is exacerbated by defects in the epithelial barrier and subsequent infiltration of microbes and toxins into the underlying mucosa. Production of chemokines and antimicrobial peptides by an intact epithelium provide the first line of defense against invading organisms. In addition to its antimicrobial actions, human beta defensin-2 (HBD2) may also stimulate the migration of dendritic cells through binding the chemokine receptor CCR6. As human colonic epithelium expresses CCR6, we investigated the potential of HBD2 to stimulate intestinal epithelial migration. Using polarized human intestinal Caco2 and T84 cells and non-transformed IEC6 cells, HBD2 was equipotent to CCL20 in stimulating migration. Neutralizing antibodies confirmed HBD2 and CCL20 engagement to CCR6 were sufficient to induce epithelial cell migration. Consistent with restitution, motogenic concentrations of HBD2 and CCL20 did not induce proliferation. Stimulation with those CCR6 ligands leads to calcium mobilization and elevated active RhoA, phosphorylated myosin light chain, and F-actin accumulation. HBD2 and CCL20 were unable to stimulate migration in the presence of either Rho-kinase or phosphoinositide 3-kinase inhibitors or an intracellular calcium chelator. Together, these data indicate that the canonical wound healing regulatory pathway, along with calcium mobilization, regulates CCR6-directed epithelial cell migration. These findings expand the mechanistic role for chemokines and HBD2 in mucosal inflammation to include immunocyte trafficking and killing of microbes with the concomitant activation of restitutive migration and barrier repair.	[Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Bobbie Nick Voss Lab, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Bobbie Nick Voss Lab, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu			National Institutes of Health [DK062066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062066, R01DK062066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062066 from NIDDK.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Beck PL, 2003, AM J PATHOL, V162, P597, DOI 10.1016/S0002-9440(10)63853-9; BOUCEK MM, 1976, SCIENCE, V193, P905, DOI 10.1126/science.948752; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Commane DM, 2005, NUTR CANCER, V51, P102, DOI 10.1207/s15327914nc5101_14; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Ina K, 1997, AM J GASTROENTEROL, V92, P1342; Isomoto H, 2005, WORLD J GASTROENTERO, V11, P4782, DOI 10.3748/wjg.v11.i31.4782; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jia HP, 1999, INFECT IMMUN, V67, P4827, DOI 10.1128/IAI.67.9.4827-4833.1999; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Katchar K, 2007, AM J PHYSIOL-GASTR L, V292, pG1263, DOI 10.1152/ajpgi.00409.2006; KATZ KD, 1989, GASTROENTEROLOGY, V97, P927, DOI 10.1016/0016-5085(89)91499-6; Khandaker MH, 1998, J IMMUNOL, V161, P1930; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Lotz MM, 1997, AM J PATHOL, V150, P747; MacDermott RP, 1998, INFLAMM BOWEL DIS, V4, P54, DOI 10.1097/00054725-199802000-00009; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Middel P, 2006, GUT, V55, P220, DOI 10.1136/gut.2004.063008; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nejdfors P, 2000, DIS COLON RECTUM, V43, P1582, DOI 10.1007/BF02236743; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pernet I, 2003, EXP DERMATOL, V12, P755, DOI 10.1111/j.0906-6705.2003.00086.x; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; REINECKER HC, 1995, GASTROENTEROLOGY, V108, P40, DOI 10.1016/0016-5085(95)90006-3; Riegler M, 1996, GASTROENTEROLOGY, V111, P28, DOI 10.1053/gast.1996.v111.pm8698221; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Rutgeerts Paul J, 2004, Rev Gastroenterol Disord, V4 Suppl 3, pS1; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Turner JR, 1999, AM J PHYSIOL-CELL PH, V277, pC554, DOI 10.1152/ajpcell.1999.277.3.C554; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2001, J LEUKOCYTE BIOL, V69, P691	73	59	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					10034	10045		10.1074/jbc.M805289200	http://dx.doi.org/10.1074/jbc.M805289200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233848	hybrid, Green Published			2022-12-25	WOS:000264892900046
J	Bianco-Miotto, T; Hussey, DJ; Day, TK; O'Keefe, DS; Dobrovic, A				Bianco-Miotto, Tina; Hussey, Damian J.; Day, Tanya K.; O'Keefe, Denise S.; Dobrovic, Alexander			DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients	PLOS ONE			English	Article							BLOOD-GROUP-A; RELIABLE PCR METHOD; GROUP ANTIGEN-A; RED-CELL; RAPID METHOD; H-ANTIGENS; DOVAM-S; BLADDER; GENE; CLONING	Background: Loss of A, B and H antigens from the red blood cells of patients with myeloid malignancies is a frequent occurrence. Previously, we have reported alterations in ABH antigens on the red blood cells of 55% of patients with myeloid malignancies. Methodology/Principal Findings: To determine the underlying molecular mechanisms of this loss, we assessed ABO allelic expression in 21 patients with ABH antigen loss previously identified by flow cytometric analysis as well as an additional 7 patients detected with ABH antigen changes by serology. When assessing ABO mRNA allelic expression, 6/12 (50%) patients with ABH antigen loss detected by flow cytometry and 5/7 (71%) of the patients with ABH antigen loss detected by serology had a corresponding ABO mRNA allelic loss of expression. We examined the ABO locus for copy number and DNA methylation alterations in 21 patients, 11 with loss of expression of one or both ABO alleles, and 10 patients with no detectable allelic loss of ABO mRNA expression. No loss of heterozygosity (LOH) at the ABO locus was observed in these patients. However in 8/11 (73%) patients with loss of ABO allelic expression, the ABO promoter was methylated compared with 2/10 (20%) of patients with no ABO allelic expression loss (P = 0.03). Conclusions/Significance: We have found that loss of ABH antigens in patients with hematological malignancies is associated with a corresponding loss of ABO allelic expression in a significant proportion of patients. Loss of ABO allelic expression was strongly associated with DNA methylation of the ABO promoter.	[Bianco-Miotto, Tina; Hussey, Damian J.; Day, Tanya K.; Dobrovic, Alexander] Dept Haematol Oncol, Woodville, SA, Australia; [Bianco-Miotto, Tina; Hussey, Damian J.; Day, Tanya K.; Dobrovic, Alexander] Univ Adelaide, Queen Elizabeth Hosp, Woodville, SA, Australia; [Bianco-Miotto, Tina] Univ Adelaide, Hanson Inst, Dame Roma Mitchell Canc Res Lab, Adelaide, SA 5005, Australia; [Hussey, Damian J.] Flinders Univ S Australia, Flinders Med Ctr, Dept Surg, Bedford Pk, SA 5001, Australia; [O'Keefe, Denise S.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA; [Dobrovic, Alexander] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Dobrovic, Alexander] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	University of Adelaide; Hanson Institute; University of Adelaide; Flinders Medical Centre; Flinders University South Australia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peter Maccallum Cancer Center; University of Melbourne	Bianco-Miotto, T (corresponding author), Dept Haematol Oncol, Woodville, SA, Australia.	tina.bianco-miotto@imvs.sa.gov.au	Day, Tanya/J-2187-2012; Bianco-Miotto, Tina/C-4808-2008; O'Keefe, Denise/A-6273-2010	Bianco-Miotto, Tina/0000-0002-8431-5338; Hussey, Damian/0000-0002-6121-6740; Dobrovic, Alexander/0000-0003-3414-112X	National Health and Medical Research Council Peter Doherty Fellowship	National Health and Medical Research Council Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	TBM is supported by a National Health and Medical Research Council Peter Doherty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco T, 2001, BLOOD, V97, P3633, DOI 10.1182/blood.V97.11.3633; Bianco T, 1999, HUM MUTAT, V14, P289, DOI 10.1002/(SICI)1098-1004(199910)14:4<289::AID-HUMU3>3.0.CO;2-A; Buzin CH, 2000, BIOTECHNIQUES, V28, P746, DOI 10.2144/00284rr04; Chihara Y, 2005, LAB INVEST, V85, P895, DOI 10.1038/labinvest.3700268; DABELSTEEN E, 1988, Proceedings of the Finnish Dental Society, V84, P19; DABELSTEEN E, 1988, CANCER RES, V48, P181; DANIELS G, 1995, HUMAN BLOOD GROUPS; Dobrovic A, 2002, METHODS, V27, P134, DOI 10.1016/S1046-2023(02)00065-8; Dobrovic A, 2005, MOL DIAGNOSTICS CLIN, P149; Eaton MC, 1997, BIOTECHNIQUES, V22, P100, DOI 10.2144/97221st01; EVDOKIOU A, 1993, GENOMICS, V18, P731, DOI 10.1016/S0888-7543(05)80388-X; FIALKOW PJ, 1981, BLOOD, V57, P1068; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Hata Y, 2002, VOX SANG, V82, P39, DOI 10.1046/j.0042-9007.2001.00134.x; HIROHASHI S, 1984, J NATL CANCER I, V72, P1299; Ichikawa D, 1998, INT J CANCER, V76, P284, DOI 10.1002/(SICI)1097-0215(19980413)76:2<284::AID-IJC17>3.0.CO;2-C; KAHN A, 1971, LANCET, V2, P933; KEINANEN M, 1988, NEW ENGL J MED, V318, P1153, DOI 10.1056/NEJM198805053181803; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Kominato Y, 1999, J BIOL CHEM, V274, P37240, DOI 10.1074/jbc.274.52.37240; Kuemmel A, 2007, TUMOR BIOL, V28, P340, DOI 10.1159/000124298; LANGE PH, 1978, J UROLOGY, V119, P52, DOI 10.1016/S0022-5347(17)57379-6; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LEE JCI, 1992, J FORENSIC SCI, V37, P1269; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; LIMAS C, 1979, CANCER, V44, P2099, DOI 10.1002/1097-0142(197912)44:6<2099::AID-CNCR2820440621>3.0.CO;2-I; Liu Q, 1999, BIOTECHNIQUES, V26, P932, DOI 10.2144/99265rr03; MARSDEN KA, 1992, CANCER GENET CYTOGEN, V64, P80, DOI 10.1016/0165-4608(92)90328-6; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moldvay J, 2000, CLIN CANCER RES, V6, P1125; Nakagoe T, 1998, CANCER DETECT PREV, V22, P499, DOI 10.1046/j.1525-1500.1998.00045.x; OKeefe DS, 1996, BLOOD, V87, P3061, DOI 10.1182/blood.V87.7.3061b.bloodjournal8773061b; OKEEFE DS, 1993, HUM MUTAT, V2, P67, DOI 10.1002/humu.1380020112; OKeefe DS, 1996, HUM MUTAT, V8, P358, DOI 10.1002/(SICI)1098-1004(1996)8:4<358::AID-HUMU9>3.0.CO;2-3; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; ORNTOFT TF, 1989, J HISTOCHEM CYTOCHEM, V37, P1153, DOI 10.1177/37.7.2732458; PERLMAN EJ, 1990, AM J SURG PATHOL, V14, P810, DOI 10.1097/00000478-199009000-00002; Race RR., 1975, BLOOD GROUPS MAN; SALMON C, 1968, REV FR ETUD CLIN BIO, V13, P296; SALMON C, 1984, REV FR TRANSFUS IMMU, V27, P625, DOI 10.1016/S0338-4535(84)80084-7; SCHOENTAG R, 1987, CANCER RES, V47, P1695; SUCIU S, 1993, CANCER GENET CYTOGEN, V70, P1, DOI 10.1016/0165-4608(93)90122-3; VAN LOGHEM J J Jr, 1957, Vox Sang, V2, P16; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Worm J, 2001, CLIN CHEM, V47, P1183; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Xu Hua, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P240; YAMAMOTO F, 1990, TRANSFUSION, V30, P671, DOI 10.1046/j.1537-2995.1990.30891020320.x; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; Yamamoto F, 2004, Immunohematology, V20, P3; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yamamoto F, 2001, TRANSFUSION MED, V11, P281, DOI 10.1046/j.1365-3148.2001.00316.x	55	39	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4788	10.1371/journal.pone.0004788	http://dx.doi.org/10.1371/journal.pone.0004788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274076	Green Published, Green Accepted, gold			2022-12-25	WOS:000265496000024
J	Akundi, RS; Rivkees, SA				Akundi, Ravi Shankar; Rivkees, Scott A.			Hypoxia Alters Cell Cycle Regulatory Protein Expression and Induces Premature Maturation of Oligodendrocyte Precursor Cells	PLOS ONE			English	Article								Background: Periventricular white matter injury (PWMI) is a common form of brain injury sustained by preterm infants. A major factor that predisposes to PWMI is hypoxia. Because oligodendrocytes (OLs) are responsible for myelination of axons, abnormal OL development or function may affect brain myelination. At present our understanding of the influences of hypoxia on OL development is limited. To examine isolated effects of hypoxia on OLs, we examined the influences of hypoxia on OL development in vitro. Methodology/Findings: Cultures of oligodendrocyte precursor cells (OPCs) were prepared from mixed glial cultures and were 99% pure. OPCs were maintained at 21% O-2 or hypoxia (1% or 4% O-2) for up to 7 days. We observed that 1% O2 lead to an increase in the proportion of myelin basic protein (MBP)-positive OLs after 1 week in culture, and a decrease in the proportion of platelet-derived growth factor receptor a (PDGFRa)-positive cells suggesting premature OL maturation. Increased expression of the cell cycle regulatory proteins p27(Kip1) and phospho-cdc2, which play a role in OL differentiation, was seen as well. Conclusions: These results show that hypoxia interferes with the normal process of OL differentiation by inducing premature OPC maturation.	[Akundi, Ravi Shankar; Rivkees, Scott A.] Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Sect Dev Biol & Endocrinol, New Haven, CT 06520 USA	Yale University	Akundi, RS (corresponding author), Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Sect Dev Biol & Endocrinol, New Haven, CT 06520 USA.	scott.rivkees@yale.edu	Messier, Claude/A-2322-2008; Akundi, Ravi Shankar/J-2673-2019	Messier, Claude/0000-0002-4791-1763; Akundi, Ravi Shankar/0000-0003-3782-5965	American Heart Association; March of Dimes; National Institutes of Health [NS051191]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051191] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by awards from the American Heart Association (RSA), March of Dimes (SAR), and the National Institutes of Health (NS051191, SAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Back SA, 2001, AM HEART MONOGR S, P131; Back SA, 1997, MENT RETARD DEV D R, V3, P96, DOI 10.1002/(SICI)1098-2779(1997)3:1<96::AID-MRDD12>3.0.CO;2-M; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Bansal R, 2005, J NEUROSCI RES, V80, P360, DOI 10.1002/jnr.20454; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; CRAIG A, 2003, EXP NEUROL, P181; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; FAULSTICH H, 1988, J MUSCLE RES CELL M, V9, P370, DOI 10.1007/BF01774064; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; GARD AL, 1993, NEUROPROTOCOLS, V2, P209; GOEBEL HH, 1987, ACTA HISTOCHEM, P81; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Li S, 1999, J CLIN INVEST, V103, P1141, DOI 10.1172/JCI5367; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; NIGG EA, 1992, CIBA F SYMP, V170, P72; NIGG EA, 1992, CIBA F SYMP, V170, P84; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Raff M, 2001, NOVART FDN SYMP, V237, P100, DOI 10.1002/0470846666.ch9; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Resnik ER, 2007, P NATL ACAD SCI USA, V104, P18789, DOI 10.1073/pnas.0706019104; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stark George R, 2004, Methods Mol Biol, V280, P51; WARRINGTON AE, 1992, DEV NEUROSCI-BASEL, V14, P93, DOI 10.1159/000111652; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; YAN H, 2005, NEUROREPORT IN PRESS; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323	39	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4739	10.1371/journal.pone.0004739	http://dx.doi.org/10.1371/journal.pone.0004739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270736	gold, Green Published, Green Submitted			2022-12-25	WOS:000265495900008
J	Milner, ARC; Harris, JD; Lockley, MG; Kirkland, JI; Matthews, NA				Milner, Andrew R. C.; Harris, Jerald D.; Lockley, Martin G.; Kirkland, James I.; Matthews, Neffra A.			Bird-Like Anatomy, Posture, and Behavior Revealed by an Early Jurassic Theropod Dinosaur Resting Trace	PLOS ONE			English	Article							TROODONTID DINOSAUR; MOENAVE FORMATION; FORELIMB; SANDSTONE; ARIZONA; CHINA; UTAH; AGE	Background: Fossil tracks made by non-avian theropod dinosaurs commonly reflect the habitual bipedal stance retained in living birds. Only rarely-captured behaviors, such as crouching, might create impressions made by the hands. Such tracks provide valuable information concerning the often poorly understood functional morphology of the early theropod forelimb. Methodology/Principal Findings: Here we describe a well-preserved theropod trackway in a Lower Jurassic (similar to 198 million-year-old) lacustrine beach sandstone in the Whitmore Point Member of the Moenave Formation in southwestern Utah. The trackway consists of prints of typical morphology, intermittent tail drags and, unusually, traces made by the animal resting on the substrate in a posture very similar to modern birds. The resting trace includes symmetrical pes impressions and well-defined impressions made by both hands, the tail, and the ischial callosity. Conclusions/Significance: The manus impressions corroborate that early theropods, like later birds, held their palms facing medially, in contrast to manus prints previously attributed to theropods that have forward-pointing digits. Both the symmetrical resting posture and the medially-facing palms therefore evolved by the Early Jurassic, much earlier in the theropod lineage than previously recognized, and may characterize all theropods.	[Milner, Andrew R. C.] St George Dinosaur Discovery Site Johnson Farm, St George, UT USA; [Harris, Jerald D.] Dixie State Coll, St George, UT USA; [Lockley, Martin G.] Univ Colorado Denver, Dinosaur Tracks Museum, Denver, CO USA; [Kirkland, James I.] Utah Geol Survey, Salt Lake City, UT USA; [Matthews, Neffra A.] USDOI Bureau Land Management, Natl Operat Ctr, Denver, CO USA	Utah System of Higher Education; Dixie State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Milner, ARC (corresponding author), St George Dinosaur Discovery Site Johnson Farm, St George, UT USA.	amilner@sgcity.org						[Anonymous], 1964, ESTUDIOS ICNOLOGICOS; Baird D., 1980, P219; Baird D., 1957, Bulletin of the Museum of Comparative Zoology, V117, P449; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; BOCK WILHELM, 1952, JOUR PALEONTOL, V26, P395; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; Branson E.B., 1932, GEOLOGICAL SOC AM B, V43, P383; BULKLEY S, 1996, MUS N ARIZ B, V60, P167; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Chatterjee S, 2004, LIFE O PAST, P251; Clark James M., 1999, American Museum Novitates, V3265, P1; CLEMMENSEN LB, 1989, GEOL SOC AM BULL, V101, P759, DOI 10.1130/0016-7606(1989)101<0759:EMDITL>2.3.CO;2; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Demathieu Georges R.S., 1993, Zubia Monografico, V5, P229; Ellenberger P., 1972, PALAEOVERTEBRATA, P1; ELLENBERGER P, 1974, CONTRIBUTION CLASSIF, V1, P1; Farlow JO, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P248; FRASER NC, 1996, TRIASSIC VIRGINIA JE, V7, P1; GIERLINSKI G, 1991, PALAEOGEOGR PALAEOCL, V85, P137, DOI 10.1016/0031-0182(91)90030-U; GIERLINSKI G, 1996, GEOL Q, V40, P119; Gierlinski Gerard, 2004, Ichnos, V11, P195, DOI 10.1080/10420940490444861; Gierlinski Gerard, 2002, Geological Quarterly, V46, P467; Gierlinski Gerard, 1994, Przeglad Geologiczny, V42, P280; HAMBLIN AH, 2006, N M MUS NAT HIST SCI, V37, P276; Harris JD, 1996, CRETACEOUS RES, V17, P381, DOI 10.1006/cres.1996.0024; Haubold H., 1984, SAURIERFAHRTEN; HAUBOLD H, 1986, BEGINNING AGE DINOSA, P189; Haubold Hartmut, 2000, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V22, P59; HITCHCOCK E, 1856, AM J SCI, V21, P96; Hitchcock E., 1858, ICHNOLOGY NEW ENGLAN; HITCHCOCK EH, 1845, P 6 ANN M ASS AM GEO, V6, P23; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P21; Irby Grace V., 1996, Museum of Northern Arizona Bulletin, V60, P147; Kirkland, 2006, NEW MEXICO MUSEUM NA, V37, P510; Kirkland, 2007, UTAH GEOLOGICAL SURV, V39, P1; Kirkland J.I., 2006, NEW MEXICO MUSEUM NA, V37, P289; KIRKLAND JI, 2002, UTAH SURVEY NOTES, V34, P4; KIRKLAND JI, 2002, UTAH SURVEY NOTES, V34, P12; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Lingham-Soliar Theagarten, 2000, Ichnos, V7, P135; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Lockley Martin, 2003, Ichnos, V10, P169, DOI 10.1080/10420940390256249; Lockley Martin, 2000, Gaia (Lisboa), V15, P279; Lockley Martin G., 1996, Museum of Northern Arizona Bulletin, V60, P113; LOCKLEY MG, 2005, TRACKING DINOSAUR OR, P12; LOCKLEY MG, 2006, NEW MEXICO MUSEUM NA, V37, P269; LUCAS S.G., 2006, NEW MEXICO MUSEUM NA, V37, P421; Lucas SG, 2001, NEUES JAHRB GEOL P-M, P435; LUCAS SG, 1994, WYOMING GEOLOGICAL A, V44, P105; LUCAS SG, 1993, MUSEUM NO ARIZONA B, V59, P27; LUCAS SG, 1997, SW PALEONTOLOGICAL S, V1, P49; LUCAS SG, 2006, NEW MEXICO MUSEUM NA, V37, P128; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V29, P84; LUCAS SG, 2005, NEW MEXICO MUSEUM NA, V29, P95; LULL RS, 1953, B CONNECTICUT STATE, V81, P1; Lull RS., 1904, MEMOIRS BOSTON SOC N, V5, P461; Martin A, 2005, J VERTEBR PALEONTOL, V25, p89A; MARZOLF JE, 1991, GEOLOGY, V19, P320, DOI 10.1130/0091-7613(1991)019<0320:LJUJFT>2.3.CO;2; MARZOLF JE, 1996, MUS N ARIZ B, V60, P441; MATTHEWS NA, 2006, NEW MEXICO MUSEUM NA, V34, P119; McCrea Richard T., 2002, Journal of Vertebrate Paleontology, V22, p86A; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Milan J, 2008, ACTA PALAEONTOL POL, V53, P197, DOI 10.4202/app.2008.0203; Milner A. R. C., 2006, NEW MEXICO MUS NAT H, V37, P315; Milner A.R.C., 2006, NEW MEXICO MUS NAT H, V37, P329; MILNER ARC, 2005, GEOL SOC AM ABSTR, V37, P5; Molina-Garza RS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001909; Molnar R.E., 1985, P209; MORALES M, 1993, NEW MEXICO MUSEUM NA, V3, P357; Morales Michael, 1996, Museum of Northern Arizona Bulletin, V60, P143; Naish Darren, 2000, Archaeopteryx, V18, P35; Olsen P.E., 1986, P61; Olsen PE, 1998, J VERTEBR PALEONTOL, V18, P586, DOI 10.1080/02724634.1998.10011086; Piubelli D, 2005, BOLL SOC GEOL ITAL, V124, P259; RAIKOW RJ, 1968, WILSON BULL, V80, P312; RAINFORTH E., 1997, VERTEBRATE ICH UNPUB; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Romer A, 1956, OSTEOLOGY REPTILES; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; SAFRAN J, 2004, GEOL SOC AM ABSTR, V36, P96; Schudack M.E., 2006, TRIASSIC JURASSIC TE, V37, P427; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; SERENO PC, 2006, HIST BIOL, V19, P145; SERENO PC, 1998, DIN S APR 17 19 1998; Smith JB, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P273; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; SULLIVAN RM, 1994, GEOL, V25, P2; THULBORN RA, 1984, ALCHERINGA, V8, P243, DOI 10.1080/03115518408618947; Thulborn RA., 1990, DINOSAUR TRACKS; Tidwell WD, 2006, NEW MEXICO MUSEUM NA, V37, P414; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; VAZQUEZ RJ, 1994, ZOOMORPHOLOGY, V114, P59, DOI 10.1007/BF00574915; Weems R.E., 1992, P 26 FORUM GEOLOGY I, V119, P113; Weems RE, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P293; Weems RE, 2006, NEW MEXICO MUSEUM NA, V37, P369; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Welles S.P., 1971, Plateau, V44, P27; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu Xing, 2003, Vertebrata Palasiatica, V41, P195; YOUNG CHUNG-CHIEN, 1960, VERTEBR PALASIAT [CHINA], V4, P53; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; [No title captured]	104	56	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4591	10.1371/journal.pone.0004591	http://dx.doi.org/10.1371/journal.pone.0004591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259260	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490500002
J	Valverde, O; Celerier, E; Baranyi, M; Vanderhaeghen, P; Maldonado, R; Sperlagh, B; Vassart, G; Ledent, C				Valverde, Olga; Celerier, Evelyne; Baranyi, Maria; Vanderhaeghen, Pierre; Maldonado, Rafael; Sperlagh, Beata; Vassart, Gilbert; Ledent, Catherine			GPR3 Receptor, a Novel Actor in the Emotional-Like Responses	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; TAIL SUSPENSION TEST; MICE DEFICIENT; MOLECULAR-CLONING; INVERSE AGONIST; MEIOTIC ARREST; MUTANT MICE; ANXIETY; DEPRESSION; HABENULA	GPR3 is an orphan G protein-coupled receptor endowed with constitutive Gs signaling activity, which is expressed broadly in the central nervous system, with maximal expression in the habenula. We investigated the consequences of its genetic deletion in several behavioral paradigms and on neurotransmission. Compared to wild-type, hippocampal neurons from Gpr3(-/-) mice displayed lower basal intracellular cAMP levels, consistent with the strong constitutive activity of GPR3 in transiently transfected cells. Behavioral analyses revealed that Gpr3(-/-) mice exhibited a high level of avoidance of novel and unfamiliar environment, associated with increased stress reactivity in behavioral despair paradigms and aggressive behavior in the resident-intruder test. On the contrary, no deficit was found in the learning ability to avoid an aversive event in active avoidance task. The reduced ability of Gpr3(-/-) mice to cope with stress was unrelated to dysfunction of the hypothalamic-pituitary-adrenal axis, with Gpr3(-/-) mice showing normal corticosterone production under basal or stressful conditions. In contrast, dramatic alterations of monoamine contents were found in hippocampus, hypothalamus and frontal cortex of Gpr3(-/-) mice. Our results establish a link between tonic stimulation of the cAMP signaling pathway by GPR3 and control of neurotransmission by monoamines throughout the forebrain. GPR3 qualifies as a new player in the modulation of behavioral responses to stress and constitutes a novel promising pharmacological target for treatment of emotional disorders.	[Valverde, Olga] Univ Pompeu Fabra, Grp Recerca Neurobiol Comportament, Dept Ciencies Expt & Salut, Barcelona, Spain; [Celerier, Evelyne; Maldonado, Rafael] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Lab Neurofarmacol, Barcelona, Spain; [Baranyi, Maria; Sperlagh, Beata] Hungarian Acad Sci, Inst Expt Med, H-1051 Budapest, Hungary; [Vanderhaeghen, Pierre; Vassart, Gilbert; Ledent, Catherine] Free Univ Brussels, IRIBHM, Campus Erasme, B-1050 Brussels, Belgium	Pompeu Fabra University; Pompeu Fabra University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Valverde, O (corresponding author), Univ Pompeu Fabra, Grp Recerca Neurobiol Comportament, Dept Ciencies Expt & Salut, Barcelona, Spain.	cledent@ulb.ac.be	Valverde, Olga/D-8654-2012; Maldonado, Rafael/F-5657-2014	Valverde, Olga/0000-0003-2264-7852; Maldonado, Rafael/0000-0002-4359-8773; Vanderhaeghen, Pierre/0000-0001-7899-5720	Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy; Fondation Medicale Reine Elisabeth; Walloon Region (Programme d'Excellence "CIBLES"); Fonds National de la Recherche Scientifique; Spanish Ministry of Science and Technology [SAF2007/60249]; Spanish Ministery of Health [RD06/0001/1001]; Hungarian Research and Development Fund [OTKA 061758]	Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); Fondation Medicale Reine Elisabeth; Walloon Region (Programme d'Excellence "CIBLES"); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministery of Health; Hungarian Research and Development Fund	This work was supported by the Interuniversity Attraction Poles Programme (P6-14) - Belgian State - Belgian Science Policy, the Fondation Medicale Reine Elisabeth, the Walloon Region (Programme d'Excellence "CIBLES"), the Fonds National de la Recherche Scientifique, the Spanish Ministry of Science and Technology (SAF2007/60249), the Spanish Ministery of Health (PNSD and RD06/0001/1001) and the Hungarian Research and Development Fund (OTKA 061758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; BAGDY G, 1995, EUR J PHARMACOL, V275, P301, DOI 10.1016/0014-2999(95)00051-L; Baranyi M, 2006, J CHROMATOGR A, V1120, P13, DOI 10.1016/j.chroma.2006.03.018; Bjork JM, 1999, PSYCHOPHARMACOLOGY, V142, P24, DOI 10.1007/s002130050858; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHAMBERLAIN B, 1987, PHARMACOL BIOCHEM BE, V28, P503, DOI 10.1016/0091-3057(87)90513-2; Cherry JA, 1999, J COMP NEUROL, V407, P287; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DENG J, 2008, J BIOL CHEM, V193, P265; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Ferraro G, 1997, J NEURAL TRANSM, V104, P615, DOI 10.1007/BF01291880; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Hen R, 1996, NEURON, V16, P17, DOI 10.1016/S0896-6273(00)80019-7; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Joost P, 2002, GENOME BIOL, V3; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Leurs R, 1998, TRENDS BIOCHEM SCI, V23, P418, DOI 10.1016/S0968-0004(98)01287-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malberg JE, 2005, TRENDS PHARMACOL SCI, V26, P631, DOI 10.1016/j.tips.2005.10.005; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; PUCILOWSKI O, 1983, BEHAV BRAIN RES, V9, P33, DOI 10.1016/0166-4328(83)90012-8; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; SAEKI Y, 1993, FEBS LETT, V336, P317, DOI 10.1016/0014-5793(93)80828-I; Salas R, 2003, J NEUROSCI, V23, P6255; SANSONE M, 1975, ARCH INT PHARMACOD T, V218, P125; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; VACCARI S, 2008, DEV BIOL; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Wilson MA, 2004, PHARMACOL BIOCHEM BE, V78, P445, DOI 10.1016/j.pbb.2004.04.017; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	53	50	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4704	10.1371/journal.pone.0004704	http://dx.doi.org/10.1371/journal.pone.0004704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259266	Green Published, gold			2022-12-25	WOS:000265490500015
J	Kang, SM; Yoo, DG; Lipatov, AS; Song, JM; Davis, CT; Quan, FS; Chen, LM; Donis, RO; Compans, RW				Kang, Sang-Moo; Yoo, Dae-Goon; Lipatov, Aleksandr S.; Song, Jae-Min; Davis, C. Todd; Quan, Fu-Shi; Chen, Li-Mei; Donis, Ruben O.; Compans, Richard W.			Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles	PLOS ONE			English	Article							MEMORY B-CELLS; A VIRUS; PANDEMIC INFLUENZA; LETHAL INFLUENZA; T-CELL; MF59-ADJUVANTED INFLUENZA; VACCINE; HEMAGGLUTININ; IMMUNIZATION; CHALLENGE	Background: Recurrent outbreaks of highly pathogenic H5N1 avian influenza virus pose a threat of eventually causing a pandemic. Early vaccination of the population would be the single most effective measure for the control of an emerging influenza pandemic. Methodology/Principal Findings: Influenza virus-like particles (VLPs) produced in insect cell-culture substrates do not depend on the availability of fertile eggs for vaccine manufacturing. We produced VLPs containing influenza A/Viet Nam1203/04 (H5N1) hemagglutinin, neuraminidase, and matrix proteins, and investigated their preclinical immunogenicity and protective efficacy. Mice immunized intranasally with H5N1 VLPs developed high levels of H5N1 specific antibodies and were 100% protected against a high dose of homologous H5N1 virus infection at 30 weeks after immunization. Protection is likely to be correlated with humoral and cellular immunologic memory at systemic and mucosal sites as evidenced by rapid anamnestic responses to re-stimulation with viral antigen in vivo and in vitro. Conclusions/Significance: These results provide support for clinical evaluation of H5N1 VLP vaccination as a public health intervention to mitigate a possible pandemic of H5N1 influenza.	[Kang, Sang-Moo; Yoo, Dae-Goon; Song, Jae-Min; Quan, Fu-Shi; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Kang, Sang-Moo; Yoo, Dae-Goon; Song, Jae-Min; Quan, Fu-Shi; Compans, Richard W.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Lipatov, Aleksandr S.; Davis, C. Todd; Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA	Emory University; Emory University; Centers for Disease Control & Prevention - USA	Kang, SM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	skang2@emory.edu; compans@microbio.emory.edu	Quan, Fu-Shi/V-1826-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X	NIH/NIAID [AI0680003]; Korea Ginseng Society	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Korea Ginseng Society	This work was supported by NIH/NIAID grant AI0680003 (R.W.C.) and partially by funds from Korea Ginseng Society (S.K.). The funders did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The findings and conclusions of this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC). Proprietary or brand names used are necessary to report factually on available data. However, the CDC neither guarantees nor warrants the standard of the product, and the use of names by the CDC implies no approval of the product to the exclusion of others that may also be suitable.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], FIELDS VIROLOGY; ARORA DJS, 1985, ANAL BIOCHEM, V144, P189, DOI 10.1016/0003-2697(85)90103-4; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; BLOCK SL, 2008, SHEDDING IMMUNOGENIC; Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen JJ, 2005, VACCINE, V23, P4322, DOI 10.1016/j.vaccine.2005.03.035; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Cintra Otávio A. L., 2006, J. Pediatr. (Rio J.), V82, ps83, DOI [10.1590/S0021-75572006000400010, 10.2223/JPED.1494]; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; DESHEVA J, 2006, VACCINE; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Galarza JM, 2005, VIRAL IMMUNOL, V18, P244, DOI 10.1089/vim.2005.18.244; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; LU X, 2006, VACCINE; Luke CJ, 2006, EMERG INFECT DIS, V12, P66, DOI 10.3201/eid1201.051147; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Pushko P, 2007, VACCINE, V25, P4283, DOI 10.1016/j.vaccine.2007.02.059; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Ruat C, 2008, J VIROL, V82, P2565, DOI 10.1128/JVI.01928-07; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Slifka MK, 1996, J VIROL, V70, P2902, DOI 10.1128/JVI.70.5.2902-2910.1996; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; SUGUITAN AL, 2006, PLOS MED, V360, pN1; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Trollfors B, 2006, ACTA PAEDIATR, V95, P774, DOI 10.1080/08035250600729126; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1988, VIROLOGY, V164, P230, DOI 10.1016/0042-6822(88)90640-X; Wu HY, 1997, SCAND J IMMUNOL, V46, P506, DOI 10.1046/j.1365-3083.1997.d01-159.x; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008	54	88	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4667	10.1371/journal.pone.0004667	http://dx.doi.org/10.1371/journal.pone.0004667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252744	Green Published, Green Submitted, gold			2022-12-25	WOS:000265489900009
J	Reich, J; Snee, MJ; Macdonald, PM				Reich, John; Snee, Mark J.; Macdonald, Paul M.			miRNA-Dependent Translational Repression in the Drosophila Ovary	PLOS ONE			English	Article							OSKAR MESSENGER-RNA; SELFISH GENETIC ELEMENTS; BINDING-PROTEIN; LOCALIZATION; MICRORNA; AUBERGINE; INITIATION; DECAY; ASSOCIATION; MECHANISM	Background: The Drosophila ovary is a tissue rich in post-transcriptional regulation of gene expression. Many of the regulatory factors are proteins identified via genetic screens. The more recent discovery of microRNAs, which in other animals and tissues appear to regulate translation of a large fraction of all mRNAs, raised the possibility that they too might act during oogenesis. However, there has been no direct demonstration of microRNA-dependent translational repression in the ovary. Methodology/Principal Findings: Here, quantitative analyses of transcript and protein levels of transgenes with or without synthetic miR-312 binding sites show that the binding sites do confer translational repression. This effect is dependent on the ability of the cells to produce microRNAs. By comparison with microRNA-dependent translational repression in other cell types, the regulated mRNAs and the protein factors that mediate repression were expected to be enriched in sponge bodies, subcellular structures with extensive similarities to the P bodies found in other cells. However, no such enrichment was observed. Conclusions/Significance: Our results reveal the variety of post-transcriptional regulatory mechanisms that operate in the Drosophila ovary, and have implications for the mechanisms of miRNA-dependent translational control used in the ovary.	[Reich, John; Snee, Mark J.; Macdonald, Paul M.] Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Reich, J (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	pmacdonald@mail.utexas.edu		Snee, Mark/0000-0003-4018-816X	NIH [GM54409, 1-FY08-445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant GM54409 and in part by Research Grant No. 1-FY08-445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burgler C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-88; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cox DN, 2000, DEVELOPMENT, V127, P503; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Snee M, 2008, RNA BIOL, V5, P49, DOI 10.4161/rna.5.1.5735; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; SNEE MJ, 2009, DEV DYNAMIC IN PRESS; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	65	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4669	10.1371/journal.pone.0004669	http://dx.doi.org/10.1371/journal.pone.0004669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252745	gold, Green Published, Green Submitted			2022-12-25	WOS:000265489900010
J	Duellman, SJ; Burgess, RR				Duellman, Sarah J.; Burgess, Richard R.			Antigen-Binding Properties of Monoclonal Antibodies Reactive with EBNA1 and Use in Immunoaffinity Chromatography	PLOS ONE			English	Article								Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) was overexpressed and purified from Escherichia coli. Mouse monoclonal antibodies (mAbs) were prepared that react with EBNA1. Eleven high affinity mAbs were recovered. Nine mAbs are isotype IgG (all subisotype IgG(1)) and two mAbs are isotype IgM. All mAbs react strongly with EBNA1 in an ELISA assay while only one mAb (designated 1EB6) fails to react in a Western blot assay. The epitopes for these mAbs were mapped to seven different regions, providing good coverage of the entire EBNA1 protein. The mAbs had differing affinity for an EBNA1/DNA complex with four mAbs able to supershift the complex completely. All mAbs can immunoprecipitate EBNA1 from E. coli overexpressing EBNA1. A modified ELISA assay, termed ELISA-elution assay, was used to screen for mAbs that release EBNA1 in the presence of a low molecular weight polyhydroxylated compound (polyol) and a nonchaotropic salt. MAbs with this property, termed polyol-responsive (PR)-mAbs, allow gentle elution of labile proteins and protein complexes. Four mAbs are polyol-responsive with two showing usefulness in gentle immunoaffinity chromatography. Purification with these PR-mAbs may be useful in purifying EBNA1 complexes and elucidating EBNA1-associated proteins. This panel of anti-EBNA1 mAbs will advance the study of EBV by providing new tools to detect and purify EBNA1.	[Duellman, Sarah J.; Burgess, Richard R.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Duellman, SJ (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	burgess@oncology.wisc.edu						Aiyar A, 1998, J BIOL CHEM, V273, P33073, DOI 10.1074/jbc.273.49.33073; Bochkarev A, 1996, CELL, V84, P791, DOI 10.1016/S0092-8674(00)81056-9; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Duellman SJ, 2006, PROTEIN EXPRES PURIF, V47, P434, DOI 10.1016/j.pep.2005.11.023; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; GAHN TA, 1995, J VIROL, V69, P2633, DOI 10.1128/JVI.69.4.2633-2636.1995; GRASSER FA, 1994, BLOOD, V84, P3792, DOI 10.1182/blood.V84.11.3792.bloodjournal84113792; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; Kennedy G, 2003, MOL CELL BIOL, V23, P6901, DOI 10.1128/MCB.23.19.6901-6908.2003; Lee MA, 1999, J VIROL, V73, P2974, DOI 10.1128/JVI.73.4.2974-2982.1999; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Lynch NA, 1996, APPL ENVIRON MICROB, V62, P2133, DOI 10.1128/AEM.62.6.2133-2137.1996; MACKEY D, 1995, J VIROL, V69, P6199, DOI 10.1128/JVI.69.10.6199-6208.1995; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shire K, 2006, J VIROL, V80, P5261, DOI 10.1128/JVI.02682-05; SU W, 1991, P NATL ACAD SCI USA, V88, P10870, DOI 10.1073/pnas.88.23.10870; SUGDEN B, 1989, J VIROL, V63, P2644, DOI 10.1128/JVI.63.6.2644-2649.1989; Thompson N.E., 2001, CURRENT PROTOCOLS MO; Thompson NE, 1996, METHOD ENZYMOL, V274, P513; THOMPSON NE, 1992, BIOCHEMISTRY-US, V31, P7003, DOI 10.1021/bi00145a019; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	25	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4614	10.1371/journal.pone.0004614	http://dx.doi.org/10.1371/journal.pone.0004614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242546	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500016
J	Gandhi, J; Zhang, JL; Xie, Y; Soh, J; Shigematsu, H; Zhang, W; Yamamoto, H; Peyton, M; Girard, L; Lockwood, WW; Lam, WL; Varella-Garcia, M; Minna, JD; Gazdar, AF				Gandhi, Jeet; Zhang, Jianling; Xie, Yang; Soh, Junichi; Shigematsu, Hisayuki; Zhang, Wei; Yamamoto, Hiromasa; Peyton, Michael; Girard, Luc; Lockwood, William W.; Lam, Wan L.; Varella-Garcia, Marileila; Minna, John D.; Gazdar, Adi F.			Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines	PLOS ONE			English	Article								Background: Deregulation of EGFR signaling is common in non-small cell lung cancers (NSCLC) and this finding led to the development of tyrosine kinase inhibitors (TKIs) that are highly effective in a subset of NSCLC. Mutations of EGFR (mEGFR) and copy number gains (CNGs) of EGFR (gEGFR) and HER2 (gHER2) have been reported to predict for TKI response. Mutations in KRAS (mKRAS) are associated with primary resistance to TKIs. Methodology/Principal Findings: We investigated the relationship between mutations, CNGs and response to TKIs in a large panel of NSCLC cell lines. Genes studied were EGFR, HER2, HER3 HER4, KRAS, BRAF and PIK3CA. Mutations were detected by sequencing, while CNGs were determined by quantitative PCR (qPCR), fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH). IC50 values for the TKIs gefitinib (Iressa) and erlotinib (Tarceva) were determined by MTS assay. For any of the seven genes tested, mutations (39/77, 50.6%), copy number gains (50/77, 64.9%) or either (65/77, 84.4%) were frequent in NSCLC lines. Mutations of EGFR (13%) and KRAS (24.7%) were frequent, while they were less frequent for the other genes. The three techniques for determining CNG were well correlated, and qPCR data were used for further analyses. CNGs were relatively frequent for EGFR and KRAS in adenocarcinomas. While mutations were largely mutually exclusive, CNGs were not. EGFR and KRAS mutant lines frequently demonstrated mutant allele specific imbalance i.e. the mutant form was usually in great excess compared to the wild type form. On a molar basis, sensitivity to gefitinib and erlotinib were highly correlated. Multivariate analyses led to the following results: 1. mEGFR and gEGFR and gHER2 were independent factors related to gefitinib sensitivity, in descending order of importance. 2. mKRAS was associated with increased in vitro resistance to gefitinib. Conclusions/Significance: Our in vitro studies confirm and extend clinical observations and demonstrate the relative importance of both EGFR mutations and CNGs and HER2 CNGs in the sensitivity to TKIs.	[Gandhi, Jeet; Zhang, Jianling; Soh, Junichi; Shigematsu, Hisayuki; Zhang, Wei; Yamamoto, Hiromasa; Peyton, Michael; Girard, Luc; Minna, John D.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA; [Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX USA; [Lockwood, William W.; Lam, Wan L.] British Columbia Canc Res Ctr, Dept Canc Genet & Dev Biol, Vancouver, BC, Canada; [Varella-Garcia, Marileila] Univ Colorado Canc Ctr, Dept Internal Med, Aurora, CO USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; British Columbia Cancer Agency; University of Colorado System; University of Colorado Anschutz Medical Campus	Gandhi, J (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	adi.gazdar@utsouthwestern.edu	Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; Peyton, Michael/A-8728-2008; Lockwood, William W/A-2879-2009	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; 	Specialized Program of Research Excellence in Lung Cancer [P50CA70907]; Early Detection Research Network, National Cancer Institute, Bethesda, Maryland [U01CA084971]; NATIONAL CANCER INSTITUTE [U01CA084971, P50CA070907] Funding Source: NIH RePORTER	Specialized Program of Research Excellence in Lung Cancer; Early Detection Research Network, National Cancer Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was recieved from the Specialized Program of Research Excellence in Lung Cancer (P50CA70907) and Early Detection Research Network, National Cancer Institute, Bethesda, Maryland (U01CA084971). Funds from both grants were utilized for salary support and for performance of assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieche I, 1999, CLIN CHEM, V45, P1148; Cappuzzo F, 2005, BRIT J CANCER, V93, P1334, DOI 10.1038/sj.bjc.6602865; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; EVERIT B, 1994, STAT METHODS MED INV; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Galanis E, 1997, CANCER-AM CANCER SOC, V79, P1729, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1729::AID-CNCR14>3.0.CO;2-#; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; GAZDAR AF, 2008, CANCER PREV RES, V1, P6; Gondek LP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001225; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Jung SH, 2001, STAT MED, V20, P1971, DOI 10.1002/sim.846.abs; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lockwood WW, 2007, INT J CANCER, V120, P436, DOI 10.1002/ijc.22335; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Lyng H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r86; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Mellinghoff IK, 2007, CLIN CANCER RES, V13, P378, DOI 10.1158/1078-0432.CCR-06-1992; Naoki K, 2002, CANCER RES, V62, P7001; NETTER J, 1996, APPL LINEAR STAT MOD; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nomura M, 2007, PLOS MED, V4, P715, DOI 10.1371/journal.pmed.0040125; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; PAWSON T, 1994, BIOCHEM SOC T, V22, P455, DOI 10.1042/bst0220455; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rosenberg C, 1997, CYTOMETRY, V29, P113, DOI 10.1002/(SICI)1097-0320(19971001)29:2<113::AID-CYTO3>3.0.CO;2-E; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2007, J THORAC ONCOL, V2, pS68, DOI 10.1097/01.JTO.0000269737.05962.a0; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soh J, 2008, J THORAC ONCOL, V3, P340, DOI 10.1097/JTO.0b013e318168d20a; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; TANG X, 2008, CANCER PREV RES, V1, P9; Tyybakinoja A, 2008, HAEMATOLOGICA, V93, P631, DOI 10.3324/haematol.12232; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Varella-Garcia M, 2003, ONCOLOGIST, V8, P45, DOI 10.1634/theoncologist.8-1-45; YAMAMOTO H, 2008, CANC RES, V68; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211; Zhang J, 2008, CANCER PREV RES, V1, P201, DOI 10.1158/1940-6207.CAPR-08-0014; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	54	160	164	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4576	10.1371/journal.pone.0004576	http://dx.doi.org/10.1371/journal.pone.0004576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238210	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487400009
J	Novakovic, B; Sibson, M; Ng, HK; Manuelpillai, U; Rakyan, V; Down, T; Beck, S; Fournier, T; Evain-Brion, D; Dimitriadis, E; Craig, JM; Morley, R; Saffery, R				Novakovic, Boris; Sibson, Mandy; Ng, Hong Kiat; Manuelpillai, Ursula; Rakyan, Vardhman; Down, Thomas; Beck, Stephan; Fournier, Thierry; Evain-Brion, Danielle; Dimitriadis, Eva; Craig, Jeffrey M.; Morley, Ruth; Saffery, Richard			Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 DIABETES-MELLITUS; D-RESISTANT RICKETS; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; DNA METHYLATION; EARLY-PREGNANCY; EPIGENETIC REGULATION; METABOLIC-CLEARANCE; ADDISONS-DISEASE	Plasma concentrations of biologically active vitamin D (1,25(OH)(2)D) are tightly controlled via feedback regulation of renal 1 alpha-hydroxylase (CYP27B1; positive) and 24-hydroxylase (CYP24A1; catabolic) enzymes. In pregnancy, this regulation is uncoupled, and 1,25-(OH)(2)D levels are significantly elevated, suggesting a role in pregnancy progression. Epigenetic regulation of CYP27B1 and CYP24A1 has previously been described in cell and animal models, and despite emerging evidence for a critical role of epigenetics in placentation generally, little is known about the regulation of enzymes modulating vitamin D homeostasis at the fetomaternal interface. In this study, we investigated the methylation status of genes regulating vitamin D bioavailability and activity in the placenta. No methylation of the VDR (vitamin D receptor) and CYP27B1 genes was found in any placental tissues. In contrast, the CYP24A1 gene is methylated in human placenta, purified cytotrophoblasts, and primary and cultured chorionic villus sampling tissue. No methylation was detected in any somatic human tissue tested. Methylation was also evident in marmoset and mouse placental tissue. All three genes were hypermethylated in choriocarcinoma cell lines, highlighting the role of vitamin D deregulation in this cancer. Gene expression analysis confirmed a reduced capacity for CYP24A1 induction with promoter methylation in primary cells and in vitro reporter analysis demonstrated that promoter methylation directly down-regulates basal promoter activity and abolishes vitamin D-mediated feedback activation. This study strongly suggests that epigenetic decoupling of vitamin D feedback catabolism plays an important role in maximizing active vitamin D bioavailability at the fetomaternal interface.	[Novakovic, Boris; Sibson, Mandy; Ng, Hong Kiat; Craig, Jeffrey M.; Morley, Ruth; Saffery, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Ng, Hong Kiat; Craig, Jeffrey M.; Morley, Ruth; Saffery, Richard] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Rakyan, Vardhman] Barts & London, Inst Cell & Mol Sci, London E1 2AT, England; [Down, Thomas] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; [Down, Thomas] Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; [Beck, Stephan] UCL, UCL Canc Inst, London WC1E 6BT, England; [Fournier, Thierry; Evain-Brion, Danielle] Univ Paris 05, INSERM, U427, Fac Sci Pharmaceut & Biol, F-75006 Paris, France; [Dimitriadis, Eva] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of London; Queen Mary University London; University of Cambridge; University of Cambridge; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Prince Henry's Institute of Medical Research	Saffery, R (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	richard.saffery@mcri.edu.au	Craig, Jeffrey M/B-3484-2012; Fournier, Thierry C/E-5836-2016; dimitriadis, e/AAD-7601-2021; Saffery, Richard/GLS-1976-2022; Novakovic, Boris/D-8018-2013	Craig, Jeffrey M/0000-0003-3979-7849; Saffery, Richard/0000-0002-9510-4181; Novakovic, Boris/0000-0002-5623-9008; dimitriadis, eva/0000-0003-1425-950X; Fournier, Thierry/0000-0002-7515-339X	Wellcome Trust [084071]; National Health and Medical Research Council Research Fellowships	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	Supported by Wellcome Trust Grant 084071.; Supported by National Health and Medical Research Council Research Fellowships.	Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; Avila E, 2007, J STEROID BIOCHEM, V103, P90, DOI 10.1016/j.jsbmb.2006.07.010; Barrera D, 2007, J STEROID BIOCHEM, V103, P529, DOI 10.1016/j.jsbmb.2006.12.097; Barrera D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-3; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chung I, 2007, J BIOL CHEM, V282, P8704, DOI 10.1074/jbc.M608894200; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; d'Alesio A, 2005, HUM MOL GENET, V14, P3539, DOI 10.1093/hmg/ddi382; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DELVIN EE, 1985, J CLIN ENDOCR METAB, V60, P880, DOI 10.1210/jcem-60-5-880; DELVIN EE, 1982, ARCH DIS CHILD, V57, P754, DOI 10.1136/adc.57.10.754; Diaz L, 2002, J CLIN ENDOCR METAB, V87, P3876, DOI 10.1210/jc.87.8.3876; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Dodds L, 2008, CLIN CHEM, V54, P326, DOI 10.1373/clinchem.2007.097469; Du HL, 2005, MOL ENDOCRINOL, V19, P2222, DOI 10.1210/me.2004-0336; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Fischer D, 2007, CLIN EXP OBSTET GYN, V34, P80; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Holick CN, 2007, CANCER EPIDEM BIOMAR, V16, P1990, DOI 10.1158/1055-9965.EPI-07-0487; Jennings CE, 2005, J MOL ENDOCRINOL, V34, P859, DOI 10.1677/jme.1.01760; Kim S, 2008, Pac Symp Biocomput, P315; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; KUMAR R, 1984, PHYSIOL REV, V64, P478, DOI 10.1152/physrev.1984.64.2.478; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lechner D, 2007, MOL CELL ENDOCRINOL, V263, P55, DOI 10.1016/j.mce.2006.08.009; Li HW, 2002, PLACENTA, V23, P20, DOI 10.1053/plac.2001.0744; Liu N, 2009, BIOL REPROD, V80, P398, DOI 10.1095/biolreprod.108.073577; LOHNES D, 1987, J BIOL CHEM, V262, P14394; Lopez ER, 2004, J STEROID BIOCHEM, V89-90, P155, DOI 10.1016/j.jsbmb.2004.03.095; Lopez ER, 2004, EUR J ENDOCRINOL, V151, P193, DOI 10.1530/eje.0.1510193; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Malloy PJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P285, DOI 10.1016/j.abb.2006.09.027; Masuda S, 2006, MOL CANCER THER, V5, P797, DOI 10.1158/1535-7163.MCT-05-0539; Muller K, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996, V1, P68; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nelen WLDM, 2000, FERTIL STERIL, V74, P1196, DOI 10.1016/S0015-0282(00)01595-8; Nelen WLDM, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(97)24038-9; Nelen WLDM, 1998, J NUTR, V128, P1336, DOI 10.1093/jn/128.8.1336; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; OHYAMA Y, 2002, NUCL ACIDS RES S, V2, P249; PATTILLO RA, 1968, CANCER RES, V28, P1231; PATTILLO RA, 1971, ANN NY ACAD SCI, V172, P288, DOI 10.1111/j.1749-6632.1971.tb34942.x; PAULSON SK, 1990, AM J PHYSIOL, V258, pE158, DOI 10.1152/ajpendo.1990.258.1.E158; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; PEEHL DM, 1994, CANCER RES, V54, P805; Pendas-Franco N, 2008, ONCOGENE, V27, P4467, DOI 10.1038/onc.2008.88; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; RON M, 1984, AM J OBSTET GYNECOL, V148, P370, DOI 10.1016/0002-9378(84)90709-9; ROSS R, 1989, PEDIATR RES, V26, P633, DOI 10.1203/00006450-198912000-00024; ROSS R, 1990, PEDIATR RES, V27, pA192; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Seely EW, 2007, J CLIN ENDOCR METAB, V92, P3402, DOI 10.1210/jc.2007-1554; Serman L, 2007, PLACENTA, V28, P803, DOI 10.1016/j.placenta.2007.04.001; Shih Ie-Ming, 2002, Current Molecular Medicine (Hilversum), V2, P1; Sikora J, 2007, NEUROENDOCRINOL LETT, V28, P507; SIUCALDERA ML, 1995, ENDOCRINOLOGY, V136, P4195, DOI 10.1210/en.136.10.4195; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; STEPHANOU A, 1994, ENDOCRINOLOGY, V135, P2651, DOI 10.1210/en.135.6.2651; Sung V, 2000, MOL CELL ENDOCRINOL, V164, P133, DOI 10.1016/S0303-7207(00)00226-4; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tashiro K, 2007, BIOCHEM BIOPH RES CO, V358, P259, DOI 10.1016/j.bbrc.2007.04.103; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; TSANG RC, 1981, CLIN PERINATOL, V8, P287, DOI 10.1016/S0095-5108(18)31081-9; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; van der Molen EF, 2000, AM J OBSTET GYNECOL, V182, P1258, DOI 10.1067/mob.2000.105199; Vigano P, 2006, J MOL ENDOCRINOL, V36, P415, DOI 10.1677/jme.1.01946; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Wietrzyk J, 2008, ONCOL REP, V20, P941, DOI 10.3892/or_00000094; Wong NC, 2008, CANCER LETT, V268, P56, DOI 10.1016/j.canlet.2008.03.033; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Xie ZJ, 2002, J BIOL CHEM, V277, P36987, DOI 10.1074/jbc.M201404200; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhou YL, 2009, J BONE MINER RES, V24, P643, DOI 10.1359/JBMR.081216	89	187	194	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14838	14848		10.1074/jbc.M809542200	http://dx.doi.org/10.1074/jbc.M809542200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19237542	Green Published, hybrid			2022-12-25	WOS:000266288200019
J	Panchal, RG; Ulrich, RL; Bradfute, SB; Lane, D; Ruthel, G; Kenny, TA; Iversen, PL; Anderson, AO; Gussio, R; Raschke, WC; Bavari, S				Panchal, Rekha G.; Ulrich, Ricky L.; Bradfute, Steven B.; Lane, Douglas; Ruthel, Gordon; Kenny, Tara A.; Iversen, Patrick L.; Anderson, Arthur O.; Gussio, Rick; Raschke, William C.; Bavari, Sina			Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; LETHAL TOXIN; MACROPHAGES; INHIBITORS; KINASE; INTERNALIZATION; EXPLOITATION; REGULATOR; INFECTION; APOPTOSIS	The modulation of cellular processes by small molecule inhibitors, gene inactivation, or targeted knockdown strategies combined with phenotypic screens are powerful approaches to delineate complex cellular pathways and to identify key players involved in disease pathogenesis. Using chemical genetic screening, we tested a library of known phosphatase inhibitors and identified several compounds that protected Bacillus anthracis infected macrophages from cell death. The most potent compound was assayed against a panel of sixteen different phosphatases of which CD45 was found to be most sensitive to inhibition. Testing of a known CD45 inhibitor and antisense phosphorodiamidate morpholino oligomers targeting CD45 also protected B. anthracis-infected macrophages from cell death. However, reduced CD45 expression did not protect anthrax lethal toxin ( LT) treated macrophages, suggesting that the pathogen and independently added LT may signal through distinct pathways. Subsequent, in vivo studies with both gene-targeted knockdown of CD45 and genetically engineered mice expressing reduced levels of CD45 resulted in protection of mice after infection with the virulent Ames B. anthracis. Intermediate levels of CD45 expression were critical for the protection, as mice expressing normal levels of CD45 or disrupted CD45 phosphatase activity or no CD45 all succumbed to this pathogen. Mechanism-based studies suggest that the protection provided by reduced CD45 levels results from regulated immune cell homeostasis that may diminish the impact of apoptosis during the infection. To date, this is the first report demonstrating that reduced levels of host phosphatase CD45 modulate anthrax pathogenesis.	[Panchal, Rekha G.; Ulrich, Ricky L.; Bradfute, Steven B.; Ruthel, Gordon; Anderson, Arthur O.; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Lane, Douglas; Kenny, Tara A.] NCI, NIH, Target Struct Based Drug Discovery Grp, SAIC Frederick Inc, Frederick, MD 21702 USA; [Iversen, Patrick L.] AVI BioPharma Inc, Corvallis, OR 97333 USA; [Gussio, Rick] NCI, NIH, Target Struct Based Drug Discovery Grp, Informat Technol Branch,Dev Therapeut Program, Frederick, MD 21702 USA; [Raschke, William C.] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Raschke, William C.] Virogenics Inc, Del Mar, CA 92014 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Panchal, RG (corresponding author), USA, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.	rekha.panchal@amedd.army.mil; sina.bavari@amedd.army.mil	Iversen, Patrick L/D-8854-2019; Bavari, Sina/L-3642-2019; Ruthel, Gordon/GYU-9133-2022; Iversen, Patrick L./L-5454-2019; Panchal, Rekha/None	Iversen, Patrick L/0000-0003-0106-9790; Bavari, Sina/0000-0001-8424-5635; Iversen, Patrick L./0000-0003-0106-9790; Panchal, Rekha/0000-0001-8621-9078	National Institutes of Health [N01-CO-12400, R43 A1055102]; Defense Threat Reduction Agency; NIAID; Developmental Therapeutics Program; Division of Cancer Treatment and Diagnosis of the NCI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Developmental Therapeutics Program; Division of Cancer Treatment and Diagnosis of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)	This work was supported, in whole or in part, by National Institutes of Health Grant N01-CO-12400, by the Defense Threat Reduction Agency (to S. B. and R. G. P.), the NIAID, National Institutes of Health Grant R43 A1055102 (to W. C. R.), and by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the NCI, National Institutes of Health.	Agrawal A, 2004, CELL MOL LIFE SCI, V61, P2859, DOI 10.1007/s00018-004-4251-4; Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; BERGER SA, 1994, J EXP MED, V180, P471, DOI 10.1084/jem.180.2.471; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Bottini N, 2002, ARCH IMMUNOL THER EX, V50, P95; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brossier F, 2000, INFECT IMMUN, V68, P1781, DOI 10.1128/IAI.68.4.1781-1786.2000; Cote CK, 2004, MICROB PATHOGENESIS, V37, P169, DOI 10.1016/j.micpath.2004.06.013; Crawford MA, 2009, INFECT IMMUN, V77, P1664, DOI 10.1128/IAI.01208-08; DESAI DM, 1994, EMBO J, V13, P4002, DOI 10.1002/j.1460-2075.1994.tb06716.x; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; Gao HL, 2000, EXP HEMATOL, V28, P1062, DOI 10.1016/S0301-472X(00)00513-0; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Kang TJ, 2008, EUR J IMMUNOL, V38, P1574, DOI 10.1002/eji.200838141; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; Lazo JS, 2003, ONCOL RES, V13, P347; Lazo JS, 2002, MOL PHARMACOL, V61, P720, DOI 10.1124/mol.61.4.720; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Montoya M, 2006, EUR J IMMUNOL, V36, P2150, DOI 10.1002/eji.200535304; Moulton HM, 2004, BIOCONJUGATE CHEM, V15, P290, DOI 10.1021/bc034221g; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Nandan D, 2000, J LEUKOCYTE BIOL, V67, P464, DOI 10.1002/jlb.67.4.464; Panchal RG, 2007, CHEM BIOL, V14, P245, DOI 10.1016/j.chembiol.2007.01.007; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pei ZH, 2004, CURR PHARM DESIGN, V10, P3481, DOI 10.2174/1381612043382954; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Pickering AK, 2004, INFECT IMMUN, V72, P6382, DOI 10.1128/IAI.72.11.6382-6389.2004; Piercy J, 2006, IMMUNOLOGY, V118, P250, DOI 10.1111/j.1365-2567.2006.02363.x; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Ryan PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001817; SHEN F, 1995, J IMMUNOL, V154, P644; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Umezawa K, 2003, PHARMACOL THERAPEUT, V99, P15, DOI 10.1016/S0163-7258(03)00050-0; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Virts EL, 2003, BLOOD, V101, P849, DOI 10.1182/blood-2002-07-1969; Virts EL, 2001, J BIOL CHEM, V276, P19913, DOI 10.1074/jbc.M100448200; Walberg K, 2008, J INTERF CYTOK RES, V28, P597, DOI 10.1089/jir.2007.0143; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Zamoyska R, 2007, IMMUNITY, V27, P421, DOI 10.1016/j.immuni.2007.08.009	56	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12874	12885		10.1074/jbc.M809633200	http://dx.doi.org/10.1074/jbc.M809633200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269962	Green Published, hybrid			2022-12-25	WOS:000265688300033
J	Yuan, HJ; Vance, KM; Junge, CE; Geballe, MT; Snyder, JP; Hepler, JR; Yepes, M; Low, CM; Traynelis, SF				Yuan, Hongjie; Vance, Katie M.; Junge, Candice E.; Geballe, Matthew T.; Snyder, James P.; Hepler, John R.; Yepes, Manuel; Low, Chian-Ming; Traynelis, Stephen F.			The Serine Protease Plasmin Cleaves the Amino-terminal Domain of the NR2A Subunit to Relieve Zinc Inhibition of the N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; HUMAN-FIBRINOGEN; BINDING-SITE; NR1 SUBUNIT; ACTIVATOR; THROMBIN	Zinc is hypothesized to be co-released with glutamate at synapses of the central nervous system. Zinc binds to NR1/NR2A N-methyl-D-aspartate (NMDA) receptors with high affinity and inhibits NMDAR function in a voltage-independent manner. The serine protease plasmin can cleave a number of substrates, including protease activated receptors, and may play an importantrole in several disorders of the central nervous system, including ischemia and spinal cord injury. Here, we demonstrate that plasmin can cleave the native NR2A amino-terminal domain (NR2A(ATD)), removing the functional high affinity Zn2+ binding site. Plasmin also cleaves recombinant NR2A(ATD) at lysine 317 (Lys(317)), thereby producing a similar to 40-kDa fragment, consistent with plasmin-induced NR2A cleavage fragments observed in rat brain membrane preparations. A homology model of the NR2AATD predicts that Lys317 is near the surface of the protein and is accessible to plasmin. Recombinant expression of NR2A with an amino-terminal deletion at Lys(317) is functional and Zn2+ insensitive. Whole cell voltage-clamp recordings show that Zn2+ inhibition of agonist-evoked NMDA receptor currents of NR1/NR2A-transfected HEK 293 cells and cultured cortical neurons is significantly reduced by plasmin treatment. Mutating the plasmin cleavage site Lys317 on NR2A to alanine blocks the effect of plasmin on Zn2+ inhibition. The relief of Zn2+ inhibition by plasmin occurs in PAR1(-/-) cortical neurons and thus is independent of interaction with protease-activated receptors. These results suggest that plasmin can directly interact with NMDA receptors, and plasmin may increase NMDA receptor responses through disruption or removal of the amino-terminal domain and relief of Zn2+ inhibition.	[Yuan, Hongjie; Vance, Katie M.; Junge, Candice E.; Hepler, John R.; Traynelis, Stephen F.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Pharmacol, Atlanta, GA 30322 USA; [Geballe, Matthew T.; Snyder, James P.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Chem, Atlanta, GA 30322 USA; [Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Neurol, Atlanta, GA 30322 USA; [Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore S117597, Singapore	Emory University; Emory University; Emory University; National University of Singapore	Traynelis, SF (corresponding author), Emory Univ, Rollins Res Ctr 5062, 1510 Clifton Rd, Atlanta, GA 30322 USA.	strayne@emory.edu	Yepes, Manuel/C-3576-2011; Low, Chian-Ming/V-9271-2017	Low, Chian-Ming/0000-0002-1154-4842; Yuan, Hongjie/0000-0002-8127-7145	National Institutes of Health NINDS [NS39419, NS36654]; National Alliance for Research on Schizophrenia and Depression; Michael J. Fox Foundation for Parkinson's Research; National Medical Research Council; Biomedical Research Council; Academic Research Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036654, R01NS036654, R01NS039419] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Michael J. Fox Foundation for Parkinson's Research; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Academic Research Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grants NS39419 and NS36654 (to S. F. T.). This work was also supported by grants from National Alliance for Research on Schizophrenia and Depression (to S.F.T.), the Michael J. Fox Foundation for Parkinson's Research (toS. F. T.), National Medical Research Council (to C. M. L.), Biomedical Research Council (to C. M. L.), and Academic Research Funds (to C. M. L.).	Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Biswas N, 2008, ENDOCRINOLOGY, V149, P749, DOI 10.1210/en.2007-0838; Bokesch PM, 2006, STROKE, V37, P1432, DOI 10.1161/01.STR.0000221295.14547.c8; Carmeliet P, 1997, CURR OPIN LIPIDOL, V8, P118, DOI 10.1097/00041433-199704000-00010; CHAIN D, 1991, FEBS LETT, V285, P251, DOI 10.1016/0014-5793(91)80810-P; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Dambinova SA, 2002, STROKE, V33, P1181, DOI 10.1161/01.STR.0000014922.83673.86; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Gray K, 2008, FEBS LETT, V582, P907, DOI 10.1016/j.febslet.2008.02.026; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kidwell CS, 2008, CEREBROVASC DIS, V25, P338, DOI 10.1159/000118379; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LIOTTA LA, 1981, CANCER RES, V41, P4629; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Mannaioni G, 2008, J BIOL CHEM, V283, P20600, DOI 10.1074/jbc.M803015200; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P351, DOI 10.1113/jphysiol.1989.sp017725; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Novak JF, 1997, J BONE MINER RES, V12, P1035, DOI 10.1359/jbmr.1997.12.7.1035; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Pryzdial ELG, 1999, J BIOL CHEM, V274, P8500, DOI 10.1074/jbc.274.13.8500; Qureshi N, 1996, NEW ENGL J MED, V334, P1406; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6; Sheehan JJ, 2005, GLIA, V50, P340, DOI 10.1002/glia.20150; SOUTHAN C, 1985, J BIOL CHEM, V260, P3095; Stys PK, 2007, TRENDS PHARMACOL SCI, V28, P561, DOI 10.1016/j.tips.2007.10.003; TAKAGI T, 1975, BIOCHEMISTRY-US, V14, P5149, DOI 10.1021/bi00694a020; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tsirka SE, 1997, J MOL MED, V75, P341, DOI 10.1007/s001090050119; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; Wong E, 2005, PROTEIN SCI, V14, P2275, DOI 10.1110/ps.051509905; Woodburn V L, 1994, Adv Pharmacol, V30, P1, DOI 10.1016/S1054-3589(08)60170-2; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408	76	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12862	12873		10.1074/jbc.M805123200	http://dx.doi.org/10.1074/jbc.M805123200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240037	Green Published, hybrid			2022-12-25	WOS:000265688300032
J	Ermak, G; Hench, KJ; Chang, KT; Sachdev, S; Davies, KJA				Ermak, Gennady; Hench, Karl J.; Chang, Kevin T.; Sachdev, Sean; Davies, Kelvin J. A.			Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; DOWN-SYNDROME; DSCR1 ADAPT78; INHIBITS CALCINEURIN; OXIDATIVE STRESS; ST14A CELLS; PHOSPHORYLATION; PROTEIN; EXPRESSION; CALCIUM	Our work suggests an important new link between the RCAN1 gene and Huntington disease. Huntington disease is caused by expansion of glutamine repeats in the huntingtin protein. How the huntingtin protein with expanded polyglutamines (mutant huntingtin) causes the disease is still unclear, but phosphorylation of huntingtin appears to be protective. Increased huntingtin phosphorylation can be produced either by inhibition of the phosphatase calcineurin or by activation of the Akt kinase. The RCAN1 gene encodes regulators of calcineurin, and we now demonstrate, for the first time, that RCAN1-1L is depressed in Huntington disease. We also show that RCAN1-1L overexpression can protect against mutant huntingtin toxicity in an ST14A cell culture model of Huntington disease and that increased phosphorylation of huntingtin via calcineurin inhibition, rather than via Akt induction or activation, is the likely mechanism by which RCAN1-1L may be protective against mutant huntingtin. These findings suggest that RCAN1-1L "deficiency" may actually play a role in the etiology of Huntington disease. In addition, our results allow for the possibility that controlled overexpression of RCAN1-1L in the striatal region of the brain might be a viable avenue for therapeutic intervention in Huntington disease patients (and perhaps other polyglutamine expansion disorders).	[Davies, Kelvin J. A.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Div Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Davies, Kelvin/0000-0001-7790-3003	CHDI Foundation, Inc.; NINDS; National Institutes of Health; National Institute of Mental Health; National Multiple Sclerosis Society; Department of Veterans Affairs	CHDI Foundation, Inc.; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the CHDI Foundation, Inc. All tissue specimens were obtained from the Human Brain and Spinal Fluid Resource Center of the Veterans Affairs West Los Angeles Healthcare Center, which is supported by NINDS, National Institutes of Health, the National Institute of Mental Health, the National Multiple Sclerosis Society, and the Department of Veterans Affairs.	Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2004, FASEB J, V18, P62, DOI 10.1096/fj.03-0451com; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100	22	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11845	11853		10.1074/jbc.M900639200	http://dx.doi.org/10.1074/jbc.M900639200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270310	Green Published, hybrid			2022-12-25	WOS:000265494600016
J	Kabaleeswaran, V; Shen, H; Symersky, J; Walker, JE; Leslie, AGW; Mueller, DM				Kabaleeswaran, Venkataraman; Shen, Hong; Symersky, Jindrich; Walker, John E.; Leslie, Andrew G. W.; Mueller, David M.			Asymmetric Structure of the Yeast F-1 ATPase in the Absence of Bound Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART MITOCHONDRIAL ATPASE; CATALYTIC SITES; BINDING-SITES; COOPERATIVE INTERACTIONS; F-1-ATPASE; HYDROLYSIS; F1-ATPASE; CRYSTALLIZATION; RESOLUTION; MECHANISM	The crystal structure of nucleotide-free yeast F-1 ATPase has been determined at a resolution of 3.6 angstrom. The overall structure is very similar to that of the ground state enzyme. In particular, the beta(DP) and beta(TP) subunits both adopt the closed conformation found in the ground state structure despite the absence of bound nucleotides. This implies that interactions between the gamma and beta subunits are as important as nucleotide occupancy in determining the conformational state of the beta subunits. Furthermore, this result suggests that for the mitochondrial enzyme, there is no state of nucleotide occupancy that would result in more than one of the beta subunits adopting the open conformation. The adenine-binding pocket of the beta(TP) subunit is disrupted in the apoenzyme, suggesting that the beta(DP) subunit is responsible for unisite catalytic activity.	[Mueller, David M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Walker, John E.] Med Res Council MRC Dunn Human Nutr, Cambridge CB2 0XY, England; [Leslie, Andrew G. W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Chicago Medical School; Rosalind Franklin University Medical & Science; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; MRC Laboratory Molecular Biology	Mueller, DM (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	David.Mueller@RosalindFranklin.edu		Walker, John/0000-0001-7929-2162	National Institutes of Health [R01-GM067091]; Medical Research Council; Medical Research Council [MC_U105184325, MC_U105663150] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066223] Funding Source: NIH RePORTER; MRC [MC_U105663150, MC_U105184325] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM067091) (to D.M.M.). This work was also supported by a grant from the Medical Research Council (to J.E.W. and A.G.W.L.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; CROSS RL, 1982, J BIOL CHEM, V257, P2101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; Groth G, 2001, J BIOL CHEM, V276, P1345, DOI 10.1074/jbc.M008015200; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; HOWARD A, 2000, ACTA CRYSTALLOGR D, V54, P905; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; KALASHNIKOVA TY, 1988, EUR J BIOCHEM, V177, P213, DOI 10.1111/j.1432-1033.1988.tb14364.x; KAYALAR C, 1977, J BIOL CHEM, V252, P2486; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; Milgrom YM, 2005, P NATL ACAD SCI USA, V102, P13831, DOI 10.1073/pnas.0507139102; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Mueller DM, 2004, ACTA CRYSTALLOGR D, V60, P1441, DOI 10.1107/S0907444904012661; MURATALIEV MB, 1992, BIOCHEMISTRY-US, V31, P12885, DOI 10.1021/bi00166a025; SHIRAKIHARA Y, 1991, J BIOCHEM-TOKYO, V109, P466, DOI 10.1093/oxfordjournals.jbchem.a123405; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER J, 1995, J BIOL CHEM, V270, P12653, DOI 10.1074/jbc.270.21.12653	22	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10546	10551		10.1074/jbc.M900544200	http://dx.doi.org/10.1074/jbc.M900544200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233840	Green Published, hybrid			2022-12-25	WOS:000265104600028
J	Samanta, AK; Chakraborty, SN; Wang, Y; Kantarjian, H; Sun, X; Hood, J; Perrotti, D; Arlinghaus, RB				Samanta, A. K.; Chakraborty, S. N.; Wang, Y.; Kantarjian, H.; Sun, X.; Hood, J.; Perrotti, D.; Arlinghaus, R. B.			Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients	ONCOGENE			English	Article						BCR-ABL; Jak2; Lyn; SET; PP2A; drug-resistance	PROTEIN PHOSPHATASE 2A; BCR-ABL; TYROSINE PHOSPHORYLATION; MYELOID-LEUKEMIA; SODIUM STIBOGLUCONATE; SIGNALING PATHWAY; POTENT INHIBITOR; BLAST CRISIS; BCR/ABL; MESYLATE	Chronic myelogenous leukemia (CML) patients treated with imatinib mesylate (IM) become drug resistant by mutations within the kinase domain of Bcr-Abl, and by other changes that cause progression to advanced stage (blast crisis) and increased expression of the Lyn tyrosine kinase, the regulation of which is not understood yet. In Bcr-Abl + cells inhibition of Jak2, a downstream target of Bcr-Abl, by either Jak2 inhibitors or Jak2-specific short interfering RNA (siRNA) reduced the level of the SET protein, and increased PP2A Ser/Thr phosphatase and Shp1 tyrosine phosphatase activities, which led to decreased levels of activated Lyn. Activation of PP2A combined with Jak2 inhibition enhanced the reduction of activated Lyn kinase compared with Jak2 inhibition alone. In contrast, inhibition of either PP2A or Shp1 combined with Jak2 inhibition interfered with the loss of Lyn kinase activation more so than Jak2 inhibition alone, indicating the involvement of PP2A and Shp1 in the inactivation of the Lyn kinase caused by Jak2 inhibition. Inhibition of Jak2 induced apoptosis and reduced colony formation in IM-sensitive and -resistant Bcr-Abl mutant cell lines. Jak2 inhibition also induced apoptosis in CML cells from blast crisis patients but not in normal hematopoietic cells. These results indicate that Lyn is downstream of Jak2, and Jak2 maintains activated Lyn kinase in CML through the SET-PP2A-Shp1 pathway.	[Arlinghaus, R. B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Unit 951, Houston, TX 77054 USA; [Kantarjian, H.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77054 USA; [Sun, X.] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77054 USA; [Hood, J.] TargeGen Inc, San Diego, CA USA; [Perrotti, D.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University	Arlinghaus, RB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Unit 951, 7435 Fannin St, Houston, TX 77054 USA.	rarlingh@mdanderson.org	Perrotti, Danilo/E-3852-2011		DOD [WB1XWH-07-1-0270];  [CA49639];  [CA093792];  [CA095512];  [CA100632]; NATIONAL CANCER INSTITUTE [R01CA093792, P01CA049639, R01CA095512, P50CA100632] Funding Source: NIH RePORTER	DOD(United States Department of Defense); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants CA49639 and CA093792 (RBA), CA095512 and DOD WB1XWH-07-1-0270 (DP), Leukemia Spore grant CA100632 (AKS), and Ladies Leukemia League ( AKS). We thank Santhanam Ramasami, PhD in the Perrotti lab for his help in PP2A assay.	Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Bruno O, 2007, MED CHEM, V3, P127, DOI 10.2174/157340607780059549; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; DONATO NJ, 2004, CANCER RES, V22, P5766; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Kantarjian HM, 2003, BLOOD, V101, P97, DOI 10.1182/blood-2002-02-0545; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Nawa M, 2008, CELL SIGNAL, V20, P493, DOI 10.1016/j.cellsig.2007.11.004; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nimmanapalli R, 2002, CANCER RES, V62, P5761; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Perrotti D, 2006, BRIT J CANCER, V95, P775, DOI 10.1038/sj.bjc.6603317; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; WilsonRawls J, 1996, CANCER RES, V56, P3426; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yi TL, 2002, J IMMUNOL, V169, P5978, DOI 10.4049/jimmunol.169.10.5978; Yokota A, 2007, BLOOD, V109, P306, DOI 10.1182/blood-2006-03-013250; Yokoyama N, 2003, ARCH BIOCHEM BIOPHYS, V417, P87, DOI 10.1016/S0003-9861(03)00333-3; Yokoyama N, 2001, J INTERF CYTOK RES, V21, P369, DOI 10.1089/107999001750277844	35	88	94	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2009	28	14					1669	1681		10.1038/onc.2009.7	http://dx.doi.org/10.1038/onc.2009.7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	430WQ	19234487	Green Accepted			2022-12-25	WOS:000265022000002
J	Popp, A; Jaenisch, N; Witte, OW; Frahm, C				Popp, Anke; Jaenisch, Nadine; Witte, Otto W.; Frahm, Christiane			Identification of Ischemic Regions in a Rat Model of Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HEAT-SHOCK-PROTEIN; HSP70 MESSENGER-RNA; MICROTUBULE-ASSOCIATED PROTEIN-2; ARTERY OCCLUSION; DIFFERENTIAL EXPRESSION; C-FOS; INDUCTION; BRAIN; CHLORIDE	Background: Investigations following stroke first of all require information about the spatio-temporal dimension of the ischemic core as well as of perilesional and remote affected tissue. Here we systematically evaluated regions differently impaired by focal ischemia. Methodology/Principal Findings: Wistar rats underwent a transient 30 or 120 min suture-occlusion of the middle cerebral artery (MCAO) followed by various reperfusion times (2 h, 1 d, 7 d, 30 d) or a permanent MCAO (1 d survival). Brains were characterized by TTC, thionine, and immunohistochemistry using MAP2, HSP72, and HSP27. TTC staining reliably identifies the infarct core at 1 d of reperfusion after 30 min MCAO and at all investigated times following 120 min and permanent MCAO. Nissl histology denotes the infarct core from 2 h up to 30 d after transient as well as permanent MCAO. Absent and attenuated MAP2 staining clearly identifies the infarct core and perilesional affected regions at all investigated times, respectively. HSP72 denotes perilesional areas in a limited post-ischemic time (1 d). HSP27 detects perilesional and remote impaired tissue from post-ischemic day 1 on. Furthermore a simultaneous expression of HSP72 and HSP27 in perilesional neurons was revealed. Conclusions/Significance: TTC and Nissl staining can be applied to designate the infarct core. MAP2, HSP72, and HSP27 are excellent markers not only to identify perilesional and remote areas but also to discriminate affected neuronal and glial populations. Moreover markers vary in their confinement to different reperfusion times. The extent and consistency of infarcts increase with prolonged occlusion of the MCA. Therefore interindividual infarct dimension should be precisely assessed by the combined use of different markers as described in this study.	[Popp, Anke; Jaenisch, Nadine; Witte, Otto W.; Frahm, Christiane] Univ Jena, Dept Neurol, Jena, Germany	Friedrich Schiller University of Jena	Popp, A (corresponding author), Univ Jena, Dept Neurol, Jena, Germany.	christiane.frahm@med.uni-jena.de	Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	BMBF [01GZ0306, 0311578]; Kompetenznetzwerk Schlaganfall, BMBF [01GI9905]	BMBF(Federal Ministry of Education & Research (BMBF)); Kompetenznetzwerk Schlaganfall, BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (nos. 01GZ0306 and 0311578) and the Kompetenznetzwerk Schlaganfall, BMBF (no. 01GI9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Butler TL, 2002, BRAIN RES, V929, P252, DOI 10.1016/S0006-8993(01)03371-6; COLE DJ, 1990, ACTA NEUROPATHOL, V80, P152, DOI 10.1007/BF00308918; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dittmar MS, 2006, J NEUROSCI METH, V156, P50, DOI 10.1016/j.jneumeth.2006.02.003; FEENEY C, 2005, NEUROGLIA, P421; Haupt C, 2007, NEUROSCIENCE, V144, P562, DOI 10.1016/j.neuroscience.2006.09.054; Haupt C, 2007, MOL CELL NEUROSCI, V35, P89, DOI 10.1016/j.mcn.2007.02.005; He Z, 1999, STROKE, V30, P2743, DOI 10.1161/01.STR.30.12.2743; Imura T, 1999, J NEUROSCI, V19, P9768; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kanemitsu H, 2002, J CEREBR BLOOD F MET, V22, P1196, DOI 10.1097/01.wcb.0000037992.07114.95; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Keyvani K, 2002, J CEREBR BLOOD F MET, V22, P153, DOI 10.1097/00004647-200202000-00003; KINOUCHI H, 1993, J CEREBR BLOOD F MET, V13, P105, DOI 10.1038/jcbfm.1993.13; KINOUCHI H, 1994, J CEREBR BLOOD F MET, V14, P808, DOI 10.1038/jcbfm.1994.101; KINOUCHI H, 1993, BRAIN RES, V619, P334, DOI 10.1016/0006-8993(93)91630-B; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Klettner A, 2004, DRUG NEWS PERSPECT, V17, P299, DOI 10.1358/dnp.2004.17.5.829033; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kokubo Y, 2003, NEUROSURGERY, V53, P186, DOI 10.1227/01.NEU.0000069023.01440.D6; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; Lafuente JV, 2007, NEUROSCI RES, V57, P354, DOI 10.1016/j.neures.2006.11.005; LI Y, 1993, J NEUROL SCI, V120, P187, DOI 10.1016/0022-510X(93)90272-Z; LI Y, 1992, STROKE, V23, P1292, DOI 10.1161/01.STR.23.9.1292; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mathews KS, 2000, J NEUROSCI METH, V102, P43, DOI 10.1016/S0165-0270(00)00277-6; MERKSZ M, 1978, ACTA MORPHOL HUNG, V26, P139; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Nishino K, 2004, J CEREBR BLOOD F MET, V24, P167, DOI 10.1097/01.WCB.0000100853.67976.8B; Noto T, 2007, BIOL PHARM BULL, V30, P313, DOI 10.1248/bpb.30.313; Oechmichen M, 2006, J FORENSIC SCI, V51, P880, DOI 10.1111/j.1556-4029.2006.00174.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Plumier JCL, 1997, J CEREBR BLOOD F MET, V17, P781; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Plumier JCL, 1997, J COMP NEUROL, V384, P409; RIEKE GK, 1987, AM J ANAT, V178, P45, DOI 10.1002/aja.1001780106; SCHROETER M, 1995, EXP BRAIN RES, V106, P1; SHARP FR, 1991, J CEREBR BLOOD F MET, V11, P621, DOI 10.1038/jcbfm.1991.113; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; States BA, 1996, J CEREBR BLOOD F MET, V16, P1165, DOI 10.1097/00004647-199611000-00011; STOLL G, 2008, J CEREB BLOOD FLOW M; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Wang W, 2008, J CLIN NEUROSCI, V15, P278, DOI 10.1016/j.jocn.2007.02.004; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Witte OW, 2000, J CEREBR BLOOD F MET, V20, P1149, DOI 10.1097/00004647-200008000-00001; Zhan XH, 2008, BRAIN RES, V1234, P183, DOI 10.1016/j.brainres.2008.07.094	59	166	172	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4764	10.1371/journal.pone.0004764	http://dx.doi.org/10.1371/journal.pone.0004764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274095	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000005
J	Aldinger, KA; Sokoloff, G; Rosenberg, DM; Palmer, AA; Millen, KJ				Aldinger, Kimberly A.; Sokoloff, Greta; Rosenberg, David M.; Palmer, Abraham A.; Millen, Kathleen J.			Genetic Variation and Population Substructure in Outbred CD-1 Mice: Implications for Genome-Wide Association Studies	PLOS ONE			English	Article								Outbred laboratory mouse populations are widely used in biomedical research. Since little is known about the degree of genetic variation present in these populations, they are not widely used for genetic studies. Commercially available outbred CD-1 mice are drawn from an extremely large breeding population that has accumulated many recombination events, which is desirable for genome-wide association studies. We therefore examined the degree of genome-wide variation within CD-1 mice to investigate their suitability for genetic studies. The CD-1 mouse genome displays patterns of linkage disequilibrium and heterogeneity similar to wild-caught mice. Population substructure and phenotypic differences were observed among CD-1 mice obtained from different breeding facilities. Differences in genetic variation among CD-1 mice from distinct facilities were similar to genetic differences detected between closely related human populations, consistent with a founder effect. This first large-scale genetic analysis of the outbred CD-1 mouse strain provides important considerations for the design and analysis of genetic studies in CD-1 mice.	[Aldinger, Kimberly A.; Rosenberg, David M.; Palmer, Abraham A.; Millen, Kathleen J.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Sokoloff, Greta; Palmer, Abraham A.; Millen, Kathleen J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Millen, Kathleen J.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Aldinger, KA (corresponding author), Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA.	kmillen@genetics.bsd.uchicago.edu	Palmer, Abraham/L-2158-2014; Aldinger, Kimberly/ABB-1561-2020	Palmer, Abraham/0000-0003-3634-0747; Aldinger, Kimberly/0000-0002-5406-8911; Millen, Kathleen/0000-0001-9978-675X; Rosenberg, David/0000-0003-4914-3195; Sokoloff, Greta/0000-0003-3651-1980	National Institutes of Health [HD053703, DA021336, MH70933, MH79103, DA024845]; Autism Speaks [Pre-doctoral Fellowship]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH070933, R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336, R21DA024845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health (HD053703 to KJM and DA021336, MH70933, MH79103 and DA024845 to AAP). KAA was supported by an Autism Speaks Pre-doctoral Fellowship (to KAA and KJM). Funding agencies had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Brown JA, 2000, AM J PHYSIOL-REG I, V278, pR320, DOI 10.1152/ajpregu.2000.278.2.R320; CHESLER EJ, 2008, COLLABORATIVE CROSS; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; CUI SL, 1993, LAB ANIM, V27, P116, DOI 10.1258/002367793780810397; Falush D, 2003, GENETICS, V164, P1567; Festing MFW, 1999, NEUROBIOL AGING, V20, P237; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P1321, DOI 10.1038/sj.npp.1301254; Graber JH, 2006, J EXP ZOOL PART A, V305A, P683, DOI 10.1002/jez.a.322; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; HAYAKAWA J, 1980, LAB ANIM-UK, V14, P233, DOI 10.1258/002367780780937625; Iraqi FA, 2008, MAMM GENOME, V19, P379, DOI 10.1007/s00335-008-9113-1; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Kuc KA, 2006, GENES BRAIN BEHAV, V5, P355, DOI 10.1111/j.1601-183X.2005.00168.x; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Lehoczky JA, 2006, MAMM GENOME, V17, P903, DOI 10.1007/s00335-006-0041-7; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lewis SR, 2006, PHYSIOL BEHAV, V88, P516, DOI 10.1016/j.physbeh.2006.05.003; Lewis SR, 2006, PHYSIOL BEHAV, V87, P595, DOI 10.1016/j.physbeh.2005.12.002; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Manenti G, 2003, CARCINOGENESIS, V24, P1143, DOI 10.1093/carcin/bgg065; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McKerchar TL, 2005, J EXP ANAL BEHAV, V84, P339, DOI 10.1901/jeab.2005.95-04; Miller RA, 1999, NEUROBIOL AGING, V20, P217; Morahan G, 2008, MAMM GENOME, V19, P390, DOI 10.1007/s00335-008-9134-9; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; MORAN JL, 2006, ASHG ANN M NEW ORL L; Novembre J, 2008, NATURE, V456, P274, DOI 10.1038/nature07566; Peirce JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001977; Petkov PM, 2007, PLOS BIOL, V5, P984, DOI 10.1371/journal.pbio.0050127; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wahlsten D, 2003, GENES BRAIN BEHAV, V2, P71, DOI 10.1034/j.1601-183X.2003.00012.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	49	92	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4729	10.1371/journal.pone.0004729	http://dx.doi.org/10.1371/journal.pone.0004729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266100	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490800010
J	Graubert, TA; Payton, MA; Shao, J; Walgren, RA; Monahan, RS; Frater, JL; Walshauser, MA; Martin, MG; Kasai, Y; Walter, MJ				Graubert, Timothy A.; Payton, Michelle A.; Shao, Jin; Walgren, Richard A.; Monahan, Ryan S.; Frater, John L.; Walshauser, Mark A.; Martin, Mike G.; Kasai, Yumi; Walter, Matthew J.			Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; IN-SITU HYBRIDIZATION; CANDIDATE; INVOLVEMENT	Deletions spanning chromosome 5q31.2 are among the most common recurring cytogenetic abnormalities detectable in myelodysplastic syndromes (MDS). Prior genomic studies have suggested that haploinsufficiency of multiple 5q31.2 genes may contribute to MDS pathogenesis. However, this hypothesis has never been formally tested. Therefore, we designed this study to systematically and comprehensively evaluate all 28 chromosome 5q31.2 genes and directly test whether haploinsufficiency of a single 5q31.2 gene may result from a heterozygous nucleotide mutation or microdeletion. We selected paired tumor (bone marrow) and germline (skin) DNA samples from 46 de novo MDS patients (37 without a cytogenetic 5q31.2 deletion) and performed total exonic gene resequencing (479 amplicons) and array comparative genomic hybridization (CGH). We found no somatic nucleotide changes in the 46 MDS samples, and no cytogenetically silent 5q31.2 deletions in 20/20 samples analyzed by array CGH. Twelve novel single nucleotide polymorphisms were discovered. The mRNA levels of 7 genes in the commonly deleted interval were reduced by 50% in CD34+ cells from del(5q) MDS samples, and no gene showed complete loss of expression. Taken together, these data show that small deletions and/or point mutations in individual 5q31.2 genes are not common events in MDS, and implicate haploinsufficiency of multiple genes as the relevant genetic consequence of this common deletion.	[Graubert, Timothy A.; Payton, Michelle A.; Shao, Jin; Walgren, Richard A.; Monahan, Ryan S.; Walshauser, Mark A.; Martin, Mike G.; Walter, Matthew J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Graubert, Timothy A.; Walter, Matthew J.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Frater, John L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kasai, Yumi] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA; [Kasai, Yumi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai	Graubert, TA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	mjwalter@dom.wustl.edu	Walter, Matthew J/S-7758-2018	Graubert, Timothy/0000-0002-7710-1171	National Institutes of Health [HL082973, T32-HL07088]; Center for Genome Sciences. Washington University School of Medicine; Aplastic Anemia & MDS International Foundation, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088, R01HL082973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Genome Sciences. Washington University School of Medicine; Aplastic Anemia & MDS International Foundation, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL082973 (TAG, MJW), T32-HL07088 (RAW), the Center for Genome Sciences. Washington University School of Medicine (TAG, MJW), and the Aplastic Anemia & MDS International Foundation, Inc. (MJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2002, CANCER GENET CYTOGEN, V136, P101, DOI 10.1016/S0165-4608(02)00515-0; Bigoni R, 2001, HAEMATOLOGICA, V86, P375; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Dubourg C, 2002, CANCER GENET CYTOGEN, V134, P33, DOI 10.1016/S0165-4608(01)00605-7; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; GRAVEN SE, 2005, BLOOD, V103, P3528; Horrigan SK, 2000, BLOOD, V95, P2372, DOI 10.1182/blood.V95.7.2372.007k20_2372_2377; Hu ZB, 2001, ONCOGENE, V20, P6946, DOI 10.1038/sj.onc.1204850; JAJN RJ, 2000, GENE CHROMOSOME CANC, V29, P276; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; LEBEAU MM, 1993, P NATL ACAD SCI USA, V90, P5484, DOI 10.1073/pnas.90.12.5484; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; OLNEY BJ, 2007, LEUKEMIA RES, V31, P127; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; TOTNASSON MH, 2008, BLOOD, V11, P1797; Xie H, 2000, LEUKEMIA, V14, P2128, DOI 10.1038/sj.leu.2401935; ZHAO N, 1997, P NATL ACAD SCI USA, V91, P6918	24	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4583	10.1371/journal.pone.0004583	http://dx.doi.org/10.1371/journal.pone.0004583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240791	Green Submitted, Green Published, gold			2022-12-25	WOS:000278086700005
J	Ande, SR; Moulik, S; Mishra, S				Ande, Sudharsana R.; Moulik, Saby; Mishra, Suresh			Interaction between O-GlcNAc Modification and Tyrosine Phosphorylation of Prohibitin: Implication for a Novel Binary Switch	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; LIPID RAFTS; INSULIN; TRANSFERASE; PROTEINS; DOMAIN; ROLES; CELLS	Prohibitin (PHB or PHB1) is an evolutionarily conserved, multifunctional protein which is present in various cellular compartments including the plasma membrane. However, mechanisms involved in various functions of PHB are not fully explored yet. Here we report for the first time that PHB interacts with O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) and is O-GlcNAc modified; and also undergoes tyrosine phosphorylation in response to insulin. Tyrosine 114 (Tyr114) and tyrosine 259 (Tyr259) in PHB are in the close proximity of potential O-GlcNAc sites serine 121 (Ser121) and threonine 258 (Thr258) respectively. Substitution of Tyr114 and Tyr259 residues in PHB with phenylalanine by site-directed mutagenesis results in reduced tyrosine phosphorylation as well as reduced O-GlcNAc modification of PHB. Surprisingly, this also resulted in enhanced tyrosine phosphorylation and activity of OGT. This is attributed to the presence of similar tyrosine motifs in PHB and OGT. Substitution of Ser121 and Thr258 with alanine and isoleucine respectively resulted in attenuation of O-GlcNAc modification and increased tyrosine phosphorylation of PHB suggesting an association between these two dynamic modifications. Sequence analysis of O-GlcNAc modified proteins having known O-GlcNAc modification site(s) or known tyrosine phosphorylation site(s) revealed a strong potential association between these two posttranslational modifications in various proteins. We speculate that O-GlcNAc modification and tyrosine phosphorylation of PHB play an important role in tyrosine kinase signaling pathways including insulin, growth factors and immune receptors signaling. In addition, we propose that O-GlcNAc modification and tyrosine phosphorylation is a novel previously unidentified binary switch which may provide new mechanistic insights into cell signaling pathways and is open for direct experimental examination.	[Ande, Sudharsana R.; Mishra, Suresh] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Moulik, Saby; Mishra, Suresh] Univ Manitoba, Dept Physiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	Ande, SR (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	Mishra@cc.umanitoba.ca	Moulik, Sabyasachi/AAV-4234-2020; Mishra, Suresh/W-1633-2019; Ande, Sudharsana Rao/AAU-6950-2021	Ande, Sudharsana Rao/0000-0001-8194-2902; Mishra, Suresh/0000-0002-0364-1538; Moulik, Sabyasachi/0000-0003-2225-2615	Manitoba Health Research Council (MHRC) [Postdoctoral Fellowship]; Winnipeg Health Sciences Centre Foundation	Manitoba Health Research Council (MHRC); Winnipeg Health Sciences Centre Foundation	This work was supported by funds from Manitoba Health Research Council (MHRC) and Winnipeg Health Sciences Centre Foundation to SM. SRA is a recipient of MHRC Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Han EKH, 2008, ANTICANCER RES, V28, P957; Ikonen E., 2005, SCI STKE, V268, ppe3; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; MISHRA S, 2007, END M; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; SLAWSON C, 2008, MOL BIOL CELL   0723, V23; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	27	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4586	10.1371/journal.pone.0004586	http://dx.doi.org/10.1371/journal.pone.0004586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238206	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487400015
J	Kam, Y; Quaranta, V				Kam, Yoonseok; Quaranta, Vito			Cadherin-Bound beta-Catenin Feeds into the Wnt Pathway upon Adherens Junctions Dissociation: Evidence for an Intersection between beta-Catenin Pools	PLOS ONE			English	Article								beta-catenin is an essential component of two cellular systems: cadherin-based adherens junctions (AJ) and the Wnt signaling pathway. A functional or physical connection between these beta-catenin pools has been suggested in previous studies, but not conclusively demonstrated to date. To further examine this intersection, we treated A431 cell colonies with lysophosphatidic acid (LPA), which forces rapid and synchronized dissociation of AJ. A combination of immunostaining, time-lapse microscopy using photoactivatable-GFP-tagged beta-catenin, and image analyses indicate that the cadherin-bound pool of beta-catenin, internalized together with E-cadherin, accumulates at the perinuclear endocytic recycling compartment (ERC) upon AJ dissociation, and can be translocated into the cell nucleus upon Wnt pathway activation. These results suggest that the ERC may be a site of residence for beta-catenin destined to enter the nucleus, and that dissociation of AJ may influence beta-catenin levels in the ERC, effectively affecting beta-catenin substrate levels available downstream for the Wnt pathway. This intersection provides a mechanism for integrating cell-cell adhesion with Wnt signaling and could be critical in developmental and cancer processes that rely on beta-catenin-dependent gene expression.	[Kam, Yoonseok; Quaranta, Vito] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University	Kam, Y (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	vito.quaranta@vanderbilt.edu	Quaranta, Vito/G-6512-2016	Quaranta, Vito/0000-0001-7491-8672; Kam, Yoonseok/0000-0003-4712-9058	NIH [RO1 GM067221]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding received from NIH RO1 GM067221 awarded to Vito Quaranta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 2000, EXP CELL RES, V261, P75, DOI 10.1006/excr.2000.5045; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant DM, 2005, MOL BIOL CELL, V16, P14, DOI 10.1091/mbc.E04-09-0845; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gavard J, 2005, BIOL CELL, V97, P921; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; HUOT J, 1972, EXPERIENTIA, V28, P456, DOI 10.1007/BF02008338; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jourquin J, 2006, J CELL PHYSIOL, V206, P337, DOI 10.1002/jcp.20470; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kappes A, 2007, SURGERY, V141, P161, DOI 10.1016/j.surg.2006.12.005; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9; Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; THIERY JP, 2002, NATURE, V2, P444; TOMOOKA Y, 1983, J CELL PHYSIOL, V117, P290, DOI 10.1002/jcp.1041170303; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	60	115	119	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4580	10.1371/journal.pone.0004580	http://dx.doi.org/10.1371/journal.pone.0004580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238201	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487400012
J	Neuman, NA; Ma, S; Schnitzler, GR; Zhu, Y; Lagna, G; Hata, A				Neuman, Nicole A.; Ma, Susan; Schnitzler, Gavin R.; Zhu, Yan; Lagna, Giorgio; Hata, Akiko			The Four-and-a-half LIM Domain Protein 2 Regulates Vascular Smooth Muscle Phenotype and Vascular Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PRIMARY PULMONARY-HYPERTENSION; ONLY PROTEIN; TRANSCRIPTION FACTOR; ALPHA-ACTIN; IN-VIVO; BMPR-II; GENE; MYOCARDIN; FHL2	In response to vascular injury, differentiated vascular smooth muscle cells (vSMCs) undergo a unique process known as "phenotype modulation," transitioning from a quiescent, "contractile" phenotype to a proliferative, "synthetic" state. We have demonstrated previously that the signaling pathway of bone morphogenetic proteins, members of the transforming growth factor beta family, play a role in the induction and maintenance of a contractile phenotype in human primary pulmonary artery smooth muscle cells. In this study, we show that a four-and-a-half LIM domain protein 2 (FHL2) inhibits transcriptional activation of vSMC-specific genes mediated by the bone morphogenetic protein signaling pathway through the CArG box-binding proteins, such as serum response factor and members of the myocardin (Myocd) family. Interestingly, FHL2 does not affect recruitment of serum response factor or Myocd, however, it inhibits recruitment of a component of the SWI/SNF chromatin remodeling complex, Brg1, and RNA polymerase II, which are essential for the transcriptional activation. This is a novel mechanism of regulation of SMC-specific contractile genes by FHL2. Finally, aortic rings from homozygous FHL2-null mice display abnormalities in both endothelial-dependent and -independent relaxation, suggesting that FHL2 is essential for the regulation of vasomotor tone.	[Neuman, Nicole A.; Ma, Susan; Zhu, Yan; Lagna, Giorgio; Hata, Akiko] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Neuman, Nicole A.; Schnitzler, Gavin R.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Hata, A (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 8486, Boston, MA 02111 USA.	akiko.hata@tufts.edu	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936	National Institutes of Health [HL082854]; NHLBI [HL086572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082854, R21HL086572, R01HL108317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082854 (to A. H.) and HL086572 (to G. L.) from NHLBI.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Chan MC, 2007, MOL CELL BIOL, V27, P5776, DOI 10.1128/MCB.00218-07; Chang DF, 2007, P NATL ACAD SCI USA, V104, P157, DOI 10.1073/pnas.0605635103; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kong YF, 2001, CIRCULATION, V103, P2731; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Ngo P, 2006, METH MOL B, V341, P103; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; RUBIN LJ, 1997, PRIMARY PULMONARY HY, P19; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Sundberg-Smith LJ, 2008, CIRC RES, V102, P1502, DOI 10.1161/CIRCRESAHA.107.170357; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	50	26	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13202	13212		10.1074/jbc.M900282200	http://dx.doi.org/10.1074/jbc.M900282200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19265191	Green Published, hybrid			2022-12-25	WOS:000265688300067
J	Gitcho, MA; Strider, J; Carter, D; Taylor-Reinwald, L; Forman, MS; Goate, AM; Cairns, NJ				Gitcho, Michael A.; Strider, Jeffrey; Carter, Deborah; Taylor-Reinwald, Lisa; Forman, Mark S.; Goate, Alison M.; Cairns, Nigel J.			VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING-PROTEIN; INCLUSION-BODY MYOPATHY; RETICULUM-ASSOCIATED DEGRADATION; UBIQUITIN-POSITIVE INCLUSIONS; AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN NEUROBLASTOMA-CELLS; TAU-NEGATIVE INCLUSIONS; MOTOR-NEURON DISEASE; AAA ATPASE P97/VCP; ENDOPLASMIC-RETICULUM	Frontotemporal lobar degeneration (FTLD) with inclusion body myopathy and Paget disease of bone is a rare, autosomal dominant disorder caused by mutations in the VCP (valosin-containing protein) gene. The disease is characterized neuropathologically by frontal and temporal lobar atrophy, neuron loss and gliosis, and ubiquitin-positive inclusions (FTLD-U), which are distinct from those seen in other sporadic and familial FTLD-U entities. The major component of the ubiquitinated inclusions of FTLD with VCP mutation is TDP-43 (TAR DNA-binding protein of 43 kDa). TDP-43 proteinopathy links sporadic amyotrophic lateral sclerosis, sporadic FTLD-U, and most familial forms of FTLD-U. Understanding the relationship between individual gene defects and pathologic TDP-43 will facilitate the characterization of the mechanisms leading to neurodegeneration. Using cell culture models, we have investigated the role of mutant VCP in intracellular trafficking, proteasomal function, and cell death and demonstrate that mutations in the VCP gene 1) alter localization of TDP-43 between the nucleus and cytosol, 2) decrease proteasome activity, 3) induce endoplasmic reticulum stress, 4) increase markers of apoptosis, and 5) impair cell viability. These results suggest that VCP mutation-induced neurodegeneration is mediated by several mechanisms.	[Strider, Jeffrey; Carter, Deborah; Taylor-Reinwald, Lisa; Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gitcho, Michael A.; Strider, Jeffrey; Carter, Deborah; Taylor-Reinwald, Lisa; Goate, Alison M.; Cairns, Nigel J.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Gitcho, Michael A.; Goate, Alison M.; Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Goate, Alison M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Forman, Mark S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania	Cairns, NJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118, St Louis, MO 63110 USA.	cairns@wustl.edu	Cairns, Nigel/AAB-9713-2020	Cairns, Nigel/0000-0001-9858-3344; Gitcho, Michael/0000-0002-9223-5426; Goate, Alison/0000-0002-0576-2472	National Institutes of Health, NIA [P50-AG05681, 01-AG03991, P30-NS057105]; Buchanan Fund; Charles and Joanne Knight Alzheimer Research Initiative; Barnes- Jewish Hospital Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Buchanan Fund; Charles and Joanne Knight Alzheimer Research Initiative; Barnes- Jewish Hospital Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grants P50-AG05681, P01-AG03991, and P30-NS057105. This work was also supported by the Buchanan Fund, the Charles and Joanne Knight Alzheimer Research Initiative, and the Barnes- Jewish Hospital Foundation (St. Louis, MO). A preliminary report of these data was presented (81).	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Aravindan N, 2008, MOL CELL BIOCHEM, V310, P167, DOI 10.1007/s11010-007-9678-0; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Bertram C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-12; Bird T, 2003, ANN NEUROL, V54, pS29, DOI 10.1002/ana.10572; Bursztajn S, 2001, MOL BRAIN RES, V91, P57, DOI 10.1016/S0169-328X(01)00123-1; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Daroszewska A, 2006, NAT CLIN PRACT RHEUM, V2, P270, DOI 10.1038/ncprheum0172; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; GITCHO MA, 2008, 6 INT C FRONT DEM RO; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Hui L, 2005, BRAIN RES, V1052, P1, DOI 10.1016/j.brainres.2005.05.043; Ito M, 2007, BIOCHEM BIOPH RES CO, V360, P615, DOI 10.1016/j.bbrc.2007.06.087; JU JS, 2008, J BIOL CHEM; Kano F, 2005, GENES CELLS, V10, P333, DOI 10.1111/j.1365-2443.2005.00837.x; Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Langer R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-70; Lass A, 2008, INT J BIOCHEM CELL B, V40, P2865, DOI 10.1016/j.biocel.2008.06.003; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Li XP, 2007, NEUROCHEM INT, V50, P959, DOI 10.1016/j.neuint.2007.04.014; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meares GP, 2008, CELL SIGNAL, V20, P347, DOI 10.1016/j.cellsig.2007.10.032; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Miyachi K, 2004, CLIN EXP IMMUNOL, V136, P568, DOI 10.1111/j.1365-2249.2004.02456.x; Mukherjee O, 2008, HUM MUTAT, V29, P512, DOI 10.1002/humu.20681; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nilbratt M, 2007, J NEUROSCI RES, V85, P504, DOI 10.1002/jnr.21156; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Peng Y, 2008, MOL BIOL CELL, V19, P546, DOI 10.1091/mbc.E07-08-0774; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Schmitz A, 2004, EUR J CELL BIOL, V83, P501, DOI 10.1078/0171-9335-00412; Shenkman M, 2007, CELL STRESS CHAPERON, V12, P373, DOI 10.1379/CSC-281.1; Shenkman M, 2007, BIOCHEM J, V404, P509, DOI 10.1042/BJ20061854; Shiozawa K, 2004, J BIOL CHEM, V279, P50060, DOI 10.1074/jbc.M407837200; Shiozawa K, 2006, FEBS J, V273, P4959, DOI 10.1111/j.1742-4658.2006.05494.x; Snider BJ, 2002, EUR J NEUROSCI, V15, P419, DOI 10.1046/j.0953-816x.2001.01867.x; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Xing CG, 2008, ACTA BIOCH BIOPH SIN, V40, P194, DOI 10.1111/j.1745-7270.2008.00393.x; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Zhang HT, 2000, DNA CELL BIOL, V19, P253, DOI 10.1089/10445490050021168; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhivotosky B, 2001, CURRENT PROTOCOLS CE; Zucchini C, 2008, INT J ONCOL, V32, P17	81	88	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12384	12398		10.1074/jbc.M900992200	http://dx.doi.org/10.1074/jbc.M900992200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19237541	Green Published, hybrid			2022-12-25	WOS:000265494600069
J	Kish-Trier, E; Wilkens, S				Kish-Trier, Erik; Wilkens, Stephan			Domain Architecture of the Stator Complex of the A(1)A(0)-ATP Synthase from Thermoplasma acidophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT-E; ATP SYNTHASE; PERIPHERAL STALK; STRUCTURAL-CHARACTERIZATION; SECONDARY STRUCTURE; B-SUBUNIT; V-TYPE; F-TYPE; A-TYPE; PROTEINS	A key structural element in the ion translocating F-, A-, and V-ATPases is the peripheral stalk, an assembly of two polypeptides that provides a structural link between the ATPase and ion channel domains. Previously, we have characterized the peripheral stalk forming subunits E and H of the A-ATPase from Thermoplasma acidophilum and demonstrated that the two polypeptides interact to form a stable heterodimer with 1:1 stoichiometry (Kish-Trier, E., Briere, L. K., Dunn, S. D., and Wilkens, S. (2008) J. Mol. Biol. 375, 673-685). To define the domain architecture of the A- ATPase peripheral stalk, we have now generated truncated versions of the E and H subunits and analyzed their ability to bind each other. The data show that the N termini of the subunits form an alpha-helical coiled-coil, similar to 80 residues in length, whereas the C-terminal residues interact to form a globular domain containing alpha- and beta-structure. We find that the isolated C-terminal domain of the E subunit exists as a dimer in solution, consistent with a recent crystal structure of the related Pyrococcus horikoshii A- ATPase E subunit (Lokanath, N. K., Matsuura, Y., Kuroishi, C., Takahashi, N., and Kunishima, N. (2007) J. Mol. Biol. 366, 933-944). However, upon the addition of a peptide comprising the C-terminal 21 residues of the H subunit (or full-length H subunit), dimeric E subunit C-terminal domain dissociates to form a 1: 1 heterodimer. NMR spectroscopy was used to show that H subunit C terminal peptide binds to E subunit C-terminal domain via the terminal alpha-helices, with little involvement of the beta-sheet region. Based on these data, we propose a structural model of the A-ATPase peripheral stalk.	[Kish-Trier, Erik; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM58600, CA100246]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58600 and CA100246 (to S.W.)	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Dunn SD, 2000, J BIOENERG BIOMEMBR, V32, P347, DOI 10.1023/A:1005571818730; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gayen S, 2008, FEBS J, V275, P1803, DOI 10.1111/j.1742-4658.2008.06338.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Neukirch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038105; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; SUPEKOVA L, 1995, J BIOL CHEM, V270, P13726; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wise JG, 2008, BIOPHYS J, V94, P5040, DOI 10.1529/biophysj.107.121012; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	37	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12031	12040		10.1074/jbc.M808962200	http://dx.doi.org/10.1074/jbc.M808962200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19234304	Green Published, hybrid			2022-12-25	WOS:000265494600035
J	Bartholomeeusen, K; Christ, F; Hendrix, J; Rain, JC; Emiliani, S; Benarous, R; Debyser, Z; Gijsbers, R; De Rijck, J				Bartholomeeusen, Koen; Christ, Frauke; Hendrix, Jelle; Rain, Jean-Christophe; Emiliani, Stephane; Benarous, Richard; Debyser, Zeger; Gijsbers, Rik; De Rijck, Jan			Lens Epithelium-derived Growth Factor/p75 Interacts with the Transposase-derived DDE Domain of PogZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRASE-BINDING DOMAIN; HIV-1 INTEGRASE; NUP98-LEDGF FUSION; COMPLEX-FORMATION; LEDGF/P75; PROTEIN; IDENTIFICATION; NUCLEAR; GENE; RECOGNITION	Lens epithelium-derived growth factor/p75 (LEDGF/p75) is a prominent cellular interaction partner of human immunodeficiency virus-1 (HIV-1) integrase, tethering the preintegration complex to the host chromosome. In light of the development of LEDGF/p75-integrase interaction inhibitors, it is essential to understand the cell biology of LEDGF/p75. We identified pogZ as new cellular interaction partner of LEDGF/p75. Analogous to lentiviral integrase, pogZ, a domesticated transposase, carries a DDE domain, the major determinant for LEDGF/p75 interaction. Using different in vitro and in vivo approaches, we corroborated the interaction between the C terminus of LEDGF/p75 and the DDE domain of pogZ, revealing an overlap in the binding of pogZ and HIV-1 integrase. Competition experiments showed that integrase is efficient in displacing pogZ from LEDGF/p75. Moreover, pogZ does not seem to play a role as a restriction factor of HIV. The finding that LEDGF/p75 is capable of interacting with a DDE domain protein that is not a lentiviral integrase points to a profound role of LEDGF/p75 in DDE domain protein function.	[Bartholomeeusen, Koen; Christ, Frauke; Debyser, Zeger; Gijsbers, Rik; De Rijck, Jan] Katholieke Univ Leuven, Div Mol Med, Lab Mol Virol & Gene Therapy, B-3000 Louvain, Flanders, Belgium; [Bartholomeeusen, Koen; Christ, Frauke; Debyser, Zeger; Gijsbers, Rik; De Rijck, Jan] Katholieke Univ Leuven, Interdisciplinary Res Ctr, B-3000 Louvain, Belgium; [Hendrix, Jelle] Katholieke Univ Leuven, Dept Chem, Lab Biomol Dynam, B-3000 Louvain, Belgium; [Emiliani, Stephane; Benarous, Richard] Inst Cochin Genet Mol, CNRS, INSERM,UMR8104, Dept Infect Dis,U567, F-75104 Paris, France; [Rain, Jean-Christophe] Hybrigen SA, F-75014 Paris, France	KU Leuven; KU Leuven; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Debyser, Z (corresponding author), Katholieke Univ Leuven, Div Mol Med, Lab Mol Virol & Gene Therapy, Campus Kortrijk,Kapucijnenvoer 33, B-3000 Louvain, Flanders, Belgium.	zeger.debyser@med.kuleuven.be	HENDRIX, Jelle/H-1721-2018; De Rijck, Jan/A-2729-2013; Christ, Frauke/H-7513-2018; bartholomeeusen, koen/J-1843-2015	HENDRIX, Jelle/0000-0001-5731-1297; bartholomeeusen, koen/0000-0001-9576-2400; Christ, Frauke/0000-0001-9580-3874; RAIN, Jean-Christophe/0000-0001-8110-0641	European Union [LSHB-CT-2003-503480]; THINC [HEALTH-2007-2.3.2-1]; Institute for the Promotion of Innovation by Science and Technology in Flanders	European Union(European Commission); THINC; Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the FP6 and FP7 framework of the European Union (TRIoH, LSHB-CT-2003-503480 and THINC, HEALTH-2007-2.3.2-1) and the CellCoVir SBO project of the Institute for the Promotion of Innovation by Science and Technology in Flanders.	Al-Mawsawi LQ, 2008, FEBS LETT, V582, P1425, DOI 10.1016/j.febslet.2008.02.076; Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Capy P, 1996, J MOL EVOL, V42, P359, DOI 10.1007/BF02337546; Capy P, 1997, GENETICA, V100, P63, DOI 10.1023/A:1018300721953; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Fromont-Racine M, 2002, METHOD ENZYMOL, V350, P513, DOI 10.1016/S0076-6879(02)50982-4; Ganapathy V, 2003, AUTOIMMUN REV, V2, P290, DOI 10.1016/S1568-9972(03)00063-6; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Grand FH, 2005, LEUKEMIA RES, V29, P1469, DOI 10.1016/j.leukres.2005.05.002; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Hussey DJ, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-20; Hwang Y, 2000, NUCLEIC ACIDS RES, V28, P4884, DOI 10.1093/nar/28.24.4884; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Morerio C, 2005, LEUKEMIA RES, V29, P467, DOI 10.1016/j.leukres.2004.09.002; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; PLASTERK RHA, 1995, NAT STRUCT BIOL, V2, P87, DOI 10.1038/nsb0295-87; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	50	72	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11467	11477		10.1074/jbc.M807781200	http://dx.doi.org/10.1074/jbc.M807781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244240	hybrid, Green Published			2022-12-25	WOS:000265494500051
J	Bergsdorf, EY; Zdebik, AA; Jentsch, TJ				Bergsdorf, Eun-Yeong; Zdebik, Anselm A.; Jentsch, Thomas J.			Residues Important for Nitrate/Proton Coupling in Plant and Mammalian CLC Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CHLORIDE CHANNEL; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; ANION; VOLTAGE; DISRUPTION; GENE; ARABIDOPSIS; ANTIPORTER; MECHANISM	Members of the CLC gene family either function as chloride channels or as anion/proton exchangers. The plant AtClC-a uses the pH gradient across the vacuolar membrane to accumulate the nutrient NO3- in this organelle. When AtClC-a was expressed in Xenopus oocytes, it mediated NO3-/H+ exchange and less efficiently mediated Cl-/H+ exchange. Mutating the "gating glutamate" Glu-203 to alanine resulted in an uncoupled anion conductance that was larger for Cl- than NO3-. Replacing the "proton glutamate" Glu-270 by alanine abolished currents. These could be restored by the uncoupling E203A mutation. Whereas mammalian endosomal ClC-4 and ClC-5 mediate stoichiometrically coupled 2Cl(-)/H+ exchange, their NO3-transport is largely uncoupled from protons. By contrast, the AtClC-amediated NO3- accumulation in plant vacuoles requires tight NO3-/H+ coupling. Comparison of AtClC-a and ClC-5 sequences identified a proline in AtClC-a that is replaced by serine in all mammalian CLC isoforms. When this proline was mutated to serine (P160S), Cl-/H+ exchange of AtClC-a proceeded as efficiently as NO3-/H+ exchange, suggesting a role of this residue in NO3-/H+ exchange. Indeed, when the corresponding serine of ClC-5 was replaced by proline, this Cl-/H+ exchanger gained efficient NO3-/H+ coupling. When inserted into the model Torpedo chloride channel ClC-0, the equivalent mutation increased nitrate relative to chloride conductance. Hence, proline in the CLC pore signature sequence is important for NO3-/H+ exchange and NO3- conductance both in plants and mammals. Gating and proton glutamates play similar roles in bacterial, plant, and mammalian CLC anion/proton exchangers.	[Bergsdorf, Eun-Yeong; Zdebik, Anselm A.; Jentsch, Thomas J.] Leibniz Inst Mol Pharmacol, Dept Physiol & Pathol Ion Transport, D-13125 Berlin, Germany; [Bergsdorf, Eun-Yeong; Zdebik, Anselm A.; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Zdebik, Anselm A.] UCL, London Epithelial Grp, Dept Neurosci Physiol & Pharmacol, London NW3 2PF, England	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of London; University College London	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmacol, Dept Physiol & Pathol Ion Transport, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft; Leibniz Graduate School of Biophysics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Graduate School of Biophysics	This work was supported by a Deutsche Forschungsgemeinschaft grant ( to A.A.Z. and T.J.J.) and by the Leibniz Graduate School of Biophysics.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hechenberger M, 1996, J BIOL CHEM, V271, P33632, DOI 10.1074/jbc.271.52.33632; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Lurin C, 1996, PLANT CELL, V8, P701, DOI 10.1105/tpc.8.4.701; Marmagne A, 2007, J EXP BOT, V58, P3385, DOI 10.1093/jxb/erm187; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; von der Fecht-Bartenbach J, 2007, PLANT J, V50, P466, DOI 10.1111/j.1365-313X.2007.03061.x; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2008, BIOPHYS J, V94, P53, DOI 10.1529/biophysj.107.111310; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284; Zuniga L, 2004, J PHYSIOL-LONDON, V555, P671, DOI 10.1113/jphysiol.2003.060046	45	79	85	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11184	11193		10.1074/jbc.M901170200	http://dx.doi.org/10.1074/jbc.M901170200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261613	Green Published, hybrid			2022-12-25	WOS:000265494500022
J	Sun, JM; Pedersen, M; Ronnstrand, L				Sun, Jianmin; Pedersen, Malin; Ronnstrand, Lars			The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR/C-KIT; 2 SPLICE FORMS; TYROSINE KINASE; ACTIVATING MUTATION; NEGATIVE REGULATION; STRUCTURAL BASIS; GENE-MUTATIONS; MUTANT; CELLS; CBL	The receptor tyrosine kinase c-Kit plays a critical role in hematopoiesis, and gain-of-function mutations of the receptor are frequently seen in several malignancies, including acute myeloid leukemia, gastrointestinal stromal tumors, and testicular carcinoma. The most common mutation of c-Kit in these disorders is a substitution of the aspartic acid residue in position 816 to a valine (D816V), leading to constitutive activation of the receptor. In this study, we aimed to investigate the role of Src family kinases in c-Kit/D816V signaling. Src family kinases are necessary for the phosphorylation of wild-type c-Kit as well as of activation of downstream signaling pathways including receptor ubiquitination and the Ras/Mek/Erk pathway. Our data demonstrate that, unlike wild-type c-Kit, the phosphorylation of c-Kit/D816V is not dependent on Src family kinases. In addition, we found that neither receptor ubiquitination nor Erk activation by c-Kit/D816V required activation of Src family kinases. In vitro kinase assay using synthetic peptides revealed that c-Kit/D816V had an altered substrate specificity resembling Src and Abl tyrosine kinases. We further present evidence that, in contrast to wild-type c-Kit, Src family kinases are dispensable for c-Kit/D816V cell survival, proliferation, and colony formation. Taken together, we demonstrate that the signal transduction pathways mediated by c-Kit/D816V are markedly different from those activated by wild-type c-Kit and that altered substrate specificity of c-Kit circumvents a need for Src family kinases in signaling of growth and survival, thereby contributing to the transforming potential of c-Kit/D816V.	[Ronnstrand, Lars] Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Dept Lab Med, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Malmo Univ Hosp, Wallenberg Lab, Dept Lab Med, SE-20502 Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Ronnstrand, Lars/A-2429-2011; Sun, Jianmin/AAX-5094-2021	Ronnstrand, Lars/0000-0003-1275-5809; Sun, Jianmin/0000-0003-2327-4285	Swedish Cancer Society; Swedish Research Council; Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society; Wallenberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society(Royal Society of London); Wallenberg Foundation(European Commission)	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Gunnar Nilsson Cancer Foundation, the Alfred Osterlund Foundation, the Malmo University Hospital Foundation, the Malmo University Hospital Cancer Foundation, the Royal Physiographical Society, and the Wallenberg Foundation.	Beghini A, 2000, BLOOD, V95, P726, DOI 10.1182/blood.V95.2.726; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Hashimoto K, 2003, BLOOD, V101, P1094, DOI 10.1182/blood-2002-01-0177; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hongyo T, 2000, CANCER RES, V60, P2345; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lennartsson J, 2006, CURR CANCER DRUG TAR, V6, P65, DOI 10.2174/156800906775471725; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Michieli P, 1999, ONCOGENE, V18, P5221, DOI 10.1038/sj.onc.1202899; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Nakaigawa N, 2000, ONCOGENE, V19, P2996, DOI 10.1038/sj.onc.1203628; Ning ZQ, 2001, LEUKEMIA LYMPHOMA, V41, P513, DOI 10.3109/10428190109060342; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pauls K, 2004, VIRCHOWS ARCH, V445, P651, DOI 10.1007/s00428-004-1112-3; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; SCHMIDTARRAS D, 2009, BLOOD IN PRESS; SERVE H, 1994, J BIOL CHEM, V269, P6026; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shivakrupa R, 2005, CELL SIGNAL, V17, P103, DOI 10.1016/j.cellsig.2004.06.004; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Taylor ML, 2001, BLOOD, V98, P1195, DOI 10.1182/blood.V98.4.1195; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Wollberg P, 2003, BIOCHEM J, V370, P1033, DOI 10.1042/BJ20020716; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768	44	51	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11039	11047		10.1074/jbc.M808058200	http://dx.doi.org/10.1074/jbc.M808058200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19265199	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000265494500008
J	Tilman, G; Loriot, A; Van Beneden, A; Arnoult, N; Londono-Vallejo, JA; De Smet, C; Decottignies, A				Tilman, G.; Loriot, A.; Van Beneden, A.; Arnoult, N.; Londono-Vallejo, J. A.; De Smet, C.; Decottignies, A.			Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells	ONCOGENE			English	Article						telomeres; DNA methylation; T-SCE; ALT; subtelomeric D4Z4 and DNF92	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; HUMAN-CHROMOSOMES; REVERSE-TRANSCRIPTASE; EPIGENETIC REGULATION; MAMMALIAN TELOMERES; MELANOMA-CELLS; HUMAN CANCER; TUMOR-CELLS; RECOMBINATION; EXPRESSION	Most human tumor cells acquire immortality by activating the expression of telomerase, a ribonucleoprotein that maintains stable telomere lengths at chromosome ends throughout cell divisions. Other tumors use an alternative mechanism of telomere lengthening (ALT), characterized by high frequencies of telomeric sister chromatid exchanges (T-SCEs). Mechanisms of ALT activation are still poorly understood, but recent studies suggest that DNA hypomethylation of chromosome ends might contribute to the process by facilitating T-SCEs. Here, we show that ALT/T-SCEhigh tumor cells display low DNA-methylation levels at the D4Z4 and DNF92 subtelomeric sequences. Surprisingly, however, the same sequences retained high methylation levels in ALT/T-SCEhigh SV40-immortalized fibroblasts. Moreover, T-SCE rates were efficiently reduced by ectopic expression of active telomerase in ALT tumor cells, even though subtelomeric sequences remained hypomethylated. We also show that hypomethylation of subtelomeric sequences in ALT tumor cells is correlated with genome-wide hypomethylation of Alu repeats and pericentromeric Sat2 DNA sequences. Overall, this study suggests that, although subtelomeric DNA hypomethylation is often coincident with the ALT process in human tumor cells, it is not required for T-SCE.	[Tilman, G.; Loriot, A.; Van Beneden, A.; De Smet, C.; Decottignies, A.] Catholic Univ Louvain, de Duve Inst, Genet & Epigenet Alterat Genome Grp, Fac Med, Brussels, Belgium; [Arnoult, N.; Londono-Vallejo, J. A.] Inst Curie, Telomeres & Canc Lab, Paris, France	Universite Catholique Louvain; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decottignies, A (corresponding author), Catholic Univ Louvain, de Duve Inst, Genet & Epigenet Alterat Genome Grp, Fac Med, 74 Ave Hippocrate,ICP Tower, Brussels, Belgium.	anabelle.decottignies@uclouvain.be	Londono-Vallejo, Arturo/ABH-5555-2020	Londono-Vallejo, Arturo/0000-0003-3535-7563; Arnoult, Nausica/0000-0003-2633-0270	Fonds National de la Recherche Scientifique (FNRS), Belgium; Televie/FNRS; ANR; ARC; INCa; La Ligue	Fonds National de la Recherche Scientifique (FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); Televie/FNRS(Fonds de la Recherche Scientifique - FNRS); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); La Ligue	We are grateful to M Swinarska, F Brasseur, W Wright, F Fuks, J Lingner, F d'Adda di Fagagna, F Journe, H Id Boufker and C Heirman for the generous gifts of cell lines and plasmids. We thank all the members of the GENEPI group for their constant support and help. This study was supported by the Fonds National de la Recherche Scientifique (FNRS), Belgium. GT is supported by a PhD fellowship grant from Televie/FNRS. AL is supported by a post-doctoral grant from the FNRS. Work in the 'Telomere- &Cancer' laboratory is supported by grants from ANR, ARC, INCa and La Ligue.	Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bechter OE, 2004, CELL CYCLE, V3, P547; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brock GJR, 1999, GENE, V240, P269, DOI 10.1016/S0378-1119(99)00442-4; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cacurri S, 1998, AM J HUM GENET, V63, P181, DOI 10.1086/301906; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Cornforth MN, 2001, MUTAGENESIS, V16, P85, DOI 10.1093/mutage/16.1.85; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Der-Sarkissian H, 2002, GENOME RES, V12, P1673, DOI 10.1101/gr.322802; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Loriot A, 2006, J BIOL CHEM, V281, P10118, DOI 10.1074/jbc.M510469200; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Monfouilloux S, 1998, GENOMICS, V51, P165, DOI 10.1006/geno.1998.5358; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Riethman H, 2005, CHROMOSOME RES, V13, P505, DOI 10.1007/s10577-005-0998-1; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shimojima M, 2004, HEPATOL RES, V29, P31, DOI 10.1016/j.hepres.2004.02.005; Siedlecki P, 2006, ACTA BIOCHIM POL, V53, P245; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vera E, 2008, ONCOGENE, V27, P6817, DOI 10.1038/onc.2008.289; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Young JI, 2003, J BIOL CHEM, V278, P19904, DOI 10.1074/jbc.M301685200	49	45	46	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2009	28	14					1682	1693		10.1038/onc.2009.23	http://dx.doi.org/10.1038/onc.2009.23			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	430WQ	19252523				2022-12-25	WOS:000265022000003
J	Sanz, MA; Castello, A; Ventoso, I; Berlanga, JJ; Carrasco, L				Angel Sanz, Miguel; Castello, Alfredo; Ventoso, Ivan; Jose Berlanga, Juan; Carrasco, Luis			Dual Mechanism for the Translation of Subgenomic mRNA from Sindbis Virus in Infected and Uninfected Cells	PLOS ONE			English	Article								Infection of BHK cells by Sindbis virus (SV) gives rise to a profound inhibition of cellular protein synthesis, whereas translation of viral subgenomic mRNA that encodes viral structural proteins, continues for hours. To gain further knowledge on the mechanism by which this subgenomic mRNA is translated, the requirements for some initiation factors (eIFs) and for the presence of the initiator AUG were examined both in infected and in uninfected cells. To this end, BHK cells were transfected with different SV replicons or with in vitro made SV subgenomic mRNAs after inactivation of some eIFs. Specifically, eIF4G was cleaved by expression of the poliovirus 2A protease (2A(pro)) and the alpha subunit of eIF2 was inactivated by phosphorylation induced by arsenite treatment. Moreover, cellular location of these and other translation components was analyzed in BHK infected cells by confocal microscopy. Cleavage of eIF4G by poliovirus 2A(pro) does not hamper translation of subgenomic mRNA in SV infected cells, but bisection of this factor blocks subgenomic mRNA translation in uninfected cells or in cell-free systems. SV infection induces phosphorylation of eIF2 alpha, a process that is increased by arsenite treatment. Under these conditions, translation of subgenomic mRNA occurs to almost the same extent as controls in the infected cells but is drastically inhibited in uninfected cells. Notably, the correct initiation site on the subgenomic mRNA is still partially recognized when the initiation codon AUG is modified to other codons only in infected cells. Finally, immunolocalization of different eIFs reveals that eIF2 alpha and eIF4G are excluded from the foci, where viral RNA replication occurs, while eIF3, eEF2 and ribosomes concentrate in these regions. These findings support the notion that canonical initiation takes place when the subgenomic mRNA is translated out of the infection context, while initiation can occur without some eIFs and even at non-AUG codons in infected cells.	[Angel Sanz, Miguel; Castello, Alfredo; Ventoso, Ivan; Jose Berlanga, Juan; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol, Severo Ochoa CSIC UAM, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanz, MA (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, Severo Ochoa CSIC UAM, E-28049 Madrid, Spain.	lcarrasco@cbm.uam.es	Castello, Alfredo/U-6317-2018; Carrasco, Luis/E-2435-2012; Palomares, Alfredo Castello/K-8062-2019; Carrasco, Luis/H-3001-2017; sanz-gomez, miguel/Y-6244-2019; Berlanga, Juan José/N-1718-2015; Ventoso, Iván/N-4018-2014; Sanz, Miguel A/H-1914-2015	Castello, Alfredo/0000-0002-1499-4662; Palomares, Alfredo Castello/0000-0002-1499-4662; Carrasco, Luis/0000-0003-3833-8835; sanz-gomez, miguel/0000-0002-5761-9010; Berlanga, Juan José/0000-0002-2408-6561; Ventoso, Iván/0000-0001-7887-3520; Sanz, Miguel A/0000-0001-6573-883X	DGICYT [BFU 2006-02182]	DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	DGICYT Grant (BFU 2006-02182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Annamalai P, 2008, J VIROL, V82, P1484, DOI 10.1128/JVI.01540-07; BELSHAM GJ, 2008, DIVERGENT PICORNAVIR; Bonderoff JM, 2008, CURR TOP MICROBIOL, V323, P123; Burgui I, 2007, J VIROL, V81, P12427, DOI 10.1128/JVI.01105-07; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Feduchi E, 1995, EUR J BIOCHEM, V234, P849, DOI 10.1111/j.1432-1033.1995.849_a.x; FROLOV I, 1994, J VIROL, V68, P1721, DOI 10.1128/JVI.68.3.1721-1727.1994; Frolov I, 1996, J VIROL, V70, P1182, DOI 10.1128/JVI.70.2.1182-1190.1996; FROLOV I, 1994, J VIROL, V68, P8111, DOI 10.1128/JVI.68.12.8111-8117.1994; Frolova E, 2006, J VIROL, V80, P4122, DOI 10.1128/JVI.80.8.4122-4134.2006; FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075; Gorchakov R, 2004, J VIROL, V78, P8455, DOI 10.1128/JVI.78.16.8455-8467.2004; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Li ML, 2007, J VIROL, V81, P4371, DOI 10.1128/JVI.02672-06; LILJESTROM P, 1991, J VIROL, V65, P4107; LUKAVSKY PJ, 2008, VIRUS RES; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Mizumoto H, 2006, J VIROL, V80, P3781, DOI 10.1128/JVI.80.8.3781-3791.2006; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Novoa I, 1997, BIOCHEMISTRY-US, V36, P7802, DOI 10.1021/bi9631172; OU JH, 1982, P NATL ACAD SCI-BIOL, V79, P5235, DOI 10.1073/pnas.79.17.5235; Perales C, 2005, BBA-MOL CELL RES, V1743, P169, DOI 10.1016/j.bbamcr.2004.09.030; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pfingsten JS, 2008, RNA, V14, P1255, DOI 10.1261/rna.987808; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Sanz MA, 2003, J BIOL CHEM, V278, P2051, DOI 10.1074/jbc.M206611200; Sanz MA, 2001, J VIROL, V75, P7778, DOI 10.1128/JVI.75.16.7778-7784.2001; Sanz MA, 2007, J VIROL, V81, P7061, DOI 10.1128/JVI.02529-06; Savinova O, 1997, METHODS, V11, P419, DOI 10.1006/meth.1996.0438; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; Walsh D, 2008, MOL CELL BIOL, V28, P2648, DOI 10.1128/MCB.01631-07; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Xi QR, 2004, GENE DEV, V18, P1997, DOI 10.1101/gad.1212504	52	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4772	10.1371/journal.pone.0004772	http://dx.doi.org/10.1371/journal.pone.0004772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274090	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000265496000012
J	Doube, M; Conroy, AW; Christiansen, P; Hutchinson, JR; Shefelbine, S				Doube, Michael; Conroy, Alexis Wiktorowicz; Christiansen, Per; Hutchinson, John R.; Shefelbine, Sandra			Three-Dimensional Geometric Analysis of Felid Limb Bone Allometry	PLOS ONE			English	Article								Background: Studies of bone allometry typically use simple measurements taken in a small number of locations per bone; often the midshaft diameter or joint surface area is compared to body mass or bone length. However, bones must fulfil multiple roles simultaneously with minimum cost to the animal while meeting the structural requirements imposed by behaviour and locomotion, and not exceeding its capacity for adaptation and repair. We use entire bone volumes from the forelimbs and hindlimbs of Felidae (cats) to investigate regional complexities in bone allometry. Method/Principal Findings: Computed tomographic (CT) images (16435 slices in 116 stacks) were made of 9 limb bones from each of 13 individuals of 9 feline species ranging in size from domestic cat (Felis catus) to tiger (Panthera tigris). Eleven geometric parameters were calculated for every CT slice and scaling exponents calculated at 5% increments along the entire length of each bone. Three-dimensional moments of inertia were calculated for each bone volume, and spherical radii were measured in the glenoid cavity, humeral head and femoral head. Allometry of the midshaft, moments of inertia and joint radii were determined. Allometry was highly variable and related to local bone function, with joint surfaces and muscle attachment sites generally showing stronger positive allometry than the midshaft. Conclusions/Significance: Examining whole bones revealed that bone allometry is strongly affected by regional variations in bone function, presumably through mechanical effects on bone modelling. Bone's phenotypic plasticity may be an advantage during rapid evolutionary divergence by allowing exploitation of the full size range that a morphotype can occupy. Felids show bone allometry rather than postural change across their size range, unlike similar-sized animals.	[Doube, Michael; Shefelbine, Sandra] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Conroy, Alexis Wiktorowicz; Hutchinson, John R.] Univ London Royal Vet Coll, Structure & Motion Lab, Hatfield, Herts, England; [Christiansen, Per] Universitetsparken, Zool Museum, Copenhagen, Denmark	Imperial College London; University of London; University of London Royal Veterinary College	Doube, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	m.doube@imperial.ac.uk	Hutchinson, John/AAH-1593-2020; Doube, Michael/L-6769-2016	Doube, Michael/0000-0002-8021-8127; Hutchinson, John/0000-0002-6767-7038	Biotechnology and Biological Sciences Research Council, UK; BBSRC [BB/F000863/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000863/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1979, J ZOOL, V189, P305; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; BIEWENER AA, 1988, J ZOOL, V214, P547, DOI 10.1111/j.1469-7998.1988.tb03759.x; Boyde A, 2003, J ANAT, V203, P173, DOI 10.1046/j.1469-7580.2003.00213.x; Brianza SZM, 2007, BONE, V40, P1635, DOI 10.1016/j.bone.2007.02.013; Bulstrode C, 1986, LANCET, V327, P29, DOI DOI 10.1016/S0140-6736(86)91905-7; Carpenter RD, 2008, BIOMECH MODEL MECHAN, V7, P227, DOI 10.1007/s10237-007-0087-9; CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136; Castleman K. R., 1996, DIGITAL IMAGE PROCES; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.0.CO;2-8; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; DAVIS DD, 1962, EVOLUTION, V16, P505, DOI 10.2307/2406182; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; ECONOMOS AC, 1983, J THEOR BIOL, V103, P167, DOI 10.1016/0022-5193(83)90206-0; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Firth EC, 2005, NEW ZEAL VET J, V53, P101, DOI 10.1080/00480169.2005.36487; Franklyn M, 2008, AM J SPORT MED, V36, P1179, DOI 10.1177/0363546508314408; Garcia GJM, 2006, PHYS LIFE REV, V3, P188, DOI 10.1016/j.plrev.2006.07.002; Gautier E, 2000, INJURY, V31, P37, DOI 10.1016/S0020-1383(00)80030-3; GODFREY L, 1991, J ZOOL, V223, P603, DOI 10.1111/j.1469-7998.1991.tb04391.x; GOODSHIP AE, 1979, J BONE JOINT SURG AM, V61, P539, DOI 10.2106/00004623-197961040-00008; HARTMAN W, 1984, AM J VET RES, V45, P880; ILIZAROV GA, 1990, CLIN ORTHOP RELAT R, P8; Lamb KJ, 2003, INT J EXP PATHOL, V84, P191, DOI 10.1046/j.1365-2613.2003.00353.x; LANYON LE, 1980, J ZOOL, V192, P457; Lascelles BDX, 2007, VET REC, V160, P512, DOI 10.1136/vr.160.15.512; Main RP, 2007, J ANAT, V210, P272, DOI 10.1111/j.1469-7580.2007.00696.x; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; MCMAHON TA, 1975, J APPL PHYSIOL, V39, P619, DOI 10.1152/jappl.1975.39.4.619; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; Mow V.C., 2005, BASIC ORTHOPAEDIC BI; Nowak RM, 1983, WALKERS MAMMALS WORL, VII; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; Preparata F.P., 1985, COMPUTATIONAL GEOMET; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Reilly GC, 1999, J EXP BIOL, V202, P543; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Rho JY, 2001, J EXP BIOL, V204, P1775; Riggs CM, 1999, EQUINE VET J, V31, P130, DOI 10.1111/j.2042-3306.1999.tb03806.x; RIGGS CM, 1993, ANAT EMBRYOL, V187, P231; Roberts-Harry D, 2004, BRIT DENT J, V196, P391, DOI 10.1038/sj.bdj.4811129; RODRIGUEZ JI, 1992, TERATOLOGY, V45, P213, DOI 10.1002/tera.1420450215; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruohola JPS, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000194668.70225.24; SELKER F, 1989, J BIOMECH, V22, P1175, DOI 10.1016/0021-9290(89)90219-4; Takano Y, 1999, J ORTHOP RES, V17, P59, DOI 10.1002/jor.1100170110; TAKEBE K, 1984, ROLE FIBULA WEIGHT B, P289; Ventura J, 2005, J WILDLIFE DIS, V41, P728, DOI 10.7589/0090-3558-41.4.728; Wang Q, 1996, CLIN ORTHOP RELAT R, P261; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Warton D. I., 2007, SMATR STANDARDISED M; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WOBESER G, 1992, J WILDLIFE DIS, V28, P268, DOI 10.7589/0090-3558-28.2.268; Yang Y, 2008, THESIS IMPERIAL COLL	61	49	49	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4742	10.1371/journal.pone.0004742	http://dx.doi.org/10.1371/journal.pone.0004742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270749	gold, Green Published			2022-12-25	WOS:000265495900010
J	Knorr, E; Schmidtberg, H; Vilcinskas, A; Altincicek, B				Knorr, Eileen; Schmidtberg, Henrike; Vilcinskas, Andreas; Altincicek, Boran			MMPs Regulate both Development and Immunity in the Tribolium Model Insect	PLOS ONE			English	Article								Background: Matrix metalloproteinases (MMPs) are evolutionarily conserved and multifunctional effector molecules in development and homeostasis. In spite of previous, intensive investigation in vitro and in cell culture, their pleiotrophic functions in vivo are still not well understood. Methodology/Principal Findings: We show that the genetically amenable beetle Tribolium castaneum represents a feasible model organism to explore MMP functions in vivo. We silenced expression of three insect-type Tribolium MMP paralogs and their physiological inhibitors, TIMP and RECK, by dsRNA-mediated genetic interference (RNAi). Knock-down of MMP-1 arrested development during pupal morphogenesis giving phenotypes with altered antennae, compound eyes, wings, legs, and head. Parental RNAi-mediated knock-down of MMP-1 or MMP-2 resulted in larvae with non-lethal tracheal defects and with abnormal intestines, respectively, implicating additional roles of MMPs during beetle embryogenesis. This is different to findings from the fruit fly Drosophila melanogaster, in which MMPs have a negligible role in embryogenesis. Confirming pleiotrophic roles of MMPs our results also revealed that MMPs are required for proper insect innate immunity because systemic knock-down of Tribolium MMP-1 resulted in significantly higher susceptibility to the entomopathogenic fungus Beauveria bassiana. Moreover, mRNA levels of MMP-1, TIMP, and RECK, and also MMP enzymatic activity were significantly elevated in immune-competent hemocytes upon stimulation. To confirm collagenolytic activity of Tribolium MMP-1 we produced and purified recombinant enzyme and determined a similar collagen IV degrading activity as observed for the most related human MMP, MMP-19. Conclusions/Significance: This is the first study, to our knowledge, investigating the in vivo role of virtually all insect MMP paralogs along with their inhibitors TIMP and RECK in both insect development and immunity. Our results from the Tribolium model insect indicate that MMPs regulate tracheal and gut development during beetle embryogenesis, pupal morphogenesis, and innate immune defense reactions thereby revealing the evolutionarily conserved roles of MMPs.	[Knorr, Eileen; Schmidtberg, Henrike; Vilcinskas, Andreas; Altincicek, Boran] Univ Giessen, Inst Phytopathol & Appl Zool, Interdisciplinary Res Ctr, Giessen, Germany	Justus Liebig University Giessen	Knorr, E (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Interdisciplinary Res Ctr, Giessen, Germany.	Boran.Altincicek@agrar.uni-giessen.de	Altincicek, Boran/C-1191-2009	Altincicek, Boran/0000-0003-2019-452X	Deutsche Forschungsgemeinschaft (Bonn, Germany) [AL 902/2-1]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG))	This project was supported by a grant (AL 902/2-1) to B. A. from the Deutsche Forschungsgemeinschaft (Bonn, Germany). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-6; Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P400, DOI 10.1016/j.dci.2007.08.001; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Altincicek B, 2006, DEV COMP IMMUNOL, V30, P1108, DOI 10.1016/j.dci.2006.03.002; Beck IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002343; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hillegass JM, 2007, TOXICOL SCI, V100, P168, DOI 10.1093/toxsci/kfm192; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Leontovich AA, 2000, DEVELOPMENT, V127, P907; Llano E, 2002, J BIOL CHEM, V277, P23321, DOI 10.1074/jbc.M200121200; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Madri J A, 2000, Dev Immunol, V7, P103, DOI 10.1155/2000/79045; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Munoz P, 2003, J PARASITOL, V89, P941, DOI 10.1645/GE-3126; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, BIOINFORMATICS METHO; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Sadowski T, 2003, J INVEST DERMATOL, V121, P989, DOI 10.1046/j.1523-1747.2003.12526.x; Schroder R, 2008, DEV GENES EVOL, V218, P119, DOI 10.1007/s00427-008-0214-3; Sokoloff A, 1974, BIOL TRIBOLIUM SPECI; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wedde M, 2007, BIOL CHEM, V388, P119, DOI 10.1515/BC.2007.013; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WHITTEN JM, 1957, J CELL SCI, V41, P123; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhang JS, 2003, DEV GENES EVOL, V213, P456, DOI 10.1007/s00427-003-0346-4	62	64	68	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4751	10.1371/journal.pone.0004751	http://dx.doi.org/10.1371/journal.pone.0004751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270735	Green Published, gold, Green Submitted			2022-12-25	WOS:000265495900018
J	Ong, PC; Golding, SJ; Pearce, MC; Irving, JA; Grigoryev, SA; Pike, D; Langendorf, CG; Bashtannyk-Puhalovich, TA; Bottomley, SP; Whisstock, JC; Pike, RN; McGowan, S				Ong, Poh Chee; Golding, Sarah J.; Pearce, Mary C.; Irving, James A.; Grigoryev, Sergei A.; Pike, Debbie; Langendorf, Christopher G.; Bashtannyk-Puhalovich, Tanya A.; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.; McGowan, Sheena			Conformational Change in the Chromatin Remodelling Protein MENT	PLOS ONE			English	Article								Chromatin condensation to heterochromatin is a mechanism essential for widespread suppression of gene transcription, and the means by which a chromatin-associated protein, MENT, induces a terminally differentiated state in cells. MENT, a protease inhibitor of the serpin superfamily, is able to undergo conformational change in order to effect enzyme inhibition. Here, we sought to investigate whether conformational change in MENT is 'fine-tuned' in the presence of a bound ligand in an analogous manner to other serpins, such as antithrombin where such movements are reflected by a change in intrinsic tryptophan fluorescence. Using this technique, MENT was found to undergo structural shifts in the presence of DNA packaged into nucleosomes, but not naked DNA. The contribution of the four Trp residues of MENT to the fluorescence change was mapped using deconvolution analysis of variants containing single Trp to Phe mutations. The analysis indicated that the overall emission spectra is dominated by a helix-H tryptophan, but this residue did not dominate the conformational change in the presence of chromatin, suggesting that other Trp residues contained in the A-sheet and RCL regions contribute to the conformational change. Mutagenesis revealed that the conformational change requires the presence of the DNA-binding 'M-loop' and D-helix of MENT, but is independent of the protease specificity determining 'reactive centre loop'. The D-helix mutant of MENT, which is unable to condense chromatin, does not undergo a conformational change, despite being able to bind chromatin, indicating that the conformational change may contribute to chromatin condensation by the serpin.	[Ong, Poh Chee; Golding, Sarah J.; Pearce, Mary C.; Irving, James A.; Pike, Debbie; Langendorf, Christopher G.; Bashtannyk-Puhalovich, Tanya A.; Bottomley, Stephen P.; Whisstock, James C.; Pike, Robert N.; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA USA	Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ong, PC (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	rob.pike@med.monash.edu.au; sheena.mcgowan@med.monash.edu.au	Irving, James A/I-8467-2015; Irving, James/P-3860-2019; McGowan, Sheena/C-4797-2014	Irving, James/0000-0003-3204-6356; McGowan, Sheena/0000-0001-6863-1106; Pike, Robert/0000-0002-2083-0269; Golding, Sarah/0000-0002-6578-4390; Whisstock, James/0000-0003-4200-5611; Langendorf, Christopher/0000-0002-9049-5283	National Health and Medical Research Council (NHMRC) of Australia [Senior Research Fellow, CJ Martin Postdoctoral Research Fellow]; Australian Research Council (ARC) [Federation Fellow]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	We thank the National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC) for generous support. JCW is a ARC Federation Fellow. SPB is a NHMRC Senior Research Fellow. JAI is a NHMRC CJ Martin Postdoctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Dafforn TR, 2004, METHODS, V32, P150, DOI 10.1016/S1046-2023(03)00206-8; GRIGORYEV SA, 1992, EXP CELL RES, V198, P268, DOI 10.1016/0014-4827(92)90379-M; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; HASSELBACHER CA, 1995, BIOPHYS J, V69, P20, DOI 10.1016/S0006-3495(95)79891-5; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200; LOCKE BC, 1992, BIOCHEMISTRY-US, V31, P2376, DOI 10.1021/bi00123a024; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mazumder A, 2007, BIOPHYS J, V93, P2209, DOI 10.1529/biophysj.106.102202; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; Montel F, 2007, BIOPHYS J, V93, P566, DOI 10.1529/biophysj.107.105569; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4727	10.1371/journal.pone.0004727	http://dx.doi.org/10.1371/journal.pone.0004727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266095	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490800008
J	Bellgard, MI; Wanchanthuek, P; La, T; Ryan, K; Moolhuijzen, P; Albertyn, Z; Shaban, B; Motro, Y; Dunn, DS; Schibeci, D; Hunter, A; Barrero, R; Phillips, ND; Hampson, DJ				Bellgard, Matthew I.; Wanchanthuek, Phatthanaphong; La, Tom; Ryan, Karon; Moolhuijzen, Paula; Albertyn, Zayed; Shaban, Babak; Motro, Yair; Dunn, David S.; Schibeci, David; Hunter, Adam; Barrero, Roberto; Phillips, Nyree D.; Hampson, David J.			Genome Sequence of the Pathogenic Intestinal Spirochete Brachyspira hyodysenteriae Reveals Adaptations to Its Lifestyle in the Porcine Large Intestine	PLOS ONE			English	Article								Brachyspira hyodysenteriae is an anaerobic intestinal spirochete that colonizes the large intestine of pigs and causes swine dysentery, a disease of significant economic importance. The genome sequence of B. hyodysenteriae strain WA1 was determined, making it the first representative of the genus Brachyspira to be sequenced, and the seventeenth spirochete genome to be reported. The genome consisted of a circular 3,000,694 base pair (bp) chromosome, and a 35,940 bp circular plasmid that has not previously been described. The spirochete had 2,122 protein-coding sequences. Of the predicted proteins, more had similarities to proteins of the enteric Escherichia coli and Clostridium species than they did to proteins of other spirochetes. Many of these genes were associated with transport and metabolism, and they may have been gradually acquired through horizontal gene transfer in the environment of the large intestine. A reconstruction of central metabolic pathways identified a complete set of coding sequences for glycolysis, gluconeogenesis, a non-oxidative pentose phosphate pathway, nucleotide metabolism, lipooligosaccharide biosynthesis, and a respiratory electron transport chain. A notable finding was the presence on the plasmid of the genes involved in rhamnose biosynthesis. Potential virulence genes included those for 15 proteases and six hemolysins. Other adaptations to an enteric lifestyle included the presence of large numbers of genes associated with chemotaxis and motility. B. hyodysenteriae has diverged from other spirochetes in the process of accommodating to its habitat in the porcine large intestine.	[Bellgard, Matthew I.; Wanchanthuek, Phatthanaphong; Ryan, Karon; Moolhuijzen, Paula; Albertyn, Zayed; Shaban, Babak; Motro, Yair; Dunn, David S.; Schibeci, David; Hunter, Adam; Barrero, Roberto] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia; [Wanchanthuek, Phatthanaphong] Mahasarakham Univ, Fac Informat, Maha Sarakham, Thailand; [La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Biomed Sci, Anim Res Inst, Murdoch, WA 6150, Australia	Murdoch University; Mahasarakham University; Murdoch University	Bellgard, MI (corresponding author), Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia.	d.hampson@murdoch.edu.au	Hampson, David/AAE-3666-2019; Hampson, David J/A-9464-2008	Hampson, David J/0000-0002-7729-0427; Barrero, Roberto/0000-0002-7735-665X; Bellgard, Matthew/0000-0002-6303-9469	Australian Research Council; Novartis Animal Vaccines [LP0348441]; Western Australian State Government	Australian Research Council(Australian Research Council); Novartis Animal Vaccines; Western Australian State Government	This study was supported by the Australian Research Council and Novartis Animal Vaccines through Linkage grant number LP0348441 for Genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery, and by the Western Australian State Government in establishment of the WA Centre of Excellence for Comparative Genomics and support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Born TL, 1999, CURR OPIN CHEM BIOL, V3, P607, DOI 10.1016/S1367-5931(99)00016-2; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Bulach DM, 2000, INFECT IMMUN, V68, P3793, DOI 10.1128/IAI.68.7.3793-3798.2000; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Cho NH, 2005, ANN NY ACAD SCI, V1063, P100, DOI 10.1196/annals.1355.016; Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Farn J, 2004, INFECT IMMUN, V72, P7357, DOI 10.1128/IAI.72.12.7357-7359.2004; Fondi M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S12; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; Goonesekere NCW, 2008, PROTEINS, V71, P910, DOI 10.1002/prot.21775; HALTER MR, 1988, INFECT IMMUN, V56, P3152, DOI 10.1128/IAI.56.12.3152-3156.1988; HAMPSON DJ, 2006, DIS SWINE, P785; HENNEBERRY RC, 1970, CAN J MICROBIOL, V16, P41, DOI 10.1139/m70-007; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; HUNTER A, 2005, AUSTR WORKSH GRID CO; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Kada S, 2004, FEMS MICROBIOL LETT, V236, P13, DOI 10.1016/j.femsle.2004.05.028; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY MJ, 1988, J GEN MICROBIOL, V134, P1565; KUNKLE RA, 1986, J CLIN MICROBIOL, V24, P669, DOI 10.1128/JCM.24.4.669-671.1986; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lux R, 2000, J MOL MICROB BIOTECH, V2, P355; MAGASANIK B, 1982, ANNU REV GENET, V16, P135, DOI 10.1146/annurev.ge.16.120182.001031; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; MENESTRINA G, 1994, TOXICOLOGY, V87, P249, DOI 10.1016/0300-483X(94)90254-2; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MILNER JA, 1994, INFECT IMMUN, V62, P4095, DOI 10.1128/IAI.62.9.4095-4099.1994; MOTRO Y, 2009, VET MICROBI IN PRESS; Mulder Nicola, 2007, V396, P59; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Rashid N, 2004, J BACTERIOL, V186, P4185, DOI 10.1128/JB.186.13.4185-4191.2004; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; STANTON TB, 1987, INFECT IMMUN, V55, P304, DOI 10.1128/IAI.55.2.304-308.1987; STANTON TB, 1989, APPL ENVIRON MICROB, V55, P2365, DOI 10.1128/AEM.55.9.2365-2371.1989; Stanton TB, 2001, APPL ENVIRON MICROB, V67, P2037, DOI 10.1128/AEM.67.5.2037-2043.2001; Stanton TB, 1999, APPL ENVIRON MICROB, V65, P5028; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TERHUURNE AAHM, 1995, VET MICROBIOL, V46, P347, DOI 10.1016/0378-1135(95)00049-G; TERHUURNE AAHM, 1994, MICROB PATHOGENESIS, V16, P269, DOI 10.1006/mpat.1994.1028; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wilson K, 1990, CURRENT PROTOCOLS MO, P241; XIANG SH, 1993, J BACTERIOL, V175, P4877, DOI 10.1128/JB.175.15.4877-4884.1993; ZUERNER RL, 1994, J BACTERIOL, V176, P1087, DOI 10.1128/JB.176.4.1087-1092.1994	63	78	192	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4641	10.1371/journal.pone.0004641	http://dx.doi.org/10.1371/journal.pone.0004641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262690	Green Published, gold			2022-12-25	WOS:000265490600002
J	Kloting, N; Berthold, S; Kovacs, P; Schon, MR; Fasshauer, M; Ruschke, K; Stumvoll, M; Bluher, M				Kloeting, Nora; Berthold, Susan; Kovacs, Peter; Schoen, Michael R.; Fasshauer, Mathias; Ruschke, Karen; Stumvoll, Michael; Blueher, Matthias			MicroRNA Expression in Human Omental and Subcutaneous Adipose Tissue	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FAT; IDENTIFICATION; PROFILES	MicroRNAs (miRNAs) are small non-coding RNAs, that play important regulatory roles in a variety of biological processes, including development, differentiation, apoptosis, and metabolism. In mammals, miRNAs have been shown to modulate adipocyte differentiation. Therefore, we performed a global miRNA gene expression assay in different fat depots of overweight and obese individuals to investigate whether miRNA expression in human adipose tissue is fat-depot specific and associated with parameters of obesity and glucose metabolism. Paired samples of abdominal subcutaneous (SC) and intraabdominal omental adipose tissue were obtained from fifteen individuals with either normal glucose tolerance (NGT, n = 9) or newly diagnosed type 2 diabetes (T2D, n = 6). Expression of 155 miRNAs was carried out using the TaqMan (R) MicroRNA Assays Human Panel Early Access Kit (Applied Biosystems, Darmstadt, Germany). We identified expression of 106 (68%) miRNAs in human omental and SC adipose tissue. There was no miRNA exclusively expressed in either fat depot, suggesting common developmental origin of both fat depots. Sixteen miRNAs (4 in NGT, 12 in T2D group) showed a significant fat depot specific expression pattern. We identified significant correlations between the expression of miRNA-17-5p, -132, -99a, -134, 181a, -145, -197 and both adipose tissue morphology and key metabolic parameters, including visceral fat area, HbA(1c), fasting plasma glucose, and circulating leptin, adiponectin, interleukin-6. In conclusion, microRNA expression differences may contribute to intrinsic differences between omental and subcutaneous adipose tissue. In addition, human adipose tissue miRNA expression correlates with adipocyte phenotype, parameters of obesity and glucose metabolism.	[Kloeting, Nora; Berthold, Susan; Fasshauer, Mathias; Ruschke, Karen; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, IZKF, Junior Res Grp N06, Leipzig, Germany; [Schoen, Michael R.] Clin Visceral Surg, Stadtisches Klin Karlsruhe, Karlsruhe, Germany	Leipzig University; Leipzig University; Municipal Hospital Karlsruhe	Kloting, N (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	bluma@medizin.uni-leipzig.de	Ruschke, Karen/E-6320-2014; Stumvoll, Michael/ABE-1121-2021	Ruschke, Karen/0000-0001-5285-9675; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Schon, Michael/0000-0002-0698-4130	Deutsche Forschungsgemeinschaft (DFG) [BL 833/1-1]; Interdisciplinary Center of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig	This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) the Clinical Research group "Atherobesity" KFO 152 (project BL 833/1-1) (MB), the Interdisciplinary Center of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig (Project B24 to MB and Project N06 to PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Gavin JR, 2000, DIABETES CARE, V23, pS4; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001713; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	26	237	248	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4699	10.1371/journal.pone.0004699	http://dx.doi.org/10.1371/journal.pone.0004699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259271	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490500014
J	Babu, CK; Suwansrinon, K; Bren, GD; Badley, AD; Rizza, SA				Babu, Challagundla K.; Suwansrinon, Kanitta; Bren, Gary D.; Badley, Andrew D.; Rizza, Stacey A.			HIV Induces TRAIL Sensitivity in Hepatocytes	PLOS ONE			English	Article								Background: HIV infected patients have an increased susceptibility to liver disease due to Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), alcoholic, and non-alcoholic steatohepatitis. Clinically, this results in limited options for antiretroviral therapy and accelerated rates of liver disease, causing liver disease to be the second leading cause of death for HIV infected patients. The mechanisms causing this propensity for liver dysfunction during HIV remains unknown. Methodology/Principal Findings: We demonstrate that HIV and/or the HIV glycoprotein gp120 ligation of CXCR4 on hepatocytes selectively up-regulates TRAIL R2 expression and confers an acquired sensitivity to TRAIL mediated apoptosis which is mediated by JNK II, but not p38 nor G-proteins. Conclusions/Significance: These findings suggest that HIV infection renders hepatocytes more susceptible to liver injury during disease states associated with enhanced TRAIL production such as HBV, HCV, or steatohepatitis.	[Babu, Challagundla K.; Suwansrinon, Kanitta; Bren, Gary D.; Badley, Andrew D.; Rizza, Stacey A.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Badley, Andrew D.; Rizza, Stacey A.] Mayo Clin, Program Translat Immunovirol & Biodefense, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Babu, CK (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	rizza.stacey@mayo.edu	Challagundla, Kishore B./H-8189-2019; badley, andrew d/O-9022-2014; Serei, Virian D/B-4616-2015	Challagundla, Kishore B./0000-0001-8654-7717; Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261, R01 AI40384, R21DK 77575-1]; Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research [1005160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040384, R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Andrew Badley is supported by grants from the National Institutes of Health (R01 AI62261 and R01 AI40384), and the Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research (ID#1005160). Dr. Stacey Rizza is supported by a grant from the National Institute of Health (R21DK 77575-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt C, 1998, P NATL ACAD SCI USA, V95, P12556, DOI 10.1073/pnas.95.21.12556; Bongiovanni M, 2007, CURR HIV RES, V5, P490, DOI 10.2174/157016207781662407; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; de Ledinghen V, 2008, J VIRAL HEPATITIS, V15, P427, DOI 10.1111/j.1365-2893.2007.00962.x; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gores GJ, 2001, HEPATOLOGY, V34, P3, DOI 10.1053/jhep.2001.25173; Hao CH, 2004, CANCER RES, V64, P8502, DOI 10.1158/0008-5472.CAN-04-2599; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; HOUSSET C, 1990, HUM PATHOL, V21, P404, DOI 10.1016/0046-8177(90)90202-G; Janssen HLA, 2003, J HEPATOL, V39, P414, DOI 10.1016/S0168-8278(03)00265-4; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kim N, 2007, J VIROL, V81, P7584, DOI 10.1128/JVI.02616-06; LEFKOWITCH JH, 1994, DIGEST DIS, V12, P321, DOI 10.1159/000171468; Liu YG, 2007, BIOCHEM BIOPH RES CO, V352, P329, DOI 10.1016/j.bbrc.2006.11.024; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Ohtsuka T, 2003, ONCOGENE, V22, P2034, DOI 10.1038/sj.onc.1206290; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Trushin SA, 2007, J IMMUNOL, V178, P4846, DOI 10.4049/jimmunol.178.8.4846; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Vlahakis SR, 2001, J CLIN INVEST, V107, P207, DOI 10.1172/JCI11109; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yang Y, 2007, INTERVIROLOGY, V50, P323, DOI 10.1159/000106463; Yi YJ, 2004, J NEUROVIROL, V10, P91, DOI 10.1080/13550280490268313	42	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4623	10.1371/journal.pone.0004623	http://dx.doi.org/10.1371/journal.pone.0004623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247452	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487800006
J	Dall, SRX; Wright, J				Dall, Sasha R. X.; Wright, Jonathan			Rich Pickings Near Large Communal Roosts Favor 'Gang' Foraging by Juvenile Common Ravens, Corvus corax	PLOS ONE			English	Article							INFORMATION-CENTER HYPOTHESIS; BLACK VULTURES; RECRUITMENT; FOOD	Ravens (Corvus corax) feed primarily on rich but ephemeral carcasses of large animals, which are usually defended by territorial pairs of adults. Non-breeding juveniles forage socially and aggregate in communal winter roosts, and these appear to function as 'information centers' regarding the location of the rare food bonanzas: individuals search independently of one another and pool their effort by recruiting each other at roosts. However, at a large raven roost in Newborough on Anglesey, North Wales, some juveniles have been observed recently to forage in 'gangs' and to roost separately from other birds. Here we adapt a general model of juvenile common raven foraging behavior where, in addition to the typical co-operative foraging strategy, such gang foraging behavior could be evolutionarily stable near winter raven roosts. We refocus the model on the conditions under which this newly documented, yet theoretically anticipated, gang-based foraging has been observed. In the process, we show formally how the trade off between search efficiency and social opportunity can account for the existence of the alternative social foraging tactics that have been observed in this species. This work serves to highlight a number of fruitful avenues for future research, both from a theoretical and empirical perspective.	[Dall, Sasha R. X.; Wright, Jonathan] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Dall, SRX (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England.	sashadall@iname.com; jonathan.wright@bio.ntnu.no	Dall, Sasha/B-2642-2010	Dall, Sasha/0000-0001-9873-6507	Natural Environment Research Council (U.K.) [AF11/03, NER/A/S/2002/00898]; Natural Environment Research Council [NER/A/S/2002/00898] Funding Source: researchfish	Natural Environment Research Council (U.K.)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was undertaken as an unfunded side project while SRXD was supported by grants to I. L. Boyd and T. H. Clutton-Brock (AF11/03) and R. A. Johnstone (NER/A/S/2002/00898) by the Natural Environment Research Council (U.K.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, RAVEN NATURAL HIST B; BARTA Z, 1992, BEHAV ECOL, V3, P318, DOI 10.1093/beheco/3.4.318; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Dall SRX, 2002, BEHAV ECOL, V13, P42, DOI 10.1093/beheco/13.1.42; GIBBONS MM, 1999, BEHAV ECOL, V10, P377; GIRALDEAN LA, 2000, SOCIAL FORAGING THEO; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; HEINRICH B, 1994, CONDOR, V96, P545, DOI 10.2307/1369334; HEINRICH B, 1994, AUK, V111, P764; HEINRICH B, 1993, AUK, V110, P247; HEINRICH B, 1988, CONDOR, V90, P950, DOI 10.2307/1368859; Heinrich B., 1989, RAVENS WINTER; Houston AI, 1999, MODELS ADAPTIVE BEHA; HURRELL HG, 1956, BR BIRDS, V19, P28; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; MARZLUFF JM, 1991, ANIM BEHAV, V42, P755, DOI 10.1016/S0003-3472(05)80121-6; Maynard Smith J., 1982, pi; Mesterton-Gibbons M, 1998, P ROY SOC B-BIOL SCI, V265, P1237, DOI 10.1098/rspb.1998.0425; RABENOLD PP, 1987, ANIM BEHAV, V35, P1775, DOI 10.1016/S0003-3472(87)80070-2; RABENOLD PP, 1986, AUK, V103, P32, DOI 10.1093/auk/103.1.32; RABENOLD PP, 1983, VULTURE BIOL MANAGEM, P303; Richner H, 1996, BEHAV ECOL, V7, P115, DOI 10.1093/beheco/7.1.115; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wolfram S., 1991, MATH SYSTEM DOING MA; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	27	29	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4530	10.1371/journal.pone.0004530	http://dx.doi.org/10.1371/journal.pone.0004530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240813	Green Published, gold, Green Submitted			2022-12-25	WOS:000278086700002
J	Macri, V; Nazzari, H; McDonald, E; Accili, EA				Macri, Vincenzo; Nazzari, Hamed; McDonald, Evan; Accili, Eric A.			Alanine Scanning of the S6 Segment Reveals a Unique and cAMP-sensitive Association between the Pore and Voltage-dependent Opening in HCN Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CATION CHANNEL; NUCLEOTIDE-GATED CHANNELS; RABBIT SA NODE; PACEMAKER CHANNELS; POTASSIUM CHANNEL; SENSING MECHANISM; K+ CHANNEL; BINDING; MODEL; IDENTIFICATION	Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels resemble Shaker K+ channels in structure and function. In both, changes in membrane voltage produce directionally similar movement of positively charged residues in the voltage sensor to alter the pore structure at the intracellular side and gate ion flow. However, HCNs open when hyperpolarized, whereas Shaker opens when depolarized. Thus, electromechanical coupling between the voltage sensor and gate is opposite. A key determinant of this coupling is the intrinsic stability of the pore. In Shaker, an alanine/valine scan of residues across the pore, by single point mutation, showed that most mutations made the channel easier to open and steepened the response of the channel to changes in voltage. Because most mutations likely destabilize protein packing, the Shaker pore is most stable when closed, and the voltage sensor works to open it. In HCN channels, the pore energetics and vector of work by the voltage sensor are unknown. Accordingly, we performed a 22-residue alanine/valine scan of the distal pore of the HCN2 isoform and show that the effects of mutations on channel opening and on the steepness of the response of the channel to voltage are mixed and smaller than those in Shaker. These data imply that the stabilities of the open and closed pore are similar, the voltage sensor must apply force to close the pore, and the interactions between the pore and voltage sensor are weak. Moreover, cAMP binding to the channel heightens the effects of the mutations, indicating stronger interactions between the pore and voltage sensor, and tips the energetic balance toward a more stable open state.	[Macri, Vincenzo; Nazzari, Hamed; McDonald, Evan; Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Accili, EA (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	eaaccili@interchange.ubc.ca		Macri, Vincenzo/0000-0003-3463-2877	Heart and Stroke Foundation of British Columbia the Yukon	Heart and Stroke Foundation of British Columbia the Yukon	This work was supported in part by grants from the Heart and Stroke Foundation of British Columbia & the Yukon (to E. A. A.).	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; BRUENINGWRIGHT A, 2008, BIOPHYS J, V94, P119; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Cheng L, 2007, J PHARMACOL EXP THER, V322, P931, DOI 10.1124/jpet.107.121467; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Giorgetti A, 2005, BIOPHYS J, V89, P932, DOI 10.1529/biophysj.104.045286; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nazzari H, 2008, AM J PHYSIOL-CELL PH, V295, pC642, DOI 10.1152/ajpcell.00062.2008; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	38	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15659	15667		10.1074/jbc.M809164200	http://dx.doi.org/10.1074/jbc.M809164200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19269964	Green Published, hybrid			2022-12-25	WOS:000266501000034
J	Choi, YE; Butterworth, M; Malladi, S; Duckett, CS; Cohen, GM; Bratton, SB				Choi, Young Eun; Butterworth, Michael; Malladi, Srinivas; Duckett, Colin S.; Cohen, Gerald M.; Bratton, Shawn B.			The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and-7 via Unique Mechanisms at Distinct Steps in Their Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; INDUCED CELL-DEATH; APAF-1 APOPTOSOME; STRUCTURAL BASIS; PROTEIN LIGASE; IAP PROTEINS; IN-VITRO; XIAP; ACTIVATION; INHIBITION	Inhibitor of apoptosis (IAP) proteins are widely expressed throughout nature and suppress cell death under a variety of circumstances. X-linked IAP, the prototypical IAP in mammals, inhibits apoptosis largely through direct inhibition of the initiator caspase-9 and the effector caspase-3 and -7. Two additional IAP family members, cellular IAP1 (cIAP1) and cIAP2, were once thought to also inhibit caspases, but more recent studies have suggested otherwise. Here we demonstrate that cIAP1 does not significantly inhibit the proteolytic activities of effector caspases on fluorogenic or endogenous substrates. However, cIAP1 does bind to caspase-3 and -7 and does so, remarkably, at distinct steps prior to or following the removal of their prodomains, respectively. Indeed, cIAP1 bound to an exposed IAP-binding motif, AKPD, on the N terminus of the large subunit of fully mature caspase-7, whereas cIAP1 bound to partially processed caspase-3 in a manner that required its prodomain and cleavage between its large and small subunits but did not involve a classical IAP-binding motif. As a ubiquitin-protein isopeptide ligase, cIAP1 ubiquitinated caspase-3 and -7, concomitant with binding, in a reaction catalyzed by members of the UbcH5 subfamily (ubiquitin carrier protein/ubiquitin-conjugating enzymes), and in the case of caspase-3, differentially by UbcH8. Moreover, wild-type caspase-7 and a chimeric caspase-3 (bearing the AKPD motif) were degraded in vivo in a proteasome-dependent manner. Thus, cIAPs likely suppress apoptosis, at least in part, by facilitating the ubiquitination and turnover of active effector caspases in cells.	[Choi, Young Eun; Malladi, Srinivas; Duckett, Colin S.; Bratton, Shawn B.] Univ Texas Austin, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Choi, Young Eun; Bratton, Shawn B.] Univ Texas Austin, Div Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; [Malladi, Srinivas; Bratton, Shawn B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Butterworth, Michael; Cohen, Gerald M.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Leicester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bratton, SB (corresponding author), Univ Texas Austin, Ctr Mol & Cellular Toxicol, 1 Univ Stn A1915, Austin, TX 78712 USA.	sbbratton@mail.utexas.edu		Duckett, Colin/0000-0001-9413-2263; Bratton, Shawn/0000-0003-2895-5020	NCI [CA129521]; American Cancer Society [RSG-05-029-01-CCG]; PhRMA Foundation; Medical Research Council [MC_U132615750] Funding Source: researchfish; MRC [MC_U132615750] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); PhRMA Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129521 from NCI (to S. B. B.). This work was also supported by American Cancer Society Grant RSG-05-029-01-CCG and PhRMA Foundation (to S. B. B.).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Bratton SB, 2003, CELL DEATH DIFFER, V10, P4, DOI 10.1038/sj.cdd.4401176; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chai JJ, 2003, NAT STRUCT BIOL, V10, P892, DOI 10.1038/nsb989; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Imoto I, 2002, CANCER RES, V62, P4860; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Krauss SW, 2005, BLOOD, V106, P2200, DOI 10.1182/blood-2005-04-1357; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Rumble JM, 2008, BIOCHEM J, V415, P21, DOI 10.1042/BJ20081188; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2005, CANCER RES, V65, P210; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361	63	109	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12772	12782		10.1074/jbc.M807550200	http://dx.doi.org/10.1074/jbc.M807550200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19258326	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000265688300022
J	Abreu, RD; Sanchez-Diaz, PC; Vogel, C; Burns, SC; Ko, DJ; Burton, TL; Vo, DT; Chennasamudaram, S; Le, SY; Shapiro, BA; Penalva, LOF				Abreu, Raquel de Sousa; Sanchez-Diaz, Patricia C.; Vogel, Christine; Burns, Suzanne C.; Ko, Daijin; Burton, Tarea L.; Vo, Dat T.; Chennasamudaram, Soudhamini; Le, Shu-Yun; Shapiro, Bruce A.; Penalva, Luiz O. F.			Genomic Analyses of Musashi1 Downstream Targets Show a Strong Association with Cancer-related Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; ARF TUMOR-SUPPRESSOR; MESSENGER-RNA; STEM-CELLS; RIBONUCLEOPROTEIN COMPLEXES; POSTTRANSCRIPTIONAL OPERONS; STATISTICAL-MODEL; GENE-EXPRESSION; P53; MDM2	Musashi1 (Msi1) is a highly conserved RNA-binding protein with pivotal functions in stem cell maintenance, nervous system development, and tumorigenesis. Despite its importance, only three direct mRNA targets have been characterized so far: m-numb, CDKN1A, and c-mos. Msi1 has been shown to affect their translation by binding to short elements located in the 3'-untranslated region. To better understand Msi1 functions, we initially performed an RIP-Chip analysis in HEK293T cells; this method consists of isolation of specific RNA-protein complexes followed by identification of the RNA component via microarrays. A group of 64 mRNAs was found to be enriched in the Msi1-associated population compared with controls. These genes belong to two main functional categories pertinent to tumorigenesis: 1) cell cycle, cell proliferation, cell differentiation, and apoptosis and 2) protein modification (including ubiquitination and ubiquitin cycle). To corroborate our findings, we examined the impact of Msi1 expression on both mRNA (transcriptomic) and protein (proteomic) expression levels. Genes whose mRNA levels were affected by Msi1 expression have a Gene Ontology distribution similar to RIP-Chip results, reinforcing Msi1 participation in cancer-related processes. The proteomics study revealed that Msi1 can have either positive or negative effects on gene expression of its direct targets. In summary, our results indicate that Msi1 affects a network of genes and could function as a master regulator during development and tumor formation.	[Burton, Tarea L.; Vo, Dat T.; Chennasamudaram, Soudhamini; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Vogel, Christine] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ko, Daijin] Univ Texas San Antonio, Dept Management Sci & Stat, San Antonio, TX 78229 USA; [Le, Shu-Yun; Shapiro, Bruce A.] NCI, Ctr Canc Res Nanobiol Program, Computat RNA Struct Grp, NIH, Frederick, MD 21702 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Austin; University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Penalva, LOF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Childrens Canc Res Inst, Mail Code 7784,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	penalva@uthscsa.edu		de Sousa Abreu, Raquel/0000-0002-8211-6052; Penalva, Luiz/0000-0003-4491-6769	National Institutes of Health Intramural Research Program; NCI; Center for Cancer Research; San Antonio Area Foundation [PGID122760]; San Antonio Cancer Institute; American Cancer Society [PGID 124139]; Tengg Foundation [PGID 127793]; International Human Frontier Science Program; NATIONAL CANCER INSTITUTE [ZIABC008382, Z01BC008382] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); San Antonio Area Foundation; San Antonio Cancer Institute; American Cancer Society(American Cancer Society); Tengg Foundation; International Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research. This work was also supported by the San Antonio Area Foundation (Grant PGID122760), the San Antonio Cancer Institute, the American Cancer Society (Grant PGID 124139), and the Tengg Foundation (Grant PGID 127793).; Supported by the International Human Frontier Science Program.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Clarke RB, 2005, CELL PROLIFERAT, V38, P375, DOI 10.1111/j.1365-2184.2005.00357.x; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Crosetto N, 2006, MOL CANCER RES, V4, P899, DOI 10.1158/1541-7786.MCR-06-0328; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobson NR, 2008, GLIA, V56, P318, DOI 10.1002/glia.20615; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Higuchi S, 2008, MECH DEVELOP, V125, P631, DOI 10.1016/j.mod.2008.03.002; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Le SY, 2003, BIOINFORMATICS, V19, P354, DOI 10.1093/bioinformatics/btf826; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mckee AE, 2007, CELL RES, V17, P581, DOI 10.1038/cr.2007.54; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Penalva LOF, 2004, BIOTECHNIQUES, V37, P604, DOI 10.2144/04374ST05; Penalva LOF, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-24; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vogel C, 2008, NAT PROTOC, V3, P1444, DOI [10.1038/nprot.2008.132, 10.1038/nport.2008.132]; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Yoon KH, 2008, RNA BIOL, V5, P255, DOI 10.4161/rna.7116; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	48	73	76	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12125	12135		10.1074/jbc.M809605200	http://dx.doi.org/10.1074/jbc.M809605200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258308	Green Published, hybrid			2022-12-25	WOS:000265494600044
J	Klockner, C; Schneider, M; Lutz, S; Jani, D; Kressler, D; Stewart, M; Hurt, E; Kohler, A				Kloeckner, Christoph; Schneider, Maren; Lutz, Sheila; Jani, Divyang; Kressler, Dieter; Stewart, Murray; Hurt, Ed; Koehler, Alwin			Mutational Uncoupling of the Role of Sus1 in Nuclear Pore Complex Targeting of an mRNA Export Complex and Histone H2B Deubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; IN-VIVO; SAGA; ASSOCIATION; GENES; ACETYLTRANSFERASE; UBP8; UBIQUITYLATION; ELONGATION; DEUBIQUITYLATION	Sus1 is an evolutionary conserved protein that functions both in transcription and mRNA export and has been proposed to contribute to coupling these processes in yeast. Sus1 mediates its different roles as a component of both the histone H2B deubiquitinating module (Sus1-Sgf11-Ubp8-Sgf73) of the SAGA (Spt-Ada-Gcn5 acetyltransferase) transcriptional co-activator and the mRNA export complex, TREX-2 (Sus1-Sac3-Thp1-Cdc31). We have dissected the different functions of Sus1 with respect to its partitioning in transcription and export complexes using a mutational approach. Here we show that the sus1-10 (E18A, S19A, and G20A) and sus1-12 (V73A and D75A) alleles of Sus1 can be dissociated from TREX-2 while leaving its interaction with SAGA largely intact. Conversely, the binding to both TREX-2 and SAGA was impaired in the sus1-11 allele (G37A and W38A),in which two highly conserved residues were mutated. In vitro experiments demonstrated that dissociation of mutant Sus1 from its partners is caused by a reduced affinity toward the TREX-2 subunit, Sac3, and the SAGA factor, Sgf11, respectively. Consistent with the biochemical data, these sus1 mutant alleles showed differential genetic relationships with SAGA and mRNA export mutants. In vivo, all three sus1 mutants were impaired in targeting TREX-2 (i.e. Sac3) to the nuclear pore complexes and exhibited nuclear mRNA export defects. This study has implications for how Sus1, in combination with distinct interaction partners, can regulate diverse aspects of gene expression.	[Kloeckner, Christoph; Schneider, Maren; Lutz, Sheila; Kressler, Dieter; Hurt, Ed; Koehler, Alwin] Heidelberg Univ, Biochem Zentrum, D-69120 Heidelberg, Germany; [Jani, Divyang; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Ruprecht Karls University Heidelberg; MRC Laboratory Molecular Biology	Hurt, E (corresponding author), Heidelberg Univ, Biochem Zentrum, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Kressler, Dieter/C-2218-2012; Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Kressler, Dieter/0000-0003-4855-3563; Lutz, Sheila/0000-0002-6729-4598	MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bauer A, 1996, J CELL SCI, V109, P1575; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chekanova JA, 2008, RNA, V14, P66, DOI 10.1261/rna.764108; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jones AL, 2000, P NATL ACAD SCI USA, V97, P3224, DOI 10.1073/pnas.050432997; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Kuwahara K, 2001, P NATL ACAD SCI USA, V98, P10279, DOI 10.1073/pnas.181335698; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lei EP, 2003, MOL BIOL CELL, V14, P836, DOI 10.1091/mbc.E02-08-0520; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Resendes KK, 2008, MOL CELL BIOL, V28, P1755, DOI 10.1128/MCB.01697-07; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; WERTMAN KF, 1992, GENETICS, V132, P337; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Yoshida M, 2007, GENES CELLS, V12, P1205, DOI 10.1111/j.1365-2443.2007.01119.x; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	53	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12049	12056		10.1074/jbc.M900502200	http://dx.doi.org/10.1074/jbc.M900502200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269973	Green Published, hybrid			2022-12-25	WOS:000265494600037
J	Lee, CM; Hickey, MM; Sanford, CA; McGuire, CG; Cowey, CL; Simon, MC; Rathmell, WK				Lee, C. M.; Hickey, M. M.; Sanford, C. A.; McGuire, C. G.; Cowey, C. L.; Simon, M. C.; Rathmell, W. K.			VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo	ONCOGENE			English	Article						von Hippel-Lindau; hypoxia inducible factors; renal cell carcinoma	TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTOR; HIPPEL-LINDAU-DISEASE; RENAL-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; CHUVASH POLYCYTHEMIA; EMBRYONIC LETHALITY; UBIQUITIN LIGASE; VASCULAR TUMORS; BINDING-SITES	Von Hippel-Lindau (VHL) disease is caused by germline mutations in the VHL tumor suppressor gene, with Type 2B missense VHL mutations predisposing to renal cell carcinoma, hemangioblastoma and pheochromocytoma. Type 2B mutant pVHL is predicted to be defective in hypoxia inducible factor (HIF)-alpha regulation. Murine embryonic stem (ES) cells in which the endogenous wildtype Vhl gene was replaced with the representative Type 2B VHL hotspot mutation R167Q (Vhl(2B/2B)) displayed preserved physiological regulation of both HIF factors with slightly greater normoxic dysregulation of HIF-2 alpha. Differentiated Vhl(2B/2B)-derived teratomas overexpressed joint HIF targets Vegf and EglN3 but not the HIF-1 alpha-specific target Pfk1. Vhl(2B/2B) teratomas additionally displayed a growth advantage over Vhl(-/-)-derived teratomas, suggestive of a tight connection between perturbations in the degree and ratio of HIF-1 alpha and HIF-2 alpha stabilization and cell growth. Vhl(2B/2B) mice displayed mid-gestational embryonic lethality, whereas adult Vhl(2B/+) mice exhibited susceptibility to carcinogen-promoted renal neoplasia compared with wild-type littermates at 12 months. Our experiments support a model in which the representative Type 2B R167Q mutant pVhl produces a unique pro. le of HIF dysregulation, thereby promoting tissue-specific effects on cell growth, development and tumor predisposition.	[Lee, C. M.; Sanford, C. A.; McGuire, C. G.; Cowey, C. L.; Rathmell, W. K.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lee, C. M.; Rathmell, W. K.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Hickey, M. M.; Simon, M. C.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Hickey, M. M.; Simon, M. C.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Hickey, M. M.; Simon, M. C.] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 W Dr,Room 21-237,Campus Box 7295, Chapel Hill, NC 27599 USA.	rathmell@med.unc.edu	Simon, Celeste/AAG-3941-2021		V Foundation; American Cancer Society; VHL Family Alliance; NCI [K08098410, R01121781]; Howard Hughes Medical Institute; NIEHS [F30015248]; NATIONAL CANCER INSTITUTE [R01CA121781, K08CA098410] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066310] Funding Source: NIH RePORTER	V Foundation; American Cancer Society(American Cancer Society); VHL Family Alliance; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr T Van Dyke and members of her laboratory, Dr I Davis, and Dr WY Kim for many helpful discussions. This work was supported by the V Foundation, the American Cancer Society, the VHL Family Alliance, and the NCI K08098410 and R01121781 (WKR); by the Howard Hughes Medical Institute (MCS, MMH); and by the NIEHS F30015248 (CML).	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Covello KL, 2005, CANCER RES, V65, P2277, DOI 10.1158/0008-5472.CAN-04-3246; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gallou C, 2004, HUM MUTAT, V24, P215, DOI 10.1002/humu.20082; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hacker KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003801; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kobayashi T, 1999, CANCER RES, V59, P1206; Kondo K, 2002, GENE CHROMOSOME CANC, V34, P58, DOI 10.1002/gcc.10054; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Ma WB, 2003, CANCER RES, V63, P5320; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miller MS, 2004, TOXICOL APPL PHARM, V198, P95, DOI 10.1016/j.taap.2003.07.018; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rathmell WK, 2008, EXPERT REV ANTICANC, V8, P63, DOI 10.1586/14737140.8.1.63; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Voss AK, 2000, DEVELOPMENT, V127, P1; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	65	32	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2009	28	14					1694	1705		10.1038/onc.2009.12	http://dx.doi.org/10.1038/onc.2009.12			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	430WQ	19252526	Green Accepted, Green Submitted			2022-12-25	WOS:000265022000004
J	Helmy, M; Gohda, J; Inoue, J; Tomita, M; Tsuchiya, M; Selvarajoo, K				Helmy, Mohamed; Gohda, Jin; Inoue, Jun-ichiro; Tomita, Masaru; Tsuchiya, Masa; Selvarajoo, Kumar			Predicting Novel Features of Toll-Like Receptor 3 Signaling in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR; REGULATORY FACTOR-3; ACTIVATION; TOLL-LIKE-RECEPTOR-4; INTERFERON; EXPRESSION; TRADD; TLR; RECOGNITION	The Toll-like receptor (TLR) 3 plays a critical role in mammalian innate immune response against viral attacks by recognizing double-stranded RNA (dsRNA) or its synthetic analog polyinosinic-polycytidylic acid (poly (I: C)). This leads to the activation of MAP kinases and NF-kappa B which results in the induction of type I interferons and proinflammatory cytokines to combat the viral infection. To understand the complex interplay of the various intracellular signaling molecules in the regulation of NF kappa B and MAP kinases, we developed a computational TLR3 model based upon perturbation-response approach. We curated literature and databases to determine the TLR3 signaling topology specifically for murine macrophages. For initial model creation, we used wildtype temporal activation profiles of MAP kinases and NF-kappa B and, for model testing, used TRAF6 KO and TRADD KO data. From dynamic simulations we predict i) the existence of missing intermediary steps between extracellular poly (I: C) stimulation and intracellular TLR3 binding, and ii) the presence of a novel pathway which is essential for JNK and p38, but not NF-kappa B, activation. Our work shows activation dynamics of signaling molecules can be used in conjunction with perturbation-response models to decipher novel signaling features of complicated immune pathways.	[Helmy, Mohamed; Tomita, Masaru; Tsuchiya, Masa; Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Helmy, Mohamed] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Gohda, Jin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan	Keio University; Keio University; University of Tokyo	Helmy, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; kumar@ttck.keio.ac.jp		Selvarajoo, Kumar/0000-0002-0314-9666; Helmy, Mohamed/0000-0002-9561-7956	JST CREST; the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Egyptian bureau of culture, sciences and education in Japan; Tsuruoka City, Yamagata prefecture	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Egyptian bureau of culture, sciences and education in Japan; Tsuruoka City, Yamagata prefecture	This study is funded by JST CREST, from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Egyptian bureau of culture, sciences and education in Japan (M. Helmy) and by the Tsuruoka City, Yamagata prefecture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bach JF, 2005, NAT MED, V11, P120, DOI 10.1038/nm0205-120; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hulejova H, 2007, CYTOKINE, V38, P151, DOI 10.1016/j.cyto.2007.06.001; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pindado J, 2007, J IMMUNOL, V179, P4821, DOI 10.4049/jimmunol.179.7.4821; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Selvarajoo K, 2006, FEBS LETT, V580, P1457, DOI 10.1016/j.febslet.2006.01.046; SELVARAJOO K, 2007, INTRO SYSTEMS BIOL, P449; SELVARAJOO K, 2008, J BIOINFORM IN PRESS; SELVARAJOO K, 2006, E CELL SYSTEM BASIC; SELVARAJOO K, 2008, 10 INT C MOL SYST BI, P110; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Vance W, 2002, P NATL ACAD SCI USA, V99, P5816, DOI 10.1073/pnas.022049699; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	45	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4661	10.1371/journal.pone.0004661	http://dx.doi.org/10.1371/journal.pone.0004661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252739	gold, Green Submitted, Green Published			2022-12-25	WOS:000265489900004
J	Marguet, C; Lubrano, M; Gueudin, M; Le Roux, P; Deschildre, A; Forget, C; Couderc, L; Siret, D; Donnou, MD; Bubenheim, M; Vabret, A; Freymuth, F				Marguet, Christophe; Lubrano, Marc; Gueudin, Marie; Le Roux, Pascal; Deschildre, Antoine; Forget, Chantal; Couderc, Laure; Siret, Daniel; Donnou, Marie-Dominique; Bubenheim, Michael; Vabret, Astrid; Freymuth, Francois			In Very Young Infants Severity of Acute Bronchiolitis Depends On Carried Viruses	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; INFECTION; CHILDREN; IMPACT; PCR; ASSOCIATION; DISEASE; SINGLE	Background: RI amplification reaction has revealed that various single viruses or viral co-infections caused acute bronchiolitis in infants, and RV appeared to have a growing involvement in early respiratory diseases. Because remaining controversial, the objective was to determine prospectively the respective role of RSV, RV, hMPV and co-infections on the severity of acute bronchiolitis in very young infants. Methods and Principal Findings: 209 infants (median age: 2.4 months) were enrolled in a prospective study of infants <1 year old, hospitalized for a first episode of bronchiolitis during the winter epidemic season and with no high risk for severe disease. The severity was assessed by recording SaO(2)% at admission, a daily clinical score (scale 0-18), the duration of oxygen supplementation and the length of hospitalization. Viruses were identified in 94.7% by RT amplification reaction: RSV only (45.8%), RV only (7.2%), hMPV only (3.8%), dual RSV/RV (14.3%), and other virus only (2%) or coinfections (9%). RV compared respectively with RSV and dual RSV/RV infection caused a significant less severe disease with a lower clinical score (5[3.2-6] vs. 6[4-8], p=0.01 and 5.5[5-7], p=0.04), a shorter time in oxygen supplementation (0[0-1] days vs. 2[0-3] days, p=0.02 and 2[0-3] days, p=0.03) and a shorter hospital stay (3[3-4.7] days vs.6 [5-8] days, p=0.001 and 5[4-6] days, p=0.04). Conversely, RSV infants had also longer duration of hospitalization in comparison with RSV/RV (p=0.01) and hMPV (p=0.04). The multivariate analyses showed that the type of virus carried was independently associated with the duration of hospitalization. Conclusion: This study underlined the role of RV in early respiratory diseases, as frequently carried by young infants with a first acute bronchiolitis. RSV caused the more severe disease and conversely RV the lesser severity. No additional effect of dual RSV/RV infection was observed on the severity.	[Marguet, Christophe; Lubrano, Marc; Couderc, Laure] Rouen Univ Hosp Charles Nicolle, Dept Pediat, Resp Dis Allergy & CF Unit, Rouen, France; [Gueudin, Marie] Rouen Univ Hosp Charles Nicolle, Dept Virol, Rouen, France; [Le Roux, Pascal] Reg Hosp Flaubert, Dept Pediat, Resp Dis Allergy & CF Unit, Le Havre, France; [Deschildre, Antoine] Lille Univ Hosp Jeanne de Flandres, Dept Pediat, Resp Dis Allergy & CF Unit, Lille, France; [Forget, Chantal] Reg Hosp, Dept Pediat, Resp Dis & Allergy Unit, Elbeuf, France; [Siret, Daniel] Reg Hosp Moulin du Pre, Dept Pediat, Resp Dis Allergy & CF Unit, St Nazaire, France; [Donnou, Marie-Dominique] Brest Univ Hosp, Pediat Lung Funct Tests & Resp Dis Unit, Brest, France; [Bubenheim, Michael] Rouen Univ Hosp Charles Nicolle, Dept Biostat, Rouen, France; [Vabret, Astrid; Freymuth, Francois] Caen Univ Hosp Clemenceau, Lab Human & Mol Virol, Caen, France	CHU de Rouen; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; CHU Brest; CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie	Marguet, C (corresponding author), Rouen Univ Hosp Charles Nicolle, Dept Pediat, Resp Dis Allergy & CF Unit, Rouen, France.	christophe.marguet@chu-rouen.fr		VABRET, Astrid/0000-0002-8940-7645	French National Clinical Research Program [2000/020/HP]	French National Clinical Research Program	This work has been funded by the French National Clinical Research Program n. 2000/020/HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Causse M, 2007, J CLIN MICROBIOL, V45, P3811, DOI 10.1128/JCM.00345-07; Eugene-Ruellan G, 1998, J CLIN MICROBIOL, V36, P796, DOI 10.1128/JCM.36.3.796-801.1998; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; HELMINEN M, 2008, PEDIAT PULMONOL, V13, P394; Jacques J, 2006, J CLIN VIROL, V35, P463, DOI 10.1016/j.jcv.2005.11.009; Korppi M, 2004, PEDIATR INFECT DIS J, V23, P995, DOI 10.1097/01.inf.0000143642.72480.53; Korppi M, 2007, J ALLERGY CLIN IMMUN, V119, P1561, DOI 10.1016/j.jaci.2007.02.008; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Legg JP, 2005, PEDIATR INFECT DIS J, V24, P611, DOI 10.1097/01.inf.0000168747.94999.aa; Manoha C, 2007, J CLIN VIROL, V38, P221, DOI 10.1016/j.jcv.2006.12.005; Mansbach JM, 2008, PEDIATRICS, V121, P680, DOI 10.1542/peds.2007-1418; Marguet C, 2008, PEDIAT ALLERG IMM-UK, V19, P157, DOI 10.1111/j.1399-3038.2007.00600.x; MAUSBACH JM, 2008, ACAD EMERG MED, V15, P111; McNamara PS, 2007, PEDIATR PULM, V42, P740, DOI 10.1002/ppul.20649; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Ordas J, 2006, J CLIN MICROBIOL, V44, P2739, DOI 10.1128/JCM.00164-06; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Parkin PC, 1996, J CLIN EPIDEMIOL, V49, P821, DOI 10.1016/0895-4356(96)00027-3; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Xepapadaki P, 2004, J CLIN VIROL, V30, P267, DOI 10.1016/j.jcv.2003.12.012	30	116	121	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4596	10.1371/journal.pone.0004596	http://dx.doi.org/10.1371/journal.pone.0004596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240806	Green Published, Green Submitted, gold			2022-12-25	WOS:000278086700011
J	Ruckenstuhl, C; Buttner, S; Carmona-Gutierrez, D; Eisenberg, T; Kroemer, G; Sigrist, SJ; Frohlich, KU; Madeo, F				Ruckenstuhl, Christoph; Buettner, Sabrina; Carmona-Gutierrez, Didac; Eisenberg, Tobias; Kroemer, Guido; Sigrist, Stephan J.; Froehlich, Kai-Uwe; Madeo, Frank			The Warburg Effect Suppresses Oxidative Stress Induced Apoptosis in a Yeast Model for Cancer	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; CYTOCHROME-C; MITOCHONDRIA; METABOLISM; GROWTH; PROLIFERATION; RELEASE; OXYGEN; TUMORS	Background: Otto Warburg observed that cancer cells are often characterized by intense glycolysis in the presence of oxygen and a concomitant decrease in mitochondrial respiration. Research has mainly focused on a possible connection between increased glycolysis and tumor development whereas decreased respiration has largely been left unattended. Therefore, a causal relation between decreased respiration and tumorigenesis has not been demonstrated. Methodology/Principal Findings: For this purpose, colonies of Saccharomyces cerevisiae, which is suitable for manipulation of mitochondrial respiration and shows mitochondria-mediated cell death, were used as a model. Repression of respiration as well as ROS-scavenging via glutathione inhibited apoptosis and conferred a survival advantage during seeding and early development of this fast proliferating solid cell population. In contrast, enhancement of respiration triggered cell death. Conclusion/Significance: Thus, the Warburg effect might directly contribute to the initiation of cancer formation - not only by enhanced glycolysis - but also via decreased respiration in the presence of oxygen, which suppresses apoptosis.	[Ruckenstuhl, Christoph; Buettner, Sabrina; Carmona-Gutierrez, Didac; Eisenberg, Tobias; Froehlich, Kai-Uwe; Madeo, Frank] Graz Univ, Inst Mol Biosci, Graz, Austria; [Kroemer, Guido] INSERM, U848, Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Kroemer, Guido] Univ Paris 11, Villejuif, France; [Sigrist, Stephan J.] FU Berlin, Inst Biol, Berlin, Germany; [Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, Berlin, Germany	University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruckenstuhl, C (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	frank.madeo@uni-graz.at	Kroemer, Guido/AAY-9859-2020; Eisenberg, Tobias/AAV-7806-2021; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Madeo, Frank/0000-0002-5070-1329; Buttner, Sabrina/0000-0002-2786-8542; Ruckenstuhl, Christoph/0000-0002-4338-4679; Eisenberg, Tobias/0000-0003-3559-1130	FWF-FSP [593]; EU STREP [511983]	FWF-FSP(Austrian Science Fund (FWF)); EU STREP(European Commission)	This work was supported by grant FWF-FSP 593 to F. M. and grant EU STREP 511983 (TransDeath) to K-U.F.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denko NC, 2008, NAT REV CANC; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; HANSSMANN P, 1976, MOL GEN GENET, V148, P205; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kondoh H, 2008, EXP CELL RES, V314, P1923, DOI 10.1016/j.yexcr.2008.03.007; Kroemer G, 1997, CELL DEATH DIFFER, V4, P443, DOI 10.1038/sj.cdd.4400266; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Meunier JR, 1999, YEAST, V15, P1159, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1159::AID-YEA441>3.0.CO;2-D; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; VAUGHU AE, 2008, NAT CELL BIOL, V10, P1177; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138	34	89	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4592	10.1371/journal.pone.0004592	http://dx.doi.org/10.1371/journal.pone.0004592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240798	Green Published, gold, Green Submitted			2022-12-25	WOS:000278086700009
J	Magdaleno, A; Ahn, IY; Paes, LS; Silber, AM				Magdaleno, Anahi; Ahn, Il-Young; Paes, Lisvane Silva; Silber, Ariel M.			Actions of a Proline Analogue, L-Thiazolidine-4-Carboxylic Acid (T4C), on Trypanosoma cruzi	PLOS ONE			English	Article								It is well established that L-proline has several roles in the biology of trypanosomatids. In Trypanosoma cruzi, the etiological agent of Chagas' disease, this amino acid is involved in energy metabolism, differentiation processes and resistance to osmotic stress. In this study, we analyzed the effects of interfering with L-proline metabolism on the viability and on other aspects of the T. cruzi life cycle using the proline analogue L- thiazolidine-4-carboxylic acid (T4C). The growth of epimastigotes was evaluated using different concentrations of T4C in standard culture conditions and at high temperature or acidic pH. We also evaluated possible interactions of this analogue with stress conditions such as those produced by nutrient starvation and oxidative stress. T4C showed a dose-response effect on epimastigote growth (IC50 = 0.89+/-0.02 mM at 28 degrees C), and the inhibitory effect of this analogue was synergistic (p<0.05) with temperature (0.54+/-0.01 mM at 37 degrees C). T4C significantly diminished parasite survival (p<0.05) in combination with nutrient starvation and oxidative stress conditions. Pre-incubation of the parasites with L-proline resulted in a protective effect against oxidative stress, but this was not seen in the presence of the drug. Finally, the trypomastigote bursting from infected mammalian cells was evaluated and found to be inhibited by up to 56% when cells were treated with non-toxic concentrations of T4C (between 1 and 10 mM). All these data together suggest that T4C could be an interesting therapeutic drug if combined with others that affect, for example, oxidative stress. The data also support the participation of proline metabolism in the resistance to oxidative stress.	[Magdaleno, Anahi; Ahn, Il-Young; Paes, Lisvane Silva; Silber, Ariel M.] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil	Universidade de Sao Paulo	Magdaleno, A (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Sao Paulo, Brazil.	asilber@usp.br	Vieira, Lisvane Paes/AAI-6761-2020; 4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Silber, Ariel/O-6951-2015	Vieira, Lisvane Paes/0000-0001-8589-5939; Silber, Ariel/0000-0003-4528-4732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/57596-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473906/2008-2]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant #08/57596-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant # 473906/2008-2) and Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-de-Faria M, 1999, EXP PARASITOL, V92, P263, DOI 10.1006/expr.1999.4423; Alves MJM, 2007, IUBMB LIFE, V59, P274, DOI 10.1080/15216540701200084; Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; ASIN S, 1995, J PARASITOL, V81, P1, DOI 10.2307/3283997; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOHLER S, 1989, INFUSIONSTHERAPIE, V16, P82; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Cazzulo JJ, 1997, BIOL CHEM, V378, P1; Chen CB, 2006, APPL ENVIRON MICROB, V72, P4001, DOI 10.1128/AEM.02428-05; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; DESOUZA W, 1984, INT REV CYTOL, V86, P197, DOI 10.1016/S0074-7696(08)60180-1; Deutch CE, 2004, FEMS MICROBIOL LETT, V238, P383, DOI 10.1016/j.femsle.2004.08.001; ELTHON TE, 1984, PLANT PHYSIOL, V74, P213, DOI 10.1104/pp.74.2.213; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Finzi JK, 2004, MOL BIOCHEM PARASIT, V133, P37, DOI 10.1016/j.molbiopara.2003.08.011; Kollien AH, 1998, AM J TROP MED HYG, V59, P166, DOI 10.4269/ajtmh.1998.59.166; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Landfear SM, 2008, ADV EXP MED BIOL, V625, P22; Miranda MR, 2006, EXP PARASITOL, V114, P341, DOI 10.1016/j.exppara.2006.04.004; Molinari BL, 2003, ANAL QUANT CYTOL, V25, P254; Monaghan PJ, 2007, FEBS J, V274, P2070, DOI 10.1111/j.1742-4658.2007.05750.x; Nomura M, 2003, J BIOCHEM, V133, P67, DOI 10.1093/jb/mvg003; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Ratner S, 1937, J AM CHEM SOC, V59, P200, DOI 10.1021/ja01280a050; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Silber AM, 2006, INT J PARASITOL, V36, P157, DOI 10.1016/j.ijpara.2005.10.006; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Tempone Andre Gustavo, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P222; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; UNGER L, 1966, J BACTERIOL, V91, P1564, DOI 10.1128/JB.91.4.1564-1569.1966; UNGER L, 1966, J BACTERIOL, V91, P1556, DOI 10.1128/JB.91.4.1556-1563.1966; Urbina JA, 2002, CURR PHARM DESIGN, V8, P287, DOI 10.2174/1381612023396177; *WHO, 2002, WHO TECH REP SER, V905, P64; ZILBERSTEIN D, 1993, ADV PARASIT, V32, P261, DOI 10.1016/S0065-308X(08)60209-2	49	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4534	10.1371/journal.pone.0004534	http://dx.doi.org/10.1371/journal.pone.0004534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229347	gold, Green Published			2022-12-25	WOS:000265486200011
J	Sudo, R; Chung, S; Zervantonakis, IK; Vickerman, V; Toshimitsu, Y; Griffith, LG; Kamm, RD				Sudo, Ryo; Chung, Seok; Zervantonakis, Ioannis K.; Vickerman, Vernella; Toshimitsu, Yasuko; Griffith, Linda G.; Kamm, Roger D.			Transport-mediated angiogenesis in 3D epithelial coculture	FASEB JOURNAL			English	Article						microfluidics; vascularization; tissue engineering	CELL-CELL INTERACTIONS; IN-VITRO; MICROFLUIDIC PLATFORM; LIVER-REGENERATION; ENDOTHELIAL-CELLS; PERFUSION-CULTURE; TISSUE; HEPATOCYTES; MORPHOGENESIS; TECHNOLOGIES	Increasing interest has focused on capturing the complexity of tissues and organs in vitro as models of human pathophysiological processes. In particular, a need exists for a model that can investigate the interactions in three dimensions (3D) between epithelial tissues and a microvascular network since vascularization is vital for reconstructing functional tissues in vitro. Here, we implement a microfluidic platform to analyze angiogenesis in 3D cultures of rat primary hepatocytes and rat/human microvascular endothelial cells (rMVECs/hMVECs). Liver and vascular cells were cultured on each sidewall of a collagen gel scaffold between two microfluidic channels under static or flow conditions. Morphogenesis of 3D hepatocyte cultures was found to depend on diffusion and convection across the nascent tissue. Furthermore, rMVECs formed 3D capillary-like structures that extended across an intervening gel to the hepatocyte tissues in hepatocyter-MVEC coculture while they formed 2D sheet-like structures in rMVEC monoculture. In addition, diffusion of fluorescent dextran across the gel scaffold was analyzed, demonstrating that secreted proteins from the hepatocytes and MVECs can be exchanged across the gel scaffold by diffusional transport. The experimental approach described here is useful more generally for investigating microvascular networks within 3D engineered tissues with multiple cell types in vitro.-Sudo, R., Chung, S., Zervantonakis, I. K., Vickerman, V., Toshimitsu, Y., Griffith, L. G., Kamm, R. D. Transport-mediated angiogenesis in 3D epithelial coculture. FASEB J. 23, 2155-2164 (2009)	[Sudo, Ryo; Chung, Seok; Toshimitsu, Yasuko; Griffith, Linda G.; Kamm, Roger D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Zervantonakis, Ioannis K.; Griffith, Linda G.; Kamm, Roger D.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Vickerman, Vernella] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kamm, RD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave,NE47-321, Cambridge, MA 02139 USA.	rdkamm@mit.edu	Sudo, Ryo/D-2319-2010; Zervantonakis, Ioannis/C-2890-2011; Kamm, Roger D/I-7630-2012; Zervantonakis, Ioannis/ADS-2519-2022; Zervantonakis, Ioannis/N-9717-2019; Chung, Seok/B-1501-2015	Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Sudo, Ryo/0000-0002-1053-9662; /0000-0002-7232-304X; Griffith, Linda/0000-0002-1801-5548	National Institute of Biomedical Imaging and Bioengineering [EB003805]; Draper Laboratories Inc [DL-H-550151]; Singapore-MIT Alliance for Research and Technology; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003805] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Draper Laboratories Inc; Singapore-MIT Alliance for Research and Technology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Jose Antonio Sanz-Hererrea for analyzing the diffusion experiments; Chen-rei Wan and Nathan Hammond for critical reading of the manuscript; and Laura Vineyard, Romie Littrell, and Ta- Chun Hang for technical assistance. We also appreciate helpful discussions with Carlos Semino at the Massachusetts Institute of Technology (MIT) and Donna Stolz at the University of Pittsburgh. This research is supported by the National Institute of Biomedical Imaging and Bioengineering (EB003805), Draper Laboratories Inc. (UR&D project DL-H-550151), Singapore-MIT Alliance for Research and Technology, and Japan Society for the Promotion of Science postdoctoral fellowships for research abroad ( R. S.).	Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Hwa AJ, 2007, FASEB J, V21, P2564, DOI 10.1096/fj.06-7473com; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Lauffenburger DA, 2001, P NATL ACAD SCI USA, V98, P4282, DOI 10.1073/pnas.081083698; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Nahmias Y, 2007, ADV BIOCHEM ENG BIOT, V103, P309, DOI 10.1007/10_029; Nahmias Y, 2006, TISSUE ENG, V12, P1627, DOI 10.1089/ten.2006.12.1627; Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143; Ross MA, 2001, HEPATOLOGY, V34, P1135, DOI 10.1053/jhep.2001.29624; Sudo R, 2005, FASEB J, V19, P1695, DOI 10.1096/fj.04-3269fje; Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333	28	143	149	2	94	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2155	2164		10.1096/fj.08-122820	http://dx.doi.org/10.1096/fj.08-122820			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246488	Green Published			2022-12-25	WOS:000268836500015
J	Ahn, J; Byeon, IJL; Byeon, CH; Gronenborn, AM				Ahn, Jinwoo; Byeon, In-Ja L.; Byeon, Chang-Hyeock; Gronenborn, Angela M.			Insight into the Structural Basis of Pro- and Antiapoptotic p53 Modulation by ASPP Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; APOPTOTIC FUNCTION; P53-DEPENDENT APOPTOSIS; SV40-TRANSFORMED CELLS; TUMOR-ANTIGEN; DEATH; 53BP2; MUTANTS; BINDING; ACETYLATION	p53-dependent apoptosis is modulated by the ASPP family of proteins (apoptosis-stimulating proteins of p53; also called ankyrin repeat-, Src homology 3 domain-, and Pro-rich region-containing proteins). Its three known members, ASPP1, ASPP2, and iASPP, were previously found to interact with p53, influencing the apoptotic response of cells without affecting p53-induced cell cycle arrest. More specifically, the bona fide tumor suppressors, ASPP1 and ASPP2, bind to the core domain of p53 and stimulate transcription of apoptotic genes, whereas oncogenic iASPP also binds to the p53 core domain but inhibits p53-dependent apoptosis. Although the general interaction regions are known, details of the interfaces for each p53-ASPP complex have not been evaluated. We undertook a comprehensive biophysical characterization of ASPP-p53 complex formation and mapped the binding interfaces by NMR. We found that the interaction interface on p53 for the proapoptotic protein ASPP2 is distinct from that for the antiapoptotic iASPP. ASPP2 primarily binds to the core domain of p53, whereas iASPP predominantly interacts with a linker region adjacent to the core domain. Our detailed structural analyses of the ASPP-p53 interactions provide insight into the structural basis of the differential behavior of pro-and antiapoptotic ASPP family members.	[Ahn, Jinwoo; Byeon, In-Ja L.; Byeon, Chang-Hyeock; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), 3501 5th Ave, Pittsburgh, PA 15260 USA.	amg100@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525				Ao Y, 2001, ONCOGENE, V20, P2720, DOI 10.1038/sj.onc.1204352; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; LINZER DIH, 1979, VIROLOGY, V98, P308, DOI 10.1016/0042-6822(79)90554-3; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu ZJ, 2004, LEUKEMIA, V18, P880, DOI 10.1038/sj.leu.2403300; Lopez CD, 2000, MOL CELL BIOL, V20, P8018, DOI 10.1128/MCB.20.21.8018-8025.2000; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Olivier Magali, 2004, IARC Sci Publ, P247; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Smith BO, 1996, J BIOMOL NMR, V8, P360, DOI 10.1007/BF00410335; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tidow H, 2006, J BIOL CHEM, V281, P32526, DOI 10.1074/jbc.M604725200; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	46	42	49	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13812	13822		10.1074/jbc.M808821200	http://dx.doi.org/10.1074/jbc.M808821200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19246451	Green Published, hybrid			2022-12-25	WOS:000265877300058
J	Vanlandingham, PA; Ceresa, BP				Vanlandingham, Phillip A.; Ceresa, Brian P.			Rab7 Regulates Late Endocytic Trafficking Downstream of Multivesicular Body Biogenesis and Cargo Sequestration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ESCRT-II; FACTOR RECEPTORS; RILP INTERACTS; PROTEIN RILP; TRANSPORT; DEGRADATION; ENDOSOMES; LYSOSOMES; COMPLEX	The small molecular weight G-protein RAB7 is localized to both early and late endosomes and has been shown to be critical for trafficking through the endocytic pathway. The role of RAB7 in the endocytic pathway has been controversial, with some groups reporting that it regulates trafficking from early to late endosomes and others ascribing its role to trafficking between late endosomes and lysosomes. In this study, we use RNA interference to identify the exact step RAB7 regulates in the movement of the epidermal growth factor receptor (EGFR) from the cell surface to the lysosome. In the absence of RAB7, trafficking of the EGF center dot EGFR complex through the early endosome to the late endosome/multivesicular body (LE/MVB) does not change, but exiting from the LE/MVB is blocked. Ultrastructural analysis reveals that RAB7 is not required for formation of intraluminal vesicles of the LE/MVB, since RAB7-deficient cells have an increased number of enlarged LE/MVBs densely packed with intraluminal vesicles. Biochemical data indicate that the EGFR complex is sequestered in these intraluminal vesicles. Together, these data provide evidence that RAB7 is required for the transfer of cargo from the LE/MVB to the lysosome and for endocytic organelle maintenance.	[Vanlandingham, Phillip A.; Ceresa, Brian P.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, Oklahoma City, OK 73126 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ceresa, BP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, POB 26901,Biomed Sci Bldg,Rm 553, Oklahoma City, OK 73126 USA.	Brian-Ceresa@ouhsc.edu			National Institutes of Health [P20 RR017703]; National Institutes of Health, NEI [EY09391]; American Cancer Society [RSG-03-021-01]; Oklahoma Center for the Advancement of Science and Technology [HR03-014]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Cancer Society(American Cancer Society); Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR017703. The Fluoview 1000 microscope was funded through National Institutes of Health, NEI, Grant EY09391 (to J. A. Summers Rada, Principal Investigator). This work was also supported by American Cancer Society Grant RSG-03-021-01 and Oklahoma Center for the Advancement of Science and Technology Grant HR03-014.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fullmon R.L, 1953, J MET, V5, P447; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; KING AC, 1984, BIOCHEM BIOPH RES CO, V124, P585, DOI 10.1016/0006-291X(84)91594-8; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; MERESSE S, 1995, J CELL SCI, V108, P3349; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301; Progida C, 2006, BIOCHEM BIOPH RES CO, V347, P1074, DOI 10.1016/j.bbrc.2006.07.007; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; ROBBINS AR, 1979, P NATL ACAD SCI USA, V76, P1911, DOI 10.1073/pnas.76.4.1911; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shah AH, 2007, J CELL BIOL, V179, P965, DOI 10.1083/jcb.200702187; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Van Meel E, 2008, HISTOCHEM CELL BIOL, V129, P253, DOI 10.1007/s00418-008-0384-0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; WILLIAMS MA, 1985, QUANTITATIVE METHODS, P52; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	53	272	276	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12110	12124		10.1074/jbc.M809277200	http://dx.doi.org/10.1074/jbc.M809277200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265192	hybrid, Green Published			2022-12-25	WOS:000265494600043
J	Lin, EA; Kong, L; Bai, XH; Luan, Y; Liu, CJ				Lin, Edward A.; Kong, Li; Bai, Xiao-Hui; Luan, Yi; Liu, Chuan-ju			miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; INDUCIBLE P204 PROTEIN; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; MICROMASS CULTURES; MESSENGER-RNA; STEM-CELLS; SKELETOGENESIS	MicroRNAs (miRNA) are short non-coding RNA molecules that regulate a variety of biological processes. The role of miRNAs in BMP2-mediated biological processes is of considerable interest. A comparative miRNA array led to the isolation of several BMP2-responsive miRNAs. Among them, miR-199a* is of particular interest, because it was reported to be specifically expressed in the skeletal system. Here we demonstrate that miR-199a* is an early responsive target of BMP2: its level was dramatically reduced at 5 h, quickly increased at 24 h and remained higher thereafter in the course of BMP2-triggered chondrogenesis of a micromass culture of pluripotent C3H10T1/2 stem cells. miR-199a* significantly inhibited early chondrogenesis, as revealed by the reduced expression of early marker genes for chondrogenesis such as cartilage oligomeric matrix protein (COMP), type II collagen, and Sox9, whereas anti-miR-199a* increased the expression of these chondrogenic marker genes. A computer-based prediction algorithm led to the identification of Smad1, a well established downstream molecule of BMP-2 signaling, as a putative target of miR-199a*. The pattern of Smad1 mRNA expression exhibited the mirror opposite of miR-199a* expression following BMP-2 induction. Furthermore, miR-199a* demonstrated remarkable inhibition of both endogenous Smad1 as well as a reporter construct bearing the 3-un-translated region of Smad1 mRNA. In addition, mutation of miR-199a* binding sites in the 3'-untranslated region of Smad1 mRNA abolished miR-199a*-mediated repression of reporter gene activity. Mechanism studies revealed that miR-199a* inhibits Smad1/Smad4-mediated transactivation of target genes, and that overexpression of Smad1 completely corrects miR-199a*-mediated repression of early chondrogenesis. Taken together, miR-199a* is the first BMP2 responsive microRNA found to adversely regulate early chondrocyte differentiation via direct targeting of the Smad1 transcription factor.	[Lin, Edward A.; Kong, Li; Bai, Xiao-Hui; Luan, Yi; Liu, Chuan-ju] NYU, Sch Med, Dept Orthopaed Surg, New York, NY 10003 USA; [Liu, Chuan-ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Liu, CJ (corresponding author), NYU, Sch Med, Dept Orthopaed Surg, 301 E 17th St, New York, NY 10003 USA.	Chuanju.liu@med.nyu.edu	Liu, Chuan-ju/AAT-8165-2021	liu, chuanju/0000-0002-7181-8032; Bai, Xiaohui/0000-0002-4027-7798	National Institutes of Health [AR050620, AR053210, AG029388]; Arthritis National Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050620, AR053210, and AG029388. This work was also supported by a grant from the Arthritis National Research Foundation. 1 Both authors contributed equally to this work.	Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan Shih-Peng, 2006, RNA Biol, V3, P97; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Chimal-Monroy J, 2002, DEV DYNAM, V224, P314, DOI 10.1002/dvdy.10110; Church VL, 2002, INT J DEV BIOL, V46, P927; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hatakeyama Y, 2003, J BONE JOINT SURG AM, V85A, P13, DOI 10.2106/00004623-200300003-00004; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kong L, 2008, CELL MOL LIFE SCI, V65, P3494, DOI 10.1007/s00018-008-8342-5; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lin EA, 2009, FRONT BIOSCI-LANDMRK, V14, P2757, DOI 10.2741/3412; Liu C., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P340; Liu CJ, 2007, FRONT BIOSCI, V12, P3899, DOI 10.2741/2359; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Luan Y, 2008, MOL BIOL CELL, V19, P2113, DOI 10.1091/mbc.E07-10-1057; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yates KE, 2004, OSTEOARTHR CARTILAGE, V12, P497, DOI 10.1016/j.joca.2004.02.009; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang Y, 2008, CELL DEATH DIFFER, V15, P1760, DOI 10.1038/cdd.2008.112; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	57	195	213	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11326	11335		10.1074/jbc.M807709200	http://dx.doi.org/10.1074/jbc.M807709200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251704	hybrid, Green Published			2022-12-25	WOS:000265494500037
J	Widenmaier, SB; Sampaio, AV; Underhill, TM; McIntosh, CHS				Widenmaier, Scott B.; Sampaio, Arthur V.; Underhill, T. Michael; McIntosh, Christopher H. S.			Noncanonical Activation of Akt/Protein Kinase B in beta-Cells by the Incretin Hormone Glucose-dependent Insulinotropic Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; SURVIVAL; AKT; MECHANISM; RECEPTOR; PROLIFERATION; STIMULATION	Therapeutics based on the actions of the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), have recently been introduced for the treatment of type 2 diabetes mellitus. The serine/threonine kinase Akt is a major mediator of incretin action on the pancreatic islet, increasing beta-cell mass and function and promoting beta-cell survival. The mechanisms underlying incretin activation of Akt are thought to involve an essential phosphoinositide 3-kinase-mediated phosphorylation of threonine 308, similar to the prototypical Akt activator, insulin-like growth factor-I (IGF-I). In this study, using activity assays on immunoprecipitated Akt, we discovered that GIP and GLP-1 were capable of stimulating Akt in the INS-1 beta-cell line and isolated mouse islets via a mechanism that did not require phosphoinositide 3-kinase or phosphorylation of Thr(308) and Ser(473), and this pathway involved the production of cAMP. Furthermore, we found that GIP stimulated anti-apoptotic signaling via this alternate mode of Akt activation. We conclude that incretins can activate Akt via a novel noncanonical mechanism that may provide an alternative therapeutic target for the treatment of type 2 diabetes mellitus and have broader implications for Akt physiology in human health and disease.	[McIntosh, Christopher H. S.] Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Diabet Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca		Widenmaier, Scott/0000-0001-5684-2707	Canadian Institutes of Health Research and the Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research and the Canadian Foundation for Innovation(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Institutes of Health Research and the Canadian Foundation for Innovation ( to C. H. S. M.) and scholarships from the Natural Sciences and Engineering Research Council of Canada and the Michael Smith Foundation for Health Research ( to S. W.).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Balas B, 2007, J CLIN ENDOCR METAB, V92, P1249, DOI 10.1210/jc.2006-1882; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Elghazi L, 2006, INT J BIOCHEM CELL B, V38, P157, DOI 10.1016/j.biocel.2005.08.017; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Leech CA, 1996, ANN NY ACAD SCI, V805, P81; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McIntosh CHS, 2008, FRONT BIOSCI-LANDMRK, V13, P1753, DOI 10.2741/2797; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Rao P, 2005, DIABETES, V54, P1664, DOI 10.2337/diabetes.54.6.1664; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; SIEGEL EG, 1985, DIABETOLOGIA, V28, P857, DOI 10.1007/BF00291078; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tews D, 2008, HORM METAB RES, V40, P172, DOI 10.1055/s-2008-1042426; Trumper A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740233; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	57	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10764	10773		10.1074/jbc.M809116200	http://dx.doi.org/10.1074/jbc.M809116200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233842	Green Published, hybrid			2022-12-25	WOS:000265104600051
J	Rigel, NW; Gibbons, HS; McCann, JR; McDonough, JA; Kurtz, S; Braunstein, M				Rigel, Nathan W.; Gibbons, Henry S.; McCann, Jessica R.; McDonough, Justin A.; Kurtz, Sherry; Braunstein, Miriam			The Accessory SecA2 System of Mycobacteria Requires ATP Binding and the Canonical SecA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; STREPTOCOCCUS-PARASANGUIS; IN-VIVO; SECRETION SYSTEMS; WILD-TYPE; MEMBRANE; TUBERCULOSIS; SMEGMATIS; BACILLUS	In bacteria, the majority of exported proteins are transported by the general Sec pathway from their site of synthesis in the cytoplasm across the cytoplasmic membrane. The essential SecA ATPase powers this Sec-mediated export. Mycobacteria possess two nonredundant SecA homologs: SecA1 and SecA2. In pathogenic Mycobacterium tuberculosis and the nonpathogenic model mycobacterium Mycobacterium smegmatis, SecA1 is essential for protein export and is the "housekeeping" SecA, whereas SecA2 is an accessory SecA that exports a specific subset of proteins. In M. tuberculosis the accessory SecA2 pathway plays a role in virulence. In this study, we uncovered basic properties of the mycobacterial SecA2 protein and its pathway for exporting select proteins. By constructing secA2 mutant alleles that encode proteins defective in ATP binding, we showed that ATP binding is required for SecA2 function. SecA2 mutant proteins unable to bind ATP were nonfunctional and dominant negative. By evaluating the subcellular distribution of each SecA, SecA1 was shown to be equally divided between cytosolic and cell envelope fractions, whereas SecA2 was predominantly localized to the cytosol. Finally, we showed that the canonical SecA1 has a role in the process of SecA2-dependent export. The accessory SecA2 export system is important to the physiology and virulence of mycobacteria. These studies help establish the mechanism of this new type of specialized protein export pathway.	[Rigel, Nathan W.; Gibbons, Henry S.; McCann, Jessica R.; McDonough, Justin A.; Kurtz, Sherry; Braunstein, Miriam] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Braunstein, M (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, CB 7920,804 Mary Ellen Jones Bldg, Chapel Hill, NC 27599 USA.	braunste@med.unc.edu		Kurtz, Sherry/0000-0002-2281-8984; Gibbons, Henry/0000-0002-5603-8679; McCann, Jessica/0000-0001-6139-7089	National Institutes of Health [AI054540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI054540.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Appling DR, 1999, METHODS, V19, P338, DOI 10.1006/meth.1999.0861; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Chen Q, 2006, FEMS MICROBIOL LETT, V264, P174, DOI 10.1111/j.1574-6968.2006.00455.x; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Das S, 2008, J BACTERIOL, V190, P7302, DOI 10.1128/JB.00593-08; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hou JM, 2008, J BACTERIOL, V190, P4880, DOI 10.1128/JB.00412-08; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; KLOSE M, 1993, J BIOL CHEM, V268, P4504; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Or E, 2007, FEBS LETT, V581, P2616, DOI 10.1016/j.febslet.2007.04.083; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Sakai D, 2001, J BIOL CHEM, V276, P17968, DOI 10.1074/jbc.M010652200; Sambrook J, 2001, MOL CLONING LAB MANU; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; SUN Y, 1993, FASEB J, V7, P944, DOI 10.1096/fasebj.7.10.8344492; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; VANDERWOLK J, 1993, MOL MICROBIOL, V8, P31; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004	49	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9927	9936		10.1074/jbc.M900325200	http://dx.doi.org/10.1074/jbc.M900325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19240020	Green Published, hybrid			2022-12-25	WOS:000264892900035
J	Albrecht-Buehler, G				Albrecht-Buehler, Guenter			Outline of a Genome Navigation System Based on the Properties of GA-Sequences and Their Flanks	PLOS ONE			English	Article							ALU; TRANSCRIPTION; BINDING; DNA	Introducing a new method to visualize large stretches of genomic DNA (see Appendix S1) the article reports that most GA-sequences [1] shared chains of tetra-GA-motifs and contained upstream poly(A)-segments. Although not integral parts of them, Alu-elements were found immediately upstream of all human and chimpanzee GA-sequences with an upstream poly(A)-segment. The article hypothesizes that genome navigation uses these properties of GA-sequences in the following way. (1) Poly(A) binding proteins interact with the upstream poly(A)-segments and arrange adjacent GA-sequences side-byside ('GA-ribbon'), while folding the intervening DNA sequences between them into loops ('associated DNA-loops'). (2) Genome navigation uses the GA-ribbon as a search path for specific target genes that is up to 730-fold shorter than the full-length chromosome. (3) As to the specificity of the search, each molecule of a target protein is assumed to catalyze the formation of specific oligomers from a set of transcription factors that recognize tetra-GA-motifs. Their specific combinations of tetra-GA motifs are assumed to be present in the particular GA-sequence whose associated loop contains the gene for the target protein. As long as the target protein is abundant in the cell it produces sufficient numbers of such oligomers which bind to their specific GA-sequences and, thereby, inhibit locally the transcription of the target protein in the associated loop. However, if the amount of target protein drops below a certain threshold, the resultant reduction of specific oligomers leaves the corresponding GA-sequence 'denuded'. In response, the associated DNA-loop releases its nucleosomes and allows transcription of the target protein to proceed. (4) The Alu-transcripts may help control the general background of protein synthesis proportional to the number of transcriptionally active associated loops, especially in stressed cells. (5) The model offers a new mechanism of co-regulation of protein synthesis based on the shared segments of different GA-sequences.	[Albrecht-Buehler, Guenter] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Albrecht-Buehler, G (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	g-buehler@northwestern.edu						Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Albrecht-Buehler G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003818; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; CHU WM, 1995, NUCLEIC ACIDS RES, V23, P1750, DOI 10.1093/nar/23.10.1750; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Kim C, 2001, GENE, V276, P127, DOI 10.1016/S0378-1119(01)00639-4; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; MARKHAM R, 1963, VIROLOGY, V20, P88, DOI 10.1016/0042-6822(63)90143-0; Melnikova L, 2004, P NATL ACAD SCI USA, V101, P14806, DOI 10.1073/pnas.0403959101; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4701	10.1371/journal.pone.0004701	http://dx.doi.org/10.1371/journal.pone.0004701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270754	Green Submitted, Green Published, gold			2022-12-25	WOS:000265495900002
J	Chatterjee, C; Sarkar, RR				Chatterjee, Chandrajit; Sarkar, Ram Rup			Multi-Step Polynomial Regression Method to Model and Forecast Malaria Incidence	PLOS ONE			English	Article							INFECTIOUS-DISEASES; FALCIPARUM-MALARIA; RISK; EPIDEMICS; PATTERNS; DIPTERA; SPREAD	Malaria is one of the most severe problems faced by the world even today. Understanding the causative factors such as age, sex, social factors, environmental variability etc. as well as underlying transmission dynamics of the disease is important for epidemiological research on malaria and its eradication. Thus, development of suitable modeling approach and methodology, based on the available data on the incidence of the disease and other related factors is of utmost importance. In this study, we developed a simple non-linear regression methodology in modeling and forecasting malaria incidence in Chennai city, India, and predicted future disease incidence with high confidence level. We considered three types of data to develop the regression methodology: a longer time series data of Slide Positivity Rates (SPR) of malaria; a smaller time series data (deaths due to Plasmodium vivax) of one year; and spatial data (zonal distribution of P. vivax deaths) for the city along with the climatic factors, population and previous incidence of the disease. We performed variable selection by simple correlation study, identification of the initial relationship between variables through non-linear curve fitting and used multistep methods for induction of variables in the non-linear regression analysis along with applied Gauss-Markov models, and ANOVA for testing the prediction, validity and constructing the confidence intervals. The results execute the applicability of our method for different types of data, the autoregressive nature of forecasting, and show high prediction power for both SPR and P. vivax deaths, where the one-lag SPR values plays an influential role and proves useful for better prediction. Different climatic factors are identified as playing crucial role on shaping the disease curve. Further, disease incidence at zonal level and the effect of causative factors on different zonal clusters indicate the pattern of malaria prevalence in the city. The study also demonstrates that with excellent models of climatic forecasts readily available, using this method one can predict the disease incidence at long forecasting horizons, with high degree of efficiency and based on such technique a useful early warning system can be developed region wise or nation wise for disease prevention and control activities.	[Chatterjee, Chandrajit; Sarkar, Ram Rup] Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chatterjee, C (corresponding author), Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India.	ramrup@ccmb.res.in		SARKAR, RAM RUP/0000-0001-7115-163X	Department of Science and Technology (DST), Govt. of India [SR/FTP/MS-06/2005]	Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India))	R.R. Sarkar is thankful to the Department of Science and Technology (DST), Govt. of India, for financial support under the project grant SR/FTP/MS-06/2005.	Abeku TA, 2002, TROP MED INT HEALTH, V7, P851, DOI 10.1046/j.1365-3156.2002.00924.x; AGUR Z, 1993, P NATL ACAD SCI USA, V90, P11698, DOI 10.1073/pnas.90.24.11698; ANDERSON R M, 1991; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Anderson T. W., 1958, INTRO MULTIVARIATE S; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-76; Cancre N, 2000, AM J EPIDEMIOL, V152, P760, DOI 10.1093/aje/152.8.760; Chattopadhyay J, 2004, ECOL MODEL, V177, P179, DOI 10.1016/j.ecolmodel.2004.03.001; Cliff A D, 1983, Ecol Dis, V2, P377; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; FIELD A, 2004, FACTOR ANAL USING SP; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HETHCOTE HW, 1981, SIAM J APPL MATH, V40, P1, DOI 10.1137/0140001; Himeidan Y. E., 2007, Eastern Mediterranean Health Journal, V13, P17; KALLEN A, 1985, J THEOR BIOL, V116, P377, DOI 10.1016/S0022-5193(85)80276-9; KHANUM S, 2007, REGIONAL HLTH FORUM, V11, P33; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; KSHIRSAGAR AM, 1972, MULTIVARIATE ANAL, V2; Kuhn KG, 2002, J MED ENTOMOL, V39, P621, DOI 10.1603/0022-2585-39.4.621; Kumar AR, 2008, CURR SCI INDIA, V94, P1012; LAYNE SP, 2007, EPIDEMIOLOGY EPI, V220; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; MORITA T, 1994, ESTIMATION CLIMATE C; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546; RURU Y, 2003, PHILIPPINE STAT, V52, P27; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; *WHO, WORLD HLTH ORG WHO G; WICKWIRE K, 1977, THEOR POPUL BIOL, V11, P182, DOI 10.1016/0040-5809(77)90025-9; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; [No title captured]	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4726	10.1371/journal.pone.0004726	http://dx.doi.org/10.1371/journal.pone.0004726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266093	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490800007
J	Sellick, MJ; Kyser, TK; Wunder, MB; Chipley, D; Norris, DR				Sellick, Megan J.; Kyser, T. Kurt; Wunder, Michael B.; Chipley, Don; Norris, D. Ryan			Geographic Variation of Strontium and Hydrogen Isotopes in Avian Tissue: Implications for Tracking Migration and Dispersal	PLOS ONE			English	Article							STABLE-ISOTOPES; WINTERING GROUNDS; BREEDING ORIGINS; NORTH-AMERICA; RATIOS; FEATHERS; TRACERS; BIRDS; PRECIPITATION; ASSIGNMENT	Background: Isotopes can provide unique solutions to fundamental problems related to the ecology and evolution of migration and dispersal because prior movements of individuals can theoretically be tracked from tissues collected from a single capture. However, there is still remarkably little information available about how and why isotopes vary in wild animal tissues, especially over large spatial scales. Methodology/Principal Findings: Here, we describe variation in both stable-hydrogen (delta D-F) and strontium (Sr-87/Sr-86(F)) isotopic compositions in the feathers of a migratory songbird, the Tree Swallow ( Tachycineta bicolor), across 18 sampling sites in North America and then examine potential mechanisms driving this variation. We found that dDF was correlated with latitude of the sampling site, whereas Sr-87/Sr-86(F) was correlated with longitude. delta D-F was related to delta D of meteoric waters where molting occurred and Sr-87/Sr-86(F) was influenced primarily by the geology in the area where feathers were grown. Using simulation models, we then assessed the utility of combining both markers to estimate the origin of individuals. Using 13 geographic regions, we found that the number of individuals correctly assigned to their site of origin increased from less than 40% using either delta D or Sr-87/Sr-86 alone to 74% using both isotopes. Conclusions/Significance: Our results suggest that these isotopes have the potential to provide predictable and complementary markers for estimating long-distance animal movements. Combining isotopes influenced by different global-scale processes may allow researchers to link the population dynamics of animals across large geographic ranges.	[Sellick, Megan J.; Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Kyser, T. Kurt; Chipley, Don] Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada; [Wunder, Michael B.] Univ Colorado, Dept Biol, Denver, CO USA	University of Guelph; Queens University - Canada; University of Colorado System; University of Colorado Denver	Sellick, MJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	rnorris@uoguelph.ca	Norris, Ryan/F-4720-2011	Norris, Ryan/0000-0003-4874-1425; Kyser, Kurt/0000-0001-9667-4103	Natural Sciences and Engineering Research Council; Canadian Foundation for Innovation; Ontario Innovation Trust; University of Guelph; Queen's University; Ontario Graduate Scholarship; American Ornithologist' Union; Society of Canadian Ornithologists; Ellis Bird Farm	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; University of Guelph; Queen's University; Ontario Graduate Scholarship(Ontario Graduate Scholarship); American Ornithologist' Union; Society of Canadian Ornithologists; Ellis Bird Farm	Funding for this research was provided by the Natural Sciences and Engineering Research Council (DRN, TKK, MJS), Canadian Foundation for Innovation (TKK, DRN), Ontario Innovation Trust (TKK), University of Guelph (DRN) and Queen's University (TKK), Ontario Graduate Scholarship (MJS), American Ornithologist' Union (MJS), Society of Canadian Ornithologists (MJS), and the Ellis Bird Farm (MJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; Bairlein F, 2001, ARDEA, V89, P7; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; BREWER D, 2000, CANADIAN ATLAS BIRD; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; Colbert J, 2001, DISPERSAL; CRESSIE N, 1990, MATH GEOL, V22, P241; DANSGAARD W, 1964, TELLUS, V16, P436; ESTEP MF, 1981, SCIENCE, V214, P1374; Faure G., 1972, STRONTIUM ISOTOPE GE; Font L, 2007, J ANAL ATOM SPECTROM, V22, P513, DOI 10.1039/b616328a; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2001, AUK, V118, P16, DOI 10.1642/0004-8038(2001)118[0016:LBAWGO]2.0.CO;2; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoppe KA, 1999, GEOLOGY, V27, P439, DOI 10.1130/0091-7613(1999)027<0439:TMAMRO>2.3.CO;2; Hoppe KA, 2007, QUATERNARY RES, V68, P347, DOI 10.1016/j.yqres.2007.08.001; HUSSELL DJT, 1983, WILSON BULL, V95, P470; Kelly JF, 2008, ECOL APPL, V18, P568, DOI 10.1890/07-0027.1; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Lott CA, 2006, AUK, V123, P822, DOI 10.1642/0004-8038(2006)123[822:AGATET]2.0.CO;2; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; Meehan TD, 2001, CONDOR, V103, P11, DOI 10.1650/0010-5422(2001)103[0011:UHIGTE]2.0.CO;2; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Pyle P., 1997, IDENTIFICATION GUI 1; ROBERTSON RJ, 1992, TREE SWALLOW, P1, DOI DOI 10.2173/BNA.11; Rocque DA, 2006, J ORNITHOL, V147, P395, DOI 10.1007/s10336-006-0068-2; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Sauer J. R., 2005, N AM BREEDING BIRD S; Vann J, 2003, AUSTRALAS I MIN MET, V2003, P215; VOGEL JC, 1990, NATURE, V346, P747, DOI 10.1038/346747a0; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2001, ENVIRON SCI TECHNOL, V35, P1845, DOI 10.1021/es0010204; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, 2005, OECOLOGIA, V144, P607, DOI 10.1007/s00442-005-0071-y; Wunder MB, 2008, TERR ECOL SER, V2, P107, DOI 10.1016/S1936-7961(07)00005-X; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	49	52	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4735	10.1371/journal.pone.0004735	http://dx.doi.org/10.1371/journal.pone.0004735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266102	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490800015
J	Williams, R; Lim, JE; Harr, B; Wang, C; Walters, R; Distler, MG; Teschke, M; Wu, CL; Wiltshire, T; Su, AI; Sokoloff, G; Tarantino, LM; Borevitz, JO; Palmer, AA				Williams, Richard; Lim, Jackie E.; Harr, Bettina; Wang, Claudia; Walters, Ryan; Distler, Margaret G.; Teschke, Meike; Wu, Chunlei; Wiltshire, Tim; Su, Andrew I.; Sokoloff, Greta; Tarantino, Lisa M.; Borevitz, Justin O.; Palmer, Abraham A.			A Common and Unstable Copy Number Variant Is Associated with Differences in Glo1 Expression and Anxiety-Like Behavior	PLOS ONE			English	Article							GLYOXALASE-I; CANDIDATE GENES; TRAIT ANXIETY; MOUSE MODEL; MICE; POLYMORPHISM; DISORDER; AUTISM; IDENTIFICATION; NUCLEOTIDE	Glyoxalase 1 (Glo1) has been implicated in anxiety-like behavior in mice and in multiple psychiatric diseases in humans. We used mouse Affymetrix exon arrays to detect copy number variants (CNV) among inbred mouse strains and thereby identified a similar to 475 kb tandem duplication on chromosome 17 that includes Glo1 ( 30,174,390 - 30,651,226 Mb; mouse genome build 36). We developed a PCR-based strategy and used it to detect this duplication in 23 of 71 inbred strains tested, and in various outbred and wild-caught mice. Presence of the duplication is associated with a cis-acting expression QTL for Glo1 (LOD > 30) in BXD recombinant inbred strains. However, evidence for an eQTL for Glo1 was not obtained when we analyzed single SNPs or 3-SNP haplotypes in a panel of 27 inbred strains. We conclude that association analysis in the inbred strain panel failed to detect an eQTL because the duplication was present on multiple highly divergent haplotypes. Furthermore, we suggest that non-allelic homologous recombination has led to multiple reversions to the non-duplicated state among inbred strains. We show associations between multiple duplication-containing haplotypes, Glo1 expression and anxiety-like behavior in both inbred strain panels and outbred CD-1 mice. Our findings provide a molecular basis for differential expression of Glo1 and further implicate Glo1 in anxiety-like behavior. More broadly, these results identify problems with commonly employed tests for association in inbred strains when CNVs are present. Finally, these data provide an example of biologically significant phenotypic variability in model organisms that can be attributed to CNVs.	[Williams, Richard] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA; [Lim, Jackie E.; Wang, Claudia; Walters, Ryan; Distler, Margaret G.; Sokoloff, Greta; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Harr, Bettina; Teschke, Meike] Max Planck Inst Evolut Biol, Dept Evolut Genet, Plon, Germany; [Wu, Chunlei; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Wiltshire, Tim] Univ N Carolina, Sch Pharm, Department of Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Tarantino, Lisa M.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL USA	University of Chicago; University of Chicago; Max Planck Society; Novartis; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Chicago; University of Chicago	Williams, R (corresponding author), Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA.	aap@uchicago.edu	Palmer, Abraham/L-2158-2014; Borevitz, Justin/B-5423-2012	Palmer, Abraham/0000-0003-3634-0747; Borevitz, Justin/0000-0001-8408-3699; Su, Andrew I./0000-0002-9859-4104; Sokoloff, Greta/0000-0003-3651-1980; Wing, Claudia/0000-0002-8243-5598	 [MH070933];  [MH79103];  [MH020065]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079103, K01MH070933] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	These studies were funded by MH070933, MH79103 and MH020065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DW, 1978, ORIGINS INBRED MICE, P197; Bogue MA, 2007, NUCLEIC ACIDS RES, V35, pD643, DOI 10.1093/nar/gkl1049; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bouayed J, 2007, EUR J PHARMACOL, V564, P146, DOI 10.1016/j.ejphar.2007.02.055; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; COOPER GM, 2007, NAT GENET; CUTLER G, 2007, GENOME RES; Ditzen C, 2006, MOL CELL PROTEOMICS, V5, P1914, DOI 10.1074/mcp.M600088-MCP200; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fujimoto M, 2008, NEUROSCI LETT, V438, P196, DOI 10.1016/j.neulet.2008.04.024; Gingrich JA, 2005, NAT MED, V11, P1281, DOI 10.1038/nm1205-1281; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Junaid MA, 2004, AM J MED GENET A, V131A, P11, DOI 10.1002/ajmg.a.30349; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Liu XQ, 2003, BRAIN RES BULL, V60, P223, DOI 10.1016/S0361-9230(03)00033-9; MCCARROLL SA, 2007, NAT GENET; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; MEO T, 1977, SCIENCE, V198, P311, DOI 10.1126/science.910130; Politi P, 2006, NEUROSCI LETT, V396, P163, DOI 10.1016/j.neulet.2005.11.028; Rehnstrom K, 2008, AM J MED GENET B, V147B, P124, DOI 10.1002/ajmg.b.30582; Rottscheidt R, 2007, GENETICS, V177, P1553, DOI 10.1534/genetics.107.076190; Sacco R, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-11; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Thornalley PJ, 2006, TRENDS MOL MED, V12, P195, DOI 10.1016/j.molmed.2006.03.004; WAHLSTEN D, 2006, COVER STABILITY INBR, P16364; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wu YY, 2008, PROG NEURO-PSYCHOPH, V32, P1740, DOI 10.1016/j.pnpbp.2008.07.019	38	69	71	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4649	10.1371/journal.pone.0004649	http://dx.doi.org/10.1371/journal.pone.0004649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266052	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490800001
J	Ahn, B; Lee, JW; Jung, H; Beck, G; Bohr, VA				Ahn, Byungchan; Lee, Jae Wan; Jung, Hana; Beck, Gad; Bohr, Vilhelm A.			Mechanism of Werner DNA Helicase: POT1 and RPA Stimulates WRN to Unwind beyond Gaps in the Translocating Strand	PLOS ONE			English	Article							SYNDROME PROTEIN; EXCISION-REPAIR; MUTATIONS; BASE; MODULATION; COMPLEX	WRN belongs to the RecQ family of DNA helicases and it plays a role in recombination, replication, telomere maintenance and long-patch base excision repair. Here, we demonstrate that WRN efficiently unwinds DNA substrates containing a 1-nucleotide gap in the translocating DNA strand, but when the gap size is increased to 3-nucleotides unwinding activity significantly declines. In contrast, E. coli UvrD (3'-> 5' helicase), which recognizes nicks in DNA to initiate unwinding, does not unwind past a 1-nucleotide gap. This unique ability of WRN to bypass gaps supports its involvement in DNA replication and LP-BER where such gaps can be produced by glycosylases and the apurinic/apyrimidinic endonuclease 1 (APE1). Furthermore, we tested telomere repeat binding factor 2 (TRF2), both variants 1 and 2 of protector of telomeres 1 (POT1v1 and POT1v2) and RPA on telomeric DNA substrates containing much bigger gaps than 3-nucleotides in order to determine whether unwinding could be facilitated through WRN-protein interaction. Interestingly, POT1v1 and RPA are capable of stimulating WRN helicase on gapped DNA and 5'-overhang substrates, respectively.	[Ahn, Byungchan; Jung, Hana; Beck, Gad] Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea; [Lee, Jae Wan; Bohr, Vilhelm A.] NIA, NIH, Biomed Res Ctr, Lab Mol Gerontol, Baltimore, MD USA	University of Ulsan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ahn, B (corresponding author), Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea.	bohrv@grc.nia.nih.gov	Bohr, Vilhelm/AAP-5931-2020		Intramural Research Program of the National Institute of Health, National Institute on Aging; Korean Government (MOEHRD) [KRF-2008-521-C00211]; Basic Research Promotion Fund [KRF-2008-412-J00303]; NATIONAL INSTITUTE ON AGING [ZIAAG000721, Z01AG000721] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute of Health, National Institute on Aging (to V.A.B). This work was supported by the Brain Korea 21 Project in 2008 from KRF, a Korea Research Foundation Grant of the Korean Government (MOEHRD) (KRF-2008-521-C00211), and the Basic Research Promotion Fund (KRF-2008-412-J00303) (to B.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn B, 2004, J BIOL CHEM, V279, P53465, DOI 10.1074/jbc.M409624200; Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; Choudhary S, 2006, J BIOL CHEM, V281, P6000, DOI 10.1074/jbc.M510122200; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Goto M, 2000, CLIN EXP RHEUMATOL, V18, P760; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Harrigan JA, 2003, J BIOL CHEM, V278, P22686, DOI 10.1074/jbc.M213103200; HOEIJMAKERS JHJ, 1990, CANCER CELL-MON REV, V2, P311; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lee JW, 2005, J BIOL CHEM, V280, P39627, DOI 10.1074/jbc.M506112200; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Moser MJ, 1999, HUM MUTAT, V13, P271, DOI 10.1002/(SICI)1098-1004(1999)13:4<271::AID-HUMU2>3.0.CO;2-Q; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Oshima J, 1996, HUM MOL GENET, V5, P1909, DOI 10.1093/hmg/5.12.1909; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; VAN OM, 2006, CURR BIOL; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wong D, 2003, J BIOL CHEM, V278, P36242, DOI 10.1074/jbc.M306065200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yu CE, 1997, AM J HUM GENET, V60, P330	42	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4673	10.1371/journal.pone.0004673	http://dx.doi.org/10.1371/journal.pone.0004673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262689	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600006
J	van Zweden, JS; Heinze, J; Boomsma, JJ; d'Ettorre, P				van Zweden, Jelle S.; Heinze, Juergen; Boomsma, Jacobus J.; d'Ettorre, Patrizia			Ant Queen Egg-Marking Signals: Matching Deceptive Laboratory Simplicity with Natural Complexity	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; DUFOURS GLAND; WORKER; FERTILITY; BEHAVIOR; REPRODUCTIVES; CONFLICT; ORIGIN	Background: Experiments under controlled laboratory conditions can produce decisive evidence for testing biological hypotheses, provided they are representative of the more complex natural conditions. However, whether this requirement is fulfilled is seldom tested explicitly. Here we provide a lab/field comparison to investigate the identity of an egg-marking signal of ant queens. Our study was based on ant workers resolving conflict over male production by destroying each other's eggs, but leaving queen eggs unharmed. For this, the workers need a proximate cue to discriminate between the two egg types. Earlier correlative evidence indicated that, in the ant Pachycondyla inversa, the hydrocarbon 3,11-dimethylheptacosane ( 3,11-diMeC(27)) is more abundant on the surface of queen-laid eggs. Methodology: We first tested the hypothesis that 3,11-diMeC(27) functions as a queen egg-marking pheromone using laboratory-maintained colonies. We treated worker-laid eggs with synthetic 3,11-diMeC(27) and found that they were significantly more accepted than sham-treated worker-laid eggs. However, we repeated the experiment with freshly collected field colonies and observed no effect of treating worker-laid eggs with 3,11-diMeC(27), showing that this compound by itself is not the natural queen egg-marking pheromone. We subsequently investigated the overall differences of entire chemical profiles of eggs, and found that queen-laid eggs in field colonies are more distinct from worker-laid eggs than in lab colonies, have more variation in profiles, and have an excess of longer-chain hydrocarbons. Conclusions: Our results suggest that queen egg-marking signals are significantly affected by transfer to the laboratory, and that this change is possibly connected to reduced queen fertility as predicted by honest signaling theory. This change is reflected in the worker egg policing response under field and laboratory conditions.	[van Zweden, Jelle S.; Boomsma, Jacobus J.; d'Ettorre, Patrizia] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [van Zweden, Jelle S.; Heinze, Juergen; d'Ettorre, Patrizia] Univ Regensburg, D-8400 Regensburg, Germany	University of Copenhagen; University of Regensburg	van Zweden, JS (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	jvzweden@bio.ku.dk	Boomsma, Jacobus J/M-2785-2014; van Zweden, Jelle S./AAD-7858-2020	Boomsma, Jacobus J/0000-0002-3598-1609; van Zweden, Jelle S./0000-0001-5283-5470	EU Marie Curie Excellence Grant [CODICES-EXT-CT-2004-014202]; Faculty of Science, University of Copenhagen [Freia]; Deutsche Forschungsgemeinschaft [DE 893/1-2]; Danish National Research Foundation	EU Marie Curie Excellence Grant; Faculty of Science, University of Copenhagen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish National Research Foundation(Danmarks Grundforskningsfond)	The work was supported by the EU Marie Curie Excellence Grant CODICES-EXT-CT-2004-014202 granted to Patrizia d'Ettorre, a "Freia grant" from the Faculty of Science, University of Copenhagen, assigned to PdE, the Deutsche Forschungsgemeinschaft Grant DE 893/1-2, also to Patrizia d'Ettorre, and the Danish National Research Foundation to Jacobus J. Boomsma. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravo ISJ, 1998, ENTOMOL EXP APPL, V87, P67, DOI 10.1023/A:1003211931514; Christensen JH, 2007, J CHROMATOGR A, V1169, P1, DOI 10.1016/j.chroma.2007.08.077; Christensen JH, 2004, ENVIRON SCI TECHNOL, V38, P2912, DOI 10.1021/es035261y; CROSLAND MWJ, 1989, ANIM BEHAV, V37, P912, DOI 10.1016/0003-3472(89)90135-8; Cuvillier-Hot V, 2004, ANIM BEHAV, V68, P1209, DOI 10.1016/j.anbehav.2003.11.026; Cuvillier-Hot V, 2001, J INSECT PHYSIOL, V47, P485, DOI 10.1016/S0022-1910(00)00137-2; D'Ettorre P, 2006, NATURWISSENSCHAFTEN, V93, P136, DOI 10.1007/s00114-005-0075-9; D'Ettorre P, 2004, P ROY SOC B-BIOL SCI, V271, P1427, DOI 10.1098/rspb.2004.2742; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; de Biseau JC, 2004, J INSECT PHYSIOL, V50, P585, DOI 10.1016/j.jinsphys.2004.04.005; dEttorre P., 2008, SOCIOBIOLOGY COMMUNI, P81, DOI [10.1093/acprof:oso/9780199216840.003.0005, DOI 10.1093/ACPROF:OSO/9780199216840.003.0005, DOI 10.1093/ACPR0F:0S0/9780199216840.003.0005]; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; ENDLER A, 2006, BEHAV ECOL SOCIOBIOL, P1; GAMBOA GJ, 1986, ANIM BEHAV, V34, P685, DOI 10.1016/S0003-3472(86)80053-7; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; Hannonen M, 2002, ANIM BEHAV, V64, P477, DOI 10.1006/anbe.2002.4001; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; HELANTERA H, 2009, BEHAV ECOLOGY SOCIOB; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hurst JL, 2005, P ROY SOC B-BIOL SCI, V272, P715, DOI 10.1098/rspb.2004.3004; KALMUS H, 1952, PROC R SOC SER B-BIO, V140, P50, DOI 10.1098/rspb.1952.0043; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Liebig J, 1999, P ROY SOC B-BIOL SCI, V266, P1865, DOI 10.1098/rspb.1999.0858; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Lommelen E, 2006, J CHEM ECOL, V32, P2023, DOI 10.1007/s10886-006-9126-8; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Martin SJ, 2004, PHYSIOL ENTOMOL, V29, P395, DOI 10.1111/j.0307-6962.2004.00404.x; Martin SJ, 2002, NATURWISSENSCHAFTEN, V89, P528, DOI 10.1007/s00114-002-0367-2; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Martin Stephen J., 2005, Journal of Negative Results Ecology & Evolutionary Biology, V2, P1; Meza-Hernandez JS, 2006, J ECON ENTOMOL, V99, P1979, DOI 10.1603/0022-0493-99.6.1979; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; OBIN MS, 1988, ANIM BEHAV, V36, P1361, DOI 10.1016/S0003-3472(88)80205-7; Postma E, 2007, J EVOLUTION BIOL, V20, P1823, DOI 10.1111/j.1420-9101.2007.01379.x; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Smith AA, 2008, J CHEM ECOL, V34, P1275, DOI 10.1007/s10886-008-9529-9; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; van Zweden JS, 2007, P ROY SOC B-BIOL SCI, V274, P1421, DOI 10.1098/rspb.2007.0113; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Zahavi Amotz, 1997, HANDICAP PRINCIPLE M; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	49	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4718	10.1371/journal.pone.0004718	http://dx.doi.org/10.1371/journal.pone.0004718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262683	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490600028
J	Gregory, RD; Willis, SG; Jiguet, F; Vorisek, P; Klvanova, A; van Strien, A; Huntley, B; Collingham, YC; Couvet, D; Green, RE				Gregory, Richard D.; Willis, Stephen G.; Jiguet, Frederic; Vorisek, Petr; Klvanova, Alena; van Strien, Arco; Huntley, Brian; Collingham, Yvonne C.; Couvet, Denis; Green, Rhys E.			An Indicator of the Impact of Climatic Change on European Bird Populations	PLOS ONE			English	Article								Rapid climatic change poses a threat to global biodiversity. There is extensive evidence that recent climatic change has affected animal and plant populations, but no indicators exist that summarise impacts over many species and large areas. We use data on long-term population trends of European birds to develop such an indicator. We find a significant relationship between interspecific variation in population trend and the change in potential range extent between the late 20(th) and late 21(st) centuries, forecasted by climatic envelope models. Our indicator measures divergence in population trend between bird species predicted by climatic envelope models to be favourably affected by climatic change and those adversely affected. The indicator shows a rapid increase in the past twenty years, coinciding with a period of rapid warming.	[Gregory, Richard D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Willis, Stephen G.; Huntley, Brian; Collingham, Yvonne C.] Univ Durham, Sch Biol & Biomed Sci, Inst Ecosyst Sci, Durham DH1 3HP, England; [Jiguet, Frederic; Couvet, Denis] CRBPO, MNHN, CNRS, UPMC, Museum Natl Hist Nat, Paris, France; [Vorisek, Petr; Klvanova, Alena] Czech Soc Ornithol, Prague, Czech Republic; [van Strien, Arco] Stat Netherlands, Voorburg, Netherlands; [Green, Rhys E.] Royal Soc Protect Birds, Sandy, Beds, England; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 1TN, England	Royal Society for Protection of Birds; Durham University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Royal Society for Protection of Birds; University of Cambridge	Gregory, RD (corresponding author), Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England.	richard.gregory@rspb.org.uk	Willis, Stephen G/F-8503-2015; van Strien, Arco/AAG-1843-2020; Vorisek, Petr/E-3336-2012	Willis, Stephen G/0000-0002-8656-5808; couvet, denis/0000-0001-8692-9694; Gregory, Richard/0000-0002-7419-5053; Klvanova, Alena/0000-0002-6061-0930	European Commission; RSPB; NERC	European Commission(European CommissionEuropean Commission Joint Research Centre); RSPB; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The European Commission and RSPB support the Pan-European Common Bird Monitoring Scheme. RSPB and NERC supported the initial climate envelope modelling work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; [Anonymous], 2007, 11 EEA; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Blumstein DT, 2008, BIOL LETTERS, V4, P146, DOI 10.1098/rsbl.2007.0606; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; *CRU, 2003, CRU GLOB AV TEMP CHA; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; IPCC, 2007, CLIM CHANG 2007 PHYS; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Pannekoek J., 2001, 0102 CBS VOORB; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Zimmer C, 2007, SCIENCE, V317, P892, DOI 10.1126/science.317.5840.892; FURTHER MAT METHODS	28	193	219	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4678	10.1371/journal.pone.0004678	http://dx.doi.org/10.1371/journal.pone.0004678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259270	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000265490500006
J	Harbaugh, DT; Wagner, WL; Percy, DM; James, HF; Fleischer, RC				Harbaugh, Danica T.; Wagner, Warren L.; Percy, Diana M.; James, Helen F.; Fleischer, Robert C.			Genetic Structure of the Polymorphic Metrosideros (Myrtaceae) Complex in the Hawaiian Islands Using Nuclear Microsatellite Data	PLOS ONE			English	Article							POPULATION-STRUCTURE; SIZE HOMOPLASY; TREE; DIVERSITY; LOCI; DIFFERENTIATION; DISPERSAL; GRADIENT; ORIGIN; FLOW	Background: Five species of Metrosideros (Myrtaceae) are recognized in the Hawaiian Islands, including the widespread M. polymorpha, and are characterized by a multitude of distinctive, yet overlapping, habit, ecological, and morphological forms. It remains unclear, despite several previous studies, whether the morphological variation within Hawaiian Metrosideros is due to hybridization, genetic polymorphism, phenotypic plasticity, or some combination of these processes. The Hawaiian Metrosideros complex has become a model system to study ecology and evolution; however this is the first study to use microsatellite data for addressing inter-island patterns of variation from across the Hawaiian Islands. Methodology/Principal Findings: Ten nuclear microsatellite loci were genotyped from 143 individuals of Metrosideros. We took advantage of the bi-parental inheritance and rapid mutation rate of these data to examine the validity of the current taxonomy and to investigate whether Metrosideros plants from the same island are more genetically similar than plants that are morphologically similar. The Bayesian algorithm of the program STRUCTURE was used to define genetic groups within Hawaiian Metrosideros and the closely related taxon M. collina from the Marquesas and Austral Islands. Several standard and nested AMOVAs were conducted to test whether the genetic diversity is structured geographically or taxonomically. Conclusions/Significance: The results suggest that Hawaiian Metrosideros have dynamic gene flow, with genetic and morphological diversity structured not simply by geography or taxonomy, but as a result of parallel evolution on islands following rampant island-island dispersal, in addition to ancient chloroplast capture. Results also suggest that the current taxonomy requires major revisions in order to reflect the genetic structure revealed in the microsatellite data.	[Harbaugh, Danica T.; Wagner, Warren L.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Percy, Diana M.] Univ British Columbia, Ctr Plant Res, Vancouver, BC V5Z 1M9, Canada; [Percy, Diana M.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [James, Helen F.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC USA; [Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Washington, DC USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of British Columbia; University of British Columbia; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Harbaugh, DT (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	harbaughd@si.edu		James, Helen/0000-0002-2495-6133	Center for Conservation and Evolutionary Genetics at the Smithsonian Institution; National Tropical Botanical Garden	Center for Conservation and Evolutionary Genetics at the Smithsonian Institution; National Tropical Botanical Garden	Laboratory expenses for this study were covered by the Center for Conservation and Evolutionary Genetics at the Smithsonian Institution, and by the National Tropical Botanical Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 2000, MOL BIOL EVOL, V17, P1926, DOI 10.1093/oxfordjournals.molbev.a026294; ARADHYA KM, 1993, GENET RES, V61, P159, DOI 10.1017/S0016672300031335; ARADHYA KM, 1991, HEREDITY, V67, P129, DOI 10.1038/hdy.1991.72; BAZZAZ EA, 1996, PLANTS CHANGING ENV; Bottin L, 2005, MOL ECOL, V14, P1979, DOI 10.1111/j.1365-294X.2005.02576.x; Bradshaw HD, 1998, GENETICS, V149, P367; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; Corn C. A., 1972, CHALLENGING BIOL PRO, P422; CORN CA, 1973, AM J BOT, V60, P991, DOI 10.2307/2441513; Crawford NG, 2008, MOL ECOL RESOUR, V8, P308, DOI 10.1111/j.1471-8286.2007.01937.x; Dawson J., 1999, MANUAL FLOWERING PLA, P964; Doyle JJ, 1998, MOL BIOL EVOL, V15, P215, DOI 10.1093/oxfordjournals.molbev.a025916; DRAKE DR, 1992, AM J BOT, V79, P1224, DOI 10.2307/2445048; Dutech C, 2004, HEREDITY, V92, P69, DOI 10.1038/sj.hdy.6800384; England PR, 2002, MOL ECOL, V11, P967, DOI 10.1046/j.1365-294X.2002.01500.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Funk V. A., 1995, P379; Gardner RC, 2004, BIOL J LINN SOC, V83, P399, DOI 10.1111/j.1095-8312.2004.00398.x; GEESKE J, 1994, BIOTROPICA, V26, P17, DOI 10.2307/2389106; Harr B, 1998, CURR BIOL, V8, P1183, DOI 10.1016/S0960-9822(07)00490-3; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; James SA, 2004, NEW ZEAL J BOT, V42, P263, DOI 10.1080/0028825X.2004.9512903; Jarvi SI, 2004, MOL ECOL, V13, P2157, DOI 10.1111/j.1365-294X.2004.02228.x; Kikuchi S, 2002, HEREDITY, V88, P313, DOI 10.1038/sj.hdy.6800047; Koskinen MT, 2002, HEREDITY, V88, P391, DOI 10.1038/sj.hdy.6800072; Lhuillier E, 2006, MOL ECOL NOTES, V6, P653, DOI 10.1111/j.1471-8286.2006.01279.x; Orti G, 1997, P NATL ACAD SCI USA, V94, P10745, DOI 10.1073/pnas.94.20.10745; Percy DM, 2008, P ROY SOC B-BIOL SCI, V275, P1479, DOI 10.1098/rspb.2008.0191; PORTER JR, 1973, 27 U HAW; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schweitzer JA, 1999, J TORREY BOT SOC, V126, P15, DOI 10.2307/2997251; STEMMERMANN L, 1983, PAC SCI, V37, P361; Tarr Cheryl L., 1995, P147; Treseder KK, 2001, OECOLOGIA, V126, P266, DOI 10.1007/s004420000523; WILLIAMS DG, 1995, ECOLOGY, V76, P1569, DOI 10.2307/1938158; WITTER MS, 1988, EVOLUTION, V42, P1278, DOI 10.1111/j.1558-5646.1988.tb04187.x; Wright SD, 2001, J BIOGEOGR, V28, P769, DOI 10.1046/j.1365-2699.2001.00605.x; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x	45	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4698	10.1371/journal.pone.0004698	http://dx.doi.org/10.1371/journal.pone.0004698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259272	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490500013
J	Blagoev, KB				Blagoev, Krastan B.			Cell Proliferation in the Presence of Telomerase	PLOS ONE			English	Article							LENGTH HOMEOSTASIS; CANCER-CELLS; RECOMBINATION; MAINTENANCE; SENESCENCE; ALT; ACCUMULATION; CHROMOSOMES; DEFICIENT; PATHWAY	Background: Telomerase, which is active early in development and later in stem and germline cells, is also active in the majority of human cancers. One of the known functions of telomerase is to extend the ends of linear chromosomes, countering their gradual shortening at each cell division due to the end replication problem and postreplication processing. Telomerase concentration levels vary between different cell types as well as between different tumors. In addition variable telomerase concentrations will exist in different cells in the same tumor when telomerase inhibitors are used, because of limitations of drug delivery in tissue. Telomerase extends short telomeres more frequently than long telomeres and the relation between the extension frequency and the telomere length is nonlinear. Methodolgy/Principal Findings: Here, the biological data of the nonlinear telomerase-telomere dynamics is incorporated in a mathematical theory to relate the proliferative potential of a cell to the telomerase concentration in that cell. The main result of the paper is that the proliferative capacity of a cell grows exponentially with the telomerase concentration. Conclusions/Significance: The theory presented here suggests that long term telomerase inhibition in every cancer progenitor or cancer stem cell is needed for successful telomere targeted cancer treatment. This theory also can be used to plan and asses the results of clinical trials targeting telomerase.	[Blagoev, Krastan B.] Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Blagoev, KB (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	kblagoev@nsf.gov			National Science Foundation of the United States of America	National Science Foundation of the United States of America(National Science Foundation (NSF))	This work was funded by the National Science Foundation of the United States of America.	Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Blagoev KB, 2008, DNA REPAIR, V7, P199, DOI 10.1016/j.dnarep.2007.09.012; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Datar RH, 1999, GYNECOL ONCOL, V74, P338, DOI 10.1006/gyno.1999.5506; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Fordyce CA, 2006, BREAST CANCER RES TR, V99, P193, DOI 10.1007/s10549-006-9204-1; Gertler R, 2008, CANCER-AM CANCER SOC, V112, P2173, DOI 10.1002/cncr.23419; Goldman FD, 2008, BLOOD, V111, P4523, DOI 10.1182/blood-2007-10-120204; Greider CW, 2006, COLD SPRING HARB SYM, V71, P225, DOI 10.1101/sqb.2006.71.063; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gryaznov SM, 2007, NUCLEOS NUCLEOT NUCL, V26, P1577, DOI 10.1080/15257770701547271; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hemann MT, 2000, COLD SPRING HARB SYM, V65, P275, DOI 10.1101/sqb.2000.65.275; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ju Z, 2006, GENOME DYN, V1, P84, DOI 10.1159/000092502; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Neumann AA, 2002, NAT REV CANCER, V2, P879, DOI 10.1038/nrc929; Ogino H, 1998, BIOCHEM BIOPH RES CO, V248, P223, DOI 10.1006/bbrc.1998.8875; Oh BK, 2008, LAB INVEST, V88, P144, DOI 10.1038/labinvest.3700710; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Quinones-Hinojosa A, 2005, J NEURO-ONCOL, V74, P19, DOI 10.1007/s11060-004-5758-0; Roth CW, 1997, MOL CELL BIOL, V17, P5176, DOI 10.1128/MCB.17.9.5176; SHAMMAS MA, 2008, LEUKEMIA; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tapia C, 2006, AM J SURG PATHOL, V30, P83, DOI 10.1097/01.pas.0000183572.94140.43; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; Yeager TR, 1999, CANCER RES, V59, P4175; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	51	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4622	10.1371/journal.pone.0004622	http://dx.doi.org/10.1371/journal.pone.0004622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247450	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800005
J	Guilmoto, CZ; Hoang, X; Van, TN				Guilmoto, Christophe Z.; Hoang, Xuyen; Van, Toan Ngo			Recent Increase in Sex Ratio at Birth in Viet Nam	PLOS ONE			English	Article							INDIA	Introduction: Since the 1980s, sex ratio at birth (male births per 100 female births) has increased in many Asian countries as a result of selective abortions, but to date there has been no such evidence for Viet Nam. Our aim in this paper is to ascertain the situation with respect to sex ratio at birth in Viet Nam over the past five years. Materials and Methods: Original data were obtained from sample population surveys in Viet Nam recording annual birth rates since 2000 of about 450,000 women, as well as from two successive birth surveys conducted for the first time in 2007 (1.1 million births). The annual population surveys include specific information on birth history and mothers' characteristics to be used for the analysis of trends and differentials in sex ratio at birth. Results and Discussion: Birth history statistics indicate that the SRB in Viet Nam has recorded a steady growth since 2001. Starting from a level probably close to the biological standard of 105, the SRB reached 108 in 2005 and 112 in 2006, a value significantly above the normal level. An independent confirmation of these results comes from the surveys of births in health facilities which yielded a SRB of 110 in 2006-07. High SRB is linked to various factors such as access to modern health care, number of prenatal visits, level of higher education and employment status, young age, province of residence and prenatal sex determination. These results suggest that prenatal sex determination followed by selective abortion has recently become more common in Viet Nam. This recent trend is a consequence of various factors such as preference for sons, declining fertility, easy access to abortion, economic development as well as the increased availability of ultrasonography facilities.	[Guilmoto, Christophe Z.] CEPED Univ Paris Descartes Ined IRD, Paris, France; [Hoang, Xuyen] Gen Stat Office, Hanoi, Vietnam; [Van, Toan Ngo] Hanoi Med Univ, Hanoi, Vietnam	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Hanoi Medical University	Guilmoto, CZ (corresponding author), CEPED Univ Paris Descartes Ined IRD, Paris, France.	guilmoto@ird.fr			United National Population Fund Country Office; CEPED	United National Population Fund Country Office; CEPED	The General Statistics Office, Hanoi has conducted the surveys and the United National Population Fund Country Office has supported the primary analysis of results. Additional support from CEPED is gratefully acknowledged. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Attane Isabelle, 2007, WATERING NEIGHBOURS; Belanger D, 2002, STUD FAMILY PLANN, V33, P321, DOI 10.1111/j.1728-4465.2002.00321.x; BELANGER D, 2003, POPULATION, V2, P231; BHAT PNM, 2002, ECON POLIT WEEKLY, V51, P5105; BHAT PNM, 2002, ECON POLIT WEEKLY, V52, P5244; BOOTH BE, 1994, BRIT MED J, V309, P1259, DOI 10.1136/bmj.309.6964.1259; Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80; DOUGLAS A, 2008, PNAS, V15, P5681; Dubuc S, 2007, POPUL DEV REV, V33, P383, DOI 10.1111/j.1728-4457.2007.00173.x; Gallo MF, 2007, SOC SCI MED, V64, P1812, DOI 10.1016/j.socscimed.2007.02.005; Gammeltoft T, 2007, REPROD HEALTH MATTER, V15, P163, DOI 10.1016/S0968-8080(06)29280-2; Gammeltoft T, 2007, SOC SCI MED, V64, P2248, DOI 10.1016/j.socscimed.2007.02.015; *GEN STAT OFF, 2008, 2007 POP CHANG FAM P; GOODKIND D, 1994, STUD FAMILY PLANN, V25, P342, DOI 10.2307/2137878; GOODKIND D, 2008, ANN M POP ASS AM NEW; *GSO UNICEF, 2007, MULT IND CLUST SURV; GUBRY P, 2000, POPULATION DEV VIET; GUILMOTO CZ, 2007, ANN M POP ASS AM MAR; Haughton J, 1995, STUD FAMILY PLANN, V26, P325, DOI 10.2307/2138098; Heinimann A., 2004, SOCIOECONOMIC ATLAS; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; *I SOC DEV STUD, 2007, NEW COMM SENS FAM PL; LE LC, 2006, ASIA PACIFIC POP J, V2, P45; MENCHINI L, 2007, 200701 UNICEF INN RE; *MIN HLTH, 2006, VIET NAM HLTH REP 20; *MIN HLTH, HLTH STAT YB MIN HLT; *NAT COMM POP FAM, 1999, DEM HLTH SURV 1997; PARK CB, 1995, POPUL DEV REV, V21, P59, DOI 10.2307/2137413; Sahni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002224; SCORNET C, 2001, POPULATION, V2, P101; *UNFPA, 2007, POP GROWTH VIET NAM; *VIET COMM POP FAM, 2003, VIET DEM HLTH SURV 2; VO AD, 2005, INT C FEM DEF AS TRE; Waller L.A., 2004, APPL SPATIAL STAT PU; 2007, VIET NAM NEWS   1226	36	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4624	10.1371/journal.pone.0004624	http://dx.doi.org/10.1371/journal.pone.0004624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247453	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487800007
J	Miyagawa, Y; Okita, H; Itagaki, M; Toyoda, M; Katagiri, YU; Fujimoto, J; Hata, J; Umezawa, A; Kiyokawa, N				Miyagawa, Yoshitaka; Okita, Hajime; Itagaki, Mitsuko; Toyoda, Masashi; Katagiri, Yohko U.; Fujimoto, Junichiro; Hata, Jun-ichi; Umezawa, Akihiro; Kiyokawa, Nobutaka			EWS/ETS Regulates the Expression of the Dickkopf Family in Ewing Family Tumor Cells	PLOS ONE			English	Article								Background: The Dickkopf (DKK) family comprises a set of proteins that function as regulators of Wnt/beta-catenin signaling and has a crucial role in development. Recent studies have revealed the involvement of this family in tumorigenesis, however their role in tumorigenesis is still remained unclear. Methodology/Principal Findings: We found increased expression of DKK2 but decreased expression of DKK1 in Ewing family tumor (EFT) cells. We showed that EFT-specific EWS/ETS fusion proteins enhance the DKK2 promoter activity, but not DKK1 promoter activity, via ets binding sites (EBSs) in the 5' upstream region. EWS/ETS-mediated transactivation of the promoter was suppressed by the deletion and mutation of EBSs located upstream of the DKK2 gene. Interestingly, the inducible expression of EWS/ETS resulted in the strong induction of DKK2 expression and inhibition of DKK1 expression in human primary mesenchymal progenitor cells that are thought to be a candidate of cell origin of EFT. In addition, using an EFT cell line SK-ES1 cells, we also demonstrated that the expression of DKK1 and DKK2 is mutually exclusive, and the ectopic expression of DKK1, but not DKK2, resulted in the suppression of tumor growth in immuno-deficient mice. Conclusions/Significance: Our results suggested that DKK2 could not functionally substitute for DKK1 tumor-suppressive effect in EFT. Given the mutually exclusive expression of DKK1 and DKK2, EWS/ETS regulates the transcription of the DKK family, and the EWS/ETS-mediated DKK2 up-regulation could affect the tumorigenicity of EFT in an indirect manner.	[Miyagawa, Yoshitaka; Okita, Hajime; Itagaki, Mitsuko; Katagiri, Yohko U.; Hata, Jun-ichi; Kiyokawa, Nobutaka] Natl Res Inst Child Hlth & Dev, Dept Dev Biol, Setagaya Ku, Tokyo, Japan; [Fujimoto, Junichiro] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Toyoda, Masashi; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reproduct Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Miyagawa, Y (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Dev Biol, Setagaya Ku, Tokyo, Japan.	okita@nch.go.jp		Miyagawa, Yoshitaka/0000-0003-2629-7503	Health and Labour Sciences [H19-010, H18-005, H19-003]; Ministry of Health, Labour and Welfare of Japan, JSPS [KAKENHI 18790263]; CREST, JST; Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices; Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology; Foundation for Promotion of Cancer Research (Japan) [Research Resident Fellowship]	Health and Labour Sciences; Ministry of Health, Labour and Welfare of Japan, JSPS; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices; Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research (Japan)	This work was supported in part by Health and Labour Sciences Research Grants (the 3rd term comprehensive 10-year-strategy for cancer control H19-010, Research on Children and Families H18-005 and H19-003, Research on Human Genome Tailor made and Research on Publicly Essential Drugs and Medical Devices H18-005) and Grant for Child Health and Development from the Ministry of Health, Labour and Welfare of Japan, JSPS. KAKENHI 18790263. This work was also supported by CREST, JST, a grant from the Japan Health Sciences Foundation for Research on Publicly Essential Drugs and Medical Devices and the Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology, based on the screening and counseling by the Atomic Energy Commission. Y. Miyagawa is an Awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-Year-Strategy for Cancer Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Fuchs B, 2004, CLIN CANCER RES, V10, P1344, DOI 10.1158/1078-0432.CCR-03-0038; Fujii Y, 1989, Hum Cell, V2, P190; GILBERT F, 1982, CANCER GENET CYTOGEN, V7, P33, DOI 10.1016/0165-4608(82)90105-4; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200; Grotewold L, 1999, MECH DEVELOP, V89, P151, DOI 10.1016/S0925-4773(99)00194-X; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; HARA S, 1989, BRIT J CANCER, V60, P875, DOI 10.1038/bjc.1989.383; Hata J, 1989, Hum Cell, V2, P382; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Horwitz EM, 2004, TRENDS BIOTECHNOL, V22, P386, DOI 10.1016/j.tibtech.2004.05.006; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Im YH, 2000, CANCER RES, V60, P1536; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Khoury JD, 2005, ADV ANAT PATHOL, V12, P212, DOI 10.1097/01.pap.0000175114.55541.52; Kiyokawa N, 1997, J BIOL CHEM, V272, P18656, DOI 10.1074/jbc.272.30.18656; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee JN, 2008, HANN BEITR NACHRICHT, V1, P109, DOI 10.1109/ICUWB.2008.4653296; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li X, 2005, INT J CANCER, V116, P385, DOI 10.1002/ijc.21010; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; MIKHEEV AM, 2007, CANC RES TREAT; Mikheev AM, 2007, BIOCHEM BIOPH RES CO, V352, P675, DOI 10.1016/j.bbrc.2006.11.079; Miyagawa Y, 2005, INSECT MOL BIOL, V14, P245, DOI 10.1111/j.1365-2583.2005.00553.x; MIYAGAWA Y, 2008, MOL CELL BIOL; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NISHI Y, 1992, MAMM GENOME, V2, P11; Polakis P, 2000, GENE DEV, V14, P1837; Reguart Noemi, 2005, Future Oncol, V1, P787, DOI 10.2217/14796694.1.6.787; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Takahashi A, 2003, CANCER RES, V63, P8338; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Yamashita Jun, 2007, Journal of Insect Biotechnology and Sericology, V76, P137; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	58	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4634	10.1371/journal.pone.0004634	http://dx.doi.org/10.1371/journal.pone.0004634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247449	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800016
J	Saless, N; Litscher, SJ; Franco, GEL; Houlihan, MJ; Sudhakaran, S; Raheem, KA; O'Neil, TK; Vanderby, R; Demant, P; Blank, RD				Saless, Neema; Litscher, Suzanne J.; Franco, Gloria E. Lopez; Houlihan, Meghan J.; Sudhakaran, Shaan; Raheem, Khalid Abdul; O'Neil, Tyriina K.; Vanderby, Ray; Demant, Peter; Blank, Robert D.			Quantitative trait loci for biomechanical performance and femoral geometry in an intercross of recombinant congenic mice: restriction of the Bmd7 candidate interval	FASEB JOURNAL			English	Article						osteoporosis; Wnt; modeling and remodeling; linkage; endothelin	RECEPTOR-RELATED PROTEIN-5; BONE-MINERAL DENSITY; HETEROGENEOUS MOUSE-POPULATION; MECHANICAL-PROPERTIES; GENETIC DISSECTION; INBRED STRAINS; UTAH PARADIGM; MASS; STRENGTH; LRP5	Despite steady progress in identifying quantitative trait loci (QTLs) for bone phenotypes, relatively little progress has been made in moving from QTLs to identifying the relevant gene. We exploited the genetic structure of recombinant congenic mouse strains by performing a reciprocal intercross of the strains HcB-8 and HcB-23, phenotyped for body size, femoral biomechanical performance, and femoral diaphyseal geometry and mapped with R/qtl and QTL Cartographer. Significant QTLs are present on chromosomes 1, 2, 3, 4, 6, and 10. We found significant sex x QTL and cross-direction x QTL interactions. The chromosome 4 QTL affects multiple femoral anatomic features and biomechanical properties. The known segregating segment of chromosome 4 contains only 18 genes, among which Ece1, encoding endothelin-converting enzyme 1, stands out as a candidate. Endothelin signaling has been shown to promote the growth of osteoblastic metastases and to potentiate signaling via the Wnt pathway. The colocalizing chromosome 4 QTL Bmd7 (for bone mineral density 7) increases responsiveness to mechanical loading. By exploiting the short informative segment of chromosome 4 and the known biology, we propose that Ece1 is the gene responsible for Bmd7 and that it acts by increasing responsiveness to mechanical loading through modulation of Wnt signaling. Saless, N., Litscher, S. J., Lopez Franco, G. E., Houlihan, M. J., Sudhakaran, S., Raheem, K. A., O'Neil, T. K., Vanderby, R., Demant, P., Blank, R. D. Quantitative trait loci for biomechanical performance and femoral geometry in an intercross of recombinant congenic mice: restriction of the Bmd7 candidate interval. FASEB J. 23, 2142-2154 (2009)	[Saless, Neema; Litscher, Suzanne J.; Franco, Gloria E. Lopez; Houlihan, Meghan J.; Sudhakaran, Shaan; Raheem, Khalid Abdul; O'Neil, Tyriina K.; Vanderby, Ray; Blank, Robert D.] Univ Wisconsin, Madison, WI USA; [Demant, Peter] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Blank, Robert D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Roswell Park Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Blank, RD (corresponding author), H4-556 CSC 5148,600 Highland Ave, Madison, WI 53705 USA.	rdb@medicine.wisc.edu	Blank, Robert D./V-5995-2019	Blank, Robert D./0000-0003-2950-1944	Office of Research and Development, Biomedical Laboratory Research and Development Service, Department of Veterans Affairs	Office of Research and Development, Biomedical Laboratory Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs)	We thank Anath Shalev, Marc Drezner, Theresa Guise, and Charles Turner for helpful discussions. This material is based on work supported by the Office of Research and Development, Biomedical Laboratory Research and Development Service, Department of Veterans Affairs, and performed in the Geriatrics Research, Education, and Clinical Center at the William S. Middleton Memorial Veterans Hospital. This report is Madison GRECC manuscript 2008-13.	Balemans W, 2005, BONE, V36, P943, DOI 10.1016/j.bone.2005.02.019; Basten C, 1994, 5 WORLD C GEN APPL L, V22, P65; BASTEN CJ, 1999, QTL CARTOGRAPHER; Beamer WG, 2007, J BONE MINER RES, V22, P1187, DOI 10.1359/JBMR.070419; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Beamer WG, 2001, J BONE MINER RES, V16, P1195, DOI 10.1359/jbmr.2001.16.7.1195; Blank RD, 2003, CONNECT TISSUE RES, V44, P134, DOI 10.1080/03008200390223918; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; CHURCHILL GA, 1994, GENETICS, V138, P963; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Edderkaoui B, 2007, BONE, V41, P340, DOI 10.1016/j.bone.2007.05.013; Edderkaoui B, 2007, GENOME RES, V17, P577, DOI 10.1101/gr.6009507; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Ferrari SL, 2004, AM J HUM GENET, V74, P866, DOI 10.1086/420771; Franco GEL, 2004, J CLIN DENSITOM, V7, P326; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Frost HM, 2000, J BONE MINER METAB, V18, P305, DOI 10.1007/s007740070001; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jepsen KJ, 2007, MAMM GENOME, V18, P492, DOI 10.1007/s00335-007-9017-5; Jepsen KJ, 2003, MAMM GENOME, V14, P97, DOI 10.1007/s00335-002-3045-y; JIANG CJ, 1995, GENETICS, V140, P1111; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Kiel DP, 2007, BONE, V40, P587, DOI 10.1016/j.bone.2006.09.029; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Klein RF, 2002, J BONE MINER RES, V17, P1752, DOI 10.1359/jbmr.2002.17.10.1752; Koller DL, 2003, J BONE MINER RES, V18, P1758, DOI 10.1359/jbmr.2003.18.10.1758; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; Li CY, 2005, J BONE MINER RES, V20, P2150, DOI 10.1359/JBMR.050819; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lindenau S, 2006, GENE, V373, P109, DOI 10.1016/j.gene.2006.01.024; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Masinde GL, 2002, CALCIFIED TISSUE INT, V71, P421, DOI 10.1007/s00223-001-1113-z; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Shultz KL, 2003, J BONE MINER RES, V18, P175, DOI 10.1359/jbmr.2003.18.2.175; Stassen APM, 1996, MAMM GENOME, V7, P55, DOI 10.1007/s003359900013; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; Turner CH, 2001, J BONE MINER RES, V16, P206, DOI 10.1359/jbmr.2001.16.2.206; Turner CH, 2003, CALCIFIED TISSUE INT, V73, P297, DOI 10.1007/s00223-002-1062-1; Volkman SK, 2004, J BONE MINER RES, V19, P1497, DOI 10.1359/JBMR.040506; Volkman SK, 2003, J BONE MINER RES, V18, P1497, DOI 10.1359/jbmr.2003.18.8.1497; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yershov Y, 2001, J BONE MINER RES, V16, P992, DOI 10.1359/jbmr.2001.16.6.992; ZENG ZB, 1994, GENETICS, V136, P1457	64	22	22	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2142	2154		10.1096/fj.08-118679	http://dx.doi.org/10.1096/fj.08-118679			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19261723				2022-12-25	WOS:000268836500014
J	Han, S; Mistry, A; Chang, JS; Cunningham, D; Griffor, M; Bonnette, PC; Wang, H; Chrunyk, BA; Aspnes, GE; Walker, DP; Brosius, AD; Buckbinder, L				Han, Seungil; Mistry, Anil; Chang, Jeanne S.; Cunningham, David; Griffor, Matt; Bonnette, Peter C.; Wang, Hong; Chrunyk, Boris A.; Aspnes, Gary E.; Walker, Daniel P.; Brosius, Arthur D.; Buckbinder, Leonard			Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; PROTEIN-KINASES; BINDING; MICE; MECHANISM; DENSITY; CELLS; SITE	Proline-rich tyrosine kinase 2 (PYK2) is a cytoplasmic, nonreceptor tyrosine kinase implicated in multiple signaling pathways. It is a negative regulator of osteogenesis and considered a viable drug target for osteoporosis treatment. The high-resolution structures of the human PYK2 kinase domain with different inhibitor complexes establish the conventional bilobal kinase architecture and show the conformational variability of the DFG loop. The basis for the lack of selectivity for the classical kinase inhibitor, PF-431396, within the FAK family is explained by our structural analyses. Importantly, the novel DFG-out conformation with two diarylurea inhibitors (BIRB796, PF-4618433) reveals a distinct subclass of non-receptor tyrosine kinases identifiable by the gatekeeper Met-502 and the unique hinge loop conformation of Leu-504. This is the first example of a leucine residue in the hinge loop that blocks the ATP binding site in the DFG-out conformation. Our structural, biophysical, and pharmacological studies suggest that the unique features of the DFG motif, including Leu-504 hinge-loop variability, can be exploited for the development of selective protein kinase inhibitors.	[Han, Seungil; Mistry, Anil; Chang, Jeanne S.; Cunningham, David; Griffor, Matt; Bonnette, Peter C.; Wang, Hong; Chrunyk, Boris A.; Aspnes, Gary E.; Walker, Daniel P.; Brosius, Arthur D.; Buckbinder, Leonard] Pfizer Global Res & Dev, Groton, CT 06340 USA	Pfizer	Han, S (corresponding author), Pfizer Global Res & Dev, Eastern Point Rd, Groton, CT 06340 USA.	seungil.han@pfizer.com						Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Casper D, 2004, ANAL BIOCHEM, V325, P126, DOI 10.1016/j.ab.2003.10.025; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HANKS SK, 2004, ENCY BIOL CHEM, V2, P80; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Manley PW, 2004, BBA-PROTEINS PROTEOM, V1697, P17, DOI 10.1016/j.bbapap.2003.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noble MEM, 1999, PHARMACOL THERAPEUT, V82, P269, DOI 10.1016/S0163-7258(98)00051-5; Nordin H, 2005, ANAL BIOCHEM, V340, P359, DOI 10.1016/j.ab.2005.02.027; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Regan J, 2003, BIOORG MED CHEM LETT, V13, P3101, DOI 10.1016/S0960-894X(03)00656-5; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Traxler P, 1999, PHARMACOL THERAPEUT, V82, P195, DOI 10.1016/S0163-7258(98)00044-8; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Yu Y, 2005, BIOCHEM BIOPH RES CO, V334, P1085, DOI 10.1016/j.bbrc.2005.06.198	28	75	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13193	13201		10.1074/jbc.M809038200	http://dx.doi.org/10.1074/jbc.M809038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19244237	Green Published, hybrid			2022-12-25	WOS:000265688300066
J	Kim, J; Ahn, S; Rajagopal, K; Lefkowitz, RJ				Kim, Jihee; Ahn, Seungkirl; Rajagopal, Keshava; Lefkowitz, Robert J.			Independent beta-Arrestin2 and G(q)/Protein Kinase C zeta Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; MEDIATED ACTIVATION; CARDIAC MYOCYTES; TYROSINE KINASE; EGF RECEPTOR; SRC-FAMILY; PKC-XI; PROLIFERATION; PHOSPHORYLATION	Recent studies in receptor-transfected cell lines have demonstrated that extracellular signal-regulated kinase (ERK) activation by angiotensin type 1A receptor and other G protein-coupled receptors can be mediated by both G protein-dependent and beta-arrestin-dependent mechanisms. However, few studies have explored these mechanisms in primary cultured cells expressing endogenous levels of receptors. Accordingly, here we utilized the beta-arrestin biased agonist for the angiotensin type 1A receptor, SII-angiotensin (SII), and RNA interference techniques to investigate angiotensin II (ANG)-activated beta-arrestin-mediated mitogenic signaling pathways in rat vascular smooth muscle cells. Both ANG and SII induced DNA synthesis via the ERK activation cascade. Even though SII cannot induce calcium influx (G protein activation) after receptor stimulation, it does cause ERK activation, although less robustly than ANG. Activation by both ligands is diminished by depletion of beta-arrestin2 by small interfering RNA, although the effect is more complete with SII. ERK activation at early time points but not later time points is strongly inhibited by those protein kinase C inhibitors that can block protein kinase C zeta. Moreover, ANG- and SII-mediated ERK activation require transactivation of the epidermal growth factor receptor via metalloprotease 2/9 and Src kinase. beta-Arrestin2 facilitates ANG and SII stimulation of Src-mediated phosphorylation of Tyr-845 on the EGFR, a known site for Src phosphorylation. These studies delineate a convergent mechanism by which G protein-dependent and beta-arrestin-dependent pathways can independently mediate ERK-dependent transactivation of the EGFR in vascular smooth muscle cells thus controlling cellular proliferative responses.	[Kim, Jihee; Ahn, Seungkirl; Rajagopal, Keshava; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		National Institutes of Health [HL 16037, HL 70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037, R01HL070631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 16037 and HL 70631 (to R. J. L.).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; ASSENDER JW, 1994, FEBS LETT, V342, P76, DOI 10.1016/0014-5793(94)80588-1; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Demoliou-Mason CD, 1998, BIOL SIGNAL RECEPT, V7, P90; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1297, DOI 10.1152/ajpcell.00617.2005; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; KARIYA K, 1991, J BIOL CHEM, V266, P10023; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Nakashima H, 2008, HYPERTENSION, V51, P232, DOI 10.1161/HYPERTENSIONAHA.107.101253; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Nozawa Y, 1999, LIFE SCI, V64, P2061, DOI 10.1016/S0024-3205(99)00153-8; Parmentier JH, 2006, AM J PHYSIOL-HEART C, V291, pH1602, DOI 10.1152/ajpheart.01363.2005; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; PORRECA E, 1993, ATHEROSCLEROSIS, V104, P137, DOI 10.1016/0021-9150(93)90184-V; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Saito S, 2002, BIOCHEM BIOPH RES CO, V294, P1023, DOI 10.1016/S0006-291X(02)00595-8; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Wassmann S, 2006, J HYPERTENS, V24, pS15, DOI 10.1097/01.hjh.0000220402.53869.72; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361; Yu PJ, 2007, CELL SIGNAL, V19, P1359, DOI 10.1016/j.cellsig.2007.03.002; Zhou CH, 2006, EUR J PHARMACOL, V535, P61, DOI 10.1016/j.ejphar.2006.02.027; Zou YZ, 1998, CIRC RES, V82, P337, DOI 10.1161/01.RES.82.3.337	44	94	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11953	11962		10.1074/jbc.M808176200	http://dx.doi.org/10.1074/jbc.M808176200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254952	Green Published, hybrid			2022-12-25	WOS:000265494600027
J	Lu, HQ; Leung, HT; Wang, N; Pak, WL; Shieh, BH				Lu, Haiqin; Leung, Hung-Tat; Wang, Ning; Pak, William L.; Shieh, Bih-Hwa			Role of Ca2+/Calmodulin-dependent Protein Kinase II in Drosophila Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT PHOSPHORYLATION; PHOSPHATASE 2A; SUBCELLULAR TRANSLOCATION; RETINAL DEGENERATION; VISUAL ARRESTIN; PHOSRESTIN-I; TRPL-CHANNEL; PHOTOTRANSDUCTION; EXPRESSION; RHODOPSIN	Ca2+ modulates the visual response in both vertebrates and invertebrates. In Drosophila photoreceptors, an increase of cytoplasmic Ca2+ mimics light adaptation. Little is known regarding the mechanism, however. We explored the role of the sole Drosophila Ca2+/calmodulin-dependent protein kinase II (CaMKII) to mediate light adaptation. CaMKII has been implicated in the phosphorylation of arrestin 2 (Arr2). However, the functional significance of Arr2 phosphorylation remains debatable. We identified retinal CaMKII by anti-CaMKII antibodies and by its Ca2+-dependent autophosphorylation. Moreover, we show that phosphorylation of CaMKII is greatly enhanced by okadaic acid, and indeed, purified PP2A catalyzes the dephosphorylation of CaMKII. Significantly, we demonstrate that anti-CaMKII antibodies co-immunoprecipitate, and CaMKII fusion proteins pull down the catalytic subunit of PP2A from fly extracts, indicating that PP2A interacts with CaMKII to form a protein complex. To investigate the function of CaMKII in photoreceptors, we show that suppression of CaMKII in transgenic flies affects light adaptation and increases prolonged depolarizing afterpotential amplitude, whereas a reduced PP2A activity brings about reduced prolonged depolarizing afterpotential amplitude. Taken together, we conclude that CaMKII is involved in the negative regulation of the visual response affecting light adaptation, possibly by catalyzing phosphorylation of Arr2. Moreover, the CaMKII activity appears tightly regulated by the co-localized PP2A.	[Shieh, Bih-Hwa] Vanderbilt Univ, Vis Res Ctr, Nashville, TN 37232 USA; [Lu, Haiqin; Wang, Ning] Vanderbilt Univ, Ctr Mol Neurosci, Dept Pharmacol, Nashville, TN 37232 USA; [Leung, Hung-Tat; Pak, William L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Vanderbilt University; Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shieh, BH (corresponding author), Vanderbilt Univ, Vis Res Ctr, Nashville, TN 37232 USA.	bih-hwa.shieh@vanderbilt.edu			National Institutes of Health [EY09743, EY00033]; NATIONAL EYE INSTITUTE [R56EY000033, R01EY009743, R01EY000033, R37EY000033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY09743 (to B.-H. S.) and EY00033 (to W. L. P.).	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; Cronin MA, 2004, J CELL SCI, V117, P4797, DOI 10.1242/jcs.01371; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Frechter S, 2007, J NEUROSCI, V27, P5571, DOI 10.1523/JNEUROSCI.0310-07.2007; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; GuptaRoy B, 2000, MOL BRAIN RES, V80, P26, DOI 10.1016/S0169-328X(00)00115-7; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kahn ES, 1998, COMP BIOCHEM PHYS B, V119, P739, DOI 10.1016/S0305-0491(98)00050-9; Kahn ES, 1997, J NEUROCHEM, V68, P169; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leung HT, 2008, NEURON, V58, P884, DOI 10.1016/j.neuron.2008.05.001; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Morimoto-Tanifuji T, 2004, NEUROSCIENCE, V128, P797, DOI 10.1016/j.neuroscience.2004.07.018; O'Tousa JE, 2002, ADV EXP MED BIOL, V514, P493; OHSAKO S, 1993, J BIOL CHEM, V268, P2052; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shakiryanova D, 2007, J NEUROSCI, V27, P7799, DOI 10.1523/JNEUROSCI.1879-07.2007; Shoju H, 2005, J BIOCHEM, V138, P605, DOI 10.1093/jb/mvi161; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang Z, 1998, J NEUROCHEM, V71, P378; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671	48	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11100	11109		10.1074/jbc.M806956200	http://dx.doi.org/10.1074/jbc.M806956200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19254957	Green Published, hybrid			2022-12-25	WOS:000265494500014
J	Busch, A; Guazzaroni, ME; Lacal, J; Ramos, JL; Krell, T				Busch, Andreas; Guazzaroni, Maria-Eugenia; Lacal, Jesus; Luis Ramos, Juan; Krell, Tino			The Sensor Kinase TodS Operates by a Multiple Step Phosphorelay Mechanism Involving Two Autokinase Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION SYSTEM; RESPONSE REGULATOR; FUNCTIONAL-CHARACTERIZATION; TOLUENE METABOLISM; RECOGNITION SITES; IN-VITRO; PHOSPHORYLATION; BINDING; STRAIN; DIMERIZATION	Expression of the Pseudomonas putida tod operon, which encodes enzymes for toluene metabolism, takes place from the P-todX promoter and is mediated by the TodS/TodT two component system. The sensor kinase TodS has a complex domain arrangement containing two functional modules, each harboring a sensor- and an autokinase domain and separated by a receiver domain. Based on site-directed mutagenesis of phosphoaccepting His-190, Asp-500, and His-760 and in vitro transphosphorylation experiments with recombinant TodS fragments, we show that TodS uses a multiple step phosphorelay mechanism to activate TodT. Toluene binding stimulates exclusively phosphorylation of His-190, which is followed by phosphotransfer to Asp-500 and subsequently to His-760 prior to phosphorylation of TodT Asp-57. Mutation of His-190, Asp-500, and H760A prevented up-regulation of toluene-mediated stimulation of TodT transphosphorylation in vitro and reduced in vivo expression of PtodX to the basal level. Calorimetric studies support that TodT binds to the C-terminal kinase module with a K-D of similar to 200 nM and 1:1 stoichiometry. This is the first report of a multiple step phosphorelay mechanism of a sensor kinase that involves two autokinase domains.	[Busch, Andreas; Guazzaroni, Maria-Eugenia; Lacal, Jesus; Luis Ramos, Juan; Krell, Tino] CSIC, Estac Expt Zaidin, Environm Protect Dept, Granada 18008, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Krell, T (corresponding author), CSIC, Estac Expt Zaidin, Environm Protect Dept, C Prof Albareda 1, Granada 18008, Spain.	tino.krell@eez.csic.es	Lacal Romero, Jesus/G-8041-2015; Lacal, Jesus/B-1511-2019; Guazzaroni, María-Eugenia/Y-9268-2019; Guazzaroni, María Eugenia MEG/E-2599-2013; Krell, Tino/G-7296-2015	Lacal Romero, Jesus/0000-0002-2751-7291; Lacal, Jesus/0000-0002-2751-7291; Guazzaroni, María-Eugenia/0000-0002-4657-3731; Guazzaroni, María Eugenia MEG/0000-0002-4657-3731; Krell, Tino/0000-0002-9040-3166; Ramos, Juan L./0000-0002-8731-7435	Spanish Ministry of Science and Education [CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 200700010]; Junta de Andalucia [CIV344, CIV1912]	Spanish Ministry of Science and Education(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Science and Education (CICYT BIO-2006-05668, BFU 2005-0487-C02-02, CSD 200700010) and Grants CIV344 and CIV1912 from the Junta de Andalucia (to J.L.R. and T.K.), respectively.	Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Coschigano PW, 1997, APPL ENVIRON MICROB, V63, P652, DOI 10.1128/AEM.63.2.652-660.1997; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Lacal J, 2008, J MOL BIOL, V376, P325, DOI 10.1016/j.jmb.2007.12.004; Lacal J, 2006, P NATL ACAD SCI USA, V103, P8191, DOI 10.1073/pnas.0602902103; Lacal J, 2008, J MOL BIOL, V384, P1037, DOI 10.1016/j.jmb.2008.10.011; Lau PCK, 1997, P NATL ACAD SCI USA, V94, P1453, DOI 10.1073/pnas.94.4.1453; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mosqueda G, 1999, GENE, V232, P69, DOI 10.1016/S0378-1119(99)00113-4; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Perraud AL, 2000, BBA-PROTEIN STRUCT M, V1478, P341, DOI 10.1016/S0167-4838(00)00052-2; RALEIGH EA, 1989, GENETICS, V122, P279; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos-Gonzalez MI, 2002, J BACTERIOL, V184, P7062, DOI 10.1128/JB.184.24.7062-7067.2002; Rampioni G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-92; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sousa EHS, 2005, BIOCHEMISTRY-US, V44, P15359, DOI 10.1021/bi051661h; Stewart RC, 2004, BIOCHEMISTRY-US, V43, P8766, DOI 10.1021/bi0495735; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tomenius H, 2005, J BACTERIOL, V187, P7317, DOI 10.1128/JB.187.21.7317-7324.2005; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Velasco A, 1998, J BACTERIOL, V180, P1063, DOI 10.1128/JB.180.5.1063-1071.1998; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang WW, 2005, MICROBIOL-SGM, V151, P2159, DOI 10.1099/mic.0.27987-0	41	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10353	10360		10.1074/jbc.M900521200	http://dx.doi.org/10.1074/jbc.M900521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240030	Green Published, hybrid			2022-12-25	WOS:000265104600009
J	Salowe, SP; Wiltsie, J; Hawkins, JC; Sonatore, LM				Salowe, Scott P.; Wiltsie, Judyann; Hawkins, Julio C.; Sonatore, Lisa M.			The Catalytic Flexibility of tRNA(Ile)-lysidine Synthetase Can Generate Alternative tRNA Substrates for Isoleucyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SPECIFICITIES; ESCHERICHIA-COLI-B; CODON RECOGNITION; STRUCTURAL BASIS; ANTICODON CAT; 1ST POSITION; LYSIDINE; LYSINE; GENES; IDENTIFICATION	Bacteria decode the isoleucine codon AUA using a tRNA species that is posttranscriptionally modified at the wobble position of the anticodon with a lysine-containing cytidine derivative called lysidine. The lysidine modification of tRNA(Ile2) is an essential identity determinant for proper aminoacylation by isoleucyl tRNA synthetase (IleRS) and codon recognition on the ribosome. The ATP- and lysine-dependent formation of lysidine is catalyzed by tRNA(Ile)-lysidine synthetase. Using the purified recombinant enzyme from Escherichia coli and an in vitro transcribed tRNA substrate, we have confirmed that lysidine modification is both necessary and sufficient to convert tRNA(Ile2) into a substrate for IleRS. A series of lysine analogs were tested as potential inhibitors during the mechanistic characterization of tRNA(Ile)-lysidine synthetase. Gel electrophoresis revealed that many of these analogs, including some simple alkyl amines, were alternative substrates. Incorporation of these amines into alternative tRNA products was confirmed by mass spectrometry. The availability of tRNA(Ile2) with differential modifications enabled an exploration of the structural requirements of the anticodon for aminoacylation by methionyl tRNA synthetase and IleRS. All of the modifications were effective at creating negative determinants for methionyl tRNA synthetase and positive determinants for IleRS, although the tolerance of IleRS differed between the enzymes from E. coli and Bacillus subtilis.	[Salowe, Scott P.; Wiltsie, Judyann; Hawkins, Julio C.; Sonatore, Lisa M.] Merck Res Labs, Dept Infect Dis Res, Rahway, NJ 07065 USA	Merck & Company	Salowe, SP (corresponding author), Merck & Co Inc, RY80Y-340,POB 2000, Rahway, NJ 07065 USA.	scott_salowe@merck.com						ANDACHI Y, 1989, J MOL BIOL, V209, P37, DOI 10.1016/0022-2836(89)90168-X; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Grosjean H, 2004, TRENDS BIOCHEM SCI, V29, P165, DOI 10.1016/j.tibs.2004.02.009; GUPTA R, 1984, J BIOL CHEM, V259, P9461; HARADA F, 1974, BIOCHEMISTRY-US, V13, P300, DOI 10.1021/bi00699a011; HUGHES J, 1980, BIOCHEM J, V191, P209, DOI 10.1042/bj1910209; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kohrer C, 2008, RNA, V14, P117, DOI 10.1261/rna.795508; Kuratani M, 2007, STRUCTURE, V15, P1642, DOI 10.1016/j.str.2007.09.020; Macarron R, 2000, ANAL BIOCHEM, V284, P183, DOI 10.1006/abio.2000.4665; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Matsugi J, 1996, J BIOCHEM, V119, P811; MURAMATSU T, 1992, NUCLEOS NUCLEOT NUCL, V11, P719, DOI 10.1080/07328319208021736; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; MURAMATSU T, 1988, J BIOL CHEM, V263, P9261; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P7487, DOI 10.1073/pnas.0501003102; NUREKI O, 1994, J MOL BIOL, V236, P710, DOI 10.1006/jmbi.1994.1184; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Silva FJ, 2006, NUCLEIC ACIDS RES, V34, P6015, DOI 10.1093/nar/gkl739; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0	23	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9656	9662		10.1074/jbc.M809013200	http://dx.doi.org/10.1074/jbc.M809013200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233850	hybrid, Green Published			2022-12-25	WOS:000264892900005
J	Garrison, JB; Samuel, T; Reed, JC				Garrison, J. B.; Samuel, T.; Reed, J. C.			TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappa B	ONCOGENE			English	Article						TRAF2; c-IAP2/MALT1; NF-kappa B; TRAF6; BIR1; B-cell lymphoma	MALT LYMPHOMA; CELL LYMPHOMA; INHIBITOR; APOPTOSIS; GENE; T(11/18)(Q21,Q21); BCL10; UBIQUITINATION; TRANSLOCATION; TRAF2	Marginal zone mucosa-associated lymphoid tissue (MALT) B-cell lymphoma is the most common extranodal non-Hodgkin lymphoma. The t(11;18)(q21;q21) translocation occurs frequently in MALT lymphomas and creates a chimeric NF-kappa B-activating protein containing the baculoviral IAP repeat (BIR) domains of c-IAP2 (inhibitor of apoptosis protein 2) fused with portions of the MALT1 protein. The BIR1 domain of c-IAP2 interacts directly with TRAF2 (TNF alpha-receptor-associated factor-2), but its role in NF-kappa B activation is still unclear. Here, we investigated the role of TRAF2 in c-IAP2/MALT1-induced NF-kappa B activation. We show the BIR1 domain of c-IAP2 is essential for NF-kappa B activation, whereas BIR2 and BIR3 domains are not. Studies of c-IAP2/MALT1 BIR1 mutant (E47A/R48A) that fails to activate NF-kappa B showed loss of TRAF2 binding, but retention of TRAF6 binding, suggesting that interaction of c-IAP2/MALT1 with TRAF6 is insufficient forNF-kappa B induction. In addition, a dominant-negative TRAF2 mutant or down-regulation of TRAF2 achieved by small interfering RNA inhibited NF-kappa B activation by c-IAP2/MALT1 showing that TRAF2 is indispensable. Comparisons of the bioactivity of intact c-IAP2/MALT1 oncoprotein and BIR1 E47A/R48A c-IAP2/MALT1 mutant that cannot bind TRAF2 in a lymphoid cell line provided evidence that TRAF2 interaction is critical for c-IAP2/MALT1mediated increases in the NF-kappa B activity, increased expression of endogenous NF-kappa B target genes (c-FLIP, TRAF1), and resistance to apoptosis.	[Garrison, J. B.; Samuel, T.; Reed, J. C.] Burnham Inst Med Res, Ctr Canc, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, Ctr Canc, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org						Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Morgan JA, 1999, CANCER RES, V59, P6205; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vega F, 2001, ADV ANAT PATHOL, V8, P313, DOI 10.1097/00125480-200111000-00001; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zucca E, 2000, BLOOD, V96, P410	27	21	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1584	1593		10.1038/onc.2009.17	http://dx.doi.org/10.1038/onc.2009.17			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19234489				2022-12-25	WOS:000264780500003
J	Egesten, A; Olin, AI; Linge, HM; Yadav, M; Morgelin, M; Karlsson, A; Collin, M				Egesten, Arne; Olin, Anders I.; Linge, Helena M.; Yadav, Manisha; Morgelin, Matthias; Karlsson, Anna; Collin, Mattias			SpeB of Streptococcus pyogenes Differentially Modulates Antibacterial and Receptor Activating Properties of Human Chemokines	PLOS ONE			English	Article								Background: CXC chemokines are induced by inflammatory stimuli in epithelial cells and some, like MIG/CXCL9, IP-10/CXCL10 and I-TAC/CXCL11, are antibacterial for Streptococcus pyogenes. Methodology/Principal Findings: SpeB from S. pyogenes degrades a wide range of chemokines (i.e. IP10/CXCL10, I-TAC/CXCL11, PF4/CXCL4, GRO alpha/CXCL1, GRO beta/CXCL2, GRO gamma/CXCL3, ENA78/CXCL5, GCP-2/CXCL6, NAP-2/CXCL7, SDF-1/CXCL12, BCA-1/CXCL13, BRAK/CXCL14, SRPSOX/CXCL16, MIP-3 alpha/CCL20, Lymphotactin/XCL1, and Fractalkine/CX3CL1), has no activity on IL-8/CXCL8 and RANTES/CCL5, partly degrades SRPSOX/CXCL16 and MIP-3 alpha/CCL20, and releases a 6 kDa CXCL9 fragment. CXCL10 and CXCL11 loose receptor activating and antibacterial activities, while the CXCL9 fragment does not activate the receptor CXCR3 but retains its antibacterial activity. Conclusions/Significance: SpeB destroys most of the signaling and antibacterial properties of chemokines expressed by an inflamed epithelium. The exception is CXCL9 that preserves its antibacterial activity after hydrolysis, emphasizing its role as a major antimicrobial on inflamed epithelium.	[Egesten, Arne; Linge, Helena M.] Lund Univ, Div Resp Med, Dept Clin Sci Lund, Lund, Sweden; [Olin, Anders I.; Yadav, Manisha; Morgelin, Matthias; Collin, Mattias] Lund Univ, Dept Clin Sci Lund, Div Infect Med, S-22100 Lund, Sweden; [Karlsson, Anna] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Lund University; Lund University; University of Gothenburg	Egesten, A (corresponding author), Lund Univ, Div Resp Med, Dept Clin Sci Lund, Lund, Sweden.	Mattias.Collin@med.lu.se	Collin, Mattias/C-6398-2009; Karlsson, Anna/A-4130-2012	Collin, Mattias/0000-0002-6166-7410; Karlsson, Anna/0000-0001-6796-1154; Linge, Helena/0000-0002-8919-0300	Swedish Research Council [2005-4791, 2007-2880, Assistant Professorship]; Swedish Heart and Lung Foundation; Foundations of Crafoord; Foundations of Jeansson; Foundations of Zoega; Foundations of Kock; Foundations of Bergh; Foundations of Bergvall; Foundations of Hedberg; Foundations of Osterlund; Foundations of Groschinsky; Swedish Society of Medicine; Royal Physiografic Society; Medical Faculty at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Foundations of Crafoord; Foundations of Jeansson; Foundations of Zoega; Foundations of Kock; Foundations of Bergh; Foundations of Bergvall; Foundations of Hedberg; Foundations of Osterlund; Foundations of Groschinsky; Swedish Society of Medicine; Royal Physiografic Society(Royal Society of London); Medical Faculty at Lund University	This work was supported by grants from the Swedish Research Council (projects 2005-4791 and 2007-2880), the Swedish Heart and Lung Foundation, the Foundations of Crafoord, Jeansson, Zoega, Kock, Bergh, Bergvall, Hedberg, Osterlund, Groschinsky, the Swedish Society of Medicine, the Royal Physiografic Society, and the Medical Faculty at Lund University. M.C. is the recipient of an Assistant Professorship from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Ashbaugh CD, 2001, INFECT IMMUN, V69, P6683, DOI 10.1128/IAI.69.11.6683-6686.2001; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Collin M, 2008, J REPROD IMMUNOL, V79, P37, DOI 10.1016/j.jri.2008.08.003; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Eliasson M, 2007, MICROB PATHOGENESIS, V43, P224, DOI 10.1016/j.micpath.2007.06.007; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; GERLACH D, 1983, ZBL BAKT-INT J MED M, V255, P221, DOI 10.1016/S0174-3031(83)80161-9; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Linge HM, 2008, J INTERF CYTOK RES, V28, P190, DOI 10.1089/jir.2007.0100; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Lukomski S, 1999, INFECT IMMUN, V67, P1779; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Malkowski MG, 1997, J MOL BIOL, V266, P367, DOI 10.1006/jmbi.1996.0796; Matsuka YV, 1999, INFECT IMMUN, V67, P4326, DOI 10.1128/IAI.67.9.4326-4333.1999; Nyberg P, 2004, J BIOL CHEM, V279, P52820, DOI 10.1074/jbc.C400485200; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Sauty A, 1999, J IMMUNOL, V162, P3549; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schmidtchen A, 2001, MOL MICROBIOL, V39, P708, DOI 10.1046/j.1365-2958.2001.02251.x; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Stone, 1998, EFFICIENT LIB PARALL; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; SUMBY P, 2008, INFECT IMMUN, V105, P1698; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; TALKINGTON DF, 1993, INFECT IMMUN, V61, P3369, DOI 10.1128/IAI.61.8.3369-3374.1993; TANG YQ, INFECT IMMUN, V7, P6524; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; Vinh DC, 2005, LANCET INFECT DIS, V5, P501, DOI 10.1016/S1473-3099(05)70191-2; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; WOLF BB, 1994, J BIOL CHEM, V269, P30682; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yount NY, 2007, BBA-BIOMEMBRANES, V1768, P598, DOI 10.1016/j.bbamem.2006.11.011; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	65	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4769	10.1371/journal.pone.0004769	http://dx.doi.org/10.1371/journal.pone.0004769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274094	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496000009
J	Farina, AK; Bong, YS; Feltes, CM; Byers, SW				Farina, Anne K.; Bong, Yong-Sik; Feltes, Carolyn M.; Byers, Stephen W.			Post-Transcriptional Regulation of Cadherin-11 Expression by GSK-3 and beta-Catenin in Prostate and Breast Cancer Cells	PLOS ONE			English	Article								Background: The cell-cell adhesion molecule cadherin-11 is important in embryogenesis and bone morphogenesis, invasion of cancer cells, lymphangiogenesis, homing of cancer cells to bone, and rheumatoid arthritis. However, very little is known about the regulation of cadherin-11 expression. Methodology/Principal Findings: Here we show that cell density and GSK-3 beta regulate cadherin-11 levels in cancer cells. Inactivation of GSK3 beta with lithium chloride or the GSK3 inhibitor BIO and GSK3b knockdown with siRNA repressed cadherin-11 mRNA and protein levels. RNA Polymerase II chromatin immunoprecipitation experiments showed that inhibition of GSK3 does not affect cadherin-11 gene transcription. Although the cadherin-11 3'UTR contains putative microRNA target sites and is regulated by Dicer, its stability is not regulated by GSK3 inhibition or density. Our data show that GSK3b regulates cadherin-11 expression in two ways: first a beta-catenin-independent regulation of cadherin-11 steady state mRNA levels, and second a beta-catenin-dependent effect on cadherin-11 3'UTR stability and protein translation. Conclusions: Cadherin-11 mRNA and protein levels are regulated by the activity of GSK3b and a significant degree of this regulation is exerted by the GSK3 target, beta-catenin, at the level of the cadherin-11 3'UTR	[Farina, Anne K.; Bong, Yong-Sik; Feltes, Carolyn M.; Byers, Stephen W.] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Farina, Anne K.; Bong, Yong-Sik; Feltes, Carolyn M.; Byers, Stephen W.] Georgetown Univ, Sch Med, Dept Oncol & Biochem Mol & Cellular Biol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Farina, AK (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu			DOD Idea Award [DAMD17-01-1-0245]; DOD Prostate Cancer Research Predoctoral Traineeship Award [W81XWH-05-1-0559]	DOD Idea Award; DOD Prostate Cancer Research Predoctoral Traineeship Award	DOD Idea Award DAMD17-01-1-0245 (SWB), DOD Prostate Cancer Research Predoctoral Traineeship Award W81XWH-05-1-0559 (AKF).	Barker N, 2000, ADV CANCER RES, V77, P1; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Chen GTC, 1999, MOL REPROD DEV, V52, P158, DOI 10.1002/(SICI)1098-2795(199902)52:2<158::AID-MRD6>3.0.CO;2-3; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Getsios S, 1998, J REPROD FERTIL, V114, P357; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Hadeball B, 1998, MECH DEVELOP, V72, P101, DOI 10.1016/S0925-4773(98)00022-7; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ji Y, 2008, ONCOGENE, V27, P755, DOI 10.1038/sj.onc.1210667; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Lee HK, 2006, CANCER RES, V66, P10560, DOI 10.1158/0008-5472.CAN-06-2526; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McMenamin ME, 1999, CANCER RES, V59, P4291; Ohigashi T, 2005, PROSTATE, V62, P61, DOI 10.1002/pros.20117; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orlandini M, 2003, J BIOL CHEM, V278, P44650, DOI 10.1074/jbc.M304255200; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pishvaian MJ, 1999, CANCER RES, V59, P947; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; SIMONNEAU L, 1995, CELL ADHES COMMUN, V3, P115, DOI 10.3109/15419069509081281; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tomita K, 2000, CANCER RES, V60, P3650; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Whittle BJR, 2006, BRIT J PHARMACOL, V147, P575, DOI 10.1038/sj.bjp.0706509; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	43	24	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4797	10.1371/journal.pone.0004797	http://dx.doi.org/10.1371/journal.pone.0004797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274078	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496000030
J	Lehmann, M; Noack, D; Wood, M; Perego, M; Knaus, UG				Lehmann, Mandy; Noack, Deborah; Wood, Malcolm; Perego, Marta; Knaus, Ulla G.			Lung Epithelial Injury by B-Anthracis Lethal Toxin Is Caused by MKK-Dependent Loss of Cytoskeletal Integrity	PLOS ONE			English	Article							KERATINOCYTE-GROWTH-FACTOR; SIGNALING PATHWAYS; PATHOGENESIS; PROTEINS; BARRIER; CDC42; MODULATION; CORTACTIN; DYNAMICS; KINASES	Bacillus anthracis lethal toxin (LT) is a key virulence factor of anthrax and contributes significantly to the in vivo pathology. The enzymatically active component is a Zn2+-dependent metalloprotease that cleaves most isoforms of mitogen-activated protein kinase kinases (MKKs). Using ex vivo differentiated human lung epithelium we report that LT destroys lung epithelial barrier function and wound healing responses by immobilizing the actin and microtubule network. Long-term exposure to the toxin generated a unique cellular phenotype characterized by increased actin filament assembly, microtubule stabilization, and changes in junction complexes and focal adhesions. LT-exposed cells displayed randomly oriented, highly dynamic protrusions, polarization defects and impaired cell migration. Reconstitution of MAPK pathways revealed that this LT-induced phenotype was primarily dependent on the coordinated loss of MKK1 and MKK2 signaling. Thus, MKKs control fundamental aspects of cytoskeletal dynamics and cell motility. Even though LT disabled repair mechanisms, agents such as keratinocyte growth factor or dexamethasone improved epithelial barrier integrity by reducing cell death. These results suggest that co-administration of anti-cytotoxic drugs may be of benefit when treating inhalational anthrax.	[Lehmann, Mandy; Noack, Deborah; Knaus, Ulla G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wood, Malcolm] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA USA; [Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Lehmann, M (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	uknaus@scripps.edu			CDC [CI000095]; NIH/NIAID [AI024838, AI077042, AI055860]; NIH/NIGMS [GM019416, GM055594]; Stein Beneficial Trust; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077042, R01AI024838, R01AI055860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019416, R01GM019416, R01GM055594] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stein Beneficial Trust; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CDC grant CI000095 (U.G.K. and M. P.), NIH/NIAID grants AI024838 and AI077042 (U.G.K.), AI055860 (M.P.) and NIH/NIGMS grants GM019416 and GM055594 (M.P.). Oligonucleotide synthesis and DNA sequencing were supported in part by the Stein Beneficial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Agrawal A, 2004, CELL MOL LIFE SCI, V61, P2859, DOI 10.1007/s00018-004-4251-4; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Desai LP, 2004, AM J PHYSIOL-LUNG C, V287, pL1134, DOI 10.1152/ajplung.00022.2004; Duesbery NS, 1999, J APPL MICROBIOL, V87, P289, DOI 10.1046/j.1365-2672.1999.00892.x; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Frazier AA, 2006, J THORAC IMAG, V21, P252, DOI 10.1097/01.rti.0000213570.71161.84; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gomperts BN, 2007, AM J RESP CELL MOL, V37, P48, DOI 10.1165/rcmb.2006-0384OC; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Harwood A, 2003, NAT CELL BIOL, V5, P275, DOI 10.1038/ncb0403-275; Hong J, 2007, J BIOL CHEM, V282, P19781, DOI 10.1074/jbc.M700128200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Knaus Ulla G., 2007, V412, P59, DOI 10.1007/978-1-59745-467-4_5; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Peixoto EBMI, 2006, CELL BIOL INT, V30, P101, DOI 10.1016/j.cellbi.2005.08.004; Pentecost Mickey, 2006, PLoS Pathogens, V2, P29; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Russell BH, 2008, CELL MICROBIOL, V10, P945, DOI 10.1111/j.1462-5822.2007.01098.x; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; STOFEGA M, 2006, TRIPHOSPHATASE ACTIV, P269; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Ware LB, 2004, INT J RADIAT ONCOL, V60, P1345, DOI 10.1016/j.ijrobp.2004.09.015; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783	42	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4755	10.1371/journal.pone.0004755	http://dx.doi.org/10.1371/journal.pone.0004755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270742	Green Submitted, gold, Green Published			2022-12-25	WOS:000265495900022
J	Yuan, A; Farber, EL; Rapoport, AL; Tejada, D; Deniskin, R; Akhmedov, NB; Farber, DB				Yuan, Alex; Farber, Erica L.; Rapoport, Ana Lia; Tejada, Desiree; Deniskin, Roman; Akhmedov, Novrouz B.; Farber, Debora B.			Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles	PLOS ONE			English	Article							MEMBRANE MICROPARTICLES; MESSENGER-RNA; EXPRESSION; SURFACE; IDENTIFICATION; DEFECT; TIME	Microvesicles are plasma membrane-derived vesicles released into the extracellular environment by a variety of cell types. Originally characterized from platelets, microvesicles are a normal constituent of human plasma, where they play an important role in maintaining hematostasis. Microvesicles have been shown to transfer proteins and RNA from cell to cell and they are also believed to play a role in intercellular communication. We characterized the RNA and protein content of embryonic stem cell microvesicles and show that they can be engineered to carry exogenously expressed mRNA and protein such as green fluorescent protein (GFP). We demonstrate that these engineered microvesicles dock and fuse with other embryonic stem cells, transferring their GFP. Additionally, we show that embryonic stem cells microvesicles contain abundant microRNA and that they can transfer a subset of microRNAs to mouse embryonic fibroblasts in vitro. Since microRNAs are short (21-24 nt), naturally occurring RNAs that regulate protein translation, our findings open up the intriguing possibility that stem cells can alter the expression of genes in neighboring cells by transferring microRNAs contained in microvesicles. Embryonic stem cell microvesicles may be useful therapeutic tools for transferring mRNA, microRNAs, protein, and siRNA to cells and may be important mediators of signaling within stem cell niches.	[Yuan, Alex; Farber, Erica L.; Rapoport, Ana Lia; Tejada, Desiree; Deniskin, Roman; Akhmedov, Novrouz B.; Farber, Debora B.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yuan, A (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	farber@jsei.ucla.edu		Yuan, Alex/0000-0003-0191-8035; Farber, Debora/0000-0002-3207-697X	NIH [EY018739]; The Vision of Children; Hope for Vision; NATIONAL EYE INSTITUTE [R21EY018739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Vision of Children; Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from NIH (EY018739), The Vision of Children, and Hope for Vision. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahams VM, 2003, CANCER RES, V63, P5573; Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Fritzsching B, 2002, J IMMUNOL, V169, P5531, DOI 10.4049/jimmunol.169.10.5531; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Greenwalt TJ, 2006, TRANSFUSION, V46, P143, DOI 10.1111/j.1537-2995.2006.00692.x; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Manly BFJ, 1997, RANDOMIZATION BOOTST; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Quesenberry PJ, 2008, STEM CELL REV, V4, P137, DOI 10.1007/s12015-008-9036-y; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; Sloand EM, 1998, BLOOD, V92, P4439, DOI 10.1182/blood.V92.11.4439.423k24_4439_4445; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tahinci E, 2004, CURR OPIN GENET DEV, V14, P361, DOI 10.1016/j.gde.2004.06.013; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437	36	329	360	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4722	10.1371/journal.pone.0004722	http://dx.doi.org/10.1371/journal.pone.0004722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266099	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490800004
J	White, GE; Erickson, HP				White, Glenn E.; Erickson, Harold P.			The Coiled Coils of Cohesin Are Conserved in Animals, but Not In Yeast	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; SACCHAROMYCES-SENSU-STRICTO; GENE-EXPRESSION; SMC PROTEINS; DIVERGENCE TIMES; NIPPED-B; DROSOPHILA; COMPLEX; CTCF	Background: The SMC proteins are involved in DNA repair, chromosome condensation, and sister chromatid cohesion throughout Eukaryota. Long, anti-parallel coiled coils are a prominent feature of SMC proteins, and are thought to serve as spacer rods to provide an elongated structure and to separate domains. We reported recently that the coiled coils of mammalian condensin (SMC2/4) showed moderate sequence divergence (approximate to 10-15%) consistent with their functioning as spacer rods. The coiled coils of mammalian cohesins (SMC1/3), however, were very highly constrained, with amino acid sequence divergence typically <0.5%. These coiled coils are among the most highly conserved mammalian proteins, suggesting that they make extensive contacts over their entire surface. Methodology/Principal Findings: Here, we broaden our initial analysis of condensin and cohesin to include additional vertebrate and invertebrate organisms and multiple species of yeast. We found that the coiled coils of SMC1/3 are highly constrained in Drosophila and other insects, and more generally across all animal species. However, in yeast they are no more constrained than the coils of SMC2/4 and Ndc80/Nuf2p, suggesting that they are serving primarily as spacer rods. Conclusions/Significance: SMC1/3 functions for sister chromatid cohesion in all species. Since its coiled coils apparently serve only as spacer rods in yeast, it is likely that this is sufficient for sister chromatid cohesion in all species. This suggests an additional function in animals that constrains the sequence of the coiled coils. Several recent studies have demonstrated that cohesin has a role in gene expression in post-mitotic neurons of Drosophila, and other animal cells. Some variants of human Cornelia de Lange Syndrome involve mutations in human SMC1/3. We suggest that the role of cohesin in gene expression may involve intimate contact of the coiled coils of SMC1/3, and impose the constraint on sequence divergence.	[White, Glenn E.] Longwood Univ, Dept Biol & Environm Sci, Farmville, VA USA; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27706 USA	Longwood University; Duke University	White, GE (corresponding author), Longwood Univ, Dept Biol & Environm Sci, Farmville, VA USA.	h.erickson@cellbio.duke.edu			NIH [CA47056]; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH grant CA47056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley M, 2002, GENOME RES, V12, P1201, DOI 10.1101/gr107302; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Ghiselli G, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-34; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Guacci V, 2007, GENES CELLS, V12, P693, DOI 10.1111/j.1365-2443.2007.01093.x; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Jones S, 2001, GENOME BIOL, V2; Kawahara Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-9; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lin J J, 1997, Int Rev Cytol, V170, P1, DOI 10.1016/S0074-7696(08)61619-8; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McNairn AJ, 2008, TRENDS GENET, V24, P382, DOI 10.1016/j.tig.2008.06.002; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Rainieri S, 2003, J BIOSCI BIOENG, V96, P1; Revenkova E, 2005, REPRODUCTION, V130, P783, DOI 10.1530/rep.1.00864; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; REVENKOVA E, 2008, HUM MOL GENET; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Surcel A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002453; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Thomas JAI, 2008, CELL MOTIL CYTOSKEL, V65, P979, DOI 10.1002/cm.20320; Valdeolmillos AM, 2007, PLOS GENET, V3, P204, DOI 10.1371/journal.pgen.0030028; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; White GE, 2006, J STRUCT BIOL, V154, P111, DOI 10.1016/j.jsb.2006.01.001; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	63	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4674	10.1371/journal.pone.0004674	http://dx.doi.org/10.1371/journal.pone.0004674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262687	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600007
J	Zhang, Y; Zhou, X; Ge, X; Jiang, JH; Li, MW; Jia, SH; Yang, XN; Kan, YC; Miao, XX; Zhao, GP; Li, F; Huang, YP				Zhang, Yong; Zhou, Xue; Ge, Xie; Jiang, Jianhao; Li, Muwang; Jia, Shihai; Yang, Xiaonan; Kan, Yunchao; Miao, Xuexia; Zhao, Guoping; Li, Fei; Huang, Yongping			Insect-Specific microRNA Involved in the Development of the Silkworm Bombyx mori	PLOS ONE			English	Article								MicroRNAs (miRNAs) are endogenous non-coding genes that participate in post-transcription regulation by either degrading mRNA or blocking its translation. It is considered to be very important in regulating insect development and metamorphosis. We conducted a large-scale screening for miRNA genes in the silkworm Bombyx mori using sequence-by-synthesis (SBS) deep sequencing of mixed RNAs from egg, larval, pupal, and adult stages. Of 2,227,930 SBS tags, 1,144,485 ranged from 17 to 25 nt, corresponding to 256,604 unique tags. Among these non-redundant tags, 95,184 were matched to the silkworm genome. We identified 3,750 miRNA candidate genes using a computational pipeline combining RNAfold and TripletSVM algorithms. We confirmed 354 miRNA genes using miRNA microarrays and then performed expression profile analysis on these miRNAs for all developmental stages. While 106 miRNAs were expressed in all stages, 248 miRNAs were egg-and pupa-specific, suggesting that insect miRNAs play a significant role in embryogenesis and metamorphosis. We selected eight miRNAs for quantitative RT-PCR analysis; six of these were consistent with our microarray results. In addition, we searched for orthologous miRNA genes in mammals, a nematode, and other insects and found that most silkworm miRNAs are conserved in insects, whereas only a small number of silkworm miRNAs has orthologs in mammals and the nematode. These results suggest that there are many miRNAs unique to insects.	[Zhang, Yong; Ge, Xie; Jiang, Jianhao; Jia, Shihai; Yang, Xiaonan; Miao, Xuexia; Zhao, Guoping; Huang, Yongping] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Zhou, Xue; Li, Fei] Nanjing Agr Univ, Nanjing, Peoples R China; [Li, Muwang] Chinese Acad Agr Sci, Sericult Res Inst, Zhenjiang, Peoples R China; [Kan, Yunchao] Nan Yang Normal Univ, Nanyang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences	Zhang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	lifei@njau.edu.cn; yphuang@sibs.ac.cn	Zhang, Yong/G-9808-2011; Li, Fei/B-3687-2012; ZHANG, YONG/H-1671-2012	Li, Fei/0000-0002-8410-5250; Jia, Shihai/0000-0003-1144-4291; Zhao, Guo-Ping/0000-0002-7621-6620	National High-Tech R&D Program [2006AA10A119]; National Basic Research Program of China [2005CB121000]; Natural Science Foundation of Jiangsu Province [BK2007524]; National Science Foundation of China [30870337, 30174417]	National High-Tech R&D Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High-Tech R&D Program (2006AA10A119), the National Basic Research Program of China (2005CB121000), the Natural Science Foundation of Jiangsu Province (BK2007524), and grants from National Science Foundation of China (30870337, 30174417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; CAO J, 2008, INSECT BIOCH MOL BIO; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Willis Judith H., 1995, P1; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-93; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang Y, 2007, GENOMICS, V90, P372, DOI 10.1016/j.ygeno.2007.05.005; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	36	86	102	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4677	10.1371/journal.pone.0004677	http://dx.doi.org/10.1371/journal.pone.0004677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262741	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490600009
J	Biocca, S; Falconi, M; Filesi, I; Baldini, F; Vecchione, L; Mango, R; Romeo, F; Federici, G; Desideri, A; Novelli, G				Biocca, Silvia; Falconi, Mattia; Filesi, Ilaria; Baldini, Francesco; Vecchione, Lucia; Mango, Ruggiero; Romeo, Francesco; Federici, Giorgio; Desideri, Alessandro; Novelli, Giuseppe			Functional Analysis and Molecular Dynamics Simulation of LOX-1 K167N Polymorphism Reveal Alteration of Receptor Activity	PLOS ONE			English	Article								The human lectin-like oxidized low density lipoprotein receptor 1 LOX-1, encoded by the ORL1 gene, is the major scavenger receptor for oxidized low density lipoprotein in endothelial cells. Here we report on the functional effects of a coding SNP, c.501G>C, which produces a single amino acid change (K>N at codon 167). Our study was aimed at elucidating whether the c.501G>C polymorphism changes the binding affinity of LOX-1 receptor altering its function. The presence of p.K167N mutation reduces ox-LDL binding and uptake. Ox-LDL activated extracellular signal-regulated kinases 1 and 2 (ERK 1/2) is inhibited. Furthermore, ox-LDL induced biosynthesis of LOX-1 receptors is dependent on the p.K167N variation. In human macrophages, derived from c.501G>C heterozygous individuals, the ox-LDL induced LOX-1 46 kDa band is markedly lower than in induced macrophages derived from c.501G>C controls. Investigation of p.K167N mutation through molecular dynamics simulation and electrostatic analysis suggests that the ox-LDL binding may be attributed to the coupling between the electrostatic potential distribution and the asymmetric flexibility of the basic spine residues. The N/N-LOX-1 mutant has either interrupted electrostatic potential and asymmetric fluctuations of the basic spine arginines.	[Biocca, Silvia; Filesi, Ilaria; Baldini, Francesco] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Falconi, Mattia; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Biocca, Silvia; Falconi, Mattia; Desideri, Alessandro; Novelli, Giuseppe] Univ Roma Tor Vergata, Ctr Biostat & Bioinformat, Rome, Italy; [Vecchione, Lucia; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Rome, Italy; [Vecchione, Lucia; Novelli, Giuseppe] Univ Roma Tor Vergata, Sch Med, Ctr Excellence Genom Risk Assessment Multifactor, Rome, Italy; [Mango, Ruggiero; Romeo, Francesco; Federici, Giorgio] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Mango, Ruggiero] IRCCS Humanitas, Milan, Italy; [Romeo, Francesco; Novelli, Giuseppe] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR USA; [Romeo, Francesco; Novelli, Giuseppe] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Biocca, S (corresponding author), Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy.	biocca@med.uniroma2.it	Novelli, Giuseppe/A-5195-2013; Baldini, Francesco/I-3996-2019; Novelli, Giuseppe/GQB-3329-2022; Biocca, Silvia/AAH-7310-2021; Novelli, Giuseppe/T-8822-2019	Novelli, Giuseppe/0000-0002-7781-602X; Baldini, Francesco/0000-0002-5904-4070; Novelli, Giuseppe/0000-0002-7781-602X; Biocca, Silvia/0000-0001-5838-4674; desideri, alessandro/0000-0003-1541-4217; FALCONI, MATTIA/0000-0002-3990-4758	Italian Ministry of Health, Italian Ministry of University; R.E.D.D. s.r.l.	Italian Ministry of Health, Italian Ministry of University; R.E.D.D. s.r.l.	This work was supported by grants of the Italian Ministry of Health, Italian Ministry of University and Research through R.E.D.D. s.r.l., a spin-off of the Tor Vergata University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biocca S, 2008, J MOL CELL CARDIOL, V44, P561, DOI 10.1016/j.yjmcc.2007.11.017; Cardinale A, 2005, J BIOL CHEM, V280, P685, DOI 10.1074/jbc.M407360200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Chen MY, 2001, BIOCHEM BIOPH RES CO, V282, P153, DOI 10.1006/bbrc.2001.4516; Chen Q, 2003, CIRCULATION, V107, P3146, DOI 10.1161/01.CIR.0000074207.85796.36; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Hou XW, 2008, CLIN CHIM ACTA, V388, P200, DOI 10.1016/j.cca.2007.11.016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955, DOI 10.1161/01.ATV.21.6.955; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Knowles JW, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-23; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Li DY, 2000, CIRCULATION, V102, P1970, DOI 10.1161/01.CIR.102.16.1970; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Mango R, 2005, CIRC RES, V97, P152, DOI 10.1161/01.RES.0000174563.62625.8e; Mango R, 2003, J MED GENET, V40, P933, DOI 10.1136/jmg.40.12.933; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Ohmori R, 2004, CLIN CARDIOL, V27, P641, DOI 10.1002/clc.4960271112; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sattler W, 1992, ISOLATION HUMAN VLDL; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; STEPHAN ZF, 1993, J LIPID RES, V34, P325; Tanigawa H, 2006, HYPERTENSION, V48, P294, DOI 10.1161/01.HYP.0000229825.98545.5e; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Tatsuguchi M, 2003, BIOCHEM BIOPH RES CO, V303, P247, DOI 10.1016/S0006-291X(03)00326-7; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; YUAN XM, 1995, ARTERIOSCL THROM VAS, V15, P1345, DOI 10.1161/01.ATV.15.9.1345; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	42	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4648	10.1371/journal.pone.0004648	http://dx.doi.org/10.1371/journal.pone.0004648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247493	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000265487800028
J	Cheng, G; Tse, J; Jain, RK; Munn, LL				Cheng, Gang; Tse, Janet; Jain, Rakesh K.; Munn, Lance L.			Micro-Environmental Mechanical Stress Controls Tumor Spheroid Size and Morphology by Suppressing Proliferation and Inducing Apoptosis in Cancer Cells	PLOS ONE			English	Article								Background: Compressive mechanical stress produced during growth in a confining matrix limits the size of tumor spheroids, but little is known about the dynamics of stress accumulation, how the stress affects cancer cell phenotype, or the molecular pathways involved. Methodology/Principal Findings: We co-embedded single cancer cells with fluorescent micro-beads in agarose gels and, using confocal microscopy, recorded the 3D distribution of micro-beads surrounding growing spheroids. The change in micro-bead density was then converted to strain in the gel, from which we estimated the spatial distribution of compressive stress around the spheroids. We found a strong correlation between the peri-spheroid solid stress distribution and spheroid shape, a result of the suppression of cell proliferation and induction of apoptotic cell death in regions of high mechanical stress. By compressing spheroids consisting of cancer cells overexpressing anti-apoptotic genes, we demonstrate that mechanical stress-induced apoptosis occurs via the mitochondrial pathway. Conclusions/Significance: Our results provide detailed, quantitative insight into the role of micro-environmental mechanical stress in tumor spheroid growth dynamics, and suggest how tumors grow in confined locations where the level of solid stress becomes high. An important implication is that apoptosis via the mitochondrial pathway, induced by compressive stress, may be involved in tumor dormancy, in which tumor growth is held in check by a balance of apoptosis and proliferation.	[Cheng, Gang; Tse, Janet; Jain, Rakesh K.; Munn, Lance L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Cheng, Gang; Tse, Janet; Jain, Rakesh K.; Munn, Lance L.] Harvard Univ, Sch Med, Boston, MA USA; [Tse, Janet] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Cheng, G (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.	lance@steele.mgh.harvard.edu	Munn, Lance L/L-3950-2016; Jain, Rakesh K/I-1384-2017	Munn, Lance L/0000-0003-0698-7232; Jain, Rakesh K/0000-0001-7571-3548	NIH [P01CA80124, R01CA085140, R01CA126642]; NATIONAL CANCER INSTITUTE [P01CA080124, R01CA085140, R01CA126642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants P01CA80124, R01CA085140 and R01CA126642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; de Freitas PS, 2006, J BIOMED MATER RES B, V78B, P347, DOI 10.1002/jbm.b.30494; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; EAVES G, 1973, J PATHOL, V109, P233, DOI 10.1002/path.1711090308; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GARTNER MFRM, 1992, BRIT J CANCER, V65, P487, DOI 10.1038/bjc.1992.101; Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364; Guiot C, 2003, J THEOR BIOL, V225, P147, DOI 10.1016/S0022-5193(03)00221-2; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Haykal J, 2008, RADIOTHER ONCOL, V86, P412, DOI 10.1016/j.radonc.2007.10.013; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Martin M, 2003, J NATL CANCER I, V95, P704, DOI 10.1093/jnci/95.10.704; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Retsky M, 2004, J THEOR BIOL, V229, P289, DOI 10.1016/j.jtbi.2004.04.008; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; VAAGE J, 1992, INT J CANCER, V51, P325, DOI 10.1002/ijc.2910510225; YOUNG JS, 1959, J PATHOL BACTERIOL, V77, P321, DOI 10.1002/path.1700770203; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	27	293	297	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4632	10.1371/journal.pone.0004632	http://dx.doi.org/10.1371/journal.pone.0004632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247489	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487800014
J	Nekhoroshkova, E; Albert, S; Becker, M; Rapp, UR				Nekhoroshkova, Elena; Albert, Stefan; Becker, Matthias; Rapp, Ulf R.			A-RAF Kinase Functions in ARF6 Regulated Endocytic Membrane Traffic	PLOS ONE			English	Article								Background: RAF kinases direct ERK MAPK signaling to distinct subcellular compartments in response to growth factor stimulation. Methodology/Principal Findings: Of the three mammalian isoforms A-RAF is special in that one of its two lipid binding domains mediates a unique pattern of membrane localization. Specific membrane binding is retained by an N-terminal fragment (AR149) that corresponds to a naturally occurring splice variant termed DA-RAF2. AR149 colocalizes with ARF6 on tubular endosomes and has a dominant negative effect on endocytic trafficking. Moreover actin polymerization of yeast and mammalian cells is abolished. AR149/DA-RAF2 does not affect the internalization step of endocytosis, but trafficking to the recycling compartment. Conclusions/Significance: A-RAF induced ERK activation is required for this step by activating ARF6, as A-RAF depletion or inhibition of the A-RAF controlled MEK-ERK cascade blocks recycling. These data led to a new model for A-RAF function in endocytic trafficking.	[Nekhoroshkova, Elena; Albert, Stefan; Becker, Matthias; Rapp, Ulf R.] Univ Wurzburg, Inst MSZ, Wurzburg, Germany	University of Wurzburg	Nekhoroshkova, E (corresponding author), Univ Wurzburg, Inst MSZ, Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de			DFG [RA-642/11-2, GRK1141/1, SFB 581, SFB 487]	DFG(German Research Foundation (DFG))	EN was supported by DFG grant RA-642/11-2, Deutsch-Franzosiches Graduierten kolleg GRK1141/1, SFB 581 Project B5 and SFB 487 Project C3. MB was supported by SFB 487 of the DFG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Guthrie C, 1991, GUIDE YEAST GENETICS; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Improta-Brears T, 1999, MOL CELL BIOCHEM, V198, P171, DOI 10.1023/A:1006981411691; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; JANSEN HW, 1984, NATURE, V307, P281, DOI 10.1038/307281a0; Johnson LM, 2005, BIOCHEMISTRY-US, V44, P3432, DOI 10.1021/bi0487692; Lambert AA, 2007, FEMS YEAST RES, V7, P782, DOI 10.1111/j.1567-1364.2007.00239.x; Lee JE, 1996, ONCOGENE, V12, P1669; Li M, 2006, CANCER RES, V66, P1583, DOI 10.1158/0008-5472.CAN-05-2424; Luckett JCA, 2000, CELL GROWTH DIFFER, V11, P163; MARK GE, 1984, SCIENCE, V224, P285, DOI 10.1126/science.6324342; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Matsuya S, 2005, J NEUROCHEM, V93, P674, DOI 10.1111/j.1471-4159.2005.03072.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Rapp UR, 2003, ADV ENZYME REGUL, V43, P183, DOI 10.1016/S0065-2571(03)00002-5; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; Smaczynska-de Rooij II, 2008, TRAFFIC, V9, P559, DOI 10.1111/j.1600-0854.2008.00708.x; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; van Drogen F, 2001, BIOL CELL, V93, P63, DOI 10.1016/S0248-4900(01)01123-6; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4647	10.1371/journal.pone.0004647	http://dx.doi.org/10.1371/journal.pone.0004647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247477	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487800027
J	Modinos, G; Ormel, J; Aleman, A				Modinos, Gemma; Ormel, Johan; Aleman, Andre			Activation of Anterior Insula during Self-Reflection	PLOS ONE			English	Article							PREFRONTAL ACTIVITY; CONSCIOUS EMOTION; SOCIAL COGNITION; NEURAL ACTIVITY; DEFAULT MODE; JUDGMENTS; BRAIN; REPRESENTATION; AWARENESS; FEELINGS	Background: Functional neuroimaging studies have suggested activation of midline frontoparietal brain regions to be at the core of self-related processes. However, although some studies reported involvement of the insula, little attention has been paid to this region as forming part of the "self''-network. Methodology/Principal Findings: Using functional magnetic resonance imaging (fMRI), we aimed at replicating and extending previous studies by scanning subjects whilst reflecting upon their own personal qualities as compared to those of an acquaintance. A third condition with statements about general knowledge was used to control for attention, semantic processing and decision making processes. The results showed a significant effect of task in brain activity, consistent with previous findings, by which both person conditions recruited a common set of medial prefrontal and posterior regions, yet significant differences between self and other were found in the medial prefrontal cortex (MPFC) and the anterior cingulate cortex (ACC). Notably, significant neural activation in the left anterior insula was observed as uniquely associated with self-reflection. Conclusions/Significance: The results provide further evidence for the specific recruitment of anterior MPFC and ACC regions for self-related processing, and highlight a role for the insula in self-reflection. As the insula is closely connected with ascending internal body signals, this may indicate that the accumulation of changes in affective states that might be implied in self-processing may contribute to our sense of self.	[Modinos, Gemma; Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, ICPE, Dept Psychiat, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen	Modinos, G (corresponding author), Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.	g.modinos@med.umcg.nl	Modinos, Gemma/AAD-6448-2022; Aleman, Andre/E-1341-2012; ormel, johan/AAC-5584-2019; Ormel, Johan/C-6094-2013	Modinos, Gemma/0000-0002-7870-066X; ormel, johan/0000-0002-5463-037X; 	European Science Foundation EURYI [044035001]	European Science Foundation EURYI(European Science Foundation (ESF))	This work was supported by European Science Foundation EURYI grant (NWO number: 044035001) awarded to AA. The funding source had no further role in the study and preparation of the manuscript.	Aleman A, 2005, TRENDS COGN SCI, V9, P553, DOI 10.1016/j.tics.2005.10.002; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Cannon TD, 1998, ORIGINS AND DEVELOPMENT OF SCHIZOPHRENIA, P67, DOI 10.1037/10305-003; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio A, 2003, NATURE, V423, P227, DOI 10.1038/423227a; DAVID AS, 1990, BRIT J PSYCHIAT, V156, P798, DOI 10.1192/bjp.156.6.798; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fink GR, 1996, J NEUROSCI, V16, P4275; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Flashman Laura A, 2002, Curr Psychiatry Rep, V4, P346, DOI 10.1007/s11920-002-0082-x; Fossati P, 2004, NEUROIMAGE, V22, P1596, DOI 10.1016/j.neuroimage.2004.03.034; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Frijda N.H.., 1986, REV PHILOS LOUVAIN; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gray MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000546; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Heinzel A, 2006, SOC NEUROSCI, V1, P41, DOI 10.1080/17470910600663137; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Lindner M, 2008, NEUROIMAGE, V40, P963, DOI 10.1016/j.neuroimage.2007.12.022; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2009, HUM BRAIN MAPP, V30, P369, DOI 10.1002/hbm.20510; Oatley K., 1996, UNDERSTANDING EMOTIO; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7	62	123	124	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4618	10.1371/journal.pone.0004618	http://dx.doi.org/10.1371/journal.pone.0004618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KX	19242539	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500019
J	Agnew, DJ; Pearce, J; Pramod, G; Peatman, T; Watson, R; Beddington, JR; Pitcher, TJ				Agnew, David J.; Pearce, John; Pramod, Ganapathiraju; Peatman, Tom; Watson, Reg; Beddington, John R.; Pitcher, Tony J.			Estimating the Worldwide Extent of Illegal Fishing	PLOS ONE			English	Article							MARINE ECOSYSTEMS; CATCH; FISHERIES	Illegal and unreported fishing contributes to overexploitation of fish stocks and is a hindrance to the recovery of fish populations and ecosystems. This study is the first to undertake a world-wide analysis of illegal and unreported fishing. Reviewing the situation in 54 countries and on the high seas, we estimate that lower and upper estimates of the total value of current illegal and unreported fishing losses worldwide are between $10 bn and $23.5 bn annually, representing between 11 and 26 million tonnes. Our data are of sufficient resolution to detect regional differences in the level and trend of illegal fishing over the last 20 years, and we can report a significant correlation between governance and the level of illegal fishing. Developing countries are most at risk from illegal fishing, with total estimated catches in West Africa being 40% higher than reported catches. Such levels of exploitation severely hamper the sustainable management of marine ecosystems. Although there have been some successes in reducing the level of illegal fishing in some areas, these developments are relatively recent and follow growing international focus on the problem. This paper provides the baseline against which successful action to curb illegal fishing can be judged.	[Agnew, David J.; Beddington, John R.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Pearce, John; Peatman, Tom] MRAG Ltd, London, England; [Pramod, Ganapathiraju; Watson, Reg; Pitcher, Tony J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Beddington, John R.] United Kingdom Govt Off Sci, London, England	Imperial College London; University of British Columbia	Agnew, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England.	d.agnew@imperial.ac.uk	Watson, Reg A/F-4850-2012; Pramod, Ganapathiraju/AAI-5018-2020	Watson, Reg A/0000-0001-7201-8865; Ganapathiraju, Pramod/0000-0001-8126-3432	UK Department for Environment, Food and Rural Affairs; UK Department for International Development; Pew Charitable Trusts	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); UK Department for International Development; Pew Charitable Trusts	This work was supported by the UK Department for Environment, Food and Rural Affairs and the UK Department for International Development. The Sea Around Us project is supported by the Pew Charitable Trusts. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Agnew DJ, 2000, MAR POLICY, V24, P361, DOI 10.1016/S0308-597X(00)00012-9; Agnew DJ, 2005, CCAMLR SCI, V12, P119; Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Ainsworth CH, 2005, FISH RES, V75, P40, DOI 10.1016/j.fishres.2005.05.003; ANGANUZZI A, 2001, FISH PIRACY COMBATIN, P147; [Anonymous], 1995, COD COND RESP FISH; [Anonymous], RES PUBLIC POLICY SE; [Anonymous], BACKGROUND PAPER 200; Bailey M, 2008, MAR POLICY, V32, P483, DOI 10.1016/j.marpol.2007.09.010; Barnes CT, 2004, FISH PIRACY COMBATIN; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Benavente-Villena A.B., 2004, TURBULENT SEAS STATU; Bernal PA, 1999, OCEAN COAST MANAGE, V42, P119, DOI 10.1016/S0964-5691(98)00049-0; Birkun A, 2002, CETACEANS MEDITERRAN; BRACK D, 2006, ILLEGAL LOGGING; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Bray K., 2000, AUSIUU20006 FAO; BUDDYR M, 2002, FISHERIES CTR RES RE, V93, P191; Butcher John., 2004, CLOSING FRONTIER HIS; Butcher John G., 2002, INT J MARITIME HIST, V14, P85; *CEDEPESCA, 2003, 9 CEDEPESCA; CHIMANOVICH M, 2001, ZONA MARITIME; CLARKE S, 2008, ILLEGAL FISHING EXCL; *COMM EUR COMM, 2007, EST COMM SYST PREV D; *DAFF, 2005, EFF EXP CONTR ILL HA; ESMARK M, 2004, 42004 WWF; Falaye A. E., 2008, ILLEGAL UNREPORTED U; *FAO, 2006, REP FAO CECAF WORK G; FAO, 2006, STAT WORLD FISH AQ; FAO, 1997, FAO TECHN GUID RESP; *FAO, 2007, COMM 2005 YB FISH ST, V101; FLEWWELING P, 2006, 188 FAO, P168; FLEWWELLING P, 2001, C6 FAO; Gianni Matthew, 2005, CHANGING NATURE HIGH; GUENETTE S, 2001, FISHERIES CTR RES 3, V9, P206; HARIRI KI, STATUS LIVING MARINE; *HIGH SEAS TASK FO, 2006, CLOS ART STOPP ILL F; HOMELAND G, 2004, RUSSIAN FISHERY MANA; ICCAT, 2008, REP STAND COMM RES S; JOSEPH I, 1999, CASE STUDIES MANAGEM, P339; KALENTCHENKO M, 2005, ANAL ILLEGAL FISHER; KALIKOSKI D, 2008, ASSESSING ILLEGAL UN; Kelleher K., 2002, PLANNING COST EFFECT; Kraay Aart, 2007, 4280 WORLD BANK POLI; KUO CL, 2001, AQUACULTURE FISHERIE, P211; LONG R, 2002, INT J MARINE COASTAL, V17, P235; Marine Resources Assessment Group Ltd (MRAG), 2005, IUU FISH HIGH SEAS I; MATISHOV G, 2004, BARENTS SEAS GIWA RE; Melnychuk M., 2001, FISHERIES CTR RES RE, P221; Mendo J., 1987, PERUVIAN ANCHOVETA I, P109; Montes HML, 2008, FRONT ECOL ENVIRON, V6, P75, DOI 10.1890/070056; MORATO T, 2002, FISHERIES CTR RES RE, V9, P214; MORATO T, 2004, FISHERIES CTR RES RE, V125; Morgan G., 2006, FAO FISH TECH PAP, V488, P337; MRAG, 2005, REV IMP ILL UNR UNR; *MRAG CAPFISH, 2008, STUD AN STAT ICU FIS, V2; Nurhakim S., 2008, STUDY ILLEGAL UNREPO; Nurhakim S., 2008, STUDY ILLEGAL UNREPO, P41; Palma M. A., 2008, CASE STUDY IMPACTS I; PATTERSON KR, 1993, FISH RES, V18, P199, DOI 10.1016/0165-7836(93)90153-X; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PE M, 2004, NATL REPORT MYAMMAR; PEARSE MI, 1979, NMES FOREIGN FISH LE; Pitcher T., 2008, EVALUATION PROGR IMP; PITCHER TJ, 2008, SAFE CONDUCT; PITCHER TJ, 2006, FISHERIES CTR RES RE, V14; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; PRAMOD G, 2008, FISH CTR RES REPORTS, V16, P247; RAJAN PT, 2003, FIELD GUID MARINE FO; Restrepo V., 2004, FISH PIRACY COMBATIN, P155; *SCI COMM CONS ANT, 2007, REP 26 M SCI COMM; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; TAGHAVI SA, 1999, GCPINT643XOR FAO; Tesfamichael D, 2007, AFR J MAR SCI, V29, P55, DOI 10.2989/AJMS.2007.29.1.5.70; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; TUDELA S, 2001, GFCM STUDIES REV, V74; VAISMAN A, 2001, TRAWLING MIST IND FI; VARKEY DA, 2008, ASSESSING ILLEGAL UN, P120; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; WATSON R, 2004, NATURE, V44, P534; WEIDNER DM, 1993, WORLD FISHING FLEETS, V4; WILLONGHBY N, 1997, REG WORKSH PREC APPR; *WWF, 2008, ILL FISH ARCT WAT; *WWF, 2007, MIDT REV EC COMM FIS; ZULETA A, 2004, 700 FAO; [No title captured]	86	549	560	4	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4570	10.1371/journal.pone.0004570	http://dx.doi.org/10.1371/journal.pone.0004570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240812	Green Published, gold			2022-12-25	WOS:000278086700003
J	Kim, JY; Kajino-Sakamoto, R; Omori, E; Jobin, C; Ninomiya-Tsuji, J				Kim, Jae-Young; Kajino-Sakamoto, Rie; Omori, Emily; Jobin, Christian; Ninomiya-Tsuji, Jun			Intestinal Epithelial-Derived TAK1 Signaling Is Essential for Cytoprotection against Chemical-Induced Colitis	PLOS ONE			English	Article								Background: We have previously reported that intestinal epithelium-specific TAK1 deleted mice exhibit severe inflammation and mortality at postnatal day 1 due to TNF-induced epithelial cell death. Although deletion of TNF receptor 1 (TNFR1) can largely rescue those neonatal phenotypes, mice harboring double deletion of TNF receptor 1 (TNFR1) and intestinal epithelium-specific deletion of TAK1 (TNFR1KO/TAK1(IE)KO) still occasionally show increased inflammation. This indicates that TAK1 is important for TNF-independent regulation of intestinal integrity. Methodology/Principal Findings: In this study, we investigated the TNF-independent role of TAK1 in the intestinal epithelium. Because the inflammatory conditions were sporadically developed in the double mutant TNFR1KO/TAK1(IE)KO mice, we hypothesize that epithelial TAK1 signaling is important for preventing stress-induced barrier dysfunction. To test this hypothesis, the TNFR1KO/TAK1(IE)KO mice were subjected to acute colitis by administration of dextran sulfate sodium (DSS). We found that loss of TAK1 significantly augments DSS-induced experimental colitis. DSS induced weight loss, intestinal damages and inflammatory markers in TNFR1KO/TAK1(IE)KO mice at higher levels compared to the TNFR1KO control mice. Apoptosis was strongly induced and epithelial cell proliferation was decreased in the TAK1-deficient intestinal epithelium upon DSS exposure. These suggest that epithelial-derived TAK1 signaling is important for cytoprotection and repair against injury. Finally, we showed that TAK1 is essential for interleukin 1- and bacterial components-induced expression of cytoprotective factors such as interleukin 6 and cycloxygenase 2. Conclusions: Homeostatic cytokines and microbes-induced intestinal epithelial TAK1 signaling regulates cytoprotective factors and cell proliferation, which is pivotal for protecting the intestinal epithelium against injury.	[Kim, Jae-Young; Kajino-Sakamoto, Rie; Omori, Emily; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Jobin, Christian] Univ N Carolina, Ctr Gastrointest Biol & Dis, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kim, JY (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu		Kim, Jae-Young/0000-0001-6700-1372; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	Crohn's and Colitis Foundation of America; National Institutes of Health [GM068812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812, R01GM084406] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Crohn's and Colitis Foundation of America and from National Institutes of Health (GM068812) to J. N-T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; HALL PA, 1994, J CELL SCI, V107, P3569; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Inan MS, 2000, AM J PHYSIOL-GASTR L, V279, pG1282, DOI 10.1152/ajpgi.2000.279.6.G1282; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Karrasch T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000596; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Menard S, 2008, J EXP MED, V205, P183, DOI 10.1084/jem.20071022; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Seitz CS, 2000, CANCER RES, V60, P4085; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810	38	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4561	10.1371/journal.pone.0004561	http://dx.doi.org/10.1371/journal.pone.0004561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234607	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487200015
J	Li, YZ; Wray, R; Eaton, C; Blount, P				Li, Yuezhou; Wray, Robin; Eaton, Christina; Blount, Paul			An open-pore structure of the mechanosensitive channel MscL derived by determining transmembrane domain interactions upon gating	FASEB JOURNAL			English	Article						electrostatic repulsion; mechanosensation; MTS reagents; disulfide trapping; osmotic regulation	MECHANISM; TENSION; PROTEIN	Mechanosensation, the ability to detect mechanical forces, underlies the senses of hearing, balance, touch, and pain, as well as renal and cardiovascular regulation. Although the sensors are thought to be channels, relatively little is known about eukaryotic mechanosensitive channels or their molecular mechanisms. Thus, because of its tractable nature, a bacterial mechanosensitive channel that serves as an in vivo osmotic "emergency release valve," MscL, has become a paradigm of how a mechanosensitive channel can sense and respond to membrane tension. Here, we have determined the structural rearrangements and interactions between transmembrane domains of MscL that occur upon gating. We utilize an electrostatic repulsion test: If two residues approach upon gating we predicted that substituting like-charges at those sites would inhibit gating. The in vivo growth and viability and in vitro vesicular flux and electrophysiological data all support the hypothesis that residues G26 and I92 directly interact upon gating. The resulting model predicted other interacting residues. One of these sets, V23 and I96, was confirmed to truly interact upon gating by disulfide trapping as well as the electrostatic repulsion test. Together, the data strongly suggest a model for structural transitions and residue-residue proximities that occur upon MscL gating.-Li, Y., Wray, R., Eaton, C., Blount, P. An open-pore structure of the mechanosensitive channel MscL derived by determining transmembrane domain interactions upon gating. FASEB J. 23, 2197-2204 (2009)	[Li, Yuezhou; Wray, Robin; Eaton, Christina; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	paul.blount@utsouthwestern.edu			Welch Foundation [I-1420]; National Institutes of Health [GM61028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Adam Wallenfang for his technical support, Dr. Ian Booth for helpful discussions, and Drs. Irene Iscla, and Limin Yang for helpful discussions and critical reading of the manuscript. The work was supported by grant I-1420 from the Welch Foundation and grant GM61028 from the National Institutes of Health.	Bartlett JL, 2006, BIOPHYS J, V91, P3684, DOI 10.1529/biophysj.106.088062; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Batiza AF, 2002, P NATL ACAD SCI USA, V99, P5643, DOI 10.1073/pnas.082092599; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 2007, CURR TOP MEMBR, V58, P201, DOI 10.1016/S1063-5823(06)58008-1; Blount Paul, 2008, V1, P71; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Iscla I, 2004, BIOPHYS J, V87, P3172, DOI 10.1529/biophysj.104.049833; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; Levin G, 2004, BIOPHYS J, V86, P2862, DOI 10.1016/S0006-3495(04)74338-6; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li YZ, 2004, MOL MICROBIOL, V53, P485, DOI 10.1111/j.1365-2958.2004.04150.x; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	25	23	24	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2197	2204		10.1096/fj.09-129296	http://dx.doi.org/10.1096/fj.09-129296			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19261722	Green Published			2022-12-25	WOS:000268836500019
J	Oh, JE; Bae, GU; Yang, YJ; Yi, MJ; Lee, HJ; Kim, BG; Krauss, RS; Kang, JS				Oh, Ji-Eun; Bae, Gyu-Un; Yang, Youn-Joo; Yi, Min-Jeong; Lee, Hye-Jin; Kim, Bok-Geon; Krauss, Robert S.; Kang, Jong-Sun			Cdo promotes neuronal differentiation via activation of the p38 mitogen-activated protein kinase pathway	FASEB JOURNAL			English	Article						Cdc42; myogenic differentiation; tissue-specific basic helix-loop-helix transcription factors; Bnip-2; JLP; neurogenin1	EMBRYONAL CARCINOMA-CELLS; NEURITE OUTGROWTH; PC12 CELLS; MYOGENIC DIFFERENTIATION; P38-ALPHA/BETA MAPK; SURFACE PROTEIN; BHLH FACTORS; N-CADHERIN; EXPRESSION; CDC42	Neural basic helix-loop-helix transcription factors (bHLHs) control many aspects of neurogenesis, such as proliferation, fate determination, and differentiation. We have previously shown that the promyogenic cell surface receptor Cdo modulates the Cdc42 and p38 mitogen-activated protein kinase ( MAPK) pathways via a direct association with two scaffold-type proteins, JLP and Bnip-2, to regulate activities of myogenic bHLH factors and myogenic differentiation. We report here that Cdo uses similar regulatory mechanisms to promote neuronal differentiation. Expression of JLP, a scaffold protein for p38MAPK, and Bnip-2, a regulator of Cdc42, is increased during differentiation of C17.2 neural precursor cells and P19 embryonal carcinoma cells. These molecules regulate Cdc42 and p38MAPK activities, which increase in a Cdo-dependent manner during neuronal differentiation of C17.2 cells and retinoic acid-treated P19 cells. Furthermore, enhancement or reduction of Cdc42 and p38MAPK activities enhances or reduces, respectively, neuronal differentiation of these cell lines. Cdc42 and p38MAPK activities also promote heterodimerization of neurogenin1 and E47, suggesting that one way they promote neurogenesis is via regulation of neural bHLH factor activities. These results imply that a conserved intracellular signaling mechanism initiated by Cdo regulates the activities of tissue-specific bHLH factors and therefore functions as a key regulator of differentiation of several different cell lineages.-Oh, J.-E., Bae, G.-U., Yang, Y.-J., Yi, M.-J., Lee, H.-J., Kim, B.-G., Krauss, R. S., Kang, J.-S. Cdo promotes neuronal differentiation via activation of the p38 mitogen-activated protein kinase pathway. FASEB J. 23, 2088-2099 (2009)	[Oh, Ji-Eun; Bae, Gyu-Un; Yang, Youn-Joo; Yi, Min-Jeong; Lee, Hye-Jin; Kim, Bok-Geon; Kang, Jong-Sun] Sungkyunkwan Univ, Dept Mol Cell Biol, Samsung Biomed Res Inst, Sch Med, Suwon 440746, South Korea; [Bae, Gyu-Un; Krauss, Robert S.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA	Sungkyunkwan University (SKKU); Icahn School of Medicine at Mount Sinai	Kang, JS (corresponding author), Sungkyunkwan Univ, Dept Mol Cell Biol, Samsung Biomed Res Inst, Sch Med, Suwon 440746, South Korea.	jskang@med.skku.ac.kr			Korean government [KRF-2008-313-C00260]; U.S. National Institutes of Health [AR46207]; March of Dimes; T.J. Martell Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046207] Funding Source: NIH RePORTER	Korean government(Korean Government); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); T.J. Martell Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. Ruth Simon and Domenico Totorella for critical reading of the manuscript and Andrew Chan (Mount Sinai School of Medicine, New York, NY, USA) for the Cdc42V12 expression vector. This work was supported by a Korea Research Foundation grant funded by the Korean government (KRF-2008-313-C00260) to J.S.K. and by grants from the U.S. National Institutes of Health (AR46207), the March of Dimes, and the T.J. Martell Foundation to R. S. K.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; BAIN G, 1994, BIOCHEM BIOPH RES CO, V200, P1252, DOI 10.1006/bbrc.1994.1585; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Faigle R, 2004, MOL CELL BIOL, V24, P280, DOI 10.1128/MCB.24.1.280-293.2004; Farah MH, 2000, DEVELOPMENT, V127, P693; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Iwasaki S, 1996, J BIOL CHEM, V271, P17360, DOI 10.1074/jbc.271.29.17360; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones NM, 2004, J NEUROCHEM, V89, P157, DOI 10.1111/j.1471-4159.2004.02324.x; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Mulieri PJ, 2000, DEV DYNAM, V219, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1032>3.0.CO;2-M; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Yanagisawa M, 2001, GENES CELLS, V6, P1091, DOI 10.1046/j.1365-2443.2001.00483.x; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	39	38	43	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2088	2099		10.1096/fj.08-119255	http://dx.doi.org/10.1096/fj.08-119255			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19244314	Green Published			2022-12-25	WOS:000268836500009
J	Wu, YW; Goody, RS; Abagyan, R; Alexandrov, K				Wu, Yao-Wen; Goody, Roger S.; Abagyan, Ruben; Alexandrov, Kirill			Structure of the Disordered C Terminus of Rab7 GTPase Induced by Binding to the Rab Geranylgeranyl Transferase Catalytic Complex Reveals the Mechanism of Rab Prenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; AB-INITIO PREDICTION; ESCORT PROTEIN; CONFORMATIONAL SEARCHES; PEPTIDES; FARNESYLTRANSFERASE; EVOLUTION; RABGGTASE; INSIGHTS; DOCKING	Protein prenylation is a widespread process that involves the transfer of either a farnesyl or a geranylgeranyl moiety to one or more C-terminal cysteines of the target protein. Rab geranylgeranyl transferase (RabGGTase) is responsible for the largest number of individual protein prenylation events in the cell. A decade-long effort to crystallize the catalytic ternary complex of RabGGTase has remained fruitless, prompting us to use a computational approach to predict the structure of this 200-kDa assembly. On the basis of high resolution structures of two sub-complexes, we have generated a composite model where the rigid parts of the protein are represented by precomputed grid potentials, whereas the mobile parts are described in atomic details using Internal Coordinate Mechanics. Selection of the best docking solution of the flexible parts on the grid is followed by explicit atomistic refinement of the lowest energy conformations enabling realistic modeling of complex structures. Using this approach we demonstrate that the flexible C terminus of Rab7 substrate forms a series of progressively weaker and less specific interactions that channel it into the active site of RabGGTase. We have validated the computational model through biochemical experiments and demonstrated that to be prenylated RabGTPase must possess at least nine amino acids between the prenylation motif and the hydrophobic sequence anchoring the beginning of the Rab C terminus on the enzyme. This sequence, known as the C-terminal interacting motif is shown to play a dual role in Rab prenylation by contributing a significant fraction of binding energy to the catalytic complex assembly and by orienting the C terminus of RabGTPase in the vicinity of the active site of RabGGTase. This mechanism is unique to RabGGTase when compared with other prenyltransferases, which encode the specificity for their cognate substrates directly at their active site.	[Abagyan, Ruben] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wu, Yao-Wen; Goody, Roger S.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Alexandrov, Kirill] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia	Scripps Research Institute; Max Planck Society; University of Queensland; University of Queensland	Abagyan, R (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	abagyan@scripps.edu; k.alexandrov@imb.uq.edu.au	Wu, Yaowen/N-9802-2015; Goody, Roger S/J-8845-2014; Alexandrov, Kirill/A-5830-2013	Wu, Yaowen/0000-0002-2573-8736; Goody, Roger S/0000-0002-0772-0444; Alexandrov, Kirill/0000-0002-0957-6511	Deutsche Forschungsgemeinschaft [AL 484/7-2, SFB 642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AL 484/7-2 (to K. A.) and SFB 642 (to K. A., R. S. G., and H. W.).	ABAGYAN R, 1992, J MOL BIOL, V225, P519, DOI 10.1016/0022-2836(92)90936-E; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alexandrov K, 1999, EUR J BIOCHEM, V265, P160, DOI 10.1046/j.1432-1327.1999.00699.x; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; Alory C, 2003, MOL BIOL CELL, V14, P3857, DOI 10.1091/mbc.E03-04-0227; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARMSTRONG SA, 1995, METHOD ENZYMOL, V257, P30; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; Lawson MA, 2008, BIOCHEM BIOPH RES CO, V377, P453, DOI 10.1016/j.bbrc.2008.09.157; Maurer-Stroh S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-212; Neu M, 1997, PROTEINS, V27, P204, DOI 10.1002/(SICI)1097-0134(199702)27:2<204::AID-PROT6>3.0.CO;2-F; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rak A, 2002, PROTEIN EXPRES PURIF, V25, P23, DOI 10.1006/prep.2001.1605; Roelofs AJ, 2006, INT J CANCER, V119, P1254, DOI 10.1002/ijc.21977; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; Szewczuk LM, 2007, J MED CHEM, V50, P5330, DOI 10.1021/jm0706463; Thoma NH, 2001, J BIOL CHEM, V276, P48631, DOI 10.1074/jbc.M106470200; TOTROV M, 1994, NAT STRUCT BIOL, V1, P259, DOI 10.1038/nsb0494-259; Totrov M, 1997, PROTEINS, P215; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2006, CHEMBIOCHEM, V7, P1859, DOI 10.1002/cbic.200600377; Yokoyama K, 1997, J BIOL CHEM, V272, P3944, DOI 10.1074/jbc.272.7.3944; Zhou YY, 1998, FOLD DES, V3, P513, DOI 10.1016/S1359-0278(98)00067-4	34	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13185	13192		10.1074/jbc.M900579200	http://dx.doi.org/10.1074/jbc.M900579200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19240028	Green Published, hybrid			2022-12-25	WOS:000265688300065
J	Zhang, YQ; Rosado, LAR; Moon, SY; Zhang, BL				Zhang, Yaqin; Rosado, Leslie A. Rivera; Moon, Sun Young; Zhang, Baolin			Silencing of D4-GDI Inhibits Growth and Invasive Behavior in MDA-MB-231 Cells by Activation of Rac-dependent p38 and JNK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GDP-DISSOCIATION INHIBITOR; N-TERMINAL KINASE; DRUG-INDUCED APOPTOSIS; GTP-BINDING PROTEINS; HUMAN LYMPHOMA-CELLS; RHO-GTPASES; EPITHELIAL-CELLS; GENE-EXPRESSION; OVARIAN-CARCINOMA	The Rho GDP dissociation inhibitor D4-GDI is overexpressed in some human breast cancer cell lines (Zhang, Y., and Zhang, B. (2006) Cancer Res. 66, 5592-5598). Here, we show that silencing of D4-GDI by RNA interference abrogates tumor growth and lung metastasis of otherwise highly invasive MDA-MB-231 breast cancer cells. Under anchorage-independent culture conditions, D4-GDI-depleted cells undergo rapid apoptosis (anoikis), which is known to hinder metastasis. We also found that D4-GDI associates with Rac1 and Rac3 in breast cancer cells, but not with other Rho GTPases tested (Cdc42, RhoA, RhoC, and TC10). Silencing of D4-GDI results in constitutive Rac1 activation and translocation from the cytosol to cellular membrane compartments and in sustained activation of p38 and JNK kinases. Rac1 blockade inhibits p38/JNK kinase activities and the spontaneous anoikis of D4-GDI knockdown cells. These results suggest that D4-GDI regulates cell function by interacting primarily with Rac GTPases and may play an integral role in breast cancer tumorigenesis. D4-GDI could prove to be a potential new target for therapeutic intervention.	[Zhang, Yaqin; Rosado, Leslie A. Rivera; Moon, Sun Young; Zhang, Baolin] US FDA, Ctr Drug Evaluat & Res, Off Biotechnol, Div Therapeut Prot, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Zhang, BL (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Biotechnol, Div Therapeut Prot, Bldg 29A,Rm 2A01,HFD-122,29 Lincoln Dr, Bethesda, MD 20892 USA.	Baolin.zhang@fda.hhs.gov						Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheng TL, 2004, EXP CELL RES, V295, P497, DOI 10.1016/j.yexcr.2004.02.002; Coniglio SJ, 2001, J BIOL CHEM, V276, P28113, DOI 10.1074/jbc.M102299200; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dransart E, 2005, J BIOL CHEM, V280, P4674, DOI 10.1074/jbc.M409741200; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Embade N, 2000, MOL BIOL CELL, V11, P4347, DOI 10.1091/mbc.11.12.4347; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gildea JJ, 2002, CANCER RES, V62, P6418; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hu LD, 2007, ONCOL REP, V17, P1383; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kallergi G, 2007, CELL PHYSIOL BIOCHEM, V20, P977, DOI 10.1159/000110458; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Ma L, 2007, BRIT J HAEMATOL, V139, P217, DOI 10.1111/j.1365-2141.2007.06782.x; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ota T, 2004, MOL CARCINOGEN, V39, P206, DOI 10.1002/mc.20006; Ota T, 2006, CLIN EXP METASTAS, V23, P323, DOI 10.1007/s10585-006-9041-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Schunke D, 2007, CANCER RES, V67, P10694, DOI 10.1158/0008-5472.CAN-07-1621; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Tapper J, 2001, CANCER GENET CYTOGEN, V128, P1, DOI 10.1016/S0165-4608(01)00386-7; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Thorat MA, 2007, LANCET, V369, P1428, DOI 10.1016/S0140-6736(07)60663-1; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; van Golen KL, 2000, CANCER RES, V60, P5832; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Zhang BL, 2006, DRUG RESIST UPDATE, V9, P134, DOI 10.1016/j.drup.2006.06.001; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhang BL, 2003, MOL CELL BIOL, V23, P5716, DOI 10.1128/MCB.23.16.5716-5725.2003; Zhang YQ, 2006, CANCER RES, V66, P5592, DOI 10.1158/0008-5472.CAN-05-4004; Zhu ZY, 2001, CANCER RES, V61, P1707; Zugasti O, 2001, MOL CELL BIOL, V21, P6706, DOI 10.1128/MCB.21.19.6706-6717.2001; Zuo YF, 2006, BIOCHEM BIOPH RES CO, V351, P361, DOI 10.1016/j.bbrc.2006.10.043	60	48	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12956	12965		10.1074/jbc.M807845200	http://dx.doi.org/10.1074/jbc.M807845200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269969	Green Published, hybrid			2022-12-25	WOS:000265688300042
J	Lin, HM; Lee, JH; Yadav, H; Kamaraju, AK; Liu, E; Duan, ZG; Vieira, A; Kim, SJ; Collins, H; Matschinsky, F; Harlan, DM; Roberts, AB; Rane, SG				Lin, Huei-Min; Lee, Ji-Hyeon; Yadav, Hariom; Kamaraju, Anil K.; Liu, Eric; Duan Zhigang; Vieira, Anthony; Kim, Seong-Jin; Collins, Heather; Matschinsky, Franz; Harlan, David M.; Roberts, Anita B.; Rane, Sushil G.			Transforming Growth Factor-beta/Smad3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet beta-Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD BINDING-ELEMENT; TGF-BETA; TARGETED DISRUPTION; EXOCRINE PANCREAS; RECEPTOR; SECRETION; PROMOTER; REPRESSION; EXPRESSION; ACTIVIN	Pancreatic islet beta-cell dysfunction is a signature feature of Type 2 diabetes pathogenesis. Consequently, knowledge of signals that regulate beta-cell function is of immense clinical relevance. Transforming growth factor (TGF)-beta signaling plays a critical role in pancreatic development although the role of this pathway in the adult pancreas is obscure. Here, we define an important role of the TGF-beta pathway in regulation of insulin gene transcription and beta-cell function. We identify insulin as a TGF-beta target gene and show that the TGF-beta signaling effector Smad3 occupies the insulin gene promoter and represses insulin gene transcription. In contrast, Smad3 small interfering RNAs relieve insulin transcriptional repression and enhance insulin levels. Transduction of adenoviral Smad3 into primary human and non-human primate islets suppresses insulin content, whereas, dominant-negative Smad3 enhances insulin levels. Consistent with this, Smad3-deficient mice exhibit moderate hyperinsulinemia and mild hypoglycemia. Moreover, Smad3 deficiency results in improved glucose tolerance and enhanced glucose-stimulated insulin secretion in vivo. In ex vivo perifusion assays, Smad3-deficient islets exhibit improved glucose-stimulated insulin release. Interestingly, Smad3-deficient islets harbor an activated insulin-receptor signaling pathway and TGF-beta signaling regulates expression of genes involved in beta-cell function. Together, these studies emphasize TGF-beta/Smad3 signaling as an important regulator of insulin gene transcription and beta-cell function and suggest that components of the TGF-beta signaling pathway may be dysregulated in diabetes.	[Lin, Huei-Min; Lee, Ji-Hyeon; Yadav, Hariom; Kamaraju, Anil K.; Liu, Eric; Duan Zhigang; Harlan, David M.; Rane, Sushil G.] NIDDK, Diabet Branch, Bethesda, MD 20892 USA; [Vieira, Anthony; Roberts, Anita B.] NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; [Kim, Seong-Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Songdo 406840, Incheon, South Korea; [Collins, Heather; Matschinsky, Franz] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gachon University; University of Pennsylvania	Rane, SG (corresponding author), CRC, 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Yadav, Hariom/I-2455-2018	Yadav, Hariom/0000-0003-4504-1597	National Institutes of Health Intramural Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055105, ZIADK062002, Z01DK062002, Z01DK055106] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program.	Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Bindra RS, 2006, CANCER BIOL THER, V5, P1400, DOI 10.4161/cbt.5.10.3454; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Campbell SC, 1999, FEBS LETT, V463, P53, DOI 10.1016/S0014-5793(99)01584-7; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; COLLINS H, 1992, J BIOL CHEM, V267, P1357; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gannon M, 2007, CELL METAB, V5, P157, DOI 10.1016/j.cmet.2007.02.003; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Hirshberg B, 2003, DIABETES CARE, V26, P3288, DOI 10.2337/diacare.26.12.3288; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; LEE MS, 1995, AM J PATHOL, V147, P42; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Rane SG, 2006, CYTOKINE GROWTH F R, V17, P107, DOI 10.1016/j.cytogfr.2005.09.003; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; SEKINE N, 1994, DIABETES RES CLIN PR, V26, P7, DOI 10.1016/0168-8227(94)90133-3; SJOHOLM A, 1991, AM J PHYSIOL, V260, pC1046, DOI 10.1152/ajpcell.1991.260.5.C1046; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Tulachan SS, 2007, DEV BIOL, V305, P508, DOI 10.1016/j.ydbio.2007.02.033; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; YAMANAKA Y, 1993, DIABETES, V42, P746, DOI 10.2337/diabetes.42.5.746; Yamaoka T, 1998, J CLIN INVEST, V102, P294, DOI 10.1172/JCI2769; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang YQ, 2004, DIABETES, V53, P2024, DOI 10.2337/diabetes.53.8.2024	54	115	129	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12246	12257		10.1074/jbc.M805379200	http://dx.doi.org/10.1074/jbc.M805379200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265200	hybrid, Green Published			2022-12-25	WOS:000265494600056
J	McCourt, PC; Morgan, JM; Nickels, JT				McCourt, Paula C.; Morgan, Jeanelle M.; Nickels, Joseph T., Jr.			Stress-induced Ceramide-activated Protein Phosphatase Can Compensate for Loss of Amphiphysin-like Activity In Saccharomyces cerevisiae and Functions to Reinitiate Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-FACTOR RECEPTOR; ADENOVIRUS E4ORF4 PROTEIN; HIGH-CURVATURE MEMBRANES; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; YEAST RVS161; CELL-CYCLE; SPHINGOLIPID FUNCTIONS; SIGNAL-TRANSDUCTION; REGULATORY SUBUNIT	Saccharomyces cerevisiae cells lacking the amphiphysin-like orthologs, Rvs161 or Rvs167, are unable to thrive under many stress conditions. Here we show cells lacking Rvs161 require Cdc55, the B subunit of the yeast ceramide-activated protein phosphatase, for viability under heat stress. By using specific rvs mutant alleles, we linked this lethal genetic interaction to loss of Rvs161 endocytic domain function. Recessive mutations in the sphingolipid pathway, such as deletion of the very long-chain fatty acid elongase, Sur4, suppress the osmotic growth defect of rvs161 cells. We demonstrate that Cdc55 is required for sur4-dependent suppressor activity and that protein phosphatase activation, through overexpression of CDC55 alone, can also remediate this defect. Loss of SUR4 in rvs161 cells reinitiates Ste3 a-factor receptor endocytosis and requires Cdc55 function to do so. Moreover, overexpression of CDC55 reinitiates Ste3 endocytic-dependent degradation and restores fluid phase endocytosis in rvs161 cells. In contrast, loss of SUR4 or CDC55 overexpression does not remediate the actin polarization defects of osmotic stressed rvs161 cells. Importantly, remediation of rvs161 defects by protein phosphatase activation requires the ceramide-activated protein phosphatase catalytic subunit, Sit4, and the protein phosphatase 2A catalytic subunits, Pph21/Pph22. Finally, genetic analyses reveal a synthetic lethal interaction between loss of CDC55 and gene deletions lethal with rvs161, all of which function in endocytosis.	[McCourt, Paula C.; Nickels, Joseph T., Jr.] Med Diagnost Labs LLC, Pharmacogenom Div, Hamilton, NJ 08690 USA; [McCourt, Paula C.; Morgan, Jeanelle M.; Nickels, Joseph T., Jr.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Nickels, JT (corresponding author), Med Diagnost Labs LLC, Pharmacogenom Div, 2439 Kuser Rd, Hamilton, NJ 08690 USA.	jnickels@mdlab.com			National Institutes of Health [HL67401]; Medical Diagnostics Laboratories, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Diagnostics Laboratories, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL67401. This work was also supported by Medical Diagnostics Laboratories, LLC.	ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729; ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Bastians H, 1996, J CELL SCI, V109, P2865; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; Breton AM, 2001, YEAST, V18, P1053, DOI 10.1002/yea.755; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Chalfant CE, 2000, METHOD ENZYMOL, V312, P420; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200; CROUZET M, 1991, YEAST, V7, P727, DOI 10.1002/yea.320070708; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DESFARGES L, 1993, YEAST, V9, P267, DOI 10.1002/yea.320090306; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; DURRENS P, 1995, CURR GENET, V27, P213, DOI 10.1007/BF00326151; Efendiev R, 2002, J BIOL CHEM, V277, P44108, DOI 10.1074/jbc.M205173200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Germann M, 2005, J BIOL CHEM, V280, P4270, DOI 10.1074/jbc.M412454200; Gurunathan S, 2002, MOL BIOL CELL, V13, P1594, DOI 10.1091/mbc.01-11-0541; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jangati GR, 2006, BIOCHEM BIOPH RES CO, V348, P649, DOI 10.1016/j.bbrc.2006.07.100; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2003, CELL MOL LIFE SCI, V60, P701, DOI 10.1007/s00018-003-2239-0; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Li YK, 2008, J VIROL, V82, P3612, DOI 10.1128/JVI.02435-07; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; LIU J, 1994, J BIOL CHEM, V269, P3047; Liu JB, 2005, BREAST CANCER RES TR, V94, P161, DOI 10.1007/s10549-005-6942-4; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Masserini M, 2001, BBA-MOL CELL BIOL L, V1532, P149, DOI 10.1016/S1388-1981(01)00128-7; Mott DM, 2008, AM J PHYSIOL-ENDOC M, V294, pE444, DOI 10.1152/ajpendo.00386.2007; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Naqvi SN, 1998, CURR BIOL, V8, P959, DOI 10.1016/S0960-9822(98)70396-3; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shu YM, 1997, MOL CELL BIOL, V17, P3242, DOI 10.1128/MCB.17.6.3242; Sivadon P, 1997, FEBS LETT, V417, P21, DOI 10.1016/S0014-5793(97)01248-9; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Skrzypek MS, 1998, J BIOL CHEM, V273, P2829, DOI 10.1074/jbc.273.5.2829; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; SNEDDON AA, 1990, EMBO J, V9, P4339, DOI 10.1002/j.1460-2075.1990.tb07883.x; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; VANZYL W, 1992, MOL CELL BIOL, V12, P4946, DOI 10.1128/MCB.12.11.4946; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	93	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11930	11941		10.1074/jbc.M900857200	http://dx.doi.org/10.1074/jbc.M900857200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254955	Green Published, hybrid			2022-12-25	WOS:000265494600025
J	Hozoji, M; Kimura, Y; Kioka, N; Ueda, K				Hozoji, Masako; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu			Formation of Two Intramolecular Disulfide Bonds Is Necessary for ApoA-I-dependent Cholesterol Efflux Mediated by ABCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER 1; STARGARDT-DISEASE; TANGIER-DISEASE; ALLELIC VARIATION; GENE; MUTATIONS; IDENTIFICATION; TOPOLOGY; RELEASE; CELLS	ABCA1 plays a major role in cholesterol homeostasis and high density lipoprotein (HDL) metabolism. ABCA1 contains disulfide bond(s) between its N- and C-terminal halves, but it remains unclear whether disulfide bond formation is important for the functions of ABCA1 and which cysteines are involved in disulfide bond formation. To answer these questions, we constructed >30 ABCA1 mutants in which 16 extracellular domain (ECD) cysteines were replaced with serines and examined disulfide bond formation, apoA-I binding, and HDL formation in these mutants. From the single cysteine replacements, two cysteines (Cys(75) and Cys(309)) in ECD1 were found to be essential for apoA-I binding. In contrast, in ECD2, only Cys(1477) was found to be essential for HDL formation, and no single cysteine replacement impaired apoA-I binding. The concurrent replacement of two cysteines, Cys(1463) and Cys(1465), impaired apoA-I binding and HDL formation, suggesting that four of five extracellular cysteines (Cys(75), Cys(309), Cys(1463), Cys(1465), and Cys(1477)) are involved in these functions of ABCA1. Trypsin digestion experiments suggested that one disulfide bond is not sufficient and that two intramolecular disulfide bonds (between Cys(75) and Cys(309) in ECD1 and either Cys(1463) or Cys(1465) and Cys(1477) in ECD2) are required for ABCA1 to be fully functional.	[Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068502, Japan; [Hozoji, Masako; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Cellular Biochem, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X; Kimura, Yasuhisa/0000-0001-6466-1324	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation; World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by the World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Denis M, 2004, J BIOL CHEM, V279, P41529, DOI 10.1074/jbc.M406881200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	25	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11293	11300		10.1074/jbc.M900580200	http://dx.doi.org/10.1074/jbc.M900580200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258317	Green Published, hybrid			2022-12-25	WOS:000265494500033
J	Kwong, J; Hong, LX; Liao, R; Deng, QD; Han, JH; Sun, PQ				Kwong, Jinny; Hong, Lixin; Liao, Rong; Deng, Qingdong; Han, Jiahuai; Sun, Peiqing			p38 alpha and p38 gamma Mediate Oncogenic ras-induced Senescence through Differential Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; P38 MAP-KINASES; PREMATURE SENESCENCE; GROWTH ARREST; ACTIVATION; P53; TRANSFORMATION; PATHWAYS; SUPPRESSION; FIBROBLASTS	Oncogene-induced senescence is a tumor-suppressive defense mechanism triggered upon activation of certain oncogenes in normal cells. Recently, the senescence response to oncogene activation has been shown to act as a bona fide barrier to cancer development in vivo. Multiple previous studies have implicated the importance of the p38 MAPK pathway in oncogene-induced senescence. However, the contribution of each of the four p38 isoforms (encoded by different genes) to senescence induction is unclear. In the current study, we demonstrated that p38 alpha and p38 gamma, but not p38 beta, play an essential role in oncogenic ras-induced senescence. Both p38 alpha and p38 gamma are expressed in primary human fibroblasts and are activated upon transduction of oncogenic ras. Small hairpin RNA-mediated silencing of p38 alpha or p38 gamma expression abrogated ras-induced senescence, whereas constitutive activation of p38 alpha and p38 gamma caused premature senescence. Furthermore, upon activation by oncogenic ras, p38 gamma stimulated the transcriptional activity of p53 by phosphorylating p53 at Ser33, suggesting that the ability of p38 gamma to mediate senescence is at least partly achieved through p53. However, p38 alpha contributed to ras-inducted senescence via a p53-indepdendent mechanism in cells by mediating ras-induced expression of p16(INK4A), another key senescence effector. These findings have identified p38 alpha and p38 gamma as essential components of the signaling pathway that regulates the tumor-suppressing senescence response, providing insights into the molecular mechanisms underlying the differential involvement of the p38 isoforms in senescence induction.	[Kwong, Jinny; Liao, Rong; Deng, Qingdong; Sun, Peiqing] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 91037 USA; [Kwong, Jinny; Sun, Peiqing] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 91037 USA; [Hong, Lixin; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China	Scripps Research Institute; Scripps Research Institute; Xiamen University	Sun, PQ (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-41,10550 N Torrey Pines Rd, La Jolla, CA 91037 USA.	pqsun@scripps.edu	Han, J/G-4671-2010		National Institutes of Health [CA106768]; NATIONAL CANCER INSTITUTE [R01CA106768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637, R01AI068896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Grant CA106768 from the National Institutes of Health (to P.S.). This is Scripps Manuscript 19841.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Haq R, 2002, CANCER RES, V62, P5076; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; RULEY HE, 1990, CANCER CELL-MON REV, V2, P258; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; WEINBERG RA, 1989, CANCER RES, V49, P3713; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	69	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11237	11246		10.1074/jbc.M808327200	http://dx.doi.org/10.1074/jbc.M808327200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251701	Green Published, hybrid			2022-12-25	WOS:000265494500027
J	Shelton, SN; Shawgo, ME; Robertson, JD				Shelton, Shary N.; Shawgo, Mary E.; Robertson, John D.			Cleavage of Bid by Executioner Caspases Mediates Feed Forward Amplification of Mitochondrial Outer Membrane Permeabilization during Genotoxic Stress-induced Apoptosis in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; DNA-DAMAGE RESPONSE; BCL-2 PROTEIN FAMILY; DEATH; ACTIVATION; BAK; PATHWAYS; DRUG; TRANSLOCATION; REQUIREMENT	The extent to which the BH3-only protein Bid is important for intrinsic (mitochondria-mediated) apoptotic cell death induced by genotoxic stress remains controversial. In the present study, we examine this issue using a panel of gene-manipulated Bax-deficient Jurkat T-lymphocytes. Cells stably depleted of Bid were far less sensitive than control-transfected cells to etoposide-induced apoptosis. In particular, drug-induced Bak activation, cytochrome c release, loss of mitochondrial membrane potential, and caspase activation were all decreased in cells lacking Bid. Reconstitution experiments using recombinant proteins and permeabilized Bid-deficient cells demonstrated that truncated Bid (tBid), but not full-length Bid, potently induced Bak activation and the release of cytochrome c. Further, caspase-8-deficient Jurkat cells efficiently cleaved Bid and were sensitive to drug-induced apoptosis. By comparison, Apaf-1-deficient cells, as well as cells overexpressing full-length X-linked inhibitor of apoptosis protein (XIAP) or the BIR1/BIR2 domains of XIAP, failed to cleave Bid in response to genotoxic stress. These data suggest that tBid plays an important regulatory role in the execution of DNA damage-induced cytochrome c release and apoptosis. However, the fact that cleavage of Bid to tBid is mediated by executioner caspases suggests that a self-amplifying feed forward loop involving caspases, Bid, and mitochondria may help determine irreversible commitment to apoptosis.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647, P20 RR016443]; National Center for Research Resources [T32 ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647, T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 (to J.D.R.), P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources, and T32 ES007079. The Flow Cytometry Core is supported in part by NIH Grant P20 RR016443 from the NCRR.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Petak I, 2000, CANCER RES, V60, P2643; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	49	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11247	11255		10.1074/jbc.M809392200	http://dx.doi.org/10.1074/jbc.M809392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19233849	Green Published, hybrid			2022-12-25	WOS:000265494500028
J	Boesze-Battaglia, K; Brown, A; Walker, L; Besack, D; Zekavat, A; Wrenn, S; Krummenacher, C; Shenker, BJ				Boesze-Battaglia, Kathleen; Brown, Angela; Walker, Lisa; Besack, Dave; Zekavat, Ali; Wrenn, Steve; Krummenacher, Claude; Shenker, Bruce J.			Cytolethal Distending Toxin-induced Cell Cycle Arrest of Lymphocytes Is Dependent upon Recognition and Binding to Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; LIPID RAFTS; G(2) ARREST; 3 SUBUNITS; CDTB; PROTEIN; IDENTIFICATION; APOPTOSIS; SHIGELLA; SEQUENCE	Induction of cell cycle arrest in lymphocytes after exposure to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is dependent upon the integrity of lipid membrane microdomains. In this study we further demonstrate that the association of Cdt with lymphocyte plasma membranes is dependent upon binding to cholesterol. Depletion of cholesterol resulted in reduced toxin binding, whereas repletion of cholesterol-depleted cells restored binding. We employed fluorescence resonance energy transfer and surface plasmon resonance to demonstrate that toxin association with model membranes is dependent upon the concentration of cholesterol; moreover, these interactions were cholesterol-specific as the toxin failed to interact with model membranes containing stigmasterol, ergosterol, or lanosterol. Further analysis of the toxin indicated that the CdtC subunit contains a cholesterol recognition/interaction amino acid consensus (CRAC) region. Mutation of the CRAC site resulted in decreased binding of the holotoxin to cholesterol-containing model membranes as well as to the surface of Jurkat cells. The mutant toxin also exhibited reduced capacity for intracellular transfer of the active toxin subunit, CdtB, as well as reduced toxicity. Collectively, these observations indicate that membrane cholesterol serves as an essential ligand for Cdt and that this association can be blocked by either depleting membranes of cholesterol or mutation of the CRAC site.	[Brown, Angela; Walker, Lisa; Besack, Dave; Zekavat, Ali; Shenker, Bruce J.] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA; [Boesze-Battaglia, Kathleen; Krummenacher, Claude] Univ Penn, Dept Biochem, Sch Dent Med, Philadelphia, PA 19104 USA; [Wrenn, Steve] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Shenker, BJ (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, 240 S 40th St, Philadelphia, PA 19104 USA.	shenker@pobox.upenn.edu		Krummenacher, Claude/0000-0002-3492-4987	USPHS [DE06014]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY010420, R21EY018705, R01EY010420] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant DE06014 from the USPHS.	Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; De Rycke J, 2001, FEMS MICROBIOL LETT, V203, P141, DOI 10.1016/S0378-1097(01)00344-5; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Dlakic M, 2001, Science, V291, P547; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; LAFKOWICZ J, 1999, PRINCIPLES FLUORESCE, P345; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lencer WI, 2001, AM J PHYSIOL-GASTR L, V280, pG781, DOI 10.1152/ajpgi.2001.280.5.G781; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Ohara M, 2004, INFECT IMMUN, V72, P871, DOI 10.1128/IAI.72.2.871-879.2004; Okuda J, 1997, INFECT IMMUN, V65, P428, DOI 10.1128/IAI.65.2.428-433.1997; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; PICKETT CL, 1994, INFECT IMMUN, V62, P1046, DOI 10.1128/IAI.62.3.1046-1051.1994; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; SHENKER B, 1976, J IMMUNOL METHODS, V13, P161, DOI 10.1016/0022-1759(76)90154-X; Shenker BJ, 2006, INFECT IMMUN, V74, P2080, DOI 10.1128/IAI.74.4.2080-2092.2006; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506	49	60	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10650	10658		10.1074/jbc.M809094200	http://dx.doi.org/10.1074/jbc.M809094200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240023	Green Published, hybrid			2022-12-25	WOS:000265104600039
J	Yoon, YS; Seo, WY; Lee, MW; Kim, ST; Koo, SH				Yoon, Young-Sil; Seo, Woo-Young; Lee, Min-Woo; Kim, Seong-Tae; Koo, Seung-Hoi			Salt-inducible Kinase Regulates Hepatic Lipogenesis by Controlling SREBP-1c Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY LIVER-DISEASE; ELEMENT-BINDING PROTEIN-1; CREB COACTIVATOR TORC2; GENE-EXPRESSION; RAT-LIVER; ACID SYNTHASE; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL CONTROL; MESSENGER-RNA	Liver plays a major role in regulating energy homeostasis in mammals. During feeding conditions, excessive glucose is converted into a preferred storage form of energy sources as triacylglycerol in liver via a collective metabolic pathway termed lipogenesis. Sterol regulatory element-binding protein 1c is a master regulator for this process by activating number of enzyme genes, such as Fasn or Acaca, that are involved in this pathway at the transcriptional level. Here we show that the salt-inducible kinase (SIK) family of proteins regulates the hepatic lipogenesis by modulating SREBP-1c activity. Overexpression of SIK1 inhibits hepatic expression of lipogenic genes, such as Fasn, whereas knockdown of SIK1 in liver greatly enhances their expression. Regulation of the Fasn gene by SIK kinases is mediated at the level of transcription via phosphorylation and inactivation of nuclear SREBP-1c. Among candidate sites for SIK-dependent regulation of SREBP-1c, the serine 329 residue is shown to be a critical regulatory site for SIK-mediated repression of SREBP-1c activity by in vitro kinase assay and reverse transcription-PCR analysis in primary hepatocytes. Finally, reduced hepatic triacylglycerol levels and lipogenic gene expression by adenoviral SIK1 transgenic expression are restored to normal levels by co-infection of mutant SREBP-1c, suggesting that SIK-dependent regulation of hepatic lipogenesis is indeed mediated through the phosphorylation of SREBP-1c in vivo. The process for the development of nonalcoholic fatty liver involves de novo lipogenesis via the activation of SREBP-1c. Modulation of SREBP-1c activity by SIK proteins would provide an attractive means for the regulation of such diseases.	[Yoon, Young-Sil; Seo, Woo-Young; Lee, Min-Woo; Kim, Seong-Tae; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU)	Koo, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, 300 Chunchun Dong, Suwon 440746, Gyeonggi Do, South Korea.	shkoo@med.skku.ac.kr	Kim, Seong-Tae/A-9917-2013; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	Research Program for New Drug Target Discovery [M10648000089-08N4800-08910]; Korea Science and Engineering Foundation [R01-2008-000-11935-0]; Ministry of Education, Science and Technology [2006-E00037]; Ministry of Land, Transport, and Maritime Affairs, Republic of Korea	Research Program for New Drug Target Discovery(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Land, Transport, and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea)	This work was supported by Research Program for New Drug Target Discovery Grant M10648000089-08N4800-08910, Korea Science and Engineering Foundation Grant R01-2008-000-11935-0, and Korea Research Foundation Grant 2006-E00037 from the Ministry of Education, Science and Technology and a grant from the Marine Biotechnology Program funded by the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Clarke SD, 1996, J NUTR, V126, pS1105, DOI 10.1093/jn/126.suppl_4.1105S; CLARKE SD, 1990, J NUTR, V120, P218, DOI 10.1093/jn/120.2.218; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; CUIF MH, 1992, MOL CELL BIOL, V12, P4852, DOI 10.1128/MCB.12.11.4852; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; IYNEDJIAN PB, 1987, J BIOL CHEM, V262, P6032; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; Kohjima M, 2008, INT J MOL MED, V21, P507; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; MINDEROP RH, 1987, EUR J BIOCHEM, V164, P181, DOI 10.1111/j.1432-1033.1987.tb11009.x; Morais ADS, 2009, J HEPATOL, V50, P489, DOI 10.1016/j.jhep.2008.10.027; Nakamuta M, 2005, INT J MOL MED, V16, P631; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; VAULONT S, 1986, J BIOL CHEM, V261, P7621; VAULONT S, 1994, FASEB J, V8, P28, DOI 10.1096/fasebj.8.1.8299888; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	43	43	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10446	10452		10.1074/jbc.M900096200	http://dx.doi.org/10.1074/jbc.M900096200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244231	Green Published, hybrid			2022-12-25	WOS:000265104600018
J	Roybon, L; Hjalt, T; Stott, S; Guillemot, F; Li, JY; Brundin, P				Roybon, Laurent; Hjalt, Tord; Stott, Simon; Guillemot, Francois; Li, Jia-Yi; Brundin, Patrik			Neurogenin2 Directs Granule Neuroblast Production and Amplification while NeuroD1 Specifies Neuronal Fate during Hippocampal Neurogenesis	PLOS ONE			English	Article								The specification and differentiation of dentate gyrus granule neurons in the hippocampus require temporally and spatially coordinated actions of both intrinsic and extrinsic molecules. The basic helix-loop-helix transcription factor Neurogenin2 (Ngn2) and NeuroD1 are key regulators in these processes. Based on existing classification, we analyzed the molecular events occurring during hippocampal neurogenesis, primarily focusing on juvenile animals. We found that Ngn2 is transiently expressed by late type-2a amplifying progenitors. The Ngn2 progenies mature into hippocampal granule neurons. Interestingly, the loss of Ngn2 at early stages of development leads to a robust reduction in neurogenesis, but does not disturb granule neuron maturation per se. We found that the role of Ngn2 is to maintain progenitors in an undifferentiated state, allowing them to amplify prior to their maturation into granule neurons upon NeuroD1 induction. When we overexpressed Ngn2 and NeuroD1 in vivo, we found NeuroD1 to exhibit a more pronounced neuron-inductive effect, leading to granule neuron commitment, than that displayed by Ngn2. Finally, we observed that all markers expressed during the transcriptional control of hippocampal neurogenesis in rodents are also present in the human hippocampus. Taken together, we demonstrate a critical role of for Ngn2 and NeuroD1 in controlling neuronal commitment and hippocampal granule neuroblast formation, both during embryonic development and in post-natal hippocampal granule neurogenesis.	[Roybon, Laurent; Hjalt, Tord; Li, Jia-Yi; Brundin, Patrik] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden; [Stott, Simon] MRC, Natl Inst Med Res, Div Dev Neurobiol, London, England; [Guillemot, Francois] MRC, Natl Inst Med Res, Div Mol Neurobiol, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Roybon, L (corresponding author), Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden.	laurent.roybon@med.lu.se	Guillemot, Francois/AAV-1482-2021	Stott, Simon/0000-0002-5741-4664; Li, Jia-Yi/0000-0002-7770-7376	Swedish Research Council; Hjarnfonden [fellowship]; Swedish Parkinson Foundation; Syskonen Svenssons Foundation; Konung den V:s och Drottning Victorias Stiftelse; PROMEMORIA; European grant [LHSB-CT-2006-037328];  [LSHM-CT-2005-512012]; Medical Research Council [MC_U117570528] Funding Source: researchfish; MRC [MC_U117570528] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden; Swedish Parkinson Foundation; Syskonen Svenssons Foundation; Konung den V:s och Drottning Victorias Stiftelse; PROMEMORIA; European grant; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by the Swedish Research Council, Hjarnfonden, the Swedish Parkinson Foundation, the Syskonen Svenssons Foundation and the Konung den V:s och Drottning Victorias Stiftelse and PROMEMORIA (From cell-cell recognition to memory formation; new strategies for the treatment of dysfunctional plasticity, learning and memory LSHM-CT-2005-512012). L.R. was supported by a European grant (LHSB-CT-2006-037328; STEMS) and currently supported by a Hjarnfonden fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Cau E, 2002, DEVELOPMENT, V129, P1871; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Falk A, 2002, EXP CELL RES, V279, P34, DOI 10.1006/excr.2002.5569; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GALICHET C, 2008, DEVELOPMENT; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee SMK, 2000, DEVELOPMENT, V127, P457; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Ozen I, 2007, EUR J NEUROSCI, V25, P2591, DOI 10.1111/j.1460-9568.2007.05541.x; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Rogelius N, 2008, MOL CELL NEUROSCI, V38, P453, DOI 10.1016/j.mcn.2008.04.008; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tonchev AB, 2006, NEUROSCIENCE, V139, P1355, DOI 10.1016/j.neuroscience.2006.01.053; Yamashima T, 2007, REV NEUROSCIENCE, V18, P67; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	49	110	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4779	10.1371/journal.pone.0004779	http://dx.doi.org/10.1371/journal.pone.0004779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274100	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000018
J	Maor, E; Ivorra, A; Rubinsky, B				Maor, Elad; Ivorra, Antoni; Rubinsky, Boris			Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation	PLOS ONE			English	Article							RADIATION-THERAPY; TISSUE ABLATION; ELUTING STENT; ENDOTHELIALIZATION; IMPEDANCE; OCCLUSION	Background: Non thermal Irreversible electroporation (NTIRE) is a new tissue ablation method that induces selective damage only to the cell membrane while sparing all other tissue components. Our group has recently showed that NTIRE attenuated neointimal formation in rodent model. The goal of this study was to determine optimal values of NTIRE for vascular smooth muscle cell (VSMC) ablation. Methods and Results: 33 Sprague-Dawley rats were used to compare NTIRE protocols. Each animal had NTIRE applied to its left common carotid artery using a custom-made electrodes. The right carotid artery was used as control. Electric pulses of 100 microseconds were used. Eight IRE protocols were compared: 1-4) 10 pulses at a frequency of 10 Hz with electric fields of 3500, 1750, 875 and 437.5 V/cm and 5-8) 45 and 90 pulses at a frequency of 1 Hz with electric fields of 1750 and 875 V/cm. Animals were euthanized after one week. Histological analysis included VSMC counting and morphometry of 152 sections. Selective slides were stained with elastic Van Gieson and Masson trichrome to evaluate extra-cellular structures. The most efficient protocols were 10 pulses of 3500 V/cm at a frequency of 10 Hz and 90 pulses of 1750 V/cm at a frequency of 1 Hz, with ablation efficiency of 89 +/- 16% and 94 +/- 9% respectively. Extra-cellular structures were not damaged and the endothelial layer recovered completely. Conclusions: NTIRE is a promising, efficient and simple novel technology for VMSC ablation. It enables ablation within seconds without causing damage to extra-cellular structures, thus preserving the arterial scaffold and enabling endothelial regeneration. This study provides scientific information for future anti-restenosis experiments utilizing NTIRE.	[Maor, Elad; Rubinsky, Boris] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Ivorra, Antoni; Rubinsky, Boris] Univ Calif Berkeley, Dept Mechan Engn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91905 Jerusalem, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Maor, E (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	eladmaor@gmail.com	Rubinsky, Boris/B-4439-2010; Maor, Elad/J-9157-2015; Ivorra, Antoni/A-3155-2008	Rubinsky, Boris/0000-0002-2794-1543; Maor, Elad/0000-0002-5087-0464; Ivorra, Antoni/0000-0001-7718-8767	U.S. National Institutes of Health (NIH) [R01 RR018961]; Israel Science Foundation [403/06]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018961] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the U.S. National Institutes of Health (NIH) under Grant NIH R01 RR018961 and by the Israel Science Foundation (grant no 403/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; AUBART FC, 2008, MOL THER; Belov S. V., 1978, Biomedical Engineering, V12, P209, DOI 10.1007/BF00562049; Bennett MR, 2003, HEART, V89, P218, DOI 10.1136/heart.89.2.218; Cheneau E, 2003, CIRCULATION, V107, P2153, DOI 10.1161/01.CIR.0000062648.39025.09; Costa MA, 1999, CIRCULATION, V100, P789, DOI 10.1161/01.CIR.100.8.789; DAVALOS R, 2007, Patent No. 20070043345; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Esser AT, 2007, TECHNOL CANCER RES T, V6, P261, DOI 10.1177/153303460700600402; Fava M, 2004, J VASC INTERV RADIOL, V15, P1239, DOI 10.1097/01.RVI.0000136291.07304.EA; Ivorra A, 2007, IFMBE PROC, V17, P130; Jackson VM, 2002, BRIT J PHARMACOL, V137, P488, DOI 10.1038/sj.bjp.0704863; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee RC, 2005, ANN NY ACAD SCI, V1066, P85, DOI 10.1196/annals.1363.007; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; LIAO TJ, 1994, TOHOKU J EXP MED, V173, P303, DOI 10.1620/tjem.173.303; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAOR E, 2007, TECHNOL CANCER RES T, V6, P255; Maor E, 2008, IEEE T BIO-MED ENG, V55, P2268, DOI 10.1109/TBME.2008.923909; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Shiffman CA, 2003, PHYSIOL MEAS, V24, P213, DOI 10.1088/0967-3334/24/1/316; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Taylor GW, 2000, CIRCULATION, V101, P1736; Valic B, 2003, EUR BIOPHYS J BIOPHY, V32, P519, DOI 10.1007/s00249-003-0296-9; Waksman R, 2000, J AM COLL CARDIOL, V36, P65, DOI 10.1016/S0735-1097(00)00681-1; Waksman R, 2006, HEART, V92, P1138, DOI 10.1136/hrt.2005.073486; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002	36	98	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4757	10.1371/journal.pone.0004757	http://dx.doi.org/10.1371/journal.pone.0004757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270746	Green Published, gold			2022-12-25	WOS:000265495900024
J	Almendro, V; Ametller, E; Garcia-Recio, S; Collazo, O; Casas, I; Auge, JM; Maurel, J; Gascon, P				Almendro, Vanessa; Ametller, Elisabet; Garcia-Recio, Susana; Collazo, Olga; Casas, Ignasi; Auge, Josep M.; Maurel, Joan; Gascon, Pedro			The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin	PLOS ONE			English	Article								Background: The efficacy of oxaliplatin in cancer chemotherapy is limited by the development of drug resistance. MMP7 has been related to the loss of tumor cell response to cytotoxic agents although the exact mechanism is not fully understood. Moreover, MMP7 is an independent prognosis factor for survival in patients with colorectal cancer. The aim of the present study was to analyze the role of MMP7 and its cross-talk with the Fas/FasL system during the acquisition of oxaliplatin resistance in colon cancer cells. Principal Findings: For this purpose we have developed three different oxaliplatin-resistant cell lines (RHT29, RHCT116 p53(+/+), RHCT116 p53(-/-)) from the parental HT29, HCT116 p53(+/+) and HCT116 p53(-/-) colon cancer cells. MMP7 basal expression was higher in the resistant compared to the parental cell lines. MMP7 was also upregulated by oxaliplatin in both HT29 (p53 mutant) and RHCT116 p53(-/-) but not in the RHCT116 p53(+/+). Inhibition of MMP by 1,10-phenantroline monohydrate or siRNA of MMP7 restores cell sensitivity to oxaliplatin-induced apoptosis in both HT29 and RHCT116 p53(-/-) but not in the RHCT116 p53(+/+). Some of these effects are caused by alterations in Fas receptor. Fas is upregulated by oxaliplatin in colon cancer cells, however the RHT29 cells treated with oxaliplatin showed a 3.8-fold lower Fas expression at the cell surface than the HT29 cells. Decrease of Fas at the plasma membrane seems to be caused by MMP7 since its inhibition restores Fas levels. Moreover, functional analysis of Fas demonstrates that this receptor was less potent in inducing apoptosis in RHT29 cells and that its activation induces MAPK signaling in resistant cells. Conclusions: Taking together, these results suggest that MMP7 is related to the acquisition of oxaliplatin-resistance and that its inhibition restores drug sensitivity by increasing Fas receptor. Furthermore, Fas undergoes a change in its functionality in oxaliplatin-resistant cells inducing survival pathways instead of apoptotic signals.	[Almendro, Vanessa; Ametller, Elisabet; Garcia-Recio, Susana; Collazo, Olga; Casas, Ignasi; Maurel, Joan; Gascon, Pedro] Univ Barcelona, Fac Med, ICMHO,Hosp Clin, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Barcelona 7, Spain; [Auge, Josep M.] Univ Barcelona, Fac Med, Dept Biochem, ICMHO,Hosp Clin, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Barcelona 7, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Almendro, V (corresponding author), Univ Barcelona, Fac Med, ICMHO,Hosp Clin, Inst Invest Biomed Agusti Pi & Sunyer IDIBAPS, Barcelona 7, Spain.	almendro@clinic.ub.es	Gascon, Pere/F-7905-2015; Auge, Josep Maria/AAA-2963-2019	Auge, Josep Maria/0000-0001-6383-7308; Ametller, elisabet/0000-0001-9947-7033; Collazo Otero, Olga Maria/0000-0002-1775-3194	Fundacion Cellex; Asociacion Espanola Contra el Cancer (AECC)	Fundacion Cellex; Asociacion Espanola Contra el Cancer (AECC)	This work has been partially financed by grants from Fundacion Cellex, and by a grant from the Asociacion Espanola Contra el Cancer (AECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen CC, 2007, BRIT J CANCER, V97, P334, DOI 10.1038/sj.bjc.6603866; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferrer B, 2005, PATHOBIOLOGY, V72, P225, DOI 10.1159/000089416; Fingleton B, 2001, NEOPLASIA, V3, P459, DOI 10.1038/sj.neo.7900190; Giambernardi TA, 1998, MATRIX BIOL, V16, P483, DOI 10.1016/S0945-053X(98)90019-1; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Ii M, 2006, EXP BIOL MED, V231, P20; KALTSCHMIDT C, 1995, BIOL CHEM H-S, V376, P9; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kurokawa S, 2005, GUT, V54, P1751, DOI 10.1136/gut.2005.071035; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Liu KB, 2003, J IMMUNOL, V171, P4164, DOI 10.4049/jimmunol.171.8.4164; Maurel J, 2007, INT J CANCER, V121, P1066, DOI 10.1002/ijc.22799; Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783; Mitsiades N, 2001, CANCER RES, V61, P577; Mizutani Y, 2001, CANCER, V92, P287, DOI 10.1002/1097-0142(20010715)92:2<287::AID-CNCR1321>3.0.CO;2-4; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nonomura N, 2000, UROLOGY, V55, P151, DOI 10.1016/S0090-4295(99)00379-9; Osorio LM, 2001, EUR J HAEMATOL, V66, P342, DOI 10.1034/j.1600-0609.2001.066005342.x; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Petak I, 2000, CLIN CANCER RES, V6, P4432; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Vargo-Gogola T, 2002, CANCER RES, V62, P5559; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; WITTY JP, 1994, CANCER RES, V54, P4805; Yamamoto H, 1999, CANCER RES, V59, P3313; Yamamoto H, 2001, J CLIN ONCOL, V19, P1118, DOI 10.1200/JCO.2001.19.4.1118; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038	35	55	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4728	10.1371/journal.pone.0004728	http://dx.doi.org/10.1371/journal.pone.0004728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266094	Green Submitted, gold, Green Published			2022-12-25	WOS:000265490800009
J	Lim, RH; Kobzik, L				Lim, Robert H.; Kobzik, Lester			Transplacental Passage of Interleukins 4 and 13?	PLOS ONE			English	Article								The mechanisms by which prenatal events affect development of adult disease are incompletely characterized. Based on findings in a murine model of maternal transmission of asthma risk, we sought to test the role of the pro-asthmatic cytokines interleukin IL-4 and -13. To assess transplacental passage of functional cytokines, we assayed phosphorylation of STAT-6, a marker of IL-4 and -13 signaling via heterodimeric receptor complexes which require an IL-4 receptor alpha subunit. IL-4 receptor alpha-/- females were mated to wild-type males, and pregnant females were injected with supraphysiologic doses of IL-4 or 13. One hour after injection, the receptor heterozygotic embryos were harvested and tissue nuclear proteins extracts assayed for phosphorylation of STAT-6 by Western blot. While direct injection of embryos produced a robust positive control, no phosphorylation was seen after maternal injection with either IL-4 or -13, indicating that neither crossed the placenta in detectable amounts. The data demonstrate a useful approach to assay for transplacental passage of functional maternal molecules, and indicate that molecules other than IL-4 and IL-13 may mediate transplacental effects in maternal transmission of asthma risk.	[Lim, Robert H.; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lim, Robert H.] Childrens Hosp Boston, Div Resp Dis, Boston, MA USA; [Kobzik, Lester] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Lim, RH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	rlim@hsph.harvard.edu; lkobzik@hsph.harvard.edu			 [F32 HL086196-010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL086196] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by an F32 grant (F32 HL086196-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; de Rooij SR, 2006, PSYCHONEUROENDOCRINO, V31, P1257, DOI 10.1016/j.psyneuen.2006.09.007; Devereux G, 2001, CLIN EXP ALLERGY, V31, P1686, DOI 10.1046/j.1365-2222.2001.01215.x; Fasler-Kan E, 1998, EUR J BIOCHEM, V254, P514, DOI 10.1046/j.1432-1327.1998.2540514.x; Franzek EJ, 2008, ADDICTION, V103, P433, DOI 10.1111/j.1360-0443.2007.02084.x; Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Herz U, 2000, EUR J IMMUNOL, V30, P714, DOI 10.1002/1521-4141(200002)30:2<714::AID-IMMU714>3.0.CO;2-P; Herz U, 2000, AM J RESP CRIT CARE, V162, pS62, DOI 10.1164/ajrccm.162.supplement_2.ras-1; HIROTA JA, 2008, CLIN EXP ALLERGY; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hubeau C, 2006, AM J PATHOL, V168, P1931, DOI 10.2353/ajpath.2006.051231; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Ostojic S, 2003, AM J REPROD IMMUNOL, V49, P101, DOI 10.1034/j.1600-0897.2003.01150.x; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Patel BKR, 1996, J BIOL CHEM, V271, P22175, DOI 10.1074/jbc.271.36.22175; Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Rees J, 2005, BRIT MED J, V331, P443, DOI 10.1136/bmj.331.7514.443; Reisenberger K, 1996, OBSTET GYNECOL, V87, P613, DOI 10.1016/0029-7844(95)00473-4; Roth P, 1998, BLOOD, V91, P3773, DOI 10.1182/blood.V91.10.3773.3773_3773_3783; Smith JT, 2003, ENDOCRINOLOGY, V144, P3024, DOI 10.1210/en.2003-0145; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; WAYSBORT A, 1993, ANTIMICROB AGENTS CH, V37, P1232, DOI 10.1128/AAC.37.6.1232; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Zaretsky MV, 2004, OBSTET GYNECOL, V103, P546, DOI 10.1097/01.AOG.0000114980.40445.83; Zourbas S, 2001, CLIN EXP IMMUNOL, V126, P519, DOI 10.1046/j.1365-2249.2001.01607.x	33	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4660	10.1371/journal.pone.0004660	http://dx.doi.org/10.1371/journal.pone.0004660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252738	Green Submitted, Green Published, gold			2022-12-25	WOS:000265489900003
J	Gogishvili, T; Langenhorst, D; Luhder, F; Elias, F; Elflein, K; Dennehy, KM; Gold, R; Hunig, T				Gogishvili, Tea; Langenhorst, Daniela; Luehder, Fred; Elias, Fernando; Elflein, Karin; Dennehy, Kevin M.; Gold, Ralf; Huenig, Thomas			Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice	PLOS ONE			English	Article								Superagonistic CD28-specific monoclonal antibodies (CD28SA) are highly effective activators of regulatory T-cells (Treg cells) in rats, but a first-in-man trial of the human CD28SA TGN1412 resulted in an unexpected cytokine release syndrome. Using a novel mouse anti-mouse CD28SA, we re-investigate the relationship between Treg activation and systemic cytokine release. Treg activation by CD28SA was highly efficient but depended on paracrine IL-2 from CD28SA-stimulated conventional T-cells. Systemic cytokine levels were innocuous, but depletion of Treg cells prior to CD28SA stimulation led to systemic release of proinflammatory cytokines, indicating that in rodents, Treg cells effectively suppress the inflammatory response. Since the human volunteers of the TGN1412 study were not protected by this mechanism, we also tested whether corticosteroid prophylaxis would be compatible with CD28SA induced Treg activation. We show that neither the expansion nor the functional activation of Treg cells is affected by high-dose dexamethasone sufficient to control systemic cytokine release. Our findings warn that preclinical testing of activating biologicals in rodents may miss cytokine release syndromes due to the rapid and efficacious response of the rodent Treg compartment, and suggest that polyclonal Treg activation is feasible in the presence of antiphlogistic corticosteroid prophylaxis.	[Gogishvili, Tea; Langenhorst, Daniela; Elias, Fernando; Elflein, Karin; Dennehy, Kevin M.; Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Luehder, Fred] Univ Gottingen, Inst Multiple Sclerosis Res, D-3400 Gottingen, Germany; [Luehder, Fred] Gemeinnutzige Hertie Stiftung, Gottingen, Germany; [Dennehy, Kevin M.] Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72074 Tubingen, Germany; [Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany	University of Wurzburg; University of Gottingen; Eberhard Karls University of Tubingen; Ruhr University Bochum	Gogishvili, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	huenig@vim.uni-wuerzburg.de			Deutsche Forschungsgemeinschaft [SFBs479, 581, TR52]; Graduate School of Life Sciences; Hertie foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Life Sciences; Hertie foundation	Supported by Deutsche Forschungsgemeinschaft through SFBs479, 581, TR52, and the Graduate School of Life Sciences, and by the Hertie foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Adorini L, 2004, SEMIN IMMUNOL, V16, P127, DOI 10.1016/j.smim.2003.12.008; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; Chatenoud L, 1991, Curr Top Microbiol Immunol, V174, P121; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.200635873; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Duff G., 2006, FINAL REPORT 2006, P1; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Guilliams M, 2008, J INFECT DIS, V198, P781, DOI 10.1086/590439; Hanke T, 2006, LANCET, V368, P1569, DOI 10.1016/S0140-6736(06)69651-7; HEBART H, 1995, BONE MARROW TRANSPL, V15, P891; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hunig T, 2007, ADV IMMUNOL, V95, P111, DOI 10.1016/S0065-2776(07)95004-X; Kitazawa Y, 2008, J HEART LUNG TRANSPL, V27, P362, DOI 10.1016/j.healun.2008.01.004; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Muller N, 2008, J CLIN INVEST, V118, P1405, DOI 10.1172/JCI32698; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schraven B, 2008, IMMUNITY, V28, P591, DOI 10.1016/j.immuni.2008.04.003; Seifert Georg, 2006, Haematologica, V91, pECR23; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tischner D, 2006, BRAIN, V129, P2635, DOI 10.1093/brain/awl213; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T	42	64	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4643	10.1371/journal.pone.0004643	http://dx.doi.org/10.1371/journal.pone.0004643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247496	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487800023
J	Graham, DB; Zinselmeyer, BH; Mascarenhas, F; Delgado, R; Miller, MJ; Swat, W				Graham, Daniel B.; Zinselmeyer, Bernd H.; Mascarenhas, Francesca; Delgado, Ryan; Miller, Mark J.; Swat, Wojciech			ITAM Signaling by Vav Family Rho Guanine Nucleotide Exchange Factors Regulates Interstitial Transit Rates of Neutrophils In Vivo	PLOS ONE			English	Article								Background: In response to infection, neutrophils are quickly recruited from the blood into inflamed tissues. The interstitial migration of neutrophils is crucial for the efficient capture and control of rapidly proliferating microbes before microbial growth can overwhelm the host's defenses. However, the molecular mechanisms that regulate interstitial migration are incompletely understood. Methodology/Principal Findings: Here, we use two-photon microscopy (2PM) to study discrete steps of neutrophil responses during subcutaneous infection with bacteria. Our study demonstrates that signals emanating from ITAM-containing receptors mediated by Vav family Rho GEFs control the velocity, but not the directionality, of neutrophil migration towards sites of bacterial infection. Conclusions/Significance: Here we show that during neutrophil migration towards sites of bacterial infection, signals emanating from ITAM-containing receptors specifically control interstitial neutrophil velocity.	[Graham, Daniel B.; Zinselmeyer, Bernd H.; Mascarenhas, Francesca; Delgado, Ryan; Miller, Mark J.; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Graham, DB (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	miller@wustl.edu; swat@wustl.edu	Zinselmeyer, Bernd/X-4802-2018	Zinselmeyer, Bernd/0000-0003-4172-6767; Miller, Mark/0000-0001-5676-389X	NIH [AI06107703, AI06302402, T32 CA009547]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI06107703 and AI06302402 to W.S., and T32 CA009547 to D.B.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Faust N, 2000, BLOOD, V96, P719; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	26	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4652	10.1371/journal.pone.0004652	http://dx.doi.org/10.1371/journal.pone.0004652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247495	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800031
J	Pistis, G; Piras, I; Pirastu, N; Persico, I; Sassu, A; Picciau, A; Prodi, D; Fraumene, C; Mocci, E; Manias, MT; Atzeni, R; Cosso, M; Pirastu, M; Angius, A				Pistis, Giorgio; Piras, Ignazio; Pirastu, Nicola; Persico, Ivana; Sassu, Alessandro; Picciau, Andrea; Prodi, Dionigio; Fraumene, Cristina; Mocci, Evelina; Manias, Maria Teresa; Atzeni, Rossano; Cosso, Massimiliano; Pirastu, Mario; Angius, Andrea			High Differentiation among Eight Villages in a Secluded Area of Sardinia Revealed by Genome-Wide High Density SNPs Analysis	PLOS ONE			English	Article							LINKAGE-DISEQUILIBRIUM; POPULATION-STRUCTURE; SUBSTRUCTURE; PATTERNS; HAPLOTYPES; FREQUENCY; INFERENCE; HISTORY; DISEASE; ISOLATE	To better design association studies for complex traits in isolated populations it's important to understand how history and isolation moulded the genetic features of different communities. Population isolates should not "a priori" be considered homogeneous, even if the communities are not distant and part of a small region. We studied a particular area of Sardinia called Ogliastra, characterized by the presence of several distinct villages that display different history, immigration events and population size. Cultural and geographic isolation characterized the history of these communities. We determined LD parameters in 8 villages and defined population structure through high density SNPs (about 360 K) on 360 unrelated people (45 selected samples from each village). These isolates showed differences in LD values and LD map length. Five of these villages show high LD values probably due to their reduced population size and extreme isolation. High genetic differentiation among villages was detected. Moreover population structure analysis revealed a high correlation between genetic and geographic distances. Our study indicates that history, geography and biodemography have influenced the genetic features of Ogliastra communities producing differences in LD and population structure. All these data demonstrate that we can consider each village an isolate with specific characteristics. We suggest that, in order to optimize the study design of complex traits, a thorough characterization of genetic features is useful to identify the presence of sub-populations and stratification within genetic isolates.	[Pistis, Giorgio; Persico, Ivana; Pirastu, Mario; Angius, Andrea] CNR, Ist Genet Popolaz, Sassari, Italy; [Piras, Ignazio; Pirastu, Nicola; Sassu, Alessandro; Picciau, Andrea; Prodi, Dionigio; Fraumene, Cristina; Mocci, Evelina; Manias, Maria Teresa; Atzeni, Rossano; Cosso, Massimiliano; Pirastu, Mario; Angius, Andrea] Shardna Life Sci, Cagliari, Italy	Consiglio Nazionale delle Ricerche (CNR)	Pistis, G (corresponding author), CNR, Ist Genet Popolaz, Sassari, Italy.	angius@igm.ss.cnr.it	Pirastu, Nicola/G-4358-2011; Angius, Andrea/P-9549-2015; Angius, Andrea/B-8966-2015; Persico, Ivana/AAX-7255-2020; Pirastu, Nicola/AHB-6226-2022	Angius, Andrea/0000-0003-2596-6461; Persico, Ivana/0000-0001-9946-1509; Angius, Andrea/0000-0001-9372-1162; Piras, Ignazio/0000-0003-4024-3368; Pirastu, Nicola/0000-0002-5363-3886; Atzeni, Rossano/0000-0003-0020-0013	Italian Ministry of Education, University and Research (MIUR) [5571/DSPAR/2002]; FIRB [718/Ric/2005]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants from the Italian Ministry of Education, University and Research (MIUR) n: 5571/DSPAR/2002 and (FIRB) D.M. n.718/Ric/2005.	Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Angius A, 2008, HUM HERED, V65, P9, DOI 10.1159/000106058; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Babron MC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S18; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belkhir K., 2003, GENETIX LOGICIEL WIN; Benzecri Jean-Paul, 1973, ANAL DONNEES, V2; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; CLAYTON D, 2001, HDB STAT GENETICS, P519; COCCO F, 1987, DATI RELATIVI STORIA, V3; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Escofier B., 1990, ANAL FACTORIELLES SI; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; FALUSH D, 2007, MOL ECOL NOTES; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Ghiani ME, 2002, COLLEGIUM ANTROPOL, V26, P387; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Greenacre M.J., 1984, THEORY APPL CORRES A; Guinand B, 1996, BIOL J LINN SOC, V58, P173, DOI 10.1111/j.1095-8312.1996.tb01430.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; HILL WG, 1994, AM J HUM GENET, V54, P705; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jousilahti P, 1998, ANN MED, V30, P481, DOI 10.3109/07853899809002490; KIMURA M, 1964, GENETICS, V49, P725; Lampis R, 2000, TISSUE ANTIGENS, V56, P515, DOI 10.1034/j.1399-0039.2000.560605.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Latini V, 2003, HUM BIOL, V75, P855, DOI 10.1353/hub.2004.0008; Lee N, 2001, AM J HUM GENET, V68, P397, DOI 10.1086/318197; LEWONTIN RC, 1964, GENETICS, V49, P49; LONG JC, 1986, GENETICS, V112, P629; Loudianos G, 1999, J MED GENET, V36, P833; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; MANTEL N, 1967, CANCER RES, V27, P209; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marroni F, 2006, ANN HUM GENET, V70, P812, DOI 10.1111/j.1469-1809.2006.00274.x; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morelli L, 2000, HUM BIOL, V72, P585; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Pritchard JK, 2000, GENETICS, V155, P945; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; RELETHFORD JH, 1994, ANN HUM BIOL, V21, P13, DOI 10.1080/03014469400003042; REYNOLDS J, 1983, GENETICS, V105, P767; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; SHE JX, 1987, BIOL J LINN SOC, V32, P357, DOI 10.1111/j.1095-8312.1987.tb00437.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SMOUSE PE, 1988, 2ND P INT C QUANT GE, P32; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003862; TUOMILEHTO J, 1992, EUR HEART J, V13, P577, DOI 10.1093/oxfordjournals.eurheartj.a060219; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; VONA G, 1997, INT J ANTHR, V12, P71, DOI DOI 10.1007/BF02447890; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Wright S., 1978, EVOLUTION GENETICS P, V4; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	82	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4654	10.1371/journal.pone.0004654	http://dx.doi.org/10.1371/journal.pone.0004654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247500	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487800033
J	Premi, S; Srivastava, J; Chandy, SP; Ali, S				Premi, Sanjay; Srivastava, Jyoti; Chandy, Sebastian Padinjarel; Ali, Sher			Unique Signatures of Natural Background Radiation on Human Y Chromosomes from Kerala, India	PLOS ONE			English	Article							COPY NUMBER POLYMORPHISM; IONIZING-RADIATION; DAZ GENES; REGION; DELETIONS; COPIES; SRY; MICRODELETIONS; RECOMBINATION; DNA	Background: The most frequently observed major consequences of ionizing radiation are chromosomal lesions and cancers, although the entire genome may be affected. Owing to its haploid status and absence of recombination, the human Y chromosome is an ideal candidate to be assessed for possible genetic alterations induced by ionizing radiation. We studied the human Y chromosome in 390 males from the South Indian state of Kerala, where the level of natural background radiation (NBR) is ten-fold higher than the worldwide average, and that from 790 unexposed males as control. Results: We observed random microdeletions in the Azoospermia factor (AZF) a, b and c regions in >90%, and tandem duplication and copy number polymorphism (CNP) of 11 different Y-linked genes in about 80% of males exposed to NBR. The autosomal homologues of Y-linked CDY genes largely remained unaffected. Multiple polymorphic copies of the Y-linked genes showing single Y-specific signals suggested their tandem duplication. Some exposed males showed unilocus duplication of DAZ genes resulting in six copies. Notably, in the AZFa region, approximately 25% of exposed males showed deletion of the DBY gene, whereas flanking genes USP9Y and UTY remained unaffected. All these alterations were detected in blood samples but not in the germline (sperm) samples. Conclusions: Exposure to high levels of NBR correlated with several interstitial polymorphisms of the human Y chromosome. CNPs and enhanced transcription of the SRY gene after duplication are envisaged to compensate for the loss of Y chromosome in some cells. The aforesaid changes, confined to peripheral blood lymphocytes, suggest a possible innate mechanism protecting the germline DNA from the NBR. Genome analysis of a larger population focusing on greater numbers of genes may provide new insights into the mechanisms and risks of the resultant genetic damages. The present work demonstrates unique signatures of NBR on human Y chromosomes from Kerala, India.	[Premi, Sanjay; Srivastava, Jyoti; Chandy, Sebastian Padinjarel; Ali, Sher] Natl Inst Immunol, Mol Genet Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Premi, S (corresponding author), Natl Inst Immunol, Mol Genet Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	alisher@nii.res.in	SRIVASTAVA, JYOTI/J-6065-2014; Premi, Sanjay/ABB-1423-2020; Srivastava, Jyoti/AAD-7610-2022; Premi, Sanjay/J-4351-2014	SRIVASTAVA, JYOTI/0000-0002-5727-741X; Premi, Sanjay/0000-0002-5492-5469; 	Alexander Von Humboldt Foundation, Bonn, Germany; DBT [BT/PR2225/Med/13/077/2000]; DST [SP/SO/DO3/99]; Department of Biotechnology, Govt. of India to National Institute of Immunology, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi [Senior Research Fellowship]	Alexander Von Humboldt Foundation, Bonn, Germany(Alexander von Humboldt Foundation); DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); Department of Biotechnology, Govt. of India to National Institute of Immunology, New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	We thank Alexander Von Humboldt Foundation, Bonn, Germany for Equipment donation. This work was supported by DBT grant no. BT/PR2225/Med/13/077/2000 and DST grant no. SP/SO/DO3/99) to SA and a core grant from the Department of Biotechnology, Govt. of India to National Institute of Immunology, New Delhi. SP is thankful to the Council of Scientific and Industrial Research (CSIR), New Delhi for the Senior Research Fellowship. This work has been seen and approved by all the authors and they do not have any conflict of personal communication or financial interests.	Buckley PG, 2005, TRENDS GENET, V21, P315, DOI 10.1016/j.tig.2005.04.007; Bullejos M, 1999, CYTOGENET CELL GENET, V86, P46, DOI 10.1159/000015428; Cheriyan VD, 1999, RADIAT RES, V152, pS154, DOI 10.2307/3580136; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; Dubrova YE, 2002, SCIENCE, V295, P1037, DOI 10.1126/science.1068102; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499; FRIEDBERG EC, 1995, DNA REP MUTAGEN; Hande MP, 2003, AM J HUM GENET, V72, P1162, DOI 10.1086/375041; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; HOOF V, 2005, GENETICS, V171, P1455; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; KUZIN A M, 1983, Radiobiologiya, V23, P192; Loucas BD, 2004, CYTOGENET GENOME RES, V104, P206, DOI 10.1159/000077490; Lundrigan BL, 1997, J MOL EVOL, V45, P60, DOI 10.1007/PL00006202; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Murthy SK, 2005, ARCH PATHOL LAB MED, V129, P39; Nadeau JH, 2006, NATURE, V439, P798, DOI 10.1038/439798a; Nakajima M, 1996, ENVIRON HEALTH PERSP, V104, P1336, DOI 10.2307/3432971; ONEILL P, 1993, ADV RADIAT BIOL, V17, P53; Ottolenghi C, 2000, GENOMICS, V64, P170, DOI 10.1006/geno.2000.6121; Premi S, 2006, MOL HUM REPROD, V12, P113, DOI 10.1093/molehr/gal012; Premi S, 2007, HUM GENET, V121, P337, DOI 10.1007/s00439-006-0318-7; Prise KM, 2001, RADIAT RES, V156, P572, DOI 10.1667/0033-7587(2001)156[0572:AROSOI]2.0.CO;2; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Sankaranarayanan K, 1999, MUTAT RES-FUND MOL M, V429, P45, DOI 10.1016/S0027-5107(99)00100-1; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; SUNDARAM K, 1977, NATURE, V267, P728, DOI 10.1038/267728b0; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; *UNSCEAR UN SCI CO, 1993, 1993 REP GEN ASS WIT; XIONGLEI H, 2005, CURR BIOL, V15, P1016	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4541	10.1371/journal.pone.0004541	http://dx.doi.org/10.1371/journal.pone.0004541			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242544	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500002
J	Lehmann, T; Hume, JCC; Licht, M; Burns, CS; Wollenberg, K; Simard, F; Ribeiro, JMC				Lehmann, Tovi; Hume, Jen C. C.; Licht, Monica; Burns, Christopher S.; Wollenberg, Kurt; Simard, Fred; Ribeiro, Jose M. C.			Molecular Evolution of Immune Genes in the Malaria Mosquito Anopheles gambiae	PLOS ONE			English	Article								Background: As pathogens that circumvent the host immune response are favoured by selection, so are host alleles that reduce parasite load. Such evolutionary processes leave their signature on the genes involved. Deciphering modes of selection operating on immune genes might reveal the nature of host-pathogen interactions and factors that govern susceptibility in host populations. Such understanding would have important public health implications. Methodology/Findings: We analyzed polymorphisms in four mosquito immune genes (SP14D1, GNBP, defensin, and gambicin) to decipher selection effects, presumably mediated by pathogens. Using samples of Anopheles arabiensis, An. quadriannulatus and four An. gambiae populations, as well as published sequences from other Culicidae, we contrasted patterns of polymorphisms between different functional units of the same gene within and between populations. Our results revealed selection signatures operating on different time scales. At the most recent time scale, within-population diversity revealed purifying selection. Between populations and between species variation revealed reduced differentiation (GNBP and gambicin) at coding vs. noncoding-regions, consistent with balancing selection. McDonald-Kreitman tests between An. quadriannulatus and both sibling species revealed higher fixation rate of synonymous than nonsynonymous substitutions (GNBP) in accordance with frequency dependent balancing selection. At the longest time scale (>100 my), PAML analysis using distant Culicid taxa revealed positive selection at one codon in gambicin. Patterns of genetic variation were independent of exposure to human pathogens. Significance and Conclusions: Purifying selection is the most common form of selection operating on immune genes as it was detected on a contemporary time scale on all genes. Selection for "hypervariability" was not detected, but negative balancing selection, detected at a recent evolutionary time scale between sibling species may be rather common. Detection of positive selection at the deepest evolutionary time scale suggests that it occurs infrequently, possibly in association with speciation events. Our results provided no evidence to support the hypothesis that selection was mediated by pathogens that are transmitted to humans.	[Lehmann, Tovi; Licht, Monica; Burns, Christopher S.] Ctr Dis Control & Prevent, Entomol Branch, Div Parasit Dis, Chamblee, GA USA; [Lehmann, Tovi; Licht, Monica; Burns, Christopher S.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Lehmann, Tovi; Hume, Jen C. C.; Burns, Christopher S.; Ribeiro, Jose M. C.] NIAID, NIH, Lab Malaria & Vector Res, Rockville, MD USA; [Wollenberg, Kurt] NIAID, NIH, Office Cyber Infrastructure & Computat Biol, Bioinformat & Computat Biosci Branch, Bethesda, MD USA; [Simard, Fred] Org lutte Contre grandes Endemies Afrique Cent, LabInst Rech Dev, RU 016, Yaounde, Cameroon	Centers for Disease Control & Prevention - USA; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lehmann, T (corresponding author), Ctr Dis Control & Prevent, Entomol Branch, Div Parasit Dis, Chamblee, GA USA.	TLehmann@niaid.nih.gov	Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016	Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Ribeiro, Jose/0000-0002-9107-0818; Lehmann, Tovi/0000-0002-8142-3915; Wollenberg, Kurt/0000-0002-4973-9370	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); Entomology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention; Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001062, Z01AI000810, ZIAAI001062, Z01AI000629, ZIAAI000629] Funding Source: NIH RePORTER	UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); Entomology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Entomology Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention, and by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barillas-Mury C, 2000, INSECT BIOCHEM MOLEC, V30, P429, DOI 10.1016/S0965-1748(00)00018-7; BEIER JC, 1990, J MED ENTOMOL, V27, P570, DOI 10.1093/jmedent/27.4.570; Besansky NJ, 1997, GENETICS, V147, P1817; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Chun J, 2000, INSECT MOL BIOL, V9, P39, DOI 10.1111/j.1365-2583.2000.00157.x; Clark AG, 1997, GENETICS, V147, P713; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; COLLINS FH, 1988, J MED ENTOMOL, V25, P116, DOI 10.1093/jmedent/25.2.116; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRITZ RS, 1992, PLANT RESISTANCE HER; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; GITHEKO AK, 1994, ACTA TROP, V58, P307, DOI 10.1016/0001-706X(94)90024-8; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1992, GENETICS, V132, P583; HUFF CG, 1965, EXP PARASITOL, V16, P107, DOI 10.1016/0014-4894(65)90036-6; HUFF CG, 1951, J INFECT DIS, V88, P17, DOI 10.1093/infdis/88.1.17; HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Jiggins FM, 2003, J MOL EVOL, V57, P598, DOI 10.1007/s00239-003-2506-6; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2003, MOL BIOL EVOL, V20, P914, DOI 10.1093/molbev/msg109; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lenhart Audrey, 2007, Filaria J, V6, P14, DOI 10.1186/1475-2883-6-14; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; MBOGO CNM, 1993, AM J TROP MED HYG, V49, P245, DOI 10.4269/ajtmh.1993.49.245; MCDONALD GH, 1994, NONNEUTRAL EVOLUTION, P88; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mukoko DAN, 2004, ANN TROP MED PARASIT, V98, P801, DOI 10.1179/000349804X3225; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Paterson S, 1998, J HERED, V89, P289, DOI 10.1093/jhered/89.4.289; Richman AM, 1996, INSECT MOL BIOL, V5, P203, DOI 10.1111/j.1365-2583.1996.tb00055.x; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; *SAS I, 1990, SAS LANG REF VERS 6; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Schlenke TA, 2003, GENETICS, V164, P1471; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shahabuddin M, 1998, EXP PARASITOL, V89, P103, DOI 10.1006/expr.1998.4212; Simard F, 2007, INFECT GENET EVOL, V7, P285, DOI 10.1016/j.meegid.2006.11.004; Slotman MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000793; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; Wright S, 1978, VARIABILITY NATURAL; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	73	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4549	10.1371/journal.pone.0004549	http://dx.doi.org/10.1371/journal.pone.0004549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234606	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487200005
J	Roy, SW				Roy, Scott William			Probing Evolutionary Repeatability: Neutral and Double Changes and the Predictability of Evolutionary Adaptation	PLOS ONE			English	Article								Background: The question of how organisms adapt is among the most fundamental in evolutionary biology. Two recent studies investigated the evolution of Escherichia coli in response to challenge with the antibiotic cefotaxime. Studying five mutations in the beta-lactamase gene that together confer significant antibiotic resistance, the authors showed a complex fitness landscape that greatly constrained the identity and order of intermediates leading from the initial wildtype genotype to the final resistant genotype. Out of 18 billion possible orders of single mutations leading from non-resistant to fully-resistant form, they found that only 27 (1.5x10(-7)%) pathways were characterized by consistently increasing resistance, thus only a tiny fraction of possible paths are accessible by positive selection. I further explore these data in several ways. Principal Findings: Allowing neutral changes (those that do not affect resistance) increases the number of accessible pathways considerably, from 27 to 629. Allowing multiple simultaneous mutations also greatly increases the number of accessible pathways. Allowing a single case of double mutation to occur along a pathway increases the number of pathways from 27 to 259, and allowing arbitrarily many pairs of simultaneous changes increases the number of possible pathways by more than 100 fold, to 4800. I introduce the metric 'repeatability,' the probability that two random trials will proceed via the exact same pathway. In general, I find that while the total number of accessible pathways is dramatically affected by allowing neutral or double mutations, the overall evolutionary repeatability is generally much less affected. Conclusions: These results probe the conceivable pathways available to evolution. Even when many of the assumptions of the analysis of Weinreich et al. (2006) are relaxed, I find that evolution to more highly cefotaxime resistant beta-lactamase proteins is still highly repeatable.	[Roy, Scott William] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Roy, SW (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	royscott@ncbi.nlm.nih.gov			National Institutes of Health Intramural Research Program	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health Intramural Research Program	DePristo MA, 2007, MOL BIOL EVOL, V24, P1608, DOI 10.1093/molbev/msm118; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; KIMURA M, 1962, GENETICS, V47, P713; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; STEMMER WP, 1994, NATURE, V4, P389; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1175; Wilke CO, 2001, B MATH BIOL, V63, P715, DOI 10.1006/bulm.2001.0244	9	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4500	10.1371/journal.pone.0004500	http://dx.doi.org/10.1371/journal.pone.0004500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234610	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487200002
J	Sole, X; Bonifaci, N; Lopez-Bigas, N; Berenguer, A; Hernandez, P; Reina, O; Maxwell, CA; Aguilar, H; Urruticoechea, A; de Sanjose, S; Comellas, F; Capella, G; Moreno, V; Pujana, MA				Sole, Xavier; Bonifaci, Nuria; Lopez-Bigas, Nuria; Berenguer, Antoni; Hernandez, Pilar; Reina, Oscar; Maxwell, Christopher A.; Aguilar, Helena; Urruticoechea, Ander; de Sanjose, Silvia; Comellas, Francesc; Capella, Gabriel; Moreno, Victor; Pujana, Miguel Angel			Biological Convergence of Cancer Signatures	PLOS ONE			English	Article								Gene expression profiling has identified cancer prognostic and predictive signatures with superior performance to conventional histopathological or clinical parameters. Consequently, signatures are being incorporated into clinical practice and will soon influence everyday decisions in oncology. However, the slight overlap in the gene identity between signatures for the same cancer type or condition raises questions about their biological and clinical implications. To clarify these issues, better understanding of the molecular properties and possible interactions underlying apparently dissimilar signatures is needed. Here, we evaluated whether the signatures of 24 independent studies are related at the genome, transcriptome or proteome levels. Significant associations were consistently observed across these molecular layers, which suggest the existence of a common cancer cell phenotype. Convergence on cell proliferation and death supports the pivotal involvement of these processes in prognosis, metastasis and treatment response. In addition, functional and molecular associations were identified with the immune response in different cancer types and conditions that complement the contribution of cell proliferation and death. Examination of additional, independent, cancer datasets corroborated our observations. This study proposes a comprehensive strategy for interpreting cancer signatures that reveals common design principles and systems-level properties.	[Sole, Xavier; Bonifaci, Nuria; Berenguer, Antoni; Moreno, Victor; Pujana, Miguel Angel] IDIBELL, Catalan Inst Oncol, Bioinformat & Biostat Unit, Barcelona, Spain; [Bonifaci, Nuria; Hernandez, Pilar; Maxwell, Christopher A.; Aguilar, Helena; Urruticoechea, Ander; Capella, Gabriel; Pujana, Miguel Angel] IDIBELL, Hosp, Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain; [Lopez-Bigas, Nuria] UPF, Res Unit Biomed Informat IMIM, Barcelona, Spain; [Reina, Oscar; de Sanjose, Silvia] IDIBELL, Hosp, Catalan Inst Oncol, CIBERESP, Epidemiol Res Canc Program, Unit Infect & Canc, Barcelona, Spain; [Comellas, Francesc] Tech Univ Catalonia, Dept Applied Math 4, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universitat Politecnica de Catalunya	Sole, X (corresponding author), IDIBELL, Catalan Inst Oncol, Bioinformat & Biostat Unit, Barcelona, Spain.	mapujana@ico.scs.es	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011; Maxwell, Christopher A/B-3044-2011; Capella, Gabriel/I-1879-2015; bonifaci, nuria/B-8104-2019; Moreno, Victor/A-1697-2010; Solé, Xavier/AAF-3015-2019; Pujana, Miquel Angel/N-3127-2014; de Sanjosé Llongueras, Silvia/H-6339-2014; Comellas, Francesc/I-4868-2014	Lopez-Bigas, Nuria/0000-0003-4925-8988; Maxwell, Christopher A/0000-0002-0713-7136; Capella, Gabriel/0000-0002-4669-7320; bonifaci, nuria/0000-0002-8193-6825; Moreno, Victor/0000-0002-2818-5487; Solé, Xavier/0000-0002-2197-3325; Pujana, Miquel Angel/0000-0003-3222-4044; Comellas, Francesc/0000-0003-4523-0240; Reina Garcia, Oscar/0000-0002-1031-2732; Urruticoechea, Ander/0000-0003-0359-3641; Maxwell, Christopher/0000-0002-0860-4031; Berenguer-LLergo, Antoni/0000-0002-3742-8161	The la Caixa Foundation [BM 05/254]; Spanish Ministry of Health [FIS 05/1006, 06/0545, RCESP C03/09, RTICCC C03/10, postdoctoral fellowship]; AGAUR agency of the Catalan Government [Beatriu de Pinos fellowship]; Spanish Ministry of Education and Science [Ramon y Cajal Researcher]	The la Caixa Foundation; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AGAUR agency of the Catalan Government(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Spanish Ministry of Education and Science(Spanish Government)	The la Caixa Foundation grant BM 05/254 (MAP) and the Spanish Ministry of Health grants FIS 05/1006 (VM) and 06/0545 (MAP), RCESP C03/09 and RTICCC C03/10 (VM and GC). CAM is supported by a Beatriu de Pinos fellowship from the AGAUR agency of the Catalan Government, HA is supported by a postdoctoral fellowship of the Spanish Ministry of Health and MAP is a Ramon y Cajal Researcher with the Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Ambs Stefan, 2008, Cancer Res, V68, P4031, DOI 10.1158/0008-5472.CAN-08-0521; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eden P, 2004, EUR J CANCER, V40, P1837, DOI 10.1016/j.ejca.2004.02.025; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; GREIG KT, 2008, SEMIN IMMUNOL; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-185; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ishikawa H, 2007, J MOL ENDOCRINOL, V39, P333, DOI 10.1677/JME-06-0069; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jin VX, 2006, GENOME RES, V16, P1585, DOI 10.1101/gr.5520206; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Michiels S, 2007, BRIT J CANCER, V96, P1155, DOI 10.1038/sj.bjc.6603673; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morris SR, 2007, CURR OPIN ONCOL, V19, P547, DOI 10.1097/CCO.0b013e3282f0ada3; Nuyten DSA, 2008, SEMIN RADIAT ONCOL, V18, P105, DOI 10.1016/j.semradonc.2007.10.007; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pliskova M, 2005, TOXICOL SCI, V83, P246, DOI 10.1093/toxsci/kfi040; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Roepman P, 2006, CANCER RES, V66, P2361, DOI 10.1158/0008-5472.CAN-05-3960; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Shen RL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-28; Sherlock G, 2005, NAT METHODS, V2, P329, DOI 10.1038/nmeth0505-329; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Tsuchihashi Z, 2005, NEW ENGL J MED, V353, P208, DOI 10.1056/NEJM200507143530218; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vuaroqueaux V, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1681; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Wennmalm K, 2007, NEW ENGL J MED, V356, P1887; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182; Zhang Z, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-331	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4544	10.1371/journal.pone.0004544	http://dx.doi.org/10.1371/journal.pone.0004544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229342	gold, Green Published, Green Submitted			2022-12-25	WOS:000265486200015
J	Wiederhold, K; Fasshauer, D				Wiederhold, Katrin; Fasshauer, Dirk			Is Assembly of the SNARE Complex Enough to Fuel Membrane Fusion?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-SNARE; NEURONAL SNARES; HIV-1 GP120; PROTEINS; MECHANISMS; EXOCYTOSIS; ENERGETICS; BIND; CORE	The three key players in the exocytotic release of neurotransmitters from synaptic vesicles are the SNARE (soluble N-ethylmaleimidesensitive factor attachment protein receptor) proteins synaptobrevin 2, syntaxin 1a, and SNAP-25. Their assembly into a tight four-helix bundle complex is thought to pull the two membranes into close proximity. It is debated, however, whether the energy generated suffices for membrane fusion. Here, we have determined the thermodynamic properties of the individual SNARE assembly steps by isothermal titration calorimetry. We found extremely large favorable enthalpy changes counterbalanced by positive entropy changes, reflecting the major conformational changes upon assembly. To circumvent the fact that ternary complex formation is essentially irreversible, we used a stabilized syntaxin-SNAP-25 heterodimer to study synaptobrevin binding. This strategy revealed that the N-terminal synaptobrevin coil binds reversibly with nanomolar affinity. This suggests that individual, membrane-bridging SNARE complexes can provide much less pulling force than previously claimed.	[Wiederhold, Katrin; Fasshauer, Dirk] Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, D-37077 Gottingen, Germany	Max Planck Society	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Res Grp Struct Biochem, Fassberg 11, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Fasshauer, Dirk/B-1563-2013	Fasshauer, Dirk/0000-0002-1040-4282	Deutsche Forschungsgemeinschaft [SFB523]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft Grant the SFB523.	Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Durrieu MP, 2008, BIOPHYS J, V94, P3436, DOI 10.1529/biophysj.107.123117; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Frey G, 2006, P NATL ACAD SCI USA, V103, P13938, DOI 10.1073/pnas.0601036103; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim CS, 2002, BIOCHEMISTRY-US, V41, P10928, DOI 10.1021/bi026266v; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Leavitt SA, 2004, CURR PROTEIN PEPT SC, V5, P1; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu W, 2008, BIOPHYS J, V95, P419, DOI 10.1529/biophysj.107.127886; Liu W, 2006, BIOPHYS J, V91, P744, DOI 10.1529/biophysj.105.073312; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu XB, 2005, J BIOL CHEM, V280, P30538, DOI 10.1074/jbc.M506862200; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parpura V, 2008, TRENDS NEUROSCI, V31, P435, DOI 10.1016/j.tins.2008.06.003; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2008, STRUCTURE, V16, P163, DOI 10.1016/j.str.2008.01.001; Rizo J, 2007, NAT STRUCT MOL BIOL, V14, P880, DOI 10.1038/nsmb1007-880; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weiss Carol D, 2003, AIDS Rev, V5, P214; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yersin A, 2003, P NATL ACAD SCI USA, V100, P8736, DOI 10.1073/pnas.1533137100; Yoon TY, 2009, CELL MOL LIFE SCI, V66, P460, DOI 10.1007/s00018-008-8372-z; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Zhang F, 2002, J BIOL CHEM, V277, P24294, DOI 10.1074/jbc.M201200200	57	55	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13143	13152		10.1074/jbc.M900703200	http://dx.doi.org/10.1074/jbc.M900703200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19258315	Green Published, hybrid			2022-12-25	WOS:000265688300061
J	Zhang, Y; Wang, YG; Zhang, Q; Liu, XJ; Liu, X; Jiao, L; Zhu, W; Zhang, ZH; Zhao, XL; He, C				Zhang, Yong; Wang, Yong-Gang; Zhang, Qi; Liu, Xiu-Jie; Liu, Xuan; Jiao, Li; Zhu, Wei; Zhang, Zhao-Huan; Zhao, Xiao-Lin; He, Cheng			Interaction of Mint2 with TrkA Is Involved in Regulation of Nerve Growth Factor-induced Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; PHOSPHOTYROSINE-BINDING DOMAIN; SYNAPTIC VESICLE EXOCYTOSIS; ACTIVATION LOOP TYROSINES; FACTOR RECEPTOR TRKA; SIGNAL-TRANSDUCTION; SYMPATHETIC NEURONS; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN	TrkA receptor signaling is essential for nerve growth factor (NGF)-induced survival and differentiation of sensory neurons. To identify possible effectors or regulators of TrkA signaling, yeast two-hybrid screening was performed using the intracellular domain of TrkA as bait. We identified muc18-1-interacting protein 2 (Mint2) as a novel TrkA-binding protein and found that the phosphotyrosine binding domain of Mint2 interacted with TrkA in a phosphorylation-and ligand-independent fashion. Coimmunoprecipitation assays showed that endogenous TrkA interacted with Mint2 in rat tissue homogenates, and immunohistochemical evidence revealed that Mint2 and TrkA colocalized in rat dorsal root ganglion neurons. Furthermore, Mint2 overexpression inhibited NGF-induced neurite outgrowth in both PC12 and cultured dorsal root ganglion neurons, whereas inhibition of Mint2 expression by RNA interference facilitated NGF-induced neurite outgrowth. Moreover, Mint2 was found to promote the retention of TrkA in the Golgi apparatus and inhibit its surface sorting. Taken together, our data provide evidence that Mint2 is a novel TrkA-regulating protein that affects NGF-induced neurite outgrowth, possibly through a mechanism involving retention of TrkA in the Golgi apparatus.	[Zhang, Yong; Wang, Yong-Gang; Zhang, Qi; Liu, Xiu-Jie; Liu, Xuan; Jiao, Li; Zhu, Wei; Zhang, Zhao-Huan; Zhao, Xiao-Lin; He, Cheng] Second Mil Med Univ, Minist Educ, Inst Neurosci, Shanghai 200433, Peoples R China; [Zhang, Yong; Wang, Yong-Gang; Zhang, Qi; Liu, Xiu-Jie; Liu, Xuan; Jiao, Li; Zhu, Wei; Zhang, Zhao-Huan; Zhao, Xiao-Lin; He, Cheng] Second Mil Med Univ, Minist Educ, Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China; [Wang, Yong-Gang] Tongji Univ, Dept Neurol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China	Naval Medical University; Naval Medical University; Tongji University	He, C (corresponding author), Second Mil Med Univ, Minist Educ, Inst Neurosci, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn		Zhang, Zhaohuan/0000-0001-6882-9761	National Natural Science Foundation of China [30400123, 30570939, 30770657, 30530240]; National Key Basic Research Program [2006CB500702, 2007CB947100]; Program for Changjiang Scholars and Innovative Research Team [IRT0528]; Shanghai Rising- Star Program [05QMX1469]; Shanghai Metropolitan Fund for Research and Development [07DJ14005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai Rising- Star Program; Shanghai Metropolitan Fund for Research and Development	This work was supported by National Natural Science Foundation of China Grants 30400123, 30570939, 30770657, and 30530240, National Key Basic Research Program Grants 2006CB500702 and 2007CB947100, Program for Changjiang Scholars and Innovative Research Team Grant IRT0528, Shanghai Rising- Star Program Grant 05QMX1469, and Shanghai Metropolitan Fund for Research and Development Grant 07DJ14005.	Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; Eggert A, 2000, ONCOGENE, V19, P2043, DOI 10.1038/sj.onc.1203518; FRITSCH A, 1973, ANAL BIOCHEM, V55, P57, DOI 10.1016/0003-2697(73)90290-X; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; Gennuso F, 2004, P NATL ACAD SCI USA, V101, P2470, DOI 10.1073/pnas.0308452100; Grimes ML, 1996, J NEUROSCI, V16, P7950; Gryz EA, 2000, ONCOGENE, V19, P417, DOI 10.1038/sj.onc.1203330; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ide N, 1998, BIOCHEM BIOPH RES CO, V244, P258, DOI 10.1006/bbrc.1998.8243; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Jullien J, 2003, J BIOL CHEM, V278, P8706, DOI 10.1074/jbc.M202401200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; MacDonald JIS, 2000, J BIOL CHEM, V275, P18225, DOI 10.1074/jbc.M001862200; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; McLoughlin DM, 1996, FEBS LETT, V397, P197; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; NAGATAKUNO K, 1990, EXP CELL RES, V191, P273, DOI 10.1016/0014-4827(90)90014-2; Nakajima Y, 2001, MOL BRAIN RES, V92, P27, DOI 10.1016/S0169-328X(01)00126-7; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Ramoino P, 2001, EUR BIOPHYS J BIOPHY, V30, P305, DOI 10.1007/s002490100166; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Tanahashi H, 1999, NEUROREPORT, V10, P2575, DOI 10.1097/00001756-199908200-00025; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Wolf DE, 1998, BIOCHEMISTRY-US, V37, P3178, DOI 10.1021/bi9719253; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	63	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12469	12479		10.1074/jbc.M809214200	http://dx.doi.org/10.1074/jbc.M809214200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265194	hybrid, Green Published			2022-12-25	WOS:000265494600076
J	Amir, S; Wang, RX; Simons, JW; Mabjeesh, NJ				Amir, Sharon; Wang, Ruoxiang; Simons, Jonathan W.; Mabjeesh, Nicola J.			SEPT9_v1 Up-regulates Hypoxia-inducible Factor 1 by Preventing Its RACK1-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HUMAN BREAST-CANCER; FACTOR 1-ALPHA; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; EXPRESSION; HSP90; HIF-1-ALPHA; PATHWAY; GENE	A critical mediator of the cellular response to hypoxia is hypoxia-inducible factor 1 (HIF-1). Increased levels of HIF-1 alpha are often associated with increased tumor metastasis, therapeutic resistance, and poorer prognosis. We recently identified a novel interaction between HIF-1 alpha and the mammalian septin family member, SEPT9_v1. Septins are a highly conserved family of GTP-binding cytoskeletal proteins that are implicated in multiple cellular functions, including cell division and oncogenesis. SEPT9_v1 binds and stabilizes HIF-1 alpha protein and stimulates HIF-1 transcriptional activity. SEPT9_v1-HIF-1 activation promotes tumor growth and angiogenesis. The structural and functional relationships between SEPT9_v1 and HIF-1 alpha were analyzed. We found that SEPT9_v1 binds specifically with HIF-1 alpha but not with HIF2 alpha. The GTPase domain of SEPT9_v1 was identified as essential for HIF-1 alpha binding. A GTPase domain-derived polypeptide, corresponding to amino acids 252-379, was able to disrupt HIF-1 alpha-SEPT9_v1 interaction and to inhibit HIF-1 transcriptional activity. SEPT9_v1 also protected HIF-1 alpha from degradation induced by HSP90 inhibition by preventing the interaction of HIF-1 alpha with the RACK1 protein, which promotes its oxygen-independent proteasomal degradation. In conclusion, a new mechanism of oxygen-independent activation of HIF-1 has been identified that is mediated by SEPT9_v1 blockade of RACK1 activity on HIF-1 alpha degradation.	[Amir, Sharon; Mabjeesh, Nicola J.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Dept Urol,Prostate Canc Res Lab, IL-64239 Tel Aviv, Israel; [Wang, Ruoxiang] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30332 USA; [Simons, Jonathan W.] Prostate Canc Fdn, Santa Monica, CA 90401 USA; [Simons, Jonathan W.] Emory Univ, Dept Biomed Engn, NCI Ctr Nanotechnol Excellence, Atlanta, GA 30322 USA; [Simons, Jonathan W.] Georgia Inst Technol, Atlanta, GA 30322 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Georgia; Georgia Institute of Technology	Mabjeesh, NJ (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Dept Urol,Prostate Canc Res Lab, 6 Weizmann St, IL-64239 Tel Aviv, Israel.	nicolam@tasmc.health.gov.il		Simons, Jonathan/0000-0001-7660-0748	M. K. Humanitarian Foundation; Prostate Cancer Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	M. K. Humanitarian Foundation; Prostate Cancer Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	This work was supported by the M. K. Humanitarian Foundation, Prostate Cancer Foundation, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.	Amir S, 2006, CANCER RES, V66, P856, DOI 10.1158/0008-5472.CAN-05-2738; Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Taki T, 1999, CANCER RES, V59, P4261; Woelfle U, 2003, CANCER RES, V63, P5679; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05; Zhong H, 1999, CANCER RES, V59, P5830	37	44	46	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11142	11151		10.1074/jbc.M808348200	http://dx.doi.org/10.1074/jbc.M808348200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251694	Green Published, hybrid			2022-12-25	WOS:000265494500018
J	Beranek, A; Rechberger, G; Knauer, H; Wolinski, H; Kohlwein, SD; Leber, R				Beranek, Andreas; Rechberger, Gerald; Knauer, Heide; Wolinski, Heimo; Kohlwein, Sepp D.; Leber, Regina			Identification of a Cardiolipin-specific Phospholipase Encoded by the Gene CLD1 (YGR110W) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; LIPID-COMPOSITION; BIOSYNTHESIS; MITOCHONDRIA; SYNTHASE; MUTANT	The mitochondrial dimeric phospholipid cardiolipin is characterized by a high degree of unsaturation of its acyl chains, which is important for its functional interaction with mitochondrial enzymes. The unusual fatty acid composition of cardiolipin molecular species emerges from a de novo synthesized "premature" species by extensive acyl chain remodeling that involves as yet only partially identified acyltransferases and phospholipases. Recently, the yeast protein Taz1p was shown to function as a transacylase, which catalyzes the reacylation of monolysocardiolipin to mature cardiolipin. A defect in the orthologous human TAZ gene is associated with Barth syndrome, a severe genetic disorder, which may lead to cardiac failure and death in childhood. We now identified the protein encoded by reading frame YGR110W as a mitochondrial phospholipase, which deacylates de novo synthesized cardiolipin. Ygr110wp has a strong substrate preference for palmitic acid residues and functions upstream of Taz1p, to generate monolysocardiolipin for Taz1p-dependent reacylation with unsaturated fatty acids. We therefore rename the Ygr110wp as Cld1p (cardiolipin-specific deacylase 1).	[Beranek, Andreas; Rechberger, Gerald; Knauer, Heide; Wolinski, Heimo; Kohlwein, Sepp D.; Leber, Regina] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Leber, R (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-2, A-8010 Graz, Austria.	regina.leber@uni-graz.at		Kohlwein, Sepp Dieter/0000-0002-1030-0598; Wolinski, Heimo/0000-0002-1583-6092; Leber, Regina/0000-0001-5306-5834; Rechberger, Gerald N./0000-0002-0071-317X	Austrian Science Fund [P19041, F3005]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Project Number P19041 to R. L.) and Special Research Area lipotox (Grant F3005 to S. D. K.).	Brachmann CB, 1998, YEAST, V14, P115; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HAID A, 1983, METHOD ENZYMOL, V96, P192; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; MORRISON WR, 1964, J LIPID RES, V5, P600; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Tanaka K, 2008, BBA-MOL CELL BIOL L, V1781, P391, DOI 10.1016/j.bbalip.2008.06.001; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	33	99	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11572	11578		10.1074/jbc.M805511200	http://dx.doi.org/10.1074/jbc.M805511200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244244	Green Published, hybrid			2022-12-25	WOS:000265494500061
J	Fei, L; Perrett, S				Fei, Li; Perrett, Sarah			Disulfide Bond Formation Significantly Accelerates the Assembly of Ure2p Fibrils because of the Proximity of a Potential Amyloid Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PRION URE2P; SACCHAROMYCES-CEREVISIAE; PROTEIN URE2; FOLDING PATHWAY; IN-VITRO; NEURODEGENERATIVE DISEASES; GLUTAMINE REPEATS; ESCHERICHIA-COLI; POLAR ZIPPERS; DOMAINS FORM	Aggregation of the Ure2 protein is at the origin of the [URE3] prion trait in the yeast Saccharomyces cerevisiae. The N-terminal region of Ure2p is necessary and sufficient to induce the [URE3] phenotype in vivo and to polymerize into amyloid-like fibrils in vitro. However, as the N-terminal region is poorly ordered in the native state, making it difficult to detect structural changes in this region by spectroscopic methods, detailed information about the fibril assembly process is therefore lacking. Short fibril-forming peptide regions (4-7 residues) have been identified in a number of prion and other amyloid-related proteins, but such short regions have not yet been identified in Ure2p. In this study, we identify a unique cysteine mutant (R17C) that can greatly accelerate the fibril assembly kinetics of Ure2p under oxidizing conditions. We found that the segment QVNI, corresponding to residues 18-21 in Ure2p, plays a critical role in the fast assembly properties of R17C, suggesting that this segment represents a potential amyloid-forming region. A series of peptides containing the QVNI segment were found to form fibrils in vitro. Furthermore, the peptide fibrils could seed fibril formation for wild-type Ure2p. Preceding the QVNI segment with a cysteine or a hydrophobic residue, instead of a charged residue, caused the rate of assembly into fibrils to increase greatly for both peptides and full-length Ure2p. Our results indicate that the potential amyloid stretch and its preceding residue can modulate the fibril assembly of Ure2p to control the initiation of prion formation.	[Fei, Li; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Fei, Li] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@iname.com	Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997	National Natural Science Foundation of China [30470363, 30620130109, 30670428, 30870482]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences Knowledge Innovation [KSCX2-YW-R-119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences Knowledge Innovation(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30470363, 30620130109, 30670428, and 30870482; Chinese Ministry of Science and Technology Grants 2006CB500703 and 2006CB910903; and Chinese Academy of Sciences Knowledge Innovation Project KSCX2-YW-R-119.	Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baxa U, 2004, J MOL BIOL, V339, P259, DOI 10.1016/j.jmb.2004.03.033; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Catharino S, 2005, BIOL CHEM, V386, P633, DOI 10.1515/BC.2005.074; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; CREIGHTON TE, 1992, SCIENCE, V256, P111, DOI 10.1126/science.1373519; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fayard B, 2006, J MOL BIOL, V356, P843, DOI 10.1016/j.jmb.2005.12.011; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Knowles TPJ, 2006, BIOPHYS J, V91, P1494, DOI 10.1529/biophysj.106.081653; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Mason JM, 2005, J BIOL CHEM, V280, P40494, DOI 10.1074/jbc.M509281200; Mason JM, 2002, BIOCHEMISTRY-US, V41, P12093, DOI 10.1021/bi026398o; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Parrini C, 2008, J MOL BIOL, V379, P1107, DOI 10.1016/j.jmb.2008.04.051; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200; STRAUSBERG S, 1993, BIOCHEMISTRY-US, V32, P10371, DOI 10.1021/bi00090a012; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	53	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11134	11141		10.1074/jbc.M809673200	http://dx.doi.org/10.1074/jbc.M809673200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258323	hybrid, Green Published			2022-12-25	WOS:000265494500017
J	Cheon, DJ; Wang, Y; Deng, JM; Lu, Z; Xiao, L; Chen, CM; Bast, RC; Behringer, RR				Cheon, Dong-Joo; Wang, Ying; Deng, Jian Min; Lu, Zhen; Xiao, Lianchun; Chen, Chun-Ming; Bast, Robert C., Jr.; Behringer, Richard R.			CA125/MUC16 Is Dispensable for Mouse Development and Reproduction	PLOS ONE			English	Article								Cancer antigen 125 (CA125) is a blood biomarker that is routinely used to monitor the progression of human epithelial ovarian cancer (EOC) and is encoded by MUC16, a member of the mucin gene family. The biological function of CA125/MUC16 and its potential role in EOC are poorly understood. Here we report the targeted disruption of the of the Muc16 gene in the mouse. To generate Muc16 knockout mice, 6.0 kb was deleted that included the majority of exon 3 and a portion of intron 3 and replaced with a lacZ reporter cassette. Loss of Muc16 protein expression suggests that Muc16 homozygous mutant mice are null mutants. Muc16 homozygous mutant mice are viable, fertile, and develop normally. Histological analysis shows that Muc16 homozygous mutant tissues are normal. By the age of 1 year, Muc16 homozygous mutant mice appear normal. Downregulation of transcripts from another mucin gene (Muc1) was detected in the Muc16 homozygous mutant uterus. Lack of any prominent abnormal phenotype in these Muc16 knockout mice suggests that CA125/MUC16 is not required for normal development or reproduction. These knockout mice provide a unique platform for future studies to identify the role of CA125/MUC16 in organ homeostasis and ovarian cancer.	[Cheon, Dong-Joo; Chen, Chun-Ming; Behringer, Richard R.] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Cheon, Dong-Joo; Wang, Ying; Deng, Jian Min; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX USA; [Lu, Zhen; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Xiao, Lianchun] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cheon, DJ (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	rrb@mdanderson.org	Lu, Zhen/E-5221-2015; Bast, Robert C/E-6585-2011	Bast, Robert C/0000-0003-4621-8462; Lu, Zhen/0000-0002-9596-0148; Chen, Chun-Ming/0000-0001-8873-7602	United States Department of the Army [DAMD 17-03-1-0449]; Ben F. Love Endowment; Bettyann Asche-Murray Ovarian Cancer Fellowship; Schissler Foundation Fellowship in Genetics of Human Disease; NIH Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	United States Department of the Army; Ben F. Love Endowment; Bettyann Asche-Murray Ovarian Cancer Fellowship; Schissler Foundation Fellowship in Genetics of Human Disease; NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a United States Department of the Army grant DAMD 17-03-1-0449 to R.R.B. and R.C.B, Jr., the Ben F. Love Endowment to R.R.B.. D.-J. Cheon was supported by a Bettyann Asche-Murray Ovarian Cancer Fellowship and a Schissler Foundation Fellowship in Genetics of Human Disease. DNA sequencing and veterinary resources were supported by the NIH Cancer Center Support (Core) Grant, CA16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Belisle JA, 2007, IMMUNOLOGY, V122, P418, DOI 10.1111/j.1365-2567.2007.02660.x; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; BRAGA VMM, 1993, J CELL SCI, V105, P397; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; Gaetje R, 2002, Clin Exp Obstet Gynecol, V29, P34; Gaetje R, 1999, J SOC GYNECOL INVEST, V6, P278, DOI 10.1016/S1071-5576(99)00027-1; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; HARDARDOTTIR H, 1990, AM J OBSTET GYNECOL, V163, P1925, DOI 10.1016/0002-9378(90)90775-3; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jager K, 2007, HISTOCHEM CELL BIOL, V127, P433, DOI 10.1007/s00418-006-0246-6; KABAWAT SE, 1983, INT J GYNECOL PATHOL, V2, P275, DOI 10.1097/00004347-198303000-00005; Kitamura K, 1999, DEVELOPMENT, V126, P5749; McDonnel AC, 2003, REPRODUCTION, V126, P615, DOI 10.1530/reprod/126.5.615; Nagy A., 2003, MANIPULATING MOUSE E; NOUWEN EJ, 1986, CANCER RES, V46, P866; NOUWEN EJ, 1987, AM J PATHOL, V126, P230; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang Y, 2008, DIFFERENTIATION, V76, P1081, DOI 10.1111/j.1432-0436.2008.00295.x; Yin BWT, 2002, INT J CANCER, V98, P737, DOI 10.1002/ijc.10250; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	29	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4675	10.1371/journal.pone.0004675	http://dx.doi.org/10.1371/journal.pone.0004675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262696	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490600008
J	Diguet, E; Petit, F; Escartin, C; Cambon, K; Bizat, N; Dufour, N; Hantraye, P; Deglon, N; Brouillet, E				Diguet, Elsa; Petit, Fanny; Escartin, Carole; Cambon, Karine; Bizat, Nicolas; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole; Brouillet, Emmanuel			Normal Aging Modulates the Neurotoxicity of Mutant Huntingtin	PLOS ONE			English	Article								Aging likely plays a role in neurodegenerative disorders. In Huntington's disease (HD), a disorder caused by an abnormal expansion of a polyglutamine tract in the protein huntingtin (Htt), the role of aging is unclear. For a given tract length, the probability of disease onset increases with age. There are mainly two hypotheses that could explain adult onset in HD: Either mutant Htt progressively produces cumulative defects over time or "normal'' aging renders neurons more vulnerable to mutant Htt toxicity. In the present study, we directly explored whether aging affected the toxicity of mutant Htt in vivo. We studied the impact of aging on the effects produced by overexpression of an N-terminal fragment of mutant Htt, of wild-type Htt or of a beta-Galactosidase (beta-Gal) reporter gene in the rat striatum. Stereotaxic injections of lentiviral vectors were performed simultaneously in young (3 week) and old (15 month) rats. Histological evaluation at different time points after infection demonstrated that the expression of mutant Htt led to pathological changes that were more severe in old rats, including an increase in the number of small Htt-containing aggregates in the neuropil, a greater loss of DARPP-32 immunoreactivity and striatal neurons as assessed by unbiased stereological counts. The present results support the hypothesis that "normal'' aging is involved in HD pathogenesis, and suggest that age-related cellular defects might constitute potential therapeutic targets for HD.	[Diguet, Elsa; Petit, Fanny; Escartin, Carole; Cambon, Karine; Bizat, Nicolas; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole; Brouillet, Emmanuel] CEA, I2BM, MIRCen, Orsay, France; [Diguet, Elsa; Petit, Fanny; Escartin, Carole; Cambon, Karine; Bizat, Nicolas; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole; Brouillet, Emmanuel] CNRS, CEA, Unite Rech Associee, Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Diguet, E (corresponding author), CEA, I2BM, MIRCen, Orsay, France.	emmanuel.brouillet@cea.fr	Escartin, Carole/A-1952-2010; Brouillet, Emmanuel/B-4784-2014; Deglon, Nicole/A-2265-2012	Escartin, Carole/0000-0003-3613-4118; Brouillet, Emmanuel/0000-0001-6322-7403; Deglon, Nicole/0000-0003-4475-9476; Cambon, Karine/0000-0001-9263-4366	GIS (Groupement d'Interet Scientifique) "Longevite"	GIS (Groupement d'Interet Scientifique) "Longevite"	This study was partially supported by a government grant entitled GIS (Groupement d'Interet Scientifique) "Longevite". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Asanuma M, 1996, MOL BRAIN RES, V41, P210, DOI 10.1016/0169-328X(96)00098-8; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bizat N, 2003, J NEUROSCI, V23, P5020; Bogdanov MB, 1998, J NEUROCHEM, V71, P2642; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; de Almeida LP, 2002, J NEUROSCI, V22, P3473; de Almeida LP, 2001, NEUROBIOL DIS, V8, P433, DOI 10.1006/nbdi.2001.0388; Deglon N, 2002, CURR TOP MICROBIOL, V261, P191; Deglon N, 2005, J GENE MED, V7, P530, DOI 10.1002/jgm.707; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Madeira MD, 1997, J NEUROSCI, V17, P1302; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Palfi S, 2007, MOL THER, V15, P1444, DOI 10.1038/sj.mt.6300185; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Regulier E, 2002, HUM GENE THER, V13, P1981, DOI 10.1089/10430340260355383; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	65	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4637	10.1371/journal.pone.0004637	http://dx.doi.org/10.1371/journal.pone.0004637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247483	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800019
J	Franchini, DM; Benoukraf, T; Jaeger, S; Ferrier, P; Payet-Bornet, D				Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique			Initiation of V(D)J Recombination by D beta-Associated Recombination Signal Sequences: A Critical Control Point in TCR beta Gene Assembly	PLOS ONE			English	Article							CODING END SEQUENCE; V-BETA; REARRANGEMENT; RAG2; RESTRICTION; MECHANISM; LYSINE-4; PROTEINS; ENHANCER; COMPLEX	T cell receptor (TCR) beta gene assembly by V(D)J recombination proceeds via successive D beta-to-J beta and V beta-to-DJ beta rearrangements. This two-step process is enforced by a constraint, termed beyond (B) 12/23, which prohibits direct V beta-to-J beta rearrangements. However the B12/23 restriction does not explain the order of TCR beta assembly for which the regulation remains an unresolved issue. The initiation of V(D) J recombination consists of the introduction of single-strand DNA nicks at recombination signal sequences (RSSs) containing a 12 base-pairs spacer. An RSS containing a 23 base-pairs spacer is then captured to form a 12/23 RSSs synapse leading to coupled DNA cleavage. Herein, we probed RSS nicks at the TCR beta locus and found that nicks were only detectable at D beta-associated RSSs. This pattern implies that D beta 12RSS and, unexpectedly, D beta 23RSS initiate V(D) J recombination and capture their respective V beta or J beta RSS partner. Using both in vitro and in vivo assays, we further demonstrate that the D beta 23RSS impedes cleavage at the adjacent D beta 1 12RSS and consequently V beta-to-D beta 1 rearrangement first requires the D beta 1 23RSS excision. Altogether, our results provide the molecular explanation to the B12/23 constraint and also uncover a 'D beta 1 23RSS-mediated' restriction operating beyond chromatin accessibility, which directs D beta 1 ordered rearrangements.	[Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique] Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France; [Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique] CNRS, UMR6102, Marseille, France; [Franchini, Don-Marc; Benoukraf, Touati; Jaeger, Sebastien; Ferrier, Pierre; Payet-Bornet, Dominique] Inserm, U631, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Franchini, DM (corresponding author), Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France.	payet@ciml.univ-mrs.fr	Benoukraf, Touati/K-9978-2019; BORNET, Dominique PAYET/O-8367-2016; Franchini, Don Marc/A-5203-2015	Benoukraf, Touati/0000-0002-4789-8028; BORNET, Dominique PAYET/0000-0003-3196-3814; Franchini, Don Marc/0000-0002-2562-5643	Inserm; CNRS; Fondation Princesse Grace de Monaco; Association pour la Recherche sur le Cancer [ARC 3275XA0331F]; Agence Nationale de la Recherche [ANR-06-BYOS-0006]; Commission of the European Communities [MRTN-CT-2006-035733]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Princesse Grace de Monaco; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Commission of the European Communities(European Commission)	This work was supported by institutional grants from Inserm and the CNRS, and by specific grants from the 'Fondation Princesse Grace de Monaco', the 'Association pour la Recherche sur le Cancer' (ARC 3275XA0331F), the 'Agence Nationale de la Recherche' (ANR-06-BYOS-0006) and the Commission of the European Communities (MRTN-CT-2006-035733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Drejer-Teel AH, 2007, MOL CELL BIOL, V27, P6288, DOI 10.1128/MCB.00835-07; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; EZEKIEL UR, 1995, IMMUNITY, V2, P381, DOI 10.1016/1074-7613(95)90146-9; Feeney AJ, 2004, IMMUNOL REV, V200, P44, DOI 10.1111/j.0105-2896.2004.00163.x; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Hughes MM, 2003, J IMMUNOL, V171, P6604, DOI 10.4049/jimmunol.171.12.6604; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jackson AM, 2006, IMMUNOL REV, V209, P129, DOI 10.1111/j.0105-2896.2006.00342.x; Jackson AM, 2005, J IMMUNOL, V175, P5186, DOI 10.4049/jimmunol.175.8.5186; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2003, IMMUNITY, V18, P65, DOI 10.1016/S1074-7613(02)00507-1; Lee AI, 2003, PLOS BIOL, V1, P56, DOI 10.1371/journal.pbio.0000001; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Livak F, 2000, J EXP MED, V192, P1191, DOI 10.1084/jem.192.8.1191; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Nagawa F, 2004, J BIOL CHEM, V279, P38360, DOI 10.1074/jbc.M405485200; Olaru A, 2004, MOL IMMUNOL, V40, P1189, DOI 10.1016/j.molimm.2003.11.019; Olaru A, 2003, J IMMUNOL, V171, P3605, DOI 10.4049/jimmunol.171.7.3605; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; Sleckman BP, 2000, P NATL ACAD SCI USA, V97, P7975, DOI 10.1073/pnas.130190597; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Tillman RE, 2004, IMMUNOL REV, V200, P36, DOI 10.1111/j.0105-2896.2004.00156.x; Tillman RE, 2003, J IMMUNOL, V170, P5, DOI 10.4049/jimmunol.170.1.5; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; Wang XM, 2008, NAT IMMUNOL, V9, P794, DOI 10.1038/ni.1614; Wilson A, 2001, J IMMUNOL, V166, P51, DOI 10.4049/jimmunol.166.1.51; Wu C, 2003, IMMUNITY, V18, P75, DOI 10.1016/S1074-7613(02)00515-0; Yu KF, 1999, MOL CELL BIOL, V19, P8094	46	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4575	10.1371/journal.pone.0004575	http://dx.doi.org/10.1371/journal.pone.0004575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238214	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487400008
J	Halaban, R; Krauthammer, M; Cheng, MPE; Kovacs, D; Sznol, M; Ariyan, S; Narayan, D; Bacchiocchi, A; Molinaro, A; Kluger, Y; Deng, M; Tran, N; Zhang, WG; Picardo, M; Enghild, JJ				Halaban, Ruth; Krauthammer, Michael; Cheng, Mattia Pelizzola Elaine; Kovacs, Daniela; Sznol, Mario; Ariyan, Stephan; Narayan, Deepak; Bacchiocchi, Antonella; Molinaro, Annette; Kluger, Yuval; Deng, Min; Tran, Nam; Zhang, Wengeng; Picardo, Mauro; Enghild, Jan J.			Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications	PLOS ONE			English	Article							BETA-CATENIN; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; HDAC INHIBITORS; EXPRESSION; 5-AZA-2'-DEOXYCYTIDINE; METHYLATION; CANCER; GENES; DEMETHYLATION	Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methylation, is effective for some, but not all cancer patients, especially those with solid tumors. It is commonly recognized that to overcome resistance and improve outcome, treatment should be guided by tumor biology, which includes genotype, epigenotype, and gene expression profile. We therefore took an integrative approach to better understand melanoma cell response to clinically relevant dose of decitabine and identify complementary targets for combined therapy. We employed eight different melanoma cell strains, determined their growth, apoptotic and DNA damage responses to increasing doses of decitabine, and chose a low, clinically relevant drug dose to perform whole-genome differential gene expression, bioinformatic analysis, and protein validation studies. The data ruled out the DNA damage response, demonstrated the involvement of p21(Cip1) in a p53-independent manner, identified the TGF beta pathway genes CLU and TGFBI as markers of sensitivity to decitabine and revealed an effect on histone modification as part of decitabine-induced gene expression. Mutation analysis and knockdown by siRNA implicated activated beta-catenin/MITF, but not BRAF, NRAS or PTEN mutations as a source for resistance. The importance of protein stability predicted from the results was validated by the synergistic effect of Bortezomib, a proteasome inhibitor, in enhancing the growth arrest of decitabine in otherwise resistant melanoma cells. Our integrative analysis show that improved therapy can be achieved by comprehensive analysis of cancer cells, identified biomarkers for patient's selection and monitoring response, as well as targets for improved combination therapy.	[Halaban, Ruth; Bacchiocchi, Antonella; Deng, Min; Zhang, Wengeng] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Krauthammer, Michael; Tran, Nam] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Cheng, Mattia Pelizzola Elaine; Molinaro, Annette] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Sznol, Mario] Yale Univ, Sch Med, Dept Comprehensive Canc Ctr, Sect Med Oncol, New Haven, CT 06520 USA; [Ariyan, Stephan; Narayan, Deepak] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; [Kluger, Yuval] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Kovacs, Daniela; Picardo, Mauro] San Gallicano Dermatol Inst, Rome, Italy; [Enghild, Jan J.] Univ Aarhus, DK-8000 Aarhus, Denmark	Yale University; Yale University; Yale University; Yale University; Yale University; New York University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Aarhus University	Halaban, R (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	ruth.halaban@yale.edu	kovacs, daniela/H-4418-2014; Picardo, Mauro/A-6978-2011	kovacs, daniela/0000-0003-1873-0549; Picardo, Mauro/0000-0003-4899-6639; Zhang, Wengeng/0000-0002-1000-4692; Pelizzola, Mattia/0000-0001-6672-9636; Enghild, Jan Johannes/0000-0001-9292-9172; Krauthammer, Michael/0000-0002-4808-1845; Sznol, Mario/0000-0002-4359-8749	National Cancer Institute [1 P50 CA121974, K22CA123146-2]; Yale Skin Diseases Research Core Center; National Library of Medicine [K22LM009255]; Progetto Italia-USA [530/F-A1]; NATIONAL CANCER INSTITUTE [P50CA121974, K22CA123146] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM009255] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Skin Diseases Research Core Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Progetto Italia-USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Yale Spore in Skin Cancer grant from the National Cancer Institute number 1 P50 CA121974 (Halaban, PI), and the Yale Skin Diseases Research Core Center (Tigelaar, PI). M.K. was supported by the National Library of Medicine grant K22LM009255, A.M.M. by the National Cancer Institute grant K22CA123146-2 and DK by the Progetto Italia-USA Grant 530/F-A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Borden EC, 2007, CYTOKINE GROWTH F R, V18, P491, DOI 10.1016/j.cytogfr.2007.06.022; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chai GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002445; Cheng E, 2006, J INVEST DERMATOL, V126, P2257, DOI 10.1038/sj.jid.5700386; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; CHUN T, 2008, CARCINOGENESIS, V4, P4; Curtin JA, 2006, J INVEST DERMATOL, V126, P1660, DOI 10.1038/sj.jid.5700311; Dahl C, 2007, APMIS, V115, P1161, DOI 10.1111/j.1600-0463.2007.apm_855.xml.x; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Giles FJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2007.12.002; Gimsing P, 2008, EUR J HAEMATOL, V81, P170, DOI 10.1111/j.1600-0609.2008.01102.x; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Gollob JA, 2006, CLIN CANCER RES, V12, P4619, DOI 10.1158/1078-0432.CCR-06-0883; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032; Herranz Michel, 2007, Methods Mol Biol, V361, P25; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Jabbour E, 2008, CANCER-AM CANCER SOC, V112, P2341, DOI 10.1002/cncr.23463; John T, 2008, CLIN CANCER RES, V14, P5173, DOI 10.1158/1078-0432.CCR-07-4170; Kielhorn E, 2003, INT J CANCER, V103, P652, DOI 10.1002/ijc.10893; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Liu HS, 2008, RARE METALS, V27, P545, DOI 10.1016/S1001-0521(08)60179-5; Luong T, 2007, P 2 BIOCREATIVE CHAL, P145; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nojima M, 2007, ONCOGENE, V26, P4699, DOI 10.1038/sj.onc.1210259; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Reu FJ, 2006, J CLIN ONCOL, V24, P3771, DOI 10.1200/JCO.2005.03.4074; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Schmelz K, 2005, INT J CANCER, V114, P683, DOI 10.1002/ijc.20797; Scott SA, 2006, LEUKEMIA RES, V30, P69, DOI 10.1016/j.leukres.2005.05.010; Shang DH, 2008, UROLOGY, V71, P1220, DOI 10.1016/j.urology.2007.11.029; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Steele NL, 2008, CLIN CANCER RES, V14, P804, DOI 10.1158/1078-0432.CCR-07-1786; Tamm I, 2005, ANN HEMATOL, V84, P47, DOI 10.1007/s00277-005-0013-0; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	56	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4563	10.1371/journal.pone.0004563	http://dx.doi.org/10.1371/journal.pone.0004563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234609	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487200017
J	Yang, ZS; Tang, HD; Huang, H; Deng, HY				Yang, Zhangsheng; Tang, Haidong; Huang, Hai; Deng, Hongyu			RTA Promoter Demethylation and Histone Acetylation Regulation of Murine Gammaherpesvirus 68 Reactivation	PLOS ONE			English	Article								Gammaherpesviruses have a common biological characteristic, latency and lytic replication. The balance between these two phases in murine gammaherpesvirus 68 (MHV-68) is controlled by the replication and transcription activator (RTA) gene. In this report, we investigated the effect of DNA demethylation and histone acetylation on MHV-68 replication. We showed that distinctivemethylation patterns were associated with MHV-68 at the RTA promoter during latency or lytic replication. Treatment of MHV-68 latently-infected S11E cells with a DNA methyltransferases (DNMTs) inhibitor 5-azacytidine (5-AzaC), only weakly reactivated MHV-68, despite resulted in demethylation of the viral RTA promoter. In contrast, treatment with a histone deacetylase (HDAC) inhibitor trichostatin A (TSA) strongly reactivated MHV-68 from latency, and this was associated with significant change in histone H3 and H4 acetylation levels at the RTA promoter. We further showed that HDAC3 was recruited to the RTA promoter and inhibited RTA transcription during viral latency. However, TSA treatment caused rapid removal of HDAC3 and also induced passive demethylation at the RTA promoter. In vivo, we found that the RTA promoter was hypomethylated during lytic infection in the lung and that methylation level increased with virus latent infection in the spleen. Collectively, our data showed that histone acetylation, but not DNA demethylation, is sufficient for effective reactivation of MHV-68 from latency in S11E cells.	[Yang, Zhangsheng; Tang, Haidong; Huang, Hai; Deng, Hongyu] Chinese Acad Sci, Ctr Infect & Immun, Beijing, Peoples R China; [Yang, Zhangsheng; Tang, Haidong; Huang, Hai; Deng, Hongyu] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Yang, Zhangsheng; Tang, Haidong; Huang, Hai] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Deng, Hongyu] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Los Angeles	Yang, ZS (corresponding author), Chinese Acad Sci, Ctr Infect & Immun, Beijing, Peoples R China.	rrain6@yahoo.com	Yang, Zhangsheng/N-4080-2013; Huang, Hai/CZY-9855-2022; Tang, Haidong/P-1729-2019; Tang, Haidong/G-1800-2011	Yang, Zhangsheng/0000-0003-2208-8632; Huang, Hai/0000-0003-2331-6238; Tang, Haidong/0000-0002-1512-2655; 	National Science Foundation [30570075]; NIH [DE15612]; International Fogarty Program on AIDS Malignancies; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE015612] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Fogarty Program on AIDS Malignancies; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Science Foundation grant 30570075, NIH grant DE15612 and International Fogarty Program on AIDS Malignancies.	Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; BENSASSON SA, 1981, INT J CANCER, V28, P131, DOI 10.1002/ijc.2910280204; Blackman MA, 2002, J EXP MED, V195, pF29, DOI 10.1084/jem.20020243; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Esteller M, 2005, CURR OPIN ONCOL, V17, P55, DOI 10.1097/01.cco.0000147383.04709.10; Fenic I, 2004, J ANDROL, V25, P811; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Fog CK, 2007, APMIS, V115, P1060, DOI 10.1111/j.1600-0463.2007.apm_776.xml.x; Geiman TM, 2002, J CELL BIOCHEM, V87, P117, DOI 10.1002/jcb.10286; Gibbons RJ, 2005, HUM MOL GENET, V14, pR85, DOI 10.1093/hmg/ddi106; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lu F, 2003, J VIROL, V77, P11425, DOI 10.1128/JVI.77.21.11425-11435.2003; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Moore SM, 2001, ANTIMICROB AGENTS CH, V45, P2082, DOI 10.1128/AAC.45.7.2082-2091.2001; Moser JM, 2005, J VIROL, V79, P9480, DOI 10.1128/JVI.79.15.9480-9491.2005; Moser JM, 2005, J VIROL, V79, P5227, DOI 10.1128/JVI.79.8.5227-5231.2005; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Seo JS, 2008, ONCOL REP, V19, P93; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Singal R, 1999, BLOOD, V93, P4059, DOI 10.1182/blood.V93.12.4059; Speck SH, 1999, CURR OPIN MICROBIOL, V2, P403; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; Takami Y, 2000, J BIOL CHEM, V275, P16191, DOI 10.1074/jbc.M908066199; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Virgin HW, 1999, CURR OPIN IMMUNOL, V11, P371, DOI 10.1016/S0952-7915(99)80063-6; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	68	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4556	10.1371/journal.pone.0004556	http://dx.doi.org/10.1371/journal.pone.0004556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234612	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487200012
J	Cardoso, CMP; Groth-Pedersen, L; Hoyer-Hansen, M; Kirkegaard, T; Corcelle, E; Andersen, JS; Jaattela, M; Nylandsted, J				Cardoso, Carla M. P.; Groth-Pedersen, Line; Hoyer-Hansen, Maria; Kirkegaard, Thomas; Corcelle, Elizabeth; Andersen, Jens S.; Jaattela, Marja; Nylandsted, Jesper			Depletion of Kinesin 5B Affects Lysosomal Distribution and Stability and Induces Peri-Nuclear Accumulation of Autophagosomes in Cancer Cells	PLOS ONE			English	Article								Background: Enhanced lysosomal trafficking is associated with metastatic cancer. In an attempt to discover cancer relevant lysosomal motor proteins, we compared the lysosomal proteomes from parental MCF-7 breast cancer cells with those from highly invasive MCF-7 cells that express an active form of the ErbB2 (Delta N-ErbB2). Methodology/Principal Findings: Mass spectrometry analysis identified kinesin heavy chain protein KIF5B as the only microtubule motor associated with the lysosomes in MCF-7 cells, and ectopic Delta N-ErbB2 enhanced its lysosomal association. KIF5B associated with lysosomes also in HeLa cervix carcinoma cells as analyzed by subcellular fractionation. The depletion of KIF5B triggered peripheral aggregations of lysosomes followed by lysosomal destabilization, and cell death in HeLa cells. Lysosomal exocytosis in response to plasma membrane damage as well as fluid phase endocytosis functioned, however, normally in these cells. Both HeLa and MCF-7 cells appeared to express similar levels of the KIF5B isoform but the death phenotype was weaker in KIF5B-depleted MCF-7 cells. Surprisingly, KIF5B depletion inhibited the rapamycin-induced accumulation of autophagosomes in MCF-7 cells. In KIF5B-depleted cells the autophagosomes formed and accumulated in the close proximity to the Golgi apparatus, whereas in the control cells they appeared uniformly distributed in the cytoplasm. Conclusions/Significance: Our data identify KIF5B as a cancer relevant lysosomal motor protein with additional functions in autophagosome formation.	[Cardoso, Carla M. P.; Corcelle, Elizabeth] Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Groth-Pedersen, Line; Hoyer-Hansen, Maria; Kirkegaard, Thomas; Corcelle, Elizabeth; Jaattela, Marja; Nylandsted, Jesper] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept & Ctr Genotox Stress Res, Copenhagen, Denmark; [Corcelle, Elizabeth; Andersen, Jens S.] Univ So Denmark, CEBI, Odense, Denmark	Universidade de Coimbra; Danish Cancer Society; University of Southern Denmark	Cardoso, CMP (corresponding author), Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	mj@cancer.dk; jnl@cancer.dk	Nylandsted, Jesper/ABE-7192-2021; Corcelle-Termeau, Elisabeth/ABA-9247-2020; Jäättelä, Marja/AAT-7932-2021; Andersen, Jens S/L-2100-2015	Jäättelä, Marja/0000-0001-5950-7111; Andersen, Jens S/0000-0002-6091-140X; Cardoso, Carla/0000-0002-0985-7487; Nylandsted, Jesper/0000-0001-6474-5093; Corcelle-Termeau, Elisabeth/0000-0002-3706-3756	Portuguese Foundation for Science and Technology [SFRH/BPD/14448/2003]; Danish Cancer Society; Danish National Research Foundation; Danish Medical Research Council; Meyer Foundation; M.L. JArgensen and Gunnar Hansens Foundation; Novo Foundation; Vilhelm Pedersen Foundation; Danish Cancer Research Foundation; European Commission FP7 APO-SYS consortium	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Meyer Foundation; M.L. JArgensen and Gunnar Hansens Foundation; Novo Foundation; Vilhelm Pedersen Foundation; Danish Cancer Research Foundation; European Commission FP7 APO-SYS consortium	CMP Cardoso was a recipient of a grant from the Portuguese Foundation for Science and Technology (SFRH/BPD/14448/2003). This work was supported by grants from the Danish Cancer Society (MJ), the Danish National Research Foundation (MJ), the Danish Medical Research Council (JN and MJ), the Meyer Foundation (MJ), the M.L. JArgensen and Gunnar Hansens Foundation (MJ), the Novo Foundation (MJ and MHH), the Vilhelm Pedersen Foundation (JN and MJ), the Danish Cancer Research Foundation (MJ) and the European Commission FP7 APO-SYS consortium (MJ and JSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Egeblad M, 2001, INT J CANCER, V94, P185, DOI 10.1002/ijc.1459; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fehrenbacher N, 2004, CANCER RES, V64, P5301, DOI 10.1158/0008-5472.CAN-04-1427; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kasprzak AA, 2002, ACTA BIOCHIM POL, V49, P813; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Ostenfeld MS, 2008, AUTOPHAGY, V4, P487, DOI 10.4161/auto.5774; Potter H., 2001, CURR PROTOC IMMUNOL; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Ross, 1998, Oncologist, V3, P237; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2	27	77	80	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4424	10.1371/journal.pone.0004424	http://dx.doi.org/10.1371/journal.pone.0004424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19242560	Green Published, Green Submitted, gold			2022-12-25	WOS:000265484000013
J	Defer, N; Wan, JH; Souktani, R; Escoubet, B; Perier, M; Caramelle, P; Manin, S; Deveaux, V; Bourin, MC; Zimmer, A; Lotersztajn, S; Pecker, F; Pavoine, C				Defer, Nicole; Wan, Jinghong; Souktani, Richard; Escoubet, Brigitte; Perier, Magali; Caramelle, Philippe; Manin, Sylvie; Deveaux, Vanessa; Bourin, Marie-Claude; Zimmer, Andreas; Lotersztajn, Sophie; Pecker, Francoise; Pavoine, Catherine			The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy	FASEB JOURNAL			English	Article						in vivo; remodeling; apoptosis; heart failure; signaling; fibrosis	ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; INFARCT SIZE; TNF-ALPHA; MYOCARDIAL-INFARCTION; HEART-FAILURE; CB2 RECEPTOR; ENDOCANNABINOIDS; MICE; RATS	Post-myocardial infarction (MI) heart failure is a major public health problem in Western countries and results from ischemia/reperfusion (IR)-induced cell death, remodeling, and contractile dysfunction. Ex vivo studies have demonstrated the cardioprotective anti-inflammatory effect of the cannabinoid type 2 (CB2) receptor agonists within hours after IR. Herein, we evaluated the in vivo effect of CB2 receptors on IR-induced cell death, fibrosis, and cardiac dysfunction and investigated the target role of cardiac myocytes and fibroblasts. The infarct size was increased 24 h after IR in CB2(-/-) vs. wild-type (WT) hearts and decreased when WT hearts were injected with the CB2 agonist JWH133 (3 mg/kg) at reperfusion. Compared with WT hearts, CB2(-/-) hearts showed widespread injury 3 d after IR, with enhanced apoptosis and remodeling affecting the remote myocardium. Finally, CB2(-/-) hearts exhibited exacerbated fibrosis, associated with left ventricular dysfunction 4 wk after IR, whereas their WT counterparts recovered normal function. Cardiac myocytes and fibroblasts isolated from CB2(-/-) hearts displayed a higher H2O2-induced death than WT cells, whereas 1 mu M JWH133 triggered survival effects. Furthermore, H2O2-induced myofibroblast activation was increased in CB2(-/-) fibroblasts but decreased in 1 mu M JWH133-treated WT fibroblasts, compared with that in WT cells. Therefore, CB2 receptor activation may protect against post-IR heart failure through direct inhibition of cardiac myocyte and fibroblast death and prevention of myofibroblast activation.-Defer, N., Wan, J., Souktani, R., Escoubet, B., Perier, M., Caramelle, P., Manin, S., Deveaux, V., Bourin, M.-C., Zimmer, A., Lotersztajn, S., Pecker, F., Pavoine, C. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J. 23, 2120-2130 (2009)	[Defer, Nicole; Wan, Jinghong; Perier, Magali; Caramelle, Philippe; Manin, Sylvie; Deveaux, Vanessa; Bourin, Marie-Claude; Lotersztajn, Sophie; Pecker, Francoise; Pavoine, Catherine] Hop Henri Mondor, INSERM, U955, IMRB, F-94010 Creteil, France; [Defer, Nicole; Wan, Jinghong; Souktani, Richard; Perier, Magali; Caramelle, Philippe; Manin, Sylvie; Deveaux, Vanessa; Bourin, Marie-Claude; Lotersztajn, Sophie; Pecker, Francoise; Pavoine, Catherine] Univ Paris 12, Fac Med, UMR S 955, Creteil, France; [Souktani, Richard] IFR10 IM3, Creteil, France; [Escoubet, Brigitte] Univ Paris 07, INSERM, Assistance Publ Hop Paris, Hop Bichat,UFR Med,U872, Paris, France; [Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-5300 Bonn, Germany; [Pecker, Francoise] Grp Hosp Henri Mondor Albert Chenevier, Assistance Publ Hop Paris, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Pavoine, C (corresponding author), Hop Henri Mondor, INSERM, U955, IMRB, F-94010 Creteil, France.	catherine.pavoine@inserm.fr	Lotersztajn, Sophie/K-9160-2017; Pavoine, Catherine/N-4405-2018; Zimmer, Andreas/B-8357-2009	Pavoine, Catherine/0000-0002-0598-5545; lotersztajn, Sophie/0000-0002-0053-7807	INSERM; Universite Paris-Val de Marne; Assistance Publique des Hopitaux de Paris; Agence Nationale de la Recherche [R06403JS]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Val de Marne; Assistance Publique des Hopitaux de Paris; Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank A. Berdeaux for helpful discussions and M. Muffat-Joly for hemodynamic measurements that were performed at the Comite d'Etudes sur les Formations d'Ingenieurs-Institut Federatif de Recherche 2 ( Paris). This work was supported by INSERM, by the Universite Paris-Val de Marne, by the Assistance Publique des Hopitaux de Paris ( as a contrat d'interface to F. P.), and by a grant (R06403JS) from the Agence Nationale de la Recherche. J.W. was supported by a fellowship ( R06403JS, canna licoca) from the Agence Nationale de la Recherche.	Ait-Mamar B, 2005, J BIOL CHEM, V280, P18881, DOI 10.1074/jbc.M410305200; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH1689, DOI 10.1152/ajpheart.00538.2007; Beggah AT, 2002, P NATL ACAD SCI USA, V99, P7160, DOI 10.1073/pnas.102673599; Billet S, 2007, J CLIN INVEST, V117, P1914, DOI 10.1172/JCI28764; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; BRAUNWALD E, 1991, AM J CARDIOL, V68, pD1; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Cailleret M, 2004, CIRCULATION, V109, P406, DOI 10.1161/01.CIR.0000109499.00587.FF; Condorelli G, 2001, P NATL ACAD SCI USA, V98, P9977, DOI 10.1073/pnas.161120198; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Di Filippo C, 2004, J LEUKOCYTE BIOL, V75, P453, DOI 10.1189/jlb.0703303; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Duffy D, 2007, TRENDS CARDIOVAS MED, V17, P35, DOI 10.1016/j.tcm.2006.11.003; Duran WN, 2008, AM J PHYSIOL-HEART C, V295, pH2221, DOI 10.1152/ajpheart.01050.2008; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH2242, DOI 10.1152/ajpheart.00587.2008; Gaskari SA, 2005, BRIT J PHARMACOL, V146, P315, DOI 10.1038/sj.bjp.0706331; Gottlieb RA, 1999, ANN NY ACAD SCI, V874, P412, DOI 10.1111/j.1749-6632.1999.tb09255.x; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Idris AI, 2008, ENDOCRINOLOGY, V149, P5619, DOI 10.1210/en.2008-0150; Ikeuchi M, 2004, CARDIOVASC RES, V64, P526, DOI 10.1016/j.cardiores.2004.07.017; Joyeux M, 2002, CARDIOVASC RES, V55, P619, DOI 10.1016/S0008-6363(02)00268-7; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Lagneux C, 2001, BRIT J PHARMACOL, V132, P793, DOI 10.1038/sj.bjp.0703902; Lepicier P, 2007, LIFE SCI, V81, P1373, DOI 10.1016/j.lfs.2007.08.042; Lepicier P, 2006, J PHARMACOL SCI, V102, P155, DOI 10.1254/jphs.CRJ06011X; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Lotersztajn S, 2008, BRIT J PHARMACOL, V153, P286, DOI 10.1038/sj.bjp.0707511; Mach F, 2008, BRIT J PHARMACOL, V153, P290, DOI 10.1038/sj.bjp.0707517; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Mann DL, 2003, ANNU REV PHYSIOL, V65, P81, DOI 10.1146/annurev.physiol.65.092101.142249; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Sarkar S, 2004, AM J PHYSIOL-HEART C, V287, pH107, DOI 10.1152/ajpheart.00763.2003; Shivakumar K, 2008, AM J PHYSIOL-HEART C, V294, pH2653, DOI 10.1152/ajpheart.91443.2007; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0; Yaoita H, 1998, CIRCULATION, V97, P276, DOI 10.1161/01.CIR.97.3.276; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	50	92	112	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2120	2130		10.1096/fj.09-129478	http://dx.doi.org/10.1096/fj.09-129478			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246487				2022-12-25	WOS:000268836500012
J	Horiuchi, M; Takeuchi, K; Noda, N; Muroya, N; Suzuki, T; Nakamura, T; Kawamura-Tsuzuku, J; Takahasi, K; Yamamoto, T; Inagaki, F				Horiuchi, Masataka; Takeuchi, Kosei; Noda, Nobuo; Muroya, Nobuyuki; Suzuki, Toru; Nakamura, Takahisa; Kawamura-Tsuzuku, Junko; Takahasi, Kiyohiro; Yamamoto, Tadashi; Inagaki, Fuyuhiko			Structural Basis for the Antiproliferative Activity of the Tob-hCaf1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; PC3/BTG/TOB FAMILY; CRYSTAL-STRUCTURE; CCR4-NOT COMPLEX; TOB/BTG1 FAMILY; MICE LACKING; TOB; COMPONENT	The Tob/BTG family is a group of antiproliferative proteins containing two highly homologous regions, Box A and Box B. These proteins all associate with CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D (RNase D) family of deadenylases and is a component of the CCR4-Not deadenylase complex. Here we determined the crystal structure of the complex of the N-terminal region of Tob and human Caf1 (hCaf1). Tob exhibited a novel fold, whereas hCaf1 most closely resembled the catalytic domain of yeast Pop2 and human poly(A)-specific ribonuclease. Interestingly, the association of hCaf1 was mediated by both Box A and Box B of Tob. Cell growth assays using both wild-type and mutant proteins revealed that deadenylase activity of Caf1 is not critical but complex formation is crucial to cell growth inhibition. Caf1 tethers Tob to the CCR4-Not deadenylase complex, and thereby Tob gathers several factors at its C-terminal region, such as poly(A)-binding proteins, to exert antiproliferative activity.	[Horiuchi, Masataka; Noda, Nobuo; Muroya, Nobuyuki; Takahasi, Kiyohiro; Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Takeuchi, Kosei] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Cellular Biol, Chuo Ku, Niigata 9518510, Japan; [Suzuki, Toru; Nakamura, Takahisa; Kawamura-Tsuzuku, Junko; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan	Hokkaido University; Niigata University; University of Tokyo	Inagaki, F (corresponding author), Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, N12,W6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp	Takeuchi, Kosei/AAV-3577-2021; Horiuchi, Masataka/D-5491-2012; Noda, Nobuo/P-1397-2015	Takeuchi, Kosei/0000-0001-6397-2243; Noda, Nobuo/0000-0002-6940-8069	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [15770063]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Grant-in-aid for Scientific Research 15770063 and the National Projects on Protein Structural and Functional Analyses and Targeted Proteins Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Berthet C, 2004, MOL CELL BIOL, V24, P5808, DOI 10.1128/MCB.24.13.5808-5820.2004; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Bogdan JA, 1998, BIOCHEM J, V336, P471, DOI 10.1042/bj3360471; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; ELLIS RE, 1995, GENETICS, V139, P561; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Jonstrup AT, 2007, NUCLEIC ACIDS RES, V35, P3153, DOI 10.1093/nar/gkm178; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Maekawa M, 2002, J BIOL CHEM, V277, P37783, DOI 10.1074/jbc.M204506200; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsuda S, 1996, ONCOGENE, V12, P705; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Molin L, 2005, GENE, V358, P73, DOI 10.1016/j.gene.2005.05.023; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Onishi M, 1996, EXP HEMATOL, V24, P324; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sasajima H, 2002, EUR J BIOCHEM, V269, P3596, DOI 10.1046/j.1432-1033.2002.03052.x; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Thore S, 2003, EMBO REP, V4, P1150, DOI 10.1038/sj.embor.7400020; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Yoshida Y, 2003, MECH DEVELOP, V120, P629, DOI 10.1016/S0925-4773(03)00020-0; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Yoshida Y, 2001, JPN J CANCER RES, V92, P592, DOI 10.1111/j.1349-7006.2001.tb01135.x	53	70	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13244	13255		10.1074/jbc.M809250200	http://dx.doi.org/10.1074/jbc.M809250200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276069	Green Published, hybrid			2022-12-25	WOS:000265688300071
J	Kudrnac, M; Beyl, S; Hohaus, A; Stary, A; Peterbauer, T; Timin, E; Hering, S				Kudrnac, Michaela; Beyl, Stanislav; Hohaus, Annette; Stary, Anna; Peterbauer, Thomas; Timin, Eugen; Hering, Steffen			Coupled and Independent Contributions of Residues in IS6 and IIS6 to Activation Gating of Ca(V)1.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; DEPENDENT K+ CHANNEL; CA2+ CHANNELS; CRYSTAL-STRUCTURE; RETINAL DISORDER; MUTANT CYCLES; INNER PORE; ARCHITECTURE; DOMAIN; DETERMINANTS	Voltage dependence and kinetics of Ca(V)1.2 activation are affected by structural changes in pore-lining S6 segments of the alpha(1)-subunit. Significant effects are induced by either proline or threonine substitutions in the lower third of segment IIS6 ("bundle crossing region"), where S6 segments are likely to seal the channel in the closed conformation (Hohaus, A., Beyl, S., Kudrnac, M., Berjukow, S., Timin, E. N., Marksteiner, R., Maw, M. A., and Hering, S. (2005) J. Biol. Chem. 280, 38471-38477). Here we report that S435P in IS6 results in a large shift of the activation curve (-25.9 +/- 1.2 mV) and slower current kinetics. Threonine substitutions at positions Leu-429 and Leu-434 induced a similar kinetic phenotype with shifted activation curves (L429T by -6.6 +/- 1.2 and L434T by -12.1 +/- 1.7 mV). Inactivation curves of all mutants were shifted to comparable extents as the activation curves. Interdependence of IS6 and IIS6 mutations was analyzed by means of mutant cycle analysis. Double mutations in segments IS6 and IIS6 induce either additive (L429T/I781T, -34.1 +/- 1.4 mV; L434T/I781T, -40.4 +/- 1.3 mV; L429T/L779T, -12.6 +/- 1.3 mV; and L434T/L779T, -22.4 +/- 1.3 mV) or nonadditive shifts of the activation curves along the voltage axis (S435P/I781T, -33.8 +/- 1.4 mV). Mutant cycle analysis revealed energetic coupling between residues Ser-435 and Ile-781, whereas other paired mutations in segments IS6 and IIS6 had independent effects on activation gating.	[Kudrnac, Michaela; Beyl, Stanislav; Hohaus, Annette; Peterbauer, Thomas; Timin, Eugen; Hering, Steffen] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria; [Stary, Anna] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany	University of Vienna; Max Planck Society	Hering, S (corresponding author), Univ Vienna, Dept Pharmacol & Toxicol, Althanstr 14, A-1090 Vienna, Austria.	steffen.hering@univie.ac.at	Peterbauer, Thomas/A-8001-2008; Stary-Weinzinger, Anna/A-3629-2014	Peterbauer, Thomas/0000-0002-2362-5711; Stary-Weinzinger, Anna/0000-0002-9202-0484	Austrian Science Fund [15914]; GenBankTM/EBI Data Bank [X15539]	Austrian Science Fund(Austrian Science Fund (FWF)); GenBankTM/EBI Data Bank	This work was supported by Austrian Science Fund 15914 (to S. H.). The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) X15539.	Beyl S, 2007, J BIOL CHEM, V282, P3864, DOI 10.1074/jbc.M609153200; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hering S, 2008, CHANNELS, V2, P61, DOI 10.4161/chan.2.2.5999; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Lipkind GM, 2003, MOL PHARMACOL, V63, P499, DOI 10.1124/mol.63.3.499; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shafrir Y, 2008, BIOPHYS J, V95, P3650, DOI 10.1529/biophysj.108.135327; Shrivastava IH, 2000, BIOPHYS J, V78, P79, DOI 10.1016/S0006-3495(00)76574-X; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stary A, 2008, CHANNELS, V2, P216, DOI 10.4161/chan.2.3.6160; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Stotz SC, 2001, J BIOL CHEM, V276, P33001, DOI 10.1074/jbc.M104387200; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	40	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12276	12284		10.1074/jbc.M808402200	http://dx.doi.org/10.1074/jbc.M808402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265197	hybrid, Green Published			2022-12-25	WOS:000265494600059
J	Wang, QL; Chen, B; Liu, P; Zheng, MZ; Wang, YQ; Cui, SJ; Sun, DY; Fang, XH; Liu, CM; Lucas, WJ; Lin, JX				Wang, Qinli; Chen, Bo; Liu, Peng; Zheng, Maozhong; Wang, Yuqing; Cui, Sujuan; Sun, Daye; Fang, Xiaohong; Liu, Chun-Ming; Lucas, William J.; Lin, Jinxing			Calmodulin Binds to Extracellular Sites on the Plasma Membrane of Plant Cells and Elicits a Rise in Intracellular Calcium Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; SUSPENSION-CULTURED CELLS; QUANTUM DOTS; CA2+ INFLUX; PROTOPLASTS; EXPRESSION; DYNAMICS; SYSTEM; PROBES	Calmodulin (CaM) is a highly conserved intracellular calcium sensor. In plants, CaM also appears to be present in the apoplasm, and application of exogenous CaM has been shown to influence a number of physiological functions as a polypeptide signal; however, the existence and localization of its corresponding apoplasmic binding sites remain controversial. To identify the site(s) of action, a CaM-conjugated quantum dot (QD) system was employed for single molecule level detection at the surface of plant cells. Using this approach, we show that QD-CaM binds selectively to sites on the outer surface of the plasma membrane, which was further confirmed by high resolution transmission electron microscopy. Measurements of Ca2+ fluxes across the plasma membrane, using ion-selective microelectrodes, demonstrated that exogenous CaM induces a net influx into protoplasts. Consistent with these flux studies, calcium-green-dextran and FRET experiments confirmed that applied CaM/QD-CaM elicited an increase in cytoplasmic Ca2+ levels. These results support the hypothesis that apoplasmic CaM can act as a signaling agent. These findings are discussed in terms of CaM acting as an apoplasmic peptide ligand to mediate transmembrane signaling in the plant kingdom.	[Wang, Qinli; Liu, Peng; Zheng, Maozhong; Wang, Yuqing; Liu, Chun-Ming; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing 100093, Peoples R China; [Chen, Bo; Fang, Xiaohong] Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China; [Cui, Sujuan; Sun, Daye] Hebei Normal Univ, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei Province, Peoples R China; [Lucas, William J.] Univ Calif Davis, Dept Plant Biol, Coll Biol Sci, Davis, CA 95616 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Chemistry, CAS; Hebei Normal University; University of California System; University of California Davis	Lin, JX (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing 100093, Peoples R China.	linjx@ibcas.ac.cn	chen, bo/G-4459-2013; 刘, 春明/GLU-4320-2022; Liu, Chun-Ming/G-1006-2010	chen, bo/0000-0003-3935-305X; 刘, 春明/0000-0002-7271-362X; Liu, Chun-Ming/0000-0002-7271-362X; Lin, Jinxing/0000-0001-9338-1356	MOST [2006CB910600]; Key Program Grant [30730009]; National Science Fund of China [30600030]	MOST; Key Program Grant; National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grant 2006CB910600 from MOST, Key Program Grant 30730009, and General Program Grant 30600030 from the National Science Fund of China.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; ADACHI T, 2008, BIOCHEM BIOPH RES CO, V283, P5972; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Bahyrycz A, 2007, J PEPT SCI, V13, P787, DOI 10.1002/psc.915; BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Chalmers NI, 2007, APPL ENVIRON MICROB, V73, P630, DOI 10.1128/AEM.02164-06; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; CHEN B, 2005, ANAL BIOANAL CHEM, V381, P98; Chen YL, 2004, PLANT PHYSIOL, V136, P4096, DOI 10.1104/pp.104.047837; Cui SJ, 2005, J BIOL CHEM, V280, P31420, DOI 10.1074/jbc.M501349200; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DeSilva NS, 2003, AM J RESP CELL MOL, V29, P757, DOI 10.1165/rcmb.2003-0186OC; Duval FD, 2002, PLANT J, V32, P481, DOI 10.1046/j.1365-313X.2002.01409.x; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; Goddard H, 2000, P NATL ACAD SCI USA, V97, P1932, DOI 10.1073/pnas.020516397; Grecco HE, 2004, MICROSC RES TECHNIQ, V65, P169, DOI 10.1002/jemt.20129; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; KOCHIAN LV, 1992, PLANTA, V188, P601, DOI 10.1007/BF00197055; Lundstrom P, 2004, J AM CHEM SOC, V126, P928, DOI 10.1021/ja037529r; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; Mao GH, 2005, PLANTA, V222, P428, DOI 10.1007/s00425-005-1558-9; Marx J, 1996, SCIENCE, V273, P1338, DOI 10.1126/science.273.5280.1338; Matsubayashi Y, 2003, J CELL SCI, V116, P3863, DOI 10.1242/jcs.00733; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Ravindran S, 2005, NANOTECHNOLOGY, V16, P1, DOI [10.1088/0957-4484/16/1/001, 10.1088/0957-4484/1/001]; REDDY ASN, 2001, PLANT SCI, V15, P59; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Shang ZL, 2003, PROG NAT SCI, V13, P678, DOI 10.1080/10020070312331344230; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Vos JW, 1998, PROTOPLASMA, V201, P158, DOI 10.1007/BF01287412; WALTERSSON Y, 1993, BIOCHEMISTRY-US, V32, P7866, DOI 10.1021/bi00082a005; Wu XQ, 2008, J PROTEOME RES, V7, P4299, DOI 10.1021/pr800241u; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007; Zielinski Raymond E, 2002, Methods Mol Biol, V172, P143	39	27	35	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12000	12007		10.1074/jbc.M808028200	http://dx.doi.org/10.1074/jbc.M808028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254956	Green Published, hybrid			2022-12-25	WOS:000265494600032
J	Medrek, C; Landberg, G; Andersson, T; Leandersson, K				Medrek, Catharina; Landberg, Goran; Andersson, Tommy; Leandersson, Karin			Wnt-5a-CKI alpha Signaling Promotes beta-Catenin/E-Cadherin Complex Formation and Intercellular Adhesion in Human Breast Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CATENIN; WNT-5A; PHOSPHORYLATION; PROTEIN; DEGRADATION; EXPRESSION; MUTATIONS; MECHANISM; PATHWAY; BINDING	Wnt-5a is a non-transforming Wnt protein that is implicated in cell polarity, adhesion, and motility. We have previously shown that low expression of Wnt-5a is a predictor of shorter disease-free survival in human breast cancer. Here, we investigated whether beta-catenin/E-cadherin-mediated cell-cell adhesion was affected by loss of Wnt-5a in breast carcinomas, thereby promoting a metastatic behavior of the tumor. We show that Wnt-5a stimulation of human breast epithelial cells leads to an increased Ca2+-dependent cell-cell adhesion. Furthermore, Wnt-5a/casein kinase I alpha (CKI alpha)-specific Ser-45 phosphorylation of beta-catenin is associated with an increased complex formation of beta-catenin/E-cadherin. Mutation of Ser-45 decreases the beta-catenin/E-cadherin association. Also, the inhibitory effect of Wnt-5a on breast epithelial cell invasion is reduced upon mutation of beta-catenin-Ser-45. The Wnt-5a-CKI alpha-induced Ser-45 phosphorylation does not lead to degradation of beta-catenin. Finally we show that human breast cancers lacking Wnt-5a protein have a significantly lower level of membrane-associated beta-catenin. Down-regulation of Wnt-5a expression and subsequent reduction of membrane-associated beta-catenin in invasive breast cancer, can therefore contribute to a decreased cell-cell adhesion and increased motility resulting in a higher probability for metastatic disease.	[Landberg, Goran; Leandersson, Karin] Lund Univ, Univ Sjukhuset Malmo Allmanna Sjukhus, Ctr Mol Pathol, Dept Lab Med, S-20502 Malmo, Sweden	Lund University	Leandersson, K (corresponding author), Lund Univ, Univ Sjukhuset Malmo Allmanna Sjukhus, Ctr Mol Pathol, Dept Lab Med, S-20502 Malmo, Sweden.	Karin.Leandersson@med.lu.se			Swedish Cancer Foundation; Universitetssjukhuset-Malmo Allmanna Sjukhus Research Foundations; Universitetssjukhuset Malmo r Allmanna Sjukhus Cancer Foundation; Gunnar Nilsson's Cancer Foundation; Crafoord Foundation; Royal Physiographic Society in Lund	Swedish Cancer Foundation; Universitetssjukhuset-Malmo Allmanna Sjukhus Research Foundations; Universitetssjukhuset Malmo r Allmanna Sjukhus Cancer Foundation; Gunnar Nilsson's Cancer Foundation; Crafoord Foundation; Royal Physiographic Society in Lund	This work was supported in part by grants from the Swedish Cancer Foundation (to G. L., T. A., and K. L.), the Universitetssjukhuset-Malmo Allmanna Sjukhus Research Foundations (to T. A. and K. L.), Universitetssjukhuset Malmo r Allmanna Sjukhus Cancer Foundation (to T. A. and K. L.), The Swedish Research Council (to T. A.), Gunnar Nilsson's Cancer Foundation (to T. A. and K. L.), the Crafoord Foundation (to K. L.), and the Royal Physiographic Society in Lund (to K. L.).	Berx G, 1998, CELL ADHES COMMUN, V6, P171, DOI 10.3109/15419069809004474; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Catimel B, 2006, ANAL BIOCHEM, V357, P277, DOI 10.1016/j.ab.2006.07.034; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Dejmek J, 2003, INT J CANCER, V103, P344, DOI 10.1002/ijc.10752; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Jansson M, 2001, J CELL SCI, V114, P2043; Jonsson M, 2002, CANCER RES, V62, P409; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lei HX, 2002, INT J CANCER, V98, P199, DOI 10.1002/ijc.10176; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; MOON RT, 1993, DEVELOPMENT, V119, P97; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; OSBORNE MP, 2000, BREAST ANATOMY DEV; Pandur P, 2002, BIOESSAYS, V24, P881, DOI 10.1002/bies.10164; Provost E, 2003, J BIOL CHEM, V278, P31781, DOI 10.1074/jbc.M304953200; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; SHORE EM, 1991, J BIOL CHEM, V266, P19672; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	42	65	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10968	10979		10.1074/jbc.M804923200	http://dx.doi.org/10.1074/jbc.M804923200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244247	Green Published, hybrid			2022-12-25	WOS:000265104600069
J	Rensen, WM; Roscioli, E; Tedeschi, A; Mangiacasale, R; Ciciarello, M; Di Gioia, SA; Lavia, P				Rensen, W. M.; Roscioli, E.; Tedeschi, A.; Mangiacasale, R.; Ciciarello, M.; Di Gioia, S. A.; Lavia, P.			RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner	ONCOGENE			English	Article						RanBP1; mitotic spindle microtubules; taxol; apoptosis; RanGTPase; caspase-3	INDUCED APOPTOSIS; MITOTIC SPINDLE; BINDING PROTEIN-1; IMPORTIN-BETA; CYCLIN B; MICROTUBULES; GTPASE; CHECKPOINT; MITOSIS; ACTIVATION	Mitotic microtubule (MT)-targeting drugs are widely used to treat cancer. The GTPase Ran regulates multiple processes, including mitotic spindle assembly, spindle pole formation and MT dynamics; Ran activity is therefore essential to formation of a functional mitotic apparatus. The RanBP1 protein, which binds Ran and regulates its interaction with effectors, is overexpressed in many cancer types. Several observations indicate that RanBP1 contributes to regulate the function of the mitotic apparatus: RanBP1 inactivation yields hyperstable MTs and induces apoptosis during mitosis, reminiscent of the effects of the MT-stabilizing drug taxol. Here we have investigated the influence of RanBP1 on spontaneous and taxol-induced apoptosis in transformed cells. We report that RanBP1 downregulation by RNA interference activates apoptosis in several transformed cell lines regardless of their p53 status, but not in the caspase-3-defective MCF-7 breast cancer cell line. Furthermore, RanBP1-interfered cells show an increased apoptotic response to taxol compared to their counterpart with normal or high RanBP1 levels, and this response is caspase-3 dependent. These results indicate that RanBP1 can modulate the outcome of MT-targeting therapeutic protocols.	[Rensen, W. M.; Roscioli, E.; Tedeschi, A.; Mangiacasale, R.; Ciciarello, M.; Di Gioia, S. A.; Lavia, P.] Univ Roma La Sapienza, IBPM Inst Mol Biol & Pathol, CNR Natl Res Council, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Lavia, P (corresponding author), Univ Roma La Sapienza, IBPM Inst Mol Biol & Pathol, CNR Natl Res Council, Via Apuli 4, I-00185 Rome, Italy.	patrizia.lavia@uniroma1.it	Lavia, Patrizia/AAL-3982-2021; Ciciarello, Marilena/AAA-7950-2022; Lavia, Patrizia/J-5793-2019; Ciciarello, Marilena/A-4401-2015	Ciciarello, Marilena/0000-0002-4744-507X; Lavia, Patrizia/0000-0003-3310-6701; Tedeschi, Antonio/0000-0001-7276-4550; Di Gioia, Silvio Alessandro/0000-0002-7235-5682	Italian Association for Cancer Research ( AIRC); MIUR-FIRB [RBIN04T7MT]; AIRC; ER; MIUR-FIRB	Italian Association for Cancer Research ( AIRC)(Fondazione AIRC per la ricerca sul cancro); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); AIRC(Fondazione AIRC per la ricerca sul cancro); ER; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	We thank Dr Christopher J Froelich (Northwestern University Medical School, Evanston, IL) for gifting the MCF-7/casp-3 cell line. We also thank Dr Giulia Guarguaglini for discussions and advice. This work was supported by the Italian Association for Cancer Research (AIRC) and by MIUR-FIRB ( grant RBIN04T7MT). WMR and MC were supported by AIRC, ER and RM by MIUR-FIRB research contracts.	Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Alli E, 2002, CANCER RES, V62, P6864; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Battistoni A, 1997, J CELL SCI, V110, P2345; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BRITO DA, 2008, CELL MOTIL CYTOSKELE; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; De Luca A, 2003, CANCER RES, V63, P1430; Di Fiore B, 1999, J BIOL CHEM, V274, P10339, DOI 10.1074/jbc.274.15.10339; Di Fiore B, 2004, CELL CYCLE, V3, P305; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; DIMATTEO G, 1995, CELL GROWTH DIFFER, V6, P1213; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giodini A, 2002, CANCER RES, V62, P2462; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; Holland AJ, 2008, CANCER CELL, V14, P103, DOI 10.1016/j.ccr.2008.07.010; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Iancu C, 2000, CANCER RES, V60, P3537; Iancu C, 2001, J CELL SCI, V114, P909; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Impens F, 2008, ONCOGENE, V27, P4580, DOI 10.1038/onc.2008.96; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jiang Y, 2003, ONCOGENE, V22, P8293, DOI 10.1038/sj.onc.1206873; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Lu KH, 2005, J ORTHOP RES, V23, P988, DOI 10.1016/j.orthres.2005.01.018; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; OUSPENSKI II, 1995, J BIOL CHEM, V270, P1975, DOI 10.1074/jbc.270.5.1975; Oyaizu H, 1999, Mol Cell Biol Res Commun, V2, P36, DOI 10.1006/mcbr.1999.0146; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Spankuch B, 2007, ONCOGENE, V26, P5793, DOI 10.1038/sj.onc.1210355; Spankuch B, 2006, CANCER RES, V66, P5836, DOI 10.1158/0008-5472.CAN-06-0343; Tanaka E, 2007, CLIN CANCER RES, V13, P1331, DOI 10.1158/1078-0432.CCR-06-1192; Tedeschi A, 2007, J CELL SCI, V120, P3748, DOI 10.1242/jcs.009308; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Wang TH, 1999, J BIOL CHEM, V274, P8208, DOI 10.1074/jbc.274.12.8208; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Xia F, 2008, MOL CELL BIOL, V28, P5299, DOI 10.1128/MCB.02039-07; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319; Yang XH, 2001, CANCER RES, V61, P348; Yuan J, 2006, ONCOGENE, V25, P1753, DOI 10.1038/sj.onc.1209202	70	28	29	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1748	1758		10.1038/onc.2009.24	http://dx.doi.org/10.1038/onc.2009.24			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19270727	Bronze			2022-12-25	WOS:000265640400002
J	Abdelkarim, M; Guenin, E; Sainte-Catherine, O; Vintonenko, N; Peyri, N; Perret, GY; Crepin, M; Khatib, AM; Lecouvey, M; Di Benedetto, M				Abdelkarim, Mohamed; Guenin, Erwann; Sainte-Catherine, Odile; Vintonenko, Nadejda; Peyri, Nicole; Perret, Gerard Yves; Crepin, Michel; Khatib, Abdel-Majid; Lecouvey, Marc; Di Benedetto, Melanie			New Symmetrically Esterified m-Bromobenzyl Non-Aminobisphosphonates Inhibited Breast Cancer Growth and Metastases	PLOS ONE			English	Article							IN-VITRO; BISPHOSPHONATES; BONE; PROLIFERATION; OSTEONECROSIS; JAW	Background: Although there was growing evidence in the potential use of Bisphosphonates (BPs) in cancer therapy, their strong osseous affinities that contrast their poor soft tissue uptake limited their use. Here, we developed a new strategy to overcome BPs hydrophilicity by masking the phosphonic acid through organic protecting groups and introducing hydrophobic functions in the side chain. Methodology/Principal Findings: We synthesized non-nitrogen BPs (non N-BPs) containing bromobenzyl group (BP7033Br) in their side chain that were symmetrically esterified with hydrophobic 4-methoxphenyl (BP7033BrALK) and assessed their effects on breast cancer estrogen-responsive cells (T47D, MCF-7) as well as on non responsive ones (SKBR3, MDA-MB-231 and its highly metastatic derived D3H2LN subclone). BP7033Br ALK was more efficient in inhibiting tumor cell proliferation, migration and survival when compared to BP7033Br. Although both compounds inhibited tumor growth without side effects, only BP7033Br ALK abrogated tumor angiogenesis and D3H2LN cells-induced metastases formation. Conclusion/Significance: Taken together these data suggest the potential therapeutic use of this new class of esterified Bisphosphonates (BPs) in the treatment of tumor progression and metastasis without toxic adverse effects.	[Abdelkarim, Mohamed; Guenin, Erwann; Sainte-Catherine, Odile; Vintonenko, Nadejda; Perret, Gerard Yves; Lecouvey, Marc; Di Benedetto, Melanie] Univ Paris 13, CNRS FRE CSPBAT, Lab Chim Struct Biomol, Lab Pharmacol,UFR SMBH, Bobigny, France; [Abdelkarim, Mohamed; Vintonenko, Nadejda; Peyri, Nicole; Crepin, Michel] INSERM 553, Endothelium Angiogenese Lab Hemostase, Paris, France; [Khatib, Abdel-Majid; Di Benedetto, Melanie] INSERM, UP7 UMRS 940, Equipe Avenir, IGM, Paris, France	Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Abdelkarim, M (corresponding author), Univ Paris 13, CNRS FRE CSPBAT, Lab Chim Struct Biomol, Lab Pharmacol,UFR SMBH, Bobigny, France.	dibenedetto22@yahoo.fr	abdelkarim, mohamed/AAK-5563-2020; KHATIB, Abdel-Majid/A-9948-2015; Di Benedetto, Melanie MD/C-1512-2018; PERRET, gerard/A-7379-2008	abdelkarim, mohamed/0000-0002-0984-6083; KHATIB, Abdel-Majid/0000-0001-6957-0384; Di Benedetto, Melanie MD/0000-0003-1119-3752; PERRET, gerard/0000-0003-0645-3337; Guenin, Erwann/0000-0002-7125-9074	Association Martine Midy; Institut National de Recherche sur le Cancer (INCA); Ligue regionale contre le cancer-comite Ile de France	Association Martine Midy; Institut National de Recherche sur le Cancer (INCA)(Institut National du Cancer (INCA) France); Ligue regionale contre le cancer-comite Ile de France	This work was supported by grants from the Association Martine Midy and by the Institut National de Recherche sur le Cancer (INCA) and the Ligue regionale contre le cancer-comite Ile de France. We particularly acknowledge Dr. Olivier Rixe and Tatiana Theys for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2001, CLIN CANCER RES, V7, P1246; Caraglia M, 2006, ENDOCR-RELAT CANCER, V13, P7, DOI 10.1677/erc.1.01094; Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; Clezardin P, 2003, CURR MED CHEM, V10, P173, DOI 10.2174/0929867033368529; Diel IJ, 2007, CRIT REV ONCOL HEMAT, V64, P198, DOI 10.1016/j.critrevonc.2007.07.005; Ezra A, 2000, ADV DRUG DELIVER REV, V42, P175, DOI 10.1016/S0169-409X(00)00061-2; Fromigue O, 2000, J BONE MINER RES, V15, P2211, DOI 10.1359/jbmr.2000.15.11.2211; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Guenin E, 2005, ANTICANCER RES, V25, P1139; Hamma-Kourbali Y, 2003, BIOCHEM BIOPH RES CO, V310, P816, DOI 10.1016/j.bbrc.2003.09.083; HIGARA T, 2001, CANCER RES, V61, P4418; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Journe F, 2004, BRIT J CANCER, V91, P1703, DOI 10.1038/sj.bjc.6602181; Kavanagh KL, 2006, J BIOL CHEM, V281, P22004, DOI 10.1074/jbc.M602603200; Lecouvey M, 2001, TETRAHEDRON LETT, V42, P8475, DOI 10.1016/S0040-4039(01)01844-5; Ledoux D, 2006, ANTI-CANCER DRUG, V17, P479, DOI 10.1097/01.cad.0000198909.52701.0f; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Mao JH, 2006, J AM CHEM SOC, V128, P14485, DOI 10.1021/ja061737c; Migianu E, 2005, NUCLEOS NUCLEOT NUCL, V24, P121, DOI 10.1081/NCN-200051890; Monkkonen H, 2008, ANTI-CANCER DRUG, V19, P391, DOI 10.1097/CAD.0b013e3282f632bf; Monteil M, 2005, TETRAHEDRON, V61, P7528, DOI 10.1016/j.tet.2005.05.053; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; SASAKI A, 1995, CANCER RES, V55, P3551; Sebbah-Louriki M, 2002, ANTICANCER RES, V22, P3925; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Tetko IV, 2008, J INORG BIOCHEM, V102, P1424, DOI 10.1016/j.jinorgbio.2007.12.029; Van den Wyngaert T, 2006, ANN ONCOL, V17, P1197, DOI 10.1093/annonc/mdl294; Wakchoure S, 2006, CLIN CANCER RES, V12, P2862, DOI 10.1158/1078-0432.CCR-05-2766; Wang WG, 2002, CANCER RES, V62, P6278; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4685	10.1371/journal.pone.0004685	http://dx.doi.org/10.1371/journal.pone.0004685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262688	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490600013
J	Coron, E; Flamant, M; Aubert, P; Wedel, T; Pedron, T; Letessier, E; Galmiche, JP; Sansonetti, PJ; Neunlist, M				Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Wedel, Thilo; Pedron, Thierry; Letessier, Eric; Galmiche, Jean P.; Sansonetti, Philippe J.; Neunlist, Michel			Characterisation of Early Mucosal and Neuronal Lesions Following Shigella flexneri Infection in Human Colon	PLOS ONE			English	Article								Background: Shigella, an enteroinvasive bacteria induces a major inflammatory response responsible for acute rectocolitis in humans. However, early effect of Shigella flexneri (S. flexneri) infection upon the human mucosa and its microenvironement, in particular the enteric nervous system, remains currently unknown. Therefore, in this study, we sought to characterize ex vivo the early events of shigellosis in a model of human colonic explants. In particular, we aimed at identifying factors produced by S. flexneri and responsible for the lesions of the barrier. We also aimed at determining the putative lesions of the enteric nervous system induced by S. flexneri. Methodology/Principal Findings: We first showed that, following 3 h of infection, the invasive but not the non-invasive strain of S. flexneri induced significant desquamation of the intestinal epithelial barrier and a reduction of epithelial height. These changes were significantly reduced following infection with SepA deficient S. flexneri strains. Secondly, S. flexneri induced rapid neuronal morphological alterations suggestive of cell death in enteric submucosal neurones. These alterations were associated with a significant increase in the proportion of vasoactive intestinal peptide (VIP) immunoreactive (IR) neurons but not in total VIP levels. The NMDA receptor antagonist MK-801 blocked neuronal morphological changes induced by S. flexneri, but not the increase in the proportion of VIP-IR. Conclusions/Significance: This human explant model can be used to gain better insight into the early pathogenic events following S. flexneri infection and the mechanisms involved.	[Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Galmiche, Jean P.; Neunlist, Michel] INSERM, U913, Nantes, France; [Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Letessier, Eric; Galmiche, Jean P.; Neunlist, Michel] Univ Nantes, Fac Med, F-44035 Nantes, France; [Coron, Emmanuel; Flamant, Mathurin; Aubert, Philippe; Letessier, Eric; Galmiche, Jean P.; Neunlist, Michel] CHU Nantes, Inst Maladies Appareil Digest, Hotel Dieu, Nantes, France; [Wedel, Thilo] Univ Kiel, Inst Anat, D-24098 Kiel, Germany; [Pedron, Thierry; Sansonetti, Philippe J.] Inst Pasteur, Unite INSERM 786, Unite Pathogen Microbienne Mol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; University of Kiel; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Coron, E (corresponding author), INSERM, U913, Nantes, France.	michel.neunlist@univ-nantes.fr	Neunlist, Michel/K-2388-2015; Aubert, Philippe/K-2352-2015; Wedel, Thilo/B-1247-2010; Coron, Emmanuel/K-2415-2015	Aubert, Philippe/0000-0001-7471-7694; Wedel, Thilo/0000-0002-8146-2711; Aubert, Philippe/0000-0002-3126-6202				Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Benjelloun-Touimi Z, 1998, MICROBIOL-SGM, V144, P1815, DOI 10.1099/00221287-144-7-1815; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; Cattaruzza F, 2006, AM J PATHOL, V169, P177, DOI 10.2353/ajpath.2006.051098; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; De Giorgio R, 2004, GASTROENTEROLOGY, V126, P1872, DOI 10.1053/j.gastro.2004.02.024; Jarry A, 2006, BRIT J PHARMACOL, V147, P64, DOI 10.1038/sj.bjp.0706449; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; Kirchgessner AL, 1997, J NEUROSCI, V17, P8804; Neunlist M, 2008, J INTERN MED, V263, P577, DOI 10.1111/j.1365-2796.2008.01963.x; Niyogi SK, 2005, J MICROBIOL, V43, P133; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; Schemann M, 2004, NEUROGASTROENT MOTIL, V16, P55, DOI 10.1111/j.1743-3150.2004.00476.x; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Tixier E, 2005, CELL MICROBIOL, V7, P1798, DOI 10.1111/j.1462-5822.2005.00596.x; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vergnolle N, 2006, J CLIN INVEST, V116, P2056, DOI 10.1172/JCI21689R1; Wang LH, 2004, GUT, V53, P1390, DOI 10.1136/gut.2003.021154corr1; Zhang Z, 2001, INFECT IMMUN, V69, P3240, DOI 10.1128/IAI.69.5.3240-3247.2001	24	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4713	10.1371/journal.pone.0004713	http://dx.doi.org/10.1371/journal.pone.0004713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19274103	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600023
J	Wagai, J; Senga, J; Fegan, G; English, M				Wagai, John; Senga, John; Fegan, Greg; English, Mike			Examining Agreement between Clinicians when Assessing Sick Children	PLOS ONE			English	Article								Background: Case management guidelines use a limited set of clinical features to guide assessment and treatment for common childhood diseases in poor countries. Using video records of clinical signs we assessed agreement among experts and assessed whether Kenyan health workers could identify signs defined by expert consensus. Methodology: 104 videos representing 11 clinical sign categories were presented to experts using a web questionnaire. Proportionate agreement and agreement beyond chance were calculated using kappa and the AC1 statistic. 31 videos were selected and presented to local health workers, 20 for which experts had demonstrated clear agreement and 11 for which experts could not demonstrate agreement. Principal Findings: Experts reached very high level of chance adjusted agreement for some videos while for a few videos no agreement beyond chance was found. Where experts agreed Kenyan hospital staff of all cadres recognised signs with high mean sensitivity and specificity (sensitivity: 0.897-0.975, specificity: 0.813-0.894); years of experience, gender and hospital had no influence on mean sensitivity or specificity. Local health workers did not agree on videos where experts had low or no agreement. Results of different agreement statistics for multiple observers, the AC1 and Fleiss' kappa, differ across the range of proportionate agreement. Conclusion: Videos provide a useful means to test agreement amongst geographically diverse groups of health workers. Kenyan health workers are in agreement with experts where clinical signs are clear-cut supporting the potential value of assessment and management guidelines. However, clinical signs are not always clear-cut. Video recordings offer one means to help standardise interpretation of clinical signs.	[Wagai, John; Senga, John; English, Mike] KEMRI, Child & Newborn Hlth Grp, Ctr Geog Med, Wellcome Trust Programme, Nairobi, Kenya; [Fegan, Greg] KEMRI, Ctr Geograph Med Res Coast, Kilifi, Kenya; [Fegan, Greg] London Sch Hygiene & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London, England; [English, Mike] Univ Oxford, Dept Paediat, Oxford OX1 2JD, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Wagai, J (corresponding author), KEMRI, Child & Newborn Hlth Grp, Ctr Geog Med, Wellcome Trust Programme, Nairobi, Kenya.	jwagai@nairobi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018	Fegan, Greg W/0000-0002-2663-2765; English, Michael/0000-0002-7427-0826	Wellcome Trust Senior Fellowship [076827]	Wellcome Trust Senior Fellowship(Wellcome Trust)	Funds from a Wellcome Trust Senior Fellowship awarded to Dr. Mike English (#076827) made this work possible. The funders had no role in the design, conduct, analyses or writing of this study nor in the decision to submit for publication.	Basnet Sudha, 2006, Indian Journal of Pediatrics, V73, P777, DOI 10.1007/BF02790384; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Casebeer L, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-37; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; ENGLISH M, 1995, ARCH DIS CHILD, V72, P334, DOI 10.1136/adc.72.4.334; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Goswami V, 2006, INDIAN PEDIATR, V43, P1042; Gupta R, 2000, Indian Pediatr, V37, P383; Gwet KL., 2001, HDB INTERRATER RELIA; Handschu R, 2003, STROKE, V34, P2842, DOI 10.1161/01.STR.0000102043.70312.E9; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Kernaghan D, 2006, QUAL SAF HEALTH CARE, V15, P359, DOI 10.1136/qshc.2006.018572; LANDIS JR, 1977, BIOMETRICS, V33, P174; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Usen S, 1999, BMJ-BRIT MED J, V318, P86, DOI 10.1136/bmj.318.7176.86; Zucker JR, 1997, B WORLD HEALTH ORGAN, V75, P97	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4626	10.1371/journal.pone.0004626	http://dx.doi.org/10.1371/journal.pone.0004626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247448	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000265487800008
J	Wang, L; Di, LJ; Lv, X; Zheng, W; Xue, Z; Guo, ZC; Liu, DP; Liang, CC				Wang, Li; Di, Li-Jun; Lv, Xiang; Zheng, Wei; Xue, Zheng; Guo, Zhi-Chen; Liu, De-Pei; Liang, Chi-Chuan			Inter-MAR Association Contributes to Transcriptionally Active Looping Events in Human beta-globin Gene Cluster	PLOS ONE			English	Article								Matrix attachment regions (MARs) are important in chromatin organization and gene regulation. Although it is known that there are a number of MAR elements in the beta-globin gene cluster, it is unclear that how these MAR elements are involved in regulating beta-globin genes expression. Here, we report the identification of a new MAR element at the LCR(locus control region) of human beta-globin gene cluster and the detection of the inter-MAR association within the beta-globin gene cluster. Also, we demonstrate that SATB1, a protein factor that has been implicated in the formation of network like higher order chromatin structures at some gene loci, takes part in beta-globin specific inter-MAR association through binding the specific MARs. Knocking down of SATB1 obviously reduces the binding of SATB1 to the MARs and diminishes the frequency of the inter-MAR association. As a result, the ACH establishment and the alpha-like globin genes and beta-like globin genes expressions are affected either. In summary, our results suggest that SATB1 is a regulatory factor of hemoglobin genes, especially the early differentiation genes at least through affecting the higher order chromatin structure.	[Wang, Li; Di, Li-Jun; Lv, Xiang; Zheng, Wei; Xue, Zheng; Guo, Zhi-Chen; Liu, De-Pei; Liang, Chi-Chuan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100037, Peoples R China; [Wang, Li; Di, Li-Jun; Lv, Xiang; Zheng, Wei; Xue, Zheng; Guo, Zhi-Chen; Liu, De-Pei; Liang, Chi-Chuan] PUMC, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100037, Peoples R China.	liudp@pumc.edu.cn	Di, Li-jun/B-3352-2011	Liu, De-Pei/0000-0002-2636-4297	National Natural Science Foundation of China [30721063, U0632005]; "973" program of China [2005CB522402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (grant No. 30721063 and U0632005) and "973" program of China (grant No. 2005CB522402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkuhn M, 2008, BBA-MOL CELL RES, V1783, P2161, DOI 10.1016/j.bbamcr.2008.07.011; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Boulikas T, 1995, INT REV CYTOL, V162A, P279; BOULIKAS T, 1993, J CELL BIOCHEM, V52, P23, DOI 10.1002/jcb.240520105; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Case SS, 1999, DNA CELL BIOL, V18, P805, DOI 10.1089/104454999314809; CHOU RH, 1990, CANCER RES, V50, P3199; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; CUNNINGHAM JM, 1994, BLOOD, V84, P1298; DEAN A, 1981, SCIENCE, V212, P459, DOI 10.1126/science.6163216; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Di LJ, 2008, J CELL BIOCHEM, V105, P301, DOI 10.1002/jcb.21826; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; GAZIT B, 1982, SCIENCE, V217, P648, DOI 10.1126/science.6283640; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; JACKSON CE, 1995, J BIOL CHEM, V270, P28448; JARMAN AP, 1988, EMBO J, V7, P3337, DOI 10.1002/j.1460-2075.1988.tb03205.x; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; LI QL, 1994, MOL CELL BIOL, V14, P6087, DOI 10.1128/MCB.14.9.6087; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Ma C, 2007, ONCOGENE, V26, P2649, DOI 10.1038/sj.onc.1210069; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ostermeier GC, 2003, NUCLEIC ACIDS RES, V31, P3257, DOI 10.1093/nar/gkg424; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; ROWLEY PT, 1984, LEUKEMIA RES, V8, P45, DOI 10.1016/0145-2126(84)90030-4; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Smith RD, 2000, NUCLEIC ACIDS RES, V28, P4998, DOI 10.1093/nar/28.24.4998; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Yan Z J, 1998, Cell Res, V8, P209; Zhou GL, 2006, MOL CELL BIOL, V26, P5096, DOI 10.1128/MCB.02454-05	59	27	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4629	10.1371/journal.pone.0004629	http://dx.doi.org/10.1371/journal.pone.0004629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247486	Green Published, gold			2022-12-25	WOS:000265487800011
J	Altaba, CR				Altaba, Cristian R.			Universal Artifacts Affect the Branching of Phylogenetic Trees, Not Universal Scaling Laws	PLOS ONE			English	Article							DNA-SEQUENCE DATA; MOLECULAR PHYLOGENY; DIVERSIFICATION RATES; EVOLUTIONARY HISTORY; MAXIMUM-LIKELIHOOD; STOCHASTIC-MODELS; EXTINCTION RATES; CYTOCHROME-B; SPECIATION; GASTROPODA	Background: The superficial resemblance of phylogenetic trees to other branching structures allows searching for macroevolutionary patterns. However, such trees are just statistical inferences of particular historical events. Recent meta-analyses report finding regularities in the branching pattern of phylogenetic trees. But is this supported by evidence, or are such regularities just methodological artifacts? If so, is there any signal in a phylogeny? Methodology: In order to evaluate the impact of polytomies and imbalance on tree shape, the distribution of all binary and polytomic trees of up to 7 taxa was assessed in tree-shape space. The relationship between the proportion of outgroups and the amount of imbalance introduced with them was assessed applying four different tree-building methods to 100 combinations from a set of 10 ingroup and 9 outgroup species, and performing covariance analyses. The relevance of this analysis was explored taking 61 published phylogenies, based on nucleic acid sequences and involving various taxa, taxonomic levels, and tree-building methods. Principal Findings: All methods of phylogenetic inference are quite sensitive to the artifacts introduced by outgroups. However, published phylogenies appear to be subject to a rather effective, albeit rather intuitive control against such artifacts. The data and methods used to build phylogenetic trees are varied, so any meta-analysis is subject to pitfalls due to their uneven intrinsic merits, which translate into artifacts in tree shape. The binary branching pattern is an imposition of methods, and seldom reflects true relationships in intraspecific analyses, yielding artifactual polytomies in short trees. Above the species level, the departure of real trees from simplistic random models is caused at least by two natural factors uneven speciation and extinction rates; and artifacts such as choice of taxa included in the analysis, and imbalance introduced by outgroups and basal paraphyletic taxa. This artifactual imbalance accounts for tree shape convergence of large trees. Significance: There is no evidence for any universal scaling in the tree of life. Instead, there is a need for improved methods of tree analysis that can be used to discriminate the noise due to outgroups from the phylogenetic signal within the taxon of interest, and to evaluate realistic models of evolution, correcting the retrospective perspective and explicitly recognizing extinction as a driving force. Artifacts are pervasive, and can only be overcome through understanding the structure and biological meaning of phylogenetic trees. Catalan Abstract in Translation S1.	[Altaba, Cristian R.] Univ Balearic Isl, Lab Human Systemat, Balearic Isl, Spain	Universitat de les Illes Balears	Altaba, CR (corresponding author), Univ Balearic Isl, Lab Human Systemat, Balearic Isl, Spain.	cristianr.altaba@uib.es						Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Alonso MR, 2006, BIOL J LINN SOC, V89, P169, DOI 10.1111/j.1095-8312.2006.00670.x; Altaba CR, 1997, CONTRIB ZOOL, V66, P257; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Barriel V, 1998, CLADISTICS, V14, P193, DOI 10.1111/j.1096-0031.1998.tb00332.x; Billera LJ, 2001, ADV APPL MATH, V27, P733, DOI 10.1006/aama.2001.0759; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Bokma F, 2003, EVOLUTION, V57, P2469; BOKMA F, 2008, EVOLUTION IN PRESS; Bokma F, 2006, J THEOR BIOL, V243, P449, DOI 10.1016/j.jtbi.2006.06.023; Bonett RM, 2004, MOL ECOL, V13, P1189, DOI 10.1111/j.1365-294X.2004.02130.x; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Brambilla M, 2008, MOL PHYLOGENET EVOL, V48, P461, DOI 10.1016/j.ympev.2008.05.013; Bretagnolle V, 1998, AUK, V115, P188, DOI 10.2307/4089123; Cela-Conde CJ, 2002, S AFR J SCI, V98, P229; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Cicero C, 2001, MOL PHYLOGENET EVOL, V20, P27, DOI 10.1006/mpev.2001.0944; Coddington JA, 1996, CLADISTICS, V12, P139, DOI 10.1111/j.1096-0031.1996.tb00198.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dietzen C, 2008, J ORNITHOL, V149, P1, DOI 10.1007/s10336-007-0192-7; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubey S, 2008, MOL PHYLOGENET EVOL, V47, P877, DOI 10.1016/j.ympev.2007.12.014; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, INFERRING PHYLOGENIE; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; FORD DJ, 2005, ARXIVMATH0511246V1; Francois O, 2007, MATH BIOSCI, V209, P108, DOI 10.1016/j.mbs.2007.01.005; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Geiger Daniel L., 2005, Molluscan Research, V25, P47; Giribet G, 2002, CLADISTICS, V18, P5, DOI 10.1006/clad.2001.0185; GOLOBOFF P, 2000, TNT TREE ANAL USING; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOULD S J, 1977, Paleobiology, V3, P23; Guan F, 2008, MOL PHYLOGENET EVOL, V48, P702, DOI 10.1016/j.ympev.2008.04.021; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; HARVEY PH, 1994, BIOESSAYS, V16, P767, DOI 10.1002/bies.950161012; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Heard SB, 1996, SYST BIOL, V45, P115, DOI 10.2307/2413517; Herrada EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002757; HEY J, 1992, EVOLUTION, V46, P627, DOI [10.2307/2409633, 10.1111/j.1558-5646.1992.tb02071.x]; Hidalgo O, 2006, ANN BOT-LONDON, V97, P705, DOI 10.1093/aob/mcl029; HOELZER GA, 1994, TRENDS ECOL EVOL, V9, P104, DOI 10.1016/0169-5347(94)90207-0; Holmes S, 2003, THEOR POPUL BIOL, V63, P17, DOI 10.1016/S0040-5809(02)00005-9; Huelsenbeck JP, 1996, EVOLUTION, V50, P1418, DOI 10.1111/j.1558-5646.1996.tb03915.x; Huff SW, 2004, J MOLLUS STUD, V70, P379, DOI 10.1093/mollus/70.4.379; Hyman IT, 2007, MOL PHYLOGENET EVOL, V45, P792, DOI 10.1016/j.ympev.2007.08.018; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P250, DOI 10.1006/mpev.1999.0615; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Marjanovic D, 2007, SYST BIOL, V56, P369, DOI 10.1080/10635150701397635; Matsen FA, 2006, SYST BIOL, V55, P652, DOI 10.1080/10635150600889617; Mooers A.O., 2007, RECONSTRUCTING EVOLU, P149; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; MOOERS AO, 1995, EVOLUTION, V49, P379, DOI [10.2307/2410349, 10.1111/j.1558-5646.1995.tb02251.x]; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Murtagh F, 2007, ST CLASS DAT ANAL, P263, DOI 10.1007/978-3-540-70981-7_30; Murtagh F, 2006, AIP CONF PROC, V826, P151, DOI 10.1063/1.2193119; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Page RDM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-158; Paradis E, 2003, P ROY SOC B-BIOL SCI, V270, P2499, DOI 10.1098/rspb.2003.2513; Paxinos EE, 2002, P NATL ACAD SCI USA, V99, P1399, DOI 10.1073/pnas.032166399; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Piaggio AJ, 2001, MOL PHYLOGENET EVOL, V20, P335, DOI 10.1006/mpev.2001.0975; Plucinski M, 2008, J THEOR BIOL, V251, P82, DOI 10.1016/j.jtbi.2007.10.042; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Puslednik L, 2008, MOL PHYLOGENET EVOL, V48, P1178, DOI 10.1016/j.ympev.2008.05.006; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; RAMMAL R, 1986, REV MOD PHYS, V58, P765, DOI 10.1103/RevModPhys.58.765; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; ROBERTS MD, 2008, ARXIVCS9810012V4; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salisbury BA, 1999, SYST BIOL, V48, P153, DOI 10.1080/106351599260508; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Sanderson MJ, 1996, TRENDS ECOL EVOL, V11, P15, DOI 10.1016/0169-5347(96)81059-7; Sasaki T, 2006, SYST BIOL, V55, P912, DOI 10.1080/10635150601058014; Simon C, 2005, SYST BIOL, V54, P1, DOI 10.1080/10635150590930463; Sousa A, 2008, MOL PHYLOGENET EVOL, V48, P563, DOI 10.1016/j.ympev.2008.04.030; SRIDHAR S, 2007, THESIS CARNEGIE MELL; Stam E, 2002, EVOLUTION, V56, P1292; Steel M, 2000, SYST BIOL, V49, P363, DOI 10.1093/sysbio/49.2.363; Steel M, 2005, TRENDS GENET, V21, P307, DOI 10.1016/j.tig.2005.04.001; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Sumner JG, 2008, J THEOR BIOL, V253, P601, DOI 10.1016/j.jtbi.2008.04.001; Sundberg P, 2001, MOL PHYLOGENET EVOL, V20, P327, DOI 10.1006/mpev.2001.0982; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Tuffley C, 1997, B MATH BIOL, V59, P581, DOI 10.1016/S0092-8240(97)00001-3; Vela E, 2008, GEODIVERSITAS, V30, P233; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Vogt L, 2008, CLADISTICS, V24, P62, DOI 10.1111/j.1096-0031.2007.00169.x; Wallace RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001697; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Westerman Michael, 1999, Journal of Mammalian Evolution, V6, P271, DOI 10.1023/A:1020565724799; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilke T, 2000, AM J TROP MED HYG, V62, P453, DOI 10.4269/ajtmh.2000.62.453; Zeng LY, 2005, CAN J ZOOL, V83, P24, DOI 10.1139/z05-010; Zhou Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-206	124	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4611	10.1371/journal.pone.0004611	http://dx.doi.org/10.1371/journal.pone.0004611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242549	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487500013
J	Stavrum, R; Myneedu, VP; Arora, VK; Ahmed, N; Grewal, HMS				Stavrum, Ruth; Myneedu, Vithal Prasad; Arora, Virendra K.; Ahmed, Niyaz; Grewal, Harleen M. S.			In-Depth Molecular Characterization of Mycobacterium tuberculosis from New Delhi - Predominance of Drug Resistant Isolates of the 'Modern' (TbD1(-)) Type	PLOS ONE			English	Article							PYRAZINAMIDE RESISTANCE; PULMONARY TUBERCULOSIS; RIFAMPICIN-RESISTANCE; PNCA MUTATIONS; COMPLEX; GENE; EPIDEMIOLOGY; IDENTIFICATION; STRAINS; RECOMMENDATIONS	Background: India has the highest estimated burden of tuberculosis in the world, accounting for 21% of all tuberculosis cases world-wide. However, due to lack of systematic analysis using multiple markers the available information on the genomic diversity of Mycobacterium tuberculosis in India is limited. Methodology/Principal Findings: Thus, 65 M. tuberculosis isolates from New Delhi, India were analyzed by spoligotyping, MIRU-VNTR, large deletion PCR typing and single nucleotide polymorphism analysis (SNP). The Central Asian (CAS) 1_DELHI sub-lineage was the most prevalent sub-lineage comprising 46.2% (n = 30) of all isolates, with shared-type (ST) 26 being the most dominant genotype comprising 24.6% (n = 16) of all isolates. Other sub-lineages observed were: East-African Indian (EAI)-5 (9.2%, n = 6), EAI6_BGD1 (6.2%, n = 4), EAI3_IND, CAS and T1 with 6.2% each (n = 4 each), Beijing (4.6%, n = 3), CAS2 (3.1%, n = 2), and X1 and X2 with 1 isolate each. Genotyping results from five isolates (7.7%) did not match any existing spoligopatterns, and one isolate, ST124, belonged to an undefined lineage. Twenty-six percent of the isolates belonged to the TbD1+ PGG1 genogroup. SNP analysis of the pncA gene revealed a CAS-lineage specific silent mutation, S65S, which was observed for all CAS-lineage isolates (except two ST26 isolates) and in 1 orphan. Mutations in the pncA gene, conferring resistance to pyrazinamide, were observed in 15.4% of all isolates. Collectively, mutations in the rpoB gene, the katG gene and in both rpoB and katG genes, conferring resistance to rifampicin and isoniazid, respectively, were more frequent in CAS1_DELHI isolates compared to non-CAS_DELHI isolates (OR: 3.1, CI95% [1.11, 8.70], P = 0.045). The increased frequency of drug-resistance could not be linked to the patients' history of previous anti-tuberculosis treatment (OR: 1.156, CI95% [0.40, 3.36], P = 0.79). Fifty-six percent of all new tuberculosis patients had mutations in either the katG gene or the rpoB gene, or in both katG and rpoB genes. Conclusion: CAS1_DELHI isolates circulating in New Delhi, India have a high frequency of mutations in the rpoB and katG genes. A silent mutation (S65S) in the pncA gene can be used as a putative genetic marker for CAS-lineage isolates.	[Stavrum, Ruth; Grewal, Harleen M. S.] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Stavrum, Ruth; Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway; [Myneedu, Vithal Prasad; Arora, Virendra K.] Lala Ram Sarup Inst TB & Resp Dis, New Delhi, India; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India	University of Bergen; University of Bergen; Haukeland University Hospital; University of Hyderabad	Stavrum, R (corresponding author), Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway.	Harleen.Grewal@Gades.uib.no	Ahmed, Niyaz/D-2589-2010; Grewal, Harleen/ABC-5831-2020	Ahmed, Niyaz/0000-0001-6425-7583; 	Department of Biotechnology of the Indian Government; Research Council of Norway; University of Bergen; Western Norway Regional Health Authority	Department of Biotechnology of the Indian Government; Research Council of Norway(Research Council of Norway); University of Bergen; Western Norway Regional Health Authority	Department of Biotechnology of the Indian Government is acknowledged for providing core support to Niyaz Ahmed and the Research Council of Norway, University of Bergen and Western Norway Regional Health Authority for financial support.	Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; AHMED N, 2008, INFECT GENE IN PRESS, DOI DOI 10.1016/J.MEEGID.2008.1010.1001; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P31, DOI 10.1186/1476-0711-5-31; Almeida D, 2005, CLIN INFECT DIS, V40, P881, DOI 10.1086/427940; Bhanu NV, 2002, TUBERCULOSIS, V82, P105, DOI 10.1054/tube.2002.0332; Braden CR, 2002, EMERG INFECT DIS, V8, P1210; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; DEBEENHOUWER H, 1995, TUBERCLE LUNG DIS, V76, P425, DOI 10.1016/0962-8479(95)90009-8; Dooley S. W. Jr., 1994, P171; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hasan Z, 2006, J CLIN MICROBIOL, V44, P1763, DOI 10.1128/JCM.44.5.1763-1768.2006; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Mphahlele M, 2008, J CLIN MICROBIOL, V46, P3459, DOI 10.1128/JCM.00973-08; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Rahim Z, 2007, J CLIN MICROBIOL, V45, P3791, DOI 10.1128/JCM.01247-07; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P2802, DOI 10.1128/JCM.00352-07; Sharma P, 2008, INFECT GENET EVOL, V8, P621, DOI 10.1016/j.meegid.2008.05.002; Siddiqi N, 2001, INFECT GENET EVOL, V1, P109, DOI 10.1016/S1567-1348(01)00014-4; Silva MSN, 2003, J CLIN MICROBIOL, V41, P4471, DOI 10.1128/JCM.41.9.4471-4474.2003; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Somoskovi A, 2007, J CLIN MICROBIOL, V45, P595, DOI 10.1128/JCM.01454-06; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P636, DOI 10.1128/AAC.41.3.636; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TSUKAMURA M, 1972, Tubercle, V53, P111, DOI 10.1016/0041-3879(72)90027-X; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; Victor T. C., 1999, Tubercle and Lung Disease, V79, P343, DOI 10.1054/tuld.1999.0222; WHO, 2008, 2008 WHO; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	47	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4540	10.1371/journal.pone.0004540	http://dx.doi.org/10.1371/journal.pone.0004540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234602	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487200003
J	Yoon, J; Deisboeck, TS				Yoon, Jeongah; Deisboeck, Thomas S.			Investigating Differential Dynamics of the MAPK Signaling Cascade Using a Multi-Parametric Global Sensitivity Analysis	PLOS ONE			English	Article								Cell growth critically depends on signalling pathways whose regulation is the focus of intense research. Without utilizing a priori knowledge of the relative importance of pathway components, we have applied in silico computational methods to the EGF-induced MAPK cascade. Specifically, we systematically perturbed the entire parameter space, including initial conditions, using a Monte Carlo approach, and investigate which protein components or kinetic reaction steps contribute to the differentiation of ERK responses. The model, based on previous work by Brightman and Fell (2000), is composed of 28 reactions, 27 protein molecules, and 48 parameters from both mass action and Michaelis-Menten kinetics. Our multiparametric systems analysis confirms that Raf inactivation is one of the key steps regulating ERK responses to be either transient or sustained. Furthermore, the results of amplitude-differential ERK phosphorylations within the transient case are mainly attributed to the balance between activation and inactivation of Ras while duration-differential ERK responses for the sustained case are, in addition to Ras, markedly affected by dephospho-/phosphorylation of both MEK and ERK. Our sub-module perturbations showed that MEK and ERK's contribution to this differential ERK activation originates from fluctuations in intermediate pathway module components such as Ras and Raf, implicating a cooperative regulatory mode among the key components. The initial protein concentrations of corresponding reactions such as Ras, GAP, and Raf also influence the distinct signalling outputs of ERK activation. We then compare these results with those obtained from a single-parametric perturbation approach using an overall state sensitivity (OSS) analysis. The OSS findings indicate a more pronounced role of ERK's inhibitory feedback effect on catalysing the dissociation of the SOS complex. Both approaches reveal the presence of multiple specific reactions involved in the distinct dynamics of ERK responses and the cell fate decisions they trigger. This work adds a mechanistic insight of the contribution of key pathway components, thus may support the identification of biomarkers for pharmaceutical drug discovery processes.	[Yoon, Jeongah; Deisboeck, Thomas S.] Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Harvard MIT HST, Complex Biosyst Modeling Lab, Charlestown, MA USA	Harvard University; Massachusetts General Hospital	Yoon, J (corresponding author), Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Harvard MIT HST, Complex Biosyst Modeling Lab, Charlestown, MA USA.	deisboec@helix.mgh.harvard.edu			NIH [CA 113004]; Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging and the Department of Radiology at Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [U56CA113004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging and the Department of Radiology at Massachusetts General Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by NIH grant CA 113004 and by the Harvard-MIT (HST) Athinoula A. Martinos Center for Biomedical Imaging and the Department of Radiology at Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; BRIGHTMAN FA, 2001, COMPUTER SIMULATION; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Smolen P, 2008, AM J PHYSIOL-CELL PH, V294, pC503, DOI 10.1152/ajpcell.00447.2007; Snoep JL, 2005, CURR OPIN BIOTECH, V16, P336, DOI 10.1016/j.copbio.2005.05.003; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Tombes RM, 1998, BIOCHEM J, V330, P1451; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Yaka R, 1998, J CELL BIOCHEM, V70, P425, DOI 10.1002/(SICI)1097-4644(19980901)70:3<425::AID-JCB15>3.0.CO;2-J; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034	37	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4560	10.1371/journal.pone.0004560	http://dx.doi.org/10.1371/journal.pone.0004560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234599	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487200014
J	Paris, I; Perez-Pastene, C; Couve, E; Caviedes, P; LeDoux, S; Segura-Aguilar, J				Paris, Irmgard; Perez-Pastene, Carolina; Couve, Eduardo; Caviedes, Pablo; LeDoux, Susan; Segura-Aguilar, Juan			Copper center dot Dopamine Complex Induces Mitochondrial Autophagy Preceding Caspase-independent Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SUBSTANTIA-NIGRA; DEPENDENT IRON TOXICITY; ALPHA-SYNUCLEIN; MOLECULAR-MECHANISMS; CARCINOMA-CELLS; DISEASE; NECROSIS; NEUROTOXICITY; INHIBITION; PATHWAYS	Parkinsonism is one of the major neurological symptoms in Wilson disease, and young workers who worked in the copper smelting industry also developed Parkinsonism. We have reported the specific neurotoxic action of copper center dot dopamine complex in neurons with dopamine uptake. Copper center dot dopamine complex (100 mu M) induces cell death in RCSN-3 cells by disrupting the cellular redox state, as demonstrated by a 1.9-fold increase in oxidized glutathione levels and a 56% cell death inhibition in the presence of 500 mu M ascorbic acid; disruption of mitochondrial membrane potential with a spherical shape and well preserved morphology determined by transmission electron microscopy; inhibition (72%, p < 0.001) of phosphatidylserine externalization with 5 mu M cyclosporine A; lack of caspase-3 activation; formation of autophagic vacuoles containing mitochondria after 2 h; transfection of cells with green fluorescent protein-light chain 3 plasmid showing that 68% of cells presented autophagosome vacuoles; colocalization of positive staining for green fluorescent protein-light chain 3 and Rhod-2AM, a selective indicator of mitochondrial calcium; and DNA laddering after 12-h incubation. These results suggest that the copper center dot dopamine complex induces mitochondrial autophagy followed by caspase-3-independent apoptotic cell death. However, a different cell death mechanism was observed when 100 mu M copper center dot dopamine complex was incubated in the presence of 100 mu M dicoumarol, an inhibitor of NAD(P) H quinone: oxidoreductase (EC 1.6.99.2, also known as DT-diaphorase and NQ01), because a more extensive and rapid cell death was observed. In addition, cyclosporine A had no effect on phosphatidylserine externalization, significant portions of compact chromatin were observed within a vacuolated nuclear membrane, DNA laddering was less pronounced, the mitochondria morphology was more affected, and the number of cells with autophagic vacuoles was a near 4-fold less.	[Segura-Aguilar, Juan] Fac Med, Dept Mol & Clin Pharmacol, Programme Mol & Clin Pharmacol, Santiago 7, Chile; [Paris, Irmgard] Univ Santo Tomas, Dept Basic Sci, Vina Del Mar 2561780, Chile; [Paris, Irmgard] Univ Andres Bello, Dept Biol Sci, Vina Del Mar 2561156, Chile; [Couve, Eduardo] Univ Valparaiso, Dept Biol, Valparaiso, Chile; [LeDoux, Susan] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36608 USA	Universidad Santo Tomas; Universidad Andres Bello; Universidad de Valparaiso; University of South Alabama	Segura-Aguilar, J (corresponding author), Fac Med, Dept Mol & Clin Pharmacol, Programme Mol & Clin Pharmacol, Independencia 1027,Casilla 70000, Santiago 7, Chile.	jsegura@med.uchile.cl	Segura-Aguilar, Juan/H-8839-2013; Paris, Irmgard/AAM-7272-2020	Segura-Aguilar, Juan/0000-0002-1018-673X; Paris, Irmgard/0000-0003-2331-7513	Fogarty International Research Collaboration Award [R03 TW07044-01]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1020672, 1061083]; FOGARTY INTERNATIONAL CENTER [R03TW007044] Funding Source: NIH RePORTER	Fogarty International Research Collaboration Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Fogarty International Research Collaboration Award Grant R03 TW07044-01 and Fondo Nacional de Desarrollo Cientifico y Tecnologico Grants 1020672 and 1061083.	Argaud L, 2004, CARDIOVASC RES, V61, P115, DOI 10.1016/j.cardiores.2003.11.003; Arriagada C, 2004, NEUROBIOL DIS, V16, P468, DOI 10.1016/j.nbd.2004.03.014; Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Barthel H, 2003, AM J NEURORADIOL, V24, P234; Bredesen DE, 2007, STROKE, V38, P652, DOI 10.1161/01.STR.0000257802.82826.a7; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Bursch W, 2004, FEMS YEAST RES, V5, P101, DOI 10.1016/j.femsyr.2004.07.006; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cardenas S.P., 2008, NEUROTOX RES, V13, P136; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Caviedes P, 2001, NEUROREPORT, V12, pA25, DOI 10.1097/00001756-200103260-00004; Chikira M, 1997, J INORG BIOCHEM, V66, P131, DOI 10.1016/S0162-0134(96)00193-6; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dagnino-Subiabre A, 2000, MOL CELL BIOCHEM, V212, P131, DOI 10.1023/A:1007129609928; Diaz-Veliz G, 2004, NEUROTOX RES, V5, P629; Diaz-Veliz G, 2008, CHEM RES TOXICOL, V21, P1180, DOI 10.1021/tx8001143; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fuentes P, 2007, CHEM RES TOXICOL, V20, P776, DOI 10.1021/tx600325u; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Higuchi Y, 2003, BIOCHEM PHARMACOL, V66, P1527, DOI 10.1016/S0006-2952(03)00508-2; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hwang SO, 2008, BIOTECHNOL BIOENG, V99, P678, DOI 10.1002/bit.21589; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KISS T, 1985, J INORG BIOCHEM, V25, P247, DOI 10.1016/0162-0134(85)80024-6; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lepretre C, 2009, INT J BIOCHEM CELL B, V41, P1046, DOI 10.1016/j.biocel.2008.09.026; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moreira PI, 2007, AUTOPHAGY, V3, P614, DOI 10.4161/auto.4872; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; ODER W, 1993, NEUROLOGY, V43, P120, DOI 10.1212/WNL.43.1_Part_1.120; Paris I, 2005, CHEM RES TOXICOL, V18, P415, DOI 10.1021/tx0497144; Paris I, 2005, J NEUROCHEM, V92, P1021, DOI 10.1111/j.1471-4159.2004.02931.x; Paris I, 2001, J NEUROCHEM, V77, P519, DOI 10.1046/j.1471-4159.2001.00243.x; Paris I, 2008, NEUROTOX RES, V13, P221, DOI 10.1007/BF03033505; Paris I, 2007, NEUROTOX RES, V12, P125, DOI 10.1007/BF03033921; Park SY, 2005, CANCER LETT, V224, P123, DOI 10.1016/j.canlet.2004.10.009; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rickmann M, 2007, GASTROENTEROLOGY, V132, P2518, DOI 10.1053/j.gastro.2007.03.107; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Segura-Aguilar J, 2002, NEUROTOX RES, V4, P127, DOI 10.1080/10298420290015926; Shrivastava A, 2006, J BIOL CHEM, V281, P19762, DOI 10.1074/jbc.M600746200; Taly AB, 2007, MEDICINE, V86, P112, DOI 10.1097/MD.0b013e318045a00e; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tettamanti G, 2008, CURR PHARM DESIGN, V14, P116, DOI 10.2174/138161208783378716; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Xilouri M, 2008, AUTOPHAGY, V4, P917, DOI 10.4161/auto.6685; Yu Wen-Ran, 2008, Neurosci Bull, V24, P73, DOI 10.1007/s12264-008-0073-y	60	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13306	13315		10.1074/jbc.M900323200	http://dx.doi.org/10.1074/jbc.M900323200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19265190	Green Published, hybrid			2022-12-25	WOS:000265877300006
J	Schmid, A; Neumayer, W; Trulzsch, K; Israel, L; Imhof, A; Roessle, M; Sauer, G; Richter, S; Lauw, S; Eylert, E; Eisenreich, W; Heesemann, J; Wilharm, G				Schmid, Annika; Neumayer, Wibke; Truelzsch, Konrad; Israel, Lars; Imhof, Axel; Roessle, Manfred; Sauer, Guido; Richter, Susanna; Lauw, Susan; Eylert, Eva; Eisenreich, Wolfgang; Heesemann, Juergen; Wilharm, Gottfried			Cross-talk between Type Three Secretion System and Metabolism in Yersinia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-CALCIUM RESPONSE; TARGET-CELL CONTACT; PROTON MOTIVE FORCE; III SECRETION; PHOSPHOENOLPYRUVATE CARBOXYLASE; ESCHERICHIA-COLI; YOP SECRETION; PSEUDOMONAS-AERUGINOSA; PASTEURELLA-PESTIS; CARBON METABOLISM	Pathogenic yersiniae utilize a type three secretion system (T3SS) to inject Yop proteins into host cells in order to undermine their immune response. YscM1 and YscM2 proteins have been reported to be functionally equivalent regulators of the T3SS in Yersinia enterocolitica. Here, we show by affinity purification, native gel electrophoresis and small angle x-ray scattering that both YscM1 and YscM2 bind to phosphoenolpyruvate carboxylase (PEPC) of Y. enterocolitica. Under in vitro conditions, YscM1, but not YscM2, was found to inhibit PEPC with an apparent IC50 of 4 mu M (K-i = 1 mu M). To analyze the functional roles of PEPC, YscM1, and YscM2 in Yop-producing bacteria, cultures of Y. enterocolitica wild type and mutants defective in the formation of PEPC, YscM1, or YscM2, respectively, were grown under low calcium conditions in the presence of [U-C-13(6)] glucose. The isotope compositions of secreted Yop proteins and nine amino acids from cellular proteins were analyzed by mass spectrometry. The data indicate that a considerable fraction of oxaloacetate used as precursor for amino acids was derived from[ C-13(3)] phosphoenolpyruvate by the catalytic action of PEPC in the wild-type strain but not in the PEPC- mutant. The data imply that PEPC is critically involved in replenishing the oxaloacetate pool in the citrate cycle under virulence conditions. In the YscM1(-) and YscM2(-) mutants, increased rates of pyruvate formation via glycolysis or the Entner-Doudoroff pathway, of oxaloacetate formation via the citrate cycle, and of amino acid biosynthesis suggest that both regulators trigger the central metabolism of Y. enterocolitica. We propose a "load-and-shoot cycle" model to account for the cross-talk between T3SS and metabolism in pathogenic yersiniae.	[Wilharm, Gottfried] Robert Koch Inst, Bereich Wernigerode, D-38855 Wernigerode, Germany; [Schmid, Annika; Neumayer, Wibke; Truelzsch, Konrad; Richter, Susanna; Heesemann, Juergen; Wilharm, Gottfried] Max Von Pettenkofer Inst Hyg & Med Microbiol, Dept Bacteriol, D-80336 Munich, Germany; [Israel, Lars; Imhof, Axel] Adolf Butenandt Inst, D-80336 Munich, Germany; [Roessle, Manfred] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Sauer, Guido] Natl Res Ctr Environm & Hlth, Forschungszentrum Umwelt & Gesundheit, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany; [Sauer, Guido] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Lauw, Susan; Eylert, Eva; Eisenreich, Wolfgang] Tech Univ Munich, Dept Chem, Lehrstuhl Biochem, D-85747 Garching, Germany	Robert Koch Institute; University of Munich; University of Munich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Munich; Max Planck Society; Technical University of Munich	Wilharm, G (corresponding author), Robert Koch Inst, Bereich Wernigerode, Burgstr 37, D-38855 Wernigerode, Germany.	wilharmg@rki.de	Imhof, Axel/AAU-5313-2021; Eisenreich, Wolfgang/A-1258-2013	Imhof, Axel/0000-0003-2993-8249; Eisenreich, Wolfgang/0000-0002-9832-8279; Trulzsch, Konrad/0000-0002-1937-5043; Rossle, Manfred/0000-0003-4196-0430; Wilharm, Gottfried/0000-0002-1771-6799	Deutsche Forschungsgemeinschaft [SFB 594, B6, GRK 303, SPP 1316]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 594, Teilprojekt B6, GRK 303, and SPP 1316.	Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; ALLAOUI A, 1995, MOL MICROBIOL, V18, P343, DOI 10.1111/j.1365-2958.1995.mmi_18020343.x; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; BAUGH CL, 1964, J BACTERIOL, V88, P553, DOI 10.1128/JB.88.3.553-558.1964; Brubaker RR, 2005, INFECT IMMUN, V73, P4743, DOI 10.1128/IAI.73.8.4743-4752.2005; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; CARTER PB, 1980, INFECT IMMUN, V28, P638; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DELWICHE EA, 1959, J BACTERIOL, V77, P355, DOI 10.1128/JB.77.3.355-360.1959; Dittmann S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-67; DREYFUS LA, 1978, J BACTERIOL, V136, P757, DOI 10.1128/JB.136.2.757-764.1978; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; FOWLER JM, 1994, INFECT IMMUN, V62, P5234, DOI 10.1128/IAI.62.12.5234-5241.1994; Garcia-Alles LF, 2002, EUR J BIOCHEM, V269, P3226, DOI 10.1046/j.1432-1033.2002.02995.x; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1984, INFECT IMMUN, V46, P105, DOI 10.1128/IAI.46.1.105-110.1984; HEESEMANN J, 1986, INFECT IMMUN, V54, P561, DOI 10.1128/IAI.54.2.561-567.1986; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; IZUI K, 1983, J BIOCHEM-TOKYO, V94, P1789, DOI 10.1093/oxfordjournals.jbchem.a134530; Kai Y, 1999, P NATL ACAD SCI USA, V96, P823, DOI 10.1073/pnas.96.3.823; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kim W, 2004, MOL MICROBIOL, V54, P702, DOI 10.1111/j.1365-2958.2004.04295.x; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; MICHIELS T, 1991, J BACTERIOL, V173, P4994, DOI 10.1128/jb.173.16.4994-5009.1991; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; RIMPILAINEN M, 1992, J BACTERIOL, V174, P3355, DOI 10.1128/jb.174.10.3355-3363.1992; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schlee M, 2004, J VIROL, V78, P3941, DOI 10.1128/JVI.78.8.3941-3952.2004; Schmid A, 2006, PROTEIN EXPRES PURIF, V49, P176, DOI 10.1016/j.pep.2006.04.012; SMITH TE, 1968, ARCH BIOCHEM BIOPHYS, V128, P611, DOI 10.1016/0003-9861(68)90071-4; Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x; Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200; TERADA K, 1991, J BIOCHEM-TOKYO, V109, P49; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Wiley DJ, 2007, J MOL BIOL, V373, P27, DOI 10.1016/j.jmb.2007.07.077; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Wilharm G, 2003, PROTEIN EXPRES PURIF, V31, P167, DOI 10.1016/S1046-5928(03)00183-9; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x	62	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12165	12177		10.1074/jbc.M900773200	http://dx.doi.org/10.1074/jbc.M900773200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244229	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000265494600048
J	Pearce, MMP; Wormer, DB; Wilkens, S; Wojcikiewicz, RJH				Pearce, Margaret M. P.; Wormer, Duncan B.; Wilkens, Stephan; Wojcikiewicz, Richard J. H.			An Endoplasmic Reticulum (ER) Membrane Complex Composed of SPFH1 and SPFH2 Mediates the ER-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; P97-UFD1-NPL4 COMPLEX; UBIQUITIN LIGASES; ION CHANNELS; PROTEINS; DOMAIN; MITOCHONDRIA; CHOLESTEROL; PROTEASOME; PATHWAYS	How endoplasmic reticulum (ER) proteins that are substrates for the ER-associated degradation (ERAD) pathway are recognized for polyubiquitination and proteasomal degradation is largely unresolved. Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) form tetrameric calcium channels in ER membranes, whose primary role is to control the release of ER calcium stores, but whose levels are also regulated, in an activation-dependent manner, by the ERAD pathway. Here we report that the ER membrane protein SPFH1 and its homolog SPFH2 form a heteromeric similar to 2 MDa complex that binds to IP3R tetramers immediately after their activation and is required for their processing. The complex is ring-shaped (diameter similar to 250 angstrom), and RNA interference-mediated depletion of SPFH1 and SPFH2 blocks IP3R polyubiquitination and degradation. We propose that this novel SPFH1/2 complex is a recognition factor that targets IP(3)Rs and perhaps other substrates for ERAD.	[Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Pearce, Margaret M. P.; Wormer, Duncan B.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Panning Pearce, Margaret/0000-0002-5846-9632	National Institutes of Health [DK49194, GM58600, CA100246]; PhRMA Foundation; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49194 (to R.J.H.W.) and GM58600 and CA100246 (to S.W.). This work was also supported by a predoctoral fellowship from the PhRMA Foundation (to M.M.P.P.).	Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hoegg MB, 2009, J BIOL CHEM, V284, P7766, DOI 10.1074/jbc.M809127200; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Huh YH, 2007, BIOCHEMISTRY-US, V46, P14032, DOI 10.1021/bi701364p; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Prinz W, 2002, SEMIN CELL DEV BIOL, V13, P197, DOI 10.1016/S1084-9521(02)00048-4; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xu Q, 2004, MOL CANCER THER, V3, P1263; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024	45	66	68	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10433	10445		10.1074/jbc.M809801200	http://dx.doi.org/10.1074/jbc.M809801200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240031	Green Published, hybrid			2022-12-25	WOS:000265104600017
J	Chiel, E; Zchori-Fein, E; Inbar, M; Gottlieb, Y; Adachi-Hagimori, T; Kelly, SE; Asplen, MK; Hunter, MS				Chiel, Elad; Zchori-Fein, Einat; Inbar, Moshe; Gottlieb, Yuval; Adachi-Hagimori, Tetsuya; Kelly, Suzanne E.; Asplen, Mark K.; Hunter, Martha S.			Almost There: Transmission Routes of Bacterial Symbionts between Trophic Levels	PLOS ONE			English	Article							BEMISIA-TABACI HOMOPTERA; HORIZONTAL TRANSFER; WOLBACHIA; ENDOSYMBIONTS; RICKETTSIA; HYMENOPTERA; EVOLUTION; APHIDS; TRANSFECTION; RESISTANCE	Many intracellular microbial symbionts of arthropods are strictly vertically transmitted and manipulate their host's reproduction in ways that enhance their own transmission. Rare horizontal transmission events are nonetheless necessary for symbiont spread to novel host lineages. Horizontal transmission has been mostly inferred from phylogenetic studies but the mechanisms of spread are still largely a mystery. Here, we investigated transmission of two distantly related bacterial symbionts - Rickettsia and Hamiltonella - from their host, the sweet potato whitefly, Bemisia tabaci, to three species of whitefly parasitoids: Eretmocerus emiratus, Eretmocerus eremicus and Encarsia pergandiella. We also examined the potential for vertical transmission of these whitefly symbionts between parasitoid generations. Using florescence in situ hybridization (FISH) and transmission electron microscopy we found that Rickettsia invades Eretmocerus larvae during development in a Rickettsia-infected host, persists in adults and in females, reaches the ovaries. However, Rickettsia does not appear to penetrate the oocytes, but instead is localized in the follicular epithelial cells only. Consequently, Rickettsia is not vertically transmitted in Eretmocerus wasps, a result supported by diagnostic polymerase chain reaction (PCR). In contrast, Rickettsia proved to be merely transient in the digestive tract of Encarsia and was excreted with the meconia before wasp pupation. Adults of all three parasitoid species frequently acquired Rickettsia via contact with infected whiteflies, most likely by feeding on the host hemolymph (host feeding), but the rate of infection declined sharply within a few days of wasps being removed from infected whiteflies. In contrast with Rickettsia, Hamiltonella did not establish in any of the parasitoids tested, and none of the parasitoids acquired Hamiltonella by host feeding. This study demonstrates potential routes and barriers to horizontal transmission of symbionts across trophic levels. The possible mechanisms that lead to the differences in transmission of species of symbionts among species of hosts are discussed.	[Chiel, Elad; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Chiel, Elad; Zchori-Fein, Einat] ARO, Newe Yaar Res Ctr, Dept Entomol, Ramat Yishai, Israel; [Chiel, Elad; Adachi-Hagimori, Tetsuya; Kelly, Suzanne E.; Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Gottlieb, Yuval] ARO, Volcani Ctr, Dept Entomol, Bet Dagan, Israel; [Adachi-Hagimori, Tetsuya] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima 730, Japan; [Asplen, Mark K.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of Haifa; University of Arizona; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hiroshima University; University of Minnesota System; University of Minnesota Twin Cities	Chiel, E (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	chiel@email.arizona.edu	Gottlieb, Yuval/H-6461-2013; Hunter, Martha/AAF-5288-2020; Hunter, Martha/B-7307-2012	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Inbar, Moshe/0000-0002-4707-9508; Chiel, Elad/0000-0002-7146-3219	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel [2004416]; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2006-35302-17165]; The United-States - Israel Binational Agricultural Research and Development fund (BARD) [GS-1-2007]; Agricultural Research Organization, Bet Dagan, Israel [503/08]	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); The United-States - Israel Binational Agricultural Research and Development fund (BARD)(US-Israel Binational Science Foundation); Agricultural Research Organization, Bet Dagan, Israel	This research was supported by the following sources: grant No 2004416 from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel to EZ-F and MSH; The National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant No 2006-35302-17165 to MSH and EZ-F and The United-States - Israel Binational Agricultural Research and Development fund (BARD), Graduate Student Fellow award No GS-1-2007 to EC. Contribution No 503/08 from the Agricultural Research Organization, Bet Dagan, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplen MK, 2006, J MORPHOL, V267, P1066, DOI 10.1002/jmor.10459; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BRAIG HR, 1994, NATURE, V367, P453, DOI 10.1038/367453a0; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; CHIEL E, 2009, ANN ENTOMOL IN PRESS; Enigl M, 2005, EXP APPL ACAROL, V36, P249, DOI 10.1007/s10493-005-6075-9; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fujii Y, 2001, P ROY SOC B-BIOL SCI, V268, P855, DOI 10.1098/rspb.2001.1593; GERLING D, 1990, ARCH INSECT BIOCHEM, V13, P247, DOI 10.1002/arch.940130311; Gerling D, 2001, CROP PROT, V20, P779, DOI 10.1016/S0261-2194(01)00111-9; GERLING D, 1966, CAN ENTOMOL, V98, P707, DOI 10.4039/Ent98707-7; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Grenier S, 1998, P ROY SOC B-BIOL SCI, V265, P1441, DOI 10.1098/rspb.1998.0455; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Heraty J, 2007, CATALOG ENCARSIA WOR; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Jaenike J, 2007, BIOL LETTERS, V3, P23, DOI 10.1098/rsbl.2006.0577; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; van Meer MMM, 1999, INSECT MOL BIOL, V8, P399, DOI 10.1046/j.1365-2583.1999.83129.x; Varaldi J, 2005, PARASITOLOGY, V131, P161, DOI 10.1017/S0031182005007602; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Viljakainen L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-55; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zolnerowich G, 2008, J INSECT SCI, V8, P54	49	93	100	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4767	10.1371/journal.pone.0004767	http://dx.doi.org/10.1371/journal.pone.0004767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274091	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000007
J	Westerterp, KR; Plasqui, G				Westerterp, Klaas R.; Plasqui, Guy			Physically Active Lifestyle Does Not Decrease the Risk of Fattening	PLOS ONE			English	Article								Background: Increasing age is associated with declining physical activity and a gain in fat mass. The objective was to observe the consequence of the age-associated reduction in physical activity for the maintenance of energy balance as reflected in the fat store of the body. Methodology/Principal Findings: Young adults were observed over an average time interval of more than 10 years. Physical activity was measured over two-week periods with doubly labeled water and doubly labeled water validated triaxial accelerometers, and body fat gain was measured with isotope dilution. There was a significant association between the change in physical activity and the change in body fat, where a high initial activity level was predictive for a higher fat gain. Conclusion/Significance: The change from a physically active to a more sedentary routine does not induce an equivalent reduction of energy intake and requires cognitive restriction to maintain energy balance.	[Westerterp, Klaas R.; Plasqui, Guy] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Westerterp, KR (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	K.Westerterp@HB.Unimaas.NL						Plasqui G, 2005, OBES RES, V13, P1363, DOI 10.1038/oby.2005.165; Speakman J.R., 1997, DOUBLY LABELLED WATE; Stubbs RJ, 2004, AM J CLIN NUTR, V79, P62; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Westerterp KR, 2004, CURR OPIN CLIN NUTR, V7, P607, DOI 10.1097/00075197-200411000-00004; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475	6	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4745	10.1371/journal.pone.0004745	http://dx.doi.org/10.1371/journal.pone.0004745			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270740	Green Published, gold			2022-12-25	WOS:000265495900013
J	Byrne, LJ; Cole, DJ; Cox, BS; Ridout, MS; Morgan, BJT; Tuite, MF				Byrne, Lee J.; Cole, Diana J.; Cox, Brian S.; Ridout, Martin S.; Morgan, Byron J. T.; Tuite, Mick F.			The Number and Transmission of [PSI+] Prion Seeds (Propagons) in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							GUANIDINE-HYDROCHLORIDE; HSP104; AGGREGATION; ELIMINATION; PROPAGATION; GENERATION; URE3; APPROXIMATIONS; CHAPERONES; DIVISION	Background: Yeast (Saccharomyces cerevisiae) prions are efficiently propagated and the on-going generation and transmission of prion seeds (propagons) to daughter cells during cell division ensures a high degree of mitotic stability. The reversible inhibition of the molecular chaperone Hsp104p by guanidine hydrochloride (GdnHCl) results in cell division-dependent elimination of yeast prions due to a block in propagon generation and the subsequent dilution out of propagons by cell division. Principal Findings: Analysing the kinetics of the GdnHCl-induced elimination of the yeast [PSI+] prion has allowed us to develop novel statistical models that aid our understanding of prion propagation in yeast cells. Here we describe the application of a new stochastic model that allows us to estimate more accurately the mean number of propagons in a [PSI+] cell. To achieve this accuracy we also experimentally determine key cell reproduction parameters and show that the presence of the [PSI+] prion has no impact on these key processes. Additionally, we experimentally determine the proportion of propagons transmitted to a daughter cell and show this reflects the relative cell volume of mother and daughter cells at cell division. Conclusions: While propagon generation is an ATP-driven process, the partition of propagons to daughter cells occurs by passive transfer via the distribution of cytoplasm. Furthermore, our new estimates of n(0), the number of propagons per cell (500-1000), are some five times higher than our previous estimates and this has important implications for our understanding of the inheritance of the [PSI+] and the spontaneous formation of prion-free cells.	[Byrne, Lee J.; Cox, Brian S.; Tuite, Mick F.] Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury, Kent, England; [Cole, Diana J.; Ridout, Martin S.; Morgan, Byron J. T.] Univ Kent, Inst Math Stat & Actuar Sci, Canterbury CT2 7NZ, Kent, England	University of Kent; University of Kent	Byrne, LJ (corresponding author), Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury, Kent, England.	M.F.Tuite@kent.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X; Ridout, Martin/0000-0001-7233-2985; Cole, Diana/0000-0002-8109-4832	EPSRC; BBSRC; Biotechnology and Biological Sciences Research Council [E18382] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a project grant jointly funded by the EPSRC and the BBSRC. Neither of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailleul PA, 1999, GENETICS, V153, P81; Bailleul-Winslett PA, 2000, GENE EXPRESSION, V9, P145; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cole DJ, 2007, BIOMETRICS, V63, P1023, DOI 10.1111/j.1541-0420.2007.00780.x; Cole DJ, 2004, MATH MED BIOL, V21, P369, DOI 10.1093/imammb/21.4.369; Cox B, 2003, GENETICS, V165, P23; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; COX BS, 1980, GENETICS, V95, P589; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Fernandez-Bellot E, 2002, EMBO REP, V3, P76, DOI 10.1093/embo-reports/kvf011; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Morgan BJT, 2003, BIOMETRICS, V59, P562, DOI 10.1111/1541-0420.00066; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Ridout MS, 2006, BIOMETRICS, V62, P1216, DOI 10.1111/j.1541-0420.2006.00564.x; Ripaud L, 2004, J BIOL CHEM, V279, P50962, DOI 10.1074/jbc.M408792200; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; Tuite MF, 2007, METHOD MICROBIOL, V36, P491, DOI 10.1016/S0580-9517(06)36020-5	39	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4670	10.1371/journal.pone.0004670	http://dx.doi.org/10.1371/journal.pone.0004670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262693	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490600003
J	Lecube, A; Sampol, G; Lloberes, P; Romero, O; Mesa, J; Hernandez, C; Simo, R				Lecube, Albert; Sampol, Gabriel; Lloberes, Patricia; Romero, Odile; Mesa, Jordi; Hernandez, Cristina; Simo, Rafael			Diabetes Is an Independent Risk Factor for Severe Nocturnal Hypoxemia in Obese Patients. A Case-Control Study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; DAYTIME SLEEPINESS	Background: Type 2 diabetes mellitus (T2DM) and obesity have become two of the main threats to public health in the Western world. In addition, obesity is the most important determinant of the sleep apnea-hypopnea syndrome (SAHS), a condition that adversely affects glucose metabolism. However, it is unknown whether patients with diabetes have more severe SAHS than non-diabetic subjects. The aim of this cross-sectional case-control study was to evaluate whether obese patients with T2DM are more prone to severe SAHS than obese non-diabetic subjects. Methodology/Principal Findings: Thirty obese T2DM and 60 non-diabetic women closely matched by age, body mass index, waist circumference, and smoking status were recruited from the outpatient Obesity Unit of a university hospital. The exclusion criteria included chronic respiratory disease, smoking habit, neuromuscular and cerebrovascular disease, alcohol abuse, use of sedatives, and pregnancy. Examinations included a non-attended respiratory polygraphy, pulmonary function testing, and an awake arterial gasometry. Oxygen saturation measures included the percentage of time spent at saturations below 90% (CT90). A high prevalence of SAHS was found in both groups (T2DM: 80%, nondiabetic: 78.3%). No differences in the number of sleep apnea-hypopnea events between diabetic and non-diabetic patients were observed. However, in diabetic patients, a significantly increase in the CT90 was detected (20.2 +/- 30.2% vs. 6.8 +/- 13,5%; p = 0.027). In addition, residual volume (RV) was significantly higher in T2DM (percentage of predicted: 79.7 +/- 18.1 vs. 100.1 +/- 22.8; p<0.001). Multiple linear regression analyses showed that T2DM but not RV was independently associated with CT90. Conclusions/Significance: T2DM adversely affects breathing during sleep, becoming an independent risk factor for severe nocturnal hypoxemia in obese patients. Given that SAHS is a risk factor of cardiovascular disease, the screening for SAHS in T2DM patients seems mandatory.	[Lecube, Albert; Mesa, Jordi; Hernandez, Cristina; Simo, Rafael] Hosp Univ Vall Hebron, Inst Recerca, CIBER Diabet & Enfermedades Metab Asociadas, Diabet & Metab Res Unit,ISCIII, Barcelona, Spain; [Sampol, Gabriel; Lloberes, Patricia] Hosp Univ Vall Hebron, Inst Recerca, CIBER Enfermedades Resp, Pneumol Serv, Sleep Unit,ISCIII, Barcelona, Spain; [Romero, Odile] Hosp Univ Vall Hebron, Neurophysiol Serv, Sleep Unit, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron	Lecube, A (corresponding author), Hosp Univ Vall Hebron, Inst Recerca, CIBER Diabet & Enfermedades Metab Asociadas, Diabet & Metab Res Unit,ISCIII, Barcelona, Spain.	alecube@vhebron.net	Romero, Odile/N-8109-2015; Lloberes Canadell, Patricia/F-9707-2014; Lecube, Albert/H-3813-2019	Romero, Odile/0000-0002-0147-596X; Lloberes Canadell, Patricia/0000-0002-1595-8225; Lecube, Albert/0000-0001-9684-0183; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	Instituto de Salud Carlos III [PI060476]; CIBER de Diabetes y Enfermedades Metababolicas Asociadas (CIBERDEM); CIBER de Enfermedades Respiratorias (CIBERES)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBER de Diabetes y Enfermedades Metababolicas Asociadas (CIBERDEM); CIBER de Enfermedades Respiratorias (CIBERES)	This study was supported by a grant from the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria, PI060476). CIBER de Diabetes y Enfermedades Metababolicas Asociadas (CIBERDEM) and CIBER de Enfermedades Respiratorias (CIBERES) are an initiative of the Instituto Carlos III. Funder had no role in the research.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Bottini P, 2003, EUR RESPIR J, V22, P654, DOI 10.1183/09031936.03.00070402; BRADLEY TD, 1985, J APPL PHYSIOL, V59, P1364, DOI 10.1152/jappl.1985.59.5.1364; Campo A, 2007, EUR RESPIR J, V30, P223, DOI 10.1183/09031936.00115006; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Guazzi M, 2002, DIABETES CARE, V25, P1802, DOI 10.2337/diacare.25.10.1802; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; HEIN MS, 1994, P SOC EXP BIOL MED, V207, P213; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Lloberes P, 2001, EUR RESPIR J, V18, P530, DOI 10.1183/09031936.01.00072401; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Peltier AC, 2007, SLEEP MED, V8, P149, DOI 10.1016/j.sleep.2006.06.010; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; QUANJER PH, 1996, EUR RESPIR J, V16, P41; Ramadan W, 2007, OBESITY, V15, P1409, DOI 10.1038/oby.2007.169; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P517, DOI 10.1210/jc.86.2.517; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005	25	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4692	10.1371/journal.pone.0004692	http://dx.doi.org/10.1371/journal.pone.0004692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262746	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490600016
J	Tursun, B; Cochella, L; Carrera, I; Hobert, O				Tursun, Baris; Cochella, Luisa; Carrera, Ines; Hobert, Oliver			A Toolkit and Robust Pipeline for the Generation of Fosmid-Based Reporter Genes in C. elegans	PLOS ONE			English	Article								Engineering fluorescent proteins into large genomic clones, contained within BACs or fosmid vectors, is a tool to visualize and study spatiotemporal gene expression patterns in transgenic animals. Because these reporters cover large genomic regions, they most likely capture all cis-regulatory information and can therefore be expected to recapitulate all aspects of endogenous gene expression. Inserting tags at the target gene locus contained within genomic clones by homologous recombination ("recombineering'') represents the most straightforward method to generate these reporters. In this methodology paper, we describe a simple and robust pipeline for recombineering of fosmids, which we apply to generate reporter constructs in the nematode C. elegans, whose genome is almost entirely covered in an available fosmid library. We have generated a toolkit that allows for insertion of fluorescent proteins (GFP, YFP, CFP, VENUS, mCherry) and affinity tags at specific target sites within fosmid clones in a virtually seamless manner. Our new pipeline is less complex and, in our hands, works more robustly than previously described recombineering strategies to generate reporter fusions for C. elegans expression studies. Furthermore, our toolkit provides a novel recombineering cassette which inserts a SL2-spliced intercistronic region between the gene of interest and the fluorescent protein, thus creating a reporter controlled by all 59 and 39 cis-acting regulatory elements of the examined gene without the direct translational fusion between the two. With this configuration, the onset of expression and tissue specificity of secreted, sub-cellular compartmentalized or short-lived gene products can be easily detected. We describe other applications of fosmid recombineering as well. The simplicity, speed and robustness of the recombineering pipeline described here should prompt the routine use of this strategy for expression studies in C. elegans.	[Tursun, Baris; Cochella, Luisa; Carrera, Ines; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Tursun, B (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA.	bt2189@columbia.edu; mlc2155@columbia.edu; or38@columbia.edu	Cochella, Luisa/AHD-8261-2022; Cochella, Luisa/B-6536-2016	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722; Hobert, Oliver/0000-0002-7634-2854; Carrera, Ines/0000-0003-0903-4672; Tursun, Baris/0000-0001-7293-8629	Francis Goelet Postdoctoral Fellowship; Helen Hay Whitney Foundation [Postdoctoral Fellowship]; HHMI	Francis Goelet Postdoctoral Fellowship; Helen Hay Whitney Foundation; HHMI(Howard Hughes Medical Institute)	BT is funded by a Francis Goelet Postdoctoral Fellowship, LC by a Helen Hay Whitney Foundation Postdoctoral Fellowship and OH by the HHMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BOULIN T, 2006, REPORTER GENE FUSION, P1, DOI [10.1895/wormbook.1.106.1, DOI 10.1895/WORMBOOK.1.106.1]; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; Johnston RJ, 2005, DEVELOPMENT, V132, P5451, DOI 10.1242/dev.02163; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nonet ML, 1998, J NEUROSCI, V18, P70; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Praitis V, 2001, GENETICS, V157, P1217; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Seibler J, 1997, BIOCHEMISTRY-US, V36, P1740, DOI 10.1021/bi962443e; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	30	126	127	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4625	10.1371/journal.pone.0004625	http://dx.doi.org/10.1371/journal.pone.0004625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259264	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490500004
J	Bjorklund, M; Ranta, E; Kaitala, V; Bach, LA; Lundberg, P; Stenseth, NC				Bjorklund, Mats; Ranta, Esa; Kaitala, Veijo; Bach, Lars A.; Lundberg, Per; Stenseth, Nils Chr.			Quantitative Trait Evolution and Environmental Change	PLOS ONE			English	Article							POPULATION PERSISTENCE; EXTINCTION; SELECTION; GROWTH; COLOR; MODEL; RISK	Background: Given the recent changes in climate, there is an urgent need to understand the evolutionary ability of populations to respond to these changes. Methodology/Principal Findings: We performed individual-based simulations with different shapes of the fitness curve, different heritabilities, different levels of density compensation, and different autocorrelation of environmental noise imposed on an environmental trend to study the ability of a population to adapt to changing conditions. The main finding is that when there is a positive autocorrelation of environmental noise, the outcome of the evolutionary process is much more unpredictable compared to when the noise has no autocorrelation. In addition, we found that strong selection resulted in a higher load, and more extinctions, and that this was most pronounced when heritability was low. The level of density-compensation was important in determining the variance in load when there was strong selection, and when genetic variance was lower when the level of density-compensation was low. Conclusions: The strong effect of the details of the environmental fluctuations makes predictions concerning the evolutionary future of populations very hard to make. In addition, to be able to make good predictions we need information on heritability, fitness functions and levels of density compensation. The results strongly suggest that patterns of environmental noise must be incorporated in future models of environmental change, such as global warming.	Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [Ranta, Esa; Kaitala, Veijo] Univ Helsinki, Dept Biol & Environm Sci, Integrative Ecol Unit, FIN-00014 Helsinki, Finland; [Bach, Lars A.; Lundberg, Per] Lund Univ, Dept Theoret Ecol, Lund, Sweden; [Stenseth, Nils Chr.] Univ Oslo, CEES, Dept Biol, N-0316 Oslo, Norway	Uppsala University; University of Helsinki; Lund University; University of Oslo	Bjorklund, M (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	Mats.Bjorklund@ebc.uu.se	Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399; Bach, Lars A./0000-0001-8610-7834; Bjorklund, Mats/0000-0001-5436-6989; Lundberg, Per/0000-0002-9609-726X	EcoClim; NorFa; Swedish Research Council	EcoClim; NorFa; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was for this study was provided by EcoClim, NorFa and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Boulding EG, 2001, HEREDITY, V86, P313, DOI 10.1046/j.1365-2540.2001.00829.x; Bulmer MG, 1980, MATH THEORY QUANTITA; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Denny MW, 2000, CHANCE BIOL; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Houghton J. T., 2001, CLIMATE CHANGE 2001; JONZEN N, 2002, P ROY SOC LOND B BIO, V269, P331; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Kaitala V, 1997, P ROY SOC B-BIOL SCI, V264, P943, DOI 10.1098/rspb.1997.0130; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; KIRKPATRICK M, 1989, J MATH BIOL, V27, P429, DOI 10.1007/BF00290638; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Ranta Esa, 2006, P1; Ripa J, 1996, P ROY SOC B-BIOL SCI, V263, P1751, DOI 10.1098/rspb.1996.0256; Roff Derek, 2002, pi; Saether BE, 2002, POPULATION VIABILITY ANALYSIS, P191; Schwager M, 2006, AM NAT, V167, P879, DOI 10.1086/503609; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Zhang XS, 2005, EVOLUTION, V59, P1237	27	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4521	10.1371/journal.pone.0004521	http://dx.doi.org/10.1371/journal.pone.0004521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229330	Green Published, Green Submitted, gold			2022-12-25	WOS:000265486200008
J	Pepper, DJ; Rebe, K; Morroni, C; Wilkinson, RJ; Meintjes, G				Pepper, Dominique J.; Rebe, Kevin; Morroni, Chelsea; Wilkinson, Robert J.; Meintjes, Graeme			Clinical Deterioration during Antitubercular Treatment at a District Hospital in South Africa: The Importance of Drug Resistance and AIDS Defining Illnesses	PLOS ONE			English	Article								Background: Clinical deterioration on drug therapy for tuberculosis is a common cause of hospital admission in Africa. Potential causes for clinical deterioration in settings of high HIV-1 prevalence include drug resistant Mycobacterium tuberculosis (M. tb), co-morbid illnesses, poor adherence to therapy, tuberculosis associated-immune reconstitution inflammatory syndrome (TB-IRIS) and subtherapeutic antitubercular drug levels. It is important to derive a rapid diagnostic work-up to determine the cause of clinical deterioration as well as specific management to prevent further clinical deterioration and death. We undertook this study among tuberculosis (TB) patients referred to an adult district level hospital situated in a high HIV-1 prevalence setting to determine the frequency, reasons and outcome for such clinical deterioration. Method: A prospective observational study conducted during the first quarter of 2007. We defined clinical deterioration as clinical worsening or failure to stabilise after 14 or more days of antitubercular treatment, resulting in hospital referral. We collected data on tuberculosis diagnosis and treatment, HIV-1 status and antiretroviral treatment, and investigated reasons for clinical deterioration as well as outcome. Results: During this period, 352 TB patients met inclusion criteria; 296 were admitted to hospital accounting for 17% of total medical admissions (n = 1755). Eighty three percent of TB patients (291/352) were known to be HIV-1 co-infected with a median CD4 count of 89cells/mm(3) (IQR 38-157). Mortality among TB patients admitted to hospital was 16% (n = 48). The median duration of hospital admission was 9.5 days (IQR 4-18), longer than routine in this setting (4 days). Among patients in whom HIV-1 status was known (n = 324), 72% of TB patients (n = 232) had an additional illness to tuberculosis; new AIDS defining illnesses (n = 80) were the most frequent additional illnesses (n = 208) in HIV-1 co-infected patients (n = 291). Rifampin-resistant M. tb (n = 41), TB-IRIS (n = 51) and drug resistant bacterial infections (n = 12) were found in 12%, 14% and 3.4% of the 352 cases, respectively. Interpretation: In our setting, new AIDS defining illnesses, drug resistant M. tb and other drug resistant bacteria are important reasons for clinical deterioration in HIV-1 co-infected patients receiving antitubercular treatment. HIV-1 co-infected patients may be at increased risk of acquiring nosocomial drug resistant pathogens because profound immune suppression results in co-morbid illnesses that require prolonged inpatient admissions. Routine infection control is essential and needs to be strengthened in our setting.	[Pepper, Dominique J.; Rebe, Kevin; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Pepper, Dominique J.; Rebe, Kevin; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Infect Dis Unit, Manenberg, South Africa; [Morroni, Chelsea] Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Wilkinson, Robert J.] Imperial Coll London, Wellcome Trust Ctr Res Clin Trop Med, Div Med, London, England; [Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Cape Town, South Africa; [Wilkinson, Robert J.] Natl Inst Med Res, London, England	University of Cape Town; University of Cape Town; Imperial College London; University of Cape Town; MRC National Institute for Medical Research	Pepper, DJ (corresponding author), Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.	dominiquepepper@gmail.com		Morroni, Chelsea/0000-0002-2026-6039; Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414	United States Agency for International Development (USAID); PEPFAR; Wellcome Trust [072070, 081667]; Medical Research Council (UK); MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499] Funding Source: researchfish	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); PEPFAR; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Perinatal HIV Research Unit from the United States Agency for International Development (USAID) and PEPFAR supports Dominique Pepper. The Wellcome Trust (072070) and the Medical Research Council (UK) support Robert Wilkinson. The Wellcome Trust (081667) supports Graeme Meintjes. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; nor preparation, review, or approval of the manuscript. This research paper is made possible by funding through the Perinatal HIV-1 Research Unit affiliated with the United States Agency for International Development (USAID) and PEPFAR.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BARNARD M, 2008, AM J RESP CRIT CARE; Borges Aercio Sebastiao, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P217; Bousquet J., 2007, GLOBAL SURVEILLANCE, P146; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Brudney Karen, 1992, Journal of Public Health Policy, V13, P435, DOI 10.2307/3342533; Burch VC, 2006, SAMJ S AFR MED J, V96, P796; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Dhasmana DJ, 2008, DRUGS, V68, P191, DOI 10.2165/00003495-200868020-00004; Eza D, 2006, PATHOL RES PRACT, V202, P767, DOI 10.1016/j.prp.2006.07.005; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2001, J INFECT DIS, V184, P1127, DOI 10.1086/323649; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; MARTINSON N, 2007, 14 C RETR OPP INF; Matta F, 2008, AM J MED SCI, V336, P402, DOI 10.1097/MAJ.0b013e31816dd2fd; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Pepper DJ, 2007, DRUG DISCOV TODAY, V12, P980, DOI 10.1016/j.drudis.2007.08.001; RAO SN, 2000, AM COLL CHEST PHYS, P734; *SATBGUIDELINES, 2004, S AFR NAT TUB CONTR; SHELBURNE SA, 2006, BR SOC ANTIMICROB CH, P167; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; *TB HIVPOLICY, 2004, TB HIV POL TASK GROU; Toossi T, 2001, J ACQ IMMUN DEF SYND, V28, P1, DOI 10.1097/00042560-200109010-00001; WEYER K, 2007, B WHO, V85; WHITE NW, 1989, LANCET, V2, P434; *WHO, 2005, KEY TB TB HIV FACTS; *WHO, 2008, AIDS STAT S AFR 2007; *WHO, 2008, TB INC S AFR 2006; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; World Health Organization, 2007, GLOB MDR TB XDR TB R	38	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4520	10.1371/journal.pone.0004520	http://dx.doi.org/10.1371/journal.pone.0004520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229341	Green Published, Green Submitted, gold			2022-12-25	WOS:000265486200007
J	De Maria, A; Shi, YR; Kumar, NM; Bassnett, S				De Maria, Alicia; Shi, Yanrong; Kumar, Nalin M.; Bassnett, Steven			Calpain Expression and Activity during Lens Fiber Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT GENE; RAT LENS; MOLECULAR-CLONING; MOUSE LENS; EMBRYONIC-DEVELOPMENT; UBIQUITOUS CALPAINS; CATARACT FORMATION; MESSENGER-RNA; SPECTRIN; PROTEOLYSIS	In animal models, the dysregulated activity of calcium-activated proteases, calpains, contributes directly to cataract formation. However, the physiological role of calpains in the healthy lens is not well defined. In this study, we examined the expression pattern of calpains in the mouse lens. Real time PCR and Western blotting data indicated that calpain 1, 2, 3, and 7 were expressed in lens fiber cells. Using controlled lysis, depth-dependent expression profiles for each calpain were obtained. These indicated that, unlike calpain 1, 2, and 7, which were most abundant in cells near the lens surface, calpain 3 expression was strongest in the deep cortical region of the lens. We detected calpain activities in vitro and showed that calpains were active in vivo by microinjecting fluorogenic calpain substrates into cortical fiber cells. To identify endogenous calpain substrates, membrane/cytoskeleton preparations were treated with recombinant calpain, and cleaved products were identified by two-dimensional difference electrophoresis/mass spectrometry. Among the calpain substrates identified by this approach was alpha II-spectrin. An antibody that specifically recognized calpain-cleaved spectrin was used to demonstrate that spectrin is cleaved in vivo, late in fiber cell differentiation, at or about the time that lens organelles are degraded. The generation of the calpain-specific spectrin cleavage product was not observed in lens tissue from calpain 3-null mice, indicating that calpain 3 is uniquely activated during lens fiber differentiation. Our data suggest a role for calpains in the remodeling of the membrane cytoskeleton that occurs with fiber cell maturation.	[De Maria, Alicia; Shi, Yanrong; Bassnett, Steven] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Kumar, Nalin M.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bassnett, S (corresponding author), 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	bassnett@vision.wustl.edu		Bassnett, Steven/0000-0002-8337-2760	National Institutes of Health [P30 NS057105, R01EY09852]; Core Grant for Vision Research [EY02687]; Research to Prevent Blindness [EY01792]; University of Illinois at Chicago; NATIONAL EYE INSTITUTE [P30EY001792, R01EY009852, P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Illinois at Chicago; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 NS057105 (to Washington University). This work was also supported by Grant R01EY09852 (to S. B.), Core Grant for Vision Research EY02687, an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (to Washington University), and Core Grant EY01792 to the Department of Ophthalmology of the University of Illinois at Chicago.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azuma M, 1997, EXP EYE RES, V64, P529, DOI 10.1006/exer.1996.0234; BAGCHI M, 1985, EXP EYE RES, V40, P385, DOI 10.1016/0014-4835(85)90151-4; Barnoy S, 2005, BIOCHEM BIOPH RES CO, V332, P697, DOI 10.1016/j.bbrc.2005.05.010; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Biswas S, 2004, MOL CELL BIOCHEM, V261, P169, DOI 10.1023/B:MCBI.0000028752.89886.43; Biswas S, 2004, TRENDS MOL MED, V10, P78, DOI 10.1016/j.molmed.2003.12.007; Blankenship T, 2007, INVEST OPHTH VIS SCI, V48, P3269, DOI 10.1167/iovs.07-0109; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DAVID LL, 1994, INVEST OPHTH VIS SCI, V35, P785; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Fukiage C, 1997, BBA-MOL BASIS DIS, V1361, P304, DOI 10.1016/S0925-4439(97)00043-4; Futai E, 2001, BBA-GENE STRUCT EXPR, V1517, P316, DOI 10.1016/S0167-4781(00)00256-6; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; GLASER T, 1986, FEBS LETT, V206, P115, DOI 10.1016/0014-5793(86)81351-5; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; IRELAND M, 1984, EXP EYE RES, V38, P637, DOI 10.1016/0014-4835(84)90182-9; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu XL, 2003, J PHARMACOL EXP THER, V304, P63, DOI 10.1124/jpet.102.043406; Ma H, 2005, FEBS LETT, V579, P6745, DOI 10.1016/j.febslet.2005.11.004; Ma H, 1999, EXP EYE RES, V68, P447, DOI 10.1006/exer.1998.0625; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Ma H, 1998, EXP EYE RES, V67, P221, DOI 10.1006/exer.1998.0515; Ma H, 1998, INVEST OPHTH VIS SCI, V39, P454; MERDES A, 1991, J CELL BIOL, V115, P397, DOI 10.1083/jcb.115.2.397; More MI, 2001, J CELL BIOL, V154, P187, DOI 10.1083/jcb.200104038; Nakajima T, 2001, BBA-GENE STRUCT EXPR, V1519, P55, DOI 10.1016/S0167-4781(01)00212-3; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; PIERSCIONEK B, 1988, CURR EYE RES, V7, P11, DOI 10.3109/02713688809047015; Reed NA, 2003, EXP EYE RES, V76, P433, DOI 10.1016/S0014-4835(02)00336-6; REPASKY EA, 1982, CELL, V29, P821, DOI 10.1016/0092-8674(82)90444-5; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Robertson LJG, 2005, INVEST OPHTH VIS SCI, V46, P4634, DOI 10.1167/iovs.04-1291; Sakamoto-Mizutani K, 2002, EXP EYE RES, V75, P611, DOI 10.1006/exer.2002.2065; SANDILANDS A, 1995, J CELL SCI, V108, P1397; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; SHEARER TR, 1991, INVEST OPHTH VIS SCI, V32, P533; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shih M, 2006, EXP EYE RES, V82, P146, DOI 10.1016/j.exer.2005.06.011; Shih M, 2001, CURR EYE RES, V22, P458, DOI 10.1076/ceyr.22.6.458.5483; Singh RB, 2004, MOL CELL BIOCHEM, V263, P241, DOI 10.1023/B:MCBI.0000041865.63445.40; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; Tamada Y, 2001, CURR EYE RES, V22, P280, DOI 10.1076/ceyr.22.4.280.5505; Tang YJ, 2007, INVEST OPHTH VIS SCI, V48, P2685, DOI 10.1167/iovs.06-0926; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; TRUSCOTT RJW, 1989, BIOCHEM BIOPH RES CO, V162, P1472, DOI 10.1016/0006-291X(89)90840-1; Ueda Y, 2002, MOL CELL PROTEOMICS, V1, P357, DOI 10.1074/mcp.M200007-MCP200; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wyatt K, 2008, J BIOL CHEM, V283, P6607, DOI 10.1074/jbc.M709144200; YOSHIDA H, 1985, INVEST OPHTH VIS SCI, V26, P953; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	64	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13542	13550		10.1074/jbc.M900561200	http://dx.doi.org/10.1074/jbc.M900561200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19269960	hybrid, Green Published			2022-12-25	WOS:000265877300031
J	Carapito, R; Imberty, A; Jeltsch, JM; Byrns, SC; Tam, PH; Lowary, TL; Varrot, A; Phalip, V				Carapito, Raphael; Imberty, Anne; Jeltsch, Jean-Marc; Byrns, Simon C.; Tam, Pui-Hang; Lowary, Todd L.; Varrot, Annabelle; Phalip, Vincent			Molecular Basis of Arabinobio-hydrolase Activity in Phytopathogenic Fungi CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF FUSARIUM GRAMINEARUM GH93 EXO-alpha-L-ARABINANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; PLANT-CELL-WALL; PENICILLIUM-CHRYSOGENUM EXO-1,5-ALPHA-L-ARABINANASE; ENZYMATIC GLYCOSIDE HYDROLYSIS; FUSARIUM-GRAMINEARUM; CRYSTAL-STRUCTURE; ARABINOXYLAN-ARABINOFURANOHYDROLASE; BACTERIAL SIALIDASES; ARABINANASE 43A; BETA-PROPELLER	The phytopathogenic fungus Fusarium graminearum secretes a very diverse pool of glycoside hydrolases (GHs) aimed at degrading plant cell walls. alpha-L-Arabinanases are essential GHs participating in the complete hydrolysis of hemicellulose, a natural resource for various industrial processes, such as bioethanol or pharmaceuticals production. Arb93A, the exo-1,5-alpha-arabinanase of F. graminearum encoded by the gene fg03054.1, belongs to the GH93 family, for which no structural data exists. The enzyme is highly active (1065 units/mg) and displays a strict substrate specificity for linear alpha-1,5-L-arabinan. Biochemical assays and NMR experiments demonstrated that the enzyme releases alpha-1,5-L-arabinobiose from the nonreducing end of the polysaccharide. We determined the crystal structure of the native enzyme and its complex with alpha-1,5-L-arabinobiose, a degradation product of alpha-Me-1,5-L-arabinotetraose, at 1.85 and 2.05 angstrom resolution, respectively. Arb93A is a monomeric enzyme, which presents the six-bladed beta-propeller fold characteristic of sialidases of clan GHE. The configuration of the bound arabinobiose is consistent with the retaining mechanism proposed for the GH93 family. Catalytic residues were proposed from the structural analysis, and site-directed mutagenesis was used to validate their role. They are significantly different from those observed for GHE sialidases.	[Imberty, Anne; Varrot, Annabelle] Univ Grenoble 1, CERMAV, CNRS, F-38401 Grenoble 09, France; [Carapito, Raphael; Jeltsch, Jean-Marc; Phalip, Vincent] Univ Strasbourg, UMR 7175, Ecole Super Biotechnol Strasbourg, CNRS, F-67412 Illkirch Graffenstaden, France; [Imberty, Anne; Varrot, Annabelle] Inst Chim Mol Grenoble, F-38401 Grenoble 09, France; [Byrns, Simon C.; Tam, Pui-Hang; Lowary, Todd L.] Univ Alberta, Alberta Ingenu Ctr Carbohydrate Sci, Gunning Lemieux Chem Ctr E5 52A, Edmonton, AB T6G 2G2, Canada; [Byrns, Simon C.; Tam, Pui-Hang; Lowary, Todd L.] Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr E5 52A, Edmonton, AB T6G 2G2, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Alberta; University of Alberta	Varrot, A (corresponding author), Univ Grenoble 1, CERMAV, CNRS, BP53, F-38401 Grenoble 09, France.	Annabelle.Varrot@cermav.cnrs.fr	Carapito, Raphael/ABG-5061-2020; Lowary, Todd L/F-9608-2019; Carapito, Raphael/O-5317-2016; Imberty, Anne/P-6451-2018	Carapito, Raphael/0000-0002-7036-442X; Lowary, Todd L/0000-0002-8331-8211; Carapito, Raphael/0000-0002-7036-442X; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	CNRS; Universite de Strasbourg	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg	This work was supported by CNRS and the Universite de Strasbourg. The atomic coordinates and structure factors (codes 2w5n and 2w5o) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carapito R, 2009, BIORESOURCE TECHNOL, V100, P845, DOI 10.1016/j.biortech.2008.07.006; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; CROS S, 1993, CARBOHYD RES, V248, P81, DOI 10.1016/0008-6215(93)84117-O; CROS S, 1994, BIOPOLYMERS, V34, P1433, DOI 10.1002/bip.360341014; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gielkens MMC, 1997, CURR GENET, V31, P22, DOI 10.1007/s002940050172; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD456, DOI 10.1093/nar/gkj026; Hatsch D, 2006, BIOCHEM BIOPH RES CO, V345, P959, DOI 10.1016/j.bbrc.2006.04.171; Heightman TD, 1999, ANGEW CHEM INT EDIT, V38, P750, DOI 10.1002/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Joe M, 2007, J AM CHEM SOC, V129, P9885, DOI 10.1021/ja072892+; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P3840, DOI 10.1128/AEM.62.10.3840-3846.1996; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mitchell DB, 1997, MICROBIOL-SGM, V143, P245, DOI 10.1099/00221287-143-1-245; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narine AA, 2006, BIOCHEMISTRY-US, V45, P9319, DOI 10.1021/bi0607507; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Numan MT, 2006, J IND MICROBIOL BIOT, V33, P247, DOI 10.1007/s10295-005-0072-1; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Paes G, 2008, BIOCHEMISTRY-US, V47, P7441, DOI 10.1021/bi800424e; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Phalip V, 2005, CURR GENET, V48, P366, DOI 10.1007/s00294-005-0040-3; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Sabini E, 1999, CHEM BIOL, V6, P483, DOI 10.1016/S1074-5521(99)80066-0; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sakamoto T, 2004, BBA-GEN SUBJECTS, V1674, P85, DOI 10.1016/j.bbagen.2004.06.001; Sakamoto T, 2004, FEBS LETT, V560, P199, DOI 10.1016/S0014-5793(04)00106-1; Sakamoto T., 2006, Journal of Applied Glycoscience, V53, P115; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3319, DOI 10.1128/AEM.67.7.3319-3321.2001; Taylor EJ, 2006, BIOCHEM J, V395, P31, DOI 10.1042/BJ20051780; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Varrot A, 2000, J MOL BIOL, V297, P819, DOI 10.1006/jmbi.2000.3567; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WARD OP, 1989, CRIT REV BIOTECHNOL, V8, P237, DOI 10.3109/07388558909148194; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078; Yin HF, 2002, J ORG CHEM, V67, P892, DOI 10.1021/jo010910e	60	42	42	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12285	12296		10.1074/jbc.M900439200	http://dx.doi.org/10.1074/jbc.M900439200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269961	Green Published, hybrid			2022-12-25	WOS:000265494600060
J	Tcherpakov, M; Delaunay, A; Toth, J; Kadoya, T; Petroski, MD; Ronai, ZA				Tcherpakov, Marianna; Delaunay, Agnes; Toth, Julia; Kadoya, Takayuki; Petroski, Matthew D.; Ronai, Ze'ev A.			Regulation of Endoplasmic Reticulum-associated Degradation by RNF5-dependent Ubiquitination of JNK-associated Membrane Protein (JAMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER PROTEIN; INCLUSION-BODY MYOSITIS; QUALITY-CONTROL; STRESS; ACTIVATION; ERAD; TRANSLOCATION; MOTILITY; PATHWAY; TRAF2	Clearance of misfolded proteins by endoplasmic reticulum (ER)-associated degradation (ERAD) requires concerted activity of chaperones, adaptor proteins, ubiquitin ligases, and proteasomes. RNF5 is a ubiquitin ligase anchored to the ER membrane implicated in ERAD via ubiquitination of misfolded proteins. Among RNF5-associated proteins is JNK-associated membrane protein (JAMP), a 7-transmembrane protein located within the ER membrane that facilitates degradation of misfolded proteins through recruitment of proteasomes and ERAD regulatory components. Here we demonstrate that RNF5 associates with JAMP in the ER membrane. This association results in Ubc13-dependent RNF5-mediated noncanonical ubiquitination of JAMP. This ubiquitination does not alter JAMP stability but rather inhibits its association with Rpt5 and p97. Consequently, clearance of misfolded proteins, such as CFTR Delta 508 and T cell receptor alpha, is less efficient, resulting in their greater accumulation. Significantly, the RNF5 effect on JAMP is seen prior to and after ER stress response, thereby highlighting a novel mechanism to limit ERAD and proteasome assembly at the ER, to the actual ER stress response.	[Tcherpakov, Marianna; Delaunay, Agnes; Toth, Julia; Kadoya, Takayuki; Petroski, Matthew D.; Ronai, Ze'ev A.] Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Ronai, ZA (corresponding author), Burnham Inst Med Res, Signal Transduct Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ronai@burnham.org	Delaunay-moisan, Agnes/GRX-7749-2022	Delaunay-moisan, Agnes/0000-0003-3105-221X; RONAI, ZEEV/0000-0002-3859-0400	National Institutes of Health Grant [CA097105]; NATIONAL CANCER INSTITUTE [R01CA097105] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA097105 (to Z.R.)	Broday L, 2004, J CELL BIOL, V165, P857, DOI 10.1083/jcb.200401133; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Chen ZJJ, 2004, CANCER BIOL THER, V3, P286, DOI 10.4161/cbt.3.3.798; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Delaunay A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001609; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Engel WK, 2006, NEUROLOGY, V66, pS20, DOI 10.1212/01.wnl.0000192260.33106.bb; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Kadoya T, 2005, MOL CELL BIOL, V25, P8619, DOI 10.1128/MCB.25.19.8619-8630.2005; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nogalska A, 2006, J NEUROCHEM, V96, P1491, DOI 10.1111/j.1471-4159.2006.03668.x; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tcherpakov M, 2008, MOL BIOL CELL, V19, P5019, DOI 10.1091/mbc.E08-08-0839; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yamasaki S, 2005, ARTHRITIS RES THER, V7, P181, DOI 10.1186/ar1808; Yamasaki S, 2006, INT J MOL MED, V18, P113; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	31	33	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12099	12109		10.1074/jbc.M808222200	http://dx.doi.org/10.1074/jbc.M808222200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269966	hybrid, Green Published			2022-12-25	WOS:000265494600042
J	Verma, NK; Dourlat, J; Davies, AM; Long, A; Liu, WQ; Garbay, C; Kelleher, D; Volkov, Y				Verma, Navin K.; Dourlat, Jennifer; Davies, Anthony M.; Long, Aideen; Liu, Wang-Qing; Garbay, Christiane; Kelleher, Dermot; Volkov, Yuri			STAT3-Stathmin Interactions Control Microtubule Dynamics in Migrating T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; TUBULIN TYROSINATION; SIGNAL TRANSDUCER; PEPTIDE-SYNTHESIS; CROSS-LINKING; IN-VITRO; STAT3; STATHMIN; TRANSCRIPTION; EXPRESSION	T-cell migration is a complex highly coordinated process that involves cell adhesion to the high endothelial venules or to the extracellular matrix by surface receptor/ligand interactions, cytoskeletal rearrangements, and phosphorylation-dependent signaling cascades. The mechanism(s) that regulates T-cell migration is of considerable relevance for understanding the pathogenesis of various diseases, such as chronic inflammatory diseases and cancer metastasis. This study was designed to identify potential involvement of STAT3, a latent transcription factor, in mediating integrin-induced T-cell migration. Using our previously characterized in vitro model for lymphocyte migration, we demonstrate that STAT3 is activated and translocated to the nucleus during the process of active motility of Hut78 T-lymphoma cells triggered via LFA-1. Blocking STAT3 signaling by multiple approaches inhibitedLFA1- induced T-cell locomotion via destabilization of microtubules and post-translational modification of tubulin. Here, we show that STAT3 physically interacts with stathmin to regulate microtubule dynamics in migrating T-cells. These observations strongly indicate that STAT3 is critically important for T-cell migration and associated signaling events.	[Verma, Navin K.; Davies, Anthony M.; Long, Aideen; Kelleher, Dermot; Volkov, Yuri] Trinity Coll Dublin, Dept Clin Med, Inst Mol Med, Dublin 8, Ireland; [Dourlat, Jennifer; Liu, Wang-Qing; Garbay, Christiane] Univ Paris 05, Lab Pharmacochim Mol & Cellulaire, INSERM, U648, F-75270 Paris 06, France	Trinity College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Verma, NK (corresponding author), Trinity Coll Dublin, Dept Clin Med, Inst Mol Med, Dublin 8, Ireland.	verman@tcd.ie	Verma, Navin Kumar/B-7641-2008; Long, Aideen/HGB-4149-2022; Volkov, Yuri/N-6774-2014; LIU, Wang-Qing/V-5422-2017	Verma, Navin Kumar/0000-0002-5940-6633; Volkov, Yuri/0000-0001-7406-518X; LIU, Wang-Qing/0000-0003-0511-3058	Higher Education Authority of Ireland under the department of Education and Science's Program	Higher Education Authority of Ireland under the department of Education and Science's Program	This work was supported by a Grant from the Higher Education Authority of Ireland under the department of Education and Science's Program for Research in Third Level Institutions and the Health Research Board of Ireland.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; BULINSKI JC, 1987, NATURE, V328, P676, DOI 10.1038/328676a0; CHAO HG, 1994, J ORG CHEM, V59, P6687, DOI 10.1021/jo00101a029; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Debidda M, 2005, J BIOL CHEM, V280, P17275, DOI 10.1074/jbc.M413187200; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dunican DJ, 2001, BIOPOLYMERS, V60, P45, DOI 10.1002/1097-0282(2001)60:1<45::AID-BIP1003>3.3.CO;2-0; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Freeley M, 2005, BIOCHEM BIOPH RES CO, V334, P619, DOI 10.1016/j.bbrc.2005.06.136; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Hauzenberger D, 1995, CRIT REV IMMUNOL, V15, P285, DOI 10.1615/CritRevImmunol.v15.i3-4.60; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Long A, 2001, J IMMUNOL, V167, P636, DOI 10.4049/jimmunol.167.2.636; Luduena RF, 1998, INT REV CYTOL, V178, P207; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sellin ME, 2008, MOL BIOL CELL, V19, P2897, DOI 10.1091/mbc.E08-01-0058; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Verma NK, 2006, DIABETOLOGIA, V49, P1656, DOI 10.1007/s00125-006-0260-1; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Volkov Y, 2006, GASTROENTEROLOGY, V130, P482, DOI 10.1053/j.gastro.2005.10.047; Volkov Y, 1998, J IMMUNOL, V161, P6487; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Wiederkehr-Adam M, 2003, J BIOL CHEM, V278, P16117, DOI 10.1074/jbc.M300261200; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	54	75	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12349	12362		10.1074/jbc.M807761200	http://dx.doi.org/10.1074/jbc.M807761200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251695	hybrid, Green Published			2022-12-25	WOS:000265494600066
J	Katsuyama, Y; Kita, T; Funa, N; Horinouchi, S				Katsuyama, Yohei; Kita, Tomoko; Funa, Nobutaka; Horinouchi, Sueharu			Curcuminoid Biosynthesis by Two Type III Polyketide Synthases in the Herb Curcuma longa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINGER ZINGIBER-OFFICINALE; CHALCONE SYNTHASE; ANIGOZANTHOS-PREISSII; ACID; DECARBOXYLATION; PATHWAY; COA; (S)-3,5-DIHYDROXYPHENYLGLYCINE; PHENYLPHENALENONES; INTERMEDIATE	Curcuminoids found in the rhizome of turmeric, Curcuma longa, possess various biological activities. Despite much attention regarding the biosynthesis of curcuminoids because of their pharmaceutically important properties and biosynthetically intriguing structures, no enzyme systems have been elucidated. Here we propose a pathway for curcuminoid biosynthesis in the herb C. longa, which includes two novel type III polyketide synthases. One of the type III polyketide synthases, named diketide-CoA synthase (DCS), catalyzed the formation of feruloyldiketide-CoA by condensing feruloyl-CoA and malonyl-CoA. The other, named curcumin synthase (CURS), catalyzed the in vitro formation of curcuminoids from cinnamoyldiketide-N-acetylcysteamine (a mimic of the CoA ester) and feruloyl-CoA. Co-incubation of DCS and CURS in the presence of feruloyl-CoA and malonyl-CoA yielded curcumin at high efficiency, although CURS itself possessed low activity for the synthesis of curcumin from feruloyl-CoA and malonyl-CoA. These findings thus revealed the curcumin biosynthetic route in turmeric, in which DCS synthesizes feruloyldiketide-CoA, and CURS then converts the diketide-CoA esters into a curcuminoid scaffold.	[Katsuyama, Yohei; Funa, Nobutaka; Horinouchi, Sueharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Kita, Tomoko] House Foods Corp, Somatech Ctr, Chiba 2840033, Japan	University of Tokyo; House Foods Corporation	Horinouchi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asuhori@mail.ecc.u-tokyo.ac.jp		Katsuyama, Yohei/0000-0003-4905-5320	Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan; Scientific Research on Priority Area "Applied Genomics" from Monkasho	Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan; Scientific Research on Priority Area "Applied Genomics" from Monkasho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Research Grant Program 2005 of the New Energy and Industrial Technology Development Organization of Japan and a Grant-in-Aid for Scientific Research on Priority Area "Applied Genomics" from Monkasho.	Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Blecher M, 1981, Methods Enzymol, V72, P404; Brand S, 2006, PLANTA, V224, P413, DOI 10.1007/s00425-006-0228-x; Cao H, 2001, BIOL PHARM BULL, V24, P1389, DOI 10.1248/bpb.24.1389; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; DENNIFF P, 1980, J CHEM SOC PERK T 1, P2637, DOI 10.1039/p19800002637; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Guthrie JP, 2002, BIOORG CHEM, V30, P32, DOI 10.1006/bioo.2001.1231; HAMMES GG, 1974, ANNU REV BIOPHYS BIO, V3, P1, DOI 10.1146/annurev.bb.03.060174.000245; Hiserodt R, 1996, J CHROMATOGR A, V740, P51, DOI 10.1016/0021-9673(96)00103-3; HOLSCHER D, 1995, J CHEM SOC CHEM COMM, P525, DOI 10.1039/c39950000525; Holtz E, 2007, TETRAHEDRON, V63, P3293, DOI 10.1016/j.tet.2007.02.062; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kamo T, 2000, BIOSCI BIOTECH BIOCH, V64, P2089, DOI 10.1271/bbb.64.2089; Katsuyama Y, 2007, J BIOL CHEM, V282, P37702, DOI 10.1074/jbc.M707569200; Katsuyama Y, 2008, MICROBIOL-SGM, V154, P2620, DOI 10.1099/mic.0.2008/018721-0; Kita T, 2008, BIOSCI BIOTECH BIOCH, V72, P1789, DOI 10.1271/bbb.80075; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; MARCUS JP, 1993, BIOCHEM BIOPH RES CO, V190, P1066, DOI 10.1006/bbrc.1993.1157; MATSUMURA S, 1985, B CHEM SOC JPN, V3, P310; Pfeifer V, 2001, J BIOL CHEM, V276, P38370, DOI 10.1074/jbc.M106580200; Ramirez-Ahumada MD, 2006, PHYTOCHEMISTRY, V67, P2017, DOI 10.1016/j.phytochem.2006.06.028; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; ROUGHLEY PJ, 1973, J CHEM SOC PERK T 1, P2379, DOI 10.1039/p19730002379; Schmitt B, 2000, PHYTOCHEMISTRY, V53, P331, DOI 10.1016/S0031-9422(99)00544-0; Schroder J, 1998, BIOCHEMISTRY-US, V37, P8417, DOI 10.1021/bi980204g; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; Tayyem RR, 2006, NUTR CANCER, V55, P126, DOI 10.1207/s15327914nc5502_2; Weber WM, 2005, BIOORGAN MED CHEM, V13, P3811, DOI 10.1016/j.bmc.2005.03.035	34	110	121	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11160	11170		10.1074/jbc.M900070200	http://dx.doi.org/10.1074/jbc.M900070200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258320	Green Published, hybrid			2022-12-25	WOS:000265494500020
J	Tong, L; Lee, S; Denu, JM				Tong, Lei; Lee, Susan; Denu, John M.			Hydrolase Regulates NAD(+) Metabolites and Modulates Cellular Redox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-ADP-RIBOSE; LIFE-SPAN EXTENSION; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE-1; NUDIX HYDROLASES; GLOBAL ANALYSIS; YEAST; NICOTINAMIDE; GENERATION; SIRTUINS	Although the classical redox functions of co-enzyme NAD(+) are firmly established in metabolism, there are numerous enzymes that catalyze cleavage of NAD(+) to yield free ADP-ribose (ADPr) or related metabolites, whose functions remain largely unknown. Here we show that the Nudix (nucleoside diphosphate linked to another moiety X) hydrolase Ysa1 from Saccharomyces cerevisiae is a major regulator of cellular ADPr and O-acetyl-ADP-ribose (OAADPr). OAADPr is the direct product of NAD(+)-dependent protein deacetylases (sirtuins) and is readily converted to ADPr. Ysa1 cleaves ADPr/OAADPr into ribose phosphate/acetyl-ribose phosphate and AMP. In cells lacking Ysa1 (Delta ysa1), ADPr and OAADPr levels increased similar to 50%, with a corresponding decrease in AMP. Strikingly, Delta ysa1 cells display higher resistance to exogenous reactive oxygen species (ROS) and 40% lower basal levels of endogenous ROS, compared with wild type. The biochemical basis for these differences in ROS-related phenotypes was investigated, and the results provide evidence that increased ADPr/OAADPr levels protect cells via the following two pathways: (i) lower ROS production through inhibition of complex I of the mitochondrial electron transport chain, and (ii) generation of higher levels of NADPH to suppress ROS damage. The latter occurs through diverting glucose into the pentose phosphate pathway by ADPr inhibition of glyceraldehyde-3-phosphate dehydrogenase, a central enzyme of glycolysis.	[Tong, Lei; Lee, Susan; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu			NIGMS NIH HHS [R01 GM065386-07, R01 GM065386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; AUSUBEL FM, 2002, SHORT PROTOCOLS MOL, V2, P9; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERGMEYER HU, 1985, METHOD ENZYMATIC ANA, V7, P253; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Du L, 2007, FEMS YEAST RES, V7, P860, DOI 10.1111/j.1567-1364.2007.00274.x; Dumitriu IE, 2004, CELL DEATH DIFFER, V11, P314, DOI 10.1038/sj.cdd.4401348; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; EBY D, 1971, BIOCHEMISTRY-US, V10, P2677; Galli F, 2005, CONTRIB NEPHROL, V149, P240, DOI 10.1159/000085686; Gao H, 2007, EXP CELL RES, V313, P984, DOI 10.1016/j.yexcr.2006.12.025; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghosh HS, 2008, CURR OPIN INVEST DR, V9, P1095; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hoff KG, 2005, NAT STRUCT MOL BIOL, V12, P560, DOI 10.1038/nsmb0705-560; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lee S, 2008, ANAL BIOCHEM, V383, P174, DOI 10.1016/j.ab.2008.08.033; Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; McClure JM, 2008, GENETICS, V180, P797, DOI 10.1534/genetics.108.091090; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MIWA M, 1971, J BIOL CHEM, V246, P6362; NELSON DL, 2000, LEHNINGER PRINCIPLES, P666; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; ROSKAMS J, 2002, LAB REF HDB RECIPES, P196; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shanmuganathan A, 2004, FEBS LETT, V556, P253, DOI 10.1016/S0014-5793(03)01428-5; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Shull NP, 2005, NUCLEIC ACIDS RES, V33, P650, DOI 10.1093/nar/gki211; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Zharova TV, 1997, BBA-BIOENERGETICS, V1320, P256, DOI 10.1016/S0005-2728(97)00029-7; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	71	56	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11256	11266		10.1074/jbc.M809790200	http://dx.doi.org/10.1074/jbc.M809790200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251690	Green Published, hybrid			2022-12-25	WOS:000265494500029
J	He, CJ; Zhou, F; Zuo, ZX; Cheng, HH; Zhou, RJ				He, Chunjiang; Zhou, Fang; Zuo, Zhixiang; Cheng, Hanhua; Zhou, Rongjia			A Global View of Cancer-Specific Transcript Variants by Subtractive Transcriptome-Wide Analysis	PLOS ONE			English	Article							IDENTIFICATION; DATABASE; MUTATIONS; DISCOVERY; ASAP	Background: Alternative pre-mRNA splicing (AS) plays a central role in generating complex proteomes and influences development and disease. However, the regulation and etiology of AS in human tumorigenesis is not well understood. Methodology/Principal Findings: A Basic Local Alignment Search Tool database was constructed for the expressed sequence tags (ESTs) from all available databases of human cancer and normal tissues. An insertion or deletion in the alignment of EST/EST was used to identify alternatively spliced transcripts. Alignment of the ESTs with the genomic sequence was further used to confirm AS. Alternatively spliced transcripts in each tissue were then subtractively cross-screened to obtain tissue-specific variants. We systematically identified and characterized cancer/tissue-specific and alternatively spliced variants in the human genome based on a global view. We identified 15,093 cancer-specific variants of 9,989 genes from 27 types of human cancers and 14,376 normal tissue-specific variants of 7,240 genes from 35 normal tissues, which cover the main types of human tumors and normal tissues. Approximately 70% of these transcripts are novel. These data were integrated into a database HCSAS (http://202.114.72.39/database/human.html, pass: 68756253). Moreover, we observed that the cancer-specific AS of both oncogenes and tumor suppressor genes are associated with specific cancer types. Cancer shows a preference in the selection of alternative splice-sites and utilization of alternative splicing types. Conclusions/Significance: These features of human cancer, together with the discovery of huge numbers of novel splice forms for cancer-associated genes, suggest an important and global role of cancer-specific AS during human tumorigenesis. We advise the use of cancer-specific alternative splicing as a potential source of new diagnostic, prognostic, predictive, and therapeutic tools for human cancer. The global view of cancer-specific AS is not only useful for exploring the complexity of the cancer transcriptome but also widens the eyeshot of clinical research.	[He, Chunjiang; Zhou, Fang; Zuo, Zhixiang; Cheng, Hanhua; Zhou, Rongjia] Wuhan Univ, Dept Genet, Wuhan 430072, Peoples R China	Wuhan University	He, CJ (corresponding author), Wuhan Univ, Dept Genet, Wuhan 430072, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019; Zuo, Zhixiang/M-4441-2016; He, Chunjiang/N-4316-2016	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009; Zuo, Zhixiang/0000-0002-2492-2689; He, Chunjiang/0000-0002-4868-331X	National Natural Science Foundation of China; National Key Basic Research project [2006CB102103, 2004CB117401]; Program for New Century Excellent Talents in University; 111 project [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 111 project(Ministry of Education, China - 111 Project)	The work was supported by the National Natural Science Foundation of China, the National Key Basic Research project (2006CB102103, 2004CB117401), the Program for New Century Excellent Talents in University, and the 111 project #B06018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gupta S, 2004, BIOINFORMATICS, V20, P2579, DOI 10.1093/bioinformatics/bth288; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; Hui LJ, 2004, ONCOGENE, V23, P3013, DOI 10.1038/sj.onc.1207362; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Ladd AN, 2002, GENOME BIOL, V3; Lee C, 2003, NUCLEIC ACIDS RES, V31, P101, DOI 10.1093/nar/gkg029; Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Roy M, 2005, NUCLEIC ACIDS RES, V33, P5026, DOI 10.1093/nar/gki792; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZN, 2003, CANCER RES, V63, P655; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-202; Zheng CL, 2005, RNA, V11, P1767, DOI 10.1261/rna.2650905	36	65	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4732	10.1371/journal.pone.0004732	http://dx.doi.org/10.1371/journal.pone.0004732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266097	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490800012
J	Maradeo, ME; Skibbens, RV				Maradeo, Marie E.; Skibbens, Robert V.			The Elg1-RFC Clamp-Loading Complex Performs a Role in Sister Chromatid Cohesion	PLOS ONE			English	Article								It is widely accepted that of the four Replication Factor C (RFC) complexes (defined by the associations of either Rfc1p, Ctf18p, Elg1p or Rad24p with Rfc2p-Rfc5p), only Ctf18-RFC functions in sister chromatid cohesion. This model is based on findings that CTF18 deletion is lethal in combination with mutations in either CTF7(ECO1) or MCD1 sister chromatid cohesion genes and that ctf18 mutant cells exhibit cohesion defects. Here, we report that Elg1-RFC not only participates in cohesion but performs a function that is distinct from that of Ctf18-RFC. The results show that deletion of ELG1 rescues both ctf7(eco1) mutant cell temperature sensitivity and cohesion defects. Moreover, over-expression of ELG1 enhances ctf7(eco1) mutant cell phenotypes. These findings suggest that the balance of Ctf7p(Eco1p) activity depends on both Ctf18-RFC and Elg1-RFC. We also report that ELG1 deletion produces cohesion defects and intensifies the conditional phenotype of mcd1 mutant cells, further supporting a role for Elg1-RFC in cohesion. Attesting to the specificity of these interactions, deletion of RAD24 neither suppressed nor exacerbated cohesion defects in either ctf7(eco1) or mcd1 mutant cells. While parallel analyses failed to uncover a similar role in cohesion for Rad24-RFC, it is well known that Rad24-RFC, Elg1-RFC and Ctf18-RFC play key roles in DNA damage responses. We tested and found that Ctf7p(Eco1p) plays a significant role in Rad24-RFC-based DNA response pathways. In combination, these findings challenge current views and document new and distinct roles for RFC complexes in cohesion and for Ctf7p(Eco1p) in DNA repair.	[Maradeo, Marie E.; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Maradeo, ME (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institutes of General Medicine [1R15GM083269]; Susan G. Komen for the Cure Foundation [BCTR0707708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083269] Funding Source: NIH RePORTER	National Institutes of General Medicine; Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RVS is supported by awards from the National Institutes of General Medicine (1R15GM083269) and by the Susan G. Komen for the Cure Foundation (BCTR0707708). Any opinions, findings, and conclusions or recommendations expressed in this study are those of the authors and do not necessarily reflect the views of the National Institutes of General Medicine nor of the Susan G. Komen Foundation. The authors are also indebted to BD for the gift of a FACSCantoII cytometer to Lehigh University.	Antoniacci LM, 2006, CURR BIOL, V16, P902, DOI 10.1016/j.cub.2006.03.060; Antoniacci LM, 2004, J BIOL CHEM, V279, P49542, DOI 10.1074/jbc.M404324200; Banerjee S, 2004, EUKARYOT CELL, V3, P1557, DOI 10.1128/EC.3.6.1557-1566.2004; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; BENAROYA S, 2003, EMBO J, V22, P4304; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Brands A, 2008, GENETICS, V180, P7, DOI 10.1534/genetics.108.092288; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kim J, 2005, NUCLEIC ACIDS RES, V33, P4078, DOI 10.1093/nar/gki728; Kondo T, 1999, MOL CELL BIOL, V19, P1136; KOUPRINA N, 1994, GENETICS, V138, P1067; Krause SA, 2001, MOL CELL BIOL, V21, P5156, DOI 10.1128/MCB.21.15.5156-5168.2001; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Naiki T, 2001, MOL CELL BIOL, V21, P5838, DOI 10.1128/MCB.21.17.5838-5845.2001; O'Donnell M, 2001, CURR BIOL, V11, pR935, DOI 10.1016/S0960-9822(01)00559-0; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 2007, J CELL SCI, V120, P2471, DOI 10.1242/jcs.011999; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Watts FZ, 2006, DNA REPAIR, V5, P399, DOI 10.1016/j.dnarep.2005.11.002; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200	47	50	50	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4707	10.1371/journal.pone.0004707	http://dx.doi.org/10.1371/journal.pone.0004707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262753	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490600018
J	Yin, J; Li, L; Shaw, N; Li, Y; Song, JK; Zhang, WP; Xia, CF; Zhang, RG; Joachimiak, A; Zhang, HC; Wang, LX; Liu, ZJ; Wang, P				Yin, Jie; Li, Lei; Shaw, Neil; Li, Yang; Song, Jing Katherine; Zhang, Wenpeng; Xia, Chengfeng; Zhang, Rongguang; Joachimiak, Andrzej; Zhang, Hou-Cheng; Wang, Lai-Xi; Liu, Zhi-Jie; Wang, Peng			Structural Basis and Catalytic Mechanism for the Dual Functional Endo-beta-N-Acetylglucosaminidase A	PLOS ONE			English	Article							TRANSGLYCOSYLATION ACTIVITY; ENHANCED TRANSGLYCOSYLATION; OLIGOSACCHARIDE SYNTHESIS; COMPLEX OLIGOSACCHARIDES; CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEINS; GLYCOPEPTIDES; PURIFICATION; GLYCOSYNTHASES; REFINEMENT	Endo-beta-N-acetylglucosaminidases (ENGases) are dual specificity enzymes with an ability to catalyze hydrolysis and transglycosylation reactions. Recently, these enzymes have become the focus of intense research because of their potential for synthesis of glycopeptides. We have determined the 3D structures of an ENGase from Arthrobacter protophormiae (Endo-A) in 3 forms, one in native form, one in complex with Man(3)GlcNAc-thiazoline and another in complex with GlcNAc-Asn. The carbohydrate moiety sits above the TIM-barrel in a cleft region surrounded by aromatic residues. The conserved essential catalytic residues - E173, N171 and Y205 are within hydrogen bonding distance of the substrate. W216 and W244 regulate access to the active site during transglycosylation by serving as "gate-keepers''. Interestingly, Y299F mutation resulted in a 3 fold increase in the transglycosylation activity. The structure provides insights into the catalytic mechanism of GH85 family of glycoside hydrolases at molecular level and could assist rational engineering of ENGases.	[Yin, Jie; Shaw, Neil; Li, Yang; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Yin, Jie; Li, Yang] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Li, Lei; Zhang, Hou-Cheng; Wang, Peng] Shandong Univ, Natl Glycoengn Res Ctr, Shandong, Peoples R China; [Li, Lei; Zhang, Hou-Cheng; Wang, Peng] Shandong Univ, Sch Life Sci, State Key Lab Microb Technol, Shandong, Peoples R China; [Li, Lei; Song, Jing Katherine; Zhang, Wenpeng; Xia, Chengfeng; Wang, Peng] Ohio State Univ, Dept Biochem & Chem, Columbus, OH 43210 USA; [Zhang, Rongguang; Joachimiak, Andrzej] Structural Biol Ctr, Argonne Natl Lab, Argonne, IL USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wang, Peng] Nankai Univ, Coll Pharm, Tianjin, Peoples R China; [Wang, Peng] Nankai Univ, State Key Lab Elemento Organ Chem, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong University; Shandong University; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nankai University; Nankai University	Yin, J (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	zjliu@ibp.ac.cn; pwang@sdu.edu.cn	Wang, Lai-Xi/E-8755-2019; Li, Yang/M-1246-2013; Ying, Chieh/E-4296-2016; Li, Yang/G-3685-2011; wang, xl/Y-8251-2019; WANG, Peng/GSN-5263-2022; Wang, Lai-Xi/E-8790-2019; Liu, Zhi-Jie/A-3946-2012; Yin, Jie/J-8932-2016	Wang, Lai-Xi/0000-0003-4293-5819; Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [20872068, 30721003, 30870483, 30700123]; Ministry of Health [2008ZX10404]; Ministry of Science and Technology of China [2006AA02A316, 2006CB910901, 2006CB910903, 2007CB914803, 2007CB914403]; CAS [KSCX2-YW-R-127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (Grants: 20872068, 30721003, 30870483 and 30700123), the Ministry of Health (Grant 2008ZX10404), the Ministry of Science and Technology of China (Grants 2006AA02A316, 2006CB910901, 2006CB910903, 2007CB914803 and 2007CB914403), CAS Research Grant (KSCX2-YW-R-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BOURGERIE S, 1994, J BACTERIOL, V176, P6170, DOI 10.1128/jb.176.20.6170-6174.1994; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN JQ, 1995, J BIOL CHEM, V270, P17723, DOI 10.1074/jbc.270.30.17723; Fujita K, 2004, BIOSCI BIOTECH BIOCH, V68, P1059, DOI 10.1271/bbb.68.1059; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Hauser S, 2005, BIOCHEM BIOPH RES CO, V328, P580, DOI 10.1016/j.bbrc.2005.01.012; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; ITO K, 1993, J BIOL CHEM, V268, P16074; KADOWAKI S, 1988, AGR BIOL CHEM TOKYO, V52, P2387; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kimura Y, 2002, BBA-GEN SUBJECTS, V1570, P38, DOI 10.1016/S0304-4165(02)00149-6; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2008, BIOORGAN MED CHEM, V16, P4670, DOI 10.1016/j.bmc.2008.02.032; LI SC, 1981, BIOCHIM BIOPHYS ACTA, V660, P278, DOI 10.1016/0005-2744(81)90171-6; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Shaw N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-46; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 1998, J BIOL CHEM, V273, P10083, DOI 10.1074/jbc.273.17.10083; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2006, CURR OPIN DRUG DISC, V9, P194; Wang LX, 2004, ACS SYM SER, V873, P73; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72	38	52	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4658	10.1371/journal.pone.0004658	http://dx.doi.org/10.1371/journal.pone.0004658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252736	Green Submitted, Green Published, gold			2022-12-25	WOS:000265489900001
J	Vij, N; Mazur, S; Zeitlin, PL				Vij, Neeraj; Mazur, Steven; Zeitlin, Pamela L.			CFTR Is a Negative Regulator of NF kappa B Mediated Innate Immune Response	PLOS ONE			English	Article								Background: Dysfunctional CFTR in the airways is associated with elevated levels of NF kappa B mediated IL-8 signaling leading to neutrophil chemotaxis and chronic lung inflammation in cystic fibrosis. The mechanism(s) by which CFTR mediates inflammatory signaling is under debate. Methodology/Principal Findings: We tested the hypothesis that wt-CFTR down-regulates NF kappa B mediated IL-8 secretion. We transiently co-expressed wt-CFTR and IL-8 or NF kappa B promoters driving luciferase expression in HEK293 cells. Wt-CFTR expression in HEK293 cells suppresses both basal and IL1 beta induced IL-8, and NF kappa B promoter activities as compared to the control cells transfected with empty vector (p<0.05). We also confirmed these results using CFBE41o- cells and observed that cells stably transduced with wt-CFTR secrete significantly lower amounts of IL-8 chemokine as compared to non-transfected control cells. To test the hypothesis that CFTR must be localized to cell surface lipid rafts in polarized airway epithelial cells in order to mediate the inflammatory response, we treated CFBE41o- cells that had been stably transduced with wt-CFTR with methyl-beta-cyclodextrin (CD). At baseline, CD significantly (p<0.05) induced IL-8 and NF kappa B reporter activities as compared to control cells suggesting a negative regulation of NF kappa B mediated IL-8 signaling by CFTR in cholesterol-rich lipid rafts. Untreated cells exposed to the CFTR channel blocker CFTR-172 inhibitor developed a similar increase in IL-8 and NF kappa B reporter activities suggesting that not only must CFTR be present on the cell surface but it must be functional. We verified these results in vivo by comparing survival, body weight and pro-inflammatory cytokine response to P. aeruginosa LPS in CFTR knock out (CFKO) mice as compared to wild type controls. There was a significant (p<0.05) decrease in survival and body weight, an elevation in IL-1 beta in whole lung extract (p<0.01), as well as a significant increase in phosphorylated I kappa B, an inducer of NF kappa B mediated signaling in the CFKO mice. Conclusions/Significance: Our data suggest that CFTR is a negative regulator of NF kappa B mediated innate immune response and its localization to lipid rafts is involved in control of inflammation.	[Vij, Neeraj; Mazur, Steven; Zeitlin, Pamela L.] Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Vij, N (corresponding author), Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD USA.	nvij1@jhmi.edu			Cystic Fibrosis Foundation [R025-CR07, VIJ07IO]; NIH [R01 HL59410]; CTSA [UL RR 025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R025-CR07 and VIJ07IO grants from the Cystic Fibrosis Foundation to NV, and in part by NIH grants R01 HL59410 and CTSA UL RR 025005 to PZ and NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DS, 1995, BRIT MED J, V310, P1571, DOI 10.1136/bmj.310.6994.1571; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Blackwell TS, 2001, AM J PHYSIOL-LUNG C, V281, pL69, DOI 10.1152/ajplung.2001.281.1.L69; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Knowles MR, 2006, CURR OPIN PULM MED, V12, P416, DOI 10.1097/01.mcp.0000245707.59138.40; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; MASSION PP, 1994, J CLIN INVEST, V93, P26, DOI 10.1172/JCI116954; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rubin BK, 2003, CHEST, V123, P1792, DOI 10.1378/chest.123.6.1792; Rubin BK, 2007, AM J PHYSIOL-LUNG C, V292, pL381, DOI 10.1152/ajplung.00375.2006; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Vij N, 2008, AM J RESP CELL MOL, V38, P176, DOI 10.1165/rcmb.2007-0197OC; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004	43	127	131	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4664	10.1371/journal.pone.0004664	http://dx.doi.org/10.1371/journal.pone.0004664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247502	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800037
J	Tibber, MS; Anderson, EJ; Melmoth, DR; Rees, G; Morgan, MJ				Tibber, Marc S.; Anderson, Elaine J.; Melmoth, Dean R.; Rees, Geraint; Morgan, Michael J.			Common Cortical Loci Are Activated during Visuospatial Interpolation and Orientation Discrimination Judgements	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-SYSTEM; OBJECT IDENTIFICATION; HUMAN BRAIN; SURFACE-ORIENTATION; PARIETAL CORTEX; NEGATIVE BOLD; ANATOMICAL LANDMARK; RECEPTIVE-FIELDS	There is a wealth of literature on the role of short-range interactions between low-level orientation-tuned filters in the perception of discontinuous contours. However, little is known about how spatial information is integrated across more distant regions of the visual field in the absence of explicit local orientation cues, a process referred to here as visuospatial interpolation (VSI). To examine the neural correlates of VSI high field functional magnetic resonance imaging was used to study brain activity while observers either judged the alignment of three Gabor patches by a process of interpolation or discriminated the local orientation of the individual patches. Relative to a fixation baseline the two tasks activated a largely over-lapping network of regions within the occipito-temporal, occipito-parietal and frontal cortices. Activated clusters specific to the orientation task (orientation. interpolation) included the caudal intraparietal sulcus, an area whose role in orientation encoding per se has been hotly disputed. Surprisingly, there were few task-specific activations associated with visuospatial interpolation (VSI. orientation) suggesting that largely common cortical loci were activated by the two experimental tasks. These data are consistent with previous studies that suggest higher level grouping processes-putatively involved in VSI-are automatically engaged when the spatial properties of a stimulus (e. g. size, orientation or relative position) are used to make a judgement.	[Tibber, Marc S.; Melmoth, Dean R.; Morgan, Michael J.] City Univ London, Dept Optometry & Visual Sci, London, England; [Anderson, Elaine J.; Rees, Geraint; Morgan, Michael J.] UCL, Inst Cognitive Neurosci, London WC1E 6BT, England; [Anderson, Elaine J.; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London WC1E 6BT, England	City University London; University of London; University College London; University of London; University College London	Tibber, MS (corresponding author), City Univ London, Dept Optometry & Visual Sci, London, England.	mtibber@yahoo.com	Rees, Geraint/C-1493-2008	Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [079766]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (grant no. 079766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2005, NEUROPSYCHOLOGIA, V43, P2101, DOI 10.1016/j.neuropsychologia.2005.03.015; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Aso T, 2007, NEUROSCI LETT, V415, P225, DOI 10.1016/j.neulet.2007.01.051; BOUCART M, 1995, J EXP PSYCHOL HUMAN, V21, P584, DOI 10.1037/0096-1523.21.3.584; Boucart M, 1997, PERCEPTION, V26, P1197, DOI 10.1068/p261197; BOUCART M, 1994, J EXP PSYCHOL HUMAN, V20, P61, DOI 10.1037/0096-1523.20.1.61; BOUCART M, 1992, J EXP PSYCHOL HUMAN, V18, P785, DOI 10.1037/0096-1523.18.3.785; Boucart M, 2000, NEUROREPORT, V11, P2379, DOI 10.1097/00001756-200008030-00009; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURBECK CA, 1987, VISION RES, V27, P417, DOI 10.1016/0042-6989(87)90090-3; CANT JS, 2004, J VISION, V4, P510; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Dupont P, 1998, EUR J NEUROSCI, V10, P3689, DOI 10.1046/j.1460-9568.1998.00376.x; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Faillenot I, 2001, EUR J NEUROSCI, V13, P585, DOI 10.1046/j.1460-9568.2001.01399.x; Faillenot I, 1999, NEUROIMAGE, V10, P114, DOI 10.1006/nimg.1999.0449; FIELD D, 2001, VISUAL NEUROSCIENCES, P1069; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Harris IM, 2008, J COGNITIVE NEUROSCI, V20, P916, DOI 10.1162/jocn.2008.20513; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; HESS RF, 1994, VISION RES, V34, P625, DOI 10.1016/0042-6989(94)90018-3; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Humphreys GW, 1997, J EXP PSYCHOL HUMAN, V23, P136; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; KELLMAN PJ, 2001, FRAGMENTS OBJECTS SE, P181; Kitada R, 2006, J NEUROSCI, V26, P7491, DOI 10.1523/JNEUROSCI.0822-06.2006; KOOI FL, 1991, VISION RES, V31, P1627, DOI 10.1016/0042-6989(91)90139-V; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; KOURTZI Z, 2005, FITTING MIND WORLD; Laurienti PJ, 2004, J COGNITIVE NEUROSCI, V16, P1481, DOI 10.1162/0898929042568596; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Levi DM, 1996, VISION RES, V36, P573, DOI 10.1016/0042-6989(95)00128-X; Marr D., 1982, VISION COMPUTATIONAL; Mendola JD, 1999, J NEUROSCI, V19, P8560; Morgan M. J., 1990, SPATIAL VISION; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; MORGAN MJ, 1987, VISION RES, V27, P107, DOI 10.1016/0042-6989(87)90147-7; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Orban GA, 1997, EUR J NEUROSCI, V9, P246, DOI 10.1111/j.1460-9568.1997.tb01395.x; Ostwald D, 2008, J NEUROPHYSIOL, V99, P2456, DOI 10.1152/jn.01307.2007; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pins D, 2004, NEUROPSYCHOLOGIA, V42, P1247, DOI 10.1016/j.neuropsychologia.2004.01.005; PINS D, 2001, J VISION, V1; Pourtois G, 2001, NEUROREPORT, V12, P2369, DOI 10.1097/00001756-200108080-00017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rice NJ, 2007, NEUROIMAGE, V36, pT87, DOI 10.1016/j.neuroimage.2007.03.032; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Talairach J., 1988, COPLANAR STEREOTAXIC; TOET A, 1988, VISION RES, V28, P133, DOI 10.1016/S0042-6989(88)80013-0; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Valyear KF, 2006, NEUROPSYCHOLOGIA, V44, P218, DOI 10.1016/j.neuropsychologia.2005.05.004; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8; WATT RJ, 1984, VISION RES, V24, P1377, DOI 10.1016/0042-6989(84)90193-7; WAUGH SJ, 1995, J OPT SOC AM A, V12, P2305, DOI 10.1364/JOSAA.12.002305; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]	85	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4585	10.1371/journal.pone.0004585	http://dx.doi.org/10.1371/journal.pone.0004585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KW	19238207	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000265487400014
J	Kourtis, N; Tavernarakis, N				Kourtis, Nikos; Tavernarakis, Nektarios			Cell-Specific Monitoring of Protein Synthesis In Vivo	PLOS ONE			English	Article								Analysis of general and specific protein synthesis provides important information, relevant to cellular physiology and function. However, existing methodologies, involving metabolic labelling by incorporation of radioactive amino acids into nascent polypeptides, cannot be applied to monitor protein synthesis in specific cells or tissues, in live specimens. We have developed a novel approach for monitoring protein synthesis in specific cells or tissues, in vivo. Fluorescent reporter proteins such as GFP are expressed in specific cells and tissues of interest or throughout animals using appropriate promoters. Protein synthesis rates are assessed by following fluorescence recovery after partial photobleaching of the fluorophore at targeted sites. We evaluate the method by examining protein synthesis rates in diverse cell types of live, wild type or mRNA translation-defective Caenorhabditis elegans animals. Because it is non-invasive, our approach allows monitoring of protein synthesis in single cells or tissues with intrinsically different protein synthesis rates. Furthermore, it can be readily implemented in other organisms or cell culture systems.	[Kourtis, Nikos; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Kourtis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466	EMBO; Empeirikeion Foundation; EU 6th Framework Programme	EMBO(European Molecular Biology Organization (EMBO)); Empeirikeion Foundation; EU 6th Framework Programme(European Commission)	This work is supported by grants from EMBO, the Empeirikeion Foundation and the EU 6th Framework Programme. N.K. is a recipient of the Manasaki scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Barstead Robert J., 2006, V351, P51; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; BRENNER S, 1974, GENETICS, V77, P71; Epstein H F, 1995, CAENORHABDITIS ELEGA; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fostel JL, 2003, BIOCHEM BIOPH RES CO, V312, P173, DOI 10.1016/j.bbrc.2003.09.248; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2000, GENETICS, V154, P1597; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gribbon P, 1998, BIOPHYS J, V75, P1032, DOI 10.1016/S0006-3495(98)77592-7; HOPE IA, 1999, C ELEGANS PRACTICAL, pR21; Hoppe PE, 2000, GENETICS, V156, P631; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; JACOBSON K, 1991, SCANNING MICROSCOPY, V5, P357; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; MARTIN R, 1998, PROTEIN SYNTHESIS  M, pR14; Mello C, 1995, METHOD CELL BIOL, V48, P451; Melov, 2007, WORMBOOK, P1, DOI DOI 10.I895/W0RMB00K.I.127.2; OKKEMA PG, 1993, GENETICS, V135, P385; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; RENNIE MJ, 1994, AM J PHYSIOL, V266, pE298, DOI 10.1152/ajpendo.1994.266.3.E298; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; STRANGE K, 2006, C ELEGANS METHODS AP, pR12; Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	34	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4547	10.1371/journal.pone.0004547	http://dx.doi.org/10.1371/journal.pone.0004547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234598	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487200004
J	Kim, Y; McBride, J; Kimlin, L; Pae, EK; Deshpande, A; Wong, DT				Kim, Yong; McBride, Jim; Kimlin, Lauren; Pae, Eung-Kwon; Deshpande, Amit; Wong, David T.			Targeted Inactivation of p12(Cdk2ap1), CDK2 Associating Protein 1, Leads to Early Embryonic Lethality	PLOS ONE			English	Article								Targeted disruption of murine Cdk2ap1, an inhibitor of CDK2 function and hence G1/S transition, results in the embryonic lethality with a high penetration rate. Detailed timed pregnancy analysis of embryos showed that the lethality occurred between embryonic day 3.5 pc and 5.5 pc, a period of implantation and early development of implanted embryos. Two homozygous knockout mice that survived to term showed identical craniofacial defect, including a short snout and a round forehead. Examination of craniofacial morphology by measuring Snout Length (SL) vs. Face Width (FW) showed that the Cdk2ap1(+/-) mice were born with a reduced SL/FW ratio compared to the Cdk2ap1(+/+) and the reduction was more pronounced in Cdk2ap1(-/-) mice. A transgenic rescue of the lethality was attempted by crossing Cdk2ap1(+/-) animals with K14-Cdk2ap1 transgenic mice. Resulting Cdk2ap1(+/-:K14-Cdk2ap1) transgenic mice showed an improved incidence of full term animals (16.7% from 0.5%) on a Cdk2ap1(-/-) background. Transgenic expression of Cdk2ap1 in Cdk2ap1(-/-:K14-Cdk2ap1) animals restored SL/FW ratio to the level of Cdk2ap1(+/-:K14-Cdk2ap1) mice, but not to that of the Cdk2ap1(+/+:K14-Cdk2ap1) mice. Teratoma formation analysis using mESCs showed an abrogated in vivo pluripotency of Cdk2ap1(-/-) mESCs towards a restricted mesoderm lineage specification. This study demonstrates that Cdk2ap1 plays an essential role in the early stage of embryogenesis and has a potential role during craniofacial morphogenesis.	[Kim, Yong; McBride, Jim; Kimlin, Lauren; Deshpande, Amit; Wong, David T.] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Kim, Yong; Wong, David T.] Univ Calif Los Angeles, Jonsson Comprehensive Canc Ctr, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Div Head & Neck Surg Otolaryngol, Los Angeles, CA 90024 USA; [Wong, David T.] Univ Calif Los Angeles, Henry Samueli Sch Engn, Los Angeles, CA 90024 USA; [Pae, Eung-Kwon] Univ Calif Los Angeles, Sch Dentist, Sect Orthodont, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Div Oral Biol & Med, Los Angeles, CA 90024 USA.	thadyk@ucla.edu; dtww@ucla.edu			PHS [R01 DE 14857, T32 DE 007296-08]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014857, T32DE007296] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by PHS Grants R01 DE 14857 [D.T.W.] and T32 DE 007296-08 [Y.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Bair SR, 2004, MOL CELL BIOL, V24, P5383, DOI 10.1128/MCB.24.12.5383-5390.2004; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; CONWAY AE, 2008, STEM CELLS; Cwikla SJ, 2000, J ORAL MAXIL SURG, V58, P406, DOI 10.1016/S0278-2391(00)90924-8; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Dudas M, 2005, CURR TOP DEV BIOL, V66, P65, DOI 10.1016/S0070-2153(05)66003-6; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Figueiredo ML, 2006, MOL REPROD DEV, V73, P987, DOI 10.1002/mrd.20458; Figueiredo ML, 2005, CLIN CANCER RES, V11, P3939, DOI 10.1158/1078-0432.CCR-04-2085; Gallicano GI, 2001, FRONT BIOSCI-LANDMRK, V6, pD1089, DOI 10.2741/Gallican; Greene RM, 2005, HUM EXP TOXICOL, V24, P1, DOI 10.1191/0960327105ht492oa; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hay ED, 1995, ACTA ANAT, V154, P8; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kim Y, 2005, ONCOGENE, V24, P407, DOI 10.1038/sj.onc.1208222; Kim Y, 2001, INT J ORAL BIOL  DEC, V2001, P87; Kohno Y, 2002, ORAL ONCOL, V38, P274, DOI 10.1016/S1368-8375(01)00055-0; LeCouter JE, 1998, DEVELOPMENT, V125, P4669; Lee S, 2003, MOL REPROD DEV, V64, P405, DOI 10.1002/mrd.10232; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Mizuno S, 1998, J CLIN INVEST, V101, P1827, DOI 10.1172/JCI1709; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peng H, 2006, NEOPLASIA, V8, P1028, DOI 10.1593/neo.06580; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shintani S, 2001, CLIN CANCER RES, V7, P2776; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Strothmann K, 2004, CELL TISSUE RES, V315, P249, DOI 10.1007/s00441-003-0834-x; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	45	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4518	10.1371/journal.pone.0004518	http://dx.doi.org/10.1371/journal.pone.0004518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229340	gold, Green Published, Green Submitted			2022-12-25	WOS:000265486200005
J	Sarmann, J; Hegermann, J; von Gromoff, E; Eimer, S; Baumeister, R; Schmidt, E				Saermann, Julia; Hegermann, Jan; von Gromoff, Erika; Eimer, Stefan; Baumeister, Ralf; Schmidt, Enrico			Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL PATHOLOGY; RECESSIVE PARKINSONISM; CELL-MIGRATION; PROTEIN; MUTATIONS; LRRK2; TUNICAMYCIN; KINASE	Mutations in two genes encoding the putative kinases LRRK2 and PINK1 have been associated with inherited variants of Parkinson disease. The physiological role of both proteins is not known at present, but studies in model organisms have linked their mutants to distinct aspects of mitochondrial dysfunction, increased vulnerability to oxidative and endoplasmic reticulum stress, and intracellular protein sorting. Here, we show that a mutation in the Caenorhabditits elegans homologue of the PTEN-induced kinase pink-1 gene resulted in reduced mitochondrial cristae length and increased paraquat sensitivity of the nematode. Moreover, the mutants also displayed defects in axonal outgrowth of a pair of canal-associated neurons. We demonstrate that in the absence of lrk-1, the C. elegans homologue of human LRRK2, all phenotypic aspects of pink-1 loss-of-function mutants were suppressed. Conversely, the hypersensitivity of lrk-1 mutant animals to the endoplasmic reticulum stressor tunicamycin was reduced in a pink-1 mutant background. These results provide the first evidence of an antagonistic role of PINK-1 and LRK-1. Due to the similarity of the C. elegans proteins to human LRRK2 and PINK1, we suggest a common role of both factors in cellular functions including stress response and regulation of neurite outgrowth. This study might help to link pink-1/PINK1 and lrk-1/LRRK2 function to the pathological processes resulting from Parkinson disease-related mutants in both genes, the first manifestations of which are cytoskeletal defects in affected neurons.	[Saermann, Julia; von Gromoff, Erika; Baumeister, Ralf; Schmidt, Enrico] Univ Freiburg, Bioinformat & Mol Genet Fac Biol, ZBMZ Fac Med, D-79104 Freiburg, Germany; [Saermann, Julia; von Gromoff, Erika; Baumeister, Ralf; Schmidt, Enrico] Univ Freiburg, ZBSA Ctr Syst Biol, D-79104 Freiburg, Germany; [Baumeister, Ralf] Sch Life Sci LIFENET, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Baumeister, Ralf] Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany; [Hegermann, Jan; Eimer, Stefan] Univ Med Fac, ENI, D-37077 Gottingen, Germany; [Hegermann, Jan; Eimer, Stefan] Univ Med Fac, Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37077 Gottingen, Germany	University of Freiburg; University of Freiburg; Eni SpA	Baumeister, R (corresponding author), Bio 3,Schaenzlestr 1, D-79104 Freiburg, Brsg, Germany.	baumeister@celegans.de	Eimer, Stefan/B-1865-2013		FORSYS [03139219]; Freiburg Initiative in Systems Biology (a program of the German Federal Ministry in Research and Education); Deutsche Forschungsgemeinschaft [SFB780]; European Community [LSHG-CT-2007-036894, HEALTH-F2-2007-200611]	FORSYS; Freiburg Initiative in Systems Biology (a program of the German Federal Ministry in Research and Education); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by FORSYS Grant 03139219, the Freiburg Initiative in Systems Biology (a program of the German Federal Ministry in Research and Education), Deutsche Forschungsgemeinschaft Grant SFB780, European Community 6th Framework Network of Excellence LIFESPAN Grant LSHG-CT-2007-036894, the Deutsche Forschungsgemeinschaft German Excellence Initiative (FRIAS LIFENET, EXC 294 BIOSS), and the European Community 7th Framework MEMOSAD Grant HEALTH-F2-2007-200611.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; BRENNER S, 1974, GENETICS, V77, P71; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Finnie JW, 2000, VET PATHOL, V37, P677, DOI 10.1354/vp.37-6-677; Forrester WC, 1998, GENETICS, V148, P151; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hatano T, 2007, HUM MOL GENET, V16, P678, DOI 10.1093/hmg/ddm013; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hess DT, 1999, J NEUROBIOL, V38, P105, DOI 10.1002/(SICI)1097-4695(199901)38:1<105::AID-NEU8>3.0.CO;2-M; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lin TY, 1999, J CELL BIOCHEM, V74, P638, DOI 10.1002/(SICI)1097-4644(19990915)74:4<638::AID-JCB13>3.0.CO;2-C; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; PATTERSON SI, 1995, METHOD ENZYMOL, V250, P284; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Springer W, 2005, HUM MOL GENET, V14, P3407, DOI 10.1093/hmg/ddi371; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; WONG A, 1995, GENETICS, V139, P1247; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	43	137	144	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16482	16491		10.1074/jbc.M808255200	http://dx.doi.org/10.1074/jbc.M808255200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19251702	hybrid, Green Published			2022-12-25	WOS:000266730900045
J	Kutter, S; Weiss, MS; Wille, G; Golbik, R; Spinka, M; Konig, S				Kutter, Steffen; Weiss, Manfred S.; Wille, Georg; Golbik, Ralph; Spinka, Michael; Koenig, Stephan			Covalently Bound Substrate at the Regulatory Site of Yeast Pyruvate Decarboxylases Triggers Allosteric Enzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; ACID-BASE GROUPS; CRYSTAL-STRUCTURE; ZYMOMONAS-MOBILIS; DIRECTED MUTAGENESIS; THIAMINE DIPHOSPHATE; INFORMATION-TRANSFER; ALPHA-KETOGLUTARATE; ACTIVE-SITE; DEHYDROGENASE	The mechanism by which the enzyme pyruvate decarboxylase from two yeast species is activated allosterically has been elucidated. A total of seven three-dimensional structures of the enzyme, of enzyme variants, or of enzyme complexes from two yeast species, three of them reported here for the first time, provide detailed atomic resolution snapshots along the activation coordinate. The prime event is the covalent binding of the substrate pyruvate to the side chain of cysteine 221, thus forming a thiohemiketal. This reaction causes the shift of a neighboring amino acid, which eventually leads to the rigidification of two otherwise flexible loops, one of which provides two histidine residues necessary to complete the enzymatically competent active site architecture. The structural data are complemented and supported by kinetic investigations and binding studies, providing a consistent picture of the structural changes occurring upon enzyme activation.	[Kutter, Steffen; Wille, Georg; Golbik, Ralph; Spinka, Michael; Koenig, Stephan] Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, D-06120 Halle, Saale, Germany; [Weiss, Manfred S.] DESY, European Mol Biol Lab Outstn, D-22603 Hamburg, Germany	Martin Luther University Halle Wittenberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Konig, S (corresponding author), Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Saale, Germany.	stephan.koenig@biochemtech.uni-halle.de	Weiss, Manfred S/B-6857-2013; Koenig, Stephan/GRX-2480-2022	Kutter, Steffen/0000-0002-0349-8161; Wille, Georg/0000-0002-8948-611X; Weiss, Manfred S/0000-0002-2362-7047				ALVAREZ FJ, 1995, J AM CHEM SOC, V117, P1678, DOI 10.1021/ja00111a002; ALVAREZ ME, 1993, GENE, V130, P253, DOI 10.1016/0378-1119(93)90427-5; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Baburina I, 1998, BIOCHEMISTRY-US, V37, P1235, DOI 10.1021/bi970990+; BABURINA I, 1994, BIOCHEMISTRY-US, V33, P5630, DOI 10.1021/bi00184a035; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bera AK, 2007, J AM CHEM SOC, V129, P4120, DOI 10.1021/ja068636z; Biryukov AI, 1996, FEBS LETT, V382, P167, DOI 10.1016/0014-5793(96)00166-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNIK VI, 1992, FEBS LETT, V303, P197, DOI 10.1016/0014-5793(92)80518-L; Candy JM, 1996, BIOCHEM J, V315, P745, DOI 10.1042/bj3150745; CROSBY J, 1970, J AM CHEM SOC, V92, P5707, DOI 10.1021/ja00722a027; Dobritzsch D, 1998, J BIOL CHEM, V273, P20196, DOI 10.1074/jbc.273.32.20196; Furey W, 1998, BBA-PROTEIN STRUCT M, V1385, P253, DOI 10.1016/S0167-4838(98)00073-9; HOLZER H, 1956, BIOCHEM Z, V327, P331; Huang CY, 2001, EUR J BIOCHEM, V268, P3558, DOI 10.1046/j.1432-1327.2001.02260.x; HUBNER G, 1988, BIOMED BIOCHIM ACTA, V47, P9; HUBNER G, 1990, FEBS LETT, V266, P17, DOI 10.1016/0014-5793(90)81495-A; HUBNER G, 1978, EUR J BIOCHEM, V92, P175, DOI 10.1111/j.1432-1033.1978.tb12735.x; HUBNER G, 1986, BIOCHEM INT, V13, P767; Joseph E, 2006, BIOCHEMISTRY-US, V45, P13517, DOI 10.1021/bi0615588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Killenberg-Jabs M, 2001, EUR J BIOCHEM, V268, P1698; KillenbergJabs M, 1996, BIOL CHEM H-S, V377, P313; KillenbergJabs M, 1997, BIOCHEMISTRY-US, V36, P1900, DOI 10.1021/bi961341l; KLUGER R, 1981, J AM CHEM SOC, V103, P1214, DOI 10.1021/ja00395a038; KLUGER R, 1974, BIOCHEMISTRY-US, V13, P910, DOI 10.1021/bi00702a013; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krieger F, 2002, EUR J BIOCHEM, V269, P3256, DOI 10.1046/j.1432-1033.2002.03006.x; Kutter S, 2007, PROTEIN J, V26, P585, DOI 10.1007/s10930-007-9101-4; Kutter S, 2006, FEBS J, V273, P4199, DOI 10.1111/j.1742-4658.2006.05415.x; Li H, 1999, BIOCHEMISTRY-US, V38, P10004, DOI 10.1021/bi9902440; Li HJ, 1999, BIOCHEMISTRY-US, V38, P9992, DOI 10.1021/bi9902438; Liu M, 2001, BIOCHEMISTRY-US, V40, P7355, DOI 10.1021/bi002855u; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; MUCKE U, 1995, BIOL CHEM H-S, V376, P111, DOI 10.1515/bchm3.1995.376.2.111; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Schenk G, 1997, EUR J BIOCHEM, V248, P63, DOI 10.1111/j.1432-1033.1997.t01-1-00063.x; Schowen RL, 2007, ISOT ENVIRON HEALT S, V43, P1, DOI 10.1080/10256010600990393; Schutz A, 2003, EUR J BIOCHEM, V270, P2312, DOI 10.1046/j.1432-1033.2003.03601.x; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7369, DOI 10.1021/bi002856m; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Wang J, 2001, BIOCHEMISTRY-US, V40, P1755, DOI 10.1021/bi001003r; WASHABAUGH MW, 1988, BIOCHEMISTRY-US, V27, P5044, DOI 10.1021/bi00414a015; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Werther T, 2008, J BIOL CHEM, V283, P5344, DOI 10.1074/jbc.M706569200; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788; ZEHENDER H, 1987, EUR J BIOCHEM, V167, P149, DOI 10.1111/j.1432-1033.1987.tb13316.x; ZENG XP, 1993, BIOCHEMISTRY-US, V32, P2704, DOI 10.1021/bi00061a031	54	32	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12136	12144		10.1074/jbc.M806228200	http://dx.doi.org/10.1074/jbc.M806228200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246454	hybrid, Green Published			2022-12-25	WOS:000265494600045
J	Zullo, AJ; Michaud, M; Zhang, WP; Grusby, MJ				Zullo, Alfred J.; Michaud, Monia; Zhang, Weiping; Grusby, Michael J.			Identification of the Small Protein Rich in Arginine and Glycine (SRAG) A NEWLY IDENTIFIED NUCLEOLAR PROTEIN THAT CAN REGULATE CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMICS	The characterization of new proteins will aid in our explanation of normal biology and disease. Toward that goal, we describe the initial characterization of the small protein rich in arginine and glycine (SRAG). Human and mouse SRAG are 248/249-amino acid arginine-and glycine-rich proteins that are widely expressed in tissues and cell lines. Two SRAG isoforms, SRAG-5 and SRAG-3, which are truncations of full-length SRAG, were also identified. Although all SRAG proteins reside in the nucleus, they were also found within the nucleolus. Localization within the nucleolus was regulated by the N terminus of the protein. Our initial studies indicated that SRAG can interact with RNA. Full-length SRAG protein levels were highest in resting cells and were reduced in proliferating cells. The reduction in SRAG protein that occurs in proliferating cells was mapped with inhibitors to the G(2)/M phase of the cell cycle. As expected, the overexpression of SRAG reduced the percentage of cells in the G(2)/M phase and increased cell death. In sum, we have identified a new and intriguing member of the nucleolar proteome.	[Zullo, Alfred J.; Michaud, Monia; Grusby, Michael J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Zhang, Weiping] Second Mil Med Univ, Dept Pathophysiol, Shanghai 200433, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Naval Medical University	Grusby, MJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, FXB Rm 205,651 Huntington Ave, Boston, MA 02115 USA.	mgrusby@hsph.harvard.edu			G. Harold and L. Mathers Charitable Foundation; Arthritis Foundation	G. Harold and L. Mathers Charitable Foundation; Arthritis Foundation	The work was supported by a gift from the G. Harold and L. Mathers Charitable Foundation ( to M. J. G.) and an Arthritis Foundation postdoctoral fellowship ( to A. J. Z.).	ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martin RM, 2007, HISTOCHEM CELL BIOL, V127, P243, DOI 10.1007/s00418-006-0256-4; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101	15	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12504	12511		10.1074/jbc.M809436200	http://dx.doi.org/10.1074/jbc.M809436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254951	Green Published, hybrid			2022-12-25	WOS:000265494600079
J	de Bernabe, DBV; Inamori, K; Yoshida-Moriguchi, T; Weydert, CJ; Harper, HA; Willer, T; Henry, MD; Campbell, KP				de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Weydert, Christine J.; Harper, Hollie A.; Willer, Tobias; Henry, Michael D.; Campbell, Kevin P.			Loss of alpha-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; HUMAN LARGE GENE; ABNORMAL GLYCOSYLATION; EXTRACELLULAR-MATRIX; ABERRANT EXPRESSION; MUTATIONS; GLYCOSYLTRANSFERASE; RECEPTOR; BREAST	The interaction between epithelial cells and the extracellular matrix is crucial for tissue architecture and function and is compromised during cancer progression. Dystroglycan is a membrane receptor that mediates interactions between cells and basement membranes in various epithelia. In many epithelium-derived cancers, beta-dystroglycan is expressed, but alpha-dystroglycan is not detected. Here we report that alpha-dystroglycan is correctly expressed and trafficked to the cell membrane but lacks laminin binding as a result of the silencing of the like-acetylglucosaminyltransferase (LARGE) gene in a cohort of highly metastatic epithelial cell lines derived from breast, cervical, and lung cancers. Exogenous expression of LARGE in these cancer cells restores the normal glycosylation and laminin binding of alpha-dystroglycan, leading to enhanced cell adhesion and reduced cell migration in vitro. Our findings demonstrate that LARGE repression is responsible for the defects in dystroglycan-mediated cell adhesion that are observed in epithelium-derived cancer cells and point to a defect of dystroglycan glycosylation as a factor in cancer progression.	[de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Harper, Hollie A.; Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Weydert, Christine J.; Harper, Hollie A.; Willer, Tobias; Henry, Michael D.; Campbell, Kevin P.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Harper, Hollie A.; Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [de Bernabe, Daniel Beltran-Valero; Inamori, Kei-ichiro; Yoshida-Moriguchi, Takako; Harper, Hollie A.; Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Henry, Michael D.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Campbell, KP (corresponding author), 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Inamori, Kei-ichiro/ABA-2926-2020	Inamori, Kei-ichiro/0000-0002-5947-3633; Campbell, Kevin/0000-0003-2066-5889; Henry, Michael/0000-0002-7871-245X	National Institutes of Health [RO1 CA130916]; NATIONAL CANCER INSTITUTE [R01CA130916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA130916 (to M.D.H.).	Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Giancotti FG, 1996, J CELL SCI, V109, P1165; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Henry MD, 2001, HUM PATHOL, V32, P791, DOI 10.1053/hupa.2001.26468; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Jing J, 2004, EUR J CANCER, V40, P2143, DOI 10.1016/j.ejca.2004.05.018; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muschler J, 1999, MOL BIOL CELL, V10, P2817, DOI 10.1091/mbc.10.9.2817; Muschler J, 2002, CANCER RES, V62, P7102; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Satz JS, 2008, J NEUROSCI, V28, P10567, DOI 10.1523/JNEUROSCI.2457-08.2008; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Sgambato A, 2006, GYNECOL ONCOL, V103, P397, DOI 10.1016/j.ygyno.2006.03.059; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	33	80	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11279	11284		10.1074/jbc.C900007200	http://dx.doi.org/10.1074/jbc.C900007200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244252	hybrid, Green Published			2022-12-25	WOS:000265494500031
J	Noh, JY; Lee, H; Song, SM; Kim, NS; Im, W; Kim, M; Seo, H; Chung, CW; Chang, JW; Ferrante, RJ; Yoo, YJ; Ryu, H; Jung, YK				Noh, Jee-Yeon; Lee, Huikyong; Song, Sungmin; Kim, Nam Soon; Im, Wooseok; Kim, Manho; Seo, Hyemyung; Chung, Chul-Woong; Chang, Jae-Woong; Ferrante, Robert J.; Yoo, Young-Jun; Ryu, Hoon; Jung, Yong-Keun			SCAMP5 Links Endoplasmic Reticulum Stress to the Accumulation of Expanded Polyglutamine Protein Aggregates via Endocytosis Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; NEURONAL CELL-DEATH; ER STRESS; MUTANT HUNTINGTIN; AUTOPHAGIC CLEARANCE; PRONE PROTEINS; TOXICITY; BODY; E2-25K/HIP-2; DYSFUNCTION	Accumulation of expanded polyglutamine proteins is considered to be a major pathogenic biomarker of Huntington disease. We isolated SCAMP5 as a novel regulator of cellular accumulation of expanded polyglutamine track protein using cell-based aggregation assays. Ectopic expression of SCAMP5 augments the formation of ubiquitin-positive and detergent-resistant aggregates of mutant huntingtin (mtHTT). Expression of SCAMP5 is markedly increased in the striatum of Huntington disease patients and is induced in cultured striatal neurons by endoplasmic reticulum (ER) stress or by mtHTT. The increase of SCAMP5 impairs endocytosis, which in turn enhances mtHTT aggregation. On the contrary, down-regulation of SCAMP5 alleviates ER stress-induced mtHTT aggregation and endocytosis inhibition. Moreover, stereotactic injection into the striatum and intraperitoneal injection of tunicamycin significantly increase mtHTT aggregation in the striatum of R6/2 mice and in the cortex of N171-82Q mice, respectively. Taken together, these results suggest that exposure to ER stress increases SCAMP5 in the striatum, which positively regulates mtHTT aggregation via the endocytosis pathway.	[Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, BioMAX Inst, Creat Res Initiat Accelerat Res, Seoul 151742, South Korea; [Noh, Jee-Yeon; Chung, Chul-Woong; Yoo, Young-Jun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Kim, Nam Soon] Korea Res Inst Biosci & Biotechnol, Taejon 305600, South Korea; [Im, Wooseok; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Seo, Hyemyung] Hanyang Univ, Dept Mol & Life Sci, Ansan 426791, South Korea; [Ferrante, Robert J.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Bedford, MA 01730 USA	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Boston University	Jung, YK (corresponding author), Seoul Natl Univ, Sch Biol Sci, BioMAX Inst, Creat Res Initiat Accelerat Res, Gwanakro 599, Seoul 151742, South Korea.	ykjung@snu.ac.kr	Longo, Kenneth A/A-5631-2010; Kim, Manho/J-2738-2012; Yoo, Yung Joon/AAH-5002-2020	Ryu, Hoon/0000-0001-6544-3732; Jung, Yong-Keun/0000-0002-9686-3120	Brain Research Center of the 21st Century Frontier Research Program; Korean Government (Ministry of Education and Science Technology);  [R17-2008-038-01000]	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Government (Ministry of Education and Science Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); 	This work was supported in part by Creative Research Initiative Grant R17-2008-038-01000, the Brain Research Center of the 21st Century Frontier Research Program, and Ubiquitom projects funded by the Korea Science and Engineering Foundation of the Korean Government (Ministry of Education and Science Technology).	Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Chang JW, 2007, HUM MOL GENET, V16, P317, DOI 10.1093/hmg/ddl466; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kim M, 1999, J NEUROSCI, V19, P964; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Truckenmiller ME, 2002, EXP NEUROL, V175, P318, DOI 10.1006/exnr.2002.7898; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	46	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11318	11325		10.1074/jbc.M807620200	http://dx.doi.org/10.1074/jbc.M807620200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240033	Green Published, hybrid			2022-12-25	WOS:000265494500036
J	Kim, JH; Zhao, YS; Pan, XW; He, XW; Gilbert, HF				Kim, Jai-Hyun; Zhao, Yinsuo; Pan, Xuewen; He, Xiangwei; Gilbert, Hiram F.			The Unfolded Protein Response Is Necessary but Not Sufficient to Compensate for Defects in Disulfide Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMERASE; DOMAINS	Pdi1p (protein-disulfide isomerase) is a folding assistant of the endoplasmic reticulum (ER) that catalyzes disulfide formation and the isomerization of incorrect disulfides. Its disulfide forming activity is its essential function in Saccharomyces cerevisiae. A truncation mutant (Pdi1a')that is competent in disulfide formation but deficient in catalyzing isomerization has only a small effect on growth, although the maturation of isomerase-requiring substrates (carboxypeptidase Y) is impaired (Xiao, R., Wilkinson, B., Solovyov, A., Winther, J. R., Holmgren, A., Lundstrom-Ljung, J., and Gilbert, H. F. (2004) J. Biol. Chem. 279, 49780-49786). We show here that there are multiple ways to compensate for defects in disulfide formation and isomerization in the ER. Genes of the unfolded protein response are induced, and deletions of the nonessential IRE1 or HAC1 genes are synthetically lethal. Diploid synthetic lethality analysis by microarray (dSLAM) using PDIa' and a temperature-sensitive mutant of PDIa' as query mutations reveals a group of 130 synthetically lethal genes. Only 10 of these correspond to genes clearly associated with the unfolded protein response. More than half are involved in vesicle traffic, not only out of and into the ER but anterograde and retrograde traffic from most cellular compartments. This suggests that defects in protein maturation in one intracellular compartment may be compensated for by adjusting vesicular traffic patterns throughout the cell.	[Kim, Jai-Hyun; Zhao, Yinsuo; Pan, Xuewen; Gilbert, Hiram F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [He, Xiangwei] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Gilbert, HF (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	hgilbert@bcm.edu	Longo, Kenneth A/A-5631-2010	Kim, Jai-Hyun/0000-0002-6546-0142	National Institutes of Health [GM040379-19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM040379-19.	Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Amberg DC., 2005, METHODS YEAST GENETI; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Rachlin J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100103; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Solovyov A, 2004, J BIOL CHEM, V279, P34095, DOI 10.1074/jbc.M405640200; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Xiao R, 2001, J BIOL CHEM, V276, P27975, DOI 10.1074/jbc.M104203200; Xiao RY, 2004, J BIOL CHEM, V279, P49780, DOI 10.1074/jbc.M409210200; Xu Qikai, 2005, Appl Bioinformatics, V4, P281, DOI 10.2165/00822942-200504040-00008	26	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10400	10408		10.1074/jbc.M900377200	http://dx.doi.org/10.1074/jbc.M900377200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233841	Green Published, hybrid			2022-12-25	WOS:000265104600014
J	Debily, MA; El Marhomy, S; Boulanger, V; Eveno, E; Mariage-Samson, R; Camarca, A; Auffray, C; Piatier-Tonneau, D; Imbeaud, S				Debily, Marie-Anne; El Marhomy, Sandrine; Boulanger, Virginie; Eveno, Eric; Mariage-Samson, Regine; Camarca, Alessandra; Auffray, Charles; Piatier-Tonneau, Dominique; Imbeaud, Sandrine			A Functional and Regulatory Network Associated with PIP Expression in Human Breast Cancer	PLOS ONE			English	Article							DISEASE FLUID PROTEIN-15; PROLACTIN-INDUCIBLE PROTEIN; HUMAN SEMINAL PLASMA; GENE-EXPRESSION; GROWTH-FACTOR; CD4-BINDING GLYCOPROTEIN; CELL-PROLIFERATION; SIGNAL TRANSDUCER; MICROARRAY DATA; IN-VITRO	Background: The PIP (prolactin-inducible protein) gene has been shown to be expressed in breast cancers, with contradictory results concerning its implication. As both the physiological role and the molecular pathways in which PIP is involved are poorly understood, we conducted combined gene expression profiling and network analysis studies on selected breast cancer cell lines presenting distinct PIP expression levels and hormonal receptor status, to explore the functional and regulatory network of PIP co-modulated genes. Principal Findings: Microarray analysis allowed identification of genes co-modulated with PIP independently of modulations resulting from hormonal treatment or cell line heterogeneity. Relevant clusters of genes that can discriminate between [PIP+] and [PIP-] cells were identified. Functional and regulatory network analyses based on a knowledge database revealed a master network of PIP co-modulated genes, including many interconnecting oncogenes and tumor suppressor genes, half of which were detected as differentially expressed through high-precision measurements. The network identified appears associated with an inhibition of proliferation coupled with an increase of apoptosis and an enhancement of cell adhesion in breast cancer cell lines, and contains many genes with a STAT5 regulatory motif in their promoters. Conclusions: Our global exploratory approach identified biological pathways modulated along with PIP expression, providing further support for its good prognostic value of disease-free survival in breast cancer. Moreover, our data pointed to the importance of a regulatory subnetwork associated with PIP expression in which STAT5 appears as a potential transcriptional regulator.	[Debily, Marie-Anne; El Marhomy, Sandrine; Boulanger, Virginie; Eveno, Eric; Mariage-Samson, Regine; Auffray, Charles; Piatier-Tonneau, Dominique; Imbeaud, Sandrine] CNRS, Array S IMAGE Genexpress Funct Genom & Syst Biol, LGN UMR 7091, Villejuif, France; [Debily, Marie-Anne] CEA, DSV, IRCM, LEFG, Lab Genomes Funct Explorat, Evry, France; [Debily, Marie-Anne] Univ Evry Val Essonne, Evry, France; [Camarca, Alessandra] CNR, Inst Food Sci, Avellino, Italy; [Imbeaud, Sandrine] CNRS, Ctr Genet Mol, UPR 2167, GODMAP, Gif Sur Yvette, France; [Imbeaud, Sandrine] Univ Paris 11, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Debily, MA (corresponding author), CNRS, Array S IMAGE Genexpress Funct Genom & Syst Biol, LGN UMR 7091, Villejuif, France.	marie-anne.debily@cea.fr	Debily, Marie-Anne/X-7697-2018; Imbeaud, Sandrine/P-8780-2017	Debily, Marie-Anne/0000-0002-8509-6165; Imbeaud, Sandrine/0000-0001-8439-6732; Eveno, Eric/0000-0002-7282-280X	Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by grants from Association pour la Recherche sur le Cancer (ARC) to D.P.T.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbaria R, 1997, ONCOL RES, V9, P111; AKASOFU M, 1993, ACTA PATHOL JAPON, V43, P736; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; AUTIERO M, 1991, EXP CELL RES, V197, P268, DOI 10.1016/0014-4827(91)90432-T; Autiero M, 1997, IMMUNOGENETICS, V46, P345; AUTIERO M, 1995, EUR J IMMUNOL, V25, P1461, DOI 10.1002/eji.1830250550; Autiero M, 2002, INT J CANCER, V99, P370, DOI 10.1002/ijc.10368; Autiero M, 1999, DNA CELL BIOL, V18, P481, DOI 10.1089/104454999315204; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Basmaciogullari S, 2000, BIOCHEMISTRY-US, V39, P5332, DOI 10.1021/bi992398l; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson M, 2006, CURR MOL MED, V6, P695, DOI 10.2174/156652406778195044; Bertucci F, 2002, HUM MOL GENET, V11, P863, DOI 10.1093/hmg/11.8.863; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brenner AJ, 1997, PROG CLIN BIOL RES, V396, P63; Brizzi MF, 2004, FASEB J, V18, P1249, DOI 10.1096/fj.03-1053fje; Campbell I, 2000, CANCER GENE THER, V7, P1270, DOI 10.1038/sj.cgt.7700226; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; Carsol JL, 2002, MOL ENDOCRINOL, V16, P1696, DOI 10.1210/me.16.7.1696; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cho DI, 2003, LIFE SCI, V73, P2991, DOI 10.1016/S0024-3205(03)00707-0; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Ciullo M, 2002, HUM MOL GENET, V11, P2887, DOI 10.1093/hmg/11.23.2887; Clark JW, 1999, BRIT J CANCER, V81, P1002, DOI 10.1038/sj.bjc.6690799; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Cull VS, 2003, BLOOD, V101, P2727, DOI 10.1182/blood-2002-05-1521; Duan JM, 2004, INT J ONCOL, V24, P1597; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiel MI, 1996, ACTA CYTOL, V40, P637; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P1221, DOI 10.14670/HH-22.1221; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; Gaubin M, 1999, J IMMUNOL, V162, P2631; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; GUTZMAN JH, 2007, ONCOGENE; HAAGENSEN JDE, 1986, DIS BREAST, P474; Harbeck N, 1999, BRIT J CANCER, V80, P419, DOI 10.1038/sj.bjc.6690373; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Humphreys RC, 1999, CELL GROWTH DIFFER, V10, P685; Hwa V, 2004, J BIOL CHEM, V279, P2728, DOI 10.1074/jbc.M310495200; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; JIN XM, 1995, CANCER RES, V55, P3250; JOENSUU H, 1993, AM J PATHOL, V143, P867; Kim HJ, 2006, YONSEI MED J, V47, P333, DOI 10.3349/ymj.2006.47.3.333; Kim K, 1998, INT J CANCER, V79, P324, DOI 10.1002/(SICI)1097-0215(19980821)79:4<324::AID-IJC4>3.3.CO;2-N; Kloth MT, 2002, J BIOL CHEM, V277, P8693, DOI 10.1074/jbc.M111884200; Kudoh M, 2002, CANCER RES, V62, P1904; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Li Tianhong, 2003, Clin Breast Cancer, V3, P405, DOI 10.3816/CBC.2003.n.005; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loos S, 1999, INT J MOL MED, V4, P135; Lyzak JS, 1997, HUM PATHOL, V28, P772, DOI 10.1016/S0046-8177(97)90148-9; Maniatis T., 1982, MOL CLONING LAB MANU; MCPHERSON K, 1994, BRIT MED J, V309, P1003, DOI 10.1136/bmj.309.6960.1003; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mogi S, 2005, ANTICANCER RES, V25, P751; MONTEAGUDO C, 1991, HUM PATHOL, V22, P368, DOI 10.1016/0046-8177(91)90084-3; Moritani S, 2008, HUM PATHOL, V39, P666, DOI 10.1016/j.humpath.2007.09.009; MURPHY LC, 1987, CANCER RES, V47, P4160; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Nagy N, 2002, GUT, V50, P392, DOI 10.1136/gut.50.3.392; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Niedergethmann M, 2000, INT J PANCREATOL, V28, P31, DOI 10.1385/IJGC:28:1:31; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Perry A, 1997, HUM PATHOL, V28, P938, DOI 10.1016/S0046-8177(97)90009-5; Qin WX, 2003, BIOCHEM BIOPH RES CO, V308, P379, DOI 10.1016/S0006-291X(03)01387-1; RHEE K, 1995, CANCER RES, V55, P4188; Rhodes DR, 2002, BIOINFORMATICS, V18, P205, DOI 10.1093/bioinformatics/18.1.205; RIEGEL AT, 1994, BREAST CANCER RES TR, V31, P309; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; SIMARD J, 1989, MOL ENDOCRINOL, V3, P694, DOI 10.1210/mend-3-4-694; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Tajeddine N, 2005, CANCER RES, V65, P7348, DOI 10.1158/0008-5472.CAN-04-4011; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDEWALLE B, 1987, J CANCER RES CLIN, V113, P550, DOI 10.1007/BF00390864; Wang CH, 2006, J CELL PHYSIOL, V208, P246, DOI 10.1002/jcp.20660; WELLS CA, 1995, J CLIN PATHOL, V48, P737, DOI 10.1136/jcp.48.8.737; WICK MR, 1989, HUM PATHOL, V20, P281, DOI 10.1016/0046-8177(89)90137-8; Yang XH, 2001, CANCER RES, V61, P5284; Yasuda M, 2001, INT IMMUNOL, V13, P1309, DOI 10.1093/intimm/13.10.1309; Zagorianakou P, 2006, VIRCHOWS ARCH, V448, P525, DOI 10.1007/s00428-005-0095-z	107	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4696	10.1371/journal.pone.0004696	http://dx.doi.org/10.1371/journal.pone.0004696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262752	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600017
J	Busan, P; Barbera, C; Semenic, M; Monti, F; Pizzolato, G; Pelamatti, G; Battaglini, PP				Busan, Pierpaolo; Barbera, Claudia; Semenic, Mauro; Monti, Fabrizio; Pizzolato, Gilberto; Pelamatti, Giovanna; Battaglini, Piero Paolo			Effect of Transcranial Magnetic Stimulation (TMS) on Parietal and Premotor Cortex during Planning of Reaching Movements	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; MACAQUE MONKEY; AREA V6A; CORTICAL MECHANISMS; DORSAL PREMOTOR; EYE; SYSTEM; BRAIN; SELECTION; PATHWAYS	Background: Cerebral activation during planning of reaching movements occurs both in the superior parietal lobule (SPL) and premotor cortex (PM), and their activation seems to take place in parallel. Methodology: The activation of the SPL and PM has been investigated using transcranial magnetic stimulation (TMS) during planning of reaching movements under visual guidance. Principal Findings: A facilitory effect was found when TMS was delivered on the parietal cortex at about half of the time from sight of the target to hand movement, independently of target location in space. Furthermore, at the same stimulation time, a similar facilitory effect was found in PM, which is probably related to movement preparation. Conclusions: This data contributes to the understanding of cortical dynamics in the parieto-frontal network, and suggests that it is possible to interfere with the planning of reaching movements at different cortical points within a particular time window. Since similar effects may be produced at similar times on both the SPL and PM, parallel processing of visuomotor information is likely to take place in these regions.	[Busan, Pierpaolo; Battaglini, Piero Paolo] Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy; [Barbera, Claudia; Pelamatti, Giovanna] Univ Trieste, Dept Psychol, I-34127 Trieste, Italy; [Semenic, Mauro; Monti, Fabrizio; Pizzolato, Gilberto] Univ Trieste, Dept Clin & Expt Med & Clin & Expt Neurosci, I-34127 Trieste, Italy	University of Trieste; University of Trieste; University of Trieste	Busan, P (corresponding author), Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy.	busan@dfp.units.it		Battaglini, Piero Paolo/0000-0003-4697-8648	Ministero dell'Universita, Italy	Ministero dell'Universita, Italy	This work was supported by grants from the Ministero dell'Universita, Italy.	Anand S, 2002, BRAIN COGNITION, V50, P366, DOI 10.1016/S0278-2626(02)00512-2; Battaglia-Mayer A, 2007, CEREB CORTEX, V17, P1350, DOI 10.1093/cercor/bhl046; Buneo CA, 2008, EXP BRAIN RES, V188, P77, DOI 10.1007/s00221-008-1340-x; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Favilla M, 1996, NEUROPSYCHOLOGIA, V34, P609, DOI 10.1016/0028-3932(95)00135-2; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Himmelbach M, 2006, NEUROPSYCHOLOGIA, V44, P2749, DOI 10.1016/j.neuropsychologia.2006.04.030; Johnson SH, 2003, PROG BRAIN RES, V142, P127; Kalaska JF, 1998, NOVART FDN SYMP, V218, P176; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Mars RB, 2007, CEREB CORTEX, V17, P2972, DOI 10.1093/cercor/bhm022; Matelli M, 2001, NEUROIMAGE, V14, pS27, DOI 10.1006/nimg.2001.0835; Mayer AB, 1998, EXP BRAIN RES, V123, P172, DOI 10.1007/s002210050559; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Mottaghy FM, 2006, BEHAV NEUROL, V17, P177, DOI 10.1155/2006/768413; Naranjo JR, 2007, NEUROIMAGE, V34, P1673, DOI 10.1016/j.neuroimage.2006.07.049; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Ryan S, 2006, EXP BRAIN RES, V173, P389, DOI 10.1007/s00221-006-0379-9; Sawaki L, 1999, EXP BRAIN RES, V127, P402, DOI 10.1007/s002210050808; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Silvanto J, 2008, NEUROIMAGE, V39, P549, DOI 10.1016/j.neuroimage.2007.09.008; Silvanto J, 2008, J NEUROPHYSIOL, V99, P2725, DOI 10.1152/jn.01392.2007; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; Walsh V, 2003, BRADFORD BOOKS, P1	46	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4621	10.1371/journal.pone.0004621	http://dx.doi.org/10.1371/journal.pone.0004621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247490	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800004
J	Cockerham, RE; Puche, AC; Munger, SD				Cockerham, Renee E.; Puche, Adam C.; Munger, Steven D.			Heterogeneous Sensory Innervation and Extensive Intrabulbar Connections of Olfactory Necklace Glomeruli	PLOS ONE			English	Article								The mammalian nose employs several olfactory subsystems to recognize and transduce diverse chemosensory stimuli. These subsystems differ in their anatomical position within the nasal cavity, their targets in the olfactory forebrain, and the transduction mechanisms they employ. Here we report that they can also differ in the strategies they use for stimulus coding. Necklace glomeruli are the sole main olfactory bulb (MOB) targets of an olfactory sensory neuron (OSN) subpopulation distinguished by its expression of the receptor guanylyl cyclase GC-D and the phosphodiesterase PDE2, and by its chemosensitivity to the natriuretic peptides uroguanylin and guanylin and the gas CO2. In stark contrast to the homogeneous sensory innervation of canonical MOB glomeruli from OSNs expressing the same odorant receptor (OR), we find that each necklace glomerulus of the mouse receives heterogeneous innervation from at least two distinct sensory neuron populations: one expressing GC-D and PDE2, the other expressing olfactory marker protein. In the main olfactory system it is thought that odor identity is encoded by a combinatorial strategy and represented in the MOB by a pattern of glomerular activation. This combinatorial coding scheme requires functionally homogeneous sensory inputs to individual glomeruli by OSNs expressing the same OR and displaying uniform stimulus selectivity; thus, activity in each glomerulus reflects the stimulation of a single OSN type. The heterogeneous sensory innervation of individual necklace glomeruli by multiple, functionally distinct, OSN subtypes precludes a similar combinatorial coding strategy in this olfactory subsystem.	[Cockerham, Renee E.; Puche, Adam C.; Munger, Steven D.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Cockerham, RE (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	smung001@umaryland.edu			NIH/NIDCD [DC005633]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005633] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by a grant from the NIH/NIDCD (DC005633 to SDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Baker H, 1999, J NEUROSCI, V19, P9313; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Breer H, 2006, CELL MOL LIFE SCI, V63, P1465, DOI 10.1007/s00018-006-6108-5; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; CHERRY JA, 1995, J NEUROBIOL, V28, P102, DOI 10.1002/neu.480280109; Duda T, 2008, BIOCHEM BIOPH RES CO, V367, P440, DOI 10.1016/j.bbrc.2007.12.153; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fleischer J, 2006, HISTOCHEM CELL BIOL, V125, P337, DOI 10.1007/s00418-005-0077-x; FLEISCHER J, 2008, HISTOCHEM CELL BIOL; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Koos DS, 2005, NEUROREPORT, V16, P1929, DOI 10.1097/01.wnr.0000186597.72081.10; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Ma MH, 2007, CRIT REV BIOCHEM MOL, V42, P463, DOI 10.1080/10409230701693359; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mamasuew K, 2008, EUR J NEUROSCI, V28, P1775, DOI 10.1111/j.1460-9568.2008.06465.x; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Munger SD, 2008, ANN REV PHYSL; MUNGER SD, 2008, ANN REV PHY IN PRESS, V71; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ring G, 1997, J COMP NEUROL, V388, P415; Roppolo D, 2006, EUR J NEUROSCI, V23, P2887, DOI 10.1111/j.1460-9568.2006.04818.x; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; SHINODA K, 1993, BRAIN RES, V618, P160, DOI 10.1016/0006-8993(93)90440-X; SHINODA K, 1989, J COMP NEUROL, V284, P362, DOI 10.1002/cne.902840304; Shipley MY, 2004, RAT NERVOUS SYSTEM; Storan MJ, 2006, J COMP NEUROL, V494, P834, DOI 10.1002/cne.20858; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Walz A, 2007, DEVELOPMENT, V134, P4063, DOI 10.1242/dev.008722; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4657	10.1371/journal.pone.0004657	http://dx.doi.org/10.1371/journal.pone.0004657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247478	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800036
J	Dong, HY; Yauk, CL; Rowan-Carroll, A; You, SH; Zoeller, RT; Lambert, L; Wade, MG				Dong, Hongyan; Yauk, Carole L.; Rowan-Carroll, Andrea; You, Seo-Hee; Zoeller, R. Thomas; Lambert, Lain; Wade, Michael G.			Identification of Thyroid Hormone Receptor Binding Sites and Target Genes Using ChIP-on-Chip in Developing Mouse Cerebellum	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; BASIC-PROTEIN GENE; RAT-BRAIN; CONGENITAL HYPOTHYROIDISM; RESPONSE ELEMENT; NEONATAL-HYPOTHYROIDISM; DIFFERENTIAL REGULATION; UNITED-STATES; WHITE-MATTER; 1ST INTRON	Thyroid hormone (TH) is critical to normal brain development, but the mechanisms operating in this process are poorly understood. We used chromatin immunoprecipitation to enrich regions of DNA bound to thyroid receptor beta (TR beta) of mouse cerebellum sampled on post natal day 15. Enriched target was hybridized to promoter microarrays (ChIP-on-chip) spanning -8 kb to +2 kb of the transcription start site (TSS) of 5000 genes. We identified 91 genes with TR binding sites. Roughly half of the sites were located in introns, while 30% were located within 1 kb upstream (5') of the TSS. Of these genes, 83 with known function included genes involved in apoptosis, neurodevelopment, metabolism and signal transduction. Two genes, MBP and CD44, are known to contain TREs, providing validation of the system. This is the first report of TR binding for 81 of these genes. ChIP-on-chip results were confirmed for 10 of the 13 binding fragments using ChIP-PCR. The expression of 4 novel TH target genes was found to be correlated with TH levels in hyper/hypothyroid animals providing further support for TR binding. A TR beta binding site upstream of the coding region of myelin associated glycoprotein was demonstrated to be TH-responsive using a luciferase expression system. Motif searches did not identify any classic binding elements, indicating that not all TR binding sites conform to variations of the classic form. These findings provide mechanistic insight into impaired neurodevelopment resulting from TH deficiency and a rich bioinformatics resource for developing a better understanding of TR binding.	[Dong, Hongyan; Wade, Michael G.] Hlth Canada, EHSRB, Hazard Identificat Div, Ottawa, ON K1A 0L2, Canada; [Yauk, Carole L.; Rowan-Carroll, Andrea] Hlth Canada, EHSRB, Mechanist Study Div, Ottawa, ON K1A 0L2, Canada; [You, Seo-Hee; Zoeller, R. Thomas] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Lambert, Lain] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Health Canada; Health Canada; University of Massachusetts System; University of Massachusetts Amherst; Carleton University	Dong, HY (corresponding author), Hlth Canada, EHSRB, Hazard Identificat Div, Ottawa, ON K1A 0L2, Canada.	hongyan_dong@hc-sc.gc.ca		Wade, Michael/0000-0002-7331-3839; Yauk, Carole/0000-0002-6725-3454; Yauk, Carole/0000-0003-4919-876X	Health Canada Genomics RD	Health Canada Genomics RD	This work was founded by the Health Canada Genomics R&D fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; ALM J, 1984, BRIT MED J, V289, P1171, DOI 10.1136/bmj.289.6453.1171; Anderson GW, 2008, CEREBELLUM, V7, P60, DOI 10.1007/s12311-008-0021-4; Auso E, 2004, ENDOCRINOLOGY, V145, P4037, DOI 10.1210/en.2004-0274; Bansal R, 2005, DEV BRAIN RES, V156, P13, DOI 10.1016/j.devbrainres.2005.01.007; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; BOEHM T, 1991, ONCOGENE, V6, P695; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x; Delange F, 1997, HORM RES, V48, P51, DOI 10.1159/000185485; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Dong HY, 2005, BIOCHEM BIOPH RES CO, V330, P1182, DOI 10.1016/j.bbrc.2005.03.099; Dowling ALS, 2000, J NEUROSCI, V20, P2255; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GRIMA B, 1992, J NEUROCHEM, V59, P2318; Haas MJ, 2004, NEUROSCI LETT, V365, P14, DOI 10.1016/j.neulet.2004.04.028; Harris KB, 2007, MOL GENET METAB, V91, P268, DOI 10.1016/j.ymgme.2007.03.012; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Hinks GL, 1997, J NEUROSCI, V17, P5549; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Ibarrola N, 1997, BRAIN RES, V752, P285, DOI 10.1016/S0006-8993(96)01480-1; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; JACOBSEN BB, 1981, ARCH DIS CHILD, V56, P134, DOI 10.1136/adc.56.2.134; Kakizawa S, 2000, J NEUROSCI, V20, P4954; KLEIN RZ, 1996, THYROID FUNDAMENTAL, P984; Klein RZ., 1980, NEONATAL THYROID SCR, P51; KOENIG JI, 1989, TOXICOL PATHOL, V17, P256, DOI 10.1177/019262338901700204; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; MUNOZ A, 1991, MOL ENDOCRINOL, V5, P273, DOI 10.1210/mend-5-2-273; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; NICHOLSON JL, 1972, SCIENCE, V176, P530, DOI 10.1126/science.176.4034.530; Paez PM, 2007, J NEUROSCI, V27, P12690, DOI 10.1523/JNEUROSCI.2381-07.2007; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; RAMI A, 1990, DEV NEUROSCI-BASEL, V12, P398, DOI 10.1159/000111867; RODRIGUEZPENA A, 1993, J CLIN INVEST, V91, P812, DOI 10.1172/JCI116301; Ruike Y, 2007, J HUM GENET, V52, P172, DOI 10.1007/s10038-006-0099-9; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Segall MA, 1996, ALCOHOL, V13, P559, DOI 10.1016/S0741-8329(96)00068-7; Sharlin DS, 2008, ENDOCRINOLOGY, V149, P2527, DOI 10.1210/en.2007-1431; Sharlin DS, 2006, ENDOCRINOLOGY, V147, P846, DOI 10.1210/en.2005-0778; Steketee K, 2004, J MOL ENDOCRINOL, V33, P477, DOI 10.1677/jme.1.01478; Thompson CC, 1996, J NEUROSCI, V16, P7832; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Xiao Qianxun, 1998, Frontiers in Bioscience, V3, pA52; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; YEN PM, 2005, THYROID FUNDAMENTAL, P135; Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107; Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x	63	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4610	10.1371/journal.pone.0004610	http://dx.doi.org/10.1371/journal.pone.0004610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240802	Green Published, gold			2022-12-25	WOS:000278086700020
J	Koschwanez, JH; Carlson, RH; Meldrum, DR				Koschwanez, John H.; Carlson, Robert H.; Meldrum, Deirdre R.			Thin PDMS Films Using Long Spin Times or Tert-Butyl Alcohol as a Solvent	PLOS ONE			English	Article								Thin polydimethylsiloxane (PDMS) films are frequently used in "lab on a chip'' devices as flexible membranes. The common solvent used to dilute the PDMS for thin films is hexane, but hexane can swell the underlying PDMS substrate. A better solvent would be one that dissolves uncured PDMS but doesn't swell the underlying substrate. Here, we present protocols and spin curves for two alternatives to hexane dilution: longer spin times and dilution in tert-butyl alcohol. The thickness of the PDMS membranes under different spin speeds, spin times, and PDMS concentrations was measured using an optical profilometer. The use of tert-butyl alcohol to spin thin PDMS films does not swell the underlying PDMS substrate, and we have used these films to construct multilayer PDMS devices.	[Koschwanez, John H.; Carlson, Robert H.; Meldrum, Deirdre R.] Univ Washington, Dept Electrical Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Koschwanez, JH (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jkoschwanez@cgr.harvard.edu	MLSC, Colletion/B-3912-2013		NIH NHGRI;  [1 R01 HG01497]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001497] Funding Source: NIH RePORTER	NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NIH NHGRI Grant No. 1 R01 HG01497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSON R, 2007, LOW POWER LOW COST T; EMSLIE AG, 1958, J APPL PHYS, V29, P858, DOI 10.1063/1.1723300; Harmon ME, 2003, POLYMER, V44, P4547, DOI 10.1016/S0032-3861(03)00463-4; Hosokawa K, 2000, J MICROMECH MICROENG, V10, P415, DOI 10.1088/0960-1317/10/3/317; Koschwanez JH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2722400; LAWRENCE CJ, 1988, PHYS FLUIDS, V31, P2786, DOI 10.1063/1.866986; Norrman K, 2005, ANN RP CH C, V101, P174, DOI 10.1039/b408857n; Paunovic M., 2006, ECS SERIES TEXTS MON; REDON C, 1994, MACROMOLECULES, V27, P468, DOI 10.1021/ma00080a021; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Werber A, 2005, APPL OPTICS, V44, P3238, DOI 10.1364/AO.44.003238; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	12	104	105	14	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4572	10.1371/journal.pone.0004572	http://dx.doi.org/10.1371/journal.pone.0004572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238212	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487400006
J	Bonkowski, MS; Dominici, FP; Arum, O; Rocha, JS; Al Regaiey, KA; Westbrook, R; Spong, A; Panici, J; Masternak, MM; Kopchick, JJ; Bartke, A				Bonkowski, Michael S.; Dominici, Fernando P.; Arum, Oge; Rocha, Juliana S.; Al Regaiey, Khalid A.; Westbrook, Reyhan; Spong, Adam; Panici, Jacob; Masternak, Michal M.; Kopchick, John J.; Bartke, Andrzej			Disruption of Growth Hormone Receptor Prevents Calorie Restriction from Improving Insulin Action and Longevity	PLOS ONE			English	Article							LIFE-SPAN; TARGETED DISRUPTION; DIETARY RESTRICTION; GENE; MICE; EXPRESSION; RESISTANCE; MOUSE; YEAST	Most mutations that delay aging and prolong lifespan in the mouse are related to somatotropic and/or insulin signaling. Calorie restriction (CR) is the only intervention that reliably increases mouse longevity. There is considerable phenotypic overlap between long-lived mutant mice and normal mice on chronic CR. Therefore, we investigated the interactive effects of CR and targeted disruption or knock out of the growth hormone receptor (GHRKO) in mice on longevity and the insulin signaling cascade. Every other day feeding corresponds to a mild (i.e. 15%) CR which increased median lifespan in normal mice but not in GHRKO mice corroborating our previous findings on the effects of moderate (30%) CR on the longevity of these animals. To determine why insulin sensitivity improves in normal but not GHRKO mice in response to 30% CR, we conducted insulin stimulation experiments after one year of CR. In normal mice, CR increased the insulin stimulated activation of the insulin signaling cascade (IR/IRS/PI3K/AKT) in liver and muscle. Livers of GHRKO mice responded to insulin by increased activation of the early steps of insulin signaling, which was dissipated by altered PI3K subunit abundance which putatively inhibited AKT activation. In the muscle of GHRKO mice, there was elevated downstream activation of the insulin signaling cascade (IRS/PI3K/AKT) in the absence of elevated IR activation. Further, we found a major reduction of inhibitory Ser phosphorylation of IRS-1 seen exclusively in GHRKO muscle which may underpin their elevated insulin sensitivity. Chronic CR failed to further modify the alterations in insulin signaling in GHRKO mice as compared to normal mice, likely explaining or contributing to the absence of CR effects on insulin sensitivity and longevity in these long-lived mice.	[Bonkowski, Michael S.; Arum, Oge; Rocha, Juliana S.; Al Regaiey, Khalid A.; Westbrook, Reyhan; Spong, Adam; Panici, Jacob; Masternak, Michal M.; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Internal Med Geriatr Res, Springfield, IL USA; [Bonkowski, Michael S.; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Pharmacol & Physiol, Springfield, IL USA; [Dominici, Fernando P.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, RA-1053 Buenos Aires, DF, Argentina; [Rocha, Juliana S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Al Regaiey, Khalid A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh, Saudi Arabia; [Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Dept Biomed Sci, Athens, OH 45701 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Buenos Aires; Universidade Federal de Minas Gerais; King Saud University; University System of Ohio; Ohio University	Bonkowski, MS (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med Geriatr Res, Springfield, IL USA.	abartke@siumed.edu	Bartke, Andzej/D-6640-2017; Al-Regaiey, Khalid/AAG-4217-2019	Bartke, Andzej/0000-0002-2569-557X; Al-Regaiey, Khalid/0000-0001-9770-5637; Bonkowski, Michael/0000-0003-3416-4612; Dominici, Fernando Pablo/0000-0002-4351-0057	NIA [AG 19899, u19 AG023122]; Ellison Medical Foundation; SIU Geriatrics Medicine Initiative; Ohio's Eminent Scholars Program;  [AG19899-05]; NATIONAL INSTITUTE ON AGING [U19AG023122, R01AG019899] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); SIU Geriatrics Medicine Initiative; Ohio's Eminent Scholars Program; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by NIA, AG 19899 and u19 AG023122, by the Ellison Medical Foundation, and by the SIU Geriatrics Medicine Initiative. JJK is supported in part by the state of Ohio's Eminent Scholars Program that includes a gift from Milton and Lawrence Goll and by AG19899-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adochio R, 2009, ENDOCRINOLOGY, V150, P1165, DOI 10.1210/en.2008-0437; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Al-Regaiey KA, 2007, J GERONTOL A-BIOL, V62, P18, DOI 10.1093/gerona/62.1.18; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bartke A, 2008, HORM-INT J ENDOCRINO, V7, P17, DOI 10.14310/horm.2002.1111033; Bartke Andrzej, 2007, V35, P69; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Ishizuka T, 2004, ENDOCR RES, V30, P287, DOI 10.1081/ERC-120039580; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KAHN CR, 2002, MOL CELL BIOL, V22, P965; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Robertson K, 2006, AM J PHYSIOL-ENDOC M, V291, pE491, DOI 10.1152/ajpendo.00378.2005; Sharp ZD, 2005, J GERONTOL A-BIOL, V60, P293, DOI 10.1093/gerona/60.3.293; STROBL JS, 1994, PHARMACOL REV, V46, P1; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Vance ML, 1999, NEW ENGL J MED, V341, P1206, DOI 10.1056/NEJM199910143411607; WEINDRUCH R, 2007, METABOLIC SHIFTS IND, V21; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	34	102	103	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4567	10.1371/journal.pone.0004567	http://dx.doi.org/10.1371/journal.pone.0004567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234595	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487200018
J	Deck, KM; Vasanthakumar, A; Anderson, SA; Goforth, JB; Kennedy, MC; Antholine, WE; Eisenstein, RS				Deck, Kathryn M.; Vasanthakumar, Aparna; Anderson, Sheila A.; Goforth, Jeremy B.; Kennedy, M. Claire; Antholine, William E.; Eisenstein, Richard S.			Evidence That Phosphorylation of Iron Regulatory Protein 1 at Serine 138 Destabilizes the [4Fe-4S] Cluster in Cytosolic Aconitase by Enhancing 4Fe-3Fe Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; FE-S CLUSTER; NITRIC-OXIDE; SULFUR CLUSTER; RNA-BINDING; BEEF-LIVER; HOMEOSTASIS; PEROXYNITRITE; SUPEROXIDE; ACTIVATION	Iron-sulfur cluster-dependent interconversion of iron regulatory protein 1 (IRP1) between its RNA binding and cytosolic aconitase (c-acon) forms controls vertebrate iron homeostasis. Cluster removal from c-acon is thought to include oxidative demetallation as a required step, but little else is understood about the process of conversion to IRP1. In comparison with c-acon(WT), Ser(138) phosphomimetic mutants of c-acon contain an unstable [4Fe-4S] cluster and were used as tools to further define the pathway(s) of iron-sulfur cluster disassembly. Under anaerobic conditions cluster insertion into purified IRP1(S138E) and cluster loss on treatment with NO regulated aconitase and RNA binding activity over a similar range as observed for IRP1(WT). However, activation of RNA binding of c-acon(S138E) was an order of magnitude more sensitive to NO than for c-acon(WT). Consistent with this, an altered set point between RNA-binding and aconitase forms was observed for IRP1(S138E) when expressed in HEK cells. Active c-acon(S138E) could only accumulate under hypoxic conditions, suggesting enhanced cluster disassembly in normoxia. Cluster disassembly mechanisms were further probed by determining the impact of iron chelation on acon activity. Unexpectedly EDTA rapidly inhibited c-acon(S138E) activity without affecting c-acon(WT). Additional chelator experiments suggested that cluster loss can be initiated in c-acon(S138E) through a spontaneous nonoxidative demetallation process. Taken together, our results support a model wherein Ser(138) phosphorylation sensitizes IRP1/c-acon to decreased iron availability by allowing the [4Fe-4S](2+) cluster to cycle with [3Fe-4S](0) in the absence of cluster perturbants, indicating that regulation can be initiated merely by changes in iron availability.	[Deck, Kathryn M.; Vasanthakumar, Aparna; Anderson, Sheila A.; Goforth, Jeremy B.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Kennedy, M. Claire] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Antholine, William E.] Med Coll Wisconsin, Dept Biophys, Natl Biomed Esr Ctr, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Medical College of Wisconsin	Eisenstein, RS (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eisenste@nutrisci.wisc.edu			National Institutes of Health [DK 66600]; National Biomedical ESR Center [EB001980]; United States Department of Agriculture Cooperative States Research Education and Extension Service [2006-35200-16604]; University of Wisconsin-Madison Hatch [4885]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665, R01DK066600, R56DK066600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Biomedical ESR Center; United States Department of Agriculture Cooperative States Research Education and Extension Service; University of Wisconsin-Madison Hatch; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK 66600 (to R. S. E.) and National Biomedical ESR Center Grant EB001980. This work was also supported by United States Department of Agriculture Cooperative States Research Education and Extension Service Grant 2006-35200-16604 and University of Wisconsin-Madison Hatch Project 4885 (to R. S. E.).	BARTON HA, 1990, J BIOL CHEM, V265, P7000; BASILION JP, 1994, ARCH BIOCHEM BIOPHYS, V311, P517, DOI 10.1006/abbi.1994.1270; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bouton C, 1999, CELL MOL LIFE SCI, V55, P1043, DOI 10.1007/s000180050355; BOUTON C, 2003, SCI STKE, pPE17; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Cairo G, 2002, BIOCHEMISTRY-US, V41, P7435, DOI 10.1021/bi025756k; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Eisenstein RS, 1997, CH MICROBIOL SER, P157; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; HENSON CP, 1967, J BIOL CHEM, V242, P3833; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; PRESS WH, 1986, NUMERICAL RECIPES AR; Rouault T A, 1996, EXS, V77, P183; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1997, BIOCHEMISTRY-US, V36, P3950, DOI 10.1021/bi9624447; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Walden WE, 2002, P NATL ACAD SCI USA, V99, P4138, DOI 10.1073/pnas.082108799; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x	52	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12701	12709		10.1074/jbc.M807717200	http://dx.doi.org/10.1074/jbc.M807717200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269970	hybrid, Green Published			2022-12-25	WOS:000265688300014
J	Shi, XF; Zaia, J				Shi, Xiaofeng; Zaia, Joseph			Organ-specific Heparan Sulfate Structural Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-UNSUBSTITUTED GLUCOSAMINE; MOLECULAR DIVERSITY; MASS-SPECTROMETRY; GLUCURONIC ACID; GLYPICAN-1; PROTEOGLYCANS; RESIDUES; LINKAGE; CELLS; DEGRADATION	The functions of heparan sulfate (HS) depend on the expression of structural domains that interact with protein partners. Glycosaminoglycans (GAGs) exhibit a high degree of polydispersity in their composition, chain length, sulfation, acetylation, and epimerization patterns. It is essential for the understanding of GAG biochemistry to produce detailed structural information as a function of spatial and temporal factors in biological systems. Toward this end, we developed a set of procedures to extract GAGs from various rat organ tissues and examined and compared HS expression levels using liquid chromatography/mass spectrometry. Here we demonstrate detailed variations in HS GAG chains as a function of organ location. These studies shed new light on the structural variation of GAG chains with respect to average length, disaccharide composition, and expression of low abundance structural epitopes, including unsubstituted amino groups and lyase-resistant oligosaccharides. The data show the presence of a disaccharide with an unsubstituted amino group that is endogenous and widely expressed in mammalian organ tissues.	[Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019; Shi, Xiaofeng/B-8700-2011	Zaia, Joseph/0000-0001-9497-8701; Abraham, Carmela/0000-0002-6649-1960; Wang, Cong-Yi/0000-0001-7914-168X	National Institutes of Health [P41RR10888, HL74197]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR10888 and HL74197.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Behr JR, 2005, RAPID COMMUN MASS SP, V19, P2553, DOI 10.1002/rcm.2079; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chai WG, 2004, BIOCHEMISTRY-US, V43, P8590, DOI 10.1021/bi036250k; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Conrad H. E., 1998, HEPARIN BINDING PROT; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hitchcock AM, 2007, GLYCOBIOLOGY, V17, P25, DOI 10.1093/glycob/cwl046; Hitchcock AM, 2008, PROTEOMICS, V8, P1384, DOI 10.1002/pmic.200700787; Hitchcock AM, 2008, ELECTROPHORESIS, V29, P4538, DOI 10.1002/elps.200800335; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; LINDAHL U, 1964, BIOCHEM BIOPH RES CO, V17, P254, DOI 10.1016/0006-291X(64)90393-6; LINDAHL U, 1965, J BIOL CHEM, V240, P2821; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Rees M, 2005, FREE RADICAL BIO MED, V39, pS129; Rees MD, 2006, J AM CHEM SOC, V128, P3085, DOI 10.1021/ja0577239; Rees MD, 2005, BIOCHEM J, V391, P125, DOI 10.1042/BJ20050630; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; SHIVELY JE, 1970, BIOCHEMISTRY-US, V9, P33, DOI 10.1021/bi00803a005; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; TOOLE BP, 2000, PROTEOGLYCANS STRUCT, P61; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Xu D, 2005, BIOCHEM J, V385, P451, DOI 10.1042/BJ20040908; Zaia J, 2001, ANAL CHEM, V73, P6030, DOI 10.1021/ac015577t; Zaia J, 2005, J BIOMACROMOL MASS S, V1, P3; Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016; Ziegler A, 2006, J CHROMATOGR B, V837, P76, DOI 10.1016/j.jchromb.2006.04.013	61	107	111	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11806	11814		10.1074/jbc.M809637200	http://dx.doi.org/10.1074/jbc.M809637200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244235	hybrid, Green Published			2022-12-25	WOS:000265494600012
J	Mnatsakanyan, N; Krishnakumar, AM; Suzuki, T; Weber, J				Mnatsakanyan, Nelli; Krishnakumar, Arathianand M.; Suzuki, Toshiharu; Weber, Joachim			The Role of the beta DELSEED-loop of ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F-1-ATPASE; BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; 3 CATALYTIC SITES; EPSILON-SUBUNIT; NUCLEOTIDE-BINDING; F1F0-ATP SYNTHASE; MUTANT STRAINS; F1-ATPASE; HYDROLYSIS	ATP synthase uses a unique rotational mechanism to convert chemical energy into mechanical energy and back into chemical energy. The helix-turn-helix motif, termed "DELSEED-loop," in the C-terminal domain of the beta subunit was suggested to be involved in coupling between catalysis and rotation. Here, the role of the DELSEED-loop was investigated by functional analysis of mutants of Bacillus PS3 ATP synthase that had 3-7 amino acids within the loop deleted. All mutants were able to catalyze ATP hydrolysis, some at rates several times higher than the wild-type enzyme. In most cases ATP hydrolysis in membrane vesicles generated a transmembrane proton gradient, indicating that hydrolysis occurred via the normal rotational mechanism. Except for two mutants that showed low activity and low abundance in the membrane preparations, the deletion mutants were able to catalyze ATP synthesis. In general, the mutants seemed less well coupled than the wild-type enzyme, to a varying degree. Arrhenius analysis demonstrated that in the mutants fewer bonds had to be rearranged during the rate-limiting catalytic step; the extent of this effect was dependent on the size of the deletion. The results support the idea of a significant involvement of the DELSEED-loop in mechanochemical coupling in ATP synthase. In addition, for two deletion mutants it was possible to prepare an alpha(3)beta(3)gamma subcomplex and measure nucleotide binding to the catalytic sites. Interestingly, both mutants showed a severely reduced affinity for MgATP at the high affinity site.	[Mnatsakanyan, Nelli; Krishnakumar, Arathianand M.; Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Suzuki, Toshiharu] Japan Sci & Technol Agcy, ATP Synth Regulat Project, ICORP, Tokyo 1350064, Japan	Texas Tech University System; Texas Tech University; Japan Science & Technology Agency (JST)	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttuhsc.edu			National Institutes of Health [GM071462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071462 (to J.W.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19640; Bandyopadhyay S, 2002, BIOCHEMISTRY-US, V41, P14421, DOI 10.1021/bi026243g; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dou C, 1998, BIOCHEMISTRY-US, V37, P16757, DOI 10.1021/bi981717q; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GOELZ SE, 1982, BIOCHEMISTRY-US, V21, P189, DOI 10.1021/bi00530a032; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Lowry DS, 2005, BIOCHEMISTRY-US, V44, P7275, DOI 10.1021/bi047293j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao HZ, 2008, J BIOL CHEM, V283, P24781, DOI 10.1074/jbc.M804142200; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitome N, 2002, EUR J BIOCHEM, V269, P53, DOI 10.1046/j.0014-2956.2002.02623.x; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Ono S, 2003, BBA-BIOENERGETICS, V1607, P35, DOI 10.1016/j.bbabio.2003.08.006; Oster G, 1999, STRUCTURE, V7, pR67, DOI 10.1016/S0969-2126(99)80046-X; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Sambrook J, 2001, MOL CLONING LAB MANU; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	52	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11336	11345		10.1074/jbc.M900374200	http://dx.doi.org/10.1074/jbc.M900374200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19246448	Green Published, hybrid			2022-12-25	WOS:000265494500038
J	Sharifmoghadam, MR; Valdivieso, MH				Sharifmoghadam, Mohammad Reza; Valdivieso, M. -Henar			The Fission Yeast SEL1 Domain Protein Cfh3p A NOVEL REGULATOR OF THE GLUCAN SYNTHASE Bgs1p WHOSE FUNCTION IS MORE RELEVANT UNDER STRESS CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,3-BETA-GLUCAN SYNTHASE SUBUNIT; CELL-WALL; ASCOSPORE WALL; DIVISION SITE; MAP KINASE; GENE; CHITIN; LOCALIZATION; HOMOLOG; INTEGRITY	In Schizosaccharomyces pombe, Bgs1/Cps1p is a beta(1,3)-glucan synthase required for linear beta(1,3)-glucan synthesis and primary septum formation. Here, we have studied the regulation of Bgs1p by Cfh3/Chr4p, a member of a family of conserved adaptor proteins, which resembles the chitin synthase regulator Chs4p from Saccharomyces cerevisiae and Candida albicans. cfh3 Delta cells showed a genetic interaction with cps1-191, and Cfh3p co-immunoprecipitated with Bgs1/Cps1p. In the absence of cfh3(+), cells were more sensitive to digestion by glucanases, and both Calcofluor staining and glucan synthesis were reduced. We found that in a wild-type strain, beta(1,3)-glucan synthesis was reduced under stress conditions. In the cfh3 Delta, cps1-191, and cfh3 Delta cps1-191 strains, beta(1,3)-glucan synthesis was further reduced, and growth was impaired under stress conditions, suggesting that Cfh3p and Bgs1p might play a role in ensuring growth in unfavorable environments. In a cfh3 Delta mutant, Bgs1p was delocalized when the cells were distressed, but a blockade in endocytosis prevented this delocalization. Finally, we found that the SEL1 repeats are required for Cfh3p function. These results show that Cfh3p is a regulatory protein for Bgs1p and that its function is particularly necessary when the cells are undergoing stress.	[Sharifmoghadam, Mohammad Reza; Valdivieso, M. -Henar] Univ Salamanca, CSIC, Dept Microbiol & Genet, Inst Microbiol Bioquim, Salamanca 37007, Spain; [Sharifmoghadam, Mohammad Reza] Zabol Univ, Fac Vet Med, Zabol 98615, Iran	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Valdivieso, MH (corresponding author), Edificio Dept,Campus Miguel Unamuno, Salamanca 37007, Spain.	henar@usal.es	Valdivieso, M.-Henar/B-5199-2017; Sharifmoghadam, Mohammad Reza/AAI-8210-2021	Valdivieso, M.-Henar/0000-0002-6857-7493; Sharifmoghadam, Mohammad Reza/0000-0002-3638-0653	CICYT [BFU2007-61866]; Junta de Castilla y Leon, Spain [SA104A/07, GR231]	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon)	This work was supported by Grant BFU2007-61866 from the CICYT and Grants SA104A/07 and GR231 from the Junta de Castilla y Leon, Spain.	An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Arellano M, 2000, MOL MICROBIOL, V35, P79, DOI 10.1046/j.1365-2958.2000.01678.x; Arellano M, 1999, J CELL SCI, V112, P3569; Arellano M, 1996, EMBO J, V15, P4584, DOI 10.1002/j.1460-2075.1996.tb00836.x; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bao SL, 2001, J BIOL CHEM, V276, P14549, DOI 10.1074/jbc.C100096200; Cartagena-Lirola H, 2006, YEAST, V23, P375, DOI 10.1002/yea.1361; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Coll PM, 2007, EMBO J, V26, P1865, DOI 10.1038/sj.emboj.7601641; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Grabinska KA, 2007, EUKARYOT CELL, V6, P328, DOI 10.1128/EC.00203-06; HORISBERGER M, 1985, EXPERIENTIA, V41, P748, DOI 10.1007/BF02012578; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Iwaki T, 2004, YEAST, V21, P867, DOI 10.1002/yea.1134; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kinnunen PKJ, 2000, CELL PHYSIOL BIOCHEM, V10, P243, DOI 10.1159/000016360; KREGER DR, 1954, BIOCHIM BIOPHYS ACTA, V13, P1, DOI 10.1016/0006-3002(54)90264-4; Le Goff X, 1999, MOL GEN GENET, V262, P163; Liu JH, 2000, FEBS LETT, V478, P105, DOI 10.1016/S0014-5793(00)01828-7; Liu JH, 2000, J CELL SCI, V113, P1223; Liu JH, 2002, MOL BIOL CELL, V13, P989, DOI 10.1091/mbc.01-12-0581; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Martin-Garcia R, 2003, FEBS LETT, V549, P176, DOI 10.1016/S0014-5793(03)00812-3; Martin-Garcia R, 2006, J CELL SCI, V119, P2768, DOI 10.1242/jcs.02998; Matsuo Y, 2004, YEAST, V21, P1005, DOI 10.1002/yea.1145; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mulvihill DP, 2006, CELL MOTIL CYTOSKEL, V63, P149, DOI 10.1002/cm.20113; Onishi J, 2000, ANTIMICROB AGENTS CH, V44, P368, DOI 10.1128/AAC.44.2.368-377.2000; Ono N, 2000, MICROBIOL-UK, V146, P385, DOI 10.1099/00221287-146-2-385; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; Pelaez F, 2000, SYST APPL MICROBIOL, V23, P333, DOI 10.1016/S0723-2020(00)80062-4; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Perez P, 2004, METHODS, V33, P245, DOI 10.1016/j.ymeth.2003.11.020; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SIETSMA JH, 1990, J GEN MICROBIOL, V136, P2261, DOI 10.1099/00221287-136-11-2261; Sudoh M, 1999, MICROBIOL-UK, V145, P1613, DOI 10.1099/13500872-145-7-1613; Toda T, 1996, MOL CELL BIOL, V16, P6752; Trilla JA, 1997, YEAST, V13, P795, DOI 10.1002/(SICI)1097-0061(199707)13:9<795::AID-YEA139>3.3.CO;2-C; Yang PR, 1999, J BIOL CHEM, V274, P36052, DOI 10.1074/jbc.274.51.36052; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	55	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11070	11079		10.1074/jbc.M808353200	http://dx.doi.org/10.1074/jbc.M808353200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19237545	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000265494500011
J	Knight, AS; Notaridou, M; Watson, RJ				Knight, A. S.; Notaridou, M.; Watson, R. J.			A Lin-9 complex is recruited by B-Myb to activate transcription of G(2)/M genes in undifferentiated embryonal carcinoma cells	ONCOGENE			English	Article						cell cycle; mitosis; transcription; B-Myb; Lin-9; LINC	MUVB/DREAM COMPLEX; REPRESSOR COMPLEX; DROSOPHILA MYB; EXPRESSION; PROTEINS; PHOSPHORYLATION; PROGRESSION; DISTINCT; KINASE; CANCER	It has recently been discovered that cell-cycle gene transcription is regulated by a core complex named LINC that switches from a transcriptionally repressive complex in G(0)-G(1) with the p130 or p107 pocket proteins and E2F4 to a transcriptionally active complex in S-G(2) containing B-Myb. We have studied the function of LINC in F9 embryonal carcinoma cells, which are distinguished by a rapid cell cycle resulting from an extremely short G(1) phase. We show that suppressing expression of the LINC component, Lin-9, in F9 cells causes arrest in mitosis, and we have used this system to screen for transcriptional targets. In these cells, B-Myb was found in complexes with Lin-9 and several other LINC constituents, however, the pocket proteins did not associate with LINC unless F9 cells were differentiated. Lin-9 and B-Myb were both required for transcription of G(2)/M genes such as Cyclin B1 and Survivin. Moreover, B-Myb was demonstrated to recruit Lin-9 to the Survivin promoter through multiple Myb-binding sites. The demonstration that a B-Myb/LINC complex is vital for progression through mitosis in cells lacking a G(1)/S checkpoint has implications for both undifferentiated embryonal cells and for cancers in which pocket protein function is compromised.	[Knight, A. S.; Notaridou, M.; Watson, R. J.] Univ London Imperial Coll Sci Technol & Med, Dept Virol, Fac Med, London W2 1PG, England	Imperial College London	Watson, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Virol, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	r.watson@imperial.ac.uk			Association for International Cancer Research [06-030]	Association for International Cancer Research	We thank Stephan Gaubatz and Alexander Brehm for the kind gifts of LINC antibodies and human Lin-9 cDNA, respectively. This work was supported by a project grant from the Association for International Cancer Research (06-030).	Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Sitzmann J, 1996, ONCOGENE, V12, P1889; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tavner F, 2007, ONCOGENE, V26, P2727, DOI 10.1038/sj.onc.1210087; Taylor-Harding B, 2004, MOL CELL BIOL, V24, P9124, DOI 10.1128/MCB.24.20.9124-9136.2004; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Yamauchi T, 2008, EMBO J, V27, P1852, DOI 10.1038/emboj.2008.118; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	26	76	77	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 16	2009	28	15					1737	1747		10.1038/onc.2009.22	http://dx.doi.org/10.1038/onc.2009.22			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19252525				2022-12-25	WOS:000265640400001
J	Lallet-Daher, H; Roudbaraki, M; Bavencoffe, A; Mariot, P; Gackiere, F; Bidaux, G; Urbain, R; Gosset, P; Delcourt, P; Fleurisse, L; Slomianny, C; Dewailly, E; Mauroy, B; Bonnal, JL; Skryma, R; Prevarskaya, N				Lallet-Daher, H.; Roudbaraki, M.; Bavencoffe, A.; Mariot, P.; Gackiere, F.; Bidaux, G.; Urbain, R.; Gosset, P.; Delcourt, P.; Fleurisse, L.; Slomianny, C.; Dewailly, E.; Mauroy, B.; Bonnal, J. L.; Skryma, R.; Prevarskaya, N.			Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry	ONCOGENE			English	Article						intermediate-conductance potassium channels; TRPV6; prostate cancer; proliferation; capacitative calcium entry; patch clamp	OPERATED CA2+ CURRENT; POTASSIUM CHANNELS; EPITHELIAL-CELLS; UP-REGULATION; EXPRESSION; GROWTH; CYCLE; INVOLVEMENT; PROGRESSION; ACTIVATION	Accumulating data point to K+ channels as relevant players in controlling cell cycle progression and proliferation of human cancer cells, including prostate cancer (PCa) cells. However, the mechanism(s) by which K+ channels control PCa cell proliferation remain illusive. In this study, using the techniques of molecular biology, biochemistry, electrophysiology and calcium imaging, we studied the expression and functionality of intermediate-conductance calcium-activated potassium channels (IKCa1) in human PCa as well as their involvement in cell proliferation. We showed that IKCa1 mRNA and protein were preferentially expressed in human PCa tissues, and inhibition of the IKCa1 potassium channel suppressed PCa cell proliferation. The activation of IKCa1 hyperpolarizes membrane potential and, by promoting the driving force for calcium, induces calcium entry through TRPV6, a cation channel of the TRP (Transient Receptor Potential) family. Thus, the overexpression of the IKCa1 channel is likely to promote carcinogenesis in human prostate tissue.	[Roudbaraki, M.] USTL, Lab Physiol Cellulaire, INSERM U800, Equipe Labellisee Ligue Natl Contre Canc, F-59655 Villeneuve Dascq, Nord, France; [Lallet-Daher, H.; Roudbaraki, M.; Bavencoffe, A.; Mariot, P.; Gackiere, F.; Bidaux, G.; Delcourt, P.; Slomianny, C.; Dewailly, E.; Skryma, R.; Prevarskaya, N.] Univ Sci & Technol Lille, Villeneuve Dascq, France; [Urbain, R.] Inst Rech Pierre Fabre, Paris, France; [Gosset, P.; Fleurisse, L.] Groupement Hosp Inst Catholique Lille, Lab Anat & Cytol Pathol, Fac Libre Med, Lille, France; [Mauroy, B.; Bonnal, J. L.] Hosp St Philibert, Serv Urol, Lomme Les Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite Catholique de Lille	Roudbaraki, M (corresponding author), USTL, Lab Physiol Cellulaire, INSERM U800, Equipe Labellisee Ligue Natl Contre Canc, Batiment SN3,2E Etage, F-59655 Villeneuve Dascq, Nord, France.	morad.roudbaraki@univ-lille1.fr; natacha.prevarskaya@univ-lille1.fr	Slomianny, Christian/L-8285-2018; Bonnal, Jean-Louis JLB/U-9025-2018; Bidaux, Gabriel/F-1294-2016	Prevarskaya, natacha/0000-0003-0316-197X; Morad, Roudbaraki/0000-0001-5751-3323; Bidaux, Gabriel/0000-0002-6162-3223; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Mariot, Pascal/0000-0001-7226-9162	INSERM; Ministere de l'Education Nationale de l'Enseignement Supe'rieur et de la Recherche; La Ligue Nationale Contre le Cancer; Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale de l'Enseignement Supe'rieur et de la Recherche; La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)	We thank Dr Y Shuba (Bogomoletz Institute of Physiology, Kiev, Ukraine) for helpful discussions. This study was supported by grants from INSERM, the Ministere de l'Education Nationale de l'Enseignement Supe'rieur et de la Recherche, La Ligue Nationale Contre le Cancer. H LalletDaher was supported by the Association pour la Recherche sur les Tumeurs de la Prostate (ARTP). We also thank Dr Mao Xiang Chen ( Laboratory of Gene Expression and Protein Biochemistry, GlaxoSmithKline R&D, UK) for the generous gift of the IK<INF>Ca1</INF> antibodies.	AYUB M, 1990, BIOCHEM PHARMACOL, V40, P1569, DOI 10.1016/0006-2952(90)90456-U; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Ducret T, 2002, GLIA, V38, P200, DOI 10.1002/glia.10056; Enomoto N, 1998, J HEPATOL, V28, P221, DOI 10.1016/0168-8278(88)80009-6; Gackiere F, 2006, CELL CALCIUM, V39, P357, DOI 10.1016/j.ceca.2005.12.003; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Ghiani CA, 1999, DEVELOPMENT, V126, P1077; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gupta S, 2003, J CLIN ONCOL, V21, P106, DOI 10.1200/JCO.2003.03.024; Gut A, 1998, J BIOL CHEM, V273, P29381, DOI 10.1074/jbc.273.45.29381; HAZELTON B, 1979, J CELL BIOL, V83, P487, DOI 10.1083/jcb.83.2.487; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; ISAACS JT, 1994, VITAM HORM, V49, P433; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Legrand G, 2001, J BIOL CHEM, V276, P47608, DOI 10.1074/jbc.M107011200; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lu XH, 1999, J GEN PHYSIOL, V113, P81, DOI 10.1085/jgp.113.1.81; MagnierGaubil C, 1996, J BIOL CHEM, V271, P27788, DOI 10.1074/jbc.271.44.27788; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; MAURICE M, 1992, FASEB J, V6, P752, DOI 10.1096/fasebj.6.2.1371482; NILIUS B, 1993, AM J PHYSIOL, V265, pC1501, DOI 10.1152/ajpcell.1993.265.6.C1501; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pardo LM, 2005, MUTAT RES-FUND MOL M, V592, P89, DOI 10.1016/j.mrfmmm.2005.06.006; Parihar AS, 2003, EUR J PHARMACOL, V471, P157, DOI 10.1016/S0014-2999(03)01825-9; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Pena TL, 2000, J BIOL CHEM, V275, P13677, DOI 10.1074/jbc.275.18.13677; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; RODRIGUES AD, 1987, BIOCHEM PHARMACOL, V36, P4277, DOI 10.1016/0006-2952(87)90670-8; Roudbaraki M, 1999, ENDOCRINOLOGY, V140, P4874, DOI 10.1210/en.140.10.4874; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Skryma R, 1999, RECEPTOR CHANNEL, V6, P241; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; Skryma RN, 1997, PROSTATE, V33, P112, DOI 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thebault S, 2003, J CLIN INVEST, V111, P1691, DOI 10.1172/JCI200316293; TOMITA M, 1987, ENDOCRINOL JAPON, V34, P313; TUPPER JT, 1980, J CELL PHYSIOL, V104, P97, DOI 10.1002/jcp.1041040113; Turowski P, 2004, INVEST OPHTH VIS SCI, V45, P2786, DOI 10.1167/iovs.03-0943; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; Vanden Abeele F, 2003, J BIOL CHEM, V278, P15381, DOI 10.1074/jbc.M212106200; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Vanoverberghe K, 2003, CELL CALCIUM, V34, P75, DOI 10.1016/S0143-4160(03)00024-1; von Hahn T, 2001, CELL PHYSIOL BIOCHEM, V11, P219, DOI 10.1159/000051936; Wang SY, 1998, J CELL PHYSIOL, V176, P456, DOI 10.1002/(SICI)1097-4652(199809)176:3<456::AID-JCP2>3.0.CO;2-N; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; WOOLF SH, 1995, NEW ENGL J MED, V333, P1401, DOI 10.1056/NEJM199511233332107; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776	61	111	120	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1792	1806		10.1038/onc.2009.25	http://dx.doi.org/10.1038/onc.2009.25			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19270724	Green Published			2022-12-25	WOS:000265640400006
J	Schwindt, TT; Motta, FL; Barnabe, GF; Massant, CG; Guimaraes, AD; Calcagnotto, ME; Conceicao, FS; Pesquero, JB; Rehen, S; Mello, LE				Schwindt, Telma Tiemi; Motta, Fabiana Louise; Barnabe, Gabriela Filoso; Massant, Cristina Goncalves; Guimaraes, Alessander de Oliveira; Calcagnotto, Maria Elisa; Conceicao, Fabio Silva; Pesquero, Joao Bosco; Rehen, Stevens; Mello, Luiz E.			Short-Term Withdrawal of Mitogens Prior to Plating Increases Neuronal Differentiation of Human Neural Precursor Cells	PLOS ONE			English	Article								Background: Human neural precursor cells (hNPC) are candidates for neural transplantation in a wide range of neurological disorders. Recently, much work has been done to determine how the environment for NPC culture in vitro may alter their plasticity. Epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF-2) are used to expand NPC; however, it is not clear if continuous exposure to mitogens may abrogate their subsequent differentiation. Here we evaluated if short-term removal of FGF-2 and EGF prior to plating may improve hNPC differentiation into neurons. Principal Findings: We demonstrate that culture of neurospheres in suspension for 2 weeks without EGF-FGF-2 significantly increases neuronal differentiation and neurite extension when compared to cells cultured using standard protocols. In this condition, neurons were preferentially located in the core of the neurospheres instead of the shell. Moreover, after plating, neurons presented radial rather than randomly oriented and longer processes than controls, comprised mostly by neurons with short processes. These changes were followed by alterations in the expression of genes related to cell survival. Conclusions: These results show that EGF and FGF-2 removal affects NPC fate and plasticity. Taking into account that a three dimensional structure is essential for NPC differentiation, here we evaluated, for the first time, the effects of growth factors removal in whole neurospheres rather than in plated cell culture.	[Schwindt, Telma Tiemi; Motta, Fabiana Louise; Barnabe, Gabriela Filoso; Massant, Cristina Goncalves; Calcagnotto, Maria Elisa; Mello, Luiz E.] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Guimaraes, Alessander de Oliveira; Pesquero, Joao Bosco] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Conceicao, Fabio Silva; Rehen, Stevens] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Schwindt, TT (corresponding author), Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil.	lemello@unifesp.br	CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; Mello, Luiz E/B-4177-2009; calcagnotto, maria elisa/B-1645-2013; Pesquero, Joao/C-1470-2012; Barnabe, Gabriela/E-9033-2013; Rehen, Stevens/J-5874-2012	CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; Mello, Luiz E/0000-0002-6969-1108; calcagnotto, maria elisa/0000-0001-8196-0596; Pesquero, Joao/0000-0002-4507-632X; Barnabe, Gabriela/0000-0001-8790-4480; Rehen, Stevens/0000-0003-4216-9501; Motta, Fabiana/0000-0003-2230-995X	FAPESP (Brazil) [fellow]; CNPq [fellow]; Institutos do Milenio de Bioengenharia Tecidual	FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institutos do Milenio de Bioengenharia Tecidual	TT Schwindt, GF Barnabe and ME Calcagnotto are FAPESP (Brazil) fellows; AO Guimaraes is CNPq fellow; Supported by grants from Institutos do Milenio de Bioengenharia Tecidual and CNPq (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Ciccolini F, 1998, J NEUROSCI, V18, P7869; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Einstein O, 2006, GLIA, V53, P449, DOI 10.1002/glia.20305; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Jacobson M., 1991, DEV NEUROBIOLOGY; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kuhn HG, 1999, BIOESSAYS, V21, P625, DOI 10.1002/(SICI)1521-1878(199908)21:8<625::AID-BIES1>3.0.CO;2-6; Kuhn HG, 1996, J NEUROSCI, V16, P2027; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; PAHLMAN S, 1991, P NATL ACAD SCI USA, V88, P9994, DOI 10.1073/pnas.88.22.9994; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; SMITS A, 1993, EUR J NEUROSCI, V5, P986, DOI 10.1111/j.1460-9568.1993.tb00950.x; Svendsen C N, 2000, Prog Brain Res, V127, P13; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; Topalli I, 2004, BRAIN RES, V1030, P116, DOI 10.1016/j.brainres.2004.09.057; Vaccarino FM, 2001, NEUROPSYCHOPHARMACOL, V25, P805, DOI 10.1016/S0893-133X(01)00349-9; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012	26	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4642	10.1371/journal.pone.0004642	http://dx.doi.org/10.1371/journal.pone.0004642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247499	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487800022
J	Al-Zeer, MA; Al-Younes, HM; Braun, PR; Zerrahn, J; Meyer, TF				Al-Zeer, Munir A.; Al-Younes, Hesham M.; Braun, Peter R.; Zerrahn, Jens; Meyer, Thomas F.			IFN-gamma-Inducible Irga6 Mediates Host Resistance against Chlamydia trachomatis via Autophagy	PLOS ONE			English	Article								Chlamydial infection of the host cell induces Gamma interferon (IFN gamma), a central immunoprotector for humans and mice. The primary defense against Chlamydia infection in the mouse involves the IFN gamma-inducible family of IRG proteins; however, the precise mechanisms mediating the pathogen's elimination are unknown. In this study, we identify Irga6 as an important resistance factor against C. trachomatis, but not C. muridarum, infection in IFN gamma-stimulated mouse embryonic fibroblasts (MEFs). We show that Irga6, Irgd, Irgm2 and Irgm3 accumulate at bacterial inclusions in MEFs upon stimulation with IFN gamma, whereas Irgb6 colocalized in the presence or absence of the cytokine. This accumulation triggers a rerouting of bacterial inclusions to autophagosomes that subsequently fuse to lysosomes for elimination. Autophagy-deficient Atg5-/- MEFs and lysosomal acidification impaired cells surrender to infection. Irgm2, Irgm3 and Irgd still localize to inclusions in IFN gamma-induced Atg5-/- cells, but Irga6 localization is disrupted indicating its pivotal role in pathogen resistance. Irga6-deficient (Irga6-/-) MEFs, in which chlamydial growth is enhanced, do not respond to IFN gamma even though Irgb6, Irgd, Irgm2 and Irgm3 still localize to inclusions. Taken together, we identify Irga6 as a necessary factor in conferring host resistance by remodelling a classically nonfusogenic intracellular pathogen to stimulate fusion with autophagosomes, thereby rerouting the intruder to the lysosomal compartment for destruction.	[Al-Zeer, Munir A.; Braun, Peter R.; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Zerrahn, Jens] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Al-Younes, Hesham M.] Univ Jordan, Fac Sci, Dept Biol Sci, Amman, Jordan	Max Planck Society; Max Planck Society; University of Jordan	Al-Zeer, MA (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.	tfm@mpiib-berlin.mpg.de	Al-Younes, Hesham M./C-2808-2015; Meyer, Thomas F. F/J-2485-2013	Al-Younes, Hesham M./0000-0002-8210-9514; Meyer, Thomas F. F/0000-0002-6120-8679	Fonds der Chemischen Industrie; German Academic Exchange Service (DAAD) [doctoral fellowship]; Deutsche Forschungsgemeinschaft (DFG)	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part through the Fonds der Chemischen Industrie to T.F.M., by a doctoral fellowship grant of the German Academic Exchange Service (DAAD) to M.A.Z. and a visiting scientist grant of the Deutsche Forschungsgemeinschaft (DFG) to H.A.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Igietseme JU, 1998, MICROBIOL IMMUNOL, V42, P617, DOI 10.1111/j.1348-0421.1998.tb02332.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Perry LL, 1999, J IMMUNOL, V162, P3541; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; WYRICK PB, 1978, INFECT IMMUN, V19, P1054, DOI 10.1128/IAI.19.3.1054-1060.1978; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	48	92	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4588	10.1371/journal.pone.0004588	http://dx.doi.org/10.1371/journal.pone.0004588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242543	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487500005
J	Goodin, DS				Goodin, Douglas S.			The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; VITAMIN-D; TWIN CONCORDANCE; ANTIBODY-TITERS; INFECTIOUS-MONONUCLEOSIS; RECURRENCE RISKS; NUCLEAR ANTIGEN; GENETIC-BASIS; PREVALENCE; EXPOSURE	Background: MS pathogenesis seems to involve both genetic susceptibility and environmental risk factors. Three sequential factors are implicated in the environmental risk. The first acts near birth, the second acts during childhood, and the third acts long thereafter. Two candidate factors (vitamin D deficiency and Epstein-Barr viral infection) seem well suited to the first two environmental events. Methodology/Principal Findings: A mathematical Model for MS pathogenesis is developed, incorporating these environmental and genetic factors into a causal scheme that can explain some of the recent changes in MS-epidemiology (e. g., increasing disease prevalence, a changing sex-ratio, and regional variations in monozygotic twin concordance rates). Conclusions/Significance: This Model suggests that genetic susceptibility is overwhelmingly the most important determinant of MS pathogenesis. Indeed, over 99% of individuals seem genetically incapable of developing MS, regardless of what environmental exposures they experience. Nevertheless, the contribution of specific genes to MS-susceptibility seems only modest. Thus, despite HLA DRB1*1501 being the most consistently identified genetic marker of MS-susceptibility (being present in over 50% of northern MS patient populations), only about 1% of individuals with this allele are even genetically susceptible to getting MS. Moreover, because genetic susceptibility seems so similar throughout North America and Europe, environmental differences principally determine the regional variations in disease characteristics. Additionally, despite 75% of MS-patients being women, men are 60% more likely to be genetically-susceptible than women. Also, men develop MS at lower levels of environmental exposure than women. Nevertheless, women are more responsive to the recent changes in environmental-exposure (whatever these have been). This explains both the changing sex-ratio and the increasing disease prevalence (which has increased by a minimum of 32% in Canada over the past 35 years). As noted, environmental risk seems to result from three sequential components of environmental exposure. The potential importance of this Model for MS pathogenesis is that, if correct, a therapeutic strategy, designed to interrupt one or more of these sequential factors, has the potential to markedly reduce or eliminate disease prevalence in the future.	[Goodin, Douglas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu						ADAMS C, 1989, COLOUR ATLAS MULTIPL; ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; ALTER M, 1978, NEUROLOGY, V28, P1089, DOI 10.1212/WNL.28.11.1089; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bager P, 2006, AM J EPIDEMIOL, V163, P1112, DOI 10.1093/aje/kwj148; Barnett MH, 2003, J NEUROL SCI, V213, P1, DOI 10.1016/S0022-510X(03)00122-9; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x; Celius EG, 2001, EUR J NEUROL, V8, P463, DOI 10.1046/j.1468-1331.2001.00269.x; Chaudhuri A, 2005, MED HYPOTHESES, V64, P608, DOI 10.1016/j.mehy.2004.06.022; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2006, MCALPINES MULTIPLE S, V4th; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Ebers G, 2008, ANN NEUROL, V64, pS66; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Emmons KM, 1999, J NATL CANCER I, V91, P1269, DOI 10.1093/jnci/91.15.1269; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Farrell PJ, 2007, J CLIN INVEST, V117, P2756, DOI 10.1172/JCI33563; Fisher L, 1993, BIOSTATISTICS METHOD; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Gillie O, 2006, BRIT J DERMATOL, V154, P1052, DOI 10.1111/j.1365-2133.2006.07261.x; Goldacre MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1032, DOI 10.1136/jech.2003.018366; GOODIN D, 2008, MULTIPLE SCLEROSI S1, V14; GOODIN DS, ESTABLISHING L UNPUB; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Gronlie SA, 2000, J NEUROL, V247, P129, DOI 10.1007/PL00007793; Haahr S, 2004, ACTA NEUROL SCAND, V109, P270, DOI 10.1046/j.1600-0404.2003.00221.x; Hansen T, 2005, MULT SCLER J, V11, P504, DOI 10.1191/1352458505ms1220oa; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Herrera BM, 2007, NEUROLOGY, V69, P1208, DOI 10.1212/01.wnl.0000268486.40851.d6; Holick MF, 1998, OSTEOPOROSIS INT, V8, pS24, DOI 10.1007/PL00022729; Islam T, 2006, ANN NEUROL, V60, P56, DOI 10.1002/ana.20871; Jablonski NG, 2002, SCI AM, V287, P74, DOI 10.1038/scientificamerican1002-74; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; KAHANA E, 1994, J NEUROL, V241, P341, DOI 10.1007/BF00868444; Kantarci OH, 2006, NEUROLOGY, V67, P305, DOI 10.1212/01.wnl.0000225070.13682.11; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; Koch-Henriksen N, 1999, MULT SCLER, V5, P293, DOI 10.1191/135245899678846258; KOCHHENRIKSEN N, 1995, ACTA NEUROL SCAND, V91, P55, DOI 10.1111/j.1600-0404.1995.tb05858.x; Kuusisto H, 2008, EUR J NEUROL, V15, P1106, DOI 10.1111/j.1468-1331.2008.02262.x; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; McGuigan C, 2005, J NEUROL, V252, P1245, DOI 10.1007/s00415-005-0850-8; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; MURRY TJ, 2000, MULTIPLE SCLEROSIS D; Myhr KM, 1998, J NEUROL NEUROSUR PS, V64, P539, DOI 10.1136/jnnp.64.4.539; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nielsen NM, 2005, AM J EPIDEMIOL, V162, P774, DOI 10.1093/aje/kwi280; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; Ranzato F, 2003, MULT SCLER J, V9, P387, DOI 10.1191/1352458503ms920oa; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sadovnick AD, 2007, NEUROLOGY, V69, P60, DOI 10.1212/01.wnl.0000265053.22905.64; Sadovnick AD, 2005, LANCET NEUROL, V4, P611, DOI 10.1016/S1474-4422(05)70170-8; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sarasoja T, 2004, ACTA NEUROL SCAND, V110, P331, DOI 10.1111/j.1600-0404.2004.00326.x; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; SHIRODARIA PV, 1987, ARCH NEUROL-CHICAGO, V44, P1237, DOI 10.1001/archneur.1987.00520240019006; SINCLAIR H, 1977, BRIT MED J, V2, P1217, DOI 10.1136/bmj.2.6096.1217; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Suarez F, 1998, J CLIN ENDOCR METAB, V83, P3563, DOI 10.1210/jcem.83.10.5199; SUMAYA CV, 1980, ARCH NEUROL-CHICAGO, V37, P94, DOI 10.1001/archneur.1980.00500510052009; SUMAYA CV, 1985, ANN NEUROL, V17, P371, DOI 10.1002/ana.410170412; Sundstrom P, 2003, J NEUROL NEUROSUR PS, V74, P29, DOI 10.1136/jnnp.74.1.29; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; VAUGHAN JH, 1995, SPRINGER SEMIN IMMUN, V17, P203; Wagner HJ, 2000, VIRAL IMMUNOL, V13, P497, DOI 10.1089/vim.2000.13.497; Wechsler IS, 1922, ARCH NEURO PSYCHIATR, V8, P59, DOI 10.1001/archneurpsyc.1922.02190130062009; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8	102	105	106	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4565	10.1371/journal.pone.0004565	http://dx.doi.org/10.1371/journal.pone.0004565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242548	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500003
J	Du, F; Qian, ZM; Zhu, L; Wu, XM; Yung, WH; Tsim, TY; Ke, Y				Du, Fang; Qian, Zhong-ming; Zhu, Li; Wu, Xiao Mei; Yung, Wing-ho; Tsim, Ting-yuk; Ke, Ya			L-DOPA Neurotoxicity Is Mediated by Up-Regulation of DMT1-IRE Expression	PLOS ONE			English	Article							DIVALENT METAL TRANSPORTER-1; INDUCED DYSKINESIA; TRANSFERRIN-FREE; REACTIVE OXYGEN; PLASMA-MEMBRANE; IRON UPTAKE; NEURONS; ASTROCYTES; ISOFORMS; BRAIN	Background: The mechanisms underlying neurotoxicity caused by L-DOPA are not yet completely known. Based on recent findings, we speculated that the increased expression of divalent metal transporter 1 without iron-response element (DMT1-IRE) induced by L-DOPA might play a critical role in the development of L-DOPA neurotoxicity. To test this hypothesis, we investigated the effects of astrocyte-conditioned medium (ACM) and siRNA DMT-IRE on L-DOPA neurotoxicity in cortical neurons. Methods and Findings: We demonstrated that neurons treated with L-DOPA have a significant dose-dependent decrease in neuronal viability (MTT Assay) and increase in iron content (using a graphite furnace atomic absorption spectrophotometer), DMT1-IRE expression (Western blot analysis) and ferrous iron (55Fe(II)) uptake. Neurons incubated in ACM with or without L-DOPA had no significant differences in their morphology, Hoechst-33342 staining or viability. Also, ACM significantly inhibited the effects of L-DOPA on neuronal iron content as well as DMT1-IRE expression. In addition, we demonstrated that infection of neurons with siRNA DMT-IRE led to a significant decrease in DMT1-IRE expression as well as L-DOPA neurotoxicity. Conclusion:The up-regulation of DMT1-IRE and the increase in DMT1-IRE-mediated iron influx play a key role in L-DOPA neurotoxicity in cortical neurons.	[Du, Fang; Wu, Xiao Mei; Yung, Wing-ho; Tsim, Ting-yuk; Ke, Ya] Chinese Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Qian, Zhong-ming; Zhu, Li] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Qian, Zhong-ming; Zhu, Li] Nantong Univ, Dept Neurobiol, Nantong, Peoples R China; [Qian, Zhong-ming; Zhu, Li] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China	Chinese University of Hong Kong; Hong Kong Polytechnic University; Nantong University; Nantong University	Du, F (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	bczmqian@polyu.edu.hk; yake@cuhk.edu.hk	Yung, Ho/R-6161-2018; Ke, Ya/B-3115-2010; Qian, Zhong Ming/E-8884-2016	Yung, Ho/0000-0002-5542-8173; Ke, Ya/0000-0001-8166-6653; 	HKRGC [CUHK466907-KY]; Chinese University of Hong Kong [4450226-KY, 4450273-KY]; RGC-NSFC; Hong Kong Polytechnic University [GU-384, G-YG11]; NKLCMMP; SZ-HK Innovation Circle	HKRGC(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); RGC-NSFC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Hong Kong Polytechnic University(Hong Kong Polytechnic University); NKLCMMP; SZ-HK Innovation Circle	The studies were supported by the Competitive Earmarked Grants of HKRGC (CUHK466907-KY), Direct Grant of Chinese University of Hong Kong (A/C: 4450226-KY and 4450273-KY), RGC-NSFC Grant (KY), research grants from The Hong Kong Polytechnic University (Niche Area-I-BBBL, GU-384 and G-YG11) and NKLCMMP (Shenzhen), and SZ-HK Innovation Circle Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare that we have no financial interests.	Boll MC, 1999, NEUROSCI LETT, V265, P155, DOI 10.1016/S0304-3940(99)00221-9; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Cenci MA, 2007, TRENDS NEUROSCI, V30, P236, DOI 10.1016/j.tins.2007.03.005; Chang YZ, 2006, MOL PHARMACOL, V69, P968, DOI 10.1124/mol.105.017756; Chang YZ, 2005, J CELL PHYSIOL, V204, P623, DOI 10.1002/jcp.20321; DEXTER DT, 1990, J NEUROCHEM, V55, P16, DOI 10.1111/j.1471-4159.1990.tb08814.x; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; FOLEY P, 2008, J NEUROL TRANSM S, V60, P1; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Ho KP, 2003, MOL CELL BIOCHEM, V247, P219, DOI 10.1023/A:1024142004575; Jankovic J, 2007, CNS DRUGS, V21, P677, DOI 10.2165/00023210-200721080-00005; Ke Y, 2005, NEUROBIOL AGING, V26, P739, DOI 10.1016/j.neurobiolaging.2004.06.002; LeWitt PA, 2004, NEUROLOGY, V62, pS9, DOI 10.1212/WNL.62.1_suppl_1.S9; Li Z, 2008, J CELL BIOCHEM, V103, P564, DOI 10.1002/jcb.21427; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Mena MA, 1996, NEUROREPORT, V7, P441, DOI 10.1097/00001756-199601310-00016; Olanow W, 2006, NAT CLIN PRACT NEURO, V2, P382, DOI 10.1038/ncpneuro0222; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Qian ZM, 1999, EXP BRAIN RES, V129, P473, DOI 10.1007/s002210050916; Qian ZM, 2000, CELL MOL BIOL, V46, P541; QIAN ZM, 1992, BIOCHIM BIOPHYS ACTA, V1135, P35, DOI 10.1016/0167-4889(92)90163-6; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Wei H, 2008, INT J BIOCHEM CELL B, V40, P651, DOI 10.1016/j.biocel.2007.10.013; Zesiewicz TA, 2007, CURR NEUROL NEUROSCI, V7, P302, DOI 10.1007/s11910-007-0046-y; Zhu L, 2008, J CELL MOL MED, V12, P569, DOI 10.1111/j.1582-4934.2007.00145.x	32	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4593	10.1371/journal.pone.0004593	http://dx.doi.org/10.1371/journal.pone.0004593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240805	Green Published, gold			2022-12-25	WOS:000278086700010
J	Seberg, O; Petersen, G				Seberg, Ole; Petersen, Gitte			How Many Loci Does it Take to DNA Barcode a Crocus?	PLOS ONE			English	Article							LAND PLANTS; PLASTID GENOME; IDENTIFICATION; IDENTIFY; PROGRESS; GENUS; RBCL	Background: DNA barcoding promises to revolutionize the way taxonomists work, facilitating species identification by using small, standardized portions of the genome as substitutes for morphology. The concept has gained considerable momentum in many animal groups, but the higher plant world has been largely recalcitrant to the effort. In plants, efforts are concentrated on various regions of the plastid genome, but no agreement exists as to what kinds of regions are ideal, though most researchers agree that more than one region is necessary. One reason for this discrepancy is differences in the tests that are used to evaluate the performance of the proposed regions. Most tests have been made in a floristic setting, where the genetic distance and therefore the level of variation of the regions between taxa is large, or in a limited set of congeneric species. Methodology and Principal Findings:Here we present the first in-depth coverage of a large taxonomic group, all 86 known species (except two doubtful ones) of crocus. Even six average-sized barcode regions do not identify all crocus species. This is currently an unrealistic burden in a barcode context. Whereas most proposed regions work well in a floristic context, the majority will as is the case in crocus undoubtedly be less efficient in a taxonomic setting. However, a reasonable but less than perfect level of identification may be reached even in a taxonomic context. Conclusions/Significance: The time is ripe for selecting barcode regions in plants, and for prudent examination of their utility. Thus, there is no reason for the plant community to hold back the barcoding effort by continued search for the Holy Grail. We must acknowledge that an emerging system will be far from perfect, fraught with problems and work best in a floristic setting.	[Seberg, Ole; Petersen, Gitte] Nat Hist Museum Denmark, Lab Mol Systemat, Copenhagen, Denmark		Seberg, O (corresponding author), Nat Hist Museum Denmark, Lab Mol Systemat, Copenhagen, Denmark.	oles@snm.ku.dk	Petersen, Gitte/H-1903-2011; 赵, 鹏/B-8401-2009; Seberg, Ole/A-5111-2013	Petersen, Gitte/0000-0002-2325-0059; Seberg, Ole/0000-0001-9675-4090	Danish Natural Sciences Research Council [272-06-0436]; Sloan Foundation; Gordon and Betty Moore Foundation	Danish Natural Sciences Research Council(Danish Natural Science Research Council); Sloan Foundation(Alfred P. Sloan Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by the Danish Natural Sciences Research Council (272-06-0436), the Sloan Foundation, and Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAXTER MI, 2001, PHILO T R SOC LOND B, V359, P669; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GOLOBOFF PA, 1999, NONA NO NAMEA VERSIO; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Helfenbein KG, 2005, MOL PHYLOGENET EVOL, V35, P271, DOI 10.1016/j.ympev.2005.01.003; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Kane NC, 2008, MOL ECOL, V17, P5175, DOI 10.1111/j.1365-294X.2008.03972.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kress WJ, 2005, AM J BOT, V92, P167, DOI 10.3732/ajb.92.1.167; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; MADDISON WP, 2000, MACCLADE VERSION 1 0; Mathew B., 1982, CROCUS; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; NIXON KC, 2002, WINGLADA VERSION 1 0; OLUSTEAD RG, 1994, SYST BIOL, V43, P467; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Petersen G, 2008, TAXON, V57, P487, DOI 10.2307/25066017; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Rubinoff Daniel, 2006, Trends Ecol Evol, V21, P1, DOI 10.1016/j.tree.2005.10.019; Sang T, 1997, MOL BIOL EVOL, V14, P994, DOI 10.1093/oxfordjournals.molbev.a025716; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; SWOFFORD DL, 2001, PAUT PHYLOGENETIC AN; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tate JA, 2003, SYST BOT, V28, P723; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280	39	116	140	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4598	10.1371/journal.pone.0004598	http://dx.doi.org/10.1371/journal.pone.0004598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240801	Green Published, Green Submitted, gold			2022-12-25	WOS:000278086700012
J	Fargallo, JA; Martinez-Padilla, J; Vinuela, J; Blanco, G; Torre, I; Vergara, P; De Neve, L				Fargallo, Juan A.; Martinez-Padilla, Jesus; Vinuela, Javier; Blanco, Guillermo; Torre, Ignasi; Vergara, Pablo; De Neve, Liesbeth			Kestrel-Prey Dynamic in a Mediterranean Region: The Effect of Generalist Predation and Climatic Factors	PLOS ONE			English	Article							SMALL-RODENT DYNAMICS; POPULATION-CYCLES; SMALL MAMMALS; DENSITY-DEPENDENCE; FUNCTIONAL-RESPONSES; SEMIARID CHILE; LACERTA-LEPIDA; VOLE; SPECIALIST; ABUNDANCE	Background: Most hypotheses on population limitation of small mammals and their predators come from studies carried out in northern latitudes, mainly in boreal ecosystems. In such regions, many predators specialize on voles and predator-prey systems are simpler compared to southern ecosystems where predator communities are made up mostly of generalists and predator-prey systems are more complex. Determining food limitation in generalist predators is difficult due to their capacity to switch to alternative prey when the basic prey becomes scarce. Methodology: We monitored the population density of a generalist raptor, the Eurasian kestrel Falco tinnunculus over 15 years in a mountainous Mediterranean area. In addition, we have recorded over 11 years the inter-annual variation in the abundance of two main prey species of kestrels, the common vole Microtus arvalis and the eyed lizard Lacerta lepida and a third species scarcely represented in kestrel diet, the great white-toothed shrew Crocidura russula. We estimated the per capita growth rate (PCGR) to analyse population dynamics of kestrel and predator species. Principal Findings: Multimodel inference determined that the PCGR of kestrels was better explained by a model containing the population density of only one prey species (the common vole) than a model using a combination of the densities of the three prey species. The PCGR of voles was explained by kestrel abundance in combination with annual rainfall and mean annual temperature. In the case of shrews, growth rate was also affected by kestrel abundance and temperature. Finally, we did not find any correlation between kestrel and lizard abundances. Significance: Our study showed for the first time vertebrate predator-prey relationships at southern latitudes and determined that only one prey species has the capacity to modulate population dynamics of generalist predators and reveals the importance of climatic factors in the dynamics of micromammal species and lizards in the Mediterranean region.	[Fargallo, Juan A.; Blanco, Guillermo; Vergara, Pablo] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolutiva, E-28006 Madrid, Spain; [Martinez-Padilla, Jesus] Univ Aberdeen, ACES, Aberdeen, Scotland; [Martinez-Padilla, Jesus] Macaulay Inst, Sch Biol Sci, Aberdeen, Scotland; [Vinuela, Javier] UCLM, CSIC, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Torre, Ignasi] Museu Granollers Ciencias Nat, Barcelona, Spain; [De Neve, Liesbeth] Univ Granada, Fac Ciencias, Dept Biol Anim & Ecol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Aberdeen; James Hutton Institute; University of Aberdeen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Granada	Fargallo, JA (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolutiva, E-28006 Madrid, Spain.	fargallo@mncn.csic.es	Blanco, Guillermo/L-3170-2014; De Neve, Liesbeth/F-7896-2011; Martinez-Padilla, Jesus/C-6446-2008; Fargallo, Juan A/I-5585-2015; Vergara, Pablo/G-1860-2010	Blanco, Guillermo/0000-0001-5742-4929; De Neve, Liesbeth/0000-0003-0041-9824; Martinez-Padilla, Jesus/0000-0003-2956-5163; Fargallo, Juan A/0000-0003-4090-9000; Vinuela, Javier/0000-0002-8916-0398	Spanish Ministerio de Educacion Ciencia [CGL2004-04479/BOS, CGL2007-61395/BOS]	Spanish Ministerio de Educacion Ciencia(German Research Foundation (DFG))	The Spanish Ministerio de Educacion Ciencia (Projects: CGL2004-04479/BOS and CGL2007-61395/BOS) financed the study over the last four years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio JM, 2000, ORNIS FENNICA, V77, P169; Berryman A., 1999, PRINCIPLES POPULATIO; Berryman AA, 2001, BASIC APPL ECOL, V2, P311, DOI 10.1078/1439-1791-00069; BERRYMAN AA, 1995, ECOLOGY, V76, P336, DOI 10.2307/1941193; BERRYMAN AA, 1992, ECOLOGY, V73, P694, DOI 10.2307/1940776; Berryman A, 2006, AM NAT, V168, P784, DOI 10.1086/508670; Burnham K. P., 1998, MODEL SELECTION INFE; Costantini D, 2005, BEHAVIOUR, V142, P1403, DOI 10.1163/156853905774539409; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Diaz JA, 2006, J ZOOL, V268, P295, DOI 10.1111/j.1469-7998.2005.00031.x; DIAZ M, 1992, ECOGRAPHY, V15, P77, DOI 10.1111/j.1600-0587.1992.tb00011.x; Dickman CR, 1999, OECOLOGIA, V119, P357, DOI 10.1007/s004420050796; Eccard JA, 2000, J ARID ENVIRON, V46, P103, DOI 10.1006/jare.2000.0659; ERLINGE S, 1983, OIKOS, V40, P36, DOI 10.2307/3544197; Fargallo JA, 2001, BIRD STUDY, V48, P236, DOI 10.1080/00063650109461223; FARGALLO JA, 1999, EFECTO CERNICALO VUL; FUENTES ER, 1985, J ARID ENVIRON, V8, P67, DOI 10.1016/S0140-1963(18)31338-7; Graham IM, 2002, J ANIM ECOL, V71, P946, DOI 10.1046/j.1365-2656.2002.00657.x; GUTIERREZ JR, 1993, ACTA OECOL, V14, P271; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Jedrzejewski W, 1996, J ANIM ECOL, V65, P105, DOI 10.2307/5704; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; KACPERSKA A, 1999, COLD ADAPTED ORGANIS, P79; Klemola T, 2002, OIKOS, V99, P83, DOI 10.1034/j.1600-0706.2002.990109.x; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; Korpimaki E, 2005, J ANIM ECOL, V74, P1150, DOI 10.1111/j.1365-2656.2005.01015.x; Korpimaki E, 2004, BIOSCIENCE, V54, P1071, DOI 10.1641/0006-3568(2004)054[1071:TPOPCA]2.0.CO;2; KORPIMAKI E, 1985, Ornis Fennica, V62, P130; Korpimaki E, 2003, TRENDS ECOL EVOL, V18, P494, DOI 10.1016/S0169-5347(03)00159-9; KORPIMAKI E, 1991, OIKOS, V62, P195, DOI 10.2307/3545265; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Krebs C. J., 1974, ADV ECOL RES, V8, P268; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Lima M, 2001, J ANIM ECOL, V70, P761, DOI 10.1046/j.0021-8790.2001.00536.x; Lima M, 2006, CLIM RES, V30, P125, DOI 10.3354/cr030125; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lima M, 2006, OIKOS, V112, P555, DOI 10.1111/j.0030-1299.2006.14439.x; MACKINROGALSKA R, 1990, OIKOS, V59, P343, DOI 10.2307/3545144; MESERVE PL, 1995, J MAMMAL, V76, P580, DOI 10.2307/1382367; Meserve PL, 2001, OIKOS, V94, P548, DOI 10.1034/j.1600-0706.2001.940316.x; Morris DW, 1996, ECOLOGY, V77, P2352, DOI 10.2307/2265737; Munster-Swendsen M, 2005, OIKOS, V108, P495, DOI 10.1111/j.0030-1299.2005.13747.x; Newton Ian, 2003, P5; NORRDAHL K, 1995, BIOL REV, V70, P621, DOI 10.1111/j.1469-185X.1995.tb01654.x; ORIANS GH, 1962, AM NAT, V96, P257, DOI 10.1086/282233; Pianka ER, 1983, EVOLUTIONARY ECOLOGY; Rathke D, 2005, ECOL ENG, V24, P149, DOI 10.1016/j.ecoleng.2004.12.013; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; RIVASMARTINEZ S, 1987, VEGETACION ESPANA, P419; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Royama T., 1992, ANAL POPULATION ECOL; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Salvador A, 2004, HERPETOL J, V14, P47; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; Steffen JE, 2006, AM MIDL NAT, V156, P201, DOI 10.1674/0003-0031(2006)156[201:AOTLLL]2.0.CO;2; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; Stenseth NC, 2003, P NATL ACAD SCI USA, V100, P11478, DOI 10.1073/pnas.1935306100; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1423, DOI 10.1098/rspb.1996.0208; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; Torre I, 2004, ACTA OECOL, V25, P137, DOI 10.1016/j.actao.2003.10.007; TORRE I, 2004, THESIS U BARCELONA B, P177; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; VALKAMA J, 2005, BIOL REV, V79, P1; VEIGA JP, 1986, MAMMALIA, V50, P114	70	46	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4311	10.1371/journal.pone.0004311	http://dx.doi.org/10.1371/journal.pone.0004311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234618	Green Published, gold			2022-12-25	WOS:000265487200001
J	Urich, D; Soberanes, S; Burgess, Z; Chiarella, SE; Ghio, AJ; Ridge, KM; Kamp, DW; Chandel, NS; Mutlu, GM; Budinger, GRS				Urich, Daniela; Soberanes, Saul; Burgess, Zach; Chiarella, Sergio E.; Ghio, Andrew J.; Ridge, Karen M.; Kamp, David W.; Chandel, Navdeep S.; Mutlu, Goekhan M.; Budinger, G. R. Scott			Proapoptotic Noxa is required for particulate matter-induced cell death and lung inflammation	FASEB JOURNAL			English	Article						apoptosis; oxidant; bax; air pollution	LONG-TERM EXPOSURE; AIR-POLLUTION; APOPTOSIS; MORTALITY; PARTICLES; BCL-2; EXPRESSION; TRANSPORT; SCIENCE; PATHWAY	Elevated ambient levels of particulate matter air pollution are associated with excess daily mortality, largely attributable to increased rates of cardiovascular events. We have previously reported that particulate matter induces p53-dependent apoptosis in primary human alveolar epithelial cells. Activation of the intrinsic apoptotic pathway by p53 often requires the transcription of the proapoptotic Bcl-2 proteins Noxa, Puma, or both. In this study, we exposed alveolar epithelial cells in culture and mice to fine particulate matter <2.5 mu m in diameter (PM2.5) collected from the ambient air in Washington, D. C. Exposure to PM2.5 induced apoptosis in primary alveolar epithelial cells from wild-type but not Noxa(-/-) mice. Twenty-four hours after the intratracheal instillation of PM2.5, wildtype mice showed increased apoptosis in the lung and increased levels of mRNA encoding Noxa but not Puma. These changes were associated with increased permeability of the alveolar-capillary membrane and inflammation. All of these findings were absent or attenuated in Noxa(-/-) animals. We conclude that PM2.5-induced cell death requires Noxa both in vitro and in vivo and that Noxa-dependent cell death might contribute to PM-induced alveolar epithelial dysfunction and the resulting inflammatory response.-Urich, D., Soberanes, S., Burgess, Z., Chiarella, S. E., Ghio, A. J., Ridge, K. M., Kamp, D. W., Chandel, N. S., Mutlu, G. M., Budinger, G. R. S. Proapoptotic Noxa is required for particulate matter-induced cell death and lung inflammation. FASEB J. 23, 2055-2064 (2009)	[Urich, Daniela; Soberanes, Saul; Burgess, Zach; Chiarella, Sergio E.; Ridge, Karen M.; Kamp, David W.; Chandel, Navdeep S.; Mutlu, Goekhan M.; Budinger, G. R. Scott] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghio, Andrew J.] US EPA, Res Triangle Pk, NC 27711 USA	Northwestern University; Feinberg School of Medicine; United States Environmental Protection Agency	Budinger, GRS (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, 240 E Huron,McGaw Pavil M300, Chicago, IL 60611 USA.	s-buding@northwestern.edu		Chiarella, Sergio/0000-0002-0445-4929	NIH [HL071643, GM060472, HL067835, ES015024, ES013995]; The American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, K08HL067835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060472] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Jacob Sznajder and Dr. David Green for their advice during the performance of these experiments and preparation of the manuscript. This work was supported by NIH grants HL071643, GM060472, HL067835, ES015024, and ES013995, and by The American Lung Association.	ABBEY DE, 1991, ENVIRON HEALTH PERSP, V94, P43, DOI 10.2307/3431291; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Budinger GRS, 2002, J BIOL CHEM, V277, P15654, DOI 10.1074/jbc.M109317200; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Churg A, 2000, ULTRASTRUCT PATHOL, V24, P353; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2003, ENVIRON HEALTH PERSP, V111, P39, DOI 10.1289/ehp.5181; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703; Hudson LG, 2007, MOL CARCINOGEN, V46, P257, DOI 10.1002/mc.20257; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Matute-Bello G, 2004, CLIN DIAGN LAB IMMUN, V11, P358, DOI 10.1128/CDLI.11.2.358-361.2004; Matute-Bello G, 2003, CRIT CARE, V7, P355, DOI 10.1186/cc1861; Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, pL328, DOI 10.1152/ajplung.2001.281.2.L328; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Mutlu GM, 2006, AM J RESP CELL MOL, V34, P670, DOI 10.1165/rcmb.2005-0329OC; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Nemmar A, 2003, AM J RESP CRIT CARE, V168, P1366, DOI 10.1164/rccm.200306-801OC; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PINKERTON KE, 1986, LAB INVEST, V55, P688; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Soberanes S, 2006, AM J RESP CRIT CARE, V174, P1229, DOI 10.1164/rccm.200602-203OC; Upadhyay D, 2003, AM J RESP CELL MOL, V29, P180, DOI 10.1165/rcmb.2002-0269OC; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2005, AM J EPIDEMIOL, V161, P1030, DOI 10.1093/aje/kwi135; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhao Y, 2009, AM J RESP CELL MOL, V40, P19, DOI 10.1165/rcmb.2008-0105OC	44	28	31	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2055	2064		10.1096/fj.08-114546	http://dx.doi.org/10.1096/fj.08-114546			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19237507	Green Published			2022-12-25	WOS:000268836500006
J	Andersson, FI; Tryggvesson, A; Sharon, M; Diemand, AV; Classen, M; Best, C; Schmidt, R; Schelin, J; Stanne, TM; Bukau, B; Robinson, CV; Witt, S; Mogk, A; Clarke, AK				Andersson, Fredrik I.; Tryggvesson, Anders; Sharon, Michal; Diemand, Alexander V.; Classen, Mirjam; Best, Christoph; Schmidt, Ronny; Schelin, Jenny; Stanne, Tara M.; Bukau, Bernd; Robinson, Carol V.; Witt, Susanne; Mogk, Axel; Clarke, Adrian K.			Structure and Function of a Novel Type of ATP-dependent Clp Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; ESCHERICHIA-COLI CLPP; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; 20S PROTEASOME; CYANOBACTERIUM SYNECHOCOCCUS; HIGHER-PLANTS; CHLOROPLAST; IDENTIFICATION; ARABIDOPSIS	The Clp protease is conserved among eubacteria and most eukaryotes, and uses ATP to drive protein substrate unfolding and translocation into a chamber of sequestered proteolytic active sites. The main constitutive Clp protease in photosynthetic organisms has evolved into a functionally essential and structurally intricate enzyme. The model Clp protease from the cyanobacterium Synechococcus consists of the HSP100 molecular chaperone ClpC and a mixed proteolytic core comprised of two distinct subunits, ClpP3 and ClpR. We have purified the ClpP3/R complex, the first for a Clp proteolytic core comprised of heterologous subunits. The ClpP3/R complex has unique functional and structural features, consisting of twin heptameric rings each with an identical ClpP3(3)ClpR(4) configuration. As predicted by its lack of an obvious catalytic triad, the ClpR subunit is shown to be proteolytically inactive. Interestingly, extensive modification to ClpR to restore proteolytic activity to this subunit showed that its presence in the core complex is not rate-limiting for the overall proteolytic activity of the ClpCP3/R protease. Altogether, the ClpP3/R complex shows remarkable similarities to the 20 S core of the proteasome, revealing a far greater degree of convergent evolution than previously thought between the development of the Clp protease in photosynthetic organisms and that of the eukaryotic 26 S proteasome.	[Andersson, Fredrik I.; Tryggvesson, Anders; Stanne, Tara M.; Clarke, Adrian K.] Univ Gothenburg, Dept Plant & Environm Sci, S-40530 Gothenburg, Sweden; [Sharon, Michal; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Diemand, Alexander V.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Classen, Mirjam; Best, Christoph; Witt, Susanne] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Schmidt, Ronny; Bukau, Bernd; Mogk, Axel] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Schelin, Jenny] Lund Inst Technol, Dept Appl Microbiol, S-22100 Lund, Sweden	University of Gothenburg; University of Cambridge; Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg; Lund University	Clarke, AK (corresponding author), Box 461, S-40530 Gothenburg, Sweden.	adrian.clarke@dpes.gu.se		Sharon, Michal/0000-0003-3933-0595; Bukau, Bernd/0000-0003-0521-7199; robinson, carol/0000-0001-7829-5505				Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Clarke AK, 2005, PHYSIOL PLANTARUM, V123, P406, DOI 10.1111/j.1399-3054.2005.00452.x; Clarke AK, 1996, PLANT MOL BIOL, V31, P721, DOI 10.1007/BF00019460; CLARKE AK, 1992, PLANT PHYSIOL, V100, P2081, DOI 10.1104/pp.100.4.2081; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Diemand AV, 2004, NUCLEIC ACIDS RES, V32, pW512, DOI 10.1093/nar/gkh403; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Namikoshi M, 1996, J IND MICROBIOL BIOT, V17, P373, DOI 10.1007/BF01574768; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Peltier JB, 2001, J BIOL CHEM, V276, P16318, DOI 10.1074/jbc.M010503200; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schelin J, 2002, MICROBIOL-SGM, V148, P2255, DOI 10.1099/00221287-148-7-2255; Schiener J, 2005, BIOCHEM BIOPH RES CO, V328, P477, DOI 10.1016/j.bbrc.2005.01.005; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Tanaka K, 1998, IMMUNOL REV, V163, P161; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang JM, 1998, J STRUCT BIOL, V124, P151, DOI 10.1006/jsbi.1998.4058	48	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13519	13532		10.1074/jbc.M809588200	http://dx.doi.org/10.1074/jbc.M809588200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19237538	hybrid, Green Published			2022-12-25	WOS:000265877300029
J	Jaskolski, F; Mayo-Martin, B; Jane, D; Henley, JM				Jaskolski, Frederic; Mayo-Martin, Belen; Jane, David; Henley, Jeremy M.			Dynamin-dependent Membrane Drift Recruits AMPA Receptors to Dendritic Spines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; LATERAL MOVEMENTS; ENDOCYTIC ZONES; NMDA RECEPTORS; SYNAPSES; DIFFUSION; TRAFFICKING; PROTEINS	The surface expression and localization of AMPA receptors (AMPARs) at dendritic spines are tightly controlled to regulate synaptic transmission. Here we show that de novo exocytosis of the GluR2 AMPAR subunit occurs at the dendritic shaft and that new AMPARs diffuse into spines by lateral diffusion in the membrane. However, membrane topology restricts this lateral diffusion. We therefore investigated which mechanisms recruit AMPARs to spines from the shaft and demonstrated that inhibition of dynamin GTPase activity reduced lateral diffusion of membrane-anchored green fluorescent protein and super-ecliptic pHluorin (SEP)-GluR2 into spines. In addition, the activation of synaptic N-methyl-D-aspartate (NMDA) receptors enhanced lateral diffusion of SEP-GluR2 and increased the number of endogenous AMPARs in spines. The NMDA-invoked effects were prevented by dynamin inhibition, suggesting that activity-dependent dynamin-mediated endocytosis within spines generates a net inward membrane drift that overrides lateral diffusion barriers to enhance membrane protein delivery into spines. These results provide a novel mechanistic explanation of how AMPARs and other membrane proteins are recruited to spines by synaptic activity.	[Jaskolski, Frederic; Henley, Jeremy M.] Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Mayo-Martin, Belen; Jane, David] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	J.M.Henley@bristol.ac.uk		Henley, Jeremy/0000-0003-3589-8335	Medical Research Council (MRC); Wellcome Trust; European Union; Medical Research Council [G0601812, G0601810] Funding Source: researchfish; MRC [G0601812, G0601810] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC), the Wellcome Trust, and the European Union (GRIPPANT and ENI-NET grants).	AIZENBUD BM, 1982, BIOPHYS J, V38, P287, DOI 10.1016/S0006-3495(82)84560-8; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Ehlers MD, 2007, NEURON, V55, P686, DOI 10.1016/j.neuron.2007.08.009; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Henley J, 2001, BIOCHEM SOC T, V29, P485, DOI 10.1042/BST0290485; Henley JM, 2003, NEUROSCI RES, V45, P243, DOI 10.1016/S0168-0102(02)00229-8; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Richards DA, 2004, J PHYSIOL-LONDON, V558, P503, DOI 10.1113/jphysiol.2004.062091; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	50	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12491	12503		10.1074/jbc.M808401200	http://dx.doi.org/10.1074/jbc.M808401200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269965	Green Published, hybrid			2022-12-25	WOS:000265494600078
J	Leulliot, N; Cladiere, L; Lecointe, F; Durand, D; Hubscher, U; van Tilbeurgh, H				Leulliot, Nicolas; Cladiere, Lionel; Lecointe, Francois; Durand, Dominique; Huebscher, Ulrich; van Tilbeurgh, Herman			The Family X DNA Polymerase from Deinococcus radiodurans Adopts a Non-standard Extended Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; ANGLE SCATTERING DATA; CRYSTAL-STRUCTURES; REPAIR POLYMERASE; BETA; EXONUCLEASE; MECHANISM; LAMBDA; SOFTWARE; PHENIX	Deinococcus radiodurans is an extraordinarily radioresistant bacterium that is able to repair hundreds of radiation-induced double-stranded DNA breaks. One of the players in this pathway is an X family DNA polymerase (PolX(Dr)). Deletion of PolXDr has been shown to decrease the rate of repair of double-stranded DNA breaks and increase cell sensitivity to gamma-rays. A 3'-> 5' exonuclease activity that stops cutting close to DNA loops has also been demonstrated. The present crystal structure of PolXDr solved at 2.46-angstrom resolution reveals that PolXDr has a novel extended conformation in stark contrast to the closed "right hand" conformation commonly observed for DNA polymerases. This extended conformation is stabilized by the C-terminal PHP domain, whose putative nuclease active site is obstructed by its interaction with the polymerase domain. The overall conformation and the presence of non standard residues in the active site of the polymerase X domain makes PolXDr the founding member of a novel class of polymerases involved in DNA repair but whose detailed mode of action still remains enigmatic.	[Leulliot, Nicolas; Cladiere, Lionel; Lecointe, Francois; Durand, Dominique; van Tilbeurgh, Herman] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, IFR115, CNRS,UMR8619, F-91405 Orsay, France; [Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Zurich	van Tilbeurgh, H (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, IFR115, CNRS,UMR8619, Bat 430, F-91405 Orsay, France.	Herman.Van-Tilbeurgh@u-psud.fr	Leulliot, Nicolas/AAA-7160-2019	Leulliot, Nicolas/0000-0003-0283-4298; Lecointe, Francois/0000-0002-9596-2514	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	Supported by the Swiss National Science Foundation and by the University of Zurich.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Banos B, 2008, NUCLEIC ACIDS RES, V36, P5736, DOI 10.1093/nar/gkn526; Banos B, 2008, J MOL BIOL, V384, P1019, DOI 10.1016/j.jmb.2008.09.081; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Guinier A., 1955, SMALL ANGLE SCATTERI; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; Leslie A., 1992, JOINT CCP4 EACMB NEW; Maciejewski MW, 2001, NAT STRUCT BIOL, V8, P936, DOI 10.1038/nsb1101-936; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ramadan K, 2004, J MOL BIOL, V339, P395, DOI 10.1016/j.jmb.2004.03.056; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Showalter AK, 2001, NAT STRUCT BIOL, V8, P942, DOI 10.1038/nsb1101-942; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	35	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11992	11999		10.1074/jbc.M809342200	http://dx.doi.org/10.1074/jbc.M809342200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251692	Green Published, hybrid			2022-12-25	WOS:000265494600031
J	Misra, S; Hascall, VC; De Giovanni, C; Markwald, RR; Ghatak, S				Misra, Suniti; Hascall, Vincent C.; De Giovanni, Carla; Markwald, Roger R.; Ghatak, Shibnath			Delivery of CD44 shRNA/Nanoparticles within Cancer Cells PERTURBATION OF HYALURONAN/CD44v6 INTERACTIONS AND REDUCTION IN ADENOMA GROWTH IN Apc Min/ plus MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVELY REGULATES ACTIVATION; MULTIPLE INTESTINAL NEOPLASIA; HUMAN COLON CARCINOMAS; COLORECTAL-CANCER; GENE-TRANSFER; VARIANT 6; POLYETHYLENIMINE/DNA COMPLEXES; ADHESION MOLECULES; INFLUENCES GROWTH; HYALURONAN	Our studies have shown that constitutive interactions between hyaluronan and CD44 on tumor cells induces various anti-apoptotic cell survival pathways through the formation of a multimeric signaling complex that contains activated receptor tyrosine kinases. Inhibition of the hyaluronan-CD44 interactions on tumor cells by hyaluronan-CD44 interaction antagonists suppresses these activities by disassembling the complex. Although the anti-tumor activity of hyaluronan-oligosaccharides, a hyaluronan-CD44 interaction antagonist, is effective in sensitizing tumor cells to chemotherapeutic agents and reducing tumor growth in xenografts, hyaluronan-oligosaccharide alone was not effective in reducing tumor progression in Apc Min/+ mice. We now show in vitro and in vivo that targeted inhibition of the expression of CD44v6 depletes the ability of the colon tumor cells to signal through hyaluronan-CD44v6 interactions. First, we cloned oligonucleotides coding CD44v6 shRNA into a conditionally silenced pSico vector. Second, using pSico-CD44v6 shRNA and a colon-specific Fabpl promoter-driven Cre recombinase expression vector packaged into transferrin-coated nanoparticles, we successfully delivered the CD44v6 shRNA within pre-neoplastic and neoplastic colon malignant cells. Third, using the Apc Min/+ mice model, we demonstrated that inhibition of the CD44v6 expression reduces the signaling through a hyaluronan/CD44v6-pErbB2-Cox-2 interaction pathway and reduced adenoma number and growth. Together, these data provide insight into the novel therapeutic strategies of short hairpin RNA/nanoparticle technology and its potential for silencing genes associated with colon tumor cells.	[Misra, Suniti; Markwald, Roger R.; Ghatak, Shibnath] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Misra, Suniti; Ghatak, Shibnath] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA; [De Giovanni, Carla] Univ Bologna, Canc Res Sect, Dept Expt Pathol, I-40126 Bologna, Italy	Medical University of South Carolina; Medical University of South Carolina; Cleveland Clinic Foundation; University of Bologna	Ghatak, S (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, 171 Ashley Ave, Charleston, SC 29425 USA.	ghatak@musc.edu	De Giovanni, Carla/B-1312-2009	DE GIOVANNI, CARLA/0000-0003-4388-4988	National Institutes of Health [P20 RR016434, HLRO133756, Mitral-07CVD 04, 1 P30AR050953, P20RR017698, RO1 CA073839, RO1 CA082867]; Hollings Cancer Center Department of Defense [GC-3319-0544598]; Medical University of South Carolina URC [2204000-24330, 2204000-24329]; NATIONAL CANCER INSTITUTE [R01CA073839, R01CA082867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017698, P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center Department of Defense(United States Department of Defense); Medical University of South Carolina URC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR016434 (to S. M., S. G., and R. R. M.), HLRO133756, Mitral-07CVD 04 (to R. R. M.), 1 P30AR050953 (to V. C. H.), and P20RR017698 (to S. M.), RO1 CA073839 and RO1 CA082867 (to S. M. and S. G.). This work was also supported by Hollings Cancer Center Department of Defense Grant GC-3319-0544598 (to S. M. and R. R. M.) and Medical University of South Carolina URC Projects 2204000-24330 (to S. M.) and 2204000-24329 (to S. G.).	Adamia Sophia, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P3, DOI 10.2174/1568006053005056; Ayhan A, 2001, GYNECOL ONCOL, V80, P355, DOI 10.1006/gyno.2000.6014; Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f; Boeckle S, 2004, J GENE MED, V6, P1102, DOI 10.1002/jgm.598; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chen QZ, 2004, J UROLOGY, V172, P2153, DOI 10.1097/01.ju.0000143440.08760.3a; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Choi SH, 2000, INT J CANCER, V85, P523, DOI 10.1002/(SICI)1097-0215(20000215)85:4<523::AID-IJC13>3.0.CO;2-6; De Giovanni C, 2004, INT J CANCER, V109, P200, DOI 10.1002/ijc.11690; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Holloway K, 2007, J MOL BIOL, V365, P1271, DOI 10.1016/j.jmb.2006.10.071; Ishida T, 2000, SURG TODAY, V30, P28, DOI 10.1007/PL00010042; Kaczmarczyk SJ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e56; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2; Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351; Kurozumi K, 1998, WORLD J SURG, V22, P853, DOI 10.1007/s002689900481; Kursa M, 2003, BIOCONJUGATE CHEM, V14, P222, DOI 10.1021/bc0256087; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; MARKWALD RR, 1978, DEV BIOL, V62, P292, DOI 10.1016/0012-1606(78)90218-X; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Miyake H, 1998, J UROLOGY, V160, P1562, DOI 10.1016/S0022-5347(01)62613-2; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakazawa Hideaki, 2006, Cancer Chemother Pharmacol, V57, P165, DOI 10.1007/s00280-005-0016-5; Naor D, 1998, CURR TOP MICROBIOL, V231, P143; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Ochiai S, 1997, Nihon Kyobu Shikkan Gakkai Zasshi, V35, P1179; Omara-Opyene AL, 2004, LAB INVEST, V84, P894, DOI 10.1038/labinvest.3700112; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Ropponen KM, 1998, SCAND J GASTROENTERO, V33, P301; Roy CN, 2000, BLOOD, V96, P4020, DOI 10.1182/blood.V96.13.4020.h8004020_4020_4027; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; SaporitoIrwin SM, 1997, BIOTECHNIQUES, V23, P424, DOI 10.2144/97233bm16; Sasai H, 2000, CARCINOGENESIS, V21, P953, DOI 10.1093/carcin/21.5.953; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; Sprenger CC, 2008, BRIT J CANCER, V98, P250, DOI 10.1038/sj.bjc.6604144; Takahashi K, 1995, ONCOGENE, V11, P2223; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tucker JA, 2002, CANCER LETT, V187, P153, DOI 10.1016/S0304-3835(02)00402-0; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; YOSHIDA K, 1995, CANCER RES, V55, P4273; Yu Q, 1996, J BIOL CHEM, V271, P20603, DOI 10.1074/jbc.271.34.20603; YU Q, 1995, BIOTECHNIQUES, V19, P122; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	72	70	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12432	12446		10.1074/jbc.M806772200	http://dx.doi.org/10.1074/jbc.M806772200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246453	Green Published, hybrid			2022-12-25	WOS:000265494600073
J	Yoshihara, T; Sugihara, K; Kizuka, Y; Oka, S; Asano, M				Yoshihara, Toru; Sugihara, Kazushi; Kizuka, Yasuhiko; Oka, Shogo; Asano, Masahide			Learning/Memory Impairment and Reduced Expression of the HNK-1 Carbohydrate in beta 4-Galactosyltransferase-II-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; POLYSIALIC ACID; KNOCKOUT MICE; N-GLYCANS; DEFICIENT; GENE; DIFFERENTIATION; GLYCOSYLATION; GLYCOPROTEINS; BIOSYNTHESIS	The glycosylation of glycoproteins and glycolipids is important for central nervous system development and function. Although the roles of several carbohydrate epitopes in the central nervous system, including polysialic acid, the human natural killer-1 (HNK-1) carbohydrate, alpha 2,3-sialic acid, and oligomannosides, have been investigated, those of the glycan backbone structures, such as Gal beta 1-4GlcNAc and Gal beta 1-3GlcNAc, are not fully examined. Here we report the generation of mice deficient in beta 4-galactosyltransferase-II (beta 4GalT-II). This galactosyltransferase transfers Gal from UDP-Gal to a nonreducing terminal GlcNAc to synthesize the Gal beta 1-4GlcNAc structure, and it is strongly expressed in the central nervous system. In behavioral tests, the beta 4GalT-II-/- mice showed normal spontaneous activity in a novel environment, but impaired spatial learning/memory and motor coordination/learning. Immunohistochemistry showed that the amount of HNK-1 carbohydrate was markedly decreased in the brain of beta 4GalT-II-/- mice, whereas the expression of polysialic acid was not affected. Furthermore, mice deficient in glucuronyltransferase (GlcAT-P), which is responsible for the biosynthesis of the HNK-1 carbohydrate, also showed impaired spatial learning/memory as described in our previous report, although their motor coordination/learning was normal as shown in this study. Histological examination showed abnormal alignment and reduced number of Purkinje cells in the cerebellum of beta 4GalT-II-/- mice. These results suggest that the Gal beta 1-4GlcNAc structure in the HNK-1 carbohydrate is mainly synthesized by beta 4GalT-II and that the glycans synthesized by beta 4GalT-II have essential roles in higher brain functions, including some that are HNK-1-dependent and some that are not.	[Yoshihara, Toru; Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan; [Kizuka, Yasuhiko] Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Yoshihara, Toru; Asano, Masahide] Kanazawa Univ, 21st Century COE Program Innovat Brain Sci Dev Le, Kanazawa, Ishikawa 9208640, Japan; [Yoshihara, Toru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University; Kyoto University; Kyoto University; Kanazawa University; Kanazawa University	Asano, M (corresponding author), 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	asano@kiea.m.kanazawa-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Ministry of Education, Culture, Sports, Science and Technology of Japan [19300144]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid 19300144 and the 21st Century COE Program K-1 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Biellmann F, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-109; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Bukalo O, 2007, J NEUROSCI, V27, P6019, DOI 10.1523/JNEUROSCI.1022-07.2007; CARTER RJ, 2003, CURRENT PROTOCOLS NE; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Kido M, 1998, BIOCHEM BIOPH RES CO, V245, P860, DOI 10.1006/bbrc.1998.8537; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078; Li QX, 1997, DEV BIOL, V181, P257, DOI 10.1006/dbio.1996.8444; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Lu QX, 1997, DEVELOPMENT, V124, P4121; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mori R, 2004, AM J PATHOL, V164, P1303, DOI 10.1016/S0002-9440(10)63217-8; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Saghatelyan AK, 2003, MOL CELL NEUROSCI, V24, P271, DOI 10.1016/S1044-7431(03)00163-5; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Strekalova T, 2001, MOL CELL NEUROSCI, V17, P1102, DOI 10.1006/mcne.2001.0991; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	44	38	38	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12550	12561		10.1074/jbc.M809188200	http://dx.doi.org/10.1074/jbc.M809188200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265195	Green Published, hybrid			2022-12-25	WOS:000265494600084
J	Cummings, CM; Bentley, CA; Perdue, SA; Baas, PW; Singer, JD				Cummings, Cristina M.; Bentley, Cornelia A.; Perdue, Sarah A.; Baas, Peter W.; Singer, Jeffrey D.			The Cul3/Klhdc5 E3 Ligase Regulates p60/Katanin and Is Required for Normal Mitosis in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; UBIQUITIN-LIGASE; CAENORHABDITIS-ELEGANS; PROTEASOMAL DEGRADATION; AURORA-B; F-BOX; MICROTUBULE DYNAMICS; INTERACTING PROTEIN; SPASTIC PARAPLEGIA; SUBSTRATE ADAPTER	The proper regulation of factors involved in mitosis is crucial to ensure normal cell division. Levels and activities of proteins are regulated in many ways, one of which is ubiquitin-mediated protein degradation. E3 ubiquitin ligases are involved in targeting specific substrates for degradation by facilitating their ubiquitination. In seeking to elucidate additional biological roles for Cul3 we performed a two-hybrid screen and identified Ctb9/KLHDC5 as a Cul3-interacting protein. Overexpression of Ctb9/KLHDC5 resulted in an increase in microtubule density as well as persistent microtubule bridges between post-mitotic cells. Conversely, down-regulation of Ctb9/KLHDC5 showed a pronounced reduction in microtubule density. Based on these observations, we examined the interactions between Cul3, Ctb9/KLHDC5, and the microtubule-severing protein, p60/katanin. Here we show that p60/katanin interacts with a complex consisting of Cul3 and Ctb9/KLHDC5, which results in ubiquitin laddering of p60/katanin. Also, Cul3-deficient cells or Ctb9/KLHDC5-deficient cells show an increase in p60/katanin levels, indicating that Cul3/Ctb9/KLHDC5 is required for efficient p60/katanin removal. We demonstrate a novel regulatory mechanism for p60/katanin that occurs at the level of targeted proteolysis to allow normal mitotic progression in mammalian cells.	[Cummings, Cristina M.; Bentley, Cornelia A.; Perdue, Sarah A.; Singer, Jeffrey D.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02903 USA; [Cummings, Cristina M.; Bentley, Cornelia A.; Perdue, Sarah A.; Singer, Jeffrey D.] Brown Univ, Ctr Genom & Proteom, Providence, RI 02903 USA; [Baas, Peter W.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA	Brown University; Brown University; Drexel University	Singer, JD (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	jsinger@pdx.edu			National Institutes of Health [7R01GM082940-0208]; Emerald Foundation; Leukemia and Lymphoma Society; Rhode Island Biomedical Research Infrastructure Network; Center of Biological Research Excellence; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Rhode Island Biomedical Research Infrastructure Network; Center of Biological Research Excellence; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 7R01GM082940-0208 (to J.D.S.). This work was also supported by the Emerald Foundation (to J.D.S.), the Leukemia and Lymphoma Society (to J.D.S.), the Rhode Island Biomedical Research Infrastructure Network (National Center for Research Resources, NIH to J.D.S.), and the Center of Biological Research Excellence (National Center for Research Resources, NIH to J.D.S.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Baas PW, 2005, TRENDS CELL BIOL, V15, P183, DOI 10.1016/j.tcb.2005.02.001; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Earnshaw WC, 2001, CURR BIOL, V11, pR683, DOI 10.1016/S0960-9822(01)00407-9; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; GODT D, 1993, DEVELOPMENT, V119, P799; Guardavaccaro D, 2004, ONCOGENE, V23, P2037, DOI 10.1038/sj.onc.1207413; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; He H, 2001, P NATL ACAD SCI USA, V98, P11979, DOI 10.1073/pnas.221452098; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; MAINS PE, 1990, GENETICS, V126, P593; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2000, J CELL SCI, V113, P1623; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; SCHOLEY JM, 1985, NATURE, V318, P483, DOI 10.1038/318483a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SHIMIZU C, 1995, EUR J BIOCHEM, V229, P239, DOI 10.1111/j.1432-1033.1995.0239l.x; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Srayko M, 2000, GENE DEV, V14, P1072; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu J, 2003, MOL BIOL REP, V30, P239, DOI 10.1023/A:1026372901766; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yamanaka A, 2002, CURR BIOL, V12, P267, DOI 10.1016/S0960-9822(02)00657-7; Yan Q, 2004, J BIOL CHEM, V279, P43019, DOI 10.1074/jbc.M408018200; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou JL, 2005, J EXP ZOOL PART A, V303A, P227, DOI 10.1002/jez.a.150; ZOLLMAN TM, 1994, PROTEIN EXPRES PURIF, V5, P291, DOI 10.1006/prep.1994.1044	69	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11663	11675		10.1074/jbc.M809374200	http://dx.doi.org/10.1074/jbc.M809374200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261606	Green Published, hybrid			2022-12-25	WOS:000265494500069
J	Spitale, RC; Torelli, AT; Krucinska, J; Bandarian, V; Wedekind, JE				Spitale, Robert C.; Torelli, Andrew T.; Krucinska, Jolanta; Bandarian, Vahe; Wedekind, Joseph E.			The Structural Basis for Recognition of the PreQ(0) Metabolite by an Unusually Small Riboswitch Aptamer Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; METAL-BINDING; RNA; RIBOZYME; PROTEIN; CRYSTALLOGRAPHY; CLASSIFICATION; REDUCTASE; SOFTWARE	Riboswitches are RNA elements that control gene expression through metabolite binding. The preQ(1) riboswitch exhibits the smallest known ligand-binding domain and is of interest for its economical organization and high affinity interactions with guanine-derived metabolites required to confer tRNA wobbling. Here we present the crystal structure of a preQ(1) aptamer domain in complex with its precursor metabolite preQ(0). The structure is highly compact with a core that features a stem capped by a well organized decaloop. The metabolite is recognized within a deep pocket via Watson-Crick pairing with C15. Additional hydrogen bonds are made to invariant bases U6 and A29. The ligand-bound state confers continuous helical stacking throughout the core fold, thus providing a platform to promote Watson-Crick base pairing between C9 of the decaloop and the first base of the ribosome-binding site, G33. The structure offers insight into the mode of ribosome-binding site sequestration by a minimal RNA fold stabilized by metabolite binding and has implications for understanding the molecular basis by which bacterial genes are regulated.	[Torelli, Andrew T.; Krucinska, Jolanta; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Spitale, Robert C.; Wedekind, Joseph E.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Bandarian, Vahe] Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA	University of Rochester; University of Rochester; University of Arizona	Wedekind, JE (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu			National Institutes of Health [GM63162]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63162 (to J.E.W.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Alam S, 2005, BIOCHEMISTRY-US, V44, P14396, DOI 10.1021/bi051550i; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; BIENZ M, 1981, NATURE, V294, P188, DOI 10.1038/294188a0; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cochrane JC, 2008, RNA, V14, P993, DOI 10.1261/rna.908408; DELANO WL, 2002, PYMOL MOL GRAPHICS; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Klosterman PS, 2002, NUCLEIC ACIDS RES, V30, P392, DOI 10.1093/nar/30.1.392; Klostermeier D, 2002, BIOCHEMISTRY-US, V41, P14095, DOI 10.1021/bi025551b; Lea CR, 2007, NAT CHEM BIOL, V3, P15, DOI 10.1038/nchembio0107-16; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; MEIER F, 1985, EMBO J, V4, P823, DOI 10.1002/j.1460-2075.1985.tb03704.x; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quaranta D, 2007, J BACTERIOL, V189, P5361, DOI 10.1128/JB.00377-07; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1997, METHOD ENZYMOL, V276, P530; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Wedekind JE, 1999, NAT STRUCT BIOL, V6, P261, DOI 10.1038/6700; Wedekind JE, 2000, METHOD ENZYMOL, V317, P149; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529	42	79	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11012	11016		10.1074/jbc.C900024200	http://dx.doi.org/10.1074/jbc.C900024200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261617	Green Published, hybrid			2022-12-25	WOS:000265494500005
J	Lee, H; Lee, YJ; Choi, H; Ko, EH; Kim, JW				Lee, Haemi; Lee, Yoo Jeong; Choi, Hyeonjin; Ko, Eun Hee; Kim, Jae-Woo			Reactive Oxygen Species Facilitate Adipocyte Differentiation by Accelerating Mitotic Clonal Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; 3T3-L1 PREADIPOCYTES; OXIDATIVE STRESS; DNA-BINDING; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; ADIPOSE CONVERSION; GENE PROMOTER; MICE LACKING; ADIPOGENESIS	Growth-arrested 3T3-L1 preadipocytes rapidly express CCAAT/enhancer-binding protein-beta (C/EBP beta) upon hormonal induction of differentiation. However, the DNA binding activity of C/EBP beta is not activated until the cells synchronously reenter S phase during the mitotic clonal expansion (MCE) phase of differentiation. In this period, C/EBP beta is sequentially phosphorylated by MAPK and glycogen synthase kinase-3 beta, inducing C/EBP beta DNA binding activity and transcription of its target genes. Because the DNA binding activity of C/EBP beta is further enhanced by oxidation in vitro, we investigated how redox state affects C/EBP beta DNA binding and MCE during adipogenesis. When 3T3-L1 cells were treated with H2O2 and hormonal stimuli, differentiation was accelerated with increased expression of peroxisome proliferator-activated receptor gamma. Interestingly, cell cycle progression (S to G2/M phase) was markedly enhanced by H2O2, whereas antioxidants caused an S phase arrest during the MCE. H2O2 treatment resulted in the early appearance of a punctate pattern observed by immunofluorescent staining of C/EBP beta, which is a hallmark for C/EBP beta binding to regulatory elements, whereas a short antioxidant treatment rapidly dispersed the centromeric localization of C/EBP beta. Consistently, reactive oxygen species production was increased during 3T3-L1 differentiation. Our results indicate that redox-induced C/EBP beta DNA binding activity, along with the dual phosphorylation of C/EBP beta, is required for the MCE and terminal differentiation of adipocytes.	[Lee, Haemi; Lee, Yoo Jeong; Choi, Hyeonjin; Ko, Eun Hee; Kim, Jae-Woo] Yonsei Univ, Dept Biochem & Mol Biol, Ctr Chron Metab Dis Res, Inst Genet Sci,Coll Med,Brain Korea Project Med S, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Kim, JW (corresponding author), 134 Shinchon Dong, Seoul 120752, South Korea.	japol13@yumc.yonsei.ac.kr		Choi, Hyeonjin/0000-0002-5055-5093; Kim, Jae-woo/0000-0001-5456-9495	Korea Science and Engineering Foundation [R13-2002-054-04000-0, R01-2007-000-10641-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grants R13-2002-054-04000-0 and R01-2007-000-10641-0 funded by the Korean government.	AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; AMRI EZ, 1986, BIOCHEM BIOPH RES CO, V137, P903, DOI 10.1016/0006-291X(86)91165-4; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Castro-Munozledo F, 2003, EXP CELL RES, V284, P163, DOI 10.1016/S0014-4827(02)00036-8; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Entenmann G, 1996, AM J PHYSIOL-CELL PH, V270, pC1011, DOI 10.1152/ajpcell.1996.270.4.C1011; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lane M D, 1981, Prog Clin Biol Res, V66 Pt A, P523; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; REED BC, 1977, P NATL ACAD SCI USA, V74, P4876, DOI 10.1073/pnas.74.11.4876; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tell G, 1998, J BIOL CHEM, V273, P25062, DOI 10.1074/jbc.273.39.25062; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	45	284	291	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10601	10609		10.1074/jbc.M808742200	http://dx.doi.org/10.1074/jbc.M808742200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19237544	hybrid, Green Published			2022-12-25	WOS:000265104600034
J	Hamada, H; Tashima, Y; Kisaka, Y; Iwamoto, K; Hanai, T; Eguchi, Y; Okamoto, M				Hamada, Hiroyuki; Tashima, Yoshihiko; Kisaka, Yu; Iwamoto, Kazunari; Hanai, Taizo; Eguchi, Yukihiro; Okamoto, Masahiro			Sophisticated Framework between Cell Cycle Arrest and Apoptosis Induction Based on p53 Dynamics	PLOS ONE			English	Article							MOLECULAR INTERACTION MAP; P53-MDM2 FEEDBACK LOOP; DNA-REPAIR; G1/S PHASE; RADIATION; DATABASE	The tumor suppressor, p53, regulates several gene expressions that are related to the DNA repair protein, cell cycle arrest and apoptosis induction, which activates the implementation of both cell cycle arrest and induction of apoptosis. However, it is not clear how p53 specifically regulates the implementation of these functions. By applying several well-known kinetic mathematical models, we constructed a novel model that described the influence that DNA damage has on the implementation of both the G2/M phase cell cycle arrest and the intrinsic apoptosis induction via its activation of the p53 synthesis process. The model, which consisted of 32 dependent variables and 115 kinetic parameters, was used to examine interference by DNA damage in the implementation of both G2/M phase cell cycle arrest and intrinsic apoptosis induction. A low DNA damage promoted slightly the synthesis of p53, which showed a sigmoidal behavior with time. In contrast, in the case of a high DNA damage, the p53 showed an oscillation behavior with time. Regardless of the DNA damage level, there were delays in the G2/M progression. The intrinsic apoptosis was only induced in situations where grave DNA damage produced an oscillation of p53. In addition, to wreck the equilibrium between Bcl-2 and Bax the induction of apoptosis required an extreme activation of p53 produced by the oscillation dynamics, and was only implemented after the release of the G2/M phase arrest. When the p53 oscillation is observed, there is possibility that the cell implements the apoptosis induction. Moreover, in contrast to the cell cycle arrest system, the apoptosis induction system is responsible for safeguarding the system that suppresses malignant transformations. The results of these experiments will be useful in the future for elucidating of the dominant factors that determine the cell fate such as normal cell cycles, cell cycle arrest and apoptosis.	[Hamada, Hiroyuki; Tashima, Yoshihiko; Kisaka, Yu; Iwamoto, Kazunari; Hanai, Taizo; Okamoto, Masahiro] Kyushu Univ, Lab Bioinformat, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Eguchi, Yukihiro] Kyushu Univ, Bio Architecture Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Hamada, H (corresponding author), Kyushu Univ, Lab Bioinformat, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	okahon@brs.kyushu-u.ac.jp		Iwamoto, Kazunari/0000-0001-9794-9420				Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Iwamoto K, 2008, BIOSYSTEMS, V94, P109, DOI 10.1016/j.biosystems.2008.05.016; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li G, 1998, BRIT J DERMATOL, V139, P3; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; NOVAK B, 1993, J CELL SCI, V106, P1153; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Sekiguchi Tatsuya, 2006, Journal of Bioinformatics and Computational Biology, V4, P621, DOI 10.1142/S0219720006002132; Sun Y, 2005, INVEST OPHTH VIS SCI, V46, P1561, DOI 10.1167/iovs.04-1362; TASHIMA Y, 2006, P INT FED MED BIOL E, V14, P195; Tashima Y, 2008, J BIOSCI BIOENG, V106, P368, DOI 10.1263/jbb.106.368; Theron T, 1998, CELL PROLIFERAT, V31, P49, DOI 10.1046/j.1365-2184.1998.00107.x; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Voit E. O., 2000, COMPUTATIONAL ANAL B; YOSHIMURA J, 2003, CHEM BIO INFO J, V3, P114; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705	29	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4795	10.1371/journal.pone.0004795	http://dx.doi.org/10.1371/journal.pone.0004795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274075	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496000028
J	Singer, MS; Mace, KC; Bernays, EA				Singer, Michael S.; Mace, Kevi C.; Bernays, Elizabeth A.			Self-Medication as Adaptive Plasticity: Increased Ingestion of Plant Toxins by Parasitized Caterpillars	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; PHENOTYPIC PLASTICITY; NEST MATERIAL; DIET CHOICE; GENERALIST; RESISTANCE; BEHAVIOR; CONSEQUENCES; PARASITOIDS; CHIMPANZEES	Self-medication is a specific therapeutic behavioral change in response to disease or parasitism. The empirical literature on self-medication has so far focused entirely on identifying cases of self-medication in which particular behaviors are linked to therapeutic outcomes. In this study, we frame self-medication in the broader realm of adaptive plasticity, which provides several testable predictions for verifying self-medication and advancing its conceptual significance. First, self-medication behavior should improve the fitness of animals infected by parasites or pathogens. Second, self-medication behavior in the absence of infection should decrease fitness. Third, infection should induce self-medication behavior. The few rigorous studies of self-medication in non-human animals have not used this theoretical framework and thus have not tested fitness costs of self-medication in the absence of disease or parasitism. Here we use manipulative experiments to test these predictions with the foraging behavior of woolly bear caterpillars (Grammia incorrupta; Lepidoptera: Arctiidae) in response to their lethal endoparasites (tachinid flies). Our experiments show that the ingestion of plant toxins called pyrrolizidine alkaloids improves the survival of parasitized caterpillars by conferring resistance against tachinid flies. Consistent with theoretical prediction, excessive ingestion of these toxins reduces the survival of unparasitized caterpillars. Parasitized caterpillars are more likely than unparasitized caterpillars to specifically ingest large amounts of pyrrolizidine alkaloids. This case challenges the conventional view that self-medication behavior is restricted to animals with advanced cognitive abilities, such as primates, and empowers the science of self-medication by placing it in the domain of adaptive plasticity theory.	[Singer, Michael S.; Mace, Kevi C.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Bernays, Elizabeth A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Wesleyan University; University of Arizona	Singer, MS (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	msinger@wesleyan.edu			NSF [IOS 0744676]; Wesleyan University; Division Of Integrative Organismal Systems [0744676] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Wesleyan University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grant IOS 0744676 and Wesleyan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; BERENBAUM MR, 1992, EVOLUTION, V46, P1373, DOI 10.1111/j.1558-5646.1992.tb01130.x; Bernays EA, 2005, NATURE, V436, P476, DOI 10.1038/436476a; Bernays EA, 2002, PHYSIOL ENTOMOL, V27, P312, DOI 10.1046/j.1365-3032.2002.00304.x; BOPPRE M, 1984, J CHEM ECOL, V10, P1151, DOI 10.1007/BF00987520; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Christe P, 2003, ECOL LETT, V6, P19, DOI 10.1046/j.1461-0248.2003.00395.x; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; Dyer LA, 2003, J CHEM ECOL, V29, P2499, DOI 10.1023/A:1026310001958; EISNER T. E, 2003, LOVE INSECTS, V448; Engel C, 2002, WILD HLTH; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Godfray HCJ, 1994, PARASITOIDS BEHAV EV, P488; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P1083, DOI 10.1016/j.ibmb.2005.05.011; Hartmann T, 2004, J CHEM ECOL, V30, P229, DOI 10.1023/B:JOEC.0000017975.16399.c3; HAWKINS BA, 1994, PATTERN PROCESS HOST, P200; Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Huffman MA, 2001, BIOSCIENCE, V51, P651, DOI 10.1641/0006-3568(2001)051[0651:SMBITA]2.0.CO;2; Huffman MA, 1997, YEARB PHYS ANTHROPOL, V40, P171; Huffman MA, 2001, INT J PRIMATOL, V22, P329, DOI 10.1023/A:1010734310002; Huffman MA, 1996, INT J PRIMATOL, V17, P475, DOI 10.1007/BF02735188; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Hutchings MR, 2006, MAMMAL REV, V36, P1, DOI 10.1111/j.1365-2907.2006.00080.x; Hutchings MR, 2003, P NUTR SOC, V62, P361, DOI 10.1079/PNS2003243; Janzen D.H., 1978, P73; Karban R, 1997, ECOLOGY, V78, P603, DOI 10.1890/0012-9658(1997)078[0603:TPAHPC]2.0.CO;2; Krishnamani R, 2000, ANIM BEHAV, V59, P899, DOI 10.1006/anbe.1999.1376; Lampert EC, 2008, J CHEM ECOL, V34, P783, DOI 10.1007/s10886-008-9481-8; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mooney KA, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P43; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; RODRIGUEZ E, 1993, RECENT ADV PHYTOCHEM, V27, P89; SAS Institute, 2007, JMP VERS 7 0; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Singer MS, 2003, OIKOS, V100, P554, DOI 10.1034/j.1600-0706.2003.11720.x; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; SMILANICH AM, 2008, THESIS TULANE U; Stireman JO, 2002, ECOL ENTOMOL, V27, P588, DOI 10.1046/j.1365-2311.2002.00450.x; Villalba JJ, 2006, ANIM BEHAV, V71, P1131, DOI 10.1016/j.anbehav.2005.09.012; WRANGHAM R W, 1983, Primates, V24, P276, DOI 10.1007/BF02381090; WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404; YAMAMOTO RT, 1969, J ECON ENTOMOL, V62, P1427, DOI 10.1093/jee/62.6.1427	51	183	185	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4796	10.1371/journal.pone.0004796	http://dx.doi.org/10.1371/journal.pone.0004796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274098	gold, Green Published			2022-12-25	WOS:000265496000029
J	Young, KA; Snoeks, J; Seehausen, O				Young, Kyle A.; Snoeks, Jos; Seehausen, Ole			Morphological Diversity and the Roles of Contingency, Chance and Determinism in African Cichlid Radiations	PLOS ONE			English	Article								Background: Deterministic evolution, phylogenetic contingency and evolutionary chance each can influence patterns of morphological diversification during adaptive radiation. In comparative studies of replicate radiations, convergence in a common morphospace implicates determinism, whereas non-convergence suggests the importance of contingency or chance. Methodology/Principal Findings: The endemic cichlid fish assemblages of the three African great lakes have evolved similar sets of ecomorphs but show evidence of non-convergence when compared in a common morphospace, suggesting the importance of contingency and/or chance. We then analyzed the morphological diversity of each assemblage independently and compared their axes of diversification in the unconstrained global morphospace. We find that despite differences in phylogenetic composition, invasion history, and ecological setting, the three assemblages are diversifying along parallel axes through morphospace and have nearly identical variance-covariance structures among morphological elements. Conclusions/Significance: By demonstrating that replicate adaptive radiations are diverging along parallel axes, we have shown that non-convergence in the common morphospace is associated with convergence in the global morphospace. Applying these complimentary analyses to future comparative studies will improve our understanding of the relationship between morphological convergence and non-convergence, and the roles of contingency, chance and determinism in driving morphological diversification.	[Young, Kyle A.; Seehausen, Ole] Univ Bern, Dept Aquat Ecol & Evolut, Inst Ecol & Evolut, Bern, Switzerland; [Young, Kyle A.; Seehausen, Ole] Ctr Ecol Evolut & Biogeochem, EAWAG, Kastanienbaum, Switzerland; [Snoeks, Jos] Royal Museum Cent Africa, Dept Zool, Tervuren, Belgium; [Snoeks, Jos] Univ Leuven, Dept Biol, Louvain, Belgium	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Royal Museum for Central Africa; KU Leuven	Young, KA (corresponding author), Univ Bern, Dept Aquat Ecol & Evolut, Inst Ecol & Evolut, Bern, Switzerland.	kyle_a_young@hotmail.com	Seehausen, Ole/C-8272-2011	Seehausen, Ole/0000-0001-6598-1434	NERC (U.K.) award [NER/B/S/2003/00206]; Swiss National Science Foundation; DEFRA (U.K.) Darwin Initiative [162-15-020]	NERC (U.K.) award(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DEFRA (U.K.) Darwin Initiative(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by NERC (U.K.) award NER/B/S/2003/00206 to OS, KAY and JS. OS was supported by a grant from the Swiss National Science Foundation. KAY received additional support from DEFRA (U.K.) Darwin Initiative grant # 162-15-020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Case T., 1986, COMMUNITY ECOL, P98; CAVALCANTI MJ, 2002, MANTEL VERSION 1 15; Chakrabarty P, 2005, COPEIA, P359, DOI 10.1643/CG-04-089R2; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; Fryer G., 1972, CICHLID FISHES GREAT; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gould S. J., 1989, WONDERFUL LIFE BURGE; Greenwood P.H., 1975, B BRIT NAT HIST MUS, V6, P1; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; LIEM KF, 1970, SYST ZOOL, P425; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Price T, 2000, AM NAT, V156, P354, DOI 10.1086/303397; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Rohlf F. J., 2004, TPSDIG VERSION 1 40; ROHLF FJ, 2005, RELATIVE WARPS VERSI; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; SHEETS HD, 2001, SPACEANGLE6B; Steppan SJ, 1997, EVOLUTION, V51, P587, DOI 10.1111/j.1558-5646.1997.tb02445.x; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 2000, AM NAT, V156, pS35, DOI 10.1086/303414; Tyerman J, 2005, P ROY SOC B-BIOL SCI, V272, P1393, DOI 10.1098/rspb.2005.3068; Webster AJ, 2002, P ROY SOC B-BIOL SCI, V269, P143, DOI 10.1098/rspb.2001.1873; Williams EE., 1972, EVOL BIOL, V6, P47, DOI [DOI 10.1007/978-1-4684-9063-3_3, 10. 1007/978-1-4684-9063-3]; WITTE F, 1992, NETH J ZOOL, V42, P214; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	37	49	49	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4740	10.1371/journal.pone.0004740	http://dx.doi.org/10.1371/journal.pone.0004740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270732	Green Published, gold			2022-12-25	WOS:000265495900009
J	Zampieri, M; Passananti, C; Calabrese, R; Perilli, M; Corbi, N; De Cave, F; Guastafierro, T; Bacalini, MG; Reale, A; Amicosante, G; Calabrese, L; Zlatanova, J; Caiafa, P				Zampieri, Michele; Passananti, Claudio; Calabrese, Roberta; Perilli, Mariagrazia; Corbi, Nicoletta; De Cave, Fabiana; Guastafierro, Tiziana; Bacalini, Maria Giulia; Reale, Anna; Amicosante, Gianfranco; Calabrese, Lilia; Zlatanova, Jordanka; Caiafa, Paola			Parp1 Localizes within the Dnmt1 Promoter and Protects Its Unmethylated State by Its Enzymatic Activity	PLOS ONE			English	Article								Background: Aberrant hypermethylation of CpG islands in housekeeping gene promoters and widespread genome hypomethylation are typical events occurring in cancer cells. The molecular mechanisms behind these cancer-related changes in DNA methylation patterns are not well understood. Two questions are particularly important: (i) how are CpG islands protected from methylation in normal cells, and how is this protection compromised in cancer cells, and (ii) how does the genome-wide demethylation in cancer cells occur. The latter question is especially intriguing since so far no DNA demethylase enzyme has been found. Methodology/Principal Findings: Our data show that the absence of ADP-ribose polymers (PARs), caused by ectopic overexpression of poly(ADP-ribose) glycohydrolase (PARG) in L929 mouse fibroblast cells leads to aberrant methylation of the CpG island in the promoter of the Dnmt1 gene, which in turn shuts down its transcription. The transcriptional silencing of Dnmt1 may be responsible for the widespread passive hypomethylation of genomic DNA which we detect on the example of pericentromeric repeat sequences. Chromatin immunoprecipitation results show that in normal cells the Dnmt1 promoter is occupied by poly(ADP-ribosyl)ated Parp1, suggesting that PARylated Parp1 plays a role in protecting the promoter from methylation. Conclusions/Significance: In conclusion, the genome methylation pattern following PARG over-expression mirrors the pattern characteristic of cancer cells, supporting our idea that the right balance between Parp/Parg activities maintains the DNA methylation patterns in normal cells. The finding that in normal cells Parp1 and ADP-ribose polymers localize on the Dnmt1 promoter raises the possibility that PARylated Parp1 marks those sequences in the genome that must remain unmethylated and protects them from methylation, thus playing a role in the epigenetic regulation of gene expression.	[Zampieri, Michele; Calabrese, Roberta; De Cave, Fabiana; Guastafierro, Tiziana; Bacalini, Maria Giulia; Reale, Anna; Caiafa, Paola] Univ Roma La Sapienza, Fac Med 2, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Calabrese, Lilia] Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy; [Zampieri, Michele; Guastafierro, Tiziana; Reale, Anna; Caiafa, Paola] Pasteur Inst, Fdn Cenci Bolognetti, Rome, Italy; [Passananti, Claudio; Perilli, Mariagrazia; Corbi, Nicoletta] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Amicosante, Gianfranco] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy; [Zlatanova, Jordanka] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of L'Aquila; University of Wyoming	Zampieri, M (corresponding author), Univ Roma La Sapienza, Fac Med 2, Dept Cellular Biotechnol & Hematol, Rome, Italy.	caiafa@bce.uniroma1.it	Passananti, Claudio/K-9593-2016; Corbi, Nicoletta/AAW-8835-2020; Zampieri, Michele/F-7099-2013; guastafeierro, tiziana/J-8006-2016; Zampieri, Michele/AGF-5460-2022; Zlatanova, Jordanka/B-3273-2009; Bacalini, Maria Giulia/K-4931-2016; Corbi, Nicoletta/K-2313-2014; Reale, Anna/J-5933-2016	Zampieri, Michele/0000-0002-6799-2492; guastafeierro, tiziana/0000-0001-9433-2759; Zampieri, Michele/0000-0002-6799-2492; Bacalini, Maria Giulia/0000-0003-1618-2673; Reale, Anna/0000-0001-8988-2342; amicosante, gianfranco/0000-0002-6813-2101; CORBI, NICOLETTA/0000-0002-4505-1632; PASSANANTI, CLAUDIO/0000-0002-9288-5736	Ministero della Salute; Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy; AIRC [fellowship]; NSF [0504239]	Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); NSF(National Science Foundation (NSF))	This work was partially financed by Ministero della Salute (PC) and by Ministero dell'Istruzione, dell'Universita e della Ricerca (PC, LC, MP), Italy; MZ was supported by AIRC fellowship; JZ was supported in part by NSF grant 0504239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Branco MR, 2008, GENE DEV, V22, P1567, DOI 10.1101/gad.1690508; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; CAIAFA P, 2008, FASEB J; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; De Capoa A, 1999, FASEB J, V13, P89; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szyf M, 2008, CURR ONCOL, V15, P72; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zardo G, 1999, FASEB J, V13, P1518, DOI 10.1096/fasebj.13.12.1518; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517; Zardo G, 1997, BIOCHEMISTRY-US, V36, P7937, DOI 10.1021/bi970241s; ZLATANOVA J, 2009, CELL MOL LIFE SCI	49	71	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4717	10.1371/journal.pone.0004717	http://dx.doi.org/10.1371/journal.pone.0004717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262751	gold, Green Submitted, Green Published			2022-12-25	WOS:000265490600027
J	Wopereis, S; Rubingh, CM; van Erk, MJ; Verheij, ER; van Vliet, T; Cnubben, NHP; Smilde, AK; van der Greef, J; van Ommen, B; Hendriks, HFJ				Wopereis, Suzan; Rubingh, Carina M.; van Erk, Marjan J.; Verheij, Elwin R.; van Vliet, Trinette; Cnubben, Nicole H. P.; Smilde, Age K.; van der Greef, Jan; van Ommen, Ben; Hendriks, Henk F. J.			Metabolic Profiling of the Response to an Oral Glucose Tolerance Test Detects Subtle Metabolic Changes	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; URIC-ACID; GENOMIC BIOMARKERS; PROTEIN ADDUCTS; DICLOFENAC; GLUTATHIONE; IDENTIFICATION; INFLAMMATION; OBESITY; VALIDATION	Background: The prevalence of overweight is increasing globally and has become a serious health problem. Low-grade chronic inflammation in overweight subjects is thought to play an important role in disease development. Novel tools to understand these processes are needed. Metabolic profiling is one such tool that can provide novel insights into the impact of treatments on metabolism. Methodology: To study the metabolic changes induced by a mild anti-inflammatory drug intervention, plasma metabolic profiling was applied in overweight human volunteers with elevated levels of the inflammatory plasma marker C-reactive protein. Liquid and gas chromatography mass spectrometric methods were used to detect high and low abundant plasma metabolites both in fasted conditions and during an oral glucose tolerance test. This is based on the concept that the resilience of the system can be assessed after perturbing a homeostatic situation. Conclusions: Metabolic changes were subtle and were only detected using metabolic profiling in combination with an oral glucose tolerance test. The repeated measurements during the oral glucose tolerance test increased statistical power, but the metabolic perturbation also revealed metabolites that respond differentially to the oral glucose tolerance test. Specifically, multiple metabolic intermediates of the glutathione synthesis pathway showed time-dependent suppression in response to the glucose challenge test. The fact that this is an insulin sensitive pathway suggests that inflammatory modulation may alter insulin signaling in overweight men.	[Wopereis, Suzan; Rubingh, Carina M.; van Erk, Marjan J.; Verheij, Elwin R.; van Vliet, Trinette; Cnubben, Nicole H. P.; Smilde, Age K.; van der Greef, Jan; van Ommen, Ben; Hendriks, Henk F. J.] TNO, Dept Qual Life, NL-3700 AJ Zeist, Netherlands; [Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands	Netherlands Organization Applied Science Research; University of Amsterdam	Wopereis, S (corresponding author), TNO, Dept Qual Life, NL-3700 AJ Zeist, Netherlands.	suzan.wopereis@tno.nl	Hendriks, Henk/AAU-5987-2021	Smilde, Age/0000-0002-3052-4644	TNO	TNO	The research was completely funded by TNO. No additional funding or support was received for the work presented.	Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Boelsterli UA, 2003, TOXICOL APPL PHARM, V192, P307, DOI 10.1016/S0041-008X(03)00368-5; Bonassi S, 2001, MUTAT RES-FUND MOL M, V480, P349, DOI 10.1016/S0027-5107(01)00194-4; Bro R, 1996, J CHEMOMETR, V10, P47, DOI 10.1002/(SICI)1099-128X(199601)10:1<47::AID-CEM400>3.0.CO;2-C; Choi JS, 2005, J PHARM PHARMACOL, V57, P1185, DOI 10.1211/jpp.57.9.0013; Clish CB, 2004, OMICS, V8, P3, DOI 10.1089/153623104773547453; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dillon WilliamR., 1984, MULTIVARIATE ANAL ME; Fogarty AW, 2008, AM J CLIN NUTR, V87, P30, DOI 10.1093/ajcn/87.1.30; Ginsburg GS, 2006, EXPERT REV MOL DIAGN, V6, P179, DOI 10.1586/14737159.6.2.179; Gonzalez-Ortiz M, 2005, METAB SYNDR RELAT D, V3, P95, DOI 10.1089/met.2005.3.95; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HARSHMAN RA, 1994, COMPUT STAT DATA AN, V18, P39, DOI 10.1016/0167-9473(94)90132-5; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; He Yudong D., 2006, Cancer Biomarkers, V2, P103; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Joliffe I. T., 1986, PRINCIPAL COMPONENT; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Khuseyinova N, 2006, CURR OPIN CRIT CARE, V12, P412, DOI 10.1097/01.ccx.0000244119.16377.75; Kiers HAL, 2001, PSYCHOL METHODS, V6, P84, DOI 10.1037/1082-989X.6.1.84; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Mano Y, 2005, BIOPHARM DRUG DISPOS, V26, P35, DOI 10.1002/bdd.430; Martens H., 1992, MULTIVARIATE CALIBRA; Massart D. L., 1997, HDB CHEMOMETRICS QUA, Vfirst; Masubuchi Y, 2002, DRUG METAB DISPOS, V30, P1143, DOI 10.1124/dmd.30.10.1143; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Naylor S, 2008, CURR OPIN BIOTECH, V19, P100, DOI 10.1016/j.copbio.2008.02.009; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Rajaram V, 2004, AM J CARDIOL, V93, p32C, DOI 10.1016/j.amjcard.2004.02.004; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Smilde AK, 1997, J CHEMOMETR, V11, P367, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<367::AID-CEM481>3.0.CO;2-I; SMILDE AK, 2004, MULTIWAY ANAL APPL C, P221; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413; van der Greef J, 2007, J PROTEOME RES, V6, P1540, DOI 10.1021/pr0606530; van der Greef J, 2004, ADV MASS SPECTROM, V16, P145; Vandeginste B.G.M., 1998, DATA HANDLING SCI TE, V20, P57, DOI [10.1016/S0922-3487(98)80040-3, DOI 10.1016/S0922-3487(98)80040-3]; Verhoeckx KCM, 2004, INT IMMUNOPHARMACOL, V4, P1499, DOI 10.1016/j.intimp.2004.07.008; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wade LT, 1997, CHEM RES TOXICOL, V10, P546, DOI 10.1021/tx960153t; Wang SJ, 2006, PHARMACOGENOMICS J, V6, P82, DOI 10.1038/sj.tpj.6500363; Ware JA, 1998, CHEM RES TOXICOL, V11, P164, DOI 10.1021/tx970182j; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Yu YM, 2002, AM J PHYSIOL-ENDOC M, V282, pE247, DOI 10.1152/ajpendo.00206.2001	51	94	95	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4525	10.1371/journal.pone.0004525	http://dx.doi.org/10.1371/journal.pone.0004525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242536	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487500001
J	Damarla, M; Hasan, E; Boueiz, A; Le, A; Pae, HH; Montouchet, C; Kolb, T; Simms, T; Myers, A; Kayyali, US; Gaestel, M; Peng, XQ; Reddy, SP; Damico, R; Hassoun, PM				Damarla, Mahendra; Hasan, Emile; Boueiz, Adel; Le, Anne; Pae, Hyun Hae; Montouchet, Calypso; Kolb, Todd; Simms, Tiffany; Myers, Allen; Kayyali, Usamah S.; Gaestel, Matthias; Peng, Xinqi; Reddy, Sekhar P.; Damico, Rachel; Hassoun, Paul M.			Mitogen Activated Protein Kinase Activated Protein Kinase 2 Regulates Actin Polymerization and Vascular Leak in Ventilator Associated Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SPHINGOSINE 1-PHOSPHATE; XANTHINE OXIDOREDUCTASE; MECHANICAL VENTILATION; DEPENDENT REGULATION; ENDOTHELIAL-CELLS; MAP-KINASES; STRESS; PHOSPHORYLATION; SUSCEPTIBILITY	Mechanical ventilation, a fundamental therapy for acute lung injury, worsens pulmonary vascular permeability by exacting mechanical stress on various components of the respiratory system causing ventilator associated lung injury. We postulated that MK2 activation via p38 MAP kinase induced HSP25 phosphorylation, in response to mechanical stress, leading to actin stress fiber formation and endothelial barrier dysfunction. We sought to determine the role of p38 MAP kinase and its downstream effector MK2 on HSP25 phosphorylation and actin stress fiber formation in ventilator associated lung injury. Wild type and MK2(-/-) mice received mechanical ventilation with high (20 ml/kg) or low (7 ml/kg) tidal volumes up to 4 hrs, after which lungs were harvested for immunohistochemistry, immunoblotting and lung permeability assays. High tidal volume mechanical ventilation resulted in significant phosphorylation of p38 MAP kinase, MK2, HSP25, actin polymerization, and an increase in pulmonary vascular permeability in wild type mice as compared to spontaneous breathing or low tidal volume mechanical ventilation. However, pretreatment of wild type mice with specific p38 MAP kinase or MK2 inhibitors abrogated HSP25 phosphorylation and actin polymerization, and protected against increased lung permeability. Finally, MK2(-/-) mice were unable to phosphorylate HSP25 or increase actin polymerization from baseline, and were resistant to increases in lung permeability in response to HV(T) MV. Our results suggest that p38 MAP kinase and its downstream effector MK2 mediate lung permeability in ventilator associated lung injury by regulating HSP25 phosphorylation and actin cytoskeletal remodeling.	[Damarla, Mahendra; Hasan, Emile; Boueiz, Adel; Le, Anne; Pae, Hyun Hae; Montouchet, Calypso; Kolb, Todd; Simms, Tiffany; Myers, Allen; Peng, Xinqi; Damico, Rachel; Hassoun, Paul M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kayyali, Usamah S.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Gaestel, Matthias] Hannover Med Sch, Dept Biochem, D-3000 Hannover, Germany; [Reddy, Sekhar P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Johns Hopkins University; Tufts University; Hannover Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Damarla, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	phassoun@jhmi.edu	Kolb, Todd/ABD-8204-2020; Boueiz, Adel El/AAV-5966-2021; Gaestel, Matthias/A-6560-2013	Boueiz, Adel El/0000-0003-1638-8575; Gaestel, Matthias/0000-0002-4944-4652; Le, Anne/0000-0002-2958-8149	NIH [HL049441, HL090297, P50 HL073994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049441, R29HL049441, P50HL073994, F32HL090297] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH (HL049441, HL090297, and P50 HL073994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; BOGATCHEVA NV, 2006, AM J PHYSIOL-LUNG C; BOGATCHEVA NV, 2009, MICROVASC RES; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; BRYAN J, 2004, J CELL BIOCHEM, V92, P1075; CHAUDHURI S, 2008, AM J RESP CELL MOL B; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fan E, 2005, JAMA-J AM MED ASSOC, V294, P2889, DOI 10.1001/jama.294.22.2889; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GALEN B, 1998, J CELLULAR PHYSL, V177, P575; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Grishko V, 2001, AM J PHYSIOL-LUNG C, V280, pL1300, DOI 10.1152/ajplung.2001.280.6.L1300; Guay J, 1997, J CELL SCI, V110, P357; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LE A, 2008, J APPL PHYSIOL, P90689; Le A, 2008, J APPL PHYSIOL, V105, P1282, DOI 10.1152/japplphysiol.90689.2008; MacIntyre NR, 2005, CHEST, V128, p561S, DOI 10.1378/chest.128.5_suppl_2.561S; Moxley MA, 2000, AM J PHYSIOL-LUNG C, V279, pL985, DOI 10.1152/ajplung.2000.279.5.L985; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Parker JC, 2002, AM J PHYSIOL-LUNG C, V283, pL1203, DOI 10.1152/ajplung.00488.2001; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SCHMIDT EP, 2008, AM J PHYSL LUNG CELL; Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565; Vertii A, 2006, J BIOL CHEM, V281, P26966, DOI 10.1074/jbc.M602134200; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; YAN J, 2008, J PHARMACOL EXP THER; 2000, N ENGL J MED, V342, P1301	40	47	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4600	10.1371/journal.pone.0004600	http://dx.doi.org/10.1371/journal.pone.0004600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240800	gold, Green Submitted, Green Published			2022-12-25	WOS:000278086700014
J	Hirano, I; Nakamura, S; Yokota, D; Ono, T; Shigeno, K; Fujisawa, S; Shinjo, K; Ohnishi, K				Hirano, Isao; Nakamura, Satoki; Yokota, Daisuke; Ono, Takaaki; Shigeno, Kazuyuki; Fujisawa, Shinya; Shinjo, Kaori; Ohnishi, Kazunori			Depletion of Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatases 1 and 2 by Bcr-Abl Promotes Chronic Myelogenous Leukemia Cell Proliferation through Continuous Phosphorylation of Akt Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; PROSTATE-CANCER; KINASE-C; TRANSFORMATION; PATHWAY; GENE; ACTIVATION; ONCOGENE; BCR/ABL	The constitutive activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway commonly occurs in cancers and is a crucial event in tumorigenesis. Chronic myelogenous leukemia (CML) is characterized by a reciprocal chromosomal translocation (9;22) that generates the Bcr-Abl fusion gene. The PI3K/Akt pathway is activated by Bcr-Abl chimera protein and mediates the leukemogenesis in CML. However, the mechanism by which Bcr-Abl activates the PI3K/Akt pathway is not completely understood. In the present study, we found that pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 (PHLPP1 and PHLPP2) were depleted in CML cells. We investigated the interaction between PHLPPs and Bcr-Abl in CML cell lines and Bcr-Abl(+) progenitor cells from CML patients. The Abl kinase inhibitors and depletion of Bcr- Abl induced the expression of PHLPP1 and PHLPP2, which dephosphorylated Ser-473 on Akt1, -2, and -3, resulting in inhibited proliferation of CML cells. The reduction of PHLPP1 and PHLPP2 expression by short interfering RNA in CML cells weakened the Abl kinase inhibitor-mediated inhibition of proliferation. In colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte; colony-forming unit-granulocyte, macrophage; and burst-forming unit-erythroid, treatment with the Abl kinase inhibitors and depletion of Bcr- Abl induced PHLPP1 and PHLPP2 expression and inhibited colony formation of Bcr-Abl(+) progenitor cells, whereas depletion of PHLPP1 and PHLPP2 weakened the inhibition of colony formation activity by the Abl kinase inhibitors in Bcr-Abl(+) progenitor cells. Thus, Bcr- Abl represses the expression of PHLPP1 and PHLPP2 and continuously activates Akt1, -2, and -3 via phosphorylation on Ser-473, resulting in the proliferation of CML cells.	[Hirano, Isao; Nakamura, Satoki; Yokota, Daisuke; Ono, Takaaki; Shigeno, Kazuyuki; Shinjo, Kaori; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Shizuoka 4313192, Japan; [Hirano, Isao; Yokota, Daisuke; Ono, Takaaki; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Canc, Higashi Ku, Shizuoka 4313192, Japan; [Fujisawa, Shinya] Hamamatsu Med Ctr, Div Hematol, Naka Ku, Shizuoka 4328580, Japan		Nakamura, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, 1-20-1 Handayama, Shizuoka 4313192, Japan.	satonaka@hama-med.ac.jp		Ono, Takaaki/0000-0003-3922-7432	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590987]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research 17590987 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel A, 2003, CANCER RES, V63, P1608; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MARX JL, 1989, SCIENCE, V244, P654, DOI 10.1126/science.2566202; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Patael-Karasik Y, 2000, CANCER GENET CYTOGEN, V121, P26, DOI 10.1016/S0165-4608(00)00224-7; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; RUDKIN GT, 1964, SCIENCE, V144, P1229, DOI 10.1126/science.144.3623.1229; Safford SD, 2003, ANN SURG ONCOL, V10, P136, DOI 10.1245/ASO.2003.03.038; Sattler M, 1996, ONCOGENE, V12, P839; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Torring N, 2007, BRIT J CANCER, V96, P499, DOI 10.1038/sj.bjc.6603476; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	31	22	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					22155	22165		10.1074/jbc.M808182200	http://dx.doi.org/10.1074/jbc.M808182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19261608	Green Published, hybrid			2022-12-25	WOS:000268783700040
J	Lingwood, D; Schuck, S; Ferguson, C; Gerl, MJ; Simons, K				Lingwood, Daniel; Schuck, Sebastian; Ferguson, Charles; Gerl, Mathias J.; Simons, Kai			Generation of Cubic Membranes by Controlled Homotypic Interaction of Membrane Proteins in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMEBA CHAOS-CAROLINENSIS; LIPID-CONTAINING SYSTEMS; SELECTIVE AUTOPHAGY; UT-1 CELLS; HII-PHASE; ER; MITOCHONDRIA; ORGANIZATION; CHOLESTEROL; TRAFFICKING	Cell membranes predominantly consist of lamellar lipid bilayers. When studied in vitro, however, many membrane lipids can exhibit non-lamellar morphologies, often with cubic symmetries. An open issue is how lipid polymorphisms influence organelle and cell shape. Here, we used controlled dimerization of artificial membrane proteins in mammalian tissue culture cells to induce an expansion of the endoplasmic reticulum (ER) with cubic symmetry. Although this observation emphasizes ER architectural plasticity, we found that the changed ER membrane became sequestered into large autophagic vacuoles, positive for the autophagy protein LC3. Autophagy may be targeting irregular membrane shapes and/or aggregated protein. We suggest that membrane morphology can be controlled in cells.	[Lingwood, Daniel; Schuck, Sebastian; Ferguson, Charles; Gerl, Mathias J.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schuck, Sebastian] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ferguson, Charles] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Max Planck Society; University of California System; University of California San Francisco; University of Queensland	Simons, K (corresponding author), Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de		Gerl, Mathias/0000-0002-8074-7221; Schuck, Sebastian/0000-0002-6388-0661; Simons, Kai/0000-0002-9231-9996	European Union FP6 PRISM grant; Deutsche Forschungsgemeinschaft [SP1175]	European Union FP6 PRISM grant(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a European Union FP6 PRISM grant and Grant SP1175 from the Deutsche Forschungsgemeinschaft (to K. S.).	Almsherqi ZA, 2005, REDOX REP, V10, P167, DOI 10.1179/135100005X57373; Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; ANDERSON RGW, 1983, J CELL SCI, V63, P1; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; BOULIGAND Y, 1991, GEOMETRY CONDENSED M, P193; BOULIGAND Y, 1990, J PHYSIQUE COLL, V7, P35; BRANDENBURG K, 1992, J STRUCT BIOL, V108, P93, DOI 10.1016/1047-8477(92)90010-8; Bulbarelli A, 2002, J CELL SCI, V115, P1689; CAFFREY M, 1993, LIPIDAT; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; Deng YR, 1999, J STRUCT BIOL, V127, P231, DOI 10.1006/jsbi.1999.4147; Deng YR, 2002, PROTOPLASMA, V219, P160, DOI 10.1007/s007090200017; Deng YR, 1998, PROTOPLASMA, V203, P16, DOI 10.1007/BF01280583; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Dunn WA, 2005, AUTOPHAGY, V1, P75; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; FELDMAN D, 1981, CANCER RES, V41, P2151; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; HUI SW, 1987, COMMENTS MOL CELL BI, V4, P233; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; LANDH T, 1995, FEBS LETT, V369, P13, DOI 10.1016/0014-5793(95)00660-2; LANDH T, 1996, THESIS LUND U LUND S; LARSSON K, 1989, J PHYS CHEM-US, V93, P7304, DOI 10.1021/j100358a010; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LUZZATI V, 1993, J MOL BIOL, V229, P540, DOI 10.1006/jmbi.1993.1053; Luzzati V., 1968, BIOL MEMBR, P71; MARIANI P, 1988, J MOL BIOL, V204, P165, DOI 10.1016/0022-2836(88)90607-9; MARSH D, 1990, HDB LIPID LAYERS; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; PARRISH ML, 1995, MOL BIOL CELL, V6, P1535, DOI 10.1091/mbc.6.11.1535; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; SMITH S, 1994, P NATL ACAD SCI USA, V91, P10124, DOI 10.1073/pnas.91.21.10124; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zacchetti D, 1995, FEBS LETT, V377, P465, DOI 10.1016/0014-5793(95)01396-2; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	63	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12041	12048		10.1074/jbc.M900220200	http://dx.doi.org/10.1074/jbc.M900220200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258319	Green Published, hybrid			2022-12-25	WOS:000265494600036
J	Shaffer, JF; Kensler, RW; Harris, SP				Shaffer, Justin F.; Kensler, Robert W.; Harris, Samantha P.			The Myosin-binding Protein C Motif Binds to F-actin in a Phosphorylation-sensitive Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-A PHOSPHORYLATION; RABBIT SKELETAL-MUSCLE; VITRO MOTILITY ASSAY; HYPERTROPHIC CARDIOMYOPATHY; MYBP-C; REGULATORY DOMAIN; CARDIAC-FUNCTION; STRIATED-MUSCLE; THIN-FILAMENTS; CONTRACTION	Cardiac myosin-binding protein C (cMyBP-C) is a regulatory protein expressed in cardiac sarcomeres that is known to interact with myosin, titin, and actin. cMyBP-C modulates actomyosin interactions in a phosphorylation-dependent way, but it is unclear whether interactions with myosin, titin, or actin are required for these effects. Here we show using cosedimentation binding assays, that the 4 N-terminal domains of murine cMyBP-C (i. e. C0-C1-m-C2) bind to F-actin with a dissociation constant (K-d) of similar to 10 mu M and a molar binding ratio (B-max) near 1.0, indicating 1: 1 (mol/mol) binding to actin. Electron microscopy and light scattering analyses show that these domains cross-link F-actin filaments, implying multiple sites of interaction with actin. Phosphorylation of the MyBP-C regulatory motif, or m-domain, reduced binding to actin (reduced Bmax) and eliminated actin cross-linking. These results suggest that the N terminus of cMyBP-C interacts with F-actin through multiple distinct binding sites and that binding at one or more sites is reduced by phosphorylation. Reversible interactions with actin could contribute to effects of cMyBP-C to increase crossbridge cycling.	[Shaffer, Justin F.; Harris, Samantha P.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Shaffer, Justin F.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Kensler, Robert W.] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA	University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Harris, SP (corresponding author), 196 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	samharris@ucdavis.edu			National Institutes of Health [SC1HL096017, HL080367]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL096017, R01HL080367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1HL096017 (to R. W. K.) and HL080367 (to S. P. H.). This work was also supported by a National Science Foundation Graduate Research Fellowship (to J. F. S.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; BENNETT P, 1986, J MUSCLE RES CELL M, V7, P550, DOI 10.1007/BF01753571; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Calaghan SC, 2000, J PHYSIOL-LONDON, V528, P151, DOI 10.1111/j.1469-7793.2000.00151.x; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; ISHIKAWA M, 1983, J BIOCHEM-TOKYO, V94, P1209, DOI 10.1093/oxfordjournals.jbchem.a134466; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; KORN ED, 1982, PHYSIOL REV, V62, P672, DOI 10.1152/physrev.1982.62.2.672; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Saber W, 2008, J MOL CELL CARDIOL, V44, P1053, DOI 10.1016/j.yjmcc.2008.03.012; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Shaffer JF, 2007, FEBS LETT, V581, P1501, DOI 10.1016/j.febslet.2007.03.007; Spiess M, 1999, J STRUCT BIOL, V126, P98, DOI 10.1006/jsbi.1999.4111; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; YAMAMOTO K, 1986, FEBS LETT, V208, P123, DOI 10.1016/0014-5793(86)81545-9	46	155	155	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12318	12327		10.1074/jbc.M808850200	http://dx.doi.org/10.1074/jbc.M808850200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269976	hybrid, Green Published			2022-12-25	WOS:000265494600063
J	Yamamoto, Y; Mochida, S; Kurooka, T; Sakisaka, T				Yamamoto, Yasunori; Mochida, Sumiko; Kurooka, Takao; Sakisaka, Toshiaki			Reciprocal Intramolecular Interactions of Tomosyn Control Its Inhibitory Activity on SNARE Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL-GIANT-LARVAE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; PROTEIN; EXOCYTOSIS; MECHANISM; POLARITY; SYNTAXIN; DOCKING; SYNAPSE	Neurotransmitter release from presynaptic nerve terminals is regulated by SNARE complex-mediated synaptic vesicle fusion. Tomosyn, a negative regulator of neurotransmitter release, which is composed of N-terminal WD40 repeats, a tail domain, and a C-terminal VAMP-like domain, is known to inhibit SNARE complex formation by sequestering target SNAREs (t-SNAREs) upon interaction of its C-terminal VAMP-like domain with t-SNAREs. However, it remains unclear how the inhibitory activity of tomosyn is regulated. Here we show that the tail domain functions as a regulator of the inhibitory activity of tomosyn through intramolecular interactions. The binding of the tail domain to the C-terminal VAMP-like domain interfered with the interaction of the C-terminal VAMP-like domain with t-SNAREs, and thereby repressed the inhibitory activity of tomosyn on the SNARE complex formation. The repressed inhibitory activity of tomosyn was restored by the binding of the tail domain to the N-terminal WD40 repeats. These results indicate that the probable conformational change of tomosyn mediated by the intramolecular interactions of the tail domain controls its inhibitory activity on the SNARE complex formation, leading to a regulated inhibition of neurotransmitter release.	[Yamamoto, Yasunori; Kurooka, Takao; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	Kobe University; Tokyo Medical University	Sakisaka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp			National Project on Targeted Proteins Research Program; Scientific Research C; Ministry of Education, Culture, Sports, Science, and Technology, Japan	National Project on Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research C(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for the National Project on Targeted Proteins Research Program (to T. S.), for Scientific Research C (to T. S.), for Scientific Research on Priority Areas-Elucidation of neural network function in the brain (to T. S. and S. M.), for Scientific Research B (to S. M.), and for the Global COE Program F11 (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 2007, NAT STRUCT MOL BIOL, V14, P360, DOI 10.1038/nsmb0507-360; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x	27	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12480	12490		10.1074/jbc.M807182200	http://dx.doi.org/10.1074/jbc.M807182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258327	Green Published, hybrid			2022-12-25	WOS:000265494600077
J	de Almagro, MC; Coma, S; Noe, V; Ciudad, CJ				Cristina de Almagro, M.; Coma, Silvia; Noe, Veronique; Ciudad, Carlos J.			Polypurine Hairpins Directed against the Template Strand of DNA Knock Down the Expression of Mammalian Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX FORMATION; OLIGONUCLEOTIDE TARGET SEQUENCES; FORMING OLIGONUCLEOTIDES; TRANSCRIPTION ELONGATION; INTERFERING RNAS; 3RD STRAND; INHIBITION; PROMOTER; PURINE; CELLS	We analyzed whether polypurine hairpins (PPRHs) had the ability to knock down gene expression. These hairpins are formed by two antiparallel purine domains linked by a loop that allows the formation of Hoogsteen bonds between both domains and Watson-Crick bonds with the target polypyrimidine sequence, forming triplex structures. To set up the experimental conditions, the human dhfr gene was used as a model. The PPRHs were designed toward the template strand of DNA. The transfection of the human breast cancer cell line SKBR3 with these template hairpins against the dhfr gene produced higher than 90% of cell mortality. Template PPRHs produced a decrease in DHFR mRNA, protein, and its corresponding enzymatic activity. In addition, the activity of DHFR PPRHs was tested against breast cancer cells resistant to methotrexate, observing high cell mortality. Given the difficulty in finding long polypyrimidine stretches, we studied how to compensate for the presence of purine interruptions in the polypyrimidine target sequence. The stability of PPRH was measured, resulting in a surprisingly long half-life of about 5 days. Finally, to test the generality of usage, template PPRHs were employed against two important genes involved in cell proliferation, telomerase and survivin, producing 80 and 95% of cell death, respectively. Taken together our results show the ability of antiparallel purine hairpins to bind the template strand of double strand DNA and to decrease gene transcription. Thus, PPRHs can be considered as a new type of molecules to modulate gene expression.	[Cristina de Almagro, M.; Coma, Silvia; Noe, Veronique; Ciudad, Carlos J.] Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, E-08028 Barcelona, Spain	University of Barcelona	Ciudad, CJ (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, Av Diagonal 643, E-08028 Barcelona, Spain.	cciudad@ub.edu	Noe, Veronique/K-3615-2014; Ciudad, Carlos J./D-7917-2014	Noe, Veronique/0000-0001-7937-8038; Ciudad, Carlos J./0000-0002-7855-392X	Plan Nacional de Investigacion Cientifica (Spain) [SAF05-0247, SAF08-43]; ISCIII-RETIC [RD06/0020/0046]	Plan Nacional de Investigacion Cientifica (Spain); ISCIII-RETIC(Instituto de Salud Carlos III)	The work was supported by Grants SAF05-0247 and SAF08-43 from "Plan Nacional de Investigacion Cientifica" (Spain) and ISCIII-RETIC RD06/0020/0046. Our research group holds the Quality mention from the "Generalitat de Catalunya."	Avino A, 2003, J AM CHEM SOC, V125, P16127, DOI 10.1021/ja035039t; Avino A, 2002, NUCLEIC ACIDS RES, V30, P2609, DOI 10.1093/nar/gkf374; Avino A, 2001, BIOORG MED CHEM LETT, V11, P1761, DOI 10.1016/S0960-894X(01)00295-5; Brunet E, 2005, NUCLEIC ACIDS RES, V33, P4223, DOI 10.1093/nar/gki726; CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; Casey BP, 2001, PROG NUCLEIC ACID RE, V67, P163, DOI 10.1016/S0079-6603(01)67028-4; Chan PP, 1997, J MOL MED, V75, P267, DOI 10.1007/s001090050112; CHASIN L, 1985, MOL CELL GENETICS, P449; CIUDAD CJ, 1988, J BIOL CHEM, V263, P16274; Coma S, 2005, OLIGONUCLEOTIDES, V15, P269, DOI 10.1089/oli.2005.15.269; Cronstein BN, 1996, ARTHRITIS RHEUM-US, V39, P1951, DOI 10.1002/art.1780391203; Cubero E, 2002, J AM CHEM SOC, V124, P3133, DOI 10.1021/ja011928+; Faria M, 2000, P NATL ACAD SCI USA, V97, P3862, DOI 10.1073/pnas.97.8.3862; Faucon B, 1996, NUCLEIC ACIDS RES, V24, P3181, DOI 10.1093/nar/24.16.3181; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; GIOVANNANGELI C, 1991, J AM CHEM SOC, V113, P7775, DOI 10.1021/ja00020a058; Giovannangeli C, 1997, ANTISENSE NUCLEIC A, V7, P413, DOI 10.1089/oli.1.1997.7.413; Goni JR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-63; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Hewett PW, 2006, MOL MED, V12, P8, DOI 10.2119/2005-00046.Hewett; KANDIMALLA ER, 1995, J AM CHEM SOC, V117, P6416, DOI 10.1021/ja00128a055; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim HG, 1998, BIOCHEMISTRY-US, V37, P2299, DOI 10.1021/bi9718191; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Mills M, 2002, BIOCHEMISTRY-US, V41, P357, DOI 10.1021/bi011122m; Peyman A, 1997, ANTIVIR RES, V33, P135, DOI 10.1016/S0166-3542(96)01003-0; POSTEL EH, 1991, P NATL ACAD SCI USA, V88, P8227, DOI 10.1073/pnas.88.18.8227; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Rodriguez M, 1999, INT J CANCER, V81, P785; Ryan K, 1998, CHEM BIOL, V5, P59, DOI 10.1016/S1074-5521(98)90140-5; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sorensen JJ, 2004, NUCLEIC ACIDS RES, V32, P6078, DOI 10.1093/nar/gkh942; VASQUEZ KM, 1995, BIOCHEMISTRY-US, V34, P7243, DOI 10.1021/bi00021a040; YOUNG SL, 1991, P NATL ACAD SCI USA, V88, P10023, DOI 10.1073/pnas.88.22.10023	35	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11579	11589		10.1074/jbc.M900981200	http://dx.doi.org/10.1074/jbc.M900981200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261618	hybrid, Green Published			2022-12-25	WOS:000265494500062
J	Shiue, CN; Berkson, RG; Wright, APH				Shiue, C-N; Berkson, R. G.; Wright, A. P. H.			c-Myc induces changes in higher order rDNA structure on stimulation of quiescent cells	ONCOGENE			English	Article						c-Myc; nucleolus; transcription; ribosome biogenesis; RNA polymerase I	RNA-POLYMERASE-I; RIBOSOMAL DNA; SPATIAL-ORGANIZATION; NUCLEAR-MATRIX; TRANSCRIPTION; GENES; VIVO; NUCLEOLAR; UBF; TUMORIGENESIS	c-Myc is an oncogenic transcription factor capable of activating transcription by all three nuclear RNA polymerases, thus acting as a high-level coordinator of protein synthesis capacity and cell growth rate. c-Myc recruits RNA polymerase I-related transcription factors to the rDNA when quiescent cells are stimulated to re-enter the cell cycle. Using a model system of cell lines with variable c-Myc status, we show that on stimulation c-Myc rapidly induces gene loop structures in rDNA chromatin that juxtapose upstream and downstream rDNA sequences. c-Myc activation is both necessary and sufficient for this change in rDNA chromatin conformation. c-Myc activation induces association of TTF-1 with the rDNA, and c-Myc is physically associated with induced rDNA gene loops. The origins of two or more rDNA gene loops are closely juxtaposed, suggesting the possibility that c-Myc induces nucleolar chromatin hubs. Induction of rDNA gene loops may be an early step in the reprogramming of quiescent cells as they re-enter the growth cycle.	[Shiue, C-N; Berkson, R. G.; Wright, A. P. H.] Karolinska Inst, Sch Life Sci, Sodertorns Hogskola & Dept Biosci & Nutr, SE-14189 Huddinge, Sweden	Karolinska Institutet	Wright, APH (corresponding author), Karolinska Inst, Sch Life Sci, Sodertorns Hogskola & Dept Biosci & Nutr, Alfred Nobels Alle 7, SE-14189 Huddinge, Sweden.	anthony.wright@sh.se	Berkson, Rachel/D-3438-2009; Wright, Anthony/J-8187-2015	Wright, Anthony/0000-0003-1029-9969	Taiwan Root Medical Peace Corps; Swedish Cancer Society; Karolinska Institute	Taiwan Root Medical Peace Corps; Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet)	We thank Lars-Gunnar Larsson for the provision of rat fibroblasts HO15.15, TGR1 and Rat1MycER and Professor Dirk Eick for the generous gift of Smoxi4 cells. This work was supported by a Taiwan Fellowship from the Taiwan Root Medical Peace Corps, the Swedish Cancer Society and the research foundations of the Karolinska Institute.	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bukhari MH, 2007, INT J EXP PATHOL, V88, P47, DOI 10.1111/j.1365-2613.2006.00522.x; CASSIDY BG, 1987, MOL CELL BIOL, V7, P2388, DOI 10.1128/MCB.7.7.2388; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; DEAN M, 1986, J BIOL CHEM, V261, P9161; Fischer AH, 2004, J CELL BIOCHEM, V91, P170, DOI 10.1002/jcb.10735; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Holzel M, 2001, EMBO REP, V2, P1125, DOI 10.1093/embo-reports/kve251; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; KEPPEL F, 1986, J MOL BIOL, V187, P15, DOI 10.1016/0022-2836(86)90402-X; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seo J, 2005, J BIOL CHEM, V280, P24600, DOI 10.1074/jbc.M414076200; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	36	55	55	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2009	28	16					1833	1842		10.1038/onc.2009.21	http://dx.doi.org/10.1038/onc.2009.21			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PW	19270725				2022-12-25	WOS:000265640500002
J	Ansari, A; Talat, N; Jamil, B; Hasan, Z; Razzaki, T; Dawood, G; Hussain, R				Ansari, Ambreen; Talat, Najeeha; Jamil, Bushra; Hasan, Zahra; Razzaki, Tashmeem; Dawood, Ghaffar; Hussain, Rabia			Cytokine Gene Polymorphisms across Tuberculosis Clinical Spectrum in Pakistani Patients	PLOS ONE			English	Article								Background: Pakistan ranks 7(th) globally in terms of tuberculosis (TB) disease burden (incidence 181/100000 pop./yr; prevalence of 329/pop./yr). Reports from different populations show variable associations of TB susceptibility and severity with cytokine gene polymorphisms. Tuberculosis clinical severity is multi-factorial and cytokines play a pivotal role in the modulation of disease severity. We have recently reported that the ratio of two key cytokines (IFN gamma and IL10) show significant correlation with the severity spectrum of tuberculosis. The objective of the current study was to analyze the frequency of cytokine gene polymorphisms linked to high and low responder phenotypes (IFN gamma + 874 T-hi -> A(lo) and IL10-1082 G(lo)-> A(hi)) in tuberculosis patients. Methods and Findings: Study groups were stratified according to disease site as well as disease severity: Pulmonary N = 111 (Minimal, PMN = 19; Moderate, PMD = 63; Advance, PAD = 29); Extra-pulmonary N = 67 (Disseminated DTB = 20, Localized LTB = 47) and compared with healthy controls (TBNA = 188). Genotype analyses were carried out using amplification refractory mutation system-PCR (ARMS-PCR) and stimulated whole blood (WB) culture assay was used for assessing cytokine profiles. Our results suggest that the IFN gamma + 874 TT genotype and T allele was overrepresented in PMN (p = 0.01) and PMD (p = 0.02). IFN gamma + 874 TT in combination with IL10 GG(lo) genotypes showed the highest association (chi(2) = 6.66, OR = 6.06, 95% CI = 1.31-28.07, p = 0.01). IFN gamma AA(lo) on the other hand in combination with IL10 GG(lo) increased the risk of PAD (OR = 5.26; p = 0.005) and DTB (OR = 3.59; p = 0.045). Conclusion: These findings are consistent with the role of IL10 in reducing collateral tissue damage and the protective role of IFN gamma in limiting disease in the lung.	[Ansari, Ambreen; Talat, Najeeha; Hasan, Zahra; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Jamil, Bushra] Aga Khan Univ, Dept Pathol & Microbiol & Med, Karachi, Pakistan; [Razzaki, Tashmeem] Sindh Inst Urol & Transplant, Karachi, Pakistan; [Dawood, Ghaffar] Masoomeen Gen Hosp, Karachi, Pakistan	Aga Khan University; Aga Khan University	Ansari, A (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hasan, Zahra/AAF-2191-2020; Hasan, Zahra/F-5111-2015; Hussain, Rabia/E-9982-2015	Hasan, Zahra/0000-0001-7580-372X; 	Higher Education Commission of Pakistan [20-796/ R]; Government of Pakistan [D/07];  [PCST/NCB-AC3/2003]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Government of Pakistan; 	This work was funded by The Grant No PCST/NCB-AC3/2003 and by the Higher Education Commission of Pakistan Grant No 20-796/ R and D/07 Government of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, EPIDEMIOL INFECT, V135, P27, DOI 10.1017/S0950268806006364; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; ATES O, 2007, J CLIN IMMUNOL, P1; Bagheri M, 2006, TRANSFUSION MED, V16, P192, DOI 10.1111/j.1365-3148.2006.00666.x; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; DHINGRA VK, 2004, INDIAN J COMM MED, V29, P1; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Etokebe GE, 2006, SCAND J IMMUNOL, V63, P136, DOI 10.1111/j.1365-3083.2005.01716.x; Ferraz JC, 2006, BRAZ J MED BIOL RES, V39, P1387, DOI 10.1590/S0100-879X2006001100002; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Henao MI, 2006, TUBERCULOSIS, V86, P11, DOI 10.1016/j.tube.2005.03.001; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Lemos Antonio Carlos, 2004, Braz J Infect Dis, V8, P424, DOI 10.1590/S1413-86702004000600006; Lio D, 2002, EUR J IMMUNOGENET, V29, P371, DOI 10.1046/j.1365-2370.2002.00327.x; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Mehdi SQ, 2002, BIODIVERSITY: BIOMOLECULAR ASPECTS OF BIODIVERSITY AND INNOVATIVE UTILIZATION, P35; Moran A, 2007, INT J TUBERC LUNG D, V11, P113; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Oh JH, 2007, RESPIROLOGY, V12, P594, DOI 10.1111/j.1440-1843.2007.01108.x; Oral HB, 2006, CYTOKINE, V35, P143, DOI 10.1016/j.cyto.2006.07.015; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Perrey C, 1998, TRANSPL IMMUNOL, V6, P193, DOI 10.1016/S0966-3274(98)80045-2; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Sallakci N, 2007, TUBERCULOSIS, V87, P225, DOI 10.1016/j.tube.2006.10.002; Scola L, 2003, MECH AGEING DEV, V124, P569, DOI 10.1016/S0047-6374(03)00038-1; Shin JE, 2005, REQUIR ENG, V10, P132, DOI 10.1007/s00766-004-0207-3; Takiff HE, 2007, TUBERCULOSIS 2007 BA, P207; Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Vidyarani M, 2006, INDIAN J MED RES, V124, P403	41	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4778	10.1371/journal.pone.0004778	http://dx.doi.org/10.1371/journal.pone.0004778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274101	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496000017
J	Little, DY; Chen, L				Little, Daniel Y.; Chen, Lu			Identification of Coevolving Residues and Coevolution Potentials Emphasizing Structure, Bond Formation and Catalytic Coordination in Protein Evolution	PLOS ONE			English	Article							MUTUAL INFORMATION; CORRELATED MUTATIONS; CRYSTAL-STRUCTURE; PREDICTION; CONSERVATION; NETWORKS; CONTACTS; SYSTEM; SITES; FOLD	The structure and function of a protein is dependent on coordinated interactions between its residues. The selective pressures associated with a mutation at one site should therefore depend on the amino acid identity of interacting sites. Mutual information has previously been applied to multiple sequence alignments as a means of detecting coevolutionary interactions. Here, we introduce a refinement of the mutual information method that: 1) removes a significant, non-coevolutionary bias and 2) accounts for heteroscedasticity. Using a large, non-overlapping database of protein alignments, we demonstrate that predicted coevolving residue-pairs tend to lie in close physical proximity. We introduce coevolution potentials as a novel measure of the propensity for the 20 amino acids to pair amongst predicted coevolutionary interactions. Ionic, hydrogen, and disulfide bond-forming pairs exhibited the highest potentials. Finally, we demonstrate that pairs of catalytic residues have a significantly increased likelihood to be identified as coevolving. These correlations to distinct protein features verify the accuracy of our algorithm and are consistent with a model of coevolution in which selective pressures towards preserving residue interactions act to shape the mutational landscape of a protein by restricting the set of admissible neutral mutations.	[Little, Daniel Y.; Chen, Lu] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chen, Lu] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Little, DY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	luchen@berkeley.edu			Mabel and Arnold Beckman Foundation; David and Lucile Packard Foundation; W. M. Keck Foundation; NIH [RO1 MH069792]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069792] Funding Source: NIH RePORTER	Mabel and Arnold Beckman Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported Mabel and Arnold Beckman Foundation, the David and Lucile Packard Foundation, the W. M. Keck Foundation, and N.I.H. (L.C. RO1 MH069792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2004, J MOL BIOL, V336, P903, DOI 10.1016/j.jmb.2003.12.072; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Buss KA, 2001, J BACTERIOL, V183, P680, DOI 10.1128/JB.183.2.680-686.2001; Crisma M, 2006, BIOPOLYMERS, V84, P3, DOI 10.1002/bip.20357; DUNN SD, 2007, BIOINFORMATICS; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; FINN RD, 2007, NUCL ACIDS RES; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Giraud BG, 1998, PHYS REV E, V58, P6312, DOI 10.1103/PhysRevE.58.6312; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Miyazawa S, 1999, PROTEINS, V34, P49; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2008, METHODS MOL BIOL, V484, P523, DOI 10.1007/978-1-59745-398-1_31; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Smith AK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S5; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Wang ZO, 2007, J MOL EVOL, V65, P485, DOI 10.1007/s00239-007-9018-8; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	40	32	32	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4762	10.1371/journal.pone.0004762	http://dx.doi.org/10.1371/journal.pone.0004762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274093	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000003
J	Nowak, LG; Barone, P				Nowak, Lionel G.; Barone, Pascal			Contrast Adaptation Contributes to Contrast-Invariance of Orientation Tuning of Primate V1 Cells	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CAT STRIATE CORTEX; SPATIAL-FREQUENCY DISCRIMINATION; MARMOSETS CALLITHRIX-JACCHUS; DIRECTION-SELECTIVE ADAPTATION; ACTIVATED POTASSIUM CHANNEL; SACCADIC EYE-MOVEMENTS; CORTICAL-NEURONS; RESPONSE PROPERTIES	Background: Studies in rodents and carnivores have shown that orientation tuning width of single neurons does not change when stimulus contrast is modified. However, in these studies, stimuli were presented for a relatively long duration (e. g., 4 seconds), making it possible that contrast adaptation contributed to contrast-invariance of orientation tuning. Our first purpose was to determine, in marmoset area V1, whether orientation tuning is still contrast-invariant with the stimulation duration is comparable to that of a visual fixation. Methodology/Principal Findings: We performed extracellular recordings and examined orientation tuning of single-units using static sine-wave gratings that were flashed for 200 msec. Sixteen orientations and three contrast levels, representing low, medium and high values in the range of effective contrasts for each neuron, were randomly intermixed. Contrast adaptation being a slow phenomenon, cells did not have enough time to adapt to each contrast individually. With this stimulation protocol, we found that the tuning width obtained at intermediate contrast was reduced to 89% (median), and that at low contrast to 76%, of that obtained at high contrast. Therefore, when probed with briefly flashed stimuli, orientation tuning is not contrast-invariant in marmoset V1. Our second purpose was to determine whether contrast adaptation contributes to contrast-invariance of orientation tuning. Stationary gratings were presented, as previously, for 200 msec with randomly varying orientations, but the contrast was kept constant within stimulation blocks lasting>20 sec, allowing for adaptation to the single contrast in use. In these conditions, tuning widths obtained at low contrast were still significantly less than at high contrast (median 85%). However, tuning widths obtained with medium and high contrast stimuli no longer differed significantly. Conclusions/Significance: Orientation tuning does not appear to be contrast-invariant when briefly flashed stimuli vary in both contrast and orientation, but contrast adaptation partially restores contrast-invariance of orientation tuning.	[Nowak, Lionel G.; Barone, Pascal] Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Nowak, LG (corresponding author), Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, F-31062 Toulouse, France.	Lionel.Nowak@cerco.ups-tlse.fr	Barone, Pascal/A-4008-2009; Nowak, Lionel/D-4120-2011; BARONE, Pascal/AHE-2323-2022	BARONE, Pascal/0000-0003-0125-7468	CNRS; Ministere delegue a la Recherche et aux nouvelles Technologies [NIC 0085]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere delegue a la Recherche et aux nouvelles Technologies	This work was supported by the CNRS, by the Ministere delegue a la Recherche et aux nouvelles Technologies (Action Concerte Incitative "Neurosciences Integratives et Computationnelles", NIC 0085) (L.G.N.) and by the CNRS ATIP program (P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Ahmed B, 1997, CEREB CORTEX, V7, P559, DOI 10.1093/cercor/7.6.559; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; ALLISON JD, 1993, VISUAL NEUROSCI, V10, P1129, DOI 10.1017/S0952523800010233; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Banitt Y, 2007, J NEUROSCI, V27, P10230, DOI 10.1523/JNEUROSCI.1640-07.2007; BARLOW HB, 1976, VISION RES, V16, P1043, DOI 10.1016/0042-6989(76)90241-8; Beaudot WHA, 2006, VISION RES, V46, P26, DOI 10.1016/j.visres.2005.10.016; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; BJORKLUND RA, 1981, PERCEPTION, V10, P511, DOI 10.1068/p100511; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; BLAKEMORE C, 1973, VISION RES, V13, P1915, DOI 10.1016/0042-6989(73)90063-1; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Bourne JA, 2003, BRAIN RES PROTOC, V11, P168, DOI 10.1016/S1385-299X(03)00044-8; BOWNE SF, 1990, VISION RES, V30, P449, DOI 10.1016/0042-6989(90)90086-Z; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bressloff PC, 2003, PHILOS T R SOC B, V358, P1643, DOI 10.1098/rstb.2002.1109; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Buzas P, 2006, J COMP NEUROL, V499, P861, DOI 10.1002/cne.21134; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; Contreras D, 2003, J NEUROSCI, V23, P6936; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Delorme A, 2003, J COMPUT NEUROSCI, V15, P357, DOI 10.1023/A:1027420012134; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; Descalzo VF, 2005, J NEUROPHYSIOL, V93, P1111, DOI 10.1152/jn.00658.2004; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fritsches KA, 1996, J COMP NEUROL, V372, P264; FUCHS AF, 1967, J PHYSIOL-LONDON, V191, P609, DOI 10.1113/jphysiol.1967.sp008271; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGESON M A, 1985, Spatial Vision, V1, P103, DOI 10.1163/156856885X00125; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; GILINSKY AS, 1968, J OPT SOC AM, V58, P13, DOI 10.1364/JOSA.58.000013; GOFFART L, 2008, NEW ENCY NEUROSCIENC; GREENLEE MW, 1988, VISION RES, V28, P791, DOI 10.1016/0042-6989(88)90026-0; Guo K, 2006, EXP BRAIN RES, V171, P91, DOI 10.1007/s00221-005-0248-y; HAMMETT ST, 1994, VISION RES, V34, P31, DOI 10.1016/0042-6989(94)90254-2; HAMMOND P, 1989, VISION RES, V29, P1671, DOI 10.1016/0042-6989(89)90149-1; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTVEIT E, 1992, VISUAL NEUROSCI, V9, P515, DOI 10.1017/S0952523800011317; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Itti L, 2000, J OPT SOC AM A, V17, P1899, DOI 10.1364/JOSAA.17.001899; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; LAZAREVA N A, 1983, Neirofiziologiya, V15, P347; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; LI CY, 1984, PFLUG ARCH EUR J PHY, V401, P304; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lui LL, 2006, CEREB CORTEX, V16, P162, DOI 10.1093/cercor/bhi094; MAATTANEN LM, 1991, EXP BRAIN RES, V87, P205; Mace MJM, 2005, EUR J NEUROSCI, V21, P2007, DOI 10.1111/j.1460-9568.2005.04029.x; MADDESS T, 1988, BIOL CYBERN, V59, P229, DOI 10.1007/BF00332911; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MAFFEI L, 1973, VISION RES, V13, P1255, DOI 10.1016/0042-6989(73)90201-0; MALPELI JG, 1981, J NEUROPHYSIOL, V46, P1102, DOI 10.1152/jn.1981.46.5.1102; Mareschal I, 2004, VISION RES, V44, P57, DOI 10.1016/j.visres.2003.07.009; MARLIN SG, 1988, J NEUROPHYSIOL, V59, P1314, DOI 10.1152/jn.1988.59.4.1314; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; McIlhagga WH, 1996, VISION RES, V36, P1265, DOI 10.1016/0042-6989(95)00196-4; McLean J, 1996, VISUAL NEUROSCI, V13, P1069, DOI 10.1017/S0952523800007720; McLoughlin N, 2006, NEUROIMAGE, V31, P76, DOI 10.1016/j.neuroimage.2005.12.054; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Nasanen RE, 1997, INVEST OPHTH VIS SCI, V38, P260; NEALEY TA, 1994, J NEUROSCI, V14, P2069; NELSON SB, 1991, J NEUROSCI, V11, P344; Nowak LG, 2005, J NEUROSCI, V25, P1866, DOI 10.1523/JNEUROSCI.3897-04.2005; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PANTLE A, 1968, SCIENCE, V162, P1146, DOI 10.1126/science.162.3858.1146-a; Peterson MR, 2006, J NEUROPHYSIOL, V95, P2705, DOI 10.1152/jn.00885.2005; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Reisbeck TE, 1998, VISION RES, V38, P1105, DOI 10.1016/S0042-6989(97)00240-X; Ringach DL, 2002, J NEUROSCI, V22, P5639; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; Roe AW, 2005, ANAT REC PART A, V287A, P1213, DOI 10.1002/ar.a.20248; Rosa MGP, 1997, J COMP NEUROL, V387, P547, DOI 10.1002/(SICI)1096-9861(19971103)387:4<547::AID-CNE6>3.0.CO;2-2; Sally SL, 2007, EXP BRAIN RES, V183, P351, DOI 10.1007/s00221-007-1048-3; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sato H, 1996, J PHYSIOL-LONDON, V494, P757, DOI 10.1113/jphysiol.1996.sp021530; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2002, J NEUROPHYSIOL, V88, P1363, DOI 10.1152/jn.2002.88.3.1363; Schiessl I, 2003, NEUROIMAGE, V20, P1857, DOI 10.1016/j.neuroimage.2003.07.023; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SEKULER RW, 1965, AM J PSYCHOL, V78, P686, DOI 10.2307/1420939; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; Sengpiel F, 1996, VISUAL NEUROSCI, V13, P145, DOI 10.1017/S0952523800007197; SHAPLEY R, 1981, NATURE, V292, P543, DOI 10.1038/292543a0; SHAPLEY RM, 2002, 7206 SOC NEUR; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P264, DOI 10.1152/jn.1984.52.2.264; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; SUR M, 1982, J NEUROPHYSIOL, V47, P869, DOI 10.1152/jn.1982.47.5.869; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Teich AF, 2006, J NEUROPHYSIOL, V96, P404, DOI 10.1152/jn.00015.2005; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908; Ursino M, 2004, VISION RES, V44, P1641, DOI 10.1016/j.visres.2004.02.005; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Varela JA, 1999, J NEUROSCI, V19, P4293; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Webb BS, 2002, VISUAL NEUROSCI, V19, P583, DOI 10.1017/S0952523802195046; Webster MA, 1997, J OPT SOC AM A, V14, P2355, DOI 10.1364/JOSAA.14.002355; WEBSTER MA, 1990, J OPT SOC AM A, V7, P1034, DOI 10.1364/JOSAA.7.001034; Westheimer G, 1999, VISION RES, V39, P1631, DOI 10.1016/S0042-6989(98)00200-4; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; Yeh TY, 1995, J NEUROSCI, V15, P7892; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	160	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4781	10.1371/journal.pone.0004781	http://dx.doi.org/10.1371/journal.pone.0004781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437OE	19274097	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496000019
J	Grosso, A; Douglas, I; Hingorani, A; MacAllister, R; Smeeth, L				Grosso, Anthony; Douglas, Ian; Hingorani, Aroon; MacAllister, Raymond; Smeeth, Liam			Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis	PLOS ONE			English	Article								Background: A recent trial unexpectedly reported that atrial fibrillation, when defined as serious, occurred more often in participants randomized to an annual infusion of the relatively new parenteral bisphosphonate, zoledronic acid, than among those given placebo, but had limited power. Two subsequent population-based case-control studies of patients receiving a more established oral bisphosphonate, alendronic acid, reported conflicting results, possibly due to uncontrolled confounding factors. Methodology/Principal Findings: We used the United Kingdom General Practice Research Database to assess the risk of atrial fibrillation and flutter in women exposed to the oral bisphosphonates, alendronic acid and risedronate sodium. The self-controlled case-series method was used to minimise the potential for confounding. The age-adjusted incidence rate ratio for atrial fibrillation or flutter in individuals during their exposure to these oral bisphosphonates (n = 2195) was 1.07 (95% CI 0.94 - 1.21). The age-adjusted incidence rate ratio for alendronic acid (n = 1489) and risedronate sodium (n = 649) exposed individuals were 1.09 (95% CI 0.93 - 1.26) and 0.99 (95% CI 0.78 - 1.26) respectively. In post-hoc analyses, an increased risk of incident atrial fibrillation or flutter was detected for patients during their first few months of alendronic acid therapy. Conclusions/Significance: We found no robust evidence of an overall long-term increased risk of atrial fibrillation or flutter associated with continued exposure to the oral bisphosphonates, alendronic acid and risedronate sodium. A possible signal for an increase in risk during the first few months of therapy with alendronic acid needs to be re-assessed in additional studies.	[Grosso, Anthony] Univ Coll London Hosp NHS Fdn Trust, Dept Pharm, London, England; [Grosso, Anthony; Hingorani, Aroon; MacAllister, Raymond] UCL, Ctr Clin Pharmacol, Div Med, London, England; [Douglas, Ian; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Hingorani, Aroon] UCL, Div Populat Hlth, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Grosso, A (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Dept Pharm, London, England.	anthony.grosso@uclh.nhs.uk	; Smeeth, Liam/X-5862-2018	Hingorani, Aroon/0000-0001-8365-0081; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [Senior Research Fellowship in Clinical Science]; British Heart Foundation [Senior Research Fellowship in Clinical Science]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	Liam Smeeth is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. Aroon Hingorani is a British Heart Foundation Senior Research Fellow.	Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Donahue JG, 2002, ARCH INTERN MED, V162, P936, DOI 10.1001/archinte.162.8.936; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Grosso A, 2008, BRIT J CLIN PHARMACO, V66, P689, DOI 10.1111/j.1365-2125.2008.03273.x; Heckbert SR, 2008, ARCH INTERN MED, V168, P826, DOI 10.1001/archinte.168.8.826; Hubbard R, 2005, THORAX, V60, P848, DOI 10.1136/thx.2005.041798; Karam R, 2007, NEW ENGL J MED, V357, P712; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Majumdar SR, 2008, BRIT MED J, V336, P784, DOI 10.1136/bmj.39513.481065.80; Mant J, 2007, BMJ-BRIT MED J, V335, P380, DOI 10.1136/bmj.39227.551713.AE; *MHRA, 2008, MHRA DRUG SAF UPD JU, V1; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Sorensen HT, 2008, BMJ-BRIT MED J, V336, P813, DOI 10.1136/bmj.39507.551644.BE; Whitaker H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1069; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	19	50	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4720	10.1371/journal.pone.0004720	http://dx.doi.org/10.1371/journal.pone.0004720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266096	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000265490800002
J	Striegl, H; Roske, Y; Kummel, D; Heinemann, U				Striegl, Harald; Roske, Yvette; Kuemmel, Daniel; Heinemann, Udo			Unusual Armadillo Fold in the Human General Vesicular Transport Factor p115	PLOS ONE			English	Article							PROTEIN; REPLACEMENT; COMPLEX	The golgin family gives identity and structure to the Golgi apparatus and is part of a complex protein network at the Golgi membrane. The golgin p115 is targeted by the GTPase Rab1a, contains a large globular head region and a long region of coiled-coil which forms an extended rod-like structure. p115 serves as vesicle tethering factor and plays an important role at different steps of vesicular transport. Here we present the 2.2 angstrom-resolution X-ray structure of the globular head region of p115. The structure exhibits an armadillo fold that is decorated by elongated loops and carries a C-terminal non-canonical repeat. This terminal repeat folds into the armadillo superhelical groove and allows homodimeric association with important implications for p115 mediated multiple protein interactions and tethering.	[Striegl, Harald; Roske, Yvette; Kuemmel, Daniel; Heinemann, Udo] Max Delbruck Ctr Mol Med, Berlin, Germany; [Heinemann, Udo] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin	Striegl, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	heinemann@mdc-berlin.de	Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850	Deutsche Forschungsgemeinschaft [SFB 740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through SFB 740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Delano W. L., 2003, PYMOL MOL GENETICS G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Heinemann U, 2003, ACCOUNTS CHEM RES, V36, P157, DOI 10.1021/ar010129t; Hofmann KP, 2006, TRENDS BIOCHEM SCI, V31, P497, DOI 10.1016/j.tibs.2006.07.006; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Satoh A, 2008, TRAFFIC, V9, P1522, DOI 10.1111/j.1600-0854.2008.00783.x; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053	30	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4656	10.1371/journal.pone.0004656	http://dx.doi.org/10.1371/journal.pone.0004656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247479	Green Published, gold			2022-12-25	WOS:000265487800035
J	Adio, S; Jaud, J; Ebbing, B; Rief, M; Woehlke, G				Adio, Sarah; Jaud, Johann; Ebbing, Bettina; Rief, Matthias; Woehlke, Guenther			Dissection of Kinesin's Processivity	PLOS ONE			English	Article								The protein family of kinesins contains processive motor proteins that move stepwise along microtubules. This mechanism requires the precise coupling of the catalytic steps in the two heads, and their precise mechanical coordination. Here we show that these functionalities can be uncoupled in chimera of processive and non-processive kinesins. A chimera with the motor domain of Kinesin-1 and the dimerization domain of a non-processive Kinesin-3 motor behaves qualitatively as conventional kinesin and moves processively in TIRF and bead motility assays, suggesting that spatial proximity of two Kinein-1 motor domains is sufficient for processive behavior. In the reverse chimera, the non-processive motor domains are unable to step along microtubules, despite the presence of the Kinesin-1 neck coiled coil. Still, ATP-binding to one head of these chimera induces ADP-release from the partner head, a characteristic feature of alternating site catalysis. These results show that processive movement of kinesin dimers requires elements in the motor head that respond to ADP-release and induce stepping, in addition to a proper spacing of the motor heads via the neck coiled coil.	[Adio, Sarah; Jaud, Johann; Ebbing, Bettina; Rief, Matthias; Woehlke, Guenther] Tech Univ Munich, Phys Dept E22, D-8046 Garching, Germany; [Rief, Matthias] Munich Ctr Integrated Protein Sci, Munich, Germany	Technical University of Munich	Adio, S (corresponding author), Tech Univ Munich, Phys Dept E22, D-8046 Garching, Germany.	guenther.woehlke@lrz.uni-muenchen.de	Lechner, Bettina/A-2448-2013	Adio, Sarah/0000-0002-6555-0850; Woehlke, Gunther/0000-0001-8462-9962	Deutsche Forschungsgemeinschaft DFG [SFB 614, SPP 1068, WO 614/4-1]; Fridrich-Baur-Foundation	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Fridrich-Baur-Foundation	The work presented was supported by public research funding by the Deutsche Forschungsgemeinschaft DFG (SFB 614, SPP 1068, and WO 614/4-1), and the Fridrich-Baur-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bathe F, 2005, MOL BIOL CELL, V16, P3529, DOI 10.1091/mbc.E04-11-0957; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 1999, NAT CELL BIOL, V1, pE163, DOI 10.1038/14113; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; Jaud J, 2006, BIOPHYS J, V91, P1407, DOI 10.1529/biophysj.105.076265; Kallipolitou A, 2001, EMBO J, V20, P6226, DOI 10.1093/emboj/20.22.6226; Lakamper S, 2005, BIOPHYS J, V89, P3223, DOI 10.1529/biophysj.104.057505; Lakamper S, 2003, BIOPHYS J, V84, P1833, DOI 10.1016/S0006-3495(03)74991-1; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MARX A, 2008, BIOCHEMISTRY; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Schafer F, 2003, EMBO J, V22, P450, DOI 10.1093/emboj/cdg036; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4612	10.1371/journal.pone.0004612	http://dx.doi.org/10.1371/journal.pone.0004612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242550	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487500014
J	Liu, WQ; Feng, Y; Wang, Y; Zou, QH; Chen, F; Guo, JT; Peng, YH; Jin, Y; Li, YG; Hu, SN; Johnston, RN; Liu, GR; Liu, SL				Liu, Wei-Qiao; Feng, Ye; Wang, Yan; Zou, Qing-Hua; Chen, Fang; Guo, Ji-Tao; Peng, Yi-Hong; Jin, Yan; Li, Yong-Guo; Hu, Song-Nian; Johnston, Randal N.; Liu, Gui-Rong; Liu, Shu-Lin			Salmonella paratyphi C: Genetic Divergence from Salmonella choleraesuis and Pathogenic Convergence with Salmonella typhi	PLOS ONE			English	Article							GENOMIC CLEAVAGE MAP; ENTERICA SEROTYPE CHOLERAESUIS; VIRULENCE PLASMID; TYPHIMURIUM; SEQUENCE; SEROVARS; STRAINS; ENTERITIDIS; CHROMOSOME; RECOMBINATION	Background: Although over 1400 Salmonella serovars cause usually self-limited gastroenteritis in humans, a few, e. g., Salmonella typhi and S. paratyphi C, cause typhoid, a potentially fatal systemic infection. It is not known whether the typhoid agents have evolved from a common ancestor (by divergent processes) or acquired similar pathogenic traits independently (by convergent processes). Comparison of different typhoid agents with non-typhoidal Salmonella lineages will provide excellent models for studies on how similar pathogens might have evolved. Methodologies/Principal Findings: We sequenced a strain of S. paratyphi C, RKS4594, and compared it with previously sequenced Salmonella strains. RKS4594 contains a chromosome of 4,833,080 bp and a plasmid of 55,414 bp. We predicted 4,640 intact coding sequences (4,578 in the chromosome and 62 in the plasmid) and 152 pseudogenes (149 in the chromosome and 3 in the plasmid). RKS4594 shares as many as 4346 of the 4,640 genes with a strain of S. choleraesuis, which is primarily a swine pathogen, but only 4008 genes with another human-adapted typhoid agent, S. typhi. Comparison of 3691 genes shared by all six sequenced Salmonella strains placed S. paratyphi C and S. choleraesuis together at one end, and S. typhi at the opposite end, of the phylogenetic tree, demonstrating separate ancestries of the human-adapted typhoid agents. S. paratyphi C seemed to have suffered enormous selection pressures during its adaptation to man as suggested by the differential nucleotide substitutions and different sets of pseudogenes, between S. paratyphi C and S. choleraesuis. Conclusions: S. paratyphi C does not share a common ancestor with other human-adapted typhoid agents, supporting the convergent evolution model of the typhoid agents. S. paratyphi C has diverged from a common ancestor with S. choleraesuis by accumulating genomic novelty during adaptation to man.	[Liu, Wei-Qiao; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China; [Liu, Wei-Qiao; Wang, Yan; Jin, Yan; Liu, Gui-Rong; Liu, Shu-Lin] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Feng, Ye; Hu, Song-Nian] Zhejiang Univ, JD Watson Inst Genome Sci, Hangzhou, Peoples R China; [Feng, Ye; Hu, Song-Nian] Chinese Acad Sci, Beijing Inst Genom, Beijing 100864, Peoples R China; [Zou, Qing-Hua; Chen, Fang; Guo, Ji-Tao; Peng, Yi-Hong; Liu, Gui-Rong; Liu, Shu-Lin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing, Peoples R China; [Li, Yong-Guo; Liu, Shu-Lin] Harbin Med Univ, Hosp 1, Dept Infect Dis, Harbin, Peoples R China; [Johnston, Randal N.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	Harbin Medical University; University of Calgary; Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Peking University; Harbin Medical University; University of Calgary	Liu, WQ (corresponding author), Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China.	grliu@ucalgary.ca; slliu@ucalgary.ca	Guo, Jitao/AAP-4971-2020; Johnston, Randal/B-9247-2009; Hu, Songnian/C-6509-2013	Guo, Jitao/0000-0002-0927-4249; Hu, Songnian/0000-0003-3966-3111; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	Canadian Institutes of Health Research; Harbin Medical University; National Natural Science Foundation of China [NSFC30370774, NSFC30870098]; Peking University Health Science Center; Specialized Research Fund for the Doctoral Program of Higher Education [20030001029]; Natural Sciences and Engineering Research Council of Canada [Discovery Grant]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Harbin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University Health Science Center(Peking University); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Canadian Institutes of Health Research grant to RNJ; and a grant of Harbin Medical University, National Natural Science Foundation of China grants (NSFC30370774, NSFC30870098), a 985 Project grant of Peking University Health Science Center, a Specialized Research Fund for the Doctoral Program of Higher Education (No. 20030001029), and a Discovery Grant from Natural Sciences and Engineering Research Council of Canada to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Alokam S, 2002, J BACTERIOL, V184, P6190, DOI 10.1128/JB.184.22.6190-6197.2002; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Chiu CH, 2006, PEDIATRICS, V117, pE1193, DOI 10.1542/peds.2005-2251; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Chu CS, 1999, INFECT IMMUN, V67, P2611, DOI 10.1128/IAI.67.5.2611-2614.1999; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; JACOBS MR, 1978, S AFR MED J, V54, P434; Jean Shio-Shin, 2006, Journal of Microbiology Immunology and Infection, V39, P358; Kariuki S, 1999, J CLIN MICROBIOL, V37, P2058, DOI 10.1128/JCM.37.6.2058-2060.1999; LAURENT E, 1979, NOUV PRESSE MED, V8, P1100; Ledeboer NA, 2006, INFECT IMMUN, V74, P3156, DOI 10.1128/IAI.01428-05; LEMINOR L, 1985, ANN INST PASTEUR MIC, V136B, P225, DOI 10.1016/S0769-2609(85)80047-8; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1995, J BACTERIOL, V177, P3355, DOI 10.1128/jb.177.11.3355-3357.1995; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; LIU SL, 1993, MOL MICROBIOL, V10, P655, DOI 10.1111/j.1365-2958.1993.tb00937.x; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; POPOFF M.Y., 2005, BERGEYS MANUAL SYSTE, V2, P764; RodriguezPena JM, 1997, MICROBIOL-UK, V143, P1405, DOI 10.1099/00221287-143-4-1405; ROOF MB, 1992, VET MICROBIOL, V30, P355, DOI 10.1016/0378-1135(92)90022-L; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; SELANDER RK, 1990, INFECT IMMUN, V58, P2262, DOI 10.1128/IAI.58.7.2262-2275.1990; Soravia-Dunand VA, 1999, CLIN INFECT DIS, V29, P862, DOI 10.1086/520450; Straw BE, 2006, DIS SWINE; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Tam CKP, 2004, INFECT IMMUN, V72, P22, DOI 10.1128/IAI.72.1.22-28.2004; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Uzzau S, 1999, EPIDEMIOL INFECT, V123, P37, DOI 10.1017/S0950268899002654; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005	45	78	682	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4510	10.1371/journal.pone.0004510	http://dx.doi.org/10.1371/journal.pone.0004510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229335	gold, Green Published, Green Submitted			2022-12-25	WOS:000265486200003
J	Medina-Martinez, O; Amaya-Manzanares, F; Liu, CM; Mendoza, M; Shah, R; Zhang, L; Behringer, RR; Mahon, KA; Jamrich, M				Medina-Martinez, Olga; Amaya-Manzanares, Felipe; Liu, Chaomei; Mendoza, Marisela; Shah, Rina; Zhang, Li; Behringer, Richard R.; Mahon, Kathleen A.; Jamrich, Milan			Cell-Autonomous Requirement for Rx Function in the Mammalian Retina and Posterior Pituitary	PLOS ONE			English	Article								Rx is a paired-like homeobox gene that is required for vertebrate eye formation. Mice lacking Rx function do not develop eyes or the posterior pituitary. To determine whether Rx is required cell autonomously in these tissues, we generated embryonic chimeras consisting of wild type and Rx2/2 cells. We found that in the eye, Rx-deficient cells cannot participate in the formation of the neuroretina, retina pigment epithelium and the distal part of the optic stalk. In addition, in the ventral forebrain, Rx function is required cell autonomously for the formation of the posterior pituitary. Interestingly, Rx-/- and wild type cells segregate before the morphogenesis of these two tissues begins. Our observations suggest that Rx function is not only required for the morphogenesis of the retina and posterior pituitary, but also prior to morphogenesis, for the sorting out of cells to form distinct fields of retinal/pituitary cells.	[Medina-Martinez, Olga; Liu, Chaomei; Jamrich, Milan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Amaya-Manzanares, Felipe; Mendoza, Marisela; Shah, Rina; Zhang, Li; Mahon, Kathleen A.; Jamrich, Milan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Behringer, Richard R.] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Medina-Martinez, O (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jamrich@bcm.tmc.edu			NIH/NEI [EY12505, EY12163, T32 EY07102]; Retina Research Foundation; NATIONAL EYE INSTITUTE [T32EY007102, R01EY012505, R01EY012163] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was sponsored by NIH/NEI grants EY12505 and EY12163 to M.J., NIH/NEI training grant T32 EY07102 to O.M. and by the Retina Research Foundation to M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreazzoli M, 2003, DEVELOPMENT, V130, P5143, DOI 10.1242/dev.00665; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Ericson J, 1998, DEVELOPMENT, V125, P1005; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; GARDNER RL, 1968, NATURE, V220, P596, DOI 10.1038/220596a0; Gardner RL, 2000, METH MOL B, V135, P397; GARDNER RL, 1975, S SOC DEV BIOL, V33, P207; Hermesz E, 1996, DEVELOPMENT, V122, P41; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Kennedy BN, 2004, DEV BIOL, V270, P336, DOI 10.1016/j.ydbio.2004.02.026; Kondoh H, 2000, MECH DEVELOP, V96, P165, DOI 10.1016/S0925-4773(00)00387-7; Li X, 2002, SCIENCE, V297, P1180; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 2001, DEVELOPMENT, V128, P4035; Lopez-Rios J, 1999, MECH DEVELOP, V83, P155, DOI 10.1016/S0925-4773(99)00017-9; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; NAGY A, 2000, MANIPULATING MOUSE E; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ohuchi H, 1999, MECH DEVELOP, V85, P193, DOI 10.1016/S0925-4773(99)00094-5; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rojas-Munoz A, 2005, DEV BIOL, V288, P348, DOI 10.1016/j.ydbio.2005.08.046; Rosenfeld MG, 2000, RECENT PROG HORM RES, V55, P1; Schwind JL, 1928, AM J ANAT, V41, P295, DOI 10.1002/aja.1000410206; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Stigloher C, 2006, DEVELOPMENT, V133, P2925, DOI 10.1242/dev.02450; Swindell EC, 2008, DEV BIOL, V322, P56, DOI 10.1016/j.ydbio.2008.07.009; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Takuma N, 1998, DEVELOPMENT, V125, P4835; Terada K, 2006, DEV BIOL, V291, P398, DOI 10.1016/j.ydbio.2005.12.029; Toy J, 1999, MECH DEVELOP, V83, P183, DOI 10.1016/S0925-4773(99)00049-0; Toy J, 1998, P NATL ACAD SCI USA, V95, P10643, DOI 10.1073/pnas.95.18.10643; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Tucker P, 2001, GENESIS, V31, P43, DOI 10.1002/gene.10003; Volokh KY, 2006, INT J DEV BIOL, V50, P359, DOI 10.1387/ijdb.052039kv; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Winkler S, 2000, DEVELOPMENT, V127, P1911; Zhang L, 2000, GENESIS, V28, P135, DOI 10.1002/1526-968X(200011/12)28:3/4<135::AID-GENE70>3.0.CO;2-P; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	47	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4513	10.1371/journal.pone.0004513	http://dx.doi.org/10.1371/journal.pone.0004513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229337	Green Submitted, Green Published, gold			2022-12-25	WOS:000265486200004
J	Yamasaki, K; Muto, J; Taylor, KR; Cogen, AL; Audish, D; Bertin, J; Grant, EP; Coyle, AJ; Misaghi, A; Hoffman, HM; Gallo, RL				Yamasaki, Kenshi; Muto, Jun; Taylor, Kristen R.; Cogen, Anna L.; Audish, David; Bertin, John; Grant, Ethan P.; Coyle, Anthony J.; Misaghi, Amirhossein; Hoffman, Hal M.; Gallo, Richard L.			NLRP3/Cryopyrin Is Necessary for Interleukin-1 beta (IL-1 beta) Release in Response to Hyaluronan, an Endogenous Trigger of Inflammation in Response to Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; MUCKLE-WELLS-SYNDROME; ANGIOGENIC OLIGOSACCHARIDES; MURINE MACROPHAGES; MOUSE MACROPHAGES; MEDIATED ENDOCYTOSIS; DIAMINOPIMELIC ACID; DEPENDENT MECHANISM; CROHNS-DISEASE; CD44	Inflammation under sterile conditions is a key event in autoimmunity and following trauma. Hyaluronan, a glycosaminoglycan released from the extracellular matrix after injury, acts as an endogenous signal of trauma and can trigger chemokine release in injured tissue. Here, we investigated whether NLRP3/cryopyrin, a component of the inflammasome, participates in the inflammatory response to injury or the cytokine response to hyaluronan. Mice with a targeted deletion in cryopyrin showed a normal increase in Cxcl2 in response to sterile injuries but had decreased inflammation and release of interleukin-1 beta (IL-1 beta). Similarly, the addition of hyaluronan to macrophages derived from cryopyrin-deficient mice increased release of Cxcl2 but did not increase IL-1 beta release. To define the mechanism of hyaluronan-mediated activation of cryopyrin, elements of the hyaluronan recognition process were studied in detail. IL-1 beta release was inhibited in peritoneal macrophages derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or by inhibitors of lysosome function. The requirement for CD44 binding and hyaluronan internalization could be bypassed by intracellular administration of hyaluronan oligosaccharides (10-18-mer) in lipopolysaccharide-primed macrophages. Therefore, the action of CD44 and subsequent hyaluronan catabolism trigger the intracellular cryopyrin -> IL-1 beta pathway. These findings support the hypothesis that hyaluronan works through IL-1 beta and the cryopyrin system to signal sterile inflammation.	[Yamasaki, Kenshi; Muto, Jun; Taylor, Kristen R.; Cogen, Anna L.; Audish, David; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92161 USA; [Yamasaki, Kenshi; Muto, Jun; Taylor, Kristen R.; Cogen, Anna L.; Audish, David; Gallo, Richard L.] Vet Affairs San Diego Hlth Care Syst, San Diego, CA 92161 USA; [Misaghi, Amirhossein; Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92161 USA; [Hoffman, Hal M.] Ludwig Inst Canc Res, San Diego, CA 92161 USA; [Bertin, John; Grant, Ethan P.; Coyle, Anthony J.] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Gallo, RL (corresponding author), MC 9111B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	rgallo@ucsd.edu	Grant, Ethan/GQP-2720-2022; Yamasaki, Kenshi/C-8905-2018; Gallo, Richard L/A-8931-2009	Yamasaki, Kenshi/0000-0002-5495-4956; Gallo, Richard L/0000-0002-1401-7861	National Institutes of Health [P01-HL057345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL057345 (to R. L. G.).	AFIFY AM, 1993, ARCH BIOCHEM BIOPHYS, V305, P434, DOI 10.1006/abbi.1993.1443; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; *APPL BIOS, 2001, US B APPL BIOS, V2; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Berg S, 1997, J INTERN MED, V242, P73, DOI 10.1046/j.1365-2796.1997.00177.x; BERG S, 1988, SCAND J CLIN LAB INV, V48, P727, DOI 10.3109/00365518809088752; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; CULTY M, 1992, J CELL BIOL, V116, P1055, DOI 10.1083/jcb.116.4.1055; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horton MR, 1999, J IMMUNOL, V162, P4171; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; HUA Q, 1993, J CELL SCI, V106, P365; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kile RL., 1940, J AM MED ASS, V114, P1067, DOI [10.1001/jama.1940.62810120003010b, DOI 10.1001/JAMA.1940.62810120003010B]; Lago G, 2005, CARBOHYD POLYM, V62, P321, DOI 10.1016/j.carbpol.2005.04.014; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; ONARHEIM H, 1992, CIRC SHOCK, V37, P159; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Vachon E, 2006, BLOOD, V107, P4149, DOI 10.1182/blood-2005-09-3808; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	76	214	221	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12762	12771		10.1074/jbc.M806084200	http://dx.doi.org/10.1074/jbc.M806084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19258328	Green Published, hybrid			2022-12-25	WOS:000265688300021
J	Zhou, XD; Agazie, YM				Zhou, Xiangdong; Agazie, Yehenew M.			Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; GROWTH-FACTOR RECEPTOR; ACUTE MYELOID-LEUKEMIA; BASEMENT-MEMBRANE CULTURES; SUBSTRATE-TRAPPING MUTANT; PDGF-BETA-RECEPTOR; PTPN11 MUTATIONS; NOONAN-SYNDROME; BREAST-CANCER; FOCAL ADHESION	The Src homology phosphotyrosyl phosphatase 2 (SHP2) plays a positive role in HER2-induced signaling and transformation, but its mechanism of action is poorly understood. Given the significance of HER2 in breast cancer, defining a mechanism for SHP2 in the HER2 signaling pathway is of paramount importance. In the current report we show that SHP2 positively modulates the Ras-extracellular signal-regulated kinase 1 and 2 and the phospoinositide-3-kinase-Akt pathways downstream of HER2 by increasing the half-life the activated form of Ras. This is accomplished by dephosphorylating an autophosphorylation site on HER2 that serves as a docking platform for the SH2 domains of the Ras GTPase-activating protein (RasGAP). The net effect is an increase in the intensity and duration of GTP-Ras levels with the overall impact of enhanced HER2 signaling and cell transformation. In conformity to these findings, the HER2 mutant that lacks the SHP2 target site exhibits an enhanced signaling and cell transformation potential. Therefore, SHP2 promotes HER2-induced signaling and transformation at least in part by dephosphorylating a negative regulatory autophosphorylation site. These results suggest that SHP2 might serve as a therapeutic target against breast cancer and other cancers characterized by HER2 overexpression.	[Zhou, Xiangdong; Agazie, Yehenew M.] W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Agazie, Yehenew M.] W Virginia Univ, Marry Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Agazie, YM (corresponding author), W Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA.	yagazie@hsc.wvu.edu			National Institutes of Health [CA124940]; NATIONAL CANCER INSTITUTE [R01CA124940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124940 (NCI, to Y. M. A.).	Agazie Y, 2002, ONCOGENE, V21, P697, DOI 10.1038/sj.onc.1205115; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Agazie YM, 2003, ONCOGENE, V22, P6909, DOI 10.1038/sj.onc.1206798; Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Badache A, 2006, J MAMMARY GLAND BIOL, V11, P13, DOI 10.1007/s10911-006-9009-1; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Burks J, 2006, ONCOGENE, V25, P7166, DOI 10.1038/sj.onc.1209728; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; DI FP, 1987, CELL, V51, P1063; FENG GS, 1994, ONCOGENE, V9, P1545; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Frearson JA, 1998, J EXP MED, V187, P1417, DOI 10.1084/jem.187.9.1417; GERLACH MS, 1995, J BIOL CHEM, V270, P24635, DOI 10.1074/jbc.270.42.24635; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Manes S, 1999, MOL CELL BIOL, V19, P3125; Merritt R, 2006, BBA-MOL CELL RES, V1763, P45, DOI 10.1016/j.bbamcr.2005.11.013; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; PASLEAU F, 1993, ONCOGENE, V8, P849; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1995, METHOD ENZYMOL, V254, P523; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	49	46	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12226	12234		10.1074/jbc.M900020200	http://dx.doi.org/10.1074/jbc.M900020200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261604	Green Published			2022-12-25	WOS:000265494600054
J	Chen, KF; Yeh, PY; Hsu, C; Hsu, CH; Lu, YS; Hsieh, HP; Chen, PJ; Cheng, AL				Chen, Kuen-Feng; Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Hsieh, Hsing-Pang; Chen, Pei-Jer; Cheng, Ann-Lii			Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; PROSTATE-CANCER CELLS; NF-KAPPA-B; RECEPTOR-MEDIATED APOPTOSIS; PROTEASOME INHIBITOR; C-FLIP; MULTIPLE-MYELOMA; DOWN-REGULATION; UP-REGULATION; DEATH	Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies. Recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anti-tumor agent. However, many HCC cells show resistance to TRAIL-induced apoptosis. In this study, we showed that bortezomib, a proteasome inhibitor, overcame TRAIL resistance in HCC cells, including Huh-7, Hep3B, and Sk-Hep1. The combination of bortezomib and TRAIL restored the sensitivity of HCC cells to TRAIL-induced apoptosis. Comparing the molecular change in HCC cells treated with these agents, we found that down-regulation of phospho-Akt (P-Akt) played a key role in mediating TRAIL sensitization of bortezomib. The first evidence was that bortezomib down-regulated P-Akt in a dose-and time-dependent manner in TRAIL-treated HCC cells. Second, LY294002, a PI3K inhibitor, also sensitized resistant HCC cells to TRAIL-induced apoptosis. Third, knocking down Akt1 by small interference RNA also enhanced TRAIL-induced apoptosis in Huh-7 cells. Finally, ectopic expression of mutant Akt (constitutive active) in HCC cells abolished TRAIL sensitization effect of bortezomib. Moreover, okadaic acid, a protein phosphatase 2A (PP2A) inhibitor, reversed down-regulation of P-Akt in bortezomib-treated cells, and PP2A knockdown by small interference RNA also reduced apoptosis induced by the combination of TRAIL and bortezomib, indicating that PP2A may be important in mediating the effect of bortezomib on TRAIL sensitization. Together, bortezomib overcame TRAIL resistance at clinically achievable concentrations in hepatocellular carcinoma cells, and this effect is mediated at least partly via inhibition of the PI3K/Akt pathway.	[Chen, Kuen-Feng; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Chen, Kuen-Feng; Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Chen, Pei-Jer; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Chen, Kuen-Feng; Yeh, Pei-Yen; Hsu, Chiun; Hsu, Chih-Hung; Lu, Yen-Shen; Chen, Pei-Jer; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei, Taiwan; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Canc Res, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Cheng, AL (corresponding author), 7 Chung Shan S Rd, Taipei, Taiwan.	alcheng@ntu.edu.tw	Hsieh, Hsing-Pang/B-2649-2010	Hsieh, Hsing-Pang/0000-0002-1332-005X; Chen, Kuen-Feng/0000-0002-4686-7019; Chen, Pei-Jer/0000-0001-8316-3785; Hsu, Chiun/0000-0002-1122-0055; Lu, Yen-Shen/0000-0001-7461-1291; HSU, CHIH-HUNG/0000-0003-0495-973X; Cheng, Ann-Lii/0000-0002-9152-6512	National Taiwan University [NTUH (95-96) A11, NTUH97A07, NTU95R0066-BM-1-02]; National Science Council, Taiwan, Republic of China [NSC95-2314-B-002-072]; Department of Health, Executive Yuan, Republic of China [DOH (94-96) TD-B-111-001]	National Taiwan University(National Taiwan University); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Republic of China	This work was supported by National Taiwan University Grant NTUH (95-96) A11, NTUH97A07; National Science Council, Taiwan, Republic of China, Grant NSC95-2314-B-002-072; National Taiwan University Grant NTU95R0066-BM-1-02; and Department of Health, Executive Yuan, Republic of China, Grant DOH (94-96) TD-B-111-001.	Burns TF, 2001, J BIOL CHEM, V276, P37879; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; Conticello C, 2007, J CLIN ENDOCR METAB, V92, P1938, DOI 10.1210/jc.2006-2157; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Hallett WHD, 2008, J IMMUNOL, V180, P163, DOI 10.4049/jimmunol.180.1.163; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hideshima T, 2001, CANCER RES, V61, P3071; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Koschny R, 2007, CLIN CANCER RES, V13, P3403, DOI 10.1158/1078-0432.CCR-07-0251; Koschny R, 2007, HEPATOLOGY, V45, P649, DOI 10.1002/hep.21555; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Lashinger LM, 2005, CANCER RES, V65, P4902, DOI 10.1158/0008-5472.CAN-04-3701; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Liu FT, 2008, BLOOD, V111, P2797, DOI 10.1182/blood-2007-08-110445; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lu GR, 2008, CANCER BIOL THER, V7, P603, DOI 10.4161/cbt.7.4.5564; Lundqvist A, 2006, CANCER RES, V66, P7317, DOI 10.1158/0008-5472.CAN-06-0680; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Nagy K, 2006, PATHOL ONCOL RES, V12, P133, DOI 10.1007/BF02893359; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Nencioni A, 2005, CLIN CANCER RES, V11, P4259, DOI 10.1158/1078-0432.CCR-04-2496; Nikrad M, 2005, MOL CANCER THER, V4, P443; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Shanker A, 2008, JNCI-J NATL CANCER I, V100, P649, DOI 10.1093/jnci/djn113; Smith MR, 2007, CLIN CANCER RES, V13, p5528S, DOI 10.1158/1078-0432.CCR-07-0982; Strauss SJ, 2007, CANCER RES, V67, P2783, DOI 10.1158/0008-5472.CAN-06-3254; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Thorpe JA, 2008, PROSTATE, V68, P200, DOI 10.1002/pros.20706; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Voortman J, 2007, MOL CANCER THER, V6, P2103, DOI 10.1158/1535-7163.MCT-07-0167; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Zhao XX, 2008, LEUKEMIA RES, V32, P275, DOI 10.1016/j.leukres.2007.05.024; Zhu HB, 2005, CANCER BIOL THER, V4, P781, DOI 10.4161/cbt.4.7.1897; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683	48	83	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11121	11133		10.1074/jbc.M806268200	http://dx.doi.org/10.1074/jbc.M806268200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261616	Green Published, hybrid			2022-12-25	WOS:000265494500016
J	Gobert, RP; van den Eijnden, M; Szyndralewiez, C; Jorand-Lebrun, C; Swinnen, D; Chen, LF; Gillieron, C; Pixley, F; Juillard, P; Gerber, P; Johnson-Leger, C; Halazy, S; Camps, M; Bombrun, A; Shipp, M; Vitte, PA; Ardissone, V; Ferrandi, C; Perrin, D; Rommel, C; van Huijsduijnen, RH				Gobert, Rosanna Pescini; van den Eijnden, Monique; Szyndralewiez, Cedric; Jorand-Lebrun, Catherine; Swinnen, Dominique; Chen, Linfeng; Gillieron, Corine; Pixley, Fiona; Juillard, Pierre; Gerber, Patrick; Johnson-Leger, Caroline; Halazy, Serge; Camps, Montserrat; Bombrun, Agnes; Shipp, Margaret; Vitte, Pierre-Alain; Ardissone, Vittoria; Ferrandi, Chiara; Perrin, Dominique; Rommel, Christian; van Huijsduijnen, Rob Hooft			GLEPP1/Protein-tyrosine Phosphatase phi Inhibitors Block Chemotaxis in Vitro and in Vivo and Improve Murine Ulcerative Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR-TYPE-O; GROWTH-HORMONE RECEPTOR; MOLECULAR-CLONING; IMMUNE-RESPONSE; PTP-OC; EXPRESSION; IDENTIFICATION; SYK; PROMOTER	We describe novel, cell-permeable, and bioavailable salicylic acid derivatives that are potent and selective inhibitors of GLEPP1/protein-tyrosine phosphatase phi. Two previously described GLEPP1 substrates, paxillin and Syk, are both required for cytoskeletal rearrangement and cellular motility of leukocytes in chemotaxis. We show here that GLEPP1 inhibitors prevent dephosphorylation of Syk1 and paxillin in resting cells and block primary human monocyte and mouse bone marrow-derived macrophage chemotaxis in a gradient of monocyte chemotactic protein-1. In mice, the GLEPP1 inhibitors also reduce thioglycolate-induced peritoneal chemotaxis of neutrophils, lymphocytes, and macrophages. In murine disease models, the GLEPP1 inhibitors significantly reduce severity of contact hypersensitivity, a model for allergic dermatitis, and dextran sulfate sodium-induced ulcerative colitis, a model for inflammatory bowel disease. Taken together, our data provide confirmation that GLEPP1 plays an important role in controlling chemotaxis of multiple types of leukocytes and that pharmacological inhibition of this phosphatase may have therapeutic use.	[Gobert, Rosanna Pescini; van den Eijnden, Monique; Szyndralewiez, Cedric; Jorand-Lebrun, Catherine; Swinnen, Dominique; Gillieron, Corine; Juillard, Pierre; Gerber, Patrick; Johnson-Leger, Caroline; Halazy, Serge; Camps, Montserrat; Bombrun, Agnes; Vitte, Pierre-Alain; Perrin, Dominique; Rommel, Christian; van Huijsduijnen, Rob Hooft] Merck Serono Int, CH-1211 Geneva, Switzerland; [Chen, Linfeng; Shipp, Margaret] Dana Farber Canc Inst, Boston, MA 02115 USA; [Pixley, Fiona] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Ardissone, Vittoria; Ferrandi, Chiara] Merck Serono Ist Ric Biomed Antoine Marxer, I-10010 Colleretto Giacosa, TO, Italy	Merck KGaA; EMD Serono Inc.; Harvard University; Dana-Farber Cancer Institute; University of Western Australia; Merck KGaA; EMD Serono Inc.	van Huijsduijnen, RH (corresponding author), Merck Serono Int, 9 Chemin Mines, CH-1211 Geneva, Switzerland.	rob.hooft@merckserono.net	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009; Pixley, Fiona/ABD-5567-2020	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Pixley, Fiona/0000-0002-1571-2532; Camps, Montserrat/0000-0002-9849-8657	European Union Research Training Network [MRTN-CT-2006-035830]	European Union Research Training Network(European Commission)	Supported by European Union Research Training Network Grant MRTN-CT-2006-035830.	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Amoui M, 2003, J BIOL CHEM, V278, P44273, DOI 10.1074/jbc.M303933200; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; DENOTTER W, 1982, EXP MOL PATHOL, V36, P403; Dolton GM, 2006, BIOCHEM SOC T, V34, P1041, DOI 10.1042/BST0341041; Erbe DV, 2005, MOL PHARMACOL, V67, P69, DOI 10.1124/mol.104.005553; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Garaczi E, 2004, INT IMMUNOL, V16, P1781, DOI 10.1093/intimm/dxh179; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Jinquan T, 2001, J IMMUNOL, V167, P4405, DOI 10.4049/jimmunol.167.8.4405; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Luangdilok S, 2007, CANCER RES, V67, P7907, DOI 10.1158/0008-5472.CAN-07-0331; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mori Y, 2004, CANCER RES, V64, P2434, DOI 10.1158/0008-5472.CAN-03-3508; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Mustelin T, 2003, IMMUNOL REV, V191, P139, DOI 10.1034/j.1600-065X.2003.00014.x; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Pilecka I, 2007, J BIOL CHEM, V282, P35405, DOI 10.1074/jbc.M705814200; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; PIXLEY FJ, 1995, J BIOL CHEM, V270, P27339, DOI 10.1074/jbc.270.45.27339; Pixley FJ, 2001, MOL CELL BIOL, V21, P1795, DOI 10.1128/MCB.21.5.1795-1809.2001; SEIMIYA H, 1993, CELL GROWTH DIFFER, V4, P1033; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Stepanek L, 2005, J NEUROSCI, V25, P3813, DOI 10.1523/JNEUROSCI.4531-04.2005; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suhr SM, 2001, J BONE MINER RES, V16, P1795, DOI 10.1359/jbmr.2001.16.10.1795; THOMAS PE, 1994, J BIOL CHEM, V269, P19953; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van Huijsduijnen RH, 2004, J MED CHEM, V47, P4142, DOI 10.1021/jm030629n; van Huijsduijnen RH, 2002, DRUG DISCOV TODAY, V7, P1013, DOI 10.1016/S1359-6446(02)02438-8; van Huijsduijnen RH, 2006, J MOL MED, V84, P802, DOI 10.1007/s00109-006-0080-2; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Walchli S, 2000, J BIOL CHEM, V275, P9792, DOI 10.1074/jbc.275.13.9792; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; Wu LW, 1996, BIOCHEM J, V316, P515, DOI 10.1042/bj3160515; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001; Yang JH, 2007, ARCH BIOCHEM BIOPHYS, V465, P72, DOI 10.1016/j.abb.2007.04.032; Yang JH, 2007, FEBS LETT, V581, P2503, DOI 10.1016/j.febslet.2007.04.063; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	53	11	12	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11385	11395		10.1074/jbc.M807241200	http://dx.doi.org/10.1074/jbc.M807241200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19233845	Green Published, hybrid			2022-12-25	WOS:000265494500043
J	Ogilvie, RL; SternJohn, JR; Rattenbacher, B; Vlasova, IA; Williams, DA; Hau, HH; Blackshear, PJ; Bohjanen, PR				Ogilvie, Rachel L.; SternJohn, Julius R.; Rattenbacher, Bernd; Vlasova, Irina A.; Williams, Darlisha A.; Hau, Heidi H.; Blackshear, Perry J.; Bohjanen, Paul R.			Tristetraprolin Mediates Interferon-gamma mRNA Decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; GENOME-WIDE ANALYSIS; RICH ELEMENT; HUMAN-MONOCYTES; BINDING PROTEIN; GENE-EXPRESSION; ELAV PROTEIN; STABILITY; PATHWAY; STABILIZATION	Tristetraprolin (TTP) regulates expression at the level of mRNA decay of several cytokines, including the T cell-specific cytokine, interleukin-2. We performed experiments to determine whether another T cell-specific cytokine, interferon-gamma (IFN-gamma), is also regulated by TTP and found that T cell receptoractivatedTcells fromTTPknock-out mice overproduced IFN-gamma mRNA and protein compared with activated T cells from wild-type mice. The half-life of IFN-gamma mRNA was 23 min in anti-CD3-stimulated T cells from wild-type mice, whereas it was 51 min in anti-CD3-stimulated T cells from TTP knock-out mice, suggesting that the overexpression of IFN-gamma mRNA in TTP knock-out mice was due to stabilization of IFN-gamma mRNA. Insertion of a 70-nucleotide AU-rich sequence from the murine IFN-gamma 3'-untranslated region, which contained a high affinity binding site for TTP, into the 3'-untranslated region of a beta-globin reporter transcript conferred TTP-dependent destabilization on the beta-globin transcript. Together these results suggest that TTP binds to a functional AU-rich element in the 3'-untranslated region of IFN-gamma mRNA and mediates rapid degradation of the IFN-gamma transcript. Thus, TTP plays an important role in turning off IFN-gamma expression at the appropriate time during an immune response.	[SternJohn, Julius R.; Rattenbacher, Bernd; Vlasova, Irina A.; Williams, Darlisha A.; Bohjanen, Paul R.] Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Ogilvie, Rachel L.; Vlasova, Irina A.; Hau, Heidi H.; Bohjanen, Paul R.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Ogilvie, Rachel L.; SternJohn, Julius R.; Rattenbacher, Bernd; Vlasova, Irina A.; Williams, Darlisha A.; Hau, Heidi H.; Bohjanen, Paul R.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bohjanen, Paul R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Blackshear, Perry J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bohjanen, PR (corresponding author), Univ Minnesota, Ctr Infect Dis & Microbiol Translat Res, 2001 6th St S E,Rm 3-214,Delivery Code 2873, Minneapolis, MN 55455 USA.	bohja001@umn.edu	Louis, Vlasova-St./ABC-1933-2020; Blackshear, Perry J./C-6206-2019; Bohjanen, Paul/B-2329-2015	Blackshear, Perry J./0000-0002-9561-8529; Bohjanen, Paul/0000-0002-2772-3597; Rattenbacher, Bernd/0000-0003-1435-0100; Vlasova-St. Louis, Irina/0000-0003-0795-4723	National Institutes of Health [R56AI057484, R01AI072068, T32AI007313, T32DE007288]; Lymphoma Research Foundation; Swiss National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072068, T32AI007313, R56AI057484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R56AI057484, R01AI072068, T32AI007313, and T32DE007288. This work was also supported by fellowships from the Lymphoma Research Foundation and the Swiss National Science Foundation.	Atasoy U, 1998, J CELL SCI, V111, P3145; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Briscoe J, 1996, TRENDS CELL BIOL, V6, P336, DOI 10.1016/0962-8924(96)10028-3; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; COLTEN HR, 1986, CIBA F SYMP, V118, P141, DOI 10.1002/9780470720998.ch10; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; Spoelstra FM, 1999, EUR RESPIR J, V14, P759, DOI 10.1034/j.1399-3003.1999.14d06.x; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; STRUNK RC, 1985, J BIOL CHEM, V260, P5280; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; VINCENT F, 1993, DNA CELL BIOL, V12, P415, DOI 10.1089/dna.1993.12.415; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200	59	92	95	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11216	11223		10.1074/jbc.M901229200	http://dx.doi.org/10.1074/jbc.M901229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258311	hybrid, Green Published			2022-12-25	WOS:000265494500025
J	Sakamoto, K; Ito, Y; Hatanaka, T; Soni, PB; Mori, T; Sugimura, K				Sakamoto, Kotaro; Ito, Yuji; Hatanaka, Takaaki; Soni, Preeti Brijiral; Mori, Toshiyuki; Sugimura, Kazuhisa			Discovery and Characterization of a Peptide Motif That Specifically Recognizes a Non-native Conformation of Human IgG Induced by Acidic pH Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; PHAGE DISPLAY; PROTEIN-A; AFFINITY PURIFICATION; SYNTHETIC LIGAND; IMMUNOGLOBULIN-G; LIBRARY; BINDING; DESIGN; REGION	In therapeutic antibody preparation, acidic pH conditions are generally used for elution from Protein A affinity column of IgG or for its viral inactivation. Exposing IgG to low pH conditions induces conformational changes, leading to its functional damage or loss, although the mechanisms have not been fully elucidated. In this study using random peptide T7 phage display libraries, we isolated a unique and novel peptide motif that specifically recognized the non-native conformer ( acid conformer) of human IgG that was generated by the low pH treatment, but not the native conformer. We examined the generation conditions and biochemical properties of acid conformer using the peptide motif as an affinity ligand. The acid conformer was easily generated at acidic pH (<pH 3.0) and at moderate temperatures (20-40 degrees C). The conformer was present in a monomeric form functionally maintaining antigen or Fc receptor binding, but showed a tendency to aggregate with a long incubation time at neutral pH (>25 degrees C). The peptides isolated here could contribute to the elucidation of the mechanisms of antibody dysfunction or aggregation during acid exposure as well as storage of human IgG.	[Sakamoto, Kotaro; Ito, Yuji; Hatanaka, Takaaki; Sugimura, Kazuhisa] Kagoshima Univ, Fac Engn, Kagoshima 8900065, Japan; [Mori, Toshiyuki] NCI, Mol Targets Dev Program, Ctr Canc Res, NIH, Ft Detrick, MD 21702 USA; [Ito, Yuji; Soni, Preeti Brijiral] Japan Sci & Technol Agcy, Innovat Satellite Miyazaki, Miyazaki 8800805, Japan	Kagoshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Japan Science & Technology Agency (JST)	Ito, Y (corresponding author), Kagoshima Univ, Fac Engn, Kagoshima 8900065, Japan.	yito@be.kagoshima-u.ac.jp		Hatanaka, Takaaki/0000-0002-1154-6004	National Institutes of Health NCI Center for Cancer Research; Japan Science and Technology Agency.	National Institutes of Health NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Science and Technology Agency.(Japan Science & Technology Agency (JST))	This work was supported, in whole or in part, by the National Institutes of Health NCI Center for Cancer Research ( Intramural Research Program). This work was also supported by funds from the Japan Science and Technology Agency.	Boonyarattanakalin S, 2006, J AM CHEM SOC, V128, P11463, DOI 10.1021/ja062377w; Brorson K, 2003, BIOTECHNOL BIOENG, V82, P321, DOI 10.1002/bit.10574; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Castagnoli L, 2001, COMB CHEM HIGH T SCR, V4, P121; D'Agostino B, 2008, J IMMUNOL METHODS, V333, P126, DOI 10.1016/j.jim.2008.01.014; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; Ehrlich GK, 1998, J MOL RECOGNIT, V11, P121, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<121::AID-JMR406>3.0.CO;2-Z; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Fassina G, 1998, J MOL RECOGNIT, V11, P128, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<128::AID-JMR408>3.0.CO;2-8; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Herman RE, 2007, J BIOL CHEM, V282, P9813, DOI 10.1074/jbc.M610722200; Krook M, 1998, J IMMUNOL METHODS, V221, P151, DOI 10.1016/S0022-1759(98)00177-X; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Li RX, 1998, NAT BIOTECHNOL, V16, P190, DOI 10.1038/nbt0298-190; MARTSEV SP, 1995, FEBS LETT, V361, P173, DOI 10.1016/0014-5793(95)00145-Y; Newkirk MM, 2002, CLIN IMMUNOL, V104, P1, DOI 10.1006/clim.2002.5210; Sethuraman N, 2006, CURR OPIN BIOTECH, V17, P341, DOI 10.1016/j.copbio.2006.06.010; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; Verdoliva A, 2005, CHEMBIOCHEM, V6, P1242, DOI 10.1002/cbic.200400368; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002	22	30	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2009	284	15					9986	9993		10.1074/jbc.M807618200	http://dx.doi.org/10.1074/jbc.M807618200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	429AJ	19233852	Green Published, hybrid			2022-12-25	WOS:000264892900041
J	Demontis, F; Dahmann, C				Demontis, Fabio; Dahmann, Christian			Characterization of the Drosophila Ortholog of the Human Usher Syndrome Type 1G Protein Sans	PLOS ONE			English	Article								Background: The Usher syndrome (USH) is the most frequent deaf-blindness hereditary disease in humans. Deafness is attributed to the disorganization of stereocilia in the inner ear. USH1, the most severe subtype, is associated with mutations in genes encoding myosin VIIa, harmonin, cadherin 23, protocadherin 15, and sans. Myosin VIIa, harmonin, cadherin 23, and protocadherin 15 physically interact in vitro and localize to stereocilia tips in vivo, indicating that they form functional complexes. Sans, in contrast, localizes to vesicle-like structures beneath the apical membrane of stereocilia-displaying hair cells. How mutations in sans result in deafness and blindness is not well understood. Orthologs of myosin VIIa and protocadherin 15 have been identified in Drosophila melanogaster and their genetic analysis has identified essential roles in auditory perception and microvilli morphogenesis, respectively. Principal Findings: Here, we have identified and characterized the Drosophila ortholog of human sans. Drosophila Sans is expressed in tubular organs of the embryo, in lens-secreting cone cells of the adult eye, and in microvilli-displaying follicle cells during oogenesis. Sans mutants are viable, fertile, and mutant follicle cells appear to form microvilli, indicating that Sans is dispensable for fly development and microvilli morphogenesis in the follicle epithelium. In follicle cells, Sans protein localizes, similar to its vertebrate ortholog, to intracellular punctate structures, which we have identified as early endosomes associated with the syntaxin Avalanche. Conclusions: Our work is consistent with an evolutionary conserved function of Sans in vesicle trafficking. Furthermore it provides a significant basis for further understanding of the role of this Usher syndrome ortholog in development and disease.	[Demontis, Fabio; Dahmann, Christian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Demontis, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	dahmann@mpi-cbg.de	Dahmann, Christian/B-5841-2017	Demontis, Fabio/0000-0002-8698-9555	Deutsche Forschungsgemeinschaft [DA586/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant DA586/4-1 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; DeRosier DJ, 2000, J CELL BIOL, V148, P1; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Fung S, 2008, J COMP NEUROL, V506, P469, DOI 10.1002/cne.21539; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Johnston AM, 2004, GENES CELLS, V9, P967, DOI 10.1111/j.1365-2443.2004.00776.x; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Kikkawa Y, 2003, HUM MOL GENET, V12, P453, DOI 10.1093/hmg/ddg042; LASKO PF, 1988, GENETICS, V120, P495; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pignoni F, 1997, DEVELOPMENT, V124, P271; Reiners J, 2005, MOL VIS, V11, P347; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Spradling Allan C., 1993, P1; Todi SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002115; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940; Zartman JJ, 2009, GENE EXPR PATTERNS, V9, P31, DOI 10.1016/j.gep.2008.09.001	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4753	10.1371/journal.pone.0004753	http://dx.doi.org/10.1371/journal.pone.0004753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270738	gold, Green Published, Green Submitted			2022-12-25	WOS:000265495900020
J	Broedl, UC; Lebherz, C; Lehrke, M; Stark, R; Greif, M; Becker, A; von Ziegler, F; Tittus, J; Reiser, M; Becker, C; Goke, B; Parhofer, KG; Leber, AW				Broedl, Uli C.; Lebherz, Corinna; Lehrke, Michael; Stark, Renee; Greif, Martin; Becker, Alexander; von Ziegler, Franz; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Goeke, Burkhard; Parhofer, Klaus G.; Leber, Alexander W.			Low Adiponectin Levels Are an Independent Predictor of Mixed and Non-Calcified Coronary Atherosclerotic Plaques	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PLASMA ADIPONECTIN; ARTERY-DISEASE; COMPUTED-TOMOGRAPHY; ATHEROGENIC DYSLIPIDEMIA; ANGIOGRAPHIC PROGRESSION; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; HEART-DISEASE	Background: Atherosclerosis is the primary cause of coronary artery disease (CAD). There is increasing recognition that lesion composition rather than size determines the acute complications of atherosclerotic disease. Low serum adiponectin levels were reported to be associated with coronary artery disease and future incidence of acute coronary syndrome (ACS). The impact of adiponectin on lesion composition still remains to be determined. Methodology/Principal Findings: We measured serum adiponectin levels in 303 patients with stable typical or atypical chest pain, who underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified as calcified, mixed or non-calcified. In bivariate analysis adiponectin levels were inversely correlated with total coronary plaque burden (r = -0.21, p = 0.0004), mixed (r = -0.20, p = 0.0007) and non-calcified plaques (r = -0.18, p = 0.003). No correlation was seen with calcified plaques (r = -0.05, p = 0.39). In a fully adjusted multivariate model adiponectin levels remained predictive of total plaque burden (estimate: -0.036, 95% CI: -0.052 to -0.020, p < 0.0001), mixed (estimate: -0.087, 95% CI: -0.132 to -0.042, p = 0.0001) and non-calcified plaques (estimate: -0.076, 95% CI: -0.115 to -0.038, p = 0.0001). Adiponectin levels were not associated with calcified plaques (estimate: -0.021, 95% CI: -0.043 to -0.001, p = 0.06). Since the majority of coronary plaques was calcified, adiponectin levels account for only 3% of the variability in total plaque number. In contrast, adiponectin accounts for approximately 20% of the variability in mixed and non-calcified plaque burden. Conclusions/Significance: Adiponectin levels predict mixed and non-calcified coronary atherosclerotic plaque burden. Low adiponectin levels may contribute to coronary plaque vulnerability and may thus play a role in the pathophysiology of ACS.	[Broedl, Uli C.; Lehrke, Michael; Goeke, Burkhard; Parhofer, Klaus G.] Univ Munich, Dept Internal Med 2, Munich, Germany; [Lebherz, Corinna; Greif, Martin; Becker, Alexander; von Ziegler, Franz; Tittus, Janine; Leber, Alexander W.] Univ Munich, Dept Internal Med 1, Munich, Germany; [Stark, Renee] Helmholtz Zent, Munich, Germany; [Reiser, Maximilian; Becker, Christoph] Univ Munich, Dept Radiol, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Broedl, UC (corresponding author), Univ Munich, Dept Internal Med 2, Munich, Germany.	uli.broedl@med.uni-muenchen.de	Lehrke, Michael/AAY-7558-2021	Becker, Hans-Christoph/0000-0001-6059-4937	Deutsche Forschungsgemeinschaft [BR 2151/4-1, LE 1350/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants BR 2151/4-1 (UCB) and LE 1350/2-1 (ML) from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Gorter PM, 2008, ATHEROSCLEROSIS, V197, P896, DOI 10.1016/j.atherosclerosis.2007.08.016; Hattori Y, 2003, DIABETOLOGIA, V46, P1543, DOI 10.1007/s00125-003-1224-3; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Leber AW, 2008, INT J CARDIOVAS IMAG, V24, P423, DOI 10.1007/s10554-007-9278-9; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Maahs DM, 2005, CIRCULATION, V111, P747, DOI 10.1161/01.CIR.0000155251.03724.A5; Marso SP, 2008, DIABETES CARE, V31, P989, DOI 10.2337/dc07-2024; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Ng TWK, 2005, DIABETES, V54, P795, DOI 10.2337/diabetes.54.3.795; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Otake H, 2008, AM J CARDIOL, V101, P1, DOI 10.1016/j.amjcard.2007.07.041; Otsuka F, 2006, J AM COLL CARDIOL, V48, P1155, DOI 10.1016/j.jacc.2006.05.054; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pasterkamp G, 2000, J AM COLL CARDIOL, V36, P13, DOI 10.1016/S0735-1097(00)00677-X; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pischon T, 2007, CIRCULATION, V115, pE322, DOI 10.1161/CIRCULATIONAHA.106.666677; Pundziute G, 2007, J AM COLL CARDIOL, V49, P62, DOI 10.1016/j.jacc.2006.07.070; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Selcuk MT, 2008, CORONARY ARTERY DIS, V19, P79, DOI 10.1097/MCA.0b013e3282f3c40b; Son BK, 2008, ENDOCRINOLOGY, V149, P1646, DOI 10.1210/en.2007-1021; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tan KCB, 2004, J CLIN ENDOCR METAB, V89, P765, DOI 10.1210/jc.2003-031012; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Eynatten M, 2008, EUR HEART J, V29, P1307, DOI 10.1093/eurheartj/ehn135; von Eynatten M, 2006, J AM COLL CARDIOL, V47, P2124, DOI 10.1016/j.jacc.2006.02.033; Wolk R, 2007, EUR HEART J, V28, P292, DOI 10.1093/eurheartj/ehl361; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Zhao T, 2005, CELL IMMUNOL, V238, P19, DOI 10.1016/j.cellimm.2005.12.002	46	50	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4733	10.1371/journal.pone.0004733	http://dx.doi.org/10.1371/journal.pone.0004733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266101	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490800013
J	Sun, W; Xie, W; Xu, F; Grunstein, M; Li, KC				Sun, Wei; Xie, Wei; Xu, Feng; Grunstein, Michael; Li, Ker-Chau			Dissecting Nucleosome Free Regions by a Segmental Semi-Markov Model	PLOS ONE			English	Article							HIGH-RESOLUTION MAP; PREFERENTIAL ACCESSIBILITY; SACCHAROMYCES-CEREVISIAE; CHROMATIN-STRUCTURE; YEAST; PROMOTER; TRANSCRIPTION; IDENTIFICATION; OCCUPANCY; POSITIONS	Background: Nucleosome free regions (NFRs) play important roles in diverse biological processes including gene regulation. A genome-wide quantitative portrait of each individual NFR, with their starting and ending positions, lengths, and degrees of nucleosome depletion is critical for revealing the heterogeneity of gene regulation and chromatin organization. By averaging nucleosome occupancy levels, previous studies have identified the presence of NFRs in the promoter regions across many genes. However, evaluation of the quantitative characteristics of individual NFRs requires an NFR calling method. Methodology: In this study, we propose a statistical method to identify the patterns of NFRs from a genome-wide measurement of nucleosome occupancy. This method is based on an appropriately designed segmental semi-Markov model, which can capture each NFR pattern and output its quantitative characterizations. Our results show that the majority of the NFRs are located in intergenic regions or promoters with a length of about 400-600bp and varying degrees of nucleosome depletion. Our quantitative NFR mapping allows for an investigation of the relative impacts of transcription machinery and DNA sequence in evicting histones from NFRs. We show that while both factors have significant overall effects, their specific contributions vary across different subtypes of NFRs. Conclusion: The emphasis of our approach on the variation rather than the consensus of nucleosome free regions sets the tone for enabling the exploration of many subtler dynamic aspects of chromatin biology.	[Sun, Wei] Univ N Carolina, Dept Biostat, Carolina Ctr Genome Sci, Chapel Hill, NC 27515 USA; [Sun, Wei] Univ N Carolina, Carolina Ctr Genome Sci, Dept Genet, Chapel Hill, NC USA; [Xie, Wei; Xu, Feng; Grunstein, Michael] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Xie, Wei; Li, Ker-Chau] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90024 USA; [Li, Ker-Chau] Acad Sinica, Genom Res Ctr, Inst Stat Sci, Taipei, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Academia Sinica - Taiwan	Sun, W (corresponding author), Univ N Carolina, Dept Biostat, Carolina Ctr Genome Sci, Chapel Hill, NC 27515 USA.	mg@mbi.ucla.edu; kcli@stat.ucla.edu	Li, Ker-Chau/AAQ-4886-2021	Xu, Feng/0000-0003-2016-7521	NIH; NSF [DMS-0201005, DMS-0406091, DMS-0707160]; MIB, Institute of Statistical Science, Academia Sinica [NSC95-3114-P-002-005-Y, NSC97-2627-P001-003]; United States Environmental protection Agency [RD833825]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); MIB, Institute of Statistical Science, Academia Sinica(Academia Sinica - Taiwan); United States Environmental protection Agency(United States Environmental Protection Agency)	This work is supported by NIH grants to M.G. and by NSF grants DMS-0201005, DMS-0406091, and DMS-0707160 to K.C.L. K.C.L.'s work is also supported in part by MIB, Institute of Statistical Science, Academia Sinica and grant NSC95-3114-P-002-005-Y and NSC97-2627-P001-003. W.S.'s work is also supported in part by the United States Environmental protection Agency grant (RD833825). However, the research described in this article has not been subjected to the Agency's peer review and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KROGH A, 1994, NUCLEIC ACIDS RES, V22, P4768, DOI 10.1093/nar/22.22.4768; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEE MS, 1992, P NATL ACAD SCI USA, V89, P9166, DOI 10.1073/pnas.89.19.9166; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li W, 2005, BIOINFORMATICS, V21, pI274, DOI 10.1093/bioinformatics/bti1046; Mai X, 2000, MOL CELL BIOL, V20, P6668, DOI 10.1128/MCB.20.18.6668-6676.2000; MORSE RH, 1992, MOL CELL BIOL, V12, P4015, DOI 10.1128/MCB.12.9.4015; Newton MA, 1998, STAT MED, V17, P1425, DOI 10.1002/(SICI)1097-0258(19980715)17:13<1425::AID-SIM861>3.0.CO;2-V; Ostendorf M, 1996, IEEE T SPEECH AUDI P, V4, P360, DOI 10.1109/89.536930; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Sakaki K, 2003, J BIOCHEM, V134, P373, DOI 10.1093/jb/mvg155; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	34	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4721	10.1371/journal.pone.0004721	http://dx.doi.org/10.1371/journal.pone.0004721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266098	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490800003
J	Uzan, B; Figeac, F; Portha, B; Movassat, J				Uzan, Benjamin; Figeac, Florence; Portha, Bernard; Movassat, Jamileh			Mechanisms of KGF Mediated Signaling in Pancreatic Duct Cell Proliferation and Differentiation	PLOS ONE			English	Article								Background: Keratinocyte growth factor (KGF; palifermin) is a growth factor with a high degree of specificity for epithelial cells. KGF is an important effector of epithelial growth and tissue homeostasis in various organs including the pancreas. Here we investigated the intracellular signaling pathways involved in the mediation of pancreatic ductal cell proliferation and differentiation induced by exogenous KGF during beta-cell regeneration in diabetic rat. Methodology and Results: In vitro and in vivo duct cell proliferation was measured by BrdU incorporation assay. The implication of MAPK-ERK1/2 in the mediation of KGF-induced cell proliferation was determined by inactivation of this pathway, using the pharmacological inhibitor or antisense morpholino-oligonucleotides against MEK1. In vivo KGF-induced duct cell differentiation was assessed by the immunolocalization of PDX1 and Glut2 in ductal cells and the implication of PI3K/AKT in this process was investigated. We showed that KGF exerted a potent mitogenic effect on ductal cells. Both in vitro and in vivo, its effect on cell proliferation was mediated through the activation of ERK1/2 as evidenced by the abolition of duct cell proliferation in the context of MEK/ERK inactivation. In vivo, KGF treatment triggered ductal cell differentiation as revealed by the expression of PDX1 and Glut2 in a subpopulation of ductal cells via a PI3K-dependent mechanism. Conclusion: Here we show that KGF promotes beta-cell regeneration by stimulating duct cell proliferation in vivo. Moreover, we demonstrated for the first time that KGF directly induces the expression of PDX1 in some ductal cells thus inducing beta-cell neogenesis. We further explored the molecular mechanisms involved in these processes and showed that the effects of KGF on duct cell proliferation are mediated by the MEK-ERK1/2 pathway, while the KGF-induced cell differentiation is mediated by the PI3K/AKT pathway. These findings might have important implications for the in vivo induction of duct-to-beta cell neogenesis in patients with beta-cell deficiency.	[Uzan, Benjamin; Figeac, Florence; Portha, Bernard; Movassat, Jamileh] Univ Paris 07, CNRS, Dept Life Sci, Lab Pathophysiol Nutr,UMR 7059, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Uzan, B (corresponding author), Univ Paris 07, CNRS, Dept Life Sci, Lab Pathophysiol Nutr,UMR 7059, Paris, France.	movassat@paris7.jussieu.fr	Portha, Bernard/AAW-3021-2021	UZAN, Benjamin/0000-0001-6323-5737	Centre National de la Recherche Scientifique/CNRS; Ministere de lEnseignement Superieur et de la Recherche [fellowship]	Centre National de la Recherche Scientifique/CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de lEnseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	The authors are supported by grants from the Centre National de la Recherche Scientifique/CNRS. Florence Figeac is a recipient of a fellowship from the Ministere de lEnseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Anastasi E, 1999, EUR J ENDOCRINOL, V141, P644, DOI 10.1530/eje.0.1410644; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Bouwens L, 1996, VIRCHOWS ARCH, V427, P553; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; Bouwens L, 1998, J PATHOL, V184, P234; BROCKENBROUGH JS, 1988, DIABETES, V37, P232, DOI 10.2337/diabetes.37.2.232; Bulotta A, 2002, J MOL ENDOCRINOL, V29, P347, DOI 10.1677/jme.0.0290347; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; Edlund H, 1999, CURR OPIN CELL BIOL, V11, P663, DOI 10.1016/S0955-0674(99)00033-2; Elghazi L, 2002, P NATL ACAD SCI USA, V99, P3884, DOI 10.1073/pnas.062321799; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; GU DL, 1993, DEVELOPMENT, V118, P33; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Habener JF, 1998, P ASSOC AM PHYSICIAN, V110, P12; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Ishiwata T, 1998, AM J PATHOL, V153, P213, DOI 10.1016/S0002-9440(10)65562-9; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaji H, 1999, CANCER RES, V59, P5097; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Krakowski ML, 1999, AM J PATHOL, V154, P683, DOI 10.1016/S0002-9440(10)65315-1; Kumar M, 2003, CURR OPIN GENET DEV, V13, P401, DOI 10.1016/S0959-437X(03)00089-3; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Kurokawa M, 2008, INT J NEUROSCI, V118, P693, DOI 10.1080/00207450701555714; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Lupfer C, 2008, ARCH VIROL, V153, P929, DOI 10.1007/s00705-008-0067-0; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Mei CL, 2005, NEPHROL DIAL TRANSPL, V20, P2368, DOI 10.1093/ndt/gfi040; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Miyatsuka T, 2007, BIOCHEM BIOPH RES CO, V362, P905, DOI 10.1016/j.bbrc.2007.08.076; Morisset J, 1999, AM J PHYSIOL-GASTR L, V277, pG953, DOI 10.1152/ajpgi.1999.277.5.G953; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Movassat J, 2003, DIABETOLOGIA, V46, P822, DOI 10.1007/s00125-003-1117-5; Movassat J, 2007, J ENDOCRINOL, V195, P333, DOI 10.1677/JOE-07-0098; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Plachot C, 2001, HISTOCHEM CELL BIOL, V116, P131; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rutter W J, 1980, Monogr Pathol, V21, P30; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Taniguchi F, 2003, J CLIN ENDOCR METAB, V88, P773, DOI 10.1210/jc.2002-021062; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/BF00403301; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Watanabe H, 2008, BIOCHEM BIOPH RES CO, V370, P33, DOI 10.1016/j.bbrc.2008.03.012; Watanabe H, 2008, PANCREAS, V36, P153, DOI 10.1097/MPA.0b013e318157753e; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; YI ES, 1994, AM J PATHOL, V145, P80	61	34	35	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4734	10.1371/journal.pone.0004734	http://dx.doi.org/10.1371/journal.pone.0004734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266047	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490800014
J	Kranjc, A; Grillo, FW; Rievaj, J; Boccaccio, A; Pietrucci, F; Menini, A; Carloni, P; Anselmi, C				Kranjc, Agata; Grillo, Federico W.; Rievaj, Juraj; Boccaccio, Anna; Pietrucci, Fabio; Menini, Anna; Carloni, Paolo; Anselmi, Claudio			Regulation of Bestrophins by Ca2+: A Theoretical and Experimental Study	PLOS ONE			English	Article								Bestrophins are a recently discovered family of Cl- channels, for which no structural information is available. Some family members are activated by increased intracellular Ca2+ concentration. Bestrophins feature a well conserved Asp-rich tract in their COOH terminus (Asp-rich domain), which is homologous to Ca2+-binding motifs in human thrombospondins and in human big-conductance Ca2+- and voltage-gated K+ channels (BKCa). Consequently, the Asp-rich domain is also a candidate for Ca2+ binding in bestrophins. Based on these considerations, we constructed homology models of human bestrophin-1 (Best1) Asp-rich domain using human thrombospondin-1 X-ray structure as a template. Molecular dynamics simulations were used to identify Asp and Glu residues binding Ca2+ and to predict the effects of their mutations to alanine. We then proceeded to test selected mutations in the Asp-rich domain of the highly homologous mouse bestrophin-2. The mutants expressed in HEK-293 cells were investigated by electrophysiological experiments using the whole-cell voltage-clamp technique. Based on our molecular modeling results, we predicted that Asp-rich domain has two defined binding sites and that D301A and D304A mutations may impact the binding of the metal ions. The experiments confirmed that these mutations do actually affect the function of the protein causing a large decrease in the Ca2+-activated Cl- current, fully consistent with our predictions. In addition, other studied mutations (E306A, D312A) did not decrease Ca2+-activated Cl- current in agreement with modeling results.	[Kranjc, Agata; Grillo, Federico W.; Rievaj, Juraj; Boccaccio, Anna; Pietrucci, Fabio; Menini, Anna; Carloni, Paolo; Anselmi, Claudio] SISSA ISAS, Trieste, Italy; [Boccaccio, Anna; Menini, Anna; Carloni, Paolo] SISSA, IIT, Trieste, Italy; [Carloni, Paolo; Anselmi, Claudio] CNR, INFM, DEMOCRITOS Model Ctr Res Atomist Simulat, Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Kranjc, A (corresponding author), SISSA ISAS, Trieste, Italy.	claudio.anselmi@mpibp-frankfurt.mpg.de	Pietrucci, Fabio/AAS-7018-2020; Boccaccio, Anna/H-6816-2012; Carloni, Paolo/H-8736-2013; Pietrucci, Fabio/C-2326-2009; Anselmi, Claudio/D-6244-2012	Pietrucci, Fabio/0000-0002-4892-2667; Boccaccio, Anna/0000-0002-6219-2285; Pietrucci, Fabio/0000-0002-4892-2667; Anselmi, Claudio/0000-0002-3017-5085; Grillo, Federico/0000-0002-9097-1091; Menini, Anna/0000-0001-9304-0412	Italian Institute of Technology (IIT)	Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT)	This work was supported by Italian Institute of Technology (IIT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boccaccio A, 2007, J NEUROPHYSIOL, V98, P153, DOI 10.1152/jn.00270.2007; Bulo RE, 2007, MACROMOLECULES, V40, P3437, DOI 10.1021/ma062467l; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Duta V, 2004, FEBS LETT, V577, P551, DOI 10.1016/j.febslet.2004.10.068; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HORLING F, 2006, VMD2 DATABASE; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kramer F, 2004, CYTOGENET GENOME RES, V105, P107, DOI 10.1159/000078016; Kranjc A, 2007, COMPUT PHYS COMMUN, V177, P21, DOI 10.1016/j.cpc.2007.02.006; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marchant D, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044511; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Milenkovic VM, 2007, J BIOL CHEM, V282, P1313, DOI 10.1074/jbc.M607383200; MISENHEIMER TM, 1995, J BIOL CHEM, V270, P1729, DOI 10.1074/jbc.270.4.1729; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Piskorowski R, 2002, NATURE, V420, P499, DOI 10.1038/nature01199; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2006, FEBS LETT, V580, P2141, DOI 10.1016/j.febslet.2006.03.025; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Sheng JZ, 2005, BIOPHYS J, V89, P3079, DOI 10.1529/biophysj.105.063610; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; SORIA RB, 2006, J BIOL CHEM; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrance JW, 2008, PROTEINS, V71, P813, DOI 10.1002/prot.21741; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; White K, 2000, HUM MUTAT, V15, P301, DOI 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N; YANG YD, 2008, NATURE; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301	64	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4672	10.1371/journal.pone.0004672	http://dx.doi.org/10.1371/journal.pone.0004672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262692	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600005
J	Menzel, R				Menzel, Randolf			Serial Position Learning in Honeybees	PLOS ONE			English	Article							MEMORY DYNAMICS; APIS-MELLIFERA; BEES; NAVIGATION; INFORMATION; HIPPOCAMPUS; STRATEGIES; RETRIEVAL; LANDMARKS; COGNITION	Learning of stimulus sequences is considered as a characteristic feature of episodic memory since it contains not only a particular item but also the experience of preceding and following events. In sensorimotor tasks resembling navigational performance, the serial order of objects is intimately connected with spatial order. Mammals and birds develop episodic(like) memory in serial spatio-temporal tasks, and the honeybee learns spatio-temporal order when navigating between the nest and a food source. Here I examine the structure of the bees' memory for a combined spatio-temporal task. I ask whether discrimination and generalization are based solely on simple forms of stimulus-reward learning or whether they require sequential configurations. Animals were trained to fly either left or right in a continuous T-maze. The correct choice was signaled by the sequence of colors (blue, yellow) at four positions in the access arm. If only one of the possible 4 signals is shown (either blue or yellow), the rank order of position salience is 1, 2 and 3 (numbered from T-junction). No learning is found if the signal appears at position 4. If two signals are shown, differences at positions 1 and 2 are learned best, those at position 3 at a low level, and those at position 4 not at all. If three or more signals are shown these results are corroborated. This salience rank order again appeared in transfer tests, but additional configural phenomena emerged. Most of the results can be explained with a simple model based on the assumption that the four positions are equipped with different salience scores and that these add up independently. However, deviations from the model are interpreted by assuming stimulus configuration of sequential patterns. It is concluded that, under the conditions chosen, bees rely most strongly on memories developed during simple forms of associative reward learning, but memories of configural serial patterns contribute, too.	Free Univ Berlin, Inst Biol, Berlin, Germany	Free University of Berlin	Menzel, R (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	menzel@neurobiologie.fu-berlin.de						Agster KL, 2002, J NEUROSCI, V22, P5760; [Anonymous], [No title captured]; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BRANNON EM, 2008, COGNITIVE ANIMAL EMP, P197; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Cheng K, 2006, ANIM COGN, V9, P141, DOI 10.1007/s10071-005-0012-5; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; CHITTKA L, 1995, ANIM BEHAV, V50, P23, DOI 10.1006/anbe.1995.0217; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; COLLETT TS, 1993, J COMP PHYSIOL A, V172, P693, DOI 10.1007/BF00195395; Collett TS, 1997, J COMP PHYSIOL A, V181, P47, DOI 10.1007/s003590050092; COUVILLON PA, 1983, J COMP PSYCHOL, V97, P154, DOI 10.1037/0735-7036.97.2.154; CROWDER RG, 1968, J EXP PSYCHOL, V76, P497, DOI 10.1037/h0025691; DACKE M, 2008, ANIM COGN EARLY ELEC; De Marco R, 2005, J EXP BIOL, V208, P3885, DOI 10.1242/jeb.01832; Deisig N, 2003, LEARN MEMORY, V10, P199, DOI 10.1101/lm.55803; DEMARCO R, 2008, LEARNING MEMORY COMP, V1; DEVENPORT LD, 1994, ANIM BEHAV, V47, P787, DOI 10.1006/anbe.1994.1111; Ebbinghaus, 1885, GEDACHTNIS; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Fulop A, 2000, ANIM BEHAV, V60, P657, DOI 10.1006/anbe.2000.1492; Gallistel C. R., 1990, ORG LEARNING; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GIL M, 2007, LEARNING RE IN PRESS; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GIURFA M, 2001, P 28 GOTT NEUR C GOT, P685; GREGGERS U, 1993, BEHAV ECOL SOCIOBIOL, V32, P17, DOI 10.1007/BF00172219; GROSSMANN K E, 1970, Zeitschrift fuer Tierpsychologie, V27, P553; Hauser MD, 2000, TRENDS COGN SCI, V4, P127, DOI 10.1016/S1364-6613(00)01473-X; HEALY AF, 2008, SERIAL LEARNING, P53; HEALY AF, 1975, J VERB LEARN VERB BE, V14, P495; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; James W., 1890, PRINCIPLES PSYCHOL; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; MENZEL R, 1969, Z VERGL PHYSIOL, V63, P290, DOI 10.1007/BF00298164; Menzel R, 2007, EVOLUTION NERVOUS SY, V2, P403; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Prabhu C, 2008, BEHAV ECOL SOCIOBIOL, V63, P11, DOI 10.1007/s00265-008-0631-3; Shettleworth, 2010, COGNITION EVOLUTION; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Srinivasan MV, 1997, J EXP BIOL, V200, P2513; STARKEY P, 1990, COGNITION, V36, P97, DOI 10.1016/0010-0277(90)90001-Z; TULVING E, 1972, ANNU REV PSYCHOL, V53, P1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wright AA, 1999, J COMP PSYCHOL, V113, P74, DOI 10.1037/0735-7036.113.1.74; Wright AA, 2007, J EXP ANAL BEHAV, V88, P405, DOI 10.1901/jeab.2007.88-405; Zar JH., 1999, BIOSTAT ANAL; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102; Zhang SW, 2000, LEARN MEMORY, V7, P363, DOI 10.1101/lm.32900; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	59	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4694	10.1371/journal.pone.0004694	http://dx.doi.org/10.1371/journal.pone.0004694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MB	19259265	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490500012
J	Fontana, P; Cestaro, A; Velasco, R; Formentin, E; Toppo, S				Fontana, Paolo; Cestaro, Alessandro; Velasco, Riccardo; Formentin, Elide; Toppo, Stefano			Rapid Annotation of Anonymous Sequences from Genome Projects Using Semantic Similarities and a Weighting Scheme in Gene Ontology	PLOS ONE			English	Article							PROTEIN FUNCTION PREDICTION; GO; TOOL	Background: Large-scale sequencing projects have now become routine lab practice and this has led to the development of a new generation of tools involving function prediction methods, bringing the latter back to the fore. The advent of Gene Ontology, with its structured vocabulary and paradigm, has provided computational biologists with an appropriate means for this task. Methodology: We present here a novel method called ARGOT (Annotation Retrieval of Gene Ontology Terms) that is able to process quickly thousands of sequences for functional inference. The tool exploits for the first time an integrated approach which combines clustering of GO terms, based on their semantic similarities, with a weighting scheme which assesses retrieved hits sharing a certain number of biological features with the sequence to be annotated. These hits may be obtained by different methods and in this work we have based ARGOT processing on BLAST results. Conclusions: The extensive benchmark involved 10,000 protein sequences, the complete S. cerevisiae genome and a small subset of proteins for purposes of comparison with other available tools. The algorithm was proven to outperform existing methods and to be suitable for function prediction of single proteins due to its high degree of sensitivity, specificity and coverage.	[Fontana, Paolo; Cestaro, Alessandro; Velasco, Riccardo] FEM IASMA Res Ctr, San Michele All Adige, TN, Italy; [Formentin, Elide] Univ Padua, Dept Biol, I-35100 Padua, Italy; [Toppo, Stefano] Univ Padua, Dept Biol Chem, I-35100 Padua, Italy	Fondazione Edmund Mach; University of Padua; University of Padua	Fontana, P (corresponding author), FEM IASMA Res Ctr, San Michele All Adige, TN, Italy.	stefano.toppo@unipd.it	Velasco, Riccardo/G-8710-2011; Toppo, Stefano/Z-5479-2019	Toppo, Stefano/0000-0002-0246-3119; Velasco, Riccardo/0000-0002-8760-5031; Cestaro, Alessandro/0000-0003-1439-5165	Autonomous Province of Trento	Autonomous Province of Trento(Autonomous Province of Trento)	This work was supported by the Autonomous Province of Trento as part of the "Grapevine genome sequencing" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Enault F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-247; Friedberg I, 2006, NUCLEIC ACIDS RES, V34, pW379, DOI 10.1093/nar/gkl045; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Godzik A, 2007, CELL MOL LIFE SCI, V64, P2505, DOI 10.1007/s00018-007-7211-y; Groth D, 2004, NUCLEIC ACIDS RES, V32, pW313, DOI 10.1093/nar/gkh406; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Jiang J.J., 1997, SEMANTIC SIMILARITY, P19; Jones CE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-272; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Joshi T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-222; Kimura M, 2004, NUCLEIC ACIDS RES, V32, P6706, DOI 10.1093/nar/gkh1000; King OD, 2003, GENOME RES, V13, P896, DOI 10.1101/gr.440803; Leacock C, 1998, LANG SPEECH & COMMUN, P265; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Lee Vivian, 2005, In Silico Biology, V5, P5; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIND, 1998, P 15 INT C MACH LEAR, P296; LORD P, 2003, PAC S BIOCOMPUT, V8, P601; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Majer F, 2002, J BACTERIOL, V184, P1234, DOI 10.1128/JB.184.5.1234-1243.2002; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; Mulder Nicola, 2007, V396, P59; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Park JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S7; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rodrigues APC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S1; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; Sasson O, 2006, PROTEIN SCI, V15, P1557, DOI 10.1110/ps.062185706; Tao Y, 2007, BIOINFORMATICS, V23, pI529, DOI 10.1093/bioinformatics/btm195; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Tosatto SCE, 2006, CURR PHARM DESIGN, V12, P2067, DOI 10.2174/138161206777585238; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Verspoor K, 2006, PROTEIN SCI, V15, P1544, DOI 10.1110/ps.062184006; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; NUCL ACIDS RES, V36, pD440	48	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4619	10.1371/journal.pone.0004619	http://dx.doi.org/10.1371/journal.pone.0004619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247487	Green Published, gold			2022-12-25	WOS:000265487800002
J	Kumar, RA; Marshall, CR; Badner, JA; Babatz, TD; Mukamel, Z; Aldinger, KA; Sudi, J; Brune, CW; Goh, G; KaraMohamed, S; Sutcliffe, JS; Cook, EH; Geschwind, DH; Dobyns, WB; Scherer, SW; Christian, SL				Kumar, Ravinesh A.; Marshall, Christian R.; Badner, Judith A.; Babatz, Timothy D.; Mukamel, Zohar; Aldinger, Kimberly A.; Sudi, Jyotsna; Brune, Camille W.; Goh, Gerald; KaraMohamed, Samer; Sutcliffe, James S.; Cook, Edwin H.; Geschwind, Daniel H.; Dobyns, William B.; Scherer, Stephen W.; Christian, Susan L.			Association and Mutation Analyses of 16p11.2 Autism Candidate Genes	PLOS ONE			English	Article								Background: Autism is a complex childhood neurodevelopmental disorder with a strong genetic basis. Microdeletion or duplication of a similar to 500-700-kb genomic rearrangement on 16p11.2 that contains 24 genes represents the second most frequent chromosomal disorder associated with autism. The role of common and rare 16p11.2 sequence variants in autism etiology is unknown. Methodology/Principal Findings: To identify common 16p11.2 variants with a potential role in autism, we performed association studies using existing data generated from three microarray platforms: Affymetrix 5.0 (777 families), Illumina 550 K (943 families), and Affymetrix 500 K (60 families). No common variants were identified that were significantly associated with autism. To look for rare variants, we performed resequencing of coding and promoter regions for eight candidate genes selected based on their known expression patterns and functions. In total, we identified 26 novel variants in autism: 13 exonic (nine non-synonymous, three synonymous, and one untranslated region) and 13 promoter variants. We found a significant association between autism and a coding variant in the seizure-related gene SEZ6L2 (12/1106 autism vs. 3/1161 controls; p = 0.018). Sez6l2 expression in mouse embryos was restricted to the spinal cord and brain. SEZ6L2 expression in human fetal brain was highest in post-mitotic cortical layers, hippocampus, amygdala, and thalamus. Association analysis of SEZ6L2 in an independent sample set failed to replicate our initial findings. Conclusions/Significance: We have identified sequence variation in at least one candidate gene in 16p11.2 that may represent a novel genetic risk factor for autism. However, further studies are required to substantiate these preliminary findings.	[Kumar, Ravinesh A.; Babatz, Timothy D.; Sudi, Jyotsna; Goh, Gerald; KaraMohamed, Samer; Dobyns, William B.; Christian, Susan L.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Badner, Judith A.] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Inst Juvenile Res, Dept Psychiat, Chicago, IL 60680 USA; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Ctr Applied Genom, Dept Mol & Med Genet, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON, Canada; [Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA; [Mukamel, Zohar; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Program Neurogenet, Los Angeles, CA 90024 USA; [Mukamel, Zohar; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment, Los Angeles, CA 90024 USA; [Aldinger, Kimberly A.] Univ Chicago, Committee Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Vanderbilt University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Kumar, RA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	schrist@bsd.uchicago.edu	Sutcliffe, James S/C-1348-2012; Goh, Gerald/E-9158-2014; Dobyns, William/AAI-2768-2020; Goh, Gerald/N-1684-2015; Aldinger, Kimberly/ABB-1561-2020; Scherer, Stephen W./B-3785-2013; Dobyns, William Brian/ABC-6525-2021	Sutcliffe, James S/0000-0001-5200-6007; Goh, Gerald/0000-0002-3832-6466; Dobyns, William/0000-0002-7681-2844; Goh, Gerald/0000-0002-3832-6466; Aldinger, Kimberly/0000-0002-5406-8911; Scherer, Stephen W./0000-0002-8326-1999; Cook, Edwin/0000-0002-5848-5114	National Alliance for Autism Research; National Institute of Neurological Diseases and Stroke [1R01 NS51812]; National Institute of Mental Health [MH64547, MH081754, MH60233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, R37MH060233, R01MH060233, R56MH060233, R01MH064547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051812] Funding Source: NIH RePORTER	National Alliance for Autism Research; National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants to Susan L. Christian from the National Alliance for Autism Research and the National Institute of Neurological Diseases and Stroke (1R01 NS51812), as well as to Daniel H. Geschwind (PI) from the National Institute of Mental Health (MH64547), National Institute of Mental Health (MH081754) and the Method to Extend Research in Time (MERIT) from the National Institute of Mental Health (MH60233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BORK P, 1991, FEBS LETT, V282, P9, DOI 10.1016/0014-5793(91)80433-4; Chizhikov VV, 2004, J NEUROSCI, V24, P5694, DOI 10.1523/JNEUROSCI.0758-04.2004; CHRISTIAN SL, 2008, BIOL PSYCHIAT; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fombonne E., 2006, UNDERSTANDING AUTISM, P25; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P940, DOI 10.1001/jama.297.9.940; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lecavalier L, 2006, J AUTISM DEV DISORD, V36, P1101, DOI 10.1007/s10803-006-0147-5; Levick SE, 2007, CLONING STEM CELLS, V9, P33, DOI 10.1089/clo.2006.0087; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin Christa Lese, 2007, Curr Psychiatry Rep, V9, P141; Miyazaki T, 2006, FEBS LETT, V580, P4057, DOI 10.1016/j.febslet.2006.06.043; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Sakaguchi G, 1999, EUR J NEUROSCI, V11, P4262, DOI 10.1046/j.1460-9568.1999.00855.x; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SHIMIZUNISHIKAWA K, 1995, BIOCHEM BIOPH RES CO, V216, P382, DOI 10.1006/bbrc.1995.2635; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; XU J, 2004, CURR GENOMICS, V5, P1; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Zafeiriou DI, 2007, BRAIN DEV-JPN, V29, P257, DOI 10.1016/j.braindev.2006.09.003	47	72	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4582	10.1371/journal.pone.0004582	http://dx.doi.org/10.1371/journal.pone.0004582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242545	gold, Green Submitted, Green Published			2022-12-25	WOS:000265487500004
J	Mair, W; Panowski, SH; Shaw, RJ; Dillin, A				Mair, William; Panowski, Siler H.; Shaw, Reuben J.; Dillin, Andrew			Optimizing Dietary Restriction for Genetic Epistasis Analysis and Gene Discovery in C. elegans	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; ACTIVATED PROTEIN-KINASE; NEMATODE CAENORHABDITIS-ELEGANS; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; MEDIATES LONGEVITY; REPRODUCTION; PATHWAY; GROWTH	Dietary restriction (DR) increases mammalian lifespan and decreases susceptibility to many age-related diseases. Lifespan extension due to DR is conserved across a wide range of species. Recent research has focused upon genetically tractable model organisms such as C. elegans to uncover the genetic mechanisms that regulate the response to DR, in the hope that this information will provide insight into the mammalian response and yield potential therapeutic targets. However, no consensus exists as to the best protocol to apply DR to C. elegans and potential key regulators of DR are protocol-specific. Here we define a DR method that better fulfills criteria required for an invertebrate DR protocol to mirror mammalian studies. The food intake that maximizes longevity varies for different genotypes and informative epistasis analysis with another intervention is only achievable at this 'optimal DR' level. Importantly therefore, the degree of restriction imposed using our method can easily be adjusted to determine the genotype-specific optimum DR level. We used this protocol to test two previously identified master regulators of DR in the worm. In contrast to previous reports, we find that DR can robustly extend the lifespan of worms lacking the AMP-activated protein kinase catalytic subunit AAK2 or the histone deacetylase SIR-2.1, highlighting the importance of first optimizing DR to identify universal regulators of DR mediated longevity.	[Mair, William; Panowski, Siler H.; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Mair, William; Panowski, Siler H.; Dillin, Andrew] Howard Hughes Med Inst, La Jolla, CA USA	Salk Institute; Howard Hughes Medical Institute	Mair, W (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mair@salk.edu; dillin@salk.edu		Mair, William/0000-0002-0661-1342	George E. Hewitt Foundation for Medical Research; National Institutes of Health (NIH) [UCSD CMG Training Grant, R01 DK080425, P01 CA120964]; NIH/NIA; The Ellison Medical Foundation; American Diabetes Association; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The Ellison Medical Foundation(Lawrence Ellison Foundation); American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WM is funding by the George E. Hewitt Foundation for Medical Research, SP is funded by the National Institutes of Health (NIH) UCSD CMG Training Grant, RS is funded by the NIH R01 DK080425 and P01 CA120964 and AD is supported by grants from the NIH/NIA, The Ellison Medical Foundation, the American Diabetes Association and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169; AVERY L, 1993, GENETICS, V133, P897; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Boivin A, 2008, MECH AGEING DEV, V129, P714, DOI 10.1016/j.mad.2008.09.011; BRENNER S, 1974, GENETICS, V77, P71; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Dirkswager E., 2002, TEACHERS OWNERS KEY; Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 1998, GENETICS, V150, P129; Gems D, 2000, GENETICS, V154, P1597; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; HOLEHAN AM, 1985, MECH AGEING DEV, V33, P19, DOI 10.1016/0047-6374(85)90106-X; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; HOPE IA, 1999, C ELEGANS; HOSONO R, 1989, EXP GERONTOL, V24, P251, DOI 10.1016/0531-5565(89)90016-8; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jolly CA, 2007, CURR OPIN LIPIDOL, V18, P53, DOI 10.1097/MOL.0b013e3280115416; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; KAEBERLEIN TL, 2006, AGING CELL; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; LEE GD, 2006, AGING CELL; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wang XM, 2006, GLOBAL ENVIRON CHANG, V16, P48, DOI 10.1016/j.gloenvcha.2005.06.006; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Weindruch R., 1988, RETARDATION AGING DI; Yamawaki TM, 2008, GENETICS, V178, P513, DOI 10.1534/genetics.107.083253	61	60	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4535	10.1371/journal.pone.0004535	http://dx.doi.org/10.1371/journal.pone.0004535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229346	Green Submitted, gold, Green Published			2022-12-25	WOS:000265486200012
J	Sheng, F; Jia, XF; Yep, A; Preiss, J; Geiger, JH				Sheng, Fang; Jia, Xiaofei; Yep, Alejandra; Preiss, Jack; Geiger, James H.			The Crystal Structures of the Open and Catalytically Competent Closed Conformation of Escherichia coli Glycogen Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; D-GLUCOPYRANOSYL FLUORIDE; GLY-GLY SEQUENCE; MALTODEXTRIN PHOSPHORYLASE; BACTERIAL GLYCOGEN; ACTIVE-SITE; X-RAY; REGULATORY ENZYME; SMALL MOLECULES; BINDING-SITE	Escherichia coli glycogen synthase (EcGS, EC 2.4.1.21) is a retaining glycosyltransferase (GT) that transfers glucose from adenosine diphosphate glucose to a glucan chain acceptor with retention of configuration at the anomeric carbon. EcGS belongs to the GT-B structural superfamily. Here we report several EcGS x-ray structures that together shed considerable light on the structure and function of these enzymes. The structure of the wild-type enzyme bound to ADP and glucose revealed a 15.2 degrees overall domain-domain closure and provided for the first time the structure of the catalytically active, closed conformation of a glycogen synthase. The main chain carbonyl group of His-161, Arg-300, and Lys-305 are suggested by the structure to act as critical catalytic residues in the transglycosylation. Glu-377, previously thought to be catalytic is found on the alpha-face of the glucose and plays an electrostatic role in the active site and as a glucose ring locator. This is also consistent with the structure of the EcGS(E377A)-ADP-HEPPSO complex where the glucose moiety is either absent or disordered in the active site.	[Geiger, James H.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Yep, Alejandra; Preiss, Jack] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	geiger@chemistry.msu.edu	Jia, Xiaofei/O-3258-2013; Jia, Xiaofei/B-4721-2014	Geiger, James/0000-0002-9443-4488	Department of Energy [DE-FG02-06ER15822]	Department of Energy(United States Department of Energy (DOE))	This work was supported by Department of Energy Grant DE-FG02-06ER15822.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BANAIT NS, 1991, J AM CHEM SOC, V113, P7951, DOI 10.1021/ja00021a021; BANAIT NS, 1991, J AM CHEM SOC, V113, P7958, DOI 10.1021/ja00021a022; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; BOYER C, 1977, BIOCHEMISTRY-US, V16, P3693, DOI 10.1021/bi00635a029; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Campagnolo M, 2008, ARCH BIOCHEM BIOPHYS, V471, P11, DOI 10.1016/j.abb.2007.11.023; Chiappe C, 1997, TETRAHEDRON, V53, P10471, DOI 10.1016/S0040-4020(97)00660-1; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; CLELAND WW, 1967, ANNU REV BIOCHEM, V36, P77, DOI 10.1146/annurev.bi.36.070167.000453; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; CRISTINA H, 2006, J BIOL CHEM, V281, P2923; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FOX J, 1976, BIOCHEMISTRY-US, V15, P849, DOI 10.1021/bi00649a019; FURUKAWA K, 1993, J BIOL CHEM, V268, P23837; FURUKAWA K, 1990, J BIOL CHEM, V265, P2086; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Geremia S, 2002, J MOL BIOL, V322, P413, DOI 10.1016/S0022-2836(02)00771-4; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; GOLDSMITH EJ, 1989, SCIENCE, V245, P528, DOI 10.1126/science.2756432; HOWARD AJ, 2000, CRYSTALLOGRAPHIC COM, V7, P1; Iglesias A.A., 1992, BIOCHEM EDUC, V20, P196, DOI 10.1016/0307-4412(92)90191-N; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KLEIN HW, 1986, EUR J BIOCHEM, V157, P107, DOI 10.1111/j.1432-1033.1986.tb09645.x; Lairson LL, 2004, J BIOL CHEM, V279, P28339, DOI 10.1074/jbc.M400451200; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lariviere L, 2005, J MOL BIOL, V352, P139, DOI 10.1016/j.jmb.2005.07.007; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; PREISS J, 1989, ADV MICROB PHYSIOL, V30, P183; PREISS J, 1999, COMPREHENSIVE NATURA, P441; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; SCHINZEL R, 1990, BIOCHEMISTRY-US, V29, P9956, DOI 10.1021/bi00494a028; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SINNOTT ML, 1980, J AM CHEM SOC, V102, P2026, DOI 10.1021/ja00526a043; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619; Watson KA, 1997, EMBO J, V16, P1, DOI 10.1093/emboj/16.1.1; Yep A, 2004, BIOCHEM BIOPH RES CO, V316, P960, DOI 10.1016/j.bbrc.2004.02.136; Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200; Yep A, 2006, ARCH BIOCHEM BIOPHYS, V453, P188, DOI 10.1016/j.abb.2006.07.003	50	65	65	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17796	17807		10.1074/jbc.M809804200	http://dx.doi.org/10.1074/jbc.M809804200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19244233	Green Published, hybrid			2022-12-25	WOS:000267202500045
J	Akhtar, K; Gupta, V; Koul, A; Alam, N; Bhat, R; Bamezai, RNK				Akhtar, Kamal; Gupta, Vibhor; Koul, Anita; Alam, Neelima; Bhat, Rajiv; Bamezai, Rameshwar N. K.			Differential Behavior of Missense Mutations in the Intersubunit Contact Domain of the Human Pyruvate Kinase M-2 Isozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; MUSCLE; M2; BINDING; ENZYME; GENE; METABOLISM	In this study, we attempted to understand the mechanism of regulation of the activity and allosteric behavior of the pyruvate kinase M-2 enzyme and two of its missense mutations, H391Y and K422R, found in cells from Bloom syndrome patients, prone to develop cancer. Results show that despite the presence of mutations in the intersubunit contact domain, the K422R and H391Y mutant proteins maintained their homotetrameric structure, similar to the wild-type protein, but showed a loss of activity of 75 and 20%, respectively. Interestingly, H391Y showed a 6-fold increase in affinity for its substrate phosphoenolpyruvate and behaved like a non-allosteric protein with compromised cooperative binding. However, the affinity for phosphoenolpyruvate was lost significantly in K422R. Unlike K422R, H391Y showed enhanced thermal stability, stability over a range of pH values, a lesser effect of the allosteric inhibitor Phe, and resistance toward structural alteration upon binding of the activator (fructose 1,6-bisphosphate) and inhibitor (Phe). Both mutants showed a slight shift in the pH optimum from 7.4 to 7.0. Although this study signifies the importance of conserved amino acid residues in long-range communications between the subunits of multimeric proteins, the altered behavior of mutants is suggestive of their probable role in tumor-promoting growth and metabolism in Bloom syndrome patients with defective pyruvate kinase M-2.	[Akhtar, Kamal; Gupta, Vibhor; Koul, Anita; Alam, Neelima; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India; [Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi 110067, India.	bamezai@hotmail.com		Bamezai, R.N.K/0000-0002-5128-2859	University Grant Commission (New Delhi, India)	University Grant Commission (New Delhi, India)(University Grants Commission, India)	The work performed in the National Centre of Applied Human Genetics was supported by the University Grant Commission (New Delhi, India).	Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDENAS JM, 1982, METHOD ENZYMOL, V90, P140; CARDENAS JM, 1975, ISOZYMES, V1, P523; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; CONSLER TG, 1989, BIOCHEMISTRY-US, V28, P8756, DOI 10.1021/bi00448a012; Demina A, 1998, BLOOD, V92, P647, DOI 10.1182/blood.V92.2.647.414k13_647_652; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Friesen RHE, 1998, J BIOL CHEM, V273, P14772, DOI 10.1074/jbc.273.24.14772; Friesen RHE, 1998, BIOCHEMISTRY-US, V37, P15266, DOI 10.1021/bi981273y; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; IMAMURA K, 1982, METHOD ENZYMOL, V90, P150; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; KUO DJ, 1979, J AM CHEM SOC, V101, P5024; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 1997, J BIOENERG BIOMEMBR, V29, P315, DOI 10.1023/A:1022490512705; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; MUIRHEAD H, 1990, BIOCHEM SOC T, V18, P193, DOI 10.1042/bst0180193; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Reddy BSN, 2000, INT J DERMATOL, V39, P760, DOI 10.1046/j.1365-4362.2000.00047.x; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; TAKENAKA M, 1991, EUR J BIOCHEM, V198, P101, DOI 10.1111/j.1432-1033.1991.tb15991.x; TAKENAKA M, 1989, J BIOL CHEM, V264, P2363; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; vanSolinge WW, 1997, BLOOD, V90, P4987, DOI 10.1182/blood.V90.12.4987.4987_4987_4995; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Wang Y, 2006, STARCH-STARKE, V58, P501, DOI 10.1002/star.200600493; Wooll JO, 2001, J MOL BIOL, V312, P525, DOI 10.1006/jmbi.2001.4978; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	43	17	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11971	11981		10.1074/jbc.M808761200	http://dx.doi.org/10.1074/jbc.M808761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265196	Green Published, hybrid			2022-12-25	WOS:000265494600029
J	Chiku, T; Padovani, D; Zhu, WD; Singh, S; Vitvitsky, V; Banerjee, R				Chiku, Taurai; Padovani, Dominique; Zhu, Weidong; Singh, Sangita; Vitvitsky, Victor; Banerjee, Ruma			H2S Biogenesis by Human Cystathionine gamma-Lyase Leads to the Novel Sulfur Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of Hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; AMINO-ACID; BOVINE BRAIN; ACCUMULATION; HOMOCYSTEINE; INFLAMMATION; INHIBITION; MEDIATOR; CYSTEINE; INJURY	Although there is a growing recognition of the significance of hydrogen sulfide (H2S) as a biological signaling molecule involved in vascular and nervous system functions, its biogenesis and regulation are poorly understood. It is widely assumed that desulfhydration of cysteine is the major source of H2S in mammals and is catalyzed by the transsulfuration pathway enzymes, cystathionine beta-synthase and cystathionine gamma-lyase (CSE). In this study, we demonstrate that the profligacy of human CSE results in a variety of reactions that generate H2S from cysteine and homocysteine. The gamma-replacement reaction, which condenses two molecules of homocysteine, yields H2S and a novel biomarker, homolanthionine, which has been reported in urine of homocystinuric patients, whereas a beta-replacement reaction, which condenses two molecules of cysteine, generates lanthionine. Kinetic simulations at physiologically relevant concentrations of cysteine and homocysteine, reveal that the alpha,beta-elimination of cysteine accounts for similar to 70% of H2S generation. However, the relative importance of homocysteine-derived H2S increases progressively with the grade of hyperhomocysteinemia, and under conditions of severely elevated homocysteine (200 mu M), the alpha,beta-elimination and gamma-replacement reactions of homocysteine together are predicted to account for similar to 90% of H2S generation by CSE. Excessive H2S production in hyperhomocysteinemia may contribute to the associated cardiovascular pathology.	[Chiku, Taurai; Padovani, Dominique; Singh, Sangita; Vitvitsky, Victor; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Zhu, Weidong; Singh, Sangita] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022; Vitvitsky, Victor/ABA-2967-2021	Vitvitsky, Victor/0000-0001-6251-6115; PADOVANI, Dominique/0000-0003-1166-5801	National Institutes of Health [HL58984]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984 (to R.B.). This work was also supported by an American Heart Association postdoctoral fellowship award (to W.Z.).	Abe K, 1996, J NEUROSCI, V16, P1066; ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; Aitken SM, 2005, ARCH BIOCHEM BIOPHYS, V433, P166, DOI 10.1016/j.abb.2004.08.024; Alvarez MP, 2006, GEN COMP ENDOCR, V146, P257, DOI 10.1016/j.ygcen.2005.11.021; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; BRAUNSTEIN AE, 1984, ADV ENZYMOL RAMB, V56, P1; CANEVARI L, 1992, ANAL BIOCHEM, V205, P137, DOI 10.1016/0003-2697(92)90590-4; CAVALLINI D, 1962, ARCH BIOCHEM BIOPHYS, V96, P456, DOI 10.1016/0003-9861(62)90436-8; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2004, J NEUROSCI, V24, P5649; Eto K, 2002, J NEUROSCI, V22, P3386; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; FONTANA M, 1990, BIOCHEM BIOPH RES CO, V171, P480, DOI 10.1016/0006-291X(90)91418-R; GOODWIN LR, 1989, J ANAL TOXICOL, V13, P105, DOI 10.1093/jat/13.2.105; HUANG HT, 1963, BIOCHEMISTRY-US, V2, P296, DOI 10.1021/bi00902a018; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kromer JO, 2006, J BACTERIOL, V188, P609, DOI 10.1128/JB.188.2.609-618.2006; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; NEUBERGER A, 1973, BIOCHEM J, V136, P477, DOI 10.1042/bj1360477; PASZEWSKI A, 1975, ACTA BIOCHIM POL, V22, P263; PERRY TL, 1966, SCIENCE, V152, P1750, DOI 10.1126/science.152.3730.1750; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; RICCI G, 1989, BIOCHIM BIOPHYS ACTA, V990, P211, DOI 10.1016/S0304-4165(89)80036-4; SODA K, 1968, ANAL BIOCHEM, V25, P228, DOI 10.1016/0003-2697(68)90095-X; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; SZCZEPKOWSKI TW, 1967, BIOCHIM BIOPHYS ACTA, V139, P469, DOI 10.1016/0005-2744(67)90050-2; TALLAN HH, 1971, BIOCHEM BIOPH RES CO, V43, P303, DOI 10.1016/0006-291X(71)90753-4; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; UELAND PM, 1995, CLIN CHEM, V41, P340; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; WILLHARDT I, 1975, ANAL BIOCHEM, V63, P263, DOI 10.1016/0003-2697(75)90213-4; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	47	329	346	4	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11601	11612		10.1074/jbc.M808026200	http://dx.doi.org/10.1074/jbc.M808026200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261609	hybrid, Green Published			2022-12-25	WOS:000265494500064
J	Harburger, DS; Bouaouina, M; Calderwood, DA				Harburger, David S.; Bouaouina, Mohamed; Calderwood, David A.			Kindlin-1 and-2 Directly Bind the C-terminal Region of beta Integrin Cytoplasmic Tails and Exert Integrin-specific Activation Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MATRIX ADHESION; STRUCTURAL BASIS; PLATELET-AGGREGATION; TALIN BINDING; IN-VIVO; DOMAIN; PROTEINS; COMPETITION; MEMBRANE; FILAMIN	Integrin activation, the rapid conversion of integrin adhesion receptors from low to high affinity, occurs in response to intracellular signals that act on the short cytoplasmic tails of integrin beta subunits. Talin binding to integrin beta tails provides one key activation signal, but additional factors are likely to cooperate with talin to regulate integrin activation. The integrin beta tail-binding proteins kindlin-2 and kindlin-3 were recently identified as integrin co-activators. Here we report an analysis of kindlin-1 and kindlin-2 interactions with beta 1 and beta 3 integrin tails and describe the effect of kindlin expression on integrin activation. We demonstrate a direct interaction of kindlin-1 and -2 with recombinant integrin beta tails in pulldown binding assays. Our mutational analysis shows that the second conserved NXXY motif (Tyr(795)), a preceding threonine-containing region (Thr(788) and Thr(789)) of the integrin beta 1A tail, and a conserved tryptophan in the F3 subdomain of the kindlin FERM domain (kindlin-1 Trp(612) and kindlin-2 Trp(615)) are required for direct kindlin-integrin interactions. Similar interactions were observed for integrin beta 3 tails. Using fluorescence-activated cell sorting we further show that transient expression of kindlin-1 or -2 in Chinese hamster ovary cells inhibits the activation of endogenous alpha 5 beta 1 or stably expressed alpha IIb beta 3 integrins. This inhibition is not dependent on direct kindlin-integrin interactions because mutant kindlins exhibiting impaired integrin binding activity effectively inhibit integrin activation. Consistent with previous reports, we find that when co-expressed with the talin head, kindlin-1 or -2 can activate alpha IIb beta 3. This effect is dependent on an intact integrin-binding site in kindlin. Notably however, even when co-expressed with activating levels of talin head, neither kindlin-1 or -2 can cooperate with talin to activate beta 1 integrins; instead they strongly inhibit talin-mediated activation. We suggest that kindlins are adaptor proteins that regulate integrin activation, that kindlin expression levels determine their effects, and that kindlins may exert integrin-specific effects.	[Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdepartmental Program Vasc Biol & Transplanta, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142	National Institutes of Health [RO1 GM068600, R21 HL089433]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM068600 and R21 HL089433. This work was also supported by a National Science Foundation Graduate Research Fellowship Award (to D. S. H.).	Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Heckmann D, 2007, ANGEW CHEM INT EDIT, V46, P3571, DOI 10.1002/anie.200700008; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weinstein EJ, 2003, BBA-MOL BASIS DIS, V1637, P207, DOI 10.1016/S0925-4439(03)00035-8; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	48	231	239	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11485	11497		10.1074/jbc.M809233200	http://dx.doi.org/10.1074/jbc.M809233200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240021	hybrid, Green Published			2022-12-25	WOS:000265494500053
J	Oshima, M; Mimura, J; Sekine, H; Okawa, H; Fujii-Kuriyama, Y				Oshima, Motohiko; Mimura, Junsei; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki			SUMO Modification Regulates the Transcriptional Repressor Function of Aryl Hydrocarbon Receptor Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSLOCATOR ARNT; AHR REPRESSOR; DIOXIN RECEPTOR; EXPRESSION; GENE; SUMOYLATION; CONJUGATION; MECHANISM; FAMILY; SWITCH	The aryl hydrocarbon receptor (AhR) repressor (AhRR) inhibits the AhR activity. AhRR acts by competing with AhR for heterodimer formation with the AhR nuclear translocator (Arnt) and preventing the AhR.Arnt complex from binding the xenobiotic-responsive elements. Here, we report that AhRR has three evolutionarily conserved SUMOylation consensus sequences within its C-terminal repression domain and that Lys-542, Lys-583, and Lys-660 at the SUMOylation sites are modified by SUMO-1 in vivo. Arginine mutation of the three lysines results in a significant reduction of transcriptional repression activity. SUMOylation of the three lysine residues is important for the interaction between AhRR and ANKRA2, HDAC4, and HDAC5, which are important corepressors for AhRR. Arnt, a heterodimer partner for AhRR, markedly enhanced the SUMOylation of AhRR. AhRR, but not AhR, also significantly enhanced the SUMOylation of Arnt. The SUMOylation of both AhRR and Arnt is important for the efficient transcriptional repression activity of the AhRR/Arnt heterodimer.	[Oshima, Motohiko; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Oshima, Motohiko; Mimura, Junsei; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; [Mimura, Junsei] Hirosaki Univ, Grad Sch Med, Dept Stress Response Sci, Aomori 0368562, Japan; [Oshima, Motohiko; Sekine, Hiroki; Okawa, Hiromi; Fujii-Kuriyama, Yoshiaki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	University of Tsukuba; University of Tsukuba; Hirosaki University; Japan Science & Technology Agency (JST)	Fujii-Kuriyama, Y (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	ykfujii@tara.tsukuba.ac.jp	Mimura, Junsei/E-7893-2013		Ministry of Health, Labor, and Welfare of Japan and Solution Oriented Research for Science and Technology, Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare of Japan and Solution Oriented Research for Science and Technology, Japan Science and Technology Agency(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a scientific research grant from the Ministry of Health, Labor, and Welfare of Japan and Solution Oriented Research for Science and Technology, Japan Science and Technology Agency.	Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hosoya T, 2008, BIOCHEM BIOPH RES CO, V365, P562, DOI 10.1016/j.bbrc.2007.11.016; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kanno Y, 2006, BIOL PHARM BULL, V29, P1254, DOI 10.1248/bpb.29.1254; Karchner SI, 2002, J BIOL CHEM, V277, P6949, DOI 10.1074/jbc.M110779200; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Nishihashi H, 2006, BIOL PHARM BULL, V29, P640, DOI 10.1248/bpb.29.640; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Oshima M, 2007, BIOCHEM BIOPH RES CO, V364, P276, DOI 10.1016/j.bbrc.2007.09.131; Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	23	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11017	11026		10.1074/jbc.M808694200	http://dx.doi.org/10.1074/jbc.M808694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251700	hybrid, Green Published			2022-12-25	WOS:000265494500006
J	Chen, WQ; Huang, TT; He, XY; Meng, QQ; You, DL; Bai, LQ; Li, JL; Wu, MX; Li, R; Xie, ZJ; Zhou, HC; Zhou, XF; Tan, HR; Deng, ZX				Chen, Wenqing; Huang, Tingting; He, Xinyi; Meng, Qingqing; You, Delin; Bai, Linquan; Li, Jialiang; Wu, Mingxuan; Li, Rui; Xie, Zhoujie; Zhou, Huchen; Zhou, Xiufen; Tan, Huarong; Deng, Zixin			Characterization of the Polyoxin Biosynthetic Gene Cluster from Streptomyces cacaoi and Engineered Production of Polyoxin H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE PEPTIDE ANTIBIOTICS; CO-TRANSCRIBED GENES; NIKKOMYCIN BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; COELICOLOR A3(2); ANTIFUNGAL ANTIBIOTICS; GENOME SEQUENCE; CLONING; ACID; ANSOCHROMOGENES	A gene cluster (pol) essential for the biosynthesis of polyoxin, a nucleoside antibiotic widely used for the control of phytopathogenic fungi, was cloned from Streptomyces cacaoi. A 46,066-bp region was sequenced, and 20 of 39 of the putative open reading frames were defined as necessary for polyoxin biosynthesis as evidenced by its production in a heterologous host, Streptomyces lividans TK24. The role of PolO and PolA in polyoxin synthesis was demonstrated by in vivo experiments, and their functions were unambiguously characterized as O-carbamoyltransferase and UMP-enolpyruvyltransferase, respectively, by in vitro experiments, which enabled the production of a modified compound differing slightly from that proposed earlier. These studies should provide a solid foundation for the elucidation of the molecular mechanisms for polyoxin biosynthesis, and set the stage for combinatorial biosynthesis using genes encoding different pathways for nucleoside antibiotics.	[Chen, Wenqing; Huang, Tingting; He, Xinyi; You, Delin; Bai, Linquan; Li, Jialiang; Zhou, Xiufen; Deng, Zixin] Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China; [Chen, Wenqing; Huang, Tingting; He, Xinyi; You, Delin; Bai, Linquan; Li, Jialiang; Zhou, Xiufen; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Meng, Qingqing; Wu, Mingxuan; Zhou, Huchen] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Li, Rui; Xie, Zhoujie; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China.	tanhr@im.ac.cn; zxdeng@sjtu.edu.cn	BAI, Linquan/AAI-9833-2020; Wu, Mingxuan/G-8519-2017	Li, Rui/0000-0001-5796-2778; Chen, Wenqing/0000-0003-2557-8960	Ministry of Science and Technology [973, 863]; National Science Foundation of China; Shanghai Municipal Council of Science and Technology; Shanghai Leading Academic Discipline Project [B203]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by Grants 973 and 863 from the Ministry of Science and Technology, the National Science Foundation of China, the Shanghai Municipal Council of Science and Technology, and Shanghai Leading Academic Discipline Project B203.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai L, 2006, CHEM BIOL, V13, P387, DOI 10.1016/j.chembiol.2006.02.002; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bruntner C, 1999, MOL GEN GENET, V262, P102; Bruntner C, 1998, EUR J BIOCHEM, V254, P347, DOI 10.1046/j.1432-1327.1998.2540347.x; Carrell CJ, 2007, STRUCTURE, V15, P928, DOI 10.1016/j.str.2007.06.010; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen W, 2000, CURR MICROBIOL, V41, P312, DOI 10.1007/s002840010141; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; FIEDLER HP, 1984, J CHROMATOGR, V316, P487, DOI 10.1016/S0021-9673(00)96176-4; FUNAYAMA S, 1977, BIOCHEMISTRY-US, V16, P3121, DOI 10.1021/bi00633a013; FUNAYAMA S, 1975, BIOCHEMISTRY-US, V14, P5568, DOI 10.1021/bi00697a005; Garcia M, 2000, TETRAHEDRON-ASYMMETR, V11, P991, DOI 10.1016/S0957-4166(00)00020-3; Ginj C, 2005, CHEMBIOCHEM, V6, P1974, DOI 10.1002/cbic.200500208; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HINDLE Z, 1994, MICROBIOL-SGM, V140, P311, DOI 10.1099/13500872-140-2-311; HORI M, 1974, J ANTIBIOT, V27, P260, DOI 10.7164/antibiotics.27.260; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; ISONO K, 1976, ARCH BIOCHEM BIOPHYS, V173, P141, DOI 10.1016/0003-9861(76)90244-7; ISONO K, 1975, BIOCHEMISTRY-US, V14, P2992, DOI 10.1021/bi00684a031; ISONO K, 1965, AGR BIOL CHEM TOKYO, V29, P848, DOI 10.1080/00021369.1965.10858475; ISONO K, 1967, AGR BIOL CHEM TOKYO, V31, P190, DOI 10.1080/00021369.1967.10858788; ISONO K, 1978, J AM CHEM SOC, V100, P3937, DOI 10.1021/ja00480a052; ISONO K, 1988, J ANTIBIOT, V41, P1711, DOI 10.7164/antibiotics.41.1711; KIESER T, 2000, PRACTICAL STREPTOMYC, P169; LACALLE RA, 1992, EMBO J, V11, P785, DOI 10.1002/j.1460-2075.1992.tb05112.x; Lauer B, 2000, EUR J BIOCHEM, V267, P1698, DOI 10.1046/j.1432-1327.2000.01162.x; Lauer B, 2001, MOL GEN GENET, V264, P662, DOI 10.1007/s004380000352; Lauer B, 2000, J ANTIBIOT, V53, P385, DOI 10.7164/antibiotics.53.385; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Li YR, 2004, CURR MICROBIOL, V49, P128, DOI 10.1007/s00284-004-4260-4; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Ostash B, 2007, CHEM BIOL, V14, P257, DOI 10.1016/j.chembiol.2007.01.008; Sambrook J., 2002, MOL CLONING LAB MANU; Sun YH, 2002, MICROBIOL-SGM, V148, P361, DOI 10.1099/00221287-148-2-361; Tahlan K, 2004, CAN J MICROBIOL, V50, P803, DOI 10.1139/W04-070; VANRHIJN P, 1994, APPL ENVIRON MICROB, V60, P3615, DOI 10.1128/AEM.60.10.3615-3623.1994; WEN Z, 2004, CHINESE J BIOL, V21, P36; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zhang D, 1999, CURR PHARM DESIGN, V5, P73	41	65	72	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10627	10638		10.1074/jbc.M807534200	http://dx.doi.org/10.1074/jbc.M807534200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233844	Green Published, hybrid			2022-12-25	WOS:000265104600037
J	Gerin, I; Bommer, GT; Lidell, ME; Cederberg, A; Enerback, S; MacDougald, OA				Gerin, Isabelle; Bommer, Guido T.; Lidell, Martin E.; Cederberg, Anna; Enerback, Sven; MacDougald, Ormond A.			On the Role of FOX Transcription Factors in Adipocyte Differentiation and Insulin-stimulated Glucose Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-ALPHA; ADIPONECTIN GENE-EXPRESSION; C/EBP-ALPHA; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; ADIPOSE-TISSUE; RECEPTOR-GAMMA; ADIPOGENESIS; METABOLISM; INHIBITION	In this study, we explore the effects of several FOX and mutant FOX transcription factors on adipocyte determination, differentiation, and metabolism. In addition to Foxc2 and Foxo1, we report that Foxf2, Foxp1, and Foxa1 are other members of the Fox family that show regulated expression during adipogenesis. Although enforced expression of FOXC2 inhibits adipogenesis, Foxf2 slightly enhances the rate of differentiation. Constitutively active FOXC2-VP16 inhibits adipogenesis through multiple mechanisms. FOXC2-VP16 impairs the transient induction of C/EBP beta during adipogenesis and induces expression of the transcriptional repressor Hey1 as well as the activator of Wnt/beta-catenin signaling, Wnt10b. The constitutive transcriptional repressor, FOXC2-Eng, enhances adipogenesis of preadipocytes and multipotent mesenchymal precursors and determines NIH-3T3 and C2C12 cells to the adipocyte lineage. Although PPAR gamma ligand or C/EBP alpha are not necessary for stimulation of adipogenesis by FOXC2-Eng, at least low levels of PPAR gamma protein are absolutely required. Finally, expression of FOXC2-Eng in adipocytes increases insulin-stimulated glucose uptake, further expanding the profound and pleiotropic effects of FOX transcription factors on adipocyte biology.	[Gerin, Isabelle; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Bommer, Guido T.; MacDougald, Ormond A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lidell, Martin E.; Cederberg, Anna; Enerback, Sven] Univ Gothenburg, Ctr Genet, Dept Med & Clin Genet, Sahlgrenska Acad,Inst Biomed, SE-40530 Gothenburg, Sweden	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Gothenburg	MacDougald, OA (corresponding author), 7708A Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	macdouga@umich.edu	; Bommer, Guido/A-8425-2011	MacDougald, Ormond/0000-0001-6907-7960; Bommer, Guido/0000-0001-6898-4884	National Institutes of Health [DK51563, DK62876]; Belgian Fonds National de la Recherche Scientifique; Center for Organogenesis; Michigan Metabolomics and Obesity Center, European Commission [LSHMCT-2005-018734]; Swedish Research Council [K2005-32BI-15324-01A]; European Union [QLK3-CT-2002-02149, LSHM-CT-2003-503041]; Arne and Inga Britt Foundation; Soderberg Foundation; Swedish Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062876, R56DK062876, R01DK051563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Center for Organogenesis; Michigan Metabolomics and Obesity Center, European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Arne and Inga Britt Foundation; Soderberg Foundation; Swedish Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51563 and DK62876 (to O.A.M.). This work was also supported by the Belgian Fonds National de la Recherche Scientifique and the Center for Organogenesis (to I. G.), the Michigan Metabolomics and Obesity Center, European Commission Contract LSHMCT-2005-018734 under Project HEPADIP, Swedish Research Council Grant K2005-32BI-15324-01A (to S. E.), European Union Grants QLK3-CT-2002-02149 and LSHM-CT-2003-503041, the Arne and Inga Britt Foundation, the Soderberg Foundation, and the Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research.	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; BURATOWSKI S, 2003, CURRENT PROTOCOLS MO, P1221; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Davis KE, 2004, J BIOL CHEM, V279, P42453, DOI 10.1074/jbc.M402197200; El-Jack AK, 1999, J BIOL CHEM, V274, P7946, DOI 10.1074/jbc.274.12.7946; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gronning LM, 2006, FEBS LETT, V580, P4126, DOI 10.1016/j.febslet.2006.06.058; Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Jarikji ZH, 2007, DEV BIOL, V304, P786, DOI 10.1016/j.ydbio.2007.01.027; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim JK, 2005, DIABETES, V54, P1657, DOI 10.2337/diabetes.54.6.1657; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Raichur S, 2007, J MOL ENDOCRINOL, V39, P29, DOI 10.1677/jme.1.00010; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steiner AB, 2006, DEVELOPMENT, V133, P4827, DOI 10.1242/dev.02663; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wijchers PJEC, 2006, BRAIN RES, V1068, P23, DOI 10.1016/j.brainres.2005.11.022; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	44	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10755	10763		10.1074/jbc.M809115200	http://dx.doi.org/10.1074/jbc.M809115200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244248	Green Published, hybrid			2022-12-25	WOS:000265104600050
J	Nakade, K; Pan, JZ; Yamasaki, T; Murata, T; Wasylyk, B; Yokoyama, KK				Nakade, Koji; Pan, Jianzhi; Yamasaki, Takahito; Murata, Takehide; Wasylyk, Bohdan; Yokoyama, Kazunari K.			JDP2 (Jun Dimerization Protein 2)-deficient Mouse Embryonic Fibroblasts Are Resistant to Replicative Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; HEMATOPOIETIC STEM-CELLS; POLYCOMB GROUP PROTEINS; PREMATURE SENESCENCE; INSERTIONAL MUTAGENESIS; DEPENDENT TRANSCRIPTION; P16(INK4A) EXPRESSION; HISTONE ACETYLATION; AP-1 REPRESSOR; DNA-DAMAGE	JDP2 (Jun dimerization protein 2, an AP-1 transcription factor) is involved in the regulation of the differentiation and proliferation of cells. We report here that JDP2-deficient mouse embryonic fibroblasts (Jdp2(-/-) MEF) are resistant to replicative senescence. In the absence of JDP2, the level of expression of p16(Ink4a), which is known to rise as normal fibroblasts age, fell significantly when cells were cultured for more than 2 months. Conversely, the overexpression of JDP2 induced the expression of genes for p16(Ink4a) and p19(Arf). Moreover, at the promoter of the gene for p16(Ink4a) in Jdp2(-/-) MEF, the extent of methylation of lysine 27 of histone H3 (H3K27), which is important for gene silencing, increased. Polycomb-repressive complexes (PRC-1 and PRC-2), which are responsible for histone methylation, bound efficiently to the promoter to repress the expression of the gene for p16(Ink4a). As a result, JDP2-deficient MEF became resistant to replicative senescence. Our results indicate that JDP2 is involved in the signaling pathway for senescence via epigenetic regulation of the expression of the gene for p16(Ink4a).	[Nakade, Koji; Pan, Jianzhi; Yamasaki, Takahito; Murata, Takehide; Yokoyama, Kazunari K.] RIKEN, BioResource Ctr, Gene Engn Div, Tsukuba, Ibaraki 3050074, Japan; [Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Ctr Excellence Environm Med, Kaohsiung 80708, Taiwan	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kaohsiung Medical University	Nakade, K (corresponding author), RIKEN, BioResource Ctr, Gene Engn Div, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	nakade@rtc.riken.jp; kazu@brc.riken.jp	Wasylyk, Bohdan/ABG-6778-2020; Yokoyama, Kazunari K./B-3671-2010	Wasylyk, Bohdan/0000-0002-1718-1237; 	RIKEN Bioresource Project; Ministry of Education, Culture, Sport, Science and Technology of Japan [18770185, 20570193, 19041069]	RIKEN Bioresource Project; Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the RIKEN Bioresource Project (to K. K. Y.) and from the Ministry of Education, Culture, Sport, Science and Technology of Japan 18770185 and 20570193 (to K. N.) and 19041069 (to K. K. Y.).	Ameyar-Zazoua M, 2005, ONCOGENE, V24, P2298, DOI 10.1038/sj.onc.1208424; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200; Cherasse Y, 2008, FEBS LETT, V582, P1537, DOI 10.1016/j.febslet.2008.03.050; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; JIN C, 2002, NUCLEIC ACIDS RES, V2, pS97; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Meng AM, 2003, CANCER RES, V63, P5414; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Pavey S, 1999, CANCER RES, V59, P4185; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Ugai H, 2005, BIOCHEM BIOPH RES CO, V331, P1053, DOI 10.1016/j.bbrc.2005.03.227; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	47	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10808	10817		10.1074/jbc.M808333200	http://dx.doi.org/10.1074/jbc.M808333200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233846	Green Published, hybrid			2022-12-25	WOS:000265104600055
J	Semenova, NP; Abarca-Heidemann, K; Loranc, E; Rothberg, BS				Semenova, Nina P.; Abarca-Heidemann, Karin; Loranc, Eva; Rothberg, Brad S.			Bimane Fluorescence Scanning Suggests Secondary Structure near the S3-S4 Linker of BK Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; VOLTAGE-SENSOR ACTIVATION; CONFORMATIONAL-CHANGES; ION CHANNELS; CLAMP FLUOROMETRY; C-TERMINUS; N-TERMINUS; SPECTROSCOPY; MEMBRANE	Gating of large conductance Ca2+-activated K+ channels (BK or maxi-K channels) is controlled by a Ca2+-sensor, formed by the channel cytoplasmic C-terminal domain, and a voltage sensor, formed by its S0-S4 transmembrane helices. Here we analyze structural properties of a portion of the BK channel voltage sensing domain, the S3-S4 linker, using fluorescence lifetime spectroscopy. Single residues in the S3-S4 linker region were substituted with cysteine, and the cysteine-substituted mutants were expressed in CHO cells and covalently labeled with the sulfhydryl-reactive fluorophore monobromo-trimethylammonio-bimane (qBBr). qBBr fluorescence is quenched by tryptophan and, to a lesser extent, tyrosine side chains. We found that qBBr fluorescence in several of the labeled cysteine-substituted channels shows position-specific quenching, as indicated by increase of the brief lifetime component of the qBBr fluorescence decay. Quenching was reduced with the mutation W203F (in the S4 segment), suggesting that Trp-203 acts as a quenching group. Our results suggest a working hypothesis for the secondary structure of the BK channel S3-S4 region, and places residues Leu-204, Gly-205, and Leu-206 within the extracellular end of the S4 helix.	[Semenova, Nina P.; Abarca-Heidemann, Karin; Loranc, Eva; Rothberg, Brad S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Rothberg, BS (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3440 N Broad St, Philadelphia, PA 19140 USA.	rothberg@temple.edu	Rothberg, Brad/AAD-1260-2022	Rothberg, Brad/0000-0003-1982-2269	National Institutes of Health [GM68523]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68523 (to B. S. R.).	Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HUANG TTF, 1984, BIOL REPROD, V31, P797, DOI 10.1095/biolreprod31.4.797; Islas LD, 2006, J GEN PHYSIOL, V128, P337, DOI 10.1085/jgp.200609556; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kachel K, 1998, J BIOL CHEM, V273, P22950, DOI 10.1074/jbc.273.36.22950; KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382; Koval OM, 2007, J GEN PHYSIOL, V129, P209, DOI 10.1085/jgp.200609662; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P585, DOI 10.1113/jphysiol.1983.sp014957; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 1999, BIOCHEMISTRY-US, V38, P16383, DOI 10.1021/bi991331v; MATE KE, 1994, MOL REPROD DEV, V37, P318, DOI 10.1002/mrd.1080370311; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SATO E, 1988, BIOORG CHEM, V16, P298, DOI 10.1016/0045-2068(88)90017-X; Savalli N, 2006, P NATL ACAD SCI USA, V103, P12619, DOI 10.1073/pnas.0601176103; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Silvius Jr, 1999, METH MOL B, V116, P177; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	50	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10684	10693		10.1074/jbc.M808891200	http://dx.doi.org/10.1074/jbc.M808891200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244238	Green Published, hybrid			2022-12-25	WOS:000265104600042
J	Xiao, ZY; Deng, PY; Rojanathammanee, L; Yang, CX; Grisanti, L; Permpoonputtana, K; Weinshenker, D; Doze, VA; Porter, JE; Lei, S				Xiao, Zhaoyang; Deng, Pan-Yue; Rojanathammanee, Lalida; Yang, Chuanxiu; Grisanti, Laurel; Permpoonputtana, Kannika; Weinshenker, David; Doze, Van A.; Porter, James E.; Lei, Saobo			Noradrenergic Depression of Neuronal Excitability in the Entorhinal Cortex via Activation of TREK-2K(+) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKGROUND POTASSIUM CHANNELS; DOMAIN K+ CHANNELS; PROTEIN-COUPLED RECEPTORS; TEMPORAL-LOBE EPILEPSY; SYSTEM IN-VITRO; GABAERGIC TRANSMISSION; PARAHIPPOCAMPAL REGION; INTRINSIC CONNECTIONS; DENTATE GYRUS; RAT-BRAIN	The entorhinal cortex is closely associated with the consolidation and recall of memories, Alzheimer disease, schizophrenia, and temporal lobe epilepsy. Norepinephrine is a neurotransmitter that plays a significant role in these physiological functions and neurological diseases. Whereas the entorhinal cortex receives profuse noradrenergic innervations from the locus coeruleus of the pons and expresses high densities of adrenergic receptors, the function of norepinephrine in the entorhinal cortex is still elusive. Accordingly, we examined the effects of norepinephrine on neuronal excitability in the entorhinal cortex and explored the underlying cellular and molecular mechanisms. Application of norepinephrine-generated hyperpolarization and decreased the excitability of the neurons in the superficial layers with no effects on neuronal excitability in the deep layers of the entorhinal cortex. Norepinephrine-induced hyperpolarization was mediated by alpha(2A) adrenergic receptors and required the functions of G alpha(i) proteins, adenylyl cyclase, and protein kinase A. Norepinephrine-mediated depression on neuronal excitability was mediated by activation of TREK-2, a type of two-pore domain K+ channel, and mutation of the protein kinase A phosphorylation site on TREK-2 channels annulled the effects of norepinephrine. Our results indicate a novel action mode in which norepinephrine depresses neuronal excitability in the entorhinal cortex by disinhibiting protein kinase A-mediated tonic inhibition of TREK-2 channels.	[Xiao, Zhaoyang; Deng, Pan-Yue; Yang, Chuanxiu; Grisanti, Laurel; Doze, Van A.; Porter, James E.; Lei, Saobo] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA; [Rojanathammanee, Lalida; Permpoonputtana, Kannika] Mahidol Univ, Inst Sci & Technol Res & Dev, Neurobehav Biol Ctr, Salaya Nakornpathom 73170, Thailand; [Rojanathammanee, Lalida; Permpoonputtana, Kannika] Mahidol Univ, Fac Sci, Ctr Neurosci, Bangkok 10400, Thailand; [Rojanathammanee, Lalida; Permpoonputtana, Kannika] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Weinshenker, David] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	University of North Dakota Grand Forks; Mahidol University; Mahidol University; Mahidol University; Emory University	Lei, S (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, 501 N Columbia Rd, Grand Forks, ND 58203 USA.	slei@medicine.nodak.edu	Weinshenker, David/V-3998-2019	Permpoonputtana, Kannika/0000-0001-6442-8629; Doze, Van/0000-0002-5288-9564	National Institutes of Health [R01MH082881, 5P20RR017699]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01MH082881 (to S. L.) and 5P20RR017699 (to S. L.).	Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; BOOZE RM, 1993, SYNAPSE, V13, P206, DOI 10.1002/syn.890130303; BOYAJIAN CL, 1987, J PHARMACOL EXP THER, V241, P1079; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buffalari DM, 2007, J NEUROSCI, V27, P12358, DOI 10.1523/JNEUROSCI.2007-07.2007; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Deng PY, 2007, J NEUROPHYSIOL, V97, P727, DOI 10.1152/jn.01089.2006; Deng PY, 2006, J PHYSIOL-LONDON, V572, P425, DOI 10.1113/jphysiol.2005.104463; DENG PY, 2006, J PHYSL, P497; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; DU F, 1992, NEUROSCI LETT, V147, P185, DOI 10.1016/0304-3940(92)90591-T; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; FALLON JH, 1978, J COMP NEUROL, V180, P509, DOI 10.1002/cne.901800308; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Galeotti N, 2004, BEHAV BRAIN RES, V153, P409, DOI 10.1016/j.bbr.2003.12.016; Galeotti N, 2004, NEUROSCIENCE, V126, P451, DOI 10.1016/j.neuroscience.2004.04.001; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Haapalinna A, 1998, EUR J PHARMACOL, V347, P29, DOI 10.1016/S0014-2999(98)00077-6; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Joyal CC, 2002, BIOL PSYCHIAT, V51, P1005, DOI 10.1016/S0006-3223(01)01368-3; Kang D, 2007, EXP DERMATOL, V16, P1016, DOI 10.1111/j.1600-0625.2007.00626.x; Kang D, 2007, J PHYSIOL-LONDON, V583, P57, DOI 10.1113/jphysiol.2007.136150; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Lei S, 2007, J NEUROPHYSIOL, V98, P2868, DOI 10.1152/jn.00679.2007; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Majak K, 2003, EUR J NEUROSCI, V18, P1652, DOI 10.1046/j.1460-9568.2003.02854.x; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Mulders WHAM, 1997, J COMP NEUROL, V385, P83; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; PALKOVITS M, 1979, BRAIN RES BULL, V4, P593, DOI 10.1016/0361-9230(79)90099-6; PRALONG E, 1994, NEUROSCI LETT, V179, P145, DOI 10.1016/0304-3940(94)90955-5; Pralong E, 1995, EUR J NEUROSCI, V7, P2370, DOI 10.1111/j.1460-9568.1995.tb01034.x; Prasad KMR, 2004, AM J PSYCHIAT, V161, P1612, DOI 10.1176/appi.ajp.161.9.1612; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; STANTON PK, 1987, EPILEPSY RES, V1, P53, DOI 10.1016/0920-1211(87)90051-9; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Stoop R, 2000, NEUROSCI LETT, V287, P5, DOI 10.1016/S0304-3940(00)01154-X; Szot P, 2004, NEUROSCIENCE, V126, P795, DOI 10.1016/j.neuroscience.2004.04.030; UNNERSTALL JR, 1984, BRAIN RES REV, V7, P69, DOI 10.1016/0165-0173(84)90030-4; UNNERSTALL JR, 1985, PHARMACOL BIOCHEM BE, V22, P859, DOI 10.1016/0091-3057(85)90538-6; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; WILCOX BJ, 1990, SYNAPSE, V6, P284, DOI 10.1002/syn.890060308; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Witter MP, 2000, HIPPOCAMPUS, V10, P398	64	57	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10980	10991		10.1074/jbc.M806760200	http://dx.doi.org/10.1074/jbc.M806760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244246	Green Published, hybrid			2022-12-25	WOS:000265104600070
J	Dahlberg, CL; Nguyen, EZ; Goodlett, D; Kimelman, D				Dahlberg, Caroline Lund; Nguyen, Elizabeth Z.; Goodlett, David; Kimelman, David			Interactions between Casein Kinase I epsilon (CKI epsilon) and Two Substrates from Disparate Signaling Pathways Reveal Mechanisms for Substrate-Kinase Specificity	PLOS ONE			English	Article							BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; WNT; PROTEIN; FAMILY; BINDING; DELTA; DEGRADATION	Background: Members of the Casein Kinase I (CKI) family of serine/threonine kinases regulate diverse biological pathways. The seven mammalian CKI isoforms contain a highly conserved kinase domain and divergent amino- and carboxy-termini. Although they share a preferred target recognition sequence and have overlapping expression patterns, individual isoforms often have specific substrates. In an effort to determine how substrates recognize differences between CKI isoforms, we have examined the interaction between CKI epsilon and two substrates from different signaling pathways. Methodology/Principal Findings: CKI epsilon, but not CKI alpha, binds to and phosphorylates two proteins: Period, a transcriptional regulator of the circadian rhythms pathway, and Disheveled, an activator of the planar cell polarity pathway. We use GSTpull-down assays data to show that two key residues in CKI alpha's kinase domain prevent Disheveled and Period from binding. We also show that the unique C-terminus of CKI epsilon does not determine Dishevelled's and Period's preference for CKI epsilon nor is it essential for binding, but instead plays an auxillary role in stabilizing the interactions of CKI epsilon with its substrates. We demonstrate that autophosphorylation of CKI epsilon's C-terminal tail prevents substrate binding, and use mass spectrometry and chemical crosslinking to reveal how a phosphorylation-dependent interaction between the C-terminal tail and the kinase domain prevents substrate phosphorylation and binding. Conclusions/Significance: The biochemical interactions between CKI epsilon and Disheveled, Period, and its own C-terminus lead to models that explain CKI epsilon's specificity and regulation.	[Dahlberg, Caroline Lund; Kimelman, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Nguyen, Elizabeth Z.; Goodlett, David] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dahlberg, CL (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	kimelman@u.washington.edu	Dahlberg, Caroline/AAP-1285-2021	Nguyen, Elizabeth/0000-0002-6495-7827	NIH [T32-GM07270]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH HD27262 (to DK) T32-GM07270 (to CLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albornoz A, 2007, BIOL RES, V40, P251, DOI 10.4067/S0716-97602007000200015; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Burzio V, 2002, J CELL BIOCHEM, V86, P805, DOI 10.1002/jcb.10263; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Green CL, 1998, GENE, V216, P189, DOI 10.1016/S0378-1119(98)00291-1; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu F, 2002, J BIOL CHEM, V277, P45393, DOI 10.1074/jbc.M204499200; Longenecker KL, 1998, ACTA CRYSTALLOGR D, V54, P473, DOI 10.1107/S0907444997011724; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; Loudon ASI, 2007, COLD SPRING HARB SYM, V72, P261, DOI 10.1101/sqb.2007.72.073; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mackey SR, 2007, COLD SPRING HARB SYM, V72, P7, DOI 10.1101/sqb.2007.72.060; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Matsubayashi H, 2004, MOL CELL BIOL, V24, P2012, DOI 10.1128/MCB.24.5.2012-2024.2004; McKay RM, 2001, DEV BIOL, V235, P378, DOI 10.1006/dbio.2001.0307; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Miyazaki K, 2004, BIOCHEM J, V380, P95, DOI 10.1042/BJ20031308; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Penton A, 2002, GENETICS, V161, P747; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Pulgar V, 1999, EUR J BIOCHEM, V260, P520, DOI 10.1046/j.1432-1327.1999.00195.x; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; SINGH P, 2008, ANAL CHEM; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Takano A, 2004, NEUROPSYCHOPHARMACOL, V29, P1901, DOI 10.1038/sj.npp.1300503; Takano A, 2000, FEBS LETT, V477, P106, DOI 10.1016/S0014-5793(00)01755-5; Trang LTD, 2006, J BIOL RHYTHM, V21, P335, DOI 10.1177/0748730406291734; Vielhaber E, 2001, IUBMB LIFE, V51, P73, DOI 10.1080/15216540152122049; Vielhaber EL, 2001, J BIOL CHEM, V276, P45921, DOI 10.1074/jbc.M107726200; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yin HS, 2006, BIOCHEMISTRY-US, V45, P5297, DOI 10.1021/bi052354e; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang L, 2006, DEV BIOL, V299, P221, DOI 10.1016/j.ydbio.2006.07.025	67	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4766	10.1371/journal.pone.0004766	http://dx.doi.org/10.1371/journal.pone.0004766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274088	Green Published, Green Submitted, gold			2022-12-25	WOS:000265496000006
J	Gaeta, RT; Yoo, SY; Pires, JC; Doerge, RW; Chen, ZJ; Osborn, TC				Gaeta, Robert T.; Yoo, Suk-Young; Pires, J. C.; Doerge, R. W.; Chen, Z. Jeffrey; Osborn, Thomas C.			Analysis of Gene Expression in Resynthesized Brassica napus Allopolyploids Using Arabidopsis 70mer Oligo Microarrays	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CYTOSINE METHYLATION; POLYPLOIDY; TRANSCRIPTOME; EVOLUTION; HYBRIDIZATION; MECHANISMS; REARRANGEMENTS; PATTERNS; SENECIO	Background: Studies in resynthesized Brassica napus allopolyploids indicate that homoeologous chromosome exchanges in advanced generations (S-5:6) alter gene expression through the loss and doubling of homoeologous genes within the rearrangements. Rearrangements may also indirectly affect global gene expression if homoeologous copies of gene regulators within rearrangements have differential affects on the transcription of genes in networks. Methodology/Principal Findings: We utilized Arabidopsis 70mer oligonucleotide microarrays for exploring gene expression in three resynthesized B. napus lineages at the S-0:1 and S-5:6 generations as well as their diploid progenitors B. rapa and B. oleracea. Differential gene expression between the progenitors and additive (midparent) expression in the allopolyploids were tested. The S-5:6 lines differed in the number of genetic rearrangements, allowing us to test if the number of genes displaying nonadditive expression was related to the number of rearrangements. Estimates using per-gene and common variance ANOVA models indicated that 6-15% of 26,107 genes were differentially expressed between the progenitors. Individual allopolyploids showed nonadditive expression for 1.6-32% of all genes. Less than 0.3% of genes displayed nonadditive expression in all S-0:1 lines and 0.1-0.2% were nonadditive among all S-5:6 lines. Differentially expressed genes in the polyploids were over-represented by genes differential between the progenitors. The total number of differentially expressed genes was correlated with the number of genetic changes in S-5:6 lines under the common variance model; however, there was no relationship using a per-gene variance model, and many genes showed nonadditive expression in S-0:1 lines. Conclusions/Significance: Few genes reproducibly demonstrated nonadditive expression among lineages, suggesting few changes resulted from a general response to polyploidization. Furthermore, our microarray analysis did not provide strong evidence that homoeologous rearrangements were a determinant of genome-wide nonadditive gene expression. In light of the inherent limitations of the Arabidopsis microarray to measure gene expression in polyploid Brassicas, further studies are warranted.	[Gaeta, Robert T.; Pires, J. C.; Osborn, Thomas C.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Yoo, Suk-Young; Doerge, R. W.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Chen, Z. Jeffrey] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX USA	University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Texas A&M University System; Texas A&M University College Station	Gaeta, RT (corresponding author), Univ Missouri, Dept Biol Sci, Columbia, MO 65211 USA.	gaetar@missouri.edu	Pires, J. Chris/O-5122-2014	Pires, J. Chris/0000-0001-9682-2639	National Science Foundation Plant Genome Program [0077774, 0501712]	National Science Foundation Plant Genome Program(National Science Foundation (NSF))	We acknowledge funding from the National Science Foundation Plant Genome Program (0077774 and 0501712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Albertin W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-56; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Chen ZJ, 2007, NEW PHYTOL, V174, P717, DOI 10.1111/j.1469-8137.2007.02084.x; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chen ZJ, 2004, BIOL J LINN SOC, V82, P689, DOI 10.1111/j.1095-8312.2004.00351.x; Clarke JD, 2006, PLANT J, V45, P630, DOI 10.1111/j.1365-313X.2006.02668.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dudoit S, 2002, STAT SINICA, V12, P111; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gottlieb LD, 2003, HEREDITY, V91, P91, DOI 10.1038/sj.hdy.6800317; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Hegarty MJ, 2005, MOL ECOL, V14, P2493, DOI 10.1111/j.1365-294X.2005.02608.x; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Hudson ME, 2007, CROP SCI, V47, pS96, DOI 10.2135/cropsci2006.12.0758tpg; Kashkush K, 2002, GENETICS, V160, P1651; Kovarik A, 2004, BIOL J LINN SOC, V82, P615, DOI 10.1111/j.1095-8312.2004.00345.x; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Meyers LA, 2006, EVOLUTION, V60, P1198, DOI 10.1111/j.0014-3820.2006.tb01198.x; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Poole R, 2007, FUNCT INTEGR GENOMIC, V7, P207, DOI 10.1007/s10142-007-0046-7; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; SAS Institute, 2006, SAS STAT US GUID; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Udall JA, 2006, GENETICS, V173, P1823, DOI 10.1534/genetics.106.058271; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang JL, 2005, METHOD ENZYMOL, V395, P570, DOI 10.1016/S0076-6879(05)95030-1; Wilson Ian D., 2005, Functional & Integrative Genomics, V5, P144, DOI 10.1007/s10142-005-0137-2; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z	45	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4760	10.1371/journal.pone.0004760	http://dx.doi.org/10.1371/journal.pone.0004760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274085	Green Submitted, Green Published, gold			2022-12-25	WOS:000265496000002
J	Al-Ejeh, F; Darby, JM; Brown, MP				Al-Ejeh, Fares; Darby, Jocelyn M.; Brown, Michael P.			Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors	PLOS ONE			English	Article								Background: To date, inefficient delivery of therapeutic doses of radionuclides to solid tumors limits the clinical utility of radioimmunotherapy. We aim to test the therapeutic utility of Yttrium-90 (Y-90)-radio-conjugates of a monoclonal antibody, which we showed previously to bind specifically to the abundant intracellular La ribonucleoprotein revealed in dead tumor cells after DNA-damaging treatment. Methodology/Principal Findings: Immunoconjugates of the DAB4 clone of the La-specific monoclonal antibody, APOMAB (R), were prepared using the metal chelator, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and then radiolabeled with Y-90. Mice bearing established subcutaneous tumors were treated with Y-90-DOTA-DAB4 alone or after chemotherapy. Non-radiosensitizing cyclophosphamide/etoposide chemotherapy was used for the syngeneic EL4 lymphoma model. Radiosensitizing cisplatin/gemcitabine chemotherapy was used for the syngeneic Lewis Lung carcinoma (LL2) model, and for the xenograft models of LNCaP prostatic carcinoma and Panc-1 pancreatic carcinoma. We demonstrate the safety, specificity, and efficacy of Y-90-DOTA-DAB4-radioimmunotherapy alone or combined with chemotherapy. EL4 lymphoma-bearing mice either were cured at higher doses of radioimmunotherapy alone or lower doses of radioimmunotherapy in synergy with chemotherapy. Radioimmunotherapy alone was less effective in chemo-and radio-resistant carcinoma models. However, radioimmunotherapy synergized with radiosensitizing chemotherapy to retard significantly tumor regrowth and so prolong the survival of mice bearing LL2, LNCaP, or Panc-1 subcutaneous tumor implants. Conclusions/Significance: We report proof-of-concept data supporting a unique form of radioimmunotherapy, which delivers bystander killing to viable cancer cells after targeting the universal cancer antigen, La, created by DNA-damaging treatment in neighboring dead cancer cells. Subsequently we propose that DAB4-targeted ionizing radiation induces additional cycles of tumor cell death, which further augments DAB4 binding to produce a tumor-lethal 'genotoxic chain reaction'. Clinically, this approach may be useful as consolidation treatment after a drug-induced cell death among (small-volume) metastatic deposits, the commonest cause of cancer death. This article is part II of a two-part series providing proof-of-concept for the diagnostic and therapeutic use of the DAB4 clone of the La-specific monoclonal antibody, APOMAB (R).	[Al-Ejeh, Fares; Darby, Jocelyn M.; Brown, Michael P.] Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia; [Brown, Michael P.] Univ Adelaide, Royal Adelaide Hosp, Dept Med Oncol, Adelaide, SA 5005, Australia; [Brown, Michael P.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia	Hanson Institute; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	Al-Ejeh, F (corresponding author), Hanson Inst, Expt Therapeut Lab, Adelaide, SA, Australia.	michael.brown@health.sa.gov.au	Al-Ejeh, Fares/M-7032-2016; Brown, Michael/C-2081-2014	Al-Ejeh, Fares/0000-0002-1553-0077; Brown, Michael/0000-0002-5796-1932; Darby, Jocelyn/0000-0002-1819-6000	Oncaidia Ltd; National Health and Medical Research Council Research [ID511303]	Oncaidia Ltd; National Health and Medical Research Council Research	Oncaidia Ltd funded the salary of FA for 2007, the salary of JMD as well as equipment and research. National Health and Medical Research Council Research also supplied funding through Project Grant ID511303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5519S, DOI 10.1158/1078-0432.CCR-07-0964; Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; ALEJEH F, NUCL MED BI IN PRESS; Ayukawa K, 2000, J BIOL CHEM, V275, P34465, DOI 10.1074/jbc.M003673200; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Chang J, 2000, CANCER-AM CANCER SOC, V89, P2145, DOI 10.1002/1097-0142(20001201)89:11<2145::AID-CNCR1>3.0.CO;2-S; Chen SL, 2005, J CLIN ONCOL, V23, P1538, DOI 10.1200/JCO.2005.06.108; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; Davis DW, 2003, CLIN CANCER RES, V9, P955; Deb N, 1996, CLIN CANCER RES, V2, P1289; EPSTEIN AL, 1988, CANCER RES, V48, P5842; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Goldenberg DM, 2006, Q J NUCL MED MOL IM, V50, P248; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoeppner Luke H, 2006, Cancer Immun, V6, P1; Koppe MJ, 2004, J NUCL MED, V45, P1224; Kovtun YV, 2006, CANCER RES, V66, P3214, DOI 10.1158/0008-5472.CAN-05-3973; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Lang D, 1998, ONCOGENE, V16, P1593, DOI 10.1038/sj.onc.1201665; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Lee CH, 2007, HUM GENE THER, V18, P27, DOI 10.1089/hum.2005.239; Leers MPG, 2002, CELL MOL LIFE SCI, V59, P1358, DOI 10.1007/s00018-002-8513-8; Liu S, 2001, BIOCONJUGATE CHEM, V12, P7, DOI 10.1021/bc000070v; Mayer A, 2006, CLIN CANCER RES, V12, P6509, DOI 10.1158/1078-0432.CCR-06-0769; McArthur C, 2002, ARCH ORAL BIOL, V47, P443, DOI 10.1016/S0003-9969(02)00025-0; Milas L, 1999, CANCER RES, V59, P107; MILLER BK, 1993, HOOSIER FARMLAND WIL, V1, P2; Milowsky MI, 2004, J CLIN ONCOL, V22, P2522, DOI 10.1200/JCO.2004.09.154; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Rokhlin OW, 2000, ONCOGENE, V19, P1959, DOI 10.1038/sj.onc.1203453; SCHMIDBERGER H, 1991, CANCER RES, V51, P1883; Sgouros G, 2008, CANCER BIOTHER RADIO, V23, P74, DOI 10.1089/cbr.2007.0408; Shewach DS, 2007, J CLIN ONCOL, V25, P4043, DOI 10.1200/JCO.2007.11.5287; Smith-Jones PM, 2003, J NUCL MED, V44, P610; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; THIERRY B, ADV MAT IN PRESS; Tran HB, 2002, ARTHRITIS RHEUM, V46, P202, DOI 10.1002/1529-0131(200201)46:1<202::AID-ART10062>3.0.CO;2-Y; Truksa J, 2003, CELL PROLIFERAT, V36, P199, DOI 10.1046/j.1365-2184.2003.00280.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wood W, 2000, DEVELOPMENT, V127, P5245; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241	49	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4630	10.1371/journal.pone.0004630	http://dx.doi.org/10.1371/journal.pone.0004630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247485	Green Published, gold			2022-12-25	WOS:000265487800012
J	Robinet, C; Roques, A; Pan, HY; Fang, GF; Ye, JR; Zhang, YZ; Sun, JH				Robinet, Christelle; Roques, Alain; Pan, Hongyang; Fang, Guofei; Ye, Jianren; Zhang, Yanzhuo; Sun, Jianghua			Role of Human-Mediated Dispersal in the Spread of the Pinewood Nematode in China	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BURSAPHELENCHUS-XYLOPHILUS; BIOLOGICAL INVASIONS; WILT DISEASE; SAWYER; COLEOPTERA; DIFFUSION; PORTUGAL; PATTERNS; SUCCESS	Background: Intensification of world trade is responsible for an increase in the number of alien species introductions. Human-mediated dispersal promotes not only introductions but also expansion of the species distribution via long-distance dispersal. Thus, understanding the role of anthropogenic pathways in the spread of invading species has become one of the most important challenges nowadays. Methodology/Principal Findings: We analysed the invasion pattern of the pinewood nematode in China based on invasion data from 1982 to 2005 and monitoring data on 7 locations over 15 years. Short distance spread mediated by long-horned beetles was estimated at 7.5 km per year. Infested sites located further away represented more than 90% of observations and the mean long distance spread was estimated at 111-339 km. Railways, river ports, and lakes had significant effects on the spread pattern. Human population density levels explained 87% of the variation in the invasion probability (P<0.05). Since 2001, the number of new records of the nematode was multiplied by a factor of 5 and the spread distance by a factor of 2. We combined a diffusion model to describe the short distance spread with a stochastic, individual based model to describe the long distance jumps. This combined model generated an error of only 13% when used to predict the presence of the nematode. Under two climate scenarios (stable climate or moderate warming), projections of the invasion probability suggest that this pest could expand its distribution 40-55% by 2025. Conclusions/Significance: This study provides evidence that human-induced dispersal plays a fundamental role in the spread of the pinewood nematode, and appropriate control measures should be taken to stop or slow its expansion. This model can be applied to Europe, where the nematode had been introduced later, and is currently expanding its distribution. Similar models could also be derived for other species that could be accidentally transported by humans.	[Robinet, Christelle; Roques, Alain] INRA, UR Zool Forestiere 633, Orleans, France; [Pan, Hongyang; Fang, Guofei] State Forest Adm, Gen Forest Pest Control Stn, Shenyang, Peoples R China; [Ye, Jianren] Nanjing Forest Univ, Nanjing, Peoples R China; [Zhang, Yanzhuo; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Manage Pest Insects & Rod, Beijing 100864, Peoples R China	INRAE; Nanjing Forestry University; Chinese Academy of Sciences; Institute of Zoology, CAS	Robinet, C (corresponding author), INRA, UR Zool Forestiere 633, Orleans, France.	sunjh@ioz.ac.cn	Zhang, Yanzhuo/E-8902-2011	Robinet, Christelle/0000-0002-4933-4656; sun, jianghua/0000-0002-9465-3672	National Natural Science Foundation of China [30730074, 30525009]; Partenariat Hubert Curien of the programme de recherches avancees franco-chinois [AHH610548C]; EU [ALARM GOCE-CT-2003-506675, PRATIQUE KBBE-2007-212459]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Partenariat Hubert Curien of the programme de recherches avancees franco-chinois; EU(European Commission)	We greatly acknowledge support for this work from the National Natural Science Foundation of China (30730074 and 30525009), a French grant from the "Partenariat Hubert Curien of the programme de recherches avancees franco-chinois" (phc pra AHH610548C- INVACHINE ), and the EU projects ALARM GOCE-CT-2003-506675 (FP6 Integrated Project, Assessing large-scale environmental risks with tested methods; www.alarmproject.net [69]) and PRATIQUE KBBE-2007-212459 (FP7 Project, Enhancements of pest risk analysis techniques). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MC, 2004, RISK ANAL, V24, P893, DOI 10.1111/j.0272-4332.2004.00487.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; Christensen J.H., 2007, CLIMATE CHANGE 2007; DOMROES M, 1988, CLIMATE CHINA; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; FU LG, 1999, PINACEAE FLORA CHINA, V4; Fujioka H., 1993, B AKITA PREFECTURE F, V2, P40; GAO TY, 1987, PLANT QUARANTINE, V1, P215; Gilbert M, 2005, J APPL ECOL, V42, P805, DOI 10.1111/j.1365-2664.2005.01074.x; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hu ZZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003651; IDO N, 1977, STUDIES CONTROL PINE, P87; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; JARVIS A, 2006, HOLE FILLED SEAMLESS; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Kolmogorov A. N., 1937, B MOSCOW STATE U, V1, DOI DOI 10.1016/B978-0-08-092523-3.50014-9; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Ma RY, 2006, ANN FOREST SCI, V63, P449, DOI 10.1051/forest:2006025; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Murray J.D., 1993, MATH BIOL, V3rd; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Perez G., 2008, V17, P269, DOI 10.1007/978-1-4020-8343-3_15; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; R Development Core Team, 2007, R LANG ENV STAT COMP; REGO A, 2008, PROTOCOLO COLABORACA; RODRIGUES J, 2006, INT S 10 14 JUL LISB; ROQUES A, 2006, EPPO B, V36, P490, DOI DOI 10.1111/J.1365-2338.2006.01049.X; Roques Alain, 2009, V3, P63; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; Shigesada N, 1997, BIOL INVASIONS THEOR; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; SMITH I M, 1985, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V33, P159; SONG YS, 2001, INTEGRATED MANAGEMEN; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Sun Jie, 2008, Nanjing Nongye Daxue Xuebao, V31, P55; Suzuki K., 2002, Dendrobiology, V48, P71; Takasu Fugo, 2000, Biological Invasions, V2, P141, DOI 10.1023/A:1010048725497; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Vieira P., 2008, PINE WILT DIS WORLDW; Vieira P, 2007, J NEMATOL, V39, P118; WAN FH, 2002, INT WORKSH BIOD MAN, P77; [王峰 Wang Feng], 2002, [云南农业大学学报, Journal of Yunnan Agricultural University], V17, P421; WANG MX, 2001, FOR PEST DIS, V2, P42; WANG YA, 1987, RES REGIONALIZATION; WANG YY, 1988, FOR PEST DIS, V1, P45; Ward DF, 2005, SOCIOBIOLOGY, V45, P401; Weber E, 2008, BIOSCIENCE, V58, P437, DOI 10.1641/B580511; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; YANG BJ, 1989, CAN J FOREST RES, V19, P1527, DOI 10.1139/x89-232; YANG BJ, 1995, EPIDEMICS MANAGEMENT, P263; YING TS, 2004, ATLAS GYMNOSPERMS CH, P70; Yoshimura A, 1999, ECOLOGY, V80, P1691, DOI 10.2307/176557; Zhao LL, 2007, CAN J FOREST RES, V37, P1867, DOI 10.1139/X07-049; [No title captured], DOI DOI 10.1111/J.1365-2338.1996.TB00594.X	69	88	99	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4646	10.1371/journal.pone.0004646	http://dx.doi.org/10.1371/journal.pone.0004646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247498	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487800026
J	Teacher, AGF; Garner, TWJ; Nichols, RA				Teacher, Amber G. F.; Garner, Trenton W. J.; Nichols, Richard A.			Evidence for Directional Selection at a Novel Major Histocompatibility Class I Marker in Wild Common Frogs (Rana temporaria) Exposed to a Viral Pathogen (Ranavirus)	PLOS ONE			English	Article							NATURAL-SELECTION; COMPLEX LOCI; MHC; VARIABILITY; ORGANIZATION; VERTEBRATES; POPULATION; PATTERNS; SYSTEM; GENES	Whilst the Major Histocompatibility Complex (MHC) is well characterized in the anuran Xenopus, this region has not previously been studied in another popular model species, the common frog (Rana temporaria). Nor, to date, have there been any studies of MHC in wild amphibian host-pathogen systems. We characterise an MHC class I locus in the common frog, and present primers to amplify both the whole region, and specifically the antigen binding region. As no more than two expressed haplotypes were found in over 400 clones from 66 individuals, it is likely that there is a single class I locus in this species. This finding is consistent with the single class I locus in Xenopus, but contrasts with the multiple loci identified in axolotls, providing evidence that the diversification of MHC class I into multiple loci likely occurred after the Caudata/Anura divergence (approximately 350 million years ago) but before the Ranidae/Pipidae divergence (approximately 230 mya). We use this locus to compare wild populations of common frogs that have been infected with a viral pathogen (Ranavirus) with those that have no history of infection. We demonstrate that certain MHC supertypes are associated with infection status (even after accounting for shared ancestry), and that the diseased populations have more similar supertype frequencies (lower F-ST) than the uninfected. These patterns were not seen in a suite of putatively neutral microsatellite loci. We interpret this pattern at the MHC locus to indicate that the disease has imposed selection for particular haplotypes, and hence that common frogs may be adapting to the presence of Ranavirus, which currently kills tens of thousands of amphibians in the UK each year.	[Teacher, Amber G. F.; Nichols, Richard A.] Univ London, Sch Biol & Chem Sci, London, England; [Teacher, Amber G. F.; Garner, Trenton W. J.] Zool Soc London, Inst Zool, London NW1 4RY, England	University of London; Zoological Society of London	Teacher, AGF (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	amber.teacher@ioz.ac.uk	Nichols, Richard/B-7732-2008; Teacher, Amber/G-9107-2012; Nichols, Richard Alan/T-4773-2019; Garner, Trenton WJ/D-6873-2011	Nichols, Richard/0000-0002-4801-9312; Garner, Trenton WJ/0000-0002-0336-9706; Griffiths, Amber/0000-0002-7455-6795	Natural Environment Research Council; Herpetofauna Consultants International Ltd.; University of London; Universities Federation for Animal Welfare; British Wildlife Health Association; Zoological Society of London	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Herpetofauna Consultants International Ltd.; University of London; Universities Federation for Animal Welfare; British Wildlife Health Association; Zoological Society of London	This work was funded by a Natural Environment Research Council studentship, with CASE support from Herpetofauna Consultants International Ltd. Additional funds were received from the University of London Central Research Fund, the Universities Federation for Animal Welfare, the British Wildlife Health Association and the Zoological Society of London. No funders played any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Berlin S, 2000, MOL ECOL, V9, P1938, DOI 10.1046/j.1365-294x.2000.01093-12.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Consuegra S, 2005, IMMUNOGENETICS, V57, P16, DOI 10.1007/s00251-004-0765-z; Cunningham A. A., 2001, INVESTIGATIONS MASS; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Doherty P C, 1975, Nature, V256, P50; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FLAJNIK MF, 1999, J IMMUNOLOGY, V163; Frankham R., 2002, INTRO CONSERVATION G; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jensen LF, 2008, HEREDITY, V100, P79, DOI 10.1038/sj.hdy.6801067; KUMAR S, 2001, MEGA2 MOL EVOLUTIONA; Maniero GD, 2006, DEV COMP IMMUNOL, V30, P649, DOI 10.1016/j.dci.2005.09.007; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Ohtsuka M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-178; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Robert J, 2005, VIROLOGY, V332, P667, DOI 10.1016/j.virol.2004.12.012; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammut B, 1999, EUR J IMMUNOL, V29, P2897, DOI 10.1002/(SICI)1521-4141(199909)29:09<2897::AID-IMMU2897>3.0.CO;2-2; Seddon JM, 2004, P ROY SOC B-BIOL SCI, V271, P2283, DOI 10.1098/rspb.2004.2869; SHUM BP, 1993, J IMMUNOL, V151, P5376; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; [No title captured]	39	78	82	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4616	10.1371/journal.pone.0004616	http://dx.doi.org/10.1371/journal.pone.0004616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240796	Green Published, Green Submitted, gold			2022-12-25	WOS:000278086700021
J	Wu, XS; Jin, L; Xiong, MM				Wu, Xuesen; Jin, Li; Xiong, Momiao			Mutual Information for Testing Gene-Environment Interaction	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; RHEUMATOID-ARTHRITIS; POLYMORPHISMS; SMOKING; EPISTASIS; HLA-DRB1; DESIGNS; CANCER	Despite current enthusiasm for investigation of gene-gene interactions and gene-environment interactions, the essential issue of how to define and detect gene-environment interactions remains unresolved. In this report, we define gene-environment interactions as a stochastic dependence in the context of the effects of the genetic and environmental risk factors on the cause of phenotypic variation among individuals. We use mutual information that is widely used in communication and complex system analysis to measure gene-environment interactions. We investigate how gene-environment interactions generate the large difference in the information measure of gene-environment interactions between the general population and a diseased population, which motives us to develop mutual information-based statistics for testing gene-environment interactions. We validated the null distribution and calculated the type 1 error rates for the mutual information-based statistics to test gene-environment interactions using extensive simulation studies. We found that the new test statistics were more powerful than the traditional logistic regression under several disease models. Finally, in order to further evaluate the performance of our new method, we applied the mutual information-based statistics to three real examples. Our results showed that P-values for the mutual information-based statistics were much smaller than that obtained by other approaches including logistic regression models.	[Wu, Xuesen; Jin, Li; Xiong, Momiao] Fudan Univ, Sch Life Sci, Theoret Syst Biol Lab, Shanghai 200433, Peoples R China; [Wu, Xuesen; Jin, Li; Xiong, Momiao] Fudan Univ, Ctr Evolutionary Biol, Shanghai 200433, Peoples R China; [Jin, Li] Chinese Acad Sci, SIBS, Inst Computat Biol, MPG, Shanghai, Peoples R China; [Xiong, Momiao] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX USA; [Wu, Xuesen] Bengbu Med Coll Bengbu, Dept Epidemiol & Stat, Anhua, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Bengbu Medical College	Wu, XS (corresponding author), Fudan Univ, Sch Life Sci, Theoret Syst Biol Lab, Shanghai 200433, Peoples R China.	momiao@gmail.com	Jin, Li/M-5063-2019; Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Institutes of Health NIAMS [P01 AR052915-01A1, P50 AR054144-01 CORT, HL74735, ES09912]; National Institutes of Health Tech Research and Development Program of China 863 [2007AA02Z312]; Shanghai Commission of Science and Technology [04dz14003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052915, P50AR054144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health Tech Research and Development Program of China 863(National High Technology Research and Development Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant from National Institutes of Health NIAMS P01 AR052915-01A1, NIAMS P50 AR054144-01 CORT, HL74735, and ES09912, and Grant from Hi- Grant from National Institutes of Health Tech Research and Development Program of China 863) (2007AA02Z312), Shanghai Commission of Science and Technology Grant (04dz14003) and Shanghai Commission of Science and Technology (04dz14003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Andrieu N, 1998, EPIDEMIOL REV, V20, P137, DOI 10.1093/oxfordjournals.epirev.a017976; Ay N, 2002, NEURAL COMPUT, V14, P2959, DOI 10.1162/089976602760805368; Brillinger DR., 2004, BRAZ J PROBAB STAT, V18, P163; Bush WS, 2006, BIOINFORMATICS, V22, P2173, DOI 10.1093/bioinformatics/btl347; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; CHEVERUD JM, 1995, GENETICS, V139, P1455; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Cover TM, 1991, ELEMENTS INFORM THEO; Dandara C, 2006, CARCINOGENESIS, V27, P791, DOI 10.1093/carcin/bgi257; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Goldstein AM, 2006, INT J EPIDEMIOL, V35, P1067, DOI 10.1093/ije/dyl048; GOODMAN M, 2006, PEDIAT BLOOD CANC; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Jakulin A, 2003, LECT NOTES ARTIF INT, V2780, P229; Jakulin A., 2005, THESIS U LJUBLJANA S; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Liberman U, 2007, THEOR POPUL BIOL, V71, P230, DOI 10.1016/j.tpb.2006.10.002; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Liu X, 2004, CURR OPIN GENET DEV, V14, P241, DOI 10.1016/j.gde.2004.04.011; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Matsuda H, 2000, PHYS REV E, V62, P3096, DOI 10.1103/PhysRevE.62.3096; MCGILL WJ, 1954, PSYCHOMETRIKA, V19, P97; Nakahara H, 2003, BIOINFORMATICS, V19, P1124, DOI 10.1093/bioinformatics/btg098; NOTHNAGEL M, 2002, AM J HUM GENET S, V71; Ottman R, 1996, PREV MED, V25, P764, DOI 10.1006/pmed.1996.0117; Puniyani A, 2004, THEOR POPUL BIOL, V66, P317, DOI 10.1016/j.tpb.2004.05.001; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Winslow RL, 2003, CIRC RES, V92, P953, DOI 10.1161/01.RES.0000072475.04373.07; Yoon Y, 2003, CLIN CHEM LAB MED, V41, P529, DOI 10.1515/CCLM.2003.080; Zhou W, 2002, CANCER RES, V62, P1377	39	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4578	10.1371/journal.pone.0004578	http://dx.doi.org/10.1371/journal.pone.0004578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238204	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487400010
J	Jessup, DA; Miller, MA; Ryan, JP; Nevins, HM; Kerkering, HA; Mekebri, A; Crane, DB; Johnson, TA; Kudela, RM				Jessup, David A.; Miller, Melissa A.; Ryan, John P.; Nevins, Hannah M.; Kerkering, Heather A.; Mekebri, Abdou; Crane, David B.; Johnson, Tyler A.; Kudela, Raphael M.			Mass Stranding of Marine Birds Caused by a Surfactant-Producing Red Tide	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; DOMOIC ACID; TOXICITY; BREVETOXICOSIS; DINOFLAGELLATE; COCHLODINIUM	In November-December 2007 a widespread seabird mortality event occurred in Monterey Bay, California, USA, coincident with a massive red tide caused by the dinoflagellate Akashiwo sanguinea. Affected birds had a slimy yellow-green material on their feathers, which were saturated with water, and they were severely hypothermic. We determined that foam containing surfactant-like proteins, derived from organic matter of the red tide, coated their feathers and neutralized natural water repellency and insulation. No evidence of exposure to petroleum or other oils or biotoxins were found. This is the first documented case of its kind, but previous similar events may have gone undetected. The frequency and amplitude of red tides have increased in Monterey Bay since 2004, suggesting that impacts on wintering marine birds may continue or increase.	[Jessup, David A.; Miller, Melissa A.; Nevins, Hannah M.] MWVCRC, Calif Dept Fish & Game, Santa Cruz, CA USA; [Ryan, John P.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Nevins, Hannah M.] Moss Landing Marine Lab, Moss Landing, CA USA; [Kerkering, Heather A.] Monterey Bay Aquarium Res Inst, CeNCOOS Program, Moss Landing, CA USA; [Mekebri, Abdou; Crane, David B.] Calif Dept Fish & Game, Water Pollut Control Lab, Rancho Cordova, CA USA; [Johnson, Tyler A.; Kudela, Raphael M.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Johnson, Tyler A.; Kudela, Raphael M.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Monterey Bay Aquarium Research Institute; Moss Landing Marine Laboratories; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Jessup, DA (corresponding author), MWVCRC, Calif Dept Fish & Game, Santa Cruz, CA USA.	Kudela@ucsc.edu		Ryan, John Phillip/0000-0001-7954-5369	NOAA Monitoring and Event Response for Harmful Algal Blooms program [NA04NOS4780239]	NOAA Monitoring and Event Response for Harmful Algal Blooms program	Partial funding was provided by the NOAA Monitoring and Event Response for Harmful Algal Blooms program (NA04NOS4780239). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Bejarano AC, 2008, HUM ECOL RISK ASSESS, V14, P544, DOI 10.1080/10807030802074220; Benson JM, 2005, TOXICON, V45, P691, DOI 10.1016/j.toxicon.2005.01.004; Benson JM, 2005, ENVIRON HEALTH PERSP, V113, P626, DOI 10.1289/ehp.7497; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; BURKHOLDER JM, 1992, NATURE, V358, P407, DOI 10.1038/358407a0; Cloern JE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023321; DOUCETTE G, 2005, MARINE ECOLOGY PROGR, V306, P303; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; FUDGE A, 1999, LAB MED AVIAN EXOTIC, P178; Glibert Patricia M., 2005, Oceanography, V18, P136; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029638; Hampton Steve, 2003, Marine Ornithology, V31, P35; HARVEY J, 2005, BEACH COMBERS COASTA; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; Jester R, 2009, HARMFUL ALGAE, V8, P291, DOI 10.1016/j.hal.2008.07.001; Kim CS, 1999, J PLANKTON RES, V21, P2105, DOI 10.1093/plankt/21.11.2105; Kreuder C, 2005, AM J VET RES, V66, P289, DOI 10.2460/ajvr.2005.66.289; KREUDER C, 2006, J ZOO WILDLIFE MED; Kudela RM, 2008, HARMFUL ALGAE, V7, P278, DOI 10.1016/j.hal.2007.12.016; Kvitek R, 2005, MAR ECOL PROG SER, V293, P303, DOI 10.3354/meps293303; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lefebvre KA, 2002, TOXICON, V40, P971, DOI 10.1016/S0041-0101(02)00093-4; Litchman E, 2002, LIMNOL OCEANOGR, V47, P86, DOI 10.4319/lo.2002.47.1.0086; Ryan JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034081; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Twiner MJ, 2000, J PLANKTON RES, V22, P1961, DOI 10.1093/plankt/22.10.1961; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	30	118	123	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4550	10.1371/journal.pone.0004550	http://dx.doi.org/10.1371/journal.pone.0004550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234604	Green Submitted, gold, Green Published			2022-12-25	WOS:000265487200006
J	Cauda, F; Sacco, K; Duca, S; Cocito, D; D'Agata, F; Geminiani, GC; Canavero, S				Cauda, Franco; Sacco, Katiuscia; Duca, Sergio; Cocito, Dario; D'Agata, Federico; Geminiani, Giuliano C.; Canavero, Sergio			Altered Resting State in Diabetic Neuropathic Pain	PLOS ONE			English	Article							MODE NETWORK ACTIVITY; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; BRAIN-FUNCTION; CORTEX; FLUCTUATIONS; MECHANISMS; SYNCHRONY; FREQUENCY; RESONANCE	Background: The spontaneous component of neuropathic pain (NP) has not been explored sufficiently with neuroimaging techniques, given the difficulty to coax out the brain components that sustain background ongoing pain. Here, we address for the first time the correlates of this component in an fMRI study of a group of eight patients suffering from diabetic neuropathic pain and eight healthy control subjects. Specifically, we studied the functional connectivity that is associated with spontaneous neuropathic pain with spatial independent component analysis (sICA). Principal Findings: Functional connectivity analyses revealed a cortical network consisting of two anti-correlated patterns: one includes the left fusiform gyrus, the left lingual gyrus, the left inferior temporal gyrus, the right inferior occipital gyrus, the dorsal anterior cingulate cortex bilaterally, the pre and postcentral gyrus bilaterally, in which its activity is correlated negatively with pain and positively with the controls; the other includes the left precuneus, dorsolateral prefrontal, frontopolar cortex (both bilaterally), right superior frontal gyrus, left inferior frontal gyrus, thalami, both insulae, inferior parietal lobuli, right mammillary body, and a small area in the left brainstem, in which its activity is correlated positively with pain and negatively with the controls. Furthermore, a power spectra analyses revealed group differences in the frequency bands wherein the sICA signal was decomposed: patients' spectra are shifted towards higher frequencies. Conclusion: In conclusion, we have characterized here for the first time a functional network of brain areas that mark the spontaneous component of NP. Pain is the result of aberrant default mode functional connectivity.	[Cauda, Franco; Sacco, Katiuscia; Duca, Sergio; D'Agata, Federico; Geminiani, Giuliano C.] Koelliker Hosp, CCS fMRI, Turin, Italy; [Cauda, Franco; Sacco, Katiuscia; D'Agata, Federico; Geminiani, Giuliano C.] Univ Turin, Dept Psychol, I-10124 Turin, Italy; [Cocito, Dario; D'Agata, Federico] AOU San Giovanni Battista, Dept Neurosci, Turin, Italy; [Canavero, Sergio] Turin Advanced Neuromodulat Grp, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Cauda, F (corresponding author), Koelliker Hosp, CCS fMRI, Turin, Italy.	franco.cauda@unito.it; sercan@inwind.it	Cocito, Dario/O-4820-2019; Cauda, Franco/G-5021-2010; D'Agata, Federico/ABG-8839-2021; Sacco, Katiuscia/J-2133-2012	Cauda, Franco/0000-0003-1526-8475; D'Agata, Federico/0000-0001-9432-0248; Sacco, Katiuscia/0000-0002-9660-5236	Regione Piemonte, Ricerca Scientifica Applicata, Settore Scienze della Vita	Regione Piemonte, Ricerca Scientifica Applicata, Settore Scienze della Vita(Regione Piemonte)	Regione Piemonte, Ricerca Scientifica Applicata, Settore Scienze della Vita, 2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brambilla M, 2004, ARCH ITAL BIOL, V142, P275; Buzsaki G., 2006, RHYTHMS BRAIN; CANAVERO S, 1993, NEUROSURGERY, V32, P185, DOI 10.1227/00006123-199302000-00006; Canavero S, 2007, CENTRAL PAIN SYNDROME: PATHOPHYSIOLOGY, DIAGNOSIS AND MANAGEMENT, P1, DOI 10.1017/CBO9780511585692; CAUDA F, 2009, J NEUROL NE IN PRESS; COLE LJ, 2008, NEUROBIOL AGING; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Foss JM, 2006, J NEUROPHYSIOL, V95, P730, DOI 10.1152/jn.00768.2005; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gusnard DA, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1267; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Ioannides AA, 2007, CURR OPIN NEUROBIOL, V17, P161, DOI 10.1016/j.conb.2007.03.008; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jones E.G., 2012, THALAMUS; Koenig T, 2005, PHILOS T R SOC B, V360, P1015, DOI 10.1098/rstb.2005.1649; KRAUTHAMER GM, 1974, BRAIN RES, V80, P141, DOI 10.1016/0006-8993(74)90732-X; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; Meyer-Base Anke, 2004, Int J Neural Syst, V14, P217, DOI 10.1142/S0129065704002017; Ohara S, 2006, PAIN, V123, P244, DOI 10.1016/j.pain.2006.02.012; PETRIDES M, 2004, HUMAN NERVOUS SYSTEM, P951; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Quiton RL, 2007, PAIN, V132, pS134, DOI 10.1016/j.pain.2007.09.001; RISSANEN J, 1983, ANN STAT, V11, P416, DOI 10.1214/aos/1176346150; Sarnthein J, 2006, BRAIN, V129, P55, DOI 10.1093/brain/awh631; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Vercelli A, 2006, NEUROINFORMATICS, V4, P319, DOI 10.1385/NI:4:4:319; Wang JY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-34; Ward LM, 2006, CAN J EXP PSYCHOL, V60, P319, DOI 10.1037/cjep2006029; WILLIS WD, 2004, HUMAN NERVOUS SYSTEM, P1125, DOI DOI 10.1016/B978-012547626-3/50031-4; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006	53	161	170	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4542	10.1371/journal.pone.0004542	http://dx.doi.org/10.1371/journal.pone.0004542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229326	Green Published, Green Submitted, gold			2022-12-25	WOS:000265486200013
J	Jeong, M; Kwon, YS; Park, SH; Kim, CY; Jeun, SS; Song, KW; Ko, Y; Robbins, PD; Billiar, TR; Kim, BM; Seol, DW				Jeong, Moonsup; Kwon, Yong-Sam; Park, Soon-Hye; Kim, Chae-Young; Jeun, Sin-Soo; Song, Kang-Won; Ko, Yong; Robbins, Paul D.; Billiar, Timothy R.; Kim, Byong-Moon; Seol, Dai-Wu			Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL	PLOS ONE			English	Article								Malignant gliomas are the most common primary brain tumors. Despite intensive clinical investigation and many novel therapeutic approaches, average survival for the patients with malignant gliomas is only about 1 year. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown potent and cancer-selective killing activity and drawn considerable attention as a promising therapy for cancers, but concerns over delivery and toxicity have limited progress. We have developed a secretable trimeric TRAIL (stTRAIL) and here evaluated the therapeutic potential of this stTRAIL-based gene therapy in brain tumors. An adenovirus (Ad-stTRAIL) delivering stTRAIL was injected into intra-cranial human glioma tumors established in nude mice and tumor growth monitored using the magnetic resonance imaging (MRI). Ad-stTRAIL gene therapy showed potent tumor suppressor activity with no toxic side effects at therapeutically effective doses. When compared with 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU), a conventional therapy for malignant gliomas, Ad-stTRAIL suppressed tumor growth more potently. The combination of Ad-stTRAIL and BCNU significantly increased survival compared to the control mice or mice receiving Ad-stTRAIL alone. Our data indicate that Ad-stTRAIL, either alone or combined with BCNU, has promise as a novel therapy for malignant gliomas.	[Jeong, Moonsup; Kwon, Yong-Sam; Park, Soon-Hye; Kim, Chae-Young; Kim, Byong-Moon] Dong A Pharmaceut Co Ltd, Biopharmaceut Res Labs, Kyonggi Do, South Korea; [Jeong, Moonsup; Jeun, Sin-Soo] Catholic Univ Korea, Dept Neurosurg, Seoul, South Korea; [Song, Kang-Won; Ko, Yong] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15260 USA; [Billiar, Timothy R.; Seol, Dai-Wu] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Seol, Dai-Wu] Kyungwon Univ, Dept Life Sci, Kyonggi Do, South Korea; [Seol, Dai-Wu] Kyungwon Univ, Gachon BioNano Res Inst, Kyonggi Do, South Korea	Catholic University of Korea; Hanyang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Gachon University; Gachon University	Jeong, M (corresponding author), Dong A Pharmaceut Co Ltd, Biopharmaceut Res Labs, Kyonggi Do, South Korea.	bmkim@donga.co.kr; seold@kyungwon.ac.kr	Kim, Chaeyoung/GPW-6531-2022		Korean Science and Engineering Foundation (KOSEF) of the Korean Ministry of Education, Science and Technology (MEST) [2007-04347]; Korean Ministry of Commerce, Industry and Energy [1007404]	Korean Science and Engineering Foundation (KOSEF) of the Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering Foundation); Korean Ministry of Commerce, Industry and Energy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported in part by a grant (2007-04347 to DWS) from the Korean Science and Engineering Foundation (KOSEF) of the Korean Ministry of Education, Science and Technology (MEST) and a grant (#1007404) from the Korean Ministry of Commerce, Industry and Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Denault JB, 1996, FEBS LETT, V379, P113, DOI 10.1016/0014-5793(95)01487-X; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kim CY, 2006, GENE THER, V13, P330, DOI 10.1038/sj.gt.3302658; Kim MH, 2004, BIOCHEM BIOPH RES CO, V321, P930, DOI 10.1016/j.bbrc.2004.07.046; Kim Y, 2003, MOL CELLS, V15, P283; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Seol DW, 2000, CANCER RES, V60, P3152; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	20	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4545	10.1371/journal.pone.0004545	http://dx.doi.org/10.1371/journal.pone.0004545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229339	Green Accepted, Green Published, gold			2022-12-25	WOS:000265486200016
J	Fischer, S; Nishio, M; Peters, SC; Tschernatsch, M; Walberer, M; Weidemann, S; Heidenreich, R; Couraud, PO; Weksler, BB; Romero, IA; Gerriets, T; Preissner, KT				Fischer, Silvia; Nishio, Miwako; Peters, Saskia C.; Tschernatsch, Marlene; Walberer, Maureen; Weidemann, Susanne; Heidenreich, Regina; Couraud, Pierre O.; Weksler, Babette B.; Romero, Ignacio A.; Gerriets, Tibo; Preissner, Klaus T.			Signaling mechanism of extracellular RNA in endothelial cells	FASEB JOURNAL			English	Article						VEGF-receptor; neuropilin-1	GROWTH-FACTOR EXPRESSION; MAP KINASE PATHWAY; VASCULAR-PERMEABILITY; RECEPTOR; BRAIN; ANGIOGENESIS; VEGF; NEUROPILIN-1; BINDING; SERUM	Extracellular RNA has been shown to induce vascular endothelial growth factor (VEGF)-dependent hyperpermeability in vivo as well as in vitro. Studies were performed to investigate the mechanism of these effects. For permeability studies primary cultures of porcine brain-derived microvascular endothelial cells (BMECs) and for all other analytical studies the human brain endothelial cell line HCMEC/D3 or human umbilical vein endothelial cells (HUVECs) were used. RNA, but not DNA, initiated signaling events by binding of VEGF to neuropilin-1, followed by VEGF-R2 phosphorylation, activation of phospholipase C ( PLC), and intracellular release of Ca2+. Activation of these pathways by RNA also resulted in the release of von Willebrand Factor from Weibel-Palade bodies. Pretreatment of cells with heparinase totally abrogated the RNA-induced permeability changes, whereas RNA together with VEGF completely restored VEGF-R2-mediated hyperpermeability. Although poly: IC increased the interleukin-6 release via activation of toll-like receptor-3 (TLR-3), permeability changes mediated by poly: IC or RNA remained unchanged after blocking TLR-3 or NF-kB activation. These results indicate that extracellular RNA serves an important cofactor function to engage VEGF for VEGF-R2-dependent signal transduction, reminiscent of the coreceptor mechanism mediated by proteoglycans, which might be of relevance for the mobilization and cellular activities of RNA-binding cytokines in general.-Fischer, S., Nishio, M., Peters, S. C., Tschernatsch, M., Walberer, M., Weidemann, S., Heidenreich, R., Couraud, P. O., Weksler, B. B., Romero, I. A., Gerriets, T., Preissner, K. T. Signaling mechanism of extracellular RNA in endothelial cells. FASEB J. 23, 2100-2109 (2007)	[Fischer, Silvia; Nishio, Miwako; Preissner, Klaus T.] Univ Giessen, Sch Med, Dept Biochem, D-35392 Giessen, Germany; [Peters, Saskia C.] Univ Giessen, Sch Med, Dept Anim Welf & Ethol, D-35392 Giessen, Germany; [Tschernatsch, Marlene; Gerriets, Tibo] Univ Giessen, Sch Med, Dept Expt Neurol, D-35392 Giessen, Germany; [Walberer, Maureen] Univ Cologne, Dept Neurol, Cologne, Germany; [Weidemann, Susanne; Heidenreich, Regina] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Couraud, Pierre O.] Univ Paris 05, Inst Cochin, Paris, France; [Weksler, Babette B.] Weill Cornell Med Coll, New York, NY USA; [Romero, Ignacio A.] Open Univ, Milton Keynes MK7 6AA, Bucks, England	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cornell University; Open University - UK	Preissner, KT (corresponding author), Univ Giessen, Sch Med, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	klaus.t.preissner@biochemie.med.uni-giessen.de	Fischer, Silvia/ABG-3104-2021	Romero, Ignacio/0000-0002-0322-9180	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SFB 547, SFB 685, SPP 1190]; Deutsche Krebshilfe [107128]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank Barbel Fuhler and Ute Niebergall for their skilful technical assistance and Prof. Martin Rocken (University of Tubingen, Tubingen, Germany) for his kind cooperation. Studies were generously supported by grants (SFB 547, SFB 685, SPP 1190) from the Deutsche Forschungsgemeinschaft (Bonn, Germany) and the Deutsche Krebshilfe (107128).	ABBOTT NJ, 1991, CEREBROVAS BRAIN MET, V3, P39; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; BAETHMAN A, 1978, NEUROSURG REV, V1, P85; Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Blagoveshchenskaya AD, 2002, MOL BIOL CELL, V13, P1582, DOI 10.1091/mbc.01-09-0462; Chen XQ, 2000, CLIN CANCER RES, V6, P3823; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; DOUKAS J, 1994, AM J PATHOL, V145, P137; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fong TAT, 1999, CANCER RES, V59, P99; Garcia-Olmo DC, 2004, HISTOL HISTOPATHOL, V19, P575, DOI 10.14670/HH-19.575; Goldman CK, 1997, NEUROSURGERY, V40, P1269, DOI 10.1097/00006123-199706000-00029; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Imaizumi T, 2007, GLYCOBIOLOGY, V17, p12C, DOI 10.1093/glycob/cwm045; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kopreski MS, 1999, CLIN CANCER RES, V5, P1961; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; LEVINE JD, 1982, BLOOD, V60, P531; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; Nakazawa F, 2005, BIOCHEM J, V385, P831, DOI 10.1042/BJ20041021; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robinson CJ, 2001, J CELL SCI, V114, P853; Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M504492200; SAMPAOLO S, 1991, ACTA NEUROPATHOL, V82, P107, DOI 10.1007/BF00293952; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Senger DR, 1996, AM J PATHOL, V149, P293; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; VRIES CD, 1992, SCIENCE, V255, P989; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; WIECZOREK AJ, 1985, P NATL ACAD SCI USA, V82, P3455, DOI 10.1073/pnas.82.10.3455; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; YANG J, 1994, J IMMUNOL, V152, P361	54	47	49	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2100	2109		10.1096/fj.08-121608	http://dx.doi.org/10.1096/fj.08-121608			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246491				2022-12-25	WOS:000268836500010
J	Mounier, R; Lantier, L; Leclerc, J; Sotiropoulos, A; Pende, M; Daegelen, D; Sakamoto, K; Foretz, M; Viollet, B				Mounier, Remi; Lantier, Louise; Leclerc, Jocelyne; Sotiropoulos, Athanassia; Pende, Mario; Daegelen, Dominique; Sakamoto, Kei; Foretz, Marc; Viollet, Benoit			Important role for AMPK alpha 1 in limiting skeletal muscle cell hypertrophy	FASEB JOURNAL			English	Article						muscle functional overload; protein synthesis; mTOR-S6K signaling	ACTIVATED PROTEIN-KINASE; MAMMALIAN TARGET; GLUCOSE-UPTAKE; AMPK; EXERCISE; GROWTH; EXPRESSION; RAPAMYCIN; PHOSPHORYLATION; CONTRACTION	Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis through the suppression of the mammalian target of rapamycin complex 1 (mTORC1), a critical regulator of muscle growth. The purpose of this investigation was to determine the role of the AMPK alpha 1 catalytic subunit on muscle cell size control and adaptation to muscle hypertrophy. We found that AMPK alpha 1(-/-) primary cultured myotubes and myofibers exhibit larger cell size compared with control cells in response to chronic Akt activation. We next subjected the plantaris muscle of AMPK alpha 1(-/-) and control mice to mechanical overloading to induce muscle hypertrophy. We observed significant elevations of AMPK alpha 1 activity in the control muscle at days 7 and 21 after the overload. Overloading-induced muscle hypertrophy was significantly accelerated in AMPK alpha 1(-/-) mice than in control mice [+32 vs. +53% at day 7 and +57 vs. +76% at day 21 in control AMPK alpha 1(-/-) mice, respectively]. This enhanced growth of AMPK alpha 1-deficient muscle was accompanied by increased phosphorylation of mTOR signaling downstream targets and decreased phosphorylation of eukaryotic elongation factor 2. These results demonstrate that AMPK alpha 1 plays an important role in limiting skeletal muscle overgrowth during hypertrophy through inhibition of the mTOR-signaling pathway. Mounier, R., Louise Lantier, Leclerc, J., Sotiropoulos, A., Pende, M., Daegelen, D., Sakamoto, K., Foretz, M., Viollet, B. Important role for AMPK alpha 1 in limiting skeletal muscle cell hypertrophy. FASEB J. 23, 2264-2273 (2009)	[Viollet, Benoit] Univ Paris 05, INSERM U567, Inst Cochin, Dept Endocrinol Metab & Canc,CNRS,UMR 8104, F-75014 Paris, France; [Pende, Mario] INSERM, U845, Paris, France; [Pende, Mario] Univ Paris 05, UMRS 845, F-75014 Paris, France; [Sakamoto, Kei] Univ Dundee, Med Res Council, Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Dundee	Viollet, B (corresponding author), Univ Paris 05, INSERM U567, Inst Cochin, Dept Endocrinol Metab & Canc,CNRS,UMR 8104, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	benoit.viollet@inserm.fr	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; sakamoto, kei/C-8806-2019; Pende, Mario/AFR-1348-2022; Sotiropoulos, Athanassia/P-4269-2017; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; sakamoto, kei/0000-0001-8839-5980; Pende, Mario/0000-0002-7864-8937; Viollet, Benoit/0000-0002-0121-0224; Sotiropoulos, Athanassia/0000-0002-7265-1473	European Union [LSHM-CT-2004-005272]; Agence Nationale de la Recherche (ANR); Association Francaise contre les Myopathies (AFM); UK Medical Research Council; Diabetes UK; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck; Merck KGaA; Pfizer; MRC [MC_U127088492] Funding Source: UKRI; Medical Research Council [MC_U127088492] Funding Source: researchfish	European Union(European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Merck KGaA; Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Union FP6 program (EXGENESIS Integrated Project LSHM-CT-2004-005272), Agence Nationale de la Recherche (ANR) and Association Francaise contre les Myopathies (AFM). K. S. is supported by the UK Medical Research Council and Diabetes UK and by the companies AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Merck KGaA, and Pfizer. We gratefully acknowledge Charlotte Lahoute and Veronique Fauveau. We thank Grahame Hardie (University of Dundee, Dundee, UK) for providing AMPK alpha 1 and -alpha 2 antibodies.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Durante PE, 2002, AM J PHYSIOL-ENDOC M, V283, pE178, DOI 10.1152/ajpendo.00404.2001; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Gordon SE, 2008, EXERC SPORT SCI REV, V36, P179, DOI 10.1097/JES.0b013e3181877e13; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee-Young RS, 2008, MED SCI SPORT EXER, V40, P1490, DOI 10.1249/MSS.0b013e318173a037; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Nader GA, 2002, CLIN ORTHOP RELAT R, pS178, DOI 10.1097/01.blo.0000031979.92980.2e; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; Thomson DM, 2006, J PHYSIOL-LONDON, V574, P291, DOI 10.1113/jphysiol.2006.107490; Thomson DM, 2005, J APPL PHYSIOL, V98, P557, DOI 10.1152/japplphysiol.00811.2004; Toyoda T, 2006, AM J PHYSIOL-ENDOC M, V290, pE583, DOI 10.1152/ajpendo.00395.2005; TSIKA RW, 1995, AM J PHYSIOL-CELL PH, V269, pC665, DOI 10.1152/ajpcell.1995.269.3.C665; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223	49	87	90	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2264	2273		10.1096/fj.08-119057	http://dx.doi.org/10.1096/fj.08-119057			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19237506	Green Submitted			2022-12-25	WOS:000268836500026
J	Dainese, M; Quarta, M; Lyfenko, AD; Paolini, C; Canato, M; Reggiani, C; Dirksen, RT; Protasi, F				Dainese, Marco; Quarta, Marco; Lyfenko, Alla D.; Paolini, Cecilia; Canato, Marta; Reggiani, Carlo; Dirksen, Robert T.; Protasi, Feliciano			Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice	FASEB JOURNAL			English	Article						excitation-contraction coupling; environmental heat stroke; malignant hyperthermia; muscle disease; ryanodine receptor	CENTRAL CORE DISEASE; POLYMORPHIC VENTRICULAR-TACHYCARDIA; EXERCISE-INDUCED RHABDOMYOLYSIS; MUSCLE RYANODINE RECEPTOR; TWITCH SKELETAL-MUSCLE; AMINO-ACID-SEQUENCE; MALIGNANT-HYPERTHERMIA; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; CARDIAC CALSEQUESTRIN	Calsequestrin-1 (CASQ1) is a moderate-affinity, high-capacity Ca2+-binding protein in the sarcoplasmic reticulum (SR) terminal cisternae of skeletal muscle. CASQ1 functions as both a Ca2+-binding protein and a luminal regulator of ryanodine receptor (RYR1)-mediated Ca2+ release. Mice lacking skeletal CASQ1 are viable but exhibit reduced levels of releasable Ca2+ and altered contractile properties. Here we report that CASQ1-null mice exhibit increased spontaneous mortality and susceptibility to heat- and anesthetic-induced sudden death. Exposure of CASQ1-null mice to either 2% halothane or heat stress triggers lethal episodes characterized by whole-body contractures, elevated core temperature, and severe rhabdomyolysis, which are prevented by prior dantrolene administration. The characteristics of these events are remarkably similar to analogous episodes observed in humans with malignant hyperthermia (MH) and animal models of MH and environmental heat stroke (EHS). In vitro studies indicate that CASQ1-null muscle exhibits increased contractile sensitivity to temperature and caffeine, temperature-dependent increases in resting Ca2+, and an increase in the magnitude of depolarization-induced Ca2+ release. These results demonstrate that CASQ1 deficiency alters proper control of RYR1 function and suggest CASQ1 as a potential candidate gene for linkage analysis in families with MH/EHS where mutations in the RYR1 gene are excluded.-Dainese, M., Quarta, M., Lyfenko, A. D., Paolini, C., Canato, M., Reggiani, C., Dirksen, R. T., Protasi, F. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. FASEB J. 23, 1710-1720 (2009)	[Dainese, Marco; Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, Dept Basic & Appl Med Sci, Ctr Sci Invecchiamento, Interuniv Inst Myol, I-66013 Chieti, Italy; [Quarta, Marco; Canato, Marta] Univ Padua, Dept Anat & Physiol, Interuniv Inst Myol, Padua, Italy; [Lyfenko, Alla D.; Reggiani, Carlo; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	G d'Annunzio University of Chieti-Pescara; University of Padua; University of Rochester	Protasi, F (corresponding author), Univ G DAnnunzio, Dept Basic & Appl Med Sci, Ctr Sci Invecchiamento, Interuniv Inst Myol, I-66013 Chieti, Italy.	fprotasi@unich.it	Paolini, Cecilia/AAI-4444-2021		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, P01AR052354, R29AR044657] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044657, AR44657, P01 AR052354, P01 AR052354-030004, 5P01AR052354, R01 AR044657-11, R29 AR044657] Funding Source: Medline; Telethon [GGP08153] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Telethon(Fondazione Telethon)		Avila G, 2001, J GEN PHYSIOL, V118, P277, DOI 10.1085/jgp.118.3.277; Avila G, 2005, CELL CALCIUM, V38, P35, DOI 10.1016/j.ceca.2005.05.001; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BOURDON L, 1995, MED HYPOTHESES, V45, P268, DOI 10.1016/0306-9877(95)90116-7; Brandom B., 2002, ANESTHESIOLOGY, V96, pA1199, DOI [10.1097/00000542-200209002-01199, DOI 10.1097/00000542-200209002-01199]; Burkman JM, 2007, ANESTHESIOLOGY, V106, P901, DOI 10.1097/01.anes.0000265148.86566.68; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1197; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; DAMIANI E, 1990, J MUSCLE RES CELL M, V11, P522, DOI 10.1007/BF01745219; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Galli L, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9442; Grogan H, 2002, BRIT J ANAESTH, V88, P700, DOI 10.1093/bja/88.5.700; GROUP TEM, 1984, BR J ANAESTHESIA, V56, P1267; Hausfater P, 2005, CRIT CARE, V9, P23, DOI 10.1186/cc2939; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; KAWASAKI T, 1994, BIOCHEM BIOPH RES CO, V199, P1120, DOI 10.1006/bbrc.1994.1347; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Migita T, 2007, J ANESTH, V21, P285, DOI 10.1007/s00540-006-0495-5; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Muldoon S, 2004, EXERC SPORT SCI REV, V32, P174; MURPHY RM, 2008, J PHYSL, V587, P443; ORDING H, 1985, ACTA ANAESTH SCAND, V29, P698, DOI 10.1111/j.1399-6576.1985.tb02283.x; PAMUKCOGLU T, 1988, AM J FOREN MED PATH, V9, P161, DOI 10.1097/00000433-198806000-00015; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Priori SG, 2001, CIRCULATION, V103, P196; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; Rizzi N, 2008, CIRC RES, V103, P298, DOI 10.1161/CIRCRESAHA.108.171660; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Ryan JF, 1997, J CLIN ANESTH, V9, P66, DOI 10.1016/S0952-8180(96)00207-3; SACCHETTO R, 1993, J MUSCLE RES CELL M, V14, P646, DOI 10.1007/BF00141561; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SIDMAN RD, 1995, ACAD EMERG MED, V2, P315, DOI 10.1111/j.1553-2712.1995.tb03229.x; STRAZIS KP, 1993, ANESTH ANALG, V77, P297, DOI 10.1213/00000539-199377020-00014; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; WEDEL DJ, 1995, MAYO CLIN PROC, V70, P241, DOI 10.4065/70.3.241; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Wyndham C H, 1977, Ann N Y Acad Sci, V301, P128, DOI 10.1111/j.1749-6632.1977.tb38192.x; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	62	83	83	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1710	1720		10.1096/fj.08-121335	http://dx.doi.org/10.1096/fj.08-121335			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19237502	Green Published			2022-12-25	WOS:000266652400011
J	Newman, RA; Prehoda, KE				Newman, Rhonda A.; Prehoda, Kenneth E.			Intramolecular Interactions Between the Src Homology 3 and Guanylate Kinase Domains of Discs Large Regulate Its Function in Asymmetric Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROBLAST SELF-RENEWAL; LARGE TUMOR-SUPPRESSOR; SIZE-DISTRIBUTION ANALYSIS; NONMUSCLE MYOSIN-II; DROSOPHILA NEUROBLASTS; SCAFFOLDING PROTEINS; SPINDLE ORIENTATION; CORTICAL POLARITY; LOCALIZATION; BINDING	Membrane-associated guanylate kinases (MAGUKs) regulate the formation and function of molecular assemblies at specialized regions of the membrane. Allosteric regulation of an intramolecular interaction between the Src homology 3 (SH3) and guanylate kinase (GK) domains of MAGUKs is thought to play a central role in regulating MAGUK function. Here we show that a mutant of the DrosophilaMAGUKDiscs large (Dlg), dlgsw, encodes a form of Dlg that disrupts the intramolecular association while leaving the SH3 and GK domains intact, providing an excellent model system to assess the role of the SH3-GK intramolecular interaction in MAGUK function. Analysis of asymmetric cell division of maternal-zygotic dlgsw embryonic neuroblasts demonstrates that the intramolecular interaction is not required for Dlg localization but is necessary for cell fate determinant segregation to the basal cortex and mitotic spindle alignment with the cortical polarity axis. These defects ultimately result in improper patterning of the embryonic central nervous system. Furthermore, we demonstrate that the sw mutation of Dlg results in unregulated complex assembly as assessed by GukHolder association with the SH3-GK versus PDZ-SH3-GK modules of Dlgsw. From these studies, we conclude that allosteric regulation of the SH3-GK intramolecular interaction is required for regulation of MAGUK function in asymmetric cell division, possibly through regulation of complex assembly.	Univ Oregon, Dept Chem, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Prehoda, KE (corresponding author), 1229 Univ Oregon, Eugene, OR 97403 USA.	prehoda@molbio.uoregon.edu			National Institutes of Health [GM068032]; National Research Service Award Postdoctoral Fellowship National Institutes of Health [F32 GM080018]; American Heart Association [0850140Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032, F32GM080018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068032 (to K. E. P.). This work was also supported by a Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship National Institutes of Health Grant F32 GM080018 (to R.A.N.) and American Heart Association Grant 0850140Z (to K. E. P.).	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Avila-Flores A, 2001, BIOCHEM J, V360, P295, DOI 10.1042/0264-6021:3600295; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Brenman JE, 1998, J NEUROSCI, V18, P8805; Chabu C, 2008, DEVELOPMENT, V135, P2739, DOI 10.1242/dev.024059; De Lorenzo C, 1999, CANCER METAST REV, V18, P295, DOI 10.1023/A:1006381526008; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fukunaga Y, 2005, J BIOCHEM, V138, P177, DOI 10.1093/jb/mvi107; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Liu SL, 2008, J BIOL CHEM, V283, P380, DOI 10.1074/jbc.M703924200; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; Marfatia SM, 2000, J BIOL CHEM, V275, P13759, DOI 10.1074/jbc.275.18.13759; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mendoza C, 2003, J NEUROSCI, V23, P2093; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Odden JP, 2002, J NEUROSCI, V22, P9143; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Paarmann I, 2002, J BIOL CHEM, V277, P40832, DOI 10.1074/jbc.M205618200; Paarmann I, 2008, PROTEIN SCI, V17, P1946, DOI 10.1110/ps.035550.108; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yamada KH, 2007, BIOCHEMISTRY-US, V46, P10039, DOI 10.1021/bi701169w; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	59	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12924	12932		10.1074/jbc.M809304200	http://dx.doi.org/10.1074/jbc.M809304200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19261607	hybrid, Green Published			2022-12-25	WOS:000265688300038
J	French, ME; Kretzmann, BR; Hicke, L				French, Michael E.; Kretzmann, Benjamin R.; Hicke, Linda			Regulation of the RSP5 Ubiquitin Ligase by an Intrinsic Ubiquitin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PROTEIN LIGASE; SACCHAROMYCES-CEREVISIAE; HECT DOMAIN; POLYUBIQUITIN CHAINS; MEMBRANE-PROTEIN; NUCLEAR EXPORT; MESSENGER-RNA; LARGE SUBUNIT; DNA-REPAIR	Rsp5 is a homologous to E6AP C terminus (HECT) ubiquitin ligase (E3) that controls many different cellular processes in budding yeast. Although Rsp5 targets a number of different substrates for ubiquitination, the mechanisms that regulate Rsp5 activity remain poorly understood. Here we demonstrate that Rsp5 carries a noncovalent ubiquitin-binding site in its catalytic HECT domain. The N-terminal lobe of the HECT domain mediates binding to ubiquitin, and point mutations that disrupt interactions with ubiquitin alter the ability of the Rsp5 HECT domain to assemble polyubiquitin chains in vitro. Point mutations that disrupt ubiquitin binding also result in temperature sensitive growth defects in yeast, indicating that the Rsp5 ubiquitin binding site is important for Rsp5 function in vivo. The Nedd4 HECT domain N-lobe also contains ubiquitin-binding activity, suggesting that interactions between the N-lobe and ubiquitin are conserved within the Nedd4 family of ubiquitin ligases. We propose that a subset of HECT E3s are regulated by a conserved ubiquitin-binding site that functions to restrict the length of polyubiquitin chains synthesized by the HECT domain.	[French, Michael E.; Kretzmann, Benjamin R.; Hicke, Linda] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Hicke, L (corresponding author), Hogan 2-100,2205 Tech Dr, Evanston, IL 60208 USA.	l-hicke@northwestern.edu			National Institutes of Health [DK53257, DK61299]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053257, R01DK061299, R56DK061299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53257 and DK61299.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Krsmanovic T, 2004, FEBS LETT, V577, P215, DOI 10.1016/j.febslet.2004.10.006; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Nuber U, 1999, J BIOL CHEM, V274, P7576, DOI 10.1074/jbc.274.11.7576; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rodriguez MS, 2003, TRAFFIC, V4, P566, DOI 10.1034/j.1600-0854.2003.00115.x; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stamenova SD, 2007, MOL CELL, V25, P273, DOI 10.1016/j.molcel.2006.12.016; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	58	62	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12071	12079		10.1074/jbc.M901106200	http://dx.doi.org/10.1074/jbc.M901106200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19252184	hybrid, Green Published			2022-12-25	WOS:000265494600039
J	Ippel, JH; de Haas, CJC; Bunschoten, A; van Strijp, JAG; Kruijtzer, JAW; Liskamp, RMJ; Kemmink, J				Ippel, Johannes H.; de Haas, Carla J. C.; Bunschoten, Anton; van Strijp, Jos A. G.; Kruijtzer, John A. W.; Liskamp, Rob M. J.; Kemmink, Johan			Structure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; CHEMOKINE RECEPTORS; BINDING DOMAIN; ANAPHYLATOXIN; ANTAGONIST; MODULATION; CONTRIBUTE; DISEASE	Complement component C5a is a potent pro-inflammatory agent inducing chemotaxis of leukocytes toward sites of infection and injury. C5a mediates its effects via its G protein-coupled C5a receptor (C5aR). Although under normal conditions highly beneficial, excessive levels of C5a can be deleterious to the host and have been related to numerous inflammatory diseases. A natural inhibitor of the C5aR is chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS). CHIPS is a 121-residue protein excreted by S. aureus. It binds the N terminus of the C5aR (residues 1-35) with nanomolar affinity and thereby potently inhibits C5a-mediated responses in human leukocytes. Therefore, CHIPS provides a starting point for the development of new anti-inflammatory agents. Two O-sulfated tyrosine residues located at positions 11 and 14 within the C5aR N terminus play a critical role in recognition of C5a, but their role in CHIPS binding has not been established so far. By isothermal titration calorimetry, using synthetic Tyr-11-and Tyr-14-sulfated and non-sulfated C5aR N-terminal peptides, we demonstrate that the sulfate groups are essential for tight binding between the C5aR and CHIPS. In addition, the NMR structure of the complex of CHIPS and a sulfated C5aR N-terminal peptide reveals the precise binding motif as well as the distinct roles of sulfated tyrosine residues sY11 and sY14. These results provide a molecular framework for the design of novel CHIPS-based C5aR inhibitors.	[Ippel, Johannes H.; Bunschoten, Anton; Kruijtzer, John A. W.; Liskamp, Rob M. J.; Kemmink, Johan] Univ Utrecht, Dept Med Chem & Chem Biol, NL-3584 CA Utrecht, Netherlands; [de Haas, Carla J. C.; van Strijp, Jos A. G.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Kemmink, J (corresponding author), Univ Utrecht, Dept Med Chem & Chem Biol, Sorbonnelaan 16, NL-3584 CA Utrecht, Netherlands.	j.kemmink@uu.nl	Liskamp, Rob M/I-5889-2012; van Strijp, Jos A.G./J-9549-2014; Ippel, Hans/D-6917-2016	Liskamp, Rob M/0000-0001-8897-8975; van Strijp, Jos A.G./0000-0001-6253-0830; Bunschoten, Anton/0000-0002-4167-5077	Dutch Technology Foundation; Applied Science Division of NWO; Ministry of Economic Affairs [UKG.06609]	Dutch Technology Foundation(Technologiestichting STW); Applied Science Division of NWO(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs	This work was supported in part by the Dutch Technology Foundation STW, Applied Science Division of NWO, and the Technology Program of the Ministry of Economic Affairs (UKG.06609).	Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen ZG, 1998, J BIOL CHEM, V273, P10411, DOI 10.1074/jbc.273.17.10411; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Haas PJ, 2005, J MOL BIOL, V353, P859, DOI 10.1016/j.jmb.2005.09.014; Heller T, 1999, J IMMUNOL, V163, P985; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; March DR, 2004, MOL PHARMACOL, V65, P868, DOI 10.1124/mol.65.4.868; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Postma B, 2005, J BIOL CHEM, V280, P2020, DOI 10.1074/jbc.M412230200; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Strachan AJ, 2000, J IMMUNOL, V164, P6560, DOI 10.4049/jimmunol.164.12.6560; VANEPPS DE, 1993, J IMMUNOL, V150, P246; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp KE, 2000, INFECT IMMUN, V68, P5908, DOI 10.1128/IAI.68.10.5908-5913.2000; Wright AJ, 2007, MOL IMMUNOL, V44, P2507, DOI 10.1016/j.molimm.2006.12.022; Zhang XL, 1997, PROTEINS, V28, P261, DOI 10.1002/(SICI)1097-0134(199706)28:2<261::AID-PROT13>3.0.CO;2-G; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P172, DOI 10.1021/bi00427a025	25	31	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12363	12372		10.1074/jbc.M808179200	http://dx.doi.org/10.1074/jbc.M808179200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251703	Green Published, hybrid			2022-12-25	WOS:000265494600067
J	Lakshmana, MK; Yoon, IS; Chen, E; Bianchi, E; Koo, EH; Kang, DE				Lakshmana, Madepalli K.; Yoon, Il-Sang; Chen, Eunice; Bianchi, Elizabetta; Koo, Edward H.; Kang, David E.			Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid beta Peptide Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; LIPID RAFTS; SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; ENDOCYTIC PATHWAY; PLASMA-MEMBRANE; DENSITY; LRP; CELLS	Accumulation of the amyloid beta(A beta) peptide derived from the proteolytic processing of amyloid precursor protein (APP) is the defining pathological hallmark of Alzheimer disease. We previously demonstrated that the C-terminal 37 amino acids of lipoprotein receptor-related protein (LRP) robustly promoted A beta generation independent of FE65 and specifically interacted with Ran-binding protein 9 (RanBP9). In this study we found that RanBP9 strongly increased BACE1 cleavage of APP and A beta generation. This pro-amyloidogenic activity of RanBP9 did not depend on the KPI domain or the Swedish APP mutation. In cells expressing wild type APP, RanBP9 reduced cell surface APP and accelerated APP internalization, consistent with enhanced beta-secretase processing in the endocytic pathway. The N-terminal half of RanBP9 containing SPRY-LisH domains not only interacted with LRP but also with APP and BACE1. Overexpression of RanBP9 resulted in the enhancement of APP interactions with LRP and BACE1 and increased lipid raft association of APP. Importantly, knockdown of endogenous RanBP9 significantly reduced A beta generation in Chinese hamster ovary cells and in primary neurons, demonstrating its physiological role in BACE1 cleavage of APP. These findings not only implicate RanBP9 as a novel and potent regulator of APP processing but also as a potential therapeutic target for Alzheimer disease.	[Lakshmana, Madepalli K.; Yoon, Il-Sang; Chen, Eunice; Koo, Edward H.; Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kang, David E.] Seoul Natl Univ, Coll Med, World Class Univ Neurocyt Program, Seoul 110799, South Korea; [Bianchi, Elizabetta] Inst Pasteur, Dept Immunol, Immunoregulat Lab, F-75724 Paris, France	University of California System; University of California San Diego; Seoul National University (SNU); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci 0691, Leichtag Biomed Res 3A17,9500 Gilman Dr, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	Kang, David E./0000-0002-7132-821X	National Institutes of Health [AG 005131-24S1]; American Health Assistance Foundation [A2007-05]; Alzheimer's Association [NIRG-07-60584]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association)	This work was supported, in whole or in part, by National Institutes of Health Grant AG 005131-24S1 (NIA, to D. E. K.). This work was also supported in part by the American Health Assistance Foundation Grant A2007-05 (to D. E. K.) and Alzheimer's Association Grant NIRG-07-60584 (to M. K. L.).	Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; De Strooper B, 2000, J CELL SCI, V113, P1857; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hafizi S, 2005, INT J BIOCHEM CELL B, V37, P2344, DOI 10.1016/j.biocel.2005.05.006; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lakshmana MK, 2008, J CELL MOL MED, V12, P2665, DOI 10.1111/j.1582-4934.2008.00320.x; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Reiner O, 2006, NEUROMOL MED, V8, P547, DOI 10.1385/NMM:8:4:547; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tonges L, 2006, RNA, V12, P1431, DOI 10.1261/rna.2252206; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wickham L, 2005, J NEUROCHEM, V92, P93, DOI 10.1111/j.1471-4159.2004.02840.x; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200	41	71	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11863	11872		10.1074/jbc.M807345200	http://dx.doi.org/10.1074/jbc.M807345200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251705	Green Published, hybrid			2022-12-25	WOS:000265494600018
J	Lee, HE; Berkowitz, P; Jolly, PS; Diaz, LA; Chua, MP; Rubenstein, DS				Lee, Hua En; Berkowitz, Paula; Jolly, Puneet S.; Diaz, Luis A.; Chua, Michael P.; Rubenstein, David S.			Biphasic Activation of p38MAPK Suggests That Apoptosis Is a Downstream Event in Pemphigus Acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN-27; SCALDED-SKIN SYNDROME; P38 MAP-KINASES; VULGARIS-IGG; HUMAN KERATINOCYTES; BULLOUS IMPETIGO; FAMILY PROTEASES; PASSIVE TRANSFER; PHOSPHORYLATION; DISEASE	In pemphigus vulgaris and pemphigus foliaceus (PF), autoantibodies against desmoglein-3 and desmoglein-1 induce epidermal cell detachment (acantholysis) and blistering. Activation of keratinocyte intracellular signaling pathways is emerging as an important component of pemphigus IgG-mediated acantholysis. We previously reported activation of p38 mitogen-activated protein kinase (MAPK) in response to pathogenic pemphigus vulgaris and PF IgG. Inhibition of p38MAPK blocked pemphigus IgG-induced cytoskeletal reorganization in tissue culture and blistering in pemphigus mouse models. We now extend these observations by demonstrating two peaks of p38MAPK activation in pemphigus tissue culture and mouse models. Administration of the p38MAPK inhibitor SB202190 before PF IgG injection blocked both peaks of p38MAPK phosphorylation and blister formation, consistent with our previous findings; however, administration of the inhibitor 4 h after PF IgG injection blocked only the later peak of p38MAPK activation but failed to block blistering. Examination of the temporal relationship of p38MAPK phosphorylation and apoptosis showed that apoptosis occurs at or after the second peak of p38MAPK activation. The time course of p38MAPK activation and apoptotic markers, as well as the ability of inhibitors of p38MAPK to block activation of the proapoptotic proteinase caspase-3, suggest that activation of apoptosis is downstream to, and a consequence of, p38MAPK activation in pemphigus acantholysis. Furthermore, these observations suggest that the earlier peak of p38MAPK activation is part of the mechanism leading to acantholysis, whereas the later peak of p38MAPK and apoptosis may not be essential for acantholysis.	[Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27599 USA; [Chua, Michael P.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lee, Hua En] Chang Gung Mem Hosp, Dept Dermatol, Tao Yuan 320338, Taiwan; [Lee, Hua En] Chang Gung Univ, Coll Med, Tao Yuan 320338, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chang Gung Memorial Hospital	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Ste 3100 Thurston Bowles CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu	Lee, Hua/AAC-9489-2021	Diaz, Luis/0000-0002-7079-8914	National Institutes of Health [RO1 AI49427, AR32599]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI49427 ( to D. S. R.) and AR32599 ( to L. A. D.).	Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Ding X, 1997, J INVEST DERMATOL, V109, P592, DOI 10.1111/1523-1747.ep12337524; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; EYRE RW, 1988, J CLIN INVEST, V81, P807, DOI 10.1172/JCI113387; Feng L, 1999, J CELL SCI, V112, P2081; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Gniadecki R, 1998, ARCH DERMATOL RES, V290, P528, DOI 10.1007/s004030050347; Guay J, 1997, J CELL SCI, V110, P357; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; Hu P, 2001, J INVEST DERMATOL, V117, P481; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Miyagawa S, 1999, BRIT J DERMATOL, V141, P1084, DOI 10.1046/j.1365-2133.1999.03209.x; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Perng MD, 1999, J CELL SCI, V112, P2099; ROSCOE JT, 1985, J INVEST DERMATOL, V85, P538, DOI 10.1111/1523-1747.ep12277362; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Wang X, 2004, FEBS LETT, V567, P281, DOI 10.1016/j.febslet.2004.04.083; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	43	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12524	12532		10.1074/jbc.M808204200	http://dx.doi.org/10.1074/jbc.M808204200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270308	Green Published, hybrid			2022-12-25	WOS:000265494600081
J	McMichael, BK; Wysolmerski, RB; Lee, BS				McMichael, Brooke K.; Wysolmerski, Robert B.; Lee, Beth S.			Regulated Proteolysis of Nonmuscle Myosin IIA Stimulates Osteoclast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CELL-CELL FUSION; CATHEPSIN-B; DIFFERENTIAL LOCALIZATION; IN-VITRO; MACROPHAGE MULTINUCLEATION; MYOBLAST DIFFERENTIATION; ADHESION STRUCTURES; PLASMA-MEMBRANE; BONE-RESORPTION	The nonmuscle myosin IIA heavy chain (Myh9) is strongly associated with adhesion structures of osteoclasts. In this study, we demonstrate that during osteoclastogenesis, myosin IIA heavy chain levels are temporarily suppressed, an event that stimulates the onset of cell fusion. This suppression is not mediated by changes in mRNA or translational levels but instead is due to a temporary increase in the rate of myosin IIA degradation. Intracellular activity of cathepsin B is significantly enhanced at the onset of osteoclast precursor fusion, and specific inhibition of its activity prevents myosin IIA degradation. Further, treatment of normal cells with cathepsin B inhibitors during the differentiation process reduces cell fusion and bone resorption capacity, whereas overexpression of cathepsin B enhances fusion. Ongoing suppression of the myosin IIA heavy chain via RNA interference results in formation of large osteoclasts with significantly increased numbers of nuclei, whereas overexpression of myosin IIA results in less osteoclast fusion. Increased multinucleation caused by myosin IIA suppression does not require RANKL. Further, knockdown of myosin IIA enhances cell spreading and lessens motility. These data taken together strongly suggest that base-line expression of nonmuscle myosin IIA inhibits osteoclast precursor fusion and that a temporary, cathepsin B-mediated decrease in myosin IIA levels triggers precursor fusion during osteoclastogenesis.	[McMichael, Brooke K.; Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Wysolmerski, Robert B.] W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Wysolmerski, Robert B.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	University System of Ohio; Ohio State University; West Virginia University; West Virginia University	Lee, BS (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	National Institutes of Health [AR051515, DK052131, HL-45788, P20RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045788, R29HL045788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR051515 and DK052131 (to B. S. L.) and HL-45788 and P20RR16440 (to R. B. W.).	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bien S, 2004, MOL PHARMACOL, V65, P1092, DOI 10.1124/mol.65.5.1092; Blair HC, 2000, J CELL BIOCHEM, V78, P627, DOI 10.1002/1097-4644(20000915)78:4<627::AID-JCB12>3.0.CO;2-3; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; CONRAD AH, 1995, CELL MOTIL CYTOSKEL, V31, P93, DOI 10.1002/cm.970310203; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; GRAINGER DJ, 1991, BIOCHEM J, V277, P145, DOI 10.1042/bj2770145; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; HILL PA, 1994, J CELL BIOCHEM, V56, P118, DOI 10.1002/jcb.240560116; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Jane DT, 2002, J CELL BIOCHEM, V84, P520, DOI 10.1002/jcb.10042; Jane DT, 2002, BIOCHEM CELL BIOL, V80, P457, DOI 10.1139/O02-134; JANE DT, 1994, BIOCHEM CELL BIOL, V72, P267, DOI 10.1139/o94-038; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kim MH, 2008, AMINO ACIDS, V34, P497, DOI 10.1007/s00726-006-0461-4; Kolega J, 1998, J CELL SCI, V111, P2085; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kotadiya P, 2008, BONE, V43, P951, DOI 10.1016/j.bone.2008.06.017; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MAUPIN P, 1994, J CELL SCI, V107, P3077; McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Steinberg TH, 2007, PURINERG SIGNAL, V3, P53, DOI 10.1007/s11302-006-9036-9; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; TURKSEN K, 1988, J BONE MINER RES, V3, P389; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	61	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12266	12275		10.1074/jbc.M808621200	http://dx.doi.org/10.1074/jbc.M808621200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269977	hybrid, Green Published			2022-12-25	WOS:000265494600058
J	Yu, JZ; Dave, RH; Allen, JA; Sarma, T; Rasenick, MM				Yu, Jiang-Zhou; Dave, Rahul H.; Allen, John A.; Sarma, Tulika; Rasenick, Mark M.			Cytosolic G alpha(s) Acts as an Intracellular Messenger to Increase Microtubule Dynamics and Promote Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; GTP-BINDING PROTEINS; ALPHA-SUBUNIT; SUBCELLULAR REDISTRIBUTION; BASAL GANGLIA; GS-ALPHA; GROWTH; TUBULIN; SIGNAL; CAMP	It is now evident that G alpha(s) traffics into cytosol following G protein-coupled receptor activation, and alpha subunits of some heterotrimeric G-proteins, including G alpha(s) bind to tubulin in vitro. Nevertheless, many features of G-protein-microtubule interaction and possible intracellular effects of G protein alpha subunits remain unclear. In this study, several biochemical approaches demonstrated that activated G alpha(s) directly bound to tubulin and cellular microtubules, and fluorescence microscopy showed that cholera toxin-activated G alpha(s) colocalized with microtubules. The activated, GTP-bound, G alpha(s) mimicked tubulin in serving as a GTPase activator for alpha-tubulin. As a result, activated G alpha(s) made microtubules more dynamic, both in vitro and in cells, decreasing the pool of insoluble microtubules without changing total cellular tubulin content. The amount of acetylated tubulin (an indicator of microtubule stability) was reduced in the presence of G alpha(s) activated by mutation. Previous studies showed that cholera toxin and cAMP analogs may stimulate neurite outgrowth in PC12 cells. However, in this study, overexpression of a constitutively activated G alpha(s) or activation of G alpha(s) with cholera toxin in protein kinase A-deficient PC12 cells promoted neurite outgrowth in a cAMP-independent manner. Thus, it is suggested that activated G alpha(s) acts as an intracellular messenger to regulate directly microtubule dynamics and promote neurite outgrowth. These data serve to link G-protein signaling with modulation of the cytoskeleton and cell morphology.	[Yu, Jiang-Zhou; Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yu, JZ (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, 835 S Wolcott Ave M C 901, Chicago, IL 60612 USA.	yujz64@uic.edu; raz@uic.edu	Allen, John A/D-6141-2011		National Institutes of Health [AG 15482, MH 57391, MH 78200, T32-HL07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078200, R01MH057391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 15482, MH 57391, MH 78200, and T32-HL07692.	AHNERTHILGER G, 1994, EUR J CELL BIOL, V65, P26; ALBRERT B, 1994, MOL BIOL CELL, P805; ALLEN JA, 2005, MOL PHARM, V20, P1452; AMOS LA, 1974, J CELL SCI, V14, P523; AOKI CY, 1992, BRAIN RES, V596, P189, DOI 10.1016/0006-8993(92)91547-R; ARONIN N, 1992, J NEUROSCI, V12, P3435; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CARLIER MF, 1991, J BIOL CHEM, V266, P12361; CASSIMERIS L, 1993, CELL MOTIL CYTOSKEL, V26, P275, DOI 10.1002/cm.970260402; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Chen NF, 2003, J BIOL CHEM, V278, P15285, DOI 10.1074/jbc.M300841200; Churcher I, 2006, CURR TOP MED CHEM, V6, P579, DOI 10.2174/156802606776743057; Cote M, 1997, ENDOCRINOLOGY, V138, P69, DOI 10.1210/en.138.1.69; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Drmota T, 1999, BIOCHEM J, V340, P529, DOI 10.1042/0264-6021:3400529; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Eiden RD, 2007, DEV PSYCHOL, V43, P1187, DOI 10.1037/0012-1649.43.5.1187; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; GINTY DD, 1991, J BIOL CHEM, V266, P15325; GINTY DD, 1991, J BIOL CHEM, V266, P17454; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Gundersen GG, 1998, BIOL BULL, V194, P358, DOI 10.2307/1543112; Holtje M, 2000, J NEUROSCI, V20, P2131; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; Hynes Thomas R., 2003, V237, P233; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Igarashi M, 1997, J NEUROSCI, V17, P1460; Janosi IM, 2002, BIOPHYS J, V83, P1317, DOI 10.1016/S0006-3495(02)73902-7; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; KEHLENBACH RH, 1994, NATURE, V372, P804; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; KIRSCHNER MW, 1986, NATURE, V324, P621, DOI 10.1038/324621a0; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Layden BT, 2008, BBA-MOL CELL RES, V1783, P964, DOI 10.1016/j.bbamcr.2008.02.017; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDER ME, 1991, METHOD ENZYMOL, V195, P202; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Mejillano MR, 1996, ARCH BIOCHEM BIOPHYS, V336, P130, DOI 10.1006/abbi.1996.0540; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Montminy M, 1997, NATURE, V387, P654, DOI 10.1038/42594; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; RASENICK MM, 1988, J NEUROCHEM, V51, P300, DOI 10.1111/j.1471-4159.1988.tb04870.x; RASENICK MM, 1984, J NEUROCHEM, V43, P1447, DOI 10.1111/j.1471-4159.1984.tb05407.x; RASENICK MM, 1989, BRAIN RES, V488, P105, DOI 10.1016/0006-8993(89)90698-7; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Rosenbaum J, 2000, CURR BIOL, V10, pR801, DOI 10.1016/S0960-9822(00)00767-3; ROYCHOWDHURY S, 1994, BIOCHEMISTRY-US, V33, P9800, DOI 10.1021/bi00198a052; Roychowdhury S, 2008, FEBS J, V275, P4654, DOI 10.1111/j.1742-4658.2008.06614.x; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; SOLOMON F, 1979, CELL, V18, P431, DOI 10.1016/0092-8674(79)90062-X; WANG N, 1991, BIOCHEMISTRY-US, V30, P10957, DOI 10.1021/bi00109a021; WANG N, 1990, J BIOL CHEM, V265, P1239; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zera EM, 1996, J BIOL CHEM, V271, P12925, DOI 10.1074/jbc.271.22.12925	66	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10462	10472		10.1074/jbc.M809166200	http://dx.doi.org/10.1074/jbc.M809166200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19237344	Green Published, hybrid			2022-12-25	WOS:000265104600020
J	Foteinou, PT; Calvano, SE; Lowry, SF; Androulakis, IP				Foteinou, Panagiota T.; Calvano, Steve E.; Lowry, Stephen F.; Androulakis, Ioannis P.			In Silico Simulation of Corticosteroids Effect on an NFkB-Dependent Physicochemical Model of Systemic Inflammation	PLOS ONE			English	Article								Background: During the onset of an inflammatory response signaling pathways are activated for "translating" extracellular signals into intracellular responses converging to the activation of nuclear factor (NF)-kB, a central transcription factor in driving the inflammatory response. An inadequate control of its transcriptional activity is associated with the culmination of a hyper-inflammatory response making it a desired therapeutic target. Predicated upon the nature of the response, a systems level analysis might provide rational leads for the development of strategies that promote the resolution of the response. Methodology and Findings: A physicochemical host response model is proposed to integrate biological information in the form of kinetic rules and signaling cascades with pharmacokinetic models of drug action for the modulation of the response. The unifying hypothesis is that the response is triggered by the activation of the NFkB signaling module and corticosteroids serve as a template for assessing anti-inflammatory strategies. The proposed in silico model is evaluated through its ability to predict and modulate uncontrolled responses. The pre-exposure of the system to hypercortisolemia, i.e. 6 hr before or simultaneously with the infectious challenge "reprograms" the dynamics of the host towards a balanced inflammatory response. However, if such an intervention occurs long before the inflammatory insult a symptomatic effect is observed instead of a protective relief while a steroid infusion after inducing inflammation requires much higher drug doses. Conclusions and Significance: We propose a reversed engineered inflammation model that seeks to describe how the system responds to a multitude of external signals. Timing of intervention and dosage regimes appears to be key determinants for the protective or symptomatic effect of exogenous corticosteroids. Such results lie in qualitative agreement with in vivo human studies exposed both to LPS and corticosteroids under various time intervals thus improving our understanding of how interacting modules generate a behavior.	[Foteinou, Panagiota T.; Androulakis, Ioannis P.] Rutgers State Univ, Piscataway, NJ 08854 USA; [Calvano, Steve E.; Lowry, Stephen F.] UMDNJ, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Foteinou, PT (corresponding author), Rutgers State Univ, Piscataway, NJ 08854 USA.	yannis@rci.rutgers.edu			NSF [0519563]; EPA [GAD R 832721-010-RRA]; Busch Biomedical Research; USPHS [GM34695]; National Institute of General Medical Sciences [2-U54-GM062119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034695, R01GM034695, U54GM062119] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); Busch Biomedical Research; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PTF and IPA acknowledge support from NSF grant 0519563, EPA grant GAD R 832721-010-RRA and a Busch Biomedical Research Grant. SEC and SFL are supported, in part, from USPHS Grant GM34695. The investigators acknowledge the contribution of the Inflammation and the Host Response to Injury Large-Scale Collaborative Project Award # 2-U54-GM062119 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Almon RR, 2005, AAPS J, V7, pE156, DOI 10.1208/aapsj070117; Almon RR, 2005, AM J PHYSIOL-ENDOC M, V289, pE870, DOI 10.1152/ajpendo.00196.2005; Almon RR, 2002, J PHARMACOKINET PHAR, V29, P103, DOI 10.1023/A:1019762323576; Annane D, 2004, BMJ-BRIT MED J, V329, P480, DOI 10.1136/bmj.38181.482222.55; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; ARZT E, 1994, ENDOCRINOLOGY, V134, P672, DOI 10.1210/en.134.2.672; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BARBER AE, 1993, J IMMUNOL, V150, P1999; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bornstein SR, 2003, AM J RESP CRIT CARE, V167, P485, DOI 10.1164/rccm.2211010; Briegel J, 2001, J AM SOC NEPHROL, V12, pS70; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; DUBOIS DC, 1995, J STEROID BIOCHEM, V54, P237, DOI 10.1016/0960-0760(95)00139-Q; FOTEINOU P, 2007, J CRITICAL CARE, V22, P337; FOTEINOU PT, 2008, TRANSLATION IN PRESS; FOTEINOU PT, 2008, MODELING EN IN PRESS; HAWES AS, 1992, INFECT IMMUN, V60, P2641, DOI 10.1128/IAI.60.7.2641-2647.1992; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Jin JY, 2003, J PHARMACOL EXP THER, V307, P93, DOI 10.1124/jpet.103.053256; JUSKO WJ, 1994, PROG CLIN BIOL RES, V387, P261; JUSKO WJ, 2005, J PHARMACOKIN PHARMA; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Klaitman V, 2003, ISRAEL MED ASSOC J, V5, P51; KLINKE DJ, 2008, BIOPHYS J BIOFAST; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Krzyzanski W, 1997, J PHARMACOKINET BIOP, V25, P107, DOI 10.1023/A:1025723927981; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; LAUFFENBURGER DA, 1981, MATH BIOSCI, V53, P189, DOI 10.1016/0025-5564(81)90018-3; LEFERING R, 1995, CRIT CARE MED, V23, P1294, DOI 10.1097/00003246-199507000-00021; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Mager DE, 2003, DRUG METAB DISPOS, V31, P510, DOI 10.1124/dmd.31.5.510; MAHONY DSO, 2008, INT J MED SCI, V5, P1; Marshall JC, 2002, CRIT CARE, V6, P342, DOI 10.1186/cc1522; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Nystrom PO, 1998, J ANTIMICROB CHEMOTH, V41, P1, DOI 10.1093/jac/41.suppl_1.1; Post TM, 2005, PHARM RES-DORDR, V22, P1038, DOI 10.1007/s11095-005-5641-5; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Ramakrishnan R, 2002, J PHARMACOKINET PHAR, V29, P1, DOI 10.1023/A:1015765201129; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; RICHARDSON RP, 1989, ANN SURG, V210, P239, DOI 10.1097/00000658-198908000-00018; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; RIFKIND D, 1967, J BACTERIOL, V93, P1463, DOI 10.1128/JB.93.4.1463-1464.1967; Romaschin Alexander D, 1998, Sepsis (Boston), V2, P119, DOI 10.1023/A:1009769923763; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Sato N, 2002, ANN SURG, V236, P184, DOI 10.1097/00000658-200208000-00006; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Senftleben U, 2003, INTENS CARE MED, V29, P1873, DOI 10.1007/s00134-003-1932-7; Shin HJ, 2007, MOL CELLS, V24, P119; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sun YN, 1998, J PHARMACOKINET BIOP, V26, P289, DOI 10.1023/A:1023233409550; Tetta C, 2005, Crit Care Resusc, V7, P32; Tschaikowsky K, 1998, J PHARMACOL EXP THER, V285, P800; vanderPoll T, 1996, J CLIN ENDOCR METAB, V81, P3604, DOI 10.1210/jc.81.10.3604; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; Xu ZX, 1995, J PHARMACOKINET BIOP, V23, P163, DOI 10.1007/BF02354270; Yang E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-10; Zurakowski R, 2006, J THEOR BIOL, V238, P368, DOI 10.1016/j.jtbi.2005.05.004	75	42	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4706	10.1371/journal.pone.0004706	http://dx.doi.org/10.1371/journal.pone.0004706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274080	gold, Green Published, Green Submitted			2022-12-25	WOS:000265496000001
J	Couthouis, J; Rebora, K; Immel, F; Berthelot, K; Castroviejo, M; Cullin, C				Couthouis, Julien; Rebora, Karine; Immel, Francoise; Berthelot, Karine; Castroviejo, Michel; Cullin, Christophe			Screening for Toxic Amyloid in Yeast Exemplifies the Role of Alternative Pathway Responsible for Cytotoxicity	PLOS ONE			English	Article								The relationship between amyloid and toxic species is a central problem since the discovery of amyloid structures in different diseases. Despite intensive efforts in the field, the deleterious species remains unknown at the molecular level. This may reflect the lack of any structure-toxicity study based on a genetic approach. Here we show that a structure-toxicity study without any biochemical prerequisite can be successfully achieved in yeast. A PCR mutagenesis of the amyloid domain of HET-s leads to the identification of a mutant that might impair cellular viability. Cellular and biochemical analyses demonstrate that this toxic mutant forms GFP-amyloid aggregates that differ from the wild-type aggregates in their shape, size and molecular organization. The chaperone Hsp104 that helps to disassemble protein aggregates is strictly required for the cellular toxicity. Our structure-toxicity study suggests that the smallest aggregates are the most toxic, and opens a new way to analyze the relationship between structure and toxicity of amyloid species.	[Couthouis, Julien; Rebora, Karine; Immel, Francoise; Berthelot, Karine; Cullin, Christophe] Univ Bordeaux 2 Victor Segalen, CNRS, UMR 5095, IBGC, Bordeaux, France; [Castroviejo, Michel] Univ Bordeaux 2 Victor Segalen, CNRS, UMR 5097, REGER, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Couthouis, J (corresponding author), Univ Bordeaux 2 Victor Segalen, CNRS, UMR 5095, IBGC, Bordeaux, France.	Christophe.Cullin@ibgc.u-bordeaux2.fr	Immel, Françoise/GNP-4167-2022; cullin, christophe/AAM-2179-2020; BERTHELOT, Karine V.J./A-5546-2011; Immel, Françoise/N-7079-2019; COUTHOUIS, Julien/G-3895-2012	Immel, Françoise/0000-0002-2028-902X; cullin, christophe/0000-0003-4110-4677; BERTHELOT, Karine V.J./0000-0003-0809-4921; COUTHOUIS, Julien/0000-0002-2378-4595	GIS; ANR [06-MRAR-011-01]; University Bordeaux2	GIS(Agency for Science Technology & Research (A*STAR)); ANR(French National Research Agency (ANR)); University Bordeaux2	The work was supported by grants from GIS "Maladie rares" and ANR Projet ANR-06-MRAR-011-01 AMYLOI. KR was supported by an ATER position provided by the University Bordeaux2. KB was supported by ANR and the "Conseil Regional d'Aquitaine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; BERTHELOT K, 2009, FASEB J IN PRESS; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Chacinska A, 2000, MOL CELL BIOL, V20, P7220, DOI 10.1128/MCB.20.19.7220-7229.2000; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; CULLIN C, 1994, YEAST, V10, P105, DOI 10.1002/yea.320100110; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; WANG Y, 2008, FASEB J; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4539	10.1371/journal.pone.0004539	http://dx.doi.org/10.1371/journal.pone.0004539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262694	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600001
J	Norscia, I; Antonacci, D; Palagi, E				Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta			Mating First, Mating More: Biological Market Fluctuation in a Wild Prosimian	PLOS ONE			English	Article							MALE VERREAUXS SIFAKA; PROPITHECUS-VERREAUXI; SCENT-MARKING; GROOMING RECIPROCITY; BEHAVIOR; REPRODUCTION; KIRINDY; COUNTERMARKING; STRATEGIES; SUCCESS	In biology, economics, and politics, distributive power is the key for understanding asymmetrical relationships and it can be obtained by force (dominance) or trading (leverage). Whenever males cannot use force, they largely depend on females for breeding opportunities and the balance of power tilts in favour of females. Thus, males are expected not only to compete within their sex-class but also to exchange services with the opposite sex. Does this mating market, described for humans and apes, apply also to prosimians, the most ancestral primate group? To answer the question, we studied a scent-oriented and gregarious lemur, Propithecus verreauxi (sifaka), showing female dominance, promiscuous mating, and seasonal breeding. We collected 57 copulations involving 8 males and 4 females in the wild (Berenty Reserve, South Madagascar), and data (all occurrences) on grooming, aggressions, and marking behaviour. We performed the analyses via exact Spearman and matrix correlations. Male mating priority rank correlated with the frequency of male countermarking over female scents but not with the proportion of fights won by males over females. Thus, males competed in an olfactory tournament more than in an arena of aggressive encounters. The copulation frequency correlated neither with the proportion of fights won by males nor with the frequency of male countermarking on female scents. Male-to-female grooming correlated with female-to-male grooming only during premating. Instead, in the mating period male-to-female grooming correlated with the copulation frequency. In short, the biological market underwent seasonal fluctuations, since males bargained grooming for sex in the mating days and grooming for itself in the premating period. Top scent-releasers gained mating priority (they mated first) and top groomers ensured a higher number of renewed copulations (they mated more). In conclusion, males maximize their reproduction probability by adopting a double tactic and by following market fluctuations.	[Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Territ, Calci, PI, Italy	University of Pisa	Norscia, I (corresponding author), Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Territ, Calci, PI, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett Louise, 2001, P119, DOI 10.1017/CBO9780511752421.009; BLAUSTEIN AR, 1981, AM NAT, V117, P1006, DOI 10.1086/283786; Brockman DK, 1999, INT J PRIMATOL, V20, P375, DOI 10.1023/A:1020500804442; Brockman DK, 1996, AM J PHYS ANTHROPOL, V100, P57; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; DAHL RA, 1957, BEHAV SCI, V2, P201, DOI 10.1002/bs.3830020303; De Waal, 1989, PEACEMAKING PRIMATES; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; Fisher HS, 2003, BEHAV ECOL SOCIOBIOL, V53, P123, DOI 10.1007/s00265-002-0552-5; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Hemelrijk C., 2007, HDB PALEOANTHROPOL 2, P1321; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; JOLLY A, 1972, FOLIA PRIMATOL, V17, P335, DOI 10.1159/000155454; Jolly Alison, 2006, P3; Jordan NR, 2007, ANIM BEHAV, V74, P531, DOI 10.1016/j.anbehav.2006.12.015; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lazaro-Perea C, 1999, BEHAV ECOL SOCIOBIOL, V46, P313, DOI 10.1007/s002650050625; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; Lewis RJ, 2005, AM J PRIMATOL, V67, P347, DOI 10.1002/ajp.20187; Lewis RJ, 2005, AM J PHYS ANTHROPOL, V128, P389, DOI 10.1002/ajpa.20206; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Mooring MS, 2004, BIOL J LINN SOC, V81, P17, DOI 10.1111/j.1095-8312.2004.00273.x; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NOE R, 1991, ETHOLOGY, V87, P97; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Noe Ronald, 2001, P93, DOI 10.1017/CBO9780511752421.008; Norscia I, 2008, INT J PRIMATOL, V29, P1099, DOI 10.1007/s10764-008-9259-4; Norscia I, 2006, INT J PRIMATOL, V27, P1001, DOI 10.1007/s10764-006-9056-x; Nunn Charles L., 2001, P42, DOI 10.1017/CBO9780511752421.005; Palagi E, 2004, INT J PRIMATOL, V25, P1019, DOI 10.1023/B:IJOP.0000043349.23082.c0; Paoli T, 2008, DEV PRIMATOL-PROG PR, P39, DOI 10.1007/978-0-387-74787-3_3; Pochron ST, 2003, BEHAV ECOL SOCIOBIOL, V54, P285, DOI 10.1007/s00265-003-0634-z; Port M, 2009, ANIM BEHAV, V77, P29, DOI 10.1016/j.anbehav.2008.08.032; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICHARD AF, 1992, J HUM EVOL, V22, P395, DOI 10.1016/0047-2484(92)90067-J; Russell Bertrand, 1938, POWER NEW SOCIAL ANA; Stopka P, 1999, ETHOLOGY, V105, P969, DOI 10.1046/j.1439-0310.1999.00485.x; Stopka Pavel, 2001, Animal Behaviour Forum, V61, pF19; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Wilson E.O., 1975, P1; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31	56	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4679	10.1371/journal.pone.0004679	http://dx.doi.org/10.1371/journal.pone.0004679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MC	19262737	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490600010
J	Kandimalla, KK; Scott, OG; Fulzele, S; Davidson, MW; Poduslo, JF				Kandimalla, Karunya K.; Scott, Olenych G.; Fulzele, Smita; Davidson, Michael W.; Poduslo, Joseph F.			Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid beta Protein	PLOS ONE			English	Article								Alzheimer's disease (AD) is characterized by significant neurodegeneration in the cortex and hippocampus; intraneuronal tangles of hyperphosphorylated tau protein; and accumulation of beta-amyloid (A beta) proteins 40 and 42 in the brain parenchyma as well as in the cerebral vasculature. The current understanding that AD is initiated by the neuronal accumulation of A beta proteins due to their inefficient clearance at the blood-brain-barrier (BBB), places the neurovascular unit at the epicenter of AD pathophysiology. The objective of this study is to investigate cellular mechanisms mediating the internalization of A beta proteins in the principle constituents of the neurovascular unit, neurons and BBB endothelial cells. Laser confocal micrographs of wild type (WT) mouse brain slices treated with fluorescein labeled A beta 40 (F-A beta 40) demonstrated selective accumulation of the protein in a subpopulation of cortical and hippocampal neurons via nonsaturable, energy independent, and nonendocytotic pathways. This groundbreaking finding, which challenges the conventional belief that A beta proteins are internalized by neurons via receptor mediated endocytosis, was verified in differentiated PC12 cells and rat primary hippocampal (RPH) neurons through laser confocal microscopy and flow cytometry studies. Microscopy studies have demonstrated that a significant proportion of F-A beta 40 or F-A beta 42 internalized by differentiated PC12 cells or RPH neurons is located outside of the endosomal or lysosomal compartments, which may accumulate without degradation. In contrast, BBME cells exhibit energy dependent uptake of F-A beta 40, and accumulate the protein in acidic cell organelle, indicative of endocytotic uptake. Such a phenomenal difference in the internalization of A beta 40 between neurons and BBB endothelial cells may provide essential clues to understanding how various cells can differentially regulate Ab proteins and help explain the vulnerability of cortical and hippocampal neurons to A beta toxicity.	[Kandimalla, Karunya K.; Fulzele, Smita] Florida A&M Univ, Dept Basic Pharmaceut Sci, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Scott, Olenych G.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Scott, Olenych G.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kandimalla, Karunya K.; Poduslo, Joseph F.] Mayo Clin, Coll Med, Dept Neurol Neurosci & Biochem Mol Biol, Mol Neurobiol Lab, Rochester, MN USA	State University System of Florida; Florida A&M University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Mayo Clinic	Kandimalla, KK (corresponding author), Florida A&M Univ, Dept Basic Pharmaceut Sci, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	karunya.kandimalla@famu.edu			NIH/NIGMS/MBRS [3S06GM008111-35S1]; NIH/NCRR/RCMI [G12RR03020]; NIH [R01 AG22034]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022034] Funding Source: NIH RePORTER	NIH/NIGMS/MBRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH/NIGMS/MBRS 3S06GM008111-35S1, NIH/NCRR/RCMI G12RR03020, and NIH R01 AG22034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems J, 2007, J NEUROL SCI, V257, P49, DOI 10.1016/j.jns.2007.01.013; Bateman DA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-29; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; COLLINGRIDGE GL, 1995, J NEUROSCI METH, V59, P5, DOI 10.1016/0165-0270(94)00187-L; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Fukuda M, 2004, J BIOCHEM, V136, P245, DOI 10.1093/jb/mvh116; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gredell JA, 2004, BRIT J ANAESTH, V93, P810, DOI 10.1093/bja/aeh272; Gregory GC, 2005, NEUROTOX RES, V7, P29, DOI 10.1007/BF03033774; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Ji SR, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1283, DOI 10.1023/A:1021361607611; Kakio A, 2004, J PEPT SCI, V10, P612, DOI 10.1002/psc.570; Kandimalla KK, 2006, J PHARMACOL EXP THER, V318, P17, DOI 10.1124/jpet.105.095711; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kim HJ, 2007, LIVER INT, V27, P633, DOI 10.1111/j.1478-3231.2007.01481.x; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Morelli L, 1999, CELL TISSUE RES, V298, P225, DOI 10.1007/s004419900109; Muller WE, 2001, BIOCHEM SOC T, V29, P617, DOI 10.1042/BST0290617; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Oshima K, 2006, ACTA NEUROPATHOL, V111, P510, DOI 10.1007/s00401-006-0070-z; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Rensink AAM, 2003, BRAIN RES REV, V43, P207, DOI 10.1016/j.brainresrev.2003.08.001; SAAVEDRA L, 2007, J BIOL CHEM; Schmidt MC, 1998, BIOCHEMISTRY-US, V37, P16582, DOI 10.1021/bi981219h; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tashima Y, 2004, J BIOL CHEM, V279, P17587, DOI 10.1074/jbc.M308622200; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Waschuk SA, 2001, J BIOL CHEM, V276, P33561, DOI 10.1074/jbc.M103598200; Weller RO, 2005, ANN NEUROL, V58, P348, DOI 10.1002/ana.20622; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Xu HX, 1996, P NATL ACAD SCI USA, V93, P4081, DOI 10.1073/pnas.93.9.4081; YAO JK, NEUROCHEM R IN PRESS; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	47	58	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4627	10.1371/journal.pone.0004627	http://dx.doi.org/10.1371/journal.pone.0004627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247480	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487800009
J	Emtage, L; Chang, H; Tiver, R; Rongo, C				Emtage, Lesley; Chang, Howard; Tiver, Rebecca; Rongo, Christopher			MAGI-1 Modulates AMPA Receptor Synaptic Localization and Behavioral Plasticity in Response to Prior Experience	PLOS ONE			English	Article								It is well established that the efficacy of synaptic connections can be rapidly modified by neural activity, yet how the environment and prior experience modulate such synaptic and behavioral plasticity is only beginning to be understood. Here we show in C. elegans that the broadly conserved scaffolding molecule MAGI-1 is required for the plasticity observed in a glutamatergic circuit. This mechanosensory circuit mediates reversals in locomotion in response to touch stimulation, and the AMPA-type receptor (AMPAR) subunits GLR-1 and GLR-2, which are required for reversal behavior, are localized to ventral cord synapses in this circuit. We find that animals modulate GLR-1 and GLR-2 localization in response to prior mechanosensory stimulation; a specific isoform of MAGI-1 (MAGI-1L) is critical for this modulation. We show that MAGI-1L interacts with AMPARs through the intracellular domain of the GLR-2 subunit, which is required for the modulation of AMPAR synaptic localization by mechanical stimulation. In addition, mutations that prevent the ubiquitination of GLR-1 prevent the decrease in AMPAR localization observed in previously stimulated magi-1 mutants. Finally, we find that previously-stimulated animals later habituate to subsequent mechanostimulation more rapidly compared to animals initially reared without mechanical stimulation; MAGI-1L, GLR-1, and GLR-2 are required for this change in habituation kinetics. Our findings demonstrate that prior experience can cause long-term alterations in both behavioral plasticity and AMPAR localization at synapses in an intact animal, and indicate a new, direct role for MAGI/S-SCAM proteins in modulating AMPAR localization and function in the wake of variable sensory experience.	[Emtage, Lesley; Chang, Howard; Tiver, Rebecca; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Emtage, L (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA.	rongo@waksman.rutgers.edu		Chang, Howard/0000-0003-4310-8890	Pew Scholar in the Biomedical Sciences; NIH [R01 NS42023]; American Heart Association [0525968T]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	Pew Scholar in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	C.R. is a Pew Scholar in the Biomedical Sciences. Funding was provided by the NIH (to C.R.; R01 NS42023) and the American Heart Association (to L.E.; 0525968T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK CDO, 1995, LEARN MEMORY, V2, P161, DOI 10.1101/lm.2.3-4.161; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chang HCH, 2005, J CELL SCI, V118, P1945, DOI 10.1242/jcs.02320; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Giles AC, 2005, INT REV NEUROBIOL, V69, P37, DOI 10.1016/S0074-7742(05)69002-2; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; IIDA J, 2007, MOL CELL BIOL; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Mendoza-Topaz C, 2008, J NEUROSCI, V28, P304, DOI 10.1523/JNEUROSCI.4395-07.2008; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rose JK, 2003, J NEUROSCI, V23, P9595; Rose JK, 2002, LEARN MEMORY, V9, P130, DOI 10.1101/lm.46802; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10781, DOI 10.1073/pnas.0604482103; WHITE JG, 1984, PHILOS T R SOC LON B, V314, P1; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	46	33	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4613	10.1371/journal.pone.0004613	http://dx.doi.org/10.1371/journal.pone.0004613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242552	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500015
J	Sukhorukov, VM; Bereiter-Hahn, J				Sukhorukov, Valerii M.; Bereiter-Hahn, Juergen			Anomalous Diffusion Induced by Cristae Geometry in the Inner Mitochondrial Membrane	PLOS ONE			English	Article								Diffusion of inner membrane proteins is a prerequisite for correct functionality of mitochondria. The complicated structure of tubular, vesicular or flat cristae and their small connections to the inner boundary membrane impose constraints on the mobility of proteins making their diffusion a very complicated process. Therefore we investigate the molecular transport along the main mitochondrial axis using highly accurate computational methods. Diffusion is modeled on a curvilinear surface reproducing the shape of mitochondrial inner membrane (IM). Monte Carlo simulations are carried out for topologies resembling both tubular and lamellar cristae, for a range of physiologically viable crista sizes and densities. Geometrical confinement induces up to several-fold reduction in apparent mobility. IM surface curvature per se generates transient anomalous diffusion (TAD), while finite and stable values of projected diffusion coefficients are recovered in a quasi-normal regime for short- and long-time limits. In both these cases, a simple area-scaling law is found sufficient to explain limiting diffusion coefficients for permeable cristae junctions, while asymmetric reduction of the junction permeability leads to strong but predictable variations in molecular motion rate. A geometry-based model is given as an illustration for the time-dependence of diffusivity when IM has tubular topology. Implications for experimental observations of diffusion along mitochondria using methods of optical microscopy are drawn out: a non-homogenous power law is proposed as a suitable approach to TAD. The data demonstrate that if not taken into account appropriately, geometrical effects lead to significant misinterpretation of molecular mobility measurements in cellular curvilinear membranes.	[Sukhorukov, Valerii M.; Bereiter-Hahn, Juergen] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany	Goethe University Frankfurt	Sukhorukov, VM (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany.	sukhorukov@kizefo.de	Sukhorukov, Valerii M/F-9735-2013		EU Integrated Project MiMage CT [2004-512020]	EU Integrated Project MiMage CT	This work has been financially supported by the EU Integrated Project MiMage CT 2004-512020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; BALAKRISHNAN V, 1995, PHYSICA A, V217, P1, DOI 10.1016/0378-4371(95)00083-J; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gustafsson S, 1997, J CHEM PHYS, V106, P1880, DOI 10.1063/1.473326; Hac AE, 2005, BIOPHYS J, V88, P317, DOI 10.1529/biophysj.104.040444; Halle B, 1997, PHYS REV E, V55, P680, DOI 10.1103/PhysRevE.55.680; HAUS JW, 1987, PHYS REP, V150, P263, DOI 10.1016/0370-1573(87)90005-6; HAVLIN S, 1987, ADV PHYS, V36, P695, DOI 10.1080/00018738700101072; Holyst R, 1999, PHYS REV E, V60, P302, DOI 10.1103/PhysRevE.60.302; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; KARP G, 2005, CELL MOL BIOL CONCEP; Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x; LENAZ G, 1988, J MEMBRANE BIOL, V104, P193, DOI 10.1007/BF01872322; MANNELLA CA, 1994, MICROSC RES TECHNIQ, V27, P278, DOI 10.1002/jemt.1070270403; More J. J., 1980, ANL8074, VIII; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; NAGLE JF, 1992, BIOPHYS J, V63, P366, DOI 10.1016/S0006-3495(92)81602-8; Naji A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2739526; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Perkins GA, 2003, MOL VIS, V9, P60; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; REVATHI S, 1993, PHYS REV E, V47, P916, DOI 10.1103/PhysRevE.47.916; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Saxton MJ, 2008, BIOPHYS J, V94, P760, DOI 10.1529/biophysj.107.114074; Saxton MJ, 2007, BIOPHYS J, V92, P1178, DOI 10.1529/biophysj.106.092619; SAXTON MJ, 1987, BIOPHYS J, V52, P989, DOI 10.1016/S0006-3495(87)83291-5; SAXTON MJ, 1989, BIOPHYS J, V55, P21, DOI 10.1016/S0006-3495(89)82776-6; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; SCHNEIDER H, 1982, J BIOL CHEM, V257, P789; SJOSTRAND FS, 1956, INT REV CYTOL, V5, P455, DOI 10.1016/S0074-7696(08)62578-4; SOWERS AE, 1981, P NATL ACAD SCI-BIOL, V78, P6246, DOI 10.1073/pnas.78.10.6246; SOWERS E, 1985, BIOCHIM BIOPHYS ACTA, V821, P85; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; WEISS GH, 1986, PHYSICA A, V134, P474, DOI 10.1016/0378-4371(86)90060-9; Weiss M, 2003, BIOPHYS J, V84, P4043, DOI 10.1016/S0006-3495(03)75130-3; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012	51	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4604	10.1371/journal.pone.0004604	http://dx.doi.org/10.1371/journal.pone.0004604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242541	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487500009
J	Joo, YE; Karrasch, T; Muhlbauer, M; Allard, B; Narula, A; Herfarth, HH; Jobin, C				Joo, Young-Eun; Karrasch, Thomas; Muehlbauer, Marcus; Allard, Brigitte; Narula, Acharan; Herfarth, Hans H.; Jobin, Christian			Tomato Lycopene Extract Prevents Lipopolysaccharide-Induced NF-kappa B Signaling but Worsens Dextran Sulfate Sodium-Induced Colitis in NF-kappa B-EGFP Mice	PLOS ONE			English	Article								Background: The impact of tomato lycopene extract (TLE) on intestinal inflammation is currently unknown. We investigated the effect of TLE on lipopolysaccharide (LPS)-induced innate signaling and experimental colitis. Methodology/Principal Findings: Mice were fed a diet containing 0.5 and 2% TLE or isoflavone free control (AIN-76). The therapeutic efficacy of TLE diet was assessed using dextran sulfate sodium (DSS) exposed mice and IL-10(-/-); NF-kappa B-EGFP mice, representing an acute and spontaneous chronic colitis model respectively. A mini-endoscope was used to determine the extent of macroscopic mucosal lesions. Murine splenocytes and intestinal epithelial cells were used to determine the in vitro impact of TLE on LPS-induced NF-kappa B signaling. In vitro, TLE blocked LPS-induced IkB alpha degradation, RelA translocation, NFkB transcriptional activity and MIP-2 mRNA accumulation in IEC-18 cells. Moreover, LPS-induced IL-12p40 gene expression was dose-dependently inhibited in TLE-treated splenocytes. Interestingly, DSS-induced acute colitis worsened in TLE-fed NF-kappa B-EGFP mice compared to control diet as measured by weight loss, colonoscopic analysis and histological scores. In contrast, TLE-fed IL-10(-/-); NF-kappa B-EGFP mice displayed decreased colonic EGFP expression compared to control diet. IL-6, TNF alpha, and MCP-1 mRNA expression were increased in the colon of TLE-fed, DSS-exposed NF-kappa B-EGFP mice compared to the control diet. Additionally, caspase-3 activation and TUNEL positive cells were enhanced in TLE diet-fed, DSS-exposed mice as compared to DSS control mice. Conclusions/Significance: These results indicate that TLE prevents LPS-induced proinflammatory gene expression by blocking of NF-kappa B signaling, but aggravates DSS-induced colitis by enhancing epithelial cell apoptosis.	[Joo, Young-Eun; Karrasch, Thomas; Muehlbauer, Marcus; Allard, Brigitte; Herfarth, Hans H.; Jobin, Christian] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Joo, Young-Eun; Karrasch, Thomas; Muehlbauer, Marcus; Allard, Brigitte; Herfarth, Hans H.; Jobin, Christian] Univ N Carolina, Ctr Gastrointest Biol & Dis, Chapel Hill, NC USA; [Narula, Acharan] Narula Res, Chapel Hill, NC USA; [Jobin, Christian] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Joo, YE (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	job@med.unc.edu	Herfarth, Hans/K-7547-2019		NIH [ROI DK 47700, P30 DK034987]; American Institute of Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, P30DK034987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute of Cancer Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH ROI DK 47700 and the American Institute of Cancer Research grants to C. Jobin; by NIH P30 DK034987 to CGIBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, Drug Metabol Drug Interact, V17, P189; Agarwal S, 1998, LIPIDS, V33, P981, DOI 10.1007/s11745-998-0295-6; Arab L, 2000, AM J CLIN NUTR, V71, p1691S, DOI 10.1093/ajcn/71.6.1691S; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Giovannucci E, 2002, EXP BIOL MED, V227, P852, DOI 10.1177/153537020222701003; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heber D, 2002, EXP BIOL MED, V227, P920, DOI 10.1177/153537020222701013; Jobin C, 1997, J IMMUNOL, V158, P226; Jobin C, 1999, J IMMUNOL, V163, P3474; Karrasch T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000596; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; KENNEDY TA, 1992, J BIOL CHEM, V267, P4658; Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1111/j.1365-2567.2004.01945.x; Kim JS, 2005, IMMUNOLOGY, V115, P375, DOI 10.1111/j.1365-2567.2005.02156.x; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Nguyen ML, 1999, FOOD TECHNOL-CHICAGO, V53, P38; Paul G, 2005, CLIN EXP IMMUNOL, V140, P547, DOI 10.1111/j.1365-2249.2005.02775.x; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rao AV, 1998, NUTR CANCER, V31, P199, DOI 10.1080/01635589809514703; Rao AVR, 2000, J AM COLL NUTR, V19, P563, DOI 10.1080/07315724.2000.10718953; Reifen R, 2004, J GASTROENTEROL, V39, P514, DOI 10.1007/s00535-003-1336-z; Roberfroid MB, 2000, AM J CLIN NUTR, V71, p1696S; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Stahl W, 1998, FEBS LETT, V427, P305, DOI 10.1016/S0014-5793(98)00434-7; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Tordoff MG, 2002, J NUTR, V132, P2288, DOI 10.1093/jn/132.8.2288; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	34	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4562	10.1371/journal.pone.0004562	http://dx.doi.org/10.1371/journal.pone.0004562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234608	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487200016
J	Kostal, V; Tollarova-Borovanska, M				Kostal, Vladimir; Tollarova-Borovanska, Michaela			The 70 kDa Heat Shock Protein Assists during the Repair of Chilling Injury in the Insect, Pyrrhocoris apterus	PLOS ONE			English	Article								Background: The Pyrrhocoris apterus (Insecta: Heteroptera) adults attain high levels of cold tolerance during their overwintering diapause. Non-diapause reproducing adults, however, lack the capacity to express a whole array of cold-tolerance adaptations and show relatively low survival when exposed to sub-zero temperatures. We assessed the competence of non-diapause males of P. apterus for responding to heat-and cold-stresses by up-regulation of 70 kDa heat shock proteins (Hsps) and the role of Hsps during repair of heat-and cold-induced injury. Principal Findings: The fragments of P. apterus homologues of Hsp70 inducible (PaHsp70) and cognate forms (PaHsc70) were cloned and sequenced. The abundance of mRNA transcripts for the inducible form (qPCR) and corresponding protein (Western blotting) were significantly up-regulated in response to high and low temperature stimuli. In the cognate form, mRNA was slightly up-regulated in response to both stressors but very low or no up-regulation of protein was apparent after heat-or cold-stress, respectively. Injection of 695 bp-long Pahsp70 dsRNA (RNAi) caused drastic suppression of the heat-and cold-stress-induced Pahsp70 mRNA response and the up-regulation of corresponding protein was practically eliminated. Our RNAi predictably prevented recovery from heat shock and, in addition, negatively influenced repair of chilling injuries caused by cold stress. Cold tolerance increased when the insects were first exposed to a mild heat shock, in order to trigger the up-regulation of PaHsp70, and subsequently exposed to cold stress. Conclusion: Our results suggest that accumulation of PaHsp70 belongs to a complex cold tolerance adaptation in the insect Pyrrhocoris apterus.	[Kostal, Vladimir; Tollarova-Borovanska, Michaela] Acad Sci Czech Republ, Inst Entomol, Biol Ctr ASCR, CR-37005 Ceske Budejovice, Czech Republic; [Kostal, Vladimir; Tollarova-Borovanska, Michaela] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kostal, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Biol Ctr ASCR, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	kostal@entu.cas.cz	Kostal, Vladimir/G-6688-2014; Borovanska, Michaela/D-1263-2016	Kostal, Vladimir/0000-0002-4994-5123; 	Czech Science Foundation [206/07/0269]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation Grant No. 206/07/0269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Chen B, 2006, J BIOCHEM MOL BIOL, V39, P749; CRAIG EA, 1994, CELL, V78, P365, DOI 10.1016/0092-8674(94)90416-2; Danks HV, 1996, EUR J ENTOMOL, V93, P383; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; HODEK I, 1968, ACTA ENTOMOL BOHEMOS, V65, P422; Hodkova M, 1997, CRYOBIOLOGY, V34, P70, DOI 10.1006/cryo.1996.1985; Hodkova M, 2002, J INSECT PHYSIOL, V48, P1009, DOI 10.1016/S0022-1910(02)00188-9; HOLMSTRUP M, 1994, J COMP PHYSIOL B, V164, P312, DOI 10.1007/BF00346448; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2004, PHYSIOL ENTOMOL, V29, P344, DOI 10.1111/j.0307-6962.2004.00396.x; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kostal V, 2001, COMP BIOCHEM PHYS B, V130, P365, DOI 10.1016/S1096-4959(01)00441-9; Kostal V, 2000, J INSECT PHYSIOL, V46, P1321, DOI 10.1016/S0022-1910(00)00056-1; Kostal V, 2008, J INSECT PHYSIOL, V54, P77, DOI 10.1016/j.jinsphys.2007.08.004; Lee R.E. Jr, 1991, P17; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Liang P, 1997, J CELL SCI, V110, P1431; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podrabsky JE, 2007, CELL STRESS CHAPERON, V12, P199, DOI 10.1379/CSC-280.1; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; Renault D, 2002, CRYOLETTERS, V23, P217; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Schill RO, 2006, J EXP ZOOL PART A, V305A, P449, DOI 10.1002/jez.a.281; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; Slachta M, 2002, EUR J ENTOMOL, V99, P181, DOI 10.14411/eje.2002.026; SLAMA K, 1964, J INSECT PHYSIOL, V10, P283, DOI 10.1016/0022-1910(64)90013-7; SOCHA R, 1992, PHYSIOL ENTOMOL, V17, P370, DOI 10.1111/j.1365-3032.1992.tb01034.x; Storey K.B., 1991, P64; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Tsai CJ, 2002, CRIT REV BIOCHEM MOL, V37, P55, DOI 10.1080/10409230290771456; Yocum GD, 2006, J INSECT PHYSIOL, V52, P1113, DOI 10.1016/j.jinsphys.2006.07.010; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; [No title captured]	57	117	127	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4546	10.1371/journal.pone.0004546	http://dx.doi.org/10.1371/journal.pone.0004546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229329	Green Published, gold, Green Submitted			2022-12-25	WOS:000265486200017
J	Dejima, K; Murata, D; Mizuguchi, S; Nomura, KH; Gengyo-Ando, K; Mitani, S; Kamiyama, S; Nishihara, S; Nomura, K				Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Gengyo-Ando, Keiko; Mitani, Shohei; Kamiyama, Shin; Nishihara, Shoko; Nomura, Kazuya			The ortholog of human solute carrier family 35 member B1 (UDP-galactose transporter-related protein 1) is involved in maintenance of ER homeostasis and essential for larval development in Caenorhabditis elegans	FASEB JOURNAL			English	Article						ER stress; RNAi; deletion mutant; glycosylation; model organism	NUCLEOTIDE-SUGAR TRANSPORTERS; ENDOPLASMIC-RETICULUM STRESS; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; SULFATE SYNTHESIS; GOLGI-APPARATUS; GENE-EXPRESSION; GLUCURONIC ACID; IDENTIFICATION	Although the solute carrier 35B1 (SLC35B1) is evolutionarily conserved, its functions in metazoans remain unknown. To elucidate its function, we examined developmental roles of an SLC35B1 family gene (HUT-1: homolog of UDP-Gal transporter) in Caenorhabditis elegans. We isolated a deletion mutant of the gene and characterized phenotypes of the mutant and hut-1 RNAi-treated worms. GFP-HUT-1 reporter analysis was performed to examine gene expression patterns. We also tested whether several nucleotide sugar transporters can compensate for hut-1 deficiency. The hut-1 deletion mutant and RNAi worms showed larval growth defect and lethality with disrupted intestinal morphology. Inactivation of hut-1 induced chronic endoplasmic reticulum ( ER) stress, and hut-1 showed genetic interactions with the atf-6, pek-1, and ire-1 genes involved in unfolded protein response signaling. ER ultrastructure and ER marker distribution in hut-1-deficient animals showed that HUT-1 is required for maintenance of ER structure. Reporter analysis revealed that HUT- 1 is an ER protein ubiquitously expressed in tissues, including the intestine. Lethality and the ER stress phenotype of the mutant were rescued with the human hut-1 ortholog UGTrel1. These results indicate important roles for hut-1 in development and maintenance of ER homeostasis in C. elegans.-Dejima, K., Murata, D., Mizuguchi, S., Nomura, K. H., Gengyo-Ando, K., Mitani, S., Kamiyama, S., Nishihara, S., Nomura, K. The ortholog of human solute carrier family 35 member B1 (UDP-galactose transporter- related protein 1) is involved in maintenance of ER homeostasis and essential for larval development in Caenorhabditis elegans. FASEB J. 23, 2215-2225 (2009)	[Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Nomura, Kazuya] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Dejima, Katsufumi; Murata, Daisuke; Mizuguchi, Souhei; Nomura, Kazuko H.; Gengyo-Ando, Keiko; Mitani, Shohei; Nishihara, Shoko; Nomura, Kazuya] Japan Sci & Technol Agcy, Saitama, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kamiyama, Shin; Nishihara, Shoko] Soka Univ, Fac Engn, Cell Biol Lab, Dept Bioinformat, Tokyo, Japan	Kyushu University; Japan Science & Technology Agency (JST); Tokyo Women's Medical University; Soka University	Nomura, K (corresponding author), Kyushu Univ, Dept Biol, Fac Sci 33, Fukuoka 8128581, Japan.	knomuscb@mbox.kyushu-u.ac.jp	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019	Nishihara, Shoko/0000-0002-1668-2603	Japan Science and Technology Corp; MEXT, Japan	Japan Science and Technology Corp(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr. Yoshifumi Jigami and Dr. Takehiko Yoko-o ( National Institute of Advanced Industrial Science and Technology, Tokyo, Japan) for providing yeast hut1 genes; Dr. Roger Tsien ( University of California, San Diego, CA, USA) for providing the mCherry gene; and the Caenorhabditis Genetics Center ( University of Minnesota, Minneapolis, MN, USA; supported by the National Institutes of Health-National Center for Research Resources) for providing C. elegans strains. This work was supported by a grant-in-aid for JSPS fellows ( to K. D.) and a grant-in-aid for young scientists ( B) ( to S. M.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The study is also supported by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Corp. (to K.N.) and for Scientific Research on Priority Areas 14082207 (to K.N.) from MEXT, Japan.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Berninsone P, 1997, J BIOL CHEM, V272, P12616, DOI 10.1074/jbc.272.19.12616; Berninsone Patricia M, 2006, WormBook, P1; BRENNER S, 1974, GENETICS, V77, P71; Caffaro CE, 2008, BIOCHEMISTRY-US, V47, P4337, DOI 10.1021/bi702468g; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kainuma M, 2001, YEAST, V18, P533, DOI 10.1002/yea.708; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Kobayashi T, 2006, BIOCHEM J, V400, P281, DOI 10.1042/BJ20060429; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Martinez-Duncker I, 2003, BIOCHIMIE, V85, P245, DOI 10.1016/S0300-9084(03)00046-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; Muraoka M, 2007, J BIOL CHEM, V282, P24615, DOI 10.1074/jbc.M611358200; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Nakanishi H, 2001, YEAST, V18, P543, DOI 10.1002/yea.707; Norambuena L, 2002, J BIOL CHEM, V277, P32923, DOI 10.1074/jbc.M204081200; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Reyes F, 2006, J BIOL CHEM, V281, P9145, DOI 10.1074/jbc.M512210200; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sasagawa Y, 2007, GENES CELLS, V12, P1063, DOI 10.1111/j.1365-2443.2007.01108.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Uccelletti D, 2008, MOL BIOL CELL, V19, P1337, DOI 10.1091/mbc.E07-06-0547; Uccelletti D, 2004, J BIOL CHEM, V279, P27390, DOI 10.1074/jbc.M402624200	58	17	21	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2215	2225		10.1096/fj.08-123737	http://dx.doi.org/10.1096/fj.08-123737			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19270184	Green Published			2022-12-25	WOS:000268836500021
J	Salmon, AB; Leonard, S; Masamsetti, V; Pierce, A; Podlutsky, AJ; Podlutskaya, N; Richardson, A; Austad, SN; Chaudhuri, AR				Salmon, Adam B.; Leonard, Shanique; Masamsetti, Venkata; Pierce, Anson; Podlutsky, Andrej J.; Podlutskaya, Natalia; Richardson, Arlan; Austad, Steven N.; Chaudhuri, Asish R.			The long lifespan of two bat species is correlated with resistance to protein oxidation and enhanced protein homeostasis	FASEB JOURNAL			English	Article						longevity; comparative biology; oxidative stress; ubiquitin-proteasome; Chiroptera	FREE-RADICAL PRODUCTION; NAKED MOLE-RATS; LIVING RODENT; ANTIOXIDANT DEFENSES; CELLULAR-RESISTANCE; HEART-MITOCHONDRIA; STRESS RESISTANCE; H2O2 PRODUCTION; MULTIPLE FORMS; METABOLIC-RATE	Altered structure, and hence function, of cellular macromolecules caused by oxidation can contribute to loss of physiological function with age. Here, we tested whether the lifespan of bats, which generally live far longer than predicted by their size, could be explained by reduced protein damage relative to short-lived mice. We show significantly lower protein oxidation (carbonylation) in Mexican free-tailed bats (Tadarida brasiliensis) relative to mice, and a trend for lower oxidation in samples from cave myotis bats (Myotis velifer) relative to mice. Both species of bat show in vivo and in vitro resistance to protein oxidation under conditions of acute oxidative stress. These bat species also show low levels of protein ubiquitination in total protein lysates along with reduced proteasome activity, suggesting diminished protein damage and removal in bats. Lastly, we show that bat-derived protein fractions are resistant to urea-induced protein unfolding relative to the level of unfolding detected in fractions from mice. Together, these data suggest that long lifespan in some bat species might be regulated by very efficient maintenance of protein homeostasis.-Salmon, A. B., Leonard, S., Masamsetti, V., Pierce, A., Podlutsky, A. J., Podlutskaya, N., Richardson, A., Austad, S. N., Chaudhuri, A. R. The long lifespan of two bat species is correlated with resistance to protein oxidation and enhanced protein homeostasis. FASEB J. 23, 2317-2326 (2009)	[Chaudhuri, Asish R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Pierce, Anson; Richardson, Arlan; Chaudhuri, Asish R.] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA; [Pierce, Anson; Richardson, Arlan; Austad, Steven N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Chaudhuri, AR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, Sam & Ann Barshop Inst Longev & Aging Studies, 15355 Lambda Dr, San Antonio, TX 78245 USA.	chaudhuria@uthscsa.edu	Podlutsky, Andrej/F-5421-2015; Pierce, Anson/D-1079-2012	Pierce, Anson/0000-0002-1383-0180; Masamsetti, Venkata Sai Durga Pragathi/0000-0002-0251-1707	NIH [T32 AG021890-05, AG23843, R37 AG26557, AG022873];  [K07 AG025063 04]; NATIONAL INSTITUTE ON AGING [K07AG025063, R37AG026557, R01AG022873, R01AG023843, T32AG021890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Bertran Friguet (Universite Paris, Paris, France) for providing 20S proteasome antibody. We also thank Tom Kunz and Louise Allen for help in obtaining our bat samples. This work was supported by K07 AG025063 04 (A. R. C., A. R., S.N.A.); NIH training grant T32 AG021890-05 (A. B. S.); and NIH grants AG23843, R37 AG26557 (A. R.), and AG022873 (S.N.A.).	Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X; Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47; Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3; BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584; BAUDRY M, 1986, NEUROBIOL AGING, V7, P255, DOI 10.1016/0197-4580(86)90004-7; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Brunet-Rossinni AK, 2004, MECH AGEING DEV, V125, P11, DOI 10.1016/j.mad.2003.09.003; Brunet-Rossinni AK, 2004, BIOGERONTOLOGY, V5, P211, DOI 10.1023/B:BGEN.0000038022.65024.d8; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Cohen AA, 2008, AM NAT, V172, P178, DOI 10.1086/589456; Csiszar A, 2007, AM J PHYSIOL-HEART C, V293, pH919, DOI 10.1152/ajpheart.01287.2006; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Finch CE, 1990, LONGEVITY SENESCENCE; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9; Holmes DJ, 2003, EXP GERONTOL, V38, P1365, DOI 10.1016/j.exger.2003.10.018; JURGENS KD, 1987, COMP BIOCHEM PHYS A, V88, P361, DOI 10.1016/0300-9629(87)90498-1; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Khidekel N, 2004, ORG BIOMOL CHEM, V2, P1, DOI 10.1039/b312466e; Labinskyy N, 2006, AM J PHYSIOL-HEART C, V291, pH2698, DOI 10.1152/ajpheart.00534.2006; Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x; Lorenzini A, 2005, MECH AGEING DEV, V126, P1130, DOI 10.1016/j.mad.2005.05.004; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Ogburn CE, 2001, J GERONTOL A-BIOL, V56, pB468, DOI 10.1093/gerona/56.11.B468; Ogburn CE, 1998, J GERONTOL A-BIOL, V53, pB287, DOI 10.1093/gerona/53A.4.B287; Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131; Pierce A, 2006, BIOCHEMISTRY-US, V45, P3077, DOI 10.1021/bi052031i; Podlutsky AJ, 2005, J GERONTOL A-BIOL, V60, P1366, DOI 10.1093/gerona/60.11.1366; Richardson A, 2004, BEST PRACT RES CL EN, V18, P393, DOI 10.1016/j.beem.2004.02.002; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232; SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M; TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777; Wilhelm D, 2007, COMP BIOCHEM PHYS C, V146, P214, DOI 10.1016/j.cbpc.2006.11.015; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; WILKINSON KD, 1995, ANNU REV NUTR, V15, P161, DOI 10.1146/annurev.nu.15.070195.001113	48	84	86	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2317	2326		10.1096/fj.08-122523	http://dx.doi.org/10.1096/fj.08-122523			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19244163	Green Published			2022-12-25	WOS:000268836500031
J	Wagner, C; Isermann, K; Roeder, T				Wagner, Christina; Isermann, Kerstin; Roeder, Thomas			Infection induces a survival program and local remodeling in the airway epithelium of the fly	FASEB JOURNAL			English	Article						Drosophila; trachea; inflammation; Foxo; Thor; asthma	JAK/STAT SIGNALING COMPONENTS; IMMUNE-RESPONSE; BRANCHING MORPHOGENESIS; CELL PROLIFERATION; GENE-EXPRESSION; INNATE IMMUNITY; TRACHEAL SYSTEM; DROSOPHILA; RNAI; IDENTIFICATION	Although the prevalence of inflammatory airway diseases is steadily growing, our knowledge regarding the underlying molecular and cellular mechanisms is fragmentary. The striking simplicity of the fruit fly's airway epithelium, which is composed of epithelial cells only, justifies its use as a model to study general features and response characteristics of airway epithelia in general. Infection with the gram-negative pathogen Erwinia carotovora induces an immune response in all epithelial cells via activation of the immune deficiency (IMD) pathway, but the transcriptional profile differs significantly from that observed after ectopic activation of this signaling pathway. After strong infections, genes controlling central aspects of tracheal development are reactivated, a response that is not seen after ectopic IMD pathway activation. Presumably to counteract infection-induced cell death-promoting signals, a survival response is launched, characterized by the concurrent expression and activation of the longevity genes dfoxo and dthor. Regions of the airways featuring the strongest immune reactions show substantial remodeling, which is characterized by a significant thickening of the epithelial cells. In conclusion, features related to those observed in inflammatory diseases of the human airways are apparently part of the normal response repertoire of airway epithelia to infection. -Wagner, C., Isermann, K., Roeder, T. Infection induces a survival program and local remodeling in the airway epithelium of the fly. FASEB J. 23, 2045-2054 (2009)	[Wagner, Christina; Isermann, Kerstin; Roeder, Thomas] Univ Kiel, Dept Zoophysiol, D-24098 Kiel, Germany; [Wagner, Christina; Roeder, Thomas] Forschungszentrum Borstel, Dept Immunol & Cell Biol, Borstel, Germany	University of Kiel; Forschungszentrum Borstel	Roeder, T (corresponding author), Univ Kiel, Dept Zoophysiol, Ohlshausenstr 40, D-24098 Kiel, Germany.	troeder@zoologie.uni-kiel.de	Wagner, Christina/M-7796-2018; Roeder, Thomas/B-9016-2011	Roeder, Thomas/0000-0002-3489-3834	Claussen-Simon-Stiftung; Stifterverb- and der deutschen Wirtschaft	Claussen-Simon-Stiftung; Stifterverb- and der deutschen Wirtschaft	This work is part of the Transregio 22 program of the Deutsche Forschungsgemeinschaft (TPA7). In addition, it was supported by the Claussen-Simon-Stiftung and the Stifterverb- and der deutschen Wirtschaft. We thank Bruno Lemaitre (Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland), Shigeo Hayashi (RIKEN Center for Developmental Biology, Kobe, Japan), Jean-Luc Imler (Institut de Biologie Moleculaire et Cellulaire, Strasbourg, France), Aya Takehana (Tohoku University, Sendai, Japan), Thomas Neufeld ( University of Minnesota, Minneapolis, MN, USA), Oscar Puig ( University of Helsinki, Helsinki, Finland), and the Bloomington Stock Center for fly stocks.	Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broide DH, 2005, P NATL ACAD SCI USA, V102, P17723, DOI 10.1073/pnas.0509235102; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Diamond G, 2000, INFECT IMMUN, V68, P113, DOI 10.1128/IAI.68.1.113-119.2000; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eynott PR, 2003, BRIT J PHARMACOL, V140, P1373, DOI 10.1038/sj.bjp.0705569; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Franz O, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.11.e3; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Imboden M, 2008, THORAX, V63, P322, DOI 10.1136/thx.2007.085555; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Londhe VA, 2008, DEV DYNAM, V237, P328, DOI 10.1002/dvdy.21413; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Persson C, 2007, INSECT BIOCHEM MOLEC, V37, P1309, DOI 10.1016/j.ibmb.2007.08.003; Ruhle H, 1932, Z WISS ZOOL ABT A, V141, P159; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schneider DS, 2007, PLOS BIOL, V5, P1847, DOI 10.1371/journal.pbio.0050247; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tingvall TO, 2001, EMBO REP, V2, P239; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; WHITTEN JM, 1957, Q J MICROSC SCI, V98, P123; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	54	31	31	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2045	2054		10.1096/fj.08-114223	http://dx.doi.org/10.1096/fj.08-114223			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19237508				2022-12-25	WOS:000268836500005
J	Makarenkova, HP; Gonzalez, KN; Kiosses, WB; Meech, R				Makarenkova, Helen P.; Gonzalez, Katie N.; Kiosses, William B.; Meech, Robyn			Barx2 Controls Myoblast Fusion and Promotes MyoD-mediated Activation of the Smooth Muscle alpha-Actin Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; HELIX-LOOP-HELIX; HOMEODOMAIN PROTEIN; SKELETAL-MUSCLE; MADS-BOX; EXPRESSION; TRANSCRIPTION; BINDING; DIFFERENTIATION; ELEMENTS	Remodeling of the actin cytoskeleton is a critical early step in skeletal muscle differentiation. Smooth muscle alpha-actin (SMA) is one of the earliest markers of myoblast differentiation and is important for the migration and cell shape changes that precede fusion. We have found that satellite cell-derived primary myoblasts from mice lacking the Barx2 homeobox gene show altered patterns of actin remodeling, reduced cell migration, and delayed differentiation. Consistent with the role of SMA in these processes, Barx2(-/-) myoblasts also show reduced expression of SMA mRNA and protein. The proximal SMA promoter contains binding sites for muscle regulatory factors and serum response factor as well as a conserved homeodomain binding site (HBS). We found that Barx2 binds to the HBS element and potentiates up-regulation of SMA promoter activity by MyoD. We also show that Barx2, MyoD, and serum response factor simultaneously occupy the SMA promoter in cells and that Barx2 interacts with MyoD. Overall these data indicate that Barx2 cooperates with other muscle-expressed transcription factors to regulate the early cytoskeletal remodeling events that underlie efficient myoblast differentiation.	Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA; [Makarenkova, Helen P.] Inst Neurosci, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute	Meech, R (corresponding author), Flinders Univ S Australia, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia.	robyn.meech@flinders.edu.au		Meech, Robyn/0000-0002-6831-0801	National Institutes of Health [1R03AR051131, 5R01AR053163-02]; Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR051131, R01AR053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03AR051131 (to R. M.) and 5R01AR053163-02 (to H. P. M.). This work was also supported by a grant from the Association Francaise contre les Myopathies (to H. P. M.).	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biressi S, 2008, CELL DEATH DIFFER, V15, P94, DOI 10.1038/sj.cdd.4402230; BLANK RS, 1992, J BIOL CHEM, V267, P984; Busson M, 2006, ENDOCRINOLOGY, V147, P3408, DOI 10.1210/en.2006-0101; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; COX RD, 1990, DIFFERENTIATION, V43, P183, DOI 10.1111/j.1432-0436.1990.tb00445.x; DUPREY P, 1994, INT J DEV BIOL, V38, P591; Edelman DB, 2000, J BIOL CHEM, V275, P21737, DOI 10.1074/jbc.M909998199; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; FOSTER DN, 1992, J BIOL CHEM, V267, P11995; Groisman R, 1996, J BIOL CHEM, V271, P5258; Hautmann MB, 1997, CIRC RES, V81, P600, DOI 10.1161/01.RES.81.4.600; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Johnson AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1420, DOI 10.1152/ajpcell.1999.276.6.C1420; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Makarenkova H, 1997, J CELL BIOL, V138, P1125, DOI 10.1083/jcb.138.5.1125; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Meech R, 2003, J BIOL CHEM, V278, P8269, DOI 10.1074/jbc.M207617200; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; MIN BH, 1990, J BIOL CHEM, V265, P16667; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Ostle B., 1975, STAT RES, V3rd, P596; Phiel CJ, 2001, J BIOL CHEM, V276, P34637, DOI 10.1074/jbc.M105826200; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Qu G, 1997, J CELL BIOCHEM, V67, P514, DOI 10.1002/(SICI)1097-4644(19971215)67:4<514::AID-JCB9>3.3.CO;2-I; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Rodriguez-Calvo R, 2006, J GERONTOL A-BIOL, V61, P773, DOI 10.1093/gerona/61.8.773; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; Stevens TA, 2004, J BIOL CHEM, V279, P14520, DOI 10.1074/jbc.M310259200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VOGEL A, 1993, DEVELOPMENT, V119, P199; WOODCOCKMITCHELL J, 1988, DIFFERENTIATION, V39, P161, DOI 10.1111/j.1432-0436.1988.tb00091.x; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	53	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14866	14874		10.1074/jbc.M807208200	http://dx.doi.org/10.1074/jbc.M807208200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19269978	Green Published, hybrid			2022-12-25	WOS:000266288200022
J	Kamenecka, T; Habel, J; Duckett, D; Chen, WM; Ling, YY; Frackowiak, B; Jiang, R; Shin, YS; Song, XY; LoGrasso, P				Kamenecka, Ted; Habel, Jeff; Duckett, Derek; Chen, Weimin; Ling, Yuan Yuan; Frackowiak, Bozena; Jiang, Rong; Shin, Youseung; Song, Xinyi; LoGrasso, Philip			Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PALLADIUM-CATALYZED AMINATION; ORALLY BIOAVAILABLE INHIBITOR; MAP KINASE; IMIDAZOLE INHIBITORS; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; HIV-1 PROTEASE; DESIGN; POTENT	c-Jun N-terminal kinase 3 alpha 1 (JNK3 alpha 1) is a mitogen-activated protein kinase family member expressed primarily in the brain that phosphorylates protein transcription factors, including c-Jun and activating transcription factor-2 (ATF-2) upon activation by a variety of stress-based stimuli. In this study, we set out to design JNK3-selective inhibitors that had > 1000-fold selectivity over p38, another closely related mitogen-activated protein kinase family member. To do this we employed traditional medicinal chemistry principles coupled with structure-based drug design. Inhibitors from the aminopyrazole class, such as SR-3576, were found to be very potent JNK3 inhibitors (IC50 = 7 nM) with > 2800-fold selectivity over p38 (p38 IC50 > 20 mu M) and had cell-based potency of similar to 1 mu M. In contrast, indazole-based inhibitors exemplified by SR-3737 were potent inhibitors of both JNK3 (IC50 = 12 nM) and p38 (IC50 = 3 nM). These selectivity differences between the indazole class and the aminopyrazole class came despite nearly identical binding (root mean square deviation = 0.33 angstrom) of these two compound classes to JNK3. The structural features within the compounds giving rise to the selectivity in the aminopyrazole class include the highly planar nature of the pyrazole, N-linked phenyl structures, which better occupied the smaller active site of JNK3 compared with the larger active site of p38.	[LoGrasso, Philip] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, P (corresponding author), Scripps Res Inst, Dept Mol Therapeut, 130 Scripps Way,2A2, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Frackowiak-Wojtasek, Bozena/0000-0002-0203-4066	National Institutes of Health [U01-NS057153]; Stanford Synchrotron Radiation Laboratory (SSRL); U.S. Dept. of Energy, Office of Basic Energy Sciences; SSRL Structural Molecular Biology Program; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources; NIH; Biomedical Technology Program; NIGMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Synchrotron Radiation Laboratory (SSRL); U.S. Dept. of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); SSRL Structural Molecular Biology Program; Dept. of Energy, Office of Biological and Environmental Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01-NS057153 (to P.L.). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the U.S. Dept. of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Dept. of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, NIH, Biomedical Technology Program, and NIGMS, NIH.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angell RM, 2007, BIOORG MED CHEM LETT, V17, P1296, DOI 10.1016/j.bmcl.2006.12.003; Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; CHEN ZG, 1994, J BIOL CHEM, V269, P26344; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Dios A, 2005, J MED CHEM, V48, P2270, DOI 10.1021/jm048978k; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421; DORSEY BD, 1994, J MED CHEM, V37, P3443, DOI 10.1021/jm00047a001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Gaillard P, 2005, J MED CHEM, V48, P4596, DOI 10.1021/jm0310986; GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0; Goldstein DM, 2006, J MED CHEM, V49, P1562, DOI 10.1021/jm050736c; Gross RS, 2005, J MED CHEM, V48, P5780, DOI 10.1021/jm049085v; Haddad J J, 2001, Curr Opin Investig Drugs, V2, P1070; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang XH, 2003, J AM CHEM SOC, V125, P6653, DOI 10.1021/ja035483w; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee MR, 2005, CURR MED CHEM, V12, P2979, DOI 10.2174/092986705774462914; LINDLEY J, 1984, TETRAHEDRON, V40, P1433, DOI 10.1016/S0040-4020(01)91791-0; Lisnock JM, 1998, BIOCHEMISTRY-US, V37, P16573, DOI 10.1021/bi981591x; Liverton NJ, 1999, J MED CHEM, V42, P2180, DOI 10.1021/jm9805236; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMITH GM, 1994, PROTEIN SCI, V3, P118, DOI 10.1002/pro.5560030115; Stelmach JE, 2003, BIOORG MED CHEM LETT, V13, P277, DOI 10.1016/S0960-894X(02)00752-7; Swahn BM, 2006, BIOORG MED CHEM LETT, V16, P1397, DOI 10.1016/j.bmcl.2005.11.039; Swahn BM, 2005, BIOORG MED CHEM LETT, V15, P5095, DOI 10.1016/j.bmcl.2005.06.083; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; Wolfe JP, 2000, J ORG CHEM, V65, P1158, DOI 10.1021/jo991699y; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang BH, 1999, J ORGANOMET CHEM, V576, P125, DOI 10.1016/S0022-328X(98)01054-7; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhao HY, 2006, J MED CHEM, V49, P4455, DOI 10.1021/jm060465l	52	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12853	12861		10.1074/jbc.M809430200	http://dx.doi.org/10.1074/jbc.M809430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19261605	Green Published, hybrid			2022-12-25	WOS:000265688300031
J	Lyu, J; Wesselschmidt, RL; Lu, WG				Lyu, Jungmook; Wesselschmidt, Robin L.; Lu, Wange			Cdc37 Regulates Ryk Signaling by Stabilizing the Cleaved Ryk Intracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT RECEPTOR RYK; GAMMA-SECRETASE; AXON GUIDANCE; HSP90; DIFFERENTIATION; P50(CDC37); PROTEASOME; EXPRESSION; BINDING; GROWTH	Ryk is a Wnt receptor that plays an important role in neurogenesis, neurite outgrowth, and axon guidance. We have reported that the Ryk receptor is cleaved by gamma-secretase and that its intracellular domain (ICD) translocates to the nucleus upon Wnt stimulation. Cleavage of Ryk and its ICD is important for the function of Ryk in neurogenesis. However, the question of how the Ryk ICD is stabilized and translocated into the nucleus remains unanswered. Here, we show that the Ryk ICD undergoes ubiquitination and proteasomal degradation. We have identified Cdc37, a subunit of the molecular chaperone Hsp90 complex, as a Ryk ICD-interacting protein that inhibits proteasomal degradation of the Ryk ICD. Overexpression of Cdc37 increases Ryk ICD levels and promotes its nuclear localization, whereas Cdc37 knockdown reduces Ryk ICD stability. Furthermore, we have discovered that the Cdc37-Ryk ICD complex is disrupted during neural differentiation of embryonic stem cells, resulting in Ryk ICD degradation. These results suggest that Cdc37 plays an essential role in regulating Ryk ICD stability and therefore in Ryk-mediated signal transduction.	[Lyu, Jungmook; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Lyu, Jungmook; Wesselschmidt, Robin L.; Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, 1501 San Pablo St,ZNI 523, Los Angeles, CA 90033 USA.				Korea Research Foundation [KRF-2006-214-C00076]; California Institute for Regenerative Medicine	Korea Research Foundation(National Research Foundation of Korea); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Supported by Korea Research Foundation Award KRF-2006-214-C00076 and a fellowship from the California Institute for Regenerative Medicine.	Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Harris KE, 2007, DEVELOPMENT, V134, P2017, DOI 10.1242/dev.001164; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Katso RM, 1999, MOL CELL BIOL, V19, P6427; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Millar JBA, 2002, GENOME BIOL, V3; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, FEBS J, V272, P4684, DOI 10.1111/j.1742-4658.2005.04884.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	38	20	20	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12940	12948		10.1074/jbc.M900207200	http://dx.doi.org/10.1074/jbc.M900207200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269974	hybrid, Green Published			2022-12-25	WOS:000265688300040
J	Couve, S; Mace-Aime, G; Rosselli, F; Saparbaev, MK				Couve, Sophie; Mace-Aime, Gaetane; Rosselli, Filippo; Saparbaev, Murat K.			The Human Oxidative DNA Glycosylase NEIL1 Excises Psoralen-induced Interstrand DNA Cross-links in a Three-stranded DNA Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-VIII; CELL NUCLEAR ANTIGEN; ABC EXCINUCLEASE; DAMAGED DNA; IN-VITRO; REPAIR; RECOMBINATION; REMOVAL; RECA; RECOGNITION	Previously, we have demonstrated that human oxidative DNA glycosylase NEIL1 excises photoactivated psoralen-induced monoadducts but not genuine interstrand cross-links (ICLs) in duplexDNA. It has been postulated that the repair of ICLs in mammalian cells is mainly linked to DNA replication and proceeds via dual incisions in one DNA strand that bracket the cross-linked site. This process, known as "unhooking," enables strand separation and translesion DNA synthesis through the gap, yielding a three-stranded DNA repair intermediate composed of a short unhooked oligomer covalently bound to the duplex. At present, the detailed molecular mechanism of ICL repair in mammalian cells remains unclear. Here, we constructed and characterized three-stranded DNA structures containing a single ICL as substrates for the base excision repair proteins. We show that NEIL1 excises with high efficiency the unhooked ICL fragment within a three-stranded DNA structure. Complete reconstitution of the repair of unhooked ICL shows that it can be processed in a short patch base excision repair pathway. The new substrate specificity of NEIL1 points to a preferential involvement in the replication-associated repair of ICLs. Based on these data, we propose a model for the mechanism of ICL repair in mammalian cells that implicates the DNA glycosylase activity of NEIL1 downstream of Xeroderma Pigmentosum group F/Excision Repair Cross-Complementing 1 endonuclease complex (XPF/ERCC1) and translesion DNA synthesis repair steps. Finally, our data demonstrate that Nei-like proteins from Escherichia coli to human cells can excise bulky unhooked psoralen-induced ICLs via hydrolysis of glycosidic bond between crosslinked base and deoxyribose sugar, thus providing an alternative heuristic solution for the removal of complex DNA lesions.	[Couve, Sophie; Saparbaev, Murat K.] Univ Paris Sud, Inst Cancerol Gustave Roussy, Grp Reparat ADN, CNRS,UMR 8126, F-94805 Villejuif, France; [Mace-Aime, Gaetane; Rosselli, Filippo] Univ Paris Sud, Inst Cancerol Gustave Roussy, Grp Voie FANC BRCA & Canc, CNRS,Commissariat Energie Atom LRC43V,FRE2939, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Saparbaev, MK (corresponding author), Inst Gustave Roussy, PR1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	smurat@igr.fr	Saparbaev, Murat/AAC-5478-2020; Saparbaev, Murat K/N-3225-2015; Filippo, Rosselli/AAO-6393-2020	Saparbaev, Murat/0000-0002-4630-1074; Saparbaev, Murat K/0000-0002-4630-1074; Filippo, Rosselli/0000-0003-1080-5745	Fondation pour la Recherche Medicale; FP6 Euroatom Grant [RISC-RAD FI6R-CT-2003-508842]; CNRS France-Pologne [GRDE 182]; Institut National du Cancer (INCa); Electricite de France (EDF); National Center for Biotechnology, Kazakhstan; La Ligue Contre le Cancer; INCa	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); FP6 Euroatom Grant(European Commission); CNRS France-Pologne; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Electricite de France (EDF)(Electricite de France (EDF)); National Center for Biotechnology, Kazakhstan(National Center for Biotechnology (NCB)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France)	This work was supported by grants from the Fondation pour la Recherche Medicale "EQUIPES FRM 2007," FP6 Euroatom Grant RISC-RAD FI6R-CT-2003-508842, CNRS France-Pologne GRDE 182, Institut National du Cancer (INCa), Electricite de France (EDF), and National Center for Biotechnology, Kazakhstan (to M. K. S.) and from La Ligue Contre le Cancer "Equipe Labellisee 2006," EDF, and INCa (to F. R.).	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; BOITEUX S, 1989, CARCINOGENESIS, V10, P1905, DOI 10.1093/carcin/10.10.1905; CHENG S, 1988, J BIOL CHEM, V263, P15110; CHENG S, 1991, NUCLEIC ACIDS RES, V19, P657, DOI 10.1093/nar/19.3.657; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cipak L, 2006, NAT STRUCT MOL BIOL, V13, P729, DOI 10.1038/nsmb1120; COLE RS, 1971, BIOCHIM BIOPHYS ACTA, V254, P30, DOI 10.1016/0005-2787(71)90111-0; Coste F, 2008, CHEM BIOL, V15, P706, DOI 10.1016/j.chembiol.2008.05.014; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Eichman BF, 2001, J MOL BIOL, V308, P15, DOI 10.1006/jmbi.2001.4567; Fang QM, 2008, BIOCHEMISTRY-US, V47, P10892, DOI 10.1021/bi8008664; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; HOY CA, 1985, CANCER RES, V45, P1737; Hwang GS, 1996, BIOCHEM BIOPH RES CO, V219, P191, DOI 10.1006/bbrc.1996.0204; Jia L, 2007, BIOCHEMISTRY-US, V46, P5305, DOI 10.1021/bi062269m; JOHNSTON BH, 1981, BIOCHEMISTRY-US, V20, P739, DOI 10.1021/bi00507a012; KANNE D, 1984, J MED CHEM, V27, P531, DOI 10.1021/jm00370a017; KUMARESAN KR, 1992, BIOCHEMISTRY-US, V31, P6774, DOI 10.1021/bi00144a018; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Parsons JL, 2007, BIOCHEMISTRY-US, V46, P4158, DOI 10.1021/bi0622569; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; SLADEK FM, 1989, J BIOL CHEM, V264, P6755; SPIELMANN HP, 1995, P NATL ACAD SCI USA, V92, P2345, DOI 10.1073/pnas.92.6.2345; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; VANHOUTEN B, 1986, J BIOL CHEM, V261, P14135; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	44	51	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11963	11970		10.1074/jbc.M900746200	http://dx.doi.org/10.1074/jbc.M900746200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258314	hybrid, Green Published			2022-12-25	WOS:000265494600028
J	Fan, WQ; Imamura, T; Sonoda, N; Sears, DD; Patsouris, D; Kim, JJ; Olefsky, JM				Fan, WuQiang; Imamura, Takeshi; Sonoda, Noriyuki; Sears, Dorothy D.; Patsouris, David; Kim, Jane J.; Olefsky, Jerrold M.			FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor gamma Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; PPAR-GAMMA; PROTEIN-KINASE; ANDROGEN RECEPTOR; 3T3-L1 ADIPOCYTES; NUCLEAR RECEPTOR; LXXLL MOTIF; PHOSPHORYLATION; SENSITIVITY; THIAZOLIDINEDIONES	The transcriptional factor FoxO1 plays an important role in metabolic homeostasis. Herein we identify a novel transrepressional function that converts FoxO1 from an activator of transcription to a promoter-specific repressor of peroxisome proliferator-activated receptor gamma (PPAR gamma) target genes that regulate adipocyte biology. FoxO1 transrepresses PPAR gamma via direct protein-protein interactions; it is recruited to PPAR response elements (PPRE) on PPAR gamma target genes by PPAR gamma bound to PPRE and interferes with promoter DNA occupancy of the receptor. The FoxO1 transrepressional function, which is independent and dissectible from the transactivational effects, does not require a functional FoxO1 DNA binding domain, but dose require an evolutionally conserved 31 amino acids LXXLL-containing domain. Insulin induces FoxO1 phosphorylation and nuclear exportation, which prevents FoxO1-PPAR gamma interactions and rescues transrepression. Adipocytes from insulin resistant mice show reduced phosphorylation and increased nuclear accumulation of FoxO1, which is coupled to lowered expression of endogenous PPAR gamma target genes. Thus the innate FoxO1 transrepression function enables insulin to augment PPAR gamma activity, which in turn leads to insulin sensitization, and this feed-forward cycle represents positive reinforcing connections between insulin and PPAR gamma signaling.	[Fan, WuQiang; Imamura, Takeshi; Sonoda, Noriyuki; Sears, Dorothy D.; Patsouris, David; Kim, Jane J.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med 0673, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Sears, Dorothy D/AHE-5524-2022	Sears, Dorothy D/0000-0002-9260-3540; Kim, Jane/0000-0002-0228-0128	National Institutes of Health [DK 033651, DK 074868]; University of California Discovery Program Project [bio03-10383]; Pfizer Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, R01DK033651, P01DK074868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Discovery Program Project; Pfizer Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 033651 and DK 074868 (to J. M. O.). This work was also supported by University of California Discovery Program Project bio03-10383 (BioStar) with matching funds from Pfizer Incorporated.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Camp HS, 1997, J BIOL CHEM, V272, P10811; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Eubank DW, 2001, J BIOL CHEM, V276, P30561, DOI 10.1074/jbc.M103019200; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Fan WQ, 2005, ENDOCRINOLOGY, V146, P85, DOI 10.1210/en.2004-1046; Fan WQ, 2004, MOL ENDOCRINOL, V18, P127, DOI 10.1210/me.2003-0110; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Roberts VL, 2005, CLIN THER, V27, P1535, DOI 10.1016/j.clinthera.2005.10.017; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Vollenweider P, 1999, MOL CELL BIOL, V19, P1081; Wu Y, 2006, MOL CELL BIOL, V26, P6633, DOI 10.1128/MCB.01534-05; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	40	83	85	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12188	12197		10.1074/jbc.M808915200	http://dx.doi.org/10.1074/jbc.M808915200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19246449	Green Published, hybrid			2022-12-25	WOS:000265494600050
J	Isaji, T; Sato, Y; Fukuda, T; Gu, JG				Isaji, Tomoya; Sato, Yuya; Fukuda, Tomohiko; Gu, Jianguo			N-Glycosylation of the I-like Domain of beta 1 Integrin Is Essential for beta 1 Integrin Expression and Biological Function IDENTIFICATION OF THE MINIMAL N-GLYCOSYLATION REQUIREMENT FOR alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID FIBRONECTIN RECEPTORS; CELL-ADHESION; LINKED OLIGOSACCHARIDES; BETA(1) INTEGRINS; SIGNALING PATHWAY; STRUCTURAL BASIS; LIGAND-BINDING; ALPHA-SUBUNIT; GROWTH-FACTOR; MIGRATION	N-Glycosylation of integrin alpha 5 beta 1 plays a crucial role in cell spreading, cell migration, ligand binding, and dimer formation, but the detailed mechanisms by which N-glycosylation mediates these functions remain unclear. In a previous study, we showed that three potential N-glycosylation sites (alpha 5S3-5) on the beta-propeller of the alpha 5 subunit are essential to the functional expression of the subunit. In particular, site 5 (alpha 5S5) is the most important for its expression on the cell surface. In this study, the function of the N-glycans on the integrin beta 1 subunit was investigated using sequential site-directed mutagenesis to remove the combined putative N-glycosylation sites. Removal of the N-glycosylation sites on the I-like domain of the beta 1 subunit (i.e. the Delta 4-6 mutant) decreased both the level of expression and heterodimeric formation, resulting in inhibition of cell spreading. Interestingly, cell spreading was observed only when the beta 1 subunit possessed these three N-glycosylation sites (i.e. the Delta 4-6 mutant). Furthermore, the S4-6 mutant could form heterodimers with either alpha 5S3-5 or alpha 5S5 mutant of the alpha 5 subunit. Taken together, the results of the present study reveal for the first time that N-glycosylation of the I-like domain of the beta 1 subunit is essential to both the heterodimer formation and biological function of the subunit. Moreover, because the alpha 5S3-5/beta 1S4-6 mutant represents the minimal N-glycosylation required for functional expression of the beta 1 subunit, it might also be useful for the study of molecular structures.	[Isaji, Tomoya; Sato, Yuya; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation, Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was supported in part by the Core Research for Evolutional Science and Technology, the Japan Science and Technology Agency, the "Academic Frontier" Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the core to core program and a grant-in-aid for young scientists ( B) ( to T. I.), Japan Society for the Promotion of Science, and Takeda Science Foundation, Japan.	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Berditchevski F, 2001, J CELL SCI, V114, P4143; CHAMMAS R, 1991, J BIOL CHEM, V266, P3349; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; GIPSON IK, 1984, DEV BIOL, V101, P212, DOI 10.1016/0012-1606(84)90131-3; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Guo HB, 2002, CANCER RES, V62, P6837; HEINO J, 1989, J BIOL CHEM, V264, P380; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3156, DOI 10.1073/pnas.94.7.3156; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Liu YM, 2008, PROTEINS, V73, P989, DOI 10.1002/prot.22126; Meng XB, 2005, J CELL SCI, V118, P4009, DOI 10.1242/jcs.02520; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Miyoshi Hiroyuki, 2004, Methods Mol Biol, V246, P429; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	53	81	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12207	12216		10.1074/jbc.M807920200	http://dx.doi.org/10.1074/jbc.M807920200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261610	Green Published, hybrid			2022-12-25	WOS:000265494600052
J	Martinez-Caballero, S; Dejean, LM; Kinnally, MS; Oh, KJ; Mannella, CA; Kinnally, KW				Martinez-Caballero, Sonia; Dejean, Laurent M.; Kinnally, Michael S.; Oh, Kyoung Joon; Mannella, Carmen A.; Kinnally, Kathleen W.			Assembly of the Mitochondrial Apoptosis-induced Channel, MAC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY PROTEINS; CELL-DEATH; BAX OLIGOMERIZATION; CONDUCTANCE CHANNEL; CERAMIDE CHANNELS; PROAPOPTOTIC BAX; MEMBRANE-BINDING; FORMING ACTIVITY; ACTIVATION	Although Bcl-2 family proteins control intrinsic apoptosis, the mechanisms underlying this regulation are incompletely understood. Patch clamp studies of mitochondria isolated from cells deficient in one or both of the pro-apoptotic proteins Bax and Bak show that at least one of the proteins must be present for formation of the cytochrome c-translocating channel, mitochondrial apoptosis-induced channel (MAC), and that the single channel behaviors of MACs containing exclusively Bax or Bak are similar. Truncated Bid catalyzes MAC formation in isolated mitochondria containing Bax and/or Bak with a time course of minutes and does not require VDAC1 or VDAC3. Mathematical analysis of the stepwise changes in conductance associated with MAC formation is consistent with pore assembly by a barrel-stave model. Assuming the staves are two transmembrane alpha-helices in Bax and Bak, mature MAC pores would typically contain similar to 9 monomers and have diameters of 5.5-6 nm. The mitochondrial permeability data are inconsistent with formation of lipidic pores capable of transporting megadaltonsized macromolecules as observed with recombinant Bax in liposomes.	[Martinez-Caballero, Sonia; Dejean, Laurent M.; Kinnally, Kathleen W.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA; [Martinez-Caballero, Sonia] Ctr Cirugia Minima Invas Jesus Uson, Dept Cell Therapy, Caceres 10071, Spain; [Kinnally, Michael S.] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Oh, Kyoung Joon] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Mannella, Carmen A.] Wadsworth Ctr, Albany, NY 12201 USA	New York University; University of California System; University of California San Diego; Rosalind Franklin University Medical & Science; Wadsworth Center	Kinnally, KW (corresponding author), NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA.	kck1@nyu.edu	Caballero, Sonia Martinez/B-7583-2013; Martínez-Caballero, Sonia/AAB-8481-2022	Martínez-Caballero, Sonia/0000-0002-4401-6165; OH, KYOUNG JOON/0000-0002-4729-9674	National Institutes of Health [GM57249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57249 (to K. W. K.).	Anishkin A, 2006, BIOPHYS J, V90, P2414, DOI 10.1529/biophysj.105.071977; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Guihard G, 2004, J BIOL CHEM, V279, P46542, DOI 10.1074/jbc.M405153200; Guo L, 2004, AM J PHYSIOL-CELL PH, V286, pC1109, DOI 10.1152/ajpcell.00183.2003; HILLE B, 2001, IONIC CHANNELS EXCIT, P291; Hirokawa T, 2000, PROTEIN ENG, V13, P771, DOI 10.1093/protein/13.11.771; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kandasamy K, 2003, CANCER RES, V63, P1712; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lartigue L, 2008, J CELL SCI, V121, P3515, DOI 10.1242/jcs.029587; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MANNELLA CA, 1981, BIOCHIM BIOPHYS ACTA, V645, P33, DOI 10.1016/0005-2736(81)90508-3; Martinez-Caballero S, 2005, J BIOENERG BIOMEMBR, V37, P155, DOI 10.1007/s10863-005-6570-z; Martinez-Caballero S, 2004, FEBS LETT, V568, P35, DOI 10.1016/j.febslet.2004.05.006; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Murphy RC, 2001, FEBS LETT, V497, P73, DOI 10.1016/S0014-5793(01)02440-1; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Parikh N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-16; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Polster BM, 2001, J BIOL CHEM, V276, P37887; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; SANSOM MSP, 1991, EUR BIOPHYS J, V20, P229, DOI 10.1007/BF00183460; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2	58	87	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12235	12245		10.1074/jbc.M806610200	http://dx.doi.org/10.1074/jbc.M806610200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261612	hybrid, Green Published			2022-12-25	WOS:000265494600055
J	Rudinskiy, N; Grishchuk, Y; Vaslin, A; Puyal, J; Delacourte, A; Hirling, H; Clarke, PGH; Luthi-Carter, R				Rudinskiy, Nikita; Grishchuk, Yulia; Vaslin, Anne; Puyal, Julien; Delacourte, Andre; Hirling, Harald; Clarke, Peter G. H.; Luthi-Carter, Ruth			Calpain Hydrolysis of alpha- and beta 2-Adaptins Decreases Clathrin-dependent Endocytosis and May Promote Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ADAPTER COMPLEX; VESICLE ENDOCYTOSIS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; CORTICAL-NEURONS; COATED VESICLES; RAT-BRAIN; APOPTOSIS; DEGRADATION	Clathrin-dependent endocytosis is mediated by a tightly regulated network of molecular interactions that provides essential protein-protein and protein-lipid binding activities. Here we report the hydrolysis of the alpha- and beta 2-subunits of the tetrameric adaptor protein complex 2 by calpain. Calcium-dependent alpha- and beta 2-adaptin hydrolysis was observed in several rat tissues, including brain and primary neuronal cultures. Neuronal alpha- and beta 2-adaptin cleavage was inducible by glutamate stimulation and was accompanied by the decreased endocytosis of transferrin. Heterologous expression of truncated forms of the beta 2-adaptin subunit significantly decreased the membrane recruitment of clathrin and inhibited clathrin-mediated receptor endocytosis. Moreover, the presence of truncated beta 2-adaptin sensitized neurons to glutamate receptor-mediated excitotoxicity. Proteolysis of alpha- and beta 2-adaptins, as well as the accessory clathrin adaptors epsin 1, adaptor protein 180, and the clathrin assembly lymphoid myeloid leukemia protein, was detected in brain tissues after experimentally induced ischemia and in cases of human Alzheimer disease. The present study further clarifies the central role of calpain in regulating clathrin-dependent endocytosis and provides evidence for a novel mechanism through which calpain activation may promote neurodegeneration: the sensitization of cells to glutamate-mediated excitotoxicity via the decreased internalization of surface receptors.	[Rudinskiy, Nikita; Grishchuk, Yulia; Hirling, Harald; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Vaslin, Anne; Puyal, Julien; Clarke, Peter G. H.] Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; [Delacourte, Andre] Jean Pierre Aubert Res Ctr, INSERM, U837, F-59045 Lille, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Luthi-Carter, R (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Stn 15, CH-1015 Lausanne, Switzerland.	ruth.luthi-carter@epfl.ch	Puyal, Julien P/G-4210-2018	Puyal, Julien P/0000-0002-8140-7026; Hirling, Harald/0000-0003-2070-100X	Swiss National Science Foundation; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by the Swiss National Science Foundation and the Ecole Polytechnique Federale de Lausanne.	Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kim JA, 2001, EXP MOL MED, V33, P245, DOI 10.1038/emm.2001.40; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Ohkawa K, 2000, NEUROREPORT, V11, P4007, DOI 10.1097/00001756-200012180-00021; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Ray SK, 2006, NEUROSCIENCE, V139, P577, DOI 10.1016/j.neuroscience.2005.12.057; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rock MT, 2000, EXP CELL RES, V261, P260, DOI 10.1006/excr.2000.5048; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Vaslin A, 2007, J NEUROCHEM, V102, P789, DOI 10.1111/j.1471-4159.2007.04564.x; Wu Y, 2007, EMBO J, V26, P2981, DOI 10.1038/sj.emboj.7601741; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yao PJ, 1999, NEUROSCIENCE, V94, P389, DOI 10.1016/S0306-4522(99)00360-7; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017	47	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12447	12458		10.1074/jbc.M804740200	http://dx.doi.org/10.1074/jbc.M804740200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19240038	Green Published, hybrid			2022-12-25	WOS:000265494600074
J	Su, DM; Zhu, S; Han, XF; Feng, YP; Huang, H; Ren, GL; Pan, LA; Zhang, Y; Lu, J; Huang, B				Su, Dongmei; Zhu, Shan; Han, Xuefang; Feng, Yunpeng; Huang, Hui; Ren, Guoling; Pan, Lina; Zhang, Yu; Lu, Jun; Huang, Baiqu			BMP4-Smad Signaling Pathway Mediates Adriamycin-induced Premature Senescence in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; TUMOR-CELLS; CARCINOMA-CELLS; IN-VIVO; CELLULAR SENESCENCE; ENDOTHELIAL-CELLS; FUNCTIONAL P53; GROWTH ARREST; EXPRESSION; SUPPRESSION	Cell senescence, an irreversible cell cycle arrest, reflects a safeguard program that limits the capacity of uncontrolled cell proliferation. Treatment of tumor cells with certain chemotherapeutic agents activates premature senescence to decrease the tumorigenecity. Here we show that sublethal concentrations of adriamycin could induce premature senescence in lung cancer cells. Adriamycin treatment resulted in the up-regulation of BMP4,which is underexpressed in NSCLC (non-small cell lung cancers). Moreover, the BMP4-Smad pathway played a key role in mediating adriamycin-induced senescence. Overexpression of BMP4 was able to induce premature senescence in lung cancer cells and this process required the participation of cyclin/cyclin-dependent kinase (cdk) inhibitors p16(INK4a) and p21(WAF1/cip1). We also show that increases of p16(INK4a) and p21(WAF1/cip1) expression in response to BMP4 were mediated by the Smad signaling pathway. Furthermore, our data revealed that p300 was recruited to P16(INK4a) and P21(WAF1/cip1) promoters by Smad1/5/8 to induce the hyperacetylation of histones H3 and H4 at the promoters. The present study provides useful clues to the evaluation of the potentiality of BMP4 as a responsive molecular target for cancer chemotherapy.	[Su, Dongmei; Feng, Yunpeng; Ren, Guoling; Zhang, Yu; Huang, Baiqu] NE Normal Univ, Inst Cytol & Genet, Changchun 130024, Peoples R China; [Zhu, Shan; Han, Xuefang; Huang, Hui; Pan, Lina; Lu, Jun] NE Normal Univ, Minist Educ, Key Lab Mol Epigenet, Changchun 130024, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Huang, B (corresponding author), 5268 Renmin St, Changchun 130024, Peoples R China.	huangbq705@nenu.edu.cn		Feng, Yunpeng/0000-0002-6912-3338	National Basic Research Program of China [2005CB522404, 2006CB910506]; The Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities [IRT0519]; National Natural Science Foundation of China [30771232, 30671184]	National Basic Research Program of China(National Basic Research Program of China); The Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2005CB522404 and 2006CB910506, The Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities (IRT0519), and National Natural Science Foundation of China Grants 30771232 and 30671184.	Beck SE, 2006, AM J PHYSIOL-GASTR L, V291, pG135, DOI 10.1152/ajpgi.00482.2005; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Cammarano MS, 2005, MOL CELL BIOL, V25, P9532, DOI 10.1128/MCB.25.21.9532-9542.2005; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Ding B, 2007, J CELL SCI, V120, P2284, DOI 10.1242/jcs.002345; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Ghebranious N, 1998, ONCOGENE, V17, P3385, DOI 10.1038/sj.onc.1202573; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Katakura Y, 2003, BIOSCI BIOTECH BIOCH, V67, P815, DOI 10.1271/bbb.67.815; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Miyazaki H, 2004, ONCOGENE, V23, P9326, DOI 10.1038/sj.onc.1208127; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Park C, 2006, MOL CANCER THER, V5, P3191, DOI 10.1158/1535-7163.MCT-06-0570; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Rao A, 2004, CANCER RES, V64, P2143, DOI 10.1158/0008-5472.CAN-03-3480; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; te Poele RH, 2002, CANCER RES, V62, P1876; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Trost TM, 2005, CANCER RES, V65, P840; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	42	45	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12153	12164		10.1074/jbc.M807930200	http://dx.doi.org/10.1074/jbc.M807930200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269967	Green Published, hybrid			2022-12-25	WOS:000265494600047
J	Yan, WS; Chen, XB				Yan, Wensheng; Chen, Xinbin			Identification of GRO1 as a Critical Determinant for Mutant p53 Gain of Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-REGULATED ONCOGENE; BREAST-CANCER CELLS; BONE MORPHOGENETIC PROTEIN-7; GENE-EXPRESSION; NEGATIVE REGULATION; SIGNALING PATHWAY; ALPHA-GENE; ANGIOGENESIS; CXCL1	Mutant p53 gain of function contributes to cancer progression, increased invasion and metastasis potentials, and resistance to anticancer therapy. The ability of mutant p53 to acquire its gain of function is shown to correlate with increased expression of progrowth genes, such as c-MYC, MDR1, and NF-kappa B2. However, most of the published studies to identify mutant p53 target genes were performed in a cell system that artificially overexpresses mutant p53. Thus, it remains unclear whether such mutant p53 targets can be regulated by endogenous physiological levels of mutant p53. Here, we utilized SW480 and MIA-PaCa-2 cells, in which endogenous mutant p53 can be inducibly knocked down, to identify mutant p53 target genes that potentially mediate mutant p53 gain of function. We found that knockdown of mutant p53 inhibits GRO1 expression, whereas ectopic expression of mutant R175H in p53-null HCT116 cells increases GRO1 expression. In addition, we found that endogenous mutant p53 is capable of binding to and activating the GRO1 promoter. Interestingly, ectopic expression of GRO1 can rescue the proliferative defect in SW480 and MIA-PaCa-2 cells induced by knockdown of mutant p53. Conversely, knockdown of endogenous GRO1 inhibits cell proliferation and thus abrogates mutant p53 gain of function in SW480 cells. Taken together, our findings define a novel mechanism by which mutant p53 acquires its gain of function via transactivating the GRO1 gene in cancer cells. Thus, targeting GRO1 for cancer therapy would be applicable to a large portion of human tumors with mutant p53, but the exploration of GRO1 as a potential target should take the mutation status of p53 into consideration.	[Yan, Wensheng; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [R01CA121137]; NATIONAL CANCER INSTITUTE [R01CA121137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA121137.	Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; ANISOWICZ A, 1991, J IMMUNOL, V147, P520; Atema A, 2002, CANCER LETT, V185, P103, DOI 10.1016/S0304-3835(02)00318-X; Bachmeier BE, 2008, CARCINOGENESIS, V29, P779, DOI 10.1093/carcin/bgm248; Bechara C, 2007, MED SCI MONITOR, V13, pRA87; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger M, 2005, ONCOGENE, V24, P2067, DOI 10.1038/SJ.ONC.1208442; Caunt M, 2006, CANCER RES, V66, P4125, DOI 10.1158/0008-5472.CAN-05-2570; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Engl T, 2006, LIFE SCI, V78, P1784, DOI 10.1016/j.lfs.2005.08.019; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Karl E, 2005, CANCER RES, V65, P5063, DOI 10.1158/0008-5472.CAN-05-0140; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lane BR, 2002, J VIROL, V76, P11570, DOI 10.1128/JVI.76.22.11570-11583.2002; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Loukinova E, 2000, ONCOGENE, V19, P3477, DOI 10.1038/sj.onc.1203687; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Nirodi C, 2001, J BIOL CHEM, V276, P26122, DOI 10.1074/jbc.M102872200; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Rennekampff HO, 1997, ARCH DERMATOL RES, V289, P204, DOI 10.1007/s004030050181; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Warner KA, 2008, NEOPLASIA, V10, P131, DOI 10.1593/neo.07815; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wood LD, 1995, J BIOL CHEM, V270, P30619, DOI 10.1074/jbc.270.51.30619; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Wu Kenneth K., 2006, V338, P281; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Zhou Y, 2005, CARCINOGENESIS, V26, P2058, DOI 10.1093/carcin/bgi182; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	39	57	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12178	12187		10.1074/jbc.M900994200	http://dx.doi.org/10.1074/jbc.M900994200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19258312	Green Published, hybrid			2022-12-25	WOS:000265494600049
J	Grewal, S; Defamie, N; Zhang, X; De Gois, S; Shawki, A; Mackenzie, B; Chen, C; Varoqui, H; Erickson, JD				Grewal, Sukhjeevan; Defamie, Norah; Zhang, Xiong; De Gois, Stephanie; Shawki, Ali; Mackenzie, Bryan; Chen, Chu; Varoqui, Helene; Erickson, Jeffrey D.			SNAT2 Amino Acid Transporter Is Regulated by Amino Acids of the SLC6 gamma-Aminobutyric Acid Transporter Subfamily in Neocortical Neurons and May Play No Role in Delivering Glutamine for Glutamatergic Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; RAT CEREBRAL-CORTEX; SYSTEM-A; VESICULAR GLUTAMATE; TAURINE-TRANSPORTER; ADAPTIVE REGULATION; SYNAPTIC-TRANSMISSION; CEREBROSPINAL-FLUID; GENE-EXPRESSION; BETA-ALANINE	System A transporters SNAT1 and SNAT2 mediate uptake of neutral alpha-amino acids (e.g. glutamine, alanine, and proline) and are expressed in central neurons. We tested the hypothesis that SNAT2 is required to support neurotransmitter glutamate synthesis by examining spontaneous excitatory activity after inducing or repressing SNAT2 expression for prolonged periods. We stimulated de novo synthesis of SNAT2 mRNA and increased SNAT2 mRNA stability and total SNAT2 protein and functional activity, whereas SNAT1 expression was unaffected. Increased endogenous SNAT2 expression did not affect spontaneous excitatory action-potential frequency over control. Long term glutamine exposure strongly repressed SNAT2 expression but increased excitatory action-potential frequency. Quantal size was not altered following SNAT2 induction or repression. These results suggest that spontaneous glutamatergic transmission in pyramidal neurons does not rely on SNAT2. To our surprise, repression of SNAT2 activity was not limited to System A substrates. Taurine, gamma-aminobutyric acid, and beta-alanine (substrates of the SLC6 gamma-aminobutyric acid transporter family) repressed SNAT2 expression more potently (10x) than did System A substrates; however, the responses to System A substrates were more rapid. Since ATF4 (activating transcription factor 4) and CCAAT/enhancer-binding protein are known to bind to an amino acid response element within the SNAT2 promoter and mediate induction of SNAT2 in peripheral cell lines, we tested whether either factor was similarly induced by amino acid deprivation in neurons. We found that glutamine and taurine repressed the induction of both transcription factors. Our data revealed that SNAT2 expression is constitutively low in neurons under physiological conditions but potently induced, together with the taurine transporter TauT, in response to depletion of neutral amino acids.	[Grewal, Sukhjeevan; Defamie, Norah; Zhang, Xiong; De Gois, Stephanie; Chen, Chu; Varoqui, Helene; Erickson, Jeffrey D.] Louisiana State Univ, Ctr Neurosci, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Shawki, Ali; Mackenzie, Bryan] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; University of Cincinnati	Erickson, JD (corresponding author), Louisiana State Univ, Ctr Neurosci, Hlth Sci Ctr, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	jerick@lsuhsc.edu	defamie, norah/AAB-7702-2020	defamie, norah/0000-0002-7504-7538; Shawki, Ali/0000-0002-6413-5313; Mackenzie, Bryan/0000-0002-9661-8838	National Institutes of Health [1P29RR16816, NS36936]; University of Cincinnati; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1P29RR16816 (to H.V.) and NS36936 (to J.D.E.). This work was also supported by the University of Cincinnati (to B.M.).	Albers A, 2001, PFLUG ARCH EUR J PHY, V443, P92, DOI 10.1007/s004240100663; BOERNER P, 1985, J CELL PHYSIOL, V122, P308, DOI 10.1002/jcp.1041220221; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; BRACY DS, 1986, J BIOL CHEM, V261, P1514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burkhalter J, 2007, J BIOL CHEM, V282, P5152, DOI 10.1074/jbc.M608548200; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; CONTI F, 1994, J HISTOCHEM CYTOCHEM, V42, P717, DOI 10.1177/42.6.7910617; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; DallAsta V, 1996, BIOCHEM SOC T, V24, P864, DOI 10.1042/bst0240864; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Dolinska M, 2004, NEUROCHEM INT, V44, P75, DOI 10.1016/S0197-0186(03)00123-2; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Evans K, 2007, J AM SOC NEPHROL, V18, P1426, DOI 10.1681/ASN.2006091014; Fastje CD, 2004, FASEB J, V18, pA461; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Franchi-Gazzola R, 2004, BBA-BIOMEMBRANES, V1667, P157, DOI 10.1016/j.bbamem.2004.09.012; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; Fujita T, 2006, PHARM RES-DORDR, V23, P689, DOI 10.1007/s11095-006-9745-3; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Gazzola RF, 2001, FEBS LETT, V490, P11; GJESSING LR, 1972, J NEUROCHEM, V19, P1807, DOI 10.1111/j.1471-4159.1972.tb06226.x; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Han X, 2006, ACTA PHYSIOL, V187, P61, DOI 10.1111/j.1748-1716.2006.01573.x; HANDLOGTEN ME, 1984, J BIOL CHEM, V259, P3519; HEATON JH, 1977, J BIOL CHEM, V252, P2900; Hertz L, 2004, NEUROCHEM INT, V45, P285, DOI 10.1016/j.neuint.2003.08.016; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2004, EUR J NEUROSCI, V20, P1752, DOI 10.1111/j.1460-9568.2004.03628.x; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; JENSTAD M, 2009, CEREB CORTE IN PRESS; Jessen H, 1997, BBA-BIOMEMBRANES, V1325, P309, DOI 10.1016/S0005-2736(97)00006-0; JONES DP, 1990, KIDNEY INT, V38, P219, DOI 10.1038/ki.1990.189; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Kanamori K, 2004, J NEUROCHEM, V90, P203, DOI 10.1111/j.1471-4159.2004.02478.x; KILBERG MS, 1985, J CELL PHYSIOL, V122, P290, DOI 10.1002/jcp.1041220219; LEHMANN A, 1991, J NEUROCHEM, V56, P690, DOI 10.1111/j.1471-4159.1991.tb08204.x; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; Liu MP, 1999, AM J PHYSIOL-GASTR L, V276, pG206, DOI 10.1152/ajpgi.1999.276.1.G206; LIU QR, 1993, J BIOL CHEM, V268, P2106; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Maallem S, 2008, NEUROSCIENCE, V153, P95, DOI 10.1016/j.neuroscience.2008.01.047; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; MACKENZIE B, 1999, BIOMEMBRANE TRANSPOR; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; Melone M, 2006, NEUROSCIENCE, V140, P281, DOI 10.1016/j.neuroscience.2006.02.042; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; MINELLI A, 1995, J NEUROSCI, V15, P7734, DOI 10.1523/jneurosci.15-11-07734.1995; Minelli A, 2003, DEV BRAIN RES, V142, P7, DOI 10.1016/S0165-3806(03)00007-5; MOFFETT J, 1984, MOL CELL BIOL, V4, P799, DOI 10.1128/MCB.4.4.799; Morimura H, 1997, MOL BRAIN RES, V44, P245, DOI 10.1016/S0169-328X(96)00226-4; Nelson N, 1998, J NEUROCHEM, V71, P1785; Novak D, 2006, BIOCHIMIE, V88, P39, DOI 10.1016/j.biochi.2005.07.002; Olsen M, 2005, NEUROCHEM RES, V30, P855, DOI 10.1007/s11064-005-6879-3; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; PALII SS, 2009, AMINOACIDS IN PRESS; Pastor-Anglada M, 2005, J GEN PHYSIOL, V125, P41, DOI 10.1085/jgp.200409201; Peterson WM, 1995, J GEN PHYSIOL, V106, P1089, DOI 10.1085/jgp.106.6.1089; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; ROY G, 1994, J EXP ZOOL, V268, P121, DOI 10.1002/jez.1402680208; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; SCHOUSBOE A, 1992, ADV EXP MED BIOL, V315, P391; Su TZ, 1997, BRAIN RES, V757, P69, DOI 10.1016/S0006-8993(97)00139-X; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; Tamarappoo BK, 1997, J NEUROCHEM, V68, P954; Thurlow RJ, 1996, BRIT J PHARMACOL, V118, P449, DOI 10.1111/j.1476-5381.1996.tb15424.x; Tomi M, 2008, BBA-BIOMEMBRANES, V1778, P2138, DOI 10.1016/j.bbamem.2008.04.012; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200	98	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11224	11236		10.1074/jbc.M806470200	http://dx.doi.org/10.1074/jbc.M806470200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19240036	hybrid, Green Published			2022-12-25	WOS:000265494500026
J	Mostowy, S; Danckaert, A; Tham, TN; Machu, C; Guadagnini, S; Pizarro-Cerda, J; Cossart, P				Mostowy, Serge; Danckaert, Anne; Tham, To Nam; Machu, Christophe; Guadagnini, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale			Septin 11 Restricts InlB-mediated Invasion by Listeria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEPTIN; FILAMENT FORMATION; MONOCYTOGENES; CELLS; ORGANIZATION; CYTOKINESIS; PROTEIN; INTERNALIZATION; MICROTUBULES; SUFFICIENT	Septins are filament-forming GTPases implicated in several cellular functions, including cytokinesis. We previously showed that SEPT2, SEPT9, and SEPT11 colocalize with several bacteria entering into mammalian non-phagocytic cells, and SEPT2 was identified as essential for this process. Here, we investigated the function of SEPT11, an interacting partner of SEPT9 whose function is still poorly understood. In uninfected HeLa cells, SEPT11 depletion by siRNA increased cell size but surprisingly did not affect actin filament formation or the colocalization of SEPT9 with actin filaments. SEPT11 depletion increased Listeria invasion, and incubating SEPT11-depleted cells with beads coated with the Listeria surface protein InlB also led to increased entry as compared with control cells. Strikingly, as shown by fluorescence resonance energy transfer, the InlB-mediated stimulation of Met signaling remained intact in SEPT11-depleted cells. Taken together, our results show that SEPT11 is not required for the bacterial entry process and rather restricts its efficacy. Because SEPT2 is essential for the InlB-mediated entry of Listeria, but SEPT11 is not, our findings distinguish the roles of different mammalian septins.	[Mostowy, Serge; Tham, To Nam; Pizarro-Cerda, Javier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mostowy, Serge; Tham, To Nam; Pizarro-Cerda, Javier; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Mostowy, Serge; Tham, To Nam; Pizarro-Cerda, Javier; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Machu, Christophe; Guadagnini, Stephanie] Inst Pasteur, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr		Mostowy, Serge/0000-0002-7286-6503	Canadian Institutes of Health Research; Canadian Foundation Louis Pasteur	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation Louis Pasteur	Supported by a long-term fellowship from the Canadian Institutes of Health Research and the Canadian Foundation Louis Pasteur.	Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; NOBUHIRO H, 2004, FEBS LETT, V568, P83; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; SPILIOTIS ET, 2008, SEPTINS, P229; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042	34	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11613	11621		10.1074/jbc.M900231200	http://dx.doi.org/10.1074/jbc.M900231200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19234302	hybrid, Green Published			2022-12-25	WOS:000265494500065
J	Browne, LE; Blaney, FE; Yusaf, SP; Clare, JJ; Wray, D				Browne, Liam E.; Blaney, Frank E.; Yusaf, Shahnaz P.; Clare, Jeff J.; Wray, Dennis			Structural Determinants of Drugs Acting on the Na(v)1.8 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT SODIUM-CHANNEL; TRANSMEMBRANE SEGMENT IVS6; MODULATE BINDING-AFFINITY; USE-DEPENDENT BLOCK; MOLECULAR-BASIS; LOCAL-ANESTHETICS; NEUROPATHIC PAIN; POINT MUTATIONS; ALPHA-SUBUNIT; EXPRESSION	The aim of this work is to study the role of pore residues on drug binding in the Na(V)1.8 channel. Alanine mutations were made in the S6 segments, chosen on the basis of their roles in other Na-V subtypes; whole cell patch clamp recordings were made from mammalian ND7/23 cells. Mutations of some residues caused shifts in voltage dependence of activation and inactivation, and gave faster time course of inactivation, indicating that the residues mutated play important roles in both activation and inactivation in the Na(V)1.8 channel. The resting and inactivated state affinities of tetracaine for the channel were reduced by mutations I381A, F1710A, and Y1717A (for the latter only inactivated state affinity was measured), and by mutation F1710A for the Na(V)1.8-selective compound A-803467, showing the involvement of these residues for each compound, respectively. For both compounds, mutation L1410A caused the unexpected appearance of a complete resting block even at extremely low concentrations. Resting block of native channels by compound A-803467 could be partially removed ("disinhibition") by repetitive stimulation or by a test pulse after recovery from inactivation; the magnitude of the latter effect was increased for all the mutants studied. Tetracaine did not show this effect for native channels, but disinhibition was seen particularly for mutants L1410A and F1710A. The data suggest differing, but partially overlapping, areas of binding of A-803467 and tetracaine. Docking of the ligands into a three-dimensional model of the Na(V)1.8 channel gave interesting insight as to how the ligands may interact with pore residues.	[Browne, Liam E.; Wray, Dennis] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Blaney, Frank E.] GlaxoSmithKline, Computat & Struct Chem, Harlow CM19 5AW, Essex, England; [Yusaf, Shahnaz P.] GlaxoSmithKline, Biol Reagents & Assay Dev, Harlow CM19 5AW, Essex, England; [Clare, Jeff J.] Ion Channel Grp, Cambridge CB5 8PB, England	University of Leeds; GlaxoSmithKline; GlaxoSmithKline	Wray, D (corresponding author), Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	d.wray@leeds.ac.uk		Browne, Liam/0000-0002-5693-7703	Biotechnology and Biological Sciences Research Council and GlaxoSmithKline	Biotechnology and Biological Sciences Research Council and GlaxoSmithKline(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Akiba I, 2003, RECEPTOR CHANNEL, V9, P291, DOI 10.3109/713745174; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Blaney Frank E., 1996, P161; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carboni M, 2005, J MEMBRANE BIOL, V207, P107, DOI 10.1007/s00232-005-0805-0; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins Theodore R, 2007, Expert Rev Neurother, V7, P1597, DOI 10.1586/14737175.7.11.1597; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Kondratiev A, 2003, MOL PHARMACOL, V64, P741, DOI 10.1124/mol.64.3.741; Kuo CC, 1998, MOL PHARMACOL, V54, P712; KUO CC, 1994, MOL PHARMACOL, V46, P716; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Laird JMA, 2002, J NEUROSCI, V22, P8352; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Liu G, 2003, NEUROPHARMACOLOGY, V44, P413, DOI 10.1016/S0028-3908(02)00400-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Nau C, 2003, MOL PHARMACOL, V63, P1398, DOI 10.1124/mol.63.6.1398; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Nau C, 1999, MOL PHARMACOL, V56, P404, DOI 10.1124/mol.56.2.404; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; ROY ML, 1992, J NEUROSCI, V12, P2104; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; Yarov-Yarovoy V, 2002, J BIOL CHEM, V277, P35393, DOI 10.1074/jbc.M206126200	46	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10523	10536		10.1074/jbc.M807569200	http://dx.doi.org/10.1074/jbc.M807569200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233853	hybrid, Green Published			2022-12-25	WOS:000265104600026
J	Chepurny, OG; Leech, CA; Kelley, GG; Dzhura, I; Dzhura, E; Li, XQ; Rindler, MJ; Schwede, F; Genieser, HG; Holz, GG				Chepurny, Oleg G.; Leech, Colin A.; Kelley, Grant G.; Dzhura, Igor; Dzhura, Elvira; Li, Xiangquan; Rindler, Michael J.; Schwede, Frank; Genieser, Hans G.; Holz, George G.			Enhanced Rap1 Activation and Insulin Secretagogue Properties of an Acetoxymethyl Ester of an Epac-selective Cyclic AMP Analog in Rat INS-1 Cells STUDIES WITH 8-pCPT-2 '-O-Me-cAMP-AM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PROTEIN-KINASE-A; GLUCAGON-LIKE PEPTIDE-1; GENE PROMOTER ACTIVITY; CAMP SENSOR EPAC; CA2+-INDUCED CA2+ RELEASE; SIGNAL-TRANSDUCTION; INDEPENDENT ACTIVATION; REGULATED EXOCYTOSIS; RESPONSE ELEMENT	To ascertain the identities of cyclic nucleotide-binding proteins that mediate the insulin secretagogue action of cAMP, the possible contributions of the exchange protein directly activated by cAMP (Epac) and protein kinase A (PKA) were evaluated in a pancreatic beta cell line (rat INS-1 cells). Assays of Rap1 activation, CREB phosphorylation, and PKA-dependent gene expression were performed in combination with live cell imaging and high throughput screening of afluorescence resonance energy transfer-based cAMP sensor (Epac1-camps) to validate the selectivity with which acetoxymethyl esters(AM-esters) of cAMP analogs preferentially activate Epac or PKA. Selective activation of Epac or PKA was achieved following exposure of INS-1 cells to 8-pCPT-2'-O-Me-cAMP-AM or Bt(2)cAMP-AM, respectively. Both cAMP analogs exerted dose-dependent and glucose metabolism-dependent actions to stimulate insulin secretion, and when each was co-administered with the other, a supra-additive effect was observed. Because 2.4-fold more insulin was secreted in response to a saturating concentration (10 mu M) of Bt(2)cAMP-AM as compared with 8-pCPT-2'-O-Me-cAMPAM, and because the action of Bt(2)cAMP-AM but not 8-pCPT-2'-O-Me-cAMP-AM was nearly abrogated by treatment with 3 mu M of the PKA inhibitor H-89, it is concluded that for INS-1 cells, it is PKA that acts as the dominant cAMP-binding protein in support of insulin secretion. Unexpectedly, 10-100 mu M of the non-AM-ester of 8-pCPT-2'-O-Me-cAMP failed to stimulate insulin secretion and was a weak activator of Rap1 in INS-1 cells. Moreover, 10 mu M of the AM-ester of 8-pCPT-2'-O-Me-cAMP stimulated insulin secretion from mouse islets, whereas the non-AM-ester did not. Thus, themembrane permeability of 8-pCPT-2'-O-Me-cAMP ininsulin-secreting cells is so low as to limit its biological activity. It is concluded that prior reports documenting the failure of 8-pCPT-2'-O-Me-cAMP to act in beta cells, or other cell types, need to be re-evaluated through the use of the AM-ester of this cAMP analog.	[Chepurny, Oleg G.; Leech, Colin A.; Kelley, Grant G.; Dzhura, Igor; Dzhura, Elvira; Li, Xiangquan; Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Kelley, Grant G.; Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Rindler, Michael J.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Schwede, Frank; Genieser, Hans G.] BIOLOG Life Sci Inst, D-28071 Bremen, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; New York University	Holz, GG (corresponding author), IHP Rm 4310,505 Irving Ave, Syracuse, NY 13210 USA.	holzg@upstate.edu	Holz, George G/A-3386-2012	Genieser, Hans-Gottfried/0000-0002-4904-5790; Holz, George/0000-0002-1781-3580	National Institutes of Health [DK045817, DK069575]; American Diabetes Association Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045817, R01DK069575, R29DK045817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research Award(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK045817 and DK069575 (to G. G. H.). This work was also supported by a American Diabetes Association Research Award ( to C. A. L.).	AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bartsch M, 2003, BIOL CHEM, V384, P1321, DOI 10.1515/BC.2003.148; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chepurny OG, 2002, ENDOCRINOLOGY, V143, P2303, DOI 10.1210/en.143.6.2303; Chepurny OG, 2002, CELL TISSUE RES, V307, P191, DOI 10.1007/s00441-001-0494-7; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gambaryan S, 2006, AM J PHYSIOL-ENDOC M, V290, pE423, DOI 10.1152/ajpendo.00128.2005; Gonzalez-Iglesias AE, 2006, MOL ENDOCRINOL, V20, P2231, DOI 10.1210/me.2005-0363; HARBECK MC, 2006, SCI STKE, pPL6; Hashiguchi H, 2006, DIABETES-METAB RES, V22, P64, DOI 10.1002/dmrr.580; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Holz George G, 2005, Sci STKE, V2005, ppe2; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Holz GG, 2003, CURR MED CHEM, V10, P2471, DOI 10.2174/0929867033456648; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Islam D, 2009, AM J PHYSIOL-ENDOC M, V296, pE174, DOI 10.1152/ajpendo.90419.2008; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kang GX, 2008, J PHYSIOL-LONDON, V586, P1307, DOI 10.1113/jphysiol.2007.143818; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Liu GH, 2006, J PHARMACOL EXP THER, V318, P152, DOI 10.1124/jpet.105.097477; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PEPE S, 1991, CANCER RES, V51, P6263; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; SCHULTZ C, 1993, J BIOL CHEM, V268, P6316; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Skoglund G, 2000, DIABETES, V49, P1156, DOI 10.2337/diabetes.49.7.1156; Thams P, 2005, EUR J ENDOCRINOL, V152, P671, DOI 10.1530/eje.1.01885; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wan QF, 2004, J GEN PHYSIOL, V124, P653, DOI 10.1085/jgp.200409082; Yang Y, 2004, J GEN PHYSIOL, V124, P641, DOI 10.1085/jgp.200409081; Zhao CN, 2006, J NEUROSCI RES, V84, P389, DOI 10.1002/jnr.20875	61	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10728	10736		10.1074/jbc.M900166200	http://dx.doi.org/10.1074/jbc.M900166200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244230	Green Published, hybrid			2022-12-25	WOS:000265104600047
J	Mishra, A; Godavarthi, SK; Maheshwari, M; Goswami, A; Jana, NR				Mishra, Amit; Godavarthi, Swetha K.; Maheshwari, Megha; Goswami, Anand; Jana, Nihar Ranjan			The Ubiquitin Ligase E6-AP Is Induced and Recruited to Aggresomes in Response to Proteasome Inhibition and May Be Involved in the Ubiquitination of Hsp70-bound Misfolded Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-CHAPERONE CHIP; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; QUALITY-CONTROL; ANGELMAN-SYNDROME; IN-VIVO; NEURODEGENERATIVE DISEASE; POLYGLUTAMINE PROTEIN; DEPENDENT DEGRADATION; CONFERS PROTECTION	Cells are equipped with an efficient quality control system to selectively eliminate abnormally folded and damaged proteins. Initially the cell tries to refold the unfolded proteins with the help of molecular chaperones, and failure to refold leads to their degradation by the ubiquitin proteasome system. But how this proteolytic machinery recognizes the abnormally folded proteins is poorly understood. Here, we report that E6-AP, a HECT domain family ubiquitin ligase implicated in Angelman syndrome, interacts with the substrate binding domain of Hsp70/Hsc70 chaperones and promotes the degradation of chaperone bound substrates. The expression of E6-AP was dramatically induced under a variety of stresses, and overexpression of E6-AP was found to protect against endoplasmic reticulum stress-induced cell death. The inhibition of proteasome function not only increases the expression of E6-AP but also causes its redistribution around microtubule-organizing center, a subcellular structure for the degradation of the cytoplasmic misfolded proteins. E6-AP is also recruited to aggresomes containing the cystic fibrosis transmembrane conductance regulator or expanded polyglutamine proteins. Finally, we demonstrate that E6-AP ubiquitinates misfolded luciferase that is bound by Hsp70. Our results suggest that E6-AP functions as a cellular quality control ubiquitin ligase and, therefore, can be implicated not only in the pathogenesis of Angelman syndrome but also in the biology of neurodegenerative disorders involving protein aggregation.	[Mishra, Amit; Godavarthi, Swetha K.; Maheshwari, Megha; Goswami, Anand; Jana, Nihar Ranjan] Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Manesar 122050, Gurgaon, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Cellular & Mol Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in		Godavarthi, Swetha/0000-0003-4665-4627; Jana, Nihar/0000-0002-6549-4211; Mishra, Amit/0000-0001-9401-4400	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dikshit P, 2007, BIOCHEM BIOPH RES CO, V357, P761, DOI 10.1016/j.bbrc.2007.04.018; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mishra A, 2008, CELL MOL LIFE SCI, V65, P656, DOI 10.1007/s00018-007-7476-1; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scott Melissa D, 2003, Methods Mol Biol, V232, P67; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106	51	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10537	10545		10.1074/jbc.M806804200	http://dx.doi.org/10.1074/jbc.M806804200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19233847	Green Published, hybrid			2022-12-25	WOS:000265104600027
J	Al-Ahmadi, W; Al-Haj, L; Al-Mohanna, FA; Silverman, RH; Khabar, KSA				Al-Ahmadi, W.; al-Haj, L.; Al-Mohanna, F. A.; Silverman, R. H.; Khabar, K. S. A.			RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth	ONCOGENE			English	Article						3 ' untranslated regions; RNase L; HuR; RNA-binding proteins; cell growth	DOUBLE-STRANDED-RNA; MESSENGER-RNA; PROGNOSTIC-FACTOR; PROSTATE-CANCER; RIBONUCLEASE-L; 3'-UNTRANSLATED REGION; INTERFERON RESPONSE; CELLS; EXPRESSION; KINASE	Ribonuclease L (RNase L) is an intracellular enzyme that is vital in innate immunity, but also is a tumor suppressor candidate. Here, we show that overexpression of RNase L decreases cellular growth and downmodulates the RNA-binding protein, HuR, a regulator of cell-cycle progression and tumorigenesis. The effect is temporal, occurring in specific cell-cycle phases and correlated with the cytoplasmic localization of RNase L. Both cellular growth and HuR were increased in RNASEL-null mouse fibroblast lines when compared to wild-type cells. Moreover, the stability of HuR mRNA was enhanced in RNASEL-null cells. The HuR 30 untranslated region (UTR), which harbors U-rich and adenylate-uridylate-rich elements, was potently responsive to RNase L when compared to control 30 UTR. Our results may offer a new explanation to the tumor suppressor function of RNase L.	[Al-Ahmadi, W.; al-Haj, L.; Al-Mohanna, F. A.; Khabar, K. S. A.] King Faisal Specialist Hosp & Res Ctr, Program BioMol Res, Riyadh 11211, Saudi Arabia; [Silverman, R. H.; Khabar, K. S. A.] Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA	King Faisal Specialist Hospital & Research Center; Cleveland Clinic Foundation	Khabar, KSA (corresponding author), King Faisal Specialist Hosp & Res Ctr, Program BioMol Res, P3354,MBC 03,Takhasusi Rd, Riyadh 11211, Saudi Arabia.	khabar@kfshrc.edu.sa	Khabar, Khalid/A-4772-2011; Khabar, Khalid/AAG-3487-2019	Khabar, Khalid/0000-0003-1003-9788; Khabar, Khalid/0000-0003-1003-9788	NATIONAL CANCER INSTITUTE [R01CA044059] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA044059-26, R01 CA044059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Zoghaibi F, 2007, GENE, V391, P130, DOI 10.1016/j.gene.2006.12.013; Andersen JB, 2007, ONCOGENE, V26, P3081, DOI 10.1038/sj.onc.1210111; Atasoy U, 1998, J CELL SCI, V111, P3145; BAYARD BA, 1993, BIOCHEM J, V296, P155, DOI 10.1042/bj2960155; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; Cirino NM, 1997, P NATL ACAD SCI USA, V94, P1937, DOI 10.1073/pnas.94.5.1937; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; DiazGuerra M, 1997, VIROLOGY, V236, P354, DOI 10.1006/viro.1997.8719; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; JACOBSEN H, 1983, P NATL ACAD SCI-BIOL, V80, P4954, DOI 10.1073/pnas.80.16.4954; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KHABAR K, 1999, J INTERFERON CYTOKIN, V19, P68; Khabar KSA, 2000, J INTERF CYTOK RES, V20, P653, DOI 10.1089/107999000414835; Khabar KSA, 2004, J MOL BIOL, V342, P833, DOI 10.1016/j.jmb.2004.07.065; Khabar KSA, 2003, J BIOL CHEM, V278, P20124, DOI 10.1074/jbc.M208766200; KUMAR R, 1994, J BIOL CHEM, V269, P25437; KUMAR R, 1988, J VIROL, V62, P3175, DOI 10.1128/JVI.62.9.3175-3181.1988; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Li XL, 2000, J BIOL CHEM, V275, P8880, DOI 10.1074/jbc.275.12.8880; Li XL, 1998, J VIROL, V72, P2752, DOI 10.1128/JVI.72.4.2752-2759.1998; Liu W, 2007, EUR J CANCER, V43, P202, DOI 10.1016/j.ejca.2006.08.024; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Mrena J, 2005, CLIN CANCER RES, V11, P7362, DOI 10.1158/1078-0432.CCR-05-0764; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; SUBBARAMAIAH K, 2003, J BIOL CHEM, V25, P25; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Xiang Y, 2003, CANCER RES, V63, P6795; Zhou AM, 1998, J INTERF CYTOK RES, V18, P953, DOI 10.1089/jir.1998.18.953; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zhu J, 2006, J IMMUNOL METHODS, V309, P25, DOI 10.1016/j.jim.2005.10.018	48	33	34	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1782	1791		10.1038/onc.2009.16	http://dx.doi.org/10.1038/onc.2009.16			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19252527	Green Accepted			2022-12-25	WOS:000265640400005
J	Stauch, D; Dernier, A; Marchese, ES; Kunert, K; Volk, HD; Pratschke, J; Kotsch, K				Stauch, Diana; Dernier, Annelie; Marchese, Elizabeth Sarmiento; Kunert, Kristina; Volk, Hans-Dieter; Pratschke, Johann; Kotsch, Katja			Targeting of Natural Killer Cells by Rabbit Antithymocyte Globulin and Campath-1H: Similar Effects Independent of Specificity	PLOS ONE			English	Article								T cell depleting strategies are an integral part of immunosuppressive regimens widely used in the hematological and solid organ transplant setting. Although it is known to induce lymphocytopenia, little is known about the effects of the polyclonal rabbit antithymocyte globulin (rATG) or the monoclonal anti-CD52 antibody alemtuzumab on Natural Killer (NK) cells in detail. Here, we demonstrate that induction therapy with rATG following kidney/pancreas transplantation results in a rapid depletion of NK cells. Treatment of NK cells with rATG and alemtuzumab in vitro leads to impairment of cytotoxicity and induction of apoptosis even at a 10-fold lower concentration (0.1 mu g/ml) compared with T and B cells. By generating Fc-parts of rATG and alemtuzumab we illustrate that their ligation to Fc gamma RIII (CD16) is sufficient for the significant induction of degranulation, apoptosis and inflammatory cytokine release (FasL, TNF alpha and IFN gamma) exclusively in CD3(-)CD56(dim) NK cells whereas application of rATG and alemtuzumab F(ab) fragments abolishes these effects. These findings are of general importance as our data suggest that NK cells are also mediators of the clinically relevant cytokine release syndrome and that their targeting by therapeutic antibodies should be considered as they are functionally relevant for the effective clearance of opportunistic viral infections and anti-tumor activity posttransplantation.	[Stauch, Diana; Dernier, Annelie; Kunert, Kristina; Volk, Hans-Dieter; Kotsch, Katja] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Marchese, Elizabeth Sarmiento] Hosp Gen Univ Gregorio Maranon, Dept Immunol, Madrid, Spain; [Pratschke, Johann] Charite Universitatsmed, Dept Surg, Campus Virchow, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; General University Gregorio Maranon Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stauch, D (corresponding author), Charite, Inst Med Immunol, Campus Mitte, D-13353 Berlin, Germany.	katja.kotsch@charite.de	Kotsch, Katja/AAG-2597-2021; volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Sarmiento, Elizabeth/0000-0001-8435-8912; Stauch, Diana/0000-0002-3922-4250	Genzyme; Deutsche Forschungsgemeinschaft [PR 578/2-3]; Instituto de Salud Carlos III, Madrid, Spain	Genzyme(Sanofi-AventisGenzyme Corporation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III)	This study was supported in part by research funding from Genzyme to K.K. and a grant from the Deutsche Forschungsgemeinschaft (DFG PR 578/2-3) to J.P. E.S. was funded by the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; BONNEFOYBERARD N, 1991, TRANSPLANTATION, V51, P669, DOI 10.1097/00007890-199103000-00024; Buggins AGS, 2002, BLOOD, V100, P1715, DOI 10.1182/blood.V100.5.1715.h81702001715_1715_1720; Calistri E, 2006, AM J HEMATOL, V81, P355, DOI 10.1002/ajh.20560; Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Chiossone L, 2007, BLOOD, V109, P3767, DOI 10.1182/blood-2006-07-037846; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohen-Solal JLF, 2004, IMMUNOL LETT, V92, P199, DOI 10.1016/j.imlet.2004.01.012; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Eischen CM, 1996, J IMMUNOL, V156, P2693; Esposito L, 2005, TRANSPL P, V37, P785, DOI 10.1016/j.transproceed.2004.12.200; Feng XM, 2008, BLOOD, V111, P3675, DOI 10.1182/blood-2008-01-130146; Fischer L, 2006, EXP HEMATOL, V34, P753, DOI 10.1016/j.exphem.2006.02.015; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Gillet-Hladky S, 2006, TRANSPLANTATION, V82, P965, DOI 10.1097/01.tp.0000235549.47976.d0; Guttmann RD, 1997, TRANSPLANT P, V29, pS24, DOI 10.1016/S0041-1345(97)00627-1; Haidinger M, 2007, TRANSPLANTATION, V84, P117, DOI 10.1097/01.tp.0000266677.45428.80; Hale G, 2002, BONE MARROW TRANSPL, V30, P797, DOI 10.1038/sj.bmt.1703733; Hardinger KL, 2004, TRANSPLANTATION, V78, P136, DOI 10.1097/01.TP.0000132329.67611.3F; Kaufman DB, 2006, AM J TRANSPLANT, V6, P331, DOI 10.1111/j.1600-6143.2005.01166.x; Kaufman DB, 2005, AM J TRANSPLANT, V5, P2539, DOI 10.1111/j.1600-6143.2005.01067.x; Knechtle SJ, 2004, SURGERY, V136, P754, DOI 10.1016/j.surg.2004.06.015; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; MCSWEENEY PA, BLOOD, V100, P1602; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Moreau T, 1996, Mult Scler, V1, P357; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Morris EC, 2003, BLOOD, V102, P404, DOI 10.1182/blood-2002-09-2687; Muller TF, 1997, TRANSPLANTATION, V64, P1432; Nashan B, 2005, BIODRUGS, V19, P39, DOI 10.2165/00063030-200519010-00005; Naujokat C, 2007, TRANSPLANTATION, V83, P485, DOI 10.1097/01.tp.0000251975.81281.22; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nuckel H, 2005, EUR J PHARMACOL, V514, P217, DOI 10.1016/j.ejphar.2005.03.024; Oertel M, 2002, TRANSPL INT, V15, P463, DOI 10.1111/j.1432-2277.2002.tb00201.x; Penack O, 2007, TRANSPL IMMUNOL, V18, P85, DOI 10.1016/j.trim.2007.05.001; PERUSSIA B, 1984, J IMMUNOL, V133, P180; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Regan JF, 2001, TRANSPL IMMUNOL, V9, P29, DOI 10.1016/S0966-3274(01)00048-X; Remberger M, 1999, BONE MARROW TRANSPL, V24, P823, DOI 10.1038/sj.bmt.1701991; Remberger M, 2001, CLIN TRANSPLANT, V15, P147, DOI 10.1034/j.1399-0012.2001.150301.x; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruzek MC, 2008, BLOOD, V111, P1726, DOI 10.1182/blood-2007-08-106526; Scheinberg P, 2007, BLOOD, V109, P3219, DOI 10.1182/blood-2006-09-045625; Sentman CL, 2006, ADV CANCER RES, V95, P249, DOI 10.1016/S0065-230X(06)95007-6; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Wang H, 2007, BLOOD, V110, P1530, DOI 10.1182/blood-2006-10-048173; Wing MG, 1996, J CLIN INVEST, V98, P2819, DOI 10.1172/JCI119110; XIA MQ, 1993, BIOCHEM J, V293, P633, DOI 10.1042/bj2930633; Zand MS, 2006, BLOOD, V107, P2895, DOI 10.1182/blood-2005-06-2269	55	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4709	10.1371/journal.pone.0004709	http://dx.doi.org/10.1371/journal.pone.0004709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19266059	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490600020
J	Limesand, KH; Said, S; Anderson, SM				Limesand, Kirsten H.; Said, Sherif; Anderson, Steven M.			Suppression of Radiation-Induced Salivary Gland Dysfunction by IGF-1	PLOS ONE			English	Article							PAROTID-GLAND; ACINAR-CELLS; APOPTOSIS; DAMAGE; IRRADIATION; MOUSE; DELTA; AKT	Background: Radiation is a primary or secondary therapeutic modality for treatment of head and neck cancer. A common side effect of irradiation to the neck and neck region is xerostomia caused by salivary gland dysfunction. Approximately 40,000 new cases of xerostomia result from radiation treatment in the United States each year. The ensuing salivary gland hypofunction results in significant morbidity and diminishes the effectiveness of anti-cancer therapies as well as the quality of life for these patients. Previous studies in a rat model have shown no correlation between induction of apoptosis in the salivary gland and either the immediate or chronic decrease in salivary function following gamma-radiation treatment. Methodology/Principal Finding: A significant level of apoptosis can be detected in the salivary glands of FVB mice following gamma-radiation treatment of the head and neck and this apoptosis is suppressed in transgenic mice expressing an activated mutant of Akt (myr-Akt1). Importantly, this suppression of apoptosis in myr-Akt1 mice preserves salivary function, as measured by saliva output, three and thirty days after gamma-radiation treatment. In order to translate these studies into a preclinal model we found that intravenous injection of IGF1 stimulated activation of endogenous Akt in the salivary glands in vivo. A single injection of IGF1 prior to exposure to gamma-radiation diminishes salivary acinar cell apoptosis and completely preserves salivary gland function three and thirty days following irradiation. Conclusions/Significance: These studies suggest that apoptosis of salivary acinar cells underlies salivary gland hypofunction occurring secondary to radiation of the head and neck region. Targeted delivery of IGF1 to the salivary gland of patients receiving head and neck irradiation may be useful in reducing or eliminating xerostomia and restoring quality of life to these patients.	[Limesand, Kirsten H.; Said, Sherif; Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	Steve.Anderson@ucdenver.edu			NIH [PO1 DE12798, R01 DE016354, F32 DE 14315]; University of Colorado Cancer Center; State of Colorado; University of Colorado Technology Transfer Office; Sjogren's Syndrome Foundation [PN0101-097]; K22 award [DE 16096]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE014315, P01DE012798, K22DE016096, R01DE016354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; State of Colorado; University of Colorado Technology Transfer Office; Sjogren's Syndrome Foundation; K22 award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the NIH grants PO1 DE12798 and R01 DE016354 to SMA, University of Colorado Cancer Center Translational Grant, and State of Colorado and University of Colorado Technology Transfer Office Bioscience Discovery Grant. KHL has received support from the Sjogren's Syndrome Foundation (PN0101-097) and NIH (F32 DE 14315). KHL is the current recipient of a K22 award DE 16096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA JL, 2008, INT J RAD, V73, P523; Baum B J, 1985, Spec Care Dentist, V5, P274, DOI 10.1111/j.1754-4505.1985.tb00593.x; BERGONIE J, 1911, ARCH ELECTR MED, V19, P241; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Coffer PJ, 1998, BIOCHEM J, V335, P1; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; HIRAMATSU Y, 1994, ARCH ORAL BIOL, V39, P77, DOI 10.1016/0003-9969(94)90038-8; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; KASHIMA HK, 1965, AMER J ROENTGENOL RA, V94, P271; KOHN WG, 1992, J ORAL PATHOL MED, V21, P134, DOI 10.1111/j.1600-0714.1992.tb00997.x; Lee AV, 2003, HORM METAB RES, V35, P651; Limesand KH, 2003, IN VITRO CELL DEV-AN, V39, P170; Limesand KH, 2003, CELL DEATH DIFFER, V10, P345, DOI 10.1038/sj.cdd.4401153; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; O'Connell AC, 1999, RADIAT RES, V151, P150, DOI 10.2307/3579765; Paardekooper GMRM, 1998, INT J RADIAT BIOL, V73, P641, DOI 10.1080/095530098141898; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Schwertfeger KL, 2001, MOL ENDOCRINOL, V15, P867, DOI 10.1210/me.15.6.867; SHIP JA, 1991, J AM DENT ASSOC, V122, P63, DOI 10.14219/jada.archive.1991.0098; SHOLLEY MM, 1974, LAB INVEST, V31, P340; WRIGHT WE, 1987, J DENT RES, V66, P699, DOI 10.1177/00220345870660S216; Zeilstra LJW, 2000, INT J RADIAT BIOL, V76, P419, DOI 10.1080/095530000138763	30	62	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4663	10.1371/journal.pone.0004663	http://dx.doi.org/10.1371/journal.pone.0004663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252741	gold, Green Published, Green Submitted			2022-12-25	WOS:000265489900006
J	Schmiedeberg, L; Skene, P; Deaton, A; Bird, A				Schmiedeberg, Lars; Skene, Pete; Deaton, Aimee; Bird, Adrian			A Temporal Threshold for Formaldehyde Crosslinking and Fixation	PLOS ONE			English	Article								Background: Formaldehyde crosslinking is in widespread use as a biological fixative for microscopy and molecular biology. An assumption behind its use is that most biologically meaningful interactions are preserved by crosslinking, but the minimum length of time required for an interaction to become fixed has not been determined. Methodology: Using a unique series of mutations in the DNA binding protein MeCP2, we show that in vivo interactions lasting less than 5 seconds are invisible in the microscope after formaldehyde fixation, though they are obvious in live cells. The stark contrast between live cell and fixed cell images illustrates hitherto unsuspected limitations to the fixation process. We show that chromatin immunoprecipitation, a technique in widespread use that depends on formaldehyde crosslinking, also fails to capture these transient interactions. Conclusions/Significance: Our findings for the first time establish a minimum temporal limitation to crosslink chemistry that has implications for many fields of research.	[Schmiedeberg, Lars; Skene, Pete; Deaton, Aimee; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Schmiedeberg, L (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	a.bird@ed.ac.uk		Deaton, Aimee/0000-0003-0365-3077; Bird, Adrian/0000-0002-8600-0372	Wellcome Trust; European Union "Epigenetics" Network of Excellence	Wellcome Trust(Wellcome TrustEuropean Commission); European Union "Epigenetics" Network of Excellence	This work was funded by the Wellcome Trust and an European Union "Epigenetics" Network of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Cherukuri S, 2008, MOL BIOL CELL, V19, P1816, DOI 10.1091/mbc.E07-10-1018; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; GILMOUR DS, 1991, METHOD CELL BIOL, V35, P369; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; KLOSE RJ, 2004, J BIOL CHEM; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nan XS, 1996, MOL CELL BIOL, V16, P414; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2	18	84	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4636	10.1371/journal.pone.0004636	http://dx.doi.org/10.1371/journal.pone.0004636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247482	Green Published, gold			2022-12-25	WOS:000265487800018
J	Gibbs, SJ; Barren, B; Beck, KE; Proft, J; Zhao, XX; Noskova, T; Braun, AP; Artemyev, NO; Braun, JEA				Gibbs, Sarah J.; Barren, Brandy; Beck, Katy E.; Proft, Juliane; Zhao, Xiaoxi; Noskova, Tatiana; Braun, Andrew P.; Artemyev, Nikolai O.; Braun, Janice E. A.			Hsp40 Couples with the CSP alpha Chaperone Complex upon Induction of the Heat Shock Response	PLOS ONE			English	Article								In response to a conditioning stress, the expression of a set of molecular chaperones called heat shock proteins is increased. In neurons, stress-induced and constitutively expressed molecular chaperones protect against damage induced by ischemia and neurodegenerative diseases, however the molecular basis of this protection is not known. Here we have investigated the crosstalk between stress-induced chaperones and cysteine string protein (CSP alpha). CSP alpha is a constitutively expressed synaptic vesicle protein bearing a J domain and a cysteine rich "string'' region that has been implicated in the long term functional integrity of synaptic transmission and the defense against neurodegeneration. We have shown previously that the CSP alpha chaperone complex increases isoproterenol-mediated signaling by stimulating GDP/GTP exchange of G alpha(s). In this report we demonstrate that in response to heat shock or treatment with the Hsp90 inhibitor geldanamycin, the J protein Hsp40 becomes a major component of the CSP alpha complex. Association of Hsp40 with CSP alpha decreases CSP alpha-CSP alpha dimerization and enhances the CSP alpha-induced increase in steady state GTP hydrolysis of G alpha(s). This newly identified CSP alpha-Hsp40 association reveals a previously undescribed coupling of J proteins. In view of the crucial importance of stress-induced chaperones in the protection against cell death, our data attribute a role for Hsp40 crosstalk with CSP alpha in neuroprotection.	[Gibbs, Sarah J.; Beck, Katy E.; Proft, Juliane; Zhao, Xiaoxi; Noskova, Tatiana; Braun, Janice E. A.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; [Gibbs, Sarah J.; Beck, Katy E.; Proft, Juliane; Zhao, Xiaoxi; Noskova, Tatiana; Braun, Janice E. A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Braun, Andrew P.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 1N4, Canada; [Braun, Andrew P.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; [Barren, Brandy; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Iowa	Gibbs, SJ (corresponding author), Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada.	braunj@ucalgary.ca	Beck, Katy/C-7990-2011; Proft, Juliane/H-6549-2014	Proft, Juliane/0000-0003-0980-8930	Canadian Institute of Health Research [MOP74713]; National Institute of Health [RO1 EY-12682]; Alberta Heritage Foundation for Medical Research [Senior Scholars]; NATIONAL EYE INSTITUTE [R01EY012682] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funding from the Canadian Institute of Health Research (MOP74713) to JEAB and National Institute of Health (RO1 EY-12682) to NOS. JEAB and APB are Senior Scholars of the Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNDT V, 2007, CELL MOL LIFE SCI; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Bai LP, 2007, BIOCHEM BIOPH RES CO, V352, P123, DOI 10.1016/j.bbrc.2006.10.178; Barclay JW, 2002, J COMP PHYSIOL A, V188, P71, DOI 10.1007/s00359-002-0279-9; Bechtold DA, 2000, J NEUROCHEM, V74, P641, DOI 10.1046/j.1471-4159.2000.740641.x; Beck KE, 2006, BIOCHEM BIOPH RES CO, V346, P866, DOI 10.1016/j.bbrc.2006.05.185; Bowyer JF, 1999, ANN NY ACAD SCI, V890, P314, DOI 10.1111/j.1749-6632.1999.tb08009.x; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brown I. R., 2007, ANN N Y ACAD SCI; Chai YH, 1999, J NEUROSCI, V19, P10338; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Cordeiro ML, 2000, J NEUROCHEM, V75, P2622, DOI 10.1046/j.1471-4159.2000.0752622.x; Cordeiro ML, 2003, J NEUROSCI RES, V73, P865, DOI 10.1002/jnr.10707; Cordeiro ML, 2000, J NEUROCHEM, V74, P2365, DOI 10.1046/j.1471-4159.2000.0742365.x; DAUGAARD M, 2007, FEBS LETT; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; KOBAYASHI N, 2008, SOLUTION STRUCTURE J; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Miller LC, 2003, J CELL SCI, V116, P2967, DOI 10.1242/jcs.00595; MORANO KA, 2007, ANN N Y ACAD SCI; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nie ZP, 1999, J NEUROSCI, V19, P10270; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Swayne LA, 2006, BIOCHEM BIOPH RES CO, V348, P83, DOI 10.1016/j.bbrc.2006.07.033; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Yamada M, 2001, NEUROSCI LETT, V301, P183, DOI 10.1016/S0304-3940(01)01638-X; Zhang W, 2002, BIOCHEM BIOPH RES CO, V291, P1038, DOI 10.1006/bbrc.2002.6555; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	53	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4595	10.1371/journal.pone.0004595	http://dx.doi.org/10.1371/journal.pone.0004595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242542	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487500006
J	Liu, WC; Vives-Bauza, C; Acin-Perez, R; Yamamoto, A; Tan, YC; Li, YP; Magrane, J; Stavarache, MA; Shaffer, S; Chang, S; Kaplitt, MG; Huang, XY; Beal, MF; Manfredi, G; Li, CJ				Liu, Wencheng; Vives-Bauza, Cristofol; Acin-Perez, Rebeca; Yamamoto, Ai; Tan, Yingcai; Li, Yanping; Magrane, Jordi; Stavarache, Mihaela A.; Shaffer, Sebastian; Chang, Simon; Kaplitt, Michael G.; Huang, Xin-Yun; Beal, M. Flint; Manfredi, Giovanni; Li, Chenjian			PINK1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit and alpha-Synuclein Aggregation in Cell Culture Models of Parkinson's Disease	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; RICH REPEAT KINASE-2; OXIDATIVE STRESS; MUTATIONS; PHOSPHORYLATION; DEGRADATION; DJ-1; DROSOPHILA-PINK1; PHOSPHOPROTEINS; DEGENERATION	Mutations in PTEN induced kinase 1 (PINK1), a mitochondrial Ser/Thr kinase, cause an autosomal recessive form of Parkinson's disease (PD), PARK6. Here, we report that PINK1 exists as a dimer in mitochondrial protein complexes that co-migrate with respiratory chain complexes in sucrose gradients. PARK6 related mutations do not affect this dimerization and its associated complexes. Using in vitro cell culture systems, we found that mutant PINK1 or PINK1 knock-down caused deficits in mitochondrial respiration and ATP synthesis. Furthermore, proteasome function is impaired with a loss of PINK1. Importantly, these deficits are accompanied by increased alpha-synclein aggregation. Our results indicate that it will be important to delineate the relationship between mitochondrial functional deficits, proteasome dysfunction and alpha-synclein aggregation.	[Liu, Wencheng; Vives-Bauza, Cristofol; Acin-Perez, Rebeca; Li, Yanping; Magrane, Jordi; Shaffer, Sebastian; Chang, Simon; Beal, M. Flint; Manfredi, Giovanni; Li, Chenjian] Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA; [Stavarache, Mihaela A.; Kaplitt, Michael G.] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [Tan, Yingcai; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; [Yamamoto, Ai] Columbia Univ, Judith P Sulzberger MD Columbia Genome Ctr, New York, NY 10027 USA; [Yamamoto, Ai] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10027 USA	Cornell University; Cornell University; Cornell University; Columbia University; Columbia University	Liu, WC (corresponding author), Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA.	gim2004@mail.med.cornell.edu; chl2011@med.cornell.edu	li, yan/GTI-4638-2022; Magrané, Jordi/AAJ-2967-2020; Vives-Bauza, Cristofol/N-7044-2015; Vives-Bauza, Cristofol/AAS-1301-2021; Acin-Perez, Rebeca/H-6160-2015; Acin-Perez, Rebeca/AAU-4913-2020; Yamamoto, Ai/D-1100-2011	Magrané, Jordi/0000-0002-6785-2166; Vives-Bauza, Cristofol/0000-0001-5735-8335; Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; 	NIH/NINDS [NS054773]; Department of Defense; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054773, R01NS050199] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported partially by grants to CJL (NIH/NINDS NS054773), MFB (Department of Defense), and to MAS (Parkinson's Disease Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hatano Y, 2004, ANN NEUROL, V56, P603, DOI 10.1002/ana.20299; Hatano Y, 2004, ANN NEUROL, V56, P424, DOI 10.1002/ana.20251; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Li CJ, 2005, P NATL ACAD SCI USA, V102, P16535, DOI 10.1073/pnas.0508350102; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; MURAKAMI T, 2007, J NEUROL NEUROSURG P; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Piccoli C, 2008, NEUROCHEM RES, V33, P2565, DOI 10.1007/s11064-008-9729-2; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Sardanelli AM, 1995, FEBS LETT, V377, P470, DOI 10.1016/0014-5793(95)01407-1; SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; Thomson M, 2002, CELL MOL LIFE SCI, V59, P213, DOI 10.1007/s00018-002-8417-7; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056	54	109	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2009	4	2							e4597	10.1371/journal.pone.0004597	http://dx.doi.org/10.1371/journal.pone.0004597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KX	19242547	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487500007
J	Clement, CR; Santos, RP; Desmouliere, SJM; Ferreira, EJL; Neto, JTF				Clement, Charles R.; Santos, Ronaldo P.; Desmouliere, Sylvain J. M.; Ferreira, Evandro J. L.; Neto, Joao Tome Farias			Ecological Adaptation of Wild Peach Palm, Its In Situ Conservation and Deforestation-Mediated Extinction in Southern Brazilian Amazonia	PLOS ONE			English	Article							GENETIC-STRUCTURE; BACTRIS-GASIPAES; PLANT DIVERSITY; CLIMATE-CHANGE; MATING SYSTEM; MICROSATELLITE; POPULATIONS; FUTURE	Background: The Arc of Fire across southern Amazonia seasonally attracts worldwide attention as forests are cut and burned for agricultural expansion. These forests contain numerous wild relatives of native South American crops, such as peach palm. Methodology/Principal Findings: Our prospecting expeditions examined critical areas for wild peach palm in the Arc of Fire in Mato Grosso, Para, Maranhao and Tocantins, as well as areas not previously examined in Amazonas and Amapa states. Recent digitization of the RADAM Brasil project permitted comparison among RADAM's parataxonomists' observations, previous botanical collections and our prospecting. Mapping on soils and vegetation types enabled us to hypothesize a set of ecological preferences. Wild peach palm is best adapted to Ultisols (Acrisols) in open forests across the Arc of Fire and westward into the more humid western Amazonia. Populations are generally small (fewer than 10 plants) on slopes above watercourses. In northern Mato Grosso and southern Para soybean fields and pastures now occupy numerous areas where RADAM identified wild peach palm. The controversial BR-163 Highway is already eroding wild peach palm as deforestation expands. Conclusions/Significance: Many of these populations are now isolated by increasing forest fragmentation, which will lead to decreased reproduction via inbreeding depression and eventual extinction even without complete deforestation. Federal conservation areas are less numerous in the Arc of Fire than in other parts of Brazilian Amazonia, although there are indigenous lands; these conservation areas contain viable populations of wild peach palm and require better protection than they are currently receiving. Ex situ conservation of these populations is not viable given the relative lack of importance of domesticated peach palm and the difficulty of maintaining even economically interesting genetic resources.	[Clement, Charles R.; Desmouliere, Sylvain J. M.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Santos, Ronaldo P.] Inst Nacl Colonizacao Reforma Agraria, Manaus, Amazonas, Brazil; [Ferreira, Evandro J. L.] Inst Nacl de Pesquisas da Amazonia, Rio Branco, Acre, Brazil; [Neto, Joao Tome Farias] Embrapa Amazonia Oriental, Belem, Para, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Clement, CR (corresponding author), Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.	cclement@inpa.gov.br	Clement, Charles Roland/G-6081-2010	Clement, Charles Roland/0000-0002-8421-1029; Linhares Ferreira, Evandro Jose/0000-0001-9591-9615	Brazilian Program on Biological Diversity (ProBio); Brazilian Environment Ministry; National Council for Scientific and Technological Development (CNPq) [fellowship]; Foundation to Support Research in Amazonas State (Fapeam) [scholarship]	Brazilian Program on Biological Diversity (ProBio); Brazilian Environment Ministry; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation to Support Research in Amazonas State (Fapeam)	This study was financed primarily by the Brazilian Program on Biological Diversity (ProBio), coordinated by the Brazilian Environment Ministry, for the project: Pupunha - racas primitivas e parentes silvestres {Peach palm - landraces and wild populations} and lead by CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CC has a fellowship (bolsa de produtividade) from the National Council for Scientific and Technological Development (CNPq). SD has a scholarship from the Foundation to Support Research in Amazonas State (Fapeam).	Allem AC, 1999, EUPHYTICA, V107, P123, DOI 10.1023/A:1026422229054; Bianchetti L, 2005, FUNDAMENTOS COLETA G, P355; Clement C. R., 1988, Advances in Economic Botany, V6, P155; CLEMENT C R, 1989, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V5, P39; Clement C.R., 1984, ACTA AMAZON, V14, P337; Clement C.R., 2008, ENCY FRUIT NUTS, P93; Clement CR, 2006, HIST ECOL SER, P165; Clement Charles R., 1999, Acta Botanica Venezuelica, V22, P29; Clement Charles R., 1990, Acta Amazonica, V20, P399; Clement CR, 2004, AGROFOREST SYST, V61-2, P195, DOI 10.1023/B:AGFO.0000028999.84655.17; CLEMENT CR, 1995, IPGRI WORKSH FIELD G; Conte R, 2008, J HERED, V99, P476, DOI 10.1093/jhered/esn055; CORADIN L, PARENTES SILVESTRES; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; EGUIARTE LE, 1992, HEREDITY, V69, P217, DOI 10.1038/hdy.1992.119; Erickson CL, 2000, NATURE, V408, P190, DOI 10.1038/35041555; Fearnside Philip M., 2006, Acta Amaz., V36, P395, DOI 10.1590/S0044-59672006000300018; Ferreira E, 1999, MEM NEW YORK BOTAN G, V83, P225; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Gaiotto FA, 2003, J HERED, V94, P399, DOI 10.1093/jhered/esg087; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; HENDERSON A, 1995, FIELD GUIDE PALMS AM; HENDERSON A, 2000, FLORA NEOTROPICA MON, V79; Ugalde JAH, 2008, REV BIOL TROP, V56, P217; Huber J, 1904, B MUS PARANESE HIST, V4, P474; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA - IBGE, 1992, MAN TECN VEG BRAS; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jordan C.F., 1985, KEY ENV AMAZONIA, P83; KAHN F, 1986, BIOTROPICA, V18, P214, DOI 10.2307/2388487; KAHN F, 1997, PALMS ELDORADO; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Leeuwen J. van, 2005, Agrociencia (Montevideo), V9, P61; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; *MMA, 2006, PLAN DES REG SUST AR; Morcote-Rios G, 2001, BOT REV, V67, P309, DOI 10.1007/BF02858098; NAMKOONG G, 1991, FOREST TREES MANAGIN; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Parssinen M., 2003, W AMAZONIA AMAZONIA, P97; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Pires JM, 1985, KEY ENV AMAZONIA, P109; *RADAM, 1973, LEV REC NAT GEOL GEO; Rodrigues DP, 2004, GENET RESOUR CROP EV, V51, P871, DOI 10.1007/s10722-005-0774-2; Rodrigues DP, 2007, THESIS U FEDERAL AMA; RODRIGUES JB, 1903, SERTUM PALMARUM BRAS; SALDIASPAZ M, 1993, 4 C INT BIOL AGR IND, P115; Salm Rodolfo, 2004, Acta Amaz., V34, P435, DOI 10.1590/S0044-59672004000300009; Scariot A, 1999, J ECOL, V87, P66, DOI 10.1046/j.1365-2745.1999.00332.x; Schaal BA, 2006, DARWINS HARVEST NEW, P269, DOI [10.7312/motl13316, DOI 10.7312/MOTL13316]; Schultes RE, 1984, PAP PEABODY MUS, V76, P19; SILVA JBF, 2005, ACTA BOT BRAS, V19, P283; URPI JM, 1999, PALMITO PEJIBAYE, P17; URPI JM, 1997, PEACH PALM, V20; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; van Leeuwen J, 2005, AGROCIENCIAS, V9, P67; van Vuuren DP, 2006, ECOL SOC, V11; Veloso H.P., 1991, CLASSIFICACAO VEGETA; VIVAN JL, 2008, THESIS U FEDERAL DE	57	15	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4564	10.1371/journal.pone.0004564	http://dx.doi.org/10.1371/journal.pone.0004564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238213	Green Published, Green Submitted, gold			2022-12-25	WOS:000265487400002
J	Berthelot, K; Immel, F; Gean, J; Lecomte, S; Oda, R; Kauffmann, B; Cullin, C				Berthelot, Karine; Immel, Francoise; Gean, Julie; Lecomte, Sophie; Oda, Reiko; Kauffmann, Brice; Cullin, Christophe			Driving amyloid toxicity in a yeast model by structural changes: a molecular approach	FASEB JOURNAL			English	Article						aggregation; FTIR; folding	HET-S PRION; FUNGUS PODOSPORA-ANSERINA; IN-VITRO; POLYGLUTAMINE OLIGOMERS; ESCHERICHIA-COLI; COMMON MECHANISM; FIBRIL FORMATION; ION CHANNELS; CONGO RED; PROTEIN	The amyloid aggregation pathway is a multistep process, and many in vitro studies have highlighted the role of particular intermediates in the cellular toxicity of various amyloid diseases. In a previous study, we generated a yeast toxic mutant (M8) of the harmless model amyloid protein Het-s(218-289). In this study, we compared the aggregation characteristics of the wild-type (WT) and the toxic mutant at the molecular level. Both proteins formed fibrillar amyloid aggregates but with different dye-binding properties and X-ray diffraction patterns. The toxic amyloid formed very unusual short (80 nm) unbranched fibers visible on transmission electron microscopy. Fourier transform infrared spectroscopy demonstrated that M8 beta-sheets were essentially organized into a mixed parallel and antiparallel structure, whereas the WT protein displayed a predominantly parallel organization. Cellular toxicity may therefore be related to assembly of the toxic amyloid in a new aggregation pathway.-Berthelot, K., Immel, F., Gean, J., Lecomte, S., Oda, R., Kauffmann, B., Cullin, C. Driving amyloid toxicity in a yeast model by structural changes: a molecular approach. FASEB J. 23, 2254-2263 (2009)	[Cullin, Christophe] Univ Bordeaux 2 Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, IBGC,UMR 5095, F-33077 Bordeaux, France; [Gean, Julie; Lecomte, Sophie; Oda, Reiko; Kauffmann, Brice] Univ Bordeaux 1, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Cullin, C (corresponding author), Univ Bordeaux 2 Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, IBGC,UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	christophe.cullin@ibgc.u-bordeaux2.fr	Kauffmann, Brice/L-6029-2015; Immel, Françoise/N-7079-2019; Oda, Reiko/AAE-4185-2021; cullin, christophe/AAM-2179-2020; BERTHELOT, Karine V.J./A-5546-2011; Immel, Françoise/GNP-4167-2022; oda, reiko/B-2214-2013	Kauffmann, Brice/0000-0002-2932-3255; cullin, christophe/0000-0003-4110-4677; BERTHELOT, Karine V.J./0000-0003-0809-4921; Immel, Françoise/0000-0002-2028-902X; oda, reiko/0000-0003-3273-8635				Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Boye-Harnasch M, 2006, J BIOTECHNOL, V125, P222, DOI 10.1016/j.jbiotec.2006.03.006; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COUTHOUIS J, 2009, PLOS ONE IN PRESS; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Elfrink K, 2008, P NATL ACAD SCI USA, V105, P10815, DOI 10.1073/pnas.0804721105; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Sreerama N., 2000, CIRCULAR DICHROISM P, P601; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; TURCQ B, 1991, MOL GEN GENET, V228, P265, DOI 10.1007/BF00282475; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839	50	22	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2254	2263		10.1096/fj.08-125724	http://dx.doi.org/10.1096/fj.08-125724			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19228879				2022-12-25	WOS:000268836500025
J	Flitney, EW; Kuczmarski, ER; Adam, SA; Goldman, RD				Flitney, Eric W.; Kuczmarski, Edward R.; Adam, Stephen A.; Goldman, Robert D.			Insights into the mechanical properties of epithelial cells: the effects of shear stress on the assembly and remodeling of keratin intermediate filaments	FASEB JOURNAL			English	Article						phosphorylation; tonofibrils; cytoskeleton	LIVING ENDOTHELIAL-CELLS; DYNAMIC PROPERTIES; PROTEIN-KINASE; MULTIPLE SITES; CULTURED-CELLS; IN-VITRO; PHOSPHORYLATION; NETWORK; FLOW; CYTOKERATINS	The effects of shear stress on the keratin intermediate filament ( KIF) cytoskeleton of cultured human alveolar epithelial (A549) cells have been investigated. Under normal culture conditions, immunofluorescence revealed a delicate network of fine tonofibrils containing KIFs, together with many nonfilamentous, keratin-containing "particles," mostly containing either keratin 8 (K8) or 18 (K18), but not both. Triton X-100 extracted similar to 10% of the cellular keratin, and this was accompanied by a loss of the particles but not the KIFs. Shear stress dramatically reduced the soluble keratin component and transformed the fine bundles of KIFs into thicker," wavy" tonofibrils. Both effects were accompanied by the disappearance of most keratin particles and by increased phosphorylation of K8 and K18 on serine residues 73 and 33, respectively. The particles that remained after shearing were phosphorylated and were closely associated with KIFs. We suggest that keratin particles constitute a reservoir of protein that can be recruited into KIFs under flow, creating a more robust cytoskeleton able to withstand shear forces more effectively. -Flitney, E. W., Kuczmarski, E. R., Adam, S. A., Goldman, R. D. Insights into the mechanical properties of epithelial cells: the effects of shear stress on the assembly and remodeling of keratin intermediate filaments. FASEB J. 23, 2110-2119 (2009)	[Flitney, Eric W.; Kuczmarski, Edward R.; Adam, Stephen A.; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Goldman, RD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-goldman@northwestern.edu		Adam, Stephen/0000-0003-3444-7655	NIH [GM36806]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036806, R01GM036806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a grant from the NIH (GM36806).	ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; BARBEE KA, 1995, AM J PHYSIOL-HEART C, V268, pH1765, DOI 10.1152/ajpheart.1995.268.4.H1765; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; CHOU CF, 1993, J CELL SCI, V105, P433; CHOU CF, 1994, J CELL SCI, V107, P1833; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Davies PF, 1995, J BIOMECH, V28, P1553, DOI 10.1016/0021-9290(95)00102-6; EICHNER R, 1985, ANN NY ACAD SCI, V455, P381, DOI 10.1111/j.1749-6632.1985.tb50424.x; ERIKSSON JE, 1992, P NATL ACAD SCI USA, V89, P11093, DOI 10.1073/pnas.89.22.11093; Feng L, 1999, J CELL SCI, V112, P2081; Flitney EW, 2004, METHOD CELL BIOL, V78, P297; FRANKE WW, 1987, EXP CELL RES, V173, P17, DOI 10.1016/0014-4827(87)90328-4; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALL L, 1987, BIOL CELL, V61, P33, DOI 10.1111/j.1768-322X.1987.tb00566.x; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2003, J CELL SCI, V116, P2345, DOI 10.1242/jcs.00526; Helmke BP, 2001, BIOPHYS J, V80, P184, DOI 10.1016/S0006-3495(01)76006-7; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Ho CL, 1998, J CELL SCI, V111, P1767; HORWITZ B, 1981, EXP CELL RES, V134, P281, DOI 10.1016/0014-4827(81)90427-4; LAMB NJC, 1989, J CELL BIOL, V108, P2409, DOI 10.1083/jcb.108.6.2409; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liovic M, 2003, J CELL SCI, V116, P1417, DOI 10.1242/jcs.00363; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; MILLER RK, 1991, J CELL BIOL, V113, P843, DOI 10.1083/jcb.113.4.843; MILLER RK, 1993, J CELL BIOL, V122, P123, DOI 10.1083/jcb.122.1.123; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; ROSEVEAR ER, 1990, CELL MOTIL CYTOSKEL, V17, P150, DOI 10.1002/cm.970170303; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Stumptner C, 2000, AM J PATHOL, V156, P77, DOI 10.1016/S0002-9440(10)64708-6; Tao GZ, 2006, J CELL SCI, V119, P1425, DOI 10.1242/jcs.02861; Toivola DM, 1997, J CELL SCI, V110, P23; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; Windoffer R, 1999, J CELL SCI, V112, P4521; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Woll S, 2005, EUR J CELL BIOL, V84, P311, DOI 10.1016/j.ejcb.2004.12.004; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503	54	66	69	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2110	2119		10.1096/fj.08-124453	http://dx.doi.org/10.1096/fj.08-124453			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246484	Green Published			2022-12-25	WOS:000268836500011
J	Roohvand, F; Maillard, P; Lavergne, JP; Boulant, S; Walic, M; Andreo, U; Goueslain, L; Helle, F; Mallet, A; McLauchlan, J; Budkowska, A				Roohvand, Farzin; Maillard, Patrick; Lavergne, Jean-Pierre; Boulant, Steeve; Walic, Marine; Andreo, Ursula; Goueslain, Lucie; Helle, Francois; Mallet, Adeline; McLauchlan, John; Budkowska, Agata			Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PROTEIN; LIPID DROPLET; MATRIX PROTEIN; TUBULIN; ASSOCIATION; TRANSPORT; ENTRY; DYNEIN; DETERMINANTS; TRAFFICKING	Early events leading to the establishment of hepatitis C virus (HCV) infection are not completely understood. We show that intact and dynamic microtubules play a key role in the initiation of productive HCV infection. Microtubules were required for virus entry into cells, as evidenced using virus pseudotypes presenting HCV envelope proteins on their surface. Studies carried out using the recent infectious HCV model revealed that microtubules also play an essential role in early, postfusion steps of the virus cycle. Moreover, low concentrations of vinblastin and nocodazol, microtubule-affecting drugs, and paclitaxel, which stabilizes microtubules, inhibited infection, suggesting that microtubule dynamic instability and/or treadmilling mechanisms are involved in HCV internalization and early transport. By protein chip and direct core-dependent pull-down assays, followed by mass spectrometry, we identified beta- and alpha-tubulin as cellular partners of the HCV core protein. Surface plasmon resonance analyses confirmed that core directly binds to tubulin with high affinity via amino acids 2-117. The interaction of core with tubulin in vitro promoted its polymerization and enhanced the formation of microtubules. Immune electron microscopy showed that HCV core associates, at least temporarily, with microtubules polymerized in its presence. Studies by confocal microscopy showed a juxtaposition of core with microtubules in HCV-infected cells. In summary, we report that intact and dynamic microtubules are required for virus entry into cells and for early postfusion steps of infection. HCV may exploit a direct interaction of core with tubulin, enhancing microtubule polymerization, to establish efficient infection and promote virus transport and/or assembly in infected cells.	[Roohvand, Farzin; Maillard, Patrick; Walic, Marine; Andreo, Ursula; Budkowska, Agata] Inst Pasteur, Unite Hepacivirus & Immunite Innee, F-75724 Paris, France; [Lavergne, Jean-Pierre] Univ Lyon 1, CNRS, IBCP UMR 5086, F-69367 Lyon, France; [Boulant, Steeve; McLauchlan, John] Med Res Council Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Goueslain, Lucie; Helle, Francois] Univ Lille 1, CNRS, Inst Pasteur Lille, Inst Biol Lille,UMR8161, F-59021 Lille, France; [Goueslain, Lucie; Helle, Francois] Univ Lille 2, CNRS, Inst Pasteur Lille, Inst Biol Lille,UMR8161, F-59021 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Budkowska, A (corresponding author), Inst Pasteur, Unite Hepacivirus & Immunite Innee, 25-28 Rue Dr Roux, F-75724 Paris, France.	agata.budkowska@pasteur.fr	HELLE, Francois/G-7427-2011; Boulant, Steeve/W-3754-2019; Roohvand, Farzin/K-8931-2018	HELLE, Francois/0000-0001-6884-2456; Boulant, Steeve/0000-0001-8614-4993; Roohvand, Farzin/0000-0002-9597-3555	Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS); Action Concerte de l'Institut Pasteur; Reseau de l'Institut Pasteur (RIP); MRC [MC_U130184143] Funding Source: UKRI; Medical Research Council [MC_U130184143] Funding Source: researchfish	Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Action Concerte de l'Institut Pasteur; Reseau de l'Institut Pasteur (RIP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) and Action Concerte de l'Institut Pasteur.; Supported by fellowship grants from the Reseau de l'Institut Pasteur (RIP) and the ANRS.; Supported by doctoral fellowship grants from the ANRS.	Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Boyko V, 2000, PLANT J, V22, P315, DOI 10.1046/j.1365-313x.2000.00740.x; BURLONE M, 2009, J GEN VIROL IN PRESS, V90; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; de Soultrait VR, 2002, BBA-GENE STRUCT EXPR, V1575, P40, DOI 10.1016/S0167-4781(02)00241-5; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Drukman S, 2002, INT J ONCOL, V21, P621; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Fan ZY, 1999, J MED VIROL, V59, P131, DOI 10.1002/(SICI)1096-9071(199910)59:2<131::AID-JMV1>3.3.CO;2-3; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; GEORGI A, 1990, P NATL ACAD SCI USA, V87, P6579, DOI 10.1073/pnas.87.17.6579; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Heald R, 2002, J CELL SCI, V115, P3; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jones DM, 2007, J GEN VIROL, V88, P470, DOI 10.1099/vir.0.82363-0; JORDAN MA, 1992, J CELL SCI, V102, P401; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kaelin K, 2000, J VIROL, V74, P474, DOI 10.1128/JVI.74.1.474-482.2000; Kalicharran K, 1996, TRENDS MICROBIOL, V4, P264, DOI 10.1016/0966-842X(96)10045-7; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Luduena RF, 1998, INT REV CYTOL, V178, P207; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; Maillard P, 2004, J BIOL CHEM, V279, P2430, DOI 10.1074/jbc.M311470200; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; MAMBER SW, 1995, J PHARMACOL EXP THER, V274, P877; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; MELKI R, 1994, VIROLOGY, V202, P339, DOI 10.1006/viro.1994.1350; Miller LM, 2008, BIOCHEMISTRY-US, V47, P7572, DOI 10.1021/bi8005225; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Nejmeddine M, 2000, J VIROL, V74, P3313, DOI 10.1128/JVI.74.7.3313-3320.2000; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Ogino T, 2003, BIOCHEM BIOPH RES CO, V311, P283, DOI 10.1016/j.bbrc.2003.09.205; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Quarmby L, 2000, J CELL SCI, V113, P2821; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Sanjuan N, 2003, VIROLOGY, V313, P105, DOI 10.1016/S0042-6822(03)00309-X; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; TAKAHASHI K, 1992, VIROLOGY, V191, P431, DOI 10.1016/0042-6822(92)90204-3; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	66	64	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13778	13791		10.1074/jbc.M807873200	http://dx.doi.org/10.1074/jbc.M807873200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19269968	Green Published, hybrid			2022-12-25	WOS:000265877300055
J	Ferrari, SR; Grubb, J; Bishop, DK				Ferrari, Susan R.; Grubb, Jennifer; Bishop, Douglas K.			The Mei5-Sae3 Protein Complex Mediates Dmc1 Activity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; YEAST RAD52 PROTEIN; COLI RECA-PROTEIN; MEIOTIC RECOMBINATION; ESCHERICHIA-COLI; BINDING-PROTEIN; RAD51-MEDIATED RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; HOMOLOGOUS RECOMBINATION; SSB PROTEIN	During homologous recombination, a number of proteins cooperate to catalyze the loading of recombinases onto single-stranded DNA. Single-stranded DNA-binding proteins stimulate recombination by coating single-stranded DNA and keeping it free of secondary structure; however, in order for recombinases to load on single-stranded-DNA-binding protein-coated DNA, the activity of a class of proteins known as recombination mediators is required. Mediator proteins coordinate the handoff of single-stranded DNA from single-stranded DNA-binding protein to recombinase. Here we show that a complex of Mei5 and Sae3 from Saccharomyces cerevisiae preferentially binds single-stranded DNA and relieves the inhibition of the strand assimilation and DNA binding abilities of the meiotic recombinase Dmc1 imposed by the single-stranded DNA-binding protein replication protein A. Additionally, we demonstrate the physical interaction of Mei5-Sae3 with replication protein A. Our results, together with previous in vivo studies, indicate that Mei5-Sae3 is a mediator of Dmc1 assembly during meiotic recombination in S. cerevisiae.	[Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Comm Canc Biol, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Ferrari, Susan R.; Grubb, Jennifer; Bishop, Douglas K.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Comm Canc Biol, 920 E 58th St, Chicago, IL 60637 USA.	dbishop@midway.uchicago.edu			National Institutes of Health [RO1-50936]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-50936 from NIGMS.	Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BIANCHI M, 1983, CELL, V34, P931, DOI 10.1016/0092-8674(83)90550-0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Fukushima K, 2000, NUCLEIC ACIDS RES, V28, P2709, DOI 10.1093/nar/28.14.2709; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; JIANG H, 1993, J BIOL CHEM, V268, P7904; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; McKee AHZ, 1997, GENETICS, V146, P817; MODESTI M, 1996, THESIS WAYNE STATE U; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MUNIYAPPA K, 1990, NUCLEIC ACIDS RES, V18, P3967, DOI 10.1093/nar/18.13.3967; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Pant K, 2008, J MOL BIOL, V380, P799, DOI 10.1016/j.jmb.2008.05.039; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; SIKORSKI RS, 1989, GENETICS, V122, P19; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sweezy MA, 1999, BIOCHEMISTRY-US, V38, P936, DOI 10.1021/bi9817055; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; YONESAKI T, 1989, J BIOL CHEM, V264, P7814; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Yuan SSF, 1999, CANCER RES, V59, P3547	51	38	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11766	11770		10.1074/jbc.C900023200	http://dx.doi.org/10.1074/jbc.C900023200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270307	Green Published, hybrid			2022-12-25	WOS:000265494600007
J	Hunter, RW; MacKintosh, C; Hers, I				Hunter, Roger W.; MacKintosh, Carol; Hers, Ingeborg			Protein Kinase C-mediated Phosphorylation and Activation of PDE3A Regulate cAMP Levels in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PHOSPHODIESTERASE 3A; INSULIN; NUCLEOTIDES; CELLS; PKB; 3B; AGGREGATION; STIMULATION; INVOLVEMENT	The elevation of [cAMP](i) is an important mechanism of platelet inhibition and is regulated by the opposing activity of adenylyl cyclase and phosphodiesterase (PDE). In this study, we demonstrate that a variety of platelet agonists, including thrombin, significantly enhance the activity of PDE3A in a phosphorylation-dependent manner. Stimulation of platelets with the PAR-1 agonist SFLLRN resulted in rapid and transient phosphorylation of PDE3A on Ser(312), Ser(428), Ser(438), Ser(465), and Ser(492), in parallel with the PKC (protein kinase C) substrate, pleckstrin. Furthermore, phosphorylation and activation of PDE3A required the activation of PKC, but not of PI3K/PKB, mTOR/p70S6K, or ERK/RSK. Activation of PKC by phorbol esters also resulted in phosphorylation of the same PDE3A sites in a PKC-dependent, PKB-independent manner. This was further supported by the finding that IGF-1, which strongly activates PI3K/PKB, but not PKC, did not regulate PDE3A. Platelet activation also led to a PKC-dependent association between PDE3Aand 14-3-3 proteins. In contrast, cAMP-elevating agents such as PGE(1) and forskolin-induced phosphorylation of Ser312 and increased PDE3A activity, but did not stimulate 14-3-3 binding. Finally, complete antagonism of PGE(1)-evoked cAMP accumulation by thrombin required bothGi andPKCactivation. Together, these results demonstrate that platelet activation stimulates PKC-dependent phosphorylation of PDE3A on Ser(312), Ser(428), Ser(438), Ser(465), and Ser(492) leading to a subsequent increase in cAMP hydrolysis and 14-3-3 binding.	[Hunter, Roger W.; Hers, Ingeborg] Univ Bristol, Dept Biochem, Sch Med Sci, Bristol BS8 1TD, Avon, England; [MacKintosh, Carol] Univ Dundee, MRC, Prot Phosphorylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Bristol; University of Dundee	Hers, I (corresponding author), Univ Bristol, Dept Biochem, Sch Med Sci, Univ Walk, Bristol BS8 1TD, Avon, England.	i.hers@bris.ac.uk	Hers, Ingeborg/ABG-3357-2020; MacKintosh, Carol/B-8210-2011	MacKintosh, Carol/0000-0001-9166-589X; Hers, Ingeborg/0000-0002-6467-5715; Hunter, Roger/0000-0003-0177-1512	British Heart Foundation [FS/05/047, FS/04/027]; British Heart Foundation [PG/08/056/25325] Funding Source: researchfish; Medical Research Council [MC_U127084354] Funding Source: researchfish; MRC [MC_U127084354] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation (Grants FS/05/047 and FS/04/027).	Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Banfic H, 1998, J BIOL CHEM, V273, P11630, DOI 10.1074/jbc.273.19.11630; DEGERMAN E, 1994, BBA-PROTEIN STRUCT M, V1205, P189, DOI 10.1016/0167-4838(94)90233-X; Dickinson NT, 1997, BIOCHEM J, V323, P371, DOI 10.1042/bj3230371; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Elbatarny HS, 2005, AM J PHYSIOL-ENDOC M, V289, pE695, DOI 10.1152/ajpendo.00125.2005; Feijge MAH, 2004, BIOCHEM PHARMACOL, V67, P1559, DOI 10.1016/j.bcp.2003.12.028; GIESBERTS AN, 1995, BIOCHEM J, V309, P613, DOI 10.1042/bj3090613; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Hanson MS, 2008, AM J PHYSIOL-HEART C, V295, pH786, DOI 10.1152/ajpheart.00349.2008; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hers I, 1998, ARTERIOSCL THROM VAS, V18, P404, DOI 10.1161/01.ATV.18.3.404; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hunter RW, 2008, J THROMB HAEMOST, V6, P1923, DOI 10.1111/j.1538-7836.2008.03140.x; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; LAGARDE M, 1977, BIOMED EXPRESS, V27, P110; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; LOPEZAPARICIO P, 1993, BIOCHEM BIOPH RES CO, V193, P1137, DOI 10.1006/bbrc.1993.1744; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; Manns JM, 2002, THROMB HAEMOSTASIS, V87, P873, DOI 10.1055/s-0037-1613099; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Onuma H, 2002, DIABETES, V51, P3362, DOI 10.2337/diabetes.51.12.3362; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Sheth SB, 1997, THROMB HAEMOSTASIS, V77, P155; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; WALKER TR, 1993, BIOCHEM J, V289, P277, DOI 10.1042/bj2890277; Yu HW, 1996, MOL PHARMACOL, V50, P549; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	33	68	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12339	12348		10.1074/jbc.M807536200	http://dx.doi.org/10.1074/jbc.M807536200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261611	hybrid, Green Published			2022-12-25	WOS:000265494600065
J	El-Tahir, HM; Abouzied, MM; Gallitzendoerfer, R; Gieselmann, V; Franken, S				El-Tahir, Heba M.; Abouzied, Mekky M.; Gallitzendoerfer, Rainer; Gieselmann, Volkmar; Franken, Sebastian			Hepatoma-derived Growth Factor-related Protein-3 Interacts with Microtubules and Promotes Neurite Outgrowth in Mouse Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SULFATED GLYCOSAMINOGLYCANS; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-FACTOR; BINDING PROTEINS; PWWP DOMAIN; GENE FAMILY; EXPRESSION; DYNAMICS; DNA	Hepatoma-derived growth factor-related proteins (HRP) comprise a family of 6 members, which the biological functions are still largely unclear. Here we show that during embryogenesis HRP-3 is strongly expressed in the developing nervous system. At early stages of development HRP-3 is located in the cytoplasm and neurites of cortical neurons. Upon maturation HRP-3 relocalizes continuously to the nuclei and in the majority of neurons of adult mice it is located exclusively in the nucleus. This redistribution from neurites to nuclei is also found in embryonic cortical neurons maturing in cell culture. We show that HRP-3 is necessary for proper neurite outgrowth in primary cortical neurons. To identify possible mechanisms of how HRP-3 modulate neuritogenesis we isolated HRP-3 interaction partners and demonstrate that it binds tubulin through the N-terminal so called HATH region, which is strongly conserved among members of the HRP family. It promotes tubulin polymerization, stabilizes and bundles microtubules. This activity depends on the extranuclear localization of HRP-3. HRP-3 thus could play an important role during neuronal development by its modulation of the neuronal cytoskeleton.	[El-Tahir, Heba M.; Abouzied, Mekky M.; Gallitzendoerfer, Rainer; Gieselmann, Volkmar; Franken, Sebastian] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Franken, S (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	franken@ibmb.uni-bonn.de	Eltahir, Heba M/S-6533-2019	Abouzied, mekky/0000-0001-5309-3552; Franken, Sebastian/0000-0003-4844-6389; eltahir, heba/0000-0003-3308-1137				Abouzied MM, 2004, BIOCHEM J, V378, P169, DOI 10.1042/BJ20030916; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; AVILA J, 1994, INT J DEV BIOL, V38, P13; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; El-Tahir HM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-6; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hasan MR, 2005, FEBS J, V272, P822, DOI 10.1111/j.1742-4658.2004.04520.x; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Ikegame K, 1999, BIOCHEM BIOPH RES CO, V266, P81, DOI 10.1006/bbrc.1999.1733; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Kishima Y, 2002, J BIOL CHEM, V277, P10315, DOI 10.1074/jbc.M111122200; KREMER L, 1988, ANAL BIOCHEM, V175, P91, DOI 10.1016/0003-2697(88)90365-X; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Marubuchi S, 2006, J NEUROCHEM, V99, P70, DOI 10.1111/j.1471-4159.2006.04021.x; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Ortega-Paino E, 2008, BLOOD, V111, P1617, DOI 10.1182/blood-2007-02-068791; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sue SC, 2004, J MOL BIOL, V343, P1365, DOI 10.1016/j.jmb.2004.09.014; Sue SC, 2007, J MOL BIOL, V367, P456, DOI 10.1016/j.jmb.2007.01.010; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Yamamoto S, 2006, CLIN CANCER RES, V12, P117, DOI 10.1158/1078-0432.CCR-05-1347; Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101; Yang J, 2009, J MOL BIOL, V386, P938, DOI 10.1016/j.jmb.2008.12.080; Yoshida K, 2006, ANN SURG ONCOL, V13, P159, DOI 10.1245/ASO.2006.11.035; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zhou ZW, 2004, J BIOL CHEM, V279, P27320, DOI 10.1074/jbc.M308650200	43	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11637	11651		10.1074/jbc.M901101200	http://dx.doi.org/10.1074/jbc.M901101200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19237540	Green Published, hybrid			2022-12-25	WOS:000265494500067
J	Hellmann, RA; Martinis, SA				Hellmann, Rachel A.; Martinis, Susan A.			Defects in Transient tRNA Translocation Bypass tRNA Synthetase Quality Control Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RIBONUCLEIC-ACID; LEUCYL-TRANSFER; AMINO-ACID; CRYSTAL-STRUCTURE; STERIC EXCLUSION; ACTIVE-SITE; SIEVE; AMINOACYLATION; PRETRANSFER; POLYMERASE	Quality control mechanisms during protein synthesis are essential to fidelity and cell survival. Leucyl-tRNA synthetase (LeuRS) misactivates non-leucine amino acids including isoleucine, methionine, and norvaline. To prevent translational errors, mischarged tRNA products are translocated 30 A from the canonical aminoacylation core to a hydrolytic editing-active site within a completely separate domain. Because it is transient, the tRNA translocation mechanism has been difficult to isolate. We have identified a "translocation peptide" within Escherichia coli LeuRS. Mutations in the translocation peptide cause tRNA to selectively bypass the editing-active site, resulting in mischarging that is lethal to the cell. This bypass mechanism also rescues aminoacylation of an editing site mutation that hydrolyzes correctly charged Leu-tRNA(Leu). Thus, these LeuRS mutants charge tRNALeu but fail to translocate these products to the hydrolytic site, where they are cleared to guard against genetic code ambiguities.	[Martinis, Susan A.] Univ Illinois, Dept Biochem, Roger Adams Lab 419, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Roger Adams Lab 419, Box B4,600 S Mathews Ave, Urbana, IL 61801 USA.	martinis@life.uiuc.edu		Martinis, Susan/0000-0001-5730-8346	National Institutes of Health [GM 063789]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 063789 (to S.A.M.).	Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Bishop AC, 2003, P NATL ACAD SCI USA, V100, P490, DOI 10.1073/pnas.0237335100; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Ellinger T, 1998, BIOTECHNIQUES, V24, P718, DOI 10.2144/98245bm03; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Hendrickson TL, 2003, MOL B INT U, P34; JOHNSON KA, 2005, ENCY LIFE SCI, V1, P1; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee KW, 2004, PROTEINS, V54, P693, DOI 10.1002/prot.10300; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LOW B, 1971, J BACTERIOL, V108, P742, DOI 10.1128/JB.108.2.742-750.1971; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; MASCARENHAS A, 2007, PROTEIN ENG; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1989, BIOCHEMISTRY-US, V28, P8479, DOI 10.1021/bi00447a031; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618	36	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11478	11484		10.1074/jbc.M807395200	http://dx.doi.org/10.1074/jbc.M807395200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258309	hybrid, Green Published			2022-12-25	WOS:000265494500052
J	Zhong, Y; Armbrecht, HJ; Christakos, S				Zhong, Yan; Armbrecht, Harvey J.; Christakos, Sylvia			Calcitonin, a Regulator of the 25-Hydroxyvitamin D-3 1 alpha-Hydroxylase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT/ENHANCER-BINDING PROTEINS; VITAMIN-D-RECEPTOR; NUCLEAR RECEPTOR; D-3-1-ALPHA-HYDROXYLASE GENE; TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; BETA; EXPRESSION; HORMONE; SWI/SNF	Although parathyroid hormone (PTH) induces 25-hydroxyvitamin D-3 (25(OH)D-3) 1 alpha-hydroxylase (1 alpha(OH) ase) under hypocalcemic conditions, previous studies showed that calcitonin, not PTH, has an important role in the maintenance of serum 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) under normocalcemic conditions. In this study we report that 1 alpha(OH) ase transcription is strongly induced by calcitonin in kidney cells and indicate mechanisms that underlie this regulation. The transcription factor C/EBP beta is up-regulated by calcitonin in kidney cells and results in a significant enhancement of calcitonin induction of 1 alpha(OH) ase transcription and protein expression. Mutation constructs of the 1 alpha(OH) ase promoter demonstrate the importance of the C/EBP beta binding site at -79/-73 for activation of the 1 alpha(OH) ase promoter by calcitonin. The SWI/SNF chromatin remodeling complex was found to cooperate with calcitonin in the regulation of 1 alpha(OH) ase. Chromatin immunoprecipitation analysis showed that calcitonin recruits C/EBP beta to the 1 alpha(OH) ase promoter, and Re-chromatin immunoprecipitation analysis (sequential chromatin immunoprecipitations using different antibodies) showed that C/EBP beta and BRG1, an ATPase that is a component of the SWI/SNF complex, bind simultaneously to the 1 alpha(OH)ase promoter. These findings are the first to address the dynamics between calcitonin, C/EBP beta, and SWI/SNF in the regulation of 1 alpha(OH) aseandprovideamechanism, forthefirsttime, for calcitonin induction of 1 alpha(OH) ase. Because plasma calcitonin as well as 1,25(OH)(2)D-3 have been reported to be increased during pregnancy and lactation and in early development, these findings suggest a mechanism that may account, at least in part, for the increase in plasma 1,25(OH)(2)D-3 during these times of increased calcium requirement.	[Zhong, Yan; Christakos, Sylvia] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Armbrecht, Harvey J.] St Louis Vet Affairs Med Ctr, Geriatr Ctr, St Louis, MO 63125 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Christakos, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	christak@umdnj.edu			National Institutes of Health [DK-38961]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-38961 (to S. C.).	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Armbrecht HJ, 2007, J STEROID BIOCHEM, V103, P330, DOI 10.1016/j.jsbmb.2006.12.035; Bikle D., 2008, PRIMER METABOLIC BON, P141; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; Brenza HL, 2001, ARCH BIOCHEM BIOPHYS, V388, P121, DOI 10.1006/abbi.2001.2279; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Chew CH, 2007, INT J BIOCHEM CELL B, V39, P1975, DOI 10.1016/j.biocel.2007.05.015; COOPER CW, 1977, ENDOCRINOLOGY, V101, P1657, DOI 10.1210/endo-101-6-1657; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; Di-Poi N, 2005, J BIOL CHEM, V280, P38700, DOI 10.1074/jbc.M507782200; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; EMMERTSEN K, 1984, ACTA ENDOCRINOL-COP, V106, P346, DOI 10.1530/acta.0.1060346; EMMERTSEN K, 1982, METAB BONE DIS RELAT, V4, P17, DOI 10.1016/0221-8747(82)90004-2; Esteban L, 2004, J STEROID BIOCHEM, V89-90, P131, DOI 10.1016/j.jsbmb.2004.03.092; GALANTE L, 1972, NATURE, V238, P271, DOI 10.1038/238271a0; Gao XH, 2002, INT J BIOCHEM CELL B, V34, P921, DOI 10.1016/S1357-2725(01)00165-0; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Gutierrez J, 2007, J BIOL CHEM, V282, P9445, DOI 10.1074/jbc.M609847200; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Henry HL, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P69; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; JAEGER P, 1986, J CLIN INVEST, V78, P456, DOI 10.1172/JCI112597; KAWASHIMA H, 1981, NATURE, V291, P327, DOI 10.1038/291327a0; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Kong XF, 1999, P NATL ACAD SCI USA, V96, P6988, DOI 10.1073/pnas.96.12.6988; Kovacs CS, 2002, AM J PHYSIOL-ENDOC M, V282, pE721, DOI 10.1152/ajpendo.00369.2001; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KUMAR R, 1979, J CLIN INVEST, V63, P342, DOI 10.1172/JCI109308; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nakamura M, 2007, J MOL ENDOCRINOL, V39, P375, DOI 10.1677/JME-07-0036; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; NISHIOKA T, 1988, EUR J PEDIATR, V147, P148, DOI 10.1007/BF00442212; Omdahl JL, 2003, J CELL BIOCHEM, V88, P356, DOI 10.1002/jcb.10366; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Segawa N, 2001, CANCER RES, V61, P6060; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shinki T, 1999, P NATL ACAD SCI USA, V96, P8253, DOI 10.1073/pnas.96.14.8253; StArnaud R, 1997, J BONE MINER RES, V12, P1552, DOI 10.1359/jbmr.1997.12.10.1552; STEVENSON JC, 1979, LANCET, V2, P769, DOI 10.1016/S0140-6736(79)92117-2; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Thomas S, 2006, MOL ENDOCRINOL, V20, P1894, DOI 10.1210/me.2005-0284; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang YQ, 2003, ENDOCRINOLOGY, V144, P2164, DOI 10.1210/en.2002-220740; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9; Zierold C, 2007, ARCH BIOCHEM BIOPHYS, V460, P233, DOI 10.1016/j.abb.2006.11.028	60	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11059	11069		10.1074/jbc.M806561200	http://dx.doi.org/10.1074/jbc.M806561200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261615	Green Published, hybrid			2022-12-25	WOS:000265494500010
J	Li, JJ; Liu, DP; Liu, GT; Xie, D				Li, J-J; Liu, D-P; Liu, G-T; Xie, D.			EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor	ONCOGENE			English	Article						ephrinA5; EGFR; c-Cbl; glioma	C-CBL; EPH RECEPTORS; TYROSINE KINASES; GENE-EXPRESSION; CANCER CELLS; T-CELLS; PHOSPHORYLATION; BINDING; LIGAND; TUMORIGENICITY	Eph receptors, the largest subfamily of receptor tyrosine kinases, and their ephrin ligands play important roles in nervous system development. Recently, they have been implicated in tumorigenesis of different cancers. In this study, we showed that the expression of ephrinA5 was dramatically downregulated in primary gliomas compared with normal tissues. Forced expression of ephrinA5 reduced tumorigenicity of human glioma U373 cells. Epidermal growth factor receptor (EGFR), which frequently acts as an oncoprotein in glioma, was greatly decreased in ephrinA5-transfected glioma cells, and the two molecules exhibited a mutually exclusive expression pattern in primary glioma samples. We found that ephrinA5 enhanced c-Cbl binding to EGFR, thus promoted ubiquitylation and degradation of the receptor. Either ephrinA5-Fc or EphA2-Fc treatment simulating bidirectional signaling of Eph/ephrin system resulted in EGFR decrease. This study discovered that ephrinA5 acted as a tumor suppressor in glioma, and its negative regulation of EGFR contributed to the suppressive effects. In addition to identifying a novel mechanism underlying tumor suppressor activity of ephrinA5, we also showed cross-talk between different receptor tyrosine kinase families in glioma. These.ndings may improve therapeutic strategies for glioma.	[Xie, D.] Chinese Acad Sci, Mol Oncol Lab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Li, J-J] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Liu, G-T] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Cedars Sinai Medical Center	Xie, D (corresponding author), Chinese Acad Sci, Mol Oncol Lab, Inst Nutr Sci, Shanghai Inst Biol Sci, 294 Tai Yuan Rd, Shanghai 200031, Peoples R China.	dxie@sibs.ac.cn		Xie, Dong/0000-0002-1150-8657				Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Finne EF, 2004, BIOCHEM J, V379, P39, DOI 10.1042/BJ20031619; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Liu DP, 2007, INT J ONCOL, V30, P865; Liu XW, 2000, J BIOL CHEM, V275, P7280, DOI 10.1074/jbc.275.10.7280; Munthe E, 2000, FEBS LETT, V466, P169, DOI 10.1016/S0014-5793(99)01793-7; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Otal R, 2006, NEUROSCIENCE, V141, P109, DOI 10.1016/j.neuroscience.2006.03.052; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Sharfe N, 2003, J IMMUNOL, V170, P6024, DOI 10.4049/jimmunol.170.12.6024; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Varelias A, 2002, CANCER, V95, P862, DOI 10.1002/cncr.10749; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang YJ, 2002, BIOCHEM BIOPH RES CO, V296, P214, DOI 10.1016/S0006-291X(02)00806-9; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; XU J, 1993, J BIOL CHEM, V268, P16065; Yarden RI, 2001, J CELL BIOCHEM, P232	36	51	55	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2009	28	15					1759	1768		10.1038/onc.2009.15	http://dx.doi.org/10.1038/onc.2009.15			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	439PV	19270726				2022-12-25	WOS:000265640400003
J	Endo, K; Kondo, S; Shackleford, J; Horikawa, T; Kitagawa, N; Yoshizaki, T; Furukawa, M; Zen, Y; Pagano, JS				Endo, K.; Kondo, S.; Shackleford, J.; Horikawa, T.; Kitagawa, N.; Yoshizaki, T.; Furukawa, M.; Zen, Y.; Pagano, J. S.			Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration	ONCOGENE			English	Article						latent membrane protein 1; ezrin; nasopharyngeal carcinoma; cell migration	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EPITHELIAL-CELLS; ERM PROTEINS; KINASE-C; MEMBRANE-PROTEIN-1; GROWTH; EXPRESSION; INDUCTION; CYTOSKELETON; MOTILITY	Tumor metastasis is a complex phenomenon that is the culmination of effects of numerous cellular factors. We have shown that the Epstein-Barr virus (EBV) oncoprotein, latent membrane protein 1(LMP1), is capable of inducing a wide range of such factors in cell culture, expression of which is also elevated in the LMP1-expressing tumor, nasopharyngeal carcinoma (NPC), a highly invasive neoplasm. Recently, the membrane crosslinker protein, ezrin, has been implicated in tumor cell metastasis and malignant progression. In this study, we evaluated the possible role of LMP1 and ezrin in the pathophysiology of NPC. We show that C-terminal phosphorylation of ezrin is increased by the expression of LMP1 in nasopharyngeal (NP) cells through a protein kinase C (PKC) pathway. LMP1 enhances the organization of a ternary complex of CD44, ezrin and F-actin, which is a prerequisite for ezrin phosphorylation. In NPC tissues, the expression of phosphoezrin and LMP1 is directly correlated. Silencing of endogenously expressed ezrin suppresses LMP1-induced cell motility and invasiveness. Moreover, the inhibition of ezrin phosphorylation by PKC inhibitor suppresses migration and invasion of NP cells. These data show that the phosphorylation of ezrin and its recruitment to the cell membrane linked to F-actin and CD44 is a process required for LMP1-stimulated cell motility and invasion of NP cells.	[Pagano, J. S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Pagano, J. S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Endo, K.; Kondo, S.; Horikawa, T.; Kitagawa, N.; Yoshizaki, T.; Furukawa, M.] Kanazawa Univ, Grad Sch Med, Div Otolaryngol, Kanazawa, Ishikawa, Japan; [Zen, Y.] Kanazawa Univ Hosp, Div Pathol, Kanazawa, Ishikawa, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Kanazawa University; Kanazawa University	Pagano, JS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, West Dr, Chapel Hill, NC 27599 USA.	joseph_pagano@med.unc.edu			NCI [CA 19014]; Nakayama Foundation for Human Science (Tokyo, Japan); NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042371] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nakayama Foundation for Human Science (Tokyo, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sai Wah Tsao and Erik K Flemington for the NP69SV40T cell line and the Ad-AH cell line, respectively. We thank Drs Yojiro Kotake and Yuki Okada for helpful advice. This work was supported by NCI (CA 19014) (JSP) and the Nakayama Foundation for Human Science (Tokyo, Japan) (KE).	Auvinen E, 2007, EXP CELL RES, V313, P824, DOI 10.1016/j.yexcr.2006.12.002; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; CONTRERASBRODIN BA, 1991, J GEN VIROL, V72, P3025, DOI 10.1099/0022-1317-72-12-3025; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Fais S, 2004, TRENDS MOL MED, V10, P249, DOI 10.1016/j.molmed.2004.04.005; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Hiscox S, 1999, J CELL SCI, V112, P3081; Hopkins AM, 2007, AM J PHYSIOL-GASTR L, V292, pG806, DOI 10.1152/ajpgi.00333.2006; Horikawa T, 2001, AM J PATHOL, V159, P27, DOI 10.1016/S0002-9440(10)61669-0; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kondo S, 2005, INT J CANCER, V115, P368, DOI 10.1002/ijc.20849; Kondo S, 2007, J VIROL, V81, P1554, DOI 10.1128/JVI.02222-06; Kondo S, 2006, CANCER RES, V66, P9870, DOI 10.1158/0008-5472.CAN-06-1679; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Miller WE, 1997, J VIROL, V71, P586, DOI 10.1128/JVI.71.1.586-594.1997; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Park JH, 2002, VIROLOGY, V303, P345, DOI 10.1006/viro.2002.1638; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; RAAB-TRAUB N, 1987, Journal of Experimental Pathology (New York), V3, P449; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; TAKIMOTO T, 1988, LARYNGOSCOPE, V98, P1334; Tsao SW, 2002, SEMIN CANCER BIOL, V12, P473, DOI 10.1016/S1044579X02000901; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Wakisaka N, 2002, CANCER RES, V62, P6337; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; WALTER J, 1995, INT J CANCER, V61, P363, DOI 10.1002/ijc.2910610315; Yan GR, 2007, CELL SIGNAL, V19, P341, DOI 10.1016/j.cellsig.2006.07.019; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Yoshizaki T, 2005, EPSTEIN-BARR VIRUS, P171; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5	43	61	70	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2009	28	14					1725	1735		10.1038/onc.2009.20	http://dx.doi.org/10.1038/onc.2009.20			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	430WQ	19234486	Green Accepted, Green Submitted			2022-12-25	WOS:000265022000007
J	Jansen, PAM; Rodijk-Olthuis, D; Hollox, EJ; Kamsteeg, M; Tjabringa, GS; de Jongh, GJ; van Vlijmen-Willems, IMJJ; Bergboer, JGM; van Rossum, MM; de Jong, EMGJ; den Heijer, M; Evers, AWM; Bergers, M; Armour, JAL; Zeeuwen, PLJM; Schalkwijk, J				Jansen, Patrick A. M.; Rodijk-Olthuis, Diana; Hollox, Edward J.; Kamsteeg, Marijke; Tjabringa, Geuranne S.; de Jongh, Gys J.; van Vlijmen-Willems, Ivonne M. J. J.; Bergboer, Judith G. M.; van Rossum, Michelle M.; de Jong, Elke M. G. J.; den Heijer, Martin; Evers, Andrea W. M.; Bergers, Mieke; Armour, John A. L.; Zeeuwen, Patrick L. J. M.; Schalkwijk, Joost			beta-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin	PLOS ONE			English	Article								Background: Previous studies have extensively documented antimicrobial and chemotactic activities of beta-defensins. Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility. It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis. Methodology/Principal Findings: We found that systemic levels of hBD-2 showed a weak but significant correlation with beta defensin copy number in healthy controls but not in psoriasis patients with active disease. In psoriasis patients but not in atopic dermatitis patients, we found high systemic hBD-2 levels that strongly correlated with disease activity as assessed by the PASI score. Our findings suggest that systemic levels in psoriasis are largely determined by secretion from involved skin and not by genomic copy number. Modelling of the in vivo epidermal hBD-2 concentration based on the secretion rate in a reconstructed skin model for psoriatic epidermis provides evidence that epidermal hBD-2 levels in vivo are probably well above the concentrations required for in vitro antimicrobial and chemokine-like effects. Conclusions/Significance: Serum hBD-2 appears to be a useful surrogate marker for disease activity in psoriasis. The discrepancy between hBD-2 levels in psoriasis and atopic dermatitis could explain the well known differences in infection rate between these two diseases.	[Jansen, Patrick A. M.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; Tjabringa, Geuranne S.; de Jongh, Gys J.; van Vlijmen-Willems, Ivonne M. J. J.; Bergboer, Judith G. M.; van Rossum, Michelle M.; de Jong, Elke M. G. J.; Bergers, Mieke; Zeeuwen, Patrick L. J. M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Jansen, Patrick A. M.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; Tjabringa, Geuranne S.; de Jongh, Gys J.; van Vlijmen-Willems, Ivonne M. J. J.; Bergboer, Judith G. M.; van Rossum, Michelle M.; de Jong, Elke M. G. J.; Bergers, Mieke; Zeeuwen, Patrick L. J. M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands; [Evers, Andrea W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, Nijmegen, Netherlands; [Armour, John A. L.] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England	Radboud University Nijmegen; Radboud University Nijmegen; University of Leicester; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Nottingham	Jansen, PAM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands.	j.schalkwijk@ncmls.ru.nl	Evers, A.W.M./L-4299-2015; Rossum, M.M./L-4614-2015; de Jong, Elke M. G. J./L-4418-2015; Zeeuwen, Patrick/N-1779-2013; Kamsteeg, M./L-4422-2015; van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; Jansen, Patrick AM/P-5602-2015; Schalkwijk, Joost/R-7509-2019; Schalkwijk, Joost/N-1774-2013; Evers, Andrea/GWV-9705-2022; den Heijer, Martin/J-8036-2015	de Jong, Elke M. G. J./0000-0003-3872-5704; Zeeuwen, Patrick/0000-0002-6878-2438; van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; Schalkwijk, Joost/0000-0002-1308-1319; den Heijer, Martin/0000-0003-3620-5617; Hollox, Edward/0000-0002-0115-2298; Armour, John/0000-0002-8558-8506	Radboud University Nijmegen Medical Centre; Netherlands Organization for Scientific Research; VENI [902.11.092]; ZONMW alternatives to animal experiments programme [114000084]	Radboud University Nijmegen Medical Centre; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); VENI(Netherlands Organization for Scientific Research (NWO)); ZONMW alternatives to animal experiments programme	This work was supported by grants from the Radboud University Nijmegen Medical Centre, the Netherlands Organization for Scientific Research, VENI grant 902.11.092 to P.Z., and the ZONMW alternatives to animal experiments programme, grant 114000084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKEMADE HAC, 1995, J INVEST DERMATOL, V104, P189, DOI 10.1111/1523-1747.ep12612749; ALKEMADE HAC, 1993, AM J PATHOL, V143, P1679; ANDERSON KS, 2008, BR J DERMATOL; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Di Nardo A, 2007, J IMMUNOL, V178, P1829, DOI 10.4049/jimmunol.178.3.1829; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; GALLAGHER WH, 1989, BIOPOLYMERS, V28, P2001, DOI 10.1002/bip.360281115; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Howell MD, 2006, CLIN IMMUNOL, V121, P332, DOI 10.1016/j.clim.2006.08.008; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; LAURENT MR, 1981, ANN RHEUM DIS, V40, P66, DOI 10.1136/ard.40.1.66; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MENSSEN A, 1995, J IMMUNOL, V155, P4078; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2002, INT IMMUNOL, V14, P421, DOI 10.1093/intimm/14.4.421; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; SCHALKWIJK J, 2006, Patent No. 2007073151; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Tjabringa G, 2008, AM J PATHOL, V173, P815, DOI 10.2353/ajpath.2008.080173; van Riel PLCM, 2001, BEST PRACT RES CL RH, V15, P67, DOI 10.1053/berh.2000.0126; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zeeuwen PLJM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002301	51	137	148	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4725	10.1371/journal.pone.0004725	http://dx.doi.org/10.1371/journal.pone.0004725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266104	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490800006
J	Garcia-Espana, A; Mares, R; Sun, TT; DeSalle, R				Garcia-Espana, Antonio; Mares, Roso; Sun, Tung-Tien; DeSalle, Rob			Intron Evolution: Testing Hypotheses of Intron Evolution Using the Phylogenomics of Tetraspanins	PLOS ONE			English	Article							SPLICEOSOMAL INTRONS; EXTRACELLULAR DOMAIN; LARGE-SCALE; PROTEIN; GENE; SUPERFAMILY; POSITIONS; GAIN; GENOME; WEB	Background: Although large scale informatics studies on introns can be useful in making broad inferences concerning patterns of intron gain and loss, more specific questions about intron evolution at a finer scale can be addressed using a gene family where structure and function are well known. Genome wide surveys of tetraspanins from a broad array of organisms with fully sequenced genomes are an excellent means to understand specifics of intron evolution. Our approach incorporated several new fully sequenced genomes that cover the major lineages of the animal kingdom as well as plants, protists and fungi. The analysis of exon/intron gene structure in such an evolutionary broad set of genomes allowed us to identify ancestral intron structure in tetraspanins throughout the eukaryotic tree of life. Methodology/Principal Findings: We performed a phylogenomic analysis of the intron/exon structure of the tetraspanin protein family. In addition, to the already characterized tetraspanin introns numbered 1 through 6 found in animals, three additional ancient, phase 0 introns we call 4a, 4b and 4c were found. These three novel introns in combination with the ancestral introns 1 to 6, define three basic tetraspanin gene structures which have been conserved throughout the animal kingdom. Our phylogenomic approach also allows the estimation of the time at which the introns of the 33 human tetraspanin paralogs appeared, which in many cases coincides with the concomitant acquisition of new introns. On the other hand, we observed that new introns (introns other than 1-6, 4a, b and c) were not randomly inserted into the tetraspanin gene structure. The region of tetraspanin genes corresponding to the small extracellular loop (SEL) accounts for only 10.5% of the total sequence length but had 46% of the new animal intron insertions. Conclusions/Significance: Our results indicate that tests of intron evolution are strengthened by the phylogenomic approach with specific gene families like tetraspanins. These tests add to our understanding of genomic innovation coupled to major evolutionary divergence events, functional constraints and the timing of the appearance of evolutionary novelty.	[Garcia-Espana, Antonio; Mares, Roso] Univ Rovira & Virgili, Unitat Recerca, Hosp Joan 23, Inst Invest Sanit Rovira & Virgili IISPV, Tarragona, Spain; [Garcia-Espana, Antonio] Univ Rovira & Virgili, CIBERDEM, Tarragona, Spain; [Sun, Tung-Tien] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Sun, Tung-Tien] NYU, Sch Med, Dept Urol, New York, NY USA; [DeSalle, Rob] American Museum Nat Hist, Sackler Inst Comparative Genom, New York, NY USA	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; New York University; New York University; New York University; New York University; American Museum of Natural History (AMNH)	Garcia-Espana, A (corresponding author), Univ Rovira & Virgili, Unitat Recerca, Hosp Joan 23, Inst Invest Sanit Rovira & Virgili IISPV, Tarragona, Spain.	agarciae.hj23.ics@gencat.cat; desalle@amnh.org	garcia-españa, antonio/I-4756-2015; Sun, Tung-Tien/J-4425-2015	garcia-españa, antonio/0000-0002-9957-3161; Sun, Tung-Tien/0000-0002-6841-1063; mares, Roso/0000-0002-7339-0172	NIH [DK39753, DK52206];  [FIS 02/3003];  [PI070789]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039753, P01DK052206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grants DK39753 and DK52206 (T.T.S.), FIS 02/3003 and PI070789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bouchard P, 2001, ORG DIVERS EVOL, V1, P17, DOI 10.1078/1439-6092-00003; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Contreras-Moreira B, 2003, J MOL BIOL, V333, P1045, DOI 10.1016/j.jmb.2003.09.023; CRAIK CS, 1983, SCIENCE, V220, P1125, DOI 10.1126/science.6344214; De Kee DW, 2007, MOL BIOL EVOL, V24, P2158, DOI 10.1093/molbev/msm151; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Kumar S, 2005, CELL, V123, P1182, DOI 10.1016/j.cell.2005.12.007; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Lee JH, 2003, CANCER RES, V63, P7247; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Logsdon JM, 2004, P NATL ACAD SCI USA, V101, P11195, DOI 10.1073/pnas.0404148101; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; MADDISON DR, 2002, MACCLADE4 VERSION 4; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Robb L, 2001, BBA-GENE STRUCT EXPR, V1522, P31, DOI 10.1016/S0167-4781(01)00306-2; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Rogozin IB, 2000, TRENDS GENET, V16, P430, DOI 10.1016/S0168-9525(00)02096-5; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2005, P NATL ACAD SCI USA, V102, P713, DOI 10.1073/pnas.0408274102; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sato Y, 1999, GENE, V238, P93, DOI 10.1016/S0378-1119(99)00321-2; Saxonov S, 2000, NUCLEIC ACIDS RES, V28, P185, DOI 10.1093/nar/28.1.185; Schmidt EE, 2007, BIOESSAYS, V29, P262, DOI 10.1002/bies.20546; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Todres E, 2000, INSECT MOL BIOL, V9, P581, DOI 10.1046/j.1365-2583.2000.00222.x; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430	66	24	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4680	10.1371/journal.pone.0004680	http://dx.doi.org/10.1371/journal.pone.0004680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262691	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490600011
J	Ma, WJ; Zhou, X; Ross, LA; Foxe, JJ; Parra, LC				Ma, Wei Ji; Zhou, Xiang; Ross, Lars A.; Foxe, John J.; Parra, Lucas C.			Lip-Reading Aids Word Recognition Most in Moderate Noise: A Bayesian Explanation Using High-Dimensional Feature Space	PLOS ONE			English	Article							AUDIOVISUAL SPEECH-PERCEPTION; MULTISENSORY INTEGRATION; VISUAL SPEECH; SUPERIOR COLLICULUS; LEXICAL DISTINCTIVENESS; CONSONANT RECOGNITION; SPATIAL LOCALIZATION; AUDITORY DETECTION; POPULATION CODES; HEARING LIPS	Watching a speaker's facial movements can dramatically enhance our ability to comprehend words, especially in noisy environments. From a general doctrine of combining information from different sensory modalities (the principle of inverse effectiveness), one would expect that the visual signals would be most effective at the highest levels of auditory noise. In contrast, we find, in accord with a recent paper, that visual information improves performance more at intermediate levels of auditory noise than at the highest levels, and we show that a novel visual stimulus containing only temporal information does the same. We present a Bayesian model of optimal cue integration that can explain these conflicts. In this model, words are regarded as points in a multidimensional space and word recognition is a probabilistic inference process. When the dimensionality of the feature space is low, the Bayesian model predicts inverse effectiveness; when the dimensionality is high, the enhancement is maximal at intermediate auditory noise levels. When the auditory and visual stimuli differ slightly in high noise, the model makes a counterintuitive prediction: as sound quality increases, the proportion of reported words corresponding to the visual stimulus should first increase and then decrease. We confirm this prediction in a behavioral experiment. We conclude that auditory-visual speech perception obeys the same notion of optimality previously observed only for simple multisensory stimuli.	[Ma, Wei Ji] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zhou, Xiang; Parra, Lucas C.] CUNY City Coll, Dept Biomed Engn, New York, NY USA; [Ross, Lars A.; Foxe, John J.] CUNY City Coll, Dept Psychol, Program Cognitive Neurosci, New York, NY USA; [Ross, Lars A.; Foxe, John J.] Nathan S Kline Inst Psychiat Res, Cognitive Neurosci Lab, Program Cognitive Neurosci & Schizophrenia, Orangeburg, NY USA; [Foxe, John J.] City Univ New York, Queens Coll, Dept Psychol, Program Neuropsychol, Flushing, NY USA	Baylor College of Medicine; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Nathan Kline Institute for Psychiatric Research; City University of New York (CUNY) System; Queens College NY (CUNY)	Ma, WJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	wjma@bcm.edu	Zhou, Xiang/D-9614-2011	Foxe, John/0000-0002-4300-3098; Ma, Wei Ji/0000-0002-9835-9083				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Auer ET, 1997, J ACOUST SOC AM, V102, P3704, DOI 10.1121/1.420402; Auer ET, 2002, PSYCHON B REV, V9, P341, DOI 10.3758/BF03196291; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Bernstein L. E., 2004, HDB MULTISENSORY PRO, P203; Bernstein LE, 2000, PERCEPT PSYCHOPHYS, V62, P233, DOI 10.3758/BF03205546; BERNSTEIN LE, 2008, BRAIN RES; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; BINNIE CA, 1974, J SPEECH HEAR RES, V17, P619, DOI 10.1044/jshr.1704.619; Bolognini N, 2005, NEUROPSYCHOLOGIA, V43, P1655, DOI 10.1016/j.neuropsychologia.2005.01.015; BRAIDA LD, 1991, Q J EXP PSYCHOL-A, V43, P647, DOI 10.1080/14640749108400991; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; BUUS S, 1985, J ACOUST SOC AM, V78, P1958, DOI 10.1121/1.392652; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; CALVERT GA, 2004, HEMODYNAMIC STUDIES; CAMPBELL R, 1998, SCAND AUDIOL S, V49; CAMPBELL R, 2007, PHILOS T R SOC LON B; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; ERBER NP, 1975, J SPEECH HEAR DISORD, V40, P481, DOI 10.1044/jshd.4004.481; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FISHER CG, 1968, J SPEECH HEAR RES, V11, P796, DOI 10.1044/jshr.1104.796; GHAHRAMANI Z, 1995, COMPUTATIONAL PSYCHO; Gillmeister H, 2007, BRAIN RES, V1160, P58, DOI 10.1016/j.brainres.2007.03.041; Gordon PC, 1997, J ACOUST SOC AM, V102, P2276, DOI 10.1121/1.419600; Grant KW, 1996, J ACOUST SOC AM, V100, P2415, DOI 10.1121/1.417950; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Grant KW, 2001, J ACOUST SOC AM, V109, P2272, DOI 10.1121/1.1362687; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Hall DA, 2005, J COGNITIVE NEUROSCI, V17, P939, DOI 10.1162/0898929054021175; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HOLMES NP, 2007, NEUROPSYCHOLOGIA; Iverson P, 1998, SPEECH COMMUN, V26, P45, DOI 10.1016/S0167-6393(98)00049-1; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jiang JT, 2007, PERCEPT PSYCHOPHYS, V69, P1070, DOI 10.3758/BF03193945; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.7.5; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2003, VISION RES, V43, P831, DOI 10.1016/S0042-6989(03)00003-8; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kucera H., 1967, COMPUTATIONAL ANAL P; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Lebib R, 2003, NEUROSCI LETT, V341, P185, DOI 10.1016/S0304-3940(03)00131-9; LEHNSCHIOLER T, THESIS; Lidestam B, 2001, SCAND AUDIOL, V30, P89, DOI 10.1080/010503901300112194; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacEachern MR, 2000, J PHONETICS, V28, P367, DOI 10.1006/jpho.2000.0119; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; Massaro D.W., 1998, PERCEIVING TALKING F; MASSARO DW, 1993, J PHONETICS, V21, P445, DOI 10.1016/S0095-4470(19)30230-X; Massaro DW, 1987, SPEECH PERCEPTION EA; Mattys SL, 2002, PERCEPT PSYCHOPHYS, V64, P667, DOI 10.3758/BF03194734; MCCORMICK B, 1979, CLIN OTOLARYNGOL, V4, P355, DOI 10.1111/j.1365-2273.1979.tb01764.x; MCGRATH M, 1985, J ACOUST SOC AM, V77, P678, DOI 10.1121/1.392336; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, BRAIN RES, V365, P350; MILLER GA, 1951, J EXP PSYCHOL, V41, P329, DOI 10.1037/h0062491; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Rach S, 2006, EXP BRAIN RES, V173, P514, DOI 10.1007/s00221-006-0452-4; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; ROSEN SM, 1981, NATURE, V291, P150, DOI 10.1038/291150a0; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Rowland B, 2007, EXP BRAIN RES, V180, P153, DOI 10.1007/s00221-006-0847-2; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Schwartz JL, 2004, COGNITION, V93, pB69, DOI 10.1016/j.cognition.2004.01.006; Sekiyama K, 1997, PERCEPT PSYCHOPHYS, V59, P73, DOI 10.3758/BF03206849; Serino A, 2007, NEUROPSYCHOLOGIA, V45, P1101, DOI 10.1016/j.neuropsychologia.2006.09.013; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stein BE., 1993, MERGING SENSES; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Thomas SM, 2004, J EXP PSYCHOL HUMAN, V30, P873, DOI 10.1037/0096-1523.30.5.873; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; WANG MD, 1978, J SPEECH HEAR RES, V21, P5, DOI 10.1044/jshr.2101.05; WANG MD, 1973, J ACOUST SOC AM, V54, P1248, DOI 10.1121/1.1914417	92	123	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4638	10.1371/journal.pone.0004638	http://dx.doi.org/10.1371/journal.pone.0004638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MB	19259259	Green Published, gold			2022-12-25	WOS:000265490500005
J	Ganatra, HA; Bhurgri, H; Channa, R; Bawany, FA; Zafar, SN; Chaudhry, RI; Batool, SH; Basit, A; Asghar, M; Saleem, S; Naqvi, H				Ganatra, Hammad Ashraf; Bhurgri, Hadi; Channa, Roomasa; Bawany, Fauzia Ahmad; Zafar, Syed Nabeel; Chaudhry, Rafia Ishfaq; Batool, Syeda Hina; Basit, Abdul; Asghar, Mehmood; Saleem, Sarah; Naqvi, Haider			Educating and Informing Patients Receiving Psychopharmacological Medications: Are Family Physicians in Pakistan up to the Task?	PLOS ONE			English	Article							PSYCHOTROPIC-DRUGS; RISK-FACTORS; HEALTH-CARE; DEPRESSION; PRACTITIONERS; PSYCHOTHERAPY; PRESCRIPTION; DISEASE; BURDEN	Introduction: Studies have shown a high prevalence of psychiatric illnesses among patients in primary health care settings. Family physicians have a fundamental role in managing psychiatric illness with psychopharmacological medications. Providing information about the disease, its management and the potential adverse effects of the medications is an important part of the management of mental illnesses. Our objective was to determine if patients who were prescribed psychopharmacological drugs by family physicians at a community health center in Karachi, Pakistan were provided adequate education about their disease and its management. Methods: A cross-sectional study was conducted at the Community Health Centre (CHC), Aga Khan University Hospital Karachi, Pakistan. Details about the prescriptions and patient education were acquired from the patients after their consultations. Results: A total of 354 adult patients were interviewed during 3 days. Among them, 73 (20.6%) were prescribed psychopharmacological medications. Among patients receiving psychopharmacological medicines, 37 (50.7%) did not know their diagnosis; 50 (68.5%) were unaware of the disease process; 52 (71.2%) were unaware of alternative treatments; 63 (86.3%) were not cautioned about the potential adverse effects of the drugs; 24 (32.9%) were unaware of the duration of treatment and in 60 (82.2%) of the participants an appropriate referral had not been discussed. For all aspects of education, patients prescribed psychopharmacological medications knew less as compared to those patients that were prescribed other medications. Discussion: The practice of imparting information to patients who receive psychopharmacological medications seems to be inadequate in Pakistan. We have hypothesized about the possible reasons for our findings, and identified a need for further research to determine the cause for such findings and to address them accordingly. At the same time there is a need to educate family physicians in Pakistan about the special importance of providing adequate information to such patients.	[Ganatra, Hammad Ashraf; Bhurgri, Hadi; Channa, Roomasa; Bawany, Fauzia Ahmad; Zafar, Syed Nabeel; Chaudhry, Rafia Ishfaq; Batool, Syeda Hina; Basit, Abdul; Asghar, Mehmood] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Naqvi, Haider] Aga Khan Univ, Dept Psychiat, Karachi, Pakistan	Aga Khan University; Aga Khan University; Aga Khan University	Ganatra, HA (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	hammadganatra@gmail.com	Ganatra, Hammad A/P-8652-2019; C, Roomasa/AAK-5176-2020	Ganatra, Hammad A/0000-0001-9534-2780; Zafar, Syed Nabeel/0000-0003-3843-9687				BELLANTUONO C, 1989, SOC PSYCH PSYCH EPID, V24, P212; Biggs JSG, 2008, JCPSP-J COLL PHYSICI, V18, P58, DOI 01.2008/JCPSP.5863; de Maat SM, 2007, EUR PSYCHIAT, V22, P1, DOI 10.1016/j.eurpsy.2006.10.008; Hansen Hanne Vibe, 2007, Expert Rev Neurother, V7, P57, DOI 10.1586/14737175.7.1.57; Hartley D, 1998, ARCH FAM MED, V7, P139, DOI 10.1001/archfami.7.2.139; JOUKAMAA M, 1995, ACTA PSYCHIAT SCAND, V92, P359, DOI 10.1111/j.1600-0447.1995.tb09597.x; Khan MM, 2006, PSYCHIATR BULL, V30, P85, DOI 10.1192/pb.30.3.85; Kisely S, 2000, PSYCHOL MED, V30, P1217, DOI 10.1017/S0033291799002743; Linden M, 1999, J CLIN PSYCHOPHARM, V19, P132, DOI 10.1097/00004714-199904000-00007; Linden M, 2008, J GEN INTERN MED, V23, P1567, DOI 10.1007/s11606-008-0648-3; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mirza I, 2006, SOC SCI MED, V63, P593, DOI 10.1016/j.socscimed.2006.01.028; Molenaar PJ, 2007, DEPRESS ANXIETY, V24, P553, DOI 10.1002/da.20254; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naqvi Haider A, 2006, J Coll Physicians Surg Pak, V16, P438; NEESHAT MQ, 2007, PHARMAGUIDE QUICK RE; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; SABOOH SM, 2001, JCPSP-J COLL PHYSICI, V11, P232; Salzman C, 1998, PSYCHIAT QUART, V69, P251, DOI 10.1023/A:1022125929946; Syed EU, 2008, ACAD PSYCHIATR, V32, P160, DOI 10.1176/appi.ap.32.2.160; Thaver IH, 1998, SOC SCI MED, V46, P1441, DOI 10.1016/S0277-9536(97)10134-4; Upshur Carole, 2008, Prim Care Companion J Clin Psychiatry, V10, P182; Ziegler DK, 2001, ARCH INTERN MED, V161, P706, DOI 10.1001/archinte.161.5.706	24	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4620	10.1371/journal.pone.0004620	http://dx.doi.org/10.1371/journal.pone.0004620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437LA	19247488	gold, Green Submitted, Green Published			2022-12-25	WOS:000265487800003
J	Hoa, N; Myers, MP; Douglass, TG; Zhang, JG; Delgado, C; Driggers, L; Callahan, LL; VanDeusen, G; Pham, JTH; Bhakta, N; Ge, LS; Jadus, MR				Hoa, Neil; Myers, Michael P.; Douglass, Thomas G.; Zhang, Jian Gang; Delgado, Christina; Driggers, Lara; Callahan, Linda L.; VanDeusen, Gerald; Pham, Jimmy T. H.; Bhakta, Nirav; Ge, Lisheng; Jadus, Martin R.			Molecular Mechanisms of Paraptosis Induction: Implications for a Non-Genetically Modified Tumor Vaccine	PLOS ONE			English	Article								Paraptosis is the programmed cell death pathway that leads to cellular necrosis. Previously, rodent and human monocytes/macrophages killed glioma cells bearing the membrane macrophage colony stimulating factor (mM-CSF) through paraptosis, but the molecular mechanism of this killing process was never identified. We have demonstrated that paraptosis of rat T9 glioma cells can be initiated through a large potassium channel (BK)-dependent process initiated by reactive oxygen species. Macrophage mediated cytotoxicity upon the mM-CSF expressing T9-C2 cells was not prevented by the addition of the caspase inhibitor, zVAD-fmk. By a combination of fluorescent confocal and electron microscopy, flow cytometry, electrophysiology, pharmacology, and genetic knock-down approaches, we demonstrated that these ion channels control cellular swelling and vacuolization of rat T9 glioma cells. Cell lysis is preceded by a depletion of intracellular ATP. Six-hour exposure to BK channel activation caused T9 cells to over express heat shock proteins (Hsp 60, 70, 90 and gp96). This same treatment forced HMGB1 translocation from the nuclear region to the periphery. These last molecules are "danger signals'' that can stimulate immune responses. Similar inductions of mitochondrial swelling and increased Hsp70 and 90 expressions by BK channel activation were observed with the non-immunogenic F98 glioma cells. Rats injected with T9 cells which were killed by prolonged BK channel activation developed immunity against the T9 cells, while the injection of x-irradiated apoptotic T9 cells failed to produce the vaccinating effect. These results are the first to show that glioma cellular death induced by prolonged BK channel activation improves tumor immunogenicity; this treatment reproduces the vaccinating effects of mM-CSF transduced cells. Elucidation of strategies as described in this study may prove quite valuable in the development of clinical immunotherapy against cancer.	[Hoa, Neil; Zhang, Jian Gang; Delgado, Christina; Driggers, Lara; Ge, Lisheng; Jadus, Martin R.] Vet Affairs Med Ctr, Diagnost & Mol Med Healthcare Grp, Long Beach, CA USA; [Zhang, Jian Gang; Jadus, Martin R.] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Zhang, Jian Gang; Jadus, Martin R.] Univ Calif Irvine, Lab Med, Irvine, CA 92717 USA; [Myers, Michael P.; VanDeusen, Gerald; Pham, Jimmy T. H.; Bhakta, Nirav] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA; [Callahan, Linda L.] Calif State Univ Long Beach, Nursing Dept, Long Beach, CA 90840 USA; [Douglass, Thomas G.] Calif State Univ Long Beach, Biol Dept, Long Beach, CA 90840 USA; [Jadus, Martin R.] Univ Calif Irvine, Chao Comprehensive Canc Ctr, Neuro Oncol Program, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Long Beach; California State University System; California State University Long Beach; California State University System; California State University Long Beach; University of California System; University of California Irvine	Hoa, N (corresponding author), Vet Affairs Med Ctr, Diagnost & Mol Med Healthcare Grp, Long Beach, CA USA.	martin.jadus@med.va.gov	Ge, Li/T-3955-2018; Pham, Jimmy Tam Huy/D-1537-2013	Ge, Li/0000-0002-1824-8034; Pham, Jimmy Tam Huy/0000-0003-0527-9832	Veterans Affairs Merit Review; AVon Breast Cancer Foundation; Howard Hughes Medical Institute; Research Corporation; CSUPERB	Veterans Affairs Merit Review(US Department of Veterans Affairs); AVon Breast Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Research Corporation(Research Corporation for Science Advancement); CSUPERB	Veterans Affairs Merit Review and AVon Breast Cancer Foundation: MRJ. Howard Hughes Medical Institute and Research Corporation and CSUPERB: MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; CASSEL D, 1986, J BIOL CHEM, V261, P5460; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen YJ, 2002, BLOOD, V100, P1373, DOI 10.1182/blood-2002-01-0174; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; Dan QH, 2001, MOL THER, V4, P427, DOI 10.1006/mthe.2001.0477; Delgado C, 2007, CYTOKINE, V38, P165, DOI 10.1016/j.cyto.2007.06.003; Eguchi Y, 1997, CANCER RES, V57, P1835; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; GABAI VL, 1994, EXP MOL PATHOL, V60, P88, DOI 10.1006/exmp.1994.1008; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Graf MR, 1999, J IMMUNOL, V163, P5544; Jadus MR, 1996, BLOOD, V87, P5232, DOI 10.1182/blood.V87.12.5232.bloodjournal87125232; Jadus MR, 1998, J IMMUNOL, V160, P361; Jadus MR, 2003, CANCER GENE THER, V10, P411, DOI 10.1038/sj.cgt.7700583; JADUS MR, 1999, RECENT RES DEV IMMUN, V1, P267; Jeffes EWB, 2005, J IMMUNOL, V174, P2533, DOI 10.4049/jimmunol.174.5.2533; Kabakov AE, 2002, AM J PHYSIOL-CELL PH, V283, pC521, DOI 10.1152/ajpcell.00503.2001; Kim JH, 2004, MACROMOL RES, V12, P53, DOI 10.1007/BF03218995; Kuppner MC, 2001, EUR J IMMUNOL, V31, P1602, DOI 10.1002/1521-4141(200105)31:5<1602::AID-IMMU1602>3.0.CO;2-W; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lipinski KS, 2006, CANCER IMMUNOL IMMUN, V55, P347, DOI 10.1007/s00262-005-0014-9; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; MYERS MP, 1999, ELECTRON J BIOTECHN, V2, P3; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; Nicotera P, 2000, BRAIN PATHOL, V10, P276, DOI 10.1111/j.1750-3639.2000.tb00261.x; Ransom CB, 2001, J NEUROPHYSIOL, V85, P790, DOI 10.1152/jn.2001.85.2.790; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sanchez R, 2002, CELL IMMUNOL, V215, P1, DOI 10.1016/S0008-8749(02)00011-4; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schneider D, 2004, CELL DEATH DIFFER, V11, P760, DOI 10.1038/sj.cdd.4401377; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; T Hoa N, 2007, LAB INVEST, V87, P115, DOI 10.1038/labinvest.3700506; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Williams CC, 2001, MOL THER, V3, P216, DOI 10.1006/mthe.2001.0253; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zakhartchenko VA, 2001, BIOTECHNIQUES, V31, P676, DOI 10.2144/01313dd06	43	51	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4631	10.1371/journal.pone.0004631	http://dx.doi.org/10.1371/journal.pone.0004631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247476	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487800013
J	El-Talatini, MR; Taylor, AH; Elson, JC; Brown, L; Davidson, AC; Konje, JC				El-Talatini, Mona R.; Taylor, Anthony H.; Elson, Janine C.; Brown, Laurence; Davidson, Allan C.; Konje, Justin C.			Localisation and Function of the Endocannabinoid System in the Human Ovary	PLOS ONE			English	Article								Background: Although anandamide (AEA) had been measured in human follicular fluid and is suggested to play a role in ovarian follicle and oocyte maturity, its exact source and role in the human ovary remains unclear. Methods and Findings: Immunohistochemical examination of normal human ovaries indicated that the endocannabinoid system was present and widely expressed in the ovarian medulla and cortex with more intense cannabinoid receptor 2 (CB2) than CB1 immunoreactivity in the granulosa cells of primordial, primary, secondary, tertiary follicles, corpus luteum and corpus albicans. The enzymes, fatty acid amide hydrolase (FAAH) and N-acyclphosphatidylethanolamine-phospholipase D (NAPE-PLD), were only found in growing secondary and tertiary follicles and corpora lutea and albicantes. The follicular fluid (FF) AEA concentrations of 260 FF samples, taken from 37 infertile women undergoing controlled ovarian hyperstimulation for in vitro fertilisation and intracytoplasmic sperm injection with embryo transfer, were correlated with ovarian follicle size (P = 0.03). Significantly higher FF AEA concentrations were also observed in mature follicles (1.43 +/- 0.04 nM; mean +/- SEM) compared to immature follicles (1.26 +/- 60.06 nM), P = 0.0142 and from follicles containing morphologically assessed mature oocytes (1.56 +/- 0.11 nM) compared to that containing immature oocytes (0.99 +/- 60.09 nM), P = 0.0011. ROC analysis indicated that a FF AEA level of 1.09 nM could discriminate between mature and immature oocytes with 72.2% sensitivity and 77.14% specificity, whilst plasma AEA levels and FF AEA levels on oocyte retrieval day were not significantly different (P = 0.23). Conclusions: These data suggest that AEA is produced in the ovary, is under hormonal control and plays a role in folliculogenesis, preovulatory follicle maturation, oocyte maturity and ovulation.	[El-Talatini, Mona R.; Taylor, Anthony H.; Konje, Justin C.] Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Endocannabinoid Res Grp, Leicester, Leics, England; [Elson, Janine C.; Davidson, Allan C.] Univ Hosp Leicester, NHS Trust, Leicester Royal Infirmary, Assisted Concept Unit, Leicester, Leics, England; [Brown, Laurence] Univ Hosp Leicester, NHS Trust, Leicester Royal Infirmary, Dept Pathol, Leicester, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester	El-Talatini, MR (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Endocannabinoid Res Grp, Leicester, Leics, England.	jck4@le.ac.uk		Taylor, Anthony/0000-0002-5746-9091	British United Provident Association (BUPA); Perkin-Elmer; Miscellaneous Research Income of the Endocannabinoid Research Group, University of Leicester	British United Provident Association (BUPA); Perkin-Elmer; Miscellaneous Research Income of the Endocannabinoid Research Group, University of Leicester	This work was supported in part by a British United Provident Association (BUPA) grant, generous funding from Perkin-Elmer, with additional funding provided from the Miscellaneous Research Income of the Endocannabinoid Research Group, University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADASHI EY, 1983, AM J PHYSIOL, V244, pE177, DOI 10.1152/ajpendo.1983.244.2.E177; Arslan M, 2005, FERTIL STERIL, V84, P555, DOI 10.1016/j.fertnstert.2005.02.053; AYALON D, 1977, NEUROENDOCRINOLOGY, V23, P31, DOI 10.1159/000122652; Braude P, 2003, BMJ-BRIT MED J, V327, P852, DOI 10.1136/bmj.327.7419.852; Brown TT, 2002, J CLIN PHARMACOL, V42, p90S, DOI 10.1002/j.1552-4604.2002.tb06008.x; CAHILL DJ, 1994, BRIT J OBSTET GYNAEC, V101, P999, DOI 10.1111/j.1471-0528.1994.tb13047.x; Chang CL, 2002, HUM REPROD, V17, P1724, DOI 10.1093/humrep/17.7.1724; Childers SR, 1998, DRUG ALCOHOL DEPEN, V51, P173, DOI 10.1016/S0376-8716(98)00075-1; Costa LOB, 2004, BRAZ J MED BIOL RES, V37, P1747, DOI 10.1590/S0100-879X2004001100021; Cutting Rachel, 2008, Hum Fertil (Camb), V11, P131, DOI 10.1080/14647270802302629; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Ebner T, 2003, HUM REPROD UPDATE, V9, P251, DOI 10.1093/humupd/dmg021; ELTALATINI MR, 2008, 18 ANN S INT CANN RE; ELTALATINI MR, 2007, 2 SGI INT SUMMIT REP; Erickson GF, 2000, MENOPAUSE BIOL PATHO, P13; Fowler CJ, 2007, BRIT J PHARMACOL, V152, P594, DOI 10.1038/sj.bjp.0707379; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Habayeb OMH, 2002, LIFE SCI, V70, P1963, DOI 10.1016/S0024-3205(01)01539-9; Habayed OM, 2008, ENDOCRINOLOGY, V9, P5052; Kenney SP, 1999, AM J OBSTET GYNECOL, V181, P491, DOI 10.1016/S0002-9378(99)70583-1; Klonoff-Cohen HS, 2006, AM J OBSTET GYNECOL, V194, P369, DOI 10.1016/j.ajog.2005.08.020; Lam PMW, 2008, ANAL BIOCHEM, V380, P195, DOI 10.1016/j.ab.2008.05.033; Lass A, 2003, FERTIL STERIL, V80, P80, DOI 10.1016/S0015-0282(03)00558-2; MENDELSON JH, 1986, J PHARMACOL EXP THER, V237, P862; Mueller B A, 1990, Epidemiology, V1, P195, DOI 10.1097/00001648-199005000-00003; NIR I, 1973, NATURE, V244, P470, DOI 10.1038/243470a0; Parolaro D, 2002, PROSTAG LEUKOTR ESS, V66, P319, DOI 10.1054/plef.2001.0355; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; ROSS HM, 2003, HISTOLOGY TEXT ATLAS, P773; Salha O, 1998, HUM REPROD, V13, P1901, DOI 10.1093/humrep/13.7.1901; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; SMITH CG, 1979, FERTIL STERIL, V31, P335; Strehler E, 2001, FERTIL STERIL, V75, P332, DOI 10.1016/S0015-0282(00)01696-4; Tarin J J, 1992, Ann Acad Med Singap, V21, P492; Taylor AH, 2007, HUM REPROD UPDATE, V13, P501, DOI 10.1093/humupd/dmm018; Taylor AH, 2005, HISTOCHEM CELL BIOL, V123, P463, DOI 10.1007/s00418-004-0748-z; Taylor AH, 2000, J MOL ENDOCRINOL, V24, P145, DOI 10.1677/jme.0.0240145; TYREY L, 1980, J PHARMACOL EXP THER, V213, P306; Wang HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003320; Wu YT, 2007, HUM REPROD, V22, P1526, DOI 10.1093/humrep/dem029	43	118	120	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4579	10.1371/journal.pone.0004579	http://dx.doi.org/10.1371/journal.pone.0004579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238202	Green Submitted, Green Published, gold			2022-12-25	WOS:000265487400011
J	Evans, J; Catalano, RD; Brown, P; Sherwin, R; Critchley, HOD; Fazleabas, AT; Jabbour, HN				Evans, Jemma; Catalano, Rob D.; Brown, Pamela; Sherwin, Rob; Critchley, Hilary O. D.; Fazleabas, Asgerally T.; Jabbour, Henry N.			Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor	FASEB JOURNAL			English	Article						human chorionic gonadotropin; implantation; decidua; adhesion; laminin; fibronectin	HUMAN CHORIONIC-GONADOTROPIN; FACTOR LIF; TROPHOBLAST DIFFERENTIATION; UNEXPLAINED INFERTILITY; IMPLANTATION; EXPRESSION; BIOSYNTHESIS; STIMULATION; RECEPTORS; SECRETION	Implantation requires communication between a receptive endometrium and a healthy blastocyst. This maternal-embryonic crosstalk involves local mediators within the uterine microenvironment. We demonstrate that a secreted protein, prokineticin 1 (PROK1), is expressed in the receptive endometrium and during early pregnancy. PROK1 induces expression of leukemia inhibitory factor (LIF) in endometrial epithelial cells and first trimester decidua via a Gq-Ca2+-cSrc-mitogen-activated protein kinase kinase-mediated pathway. We show that human embryonic chorionic gonadotropin (hCG) induces sequential mRNA expression of PROK1 and LIF in an in vivo baboon model, in human endometrial epithelial cells, and in first-trimester decidua. We have used micro RNA constructs targeted to PROK1 to demonstrate that hCG-mediated LIF expression in the endometrium is dependent on prior induction of PROK1. Dual immunohistochemical analysis colocalized expression of the luteinizing hormone/chorionic gonadotropin receptor, PROK1, PROKR1, and LIF to the glandular epithelial cells of the first trimester decidual tissue. PROK1 enhances adhesion of trophoblast cells to fibronectin and laminin matrices, which are mediated predominantly via LIF induction. These data describe a novel signaling pathway mediating maternal-embryonic crosstalk, in which embryonic hCG via endometrial PROK1 may play a pivotal role in enhancing receptivity and maintaining early pregnancy.-Evans, J., Catalano, R. D., Brown, P., Sherwin, R., Critchley, H. O. D., Fazleabas, A. T., Jabbour, H. N. Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor. FASEB J. 23, 2165-2175 (2009)	[Evans, Jemma; Catalano, Rob D.; Brown, Pamela; Jabbour, Henry N.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh EH16 4TJ, Midlothian, Scotland; [Sherwin, Rob] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Fazleabas, Asgerally T.] Univ Illinois, Coll Med, Dept Obstet & Gynecol, Chicago, IL 60612 USA	University of Edinburgh; University of Cambridge; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jabbour, HN (corresponding author), Queens Med Res Inst, MRC, Human Reprod Sci Unit, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	h.jabbour@hrsu.mrc.ac.uk	CRITCHLEY, HILARY OD/C-7575-2013	evans, jemma/0000-0002-3300-8127; CRITCHLEY, HILARY/0000-0003-1913-4044	Medical Research Council [G9900991B] Funding Source: researchfish; MRC [MC_U127684438] Funding Source: UKRI; Medical Research Council [MC_U127684438, U.1276.00.004.00002.01/2(61014)] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Bamberger AM, 1997, MOL HUM REPROD, V3, P789, DOI 10.1093/molehr/3.9.789; Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; BISCHOF P, 1995, AM J REPROD IMMUNOL, V34, P225, DOI 10.1111/j.1600-0897.1995.tb00945.x; Carlson CD, 1996, GLIA, V18, P141, DOI 10.1002/(SICI)1098-1136(199610)18:2<141::AID-GLIA6>3.3.CO;2-F; De Ziegler D, 2004, ANN NY ACAD SCI, V1034, P262, DOI 10.1196/annals.1335.028; DELAGE G, 1995, HUM REPROD, V10, P2483; Dockery P, 1998, HUM REPROD UPDATE, V4, P486, DOI 10.1093/humupd/4.5.486; ELIAS JA, 1994, AM J PHYSIOL, V266, pL426, DOI 10.1152/ajplung.1994.266.4.L426; Evans J, 2008, ENDOCRINOLOGY, V149, P2877, DOI 10.1210/en.2007-1633; FABER M, 1986, AM J PATHOL, V124, P384; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; FERENCZY A, 1993, MICROSC RES TECHNIQ, V25, P91, DOI 10.1002/jemt.1070250203; FERNANDEZ PL, 1992, LAB INVEST, V66, P572; Filicori M, 2005, FERTIL STERIL, V84, P275, DOI 10.1016/j.fertnstert.2005.02.033; Fouladi-Nashta AA, 2005, DEV BIOL, V281, P1, DOI 10.1016/j.ydbio.2005.01.033; Goto S, 2007, FERTIL STERIL, V88, P1339, DOI 10.1016/j.fertnstert.2007.01.011; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; Hoffmann P, 2006, ENDOCRINOLOGY, V147, P1675, DOI 10.1210/en.2005-0912; Ledee-Bataille N, 2002, HUM REPROD, V17, P213, DOI 10.1093/humrep/17.1.213; Licht P, 2007, MOL CELL ENDOCRINOL, V269, P85, DOI 10.1016/j.mce.2006.09.016; Licht P, 2001, Reprod Biol, V1, P10; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Mikolajczyk Mateusz, 2003, Reprod Biol, V3, P259; Nachtigall MJ, 1996, J CLIN ENDOCR METAB, V81, P801, DOI 10.1210/jc.81.2.801; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Perrier d'Hauterive S, 2004, HUM REPROD, V19, P2633, DOI 10.1093/humrep/deh450; Psychoyos A, 1973, Vitam Horm, V31, P201; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Ren S G, 1997, Early Pregnancy, V3, P102; Sawai K, 1997, BIOL REPROD, V56, P1274, DOI 10.1095/biolreprod56.5.1274; SAWAI K, 1995, J CLIN ENDOCR METAB, V80, P1449, DOI 10.1210/jc.80.4.1449; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; Srisuparp S, 2001, ARCH MED RES, V32, P627, DOI 10.1016/S0188-4409(01)00330-7; Steck T, 2004, EUR J OBSTET GYN R B, V112, P69, DOI 10.1016/S0301-2115(03)00315-4; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tabibzadeh S, 1998, HUM REPROD UPDATE, V4, P465, DOI 10.1093/humupd/4.5.465; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Vogiagis D, 1996, J ENDOCRINOL, V148, P95, DOI 10.1677/joe.0.1480095	40	65	67	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2165	2175		10.1096/fj.08-124495	http://dx.doi.org/10.1096/fj.08-124495			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19255255	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000268836500016
J	Chiang, HC; Iijima, K; Hakker, I; Zhong, Y				Chiang, Hsueh-Cheng; Iijima, Koichi; Hakker, Inessa; Zhong, Yi			Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions	FASEB JOURNAL			English	Article						Alzheimer's disease; Drosophila; neuromuscular junction; endogenous	TRANSGENIC CAENORHABDITIS-ELEGANS; LONG-TERM POTENTIATION; SUPPRESSOR GENE DLG; ALZHEIMERS-DISEASE; NEUROMUSCULAR-JUNCTION; IN-VIVO; NEURODEGENERATIVE DISEASE; DROSOPHILA EMBRYOS; NEURONAL-ACTIVITY; MOUSE MODELS	To determine how endogenously secreted beta-amyloid 42 (A beta 42) aggregates regulate synaptic functions, we examined effects of A beta 42 at the neuromuscular junction of Drosophila larvae. Voltage-clamp recordings of synaptic transmission and optical analysis of vesicle recycling at presynaptic terminals show that expression of A beta 42 in neurons leads to a reduction of neurotransmitter release. However, expression of A beta 42 in postsynaptic muscle cells enhanced neurotransmitter release. Both effects are neutralized by A beta antibody, suggesting a role for secreted A beta 42 peptides. Application of exogenously prepared A beta 42 oligomers leads to a reduction in synaptic responses, whereas mixed A beta 42 aggregates with mainly fibrils elicit an opposite effect by increasing synaptic transmission. Further analysis of long-term depression (LTD) confirms differential effects of different A beta 42 aggregates. Taken together, our data suggest that A beta 42 is secreted from neurons primarily as oligomers that inhibit neurotransmitter release and exert no effect on LTD. Whereas larger-sized aggregates, possibly fibrils, are major components secreted from muscle cells, which enhance synaptic transmission and LTD. Thus, different types of cells may secrete distinct forms of A beta 42 aggregates, leading to different modulation of synaptic functions.-Chiang, H.-C., Iijima, K., Hakker, I., Zhong, Y. Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions. FASEB J. 23, 1969-1977 (2009)	[Chiang, Hsueh-Cheng; Iijima, Koichi; Hakker, Inessa; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chiang, Hsueh-Cheng] SUNY Stony Brook, Dept Neurosci, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zhong, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.edu		Zhong, Yi/0000-0002-7927-5976; Zhong, Yi/0000-0001-7810-9899	U.S. National Institutes of Health [2R01 NS34779-06]; U.S. Army Neurofibromatosis Research Program [DAMD17-99-1-9500]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034779] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Neurofibromatosis Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Iijima-Ando Kanae (Thomas Jefferson University, Philadelphia, PA, USA) for providing G7 flies and Dr. Shouzhen Xia (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing C57 flies, and Dr. Jennifer Beshel for reading and correcting the manuscript. This work was supported by grants from the U.S. National Institutes of Health (2R01 NS34779-06), the U.S. Army Neurofibromatosis Research Program (DAMD17-99-1-9500), and Dart Neuroscience (San Diego, CA, USA) to Y. Z.	Abad MA, 2006, J NEUROSCI, V26, P12735, DOI 10.1523/JNEUROSCI.0575-06.2006; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; Chan HYE, 2000, CELL DEATH DIFFER, V7, P1075, DOI 10.1038/sj.cdd.4400757; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Fay DS, 1998, J NEUROCHEM, V71, P1616; Fu HJ, 2006, J NEUROCHEM, V98, P1400, DOI 10.1111/j.1471-4159.2006.03960.x; Graf RA, 1998, BRAIN RES, V786, P115, DOI 10.1016/S0006-8993(97)01451-0; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Guo HF, 2006, J NEUROSCI, V26, P4004, DOI 10.1523/JNEUROSCI.3616-05.2006; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Ho IS, 2007, J NEUROSCI, V27, P6852, DOI 10.1523/JNEUROSCI.0933-07.2007; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kuromi H, 1999, J NEUROSCI, V19, P1557; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Liu YB, 1998, J NEUROCHEM, V71, P2322; Lozsadi DA, 2006, DEMENT GERIATR COGN, V22, P121, DOI 10.1159/000093664; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Renden RB, 2003, J NEUROPHYSIOL, V89, P2620, DOI 10.1152/jn.01072.2002; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; Torroja L, 1999, J NEUROSCI, V19, P7793; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060	46	20	28	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2009	23	6					1969	1977		10.1096/fj.08-121152	http://dx.doi.org/10.1096/fj.08-121152			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	453ZW	19255256	Green Published			2022-12-25	WOS:000266652400035
J	Marty, C; Chaligne, R; Lacout, C; Constantinescu, SN; Vainchenker, W; Villeval, JL				Marty, Caroline; Chaligne, Ronan; Lacout, Catherine; Constantinescu, Stefan N.; Vainchenker, William; Villeval, Jean-Luc			Ligand-independent Thrombopoietin Mutant Receptor Requires Cell Surface Localization for Endogenous Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MPL LIGAND; ERYTHROPOIETIN RECEPTOR; PLATELET PRODUCTION; POLYCYTHEMIA-VERA; ACTIVATION; DOMAIN; MUTATIONS; MYELOFIBROSIS; TUMORIGENICITY; SUPERFAMILY	The activating W515L mutation in the thrombopoietin receptor (MPL) has been identified in primary myelofibrosis and essential thrombocythemia. MPL belongs to a subset of the cytokine receptor superfamily that requires the JAK2 kinase for signaling. We examined whether the ligand-independent MPLW515L mutant could signal intracellularly. Addition of the endoplasmic reticulum (ER) retention KDEL sequence to the receptor C terminus efficiently locked MPLW515L within its natural ER/Golgi maturation pathway. In contrast to cells expressing the parental MPLW515L, MPLW515L-KDEL-expressing FDC-P1 cells were unable to grow autonomously and to produce tumors in nude mice. When observed, tumor nodules resulted from in vivo selection of cells leaking the receptor at their surface. JAK2 co-immunoprecipitated with MPLW515L-KDEL but was not phosphorylated. We generated disulfide-bonded MPLW515L homodimers by the S402C substitution, both in the normal and KDEL context. Unlike MPLW515L-KDEL, MPLW515L-S402C-KDEL signaled constitutively and exhibited cell surface localization. These data establish that MPLW515L with appended JAK2 matures through the ER/Golgi system in an inactive conformation and suggest that the MPLW515L/JAK2 complex requires membrane localization for JAK2 phosphorylation, resulting in autonomous receptor signaling.	[Villeval, Jean-Luc] Inst Gustave Roussy, INSERM, U790, F-94805 Villejuif, France; [Marty, Caroline; Chaligne, Ronan; Lacout, Catherine; Vainchenker, William; Villeval, Jean-Luc] Univ Paris 11, F-94805 Villejuif, France; [Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Univ Catholique Louvain, Christian Duve Inst, B-1200 Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Villeval, JL (corresponding author), Inst Gustave Roussy, INSERM, U790, PR1,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	villeval@igr.fr	MARTY, Caroline/I-1721-2017; Constantinescu, Stefan N/E-5277-2012	MARTY, Caroline/0000-0003-4350-2302; Chaligne, Ronan/0000-0003-4332-3291; Constantinescu, Stefan N./0000-0002-8599-2699; Vainchenker, William/0000-0003-4705-202X; Villeval, Jean-Luc/0000-0002-0562-925X; Chaligne, Ronan/0000-0001-5788-5848	INSERM; Institut Gustave Roussy (IGR); Institut National du Cancer (INCa); Canceropole Ile-de-France; La Ligue Nationale Contre le Cancer (labeled team 2006)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Gustave Roussy (IGR); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); La Ligue Nationale Contre le Cancer (labeled team 2006)	This work was supported in part by grants from INSERM, Institut Gustave Roussy (IGR), Institut National du Cancer (INCa), Canceropole Ile-de-France, and by special funding from La Ligue Nationale Contre le Cancer (labeled team 2006).	ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Beer PA, 2008, BLOOD, V112, P141, DOI 10.1182/blood-2008-01-131664; BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; BROUDY VC, 1995, J LEUKOCYTE BIOL, V57, P719, DOI 10.1002/jlb.57.5.719; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chaligne R, 2007, BLOOD, V110, P3735, DOI 10.1182/blood-2007-05-089003; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; DANDREA AD, 1990, J CLIN INVEST, V86, P681, DOI 10.1172/JCI114763; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MIESENBOCK G, 1995, J CELL BIOL, V129, P309, DOI 10.1083/jcb.129.2.309; Moliterno AR, 1999, BLOOD, V94, P2555, DOI 10.1182/blood.V94.8.2555.420k14_2555_2561; Otto KG, 2001, BLOOD, V98, P2077, DOI 10.1182/blood.V98.7.2077; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Tefferi A, 2000, BLOOD, V96, P771; VAINCHENKER W, 1995, THROMB HAEMOSTASIS, V74, P526; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Wendling F, 1999, HAEMATOLOGICA, V84, P158; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0	34	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11781	11791		10.1074/jbc.M808703200	http://dx.doi.org/10.1074/jbc.M808703200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19261614	Green Published, hybrid			2022-12-25	WOS:000265494600010
J	Kumar, P; Kumar, D; Parikh, A; Rananaware, D; Gupta, M; Singh, Y; Nandicoori, VK				Kumar, Pawan; Kumar, Devanand; Parikh, Amit; Rananaware, Dimple; Gupta, Meetu; Singh, Yogendra; Nandicoori, Vinay Kumar			The Mycobacterium tuberculosis Protein Kinase K Modulates Activation of Transcription from the Promoter of Mycobacterial Monooxygenase Operon through Phosphorylation of the Transcriptional Regulator VirS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SER/THR KINASE; SERINE/THREONINE KINASE; CELL-DIVISION; ABC TRANSPORTER; MYMA OPERON; FHA DOMAINS; IN-VIVO; PKNB; SYSTEM	Mycobacterium tuberculosis encodes for 11 eukaryotic-like serine/threonine protein kinases. Genetic and biochemical studies show that these kinases regulate various cellular processes including cell shape and morphology, glucose and glutamine transport, phagosome-lysosome fusion and the expression, and/or activity of transcription factors. PknK is the largest predicted serine/threonine protein kinase in M. tuberculosis. Here, we have cloned, overexpressed, and purified protein kinaseK(PknK) to near homogeneity and show that its ability to phosphorylate proteins is dependent on the invariant lysine (Lys(55)), and on two conserved threonine residues present in its activation loop. Despite being devoid of any apparent transmembrane domain, PknK is localized to the cell wall fraction, suggesting probable anchoring of the kinase to the cell membrane region. The pknK gene is located in the vicinity of the virS gene, which is known to regulate the expression of the mycobacterial monooxygenase (mymA) operon. We report here for the first time that VirS is in fact a substrate of PknK. In addition, four of the proteins encoded by mymA operon are also found to be substrates of PknK. Results show that VirS is a bona fide substrate of PknK in vivo, and PknK-mediated phosphorylation of VirS increases its affinity for mym promoter DNA. Reporter assays reveal that PknK modulates VirS-mediated stimulation of transcription from the mym promoter. These findings suggest that the expression of mymA operon genes is regulated through PknK-mediated phosphorylation of VirS.	[Kumar, Devanand; Parikh, Amit; Rananaware, Dimple; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Kumar, Pawan; Gupta, Meetu; Singh, Yogendra] Inst Genom & Integrat Biol, Delhi 110007, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in		Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology India; Council of Scientific and Industrial Research [NWP-0038]	Department of Biotechnology India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the generous funding provided by the Department of Biotechnology India (to V. K. N.) and Project NWP-0038 of the Council of Scientific and Industrial Research (to Y. S.).	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Curry JM, 2005, INFECT IMMUN, V73, P4471, DOI 10.1128/IAI.73.8.4471-4477.2005; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HIRSCHFIELD GR, 1990, J BACTERIOL, V172, P1005, DOI 10.1128/jb.172.2.1005-1013.1990; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nourry Claire, 2003, Sci STKE, V2003, pRE7; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Purbey PK, 2006, NAT PROTOC, V1, P1820, DOI 10.1038/nprot.2006.310; RICHET E, 1989, EMBO J, V8, P981, DOI 10.1002/j.1460-2075.1989.tb03461.x; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh R, 2005, TUBERCULOSIS, V85, P325, DOI 10.1016/j.tube.2005.08.015; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	52	53	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11090	11099		10.1074/jbc.M808705200	http://dx.doi.org/10.1074/jbc.M808705200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251699	Green Published, hybrid			2022-12-25	WOS:000265494500013
J	Rauhamaki, V; Bloch, DA; Verkhovsky, MI; Wikstrom, M				Rauhamaki, Virve; Bloch, Dmitry A.; Verkhovsky, Michael I.; Wikstrom, Marten			Active Site of Cytochrome cbb(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS CONTAINS; NITRIC-OXIDE REDUCTASE; C-OXIDASE; RESPIRATORY-CHAIN; HEME CENTERS; SPHAEROIDES; EVOLUTION; IDENTIFICATION; PEROXIDASE; GENOMICS	Cytochrome cbb(3) is the most distant member of the heme-copper oxidase family still retaining the following major feature typical of these enzymes: reduction of molecular oxygen to water coupled to proton translocation across the membrane. The thermodynamic properties of the six redox centers, five hemes and a copper ion, in cytochrome cbb(3) from Rhodobacter sphaeroides were studied using optical and EPR spectroscopy. The low spin heme b in the catalytic subunit was shown to have the highest midpoint redox potential (E-m,E-7 +418 mV), whereas the three hemes c in the two other subunits titrated with apparent midpoint redox potentials of +351, +320, and +234 mV. The active site high spin heme b(3) has a very low potential (E-m,E-7 -59 mV) as opposed to the copper center (Cu-B), which has a high potential (E-m,E-7 +330 mV). The EPR spectrum of the ferric heme b(3) has rhombic symmetry. To explain the origins of the rhombicity, the Glu-383 residue located on the proximal side of heme b(3) was mutated to aspartate and to glutamine. The latter mutation caused a 10 nm blue shift in the optical reduced minus oxidized heme b(3) spectrum, and a dramatic change of the EPR signal toward more axial symmetry, whereas mutation to aspartate had far less severe consequences. These results strongly suggest that Glu-383 is involved in hydrogen bonding to the proximal His-405 ligand of heme b(3), a unique interaction among heme-copper oxidases.	[Rauhamaki, Virve; Bloch, Dmitry A.; Verkhovsky, Michael I.; Wikstrom, Marten] Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, Program Struct Biol & Biophys, Helsinki 00014, Finland	University of Helsinki	Rauhamaki, V (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, Program Struct Biol & Biophys, POB 65,Viikinkaari 1, Helsinki 00014, Finland.	virve.rauhamaki@helsinki.fi		Wikstrom, Marten/0000-0002-7527-4415	National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Academy of Finland	National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Academy of Finland(Academy of Finland)	This work was supported by the National Graduate School in Informational and Structural Biology (to V.R.), by the Sigrid Juselius Foundation, Magnus Ehrnrooth Foundation, Biocentrum Helsinki, and the Academy of Finland.	Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; CASTRESANA J, 1995, TRENDS BIOCHEM SCI, V20, P443, DOI 10.1016/S0968-0004(00)89098-2; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Euro L, 2008, BIOCHEMISTRY-US, V47, P3185, DOI 10.1021/bi702063t; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Forte E, 2001, EUR J BIOCHEM, V268, P6486, DOI 10.1046/j.0014-2956.2001.02597.x; GARCIAHORSMAN JA, 1994, BIOCHEMISTRY-US, V33, P3113, DOI 10.1021/bi00176a046; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; Gronberg KLC, 1999, BIOCHEMISTRY-US, V38, P13780, DOI 10.1021/bi9916426; Hemp J, 2005, BIOCHEMISTRY-US, V44, P10766, DOI 10.1021/bi050464f; Hemp James, 2008, V45, P1, DOI 10.1007/400_2007_046; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hemp J, 2006, BIOCHEMISTRY-US, V45, P15405, DOI 10.1021/bi062026u; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; MITCHELL R, 1991, FEBS LETT, V280, P321, DOI 10.1016/0014-5793(91)80321-S; Murgida DH, 2005, PHYS CHEM CHEM PHYS, V7, P3773, DOI 10.1039/b507989f; Oh JI, 2002, J BIOL CHEM, V277, P16220, DOI 10.1074/jbc.M200198200; PEISACH J, 1971, J BIOL CHEM, V246, P3342; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pereira MM, 2000, J BIOENERG BIOMEMBR, V32, P143, DOI 10.1023/A:1005555829301; PETTIGREW GW, 1987, CYTOCHROMES C BIOL A, P25; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, J BIOL CHEM, V277, P31474, DOI 10.1074/jbc.M204103200; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; RAITIO M, 1994, BBA-BIOENERGETICS, V1186, P100, DOI 10.1016/0005-2728(94)90140-6; Rauhamaki V, 2006, P NATL ACAD SCI USA, V103, P16135, DOI 10.1073/pnas.0606254103; Sharma V, 2008, BIOCHEMISTRY-US, V47, P4221, DOI 10.1021/bi702088r; Sharma V, 2006, BIOCHEMISTRY-US, V45, P5754, DOI 10.1021/bi060169a; Sinclair R, 1996, BIOCHEMISTRY-US, V35, P15120, DOI 10.1021/bi961064i; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Stavrakis S, 2002, J AM CHEM SOC, V124, P3814, DOI 10.1021/ja0169825; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Toledo-Cuevas M, 1998, BBA-BIOENERGETICS, V1365, P421, DOI 10.1016/S0005-2728(98)00095-4; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; VAROTSIS C, 1995, J PHYS CHEM-US, V99, P16817, DOI 10.1021/j100046a004; Verissimo AF, 2007, BIOCHEMISTRY-US, V46, P13245, DOI 10.1021/bi700733g; WANG JL, 1995, J AM CHEM SOC, V117, P9363, DOI 10.1021/ja00141a033; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Ye T, 2008, J AM CHEM SOC, V130, P6682, DOI 10.1021/ja801071n; Zufferey R, 1998, J BIOL CHEM, V273, P6452, DOI 10.1074/jbc.273.11.6452	45	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11301	11308		10.1074/jbc.M808839200	http://dx.doi.org/10.1074/jbc.M808839200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19252222	Green Published, hybrid			2022-12-25	WOS:000265494500034
J	Shin, DJ; Osborne, TF				Shin, Dong-Ju; Osborne, Timothy F.			FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; 7 ALPHA-HYDROXYLASE; CULTURED RAT HEPATOCYTES; N-TERMINAL KINASE; NUCLEAR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; FEEDBACK-REGULATION; FACTOR FKHR; COORDINATED RECRUITMENT	The current studies show FGF15 signaling decreases hepatic forkhead transcription factor 1 (FoxO1) activity through phosphatidylinositol (PI) 3-kinase-dependent phosphorylation. The bile acid receptor FXR (farnesoid X receptor) activates expression of fibroblast growth factor (FGF) 15 in the intestine, which acts through hepatic FGFR4 to suppress cholesterol-7 alpha hydroxylase (CYP7A1) and limit bile acid production. Because FoxO1 activity and CYP7A1 gene expression are both increased by fasting, we hypothesized CYP7A1 might be a FoxO1 target gene. Consistent with recently reported results, we show CYP7A1 is a direct target of FoxO1. Additionally, we show that the PI 3-kinase pathway is key for both the induction of CYP7A1 by fasting and the suppression by FGF15. FGFR4 is the major hepatic FGF receptor isoform and is responsible for the hepatic effects of FGF15. We also show that expression of FGFR4 in liver was decreased by fasting, increased by insulin, and reduced by streptozotocin-induced diabetes, implicating FGFR4 as a primary target of insulin regulation. Because insulin and FGF both target the PI 3-kinase pathway, these observations suggest FoxO1 is a key node in the convergence of FGF and insulin signaling pathways and functions as a key integrator for the regulation of glucose and bile acid metabolism.	[Osborne, Timothy F.] Univ Calif Irvine, Sch Biol Sci, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Diabet Res & Treatment, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Osborne, TF (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Mol Biol & Biochem, 3244 McGaugh Hall, Irvine, CA 92697 USA.	tim.osborne@uci.edu			National Institutes of Health [DK71021]; American Heart Association Scientist Development [0730189N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK71021 (to T.O.). This work was also supported by American Heart Association Scientist Development Grant 0730189N (to D.-J.S.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Cooper AD, 1997, J BIOL CHEM, V272, P3444, DOI 10.1074/jbc.272.6.3444; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Han SL, 2004, HEPATOLOGY, V39, P456, DOI 10.1002/hep.20043; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lamothe B, 2004, MOL CELL BIOL, V24, P5657, DOI 10.1128/MCB.24.13.5657-5666.2004; LeCluyse E L, 1996, Pharm Biotechnol, V8, P121; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Li TG, 2008, J LIPID RES, V49, P1981, DOI 10.1194/jlr.M800140-JLR200; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NESS GC, 1994, BBA-LIPID LIPID MET, V1214, P229, DOI 10.1016/0005-2760(94)90068-X; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Qiao DH, 2000, J BIOL CHEM, V275, P15090, DOI 10.1074/jbc.M908890199; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Shin DJ, 2006, NUCLEIC ACIDS RES, V34, P3853, DOI 10.1093/nar/gkl506; Stravitz RT, 1996, AM J PHYSIOL-GASTR L, V271, pG293, DOI 10.1152/ajpgi.1996.271.2.G293; TWISK J, 1995, HEPATOLOGY, V21, P501, DOI 10.1016/0270-9139(95)90113-2; Wang DP, 1996, J LIPID RES, V37, P1831; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	73	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11110	11120		10.1074/jbc.M808747200	http://dx.doi.org/10.1074/jbc.M808747200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19237543	Green Published, hybrid			2022-12-25	WOS:000265494500015
J	Zhou, YJ; Jiang, L; Rui, LY				Zhou, Yingjiang; Jiang, Lin; Rui, Liangyou			Identification of MUP1 as a Regulator for Glucose and Lipid Metabolism in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR URINARY PROTEINS; INSULIN-RESISTANCE; OBESITY; FGF-21; LIVER; AKT2	Major urinary protein (MUP) 1 is a lipocalin family member abundantly secreted into the circulation by the liver. MUP1 binds to lipophilic pheromones and is excreted in urine. Urinary MUP1/pheromone complexes mediate chemical communication in rodents. However, it is unclear whether circulatory MUP1 has additional physiological functions. Here we show that MUP1 regulates glucose and lipid metabolism. MUP1 expression was markedly reduced in both genetic and dietary fat-induced obesity and diabetes. Mice were infected with MUP1 adenoviruses via tail vein injection, and recombinant MUP1 was overexpressed in the liver and secreted into the bloodstream. Recombinant MUP1 markedly attenuated hyperglycemia and glucose intolerance in genetic (db/db) and dietary fat-induced type 2 diabetic mice as well as in streptozotocin-induced type 1 diabetic mice. MUP1 inhibited the expression of both gluconeogenic genes and lipogenic genes in the liver. Moreover, recombinant MUP1 directly decreased glucose production in primary hepatocyte cultures by inhibiting the expression of gluconeogenic genes. These data suggest that MUP1 regulates systemic glucose and/or lipid metabolism through the paracrine/autocrine regulation of the hepatic gluconeogenic and/or lipogenic programs, respectively.	[Zhou, Yingjiang; Jiang, Lin; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	Jiang, Lin/E-7468-2012		National Institutes of Health [RO1 DK 065122, RO1 DK073601]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK034933, R01DK073601, R01DK065122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 065122 and RO1 DK073601 ( to L. R.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BERGER FG, 1981, BIOCHEM GENET, V19, P1261, DOI 10.1007/BF00484578; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clemmons DR, 2006, CURR OPIN PHARMACOL, V6, P620, DOI 10.1016/j.coph.2006.08.006; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Macek P, 2006, FEBS LETT, V580, P682, DOI 10.1016/j.febslet.2005.12.088; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Vasylyeva TL, 2007, DIABETES RES CLIN PR, V76, P177, DOI 10.1016/j.diabres.2006.09.012; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	23	113	115	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11152	11159		10.1074/jbc.M900754200	http://dx.doi.org/10.1074/jbc.M900754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258313	Green Published, hybrid			2022-12-25	WOS:000265494500019
J	Essaghir, A; Dif, N; Marbehant, CY; Coffer, PJ; Demoulin, JB				Essaghir, Ahmed; Dif, Nicolas; Marbehant, Catherine Y.; Coffer, Paul J.; Demoulin, Jean-Baptiste			The Transcription of FOXO Genes Is Stimulated by FOXO3 and Repressed by Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELL-SURVIVAL; FORKHEAD BOX; EXPRESSION; PDGF; ACTIVATION; RECEPTOR; PHOSPHORYLATION; PROLIFERATION; CANCER	FOXO (Forkhead box O) transcription factors induce cell growth arrest and apoptosis, which can be prevented by FOXO phosphorylation by AKT in response to growth factors such as platelet-derived growth factors (PDGF) and insulin-like growth factor I (IGF-I). In addition to this well characterized post-translational modification, we showed that FOXO1, FOXO3, and FOXO4 were also regulated at the transcriptional level. PDGF, fibroblast growth factors (FGF), and IGF-I repressed the expression of FOXO genes in human fibroblasts. This process was sensitive to phosphatidylinositol 3-kinase inhibition by LY294002. FOXO1-specific shRNA decreased FOXO1 mRNA expression and enhanced fibroblast proliferation, mimicking the effects of growth factors. Conversely, ectopic FOXO3 activation blocked the proliferation of fibroblasts and induced the expression of FOXO1, FOXO4, and p27-KIP1. Using luciferase reporter assays and chromatin immunoprecipitations, we identified a conserved FOXO-binding site in the promoter of the FOXO1 gene, which was required for regulation by PDGF, and mediated the up-regulation of FOXO1 by itself and by FOXO3. Altogether, our results suggest that the expression of FOXO1 and FOXO4 genes is stimulated by FOXO3 and possibly by other FOXO factors in a positive feedback loop, which is disrupted by growth factors.	[Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Unite Med Expt MEXP UCL 74 30, BE-1200 Brussels, Belgium; [Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Immunol, Mol Immunol Lab, NL-3584 EA Utrecht, Netherlands	Universite Catholique Louvain; Utrecht University; Utrecht University Medical Center	Demoulin, JB (corresponding author), Catholic Univ Louvain, De Duve Inst, Unite Med Expt MEXP UCL 74 30, Ave Hippocrate 74-75, BE-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be	Demoulin, Jean-Baptiste/E-5847-2010; Coffer, Paul/AAF-7970-2020	Demoulin, Jean-Baptiste/0000-0002-8016-6689	Action de Recherches Concertees (Communaute Francaise de Belgique); Fonds de la Recherche Scientifique; WALEO (TransMaze project, Region Wallonne)	Action de Recherches Concertees (Communaute Francaise de Belgique); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); WALEO (TransMaze project, Region Wallonne)	This work was supported by grants from "Action de Recherches Concertees" (Communaute Francaise de Belgique), from Fonds de la Recherche Scientifique, and from WALEO (TransMaze project, Region Wallonne).	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Demoulin JB, 2006, GROWTH FACTORS, V24, P184, DOI 10.1080/08977190600696430; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kallin A, 2004, J BIOL CHEM, V279, P17897, DOI 10.1074/jbc.M312996200; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Lynch RL, 2005, MOL CANCER RES, V3, P163, DOI 10.1158/1541-7786.MCR-04-0163; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vantler M, 2005, J BIOL CHEM, V280, P14168, DOI 10.1074/jbc.M413310200; Vantler M, 2006, FEBS LETT, V580, P6769, DOI 10.1016/j.febslet.2006.11.034; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	42	165	171	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10334	10342		10.1074/jbc.M808848200	http://dx.doi.org/10.1074/jbc.M808848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19244250	Green Published, hybrid			2022-12-25	WOS:000265104600007
J	Garcia, R; Rodriguez-Pena, JM; Bermejo, C; Nombela, C; Arroyo, J				Garcia, Raul; Rodriguez-Pena, Jose M.; Bermejo, Clara; Nombela, Cesar; Arroyo, Javier			The High Osmotic Response and Cell Wall Integrity Pathways Cooperate to Regulate Transcriptional Responses to Zymolyase-induced Cell Wall Stress in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GENOME-WIDE ANALYSIS; KINASE PATHWAY; SIGNALING PATHWAY; MAPK PATHWAYS; SHO1 BRANCH; YEAST HOG; ACTIVATION; EXPRESSION; SLT2	The adaptation of Saccharomyces cerevisiae to situations in which cell wall integrity is seriously compromised mainly involves the cell wall integrity (CWI) pathway. However, in a recent work (Bermejo, C., Rodriguez, E., Garcia, R., Rodriguez-Pena, J. M., Rodriguez de la Concepcion, M. L., Rivas, C., Arias, P., Nombela, C., Posas, F., and Arroyo, J. (2008) Mol. Biol. Cell 19, 1113-1124) we have demonstrated the co-participation of the high osmotic response (HOG) pathway to ensure yeast survival to cell wall stress mediated by zymolyase, which hydrolyzes the beta-1,3 glucan network. Here we have characterized the role of both pathways in the regulation of the overall yeast transcriptional responses to zymolyase treatment using whole genome expression profiling. A main group of yeast genes is dependent on both MAPKs, Slt2 and Hog1, for their induction. The transcriptional activation of these genes depends on the MAPKKK Bck1, the transcription factor Rlm1, and elements of the sho1 branch of the HOG pathway, but not on the sensors of the CWI pathway. A second group of genes is dependent on Slt2 but not Hog1 or Pbs2. However, the induction of these genes is dependent on upstream elements of the HOG pathway such as Sho1, Ste50, and Ste11, in accordance with a sequential activation of the HOG and CWI pathways. Zymolyase also promotes an osmotic-like transcriptional response with the activation of a group of genes dependent on elements of the Sho1 branch of HOG pathway but not on Slt2, with the induction of many of them dependent on Msn2/4. Additionally, in the absence of Hog1, zymolyase induces an alternative response related to mating and filamentation as a consequence of the cross-talk between these pathways and the HOG pathway. Finally, in the absence of Slt2, zymolyase increases the induction of genes associated with osmotic adaptation with respect to the wild type, suggesting an inhibitory effect of the CWI pathway over the HOG pathway. These studies clearly reveal the complexity of the signal transduction machinery responsible for regulating yeast adaptation responses to cell wall stress.	[Garcia, Raul; Rodriguez-Pena, Jose M.; Bermejo, Clara; Nombela, Cesar; Arroyo, Javier] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	Complutense University of Madrid	Arroyo, J (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Pza Ramon & Cajal S-N, E-28040 Madrid, Spain.	jarroyo@farm.ucm.es	Arroyo, Javier/E-9308-2016; Sanchez, Raúl García/E-9303-2016; Nombela Cano, César/H-2565-2015; Rodriguez-Peña, Jose M/E-9624-2016	Arroyo, Javier/0000-0002-1971-1721; Sanchez, Raúl García/0000-0002-7389-4696; Nombela Cano, César/0000-0003-0757-4034; Rodriguez-Peña, Jose M/0000-0002-8792-362X	Ministerio de Educacion y Ciencia (Spanish government) [BIO2007-67821]; EU STREP FUNGWALL [LSBH-CT-2004-511952]; Comunidad de Madrid [S-SAL-0246/2006]	Ministerio de Educacion y Ciencia (Spanish government)(Spanish Government); EU STREP FUNGWALL(European Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by projects BIO2007-67821 from the Ministerio de Educacion y Ciencia (Spanish government), EU STREP FUNGWALL LSBH-CT-2004-511952 and S-SAL-0246/2006 from the Comunidad de Madrid.	Amberg DC., 2005, METHODS YEAST GENETI; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Davenport KD, 1999, GENETICS, V153, P1091; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia-Rodriguez LJ, 2005, FEBS LETT, V579, P6186, DOI 10.1016/j.febslet.2005.10.001; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; Imazu H, 2005, EUKARYOT CELL, V4, P1050, DOI 10.1128/EC.4.6.1050-1056.2005; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mattison CP, 2000, GENE DEV, V14, P1229; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Popolo L, 2001, MED MYCOL, V39, P111, DOI 10.1080/744118881; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rodriguez-Pena JM, 2005, MICROBIOL-SGM, V151, P2241, DOI 10.1099/mic.0.27989-0; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SENGUPTA P, 1990, MOL CELL BIOL, V10, P6809, DOI 10.1128/MCB.10.12.6809; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	45	120	120	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10901	10911		10.1074/jbc.M808693200	http://dx.doi.org/10.1074/jbc.M808693200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19234305	Green Published, hybrid			2022-12-25	WOS:000265104600063
J	Wang, CC; Houng, HC; Chen, CL; Wang, PJ; Kuo, CF; Lin, YS; Wu, JJ; Lin, MT; Liu, CC; Huang, W; Chuang, WJ				Wang, Chih-Chieh; Houng, Hsiang-Chee; Chen, Chun-Liang; Wang, Pei-Ju; Kuo, Chih-Feng; Lin, Yee-Shin; Wu, Jiunn-Jong; Lin, Ming T.; Liu, Ching-Chuan; Huang, Wenya; Chuang, Woei-Jer			Solution Structure and Backbone Dynamics of Streptopain INSIGHT INTO DIVERSE SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; PYROGENIC EXOTOXIN-B; MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; CYSTEINE PROTEASE; INVASIVE DISEASE; VIRULENCE FACTOR; CHEMICAL-SHIFT; PYOGENES; NMR	Streptococcal pyrogenic exotoxin B (SPE B) is a cysteine protease expressed by Streptococcus pyogenes. The D9N, G163S, G163S/A172S, and G239D mutant proteins were expressed to study the effect of the allelic variants on their protease activity. In contrast to other mutants, the G239D mutant was similar to 12-fold less active. The Gly-239 residue is located within the C-terminal S230-G239 region, which cannot be observed in the x-ray structure. The three-dimensional structure and backbone dynamics of the 28-kDa mature SPE B (mSPE B) were determined. Unlike the x-ray structure of the 40-kDa zymogen SPE B (proSPE B), we observed the interactions between the C-terminal loop and the active site residues in mSPE B. The structural differences between mSPE B and proSPE B were the conformation of the C-terminal loop and the orientation of the catalytic His-195 residue, suggesting that activation and inactivation of SPE B is involved in the His-195 side-chain rotation. Dynamics analysis of mSPEB and them SPEB/inhibitor complexes showed that the catalytic and C-terminal loops were the most flexible regions with low order parameter values of 0.5 to 0.8 and exhibited the motion on the ps/ns timescale. These findings suggest that the flexible C-terminal loop of SPE B may play an important role in controlling the substrate binding, resulting in its broad substrate specificity.	[Wang, Chih-Chieh; Houng, Hsiang-Chee; Chen, Chun-Liang; Wang, Pei-Ju; Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Wu, Jiunn-Jong; Huang, Wenya] Natl Cheng Kung Univ, Coll Med, Dept Med Technol, Tainan 701, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 701, Taiwan; [Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung 840, Taiwan; [Lin, Ming T.] Tsu Chi Univ, Coll Med, Inst Med Sci, Hualien 970, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; I Shou University; Tzu Chi University	Chuang, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem, 1 Univ Rd, Tainan 701, Taiwan.	wjcnmr@mail.ncku.edu.tw	Wu, Jiunn-Jong/E-6075-2011; Huang, Wenya/G-9115-2011	Chen, Chun-Liang/0000-0003-4625-4340	National Health Research Institutes [NHRI-EX959429SP]; National Science Council of ROC [NSC-95-2323-B006-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-EX959429SP and National Science Council of ROC Grant NSC-95-2323-B006-MY3. NMR spectra were obtained at National Cheng Kung University or the High-Field Biomacromolecular NMR Core Facility supported by the National Research Program for Genomic Medicine.	Aiyar A, 1996, Methods Mol Biol, V57, P177; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; BRUNGER A, 1992, T X PLOR VERSION 3 1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Gubba S, 1998, INFECT IMMUN, V66, P765, DOI 10.1128/IAI.66.2.765-770.1998; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Luo SC, 2003, J BIOMOL NMR, V25, P165, DOI 10.1023/A:1022291604936; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; MCINTOSH LP, 1990, BIOCHEMISTRY-US, V29, P6341, DOI 10.1021/bi00479a003; Molinari G, 1999, CURR OPIN MICROBIOL, V2, P56, DOI 10.1016/S1369-5274(99)80010-1; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; MUSSER JM, 1997, SUPERANTIGENS MOL BI, P281; NILGES M, 1998, FEBS LETT, V229, P129; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Rasmussen M, 2002, MOL MICROBIOL, V43, P537, DOI 10.1046/j.1365-2958.2002.02766.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Reid SD, 2001, J CLIN INVEST, V107, P393, DOI 10.1172/JCI11972; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Tamura F, 2004, INFECT IMMUN, V72, P4836, DOI 10.1128/IAI.72.8.4836-4847.2004; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Turk B, 1997, BIOL CHEM, V378, P141; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; Wang BN, 2006, P NATL ACAD SCI USA, V103, P2380, DOI 10.1073/pnas.0506668103; Wuthrich K, 1986, NMR PROTEINS NUCL AC	51	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10957	10967		10.1074/jbc.M807624200	http://dx.doi.org/10.1074/jbc.M807624200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19237546	hybrid, Green Published			2022-12-25	WOS:000265104600068
J	Fox, BP; Kandpal, RP				Fox, B. P.; Kandpal, R. P.			EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells	ONCOGENE			English	Article						breast cancer; EphB6; Eph receptors; ephrin ligands; invasiveness; growth rate	GENE-EXPRESSION; MATRIX METALLOPROTEINASES; CANCER METASTASIS; ESTROGEN-RECEPTOR; TYROSINE KINASES; TISSUE INHIBITOR; ASSOCIATION; APOPTOSIS; TUMORIGENICITY; IDENTIFICATION	Breast cancer mortality in women is largely attributed to the metastasis of primary breast tumors. We have analysed the function of EphB6, a kinase-deficient receptor, in the invasive phenotype of breast cancer cell lines. We have demonstrated the loss of EphB6 protein in invasive breast carcinoma cell lines and absence of EphB6 transcript in a metastatic breast tumor specimen. The function of EphB6 in invasiveness was confirmed by the ability of EphB6 protein to decrease the in vitro invasiveness of MDA-MB-231, MDA-MB-435 and BT549 cells transfected with an EphB6 expression construct. In MDA-MB-231 cells, the decreased invasiveness appeared to be mediated by decreased transcript levels of matrix metalloproteinase (MMP)7 and MMP19, and increased transcript levels of tissue inhibitors of metalloproteinase 2. In addition to affecting invasiveness phenotype, EphB6 overexpression was also responsible for altering the growth rate and colony-forming efficiency of MCF-7 and MDA-MB-231 cells in a cell-line-specific manner. We suggest that the significant decrease in the invasiveness of MDA-MB-231 and other cell lines transfected with EphB6 is likely occurring by the ability of EphB6 to transduce signals to the nucleus and altering relevant gene expression.	[Fox, B. P.; Kandpal, R. P.] Western Univ Hlth Sci, Dept Basic Med Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Kandpal, RP (corresponding author), Western Univ Hlth Sci, Dept Basic Med Sci, 309 E 2nd St, Pomona, CA 91766 USA.	rkandpal@westernu.edu						Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Bashyam MD, 2002, CANCER, V94, P1821, DOI 10.1002/cncr.10362; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Drescher U, 1997, CURR BIOL, V7, pR799, DOI 10.1016/S0960-9822(06)00409-X; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Freywald A, 2002, J BIOL CHEM, V277, P3823, DOI 10.1074/jbc.M108011200; Freywald A, 2003, J BIOL CHEM, V278, P10150, DOI 10.1074/jbc.M208179200; Hafner C, 2003, INT J ONCOL, V23, P1553; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, INT J BIOCHEM CELL B, V35, P130, DOI 10.1016/S1357-2725(02)00096-1; Hojilla CV, 2003, BRIT J CANCER, V89, P1817, DOI 10.1038/sj.bjc.6601327; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Luo HY, 2001, J IMMUNOL, V167, P1362, DOI 10.4049/jimmunol.167.3.1362; MADSEN MW, 1990, EUR J CANCER, V26, P793, DOI 10.1016/0277-5379(90)90154-L; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuoka H, 1997, BIOCHEM BIOPH RES CO, V235, P487, DOI 10.1006/bbrc.1997.6812; Matsuoka H, 2005, J BIOL CHEM, V280, P29355, DOI 10.1074/jbc.M500010200; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Munthe E, 2000, FEBS LETT, V466, P169, DOI 10.1016/S0014-5793(99)01793-7; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nagaraja GM, 2004, BIOCHEM BIOPH RES CO, V313, P654, DOI 10.1016/j.bbrc.2003.12.001; Nakamoto M, 2000, INT J BIOCHEM CELL B, V32, P7, DOI 10.1016/S1357-2725(99)00096-5; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pratt RL, 2003, MOL CANCER RES, V1, P1070; Schagdarsurengin U, 2007, ONCOGENE, V26, P3089, DOI 10.1038/sj.onc.1210107; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Tang XX, 2004, CLIN CANCER RES, V10, P5837, DOI 10.1158/1078-0432.CCR-04-0395; Tang XX, 2001, MED PEDIATR ONCOL, V36, P80, DOI 10.1002/1096-911X(20010101)36:1<80::AID-MPO1019>3.0.CO;2-N; Tang XX, 2000, MED PEDIATR ONCOL, V35, P656, DOI 10.1002/1096-911X(20001201)35:6<656::AID-MPO37>3.0.CO;2-A; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Xu QL, 1997, J MOL MED-JMM, V75, P576, DOI 10.1007/s001090050142; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	53	54	60	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2009	28	14					1706	1713		10.1038/onc.2009.18	http://dx.doi.org/10.1038/onc.2009.18			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	430WQ	19234485				2022-12-25	WOS:000265022000005
J	Hartman, TR; Nicolas, E; Klein-Szanto, A; Al-Saleem, T; Cash, TP; Simon, MC; Henske, EP				Hartman, T. R.; Nicolas, E.; Klein-Szanto, A.; Al-Saleem, T.; Cash, T. P.; Simon, M. C.; Henske, E. P.			The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis	ONCOGENE			English	Article						BHD; mTOR; folliculin; renal carcinoma; oncocytoma	TUBEROUS SCLEROSIS COMPLEX; RIBOSOMAL S6 KINASE; NIHON RAT MODEL; BHD GENE; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; TUBEROUS-SCLEROSIS-COMPLEX-2 TSC2; SPONTANEOUS PNEUMOTHORAX; EMBRYONIC LETHALITY; NATURAL-HISTORY; CELL CARCINOMA	Birt-Hogg-Dube (BHD) syndrome is a tumor-suppressor gene disorder characterized by skin tumors, cystic lung disease and renal cell carcinoma. Very little is known about the molecular pathogenesis of BHD. Clinical similarities between BHD and tuberous sclerosis complex (TSC) suggest that the BHD and TSC proteins may function within a common pathway. The TSC proteins inhibit the activity of the mammalian target of rapamycin complex 1 (TORC1), and in Schizosaccharomyces pombe, Bhd and Tsc1/Tsc2 have opposing roles in the regulation of amino-acid homeostasis. We report here that in mammalian cells, downregulation of BHD reduces the phosphorylation of ribosomal protein S6, an indicator of TORC1 activity. To determine whether folliculin, the product of the BHD gene, regulates mammalian target of rapamycin activity in vivo, we generated a mouse with targeted inactivation of the Bhd gene. The mice developed spontaneous oncocytic cysts and tumors composed of cells that resemble the renal cell carcinomas in BHD patients. The cysts and tumors had low levels of phospho-S6. Taken together, these data indicate that folliculin regulates the activity of TORC1, and suggest a new paradigm in which both inappropriately high and inappropriately low levels of TORC1 activity can be associated with renal tumorigenesis.	[Henske, E. P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Hartman, T. R.; Henske, E. P.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Nicolas, E.] Fox Chase Canc Ctr, Genom Core Facil, Philadelphia, PA 19111 USA; [Klein-Szanto, A.; Al-Saleem, T.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Cash, T. P.; Simon, M. C.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Simon, M. C.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Simon, M. C.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Henske, EP (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, 1 Blackfan Circle, Boston, MA 02115 USA.	Ehenske@partners.org	Simon, Celeste/AAG-3941-2021; Klein-Szanto, A./E-6218-2010		NIH [RO1 (DK51052), F32 (DK076443-01)]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051052, R29DK051052, F32DK076443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Victoria Robb for critical reading of this paper. We also thank Dr Laura Schmidt for the FLCN mAb, Dr Samuel Litwin for statistical analysis and the Fox Chase Cancer Center Lab Animal Facility for technical assistance with the development and maintenance of the Bhd mutant mice. This work was supported by NIH RO1 (DK51052). Dr Hartman was supported by NIH F32 (DK076443-01).	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Babbitt JT, 2000, CARCINOGENESIS, V21, P1379, DOI 10.1093/carcin/21.7.1379; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; BARBOUR G L, 1978, Urology, V12, P694, DOI 10.1016/0090-4295(78)90434-X; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Henske EP, 1996, AM J HUM GENET, V59, P400; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; Hino O, 2001, JPN J CANCER RES, V92, P1147, DOI 10.1111/j.1349-7006.2001.tb02133.x; HINO O, 1993, CANCER RES, V53, P5856; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Kobayashi T, 1999, CANCER RES, V59, P1206; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kouchi M, 2006, VIRCHOWS ARCH, V448, P463, DOI 10.1007/s00428-005-0142-9; Leter EM, 2008, J INVEST DERMATOL, V128, P45, DOI 10.1038/sj.jid.5700959; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mohr U, 1996, PATHOBIOLOGY AGING M, V1; Murakami T, 2007, J PATHOL, V211, P524, DOI 10.1002/path.2139; Nagy A, 2004, INT J CANCER, V109, P472, DOI 10.1002/ijc.11694; NELLIST M, 1993, CELL, V75, P1305; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; O'Callaghan FJK, 1998, LANCET, V351, P1490, DOI 10.1016/S0140-6736(05)78872-3; Okimoto K, 2004, CURR MOL MED, V4, P887, DOI 10.2174/1566524043359737; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Painter JN, 2005, AM J HUM GENET, V76, P522, DOI 10.1086/428455; Pavlovich CP, 2005, J UROLOGY, V173, P1482, DOI 10.1097/01.ju.0000154629.45832.30; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Robb VA, 2007, J UROLOGY, V177, P346, DOI 10.1016/j.juro.2006.08.076; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stutman O, 1975, Adv Cancer Res, V22, P261; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; Urban T, 1999, MEDICINE, V78, P321, DOI 10.1097/00005792-199909000-00004; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	58	152	157	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1594	1604		10.1038/onc.2009.14	http://dx.doi.org/10.1038/onc.2009.14			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19234517	Green Accepted			2022-12-25	WOS:000264780500004
J	Lai, A; Cairns, MJ; Tran, N; Zhang, HP; Cullen, L; Arndt, GM				Lai, Angela; Cairns, Murray J.; Tran, Nham; Zhang, Hong-Ping; Cullen, Lara; Arndt, Greg M.			RNA Modulators of Complex Phenotypes in Mammalian Cells	PLOS ONE			English	Article								RNA-mediated gene silencing, in the form of RNA interference (RNAi) or microRNAs (miRNAs) has provided novel tools for gene discovery and validation in mammalian cells. Here, we report on the construction and application of a random small RNA expression library for use in identifying small interfering RNA (siRNA) effectors that can modify complex cellular phenotypes in mammalian cells. The library is based in a retroviral vector and uses convergent promoters to produce unique small complementary RNAs. Using this library, we identify a range of small RNA-encoding gene inserts that overcome resistance to 5-fluorouracil (5-FU)-or tumour necrosis factor alpha (TNF-alpha)-induced cell death in colorectal cancer cells. We demonstrate the utility of this technology platform by identifying a key RNA effector, in the form of a siRNA, which overcomes cell death induced by the chemotherapeutic 5-FU. The technology described has the potential to identify both functional RNA modulators capable of altering physiological systems and the cellular target genes altered by these modulators.	[Lai, Angela; Cairns, Murray J.; Tran, Nham; Zhang, Hong-Ping; Cullen, Lara; Arndt, Greg M.] Johnson & Johnson Res Pty Ltd, Eveleigh, NSW, Australia; [Tran, Nham] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney Head a& Neck Canc Inst, Sydney, NSW 2006, Australia; [Tran, Nham] Univ Sydney, Sydney, NSW 2006, Australia	Johnson & Johnson; University of Sydney; University of Sydney	Lai, A (corresponding author), Johnson & Johnson Res Pty Ltd, Australian Technol Pk, Eveleigh, NSW, Australia.	garndt@its.jnj.com		Cairns, Murray/0000-0003-2490-2538; Tran, Nham/0000-0001-7747-2530	Johnson and Johnson Research Pty Ltd	Johnson and Johnson Research Pty Ltd	Financial support for this work was provided by Johnson and Johnson Research Pty Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Giordano E, 2002, GENETICS, V160, P637; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo CQ, 2008, CHINA FOUNDRY, V5, P28; Guo Q, 2007, BIOCHEM BIOPH RES CO, V358, P272, DOI 10.1016/j.bbrc.2007.04.123; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jian R, 2007, STEM CELLS, V25, P1904, DOI 10.1634/stemcells.2006-0448; Kaykas A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-16; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Puca R, 2008, GYNECOL ONCOL, V109, P403, DOI 10.1016/j.ygyno.2008.02.018; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Schmidt WM, 2004, INT J CANCER, V112, P200, DOI 10.1002/ijc.20401; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Szell M, 2008, SEMIN CANCER BIOL, V18, P141, DOI 10.1016/j.semcancer.2008.01.007; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tran N, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-21; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003171; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wolters NM, 2008, CELL DEATH DIFFER, V15, P809, DOI 10.1038/sj.cdd.4402311; Worthington MT, 2001, ANAL BIOCHEM, V294, P169, DOI 10.1006/abio.2001.5162; Wu HL, 2007, BIOL PROCED ONLINE, V9, P9, DOI 10.1251/bpo129; Zhang JZ, 2006, STEM CELLS, V24, P2661, DOI 10.1634/stemcells.2006-0017; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	50	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4758	10.1371/journal.pone.0004758	http://dx.doi.org/10.1371/journal.pone.0004758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270743	Green Published, gold			2022-12-25	WOS:000265495900025
J	Fatakia, SN; Costanzi, S; Chow, CC				Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.			Computing Highly Correlated Positions Using Mutual Information and Graph Theory for G Protein-Coupled Receptors	PLOS ONE			English	Article							SPECIFICITY-DETERMINING RESIDUES; 2ND EXTRACELLULAR LOOP; A(2A) ADENOSINE RECEPTOR; AMINO-ACID SUBSTITUTIONS; CRYSTAL-STRUCTURE; SEQUENCE-ANALYSIS; HUMAN CA2+; ALLOSTERIC COMMUNICATION; FUNCTIONAL SPECIFICITY; TRANSMEMBRANE DOMAIN	G protein-coupled receptors (GPCRs) are a superfamily of seven transmembrane-spanning proteins involved in a wide array of physiological functions and are the most common targets of pharmaceuticals. This study aims to identify a cohort or clique of positions that share high mutual information. Using a multiple sequence alignment of the transmembrane (TM) domains, we calculated the mutual information between all inter-TM pairs of aligned positions and ranked the pairs by mutual information. A mutual information graph was constructed with vertices that corresponded to TM positions and edges between vertices were drawn if the mutual information exceeded a threshold of statistical significance. Positions with high degree (i.e. had significant mutual information with a large number of other positions) were found to line a well defined inter-TM ligand binding cavity for class A as well as class C GPCRs. Although the natural ligands of class C receptors bind to their extracellular N-terminal domains, the possibility of modulating their activity through ligands that bind to their helical bundle has been reported. Such positions were not found for class B GPCRs, in agreement with the observation that there are not known ligands that bind within their TM helical bundle. All identified key positions formed a clique within the MI graph of interest. For a subset of class A receptors we also considered the alignment of a portion of the second extracellular loop, and found that the two positions adjacent to the conserved Cys that bridges the loop with the TM3 qualified as key positions. Our algorithm may be useful for localizing topologically conserved regions in other protein families.	[Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fatakia, SN (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA.	carsonc@mail.nih.gov	Chow, Carson C/A-7970-2009; Costanzi, Stefano/G-8990-2013	Costanzi, Stefano/0000-0003-3183-7332; Fatakia, Sarosh/0000-0003-0430-3191	NIDDK/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013025, Z01DK013026, Z01DK013025, ZIADK013026] Funding Source: NIH RePORTER	NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural program of NIDDK/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Banerjee R, 2008, BIOCHEMISTRY-US, V47, P7385, DOI 10.1021/bi8006127; Batagelj V, 2004, MATH VIS, P77; Brun R, 1997, NUCL INSTRUM METH A, V389, P81, DOI 10.1016/S0168-9002(97)00048-X; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; CLARKE ND, 1995, PROTEIN SCI, V4, P2269, DOI 10.1002/pro.5560041104; Costanzi S, 2005, J MED CHEM, V48, P8108, DOI 10.1021/jm050911p; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Costanzi S., 2007, FRONT DRUG DES DISCO, V3, P63; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Dimmic MW, 2005, BIOINFORMATICS, V21, pI126, DOI 10.1093/bioinformatics/bti1032; Donald JE, 2009, NUCLEIC ACIDS RES, V37, pD191, DOI 10.1093/nar/gkn716; Donald JE, 2005, NUCLEIC ACIDS RES, V33, P4455, DOI 10.1093/nar/gki755; DONALD JE, 2007, THESIS; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galitsky Boris, 2003, In Silico Biology, V3, P241; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gouldson PR, 2001, PROTEIN ENG, V14, P759, DOI 10.1093/protein/14.10.759; Govindarajan S, 2003, J MOL BIOL, V328, P1061, DOI 10.1016/S0022-2836(03)00357-7; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Harris CJ, 2006, DRUG DISCOV TODAY, V11, P880, DOI 10.1016/j.drudis.2006.08.013; Heitman LH, 2008, MOL PHARMACOL, V73, P518, DOI 10.1124/mol.107.039875; Hemmerich C, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/87356; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Hu JX, 2006, J BIOL CHEM, V281, P21558, DOI 10.1074/jbc.M603682200; Ivanov AA, 2006, J COMPUT AID MOL DES, V20, P417, DOI 10.1007/s10822-006-9054-2; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jothi R, 2006, J MOL BIOL, V362, P861, DOI 10.1016/j.jmb.2006.07.072; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kelly JW, 2005, NATURE, V437, P486, DOI 10.1038/437486a; Kim JH, 1996, MOL PHARMACOL, V49, P683; Klabunde T, 2006, E SCHERING RES FDN W, V58, P31; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kleinau G, 2007, EXP CLIN ENDOCR DIAB, V115, pS75; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kundrotas PJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-503; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; LEWYN L, 2003, P NATL ACAD SCI USA, V100, P4463; Lichtarge O, 1997, J MOL BIOL, V274, P325, DOI 10.1006/jmbi.1997.1395; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Litschig S, 1999, MOL PHARMACOL, V55, P453; Liu XB, 2008, INT J COMPUT INT SYS, V1, P24, DOI 10.2991/ijcis.2008.1.1.3; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopez-Rodriguez ML, 2001, BIOORG MED CHEM LETT, V11, P2807, DOI 10.1016/S0960-894X(01)00517-0; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Moore S, 2006, J MED CHEM, V49, P3888, DOI 10.1021/jm060247s; Moro S, 1999, BIOCHEMISTRY-US, V38, P3498, DOI 10.1021/bi982369v; Nagl S B, 1999, Pac Symp Biocomput, P90; NAGL SB, 2008, BRIEF BIOINFORM, V2, P279; *NAT CTR BIOT INF, 2002, NCBI HDB INT; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029; Ohno S., 1970, EVOLUTION GENE DUPLI; OLAH ME, 1994, J BIOL CHEM, V269, P24692; Oliveira L, 2003, PROTEINS, V52, P544, DOI 10.1002/prot.10490; Oliveira L, 2003, PROTEINS, V52, P553, DOI 10.1002/prot.10489; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Ortiz AR, 2006, CURR TOP MED CHEM, V6, P41, DOI 10.2174/156802606775193338; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pazos F, 1997, COMPUT APPL BIOSCI, V13, P319; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Pritchard L, 2001, PROTEIN ENG, V14, P549, DOI 10.1093/protein/14.8.549; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qi Y, 2004, BIOINFORMATICS, V20, P3697, DOI 10.1093/bioinformatics/bth431; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Raviscioni M, 2005, J MOL BIOL, V350, P402, DOI 10.1016/j.jmb.2005.04.054; Ray K, 2005, J BIOL CHEM, V280, P37013, DOI 10.1074/jbc.M506681200; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sato T, 1999, BRIT J PHARMACOL, V128, P272, DOI 10.1038/sj.bjp.0702813; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Sjolander K, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P165; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Thomas J, 2008, IEEE ACM T COMPUT BI, V5, P183, DOI 10.1109/TCBB.2007.70225; Thomas MC, 2006, ELEMENTS INFORM THEO; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WILLIAMSON RM, 1995, J THEOR BIOL, V174, P179, DOI 10.1006/jtbi.1995.0090; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Ye K, 2006, PROTEINS, V63, P1018, DOI 10.1002/prot.20899; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584	126	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4681	10.1371/journal.pone.0004681	http://dx.doi.org/10.1371/journal.pone.0004681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262747	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600012
J	Gaglio, D; Soldati, C; Vanoni, M; Alberghina, L; Chiaradonna, F				Gaglio, Daniela; Soldati, Chiara; Vanoni, Marco; Alberghina, Lilia; Chiaradonna, Ferdinando			Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts	PLOS ONE			English	Article								Background: Oncogene activation plays a role in metabolic reprogramming of cancer cells. We have previously shown that K-ras transformed fibroblasts have a stronger dependence on glycolysis and a reduced oxidative phosphorylation ability as compared to their normal counterparts. Another metabolic adaptation of cancer cells, that has long been established, is their propensity to exhibit increased glutamine consumption, although the effects induced by glutamine deprivation on cancer cells are still controversial. Methodology and Principal Findings: Here, by using nutritional perturbations and molecular physiology, we show that reduction or complete depletion of glutamine availability in K-ras transformed fibroblasts causes a strong decrease of proliferation ability and a slower re-entry of synchronized cells into the cell cycle. The reduced proliferation is accompanied by sustained expression of cyclin D and E, abortive S phase entrance and is dependent on Ras signalling deregulation, since it is rescued by expression of a dominant negative guanine nucleotide exchange factor. The growth potential of transformed cells as well as the ability to execute the G1 to S transition is restored by adding the four deoxyribonucleotides, indicating that the arrest of proliferation of K-ras transformed cells induced by glutamine depletion is largely due to a reduced supply of DNA in the presence of signalling pathways promoting G1 to S transition. Conclusions and Significance: Our results suggest that the differential effects of glutamine and glucose on cell viability are not a property of the transformed phenotype per se, but rather depend on the specific pathway being activated in transformation. For instance, myc-overexpressing cells have been reported to die under glutamine depletion and not under glucose shortage, while the opposite holds for ras-transformed fibroblasts as shown in this paper. These different responses of transformed cells to nutritional stress should be taken into account when designing anti-cancer therapies that aim to exploit metabolic differences between normal and transformed cells.	[Gaglio, Daniela; Soldati, Chiara; Vanoni, Marco; Alberghina, Lilia; Chiaradonna, Ferdinando] Univ Milan, Dept Biosci & Biotechnol, Milan, Italy	University of Milan	Gaglio, D (corresponding author), Univ Milan, Dept Biosci & Biotechnol, Milan, Italy.	ferdinando.chiaradonna@unimib.it	Vanoni, Marco/AAA-3699-2021; CHIARADONNA, Ferdinando/K-4959-2016	Vanoni, Marco/0000-0002-8690-2587; CHIARADONNA, Ferdinando/0000-0001-8529-2732; Alberghina, Lilia/0000-0003-1694-931X	MIUR; Regione Lombardia [INGENIO fellowship]	MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia)	From MIUR to L.A. (FIRB-ITALBIONET), M.V and F.C. (F.A.R.). D.G. and C.S. were supported by an INGENIO fellowship from Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 1999, J BIOL CHEM, V274, P28645, DOI 10.1074/jbc.274.40.28645; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Agarwal MK, 2006, P NATL ACAD SCI USA, V103, P16278, DOI 10.1073/pnas.0607210103; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Bossu P, 2000, ONCOGENE, V19, P2147, DOI 10.1038/sj.onc.1203539; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chang FM, 2001, ONCOGENE, V20, P4354, DOI 10.1038/sj.onc.1204564; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Chiaradonna F, 2006, BBA-BIOENERGETICS, V1757, P1338, DOI 10.1016/j.bbabio.2006.08.001; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Drogat B, 2007, J CELL PHYSIOL, V212, P463, DOI 10.1002/jcp.21044; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; ERIKSSON S, 1984, EXP CELL RES, V155, P129, DOI 10.1016/0014-4827(84)90774-2; ERIKSSON S, 1984, ADV EXP MED BIOL, V165, P407; EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18; FILMUS J, 1994, ONCOGENE, V9, P3627; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HIGASHIGUCHI T, 1993, JPEN-PARENTER ENTER, V17, P307, DOI 10.1177/0148607193017004307; KAHN S, 1987, ANTICANCER RES, V7, P639; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kokkinakis DM, 2005, MOL CANCER THER, V4, P1338, DOI 10.1158/1535-7163.MCT-05-0141; Lamb J, 2000, EXP CELL RES, V255, P238, DOI 10.1006/excr.1999.4779; Le Bacquer O, 2001, AM J PHYSIOL-GASTR L, V281, pG1340, DOI 10.1152/ajpgi.2001.281.6.G1340; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; MACLENNAN PA, 1987, FEBS LETT, V215, P187, DOI 10.1016/0014-5793(87)80139-4; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Mazurek S, 2003, ANTICANCER RES, V23, P1149; MCFATE T, 2008, J BIOL CHEM; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; RATHBONE MP, 1992, IN VITRO CELL DEV-AN, V28A, P529; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; TUROWSKI GA, 1994, CANCER RES, V54, P5974; Vanoni M, 1999, J BIOL CHEM, V274, P36656, DOI 10.1074/jbc.274.51.36656; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wasa M, 1996, ANN SURG, V224, P189, DOI 10.1097/00000658-199608000-00012; YAMAMOTO F, 1984, NUCLEIC ACIDS RES, V12, P8873, DOI 10.1093/nar/12.23.8873; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; ZHUANG Y, 2008, J MOL SIGNAL, P18; ZHUANG Y, 2008, J MOL SIGNAL, P3; ZIELKE HR, 1984, FED PROC, V43, P121	60	106	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4715	10.1371/journal.pone.0004715	http://dx.doi.org/10.1371/journal.pone.0004715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262748	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600025
J	Felice, B; Cattoglio, C; Cittaro, D; Testa, A; Miccio, A; Ferrari, G; Luzi, L; Recchia, A; Mavilio, F				Felice, Barbara; Cattoglio, Claudia; Cittaro, Davide; Testa, Anna; Miccio, Annarita; Ferrari, Giuliana; Luzi, Lucilla; Recchia, Alessandra; Mavilio, Fulvio			Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome	PLOS ONE			English	Article								Gamma-retroviruses and lentiviruses integrate non-randomly in mammalian genomes, with specific preferences for active chromatin, promoters and regulatory regions. Gene transfer vectors derived from gamma-retroviruses target at high frequency genes involved in the control of growth, development and differentiation of the target cell, and may induce insertional tumors or pre-neoplastic clonal expansions in patients treated by gene therapy. The gene expression program of the target cell is apparently instrumental in directing gamma-retroviral integration, although the molecular basis of this phenomenon is poorly understood. We report a bioinformatic analysis of the distribution of transcription factor binding sites (TFBSs) flanking >4,000 integrated proviruses in human hematopoietic and non-hematopoietic cells. We show that gamma-retroviral, but not lentiviral vectors, integrate in genomic regions enriched in cell-type specific subsets of TFBSs, independently from their relative position with respect to genes and transcription start sites. Analysis of sequences flanking the integration sites of Moloney leukemia virus (MLV)- and human immunodeficiency virus (HIV)-derived vectors carrying mutations in their long terminal repeats (LTRs), and of HIV vectors packaged with an MLV integrase, indicates that the MLV integrase and LTR enhancer are the viral determinants of the selection of TFBS-rich regions in the genome. This study identifies TFBSs as differential genomic determinants of retroviral target site selection in the human genome, and suggests that transcription factors binding the LTR enhancer may synergize with the integrase in tethering retroviral pre-integration complexes to transcriptionally active regulatory regions. Our data indicate that gamma-retroviruses and lentiviruses have evolved dramatically different strategies to interact with the host cell chromatin, and predict a higher risk in using gammaretroviral vs. lentiviral vectors for human gene therapy applications.	[Felice, Barbara; Luzi, Lucilla] FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; [Cattoglio, Claudia; Mavilio, Fulvio] Ist Scientifico H San Raffaele, IIT Unit Mol Neurosci, Milan, Italy; [Cittaro, Davide] Cogentech, Milan, Italy; [Testa, Anna; Recchia, Alessandra; Mavilio, Fulvio] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Miccio, Annarita; Ferrari, Giuliana] HSR Telethon Inst Gene Therapy, Milan, Italy; [Ferrari, Giuliana] Univ Vita Salute San Raffaele, Milan, Italy; [Luzi, Lucilla] European Inst Oncol, Dept Expt Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Istituto Italiano di Tecnologia - IIT; Universita di Modena e Reggio Emilia; Fondazione Telethon; Vita-Salute San Raffaele University; IRCCS European Institute of Oncology (IEO)	Felice, B (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy.	fulvio.mavilio@unimore.it	Luzi, Lucilla/K-4350-2018; Cittaro, Davide/K-2405-2018; Recchia, Alessandra/B-7954-2015; Miccio, Annarita/H-9585-2017; Ferrari, Giuliana/AAB-5546-2019; MAVILIO, Fulvio/J-6125-2013	Luzi, Lucilla/0000-0002-8746-4179; Cittaro, Davide/0000-0003-0384-3700; Recchia, Alessandra/0000-0002-3467-1094; Miccio, Annarita/0000-0002-3409-9665; Ferrari, Giuliana/0000-0003-0790-3133; Mavilio, Fulvio/0000-0003-0459-4320	Telethon Italy [GGP06101]; Italian Association for Cancer Research (AIRC); Sixth Framework Program of the European Commission; Fondazione Cariplo	Telethon Italy(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Sixth Framework Program of the European Commission(European Commission); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from Telethon Italy (GGP06101 and TIGET), the Italian Association for Cancer Research (AIRC), the Sixth Framework Program of the European Commission (CONSERT and EPITRON consortia), and Fondazione Cariplo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Ambrosi A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000144; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Coffin J, 1997, RETROVIRUSES; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Dudley JP, 2003, TRENDS MOL MED, V9, P43, DOI 10.1016/S1471-4914(03)00003-0; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Engelman A, 2005, P NATL ACAD SCI USA, V102, P1275, DOI 10.1073/pnas.0409587101; Faschinger A, 2008, J VIROL, V82, P1360, DOI 10.1128/JVI.02098-07; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Lai LL, 2001, J VIROL, V75, P11365, DOI 10.1128/JVI.75.23.11365-11372.2001; Laufs S, 2004, MOL THER, V10, P874, DOI 10.1016/j.ymthe.2004.08.001; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Lotti F, 2002, J VIROL, V76, P3996, DOI 10.1128/JVI.76.8.3996-4007.2002; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Porteus MH, 2006, PLOS GENET, V2, P1285, DOI 10.1371/journal.pgen.0020133; Recchia A, 2006, P NATL ACAD SCI USA, V103, P1457, DOI 10.1073/pnas.0507496103; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schambach A, 2000, MOL THER, V2, P435, DOI 10.1006/mthe.2000.0191; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Steinrigl A, 2007, VIROLOGY, V362, P50, DOI 10.1016/j.virol.2006.11.037; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Testa A, 2004, J BIOL CHEM, V279, P10523, DOI 10.1074/jbc.M313638200; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wu XL, 2006, VIROLOGY, V344, P292, DOI 10.1016/j.virol.2005.08.047; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	55	77	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2009	4	2							e4571	10.1371/journal.pone.0004571	http://dx.doi.org/10.1371/journal.pone.0004571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KW	19238208	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487400005
J	Koch, R; Ledermann, R; Urwyler, O; Heller, M; Suter, B				Koch, Rafael; Ledermann, Romana; Urwyler, Olivier; Heller, Manfred; Suter, Beat			Systematic Functional Analysis of Bicaudal-D Serine Phosphorylation and Intragenic Suppression of a Female Sterile Allele of BicD	PLOS ONE			English	Article								Protein phosphorylation is involved in posttranslational control of essentially all biological processes. Using mass spectrometry, recent analyses of whole phosphoproteomes led to the identification of numerous new phosphorylation sites. However, the function of most of these sites remained unknown. We chose the Drosophila Bicaudal-D protein to estimate the importance of individual phosphorylation events. Being involved in different cellular processes, BicD is required for oocyte determination, for RNA transport during oogenesis and embryogenesis, and for photoreceptor nuclei migration in the developing eye. The numerous roles of BicD and the available evidence for functional importance of BicD phosphorylation led us to identify eight phosphorylation sites of BicD, and we tested a total of 14 identified and suspected phosphoserine residues for their functional importance in vivo in flies. Surprisingly, all these serines turned out to be dispensable for providing sufficient basal BicD activity for normal growth and development. However, in a genetically sensitized background where the BicD(A40V) protein variant provides only partial activity, serine 103 substitutions are not neutral anymore, but show surprising differences. The S103D substitution completely inactivates the protein, whereas S103A behaves neutral, and the S103F substitution, isolated in a genetic screen, restores BicD(A40V) function. Our results suggest that many BicD phosphorylation events may either be fortuitous or play a modulating function as shown for Ser(103). Remarkably, amongst the Drosophila serines we found phosphorylated, Ser(103) is the only one that is fully conserved in mammalian BicD.	[Koch, Rafael; Ledermann, Romana; Urwyler, Olivier; Suter, Beat] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Koch, R (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	beat.suter@izb.unibe.ch		Heller, Manfred/0000-0002-6364-7325; Koch, Rafael/0000-0001-6105-2638; Urwyler, Olivier/0000-0001-8334-8667	Swiss National Science Foundation; Kanton Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Bern	This work was supported by funds from the Swiss National Science Foundation and the Kanton Bern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya R, 2006, CURR SCI INDIA, V90, P1179; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Houalla T, 2005, MECH DEVELOP, V122, P97, DOI 10.1016/j.mod.2004.08.005; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Mancebo R, 2001, MOL CELL BIOL, V21, P3462, DOI 10.1128/MCB.21.10.3462-3471.2001; Mirouse V, 2006, DEVELOPMENT, V133, P4005, DOI 10.1242/dev.02565; MOHLER J, 1986, GENETICS, V112, P803; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oh J, 2000, GENETICS, V154, P713; Pare C, 2000, J CELL SCI, V113, P2119; RAN B, 1994, DEVELOPMENT, V120, P1233; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; SCHRIEFER LA, 1989, J MOL BIOL, V207, P451, DOI 10.1016/0022-2836(89)90267-2; STERN DL, 2000, DROSOPHILA PROTOCOLS, P601; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TOMLINSON A, 1985, J EMBRYOL EXP MORPH, V89, P313; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a	44	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2009	4	2							e4552	10.1371/journal.pone.0004552	http://dx.doi.org/10.1371/journal.pone.0004552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KU	19234596	gold, Green Published, Green Submitted			2022-12-25	WOS:000265487200008
J	Nakai, K; Rogers, MS; Baba, T; Funakoshi, T; Birsner, AE; Luyindula, DS; D'Amato, RJ				Nakai, Kei; Rogers, Michael S.; Baba, Takashi; Funakoshi, Taisaku; Birsner, Amy E.; Luyindula, Dema S.; D'Amato, Robert J.			Genetic loci that control the size of laser-induced choroidal neovascularization	FASEB JOURNAL			English	Article						quantitative trait locus; QTL; recombinant inbred; BXD	ENDOTHELIAL GROWTH-FACTOR; QUANTITATIVE TRAIT LOCI; COMPLEMENT FACTOR-H; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; MOUSE STRAINS; GENOME SCAN; LABORATORY MOUSE; SUSCEPTIBILITY LOCI; MURINE MODEL	Angiogenesis is controlled by a balance between stimulators and inhibitors. We propose that the balance, as well as the general sensitivity of the endothelium to these factors, varies from individual to individual. Indeed, we have found that individual mouse strains have dramatically different responses to growth factor-induced neovascularization. Quantitative trait loci (QTLs), which influence the extent of corneal angiogenesis induced by vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF2), were previously identified by our laboratory. To investigate the genetic contribution to choroidal neovascularization (CNV), a leading cause of blindness, we have undertaken a similar mapping approach to identify QTLs that influence laser-induced CNV in the BXD series of recombinant inbred mouse strains. Composite interval mapping identified new angiogenic QTLs on chromosomes 2 and 19, in addition to confirming our previous corneal neovascularization QTLs of AngVq1 and AngFq2. The new QTLs are named AngCNVq1 and AngCNVq2. The newly mapped regions contain several candidate genes involved in the angiogenic process, including thrombospondin 1, delta-like 4, BclII modifying factor, phospholipase C, beta 2, adrenergic receptor, beta 1, actin-binding LIM protein 1 and colony stimulating factor 2 receptor, alpha. Differences in these regions may control individual susceptibility to CNV.-Nakai, K., Rogers, M. S., Baba, T., Funakoshi, T., Birsner, A. E., Luyindula, D. S., D'Amato, R. J. Genetic loci that control the size of laser-induced choroidal neovascularization. FASEB J. 23, 2235-2243 (2009)	[Nakai, Kei; Rogers, Michael S.; Birsner, Amy E.; Luyindula, Dema S.; D'Amato, Robert J.] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Baba, Takashi; Funakoshi, Taisaku] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Tottori 680, Japan; [D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Tottori University; Harvard University	D'Amato, RJ (corresponding author), Childrens Hosp, Dept Surg, Vasc Biol Program, Karp 11-210,300 Longwood Ave, Boston, MA 02115 USA.	robert.damato@childrens.harvard.edu	Rogers, Michael/AAE-2217-2019; Rogers, Michael S/A-9814-2009	Rogers, Michael/0000-0002-5250-8434; Rogers, Michael S/0000-0002-5250-8434	National Eye Institute [RO1 EY12726]; NATIONAL EYE INSTITUTE [R01EY012726] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Kristin Johnson for help in the preparation of digital art. Portions of this work were funded by a grant from the National Eye Institute (RO1 EY12726).	Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Balasubramanian SP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-107; Barral S, 2006, INVEST OPHTH VIS SCI, V47, P5453, DOI 10.1167/iovs.06-0655; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Brannan CI, 2001, MAMM GENOME, V12, P882, DOI 10.1007/s00335-001-2084-0; Brown AC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-12; Carroll S, 2004, J CELL SCI, V117, P105, DOI 10.1242/jcs.00847; Cherrington JM, 2000, ADV CANCER RES, V79, P1, DOI 10.1016/S0065-230X(00)79001-4; Cheverud JM, 1996, GENETICS, V142, P1305; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; DOBI ET, 1989, ARCH OPHTHALMOL-CHIC, V107, P264, DOI 10.1001/archopht.1989.01070010270035; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2008, LANCET, V372, P1828, DOI 10.1016/S0140-6736(08)61348-3; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gorin MB, 1999, MOL VIS, V5, pU31; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hamdi HK, 2002, BIOCHEM BIOPH RES CO, V295, P668, DOI 10.1016/S0006-291X(02)00728-3; Higashi S, 1998, J CANCER RES CLIN, V124, P670, DOI 10.1007/s004320050230; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Iughetti P, 2001, CANCER RES, V61, P7375; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kariyazono H, 2004, PEDIATR RES, V56, P953, DOI 10.1203/01.PDR.0000145280.26284.B9; Kenney-Hunt JP, 2006, MAMM GENOME, V17, P526, DOI 10.1007/s00335-005-0160-6; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; LANDER ES, 1989, GENETICS, V121, P185; Liu XB, 2000, CELL DEATH DIFFER, V7, P1119, DOI 10.1038/sj.cdd.4400745; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Martin G, 2004, GRAEF ARCH CLIN EXP, V242, P321, DOI 10.1007/s00417-003-0838-y; Masinde Godfred L, 2002, Funct Integr Genomics, V2, P98, DOI 10.1007/s10142-002-0053-7; Masinde Godfred L, 2002, Funct Integr Genomics, V2, P120, DOI 10.1007/s10142-002-0067-1; McLaren J, 2000, HUM REPROD UPDATE, V6, P45, DOI 10.1093/humupd/6.1.45; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Otto JM, 1999, ARTHRITIS RHEUM, V42, P2524, DOI 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rogers MS, 2004, FASEB J, V18, P1050, DOI 10.1096/fj.03-1241com; Rogers MS, 2003, FASEB J, V17, P2112, DOI 10.1096/fj.03-0246fje; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schmidt S, 2000, MOL VIS, V6, P287; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shiozawa Shunichi, 2002, Nihon Rinsho, V60, P2269; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith SK, 2001, BRIT J OBSTET GYNAEC, V108, P777, DOI 10.1111/j.1471-0528.2001.00211.x; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Stylianou IM, 2006, MAMM GENOME, V17, P22, DOI 10.1007/s00335-005-0091-2; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Symons RCA, 2002, P NATL ACAD SCI USA, V99, P11299, DOI 10.1073/pnas.162566999; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Taylor BA, 2001, MAMM GENOME, V12, P95, DOI 10.1007/s003350010254; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; ZENG ZB, 1994, P 5 WORLD C GEN APPL, V22, P65; Zheng HR, 2003, DNA SEQUENCE, V14, P369, DOI 10.1080/10425170310001605491	84	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2235	2243		10.1096/fj.08-124321	http://dx.doi.org/10.1096/fj.08-124321			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19237505	Green Published			2022-12-25	WOS:000268836500023
J	Holinger, EP; Old, WM; Giddings, TH; Wong, C; Yates, JR; Winey, M				Holinger, Eric P.; Old, William M.; Giddings, Thomas H., Jr.; Wong, Catherine; Yates, John R., III; Winey, Mark			Budding Yeast Centrosome Duplication Requires Stabilization of Spc29 via Mps1-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; SPB DUPLICATION; COMPONENT; SPC110P; PROTEIN; IDENTIFICATION; COMPLEX; MITOSIS	Protein phosphorylation plays an important role in the regulation of centrosome duplication. In budding yeast, numerous lines of evidence suggest a requirement for multiple phosphorylation events on individual components of the centrosome to ensure their proper assembly and function. Here, we report the first example of a single phosphorylation event on a component of the yeast centrosome, or spindle pole body (SPB), that is required for SPB duplication and cell viability. This phosphorylation event is on the essential SPB component Spc29 at a conserved Thr residue, Thr(240). Mutation of Thr(240) to Ala is lethal at normal gene dosage, but an increased copy number of this mutant allele results in a conditional phenotype. Phosphorylation of Thr(240) was found to promote the stability of the protein in vivo and is catalyzed in vitro by the Mps1 kinase. Furthermore, the stability of newly synthesized Spc29 is reduced in a mutant strain with reduced Mps1 kinase activity. These results demonstrate the first evidence for a single phosphorylation event on an SPB component that is absolutely required for SPB duplication and suggest that the Mps1 kinase is responsible for this protein-stabilizing phosphorylation.	[Holinger, Eric P.; Giddings, Thomas H., Jr.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Old, William M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wong, Catherine; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Scripps Research Institute	Winey, M (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Porter Biosci Bldg,CB347, Boulder, CO 80309 USA.	mark.winey@colorado.edu		OLD, WILLIAM/0000-0002-9499-8478; Wong, Catherine CL/0000-0001-7270-980X	National Institutes of Health [GM51312]; NATIONAL CANCER INSTITUTE [R01CA126240] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM051312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51312 (to M. W.) and Grant CA126240-01 from NCI (to Katheryn A. Resing).	Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; Cantin GT, 2007, ANAL CHEM, V79, P4666, DOI 10.1021/ac0618730; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Castillo AR, 2002, J CELL BIOL, V156, P453, DOI 10.1083/jcb.200111025; Cha H, 2004, BIOCHEM J, V378, P857, DOI 10.1042/BJ20031173; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Friedman DB, 1996, J CELL BIOL, V132, P903, DOI 10.1083/jcb.132.5.903; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Giddings TH, 2001, METHOD CELL BIOL, V67, P27; HERGOVICH A, 2007, BIOCHIM BIOPHYS ACTA, V1784, P3; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Huisman SM, 2007, J CELL SCI, V120, P435, DOI 10.1242/jcs.03342; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jasperson SL, 2002, J CELL BIOL, V159, P945, DOI 10.1083/jcb.200208169; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775; Tarapore P, 2002, CELL CYCLE, V1, P75, DOI 10.4161/cc.1.1.103; Venable JD, 2004, ANAL CHEM, V76, P2928, DOI 10.1021/ac0348219; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745	30	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12949	12955		10.1074/jbc.M900088200	http://dx.doi.org/10.1074/jbc.M900088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269975	Green Published, hybrid			2022-12-25	WOS:000265688300041
J	Yin, W; Romeo, S; Chang, S; Grishin, NV; Hobbs, HH; Cohen, JC				Yin, Wu; Romeo, Stefano; Chang, Shurong; Grishin, Nick V.; Hobbs, Helen H.; Cohen, Jonathan C.			Genetic Variation in ANGPTL4 Provides Insights into Protein Processing and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOPOIETIN-LIKE PROTEIN-4; LIPOPROTEIN-LIPASE; TARGET GENE; INHIBITION; OLIGOMERIZATION; MICE; LPL	Angiopoietin-like protein 4 (ANGPTL4) is a secreted protein that modulates the disposition of circulating triglycerides (TG) by inhibiting lipoprotein lipase (LPL). Here we examine the steps involved in the synthesis and post-translational processing of ANGPTL4, and the effects of a naturally occurring sequence variant (E40K) that is associated with lower plasma TG levels in humans. Expression of the wild-type and mutant proteins in HEK-293A cells indicated that ANGPTL4 formed dimers and tetramers in cells prior to secretion and cleavage of the protein. After cleavage at a canonical proprotein convertase cleavage site ((RRKR164)-R-161), the oligomeric structure of the N-terminal domain was retained whereas the C-terminal fibrinogen-like domain dissociated into monomers. Inhibition of cleavage did not interfere with oligomerization of ANGPTL4 or with its ability to inhibit LPL, whereas mutations that prevented oligomerization severely compromised the capacity of the protein to inhibit LPL. ANGPTL4 containing the E40K substitution was synthesized and processed normally, but no monomers or oligomers of the N-terminal fragments accumulated in the medium; medium from these cells failed to inhibit LPL activity. Parallel experiments performed in mice recapitulated these results. Our findings indicate that oligomerization, but not cleavage, of ANGPTL4 is required for LPL inhibition, and that the E40K substitution destabilizes the protein after secretion, preventing the extracellular accumulation of oligomers and abolishing the ability of the protein to inhibit LPL activity.	[Yin, Wu; Romeo, Stefano; Chang, Shurong; Hobbs, Helen H.; Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dept Mol Genet, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.hobbs@utsouthwestern.edu; Jonathan.Cohen@utsouthwestern.edu	Romeo, Stefano/L-6861-2015	Romeo, Stefano/0000-0001-9168-4898	National Institutes of Health [HL092550]; Donald W. Reynolds Foundation; American Heart Association; Welch Foundation [I-1505]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; American Heart Association(American Heart Association); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL092550, the Donald W. Reynolds Foundation, the American Heart Association, and a Welch Foundation grant I-1505 (to N.V.G.).	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	20	92	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13213	13222		10.1074/jbc.M900553200	http://dx.doi.org/10.1074/jbc.M900553200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19270337	hybrid, Green Published			2022-12-25	WOS:000265688300068
J	Handy, DE; Lubos, E; Yang, Y; Galbraith, JD; Kelly, N; Zhang, YY; Leopold, JA; Loscalzo, J				Handy, Diane E.; Lubos, Edith; Yang, Yi; Galbraith, John D.; Kelly, Neil; Zhang, Ying-Yi; Leopold, Jane A.; Loscalzo, Joseph			Glutathione Peroxidase-1 Regulates Mitochondrial Function to Modulate Redox-dependent Cellular Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; NF-KAPPA-B; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; KNOCKOUT MOUSE; ENDOTHELIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE; KINASE ACTIVITY; OVEREXPRESSION	Glutathione peroxidase-1 (GPx-1) is a selenocysteine-containing enzyme that plays a major role in the reductive detoxification of peroxides in cells. In permanently transfected cells with approximate 2-fold overexpression of GPx-1, we found that intracellular accumulation of oxidants in response to exogenous hydrogen peroxide was diminished, as was epidermal growth factor receptor (EGFR)-mediated Akt activation in response to hydrogen peroxide or EGF stimulation. Knockdown of GPx-1 augmented EGFR-mediated Akt activation, whereas overexpression of catalase decreased Akt activation, suggesting that EGFR signaling is regulated by redox mechanisms. To determine whether mitochondrial oxidants played a role in these processes, cells were pretreated with a mitochondrial uncoupler prior to EGF stimulation. Inhibition of mitochondrial function attenuated EGF-mediated activation of Akt in control cells but had no additional effect in GPx-1-overexpressing cells, suggesting that GPx-1 overexpression decreased EGFR signaling by decreasing mitochondrial oxidants. Consistent with this finding, GPx-1 overexpression decreased global protein disulfide bond formation, which is dependent on mitochondrially produced oxidants. GPx-1 overexpression, in permanently transfected or adenovirus-treated cells, also caused overall mitochondrial dysfunction with a decrease in mitochondrial potential and a decrease in ATP production. GPx-1 overexpression also decreased EGF- and serum-mediated [H-3] thymidine incorporation, indicating that alterations in GPx-1 can attenuate cell proliferation. Taken together, these data suggest that GPx-1 can modulate redox-dependent cellular responses by regulating mitochondrial function.	[Handy, Diane E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Handy, DE (corresponding author), Brigham & Womens Hosp, Dept Med, HMS NRB 0630,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dhandy@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021; Yang, Yi/C-1297-2013	Handy, Diane/0000-0002-4310-8527; Yang, Yi/0000-0001-7896-1184	National Institutes of Health [HL 58976, HL 61795, NO1 HV 28178, HL 81587]; Deutsche Forschungsgemeinschaft [LU 1452/1-1]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058976, R01HL061795, P01HL081587, R37HL061795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 58976, HL 61795, NO1 HV 28178, and HL 81587. This work was also supported by Deutsche Forschungsgemeinschaft Grant LU 1452/1-1.	Arita Y, 2006, AM J PHYSIOL-LUNG C, V290, pL978, DOI 10.1152/ajplung.00296.2005; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Banning A, 2008, ANTIOXID REDOX SIGN, V10, P1491, DOI 10.1089/ars.2008.2047; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Chen Y, 2004, NITRIC OXIDE-BIOL CH, V11, P121; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; Choi Y, 2002, ONCOGENE, V21, P5289, DOI 10.1038/sj.onc.1205650; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Crack PJ, 2006, STROKE, V37, P1533, DOI 10.1161/01.STR.0000221708.17159.64; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; de Haan JB, 2004, FREE RADICAL BIO MED, V36, P53, DOI 10.1016/j.freeradbiomed.2003.10.020; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; DeYulia GJ, 2005, P NATL ACAD SCI USA, V102, P5044, DOI 10.1073/pnas.0501154102; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Finch JS, 2006, FREE RADICAL BIO MED, V40, P863, DOI 10.1016/j.freeradbiomed.2005.10.036; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; Forgione MA, 2002, AM J PHYSIOL-HEART C, V282, pH1255, DOI 10.1152/ajpheart.00598.2001; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Heirman I, 2006, FREE RADICAL BIO MED, V40, P285, DOI 10.1016/j.freeradbiomed.2005.08.033; Hoehn B, 2003, STROKE, V34, P2489, DOI 10.1161/01.STR.0000091268.25816.19; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Liu JR, 2006, HUM GENE THER, V17, P105, DOI 10.1089/hum.2006.17.105; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Madamanchi NR, 2001, ARTERIOSCL THROM VAS, V21, P321, DOI 10.1161/01.ATV.21.3.321; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Nakagawa Y, 2004, BIOL PHARM BULL, V27, P956, DOI 10.1248/bpb.27.956; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; RAES M, 1987, FREE RADICAL BIO MED, V3, P3, DOI 10.1016/0891-5849(87)90032-3; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sakamoto H, 2002, J BIOL CHEM, V277, P50431, DOI 10.1074/jbc.M204190200; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shi MJ, 2004, AM J HYPERTENS, V17, P450, DOI 10.1016/j.amjhyper.2003.12.019; Shiomi T, 2004, CIRCULATION, V109, P544, DOI 10.1161/01.CIR.0000109701.77059.E9; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Wenk J, 2004, J BIOL CHEM, V279, P45634, DOI 10.1074/jbc.M408893200; Yang Y, 2007, P NATL ACAD SCI USA, V104, P10813, DOI 10.1073/pnas.0702027104; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang YF, 2005, CIRC RES, V96, P831, DOI 10.1161/01.RES.0000164401.21929.CF; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267	64	135	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11913	11921		10.1074/jbc.M900392200	http://dx.doi.org/10.1074/jbc.M900392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19254950	Green Published, hybrid			2022-12-25	WOS:000265494600023
J	Cho, SH; Beckwith, J				Cho, Seung-Hyun; Beckwith, Jon			Two Snapshots of Electron Transport across the Membrane INSIGHTS INTO THE STRUCTURE AND FUNCTION OF DsbD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; REDOX-ACTIVE CYSTEINES; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN DSBD; ISOMERASE; PERIPLASM; EXCHANGE; SYSTEM; MECHANISM	In Escherichia coli, the periplasmic protein disulfide isomerase, DsbC, is maintained reduced by transfer of electrons from cytoplasmic thioredoxin-1 (Trx1) via the cytoplasmic membrane protein, DsbD. The transmembrane domain of DsbD (DsbD beta), which comprises eight transmembrane segments (TMs), contains two redox-active cysteines (Cys-163 and Cys-285), each of which is water-exposed to both sides of the membrane. Cys-163 in TM1 and Cys-285 in TM4 can interact with cytoplasmic Trx1 and a periplasmic Trx-like domain of DsbD, respectively. When Cys-163 and Cys-285 are disulfide-bonded, the C-terminal halves of TM1 and TM4 are water-exposed, whereas the N-terminal halves of these TMs are not. To assess possible conformational changes of DsbD beta when its two cysteines are reduced, we have determined the accessibility of portions of TM1 and TM4. We substituted cysteines for amino acids in these TM segments and determined alkylation accessibility. We find that the alkylation accessibility of single Cys replacements in TM1 and TM4 is the same in oxidized and reduced DsbD beta, indicating a relatively static conformation of DsbD beta between the two redox states. We also find that the accessibility of amino acids of TM2 and TM3 when Cys-163 and Cys-285 are oxidized or reduced shows no change. Together, these results support a relatively static structure of DsbD beta in the switch between the oxidized and the reduced state but raise the possibility of conformational changes when interacting with Trx proteins. In addition, we also find water-exposed residues in the cytoplasmic proximal portion of TM3, allowing a more detailed characterization of the cavity in DsbD beta.	[Cho, Seung-Hyun; Beckwith, Jon] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jbeckwith@hms.harvard.edu		cho, seung-hyun/0000-0002-5548-4239	National Institutes of Health [GMO55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMO55090 (to J. B.).	Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Cho SH, 2007, EMBO J, V26, P3509, DOI 10.1038/sj.emboj.7601799; Cho SH, 2006, J BACTERIOL, V188, P5066, DOI 10.1128/JB.00368-06; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hiniker A, 2006, J BACTERIOL, V188, P7317, DOI 10.1128/JB.00383-06; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Katzen F, 2003, P NATL ACAD SCI USA, V100, P10471, DOI 10.1073/pnas.1334136100; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Kimball RA, 2003, J MOL MICROB BIOTECH, V5, P133, DOI 10.1159/000070263; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Rozhkova A, 2008, J MOL BIOL, V380, P783, DOI 10.1016/j.jmb.2008.05.050; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Walker KW, 1997, J BIOL CHEM, V272, P8845; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	33	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11416	11424		10.1074/jbc.M900651200	http://dx.doi.org/10.1074/jbc.M900651200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19258316	hybrid, Green Published			2022-12-25	WOS:000265494500046
J	Nemoto, S; Nakamura, M; Osawa, Y; Kono, S; Itoh, Y; Okano, Y; Murate, T; Hara, A; Ueda, H; Nozawa, Y; Banno, Y				Nemoto, Satoshi; Nakamura, Mitsuhiro; Osawa, Yosuke; Kono, Saki; Itoh, Yoshinori; Okano, Yukio; Murate, Takashi; Hara, Akira; Ueda, Hiroshi; Nozawa, Yoshinori; Banno, Yoshiko			Sphingosine Kinase Isoforms Regulate Oxaliplatin Sensitivity of Human Colon Cancer Cells through Ceramide Accumulation and Akt Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; UP-REGULATION; SPHINGOLIPID BIOSYNTHESIS; INHIBITS APOPTOSIS; EXPRESSION; P53; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; LEUKEMIA; GROWTH	The relationship between sphingosine kinase (SPHK), cellular ceramide concentration and chemosensitivity was investigated in human colon cancer cell lines. Among nine colon cancer cell lines, SPHK1 and SPHK2 activity and protein expression was highest in RKO cells and lowest in HCT116 cells. A viability assay revealed that HCT116 cells were sensitive to the effects of oxaliplatin (L-OHP), whereas RKO cells were resistant to those of L-OHP. Treatment with 5 mu g/ml L-OHP induced a marked time-dependent increase in various ceramides (C16, C24, C24:1) in HCT116 cells but not in RKO cells, as indicated by liquid chromatography/mass spectrometry. The increase in ceramide and caspase activation induced by L-OHP in the sensitive HCT116 cells was abolished by pretreatment with a neutral sphingomyelinase inhibitor, suggesting that the ceramide formation was due to the activation of neutral, rather than acid, sphingomyelinase. In contrast, in L-OHP-resistant RKO cells, treatment with an SPHK inhibitor or SPHK1 and SPHK2 silencing by RNA interference suppressed cell viability and increased caspase activity and cellular ceramide formation after L-OHP treatment. The elevated ceramide formation induced by SPHK inhibition and L-OHP was inhibited by fumonisin B1 but not myriocin, suggesting that ceramide formation was through the salvage pathway. Endogenous phosphorylated Akt levels were much higher in the resistant RKO cells than in the sensitive HCT116 cells. Either SPHK1 or SPHK2 silencing in RKO cells decreased phosphorylated Akt levels and increased p53 and p21 protein levels as well as poly(ADP-ribose) polymerase cleavage in response to L-OHP treatment. These findings indicate that SPHK isoforms and neutral sphingomyelinase contribute to the regulation of chemosensitivity by controlling ceramide formation and the downstream Akt pathway in human colon cancer cells.	[Nemoto, Satoshi; Banno, Yoshiko] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu 5011194, Japan; [Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu 5028585, Japan; [Okano, Yukio] Gifu Univ, Grad Sch Med, Dept Biomed Sci, Gifu 5011194, Japan; [Kono, Saki; Itoh, Yoshinori] Gifu Univ, Grad Sch Med, Dept Pharm, Gifu 5011194, Japan; [Osawa, Yosuke] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan; [Ueda, Hiroshi] Gifu Univ, Fac Engn, Gifu 5011193, Japan; [Hara, Akira] Gifu Pharmaceut Univ, Dept Biochem, Gifu 5028585, Japan; [Murate, Takashi] Nagoya Univ, Grad Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4618673, Japan; [Nozawa, Yoshinori] Gifu Int Inst Biotechnol, Kakamigahara 5040838, Japan	Gifu University; Gifu Pharmaceutical University; Gifu University; Gifu University; Gifu University; Gifu University; Gifu Pharmaceutical University; Nagoya University	Banno, Y (corresponding author), Yanagido 1-1, Gifu 5011194, Japan.	yobanno@gifu-u.ac.jp		Nakamura, Mitsuhiro/0000-0002-5062-5522	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20590055]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research (C) 20590055 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHARLES S, 2007, CANCER CELL, V11, P498; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; French KJ, 2003, CANCER RES, V63, P5962; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Koda M, 2005, BBA-MOL CELL BIOL L, V1733, P101, DOI 10.1016/j.bbalip.2004.12.006; Koivusalo R, 2002, CANCER RES, V62, P7364; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Linn SC, 2001, BIOCHEM SOC T, V29, P831, DOI 10.1042/0300-5127:0290831; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Manic S, 2003, CURR CANCER DRUG TAR, V3, P21, DOI 10.2174/1568009033333727; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; RAINES MA, 1993, J BIOL CHEM, V268, P14572; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Selzner M, 2001, CANCER RES, V61, P1233; Sobue S, 2008, INT J HEMATOL, V87, P266, DOI 10.1007/s12185-008-0052-0; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takeda Y, 1999, J BIOL CHEM, V274, P10654, DOI 10.1074/jbc.274.15.10654; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182	49	77	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10422	10432		10.1074/jbc.M900735200	http://dx.doi.org/10.1074/jbc.M900735200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19240026	hybrid, Green Published			2022-12-25	WOS:000265104600016
J	Ravassard, P; Bricout-Neveu, E; Hazhouz, Y; Pechberty, S; Mallet, J; Czernichow, P; Scharfmann, R				Ravassard, Philippe; Bricout-Neveu, Emilie; Hazhouz, Yasmine; Pechberty, Severine; Mallet, Jacques; Czernichow, Paul; Scharfmann, Raphael			A New Strategy to Generate Functional Insulin-Producing Cell Lines by Somatic Gene Transfer into Pancreatic Progenitors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; IN-VITRO; LENTIVIRAL VECTOR; ENDOCRINE-CELLS; HUMAN ISLETS; SCID MOUSE; MICE; EXPRESSION; RAT	Background: There is increasing interest in developing human cell lines to be used to better understand cell biology, but also for drug screening, toxicology analysis and future cell therapy. In the endocrine pancreatic field, functional human beta cell lines are extremely scarce. On the other hand, rodent insulin producing beta cells have been generated during the past years with great success. Many of such cell lines were produced by using transgenic mice expressing SV40T antigen under the control of the insulin promoter, an approach clearly inadequate in human. Our objective was to develop and validate in rodent an alternative transgenic-like approach, applicable to human tissue, by performing somatic gene transfer into pancreatic progenitors that will develop into beta cells. Methods and Findings: In this study, rat embryonic pancreases were transduced with recombinant lentiviral vector expressing the SV40T antigen under the control of the insulin promoter. Transduced tissues were next transplanted under the kidney capsule of immuno-incompetent mice allowing insulinoma development from which beta cell lines were established. Gene expression profile, insulin content and glucose dependent secretion, normalization of glycemia upon transplantation into diabetic mice validated the approach to generate beta cell lines. Conclusions: Somatic gene transfer into pancreatic progenitors represents an alternative strategy to generate functional beta cell lines in rodent. Moreover, this approach can be generalized to derive cells lines from various tissues and most importantly from tissues of human origin.	[Ravassard, Philippe; Bricout-Neveu, Emilie; Hazhouz, Yasmine; Mallet, Jacques] Univ Paris 06, INSERM, Inst Cerveau & Moelle,UMRS795, Biotechnol & Biotherapy Grp,Ctr Rech,CNRS,UMR7225, Paris, France; [Bricout-Neveu, Emilie; Hazhouz, Yasmine; Pechberty, Severine; Czernichow, Paul] Endocells, Paris, France; [Pechberty, Severine; Scharfmann, Raphael] Univ Paris 05, Fac Med, INSERM U845, Hop Necker, Ctr Rech Croissance Signalisat, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ravassard, P (corresponding author), Univ Paris 06, INSERM, Inst Cerveau & Moelle,UMRS795, Biotechnol & Biotherapy Grp,Ctr Rech,CNRS,UMR7225, Paris, France.	ravassar@chups.jussieu.fr; raphael.scharfmann@inserm.fr	scharfmann, raphael/L-3296-2017	Scharfmann, Raphael/0000-0001-7619-337X; ravassard, philippe/0000-0002-0393-9262	CNRS; INSERM; Endocells	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Endocells	This work was supported by CNRS, INSERM and Endocells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Basmaciogullari A, 2000, J ENDOCRINOL, V166, P481, DOI 10.1677/joe.0.1660481; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Castaing M, 2005, DIABETOLOGIA, V48, P709, DOI 10.1007/s00125-005-1694-6; Castaing M, 2001, DIABETOLOGIA, V44, P2066, DOI 10.1007/s001250100012; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Delplanque A, 2000, J CELL SCI, V113, P767; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; EFRAT S, 1993, DIABETES, V42, P901, DOI 10.2337/diabetes.42.6.901; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; EFRAT S, 1995, P NATL ACAD SCI USA, V92, P3576, DOI 10.1073/pnas.92.8.3576; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GUELI N, 1987, J EXP CLIN CANC RES, V6, P281; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Ju Q, 1998, DIABETOLOGIA, V41, P736, DOI 10.1007/s001250050977; Kahan BW, 2003, DIABETES, V52, P2016, DOI 10.2337/diabetes.52.8.2016; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Levy L, 1998, GENE THER, V5, P913, DOI 10.1038/sj.gt.3300689; MARTIN A, 1993, J CLIN ENDOCR METAB, V77, P305, DOI 10.1210/jc.77.2.305; Miralles F, 1998, DEVELOPMENT, V125, P1017; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Scharfmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003559; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; SOLDEVILA G, 1991, J AUTOIMMUN, V4, P381, DOI 10.1016/0896-8411(91)90154-5; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	39	10	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2009	4	3							e4731	10.1371/journal.pone.0004731	http://dx.doi.org/10.1371/journal.pone.0004731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ME	19266046	Green Submitted, Green Published, gold			2022-12-25	WOS:000265490800011
J	Lee, HG; Rohila, S; Han, KA				Lee, Hyun-Gwan; Rohila, Suman; Han, Kyung-An			The Octopamine Receptor OAMB Mediates Ovulation via Ca2+/Calmodulin-Dependent Protein Kinase II in the Drosophila Oviduct Epithelium	PLOS ONE			English	Article								Ovulation is an essential physiological process in sexual reproduction; however, the underlying cellular mechanisms are poorly understood. We have previously shown that OAMB, a Drosophila G-protein-coupled receptor for octopamine (the insect counterpart of mammalian norepinephrine), is required for ovulation induced upon mating. OAMB is expressed in the nervous and reproductive systems and has two isoforms (OAMB-AS and OAMB-K3) with distinct capacities to increase intracellular Ca2+ or intracellular Ca2+ and cAMP in vitro. Here, we investigated tissue specificity and intracellular signals required for OAMB's function in ovulation. Restricted OAMB expression in the adult oviduct epithelium, but not the nervous system, reinstated ovulation in oamb mutant females, in which either OAMB isoform was sufficient for the rescue. Consistently, strong immunoreactivities for both isoforms were observed in the wild-type oviduct epithelium. To delineate the cellular mechanism by which OAMB regulates ovulation, we explored protein kinases functionally interacting with OAMB by employing a new GAL4 driver with restricted expression in the oviduct epithelium. Conditional inhibition of Ca2+/ Calmodulin-dependent protein kinase II (CaMKII), but not protein kinase A or C, in the oviduct epithelium inhibited ovulation. Moreover, constitutively active CaMKII, but not protein kinase A, expressed only in the adult oviduct epithelium fully rescued the oamb female's phenotype, demonstrating CaMKII as a major downstream molecule conveying the OAMB's ovulation signal. This is consistent with the ability of both OAMB isoforms, whose common intracellular signal in vitro is Ca2+, to reinstate ovulation in oamb females. These observations reveal the critical roles of the oviduct epithelium and its cellular components OAMB and CaMKII in ovulation. It is conceivable that the OAMB-mediated cellular activities stimulated upon mating are crucial for secretory activities suitable for egg transfer from the ovary to the uterus.	[Lee, Hyun-Gwan; Han, Kyung-An] Penn State Univ, Huck Inst Genet, Grad Program, University Pk, PA 16802 USA; [Lee, Hyun-Gwan; Rohila, Suman; Han, Kyung-An] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, HG (corresponding author), Penn State Univ, Huck Inst Genet, Grad Program, University Pk, PA 16802 USA.	kxh29@psu.edu			NIH [HD048766]; NSF [IOB-0620056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH (HD048766) and NSF (IOB-0620056) grants to K.-A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Ajonuma LC, 2002, HUM REPROD UPDATE, V8, P255, DOI 10.1093/humupd/8.3.255; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heifetz Y, 2000, CURR BIOL, V10, P99, DOI 10.1016/S0960-9822(00)00288-8; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; HELM G, 1982, ACTA PHYSIOL SCAND, V114, P425, DOI 10.1111/j.1748-1716.1982.tb07005.x; HELM G, 1982, J REPROD FERTIL, V64, P233; HELM G, 1982, BIOL REPROD, V26, P553, DOI 10.1095/biolreprod26.4.553; HERNDON LA, 1995, P NATL ACAD SCI USA, V92, P10114, DOI 10.1073/pnas.92.22.10114; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Kiger JA, 1999, GENETICS, V152, P281; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Leese HJ, 2001, REPRODUCTION, V121, P339, DOI 10.1530/rep.0.1210339; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lung O, 1999, INSECT BIOCHEM MOLEC, V29, P1043, DOI 10.1016/S0965-1748(99)00078-8; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Mardh PA, 2004, CURR OPIN INFECT DIS, V17, P49, DOI 10.1097/00001432-200402000-00010; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nykamp DA, 2000, J INSECT PHYSIOL, V46, P809, DOI 10.1016/S0022-1910(99)00170-5; ORCHARD I, 1986, J NEUROBIOL, V17, P359, DOI 10.1002/neu.480170502; Ottiger M, 2000, J NEUROBIOL, V44, P57; Park D, 2002, J NEUROBIOL, V52, P24, DOI 10.1002/neu.10066; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; STROM C, 1986, J NEURAL TRANSM, V66, P209, DOI 10.1007/BF01260915; Wolfner M.F., 2007, P183; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	44	50	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4716	10.1371/journal.pone.0004716	http://dx.doi.org/10.1371/journal.pone.0004716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262750	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490600026
J	Cohen, CR; Montandon, M; Carrico, AW; Shiboski, S; Bostrom, A; Obure, A; Kwena, Z; Bailey, RC; Nguti, R; Bukusi, EA				Cohen, Craig R.; Montandon, Michele; Carrico, Adam W.; Shiboski, Stephen; Bostrom, Alan; Obure, Alfredo; Kwena, Zachary; Bailey, Robert C.; Nguti, Rosemary; Bukusi, Elizabeth A.			Association of Attitudes and Beliefs towards Antiretroviral Therapy with HIV-Seroprevalence in the General Population of Kisumu, Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; MALE CIRCUMCISION; COST-EFFECTIVENESS; POTENTIAL IMPACT; RISK BEHAVIOR; CONDOM USE; PREVENTION; TRANSMISSION; MEN; PREVALENCE	Background: Since antiretroviral therapy (ART) became available in the developed world, the prevalence of unprotected sex and the incidence of sexually transmitted infections (STIs) and HIV have increased. We hypothesized that a similar phenomenon may be occurring in sub-Saharan Africa concomitant with the scale-up of HIV treatment. Methods: We conducted a general population-based survey in Kisumu, Kenya. Participants completed an interview that included demographics as well as ART-related attitudes and beliefs (AB) and then underwent HIV serological testing. Exploratory and confirmatory factor analyses of AB about ART indicated two factors: 1) ART-related risk compensation (increased sexual risk taking now that ART is available); and 2) a perception that HIV is more controllable now that ART is available. Logistic regression was used to determine associations of these factors with HIV-seroprevalence after controlling for age. Findings: 1,655 (90%) of 1,844 people aged 15-49 contacted, including 749 men and 906 women, consented to participate in the study. Most participants (n = 1164; 71%) had heard of ART. Of those who had heard of ART, 23% believed ART was a cure for HIV. ART-related risk compensation (Adjusted (A) OR = 1.45, 95% CI 1.16-1.81), and a belief that ART cures HIV (AOR = 2.14, 95% CI 1.22-3.76) were associated with an increased HIV seroprevalence in men but not women after controlling for age. In particular, ART-related risk compensation was associated with an increased HIV-seroprevalence in young (aged 15-24 years) men (OR = 1.56; 95% CI 1.12-2.19). Conclusions: ART-related risk compensation and a belief that ART cures HIV were associated with an increased HIV seroprevalence among men but not women. HIV prevention programs in sub-Saharan Africa that target the general population should include educational messages about ART and address the changing beliefs about HIV in the era of greater ART availability.	[Cohen, Craig R.; Montandon, Michele; Bukusi, Elizabeth A.] Univ Calif San Francisco, Dept Obstet Gynecol & Reproduct Sci, San Francisco, CA 94143 USA; [Carrico, Adam W.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Shiboski, Stephen; Bostrom, Alan] Univ Calif San Francisco, Ctr Epidemiol & Biostat, San Francisco, CA 94143 USA; [Obure, Alfredo; Kwena, Zachary; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya; [Bailey, Robert C.] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL 60680 USA; [Nguti, Rosemary] Univ Nairobi, Dept Stat, Nairobi, Kenya	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Cohen, CR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reproduct Sci, San Francisco, CA 94143 USA.	ccohen@globalhealth.ucsf.edu			Doris Duke Charitable Foundation [ORACTA]; NIAID, Reproductive Infectious Disease Fellowship [D43 TW007388]; FOGARTY INTERNATIONAL CENTER [D43TW007388] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIAID, Reproductive Infectious Disease Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa (ORACTA) grant. AWC was supported by the Reproductive Infectious Disease Fellowship (NIAID D43 TW007388). The sponsor had no role in the design, implementaiton or publication of this study.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Ferguson A, 2004, SEX TRANSM INFECT, V80, P435, DOI 10.1136/sti.2004.010462; Global HIV Prevention Working Group, 2004, HIV PREV ER EXP TREA; Gremy I, 2004, AIDS, V18, P805, DOI [10.1097/01.aids.0000111390.02002.f4, 10.1097/00002030-200403260-00013]; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Muthen L. K., 2004, MPLUS USERS GUIDE; Nachega JB, 2005, JAIDS-J ACQ IMM DEF, V38, P196, DOI 10.1097/00126334-200502010-00011; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Orroth KK, 2006, SEX TRANSM DIS, V33, P536, DOI 10.1097/01.olq.0000204667.11192.71; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Shisana O, 2004, B WORLD HEALTH ORGAN, V82, P812; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tabachnick B. G., 2001, USING MULTIVARIATE S; van der Snoek EM, 2006, SEX TRANSM DIS, V33, P193, DOI 10.1097/01.olq.0000194593.58251.8d; van der Straten A, 2000, AIDS, V14, pF47, DOI 10.1097/00002030-200003100-00003; Vanable PA, 2003, J PSYCHOSOM RES, V54, P263, DOI 10.1016/S0022-3999(02)00483-X; Vanable PA, 2000, HEALTH PSYCHOL, V19, P134, DOI 10.1037//0278-6133.19.2.134; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Wilson TE, 2004, AM J PUBLIC HEALTH, V94, P1141, DOI 10.2105/AJPH.94.7.1141; Wools KK, 1998, E AFR MED J, V75, P679; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	41	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4573	10.1371/journal.pone.0004573	http://dx.doi.org/10.1371/journal.pone.0004573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437MB	19259267	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490500001
J	Johnson, L; van Jaarsveld, CHM; Emmett, PM; Rogers, IS; Ness, AR; Hattersley, AT; Timpson, NJ; Smith, GD; Jebb, SA				Johnson, Laura; van Jaarsveld, Cornelia H. M.; Emmett, Pauline M.; Rogers, Imogen S.; Ness, Andy R.; Hattersley, Andrew T.; Timpson, Nicholas J.; Smith, George Davey; Jebb, Susan A.			Dietary Energy Density Affects Fat Mass in Early Adolescence and Is Not Modified by FTO Variants	PLOS ONE			English	Article							FOOD-INTAKE; WEIGHT-LOSS; CHILDREN; OBESITY; OVERWEIGHT; ADJUSTMENT; CHILDHOOD; FATNESS; GENE; MEN	Background: Dietary energy density (DED) does not have a simple linear relationship to fat mass in children, which suggests that some children are more susceptible than others to the effects of DED. Children with the FTO (rs9939609) variant that increases the risk of obesity may have a higher susceptibility to the effects of DED because their internal appetite control system is compromised. We tested the relationship between DED and fat mass in early adolescence and its interaction with FTO variants. Methods and Findings: We carried out a prospective analysis on 2,275 children enrolled in the Avon Longitudinal Study of Parents and Children (ALSPAC). Diet was assessed at age 10 y using 3-day diet diaries. DED (kJ/g) was calculated excluding drinks. Children were genotyped for the FTO (rs9939609) variant. Fat mass was estimated at age 13 y using the Lunar Prodigy Dual-energy X-ray Absorptiometry scanner. There was no evidence of interaction between DED at age 10 y and the high risk A allele of the FTO gene in relation to fat mass at age 13 y (beta = 0.005, p = 0.51), suggesting that the FTO gene has no effect on the relation between DED at 10 y and fat mass at 13 y. When DED at 10 y and the A allele of FTO were in the same model they were independently related to fat mass at 13 y. Each A allele of FTO was associated with 0.35+/-0.13 kg more fat mass at 13 y and each 1 kJ/g DED at 10 y was associated with 0.16+/-0.06 kg more fat mass at age 13 y, after controlling for misreporting of energy intake, gender, puberty, overweight status at 10 y, maternal education, TV watching, and physical activity. Conclusions: This study reveals the multi-factorial origin of obesity and indicates that although FTO may put some children at greater risk of obesity, encouraging a low dietary energy density may be an effective strategy to help all children avoid excessive fat gain.	[Johnson, Laura; van Jaarsveld, Cornelia H. M.] UCL, Canc Res UK Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England; [Emmett, Pauline M.] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [Rogers, Imogen S.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4AT, E Sussex, England; [Hattersley, Andrew T.] Inst Biomed & Clin Sci, Peninsula Med Sch, Exeter, Devon, England; [Ness, Andy R.] Univ Bristol, Dept Oral & Dental Sci, Bristol, Avon, England; [Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, MRC CAiTE Ctr, Dept Social Med, Bristol, Avon, England; [Jebb, Susan A.] MRC Human Nutr Res, Cambridge, England	Cancer Research UK; University of London; University College London; University of Bristol; University of Brighton; University of Exeter; University of Bristol; University of Bristol; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Johnson, L (corresponding author), UCL, Canc Res UK Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England.	l.johnson@public-health.ucl.ac.uk	Berryman, Katie/J-4236-2014; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Johnson, Laura/C-2700-2008; Davey Smith, George/A-7407-2013; Ness, Andy R/M-7612-2013; Emmett, Pauline/AAL-6815-2021; Timpson, Nicholas John/O-7548-2015; Van Jaarsveld, Ellen CHM/A-4632-2016	Davey Smith, George/0000-0002-1407-8314; Ness, Andy R/0000-0003-3548-9523; Timpson, Nicholas John/0000-0002-7141-9189; Van Jaarsveld, Ellen CHM/0000-0002-4269-0041; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Johnson, Laura/0000-0001-8985-3154; Rogers, Imogen/0000-0001-7275-2437; Jebb, Susan/0000-0001-9190-2920; Hattersley, Andrew/0000-0001-5620-473X; s, hema/0000-0002-3440-9475; Emmett, Pauline/0000-0003-1076-4779	UK Medical Research Council; Wellcome Trust; University of Bristol; Cancer Research UK; Medical Research Council [MC_U105960389, G0600705, G9815508] Funding Source: researchfish; MRC [G0600705, MC_U105960389] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council, the Wellcome Trust and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and Children. Laura Johnson is funded by Cancer Research UK. The funding body had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ASHCROFT J, 2007, EUR J CLIN NUTR; Bell EA, 2001, AM J CLIN NUTR, V73, P1010; BESRASTROLLO M, 2008, PROSPECTIVE STUDY DI, P769; Birch LL, 1997, ANN NY ACAD SCI, V819, P194, DOI 10.1111/j.1749-6632.1997.tb51809.x; Black AE, 2000, EUR J CLIN NUTR, V54, P386, DOI 10.1038/sj.ejcn.1600970; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DEIERLEIN AL, 2008, DIETARY ENERGY DENSI, P693; Drewnowski A, 2004, NUTR REV, V62, P403, DOI 10.1111/j.1753-4887.2004.tb00012.x; Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Glynn L, 2005, J HUM NUTR DIET, V18, P7, DOI 10.1111/j.1365-277X.2004.00582.x; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GREGORY J, 2000, NATL DIET NUTR SURVE, V1; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Iqbal SI, 2006, OBESITY, V14, P106, DOI 10.1038/oby.2006.13; Johnson L, 2008, INT J OBESITY, V32, P586, DOI 10.1038/sj.ijo.0803746; JOHNSON L, 2009, OBESITY REV IN PRESS; Johnson SL, 2000, PEDIATRICS, V106, P1429, DOI 10.1542/peds.106.6.1429; JOTANGIA D, 2005, OBESITY CHILDREN 11; Ledikwe JH, 2007, AM J CLIN NUTR, V85, P1212, DOI 10.1093/ajcn/85.5.1212; McCaffrey TA, 2008, AM J CLIN NUTR, V87, P1230, DOI 10.1093/ajcn/87.5.1230; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Ness AR, 2006, INT J PEDIATR OBES, V1, P59, DOI 10.1080/17477160600569339; Northstone K, 2005, EUR J CLIN NUTR, V59, P751, DOI 10.1038/sj.ejcn.1602136; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Price GM, 1995, J HUM NUTR DIET, V8, P417, DOI 10.1111/j.1365-277X.1995.tb00337.x; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086; SAVAGE JS, 2008, DIETARY ENERGY DENSI, P677; Stubbs RJ, 1998, INT J OBESITY, V22, P980, DOI 10.1038/sj.ijo.0800715; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P330, DOI 10.1093/ajcn/62.2.330; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Torun B, 2005, PUBLIC HEALTH NUTR, V8, P968, DOI 10.1079/PHN2005791; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; WESTERTERPPLANT.JW, 2004, BR J NUTR S1, V92, pS35	40	53	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4594	10.1371/journal.pone.0004594	http://dx.doi.org/10.1371/journal.pone.0004594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259258	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490500003
J	Khandoga, AG; Khandoga, A; Reichel, CA; Bihari, P; Rehberg, M; Krombach, F				Khandoga, Alexander Georg; Khandoga, Andrej; Reichel, Christoph Andreas; Bihari, Peter; Rehberg, Markus; Krombach, Fritz			In Vivo Imaging and Quantitative Analysis of Leukocyte Directional Migration and Polarization in Inflamed Tissue	PLOS ONE			English	Article								Directional migration of transmigrated leukocytes to the site of injury is a central event in the inflammatory response. Here, we present an in vivo chemotaxis assay enabling the visualization and quantitative analysis of subtype-specific directional motility and polarization of leukocytes in their natural 3D microenvironment. Our technique comprises the combination of i) semi-automated in situ microinjection of chemoattractants or bacteria as local chemotactic stimulus, ii) in vivo near-infrared reflected-light oblique transillumination (RLOT) microscopy for the visualization of leukocyte motility and morphology, and iii) in vivo fluorescence microscopy for the visualization of different leukocyte subpopulations or fluorescence-labeled bacteria. Leukocyte motility parameters are quantified off-line in digitized video sequences using computer-assisted single cell tracking. Here, we show that perivenular microinjection of chemoattractants [macrophage inflammatory protein-1 alpha (MIP-1 alpha/Ccl3), platelet-activating factor (PAF)] or E. coli into the murine cremaster muscle induces target-oriented intravascular adhesion and transmigration as well as polarization and directional interstitial migration of leukocytes towards the locally administered stimuli. Moreover, we describe a crucial role of Rho kinase for the regulation of directional motility and polarization of transmigrated leukocytes in vivo. Finally, combining in vivo RLOT and fluorescence microscopy in Cx3CR1(gfp/gfp) mice (mice exhibiting green fluorescent protein-labeled monocytes), we are able to demonstrate differences in the migratory behavior of monocytes and neutrophils. Taken together, we propose a novel approach for investigating the mechanisms and spatiotemporal dynamics of subtype-specific motility and polarization of leukocytes during their directional interstitial migration in vivo.	[Khandoga, Alexander Georg; Reichel, Christoph Andreas; Bihari, Peter; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, D-80539 Munich, Germany; [Khandoga, Andrej] Univ Munich, Dept Surg Grosshadern, D-80539 Munich, Germany	University of Munich; University of Munich	Khandoga, AG (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany.	alexander.khandoga@med.uni-muenchen.de		Rehberg, Markus/0000-0001-7314-6332	EU [LSHG-CT-2003-502935]	EU(European Commission)	This work was supported by EU FP6 NoE "MAIN" (LSHG-CT-2003-502935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BAE SY, 2007, INT JOF LAB IN PRESS; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Bardi G, 2003, FEBS LETT, V542, P79, DOI 10.1016/S0014-5793(03)00351-X; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hickey MJ, 2000, J IMMUNOL, V165, P7164, DOI 10.4049/jimmunol.165.12.7164; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; MIGLIORISI G, 1988, J LEUKOCYTE BIOL, V44, P485, DOI 10.1002/jlb.44.6.485; Miyazaki S, 2000, INFLAMM RES, V49, P673, DOI 10.1007/s000110050645; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Normark S, 2001, NAT MED, V7, P1182, DOI 10.1038/nm1101-1182; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Reichel CA, 2008, J LEUKOCYTE BIOL, V83, P864, DOI 10.1189/jlb.1007666; Russo TA, 2003, INFECT IMMUN, V71, P6435, DOI 10.1128/IAI.71.11.6435-6445.2003; SCHUSCHKE DA, 1989, AM J PHYSIOL, V257, pH1607, DOI 10.1152/ajpheart.1989.257.5.H1607; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wan MX, 2003, BRIT J PHARMACOL, V138, P698, DOI 10.1038/sj.bjp.0705094; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wegmann F, 2006, J EXP MED, V203, P1671, DOI 10.1084/jem.20060565; Werr J, 1998, J EXP MED, V187, P2091, DOI 10.1084/jem.187.12.2091; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493	41	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4693	10.1371/journal.pone.0004693	http://dx.doi.org/10.1371/journal.pone.0004693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259262	gold, Green Published, Green Submitted			2022-12-25	WOS:000265490500011
J	Maro, GS; Klassen, MP; Shen, K				Maro, Geraldine S.; Klassen, Matthew P.; Shen, Kang			A beta-Catenin-Dependent Wnt Pathway Mediates Anteroposterior Axon Guidance in C. elegans Motor Neurons	PLOS ONE			English	Article							HOX GENE-EXPRESSION; B-CELL DIVISION; SIGNALING PATHWAY; NEURITE OUTGROWTH; NERVOUS-SYSTEM; PROTEIN; RECEPTORS; POLARITY; HOMOLOG; GROWTH	Background: Wnts are secreted glycoproteins that regulate diverse aspects of development, including cell proliferation, cell fate specification and differentiation. More recently, Wnts have been shown to direct axon guidance in vertebrates, flies and worms. However, little is known about the intracellular signaling pathways downstream of Wnts in axon guidance. Methodology/Principal Findings: Here we show that the posterior C. elegans Wnt protein LIN-44 repels the axons of the adjacent D-type motor neurons by activating its receptor LIN-17/Frizzled on the neurons. Moreover, mutations in mig-5/Disheveled, gsk-3, pry-1/Axin, bar-1/beta-catenin and pop-1/TCF, also cause disrupted D-type axon pathfinding. Reduced BAR-1/beta-catenin activity in D-type axons leads to undergrowth of axons, while stabilization of BAR-1/beta-catenin in a lin-23/SCF beta-TrCP mutant results in an overextension phenotype. Conclusions/Significance: Together, our data provide evidence that Wnt-mediated axon guidance can be transduced through a beta-catenin-dependent pathway.	[Maro, Geraldine S.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA; [Klassen, Matthew P.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Maro, GS (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA.	gmaro@stanford.edu; kangshen@stanford.edu			W. M. Keck Foundation; McKnight Endowment Fund; Searle Scholar Award; Human Frontier Science Program post-doctoral fellow	W. M. Keck Foundation(W.M. Keck Foundation); McKnight Endowment Fund; Searle Scholar Award; Human Frontier Science Program post-doctoral fellow	This work was supported by the W. M. Keck Foundation, the McKnight Endowment Fund and the Searle Scholar Award. GSM is a Human Frontier Science Program post-doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hunter CP, 1999, DEVELOPMENT, V126, P805; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Jin YS, 1999, J NEUROSCI, V19, P539; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Maloof JN, 1999, DEVELOPMENT, V126, P37; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Natarajan L, 2004, DEV BIOL, V272, P536, DOI 10.1016/j.ydbio.2004.05.027; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Sato M, 2006, NAT NEUROSCI, V9, P67, DOI 10.1038/nn1604; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schnorrer F, 2004, CURR BIOL, V14, pR19, DOI 10.1016/j.cub.2003.12.016; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Walston T, 2006, DEV BIOL, V298, P485, DOI 10.1016/j.ydbio.2006.06.053; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Wu MF, 2007, DEV BIOL, V303, P650, DOI 10.1016/j.ydbio.2006.12.002; Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006; Zou YM, 2006, NEURON, V49, P787, DOI 10.1016/j.neuron.2006.03.004; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	55	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4690	10.1371/journal.pone.0004690	http://dx.doi.org/10.1371/journal.pone.0004690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259273	Green Published, Green Submitted, gold			2022-12-25	WOS:000265490500009
J	Borlak, J; Niehof, M				Borlak, Juergen; Niehof, Monika			HNF4alpha and HNF1alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Posttransplantation Diabetes Mellitus	PLOS ONE			English	Article								Posttransplantation diabetes mellitus (PTDM) is a frequent complication in immunosuppressive therapy. To better understand the molecular events associated with PTDM we investigated the effect of cyclosporine on expression and activity of hepatic nuclear factor (HNF) 1alpha and 4alpha and on genes coding for glucose metabolism in cultures of the rat insulinoma cell line INS-1E, the human epithelial cell line Caco-2 and with Zucker diabetic fatty (ZDF) rats. In the pancreas of untreated but diabetic animals expression of HNF4alpha, insulin1, insulin2 and of phosphoenolpyruvate carboxykinase was significantly repressed. Furthermore, cyclosporine treatment of the insulinoma-1E cell line resulted in remarkable reduction in HNF4alpha protein and INS1 as well as INS2 gene expression, while transcript expression of HNF4alpha, apolipoprotein C2, glycerolkinase, pyruvatekinase and aldolase B was repressed in treated Caco-2 cells. Furthermore, with nuclear extracts of cyclosporine treated cell lines protein expression and DNA binding activity of hepatic nuclear factors was significantly repressed. As cyclosporine inhibits the calcineurin dependent dephosphorylation of nuclear factor of activated T-cells (NFAT) we also searched for binding sites for NFAT in the pancreas specific P2 promoter of HNF4alpha. Notably, we observed repressed NFAT binding to a novel DNA binding site in the P2 promoter of HNF4alpha. Thus, cyclosporine caused inhibition of DNA binding of two important regulators for insulin signaling, i.e. NFAT and HNF4alpha. We further investigated HNF4alpha transcript expression and observed >200-fold differences in abundance in n = 14 patients. Such variability in expression might help to identify individuals at risk for developing PTDM. We propose cyclosporine to repress HNF4alpha gene and protein expression, DNA-binding to targeted promoters and subsequent regulation of genes coding for glucose metabolism and of pancreatic beta-cell function.	[Borlak, Juergen; Niehof, Monika] Hannover Med Sch, Fraunhofer Inst Toxicol & Expt Med, D-3000 Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Mol Med & Med Biotechnol, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Fraunhofer Gesellschaft; Hannover Medical School; Hannover Medical School; Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Fraunhofer Inst Toxicol & Expt Med, D-3000 Hannover, Germany.	borlak@item.fraunhofer.de			Lower Saxony Ministry of Science and Culture	Lower Saxony Ministry of Science and Culture	JB received an institutional grant from the Lower Saxony Ministry of Science and Culture, but no fund was received specifically for this study. The sponsor did not influence the design or conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, NUCL RECEPTORS GENET; Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200; BASADONNA G, 1988, AM J SURG, V156, P191, DOI 10.1016/S0002-9610(88)80064-3; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dufer M, 2001, MOL PHARMACOL, V60, P873; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohlke Karen L, 2005, Curr Diab Rep, V5, P149, DOI 10.1007/s11892-005-0043-y; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Niehof M, 2008, DIABETES, V57, P1069, DOI 10.2337/db07-1065; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; RIEGEL W, 1989, TRANSPLANT INT, V2, P8; RYFFEL B, 1992, DRUG CHEM TOXICOL, V15, P95, DOI 10.3109/01480549209032293; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Schafer S, 2003, CARDIOVASC RES, V60, P447, DOI 10.1016/S0008-6363(03)00544-3; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Sivathasan C, 2004, TRANSPL P, V36, p346S, DOI 10.1016/j.transproceed.2004.01.072; STEGALL MD, 1989, TRANSPLANTATION, V48, P944, DOI 10.1097/00007890-198912000-00009; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Toriumi C, 2002, ANAL CHEM, V74, P2321, DOI 10.1021/ac020043t; VANSCHILFGAARDE R, 1987, TRANSPLANTATION, V44, P13; Vincenti F, 2005, TRANSPLANT P, V37, P1001, DOI 10.1016/j.transproceed.2004.12.017; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2009	4	3							e4662	10.1371/journal.pone.0004662	http://dx.doi.org/10.1371/journal.pone.0004662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LV	19252740	Green Submitted, gold, Green Published			2022-12-25	WOS:000265489900005
J	Eickel, V; Kahl, B; Reinisch, B; Dubbers, A; Kuster, P; Brandt, C; Spellerberg, B				Eickel, Vera; Kahl, Barbara; Reinisch, Beatrice; Duebbers, Angelika; Kuester, Peter; Brandt, Claudia; Spellerberg, Barbara			Emergence of Respiratory Streptococcus agalactiae Isolates in Cystic Fibrosis Patients	PLOS ONE			English	Article								Streptococcus agalactiae is a well-known pathogen for neonates and immunocompromized adults. Beyond the neonatal period, S. agalactiae is rarely found in the respiratory tract. During 2002-2008 we noticed S. agalactiae in respiratory secretions of 30/185 (16%) of cystic fibrosis (CF) patients. The median age of these patients was 3-6 years older than the median age CF patients not harboring S. agalactiae. To analyze, if the S. agalactiae isolates from CF patients were clonal, further characterization of the strains was achieved by capsular serotyping, surface protein determination and multilocus sequence typing (MLST). We found a variety of sequence types (ST) among the isolates, which did not substantially differ from the MLST patterns of colonizing strains from Germany. However serotype III, which is often seen in colonizing strains and invasive infections was rare among CF patients. The emergence of S. agalactiae in the respiratory tract of CF patients may represent the adaptation to a novel host environment, supported by the altered surfactant composition in older CF patients.	[Eickel, Vera; Reinisch, Beatrice; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Kahl, Barbara] Univ Clin Munster, Inst Med Microbiol, Munster, Germany; [Duebbers, Angelika] Univ Clin Muenster, Dept Pediat, Munster, Germany; [Kuester, Peter] Clemenshosp Muenster, Dept Pediat, Munster, Germany; [Brandt, Claudia] Univ Hosp Frankfurt, Inst Med Microbiol, Frankfurt, Germany	Ulm University; University of Munster; University of Munster; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Eickel, V (corresponding author), Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de	Spellerberg, Barbara/D-3443-2011	Spellerberg, Barbara/0000-0001-7552-8764; Kahl, Barbara/0000-0001-5155-3383	Unversity of Ulm	Unversity of Ulm	Unversity of Ulm. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brimil N, 2006, INT J MED MICROBIOL, V296, P39, DOI 10.1016/j.ijmm.2005.11.001; Burns JL, 1998, CLIN INFECT DIS, V27, P158, DOI 10.1086/514631; BUUHOI A, 1990, ANTIMICROB AGENTS CH, V34, P985, DOI 10.1128/AAC.34.6.985; CDC, 1999, MMWR-MORBID MORTAL W, V48, P426; Creti R, 2004, J CLIN MICROBIOL, V42, P1326, DOI 10.1128/JCM.42.3.1326-1329.2004; Cummings C G, 1981, J Clin Pathol, V34, P813, DOI 10.1136/jcp.34.7.813-a; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; DOERN GV, 1992, J CLIN MICROBIOL, V30, P2740, DOI 10.1128/JCM.30.10.2740-2742.1992; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; FERRIERI P, 1977, J CLIN MICROBIOL, V6, P136; Fluegge K, 2005, CLIN INFECT DIS, V40, P760, DOI 10.1086/427942; Griese M, 2004, AM J RESP CRIT CARE, V170, P1000, DOI 10.1164/rccm.200405-575oc; Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983; Gygax SE, 2006, ANTIMICROB AGENTS CH, V50, P1875, DOI 10.1128/AAC.50.5.1875-1877.2006; Heinrich S, 2006, CURR MED CHEM, V13, P3239, DOI 10.2174/092986706778773112; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kong FR, 2002, J CLIN MICROBIOL, V40, P216, DOI 10.1128/JCM.40.1.216-226.2002; LeVine AM, 1997, J IMMUNOL, V158, P4336; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lopardo HA, 2003, J CLIN MICROBIOL, V41, P4688, DOI 10.1128/JCM.41.10.4688-4694.2003; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Schoening TE, 2005, CLIN MICROBIOL INFEC, V11, P579, DOI 10.1111/j.1469-0691.2005.01180.x; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08; Wellinghausen N, 2007, J CLIN MICROBIOL, V45, P789, DOI 10.1128/JCM.01856-06; Zwart S, 2000, SCAND J INFECT DIS, V32, P377, DOI 10.1080/003655400750044944	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4650	10.1371/journal.pone.0004650	http://dx.doi.org/10.1371/journal.pone.0004650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247473	Green Published, gold, Green Submitted			2022-12-25	WOS:000265487800029
J	Mendonsa, G; Dobrowolska, J; Lin, A; Vijairania, P; Jong, YJI; Baenziger, NL				Mendonsa, Graziella; Dobrowolska, Justyna; Lin, Angela; Vijairania, Pooja; Jong, Y-J. I.; Baenziger, Nancy L.			Molecular Profiling Reveals Diversity of Stress Signal Transduction Cascades in Highly Penetrant Alzheimer's Disease Human Skin Fibroblasts	PLOS ONE			English	Article								The serious and growing impact of the neurodegenerative disorder Alzheimer's disease (AD) as an individual and societal burden raises a number of key questions: Can a blanket test for Alzheimer's disease be devised forecasting long-term risk for acquiring this disorder? Can a unified therapy be devised to forestall the development of AD as well as improve the lot of present sufferers? Inflammatory and oxidative stresses are associated with enhanced risk for AD. Can an AD molecular signature be identified in signaling pathways for communication within and among cells during inflammatory and oxidative stress, suggesting possible biomarkers and therapeutic avenues? We postulated a unique molecular signature of dysfunctional activity profiles in AD-relevant signaling pathways in peripheral tissues, based on a gain of function in G-protein-coupled bradykinin B2 receptor (BKB2R) inflammatory stress signaling in skin fibroblasts from AD patients that results in tau protein Ser hyperphosphorylation. Such a signaling profile, routed through both phosphorylation and proteolytic cascades activated by inflammatory and oxidative stresses in highly penetrant familial monogenic forms of AD, could be informative for pathogenesis of the complex multigenic sporadic form of AD. Comparing stimulus-specific cascades of signal transduction revealed a striking diversity of molecular signaling profiles in AD human skin fibroblasts that express endogenous levels of mutant presenilins PS-1 or PS-2 or the Trisomy 21 proteome. AD fibroblasts bearing the PS-1 M146L mutation associated with highly aggressive AD displayed persistent BKB2R signaling plus decreased ERK activation by BK, correctible by gamma-secretase inhibitor Compound E. Lack of these effects in the homologous PS-2 mutant cells indicates specificity of presenilin gamma-secretase catalytic components in BK signaling biology directed toward MAPK activation. Oxidative stress revealed a JNK-dependent survival pathway in normal fibroblasts lost in PS-1 M146L fibroblasts. Complex molecular profiles of signaling dysfunction in the most putatively straightforward human cellular models of AD suggest that risk ascertainment and therapeutic interventions in AD as a whole will likely demand complex solutions.	[Mendonsa, Graziella; Dobrowolska, Justyna; Lin, Angela; Vijairania, Pooja; Jong, Y-J. I.; Baenziger, Nancy L.] Washington Univ, Dept Anat & Neurobiol, Program Mol Cell Biol, Div Biol & Biomed Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Mendonsa, G (corresponding author), Washington Univ, Dept Anat & Neurobiol, Program Mol Cell Biol, Div Biol & Biomed Sci, St Louis, MO 63130 USA.	baenzign@thalamus.wustl.edu	Zakaria, Justyna Dobrowolska/L-7283-2019	Zakaria, Justyna Dobrowolska/0000-0003-1718-147X	Washington University Alzheimer's Disease Research Center (ADRC) [P50AG005681]; Edith and Alan L. Wolff Charitable Trust; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Washington University Alzheimer's Disease Research Center (ADRC); Edith and Alan L. Wolff Charitable Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was privately funded via the Edith and Alan L. Wolff Charitable Trust through the infrastructure support of the Washington University Alzheimer's Disease Research Center (ADRC)(P50AG005681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2004, BIOORGAN MED CHEM, V12, P4791, DOI 10.1016/j.bmc.2004.07.022; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BAENZIGER NL, 1992, EUR J CELL BIOL, V58, P71; BAENZIGER NL, 1994, J BIOL CHEM, V269, P14892; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Beales ILP, 2006, MOL CELL ENDOCRINOL, V247, P140, DOI 10.1016/j.mce.2005.12.050; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bellucci C, 2007, MOL MED, V13, P542, DOI 10.2119/2007-00034.Bellucci; BEZPROZVANNY I, 2008, TRENDS NEUROSCI; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Boo JH, 2008, BIOCHEM BIOPH RES CO, V372, P913, DOI 10.1016/j.bbrc.2008.05.153; Borroni B, 2007, CURR MED CHEM, V14, P1171, DOI 10.2174/092986707780598005; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Butterfield DA, 2002, J NUTR BIOCHEM, V13, P444, DOI 10.1016/S0955-2863(02)00205-X; Cecchi C, 2002, FREE RADICAL BIO MED, V33, P1372, DOI 10.1016/S0891-5849(02)01049-3; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; COMBARROS O, 2008, NEUROBIOL AGING; COSTANZI E, 2007, NEUROCHEM RES; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; DIMOS JT, 2008, SCIENCE; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2005, J ALZHEIMERS DIS, V8, P347; FOWLER CJ, 1995, MOL CELL BIOCHEM, V149, P287, DOI 10.1007/BF01076590; Garnier P, 2003, J NEUROSCI, V23, P7967; Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17; Gibson GE, 2002, FREE RADICAL BIO MED, V32, P1061, DOI 10.1016/S0891-5849(02)00802-X; Gu F, 2008, NEUROSCI LETT, V440, P44, DOI 10.1016/j.neulet.2008.05.050; Haddad JJ, 2004, PROG NEUROBIOL, V73, P359, DOI 10.1016/j.pneurobio.2004.06.002; Hardy J, 2007, EMBO REP, V8, P134, DOI 10.1038/sj.embor.7400899; Hashimoto Y, 2004, J NEUROSCI RES, V75, P417, DOI 10.1002/jnr.10861; Hayashi R, 2000, EUR RESPIR J, V16, P452, DOI 10.1034/j.1399-3003.2000.016003452.x; JANICKI S, 2000, NEUROBIOLOGY AGING, V21; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Jong YJI, 2002, INT IMMUNOPHARMACOL, V2, P1833, DOI 10.1016/S1567-5769(02)00168-6; Jong YJI, 2003, FASEB J, V17, P2319, DOI 10.1096/fj.02-1147fje; Jong YJI, 1996, IMMUNOPHARMACOLOGY, V33, P9, DOI 10.1016/0162-3109(96)00075-6; JONG YJI, 1993, P NATL ACAD SCI USA, V90, P10994, DOI 10.1073/pnas.90.23.10994; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Khan TK, 2006, P NATL ACAD SCI USA, V103, P13203, DOI 10.1073/pnas.0605411103; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lanni C, 2008, MOL PSYCHIATR, V13, P641, DOI 10.1038/sj.mp.4002060; Lanni C, 2007, J ALZHEIMERS DIS, V12, P93; LEE JM, 2008, CLIN CHEM; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu B, 2006, J CELL BIOCHEM, V97, P1104, DOI 10.1002/jcb.20709; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Malik B, 2008, CELL CYCLE, V7, P637, DOI 10.4161/cc.7.5.5427; Marchesi VT, 2005, P NATL ACAD SCI USA, V102, P9093, DOI 10.1073/pnas.0503181102; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McCarthy JV, 2005, BIOCHEM SOC T, V33, P568, DOI 10.1042/BST0330568; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mukherjee O, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-3; Nakajima M, 2001, J NEUROCHEM, V78, P807, DOI 10.1046/j.1471-4159.2001.00478.x; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pratico D, 2005, NEUROBIOL AGING, V26, P581, DOI 10.1016/j.neurobiolaging.2004.09.020; Quinn J, 2008, NEUROLOGY, V71, P78, DOI 10.1212/01.wnl.0000316808.21277.69; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Tan YZ, 1998, BBA-MOL BASIS DIS, V1407, P69, DOI 10.1016/S0925-4439(98)00031-3; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Turner JH, 2007, BBA-MOL CELL RES, V1773, P391, DOI 10.1016/j.bbamcr.2006.12.003; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Velez-Pardo C, 2002, NEUROTOXICOLOGY, V23, P351, DOI 10.1016/S0161-813X(02)00081-5; Wilhelm M, 2007, J BIOL CHEM, V282, P1288, DOI 10.1074/jbc.M607038200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002; Zhao WQ, 2003, NEUROBIOL DIS, V14, P458, DOI 10.1016/S0969-9961(03)00124-4; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6	96	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2009	4	2							e4655	10.1371/journal.pone.0004655	http://dx.doi.org/10.1371/journal.pone.0004655			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437LA	19247475	gold, Green Published			2022-12-25	WOS:000265487800034
J	Walther, T; Albrecht, D; Becker, M; Schubert, M; Kouznetsova, E; Wiesner, B; Maul, B; Schliebs, R; Grecksch, G; Furkert, J; Sterner-Kock, A; Schultheiss, HP; Becker, A; Siems, WE				Walther, Thomas; Albrecht, Doris; Becker, Matthias; Schubert, Mania; Kouznetsova, Elena; Wiesner, Burkard; Maul, Bjoern; Schliebs, Reinhard; Grecksch, Gisela; Furkert, Jens; Sterner-Kock, Anja; Schultheiss, Heinz-Peter; Becker, Axel; Siems, Wolf-Eberhard			Improved Learning and Memory in Aged Mice Deficient in Amyloid beta-Degrading Neutral Endopeptidase	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RAT LATERAL AMYGDALA; HIPPOCAMPAL AREA CA1; A-BETA; ALZHEIMERS-DISEASE; HORIZONTAL SLICES; NEPRILYSIN; PEPTIDE; DEPOSITION; BRAIN	Background: Neutral endopeptidase, also known as neprilysin and abbreviated NEP, is considered to be one of the key enzymes in initial human amyloid-beta (A beta) degradation. The aim of our study was to explore the impact of NEP deficiency on the initial development of dementia-like symptoms in mice. Methodology/Principal Findings: We found that while endogenous A beta concentrations were elevated in the brains of NEP-knockout mice at all investigated age groups, immunohistochemical analysis using monoclonal antibodies did not detect any AI deposits even in old NEP knockout mice. Surprisingly, tests of learning and memory revealed that the ability to learn was not reduced in old NEP-deficient mice but instead had significantly improved, and sustained learning and memory in the aged mice was congruent with improved long-term potentiation (LTP) in brain slices of the hippocampus and lateral amygdala. Our data suggests a beneficial effect of pharmacological inhibition of cerebral NEP on learning and memory in mice due to the accumulation of peptides other than A beta degradable by NEP. By conducting degradation studies and peptide measurements in the brain of both genotypes, we identified two neuropeptide candidates, glucagon-like peptide 1 and galanin, as first potential candidates to be involved in the improved learning in aged NEP-deficient mice. Conclusions/Significance: Thus, the existence of peptides targeted by NEP that improve learning and memory in older individuals may represent a promising avenue for the treatment of neurodegenerative diseases.	[Walther, Thomas; Schultheiss, Heinz-Peter] Charite, Dept Cardiol, D-13353 Berlin, Germany; [Walther, Thomas] Hull York Med Sch, Ctr Biomed Res, Kingston Upon Hull, N Humberside, England; [Albrecht, Doris; Schubert, Mania] Charite, Inst Neurophysiol, Berlin, Germany; [Becker, Matthias; Wiesner, Burkard; Maul, Bjoern; Furkert, Jens; Siems, Wolf-Eberhard] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Kouznetsova, Elena; Schliebs, Reinhard] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Grecksch, Gisela; Becker, Axel] Otto VonGuericke Univ Magdegurg, Inst Pharmacol & Toxicol, D-39016 Magdeburg, Germany; [Sterner-Kock, Anja] Free Univ Berlin, D-1000 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hull; University of York - UK; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Leipzig University; Otto von Guericke University; Free University of Berlin	Walther, T (corresponding author), Charite, Dept Cardiol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	thomas.walther@hyms.ac.uk	Schubert, Manja/AAJ-9575-2021; Becker, Axel/G-1808-2013	Schubert, Manja/0000-0003-3592-2470; Becker, Axel/0000-0002-3406-3558; Becker, Matthias/0000-0001-9965-6648	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) [SI 483/3-2, WA1441/18-1]	Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG), Grant: SI 483/3-2; Grant WA1441/18-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; Brewer A, 2005, NEUROPEPTIDES, V39, P323, DOI 10.1016/j.npep.2004.12.007; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Carvajal CC, 2004, BEHAV BRAIN RES, V153, P471, DOI 10.1016/j.bbr.2004.01.004; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; EICHENBAUM H, 1995, NATURE, V378, P131, DOI 10.1038/378131a0; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Fischer HS, 2002, J MOL NEUROSCI, V18, P129, DOI 10.1385/JMN:18:1-2:129; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hadjiivanova Christina, 2003, Acta Physiol Pharmacol Bulg, V27, P83; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; HUPESODMANN K, 1995, REGUL PEPTIDES, V58, P149, DOI 10.1016/0167-0115(95)00063-H; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kalueff A, 1996, Depress Anxiety, V4, P100, DOI 10.1002/(SICI)1520-6394(1996)4:3<100::AID-DA2>3.0.CO;2-K; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kaschel T, 2004, SYNAPSE, V53, P141, DOI 10.1002/syn.20045; Lanahan A, 1997, J NEUROSCI, V17, P2876; LARSON J, 1988, BRAIN RES, V441, P111, DOI 10.1016/0006-8993(88)91388-1; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; Mataro M, 2003, J NEUROL NEUROSUR PS, V74, P1272, DOI 10.1136/jnnp.74.9.1272; Mohajeri MH, 2004, FEBS LETT, V562, P16, DOI 10.1016/S0014-5793(04)00169-3; MOORE CI, 1993, HIPPOCAMPUS, V3, P57, DOI 10.1002/hipo.450030106; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Mouri A, 2006, BEHAV BRAIN RES, V168, P83, DOI 10.1016/j.bbr.2005.10.014; NJUNGE K, 1991, BRIT J PHARMACOL, V104, P105, DOI 10.1111/j.1476-5381.1991.tb12392.x; POPOV N, 1973, ACTA BIOL MED GER, V31, P51; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Siems WE, 2000, EUR J PHARMACOL, V397, P327, DOI 10.1016/S0014-2999(00)00222-3; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tucker HM, 2004, NEUROSCI LETT, V368, P285, DOI 10.1016/j.neulet.2004.07.011; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; Zou LB, 2006, J PHARMACOL EXP THER, V317, P334, DOI 10.1124/jpet.105.095687	56	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4590	10.1371/journal.pone.0004590	http://dx.doi.org/10.1371/journal.pone.0004590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240795	gold, Green Published, Green Submitted			2022-12-25	WOS:000278086700008
J	Chan, CX; Darling, AE; Beiko, RG; Ragan, MA				Chan, Cheong Xin; Darling, Aaron E.; Beiko, Robert G.; Ragan, Mark A.			Are Protein Domains Modules of Lateral Genetic Transfer?	PLOS ONE			English	Article								Background: In prokaryotes and some eukaryotes, genetic material can be transferred laterally among unrelated lineages and recombined into new host genomes, providing metabolic and physiological novelty. Although the process is usually framed in terms of gene sharing (e. g. lateral gene transfer, LGT), there is little reason to imagine that the units of transfer and recombination correspond to entire, intact genes. Proteins often consist of one or more spatially compact structural regions (domains) which may fold autonomously and which, singly or in combination, confer the protein's specific functions. As LGT is frequent in strongly selective environments and natural selection is based on function, we hypothesized that domains might also serve as modules of genetic transfer, i.e. that regions of DNA that are transferred and recombined between lineages might encode intact structural domains of proteins. Methodology/Principal Findings: We selected 1,462 orthologous gene sets representing 144 prokaryotic genomes, and applied a rigorous two-stage approach to identify recombination breakpoints within these sequences. Recombination breakpoints are very significantly over-represented in gene sets within which protein domain-encoding regions have been annotated. Within these gene sets, breakpoints significantly avoid the domain-encoding regions (domons), except where these regions constitute most of the sequence length. Recombination breakpoints that fall within longer domons are distributed uniformly at random, but those that fall within shorter domons may show a slight tendency to avoid the domon midpoint. As we find no evidence for differential selection against nucleotide substitutions following the recombination event, any bias against disruption of domains must be a consequence of the recombination event per se. Conclusions/Significance: This is the first systematic study relating the units of LGT to structural features at the protein level. Many genes have been interrupted by recombination following inter-lineage genetic transfer, during which the regions within these genes that encode protein domains have not been preferentially preserved intact. Protein domains are units of function, but domons are not modules of transfer and recombination. Our results demonstrate that LGT can remodel even the most functionally conservative modules within genomes.	[Chan, Cheong Xin; Darling, Aaron E.; Beiko, Robert G.; Ragan, Mark A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Chan, Cheong Xin; Darling, Aaron E.; Beiko, Robert G.; Ragan, Mark A.] ARC Ctr Excellence Bioinformat, Brisbane, Qld, Australia; [Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 3J5, Canada	University of Queensland; Dalhousie University	Chan, CX (corresponding author), Univ Iowa, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA.	m.ragan@imb.uq.edu.au	Chan, Cheong Xin/A-7005-2008; Darling, Aaron/G-8119-2017; Ragan, Mark A/A-9825-2014	Chan, Cheong Xin/0000-0002-3729-8176; Ragan, Mark A/0000-0003-1672-7020; Darling, Aaron/0000-0003-2397-7925	Australian Research Council [CE0348221]; NSF;  [DBI-0630765]	Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); 	This study was supported by Australian Research Council grant CE0348221 to MAR. AED was supported by NSF grant DBI-0630765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Beiko RG, 2005, BIOINFORMATICS, V21, P2230, DOI 10.1093/bioinformatics/bti335; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; BORK P, 1991, FEBS LETT, V286, P47, DOI 10.1016/0014-5793(91)80937-X; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; Chan CX, 2007, S AFR COMPUT J, V38, P20; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Harlow TJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-45; Inagaki Y, 2006, P NATL ACAD SCI USA, V103, P4528, DOI 10.1073/pnas.0600744103; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Lin CH, 2008, MOL BIOL EVOL, V25, P549, DOI 10.1093/molbev/msm282; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Omelchenko MV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r55; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	32	46	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4524	10.1371/journal.pone.0004524	http://dx.doi.org/10.1371/journal.pone.0004524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229333	Green Published, Green Submitted, gold			2022-12-25	WOS:000265486200009
J	Colussi, C; Gurtner, A; Rosati, J; Illi, B; Ragone, G; Piaggio, G; Moggio, M; Lamperti, C; D'Angelo, G; Clementi, E; Minetti, G; Mozzetta, C; Antonini, A; Capogrossi, MC; Puri, PL; Gaetano, C				Colussi, Claudia; Gurtner, Aymone; Rosati, Jessica; Illi, Barbara; Ragone, Gianluca; Piaggio, Giulia; Moggio, Maurizio; Lamperti, Costanza; D'Angelo, Grazia; Clementi, Emilio; Minetti, Giulia; Mozzetta, Chiara; Antonini, Annalisa; Capogrossi, Maurizio C.; Puri, Pier Lorenzo; Gaetano, Carlo			Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						histone deacetylase; protein phosphatase; differentiation; myoblast; histone	HISTONE DEACETYLASE INHIBITORS; MUSCLE SATELLITE CELLS; C-FOS PROMOTER; SKELETAL-MUSCLE; GENE-EXPRESSION; GLYCOPROTEIN COMPLEX; ENDOTHELIAL-CELLS; MDX MOUSE; ACETYLATION; SYNTHASE	The present study provides evidence that abnormal patterns of global histone modification are present in the skeletal muscle nuclei of mdx mice and Duchenne muscular dystrophy (DMD) patients. A combination of specific histone H3 modifications, including Ser-10 phosphorylation, acetylation of Lys 9 and 14, and Lys 79 methylation, were found enriched in muscle biopsies from human patients affected by DMD and in late-term fetuses, early postnatal pups, or adult mdx mice. In this context, chromatin immunoprecipitation experiments showed an enrichment of these modifications at the loci of genes involved in proliferation or inflammation, suggesting a regulatory effect on gene expression. Remarkably, the reexpression of dystrophin induced by gentamicin treatment or the administration of nitric oxide (NO) donors reversed the abnormal pattern of H3 histone modifications. These findings suggest an unanticipated link between the dystrophin-activated NO signaling and the remodeling of chromatin. In this context, the regulation of class IIa histone deacetylases (HDACs) 4 and 5 was found altered as a consequence of the reduced NO-dependent protein phosphatase 2A activity, indicating that both NO and class IIa HDACs are important for satellite cell differentiation and gene expression in mdx mice. In conclusion, this work provides the first evidence of a role for NO as an epigenetic regulator in DMD.-Colussi, C., Gurtner, A., Rosati, J., Illi, B., Ragone, G., Piaggio, G., Moggio, M., Lamperti, C., D'Angelo, G., Clementi, E., Minetti, G., Mozzetta, C., Antonini, A., Capogrossi, M. C., Puri, P. L., Gaetano, C. Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. FASEB J. 23, 2131-2141 (2009)	[Rosati, Jessica; Antonini, Annalisa; Capogrossi, Maurizio C.; Gaetano, Carlo] Ist Dermopat Immacolata, Lab Patol Vasc, I-00167 Rome, Italy; [Colussi, Claudia; Illi, Barbara] Ist Cardiol Monzino, Lab Terapia Gen & Biol Vasc, Milan, Italy; [Gurtner, Aymone; Piaggio, Giulia] Ist Regina Elena, Lab Oncogenesi Mol, I-00161 Rome, Italy; [Gurtner, Aymone; Piaggio, Giulia] Ist Regina Elena, Rome Oncogenom Ctr, I-00161 Rome, Italy; [Ragone, Gianluca] Ist Dermopat Immacolata, Mol Oncol Lab, I-00167 Rome, Italy; [Moggio, Maurizio; Lamperti, Costanza] Univ Milan, Fdn Osped Maggiore Mangiagalli & Regina Elena, Ctr Dino Ferrari, Milan, Italy; [Clementi, Emilio] Univ Milan, Dipartimento Sci Preclin, Milan, Italy; [D'Angelo, Grazia; Clementi, Emilio] Ist Sci E Medea, Bosisio Parini, Italy; [Minetti, Giulia; Mozzetta, Chiara; Puri, Pier Lorenzo] Santa Lucia Fdn, Ist Dulbecco Telethon, Ist Ricovero & Cura Carattere Sci, Rome, Italy; [Minetti, Giulia; Mozzetta, Chiara; Puri, Pier Lorenzo] European Brain Res Inst, Rome, Italy; [Puri, Pier Lorenzo] Burnham Inst Med Res, San Diego, CA USA	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Centro Cardiologico Monzino; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Eugenio Medea; IRCCS Santa Lucia	Gaetano, C (corresponding author), Ist Dermopat Immacolata, Lab Patol Vasc, Via Monti Creta 104, I-00167 Rome, Italy.	gaetano@idi.it	Mozzetta, Chiara/K-9947-2018; Piaggio, Giulia/J-7214-2018; Mozzetta, Chiara/Q-2786-2019; Illi, Barbara/AAY-8650-2020; Rosati, Jessica Diana/AAK-6084-2020; lamperti, costanza/J-8801-2016; Colussi, Claudia/H-8609-2019; gurtner, aymone/AAB-8843-2020; Rosati, Jessica Diana/H-2867-2016; Mittal, Ashwani/J-2124-2012; Piaggio, Giulia/AAD-7336-2022; Gaetano, Carlo/P-9997-2019; Gurtner, Aymone/J-7217-2018; D'Angelo, Maria Grazia/K-4685-2016	Mozzetta, Chiara/0000-0002-7147-7266; Piaggio, Giulia/0000-0003-2114-1892; Mozzetta, Chiara/0000-0002-7147-7266; Rosati, Jessica Diana/0000-0002-4483-386X; lamperti, costanza/0000-0002-2280-2253; gurtner, aymone/0000-0002-7661-9059; Rosati, Jessica Diana/0000-0002-4483-386X; Mittal, Ashwani/0000-0002-6588-6194; Gaetano, Carlo/0000-0002-5238-1832; Gurtner, Aymone/0000-0002-7661-9059; Colussi, Claudia/0000-0002-7727-8911; D'Angelo, Maria Grazia/0000-0003-1241-4350; Puri, Pier Lorenzo/0000-0003-4964-0095	Fondo per gli Investimenti della Ricerca di Base [RBLA035A4X-1-FIRB]; UE FP6 [UE-LHSB-CT-04-502988]; Association Francaise contre les Myopathies (AFM) [MNM2-06, DdT2-06]; MDA [88202]; Telethon [GGP07006, GTB07001E]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); UE FP6(European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); MDA(Muscular Dystrophy Association); Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work has been partially supported by Fondo per gli Investimenti della Ricerca di Base grant RBLA035A4X-1-FIRB to M. C. C.; UE FP6 grant UE-LHSB-CT-04-502988 to M. C. C.; Association Francaise contre les Myopathies (AFM) grants MNM2-06 to C. G and DdT2-06 to M. C. C.; MDA grant 88202 to C. G.; Telethon grant GGP07006 and an AFM grant to E. C; and Telethon project GTB07001E and Eurobiobank project QLTR-2001-02769 to M. M. G. P. was supported by Associazione Italiana per la Ricerca sul Cancro, ISS-ACC, and Ministero della Sanita grant ICS-120.4/RA00-90-R.F.02/184. P. L. P was supported by a Telethon special grant, the Muscular Dystrophy Association, Parent Project Onlus, and Compagnia San Paolo di Torino. C. M. is a recipient of an AFM fellowship, and G. M. is a recipient of a Parent Project Onlus fellowship. P. L. P. is an Associate Telethon scientist at the Dulbecco Telethon Institute. C. C. is a Ph. D. student at the "Scienze Endocrino-Metaboliche e Endocrino-Chirurgiche" School of the Chair of Endocrinology, Catholic University, Rome 00165, Italy.	Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Chen ML, 2008, J MOL NEUROSCI, V34, P89, DOI 10.1007/s12031-007-9005-y; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Crosbie RH, 2001, NAT MED, V7, P27, DOI 10.1038/83309; Dennis C, 2003, NATURE, V421, P686, DOI 10.1038/421686a; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dogra C, 2006, J CELL PHYSIOL, V208, P575, DOI 10.1002/jcp.20696; Eberharter A, 2005, BIOL CHEM, V386, P745, DOI 10.1515/BC.2005.087; Engel A.G., 1994, DYSTROPHINOPATHIES, VVolume 2; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Grozdanovic Z, 1999, HISTOL HISTOPATHOL, V14, P243, DOI 10.14670/HH-14.243; Gucuyener K, 2000, BRAIN DEV-JPN, V22, P181, DOI 10.1016/S0387-7604(00)00106-6; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kasai T, 2004, J BIOMED SCI, V11, P534, DOI 10.1159/000077905; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu T, 2006, CANCER TREAT REV, V32, P157, DOI 10.1016/j.ctrv.2005.12.006; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; McArdle A, 1998, CLIN SCI, V95, P83, DOI 10.1042/CS19980029; McKinsey TA, 2004, NOVART FDN SYMP, V259, P163; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Peter AK, 2006, EXP CELL RES, V312, P2580, DOI 10.1016/j.yexcr.2006.04.024; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pisconti A, 2006, J CELL BIOL, V172, P233, DOI 10.1083/jcb.200507083; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Punkt K, 2006, BIOCHEM BIOPH RES CO, V348, P259, DOI 10.1016/j.bbrc.2006.07.056; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Ragno R, 2008, EUR J MED CHEM, V43, P621, DOI 10.1016/j.ejmech.2007.05.004; RAHM M, 1989, J CELL PHYSIOL, V139, P237, DOI 10.1002/jcp.1041390204; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tidball JG, 2004, MOL GENET METAB, V82, P312, DOI 10.1016/j.ymgme.2004.06.006; TROUCHE D, 1993, NATURE, V363, P79, DOI 10.1038/363079a0; TROUCHE D, 1995, FEBS LETT, V361, P140, DOI 10.1016/0014-5793(95)00140-5; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yahi H, 2006, EXPERT OPIN THER TAR, V10, P923, DOI 10.1517/14728222.10.6.923; Zaccagnini G, 2005, J BIOL CHEM, V280, P14790, DOI 10.1074/jbc.M414644200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	62	58	59	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2131	2141		10.1096/fj.08-115618	http://dx.doi.org/10.1096/fj.08-115618			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19264835				2022-12-25	WOS:000268836500013
J	Wood, JM; Decker, H; Hartmann, H; Chavan, B; Rokos, H; Spencer, JD; Hasse, S; Thornton, MJ; Shalbaf, M; Paus, R; Schallreuter, KU				Wood, J. M.; Decker, H.; Hartmann, H.; Chavan, B.; Rokos, H.; Spencer, J. D.; Hasse, S.; Thornton, M. J.; Shalbaf, M.; Paus, R.; Schallreuter, K. U.			Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair	FASEB JOURNAL			English	Article						MSRA&B; tyrosinase; catalase; follicle cells	HYDROGEN-PEROXIDE H2O2; HUMAN EPIDERMAL MELANOCYTES; HUMAN SKIN; IN-VIVO; OCULOCUTANEOUS ALBINISM; FOLLICLE PIGMENTATION; VITILIGO PATHOGENESIS; AUTOIMMUNE-DISEASE; RAMAN-SPECTROSCOPY; CALCIUM IMBALANCE	Senile graying of human hair has been the subject of intense research since ancient times. Reactive oxygen species have been implicated in hair follicle melanocyte apoptosis and DNA damage. Here we show for the first time by FT-Raman spectroscopy in vivo that human gray/white scalp hair shafts accumulate hydrogen peroxide (H2O2) in millimolar concentrations. Moreover, we demonstrate almost absent catalase and methionine sulfoxide reductase A and B protein expression via immunofluorescence and Western blot in association with a functional loss of methionine sulfoxide (Met-S=O) repair in the entire gray hair follicle. Accordingly, Met-S=O formation of Met residues, including Met 374 in the active site of tyrosinase, the key enzyme in melanogenesis, limits enzyme functionality, as evidenced by FT-Raman spectroscopy, computer simulation, and enzyme kinetics, which leads to gradual loss of hair color. Notably, under in vitro conditions, Met oxidation can be prevented by L-methionine. In summary, our data feed the long-voiced, but insufficiently proven, concept of H2O2-induced oxidative damage in the entire human hair follicle, inclusive of the hair shaft, as a key element in senile hair graying, which does not exclusively affect follicle melanocytes. This new insight could open new strategies for intervention and reversal of the hair graying process.-Wood, J. M., Decker, H., Hartmann, H., Chavan, B., Rokos, H., Spencer, J. D., Hasse, S., Thornton, M. J., Shalbaf, M., Paus, R., Schallreuter, K. U. Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J. 23, 2065-2075 (2009)	[Wood, J. M.; Chavan, B.; Rokos, H.; Spencer, J. D.; Hasse, S.; Thornton, M. J.; Shalbaf, M.; Schallreuter, K. U.] Univ Bradford, Dept Biomed Sci Clin & Expt Dermatol, Bradford BD7 1DP, W Yorkshire, England; [Wood, J. M.; Rokos, H.; Spencer, J. D.; Hasse, S.] Univ Bradford, Inst Pigmentary Disorders, Bradford BD7 1DP, W Yorkshire, England; [Decker, H.; Hartmann, H.] Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany; [Paus, R.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Paus, R.] Univ Manchester, Manchester, Lancs, England	University of Bradford; University of Bradford; Johannes Gutenberg University of Mainz; University of Lubeck; University of Manchester	Schallreuter, KU (corresponding author), Univ Bradford, Dept Biomed Sci Clin & Expt Dermatol, Bradford BD7 1DP, W Yorkshire, England.	k.schallreuter@bradford.ac.uk	Paus, Ralf/F-6243-2011	Thornton, M Julie/0000-0002-3395-7066	Deutsche Forschungsgemeinschaft, Germany; Research Centre for Medicine and Science, Mainz, Germany	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); Research Centre for Medicine and Science, Mainz, Germany	We dedicate this paper to the first author, who lost the battle against cancer during the preparation of this manuscript in February 2008. A manuscript is a fitting final word for this renowned, enthusiastic scientist. This research has been supported by the University of Bradford, by a grant to K. U. S. from Stiefel International, and by private donations. H. D. is grateful for financial support from Deutsche Forschungsgemeinschaft, Germany, and the Research Centre for Medicine and Science, Mainz, Germany. Primary human HFMs were a generous gift from Professor D. J. Tobin ( University of Bradford).	Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; ARONOFF S, 1965, SCIENCE, V150, P72, DOI 10.1126/science.150.3692.72; Borovansky J, 2006, PIGM CELL RES, V19, P170, DOI 10.1111/j.1600-0749.2006.00295.x; Botchkarev VA, 2001, AM J PATHOL, V158, P1913, DOI 10.1016/S0002-9440(10)64659-7; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; Commo S, 2004, BRIT J DERMATOL, V150, P435, DOI 10.1046/j.1365-2133.2004.05787.x; Cooksey CJ, 1998, BIOCHEM J, V333, P685, DOI 10.1042/bj3330685; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Decker H, 2006, ANGEW CHEM INT EDIT, V45, P4546, DOI 10.1002/anie.200601255; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; Gibbons NQ, 2006, J INVEST DERMATOL, V126, P2576, DOI 10.1038/sj.jid.5700612; Hasse S, 2004, J INVEST DERMATOL, V122, P307, DOI 10.1046/j.0022-202X.2004.22230.x; Kauser S, 2003, J INVEST DERMATOL, V120, P1073, DOI 10.1046/j.1523-1747.2003.12242.x; KAUSER S, 2007, PIGMENT CELL RES, V20, P432; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Land EJ, 2007, TOHOKU J EXP MED, V212, P341, DOI 10.1620/tjem.212.341; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Magerl M, 2002, EXP DERMATOL, V11, P381, DOI 10.1034/j.1600-0625.2002.110414.x; Maresca V, 2006, J INVEST DERMATOL, V126, P182, DOI 10.1038/sj.jid.5700021; Moskovitz J, 2003, P NATL ACAD SCI USA, V100, P7486, DOI 10.1073/pnas.1332607100; Muller-Rover S, 1999, J INVEST DERM SYMP P, V4, P272, DOI 10.1038/sj.jidsp.5640228; NANNINGA PB, 1991, PIGM CELL RES, V4, P193, DOI 10.1111/j.1600-0749.1991.tb00438.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Ogawa F, 2006, J INVEST DERMATOL, V126, P1128, DOI 10.1038/sj.jid.5700116; PITTELKOW MR, 1989, J CELL PHYSIOL, V140, P565, DOI 10.1002/jcp.1041400323; Rokos H, 2004, J RAMAN SPECTROSC, V35, P125, DOI 10.1002/jrs.1114; Rokos H, 2008, J RAMAN SPECTROSC, V39, P1214, DOI 10.1002/jrs.1968; Sarin KY, 2007, STEM CELL REV, V3, P212, DOI 10.1007/s12015-007-0028-0; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 2008, EXP DERMATOL, V17, P141, DOI 10.1111/j.1600-0625.2007.00666_2.x; Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100; Schallreuter KU, 2007, LIFE SCI, V80, P2221, DOI 10.1016/j.lfs.2007.01.028; Schallreuter KU, 2006, J INVEST DERMATOL, V126, P947, DOI 10.1038/sj.jid.5700086; Schallreuter KU, 2006, BIOCHEM BIOPH RES CO, V349, P931, DOI 10.1016/j.bbrc.2006.08.138; Schallreuter KU, 1999, BIOCHEM BIOPH RES CO, V262, P423, DOI 10.1006/bbrc.1999.1241; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schallreuter KU, 2006, BIOCHEM BIOPH RES CO, V342, P145, DOI 10.1016/j.bbrc.2006.01.124; SCHALLREUTER KU, 1994, SCIENCE, V263, P1444, DOI 10.1126/science.8128228; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schweikardt T, 2007, PIGM CELL RES, V20, P394, DOI 10.1111/j.1600-0749.2007.00405.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Slominski A, 1996, J INVEST DERMATOL, V106, P1203, DOI 10.1111/1523-1747.ep12348479; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Spatz KR, 2008, EXP DERMATOL, V17, P632, DOI 10.1111/j.1600-0625.2008.00742_18.x; Spencer JD, 2008, ENDOCRINOLOGY, V149, P1638, DOI 10.1210/en.2007-1317; Spencer JD, 2007, J INVEST DERMATOL, V127, P411, DOI 10.1038/sj.jid.5700538; SPRITZ RA, 1993, SEMIN DERMATOL, V12, P167; Spritz RA, 1997, HUM MUTAT, V10, P171, DOI 10.1002/(SICI)1098-1004(1997)10:2<171::AID-HUMU11>3.3.CO;2-9; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tobin DJ, 1999, J INVEST DERM SYMP P, V4, P323, DOI 10.1038/sj.jidsp.5640239; Tripathi RK, 1999, PIGM CELL RES, V12, P187, DOI 10.1111/j.1600-0749.1999.tb00512.x; Trueb Ralph M, 2005, J Cosmet Dermatol, V4, P60, DOI 10.1111/j.1473-2165.2005.40203.x; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wood JM, 2004, BIOCHEM BIOPH RES CO, V325, P1412, DOI 10.1016/j.bbrc.2004.10.185; WOOD JM, 1991, BIOCHIM BIOPHYS ACTA, V1074, P378, DOI 10.1016/0304-4165(91)90088-X; WOOD JM, 1995, BIOCHEM BIOPH RES CO, V206, P480, DOI 10.1006/bbrc.1995.1068; Wood JM, 2006, J INVEST DERMATOL, V126, P13, DOI 10.1038/sj.jid.5700051	62	142	148	3	63	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2065	2075		10.1096/fj.08-125435	http://dx.doi.org/10.1096/fj.08-125435			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19237503				2022-12-25	WOS:000268836500007
J	Patterson, ST; Li, J; Kang, JA; Wickrema, A; Williams, DB; Reithmeier, RAF				Patterson, Sian T.; Li, Jing; Kang, Jeong-Ah; Wickrema, Amittha; Williams, David B.; Reithmeier, Reinhart A. F.			Loss of Specific Chaperones Involved in Membrane Glycoprotein Biosynthesis during the Maturation of Human Erythroid Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; ENDOPLASMIC-RETICULUM; ANION-EXCHANGER; QUALITY-CONTROL; HEREDITARY SPHEROCYTOSIS; N-GLYCOSYLATION; XENOPUS OOCYTES; WILD-TYPE; PROTEINS; CALNEXIN	The production of erythrocytes requires the massive synthesis of red cell-specific proteins including hemoglobin, cytoskeletal proteins, as well as membrane glycoproteins glycophorin A (GPA) and anion exchanger 1 (AE1). We found that during the terminal differentiation of human CD34(+) erythroid progenitor cells in culture, key components of the endoplasmic reticulum (ER) protein translocation (Sec61 alpha), glycosylation (OST48), and protein folding machinery, chaperones BiP, calreticulin (CRT), and Hsp90 were maintained to allow efficient red cell glycoprotein biosynthesis. Unexpected was the loss of calnexin (CNX), an ER glycoprotein chaperone, and ERp57, a protein-disulfide isomerase, as well as a major decrease of the cytosolic chaperones, Hsc70 and Hsp70, components normally involved in membrane glycoprotein folding and quality control. AE1 can traffic to the cell surface in mouse embryonic fibroblasts completely deficient in CNX or CRT, whereas disruption of the CNX/CRT-glycoprotein interactions in human K562 cells using castanospermine did not affect the cell-surface levels of endogenous GPA or expressed AE1. These results demonstrate that CNX and ERp57 are not required for major glycoprotein biosynthesis during red cell development, in contrast to their role in glycoprotein folding and quality control in other cells.	[Patterson, Sian T.; Li, Jing; Williams, David B.; Reithmeier, Reinhart A. F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kang, Jeong-Ah; Wickrema, Amittha] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Toronto; University of Chicago	Reithmeier, RAF (corresponding author), Univ Toronto, Dept Biochem, MSB5216,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	r.reithmeier@utoronto.ca			Canadian Institutes of Health Research [FRN15266]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant FRN15266 (to R.A.F.R.).	Arrigo AP, 2005, J CELL BIOCHEM, V94, P241, DOI 10.1002/jcb.20349; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; CHERNOVA MN, 1995, J MEMBRANE BIOL, V148, P203; Cheung JC, 2005, BIOCHEM J, V392, P425, DOI 10.1042/BJ20051076; DAVID V, 1993, J BIOL CHEM, V268, P9585; DAVIS JQ, 1986, J BIOL CHEM, V261, P5368; Demaurex N., 2003, CALRETICULIN, P134; Dudeja PK, 1999, AM J PHYSIOL-LUNG C, V276, pL971, DOI 10.1152/ajplung.1999.276.6.L971; Fishelson Z, 2001, INT IMMUNOL, V13, P983, DOI 10.1093/intimm/13.8.983; Fraser SA, 1998, BIOCHEM CELL BIOL, V76, P881, DOI 10.1139/bcb-76-5-881; Geminard C, 2002, BIOCELL, V26, P205; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; GROVES JD, 1994, MOL MEMBR BIOL, V11, P31, DOI 10.3109/09687689409161027; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Izak G, 1977, Prog Hematol, V10, P1; JAROLIM P, 1995, BLOOD, V85, P634, DOI 10.1182/blood.V85.3.634.bloodjournal853634; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Krebs MP, 2004, TRENDS BIOCHEM SCI, V29, P648, DOI 10.1016/j.tibs.2004.10.009; Li J, 2000, BIOCHEM J, V349, P51, DOI 10.1042/0264-6021:3490051; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; LUX S, BLOOD PRINCIPLES PRA, P1383; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Okiyoneda T, 2008, BBA-MOL CELL RES, V1783, P1585, DOI 10.1016/j.bbamcr.2008.04.002; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Popov M, 1999, J BIOL CHEM, V274, P17635, DOI 10.1074/jbc.274.25.17635; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; SARABIA VE, 1993, J BIOL CHEM, V268, P10676; SINGH MK, 1984, NATURE, V309, P631, DOI 10.1038/309631a0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; WICKREMA A, 1994, J CELL PHYSIOL, V160, P417, DOI 10.1002/jcp.1041600304; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Yeates LC, 1997, BIOCHEM BIOPH RES CO, V238, P66, DOI 10.1006/bbrc.1997.7238; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Young MT, 2000, BIOCHEM J, V350, P53, DOI 10.1042/0264-6021:3500053; Zaric J, 1998, COMP HAEMATOL INT, V8, P205, DOI 10.1007/BF02752850; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	46	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14547	14557		10.1074/jbc.M809076200	http://dx.doi.org/10.1074/jbc.M809076200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19258325	hybrid, Green Published			2022-12-25	WOS:000266286100061
J	Budzik, JM; Oh, SY; Schneewind, O				Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf			Sortase D Forms the Covalent Bond That Links BcpB to the Tip of Bacillus cereus Pili	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL ANCHOR; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PYOGENES; LPXTG MOTIF; ADHESION; SUBSTRATE	Bacillus cereus and other Gram-positive bacteria elaborate pili via a sortase D-catalyzed transpeptidation mechanism from major and minor pilin precursor substrates. After cleavage of the LPXTG sorting signal of the major pilin, BcpA, sortase D forms an amide bond between the C-terminal threonine and the amino group of lysine within the YPKN motif of another BcpA subunit. Pilus assembly terminates upon sortase A cleavage of the BcpA sorting signal, resulting in a covalent bond between BcpA and the cell wall cross-bridge. Here, we show that the IPNTG sorting signal of BcpB, the minor pilin, is cleaved by sortase D but not by sortase A. The C-terminal threonine of BcpB is amide-linked to the YPKN motif of BcpA, thereby positioning BcpB at the tip of pili. Thus, unique attributes of the sorting signals of minor pilins provide Gram-positive bacteria with a universal mechanism ordering assembly of pili.	[Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institutes of Health [AI38897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI38897 (United States Public Health Service grant, to O.S.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2006, J CLIN INVEST, V116, P2582, DOI 10.1172/JCI30088; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424	39	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12989	12997		10.1074/jbc.M900927200	http://dx.doi.org/10.1074/jbc.M900927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269972	Green Published, hybrid			2022-12-25	WOS:000265688300046
J	Patil, SM; Xu, SH; Sheftic, SR; Alexandrescu, AT				Patil, Sharadrao M.; Xu, Shihao; Sheftic, Sarah R.; Alexandrescu, Andrei T.			Dynamic alpha-Helix Structure of Micelle-bound Human Amylin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET AMYLOID POLYPEPTIDE; SODIUM DODECYL-SULFATE; COUPLING-CONSTANTS; CHEMICAL-SHIFTS; SDS MICELLES; CONFORMATIONAL PREFERENCES; SECONDARY STRUCTURE; BACKBONE DYNAMICS; PROTEIN; NMR	Amylin is an endocrine hormone that regulates metabolism. In patients afflicted with type 2 diabetes, amylin is found in fibrillar deposits in the pancreas. Membranes are thought to facilitate the aggregation of amylin, and membrane-bound oligomers may be responsible for the islet beta-cell toxicity that develops during type 2 diabetes. To better understand the structural basis for the interactions between amylin and membranes, we determined the NMR structure of human amylin bound to SDS micelles. The first four residues in the structure are constrained to form a hairpin loop by the single disulfide bond in amylin. The last nine residues near the C terminus are unfolded. The core of the structure is an alpha-helix that runs from about residues 5-28. A distortion or kink near residues 18-22 introduces pliancy in the angle between the N- and C-terminal segments of the alpha-helix. Mobility, as determined by N-15 relaxation experiments, increases from the N to the C terminus and is strongly correlated with the accessibility of the polypeptide to spin probes in the solution phase. The spin probe data suggest that the segment between residues 5 and 17 is positioned within the hydrophobic lipid environment, whereas the amyloidogenic segment between residues 20 and 29 is at the interface between the lipid and solvent. This orientation may direct the aggregation of amylin on membranes, whereas coupling between the two segments may mediate the transition to a toxic structure.	[Patil, Sharadrao M.; Xu, Shihao; Sheftic, Sarah R.; Alexandrescu, Andrei T.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Alexandrescu, AT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	andrei@uconn.edu	Xu, Shihao/B-5422-2018		National Institutes of Health [1S10RR016760]; American Parkinson Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1S10RR016760 from NCRR (NMR instrumentation). This work was also supported by a Roger C. Duvoisin, M. D., research grant from the American Parkinson Disease Association.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 2008, PROTEIN MISFOLDING; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger A. T., 1992, SYSTEM XRAY CRYSTALL; CASE DA, 1994, METHOD ENZYMOL, V239, P392; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dux P, 1997, J BIOMOL NMR, V10, P301, DOI 10.1023/A:1018393225804; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gangabadage CS, 2008, J PHYS CHEM B, V112, P4242, DOI 10.1021/jp710045e; GIERASCH LM, 1982, BIOPHYS J, V37, P275, DOI 10.1016/S0006-3495(82)84676-6; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jarvet J, 1997, BIOCHEMISTRY-US, V36, P8153, DOI 10.1021/bi970193b; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; JIMENEZ MA, 1992, EUR J BIOCHEM, V207, P39, DOI 10.1111/j.1432-1033.1992.tb17017.x; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lim YA, 2008, FEBS LETT, V582, P2188, DOI 10.1016/j.febslet.2008.05.006; Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Lycknert K, 2002, J PHYS CHEM B, V106, P5275, DOI 10.1021/jp0136462; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Mascioni A, 2003, BIOPOLYMERS, V69, P29, DOI 10.1002/bip.10305; MCLEISH MJ, 1994, BIOCHEMISTRY-US, V33, P11174, DOI 10.1021/bi00203a013; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Nesmelova IV, 2004, J MAGN RESON, V166, P129, DOI 10.1016/j.jmr.2003.09.004; Pappalardo G, 2007, CHEM-EUR J, V13, P10204, DOI 10.1002/chem.200700576; PAUL BC, 1993, B CHEM SOC JPN, V66, P703, DOI 10.1246/bcsj.66.703; Petersen M, 2003, DIABETES CARE, V26, P917; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Wiltscheck R, 1997, PROTEIN SCI, V6, P1734, DOI 10.1002/pro.5560060814; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Young Andrew, 2005, Adv Pharmacol, V52, P67, DOI 10.1016/S1054-3589(05)52004-0; Young Andrew, 2005, Adv Pharmacol, V52, P47, DOI 10.1016/S1054-3589(05)52003-9; Zdrojewicz Z., 2006, DIABETOLOGIA DOOESWI, V6, P169; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	64	149	151	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11982	11991		10.1074/jbc.M809085200	http://dx.doi.org/10.1074/jbc.M809085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19244249	hybrid, Green Published			2022-12-25	WOS:000265494600030
J	Sheng, MHC; Amoui, M; Stiffel, V; Srivastava, AK; Wergedal, JE; Lau, KHW				Sheng, Matilda H. -C.; Amoui, Mehran; Stiffel, Virginia; Srivastava, Apurva K.; Wergedal, Jon E.; Lau, K. -H. William			Targeted Transgenic Expression of an Osteoclastic Transmembrane Protein-tyrosine Phosphatase in Cells of Osteoclastic Lineage Increases Bone Resorption and Bone Loss in Male Young Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; POSITIVE REGULATOR; MOLECULAR-CLONING; PTP-OC; DIFFERENTIATION; GENE; PROMOTER; C3H/HEJ; DISEASE; GLEPP1	This study evaluated whether transgenic expression of PTP-oc (osteoclastic transmembrane protein-tyrosine phosphatase) in cells of the osteoclast lineage would affect bone resorption and bone density in young adult mice. Transgenic mice were generated with a transgenic construct using a tartrate-resistant acid phosphatase exon 1C promoter to drive expression of rabbit PTP-oc in osteoclastic cells. pQCT evaluation of femurs of young adult male progeny of three lines showed that transgenic mice had reduced bone volume and area, cortical and trabecular bone mineral content, and density. Histomorphometric analyses at secondary spongiosa of the femur and at metaphysis of the L4 vertebra confirmed that male transgenic mice had decreased trabecular surface, reduced percentage of trabecular area, decreased trabecular number, increased trabecular separation, and increased osteoclast number per bone surface length. Consistent with an increase in bone resorption, the serum C-telopeptide level was 25% higher in transgenic mice than in wild-type littermates. However, the bone phenotype was not readily observed in female young adult transgenic mice. This could in part be due to potential interactions between estrogen and PTP-oc signaling, since the bone loss phenotype was seen in young adult ovariectomized transgenic mice by microcomputed tomography analysis. In vitro, the average pit area per resorption pit created by marrow-derived transgenic osteoclasts was similar to 50% greater than that created by wild-type osteoclasts. Transgenic osteoclasts showed a lower c-Src phosphotyrosine 527 level, greater c-Src kinase activity, and increased tyrosine phosphorylation of paxillin. In summary, this study provides compelling in vivo evidence that PTP-oc is a positive regulator of osteoclasts.	[Sheng, Matilda H. -C.; Amoui, Mehran; Stiffel, Virginia; Srivastava, Apurva K.; Wergedal, Jon E.; Lau, K. -H. William] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr 151, Loma Linda, CA 92357 USA; [Sheng, Matilda H. -C.; Amoui, Mehran; Srivastava, Apurva K.; Wergedal, Jon E.; Lau, K. -H. William] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA	Loma Linda University	Lau, KHW (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr 151, 11201 Benton St, Loma Linda, CA 92357 USA.	William.Lau@med.va.gov		Lau, Kin-Hing/0000-0003-1109-5052	Veterans Affairs Merit Review grant	Veterans Affairs Merit Review grant(US Department of Veterans Affairs)	This work was supported in part by a Veterans Affairs Merit Review grant and by a special appropriation to the Jerry L. Pettis Memorial Veterans Affairs Medical Center, Musculoskeletal Disease Center. Preliminary results were presented in abstract form (43).	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Amoui M, 2004, AM J PHYSIOL-CELL PH, V287, pC874, DOI 10.1152/ajpcell.00294.2003; Amoui M, 2003, J BIOL CHEM, V278, P44273, DOI 10.1074/jbc.M303933200; Amoui M, 2007, ARCH BIOCHEM BIOPHYS, V463, P47, DOI 10.1016/j.abb.2007.02.025; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Bischof JM, 2005, PHYSIOL GENOMICS, V22, P191, DOI 10.1152/physiolgenomics.00071.2005; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; IVEY JL, 1981, METAB BONE DIS RELAT, V3, P3, DOI 10.1016/S0221-8747(81)80016-1; Jacob ST, 2005, CANCER GENE THER, V12, P665, DOI 10.1038/sj.cgt.7700828; Lau KHW, 2006, J CELL BIOCHEM, V97, P940, DOI 10.1002/jcb.20667; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Miyazaki Tsuyoshi, 2006, Mod Rheumatol, V16, P68; Mohan S, 1996, HORM RES, V45, P59, DOI 10.1159/000184833; MOSEKILDE L, 1978, ACTA MED SCAND, V204, P97; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Pan WH, 2005, J BIOL CHEM, V280, P4888, DOI 10.1074/jbc.M409052200; PARISIEN M, 1990, ENDOCRIN METAB CLIN, V19, P19, DOI 10.1016/S0889-8529(18)30337-2; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Rundle CH, 2008, J GENE MED, V10, P229, DOI 10.1002/jgm.1148; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; SEIMIYA H, 1995, ONCOGENE, V10, P1731; Seimiya H, 1998, J BIOL CHEM, V273, P21187, DOI 10.1074/jbc.273.33.21187; Sheng MHC, 2002, BONE, V30, P486, DOI 10.1016/S8756-3282(01)00693-7; SHENG MHC, 2007, M AM SOC BON MIN RES; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Srivastava AK, 2001, BONE, V29, P361, DOI 10.1016/S8756-3282(01)00581-6; Suhr SM, 2001, J BONE MINER RES, V16, P1795, DOI 10.1359/jbmr.2001.16.10.1795; Umeda S, 1999, AM J PATHOL, V155, P223, DOI 10.1016/S0002-9440(10)65116-4; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wergedal JE, 2005, BONE, V36, P111, DOI 10.1016/j.bone.2004.09.012; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; WIGGINS RC, 1995, GENOMICS, V27, P174, DOI 10.1006/geno.1995.1021; Wu LW, 1996, BIOCHEM J, V316, P515, DOI 10.1042/bj3160515; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Xiong WC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1219, DOI 10.2741/1117; Yang JH, 2007, ARCH BIOCHEM BIOPHYS, V465, P72, DOI 10.1016/j.abb.2007.04.032; Yang JH, 2007, FEBS LETT, V581, P2503, DOI 10.1016/j.febslet.2007.04.063; Zhang ZY, 2000, J BIOL CHEM, V275, P37219, DOI 10.1074/jbc.M001818200	42	22	24	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11531	11545		10.1074/jbc.M808324200	http://dx.doi.org/10.1074/jbc.M808324200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244239	Green Published, hybrid			2022-12-25	WOS:000265494500057
J	Miyai, K; Yoneda, M; Hasegawa, U; Toita, S; Izu, Y; Hemmi, H; Hayata, T; Ezura, Y; Mizutani, S; Miyazono, K; Akiyoshi, K; Yamamoto, T; Nodaa, M				Miyai, Kentaro; Yoneda, Mitsuhiro; Hasegawa, Urara; Toita, Sayaka; Izu, Yayoi; Hemmi, Hiroaki; Hayata, Tadayoshi; Ezura, Yoichi; Mizutani, Shuki; Miyazono, Kohei; Akiyoshi, Kazunari; Yamamoto, Tadashi; Nodaa, Masaki			ANA Deficiency Enhances Bone Morphogenetic Protein-induced Ectopic Bone Formation via Transcriptional Events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTOPIC OSSIFICATION; TOB/BTG1 FAMILY; TOB; EXPRESSION; MEMBER; GENE; COMPONENT; MICE; IDENTIFICATION; CLONING	Ectopic bone formation after joint replacement or brain injury in humans is a serious complication that causes immobility of joints and severe pain. However, mechanisms underlying such ectopic bone formation are not fully understood. Bone morphogenetic protein (BMPs) are defined as inducers of ectopic bone formation, and they are regulated by several types of inhibitors. ANA is an antiproliferative molecule that belongs to Tob/BTG family, but its activity in bone metabolism has not been known. Here, we examined the role of ANA on ectopic bone formation activity of BMP. In ANA-deficient and wild-type mice, BMP2 was implanted to induce ectopic bone formation in muscle. ANA deficiency increased mass of newly formed bone in vivo compared with wild-type based on 3D-mu CT analyses. ANA mRNA was expressed in bone in vivo as well as in osteoblastic cells in vitro. Such ANA mRNA levels were increased by BMP2 treatment in MC3T3-E1 osteoblastic cells. Overexpression of ANA suppressed BMP-induced expression of luciferase reporter gene linked to BMP response elements in these cells. Conversely, ANA mRNA knockdown by small interference RNA enhanced the BMP-dependent BMP response element reporter expression. It also enhanced BMP-induced osteoblastic differentiation in muscle-derived C2C12 cells. Immunoprecipitation assay indicated that ANA interacts with Smad8. Thus, ANA is a suppressor of ectopic bone formation induced by BMP, and this inhibitory ANA activity is a part of the negative feedback regulation of BMP function.	[Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, Tokyo 1088639, Japan; [Miyai, Kentaro; Izu, Yayoi; Hemmi, Hiroaki; Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan; [Miyai, Kentaro; Izu, Yayoi; Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Chiyoda Ku, Tokyo 1010062, Japan; [Hasegawa, Urara; Toita, Sayaka; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; [Miyai, Kentaro; Mizutani, Shuki] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch Med, Bunkyo Ku, Tokyo 1138519, Japan; [Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hemmi, Hiroaki] Tokyo Med & Dent Univ, Med Top Track Program, Med Res Inst, Tokyo 1010062, Japan; [Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Adv Bone & Joint Sci Strateg Res Network Project, Japan Soc Promot Sci, Core Core Program, Tokyo 1010062, Japan; [Hayata, Tadayoshi; Ezura, Yoichi; Nodaa, Masaki] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1010062, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp; noda.mph@mri.tmd.ac.jp	Hayata, Tadayoshi/AAE-9712-2021; Ezura, Yoichi/L-9485-2016		Japanese Ministry of Education [18109011, 18659438, 18123456, 20013014]; Japan Space forum; Japan Aerospace Exploration Agency; Advanced Bone and Joint Science Strategic Research Networks Projects; Japan Society for Promotion of Science Core to Core Program	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space forum; Japan Aerospace Exploration Agency; Advanced Bone and Joint Science Strategic Research Networks Projects; Japan Society for Promotion of Science Core to Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in-aid from the Japanese Ministry of Education (Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Grants 18109011, 18659438, 18123456, and 20013014), grants from the Japan Space forum, Japan Aerospace Exploration Agency, and Advanced Bone and Joint Science Strategic Research Networks Projects, and the Japan Society for Promotion of Science Core to Core Program, Research for the Future Program, Genome Science.	Ajima R, 2008, FEBS LETT, V582, P1313, DOI 10.1016/j.febslet.2008.03.012; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Bellows CG, 1998, BONE, V23, P119, DOI 10.1016/S8756-3282(98)00084-2; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kato N, 2007, J CELL BIOCHEM, V101, P1063, DOI 10.1002/jcb.21160; Kodach LL, 2008, CANCER, V112, P300, DOI 10.1002/cncr.23160; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsuda S, 1996, ONCOGENE, V12, P705; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; SHAFFER B, 1989, B HOSP JOINT DIS ORT, V49, P55; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Toom A, 2007, CALCIFIED TISSUE INT, V80, P259, DOI 10.1007/s00223-007-9000-x; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Usui M, 2000, J BONE MINER RES, V15, pS190; Usui M, 2004, P NATL ACAD SCI USA, V101, P6653, DOI 10.1073/pnas.0303093101; Washio-Oikawa K, 2007, J BONE MINER RES, V22, P1217, DOI 10.1359/JBMR.070411; Washio-Oikawa K, 2006, J CELL BIOCHEM, V99, P538, DOI 10.1002/jcb.20854; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Yoshida Y, 2001, JPN J CANCER RES, V92, P592, DOI 10.1111/j.1349-7006.2001.tb01135.x	34	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2009	284	16					10593	10600		10.1074/jbc.M807677200	http://dx.doi.org/10.1074/jbc.M807677200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	431ZZ	19234306	Green Published, hybrid			2022-12-25	WOS:000265104600033
J	Esteve-Puig, R; Canals, F; Colome, N; Merlino, G; Recio, JA				Esteve-Puig, Rosaura; Canals, Francesc; Colome, Nuria; Merlino, Glenn; Angel Recio, Juan			Uncoupling of the LKB1-AMPK alpha Energy Sensor Pathway by Growth Factors and Oncogenic BRAF(V600E)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MELANOMA-CELLS; SOMATIC MUTATIONS; BRAF MUTATIONS; LKB1 KINASE; PHOSPHORYLATION; LKB1/STK11; P53; INHIBITION; APOPTOSIS	Background: Understanding the biochemical mechanisms contributing to melanoma development and progression is critical for therapeutical intervention. LKB1 is a multi-task Ser/Thr kinase that phosphorylates AMPK controlling cell growth and apoptosis under metabolic stress conditions. Additionally, LKB1(Ser428) becomes phosphorylated in a RAS-Erk1/2-p90(RSK) pathway dependent manner. However, the connection between the RAS pathway and LKB1 is mostly unknown. Methodology/Principal Findings: Using the UV induced HGF transgenic mouse melanoma model to investigate the interplay among HGF signaling, RAS pathway and PI3K pathway in melanoma, we identified LKB1 as a protein directly modified by HGF induced signaling. A variety of molecular techniques and tissue culture revealed that LKB1(Ser428) (Ser431 in the mouse) is constitutively phosphorylated in BRAF(V600E) mutant melanoma cell lines and spontaneous mouse tumors with high RAS pathway activity. Interestingly, BRAF(V600E) mutant melanoma cells showed a very limited response to metabolic stress mediated by the LKB1-AMPK-mTOR pathway. Here we show for the first time that RAS pathway activation including BRAF(V600E) mutation promotes the uncoupling of AMPK from LKB1 by a mechanism that appears to be independent of LKB1(Ser428) phosphorylation. Notably, the inhibition of the RAS pathway in BRAF(V600E) mutant melanoma cells recovered the complex formation and rescued the LKB1-AMPK alpha metabolic stress-induced response, increasing apoptosis in cooperation with the pro-apoptotic proteins Bad and Bim, and the down-regulation of Mcl-1. Conclusions/Significance: These data demonstrate that growth factor treatment and in particular oncogenic BRAF(V600E) induces the uncoupling of LKB1-AMPK alpha complexes providing at the same time a possible mechanism in cell proliferation that engages cell growth and cell division in response to mitogenic stimuli and resistance to low energy conditions in tumor cells. Importantly, this mechanism reveals a new level for therapeutical intervention particularly relevant in tumors harboring a deregulated RAS-Erk1/2 pathway.	[Esteve-Puig, Rosaura; Angel Recio, Juan] Vall Hebron Hosp, Vall Hebron Res Inst VHIO, Med Oncol Res Program, Anim Models & Canc Lab, Barcelona, Spain; [Canals, Francesc; Colome, Nuria] Vall Hebron Hosp, Vall Hebron Res Inst VHIO, Med Oncol Res Program, Proteom Lab, Barcelona, Spain; [Merlino, Glenn] NCI, NHI, Lab Canc Biol & Genet, Bethesda, MD USA	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Esteve-Puig, R (corresponding author), Vall Hebron Hosp, Vall Hebron Res Inst VHIO, Med Oncol Res Program, Anim Models & Canc Lab, Barcelona, Spain.	jarecio@ir.vhebron.net	Esteve-Puig, R/N-1402-2017	Esteve-Puig, R/0000-0003-0547-1752; Recio, Juan Angel/0000-0002-7320-3832	Instituto Carlos III; Fondo de Investigaciones Sanitarias [PI050227, PI080653]; Marie Curie [MIRG-CT-2005-029135]; Fundacion Mutua Madrilena (FMM); Fundacion Genoma Espana; Fundacio Institut de Recerca Vall d'Hebron [REP fellowship]; NATIONAL CANCER INSTITUTE [ZIABC008756] Funding Source: NIH RePORTER	Instituto Carlos III(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Marie Curie(European Commission); Fundacion Mutua Madrilena (FMM); Fundacion Genoma Espana; Fundacio Institut de Recerca Vall d'Hebron; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Instituto Carlos III, Fondo de Investigaciones Sanitarias projects PI050227, PI080653, Marie Curie Reintegration Grant MIRG-CT-2005-029135 and Fundacion Mutua Madrilena (FMM). The Proteomics Laboratory at IR-HUVH is a member of the National Spanish Institute for Proteomics (PROTEORED), supported by Fundacion Genoma Espana. REP fellowship was sponsored by Fundacio Institut de Recerca Vall d'Hebron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9112; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; DORFMAN J, 2008, MOL BIOL CELL; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; FOGARTY S, 2008, J BIOL CHEM; Geller AC, 2007, J AM ACAD DERMATOL, V57, P555, DOI 10.1016/j.jaad.2007.06.032; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Leshem Y, 2002, EXP CELL RES, V274, P288, DOI 10.1006/excr.2002.5473; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Marignani PA, 2005, J CLIN PATHOL, V58, P15, DOI 10.1136/jcp.2003.015255; Melnikova VO, 2003, ONCOGENE, V22, P5958, DOI 10.1038/sj.onc.1206595; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Recio JA, 2002, CANCER RES, V62, P6724; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Rowan A, 1999, J INVEST DERMATOL, V112, P509, DOI 10.1046/j.1523-1747.1999.00551.x; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Scott KD, 2007, CANCER RES, V67, P5622, DOI 10.1158/0008-5472.CAN-07-0762; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shen Z, 2002, CLIN CANCER RES, V8, P2085; SHERIDAN C, 2008, J BIOL CHEM; SONG P, 2008, J BIOL CHEM; Spicer J, 2004, CURR BIOL, V14, pR383, DOI 10.1016/j.cub.2004.05.012; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; WILLIAMS T, 2008, TRENDS CELL BIOL; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	47	93	95	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4771	10.1371/journal.pone.0004771	http://dx.doi.org/10.1371/journal.pone.0004771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274086	Green Published, gold, Green Submitted			2022-12-25	WOS:000265496000011
J	Koutsonanos, DG; Martin, MD; Zarnitsyn, VG; Sullivan, SP; Compans, RW; Prausnitz, MR; Skountzou, I				Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Zarnitsyn, Vladimir G.; Sullivan, Sean P.; Compans, Richard W.; Prausnitz, Mark R.; Skountzou, Ioanna			Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays	PLOS ONE			English	Article							T-CELLS; STRATUM-CORNEUM; UNITED-STATES; DELIVERY; VIRUS; RESPONSES; ANTIGEN; MEMORY; SKIN; PATCH	Background: Influenza is a contagious disease caused by a pathogenic virus, with outbreaks all over the world and thousands of hospitalizations and deaths every year. Due to virus antigenic drift and short-lived immune responses, annual vaccination is required. However, vaccine coverage is incomplete, and improvement in immunization is needed. The objective of this study is to investigate a novel method for transdermal delivery using metal microneedle arrays (MN) coated with inactivated influenza virus to determine whether this route is a simpler and safer approach than the conventional immunization, capable to induce robust immune responses and confer protection against lethal virus challenge. Methodology/Principal Findings: Inactivated A/Aichi/2/68 (H3N2) influenza virus was coated on metal microneedle arrays and applied to mice as a vaccine in the caudal dorsal skin area. Substantial antibody titers with hemagglutination inhibition activity were detected in sera collected two and four weeks after a single vaccine dose. Challenge studies in mice with 5xLD(50) of mouse adapted Aichi virus demonstrated complete protection. Microneedle vaccination induced a broad spectrum of immune responses including CD4+ and CD8+ responses in the spleen and draining lymph node, a high frequency of antigen-secreting cells in the lung and induction of virus-specific memory B-cells. In addition, the use of MN showed a dose-sparing effect and a strong Th2 bias when compared to an intramuscular (IM) reference immunization. Conclusions/Significance: The present results show that delivery of inactivated influenza virus through the skin using metal microneedle arrays induced strong humoral and cellular immune responses capable of conferring protection against virus challenge as efficiently as intramuscular immunization, which is the standard vaccination route. In view of the convenience of delivery and the potential for self-administration, vaccine-coated metal microneedles may provide a novel and highly effective immunization method.	[Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Koutsonanos, Dimitrios G.; Martin, Maria del Pilar; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Zarnitsyn, Vladimir G.; Sullivan, Sean P.; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Koutsonanos, DG (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	prausnitz@gatech.edu; iskount@emory.edu	Skountzou, Ioanna/A-4454-2010; Compans, Richard W/I-4087-2013	Skountzou, Ioanna/0000-0002-6429-244X; Compans, Richard W/0000-0003-2360-335X; Prausnitz, Mark/0000-0002-9076-8448	National Institutes of Health [AI074579, EB006369]; Center for Drug Design, Development and Delivery; Institute for Bioengineering and Bioscience at Georgia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Drug Design, Development and Delivery; Institute for Bioengineering and Bioscience at Georgia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the National Institutes of Health grants AI074579 and EB006369 and carried out in part at the Center for Drug Design, Development and Delivery and the Institute for Bioengineering and Bioscience at Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Baxby D, 2002, VACCINE, V20, P2140, DOI 10.1016/S0264-410X(02)00028-2; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Dean HJ, 2004, VACCINE, V23, P681, DOI 10.1016/j.vaccine.2004.06.041; Deng YP, 1997, J IMMUNOL, V158, P1507; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Frerichs DM, 2008, VACCINE, V26, P2782, DOI 10.1016/j.vaccine.2008.02.070; Garg S, 2007, CLIN VACCINE IMMUNOL, V14, P926, DOI 10.1128/CVI.00450-06; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Gill HS, 2007, PHARM RES, V24, P1369, DOI 10.1007/s11095-007-9286-4; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Glenn GM, 2006, CURR TOP MICROBIOL, V304, P247; Glenn GM, 2007, INFECT IMMUN, V75, P2163, DOI 10.1128/IAI.01740-06; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Howard A, 1997, ANN ALLERG ASTHMA IM, V78, P594, DOI 10.1016/S1081-1206(10)63222-X; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Mahalingam S, 2004, TRENDS IMMUNOL, V25, P636, DOI 10.1016/j.it.2004.10.002; Martanto W, 2004, PHARM RES-DORDR, V21, P947, DOI 10.1023/B:PHAM.0000029282.44140.2e; McElhaney JE, 2008, J INFECT DIS, V198, P632, DOI 10.1086/590435; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Mikszta JA, 2002, NAT MED, V8, P415, DOI 10.1038/nm0402-415; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Oosterom R, 1979, Ann N Y Acad Sci, V332, P113, DOI 10.1111/j.1749-6632.1979.tb47104.x; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Skountzou I, 2007, J VIROL, V81, P1083, DOI 10.1128/JVI.01692-06; Skountzou I, 2006, VACCINE, V24, P6110, DOI 10.1016/j.vaccine.2006.05.014; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; Steinhoff M, 2001, CURR OPIN ALLERGY CL, V1, P469, DOI 10.1097/00130832-200110000-00014; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Stingl G, 1989, Curr Probl Dermatol, V18, P22; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; WENIGER BGP, 2008, ALTERNATIVE VACCINE; Who/Cds/Csr/Ncs, 2002, WHO MAN AN INFL DIAG; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049	53	142	149	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2009	4	3							e4773	10.1371/journal.pone.0004773	http://dx.doi.org/10.1371/journal.pone.0004773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OE	19274084	Green Published, gold			2022-12-25	WOS:000265496000013
J	Kulkarni, R; Dhakal, BK; Slechta, ES; Kurtz, Z; Mulvey, MA; Thanassi, DG				Kulkarni, Ritwij; Dhakal, Bijaya K.; Slechta, E. Susan; Kurtz, Zachary; Mulvey, Matthew A.; Thanassi, David G.			Roles of Putative Type II Secretion and Type IV Pilus Systems in the Virulence of Uropathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; OUTER-MEMBRANE BIOGENESIS; PROTEIN SECRETION; AUTOTRANSPORTER TOXIN; EPITHELIAL-CELLS; PATHWAY; BLADDER; GENES; IDENTIFICATION; EPIDEMIOLOGY	Background: Type II secretion systems (T2SS) and the evolutionarily related type IV pili (T4P) are important virulence determinants in many Gram-negative bacterial pathogens. However, the roles of T2SS and T4P in the virulence of extraintestinal pathogenic Escherichia coli have not been determined. Methodology/Principal Findings: To investigate the functions of putative T2SS and T4P gene clusters present in the model uropathogenic E. coli (UPEC) strains UTI89 and CFT073, we deleted the secretin gene present in each cluster. The secretin forms a channel in the outer membrane that is essential for the function of T2SS and T4P systems. We compared the secretin deletion mutants with their wild type counterparts using tissue culture assays and the CBA/J mouse model of ascending urinary tract infection. No deficiencies were observed with any of the mutants in adherence, invasion or replication in human bladder or kidney cell lines, but UTI89 Delta hofQ and UTI89 Delta gspD exhibited approximately 2-fold defects in fluxing out of bladder epithelial cells. In the mouse infection model, each of the knockout mutants was able to establish successful infections in the bladder and kidneys by day one post-infection. However, UTI89 Delta hofQ and a CFT073 Delta hofQ Delta yheF double mutant both exhibited defects in colonizing the kidneys by day seven post-infection. Conclusions/Significance: Based on our results, we propose that the putative T4P and T2S systems are virulence determinants of UPEC important for persistence in the urinary tract, particularly in renal tissues.	[Kulkarni, Ritwij; Kurtz, Zachary; Thanassi, David G.] SUNY Stony Brook, Ctr Infect Dis, Dept Mol Genet & Microbiol, Stony Brook, NY USA; [Dhakal, Bijaya K.; Slechta, E. Susan; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84112 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Utah System of Higher Education; University of Utah	Kulkarni, R (corresponding author), Columbia Univ, Dept Microbiol, New York, NY 10032 USA.	David.Thanassi@stonybrook.edu		Mulvey, Matthew/0000-0002-6016-7510	National Institutes of Health [GM062987, AI055621, DK068585]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055621, T32AI055434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM062987 and AI055621 (DGT), and DK068585 (MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; BOCK K, 1985, J BIOL CHEM, V260, P8545; Bose N, 2002, J BACTERIOL, V184, P2305, DOI 10.1128/JB.184.8.2305-2309.2002; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JM, 2005, INFECT IMMUN, V73, P5301, DOI 10.1128/IAI.73.9.5301-5310.2005; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; GIRON JA, 1994, MOL MICROBIOL, V12, P71, DOI 10.1111/j.1365-2958.1994.tb00996.x; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Hales LM, 1999, INFECT IMMUN, V67, P3662, DOI 10.1128/IAI.67.7.3662-3666.1999; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; JIANG B, 1992, MOL MICROBIOL, V6, P1351, DOI 10.1111/j.1365-2958.1992.tb00856.x; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Landraud L, 2004, INT J MED MICROBIOL, V293, P513, DOI 10.1078/1438-4221-00295; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MCTAGGART LA, 1990, J MED MICROBIOL, V32, P135, DOI 10.1099/00222615-32-2-135; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Pugsley AP, 1997, GENE, V192, P13, DOI 10.1016/S0378-1119(96)00803-7; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Ronald A, 2002, AM J MED, V113, p14S; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08	44	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4752	10.1371/journal.pone.0004752	http://dx.doi.org/10.1371/journal.pone.0004752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270734	gold, Green Published, Green Submitted			2022-12-25	WOS:000265495900019
J	Qi, X; Li, X; Rider, P; Fan, WX; Gu, HW; Xu, LT; Yang, YH; Lu, SW; Wang, H; Liu, FY				Qi, Xian; Li, Xihan; Rider, Paul; Fan, Weixing; Gu, Hongwei; Xu, Longtao; Yang, Yonghua; Lu, Sangwei; Wang, Hua; Liu, Fenyong			Molecular Characterization of Highly Pathogenic H5N1 Avian Influenza A Viruses Isolated from Raccoon Dogs in China	PLOS ONE			English	Article							HIGH VIRULENCE; HONG-KONG; HEMAGGLUTININ; INFECTION; DETERMINANT; ADAPTATION; RECEPTORS; DELETION; TIGERS; CATS	Background: The highly pathogenic avian influenza H5N1 virus can infect a variety of animals and continually poses a threat to animal and human health. While many genotypes of H5N1 virus can be found in chicken, few are associated with the infection of mammals. Characterization of the genotypes of viral strains in animal populations is important to understand the distribution of different viral strains in various hosts. This also facilitates the surveillance and detection of possible emergence of highly pathogenic strains of specific genotypes from unknown hosts or hosts that have not been previously reported to carry these genotypes. Methodology/Principal Findings: Two H5N1 isolates were obtained from lung samples of two raccoon dogs that had died from respiratory disease in China. Pathogenicity experiments showed that the isolates were highly pathogenic to chicken. To characterize the genotypes of these viruses, their genomic sequences were determined and analyzed. The genetic contents of these isolates are virtually identical and they may come from the same progenitor virus. Phylogenetic analysis indicated that the isolates were genetically closely related to genotype V H5N1 virus, which was first isolated in China in 2003, and were distinct from the dominant virus genotypes ( e. g. genotype Z) of recent years. The isolates also contain a multibasic amino acid motif at their HA cleavage sites and have an E residue at position 627 of the PB2 protein similar to the previously-identified avian viruses. Conclusions/Significance: This is the first report that genotype V H5N1 virus is found to be associated with a mammalian host. Our results strongly suggest that genotype V H5N1 virus has the ability to cross species barriers to infect mammalian animals. These findings further highlight the risk that avian influenza H5N1 virus poses to mammals and humans, which may be infected by specific genotypes that are not known to infect these hosts.	[Qi, Xian; Li, Xihan; Gu, Hongwei; Yang, Yonghua; Wang, Hua; Liu, Fenyong] Nanjing Univ, Jiangsu CDC, State Key Lab Pharmaceut Biotechnol, Inst Virol,Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Qi, Xian; Wang, Hua] Jiangsu Ctr Dis Control & Pevent, Nanjing, Peoples R China; [Rider, Paul; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; [Fan, Weixing] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China; [Xu, Longtao] Qilu Anim Hlth Products Co Ltd, Jinan, Peoples R China	Nanjing University; University of California System; University of California Berkeley; China Animal Health & Epidemiology Center	Qi, X (corresponding author), Nanjing Univ, Jiangsu CDC, State Key Lab Pharmaceut Biotechnol, Inst Virol,Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China.	wh@jscdc.cn; liu_fy@uclink4.berkeley.edu			Research Program of High Technology of Jiangsu Province Science Foundation, China [BG20077035]; US Public Health Services; NIH [RO1-DE016813]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016813] Funding Source: NIH RePORTER	Research Program of High Technology of Jiangsu Province Science Foundation, China; US Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was in part supported by grant no. BG20077035 from the Research Program of High Technology of Jiangsu Province Science Foundation, China, and US Public Health Services (NIH grant RO1-DE016813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Amonsin A, 2007, ARCH VIROL, V152, P1925, DOI 10.1007/s00705-007-1010-5; Amonsin A, 2006, VIROLOGY, V344, P480, DOI 10.1016/j.virol.2005.08.032; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; DE J, 2005, NEW ENGL J MED, V353, P2667; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Giese M, 2008, EMERG INFECT DIS, V14, P308, DOI 10.3201/eid1402.070864; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lipatov AS, 2007, EMERG INFECT DIS, V13, P539, DOI 10.3201/eid1304.061266; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maas R, 2007, EMERG INFECT DIS, V13, P1219, DOI 10.3201/eid1308.070393; Mase M, 2005, MICROBIOL IMMUNOL, V49, P871, DOI 10.1111/j.1348-0421.2005.tb03677.x; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Roberton SI, 2006, P ROY SOC B-BIOL SCI, V273, P1729, DOI 10.1098/rspb.2006.3549; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Thiry E, 2007, VET MICROBIOL, V122, P25, DOI 10.1016/j.vetmic.2006.12.021; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07	55	44	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4682	10.1371/journal.pone.0004682	http://dx.doi.org/10.1371/journal.pone.0004682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270752	Green Submitted, gold, Green Published			2022-12-25	WOS:000265495900001
J	Berger, K; Lindh, R; Wierup, N; Zmuda-Trzebiatowska, E; Lindqvist, A; Manganiello, VC; Degerman, E				Berger, Karin; Lindh, Rebecka; Wierup, Nils; Zmuda-Trzebiatowska, Emilia; Lindqvist, Andreas; Manganiello, Vincent C.; Degerman, Eva			Phosphodiesterase 3B Is Localized in Caveolae and Smooth ER in Mouse Hepatocytes and Is Important in the Regulation of Glucose and Lipid Metabolism	PLOS ONE			English	Article							LIVER-REGENERATION; PLASMA-MEMBRANE; RAT-LIVER; CELLS; MICE; PHOSPHORYLATION; IDENTIFICATION; INHIBITORS; ADIPOCYTE; PROTEINS	Cyclic nucleotide phosphodiesterases (PDEs) are important regulators of signal transduction processes mediated by cAMP and cGMP. One PDE family member, PDE3B, plays an important role in the regulation of a variety of metabolic processes such as lipolysis and insulin secretion. In this study, the cellular localization and the role of PDE3B in the regulation of triglyceride, cholesterol and glucose metabolism in hepatocytes were investigated. PDE3B was identified in caveolae, specific regions in the plasma membrane, and smooth endoplasmic reticulum. In caveolin-1 knock out mice, which lack caveolae, the amount of PDE3B protein and activity were reduced indicating a role of caveolin-1/caveolae in the stabilization of enzyme protein. Hepatocytes from PDE3B knock out mice displayed increased glucose, triglyceride and cholesterol levels, which was associated with increased expression of gluconeogenic and lipogenic genes/enzymes including, phosphoenolpyruvate carboxykinase, peroxisome proliferator-activated receptor c, sterol regulatory element-binding protein 1c and hydroxyl-3-methylglutaryl coenzyme A reductase. In conclusion, hepatocyte PDE3B is localized in caveolae and smooth endoplasmic reticulum and plays important roles in the regulation of glucose, triglyceride and cholesterol metabolism. Dysregulation of PDE3B could have a role in the development of fatty liver, a condition highly relevant in the context of type 2 diabetes.	[Berger, Karin; Lindh, Rebecka; Zmuda-Trzebiatowska, Emilia; Degerman, Eva] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Wierup, Nils; Lindqvist, Andreas] Lund Univ, Dept Expt Med Sci, BMC B11, Lund, Sweden; [Zmuda-Trzebiatowska, Emilia; Manganiello, Vincent C.] NHLBI, NIH, Translat Med Branch, Bethesda, MD USA	Lund University; Lund University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Berger, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C11, Lund, Sweden.	karin.berger@med.lu.se			Swedish Research Council; Lund University Diabetes Center (LUDC); Swedish Diabetes Association; Novo Nordisk, Denmark; The Swedish Society of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540, Z01HL002540] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Diabetes Center (LUDC); Swedish Diabetes Association; Novo Nordisk, Denmark(Novo Nordisk); The Swedish Society of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swedish Research Council Project 3362 to E.D; K.B. was supported by Lund University Diabetes Center (LUDC); Grants were obtained from the following foundations: Swedish Diabetes Association; Novo Nordisk, Denmark; The Swedish Society of Medicine, Dr. P. Hakansson, Albert Pahlsson, Fredrik och Ingrid Thuring, Wiberg, Lars Hierta, Ahlan, Tore Nilsson and Magn. Bergvall. The funding agencies did not take any part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Abdollahi M, 2003, MOL CELL BIOCHEM, V252, P205, DOI 10.1023/A:1025568714217; Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; BIFULCO M, 1995, J BIOL CHEM, V270, P15231, DOI 10.1074/jbc.270.25.15231; BOTTCHER G, 1986, REGUL PEPTIDES, V13, P283, DOI 10.1016/0167-0115(86)90046-7; Calvo M, 2001, HEPATOLOGY, V33, P1259, DOI 10.1053/jhep.2001.23937; CARDELL RR, 1985, J CELL BIOL, V101, P201, DOI 10.1083/jcb.101.1.201; Carlsson L, 1998, ENDOCRINOLOGY, V139, P2699, DOI 10.1210/en.139.6.2699; Choi YH, 2001, BIOCHEM J, V353, P41, DOI 10.1042/0264-6021:3530041; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DEGERMAN E, 2007, CYCLIC NUCLEOTIDE PH, P79; Dohda T, 2004, J BIOCHEM, V135, P631, DOI 10.1093/jb/mvh076; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fleischer S, 1974, Methods Enzymol, V31, P6; Frank PG, 2007, CELL CYCLE, V6, P115, DOI 10.4161/cc.6.2.3722; GARFIELD SA, 1979, DIABETES, V28, P664, DOI 10.2337/diabetes.28.7.664; HAMMAD ESF, 1982, DIGEST DIS SCI, V27, P692, DOI 10.1007/BF01393763; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Komas N., 1996, PHOSPHODIESTERASE IN, P89, DOI [10.1016/b978-012210720-7/50008-3, DOI 10.1016/B978-012210720-7/50008-3]; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Lindh R, 2007, BBA-MOL CELL RES, V1773, P584, DOI 10.1016/j.bbamcr.2007.01.010; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; PYNE NJ, 1987, BIOCHEM J, V242, P33, DOI 10.1042/bj2420033; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Thompson PE, 2007, CURR TOP MED CHEM, V7, P421, DOI 10.2174/156802607779941224; Tietz P, 2005, J LIPID RES, V46, P1426, DOI 10.1194/jlr.M400412-JLR200; Tuma P L, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0302s02; Wierup N, 2005, CELL TISSUE RES, V319, P423, DOI 10.1007/s00441-004-1044-x; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	37	21	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4671	10.1371/journal.pone.0004671	http://dx.doi.org/10.1371/journal.pone.0004671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262749	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600004
J	Lodeiro, M; Theodoropoulou, M; Pardo, M; Casanueva, FF; Camina, JP				Lodeiro, Maria; Theodoropoulou, Marily; Pardo, Maria; Casanueva, Felipe F.; Camina, Jesus P.			c-Src Regulates Akt Signaling in Response to Ghrelin via beta-Arrestin Signaling-Independent and -Dependent Mechanisms	PLOS ONE			English	Article							RECEPTOR; PHOSPHORYLATION; ACTIVATION; GROWTH; RICTOR; MTOR; IDENTIFICATION; COMPLEX-2; APOPTOSIS; HORMONE	The aim of the present study was to identify the signaling mechanisms to ghrelin-stimulated activation of the serine/threonine kinase Akt. In human embryonic kidney 293 (HEK293) cells transfected with GHS-R1a, ghrelin leads to the activation of Akt through the interplay of distinct signaling mechanisms: an early G(i/o) protein-dependent pathway and a late pathway mediated by beta-arrestins. The starting point is the G(i/o)-protein dependent PI3K activation that leads to the membrane recruitment of Akt, which is phosphorylated at Y by c-Src with the subsequent phosphorylation at A-loop (T308) and HM (S473) by PDK1 and mTORC2, respectively. Once the receptor is activated, a second signaling pathway is mediated by beta-arrestins 1 and 2, involving the recruitment of at least beta-arrestins, c-Src and Akt. This beta-arrestin-scaffolded complex leads to full activation of Akt through PDK1 and mTORC2, which are not associated to the complex. In agreement with these results, assays performed in 3T3-L1 preadipocyte cells indicate that b-arrestins and c-Src are implicated in the activation of Akt in response to ghrelin through the GHS-R1a. In summary this work reveals that c-Src is crucially involved in the ghrelin-mediated Akt activation. Furthermore, the results support the view that b-arrestins act as both scaffolding proteins and signal transducers on Akt activation.	[Lodeiro, Maria; Pardo, Maria; Casanueva, Felipe F.; Camina, Jesus P.] CHUS, Inst Invest Sanit, Lab Mol & Cellular Endocrinol, Santiago De Compostela, Spain; [Lodeiro, Maria; Pardo, Maria; Casanueva, Felipe F.; Camina, Jesus P.] CIBER Fisiopatol Obesidad Nutr, Santiago De Compostela, Spain; [Theodoropoulou, Marily] Max Planck Inst Psychiat, Dept Endocrinol, Munich, Germany; [Pardo, Maria; Casanueva, Felipe F.] Univ Santiago Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Max Planck Society; Universidade de Santiago de Compostela	Lodeiro, M (corresponding author), CHUS, Inst Invest Sanit, Lab Mol & Cellular Endocrinol, Santiago De Compostela, Spain.	jesus.perez@usc.es	Pardo, María/C-5124-2012; Theodoropoulou, Marily/S-9546-2017	Pardo, María/0000-0002-9967-1650; Theodoropoulou, Marily/0000-0002-7378-4374; Lodeiro, Maria/0000-0003-0008-5641	Instituto de Salud Carlos III [PI060239, PI060705, PI070908]; Xunta de Galicia [PGIDIT05BTF20802PR, PGIDIT06PXIB918322PR, PGIDIT06PXIB918360PR]; University of Santiago de Compostela [Pfizer Young Investigator Fellowship]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); University of Santiago de Compostela	This work was supported by grants from Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion: PI060239, PI060705, PI070908), and Xunta de Galicia (PGIDIT05BTF20802PR, PGIDIT06PXIB918322PR, PGIDIT06PXIB918360PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of M Lodeiro is funded by Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion). The work of M Theodoropoulou was supported by a research fellowship at the University of Santiago de Compostela for the Pfizer Young Investigator Fellowship. The work of JP Camina is funded by the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion) and the Xunta de Galicia (SERGAS) through a research-staff stabilization contract.	Barazzoni R, 2007, OBESITY, V15, P2614, DOI 10.1038/oby.2007.313; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Conus NM, 2002, J BIOL CHEM, V277, P38021, DOI 10.1074/jbc.M203387200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V309, P464, DOI 10.1016/j.bbrc.2003.08.024; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Iantorno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE756, DOI 10.1152/ajpendo.00570.2006; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kim MS, 2004, MOL ENDOCRINOL, V18, P2291, DOI 10.1210/me.2003-0459; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Luttrell LM, 2002, J CELL SCI, V115, P455; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Park YJ, 2008, MOL CELL ENDOCRINOL, V285, P19, DOI 10.1016/j.mce.2008.01.003; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rossi F, 2007, ATHEROSCLEROSIS, V192, P291, DOI 10.1016/j.atherosclerosis.2006.07.021; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; XU X, 2008, ENDOCRINOLO IN PRESS; Zhao H, 2007, BIOCHEM BIOPH RES CO, V362, P677, DOI 10.1016/j.bbrc.2007.08.021	39	60	64	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2009	4	3							e4686	10.1371/journal.pone.0004686	http://dx.doi.org/10.1371/journal.pone.0004686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MC	19262695	Green Published, gold, Green Submitted			2022-12-25	WOS:000265490600014
J	Peterson, BK; Hare, EE; Iyer, VN; Storage, S; Conner, L; Papaj, DR; Kurashima, R; Jang, E; Eisen, MB				Peterson, Brant K.; Hare, Emily E.; Iyer, Venky N.; Storage, Steven; Conner, Laura; Papaj, Daniel R.; Kurashima, Rick; Jang, Eric; Eisen, Michael B.			Big Genomes Facilitate the Comparative Identification of Regulatory Elements	PLOS ONE			English	Article								The identification of regulatory sequences in animal genomes remains a significant challenge. Comparative genomic methods that use patterns of evolutionary conservation to identify non-coding sequences with regulatory function have yielded many new vertebrate enhancers. However, these methods have not contributed significantly to the identification of regulatory sequences in sequenced invertebrate taxa. We demonstrate here that this differential success, which is often attributed to fundamental differences in the nature of vertebrate and invertebrate regulatory sequences, is instead primarily a product of the relatively small size of sequenced invertebrate genomes. We sequenced and compared loci involved in early embryonic patterning from four species of true fruit flies (family Tephritidae) that have genomes four to six times larger than those of Drosophila melanogaster. Unlike in Drosophila, where virtually all non-coding DNA is highly conserved, blocks of conserved non-coding sequence in tephritids are flanked by large stretches of poorly conserved sequence, similar to what is observed in vertebrate genomes. We tested the activities of nine conserved non-coding sequences flanking the even-skipped gene of the teprhitid Ceratis capitata in transgenic D. melanogaster embryos, six of which drove patterns that recapitulate those of known D. melanogaster enhancers. In contrast, none of the three non-conserved tephritid non-coding sequences that we tested drove expression in D. melanogaster embryos. Based on the landscape of non-coding conservation in tephritids, and our initial success in using conservation in tephritids to identify D. melanogaster regulatory sequences, we suggest that comparison of tephritid genomes may provide a systematic means to annotate the non-coding portion of the D. melanogaster genome. We also propose that large genomes be given more consideration in the selection of species for comparative genomics projects, to provide increased power to detect functional non-coding DNAs and to provide a less biased view of the evolution and function of animal genomes.	[Peterson, Brant K.; Hare, Emily E.; Iyer, Venky N.; Storage, Steven; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Peterson, Brant K.; Hare, Emily E.; Eisen, Michael B.] Ernest Orlando Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA USA; [Conner, Laura; Papaj, Daniel R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Kurashima, Rick; Jang, Eric] US Dept Agr, Pacific Basin Agr Res Ctr, Hilo, HI USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Calif Inst Quantitative Biosci, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Ctr Integrative Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Arizona; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Peterson, BK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Conner, Laura/0000-0002-8457-6837; Peterson, Brant/0000-0002-0433-3035; Eisen, Michael/0000-0002-7528-738X	NIH [HG002779]; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Department of Energy's Joint Genome Institute [Community Sequencing Grant]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Energy's Joint Genome Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH grant HG002779 to MBE and by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Sequencing was conducted under a Community Sequencing Grant from the Department of Energy's Joint Genome Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bergman CM, 2001, GENOME RES, V11, P1335, DOI 10.1101/gr.178701; BERGMAN CM, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0086; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Elnitski L, 1997, J BIOL CHEM, V272, P369; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Gallo SM, 2006, BIOINFORMATICS, V22, P381, DOI 10.1093/bioinformatics/bti794; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Gumucio DL, 1996, MOL PHYLOGENET EVOL, V5, P18, DOI 10.1006/mpev.1996.0004; Halfon MS, 2008, NUCLEIC ACIDS RES, V36, pD594, DOI 10.1093/nar/gkm876; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1991, GENE DEV, V5, P265, DOI 10.1101/gad.5.2.265; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Ross M.T., 1999, CURRENT PROTOCOLS HU; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Wratten NS, 2006, EVOL DEV, V8, P6, DOI 10.1111/j.1525-142X.2006.05070.x	47	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2009	4	3							e4688	10.1371/journal.pone.0004688	http://dx.doi.org/10.1371/journal.pone.0004688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437MB	19259274	Green Submitted, gold, Green Published			2022-12-25	WOS:000265490500008
J	Xiao, WF; Liu, HB; Li, Y; Li, XH; Xu, CG; Long, MY; Wang, SP				Xiao, Wenfei; Liu, Hongbo; Li, Yu; Li, Xianghua; Xu, Caiguo; Long, Manyuan; Wang, Shiping			A Rice Gene of De Novo Origin Negatively Regulates Pathogen-Induced Defense Response	PLOS ONE			English	Article							BACTERIAL-BLIGHT RESISTANCE; DISEASE RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; MOLECULAR PHYLOGENY; DROSOPHILA-YAKUBA; EXPRESSION; EVOLUTION; SEQUENCES; DNA	How defense genes originated with the evolution of their specific pathogen-responsive traits remains an important problem. It is generally known that a form of duplication can generate new genes, suggesting that a new gene usually evolves from an ancestral gene. However, we show that a new defense gene in plants may evolve by de novo origination, resulting in sophisticated disease-resistant functions in rice. Analyses of gene evolution showed that this new gene, OsDR10, had homologs only in the closest relative, Leersia genus, but not other subfamilies of the grass family; therefore, it is a rice tribe-specific gene that may have originated de novo in the tribe. We further show that this gene may evolve a highly conservative rice-specific function that contributes to the regulation difference between rice and other plant species in response to pathogen infections. Biologic analyses including gene silencing, pathologic analysis, and mutant characterization by transformation showed that the OsDR10-suppressed plants enhanced resistance to a broad spectrum of Xanthomonas oryzae pv. oryzae strains, which cause bacterial blight disease. This enhanced disease resistance was accompanied by increased accumulation of endogenous salicylic acid (SA) and suppressed accumulation of endogenous jasmonic acid (JA) as well as modified expression of a subset of defense-responsive genes functioning both upstream and downstream of SA and JA. These data and analyses provide fresh insights into the new biologic and evolutionary processes of a de novo gene recruited rapidly.	[Xiao, Wenfei; Liu, Hongbo; Li, Yu; Li, Xianghua; Xu, Caiguo; Wang, Shiping] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Huazhong Agricultural University; University of Chicago	Xiao, WF (corresponding author), Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	swang@mail.hzau.edu.cn			National Program of High Technology Development of China; National Program on the Development of Basic Research in China; National Natural Science Foundation of China	National Program of High Technology Development of China(National High Technology Research and Development Program of China); National Program on the Development of Basic Research in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Program of High Technology Development of China, the National Program on the Development of Basic Research in China, and the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Chen HL, 2002, PHYTOPATHOLOGY, V92, P750, DOI 10.1094/PHYTO.2002.92.7.750; Chen ST, 2007, PLOS GENET, V3, P1131, DOI 10.1371/journal.pgen.0030107; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; CHU Z, 2007, GENETICS IMPROVEMENT, P349; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Ge S, 2002, AM J BOT, V89, P1967, DOI 10.3732/ajb.89.12.1967; Gozzo F, 2003, J AGR FOOD CHEM, V51, P4487, DOI 10.1021/jf030025s; Guo YL, 2005, AM J BOT, V92, P1548, DOI 10.3732/ajb.92.9.1548; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Hsiao C, 1999, AUST SYST BOT, V11, P667, DOI 10.1071/SB97012; Hu KM, 2008, MOL PLANT, V1, P786, DOI 10.1093/mp/ssn039; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; LEE HI, 1995, P NATL ACAD SCI USA, V92, P4076, DOI 10.1073/pnas.92.10.4076; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Long M., 2007, NATURE, V449, P511; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; MULLER A, 2002, PLANTA, V216, P14; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; SILVERMAN P, 1995, PLANT PHYSIOL, V108, P633, DOI 10.1104/pp.108.2.633; SUEL B, 2002, GENOME RES, V12, P17; Sun X, 2003, THEOR APPL GENET, V106, P683, DOI 10.1007/s00122-002-1117-8; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WAU J, 2007, GENETICS IMPROVEMENT, P173; White SE, 1999, GENETICS, V153, P1455; Yuan B, 2007, PLANTA, V226, P953, DOI 10.1007/s00425-007-0541-z; Zhang JW, 2005, PLANT J, V42, P772, DOI 10.1111/j.1365-313X.2005.02408.x; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhou B, 2002, SCI CHINA SER C, V45, P449, DOI 10.1360/02yc9050; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	43	79	81	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2009	4	2							e4603	10.1371/journal.pone.0004603	http://dx.doi.org/10.1371/journal.pone.0004603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601TH	19240804	Green Published, gold, Green Submitted			2022-12-25	WOS:000278086700017
J	Huang, YH; Chin, CC; Ho, HN; Chou, CK; Shen, CN; Kuo, HC; Wu, TJ; Wu, YC; Hung, YC; Chang, CC; Ling, TY				Huang, Yen-Hua; Chin, Cheng-Chieh; Ho, Hong-Nerng; Chou, Chuan-Kai; Shen, Chia-Ning; Kuo, Hung-Chih; Wu, Tsai-Jung; Wu, Yu-Chih; Hung, Yu-Ching; Chang, Chih-Cheng; Ling, Thai-Yen			Pluripotency of mouse spermatogonial stem cells maintained by IGF-1-dependent pathway	FASEB JOURNAL			English	Article						germline stem cells; stem cell-microenvironment interaction; Leydig cells; serum-free culture; cell signaling	PRIMORDIAL GERM-CELLS; IN-VITRO; SELF-RENEWAL; SERUM-FREE; CULTURE; GROWTH; PROLIFERATION; TESTIS; FATE; MICE	Recent studies indicate that neonatal spermatogonial stem cells (SSCs) possess pluripotency. However, the mechanisms that regulate the pluripotent differentiation capacity of SSCs remain unclear. Here, we describe a new method to clonally derive pluripotent SSCs from neonatal mouse testis. By coculturing with testicular stromal cells, SSCs can be maintained and expanded in serum-free conditions. Unlike endogenous SSCs, these in vitro expanded SSCs showed strong alkaline phosphatase (AP) activity and displayed characteristics of embryonic stem cells and primordial germ cells, which were therefore designated as AP(+) germline stem cells (AP(+) GSCs). The pluripotency of AP(+) GSCs was confirmed by in vitro differentiation toward hepatic and neuronal lineages and formation of embryonic chimeras after injection into blastocysts. Further investigation revealed that insulin-like growth factor-1 (IGF-1) secreted from Leydig cells was a key factor involved in maintaining the pluripotency of AP(+) GSCs. The blockage of IGF-1 receptor phosphorylation and its downstream PI3K pathway by PPP or LY294002 dramatically reduced their AP activity and expression of pluripotent genes, such as Oct-4, Blimp1, and Nanog. In conclusion, the present study demonstrated that IGF-1 secreted by testicular Leydig cells plays an important role in maintaining the pluripotency of SSCs in culture, which provides an insight into the molecular mechanism underlying germ cell pluripotency. -Huang, Y.-H., Chin, C.-C., Ho, H.-N., Chou, C.-K., Shen, C.-N., Kuo, H.-C., Wu, T.-J., Wu, Y.-C., Hung, Y.-C., Chang, C.-C., Ling, T.-Y. Pluripotency of mouse spermatogonial stem cells maintained by IGF-1-dependent pathway. FASEB J. 23, 2076-2087 (2009)	[Huang, Yen-Hua; Chin, Cheng-Chieh; Wu, Tsai-Jung; Wu, Yu-Chih; Chang, Chih-Cheng] Taipei Med Univ, Taipei Med Univ Hosp, Dept Biochem, Taipei, Taiwan; [Huang, Yen-Hua; Chin, Cheng-Chieh; Wu, Tsai-Jung; Wu, Yu-Chih; Chang, Chih-Cheng] Taipei Med Univ, Taipei Med Univ Hosp, Sch Med, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan; [Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med & Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Taipei 10764, Taiwan; [Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Ling, Thai-Yen] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Chou, Chuan-Kai; Hung, Yu-Ching] Natl Appl Res Labs, Natl Lab Anim Ctr, Taipei, Taiwan; [Shen, Chia-Ning; Kuo, Hung-Chih] Acad Sinica, Stem Cell Program, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Shen, Chia-Ning; Wu, Yu-Chih] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Applied Research Laboratories - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center	Huang, YH (corresponding author), Taipei Med Univ, Sch Med, Grad Inst Med Sci, Dept Biochem, Taipei, Taiwan.	rita1204@tmu.edu.tw; tyling@ntu.edu.tw	SHEN, CHIA-NING/C-6878-2011; NTU, Ref07/AAX-7890-2021; Kuo, Hung-Chih/H-7810-2014	SHEN, CHIA-NING/0000-0002-0747-217X; Kuo, Hung-Chih/0000-0003-1336-1203; Wu, Tsai-Jung/0000-0002-4136-7218; Ling, Thai-Yen/0000-0002-3992-883X; Wu, Yu-Chih/0000-0001-5781-2665	National Science Council, Taiwan [NSC93-2311-B-038-006, NSC95-2311B-038-002-MY2, NSC96-3111-B-038-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We thank Professor John Yu at the Stem Cell Program, the Genomics Research Center, Academia Sinica for encouragement and support. We also thank Ping Wu and Shu-Fen Cheng at the Department of Biochemistry and Dr. Chien-Jui Cheng at the Department of Pathology, Graduate Institute of Medical Sciences, Taipei Medical University, for excellent technical support. This work was supported by grants from the National Science Council, Taiwan, NSC93-2311-B-038-006, NSC95-2311B-038-002-MY2, and NSC96-3111-B-038-001.	Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; GarciaCastro MI, 1997, J CELL BIOL, V138, P471, DOI 10.1083/jcb.138.2.471; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Horii T, 2003, THERIOGENOLOGY, V59, P1257, DOI 10.1016/S0093-691X(02)01166-4; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moe-Behrens GHG, 2003, MOL ENDOCRINOL, V17, P2630, DOI 10.1210/me.2003-0006; Nagano M, 2003, BIOL REPROD, V68, P2207, DOI 10.1095/biolreprod.102.014050; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STEVENS LC, 1984, CELL DIFFER DEV, V15, P69, DOI 10.1016/0045-6039(84)90054-X; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Villalpando I, 2008, EXP BIOL MED, V233, P419, DOI 10.3181/0708-RM-212; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307	37	82	86	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2076	2087		10.1096/fj.08-121939	http://dx.doi.org/10.1096/fj.08-121939			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19246485				2022-12-25	WOS:000268836500008
J	Messaoudi, S; Milliez, P; Samuel, JL; Delcayre, C				Messaoudi, Smail; Milliez, Paul; Samuel, Jane-Lise; Delcayre, Claude			Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density	FASEB JOURNAL			English	Article						hormone; VEGFa; oxidative stress; streptozotocin; transgenic animal	ENDOTHELIAL GROWTH-FACTOR; LEFT-VENTRICULAR DYSFUNCTION; MINERALOCORTICOID RECEPTOR; CORONARY DYSFUNCTION; PLASMA-ALDOSTERONE; OXIDATIVE STRESS; SPIRONOLACTONE; FAILURE; CARDIOMYOPATHY; FIBROSIS	Recent reports showed an unexpected worsening of endothelial function by aldosterone antagonism in diabetic patients, suggesting that aldosterone could interfere with the detrimental consequences of diabetes on microvasculature and thus on cardiac function. To test this hypothesis, diabetes (D) was induced using streptozotocin in transgenic (Tg) male mice overexpressing aldosterone-synthase in the heart and in wild-type (Wt) mice. Eight weeks after streptozotocin injection, impairment of left ventricular systolic function, measured by echocardiography (fractional shortening), was accompanied by a decrease in capillaries/ cardiomyocyte ratio (-20%) and VEGFa expression (-40%) in Wt-D mice compared with normoglycemic littermates. Furthermore, Wt-D mice demonstrated an increase in superoxide production (+100%) and protein carbonylation (+33%), hallmarks of oxidative stress. Except for a slight increase in protein carbonylation, all of these diabetes-associated cardiac alterations were undetectable in Tg-D mice. Fibrosis was induced similarly in both diabetic groups. Eplerenone (an aldosterone antagonist) abolished all of the effects of aldosterone-synthase overexpression but had no effect in Wt-D mice. Thus, aldosterone prevents systolic dysfunction through a mineralocorticoid receptor-dependent mechanism that may include preventing VEGFa down-regulation and maintaining capillary density. Understanding how aldosterone prevents VEGFa down-regulation in experimental diabetes could be important to define new strategies targeting the prevention of a decrease in capillary density.-Messaoudi, S., Milliez, P., Samuel, J.-L., Delcayre, C. Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density. FASEB J. 23, 2176-2185 (2009)	[Messaoudi, Smail; Milliez, Paul; Samuel, Jane-Lise; Delcayre, Claude] Hop Lariboisiere, INSERM, U942, F-75010 Paris, France; [Messaoudi, Smail; Samuel, Jane-Lise; Delcayre, Claude] Paris Diderot Univ, Paris, France; [Milliez, Paul] Cote Nacre Univ Hosp, Dept Cardiol, Caen, France; [Samuel, Jane-Lise] Lariboisiere Hosp, Assistance Publ Hop Paris, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Delcayre, C (corresponding author), Hop Lariboisiere, INSERM, U942, 41 Blvd Chapelle, F-75010 Paris, France.	claude.delcayre@inserm.fr		Samuel, Jane-Lise/0000-0002-7346-2404	Groupe de Reflexion pour la Recherche Cardiovasculaire; European Section of Aldosterone Council; Groupe Paris Nord Circulation; Fondation de France; CNRS; INSERM	Groupe de Reflexion pour la Recherche Cardiovasculaire; European Section of Aldosterone Council; Groupe Paris Nord Circulation; Fondation de France(Fondation de France); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The authors thank Dr Annabel Chen-Tournoux for editorial assistance. This work was supported by the Groupe de Reflexion pour la Recherche Cardiovasculaire, the European Section of Aldosterone Council, The Groupe Paris Nord Circulation, the Fondation de France, the CNRS, and INSERM.	Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Beggah AT, 2002, P NATL ACAD SCI USA, V99, P7160, DOI 10.1073/pnas.102673599; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; CRONIN CC, 1995, DIABETIC MED, V12, P809, DOI 10.1111/j.1464-5491.1995.tb02084.x; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Davies JI, 2004, DIABETOLOGIA, V47, P1687, DOI 10.1007/s00125-004-1510-8; DEAZEVEDO MJ, 1995, DIABETES RES CLIN PR, V27, P205, DOI 10.1016/0168-8227(95)01047-H; Delcayre C, 2002, J MOL CELL CARDIOL, V34, P1577, DOI 10.1006/jmcc.2002.2088; Dhalla NS, 1998, CARDIOVASC RES, V40, P239, DOI 10.1016/S0008-6363(98)00186-2; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fiordaliso F, 2006, LIFE SCI, V79, P121, DOI 10.1016/j.lfs.2005.12.036; Fraccarollo D, 2003, J AM COLL CARDIOL, V42, P1666, DOI 10.1016/j.jacc.2003.05.003; Garnier A, 2004, CIRCULATION, V110, P1819, DOI 10.1161/01.CIR.0000142858.44680.27; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Lai LY, 2007, LIFE SCI, V81, P570, DOI 10.1016/j.lfs.2007.06.025; McQueen AP, 2005, J MOL CELL CARDIOL, V39, P882, DOI 10.1016/j.yjmcc.2005.07.017; Michel F, 2004, CIRCULATION, V109, P1933, DOI 10.1161/01.CIR.0000127112.36796.9B; MICHEL JB, 1988, CIRC RES, V62, P641, DOI 10.1161/01.RES.62.4.641; Milliez P, 2005, EUR HEART J, V26, P2193, DOI 10.1093/eurheartj/ehi478; Miric G, 2001, BRIT J PHARMACOL, V133, P687, DOI 10.1038/sj.bjp.0704131; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; PINTO YM, 1993, CARDIOVASC RES, V27, P1933, DOI 10.1093/cvr/27.11.1933; PITT B, 1995, CARDIOVASC DRUG THER, V9, P145, DOI 10.1007/BF00877755; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Ratajczak P, 2005, J APPL PHYSIOL, V99, P244, DOI 10.1152/japplphysiol.01292.2004; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; Rocha R, 2002, AM J PHYSIOL-HEART C, V283, pH1802, DOI 10.1152/ajpheart.01096.2001; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Schiffrin EL, 2006, HYPERTENSION, V47, P312, DOI 10.1161/01.HYP.0000201443.63240.a7; SCHUNKERT H, 1993, CARDIOVASC RES, V27, P731, DOI 10.1093/cvr/27.5.731; STAESSEN J, 1981, NEW ENGL J MED, V304, P1110; Stewart RAH, 2008, AM HEART J, V156, P348, DOI 10.1016/j.ahj.2008.03.012; Strauer BE, 1997, DIABETES, V46, pS119, DOI 10.2337/diab.46.2.S119; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sun Y, 2006, CARDIOVASC RES, V71, P300, DOI 10.1016/j.cardiores.2006.03.007; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Uhrenholt TR, 2004, ACTA PHYSIOL SCAND, V181, P415, DOI 10.1111/j.1365-201X.2004.01313.x; Verma S, 2003, CAN J PHYSIOL PHARM, V81, P493, DOI 10.1139/Y03-041; Virdis A, 2002, HYPERTENSION, V40, P504, DOI 10.1161/01.HYP.0000034738.79310.06; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Young M, 2004, ENDOCRINOLOGY, V145, P3153, DOI 10.1210/en.2004-0005	47	25	27	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2009	23	7					2176	2185		10.1096/fj.08-125302	http://dx.doi.org/10.1096/fj.08-125302			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	481UC	19255254				2022-12-25	WOS:000268836500017
J	Lee, CL; Pang, PC; Yeung, WSB; Tissot, B; Panico, M; Lao, TTH; Chu, IK; Lee, KF; Chung, MK; Lam, KKW; Koistinen, R; Koistinen, H; Seppala, M; Morris, HR; Dell, A; Chiu, PCN				Lee, Cheuk-Lun; Pang, Poh-Choo; Yeung, William S. B.; Tissot, Berangere; Panico, Maria; Lao, Terence T. H.; Chu, Ivan K.; Lee, Kai-Fai; Chung, Man-Kin; Lam, Kevin K. W.; Koistinen, Riitta; Koistinen, Hannu; Seppala, Markku; Morris, Howard R.; Dell, Anne; Chiu, Philip C. N.			Effects of Differential Glycosylation of Glycodelins on Lymphocyte Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FOLLICULAR-FLUID; PROTEIN-GLYCAN INTERACTIONS; HUMAN PLACENTAL PROTEIN-14; ZONA PELLUCIDA BINDING; INHIBITORY FACTOR-I; APOPTOTIC ACTIVITY; SIALIDASE NEU3; N-ACETYLGLUCOSAMINE; HUMAN SPERMATOZOA; PLASMA-MEMBRANE	Glycodelin is a human glycoprotein with four reported glycoforms, namely glycodelin-A (GdA), glycodelin-F (GdF), glycodelin-C (GdC), and glycodelin-S (GdS). These glycoforms have the same protein core and appear to differ in their N-glycosylation. The glycosylation of GdA is completely different from that of GdS. GdA inhibits proliferation and induces cell death of T cells. However, the glycosylation and immunomodulating activities of GdF and GdC are not known. This study aimed to use ultra-high sensitivity mass spectrometry to compare the glycomes of GdA, GdC, and GdF and to study the relationship between the immunological activity and glycosylation pattern among glycodelin glycoforms. Using MALDI-TOF strategies, the glycoforms were shown to contain an enormous diversity of bi-, tri-, and tetra-antennary complex-type glycans carrying Gal beta 1-4GlcNAc (lacNAc) and/ or GalNAc beta 1-4GlcNAc (lacdiNAc) antennae backbones with varying levels of fucose and sialic acid substitution. Interestingly, they all carried a family of Sda (NeuAc alpha 2-3(GalNAc beta 1-4)Gal)-containing glycans, which were not identified in the earlier study because of less sensitive methodologies used. Among the three glycodelins, GdA is the most heavily sialylated. Virtually all the sialic acid on GdC is located on the Sda antennae. With the exception of the Sda epitope, the GdC N-glycome appears to be the asialylated counterpart of the GdA/GdF glycomes. Sialidase activity, which may be responsible for transforming GdA/GdF to GdC, was detected in cumulus cells. Both GdA and GdF inhibited the proliferation, induced cell death, and suppressed interleukin-2 secretion of Jurkat cells and peripheral blood mononuclear cells. In contrast, no immunosuppressive effect was observed for GdS and GdC.	[Pang, Poh-Choo; Tissot, Berangere; Panico, Maria; Morris, Howard R.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England; [Lee, Cheuk-Lun; Yeung, William S. B.; Lee, Kai-Fai; Chung, Man-Kin; Lam, Kevin K. W.; Chiu, Philip C. N.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Lun; Chu, Ivan K.] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Lao, Terence T. H.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Koistinen, Riitta] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki 00029, Hus, Finland; [Morris, Howard R.] M SCAN Ltd, Wokingham RG41 2TZ, Berks, England	Imperial College London; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital	Dell, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Fac Nat Sci, London SW7 2AZ, England.	a.dell@imperial.ac.uk; pchiucn@hkucc.hku.hk	Chu, Ivan Keung/D-3065-2009; Koistinen, Hannu/AGU-1279-2022; Lee, Cheuk Lun/AGX-5720-2022; /C-7476-2009; Seppala, Markku/AAT-6618-2021; Chung, Man Kin/B-9613-2012; Chiu, Chi Ngong/C-4245-2009; Chiu, Philip/A-4019-2009; Lee, Calvin Kai Fai/C-4328-2009	Koistinen, Hannu/0000-0003-0926-3109; Chung, Man Kin/0000-0003-4239-4311; Chiu, Chi Ngong/0000-0001-6217-1970; Chiu, Philip/0000-0001-9292-112X; Lee, Calvin Kai Fai/0000-0001-5957-439X; Lee, Cheuk Lun/0000-0003-1553-3478	Research Grants Council (RGC) [HKU 764706M, HKU 764007M]; Biotechnology and Biological Sciences Research Council (BBSRC) [B19088, SF19107]; Imperial College London Scholarships; Malaysian Institute of Strategic and International Studies (ISIS) Perdana Scholarship; Biotechnology and Biological Sciences Research Council [B19088, SF19107] Funding Source: researchfish	Research Grants Council (RGC)(Hong Kong Research Grants Council); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College London Scholarships; Malaysian Institute of Strategic and International Studies (ISIS) Perdana Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Research Grants Council (RGC) Grants HKU 764706M and HKU 764007M, by Grants B19088 and SF19107 from the Biotechnology and Biological Sciences Research Council (BBSRC), including a BBSRC Professorial Fellowship (to A. D.), and by Imperial College London Scholarships and the Malaysian Institute of Strategic and International Studies (ISIS) Perdana Scholarship (to P.-C. P.).	Azuma Y, 2007, BIOL PHARM BULL, V30, P1680, DOI 10.1248/bpb.30.1680; Bianco GA, 2006, AUTOIMMUN REV, V5, P349, DOI 10.1016/j.autrev.2006.02.003; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chian RC, 1999, FERTIL STERIL, V71, P61, DOI 10.1016/S0015-0282(98)00416-6; Chiu PCN, 2005, J BIOL CHEM, V280, P25580, DOI 10.1074/jbc.M504103200; Chiu PCN, 2004, BIOL REPROD, V70, P1710, DOI 10.1095/biolreprod.103.023259; Chiu PCN, 2003, BIOL REPROD, V69, P365, DOI 10.1095/biolreprod.102.012658; Chiu PCN, 2003, J BIOL CHEM, V278, P13570, DOI 10.1074/jbc.M212086200; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; CONZELMANN A, 1988, J EXP MED, V167, P119, DOI 10.1084/jem.167.1.119; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ha KT, 2004, MOL CELLS, V17, P267; Haslam SM, 2006, CURR OPIN STRUC BIOL, V16, P584, DOI 10.1016/j.sbi.2006.08.006; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Jayachandran R, 2004, J BIOL CHEM, V279, P8585, DOI 10.1074/jbc.M310480200; Jayachandran R, 2006, GLYCOBIOLOGY, V16, P1052, DOI 10.1093/glycob/cwl024; Jeschke U, 2007, ANTICANCER RES, V27, P2101; JULKUNEN M, 1988, P NATL ACAD SCI USA, V85, P8845, DOI 10.1073/pnas.85.23.8845; Klisch K, 2008, GLYCOBIOLOGY, V18, P42, DOI 10.1093/glycob/cwm113; Koistinen H, 2003, BIOL REPROD, V69, P1545, DOI 10.1095/biolreprod.103.017830; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Miller RE, 1998, FEBS LETT, V436, P455, DOI 10.1016/S0014-5793(98)01184-3; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P8577, DOI 10.1074/jbc.M306673200; Ng EHY, 2000, HUM REPROD, V15, P772; OEHNINGER S, 1995, FERTIL STERIL, V63, P377; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKAMOTO N, 1991, AM J REPROD IMMUNOL, V26, P137, DOI 10.1111/j.1600-0897.1991.tb00713.x; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; POCKLEY AG, 1989, CLIN EXP IMMUNOL, V77, P252; Poornima BL, 2007, FEBS LETT, V581, P4366, DOI 10.1016/j.febslet.2007.07.078; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Seppala M, 2007, HUM REPROD UPDATE, V13, P275, DOI 10.1093/humupd/dmm004; Seppala M, 2004, INT J GYNECOL OBSTET, V85, P105, DOI 10.1016/j.ijgo.2004.01.007; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shiyan SD, 1997, GLYCOCONJUGATE J, V14, P631, DOI 10.1023/A:1018544711767; Skornicka EL, 2004, CELL IMMUNOL, V232, P144, DOI 10.1016/j.cellimm.2005.03.007; Sutton-Smith M, 2006, CELL BIOL LAB HDB, P415; Toscano MA, 2006, MEDICINA-BUENOS AIRE, V66, P357; TSUJI T, 1987, J BIOCHEM-TOKYO, V101, P241, DOI 10.1093/oxfordjournals.jbchem.a121897; Tulsiani DRP, 2003, MICROSC RES TECHNIQ, V61, P18, DOI 10.1002/jemt.10313; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 1999, ESSENTIALS GLYCOBIOL; WAGNER H, 1980, NATURE, V284, P278, DOI 10.1038/284278a0; Yaniv E, 2003, CELL IMMUNOL, V222, P156, DOI 10.1016/S0008-8749(03)00129-1; Yao YQ, 1998, HUM REPROD, V13, P2541, DOI 10.1093/humrep/13.9.2541; Yeung William S B, 2007, Soc Reprod Fertil Suppl, V63, P143; Yeung WSB, 2006, MOL CELL ENDOCRINOL, V250, P149, DOI 10.1016/j.mce.2005.12.038	56	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15084	15096		10.1074/jbc.M807960200	http://dx.doi.org/10.1074/jbc.M807960200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19240032	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000266288200044
J	Choi, WI; Jeon, BN; Yun, CO; Kim, PH; Kim, SE; Choi, KY; Kim, SH; Hur, MW				Choi, Won-Il; Jeon, Bu-Nam; Yun, Chae-Ok; Kim, Pyung-Hwan; Kim, Sung-Eun; Choi, Kang-Yell; Kim, Se Hoon; Hur, Man-Wook			Proto-oncogene FBI-1 Represses Transcription of p21CIP1 by Inhibition of Transcription Activation by p53 and Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN INTERACTION MOTIF; CENTER B-CELLS; ZINC-FINGER PROTEIN; NF-KAPPA-B; POZ-DOMAIN; DNA-BINDING; HISTONE DEACETYLASE; P21(WAF1/CIP1) GENE; BTB/POZ DOMAIN	Aberrant transcriptional repression through chromatin remodeling and histone deacetylation has been postulated as the driving force for tumorigenesis. FBI-1 (formerly called Pokemon) is a member of the POK family of transcriptional repressors. Recently, FBI-1 was characterized as a critical oncogenic factor that specifically represses transcription of the tumor suppressor gene ARF, potentially leading indirectly to p53 inactivation. Our investigations on transcriptional repression of the p53 pathway revealed that FBI-1 represses transcription of ARF, Hdm2 (human analogue of mouse double minute oncogene), and p21CIP1 (hereafter indicated as p21) but not of p53. FBI-1 showed a more potent repressive effect on p21 than on p53. Our data suggested that FBI-1 is a master controller of the ARF-Hdm2-p53-p21 pathway, ultimately impinging on cell cycle arrest factor p21, by inhibiting upstream regulators at the transcriptional and protein levels. FBI-1 acted as a competitive transcriptional repressor of p53 and Sp1 and was shown to bind the proximal Sp1-3 GC-box and the distal p53-responsive elements of p21. Repression involved direct binding competition of FBI-1 with Sp1 and p53. FBI-1 also interacted with corepressors, such as mSin3A, NCoR, and SMRT, thereby deacetylating Ac-H3 and Ac-H4 histones at the promoter. FBI-1 caused cellular transformation, promoted cell cycle proliferation, and significantly increased the number of cells in S phase. FBI-1 is aberrantly overexpressed in many human solid tumors, particularly in adenocarcinomas and squamous carcinomas. The role of FBI-1 as a master controller of the p53 pathway therefore makes it an attractive therapeutic target.	[Choi, Won-Il; Jeon, Bu-Nam; Hur, Man-Wook] Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Project BK21, Seoul 120752, South Korea; [Yun, Chae-Ok; Kim, Pyung-Hwan] Yonsei Univ, Sch Med, Inst Canc Res, Seoul 120752, South Korea; [Kim, Sung-Eun; Choi, Kang-Yell] Yonsei Univ, Dept Biotechnol, Seoul 120752, South Korea; [Kim, Se Hoon] Yonsei Univ, Sch Med, Dept Pathol, Seoul 120752, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Project BK21, Seoul 120752, South Korea.	mwhur2@yuhs.ac	Kim, Sung-Eun/ABC-8837-2020; Yun, Chae-Ok/P-3698-2015	Kim, Sung-Eun/0000-0001-8667-3887; Hur, Man-Wook/0000-0002-3416-1334; CHOI, WONIL/0000-0002-4837-0436; Kim, Se Hoon/0000-0001-7516-7372; Yun, Chae-Ok/0000-0002-9466-4531	National Research Laboratory Research [ROA-2003-000-10318-0]; Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology [R13-2002-054-05002-0]; Korean Ministry for Health, Welfare, and Family [00001561]	National Research Laboratory Research(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology(Korea Science and Engineering Foundation); Korean Ministry for Health, Welfare, and Family	This work was supported by National Research Laboratory Research Grant ROA-2003-000-10318-0 (to M. W. H.) and Medical Research Center Grant R13-2002-054-05002-0 (to M. W. H.) from the Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology and in part by National R & D Program for Cancer Control Affairs Grant 00001561 (to M. W. H.) from the Korean Ministry for Health, Welfare, and Family.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Baron BW, 2007, P NATL ACAD SCI USA, V104, P7449, DOI 10.1073/pnas.0701770104; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Huynh KD, 2000, GENE DEV, V14, P1810; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; KACZYNSKI J, 2004, GENOME BIOL, V4; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Laudes M, 2008, J MOL MED, V86, P597, DOI 10.1007/s00109-008-0326-2; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334	57	62	70	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12633	12644		10.1074/jbc.M809794200	http://dx.doi.org/10.1074/jbc.M809794200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19244234	hybrid, Green Published			2022-12-25	WOS:000265688300007
J	Minasov, G; Padavattan, S; Shuvalova, L; Brunzelle, JS; Miller, DJ; Basle, A; Massa, C; Collart, FR; Schirmer, T; Anderson, WF				Minasov, George; Padavattan, Sivaraman; Shuvalova, Ludmilla; Brunzelle, Joseph S.; Miller, Darcie J.; Basle, Arnaud; Massa, Claudia; Collart, Frank R.; Schirmer, Tilman; Anderson, Wayne F.			Crystal Structures of YkuI and Its Complex with Second Messenger Cyclic Di-GMP Suggest Catalytic Mechanism of Phosphodiester Bond Cleavage by EAL Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC CONTROL; ACETOBACTER-XYLINUM; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; PROTEIN; DIGUANYLATE; FOLD; BLUF; CLASSIFICATION; DIMERIZATION	Cyclic di-GMP (c-di-GMP) is a ubiquitous bacterial second messenger that is involved in the regulation of cell surface-associated traits and the persistence of infections. Omnipresent GGDEF and EAL domains, which occur in various combinations with regulatory domains, catalyze c-di-GMP synthesis and degradation, respectively. Thecrystal structure of full-length YkuI from Bacillus subtilis, composed of an EAL domain and a C-terminal PAS-like domain, has been determined in its native form and in complex with c-di-GMP and Ca2+. The EAL domain exhibits a triose-phosphate isomerase-barrel fold with one antiparallel beta-strand. The complex with c-di-GMP-Ca2+ defines the active site of the putative phosphodiesterase located at the C-terminal end of the beta-barrel. The EAL motif is part of the active site with Glu-33 of the motif being involved in cation coordination. The structure of the complex allows the proposal of a phosphodiesterase mechanism, in which the divalent cation and the general base Glu-209 activate a catalytic water molecule for nucleophilic in-line attack on the phosphorus. The C-terminal domain closely resembles the PAS-fold. Its pocket-like structure could accommodate a yet unknown ligand. YkuI forms a tight dimer via EAL-EAL and trans EAL-PAS-like domain association. The possible regulatory significance of the EAL-EAL interface and a mechanism for signal transduction between sensory and catalytic domains of c-di-GMP-specific phosphodiesterases are discussed.	[Minasov, George; Shuvalova, Ludmilla; Miller, Darcie J.; Anderson, Wayne F.] NW Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Minasov, George; Shuvalova, Ludmilla; Miller, Darcie J.; Anderson, Wayne F.] NW Feinberg Sch Med, Midwest Ctr Struct Genom, Chicago, IL 60611 USA; [Padavattan, Sivaraman; Massa, Claudia; Schirmer, Tilman] Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland; [Brunzelle, Joseph S.] Argonne Natl Lab, Adv Photon Source, LS CAT, Argonne, IL 60439 USA; [Miller, Darcie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Collart, Frank R.] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Basel; United States Department of Energy (DOE); Argonne National Laboratory; St Jude Children's Research Hospital; United States Department of Energy (DOE); Argonne National Laboratory	Schirmer, T (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.	tilman.schirmer@unibas.ch; wf-anderson@northwestern.edu		Collart, Frank/0000-0001-6942-4483; Padavattan, Sivaraman/0000-0002-1732-5421; Basle, Arnaud/0000-0002-4899-3086; Minasov, George/0000-0001-5460-3462	National Institutes of Health [U54 GM074942]; Swiss National Science Foundation [3100A0-10587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 GM074942 (Midwest Center for Structural Genomics). This work was also supported by Swiss National Science Foundation Grant 3100A0-10587.	Amiot N, 2006, SYNTHESIS-STUTTGART, P4230, DOI 10.1055/s-2006-950361; Anderson S, 2004, ACTA CRYSTALLOGR D, V60, P1008, DOI 10.1107/S090744490400616X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Hasegawa K, 2006, BIOCHEMISTRY-US, V45, P3785, DOI 10.1021/bi051820x; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEBIODA L, 1989, J BIOL CHEM, V264, P3685; LESLIE A, 1992, JOINT CCP4 ESF EACBM, V27; LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nakasone Y, 2007, J AM CHEM SOC, V129, P7028, DOI 10.1021/ja065682q; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rau A, 2001, J BIOL CHEM, V276, P31994, DOI 10.1074/jbc.M102591200; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; ROUSSEL A, 1989, SILICON GRAPHICS PAR; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schroeder C, 2008, CHEMBIOCHEM, V9, P2463, DOI 10.1002/cbic.200800280; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	54	71	74	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13174	13184		10.1074/jbc.M808221200	http://dx.doi.org/10.1074/jbc.M808221200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19244251	Green Published, hybrid			2022-12-25	WOS:000265688300064
J	Mehta, H; Glogauer, M; Becart, S; Altman, A; Coggeshall, KM				Mehta, Harshini; Glogauer, Michael; Becart, Stephane; Altman, Amnon; Coggeshall, K. Mark			Adaptor Protein SLAT Modulates Fc gamma Receptor-mediated Phagocytosis in Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; ALDRICH-SYNDROME PROTEIN; SIGNAL-TRANSDUCTION; IMMUNOLOGICAL SYNAPSE; HUMAN NEUTROPHILS; RHO GTPASES; ACTIVATION; RAC1; CDC42; CELLS	SLAT (SWAP-70-like adaptor protein of T cells) is an adaptor protein expressed in cells of the hematopoietic system. SLAT interacts with and alters the function of small GTPase Rac1 in fibroblasts. In these nonhematopoietic models, the SLAT-Rac interaction leads to changes in F-actin and causes cytoskeletal reorganization. In T cells, SLAT expression regulates the development of T helper cells through Cdc42- and Rac1-mediated activation of the NF-AT transcription factor. Here we show that SLAT is expressed in macrophages. Overexpression of SLAT in a macrophage cell line inhibits the IgG Fc gamma receptor-mediated phagocytic ability of THP1 cells. In bone marrow-derived macrophages, SLAT protein is recruited to the early phagosomes formed via Fc gamma receptor engagement. SLAT recruitment to the phagosome was most efficient when the macrophages express at least one isoform of Rac (Rac1 or Rac2), because SLAT recruitment was reduced in macrophages of Rac-deficient mice. Macrophages derived from animals lacking SLAT show an elevation in the rate of Fc gamma receptor-mediated phagocytosis. The absence of SLAT is associated with an increase in the amount of F-actin formed around these phagosomes as well as an increase in the amount of Rac1 protein recruited to the phagosome. Our results suggest that SLAT acts as a gatekeeper for the amount of Rac recruited to the phagosomes formed by Fc gamma receptor engagement and thus is able to regulate F-actin re-organization and consequently phagocytosis.	[Mehta, Harshini; Coggeshall, K. Mark] Oklahoma Med Res Fdn, Program Immunobiol & Canc, Oklahoma City, OK 73104 USA; [Mehta, Harshini; Coggeshall, K. Mark] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Glogauer, Michael] Univ Toronto, Fac Dent, Canadian Inst Hlth Res Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Becart, Stephane; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Toronto; La Jolla Institute for Immunology	Coggeshall, KM (corresponding author), Oklahoma Med Res Fdn, Program Immunobiol & Canc, 825 NE 13th St, Oklahoma City, OK 73104 USA.	coggeshallm@omrf.ouhsc.edu	Glogauer, Michael/D-2504-2011	Glogauer, Michael/0000-0002-6248-5977	National Institutes of Health [AI068320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068320 (to A.A).	Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bonilla FA, 2000, P NATL ACAD SCI USA, V97, P1725, DOI 10.1073/pnas.040543597; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Castellano F, 2000, J CELL SCI, V113, P2955; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; Coppolino MG, 2001, J CELL SCI, V114, P4307; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Duchemin AM, 1997, J IMMUNOL, V158, P865; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Lee WL, 2007, J BIOL CHEM, V282, P11135, DOI 10.1074/jbc.M700823200; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Taylor L S, 2000, Rev Immunogenet, V2, P204; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Zandman-Goddard Gisele, 2005, Clin Dev Immunol, V12, P107, DOI 10.1080/17402520500116723	51	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11882	11891		10.1074/jbc.M809712200	http://dx.doi.org/10.1074/jbc.M809712200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19251698	Green Published, hybrid			2022-12-25	WOS:000265494600020
J	Autefage, H; Albinet, V; Garcia, V; Berges, H; Nicolau, ML; Therville, N; Altie, MF; Caillaud, C; Levade, T; Andrieu-Abadie, N				Autefage, Helene; Albinet, Virginie; Garcia, Virginie; Berges, Hortense; Nicolau, Marie-Laure; Therville, Nicole; Altie, Marie-Francoise; Caillaud, Catherine; Levade, Thierry; Andrieu-Abadie, Nathalie			Lysosomal Serine Protease CLN2 Regulates Tumor Necrosis Factor-alpha-mediated Apoptosis in a Bid-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPEPTIDYL-PEPTIDASE-I; CATHEPSIN-D DEFICIENCY; CYTOCHROME-C; CELL-DEATH; OXIDATIVE STRESS; SUBUNIT C; CYSTEINE CATHEPSINS; CASPASE ACTIVATION; GENE-PRODUCT; INVOLVEMENT	Apoptosis is a highly organized, energy-dependent program by which multicellular organisms eliminate damaged, superfluous, and potentially harmful cells. Although caspases are the most prominent group of proteases involved in the apoptotic process, the role of lysosomes has only recently been unmasked. This study investigated the role of the lysosomal serine protease CLN2 in apoptosis. We report that cells isolated from patients affected with late infantile neuronal ceroid lipofuscinosis (LINCL) having a deficient activity of CLN2 are resistant to the toxic effect of death ligands such as tumor necrosis factor (TNF), CD95 ligand, or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not to receptor-independent stress agents. CLN2-deficient cells exhibited a defect in TNF-induced Bid cleavage, release of cytochrome c, and caspase-9 and -3 activation. Moreover, extracts from CLN2-overexpressing cells or a CLN2 recombinant protein were able to catalyze the in vitro cleavage of Bid. Noteworthy, correction of the lysosomal enzyme defect of LINCL fibroblasts using a medium enriched in CLN2 protein enabled restoration of TNF-induced Bid and caspase-3 processing and toxicity. Conversely, transfection of CLN2-corrected cells with small interfering RNA targeting Bid abrogated TNF-induced cell death. Altogether, our study demonstrates that genetic deletion of the lysosomal serine protease CLN2 and the subsequent loss of its catalytic function confer resistance to TNF in non-neuronal somatic cells, indicating that CLN2 plays a yet unsuspected role in TNF-induced cell death.	[Andrieu-Abadie, Nathalie] Inst Med Mol Rangueil, INSERM, U858, F-31432 Toulouse, France; [Autefage, Helene; Albinet, Virginie; Garcia, Virginie; Berges, Hortense; Nicolau, Marie-Laure; Therville, Nicole; Altie, Marie-Francoise; Levade, Thierry; Andrieu-Abadie, Nathalie] Univ Toulouse 3, Inst Med Mol Rangueil, IFR31, F-31432 Toulouse, France; [Caillaud, Catherine] Univ Paris 05, Inst Cochin Genet Mol, CNRS,UMR 8104, INSERM,U567, F-75014 Paris, France; [Levade, Thierry] CHU Toulouse, Lab Biochem Metab, F-31432 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse	Andrieu-Abadie, N (corresponding author), Inst Med Mol Rangueil, INSERM, U858, BP84225, F-31432 Toulouse, France.	nathalie.andrieu@inserm.fr	Andrieu-Abadie, Nathalie/N-6793-2013; GARCIA, Virginie/W-8313-2019; Therville, Nicole/P-2371-2014; Levade, Thierry/O-8948-2014	Andrieu-Abadie, Nathalie/0000-0003-2698-1970; GARCIA, Virginie/0000-0002-9761-7036; Therville, Nicole/0000-0002-7068-1361; 	INSERM; Universite Paul Sabatier; Association Vaincre les Maladies Lysosomales; Federation pour la Recherche sur le Cerveau; Groupement d'Interet Scientifique Institut des Maladies Rares	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paul Sabatier; Association Vaincre les Maladies Lysosomales; Federation pour la Recherche sur le Cerveau; Groupement d'Interet Scientifique Institut des Maladies Rares	This work was supported by grants from INSERM, Universite Paul Sabatier, the Association Vaincre les Maladies Lysosomales, the Federation pour la Recherche sur le Cerveau, and Groupement d'Interet Scientifique Institut des Maladies Rares.	Bernardini F, 2001, Eur J Paediatr Neurol, V5 Suppl A, P69, DOI 10.1053/ejpn.2000.0438; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Brunk UT, 1999, REDOX REP, V4, P3, DOI 10.1179/135100099101534675; Chatelut M, 1997, CLIN CHIM ACTA, V262, P61, DOI 10.1016/S0009-8981(97)06527-3; Cho SG, 2000, J NEUROCHEM, V74, P1478, DOI 10.1046/j.1471-4159.2000.0741478.x; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Emert-Sedlak L, 2005, MOL CANCER THER, V4, P733, DOI 10.1158/1535-7163.MCT-04-0301; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; Ezaki J, 1999, J NEUROCHEM, V72, P2573, DOI 10.1046/j.1471-4159.1999.0722573.x; Ezaki J, 2000, J BIOCHEM-TOKYO, V128, P509, DOI 10.1093/oxfordjournals.jbchem.a022781; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2005, GASTROENTEROLOGY, V129, P269, DOI 10.1053/j.gastro.2005.05.022; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Huc L, 2006, J CELL PHYSIOL, V208, P527, DOI 10.1002/jcp.20686; Junaid MA, 2000, J NEUROCHEM, V74, P287, DOI 10.1046/j.1471-4159.2000.0740287.x; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Kopan S, 2004, BIOCHEM BIOPH RES CO, V319, P58, DOI 10.1016/j.bbrc.2004.04.142; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Liu CG, 1998, GENOMICS, V50, P206, DOI 10.1006/geno.1998.5328; Liu MJ, 2007, BIOCHEM BIOPH RES CO, V362, P295, DOI 10.1016/j.bbrc.2007.07.118; Lyly A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-22; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MCDONALD JK, 1985, BIOCHEM BIOPH RES CO, V126, P63, DOI 10.1016/0006-291X(85)90571-6; Miao Q, 2008, J BIOL CHEM, V283, P8218, DOI 10.1074/jbc.M709789200; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Nagaraj NS, 2007, APOPTOSIS, V12, P125, DOI 10.1007/s10495-006-0490-1; Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Paris C, 2007, APOPTOSIS, V12, P1257, DOI 10.1007/s10495-007-0052-1; Puranam KL, 1999, MOL GENET METAB, V66, P294, DOI 10.1006/mgme.1999.2834; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Segal MS, 2001, AM J PHYSIOL-CELL PH, V281, pC1196, DOI 10.1152/ajpcell.2001.281.4.C1196; Shacka JJ, 2007, AUTOPHAGY, V3, P474, DOI 10.4161/auto.4341; Shimizu M, 1999, J IMMUNOL, V162, P7350; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 1999, J NEUROCHEM, V73, P700, DOI 10.1046/j.1471-4159.1999.0730700.x; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Stoka V, 2007, BIOL CHEM, V388, P555, DOI 10.1515/BC.2007.064; Tardy C, 2004, J BIOL CHEM, V279, P52914, DOI 10.1074/jbc.M408261200; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Terman A, 2002, EXP CELL RES, V274, P9, DOI 10.1006/excr.2001.5441; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Walus M, 2005, FEBS LETT, V579, P1383, DOI 10.1016/j.febslet.2005.01.035; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Zhao M, 2000, FEBS LETT, V485, P104, DOI 10.1016/S0014-5793(00)02195-5; Zhao M, 2001, FEBS LETT, V509, P405, DOI 10.1016/S0014-5793(01)03185-4	68	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11507	11516		10.1074/jbc.M807151200	http://dx.doi.org/10.1074/jbc.M807151200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19246452	hybrid, Green Published			2022-12-25	WOS:000265494500055
J	Hagen, N; Van Veldhoven, PP; Proia, RL; Park, H; Merrill, AH; van Echten-Deckert, G				Hagen, Nadine; Van Veldhoven, Paul P.; Proia, Richard L.; Park, Hyejung; Merrill, Alfred H., Jr.; van Echten-Deckert, Gerhild			Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CYCLIN D1; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID METABOLISM; POSTMITOTIC NEURONS; MOLECULAR-CLONING; KINASE TYPE-2; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; PROTEIN	Cerebellar granule cells from sphingosine 1-phosphate (S1P) lyase-deficient mice were used to study the toxicity of this potent sphingolipid metabolite in terminally differentiated postmitotic neurons. Based on earlier findings with the lyase-stable, semi-synthetic, cis-4-methylsphingosine phosphate, we hypothesized that accumulation of S1P above a certain threshold induces neuronal apoptosis. The present studies confirmed this conclusion and further revealed that for S1P to induce apoptosis in lyase-deficient neurons it must also be produced by sphingosine-kinase2 (SK2). These conclusions are based on the finding that incubation of lyase-deficient neurons with either sphingosine or S1P results in a similar elevation in cellular S1P; however, only S1P addition to the culture medium induces apoptosis. This was not due to S1P acting on the S1P receptor but to hydrolysis of S1P to sphingosine that was phosphorylated by the cells, as described before for cis-4-methylsphingosine. Although the cells produced S1P from both exogenously added sphingosine as well as sphingosine derived from exogenous S1P, the S1P from these two sources were not equivalent, because the former was primarily produced by SK1, whereas the latter was mainly formed by SK2 (as also was cis-4-methylsphingosine phosphate), based on studies in neurons lacking SK1 or SK2 activity. Thus, these investigations show that, due to the existence of at least two functionally distinct intracellular origins for S1P, exogenous S1P can be neurotoxic. In this model, S1P accumulated due to a defective lyase, however, this cause of toxicity might also be important in other cases, as illustrated by the neurotoxicity of cis-4-methylsphingosine phosphate.	[Hagen, Nadine; van Echten-Deckert, Gerhild] Univ Bonn, Kekule Inst, D-53121 Bonn, Germany; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Bonn; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	van Echten-Deckert, G (corresponding author), Univ Bonn, Kekule Inst, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	g.echten.deckert@uni-bonn.de	Proia, Richard L/A-7908-2012; , Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564; Proia, Richard/0000-0003-0456-1270; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health, NIDDK Intramural Research Program; NIH [GM069338]; Deutsche Forschungsgemeinschaft [EC 118/2-2]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0405.02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056016, ZIADK056018, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK Intramural Research Program (to R. L. P.). This work was also supported by NIH Grant GM069338 for the Sphingolipid Core of the Lipid MAPS Consortium (to A. H. M.) for the mass spectrometric analyses, the Deutsche Forschungsgemeinschaft (Grant EC 118/2-2 to G. v. E.-D.), and the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (Grant G.0405.02 to P. P. V. V.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BRACHTENDORF S, 2005, THESIS U BONN; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Long JS, 2008, BIOCHEM J, V411, P371, DOI 10.1042/BJ20071607; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala SM, 2001, PROSTAG OTH LIPID M, V64, P143, DOI 10.1016/S0090-6980(01)00111-3; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Naetzker S, 2006, GENES CELLS, V11, P269, DOI 10.1111/j.1365-2443.2006.00933.x; Natzker S, 2002, BIOL CHEM, V383, P1885, DOI 10.1515/BC.2002.212; Peest U, 2008, J CELL BIOCHEM, V104, P756, DOI 10.1002/jcb.21665; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sakai K, 1999, J NEUROSCI RES, V58, P396, DOI 10.1002/(SICI)1097-4547(19991101)58:3<396::AID-JNR5>3.3.CO;2-B; Sato K, 2007, BIOCHEM BIOPH RES CO, V359, P649, DOI 10.1016/j.bbrc.2007.05.131; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Suzuki E, 2004, P NATL ACAD SCI USA, V101, P14788, DOI 10.1073/pnas.0406536101; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Terai K, 2003, NEUROSCIENCE, V116, P1053, DOI 10.1016/S0306-4522(02)00791-1; van Echten-Deckert G, 1998, J BIOL CHEM, V273, P23585, DOI 10.1074/jbc.273.36.23585; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Van Veldhoven PP, 2005, CHEM PHYS LIPIDS, V136, P164; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Yu NC, 2004, GLIA, V45, P17, DOI 10.1002/glia.10297; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	37	75	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11346	11353		10.1074/jbc.M807336200	http://dx.doi.org/10.1074/jbc.M807336200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19251691	hybrid, Green Published			2022-12-25	WOS:000265494500039
J	Kakiashvili, E; Speight, P; Waheed, F; Seth, R; Lodyga, M; Tanimura, S; Kohno, M; Rotstein, OD; Kapus, A; Szaszi, K				Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Tanimura, Susumu; Kohno, Michiaki; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin			GEF-H1 Mediates Tumor Necrosis Factor-alpha-induced Rho Activation and Myosin Phosphorylation ROLE IN THE REGULATION OF TUBULAR PARACELLULAR PERMEABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TNF-ALPHA; TIGHT JUNCTION; EPITHELIAL BARRIER; KINASE; EXPRESSION; PATHWAY; KIDNEY; CELLS; MODULATION	Tumor necrosis factor-alpha(TNF-alpha), an inflammatory cytokine, has been shown to activate the small GTPase Rho, but the underlying signaling mechanisms remained undefined. This general problem is particularly important in the kidney, because TNF-alpha, a major mediator of kidney injury, is known to increase paracellular permeability in tubular epithelia. Here we aimed to determine the effect of TNF-alpha on the Rho pathway in tubular cells (LLC-PK1 and Madin-Darby canine kidney), define the upstream signaling, and investigate the role of the Rho pathway in the TNF-alpha-induced alterations of paracellular permeability. We show that TNF-alpha induced a rapid and sustained RhoA activation that led to stress fiber formation and Rho kinase-dependent myosin light chain (MLC) phosphorylation. To identify new regulators connecting the TNF receptor to Rho signaling, we applied an affinity precipitation assay with a Rho mutant (RhoG17A), which captures activated GDP-GTP exchange factors (GEFs). Mass spectrometry analysis of the RhoG17A-precipitated proteins identified GEF-H1 as a TNF-alpha-activated Rho GEF. Consistent with a central role of GEF-H1, its down-regulation by small interfering RNA prevented the activation of the Rho pathway. Moreover GEF-H1 and Rho activation are downstream of ERK signaling as the MEK1/2 inhibitor PD98059 mitigated TNF-alpha-induced activation of these proteins. Importantly TNF-alpha enhanced the ERK pathway-dependent phosphorylation of Thr-678 of GEF-H1 that was key for activation. Finally the TNF-alpha-induced paracellular permeability increase was absent in LLC-PK1 cells stably expressing a non-phosphorylatable, dominant negative MLC. In summary, we have identified the ERK/GEF-H1/Rho/Rho kinase/phospho-MLC pathway as the mechanism mediating TNF-alpha-induced elevation of tubular epithelial permeability, which in turn might contribute to kidney injury.	[Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Kakiashvili, Eli; Speight, Pam; Waheed, Faiza; Seth, Romy; Lodyga, Monika; Rotstein, Ori D.; Kapus, Andras; Szaszi, Katalin] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Tanimura, Susumu; Kohno, Michiaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut Sci, Lab Cell Regulat, Nagasaki 8528521, Japan	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Nagasaki University	Szaszi, K (corresponding author), St Michaels Hosp, Keenan Res Ctr, Queen Wing 7-009,30 Bond St, Toronto, ON M5B 1W8, Canada.	szaszik@smh.toronto.on.ca	Szaszi, Katalin/J-7522-2012; Kohno, Michiaki/R-6532-2019	Kohno, Michiaki/0000-0002-7644-0059; Szaszi, Katalin/0000-0002-2490-8422	Natural Sciences and Engineering Research Council of Canada (NSERC) [480619]; Banting Foundation; Kidney Foundation of Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting Foundation; Kidney Foundation of Canada	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC Grant 480619) and the Banting Foundation (to K. S.) and by the Kidney Foundation of Canada (to A. K. and K. S.).	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Biancone L, 1997, EXP NEPHROL, V5, P330; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Di Ciano-Oliveira C, 2005, AM J PHYSIOL-CELL PH, V289, pC68, DOI 10.1152/ajpcell.00631.2004; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Domnina LV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P737, DOI 10.1023/A:1016336421582; Donnahoo KK, 2001, IMMUNOLOGY, V102, P53, DOI 10.1046/j.1365-2567.2001.01141.x; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Hayashi H, 2008, GENES CELLS, V13, P941, DOI 10.1111/j.1365-2443.2008.01218.x; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; Kapus A, 2006, BIOCHEM CELL BIOL, V84, P870, DOI 10.1139/O06-202; KOHNO M, 1990, BIOCHEM J, V267, P91, DOI 10.1042/bj2670091; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Mankertz J, 2000, J CELL SCI, V113, P2085; Marano CW, 1998, J MEMBRANE BIOL, V161, P263, DOI 10.1007/s002329900333; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; MULLIN JM, 1992, AM J PHYSIOL, V263, pF915, DOI 10.1152/ajprenal.1992.263.5.F915; Mullin JM, 1997, J CELL PHYSIOL, V171, P226, DOI 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B; Navarro Juan F, 2005, Kidney Int Suppl, pS98, DOI 10.1111/j.1523-1755.2005.09918.x; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; NOIRI E, 1994, AM J PATHOL, V144, P1159; Nubel T, 2004, FASEB J, V18, P140, DOI 10.1096/fj.03-0261fje; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Papakonstanti EA, 2004, MOL BIOL CELL, V15, P1273, DOI 10.1091/mbc.E03-07-0491; Pascher A, 2005, BIODRUGS, V19, P211, DOI 10.2165/00063030-200519040-00002; Patrick David M, 2006, BMC Physiol, V6, P2, DOI 10.1186/1472-6793-6-2; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Petrache I, 2003, BIOCHEM BIOPH RES CO, V306, P244, DOI 10.1016/S0006-291X(03)00945-8; Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sato H, 2004, INT J EXP PATHOL, V85, P345, DOI 10.1111/j.0959-9673.2004.00403.x; Schmitz H, 1999, J CELL SCI, V112, P137; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Soler AP, 1999, EUR J CELL BIOL, V78, P56, DOI 10.1016/S0171-9335(99)80007-7; Szaszi K, 2005, AM J PHYSIOL-CELL PH, V289, pC673, DOI 10.1152/ajpcell.00481.2004; Turner JR, 2000, ADV DRUG DELIVER REV, V41, P265, DOI 10.1016/S0169-409X(00)00046-6; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; VandenBerg E, 2004, J CELL BIOCHEM, V91, P926, DOI 10.1002/jcb.20011; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walsh SV, 2000, ADV DRUG DELIVER REV, V41, P303, DOI 10.1016/S0169-409X(00)00048-X; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; YARD BA, 1992, KIDNEY INT, V42, P383, DOI 10.1038/ki.1992.299; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	67	81	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11454	11466		10.1074/jbc.M805933200	http://dx.doi.org/10.1074/jbc.M805933200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19261619	Green Published, hybrid			2022-12-25	WOS:000265494500050
J	Wang, EM; Cambi, F				Wang, Erming; Cambi, Franca			Heterogeneous Nuclear Ribonucleoproteins H and F Regulate the Proteolipid Protein/DM20 Ratio by Recruiting U1 Small Nuclear Ribonucleoprotein through a Complex Array of G Runs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SPLICE-SITE SELECTION; HNRNP-H; BCL-X; GENE-EXPRESSION; ENHANCER; BINDING; EXON; MYELIN; INTRON	In this study, we sought to investigate the mechanism by which heterogeneous nuclear ribonucleoprotein (hnRNP) H and F regulate proteolipid protein (PLP)/DM20 alternative splicing. G-rich sequences in exon 3B, G1 and M2, are required for hnRNPH- and F-mediated regulation of the PLP/DM20 ratio and, when placed between competing 5' splice sites in an alpha-globin minigene, direct hnRNPH/F-regulated alternative splicing. In contrast, the activity of the intronic splicing enhancer, which is necessary for PLP splicing, is only modestly reduced by removal of hnRNPH/F both in PLP and alpha-globin gene context. In vivo, hnRNPH reversed reduction of DM20 splicing induced by hnRNPH/F removal, whereas hnRNPF had little effect. Tethering of the MS2-hnRNPH fusion protein downstream of the DM20 5' splice site increased DM20 splicing, whereas MS2-hnRNPF did not. Binding of U1 small nuclear ribonucleoprotein (U1snRNP) to DM20 is greatly impaired by mutation of G1 and M2 and depletion of hnRNPH and F. Reconstitution of hnRNPH/F-depleted extracts with either hn RNPH or F restored U1snRNP binding. We conclude that hnRNPH and F regulate DM20 splicing by recruiting U1snRNP and that hnRNPH plays a primary role in DM20 splice site selection in vivo. Decreased expression of hnRNPH/F in differentiated oligodendrocytes may regulate the PLP/DM20 ratio by reducing DM20 5' splice site recognition by U1snRNP.	[Cambi, Franca] Univ Kentucky, Dept Neurol, Kentucky Clin L445, Lexington, KY 40536 USA	University of Kentucky	Cambi, F (corresponding author), Univ Kentucky, Dept Neurol, Kentucky Clin L445, Lexington, KY 40536 USA.	franca.cambi@uky.edu			National Institutes of Health [RO1NS053905]; European Leukodystrophy Association; NCRR/NIH [P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Leukodystrophy Association; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant RO1NS053905 from NINDS. This work was also supported by the European Leukodystrophy Association. The mass spectrometric analysis was performed at the University of Kentucky, Center for Structural Biology Protein Core Facility. This core facility is supported in part by funds from NCRR/NIH Grant P20 RR020171.	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Carlo T, 1996, RNA, V2, P342; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chou MY, 1999, MOL CELL BIOL, V19, P69; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kurihara T, 1997, BIOCHEM BIOPH RES CO, V237, P559, DOI 10.1006/bbrc.1997.7179; LEVINE SM, 1990, DEV NEUROSCI-BASEL, V12, P235, DOI 10.1159/000111853; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; NcNally LM, 2006, J BIOL CHEM, V281, P2478, DOI 10.1074/jbc.M511215200; NUSSINOV R, 1988, J THEOR BIOL, V133, P73, DOI 10.1016/S0022-5193(88)80025-0; NUSSINOV R, 1989, J BIOMOL STRUCT DYN, V6, P985, DOI 10.1080/07391102.1989.10506526; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang E, 2008, EXP NEUROL, V214, P322, DOI 10.1016/j.expneurol.2008.09.001	45	33	34	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11194	11204		10.1074/jbc.M809373200	http://dx.doi.org/10.1074/jbc.M809373200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19244236	Green Published, hybrid			2022-12-25	WOS:000265494500023
J	Thomas, WD; Chen, J; Gao, YR; Cheung, B; Koach, J; Sekyere, E; Norris, MD; Haber, M; Ellis, T; Wainwright, B; Marshall, GM				Thomas, W. D.; Chen, J.; Gao, Y. R.; Cheung, B.; Koach, J.; Sekyere, E.; Norris, M. D.; Haber, M.; Ellis, T.; Wainwright, B.; Marshall, G. M.			Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression	ONCOGENE			English	Article						N-Myc; PP2A-B56; Sonic Hedgehog; medulloblastoma; initiation; Myc	HEDGEHOG-INDUCED MEDULLOBLASTOMA; EXTERNAL GRANULAR LAYER; C-MYC; SONIC HEDGEHOG; GENE-EXPRESSION; NEURONAL PRECURSORS; MICE; PROLIFERATION; CEREBELLUM; PATHWAY	Medulloblastoma tumorigenesis caused by inactivating mutations in the PATCHED1 (PTCH1) gene is initiated by persistently activated Sonic Hedgehog (Shh) signaling in granule neuron precursors (GNPs) during the late stages of cerebellar development. Both normal cerebellar development and Shh-driven medulloblastoma tumorigenesis require N-Myc expression. However, the mechanisms by which N-Myc affects the stages of medulloblastoma initiation and progression are unknown. Here we used a mouse model of Ptch1 heterozygosity and medulloblastoma to show that increased N-Myc expression characterized the earliest selection of focal GNP hyperplasia destined for later tumor progression. Step-wise loss of Ptch1 expression, from tumor initiation to progression, led to incremental increases in N-Myc protein, rather than mRNA, expression. Increased N-Myc resulted in enhanced proliferation and death resistance of perinatal GNPs at tumor initiation. Sequential N-Myc protein phosphorylation at serine-62 and serine-62/threonine-58 characterized the early and late stages of medulloblastoma tumorigenesis, respectively. Shh pathway activation led to increased Myc protein stability and reduced expression of key regulatory factors. Taken together our data identify N-Myc protein stability as the result of loss of Ptch1, which distinguishes normal cerebellar development from medulloblastoma tumorigenesis.	[Marshall, G. M.] Childrens Canc Inst Australia Med Res, Mol Carcinogenesis Program, Randwick, NSW 2031, Australia; [Ellis, T.; Wainwright, B.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Marshall, G. M.] Prince Wales Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Randwick, NSW 2031, Australia	Children's Cancer Institute; University of Queensland	Marshall, GM (corresponding author), Childrens Canc Inst Australia Med Res, Mol Carcinogenesis Program, POB 81, Randwick, NSW 2031, Australia.	Glenn.Marshall@SESIAHS.HEALTH.NSW.GOV.AU	Chen, Jinbiao/J-5868-2013; Chen, Jinbiao/N-9905-2019	Chen, Jinbiao/0000-0003-0339-5880; Chen, Jinbiao/0000-0003-0339-5880; Haber, Michelle/0000-0003-2036-8817; Wainwright, Brandon/0000-0003-0406-2092; Norris, Murray/0000-0002-0632-4589; Cheung, Belamy/0000-0001-8784-860X	Cure For Life Foundation; Cure Cancer Australia Foundation; National Health and Medical Research Council; Cancer Institute New South Wales; John Trivett Foundation; The Children's Cancer Institute Australia; University of New South Wales; Sydney Children's Hospital	Cure For Life Foundation; Cure Cancer Australia Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; John Trivett Foundation; The Children's Cancer Institute Australia; University of New South Wales; Sydney Children's Hospital	This work was supported by funds from the Cure For Life Foundation (WT), the Cure Cancer Australia Foundation (WT), the National Health and Medical Research Council (Australia; GMM, MDN, BW and MH), the Cancer Institute New South Wales (Australia; GMM, MDN and MH) and John Trivett Foundation (TE). The Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Barnes EA, 2005, ONCOGENE, V24, P902, DOI 10.1038/sj.onc.1208240; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Browd SR, 2006, CANCER RES, V66, P2666, DOI 10.1158/0008-5472.CAN-05-2198; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dang CV, 1999, MOL CELL BIOL, V19, P1; Eberhart CG, 2004, J NEUROPATH EXP NEUR, V63, P441, DOI 10.1093/jnen/63.5.441; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsher DW, 2008, CANCER RES, V68, P3081, DOI 10.1158/0008-5472.CAN-07-5832; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; Fogarty MP, 2005, J NEUROBIOL, V64, P458, DOI 10.1002/neu.20166; GARSON JA, 1989, BRIT J CANCER, V59, P889, DOI 10.1038/bjc.1989.188; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haber M, 1999, ONCOGENE, V18, P2777, DOI 10.1038/sj.onc.1202859; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; KADIN ME, 1970, J NEUROPATH EXP NEUR, V29, P583, DOI 10.1097/00005072-197010000-00005; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim JYH, 2003, DEV BIOL, V263, P50, DOI 10.1016/S0012-1606(03)00434-2; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOPPEL H, 1983, NEUROPATH APPL NEURO, V9, P207, DOI 10.1111/j.1365-2990.1983.tb00108.x; Lelievre V, 2008, DEV BIOL, V313, P359, DOI 10.1016/j.ydbio.2007.10.031; Lossi L, 2003, PROG NEUROBIOL, V69, P287, DOI 10.1016/S0301-0082(03)00051-0; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Moriuchi S, 1996, ANTICANCER RES, V16, P2687; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pizzo P.A., 2002, PRINCIPLES PRACTICE, V4th; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Pritchard JI, 2008, CANCER GENET CYTOGEN, V180, P47, DOI 10.1016/j.cancergencyto.2007.09.008; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; RUIZ IAA, 2004, CANC LETT, V204, P145; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Smith DP, 2006, BLOOD, V108, P653, DOI 10.1182/blood-2006-01-0172; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wechsler-Reya RJ, 2003, RECENT PROG HORM RES, V58, P227, DOI 10.1210/rp.58.1.227; Wetmore C, 2000, CANCER RES, V60, P2239; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; ZAKHARY R, 2001, BRAIN TUMORS ENCY AP, P605	57	36	37	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2009	28	13					1605	1615		10.1038/onc.2009.3	http://dx.doi.org/10.1038/onc.2009.3			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	427LJ	19234491				2022-12-25	WOS:000264780500005
J	Takishita, K; Yamaguchi, H; Maruyama, T; Inagaki, Y				Takishita, Kiyotaka; Yamaguchi, Haruyo; Maruyama, Tadashi; Inagaki, Yuji			A Hypothesis for the Evolution of Nuclear-Encoded, Plastid-Targeted Glyceraldehyde-3-Phosphate Dehydrogenase Genes in "Chromalveolate" Members	PLOS ONE			English	Article								Eukaryotes bearing red alga-derived plastids - photosynthetic alveolates (dinoflagellates plus the apicomplexan Toxoplasma gondii plus the chromerid Chromera velia), photosynthetic stramenopiles, haptophytes, and cryptophytes possess unique plastid-targeted glyceraldehyde-3-phosphate dehydrogenases (henceforth designated as "GapC1"). Pioneering phylogenetic studies have indicated a single origin of the GapC1 enzymes in eukaryotic evolution, but there are two potential idiosyncrasies in the GapC1 phylogeny: Firstly, the GapC1 tree topology is apparently inconsistent with the organismal relationship among the "GapC1-containing" groups. Secondly, four stramenopile GapC1 homologues are consistently paraphyletic in previously published studies, although these organisms have been widely accepted as monophyletic. For a closer examination of the above issues, in this study GapC1 gene sampling was improved by determining/identifying nine stramenopile and two cryptophyte genes. Phylogenetic analyses of our GapC1 dataset, which is particularly rich in the stramenopile homologues, prompt us to propose a new scenario that assumes multiple, lateral GapC1 gene transfer events to explain the incongruity between the GapC1 phylogeny and the organismal relationships amongst the "GapC1-containing" groups. Under our new scenario, GapC1 genes uniquely found in photosynthetic alveolates, photosynthetic stramenopiles, haptophytes, and cryptopyhytes are not necessarily a character vertically inherited from a common ancestor.	[Takishita, Kiyotaka; Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kanagawa, Japan; [Yamaguchi, Haruyo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 305, Japan; [Inagaki, Yuji] Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tsukuba; University of Tsukuba; University of Tsukuba	Takishita, K (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kanagawa, Japan.	takishitak@jamstec.go.jp		Inagaki, Yuji/0000-0003-0101-8483	Study for Understanding of Function and Structure of the Marine Ecosystems in the Earth Systems of JAMSTEC	Study for Understanding of Function and Structure of the Marine Ecosystems in the Earth Systems of JAMSTEC	This work was supported by the project 'Study for Understanding of Function and Structure of the Marine Ecosystems in the Earth Systems' of JAMSTEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Ben Ali A, 2002, PROTIST, V153, P123, DOI 10.1078/1434-4610-00091; Bodyl A, 2005, J PHYCOL, V41, P712, DOI 10.1111/j.1529-8817.2005.00091.x; Bodyl A, 2006, EUR J PHYCOL, V41, P435, DOI 10.1080/09670260600961080; BRINKMANN H, 1989, PLANT MOL BIOL, V13, P81, DOI 10.1007/BF00027337; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Fagan T, 1998, J MOL EVOL, V47, P633, DOI 10.1007/PL00006420; Fast NM, 2002, J EUKARYOT MICROBIOL, V49, P30, DOI 10.1111/j.1550-7408.2002.tb00336.x; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Figge RM, 1999, MOL BIOL EVOL, V16, P429, DOI 10.1093/oxfordjournals.molbev.a026125; Figge RM, 2001, MOL BIOL EVOL, V18, P2240, DOI 10.1093/oxfordjournals.molbev.a003770; Grauvogel C, 2007, J MOL EVOL, V65, P725, DOI 10.1007/s00239-007-9053-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Harper JT, 2005, INT J SYST EVOL MICR, V55, P487, DOI 10.1099/ijs.0.63216-0; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Iida K, 2007, MOL PHYLOGENET EVOL, V45, P227, DOI 10.1016/j.ympev.2007.05.003; Liaud MF, 1997, J MOL EVOL, V44, pS28, DOI 10.1007/PL00000050; LIAUD MF, 1994, J MOL EVOL, V38, P319, DOI 10.1007/BF00163149; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; Matsuzaki M, 2008, MOL BIOL EVOL, V25, P1167, DOI 10.1093/molbev/msn064; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Nosenko T, 2006, MOL BIOL EVOL, V23, P2026, DOI 10.1093/molbev/msl074; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Puerta MV, 2008, J PHYCOL, V44, P1097, DOI 10.1111/j.1529-8817.2008.00559.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; TAKISHITA K, 2008, GENE IN PRESS   0310, DOI DOI 10.1016/J.GENE.2008.03.001; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P163, DOI 10.1016/j.ejop.2007.02.002; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2009	4	3							e4737	10.1371/journal.pone.0004737	http://dx.doi.org/10.1371/journal.pone.0004737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OD	19270733	Green Published, Green Submitted, gold			2022-12-25	WOS:000265495900006
J	Hirata, M; Kugimiya, F; Fukai, A; Ohba, S; Kawamura, N; Ogasawara, T; Kawasaki, Y; Saito, T; Yano, F; Ikeda, T; Nakamura, K; Chung, UI; Kawaguchi, H				Hirata, Makoto; Kugimiya, Fumitaka; Fukai, Atsushi; Ohba, Shinsuke; Kawamura, Naohiro; Ogasawara, Toru; Kawasaki, Yosuke; Saito, Taku; Yano, Fumiko; Ikeda, Toshiyuki; Nakamura, Kozo; Chung, Ung-Il; Kawaguchi, Hiroshi			C/EBP beta Promotes Transition from Proliferation to Hypertrophic Differentiation of Chondrocytes through Transactivation of p57(Kip2)	PLOS ONE			English	Article								Background: Although transition from proliferation to hypertrophic differentiation of chondrocytes is a crucial step for endochondral ossification in physiological skeletal growth and pathological disorders like osteoarthritis, the underlying mechanism remains an enigma. This study investigated the role of the transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta) in chondrocytes during endochondral ossification. Methodology/Principal Findings: Mouse embryos with homozygous deficiency in C/EBP beta (C/EBP beta-/-) exhibited dwarfism with elongated proliferative zone and delayed chondrocyte hypertrophy in the growth plate cartilage. In the cultures of primary C/EBP beta-/- chondrocytes, cell proliferation was enhanced while hypertrophic differentiation was suppressed. Contrarily, retroviral overexpression of C/EBP beta in chondrocytes suppressed the proliferation and enhanced the hypertrophy, suggesting the cell cycle arrest by C/EBP beta. In fact, a DNA cell cycle histogram revealed that the C/EBP beta overexpression caused accumulation of cells in the G0/G1 fraction. Among cell cycle factors, microarray and real-time RT-PCR analyses have identified the cyclin-dependent kinase inhibitor p57(Kip2) as the transcriptional target of C/EBP beta. p57(Kip2) was co-localized with C/EBP beta in late proliferative and pre-hypertrophic chondrocytes of the mouse growth plate, which was decreased by the C/EBP beta deficiency. Luciferase-reporter and electrophoretic mobility shift assays identified the core responsive element of C/EBP beta in the p57(Kip2) promoter between -150 and -130 bp region containing a putative C/EBP motif. The knockdown of p57(Kip2) by the siRNA inhibited the C/EBP beta-induced chondrocyte hypertrophy. Finally, when we created the experimental osteoarthritis model by inducing instability in the knee joints of adult mice of wild-type and C/EBP beta+/- littermates, the C/EBP beta insufficiency caused resistance to joint cartilage destruction. Conclusions/Significance: C/EBPb transactivates p57(Kip2) to promote transition from proliferation to hypertrophic differentiation of chondrocytes during endochondral ossification, suggesting that the C/EBP beta-p57(Kip2) signal would be a therapeutic target of skeletal disorders like growth retardation and osteoarthritis.	[Hirata, Makoto; Kugimiya, Fumitaka; Fukai, Atsushi; Kawamura, Naohiro; Ogasawara, Toru; Kawasaki, Yosuke; Saito, Taku; Ikeda, Toshiyuki; Nakamura, Kozo; Chung, Ung-Il; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory Motor Syst Med, Tokyo 113, Japan; [Ohba, Shinsuke; Yano, Fumiko] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Hirata, M (corresponding author), Univ Tokyo, Fac Med, Dept Sensory Motor Syst Med, Tokyo 113, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Kawamura, Naohiro/J-8372-2019; Ikeda, Toshiyuki/GVS-5588-2022; Ogasawara, Toru/I-1629-2014	Ohba, Shinsuke/0000-0002-6874-8539; Ogasawara, Toru/0000-0002-2996-081X	Japanese Ministry of Education, Culture, Sports, Science, and Technology [19109007]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#19109007). The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Darlington GJ, 1999, CURR OPIN CELL BIOL, V11, P678, DOI 10.1016/S0955-0674(99)00035-6; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Imamura T, 2005, J BIOL CHEM, V280, P16625, DOI 10.1074/jbc.M411469200; Imamura T, 2008, ARTHRITIS RHEUM-US, V58, P1366, DOI 10.1002/art.23438; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kawaguchi H, 2008, MOL CELLS, V25, P1; Kawasaki H, 2003, NUCLEIC ACIDS RES, V31, P700, DOI 10.1093/nar/gkg158; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li H, 2007, CELL MOL IMMUNOL, V4, P407; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; LuValle P, 2000, FRONT BIOSCI-LANDMRK, V5, pD493, DOI 10.2741/LuValle; MacLean HE, 2004, J CLIN INVEST, V113, P1334, DOI 10.1172/JCI200421252; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Meergans T, 1998, EUR J BIOCHEM, V256, P436, DOI 10.1046/j.1432-1327.1998.2560436.x; Mizui Y, 2000, MOL BIOL REP, V27, P167, DOI 10.1023/A:1007253930568; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moro T, 2005, J CELL PHYSIOL, V204, P927, DOI 10.1002/jcp.20350; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Raymond L, 2006, J CELL PHYSIOL, V207, P683, DOI 10.1002/jcp.20608; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; Rossi F, 2002, DEV BIOL, V247, P271, DOI 10.1006/dbio.2002.0691; Schlossmann J, 2005, DRUG DISCOV TODAY, V10, P627, DOI 10.1016/S1359-6446(05)03406-9; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Thomas B, 2000, EUR J BIOCHEM, V267, P6798, DOI 10.1046/j.1432-1327.2000.01778.x; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhao Qi-jin, 2005, Journal of Shanghai Jiaotong University (English Edition), VE-10, P280	59	73	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4543	10.1371/journal.pone.0004543	http://dx.doi.org/10.1371/journal.pone.0004543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229324	gold, Green Submitted, Green Published			2022-12-25	WOS:000265486200014
